UserInput	UniProtAcc	GeneName	UniProtID	Mutation	HMMpos	Region	PTM	KnownADR	NeighSites	AILDRvN	AILDvN	AIvNLD	AIvN	LDvNAI	LDvN	AIvLD	RvN	Type	Note	Pubmed	n_PMIDs
O00141/A342V	O00141	SGK1	SGK1_HUMAN	A342V	805	αI	-	-	TKRLGaDDFME	0.196	0.233	0.558	0.274	0.15	0.144	0.724	0.188	VARIANT	A -> V (in dbSNP:rs55932330)	17344846	1
O00141/K127M	O00141	SGK1	SGK1_HUMAN	K127M	129	β3;Catalytic-Lys	-	loss	VFYAVkLQKKA	1.0	1.0	0.025	0.635	1.0	0.998	0.02	0.512	MUTAGEN	K->M: Abolishes enzymatic activity.	11696533,12911626,15040001	3
O00141/S422A	O00141	SGK1	SGK1_HUMAN	S422A	-	-	p	decrease	AFLGFsAPPTD									MUTAGEN	S->A: Low activity.	10191262,11696533,12911626,15040001	4
O00141/S422D	O00141	SGK1	SGK1_HUMAN	S422D	-	-	p	increase	AFLGFsAPPTD									MUTAGEN	S->D: 10-fold activation.	10191262,11696533,12911626,15040001	4
O00141/T256A	O00141	SGK1	SGK1_HUMAN	T256A	545	A-loop	p	decrease	NSTTStCGTPE	0.993	1.0	0.161	0.936	0.944	0.988	0.183	0.376	MUTAGEN	T->A: Low activity.	10191262	1
O00141/T256D	O00141	SGK1	SGK1_HUMAN	T256D	545	A-loop	p	decrease	NSTTStCGTPE	0.984	1.0	0.876	0.99	0.23	0.95	0.862	0.371	MUTAGEN	T->D: Low activity.	10191262	1
O00141/T256E	O00141	SGK1	SGK1_HUMAN	T256E	545	A-loop	p	decrease	NSTTStCGTPE	0.984	0.986	0.871	0.984	0.349	0.972	0.836	0.384	MUTAGEN	T->E: Low activity.	10191262	1
O00141/V219I	O00141	SGK1	SGK1_HUMAN	V219I	440	Catalytic-loop	-	-	HSLNIvRDLKP	0.164	0.141	0.445	0.163	0.114	0.144	0.607	0.123	VARIANT	V -> I (in dbSNP:rs34133418)	17344846	1
O00141/Y298A	O00141	SGK1	SGK1_HUMAN	Y298A	623	αF/αG	-	decrease	GLPPFyRNTAE	0.938	0.877	0.311	0.657	0.818	0.863	0.229	0.708	MUTAGEN	Y->A: Abolishes interaction with NEDD4 and NEDD4L.	11696533	1
O00238/C53R	O00238	BMPR1B	BMR1B_HUMAN	C53R	-	-	-	loss	STDGYcTMIEE									VARIANT	C -> R (in AMD3; mouse BMPR1B construct containing this mutation shows loss of GDF5-dependent receptor activation, chicken BMPR1B construct containing this mutation does not show reduced chondrocyte differentiation, mouse BMPR1B construct containing this mutation shows no loss of cell membrane localization; dbSNP:rs863225041)	24129431	1
O00238/D297N	O00238	BMPR1B	BMR1B_HUMAN	D297N	301	αD/αE-loop	-	-	KSTTLdKSMLK	0.167	0.185	0.456	0.202	0.172	0.159	0.661	0.107	VARIANT	D -> N (in a metastatic melanoma sample; somatic mutation)	17344846	1
O00238/I200K	O00238	BMPR1B	BMR1B_HUMAN	I200K	25	N-term-β1	-	loss	LVQRTiKQIQM	0.835	0.784	0.387	0.662	0.693	0.798	0.41	0.638	VARIANT	I -> K (in BDA2; in animal models loss of kinase activity and loss of positive regulation of chondrocyte differentiation; dbSNP:rs121434417)	14523231	1
O00238/K325N	O00238	BMPR1B	BMR1B_HUMAN	K325N	435	Catalytic-loop	-	-	FSTQGkAIAHR	0.682	0.645	0.463	0.544	0.431	0.585	0.517	0.343	VARIANT	K -> N (in BDA1D; acts in a dominant-negative manner; dbSNP:rs869025614)	25758993	1
O00238/R149W	O00238	BMPR1B	BMR1B_HUMAN	R149W	-	-	-	-	LFCYFrKRQET									VARIANT	R -> W (in dbSNP:rs34231464)	17344846	1
O00238/R224H	O00238	BMPR1B	BMR1B_HUMAN	R224H	101	β2/β3-loop	-	-	WMGKWrEKVAV	0.282	0.265	0.51	0.348	0.14	0.148	0.7	0.124	VARIANT	R -> H (in dbSNP:rs35973133)	17344846	1
O00238/R31C	O00238	BMPR1B	BMR1B_HUMAN	R31C	-	-	-	decrease	RPKVLrKCHHH									VARIANT	R -> C (in AMD3; unknown pathological significance; mouse BMPR1B construct containing this mutation shows reduced GDF5-dependent receptor activation, mouse BMPR1B construct containing this mutation shows no loss of cell membrane localization; dbSNP:rs745854387)	26105076	1
O00238/R31H	O00238	BMPR1B	BMR1B_HUMAN	R31H	-	-	-	-	RPKVLrKCHHH									VARIANT	R -> H (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs200035802)	17344846	1
O00238/R371Q	O00238	BMPR1B	BMR1B_HUMAN	R371Q	539	A-loop	-	-	IPPNTrGTKRY	0.198	0.17	0.435	0.218	0.191	0.204	0.6	0.112	VARIANT	R -> Q (in dbSNP:rs34970181)	17344846	1
O00238/R486Q	O00238	BMPR1B	BMR1B_HUMAN	R486Q	805	αI	-	-	RLTALrKKTLA	0.487	0.456	0.575	0.443	0.244	0.315	0.723	0.22	VARIANT	R -> Q (in brachydactyly type C and BDA2; with also additional features of symphalangism-1; dbSNP:rs121434419)	16957682	1
O00238/R486W	O00238	BMPR1B	BMR1B_HUMAN	R486W	805	αI	-	-	RLTALrKKTLA	0.744	0.667	0.501	0.598	0.561	0.625	0.496	0.389	VARIANT	R -> W (in BDA2; in animal models no effect on kinase activity but strongly decreased positive regulation of chondrocyte differentiation; dbSNP:rs121434418)	14523231	1
O00311/E209D	O00311	CDC7	CDC7_HUMAN	E209D	-	-	-	-	HDTKIeLKFVQ									VARIANT	E -> D (in dbSNP:rs56327502)	17344846	1
O00311/F162L	O00311	CDC7	CDC7_HUMAN	F162L	411	αE	-	neutral	YMLNLfALKRI	0.187	0.142	0.518	0.261	0.117	0.108	0.722	0.167	VARIANT	F -> L (in dbSNP:rs13447503)	17344846	1
O00311/G112W	O00311	CDC7	CDC7_HUMAN	G112W	184	αC/β4-loop	-	-	CLTVAgQDNVM	0.74	0.758	0.543	0.573	0.593	0.641	0.562	0.287	VARIANT	G -> W (in dbSNP:rs13447493)		0
O00311/I208M	O00311	CDC7	CDC7_HUMAN	I208M	-	-	-	-	THDTKiLLKFV									VARIANT	I -> M (in dbSNP:rs34979509)	17344846	1
O00311/I99V	O00311	CDC7	CDC7_HUMAN	I99V	168	αC	-	-	PTSHPiIAAEL	0.129	0.154	0.491	0.243	0.12	0.109	0.704	0.071	VARIANT	I -> V (in dbSNP:rs13447492)		0
O00311/K441R	O00311	CDC7	CDC7_HUMAN	K441R	683	αG/αH	ub	neutral	TIQAAkFGKSI	0.281	0.229	0.45	0.303	0.129	0.204	0.664	0.114	VARIANT	K -> R (in dbSNP:rs13447539)	17344846	1
O00311/Q23P	O00311	CDC7	CDC7_HUMAN	Q23P	-	-	-	-	QRDRFqEGSLK									VARIANT	Q -> P (in dbSNP:rs13447459)		0
O00311/S498A	O00311	CDC7	CDC7_HUMAN	S498A	740	αG/αH	-	-	TDHKAsLVQTP	0.14	0.236	0.398	0.121	0.24	0.212	0.539	0.111	VARIANT	S -> A (in dbSNP:rs35055915)	17344846	1
O00311/T472I	O00311	CDC7	CDC7_HUMAN	T472I	714	αG/αH	p	-	GMDSStKLTSD	0.524	0.553	0.469	0.538	0.246	0.326	0.602	0.125	VARIANT	T -> I (in dbSNP:rs56381770)	17344846	1
O00418/D609H	O00418	EEF2K	EF2K_HUMAN	D609H	-	-	-	-	AAEAGdQSMIL									VARIANT	D -> H	17344846	1
O00418/H23R	O00418	EEF2K	EF2K_HUMAN	H23R	-	-	-	neutral	SPRAGhGDSDG									VARIANT	H -> R (in dbSNP:rs9935059)	15489334,17344846	2
O00418/P75A	O00418	EEF2K	EF2K_HUMAN	P75A	-	-	-	neutral	SSSGSpNSFHF									VARIANT	P -> A (in dbSNP:rs17841292)	17344846	1
O00418/Q361R	O00418	EEF2K	EF2K_HUMAN	Q361R	-	-	-	-	KCGSPqRTLSG									VARIANT	Q -> R (in dbSNP:rs4783453)	15489334,9144159	2
O00418/R433W	O00418	EEF2K	EF2K_HUMAN	R433W	-	-	-	-	HLDNHrSENSG									VARIANT	R -> W (in dbSNP:rs56137739)	17344846	1
O00418/S366A	O00418	EEF2K	EF2K_HUMAN	S366A	-	-	p	decrease	QVRTLsSRPPL									MUTAGEN	S->A: Decreased kinase activity.	11500364,22216903	2
O00418/S78A	O00418	EEF2K	EF2K_HUMAN	S78A	-	-	p	decrease	GSPANsHFKEA									MUTAGEN	S->A: Decreased kinase activity.	22216903	1
O00418/T291M	O00418	EEF2K	EF2K_HUMAN	T291M	-	-	-	-	QIHTEtTDFGD									VARIANT	T -> M (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs147978363)	17344846	1
O00418/T348A	O00418	EEF2K	EF2K_HUMAN	T348A	-	-	p	decrease	LQSAKtLRGTE									MUTAGEN	T->A: Decreased kinase activity.	22216903	1
O00444/A226T	O00444	PLK4	PLK4_HUMAN	A226T	673	αG/αH	-	-	NKVVLaYEMPS	0.088	0.088	0.475	0.097	0.066	0.075	0.71	0.077	VARIANT	A -> T (in dbSNP:rs35448573)	17344846	1
O00444/D154A	O00444	PLK4	PLK4_HUMAN	D154A	496	A-loop;DFG-motif	-	loss	NIKIAdGLATQ	0.996	0.981	0.101	0.529	0.988	0.959	0.05	0.699	MUTAGEN	D->A: Catalytically inactive mutant that causes some centrosome amplification above background levels when overexpressed.	16244668	1
O00444/E830D	O00444	PLK4	PLK4_HUMAN	E830D	-	-	-	neutral	NYPTReASFNR									VARIANT	E -> D (in dbSNP:rs17012739)	11489907,14702039,17344846	3
O00444/I670P	O00444	PLK4	PLK4_HUMAN	I670P	-	-	-	-	SPTDNiRYSFD									MUTAGEN	I->P: Decreases substantially the interaction with TENT5C. Does not affect localization to the centrosome. Loss of TENT5C recruitment to the centrosome.	32433990	1
O00444/K41M	O00444	PLK4	PLK4_HUMAN	K41M	129	β3;Catalytic-Lys	-	loss	LEVAIkIDKKA	0.999	1.0	0.015	0.638	0.995	0.998	0.019	0.525	MUTAGEN	K->M: Abolishes ability to phosphorylate CDC25C and CHEK2.	18239451,19164942	2
O00444/N449D	O00444	PLK4	PLK4_HUMAN	N449D	-	-	-	-	FERPDnQALSN									VARIANT	N -> D (in dbSNP:rs34906574)	17344846	1
O00444/N669R	O00444	PLK4	PLK4_HUMAN	N669R	-	-	-	-	PSPTDnSRYSF									MUTAGEN	N->R: Does not affect the interaction with TENT5C.	32433990	1
O00444/P317L	O00444	PLK4	PLK4_HUMAN	P317L	-	-	-	-	LLIGQpPNKMT									VARIANT	P -> L (in dbSNP:rs35049837)	17344846	1
O00444/R146H	O00444	PLK4	PLK4_HUMAN	R146H	456	Catalytic-loop	-	-	NLLLTrMNIKI	0.132	0.151	0.416	0.116	0.109	0.136	0.624	0.084	VARIANT	R -> H (in dbSNP:rs35232579)	17344846	1
O00444/S232T	O00444	PLK4	PLK4_HUMAN	S232T	683	αG/αH	-	neutral	DYEMPsLSIEA	0.082	0.105	0.368	0.095	0.122	0.141	0.565	0.068	VARIANT	S -> T (in dbSNP:rs3811740)	11489907,14702039,17344846	3
O00444/T170D	O00444	PLK4	PLK4_HUMAN	T170D	545	A-loop	p	activating	HEKHYtCGTPN	0.999	0.992	0.861	0.99	0.137	0.964	0.866	0.44	MUTAGEN	T->D: Activating mutant.	18239451,19164942	2
O00444/W519S	O00444	PLK4	PLK4_HUMAN	W519S	-	-	-	neutral	TSKNAwDTKVK									VARIANT	W -> S (in dbSNP:rs56043017)	17344846	1
O00444/Y86C	O00444	PLK4	PLK4_HUMAN	Y86C	243	β5	-	-	DSNYVyVLEMC	0.784	0.7	0.479	0.676	0.438	0.567	0.499	0.36	VARIANT	Y -> C (in dbSNP:rs34156294)	17344846	1
O00506/D158A	O00506	STK25	STK25_HUMAN	D158A	496	A-loop;DFG-motif	-	loss	DVKLAdGVAGQ	0.991	0.999	0.068	0.516	0.994	0.968	0.03	0.715	MUTAGEN	D->A: Loss of kinase activity.	15037601	1
O00506/K49R	O00506	STK25	STK25_HUMAN	K49R	129	β3;Catalytic-Lys	-	loss	EVVAIkIDLEE	1.0	0.993	0.026	0.709	0.994	0.999	0.012	0.489	MUTAGEN	K->R: Loss of kinase activity and autophosphorylation.	15037601	1
O00506/Q64H	O00506	STK25	STK25_HUMAN	Q64H	171	αC	-	-	EIEDIqEITVL	0.453	0.42	0.598	0.453	0.309	0.3	0.727	0.248	VARIANT	Q -> H (in dbSNP:rs34341643)		0
O14578/D230V	O14578	CIT	CTRO_HUMAN	D230V	452	Catalytic-loop	-	decrease	ENILVdTGHIK	0.782	0.736	0.548	0.631	0.453	0.645	0.58	0.586	VARIANT	D -> V (in MCPH17; impairs kinase activity; exhibits abnormal mitotic cytokinesis; exhibits multipolar spindles; increases the neurons apoptotic process; dbSNP:rs886037894)	27453578	1
O14578/G106V	O14578	CIT	CTRO_HUMAN	G106V	42	β1;Gly-rich-loop	-	decrease	SLVGCgFAEVQ	0.91	0.865	0.374	0.626	0.81	0.844	0.376	0.415	VARIANT	G -> V (in MCPH17; impairs kinase activity; exhibits abnormal mitotic cytokinesis; exhibits multipolar spindles; increases the neurons apoptotic process; dbSNP:rs886037892)	27453578	1
O14578/G7E	O14578	CIT	CTRO_HUMAN	G7E	-	-	-	neutral	LKFKYgRNPLD									VARIANT	G -> E (in dbSNP:rs36054900)	17344846	1
O14578/K126Q	O14578	CIT	CTRO_HUMAN	K126Q	129	β3;Catalytic-Lys	-	decrease	DIYAMkMKKKA	0.995	0.996	0.08	0.643	0.972	0.994	0.049	0.391	VARIANT	K -> Q (in MCPH17; impairs kinase activity; exhibits abnormal mitotic cytokinesis; exhibits multipolar spindles; increases the neurons apoptotic process; dbSNP:rs886037893)	27453578	1
O14578/L183F	O14578	CIT	CTRO_HUMAN	L183F	265	αD	-	-	PGGDLlLLNRY	0.33	0.255	0.55	0.264	0.149	0.221	0.656	0.344	VARIANT	L -> F	17344846	1
O14578/R9Q	O14578	CIT	CTRO_HUMAN	R9Q	-	-	-	neutral	FKYGArPLDAG									VARIANT	R -> Q (in dbSNP:rs56193743)	17344846	1
O14730/K290A	O14730	RIOK3	RIOK3_HUMAN	K290A	-	-	ub	loss	TECAIkFKTTL									MUTAGEN	K->A: Decreases autophosphorylation (in vitro); abolishes inhibition of TNF-alpha-induced NF-kappaB activation; no effect on interaction with IRF3; fails to activate IFN-beta promoter and IRF3 phosphorylation.	19557502,24807708	2
O14730/L336V	O14730	RIOK3	RIOK3_HUMAN	L336V	-	-	-	-	KEMHNlRMQRA									VARIANT	L -> V (in dbSNP:rs35401850)	17344846	1
O14730/R441Q	O14730	RIOK3	RIOK3_HUMAN	R441Q	-	-	-	-	LEFLFrCRNVS									VARIANT	R -> Q (in dbSNP:rs33969048)	17344846	1
O14730/S447L	O14730	RIOK3	RIOK3_HUMAN	S447L	-	-	-	neutral	DCRNVsFFQKG									VARIANT	S -> L (in dbSNP:rs56282762)	17344846	1
O14733/A195T	O14733	MAP2K7	MP2K7_HUMAN	A195T	247	β5	-	-	TDVFIaELMGT	0.339	0.363	0.545	0.295	0.251	0.253	0.677	0.111	VARIANT	A -> T (in dbSNP:rs55800262)	17344846	1
O14733/L259F	O14733	MAP2K7	MP2K7_HUMAN	L259F	494	Catalytic-loop	-	-	RGQIKlDFGIS	0.795	0.785	0.349	0.66	0.626	0.691	0.354	0.579	VARIANT	L -> F (in dbSNP:rs1053566)	9535930	1
O14733/N118S	O14733	MAP2K7	MP2K7_HUMAN	N118S	29	N-term-β1	-	-	YQAEInLENLG	0.39	0.364	0.47	0.207	0.191	0.289	0.655	0.184	VARIANT	N -> S (in dbSNP:rs56316660)	17344846	1
O14733/R138C	O14733	MAP2K7	MP2K7_HUMAN	R138C	55	β2/β3-loop	-	-	QVWKMrRKTGH	0.62	0.539	0.663	0.593	0.368	0.392	0.696	0.246	VARIANT	R -> C (in dbSNP:rs56106612)	17344846	1
O14733/R162C	O14733	MAP2K7	MP2K7_HUMAN	R162C	169	αC	-	-	KEENKrLMDLD	0.653	0.613	0.583	0.591	0.406	0.493	0.642	0.273	VARIANT	R -> C (in a colorectal adenocarcinoma sample; somatic mutation)	17344846	1
O14733/R162H	O14733	MAP2K7	MP2K7_HUMAN	R162H	169	αC	-	-	KEENKrLMDLD	0.544	0.546	0.512	0.533	0.326	0.394	0.582	0.223	VARIANT	R -> H (in a colorectal adenocarcinoma sample; somatic mutation)	17344846	1
O14757/D130A	O14757	CHEK1	CHK1_HUMAN	D130A	443	Catalytic-loop;HrD-motif	-	loss	GITHRdKPENL	0.996	0.994	0.188	0.71	0.957	0.979	0.108	0.564	MUTAGEN	D->A: Abolishes kinase activity.	10673501,11390642,11535615,11821419,12588868,14681206,15311285,9278511	8
O14757/E223V	O14757	CHEK1	CHK1_HUMAN	E223V	644	αG	-	-	YSDWKeKTYLN	0.465	0.429	0.602	0.404	0.201	0.352	0.735	0.343	VARIANT	E -> V (in dbSNP:rs35817404)	17344846	1
O14757/F344A	O14757	CHEK1	CHK1_HUMAN	F344A	-	-	-	increase	VQGISfQPTCP									MUTAGEN	F->A: Impairs nuclear export.	12676962	1
O14757/I471V	O14757	CHEK1	CHK1_HUMAN	I471V	-	-	-	neutral	VSSQKiLPAT									VARIANT	I -> V (in dbSNP:rs506504)	10717241,14702039,15489334,19054851,9278511,9382850	6
O14757/K132R	O14757	CHEK1	CHK1_HUMAN	K132R	445	Catalytic-loop	ub	decrease	THRDIkENLLL	0.95	0.951	0.376	0.799	0.806	0.885	0.283	0.394	MUTAGEN	K->R: Strong reduction of chromatin-associated CHK1 ubiquitination.	32357935	1
O14757/K38R	O14757	CHEK1	CHK1_HUMAN	K38R	129	β3;Catalytic-Lys	-	loss	EAVAVkVDMKR	0.966	0.98	0.104	0.671	0.944	0.996	0.078	0.384	MUTAGEN	K->R: Abolishes kinase activity.	12446774,14681223	2
O14757/K436R	O14757	CHEK1	CHK1_HUMAN	K436R	-	-	ub	-	LEMDDkLVDFR									MUTAGEN	K->R: Enhances stability of the protein, probably by preventing ubiquitination at this site.	19716789	1
O14757/M353A	O14757	CHEK1	CHK1_HUMAN	M353A	-	-	-	increase	TCPDHmLNSQL									MUTAGEN	M->A: Impairs nuclear export.	12676962	1
O14757/R156Q	O14757	CHEK1	CHK1_HUMAN	R156Q	510	A-loop	-	-	LATVFrNNRER	0.863	0.844	0.519	0.74	0.472	0.691	0.523	0.408	VARIANT	R -> Q (in dbSNP:rs3731410)		0
O14757/R372E	O14757	CHEK1	CHK1_HUMAN	R372E	-	-	-	-	QNPWQrVKRMT									MUTAGEN	R->E: In 3RE mutant. Disrupts the folding and/or conformation, allowing increased accessibility to FBXO6 component of SCF-type E3 ubiquitin ligase complex; when associated with E-376 and E-379.	19716789	1
O14757/R376E	O14757	CHEK1	CHK1_HUMAN	R376E	-	-	-	-	QRLVKrTRFFT									MUTAGEN	R->E: In 3RE mutant. Disrupts the folding and/or conformation, allowing increased accessibility to FBXO6 component of SCF-type E3 ubiquitin ligase complex; when associated with E-372 and E-379.	19716789	1
O14757/R379E	O14757	CHEK1	CHK1_HUMAN	R379E	-	-	-	-	VKRMTrFTKLD									MUTAGEN	R->E: In 3RE mutant. Disrupts the folding and/or conformation, allowing increased accessibility to FBXO6 component of SCF-type E3 ubiquitin ligase complex; when associated with E-372 and E-376.	19716789	1
O14757/S317A	O14757	CHEK1	CHK1_HUMAN	S317A	-	-	p	decrease	VKYSSsPEPRT									MUTAGEN	S->A: Abrogates interaction with RAD51; when associated with A-345. Reduces phosphorylation and impairs activation by hydroxyurea and ionizing radiation. Abrogates nuclear retention upon checkpoint activation. Impairs interaction with FBXO6.	11390642,12588868,12676583,12676962,15665856	5
O14757/S317E	O14757	CHEK1	CHK1_HUMAN	S317E	-	-	p	increase	VKYSSsPEPRT									MUTAGEN	S->E: Enhances interaction with RAD51; when associated with E-345.	11390642,12588868,12676583,12676962,15665856	5
O14757/S345A	O14757	CHEK1	CHK1_HUMAN	S345A	-	-	p	decrease	QGISFsPTCPD									MUTAGEN	S->A: Abrogates interaction with RAD51; when associated with A-317. Reduces phosphorylation and impairs activation by hydroxyurea and ionizing radiation. Impairs interaction with YWHAZ which is required for nuclear retention after checkpoint activation.	11390642,12588868,12676583,12676962,15665856,19716789	6
O14757/S345E	O14757	CHEK1	CHK1_HUMAN	S345E	-	-	p	increase	QGISFsPTCPD									MUTAGEN	S->E: Enhances interaction with RAD51; when associated with E-317.	11390642,12588868,12676583,12676962,15665856,19716789	6
O14757/S357A	O14757	CHEK1	CHK1_HUMAN	S357A	-	-	-	-	HMLLNsLLGTP									MUTAGEN	S->A: No effect on phosphorylation induced by hydroxyurea.	11390642	1
O14757/S366A	O14757	CHEK1	CHK1_HUMAN	S366A	-	-	-	-	GTPGSsNPWQR									MUTAGEN	S->A: No effect on phosphorylation induced by hydroxyurea.	11390642	1
O14757/S468A	O14757	CHEK1	CHK1_HUMAN	S468A	-	-	p	-	IDIVSsKIWLP									MUTAGEN	S->A: No effect on phosphorylation induced by hydroxyurea.	11390642	1
O14757/V312M	O14757	CHEK1	CHK1_HUMAN	V312M	-	-	-	-	SSEENvYSSSQ									VARIANT	V -> M (in dbSNP:rs34097480)	17344846	1
O14874/L389P	O14874	BCKDK	BCKD_HUMAN	L389P	-	-	-	loss	LQLQSlGIGTD									VARIANT	L -> P (in BCKDKD; complete loss of kinase activity)	24449431	1
O14874/R174G	O14874	BCKDK	BCKD_HUMAN	R174G	-	-	-	decrease	LAEGLrSRKHI									VARIANT	R -> G (in BCKDKD; partial loss of kinase activity)	24449431	1
O14874/R224P	O14874	BCKDK	BCKD_HUMAN	R224P	-	-	-	-	GIICTrSPKKI									VARIANT	R -> P (in BCKDKD; dbSNP:rs147210405)	22956686	1
O14920/A360S	O14920	IKBKB	IKKB_HUMAN	A360S	-	-	-	-	QEAGLaIPDKP									VARIANT	A -> S (in breast cancer samples; infiltrating ductal carcinoma; somatic mutation)	16959974,17344846	2
O14920/A710T	O14920	IKBKB	IKKB_HUMAN	A710T	-	-	-	-	SEELVaAHNLC									VARIANT	A -> T (in dbSNP:rs34309584)	17344846	1
O14920/A736T	O14920	IKBKB	IKKB_HUMAN	A736T	-	-	-	-	DQSFTaDWSWL									VARIANT	A -> T (in dbSNP:rs17611716)		0
O14920/D166A	O14920	IKBKB	IKKB_HUMAN	D166A	496	A-loop;DFG-motif	-	loss	IHKIIdGYAKE	0.975	0.971	0.138	0.537	0.959	0.967	0.09	0.752	MUTAGEN	D->A: Loss of protein kinase activity.	25326418	1
O14920/F734L	O14920	IKBKB	IKKB_HUMAN	F734L	-	-	-	-	EQDQSfALDWS									VARIANT	F -> L (in dbSNP:rs56301637)	17344846	1
O14920/K163R	O14920	IKBKB	IKKB_HUMAN	K163R	493	Catalytic-loop	ub	-	QRLIHkIDLGY	0.763	0.771	0.426	0.694	0.481	0.619	0.547	0.471	MUTAGEN	K->R: Monoubiquitinated; when associated with E-177 and E-181.	19675099	1
O14920/K171E	O14920	IKBKB	IKKB_HUMAN	K171E	502	A-loop	ub	increase	DLGYAkLDQGS	0.919	0.939	0.651	0.888	0.346	0.737	0.668	0.553	MUTAGEN	K->E: Increased activation of NF-kappa-B signaling.	30337470	1
O14920/K44A	O14920	IKBKB	IKKB_HUMAN	K44A	129	β3;Catalytic-Lys	-	loss	EQIAIkCRQEL	1.0	1.0	0.029	0.642	1.0	0.997	0.006	0.642	MUTAGEN	K->A: Loss of kinase activity and no effect on binding to NIK.	9346484,9346485	2
O14920/P191A	O14920	IKBKB	IKKB_HUMAN	P191A	556	A-loop;APE-motif	-	-	LQYLApLLEQQ	0.807	0.792	0.374	0.602	0.62	0.756	0.334	0.556	MUTAGEN	P->A: Loss of hypoxic inducibility.	17114296	1
O14920/Q369R	O14920	IKBKB	IKKB_HUMAN	Q369R	-	-	-	-	DKPATqISDGK									VARIANT	Q -> R (in dbSNP:rs56411242)	17344846	1
O14920/R526Q	O14920	IKBKB	IKKB_HUMAN	R526Q	-	-	-	-	VELCGrNEVKL									VARIANT	R -> Q (in dbSNP:rs2272736)	17344846	1
O14920/R554W	O14920	IKBKB	IKKB_HUMAN	R554W	-	-	-	-	RSPMGrQGGTL									VARIANT	R -> W (in dbSNP:rs17875749)		0
O14920/S177A	O14920	IKBKB	IKKB_HUMAN	S177A	514	A-loop	p	decrease	ELDQGsCTSFV	0.924	0.916	0.266	0.785	0.838	0.868	0.228	0.371	MUTAGEN	S->A: Decrease of activity.	19675099,9346484	2
O14920/S177E	O14920	IKBKB	IKKB_HUMAN	S177E	514	A-loop	p	activating	ELDQGsCTSFV	0.932	0.927	0.812	0.933	0.149	0.767	0.861	0.369	MUTAGEN	S->E: Full activation. Interaction with TRIM21 is enhanced; when associated with E-181. Monoubiquitinated; when associated with R-163 and E-181. Strongly promoted NF-kappa-B gene expression; when associated with E-181.	19675099,9346484	2
O14920/S181A	O14920	IKBKB	IKKB_HUMAN	S181A	545	A-loop	p	decrease	GSLCTsVGTLQ	0.996	1.0	0.161	0.906	0.962	0.98	0.123	0.47	MUTAGEN	S->A: Decrease of activity.	19675099,9346484	2
O14920/S181E	O14920	IKBKB	IKKB_HUMAN	S181E	545	A-loop	p	activating	GSLCTsVGTLQ	0.999	0.989	0.792	0.994	0.259	0.961	0.795	0.399	MUTAGEN	S->E: Full activation. Interaction with TRIM21 is enhanced; when associated with E-177. Monoubiquitinated; when associated with R-163 and E-177. Strongly promoted NF-kappa-B gene expression; when associated with E-177.	19675099,9346484	2
O14920/V203I	O14920	IKBKB	IKKB_HUMAN	V203I	598	αF	-	increase	KYTVTvYWSFG	0.59	0.552	0.559	0.685	0.251	0.398	0.648	0.323	VARIANT	V -> I (in IMD15A; gain-of-function mutation resulting in increased activation of NF-kappa-B signaling pathway; dbSNP:rs1563340753)	30337470	1
O14936/D710G	O14936	CASK	CSKP_HUMAN	D710G	-	-	-	-	KKQYKdYLAKH									VARIANT	D -> G (in MICPCH; dbSNP:rs137852818)	19377476	1
O14936/G96V	O14936	CASK	CSKP_HUMAN	G96V	254	β5/αD-loop	-	-	FEFMDgDLCFE	0.656	0.655	0.544	0.567	0.452	0.547	0.578	0.601	VARIANT	G -> V (in a lung large cell carcinoma sample; somatic mutation)	17344846	1
O14936/P396S	O14936	CASK	CSKP_HUMAN	P396S	-	-	-	-	NTKSSpIRNPP									VARIANT	P -> S (in MICPCH; dbSNP:rs137852820)	19377476	1
O14936/R28L	O14936	CASK	CSKP_HUMAN	R28L	50	β2	-	-	FSVVRrINRET	0.741	0.641	0.532	0.632	0.403	0.527	0.545	0.467	VARIANT	R -> L (in FGS4; does not reveal significant alterations induced by the mutation substitution; causes a partial skipping of exon 2 of the protein; dbSNP:rs137852816)	19200522	1
O14936/Y268H	O14936	CASK	CSKP_HUMAN	Y268H	814	αI	-	-	ERITVyALNHP	0.312	0.288	0.455	0.212	0.241	0.314	0.613	0.182	VARIANT	Y -> H (in MICPCH; dbSNP:rs137852817)	19377476	1
O14965/C290A	O14965	AURKA	AURKA_HUMAN	C290A	547	A-loop	-	-	RRTTLcTLDYL	0.823	0.797	0.497	0.662	0.579	0.72	0.404	0.644	MUTAGEN	C->A: Enhances stability; when associated with A-393.	27837025	1
O14965/C393A	O14965	AURKA	AURKA_HUMAN	C393A	833	C-term-αI	-	-	SKPSNcNKESA	0.305	0.423	0.424	0.339	0.278	0.319	0.497	0.138	MUTAGEN	C->A: Enhances stability; when associated with A-290.	27837025	1
O14965/D274N	O14965	AURKA	AURKA_HUMAN	D274N	496	A-loop;DFG-motif	-	loss	ELKIAdGWSVH	0.969	0.948	0.223	0.609	0.956	0.953	0.115	0.609	MUTAGEN	D->N: Abolishes cilia disassembly and kinase activity.	14580337,17604723	2
O14965/F165A	O14965	AURKA	AURKA_HUMAN	F165A	132	β3/αC-loop	-	-	ALKVLfAQLEK	0.68	0.653	0.333	0.475	0.537	0.549	0.389	0.419	MUTAGEN	F->A: Decreases the interaction with phosphatase type 1 isoforms.	11551964	1
O14965/F31I	O14965	AURKA	AURKA_HUMAN	F31I	-	-	-	neutral	LVTQQfCQNPL									VARIANT	F -> I (in dbSNP:rs2273535)	15867347,16011022,16762494,17344846,9771714	5
O14965/F346A	O14965	AURKA	AURKA_HUMAN	F346A	675	αG/αH	-	-	ISRVEfFPDFV	0.628	0.53	0.579	0.523	0.344	0.448	0.621	0.355	MUTAGEN	F->A: Decreases the interaction with phosphatase type 1 isoforms.	11551964	1
O14965/G11R	O14965	AURKA	AURKA_HUMAN	G11R	-	-	-	-	ENCISgVKATA									VARIANT	G -> R (in dbSNP:rs6069717)		0
O14965/G198N	O14965	AURKA	AURKA_HUMAN	G198N	206	β4/β5-loop	-	decrease	ILRLYgFHDAT	0.222	0.208	0.437	0.227	0.335	0.163	0.538	0.183	MUTAGEN	G->N: Reduces interaction with TPX2. Reduces kinase activity tenfold. Promotes interaction with the AURKB binding partners INCENP and BIRC5 that are normally not bound by AURKA.	19357306	1
O14965/I57V	O14965	AURKA	AURKA_HUMAN	I57V	-	-	-	increase,neutral	NSSQRiLQAQK									VARIANT	I -> V (increased kinase activity; dbSNP:rs1047972)	15489334,15867347,16011022,17344846,9153231,9514916,9771714	7
O14965/K162R	O14965	AURKA	AURKA_HUMAN	K162R	129	β3;Catalytic-Lys	-	loss	FILALkLFKAQ	0.993	0.99	0.064	0.682	0.997	0.998	0.037	0.397	MUTAGEN	K->R: Loss of kinase activity.	14702041	1
O14965/M373V	O14965	AURKA	AURKA_HUMAN	M373V	804	αI	-	neutral	PSQRPmREVLE	0.179	0.171	0.44	0.117	0.17	0.185	0.584	0.092	VARIANT	M -> V (in dbSNP:rs33923703)	17344846	1
O14965/P50L	O14965	AURKA	AURKA_HUMAN	P50L	-	-	-	neutral	QRVLCpNSSQR									VARIANT	P -> L (in dbSNP:rs34572020)	17344846	1
O14965/Q335A	O14965	AURKA	AURKA_HUMAN	Q335A	629	αF/αG	-	decrease	EANTYqTYKRI	0.325	0.381	0.492	0.195	0.448	0.387	0.462	0.167	MUTAGEN	Q->A: Reduces binding to MYCN.	27837025	1
O14965/R205A	O14965	AURKA	AURKA_HUMAN	R205A	241	β4/β5-loop	-	-	FHDATrYLILE	0.684	0.618	0.364	0.58	0.576	0.587	0.407	0.405	MUTAGEN	R->A: Reduces ubiquitination and proteasomal degradation.	10851084	1
O14965/S104L	O14965	AURKA	AURKA_HUMAN	S104L	4	N-term-β1	-	-	KQPLPsPENNP	0.422	0.48	0.58	0.357	0.321	0.38	0.67	0.319	VARIANT	S -> L (in dbSNP:rs2230743)		0
O14965/S155R	O14965	AURKA	AURKA_HUMAN	S155R	68	β2/β3-loop	-	decrease	AREKQsFILAL	0.592	0.496	0.484	0.389	0.435	0.451	0.513	0.369	VARIANT	S -> R (in a colorectal adenocarcinoma sample; somatic mutation; reduces interaction with TPX2)	17344846,19801554	2
O14965/T287A	O14965	AURKA	AURKA_HUMAN	T287A	544	A-loop	p	-	PSSRRtLCGTL	0.794	0.838	0.464	0.737	0.574	0.825	0.45	0.312	MUTAGEN	T->A: No direct effect on catalytic activity.	19668197	1
O14965/T287E	O14965	AURKA	AURKA_HUMAN	T287E	544	A-loop	p	activating	PSSRRtLCGTL	0.829	0.827	0.728	0.826	0.264	0.724	0.82	0.293	MUTAGEN	T->E: Enhances interaction with TPX2.	19668197	1
O14965/T288A	O14965	AURKA	AURKA_HUMAN	T288A	545	A-loop	p	decrease	SSRRTtCGTLD	0.999	1.0	0.174	0.92	0.931	0.996	0.075	0.44	MUTAGEN	T->A: Reduces cilia disassembly and kinase activity.	17604723	1
O14965/T288D	O14965	AURKA	AURKA_HUMAN	T288D	545	A-loop	p	increase	SSRRTtCGTLD	0.99	1.0	0.865	1.0	0.146	0.942	0.901	0.393	MUTAGEN	T->D: Mimics phosphorylation state and increases kinase activity.	11039908	1
O14965/V174M	O14965	AURKA	AURKA_HUMAN	V174M	146	αC	-	activating	LEKAGvHQLRR	0.452	0.368	0.544	0.449	0.114	0.229	0.676	0.192	VARIANT	V -> M (in a metastatic melanoma sample; somatic mutation; constitutively enhanced kinase activity)	17344846,19801554	2
O14965/Y334A	O14965	AURKA	AURKA_HUMAN	Y334A	628	αF/αG	-	decrease	FEANTyETYKR	0.758	0.701	0.371	0.418	0.618	0.698	0.298	0.295	MUTAGEN	Y->A: Reduces binding to MYCN.	27837025	1
O14976/D1297N	O14976	GAK	GAK_HUMAN	D1297N	-	-	-	neutral	FMELNdWSEFE									VARIANT	D -> N (in dbSNP:rs1134921)	17344846	1
O14976/D787Y	O14976	GAK	GAK_HUMAN	D787Y	-	-	-	neutral	PSSSAdSRFLH									VARIANT	D -> Y (in dbSNP:rs34585705)	17344846	1
O14976/G962D	O14976	GAK	GAK_HUMAN	G962D	-	-	-	-	AADPFgLLPSS									VARIANT	G -> D (in a lung neuroendocrine carcinoma sample; somatic mutation; dbSNP:rs773153935)	17344846	1
O14976/K1265R	O14976	GAK	GAK_HUMAN	K1265R	-	-	-	neutral	PEQVKkYRRAV									VARIANT	K -> R (in dbSNP:rs2306242)	17344846	1
O14976/P1137L	O14976	GAK	GAK_HUMAN	P1137L	-	-	-	-	PPQAKpPKACT									VARIANT	P -> L (in dbSNP:rs56169884)	17344846	1
O14976/Q1120H	O14976	GAK	GAK_HUMAN	Q1120H	-	-	-	-	GSSSWqSRPPA									VARIANT	Q -> H (in dbSNP:rs55801437)	17344846	1
O14976/Q877R	O14976	GAK	GAK_HUMAN	Q877R	-	-	-	neutral	PEPVPqDGVDL									VARIANT	Q -> R (in dbSNP:rs149842313)	17344846	1
O14976/S1168N	O14976	GAK	GAK_HUMAN	S1168N	-	-	p	-	GVRAPsAQKPK									VARIANT	S -> N (in dbSNP:rs56326341)	17344846	1
O14976/S144L	O14976	GAK	GAK_HUMAN	S144L	394	αD/αE-loop	-	-	SRGPLsDTVLK	0.542	0.494	0.504	0.414	0.34	0.429	0.572	0.287	VARIANT	S -> L (in dbSNP:rs768962219)	17344846	1
O14976/T1051M	O14976	GAK	GAK_HUMAN	T1051M	-	-	-	-	SAVAPtATEGP									VARIANT	T -> M (in dbSNP:rs35227944)	17344846	1
O14976/V580M	O14976	GAK	GAK_HUMAN	V580M	-	-	-	-	ILVRAvMTPVP									VARIANT	V -> M (in dbSNP:rs34255232)	17344846	1
O15075/G29C	O15075	DCLK1	DCLK1_HUMAN	G29C	-	-	-	-	GSRVNgPSPTH									VARIANT	G -> C (in a gastric adenocarcinoma sample; somatic mutation)	17344846	1
O15075/R292H	O15075	DCLK1	DCLK1_HUMAN	R292H	-	-	-	-	IASSSrSTTKS									VARIANT	R -> H (in dbSNP:rs56185003)	17344846	1
O15075/R93Q	O15075	DCLK1	DCLK1_HUMAN	R93Q	-	-	-	-	LADLTrLSDNV									VARIANT	R -> Q (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs1366698690)	17344846	1
O15075/S291F	O15075	DCLK1	DCLK1_HUMAN	S291F	-	-	-	-	KIASSsRSTTK									VARIANT	S -> F (in a gastric adenocarcinoma sample; somatic mutation)	17344846	1
O15075/T46M	O15075	DCLK1	DCLK1_HUMAN	T46M	-	-	p	-	FYRTRtQTLSS									VARIANT	T -> M (in a gastric adenocarcinoma sample; somatic mutation)	17344846	1
O15111/K44A	O15111	CHUK	IKKA_HUMAN	K44A	129	β3;Catalytic-Lys	ub	loss	LKIAIkCRLEL	1.0	1.0	0.035	0.676	1.0	0.997	0.016	0.65	MUTAGEN	K->A: Loss of kinase activity.	9244310,9346484	2
O15111/K44M	O15111	CHUK	IKKA_HUMAN	K44M	129	β3;Catalytic-Lys	ub	loss	LKIAIkCRLEL	1.0	1.0	0.029	0.71	0.997	0.997	0.023	0.47	MUTAGEN	K->M: Loss of autophosphorylation.	9244310,9346484	2
O15111/S126C	O15111	CHUK	IKKA_HUMAN	S126C	408	αE	-	-	ILSLLsIGSGI	0.593	0.456	0.531	0.402	0.295	0.335	0.581	0.425	VARIANT	S -> C (in dbSNP:rs34427437)	17344846	1
O15111/S176A	O15111	CHUK	IKKA_HUMAN	S176A	514	A-loop	p	loss	DVDQGsCTSFV	0.908	0.913	0.277	0.751	0.836	0.87	0.205	0.327	MUTAGEN	S->A: Loss of phosphorylation and of activity.	9346484,9520446	2
O15111/S176E	O15111	CHUK	IKKA_HUMAN	S176E	514	A-loop	p	activating	DVDQGsCTSFV	0.917	0.908	0.798	0.934	0.147	0.764	0.839	0.338	MUTAGEN	S->E: Full activation.	9346484,9520446	2
O15111/S180A	O15111	CHUK	IKKA_HUMAN	S180A	545	A-loop	p	-	GSLCTsVGTLQ	0.996	0.994	0.152	0.9	0.963	0.981	0.11	0.449	MUTAGEN	S->A: No change in phosphorylation.	9520446	1
O15111/T179A	O15111	CHUK	IKKA_HUMAN	T179A	544	A-loop	ac	-	QGSLCtFVGTL	0.789	0.794	0.418	0.601	0.636	0.774	0.405	0.189	MUTAGEN	T->A: No change in phosphorylation.	9520446	1
O15111/T23A	O15111	CHUK	IKKA_HUMAN	T23A	41	β1;Gly-rich-loop	p	decrease	RERLGtGFGNV	0.852	0.876	0.321	0.633	0.74	0.763	0.36	0.274	MUTAGEN	T->A: Loss of phosphorylation and decrease of kinase activity.	10485710	1
O15111/V155A	O15111	CHUK	IKKA_HUMAN	V155A	480	Catalytic-loop	-	neutral	IVLQDvGKIIH	0.089	0.126	0.418	0.14	0.14	0.162	0.539	0.141	VARIANT	V -> A (in dbSNP:rs2230803)	17344846	1
O15111/V268I	O15111	CHUK	IKKA_HUMAN	V268I	780	αG/αH	-	neutral	SLCSLvEPMEN	0.082	0.075	0.486	0.116	0.052	0.098	0.771	0.071	VARIANT	V -> I (in dbSNP:rs2230804)	15164054,17344846,8777433,9244310,9252186,9813230	6
O15146/A27G	O15146	MUSK	MUSK_HUMAN	A27G	-	-	-	-	EKLPKaVITTP									VARIANT	A -> G (in dbSNP:rs56054734)	17344846	1
O15146/A727V	O15146	MUSK	MUSK_HUMAN	A727V	445	Catalytic-loop	-	decrease	VHRDLaRNCLV	0.901	0.911	0.412	0.67	0.776	0.875	0.394	0.374	VARIANT	A -> V (in CMS9; affects interaction with DOK7 and impairs MUSK phosphorylation; altered AChR clustering; dbSNP:rs397515450)	20371544	1
O15146/D38E	O15146	MUSK	MUSK_HUMAN	D38E	-	-	-	-	PLETVdLVEEV									VARIANT	D -> E (in CMS9; dbSNP:rs775587809)	24183479	1
O15146/D743N	O15146	MUSK	MUSK_HUMAN	D743N	496	A-loop;DFG-motif	-	loss	VVKIAdGLSRN	0.973	0.956	0.272	0.604	0.912	0.883	0.179	0.62	MUTAGEN	D->N: Severe loss of kinase activity.	25029443	1
O15146/E782D	O15146	MUSK	MUSK_HUMAN	E782D	598	αF	-	-	NRYTTeDVWAY	0.39	0.395	0.528	0.363	0.322	0.269	0.561	0.398	VARIANT	E -> D (in dbSNP:rs34614566)	17344846	1
O15146/G107E	O15146	MUSK	MUSK_HUMAN	G107E	-	-	-	-	NNGVGgVESCG									VARIANT	G -> E (in dbSNP:rs55786136)	17344846	1
O15146/G584C	O15146	MUSK	MUSK_HUMAN	G584C	42	β1;Gly-rich-loop	-	decrease	RDIGEgFGRVF	0.942	0.93	0.264	0.595	0.875	0.898	0.234	0.486	MUTAGEN	G->C,D: Mild decrease in kinase activity.	25029443	1
O15146/G584D	O15146	MUSK	MUSK_HUMAN	G584D	42	β1;Gly-rich-loop	-	decrease	RDIGEgFGRVF	0.912	0.91	0.381	0.722	0.856	0.897	0.29	0.423	MUTAGEN	G->C,D: Mild decrease in kinase activity.	25029443	1
O15146/I575T	O15146	MUSK	MUSK_HUMAN	I575T	29	N-term-β1	-	decrease	YPRNNiYVRDI	0.698	0.546	0.551	0.552	0.421	0.422	0.652	0.419	VARIANT	I -> T (in FADS1; reduces agrin-dependent AChR aggregation and tyrosine kinase activity in developing neuromuscular junction; dbSNP:rs751889864)	25537362	1
O15146/K609R	O15146	MUSK	MUSK_HUMAN	K609R	129	β3;Catalytic-Lys	-	loss	TMVAVkLKEEA	1.0	1.0	0.045	0.686	0.994	0.997	0.017	0.547	MUTAGEN	K->R: Severe loss of kinase activity.	25029443	1
O15146/L629F	O15146	MUSK	MUSK_HUMAN	L629F	176	αC	-	-	QREAAlAEFDN	0.386	0.249	0.575	0.405	0.149	0.215	0.734	0.329	VARIANT	L -> F (in dbSNP:rs34267283)	17344846	1
O15146/M413I	O15146	MUSK	MUSK_HUMAN	M413I	-	-	-	neutral	KEWLVmEKTHR									VARIANT	M -> I (in dbSNP:rs2274419)	17344846	1
O15146/M605I	O15146	MUSK	MUSK_HUMAN	M605I	119	β3	-	decrease	YEPFTmAVKML	0.594	0.541	0.534	0.43	0.387	0.438	0.622	0.306	VARIANT	M -> I (in CMS9; affects interaction with DOK7 and impairs MUSK phosphorylation; altered AChR clustering; dbSNP:rs766640370)	20371544	1
O15146/M835V	O15146	MUSK	MUSK_HUMAN	M835V	789	αH	-	-	ELYNLmLCWSK	0.628	0.609	0.596	0.649	0.318	0.499	0.659	0.391	VARIANT	M -> V (in CMS9; reduces AChR aggregation in developing neuromuscular junction)	23326516	1
O15146/N222S	O15146	MUSK	MUSK_HUMAN	N222S	-	-	-	-	APESHnTFGSF									VARIANT	N -> S (in dbSNP:rs55826142)	17344846	1
O15146/N664S	O15146	MUSK	MUSK_HUMAN	N664S	265	αD	-	-	AYGDLnFLRSM	0.351	0.243	0.553	0.275	0.157	0.184	0.664	0.209	VARIANT	N -> S (in dbSNP:rs55963442)	17344846	1
O15146/N819S	O15146	MUSK	MUSK_HUMAN	N819S	738	αG/αH	-	-	YVRDGnLSCPE	0.127	0.202	0.509	0.179	0.121	0.159	0.707	0.109	VARIANT	N -> S (in a lung neuroendocrine carcinoma sample; somatic mutation; dbSNP:rs757577755)	17344846	1
O15146/P344R	O15146	MUSK	MUSK_HUMAN	P344R	-	-	-	-	TSYADpEAQEL									VARIANT	P -> R (in CMS9; dbSNP:rs387906803)	19949040	1
O15146/P696L	O15146	MUSK	MUSK_HUMAN	P696L	396	αD/αE-loop	-	-	SPGPPpSCAEQ	0.503	0.465	0.57	0.41	0.37	0.365	0.635	0.283	VARIANT	P -> L (in dbSNP:rs56126328)	17344846	1
O15146/R858H	O15146	MUSK	MUSK_HUMAN	R858H	815	αI	-	-	HRILErCERAE	0.184	0.199	0.451	0.258	0.163	0.17	0.652	0.159	VARIANT	R -> H (in dbSNP:rs34115159)	17344846	1
O15146/S159G	O15146	MUSK	MUSK_HUMAN	S159G	-	-	-	neutral	WIKGDsLRENS									VARIANT	S -> G (in dbSNP:rs35176182)	17344846	1
O15146/T100M	O15146	MUSK	MUSK_HUMAN	T100M	-	-	-	neutral	GIYCCtNNGVG									VARIANT	T -> M (in dbSNP:rs35142681)	17344846	1
O15146/V644A	O15146	MUSK	MUSK_HUMAN	V644A	223	β4/β5-loop	-	neutral	VKLLGvAVGKP	0.277	0.271	0.522	0.312	0.212	0.234	0.62	0.278	VARIANT	V -> A (in dbSNP:rs41279055)	17344846	1
O15146/V790M	O15146	MUSK	MUSK_HUMAN	V790M	606	αF	-	decrease	VWAYGvLWEIF	0.811	0.763	0.461	0.651	0.658	0.662	0.418	0.637	VARIANT	V -> M (in CMS9; does not affect catalytic kinase activity; reduces protein expression and stability; dbSNP:rs199476083)	15496425	1
O15146/V829L	O15146	MUSK	MUSK_HUMAN	V829L	782	αH	-	neutral	PENCPvLYNLM	0.085	0.085	0.462	0.13	0.072	0.076	0.73	0.06	VARIANT	V -> L (in dbSNP:rs578430)	17344846	1
O15164/C840W	O15164	TRIM24	TIF1A_HUMAN	C840W	-	-	-	-	GGELLcEKCPK									MUTAGEN	C->W: Abolishes interaction with histone H3.	21164480	1
O15164/D827A	O15164	TRIM24	TIF1A_HUMAN	D827A	-	-	-	-	DDPNEdCAVCQ									MUTAGEN	D->A: Strongly reduced affinity for histone H3 that is not methylated at 'Lys-4' (H3K4me0).	21164480	1
O15164/I320T	O15164	TRIM24	TIF1A_HUMAN	I320T	-	-	-	-	TLMVEiKKGKA									VARIANT	I -> T (in an ovarian serous carcinoma sample; somatic mutation)	17344846	1
O15164/N796S	O15164	TRIM24	TIF1A_HUMAN	N796S	-	-	-	neutral	GLHQDnSNGKS									VARIANT	N -> S (in dbSNP:rs35356723)		0
O15164/R1009S	O15164	TRIM24	TIF1A_HUMAN	R1009S	-	-	-	neutral	LYPEKrPKPEF									VARIANT	R -> S (in dbSNP:rs34585297)	17344846	1
O15164/S762N	O15164	TRIM24	TIF1A_HUMAN	S762N	-	-	-	-	RSILTsLLNSS									VARIANT	S -> N	17344846	1
O15164/S768A	O15164	TRIM24	TIF1A_HUMAN	S768A	-	-	p	-	LLLNSsSSTSE									MUTAGEN	S->A: Ubiquitination is significantly lower than wild-type.	24820418	1
O15164/T403N	O15164	TRIM24	TIF1A_HUMAN	T403N	-	-	-	-	PVTNNtQFHCD									VARIANT	T -> N (in a lung squamous cell carcinoma sample; somatic mutation)	17344846	1
O15197/A221V	O15197	EPHB6	EPHB6_HUMAN	A221V	-	-	-	-	TGACLaVAVRL									VARIANT	A -> V	17344846	1
O15197/A603P	O15197	EPHB6	EPHB6_HUMAN	A603P	-	-	-	-	GSILGaAFLLL									VARIANT	A -> P (in a colorectal cancer sample; somatic mutation)	16959974	1
O15197/A662V	O15197	EPHB6	EPHB6_HUMAN	A662V	-	-	-	-	AIRELaEVDPA									VARIANT	A -> V (in dbSNP:rs35984674)	17344846	1
O15197/D360N	O15197	EPHB6	EPHB6_HUMAN	D360N	-	-	-	-	YRASSdPEAPC									VARIANT	D -> N (in a colorectal cancer sample; somatic mutation)	16959974	1
O15197/D930G	O15197	EPHB6	EPHB6_HUMAN	D930G	-	-	-	-	LQAGGdGERPS									VARIANT	D -> G (in a colorectal cancer sample; somatic mutation)	16959974	1
O15197/E875K	O15197	EPHB6	EPHB6_HUMAN	E875K	-	-	-	-	VLNAIeEFRLP									VARIANT	E -> K (in a glioblastoma multiforme sample; somatic mutation)	17344846	1
O15197/G122S	O15197	EPHB6	EPHB6_HUMAN	G122S	-	-	-	neutral	LGVSGgCRETF									VARIANT	G -> S (in dbSNP:rs8177173)	17344846	1
O15197/I993V	O15197	EPHB6	EPHB6_HUMAN	I993V	-	-	-	-	LPALGiLAGHQ									VARIANT	I -> V	17344846	1
O15197/P282H	O15197	EPHB6	EPHB6_HUMAN	P282H	-	-	-	-	AGGSPpLHCNG									VARIANT	P -> H	17344846	1
O15197/P282R	O15197	EPHB6	EPHB6_HUMAN	P282R	-	-	-	-	AGGSPpLHCNG									VARIANT	P -> R (in dbSNP:rs8177143)		0
O15197/P743S	O15197	EPHB6	EPHB6_HUMAN	P743S	-	-	-	-	VTKSRpMVLTE									VARIANT	P -> S (in an ovarian mucinous carcinoma sample; somatic mutation)	17344846	1
O15197/R309Q	O15197	EPHB6	EPHB6_HUMAN	R309Q	-	-	-	-	GYQPArDKACQ									VARIANT	R -> Q (in dbSNP:rs55728646)	17344846	1
O15197/R499Q	O15197	EPHB6	EPHB6_HUMAN	R499Q	-	-	-	-	VHQVSrSNSIT									VARIANT	R -> Q (in dbSNP:rs8177175)		0
O15197/R719Q	O15197	EPHB6	EPHB6_HUMAN	R719Q	-	-	-	-	MTFLGrAVLGQ									VARIANT	R -> Q (in a colorectal cancer sample; somatic mutation)	16959974	1
O15197/R813H	O15197	EPHB6	EPHB6_HUMAN	R813H	-	-	-	-	VCKVArGHSPQ									VARIANT	R -> H	17344846	1
O15197/S170T	O15197	EPHB6	EPHB6_HUMAN	S170T	-	-	-	-	PSSSSsSSSSS									VARIANT	S -> T	17344846	1
O15197/S324A	O15197	EPHB6	EPHB6_HUMAN	S324A	-	-	-	neutral	RGLYKsAGNAP									VARIANT	S -> A (in dbSNP:rs8177146)	17344846	1
O15197/S332L	O15197	EPHB6	EPHB6_HUMAN	S332L	-	-	-	neutral	GNAPCsCPARS									VARIANT	S -> L (in dbSNP:rs35189999)	17344846	1
O15264/A282V	O15264	MAPK13	MK13_HUMAN	A282V	785	αH	-	-	ASPQAaLLEKM	0.26	0.206	0.488	0.229	0.238	0.189	0.625	0.246	VARIANT	A -> V (in dbSNP:rs55990045)	17344846	1
O15264/A300T	O15264	MAPK13	MK13_HUMAN	A300T	814	αI	-	neutral	KRLTAaALTHP	0.206	0.206	0.542	0.233	0.166	0.15	0.702	0.212	VARIANT	A -> T (in dbSNP:rs41270090)	17344846	1
O15264/S41L	O15264	MAPK13	MK13_HUMAN	S41L	50	β2	-	-	YGSVCsIDKRS	0.528	0.368	0.585	0.462	0.212	0.3	0.615	0.384	VARIANT	S -> L (in dbSNP:rs55776345)	17344846	1
O15264/T180A	O15264	MAPK13	MK13_HUMAN	T180A	544	A-loop	p	loss	ADAEMtYVVTR	0.971	0.985	0.24	0.835	0.941	0.961	0.182	0.541	MUTAGEN	T->A: Loss of kinase activity.	9374491	1
O15264/Y182A	O15264	MAPK13	MK13_HUMAN	Y182A	546	A-loop	p	loss	AEMTGyVTRWY	0.97	0.983	0.214	0.73	0.931	0.906	0.171	0.603	MUTAGEN	Y->A: Loss of kinase activity.	9374491	1
O15530/A277V	O15530	PDPK1	PDPK1_HUMAN	A277V	614	αF	-	increase	IYQLVaLPPFR	0.24	0.245	0.562	0.318	0.092	0.104	0.721	0.108	MUTAGEN	A->V: 3-fold increase in kinase activity.	10364160	1
O15530/R474A	O15530	PDPK1	PDPK1_HUMAN	R474A	-	-	-	-	LFARRrLLLTE									MUTAGEN	R->A: No PDGF-dependent translocation to the membrane.	9637919	1
O15530/S241A	O15530	PDPK1	PDPK1_HUMAN	S241A	545	A-loop	p	loss	QARANsVGTAQ	0.947	0.968	0.179	0.804	0.887	0.932	0.23	0.217	MUTAGEN	S->A: No activation.	10455013	1
O15530/S25A	O15530	PDPK1	PDPK1_HUMAN	S25A	-	-	p	-	LCSCPsSMVRT									MUTAGEN	S->A: No effect.	10455013	1
O15530/S393A	O15530	PDPK1	PDPK1_HUMAN	S393A	-	-	p	-	VSSSSsHSLSA									MUTAGEN	S->A: No effect.	10455013	1
O15530/S394A	O15530	PDPK1	PDPK1_HUMAN	S394A	-	-	p	-	SSSSSsSLSAS									MUTAGEN	S->A: Abolishes phosphorylation by MAP3K5; when associated with A-398.	22544756	1
O15530/S396A	O15530	PDPK1	PDPK1_HUMAN	S396A	-	-	p	-	SSSSHsSASDT									MUTAGEN	S->A: No effect.	10455013	1
O15530/S398A	O15530	PDPK1	PDPK1_HUMAN	S398A	-	-	p	-	SSHSLsSDTGL									MUTAGEN	S->A: Abolishes phosphorylation by MAP3K5; when associated with A-394.	22544756	1
O15530/S410A	O15530	PDPK1	PDPK1_HUMAN	S410A	-	-	p	-	PQRSGsIEQYI									MUTAGEN	S->A: No effect.	10455013	1
O15530/T354A	O15530	PDPK1	PDPK1_HUMAN	T354A	847	C-term-αI	p	increase	NLHQQtPKLTA	0.616	0.7	0.363	0.529	0.527	0.439	0.429	0.102	MUTAGEN	T->A: Abolishes phosphorylation by MELK.	22544756	1
O15530/T513E	O15530	PDPK1	PDPK1_HUMAN	T513E	-	-	p	increase	AKNFKtFVHTP									MUTAGEN	T->E: Enhanced kinase activity towards PKB.	20978239	1
O15530/Y373F	O15530	PDPK1	PDPK1_HUMAN	Y373F	-	-	p	decrease	DDEDCyNYDNL									MUTAGEN	Y->F: Reduction in basal activity.	11481331	1
O15530/Y376F	O15530	PDPK1	PDPK1_HUMAN	Y376F	-	-	p	decrease	DCYGNyNLLSQ									MUTAGEN	Y->F: Reduction in basal activity.	11481331	1
O15530/Y9F	O15530	PDPK1	PDPK1_HUMAN	Y9F	-	-	p	decrease	TTSQLyAVPIQ									MUTAGEN	Y->F: Slight reduction in pervanadate-stimulated tyrosine phosphorylation.	11481331	1
O43187/D431E	O43187	IRAK2	IRAK2_HUMAN	D431E	-	-	-	neutral	DLLLSdPSSTA									VARIANT	D -> E (in dbSNP:rs708035)	17344846,9374458	2
O43187/D469N	O43187	IRAK2	IRAK2_HUMAN	D469N	-	-	-	-	GRLPEdAEALA									VARIANT	D -> N (in dbSNP:rs56242986)	17344846	1
O43187/D574H	O43187	IRAK2	IRAK2_HUMAN	D574H	-	-	-	neutral	VGREAdSSEAC									VARIANT	D -> H (in dbSNP:rs11465930)		0
O43187/I99V	O43187	IRAK2	IRAK2_HUMAN	I99V	-	-	-	neutral	KPAPEiCPIPA									VARIANT	I -> V (in dbSNP:rs55898544)	17344846	1
O43187/L392V	O43187	IRAK2	IRAK2_HUMAN	L392V	-	-	-	neutral	IRVGQlKRVDI									VARIANT	L -> V (in dbSNP:rs3844283)	17344846	1
O43187/L439V	O43187	IRAK2	IRAK2_HUMAN	L439V	-	-	-	neutral	SSTASlSRKTG									VARIANT	L -> V (in dbSNP:rs11465927)	17344846	1
O43187/L503I	O43187	IRAK2	IRAK2_HUMAN	L503I	-	-	-	neutral	AVEERlGRETL									VARIANT	L -> I (in dbSNP:rs9854688)	17344846	1
O43187/P421T	O43187	IRAK2	IRAK2_HUMAN	P421T	-	-	-	-	DNNRSpYLKDL									VARIANT	P -> T (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
O43187/R147T	O43187	IRAK2	IRAK2_HUMAN	R147T	-	-	-	neutral	GSSPArHQPAF									VARIANT	R -> T (in dbSNP:rs56053222)	17344846	1
O43187/R214G	O43187	IRAK2	IRAK2_HUMAN	R214G	-	-	-	-	DFNQNrISQGT									VARIANT	R -> G (in dbSNP:rs35060588)	17344846	1
O43187/R43Q	O43187	IRAK2	IRAK2_HUMAN	R43Q	-	-	-	-	DLTQLrIKSME									VARIANT	R -> Q (in dbSNP:rs34945585)	17344846	1
O43187/R566W	O43187	IRAK2	IRAK2_HUMAN	R566W	-	-	-	neutral	GEGRLrIVGRE									VARIANT	R -> W (in dbSNP:rs55740652)	17344846	1
O43187/S249L	O43187	IRAK2	IRAK2_HUMAN	S249L	-	-	-	-	CSSPGsERFFQ									VARIANT	S -> L (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
O43187/S47Y	O43187	IRAK2	IRAK2_HUMAN	S47Y	-	-	-	neutral	LRKIKsERVQG									VARIANT	S -> Y (in dbSNP:rs11465864)	17344846	1
O43283/E44K	O43283	MAP3K13	M3K13_HUMAN	E44K	-	-	-	-	SPKLLeQQEKG									VARIANT	E -> K (in dbSNP:rs35266179)		0
O43283/E712K	O43283	MAP3K13	M3K13_HUMAN	E712K	-	-	-	-	CWRSSeDKGQA									VARIANT	E -> K (in dbSNP:rs56309231)	17344846	1
O43283/K195A	O43283	MAP3K13	M3K13_HUMAN	K195A	129	β3;Catalytic-Lys	-	loss	EEVAIkVREQN	1.0	1.0	0.037	0.608	0.992	0.99	0.007	0.65	MUTAGEN	K->A: Kinase inactive. Fails to activate NF-kappa-B.	12492477	1
O43283/P746L	O43283	MAP3K13	M3K13_HUMAN	P746L	-	-	-	-	GSLDIpAEPVG									VARIANT	P -> L (in a metastatic melanoma sample; somatic mutation)	17344846	1
O43283/R517G	O43283	MAP3K13	M3K13_HUMAN	R517G	-	-	-	-	PGTYKrPVRPI									VARIANT	R -> G (in dbSNP:rs56408536)	17344846	1
O43283/R915H	O43283	MAP3K13	M3K13_HUMAN	R915H	-	-	-	-	ECAVRrKTQMS									VARIANT	R -> H (in dbSNP:rs3732576)		0
O43293/D161A	O43293	DAPK3	DAPK3_HUMAN	D161A	496	A-loop;DFG-motif	-	loss	RIKLIdGIAHK	0.996	0.976	0.089	0.56	0.994	0.968	0.024	0.681	MUTAGEN	D->A: Loss of kinase activity.	17158456	1
O43293/D161N	O43293	DAPK3	DAPK3_HUMAN	D161N	496	A-loop;DFG-motif	-	decrease	RIKLIdGIAHK	0.988	0.977	0.163	0.565	0.955	0.964	0.099	0.544	VARIANT	D -> N (in an ovarian mucinous carcinoma sample; somatic mutation; greatly reduces kinase activity, increases cell proliferation and cell survival)	17344846,21487036	2
O43293/K42A	O43293	DAPK3	DAPK3_HUMAN	K42A	129	β3;Catalytic-Lys	-	loss	KEYAAkIKKRR	1.0	1.0	0.021	0.629	1.0	0.998	0.003	0.668	MUTAGEN	K->A: Loss of kinase activity at low concentrations of ATP.	17158456	1
O43293/L441A	O43293	DAPK3	DAPK3_HUMAN	L441A	-	-	-	-	DLVRAlQEKLQ									MUTAGEN	L->A: Predominantly nuclear localization; when associated with A-427 and A-434.	15611134	1
O43293/P216S	O43293	DAPK3	DAPK3_HUMAN	P216S	621	αF/αG	-	decrease	LSGASpLGETK	0.824	0.765	0.433	0.607	0.58	0.698	0.391	0.603	VARIANT	P -> S (in a lung neuroendocrine carcinoma sample; somatic mutation; greatly reduces kinase activity, increases cell proliferation, cell adhesion and cell survival)	17344846,21487036	2
O43293/T112M	O43293	DAPK3	DAPK3_HUMAN	T112M	394	αD/αE-loop	-	decrease	EKESLtDEATQ	0.535	0.503	0.426	0.276	0.417	0.373	0.504	0.225	VARIANT	T -> M (in a colorectal adenocarcinoma sample; somatic mutation; greatly reduces kinase activity, increases cell proliferation and cell survival)	17344846,21487036	2
O43293/T180A	O43293	DAPK3	DAPK3_HUMAN	T180A	549	A-loop	p	decrease	KNIFGtEFVAP	0.862	0.913	0.249	0.699	0.866	0.859	0.199	0.382	MUTAGEN	T->A: Greatly reduced kinase activity.	21487036	1
O43293/T225A	O43293	DAPK3	DAPK3_HUMAN	T225A	641	αG	p	loss	ETKQEtTNISA	0.898	0.859	0.487	0.807	0.652	0.844	0.438	0.351	MUTAGEN	T->A: Loss of kinase activity.	17158456	1
O43293/T265A	O43293	DAPK3	DAPK3_HUMAN	T265A	804	αI	p	loss	PKRRMtAQSLE	0.857	0.905	0.362	0.703	0.741	0.799	0.284	0.44	MUTAGEN	T->A: Loss of phosphorylation by ROCK1, catalytically inactive.	17158456	1
O43293/T299A	O43293	DAPK3	DAPK3_HUMAN	T299A	847	C-term-αI	p	loss	RRRLKtRLKEY	0.576	0.656	0.503	0.54	0.397	0.428	0.574	0.133	MUTAGEN	T->A: Loss of phosphorylation by ROCK1.	17158456	1
O43293/T299D	O43293	DAPK3	DAPK3_HUMAN	T299D	847	C-term-αI	p	-	RRRLKtRLKEY	0.653	0.671	0.679	0.722	0.308	0.364	0.698	0.204	MUTAGEN	T->D: Predominantly cytoplasmic localization; phosphomimetic.	15611134	1
O43293/V427A	O43293	DAPK3	DAPK3_HUMAN	V427A	-	-	-	-	ALAKQvSEMRF									MUTAGEN	V->A: Predominantly nuclear localization; when associated with A-434 and A-441.	15611134	1
O43293/V434A	O43293	DAPK3	DAPK3_HUMAN	V434A	-	-	-	-	SEMRFvDLVRA									MUTAGEN	V->A: Predominantly nuclear localization; when associated with A-427 and A-441.	15611134	1
O43318/E70Q	O43318	MAP3K7	M3K7_HUMAN	E70Q	136	αC	-	-	IESESeKAFIV	0.26	0.193	0.502	0.288	0.12	0.127	0.696	0.17	VARIANT	E -> Q (in FMD2; dbSNP:rs886039231)	27426733	1
O43318/G110C	O43318	MAP3K7	M3K7_HUMAN	G110C	254	β5/αD-loop	-	-	EYAEGgLYNVL	0.863	0.851	0.44	0.679	0.583	0.712	0.451	0.707	VARIANT	G -> C (in CSCF; dbSNP:rs886039235)	27426734	1
O43318/G168R	O43318	MAP3K7	M3K7_HUMAN	G168R	482	Catalytic-loop	-	-	LLVAGgVLKIC	0.631	0.676	0.419	0.541	0.502	0.525	0.432	0.459	VARIANT	G -> R (in FMD2; increases autophosphorylation; no effect on MAPK signaling; no effect on NF-kappa-B signaling; dbSNP:rs886039233)	27426733	1
O43318/K158R	O43318	MAP3K7	M3K7_HUMAN	K158R	445	Catalytic-loop	ub	-	IHRDLkPNLLL	0.842	0.846	0.404	0.71	0.719	0.847	0.334	0.328	MUTAGEN	K->R: Abolishes ubiquitination.	29291351	1
O43318/K209R	O43318	MAP3K7	M3K7_HUMAN	K209R	598	αF	ub	-	SNYSEkDVFSW	0.723	0.751	0.484	0.681	0.427	0.512	0.592	0.359	MUTAGEN	K->R: Strongly decreases ubiquitination.	29291351	1
O43318/K34R	O43318	MAP3K7	M3K7_HUMAN	K34R	28	N-term-β1	-	-	EEIDYkIEVEE	0.351	0.36	0.454	0.241	0.229	0.316	0.609	0.216	MUTAGEN	K->R: No effect on ubiquitination.	29291351	1
O43318/K63W	O43318	MAP3K7	M3K7_HUMAN	K63W	129	β3;Catalytic-Lys	-	loss	KDVAIkIESES	0.98	0.985	0.09	0.751	0.951	0.987	0.086	0.463	MUTAGEN	K->W: Loss of kinase activity. Loss of autophosphorylation.	12589052,22802624	2
O43318/P512A	O43318	MAP3K7	M3K7_HUMAN	P512A	-	-	-	-	LQPLApPNSKE									MUTAGEN	P->R,A: Enhances autophosphorylation; Alters MAPK signaling.	27426733	1
O43318/P512L	O43318	MAP3K7	M3K7_HUMAN	P512L	-	-	-	increase	LQPLApPNSKE									VARIANT	P -> L (in FMD2; does not affect interaction with TAB2; does not affect homodimerization; increases autophosphorylation; increases MAPK signaling; increases NF-kappa-B signaling; dbSNP:rs886039230)	27426733	1
O43318/P512R	O43318	MAP3K7	M3K7_HUMAN	P512R	-	-	-	-	LQPLApPNSKE									MUTAGEN	P->R,A: Enhances autophosphorylation; Alters MAPK signaling.	27426733	1
O43318/R410Q	O43318	MAP3K7	M3K7_HUMAN	R410Q	-	-	-	-	YSKPKrHRKTA									VARIANT	R -> Q (found in a consanguineous family with intellectual disability; unknown pathological significance; dbSNP:rs201721045)	28397838	1
O43318/V100E	O43318	MAP3K7	M3K7_HUMAN	V100E	241	β4/β5-loop	-	-	ACLNPvLVMEY	0.625	0.509	0.626	0.55	0.283	0.459	0.677	0.547	VARIANT	V -> E (in FMD2; dbSNP:rs886039232)	27426733	1
O43318/W241R	O43318	MAP3K7	M3K7_HUMAN	W241R	738	αG/αH	-	-	AFRIMwVHNGT	0.628	0.518	0.615	0.6	0.329	0.46	0.608	0.401	VARIANT	W -> R (in CSCF; dbSNP:rs886039237)	27426734	1
O43353/D146N	O43353	RIPK2	RIPK2_HUMAN	D146N	443	Catalytic-loop;HrD-motif	-	loss	PLLHHdKTQNI	0.993	0.996	0.251	0.659	0.918	0.973	0.165	0.729	MUTAGEN	D->N: Abolishes kinase activity.	9705938	1
O43353/D467R	O43353	RIPK2	RIPK2_HUMAN	D467R	-	-	-	-	ALLSRdIMKED									MUTAGEN	D->R: Decreased interaction with NGFR.	26646181	1
O43353/E500R	O43353	RIPK2	RIPK2_HUMAN	E500R	-	-	-	-	DIQGEeAKVIV									MUTAGEN	E->R: Decreased interaction with NGFR.	26646181	1
O43353/I259T	O43353	RIPK2	RIPK2_HUMAN	I259T	758	αG/αH	-	neutral	SLPYDiHRARM	0.199	0.153	0.53	0.2	0.113	0.123	0.683	0.176	VARIANT	I -> T (in dbSNP:rs2230801)	17344846	1
O43353/I496A	O43353	RIPK2	RIPK2_HUMAN	I496A	-	-	-	-	LDTTDiGEEFA									MUTAGEN	I->A: Decreased interaction with NGFR.	26646181	1
O43353/K209R	O43353	RIPK2	RIPK2_HUMAN	K209R	598	αF	ub	decrease	SRASIkDIYSY	0.71	0.71	0.531	0.664	0.497	0.533	0.58	0.341	MUTAGEN	K->R: Complete loss of polyubiquitination.	18079694	1
O43353/K313N	O43353	RIPK2	RIPK2_HUMAN	K313N	835	C-term-αI	-	-	QLKKTkQSVSS	0.358	0.35	0.491	0.426	0.269	0.332	0.631	0.231	VARIANT	K -> N (in dbSNP:rs35395048)	17344846	1
O43353/K471E	O43353	RIPK2	RIPK2_HUMAN	K471E	-	-	-	-	RDLIMkDYELV									MUTAGEN	K->E: Decreased interaction with NGFR.	26646181	1
O43353/K47A	O43353	RIPK2	RIPK2_HUMAN	K47A	129	β3;Catalytic-Lys	-	loss	VQVAVkLHIHT	1.0	1.0	0.019	0.63	0.997	0.999	0.005	0.667	MUTAGEN	K->A: Abolishes kinase activity.	9575181,9642260	2
O43353/K47M	O43353	RIPK2	RIPK2_HUMAN	K47M	129	β3;Catalytic-Lys	-	-	VQVAVkLHIHT	0.985	1.0	0.045	0.588	0.991	0.999	0.028	0.502	MUTAGEN	K->M: Reduces FAS-mediated apoptosis.	9575181,9642260	2
O43353/K503R	O43353	RIPK2	RIPK2_HUMAN	K503R	-	-	-	increase	GEEFAkIVQKL									MUTAGEN	K->R: Abolished ubiquitination by ZNRF4.	28656966	1
O43353/L268V	O43353	RIPK2	RIPK2_HUMAN	L268V	788	αH	-	neutral	ARMISlESGWA	0.377	0.403	0.571	0.394	0.244	0.373	0.622	0.376	VARIANT	L -> V (in dbSNP:rs35004667)	17344846	1
O43353/Q437E	O43353	RIPK2	RIPK2_HUMAN	Q437E	-	-	-	-	QPGIAqWIQSK									MUTAGEN	Q->E: Decreased interaction with NGFR.	26646181	1
O43353/R444E	O43353	RIPK2	RIPK2_HUMAN	R444E	-	-	-	-	WIQSKrDIVNQ									MUTAGEN	R->E: Abolishes interaction with NOD1.	17054981	1
O43353/R483E	O43353	RIPK2	RIPK2_HUMAN	R483E	-	-	-	-	STKPTrSKVRQ									MUTAGEN	R->E: Abolishes interaction with NOD1.	17054981	1
O43353/R488E	O43353	RIPK2	RIPK2_HUMAN	R488E	-	-	-	-	RTSKVrLLDTT									MUTAGEN	R->E: Abolishes interaction with NOD1.	17054981	1
O43353/R528E	O43353	RIPK2	RIPK2_HUMAN	R528E	-	-	-	-	ILVVSrPSLNL									MUTAGEN	R->E: Decreased interaction with NGFR.	26646181	1
O43353/Y381A	O43353	RIPK2	RIPK2_HUMAN	Y381A	-	-	p	decrease	KAQDCyMKLHH									MUTAGEN	Y->A: Prevents phosphorylation. Reduces serine and threonine phosphorylation of ARHGEF2.	21887730	1
O43353/Y474F	O43353	RIPK2	RIPK2_HUMAN	Y474F	-	-	p	-	IMKEDyLVSTK									MUTAGEN	Y->F: Decreases interaction with NOD2.	21123652	1
O43683/A106D	O43683	BUB1	BUB1_HUMAN	A106D	-	-	-	-	LYIAWaHLEAQ									MUTAGEN	A->D,W: Loss of interaction with KNL1.	17981135	1
O43683/A106W	O43683	BUB1	BUB1_HUMAN	A106W	-	-	-	-	LYIAWaHLEAQ									MUTAGEN	A->D,W: Loss of interaction with KNL1.	17981135	1
O43683/A130S	O43683	BUB1	BUB1_HUMAN	A130S	-	-	-	-	GIQNQaPREFL									MUTAGEN	A->S: Partial rescue of the spindle-assembly checkpoint activity. Increased rate of chromosome congression errors. Impaired localization to kinetochores and loss of kinetochore binding of CENPF, SGO1 and BUBR1 but not of MCAK, MAD1L1 or MAD2L1.	19487456	1
O43683/E36D	O43683	BUB1	BUB1_HUMAN	E36D	-	-	-	-	IQWVEeFPENK									VARIANT	E -> D (in colorectal cancer; dbSNP:rs1801328)	10366450	1
O43683/E536A	O43683	BUB1	BUB1_HUMAN	E536A	-	-	-	-	EDGNKeYGLPQ									MUTAGEN	E->A: Loss of ubiquitination and CDH1-dependent degradation; when associated with A-535 and A-537.	17158872	1
O43683/E626A	O43683	BUB1	BUB1_HUMAN	E626A	-	-	-	-	ILEDKeVVAKQ									MUTAGEN	E->A: Loss of ubiquitination and CDH1-dependent degradation; when associated with A-625 and A-627.	17158872	1
O43683/G20D	O43683	BUB1	BUB1_HUMAN	G20D	-	-	-	-	MQSYKgDPLGE									VARIANT	G -> D (in dbSNP:rs35890336)	17344846	1
O43683/H265N	O43683	BUB1	BUB1_HUMAN	H265N	-	-	-	-	NQRRKhQWVNE									VARIANT	H -> N (in pancreatic cancer; associated with C-259; complete rescue of the spindle-assembly checkpoint activity; increased rate of chromosome congression errors)	12655561,19487456	2
O43683/K535A	O43683	BUB1	BUB1_HUMAN	K535A	-	-	ub	-	FEDGNkNYGLP									MUTAGEN	K->A: Loss of ubiquitination and CDH1-dependent degradation; when associated with A-536 and A-537.	17158872	1
O43683/K625A	O43683	BUB1	BUB1_HUMAN	K625A	-	-	-	-	HILEDkNVVAK									MUTAGEN	K->A: Loss of ubiquitination and CDH1-dependent degradation; when associated with A-626 and A-627.	17158872	1
O43683/K821A	O43683	BUB1	BUB1_HUMAN	K821A	137	αC	-	loss	QKFVLkQKPAN	0.892	0.861	0.425	0.592	0.733	0.815	0.368	0.63	MUTAGEN	K->A: Loss of activity.	10198256	1
O43683/L122G	O43683	BUB1	BUB1_HUMAN	L122G	-	-	-	-	HASAVlRGIQN									MUTAGEN	L->G: Loss of interaction with KNL1.	17981135	1
O43683/N534D	O43683	BUB1	BUB1_HUMAN	N534D	-	-	-	-	VFEDGnENYGL									VARIANT	N -> D (in dbSNP:rs36109304)	17344846	1
O43683/N537A	O43683	BUB1	BUB1_HUMAN	N537A	-	-	-	-	DGNKEnGLPQP									MUTAGEN	N->A: Loss of ubiquitination and CDH1-dependent degradation; when associated with A-535 and A-536.	17158872	1
O43683/N627A	O43683	BUB1	BUB1_HUMAN	N627A	-	-	-	-	LEDKEnVAKQC									MUTAGEN	N->A: Loss of ubiquitination and CDH1-dependent degradation; when associated with A-625 and A-626.	17158872	1
O43683/P648R	O43683	BUB1	BUB1_HUMAN	P648R	-	-	-	-	ENMVVpRDGKF									VARIANT	P -> R (in colorectal cancer; dbSNP:rs376649190)	10366450	1
O43683/S492Y	O43683	BUB1	BUB1_HUMAN	S492Y	-	-	-	-	KDEWQsDQNED									VARIANT	S -> Y (in colorectal cancer; dbSNP:rs121909055)	9521327	1
O43683/T609A	O43683	BUB1	BUB1_HUMAN	T609A	-	-	p	-	AQLAStFHKLP									MUTAGEN	T->A: Diminished interaction with PLK1.	16760428	1
O43683/Y259C	O43683	BUB1	BUB1_HUMAN	Y259C	-	-	-	-	LRAQKyQRRKH									VARIANT	Y -> C (in pancreatic cancer; associated with N-265; failure to rescue the spindle-assembly checkpoint activity as a result of a deficient recruitment of MAD2L1 and BUBR1 to kinetochores; efficient restoration of chromosome congression; reduced binding to BUB3; rescue of the ability of kinetochores to bind SGO1 and CENPF but not MCAK)	12655561,19487456	2
O43781/K238M	O43781	DYRK3	DYRK3_HUMAN	K238M	129	β3;Catalytic-Lys	-	loss	QYVALkVRNEK	0.999	1.0	0.012	0.616	1.0	0.999	0.012	0.532	MUTAGEN	K->M: Kinase dead; Induces formation of stress granules-like in absence of stress. Impaired dissolution of membraneless organelles during mitosis, such as stress granules, nuclear speckles and pericentriolar material.	23415227,29634919,29973724	3
O43781/M239L	O43781	DYRK3	DYRK3_HUMAN	M239L	130	β3	-	-	YVALKmRNEKR	0.518	0.459	0.489	0.532	0.407	0.413	0.592	0.353	VARIANT	M -> L	17344846	1
O43781/S350A	O43781	DYRK3	DYRK3_HUMAN	S350A	491	Catalytic-loop	p	decrease	HHGRSsKVIDF	0.763	0.765	0.338	0.586	0.547	0.597	0.423	0.22	MUTAGEN	S->A: Decreased stability of the protein.	29634919	1
O43781/S350D	O43781	DYRK3	DYRK3_HUMAN	S350D	491	Catalytic-loop	p	increase	HHGRSsKVIDF	0.81	0.74	0.773	0.83	0.182	0.5	0.825	0.242	MUTAGEN	S->E,D: Phosphomimetic mutant; increased stability of the protein.	29634919	1
O43781/S350E	O43781	DYRK3	DYRK3_HUMAN	S350E	491	Catalytic-loop	p	increase	HHGRSsKVIDF	0.807	0.719	0.718	0.778	0.237	0.512	0.753	0.319	MUTAGEN	S->E,D: Phosphomimetic mutant; increased stability of the protein.	29634919	1
O60229/E1326D	O60229	KALRN	KALRN_HUMAN	E1326D	-	-	-	-	GILNKeIIFGN									VARIANT	E -> D (in dbSNP:rs2289838)		0
O60229/R213W	O60229	KALRN	KALRN_HUMAN	R213W	-	-	-	-	QEMLArEFPVD									VARIANT	R -> W (in a colorectal cancer sample; somatic mutation; dbSNP:rs1187034389)	16959974	1
O60229/S196L	O60229	KALRN	KALRN_HUMAN	S196L	-	-	-	-	EEFFNsVHLLS									VARIANT	S -> L	17344846	1
O60285/G419D	O60285	NUAK1	NUAK1_HUMAN	G419D	-	-	-	-	TGFIEgVGPAL									VARIANT	G -> D (in dbSNP:rs55774704)	17344846	1
O60285/K84A	O60285	NUAK1	NUAK1_HUMAN	K84A	129	β3;Catalytic-Lys	-	loss	RVVAIkIRKDK	1.0	1.0	0.012	0.615	1.0	0.998	0.003	0.664	MUTAGEN	K->A: Abolishes kinase activity and ability to induce senescence.	19927127,21317932	2
O60285/P543R	O60285	NUAK1	NUAK1_HUMAN	P543R	-	-	-	-	PALVSpMPTLE									VARIANT	P -> R (in dbSNP:rs3741883)	17344846	1
O60285/S600A	O60285	NUAK1	NUAK1_HUMAN	S600A	-	-	p	loss	RQRIRsVSAEN									MUTAGEN	S->A: Abrogates phosphorylation by PKB/AKT1. Does not affect ability to induce senescence.	12409306,19927127	2
O60285/T211A	O60285	NUAK1	NUAK1_HUMAN	T211A	545	A-loop	p	loss	DKFLQtCGSPL	0.996	0.986	0.146	0.905	0.921	0.99	0.085	0.371	MUTAGEN	T->A: Prevents phosphorylation and activation by STK11/LKB1 complex. Abolishes ability to induce senescence.	14976552,19927127,21317932	3
O60307/F655L	O60307	MAST3	MAST3_HUMAN	F655L	838	C-term-αI	-	-	RHKAEfPQLEA	0.806	0.741	0.47	0.642	0.472	0.638	0.507	0.578	VARIANT	F -> L (found in a patient with autism spectrum disorder without history of seizures; unknown pathological significance)	34185323	1
O60307/G510S	O60307	MAST3	MAST3_HUMAN	G510S	498	A-loop;DFG-motif	-	-	KLTDFgSKIGL	0.923	0.926	0.383	0.765	0.549	0.845	0.347	0.574	VARIANT	G -> S (in DEE108)	34185323	1
O60307/G515S	O60307	MAST3	MAST3_HUMAN	G515S	509	A-loop	-	-	GLSKIgMSMAT	0.812	0.757	0.467	0.65	0.483	0.679	0.464	0.647	VARIANT	G -> S (in DEE108)	34185323,35095415	2
O60307/G861S	O60307	MAST3	MAST3_HUMAN	G861S	-	-	-	neutral	RPLDAgGRRLG									VARIANT	G -> S (in dbSNP:rs8108738)		0
O60307/G883S	O60307	MAST3	MAST3_HUMAN	G883S	-	-	-	-	RASSSgSGGGS									VARIANT	G -> S (in dbSNP:rs369960905)	17344846	1
O60307/L516P	O60307	MAST3	MAST3_HUMAN	L516P	510	A-loop	-	-	LSKIGlSMATN	0.852	0.814	0.638	0.778	0.43	0.673	0.573	0.485	VARIANT	L -> P (in DEE108)	34185323,35095415	2
O60307/R203Q	O60307	MAST3	MAST3_HUMAN	R203Q	-	-	-	-	YAPGArALADG									VARIANT	R -> Q (in dbSNP:rs35945810)		0
O60307/R406P	O60307	MAST3	MAST3_HUMAN	R406P	144	αC	-	-	QNLILrQIQQV	0.588	0.607	0.551	0.496	0.356	0.474	0.625	0.388	VARIANT	R -> P (in DEE108)	34185323	1
O60307/S101F	O60307	MAST3	MAST3_HUMAN	S101F	-	-	-	-	TNTPSsLSSSS									VARIANT	S -> F (in DEE108; unknown pathological significance)	35095415	1
O60307/S104L	O60307	MAST3	MAST3_HUMAN	S104L	-	-	-	-	PSSTLsSSSSR									VARIANT	S -> L (in DEE108)	35095415	1
O60307/V551L	O60307	MAST3	MAST3_HUMAN	V551L	558	αF	-	-	YIAPEvFRQGY	0.481	0.398	0.502	0.387	0.286	0.436	0.588	0.424	VARIANT	V -> L (in DEE108; unknown pathological significance)	34185323	1
O60566/A159W	O60566	BUB1B	BUB1B_HUMAN	A159W	-	-	-	-	FYISWaEYEAR									MUTAGEN	A->W: Loss of interaction with KNL1.	17981135	1
O60566/D579E	O60566	BUB1B	BUB1B_HUMAN	D579E	-	-	-	increase	SPDVCdFTGIE									MUTAGEN	D->E: Abolishes the cleavage by caspase-3.	16227576	1
O60566/D610E	O60566	BUB1B	BUB1B_HUMAN	D610E	-	-	-	increase	PEDTCdARAAR									MUTAGEN	D->E: Abolishes the cleavage by caspase-3.	16227576	1
O60566/E390D	O60566	BUB1B	BUB1B_HUMAN	E390D	-	-	-	neutral	HQQASeKKEKM									VARIANT	E -> D (in dbSNP:rs1017842)	17344846	1
O60566/F175A	O60566	BUB1B	BUB1B_HUMAN	F175A	-	-	-	-	KADAIfEGIQQ									MUTAGEN	F->A: Loss of interaction with KNL1.	17981135	1
O60566/I909T	O60566	BUB1B	BUB1B_HUMAN	I909T	494	Catalytic-loop	-	-	NQALKiDFSYS	0.672	0.599	0.487	0.575	0.385	0.513	0.542	0.426	VARIANT	I -> T (in MVA1; heterozygous compound with nonsense mutation; dbSNP:rs28989184)	15475955	1
O60566/K795A	O60566	BUB1B	BUB1B_HUMAN	K795A	6	N-term-β1	-	loss	ELTVIkSSQPV	0.869	0.831	0.431	0.618	0.655	0.778	0.396	0.661	MUTAGEN	K->A: Does not abolish the capacity to inhibit APC/CDC20.	11702782,12925705	2
O60566/K795R	O60566	BUB1B	BUB1B_HUMAN	K795R	6	N-term-β1	-	loss	ELTVIkSSQPV	0.719	0.655	0.478	0.59	0.478	0.617	0.507	0.399	MUTAGEN	K->R: Inhibits kinase activity.	11702782,12925705	2
O60566/L1012P	O60566	BUB1B	BUB1B_HUMAN	L1012P	-	-	-	-	ATVSVlELAAE									VARIANT	L -> P (in MVA1; heterozygous compound with nonsense mutation; dbSNP:rs28989185)	15475955	1
O60566/L844F	O60566	BUB1B	BUB1B_HUMAN	L844F	264	αD	-	-	INCFTlDLLQH	0.68	0.64	0.523	0.612	0.376	0.478	0.587	0.517	VARIANT	L -> F (in MVA1; associated with H-921; heterozygous compound with nonsense mutation; dbSNP:rs28989181)	15475955	1
O60566/M15T	O60566	BUB1B	BUB1B_HUMAN	M15T	-	-	-	-	ALSEAmLEGDE									VARIANT	M -> T (in a colorectal cancer cell line; dbSNP:rs1392369693)	9521327	1
O60566/P378S	O60566	BUB1B	BUB1B_HUMAN	P378S	-	-	-	-	KEEGDpQRVQS									VARIANT	P -> S (in dbSNP:rs17851677)	15489334	1
O60566/Q921H	O60566	BUB1B	BUB1B_HUMAN	Q921H	513	A-loop	-	-	VDLRVqDVFTL	0.635	0.508	0.546	0.569	0.309	0.465	0.69	0.336	VARIANT	Q -> H (in MVA1; associated with F-844; heterozygous compound with nonsense mutation; dbSNP:rs28989183)	15475955	1
O60566/R349Q	O60566	BUB1B	BUB1B_HUMAN	R349Q	-	-	-	neutral	VEETArPVMTP									VARIANT	R -> Q (in dbSNP:rs1801376)	10366450,14702039,15489334,17344846,9521327,9618306,9660858,9763420	8
O60566/R36Q	O60566	BUB1B	BUB1B_HUMAN	R36Q	-	-	-	-	PLRQGrMSTLQ									VARIANT	R -> Q (in PCS; dbSNP:rs534297115)	16411201	1
O60566/R550Q	O60566	BUB1B	BUB1B_HUMAN	R550Q	-	-	-	-	PADPPrLAQRR									VARIANT	R -> Q (in MVA1; heterozygous compound with nonsense mutation; dbSNP:rs28989187)	15475955	1
O60566/R814H	O60566	BUB1B	BUB1B_HUMAN	R814H	25	N-term-β1	-	-	LKLKErNEDFD	0.798	0.818	0.439	0.519	0.534	0.718	0.503	0.435	VARIANT	R -> H (in MVA1; heterozygous compound with nonsense mutation; dbSNP:rs28989182)	15475955	1
O60566/T40M	O60566	BUB1B	BUB1B_HUMAN	T40M	-	-	-	neutral	GRIMStQGALA									VARIANT	T -> M (in dbSNP:rs56079734)	17344846	1
O60566/T620A	O60566	BUB1B	BUB1B_HUMAN	T620A	-	-	p	-	ARFVStFHEIM									MUTAGEN	T->A: Induces chromosome congression defects and mitotic delay.	17785528	1
O60566/V618A	O60566	BUB1B	BUB1B_HUMAN	V618A	-	-	-	neutral	RAARFvTPFHE									VARIANT	V -> A (in dbSNP:rs1801528)	10366450,17344846	2
O60674/A377E	O60674	JAK2	JAK2_HUMAN	A377E	-	-	-	-	YYRLTaAHHYL									VARIANT	A -> E (in dbSNP:rs55953208)	17344846	1
O60674/D584E	O60674	JAK2	JAK2_HUMAN	D584E	-	-	-	-	LLKVLdAHRNY									VARIANT	D -> E (in dbSNP:rs17490221)		0
O60674/G127D	O60674	JAK2	JAK2_HUMAN	G127D	-	-	-	-	RWYCSgNRAYR									VARIANT	G -> D (in dbSNP:rs56118985)	17344846	1
O60674/K191Q	O60674	JAK2	JAK2_HUMAN	K191Q	-	-	-	-	MMRIAkNDQTP									VARIANT	K -> Q (in an ovarian serous carcinoma sample; somatic mutation)	17344846	1
O60674/K346R	O60674	JAK2	JAK2_HUMAN	K346R	-	-	-	-	VVTIHkDGKNL									VARIANT	K -> R (in dbSNP:rs55667734)	17344846	1
O60674/K539L	O60674	JAK2	JAK2_HUMAN	K539L	-	-	-	-	QMVFHkRNEDL									VARIANT	K -> L (in myeloproliferative disorder with erythrocytosis; requires 2 nucleotide substitutions; dbSNP:rs121912473)	17267906	1
O60674/K607N	O60674	JAK2	JAK2_HUMAN	K607N	-	-	-	-	SKLSHkLVLNY									VARIANT	K -> N (in AML; dbSNP:rs121912472)	16247455	1
O60674/L393V	O60674	JAK2	JAK2_HUMAN	L393V	-	-	-	neutral	APPAVlNIQSN									VARIANT	L -> V (in dbSNP:rs2230723)	17344846	1
O60674/R1063H	O60674	JAK2	JAK2_HUMAN	R1063H	648	αG	-	neutral	PAEFMrIGNDK	0.198	0.143	0.489	0.207	0.091	0.116	0.68	0.1	VARIANT	R -> H (in dbSNP:rs41316003)	17344846	1
O60674/V617F	O60674	JAK2	JAK2_HUMAN	V617F	-	-	-	activating	NYGVCvGDENI									VARIANT	V -> F (in PV, THCYT3 and AML; associated with susceptibility to Budd-Chiari syndrome; somatic mutation in a high percentage of patients with essential thrombocythemia or myelofibrosis; leads to constitutive tyrosine phosphorylation activity that promotes cytokine hypersensitivity; dbSNP:rs77375493)	15781101,15793561,15858187,16247455,16325696,16603627	6
O60674/V617I	O60674	JAK2	JAK2_HUMAN	V617I	-	-	-	-	NYGVCvGDENI									VARIANT	V -> I (in THCYT3; dbSNP:rs77375493)	22397670	1
O60885/A371G	O60885	BRD4	BRD4_HUMAN	A371G	-	-	-	-	AKKHAaAWPFY									VARIANT	A -> G (in dbSNP:rs55805532)	17344846	1
O60885/N140A	O60885	BRD4	BRD4_HUMAN	N140A	-	-	-	-	NCYIYnPGDDI									MUTAGEN	N->A: Abolishes binding to acetylated histones.	22464331,23728299	2
O60885/N433A	O60885	BRD4	BRD4_HUMAN	N433A	-	-	-	-	NCYKYnPDHEV									MUTAGEN	N->A: Abolishes binding to acetylated histones.	22464331	1
O60885/P37S	O60885	BRD4	BRD4_HUMAN	P37S	-	-	-	-	QAQPQpNAAST									VARIANT	P -> S (in dbSNP:rs35177876)	17344846	1
O60885/R1097H	O60885	BRD4	BRD4_HUMAN	R1097H	-	-	-	neutral	KKQELrASVVQ									VARIANT	R -> H (in dbSNP:rs35676845)		0
O60885/R669H	O60885	BRD4	BRD4_HUMAN	R669H	-	-	-	-	LRELErVTSCL									VARIANT	R -> H (in dbSNP:rs35824241)	17344846	1
O60885/S503A	O60885	BRD4	BRD4_HUMAN	S503A	-	-	p	decrease	SSTDDsEERAQ									MUTAGEN	S->A: Impaired phosphorylation by CK2 and binding to acetylated histones.	23317504	1
O60885/S563N	O60885	BRD4	BRD4_HUMAN	S563N	-	-	-	-	EENKKsAKEPP									VARIANT	S -> N (in dbSNP:rs55970906)	17344846	1
O60885/T598S	O60885	BRD4	BRD4_HUMAN	T598S	-	-	-	-	SKPPPtESEEE									VARIANT	T -> S (in dbSNP:rs34362023)	17344846	1
O75116/D1131A	O75116	ROCK2	ROCK2_HUMAN	D1131A	-	-	-	decrease	LHIGLdSSIGS									MUTAGEN	D->A: Abolishes cleavage by granzyme B.	15699075	1
O75116/D601V	O75116	ROCK2	ROCK2_HUMAN	D601V	-	-	-	-	ESNNRdQDKNC									VARIANT	D -> V (in dbSNP:rs35768389)	17344846	1
O75116/K1083M	O75116	ROCK2	ROCK2_HUMAN	K1083M	-	-	-	-	TQQMIkQKELN									VARIANT	K -> M (in dbSNP:rs34945852)		0
O75116/S1194P	O75116	ROCK2	ROCK2_HUMAN	S1194P	-	-	-	-	QDKEQsPYMVL									VARIANT	S -> P (in a metastatic melanoma sample; somatic mutation)	17344846	1
O75116/T431N	O75116	ROCK2	ROCK2_HUMAN	T431N	-	-	-	neutral	PSCREtSIQSR									VARIANT	T -> N (in dbSNP:rs2230774)	17344846,9734811,9933571	3
O75385/K46I	O75385	ULK1	ULK1_HUMAN	K46I	129	β3;Catalytic-Lys	-	loss	LEVAVkINKKN	1.0	0.996	0.025	0.653	0.993	0.999	0.025	0.533	MUTAGEN	K->I: Abolished serine/threonine-protein kinase activity.	20921139,28821708	2
O75385/P478L	O75385	ULK1	ULK1_HUMAN	P478L	-	-	-	neutral	FARASpPPAHA									VARIANT	P -> L (in dbSNP:rs12827141)	17344846	1
O75385/P714L	O75385	ULK1	ULK1_HUMAN	P714L	-	-	-	neutral	TQAPDpSTESL									VARIANT	P -> L (in dbSNP:rs11546871)	17344846	1
O75385/S298L	O75385	ULK1	ULK1_HUMAN	S298L	843	C-term-αI	-	-	PSYPSsSGSSS	0.554	0.458	0.621	0.484	0.248	0.32	0.655	0.372	VARIANT	S -> L (in dbSNP:rs56364352)	17344846	1
O75385/S665L	O75385	ULK1	ULK1_HUMAN	S665L	-	-	-	neutral	TLPDLsVGPFH									VARIANT	S -> L (in dbSNP:rs55815560)	17344846	1
O75385/S784C	O75385	ULK1	ULK1_HUMAN	S784C	-	-	-	-	TGSASsARHLV									VARIANT	S -> C (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
O75385/T503M	O75385	ULK1	ULK1_HUMAN	T503M	-	-	-	-	GGRPYtSPQVG									VARIANT	T -> M (in dbSNP:rs55824543)	17344846	1
O75385/T816A	O75385	ULK1	ULK1_HUMAN	T816A	-	-	-	neutral	FADPItNLEGA									VARIANT	T -> A (in dbSNP:rs11609348)	9693035,9872452	2
O75385/V290M	O75385	ULK1	ULK1_HUMAN	V290M	835	C-term-αI	-	-	RKSPPvVPSYP	0.237	0.269	0.454	0.236	0.139	0.181	0.65	0.062	VARIANT	V -> M (in an ovarian mucinous carcinoma sample; somatic mutation; dbSNP:rs370624303)	17344846	1
O75460/C109S	O75460	ERN1	ERN1_HUMAN	C109S	-	-	-	-	VQASPcSSDGI									MUTAGEN	C->S: No effect on dimerization. No effect on interaction with P4HB; when associated with S-148 and S-332.	12637535,32149426	2
O75460/C148S	O75460	ERN1	ERN1_HUMAN	C148S	-	-	-	-	FADSLcSTSLL									MUTAGEN	C->S: No effect on dimerization. Weakens dimer; when associated with S-332. Abolishes interaction with PDIA6. Prolonged splicing of XBP1, probably due to prolonged activation of PDIA6. Inhibits formation of oxidized multimeric forms of ERN1 in response to ER stress. No effect on interaction with P4HB; when associated with S-109 and S-332.	12637535,24508390,32149426	3
O75460/C332S	O75460	ERN1	ERN1_HUMAN	C332S	-	-	-	-	GDKGEcITPST									MUTAGEN	C->S: No effect on dimerization. Weakens dimer; when associated with S-148. No effect on interaction with P4HB; when associated with S-109 and S-148.	12637535,32149426	2
O75460/D123P	O75460	ERN1	ERN1_HUMAN	D123P	-	-	-	loss	MGKKQdWYVID									MUTAGEN	D->P: Abolishes ability to homodimerize.	16973740	1
O75460/K599A	O75460	ERN1	ERN1_HUMAN	K599A	129	β3;Catalytic-Lys	-	loss	RDVAVkILPEC	1.0	1.0	0.03	0.66	1.0	0.997	0.015	0.624	MUTAGEN	K->A: Loss of autophosphorylation and of endoribonuclease activity. Inhibition of growth arrest.	11175748,9637683	2
O75460/L474R	O75460	ERN1	ERN1_HUMAN	L474R	-	-	-	-	HQQQQlHQQFQ									VARIANT	L -> R (in a lung adenocarcinoma sample; somatic mutation; dbSNP:rs186305118)	17344846	1
O75460/N244S	O75460	ERN1	ERN1_HUMAN	N244S	-	-	-	-	KVMHInAVETL									VARIANT	N -> S (in a renal clear cell carcinoma sample; somatic mutation; dbSNP:rs1397145500)	17344846	1
O75460/N700S	O75460	ERN1	ERN1_HUMAN	N700S	480	Catalytic-loop	-	-	LISMPnHGKIK	0.164	0.161	0.486	0.192	0.169	0.178	0.617	0.24	VARIANT	N -> S (in dbSNP:rs918253870)	17344846	1
O75460/P830L	O75460	ERN1	ERN1_HUMAN	P830L	821	αI	-	-	HVLKHpFWSLE	0.773	0.747	0.496	0.7	0.574	0.682	0.448	0.664	VARIANT	P -> L (in an ovarian serous carcinoma sample; somatic mutation; dbSNP:rs1279653488)	17344846	1
O75460/Q105E	O75460	ERN1	ERN1_HUMAN	Q105E	-	-	-	decrease	IPELVqSPCRS									MUTAGEN	Q->E: Impaired ability to homodimerize.	16973740	1
O75460/R635W	O75460	ERN1	ERN1_HUMAN	R635W	239	β4/β5-loop	-	-	CTEKDrFQYIA	0.694	0.65	0.567	0.543	0.35	0.554	0.65	0.393	VARIANT	R -> W (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs146710304)	17344846	1
O75460/S769F	O75460	ERN1	ERN1_HUMAN	S769F	613	αF	-	-	FYYVIsGSHPF	0.562	0.602	0.585	0.483	0.402	0.508	0.641	0.489	VARIANT	S -> F (in a glioblastoma multiforme sample; somatic mutation)	17344846	1
O75460/V418M	O75460	ERN1	ERN1_HUMAN	V418M	-	-	-	-	NAPTTvRDVEE									VARIANT	V -> M (in dbSNP:rs55869215)	17344846	1
O75460/W125A	O75460	ERN1	ERN1_HUMAN	W125A	-	-	-	loss	KKQDIwVIDLL									MUTAGEN	W->A: Abolishes ability to homodimerize.	16973740	1
O75582/D195A	O75582	RPS6KA5	KS6A5_HUMAN	D195A	496	A-loop;DFG-motif	-	loss	HVVLTdGLSKE	0.942	0.928	0.128	0.607	0.935	0.886	0.132	0.574	MUTAGEN	D->A: Loss of kinase activity.	9687510	1
O75582/D554N	O75582	RPS6KA5	KS6A5_HUMAN	D554N	455	Catalytic-loop	-	-	NLLFTdNDNLE	0.402	0.356	0.498	0.379	0.317	0.312	0.547	0.394	VARIANT	D -> N (in dbSNP:rs55911249)	17344846	1
O75582/D565A	O75582	RPS6KA5	KS6A5_HUMAN	D565A	496	Catalytic-loop	-	loss	EIKIIdGFARL	0.996	0.967	0.114	0.567	0.987	0.97	0.078	0.696	MUTAGEN	D->A: Loss of kinase activity.	9687510	1
O75582/H190R	O75582	RPS6KA5	KS6A5_HUMAN	H190R	482	Catalytic-loop	-	-	LDSNGhVLTDF	0.723	0.747	0.389	0.599	0.555	0.607	0.409	0.435	VARIANT	H -> R (in dbSNP:rs34699345)		0
O75582/P574L	O75582	RPS6KA5	KS6A5_HUMAN	P574L	512	A-loop	-	-	ARLKPpNQPLK	0.667	0.645	0.623	0.592	0.371	0.573	0.67	0.417	VARIANT	P -> L (in dbSNP:rs34604933)	17344846	1
O75582/S212A	O75582	RPS6KA5	KS6A5_HUMAN	S212A	545	A-loop	p	loss	TERAYsCGTIE	0.965	0.988	0.172	0.85	0.91	0.988	0.153	0.412	MUTAGEN	S->A: Inactivates the N-terminal kinase domain.	15568999	1
O75582/S360A	O75582	RPS6KA5	KS6A5_HUMAN	S360A	-	-	p	decrease	MDPTYsAALPQ									MUTAGEN	S->A: Decreases kinase activity by 60% in response to PMA and UV-C.	15568999	1
O75582/S376A	O75582	RPS6KA5	KS6A5_HUMAN	S376A	-	-	p	loss	LFQGYsVAPSI									MUTAGEN	S->A: Loss of kinase activity, and decreases the phosphorylation of S-360 and T-581.	15568999	1
O75582/T581A	O75582	RPS6KA5	KS6A5_HUMAN	T581A	545	A-loop	p	loss	NQPLKtCFTLH	0.994	0.996	0.189	0.906	0.938	0.994	0.123	0.33	MUTAGEN	T->A: Loss of kinase activity, and blocks phosphorylation of S-212; S-376 and S-381 in response to 		0
O75582/T700A	O75582	RPS6KA5	KS6A5_HUMAN	T700A	837	C-term-αI	-	decrease	SNPLMtDILGS	0.507	0.584	0.427	0.298	0.482	0.606	0.48	0.12	MUTAGEN	T->A,D: Strongly reduces phosphorylation of T-581 in response to PMA and UV-C.	17117922	1
O75582/T700D	O75582	RPS6KA5	KS6A5_HUMAN	T700D	837	C-term-αI	-	decrease	SNPLMtDILGS	0.696	0.666	0.535	0.593	0.423	0.6	0.58	0.389	MUTAGEN	T->A,D: Strongly reduces phosphorylation of T-581 in response to PMA and UV-C.	17117922	1
O75582/Y599C	O75582	RPS6KA5	KS6A5_HUMAN	Y599C	592	αF	-	-	LNQNGyESCDL	0.87	0.883	0.467	0.673	0.619	0.698	0.41	0.465	VARIANT	Y -> C (in dbSNP:rs55968863)	17344846	1
O75676/F709A	O75676	RPS6KA4	KS6A4_HUMAN	F709A	-	-	-	increase	ATFMAfRGKRE									MUTAGEN	F->A: Strongly elevates basal activity.	11035004	1
O75676/S236L	O75676	RPS6KA4	KS6A4_HUMAN	S236L	619	αF	-	-	LLTGAsFTLEG	0.598	0.578	0.631	0.576	0.286	0.432	0.699	0.318	VARIANT	S -> L (in a breast infiltrating ductal carcinoma sample; somatic mutation; dbSNP:rs746466314)	17344846	1
O75676/S758A	O75676	RPS6KA4	KS6A4_HUMAN	S758A	-	-	-	neutral	RAPVAsGAPRR									VARIANT	S -> A (in dbSNP:rs17857342)	17344846	1
O75716/C6S	O75716	STK16	STK16_HUMAN	C6S	17	N-term-β1	-	-	MGHALcCSRGT	0.691	0.719	0.679	0.638	0.254	0.516	0.769	0.426	MUTAGEN	C->S: Loss of palmitoylation.	10364453	1
O75716/C8S	O75716	STK16	STK16_HUMAN	C8S	19	N-term-β1	-	-	HALCVcRGTVI	0.789	0.757	0.382	0.596	0.65	0.724	0.402	0.614	MUTAGEN	C->S: Loss of palmitoylation.	10364453	1
O75716/E55K	O75716	STK16	STK16_HUMAN	E55K	138	αC	-	-	RILCHeQDREE	0.453	0.422	0.64	0.466	0.306	0.32	0.725	0.252	VARIANT	E -> K (in dbSNP:rs35947471)	17344846	1
O75716/H41R	O75716	STK16	STK16_HUMAN	H41R	65	β2/β3-loop	-	-	LVEGLhGHFYA	0.5	0.435	0.493	0.449	0.475	0.394	0.596	0.275	VARIANT	H -> R (in dbSNP:rs34799131)	17344846	1
O75716/I77V	O75716	STK16	STK16_HUMAN	I77V	200	β4	-	-	FNHPNiRLVAY	0.222	0.246	0.495	0.277	0.211	0.217	0.65	0.241	VARIANT	I -> V (in dbSNP:rs34282267)	17344846	1
O75716/P277L	O75716	STK16	STK16_HUMAN	P277L	797	αI	-	-	MMTVDpQRPHI	0.709	0.68	0.493	0.552	0.507	0.621	0.551	0.398	VARIANT	P -> L (in dbSNP:rs35454203)	17344846	1
O75716/R266W	O75716	STK16	STK16_HUMAN	R266W	785	αH	-	neutral	HSSALrLLNSM	0.294	0.343	0.474	0.335	0.288	0.328	0.482	0.268	VARIANT	R -> W (in dbSNP:rs17849638)	15489334,17344846	2
O75914/A380E	O75914	PAK3	PAK3_HUMAN	A380E	401	αE	-	-	DEGQIaVCREC	0.72	0.674	0.683	0.658	0.392	0.501	0.711	0.444	VARIANT	A -> E (in XLID30; dbSNP:rs121434613)	12884430	1
O75914/R67C	O75914	PAK3	PAK3_HUMAN	R67C	-	-	-	-	KKEKErEISLP									VARIANT	R -> C (in XLID30; dbSNP:rs121434612)	10946356	1
O75914/T440S	O75914	PAK3	PAK3_HUMAN	T440S	549	A-loop	-	-	STMVGtYWMAP	0.852	0.858	0.354	0.725	0.664	0.832	0.393	0.372	VARIANT	T -> S (in a colorectal adenocarcinoma sample; somatic mutation)	17344846	1
O75962/D1368V	O75962	TRIO	TRIO_HUMAN	D1368V	-	-	-	-	EQLPEdGHCFV									VARIANT	D -> V (found in patient with severe intellectual disability; unknown pathological significance)	23033978	1
O75962/D348E	O75962	TRIO	TRIO_HUMAN	D348E	-	-	-	-	RLFEQdEKMFD									VARIANT	D -> E (in dbSNP:rs16903367)		0
O75962/E1299A	O75962	TRIO	TRIO_HUMAN	E1299A	-	-	-	decrease	EFIMAeIQTEK									MUTAGEN	E->A: 50% decrease in nucleotide exchange activity.	9790533	1
O75962/E1299K	O75962	TRIO	TRIO_HUMAN	E1299K	-	-	-	decrease	EFIMAeIQTEK									VARIANT	E -> K (in MRD44; severely decreased activation of RAC1-mediated signaling; severely decreased neurite outgrowth)	32109419	1
O75962/N1080I	O75962	TRIO	TRIO_HUMAN	N1080I	-	-	-	increase	TLARRnDVFLK									VARIANT	N -> I (in MRD63; slightly increased occipitofrontal circumference; increased activation of RAC1-mediated signaling; increased neurite outgrowth; dbSNP:rs879255628)	27418539,32109419	2
O75962/N1389A	O75962	TRIO	TRIO_HUMAN	N1389A	-	-	-	-	VTYCKnPDSTQ									MUTAGEN	N->A: No change in nucleotide exchange activity.	9790533	1
O75962/R1078G	O75962	TRIO	TRIO_HUMAN	R1078G	-	-	-	increase	ACTLArNADVF									VARIANT	R -> G (in MRD63; increased activation of RAC1-mediated signaling; increased neurite outgrowth)	32109419	1
O75962/R1078Q	O75962	TRIO	TRIO_HUMAN	R1078Q	-	-	-	increase	ACTLArNADVF									VARIANT	R -> Q (in MRD63; increased activation of RAC1-mediated signaling; increased neurite outgrowth)	32109419	1
O75962/R1078W	O75962	TRIO	TRIO_HUMAN	R1078W	-	-	-	increase	ACTLArNADVF									VARIANT	R -> W (in MRD63; increased activation of RAC1-mediated signaling; increased neurite outgrowth; dbSNP:rs1554065887)	32109419	1
O75962/R924S	O75962	TRIO	TRIO_HUMAN	R924S	-	-	-	-	VLGWIrGESML									VARIANT	R -> S (in MRD44; unknown pathological significance; dbSNP:rs772072746)	26721934	1
O75962/S291T	O75962	TRIO	TRIO_HUMAN	S291T	-	-	-	-	IQSSEsPKKNS									VARIANT	S -> T (in dbSNP:rs55772118)	17344846	1
O75962/T1075I	O75962	TRIO	TRIO_HUMAN	T1075I	-	-	-	increase	FLKACtARRNA									VARIANT	T -> I (in MRD63; slightly increased occipitofrontal circumference; increased activation of RAC1-mediated signaling; increased lamellipodia formation)	32109419	1
O75962/T1303A	O75962	TRIO	TRIO_HUMAN	T1303A	-	-	-	decrease	AELIQtKAYVR									MUTAGEN	T->A: 40% decrease in nucleotide exchange activity.	9790533	1
O75962/Y1238H	O75962	TRIO	TRIO_HUMAN	Y1238H	-	-	-	-	LRMEKyTSLEK									VARIANT	Y -> H (in MRD44; unknown pathological significance; dbSNP:rs756004023)	26721934	1
O76039/A374T	O76039	CDKL5	CDKL5_HUMAN	A374T	-	-	-	-	GNLAGaLSPLH									VARIANT	A -> T (in a metastatic melanoma sample; somatic mutation)	17344846	1
O76039/A40V	O76039	CDKL5	CDKL5_HUMAN	A40V	127	β3	-	decrease	THEIVaKKFKD	0.687	0.681	0.38	0.498	0.616	0.672	0.409	0.622	VARIANT	A -> V (in DEE2; causes mislocalization of the protein in the cytoplasm; dbSNP:rs122460159)	17993579,18790821	2
O76039/C152F	O76039	CDKL5	CDKL5_HUMAN	C152F	495	Catalytic-loop	-	decrease	DVLKLcFGFAR	0.841	0.768	0.446	0.574	0.673	0.739	0.433	0.518	VARIANT	C -> F (in DEE2; affect activity; causes mislocalization of the protein in the cytoplasm; dbSNP:rs122460157)	15499549,16935860	2
O76039/C291Y	O76039	CDKL5	CDKL5_HUMAN	C291Y	817	αI	-	-	YLTEQcNHPTF	0.68	0.647	0.602	0.611	0.336	0.574	0.597	0.546	VARIANT	C -> Y (in DEE2; dbSNP:rs267606714)	18809835	1
O76039/G207E	O76039	CDKL5	CDKL5_HUMAN	G207E	616	αF	-	-	GELSDgPLFPG	0.823	0.762	0.488	0.665	0.564	0.682	0.426	0.534	VARIANT	G -> E (in DEE2)	23708187	1
O76039/H127R	O76039	CDKL5	CDKL5_HUMAN	H127R	422	αE	-	-	AIHWChNDIVH	0.9	0.852	0.526	0.745	0.665	0.758	0.422	0.434	VARIANT	H -> R (in DEE2; dbSNP:rs267608468)	19241098	1
O76039/H145Y	O76039	CDKL5	CDKL5_HUMAN	H145Y	456	Catalytic-loop	-	-	NLLIShDVLKL	0.517	0.48	0.579	0.468	0.273	0.369	0.701	0.47	VARIANT	H -> Y (in DEE2; unknown pathological significance)	23708187	1
O76039/H581Y	O76039	CDKL5	CDKL5_HUMAN	H581Y	-	-	-	-	HMDSShHSLSA									VARIANT	H -> Y (in DEE2; unknown pathological significance)	23708187	1
O76039/I72N	O76039	CDKL5	CDKL5_HUMAN	I72N	200	β4	-	-	LKQENiELKEA	0.777	0.738	0.391	0.574	0.633	0.682	0.375	0.55	VARIANT	I -> N (in DEE2; dbSNP:rs62641235)	16015284	1
O76039/I72T	O76039	CDKL5	CDKL5_HUMAN	I72T	200	β4	-	-	LKQENiELKEA	0.797	0.764	0.544	0.641	0.551	0.701	0.489	0.593	VARIANT	I -> T (in DEE2; dbSNP:rs62641235)	19241098	1
O76039/L182P	O76039	CDKL5	CDKL5_HUMAN	L182P	558	αF	-	-	YRSPElLGAPY	0.855	0.763	0.506	0.647	0.619	0.656	0.492	0.626	VARIANT	L -> P (in DEE2)	23708187	1
O76039/L220P	O76039	CDKL5	CDKL5_HUMAN	L220P	651	αG	-	decrease	SEIDQlTIQKV	0.791	0.812	0.554	0.574	0.671	0.641	0.531	0.492	VARIANT	L -> P (in DEE2; causes mislocalization of the protein in the cytoplasm; dbSNP:rs267608511)	17993579,18790821	2
O76039/N368H	O76039	CDKL5	CDKL5_HUMAN	N368H	-	-	-	-	NESFLnNLAGA									VARIANT	N -> H (in a colorectal cancer sample; somatic mutation)	16959974	1
O76039/N399T	O76039	CDKL5	CDKL5_HUMAN	N399T	-	-	-	-	SKDLTnNIPHL									VARIANT	N -> T (in DEE2; dbSNP:rs267608611)	19253388	1
O76039/P180L	O76039	CDKL5	CDKL5_HUMAN	P180L	556	A-loop;APE-motif	-	-	RWYRSpLLLGA	0.71	0.673	0.473	0.623	0.63	0.627	0.447	0.598	VARIANT	P -> L (in DEE2; dbSNP:rs61749704)	16611748	1
O76039/P574Q	O76039	CDKL5	CDKL5_HUMAN	P574Q	-	-	-	-	EELKLpHMDSS									VARIANT	P -> Q (in an ovarian serous carcinoma sample; somatic mutation; dbSNP:rs199897804)	17344846	1
O76039/P647L	O76039	CDKL5	CDKL5_HUMAN	P647L	-	-	-	-	LQLLSpPGEQL									VARIANT	P -> L (probable disease-associated variant found in a patient with autism spectrum disorder)	25969726	1
O76039/Q791P	O76039	CDKL5	CDKL5_HUMAN	Q791P	-	-	-	neutral	KKKKSqVPNSD									VARIANT	Q -> P (in dbSNP:rs35478150)	12736870,15499549,17344846,19241098	4
O76039/R175S	O76039	CDKL5	CDKL5_HUMAN	R175S	551	A-loop	-	-	EYVATrYRSPE	0.915	0.769	0.472	0.663	0.616	0.719	0.428	0.61	VARIANT	R -> S (in DEE2; affect activity; does not affect the cellular distribution of the protein; dbSNP:rs61749700)	15499549,16935860	2
O76039/R178P	O76039	CDKL5	CDKL5_HUMAN	R178P	554	A-loop	-	-	ATRWYrPELLL	0.862	0.842	0.309	0.602	0.749	0.81	0.307	0.575	VARIANT	R -> P (in DEE2; dbSNP:rs267606715)	18809835	1
O76039/R178Q	O76039	CDKL5	CDKL5_HUMAN	R178Q	554	A-loop	-	-	ATRWYrPELLL	0.859	0.868	0.377	0.69	0.591	0.745	0.364	0.53	VARIANT	R -> Q (in DEE2; dbSNP:rs267606715)	23662938,23708187,24564546	3
O76039/R178W	O76039	CDKL5	CDKL5_HUMAN	R178W	554	A-loop	-	-	ATRWYrPELLL	0.787	0.821	0.364	0.653	0.616	0.71	0.374	0.517	VARIANT	R -> W (in DEE2; dbSNP:rs267608493)	26993267	1
O76039/R444C	O76039	CDKL5	CDKL5_HUMAN	R444C	-	-	-	-	RSQQNrSFMES									VARIANT	R -> C (in dbSNP:rs61753977)	16015284	1
O76039/R858C	O76039	CDKL5	CDKL5_HUMAN	R858C	-	-	-	-	ASSDPrQPLTA									VARIANT	R -> C (in DEE2; unknown pathological significance; dbSNP:rs773760466)	23708187	1
O76039/S196L	O76039	CDKL5	CDKL5_HUMAN	S196L	603	αF	-	-	SVDMWsGCILG	0.81	0.788	0.357	0.509	0.747	0.779	0.305	0.578	VARIANT	S -> L (in DEE2; dbSNP:rs267608501)	27864847	1
O76039/T288I	O76039	CDKL5	CDKL5_HUMAN	T288I	813	αI	-	-	ADRYLtQCLNH	0.273	0.264	0.691	0.401	0.195	0.194	0.809	0.334	VARIANT	T -> I (in DEE2; dbSNP:rs267606713)	18809835	1
O76039/T734A	O76039	CDKL5	CDKL5_HUMAN	T734A	-	-	-	-	ENNVStVSSLP									VARIANT	T -> A (in dbSNP:rs55803460)	17344846	1
O76039/V718M	O76039	CDKL5	CDKL5_HUMAN	V718M	-	-	-	-	GSFYRvSPRPD									VARIANT	V -> M (in DEE2; dbSNP:rs267608653)	18790821,26993267	2
O76039/V793A	O76039	CDKL5	CDKL5_HUMAN	V793A	-	-	-	-	KKSQTvNSDSP									VARIANT	V -> A (in DEE2; unknown pathological significance; dbSNP:rs62643617)	16611748	1
O94768/K62A	O94768	STK17B	ST17B_HUMAN	K62A	129	β3;Catalytic-Lys	ub	loss	QEYAAkLKKRR	1.0	1.0	0.026	0.689	1.0	0.998	0.021	0.658	MUTAGEN	K->A: Loss of activity and of apoptotic function.	9786912	1
O94768/S320F	O94768	STK17B	ST17B_HUMAN	S320F	850	C-term-αI	-	neutral	DHSVRsEDKTS	0.309	0.326	0.579	0.278	0.143	0.208	0.752	0.198	VARIANT	S -> F (in dbSNP:rs34740616)	17344846	1
O94804/C947Y	O94804	STK10	STK10_HUMAN	C947Y	-	-	-	-	SEEAEcNPSTP									VARIANT	C -> Y (in dbSNP:rs56355550)	17344846	1
O94804/K277E	O94804	STK10	STK10_HUMAN	K277E	795	αH/αI	-	-	KIALDkPETRP	0.679	0.659	0.612	0.58	0.377	0.563	0.629	0.406	VARIANT	K -> E (in TGCT; somatic mutation; dbSNP:rs757545210)	16175573,17344846	2
O94804/K65I	O94804	STK10	STK10_HUMAN	K65I	129	β3;Catalytic-Lys	-	loss	ALAAAkIETKS	0.999	0.993	0.033	0.626	0.994	0.999	0.031	0.532	MUTAGEN	K->I: Loss of kinase activity.	12639966	1
O94804/M710T	O94804	STK10	STK10_HUMAN	M710T	-	-	-	-	DLELAmRLTTD									VARIANT	M -> T (in dbSNP:rs34936670)	17344846	1
O94804/N467S	O94804	STK10	STK10_HUMAN	N467S	-	-	-	-	GEKLAnSLEPP									VARIANT	N -> S (in dbSNP:rs56063773)	17344846	1
O94804/P480L	O94804	STK10	STK10_HUMAN	P480L	-	-	-	-	QAAPGpKRDSD									VARIANT	P -> L (in dbSNP:rs34505340)		0
O94804/P520L	O94804	STK10	STK10_HUMAN	P520L	-	-	-	neutral	LSIKDpLYKKT									VARIANT	P -> L (in dbSNP:rs17074311)		0
O94804/R268C	O94804	STK10	STK10_HUMAN	R268C	785	αH	-	-	WSVEFrFLKIA	0.484	0.421	0.566	0.388	0.261	0.349	0.599	0.362	VARIANT	R -> C (in dbSNP:rs35826078)	17344846	1
O94804/R322W	O94804	STK10	STK10_HUMAN	R322W	851	C-term-αI	-	-	EIEDGrEGEEE	0.787	0.763	0.543	0.705	0.539	0.651	0.567	0.477	VARIANT	R -> W (in dbSNP:rs56214442)	17344846	1
O94804/S853L	O94804	STK10	STK10_HUMAN	S853L	-	-	-	neutral	EKRQKsRLQQQ									VARIANT	S -> L (in dbSNP:rs56066852)	17344846	1
O94804/S905T	O94804	STK10	STK10_HUMAN	S905T	-	-	-	-	KALDEsNQNLK									VARIANT	S -> T (in dbSNP:rs55791916)	17344846	1
O94804/S942N	O94804	STK10	STK10_HUMAN	S942N	-	-	-	-	MFFKLsEAECP									VARIANT	S -> N (in dbSNP:rs1128204)		0
O94804/T336I	O94804	STK10	STK10_HUMAN	T336I	-	-	-	-	VDAAStENHTQ									VARIANT	T -> I (in dbSNP:rs55972616)	17344846	1
O94806/A128T	O94806	PRKD3	KPCD3_HUMAN	A128T	-	-	-	-	QLITSaEIHEG									VARIANT	A -> T (in dbSNP:rs17852819)	15489334	1
O94806/I284V	O94806	PRKD3	KPCD3_HUMAN	I284V	-	-	-	-	YTRPTiQYCKR									MUTAGEN	I->V: Slight increase in ability to bind DAG, no effect on phorbol-ester binding.		0
O94806/K293W	O94806	PRKD3	KPCD3_HUMAN	K293W	-	-	-	-	CKRLLkLFRQG									MUTAGEN	K->W: Increased ability to bind DAG, no effect on phorbol-ester binding.	18076381	1
O94806/L445I	O94806	PRKD3	KPCD3_HUMAN	L445I	-	-	-	neutral	LDSKClLFQNE									VARIANT	L -> I (in dbSNP:rs55912911)		0
O94806/N42D	O94806	PRKD3	KPCD3_HUMAN	N42D	-	-	-	neutral	SARLSnSFSAP									VARIANT	N -> D (in dbSNP:rs11896614)		0
O94806/P165G	O94806	PRKD3	KPCD3_HUMAN	P165G	-	-	-	-	HSYKApFCDYC									MUTAGEN	P->G: No effect on ability to bind phorbol ester, loss of ability to bind DAG, reduced DAG-induced membrane translocation.	18076381	1
O94806/P225S	O94806	PRKD3	KPCD3_HUMAN	P225S	-	-	-	neutral	PGLSVpPLQPE									VARIANT	P -> S (in dbSNP:rs34280934)		0
O94806/P282G	O94806	PRKD3	KPCD3_HUMAN	P282G	-	-	-	-	HSYTRpICQYC									MUTAGEN	P->G: No effect on ability to bind phorbol ester, increase in ability to bind DAG.	18076381	1
O94806/Q546R	O94806	PRKD3	KPCD3_HUMAN	Q546R	-	-	-	-	CTSPGqKDHKD									VARIANT	Q -> R (in dbSNP:rs17856887)	15489334	1
O94806/T156A	O94806	PRKD3	KPCD3_HUMAN	T156A	-	-	-	-	QIRPHtYVHSY									MUTAGEN	T->A: Slight loss in ability to bind DAG and phorbol-ester; when associated with F-158.	18076381	1
O94806/T166A	O94806	PRKD3	KPCD3_HUMAN	T166A	-	-	-	-	SYKAPtCDYCG									MUTAGEN	T->A: Slight loss in ability to bind DAG and phorbol-ester.	18076381	1
O94806/V716M	O94806	PRKD3	KPCD3_HUMAN	V716M	492	Catalytic-loop	-	-	EPFPQvLCDFG	0.637	0.6	0.511	0.471	0.369	0.4	0.589	0.416	VARIANT	V -> M (in a glioblastoma multiforme sample; somatic mutation)	17344846	1
O94806/Y158F	O94806	PRKD3	KPCD3_HUMAN	Y158F	-	-	-	-	RPHTLyHSYKA									MUTAGEN	Y->F: Slight loss in ability to bind DAG and phorbol-ester; when associated with A-156.	18076381	1
O94806/Y170F	O94806	PRKD3	KPCD3_HUMAN	Y170F	-	-	-	-	PTFCDyGEMLW									MUTAGEN	Y->F: Slight loss in ability to bind DAG and phorbol-ester.	18076381	1
O94921/K164R	O94921	CDK14	CDK14_HUMAN	K164R	129	β3;Catalytic-Lys	-	loss	KLVALkIRLQE	1.0	0.996	0.101	0.756	0.919	0.997	0.119	0.449	MUTAGEN	K->R: Abolishes protein kinase activity.	17517622,19524571	2
O94921/M432I	O94921	CDK14	CDK14_HUMAN	M432I	836	C-term-αI	-	-	WELTDmSIFTV	0.237	0.146	0.431	0.267	0.128	0.144	0.626	0.272	VARIANT	M -> I (in an ovarian mucinous carcinoma; somatic mutation; dbSNP:rs773301216)	17344846	1
O94921/S463R	O94921	CDK14	CDK14_HUMAN	S463R	-	-	-	-	NSYGKsSNSKH									VARIANT	S -> R (in dbSNP:rs35643773)	17344846	1
O95382/A1061T	O95382	MAP3K6	M3K6_HUMAN	A1061T	-	-	-	-	AQELRaQGRLR									VARIANT	A -> T (in dbSNP:rs55990440)	17344846	1
O95382/G1233A	O95382	MAP3K6	M3K6_HUMAN	G1233A	-	-	-	neutral	LNVDSgIQMLL									VARIANT	G -> A (in dbSNP:rs17162549)		0
O95382/N622K	O95382	MAP3K6	M3K6_HUMAN	N622K	-	-	-	neutral	QAWVTnDSTAP									VARIANT	N -> K (in dbSNP:rs35659744)	17344846	1
O95382/P869T	O95382	MAP3K6	M3K6_HUMAN	P869T	675	αG/αH	-	-	MYKVHpMPSSL	0.68	0.657	0.455	0.533	0.489	0.559	0.455	0.514	VARIANT	P -> T (in a breast cancer sample; somatic mutation)	16959974	1
O95382/R499C	O95382	MAP3K6	M3K6_HUMAN	R499C	-	-	-	neutral	PGGPPrAHFWL									VARIANT	R -> C (in dbSNP:rs11247641)		0
O95382/R544W	O95382	MAP3K6	M3K6_HUMAN	R544W	-	-	-	-	AKLEVrTDPVS									VARIANT	R -> W (in dbSNP:rs55671988)	17344846	1
O95382/R668G	O95382	MAP3K6	M3K6_HUMAN	R668G	61	β2/β3-loop	-	-	YAGRDrTRVRI	0.443	0.453	0.594	0.488	0.35	0.37	0.653	0.335	VARIANT	R -> G (in dbSNP:rs55869163)	17344846	1
O95382/R673L	O95382	MAP3K6	M3K6_HUMAN	R673L	80	β2/β3-loop	-	-	RHTRVrAIKEI	0.455	0.469	0.557	0.448	0.409	0.342	0.567	0.254	VARIANT	R -> L (in dbSNP:rs56359841)	17344846	1
O95382/S925L	O95382	MAP3K6	M3K6_HUMAN	S925L	842	C-term-αI	-	-	HAPRPsAPSAS	0.271	0.252	0.594	0.313	0.235	0.207	0.646	0.412	VARIANT	S -> L (in a breast pleomorphic lobular carcinoma sample; somatic mutation)	17344846	1
O95382/S969N	O95382	MAP3K6	M3K6_HUMAN	S969N	-	-	-	-	SYGGTsLRVPE									VARIANT	S -> N (in dbSNP:rs17856498)	15489334	1
O95382/T455I	O95382	MAP3K6	M3K6_HUMAN	T455I	-	-	-	-	LANDPtVVLAA									VARIANT	T -> I (in dbSNP:rs1138294)	15489334,17210579	2
O95382/T968I	O95382	MAP3K6	M3K6_HUMAN	T968I	-	-	-	-	LSYGGtQLRVP									VARIANT	T -> I (in an ovarian endometrioid cancer sample; somatic mutation)	17344846	1
O95747/K46A	O95747	OXSR1	OXSR1_HUMAN	K46A	129	β3;Catalytic-Lys	-	loss	EKVAIkINLEK	1.0	1.0	0.034	0.67	0.995	0.997	0.013	0.639	MUTAGEN	K->A: Loss of autophosphorylation and kinase activity.	14707132,16389068	2
O95747/K46M	O95747	OXSR1	OXSR1_HUMAN	K46M	129	β3;Catalytic-Lys	-	loss	EKVAIkINLEK	1.0	0.996	0.025	0.637	0.993	0.999	0.023	0.519	MUTAGEN	K->M: Loss of RELT, RELL1 and RELL2 phosphorylation. Retention of some autophosphorylation activity may be due to complex formation with other endogenous kinases in the assay.	14707132,16389068	2
O95747/P433S	O95747	OXSR1	OXSR1_HUMAN	P433S	-	-	-	-	QETKIpSLVLR									VARIANT	P -> S (in a metastatic melanoma sample; somatic mutation)	17344846	1
O95747/S425T	O95747	OXSR1	OXSR1_HUMAN	S425T	-	-	p	-	ALSSGsSQETK									VARIANT	S -> T (in dbSNP:rs35295772)		0
O95747/T304I	O95747	OXSR1	OXSR1_HUMAN	T304I	836	C-term-αI	-	neutral	FLQEKtQRAPT	0.348	0.376	0.52	0.387	0.19	0.217	0.696	0.223	VARIANT	T -> I (in dbSNP:rs6599079)	10083736,17344846	2
O95819/S712T	O95819	MAP4K4	M4K4_HUMAN	S712T	-	-	p	-	RSSSKsGSPSQ									VARIANT	S -> T	17344846	1
O95835/F641L	O95835	LATS1	LATS1_HUMAN	F641L	-	-	-	-	PQAFKfMEQHV									VARIANT	F -> L (in dbSNP:rs35163691)	17344846	1
O95835/G1000S	O95835	LATS1	LATS1_HUMAN	G1000S	812	αI	-	-	RLGKNgDEIKA	0.528	0.517	0.47	0.409	0.377	0.423	0.535	0.407	VARIANT	G -> S (in dbSNP:rs56412005)	17344846	1
O95835/K734A	O95835	LATS1	LATS1_HUMAN	K734A	129	β3;Catalytic-Lys	-	loss	ALYATkLRKKD	0.993	1.0	0.034	0.669	0.984	0.997	0.017	0.656	MUTAGEN	K->A: Loss of kinase activity, autophosphorylation, increased ploidy, prolonged duration of mitosis and lack of p53 expression.	15122335	1
O95835/M669I	O95835	LATS1	LATS1_HUMAN	M669I	-	-	-	-	LENEMmVGLSQ									VARIANT	M -> I (in a lung adenocarcinoma sample; somatic mutation; dbSNP:rs1390558952)	17344846	1
O95835/P237Q	O95835	LATS1	LATS1_HUMAN	P237Q	-	-	-	-	QRVNPpPPQVR									VARIANT	P -> Q (in dbSNP:rs56149740)	17344846	1
O95835/P531S	O95835	LATS1	LATS1_HUMAN	P531S	-	-	-	-	TVQPSpPEGTA									VARIANT	P -> S (in dbSNP:rs55874734)	17344846	1
O95835/R370W	O95835	LATS1	LATS1_HUMAN	R370W	-	-	-	-	AGTVNrPPPPY									VARIANT	R -> W (in dbSNP:rs56348064)	17344846	1
O95835/R806P	O95835	LATS1	LATS1_HUMAN	R806P	401	αE	-	-	PESLArYIAEL	0.798	0.825	0.521	0.614	0.497	0.674	0.539	0.419	VARIANT	R -> P (in a lung large cell carcinoma sample; somatic mutation)	17344846	1
O95835/R96W	O95835	LATS1	LATS1_HUMAN	R96W	-	-	-	neutral	ETNSSrTSEVN									VARIANT	R -> W (in dbSNP:rs55945045)	17344846	1
O95835/S204G	O95835	LATS1	LATS1_HUMAN	S204G	-	-	-	neutral	AYHSEsNSQTD									VARIANT	S -> G (in dbSNP:rs34793526)	17344846	1
O95835/S464A	O95835	LATS1	LATS1_HUMAN	S464A	-	-	p	loss	PVRSNsNNPLG									MUTAGEN	S->A: Abolishes phosphorylation by NUAK1 and NUAK2.	19927127	1
O95835/Y559F	O95835	LATS1	LATS1_HUMAN	Y559F	-	-	-	decrease	GPPPPyKHLLH									MUTAGEN	Y->F: Loss of interaction with YAP1.	18158288	1
O96013/A139T	O96013	PAK4	PAK4_HUMAN	A139T	-	-	-	-	SRGRFaHSEAG									VARIANT	A -> T (in dbSNP:rs35655056)	17344846	1
O96013/R135Q	O96013	PAK4	PAK4_HUMAN	R135Q	-	-	-	neutral	GKAGSrRFAGH									VARIANT	R -> Q (in dbSNP:rs56099436)	17344846	1
O96013/S445N	O96013	PAK4	PAK4_HUMAN	S445N	448	Catalytic-loop	-	activating	DIKSDsLLTHD	0.655	0.593	0.661	0.67	0.241	0.546	0.718	0.291	MUTAGEN	S->N: Approximately 30-fold increased autophosphorylation (constitutively active mutant).	11313478	1
O96013/S474E	O96013	PAK4	PAK4_HUMAN	S474E	545	A-loop	p	increase	VPRRKsVGTPY	0.99	0.982	0.775	0.965	0.331	0.939	0.801	0.474	MUTAGEN	S->E: Approximately 3-fold increased autophosphorylation.	11313478	1
O96017/A17S	O96017	CHEK2	CHK2_HUMAN	A17S	-	-	-	-	SHGSSaSQPHG									VARIANT	A -> S (in an osteogenic sarcoma sample; somatic mutation; might influence susceptibility to breast cancer; does not cause protein abrogation in familial colorectal cancer; dbSNP:rs137853008)	11746983	1
O96017/D347A	O96017	CHEK2	CHK2_HUMAN	D347A	443	Catalytic-loop;HrD-motif	-	loss	GIIHRdKPENV	0.996	1.0	0.183	0.706	0.971	0.984	0.095	0.551	MUTAGEN	D->A: Loss of kinase activity and of the ability to phosphorylate CDC25A.	11298456,9836640	2
O96017/D347N	O96017	CHEK2	CHK2_HUMAN	D347N	443	Catalytic-loop;HrD-motif	-	-	GIIHRdKPENV	0.983	0.989	0.215	0.59	0.937	0.968	0.14	0.611	VARIANT	D -> N (in dbSNP:rs28909980)		0
O96017/D368N	O96017	CHEK2	CHK2_HUMAN	D368N	496	A-loop;DFG-motif	-	loss	LIKITdGHSKI	0.973	0.973	0.217	0.646	0.963	0.942	0.128	0.612	MUTAGEN	D->N: Loss of autophosphorylation activity.	15342622	1
O96017/E239K	O96017	CHEK2	CHK2_HUMAN	E239K	57	β2/β3-loop	-	-	VKLAFeKTCKK	0.396	0.343	0.485	0.373	0.245	0.261	0.609	0.279	VARIANT	E -> K (in prostate cancer; germline mutation; dbSNP:rs121908702)	12533788	1
O96017/E501K	O96017	CHEK2	CHK2_HUMAN	E501K	838	C-term-αI	-	-	QDLLSeNESTA	0.189	0.143	0.542	0.205	0.072	0.14	0.769	0.137	VARIANT	E -> K (in dbSNP:rs17883172)		0
O96017/E64K	O96017	CHEK2	CHK2_HUMAN	E64K	-	-	-	-	TLSSLeVSTQE									VARIANT	E -> K (in prostate cancer; somatic mutation; dbSNP:rs141568342)	12533788	1
O96017/F447I	O96017	CHEK2	CHK2_HUMAN	F447I	673	αG/αH	-	-	SGKYNfPEVWA	0.337	0.348	0.457	0.304	0.299	0.28	0.564	0.249	VARIANT	F -> I (in dbSNP:rs17881473)		0
O96017/G167R	O96017	CHEK2	CHK2_HUMAN	G167R	-	-	-	-	DHSGNgFVNTE									VARIANT	G -> R (in prostate cancer; somatic mutation; dbSNP:rs72552322)	12533788	1
O96017/H371Y	O96017	CHEK2	CHK2_HUMAN	H371Y	499	A-loop	-	decrease	ITDFGhKILGE	0.592	0.64	0.512	0.451	0.397	0.5	0.665	0.243	VARIANT	H -> Y (confers a moderate risk of breast cancer; partially reduces kinase activity; dbSNP:rs531398630)	21618645	1
O96017/I157T	O96017	CHEK2	CHK2_HUMAN	I157T	-	-	-	decrease,neutral	PKNSYiYIEDH									VARIANT	I -> T (might influence susceptibility to different types of cancer; does not cause protein abrogation in familial colorectal cancer; loss of the ability to interact with and phosphorylate CDC25A and to promote CDC25A degradation in response to ionizing radiation; dbSNP:rs17879961)	10617473,11298456,11461078,12533788,12610780,14612911,15087378,15095295,15239132,15492928,15535844,15810020,15818573	13
O96017/I251F	O96017	CHEK2	CHK2_HUMAN	I251F	131	β3	-	-	VAIKIiKRKFA	0.667	0.633	0.51	0.666	0.413	0.576	0.595	0.553	VARIANT	I -> F (in prostate cancer; unknown pathological significance; dbSNP:rs587780189)	12533788	1
O96017/I448S	O96017	CHEK2	CHK2_HUMAN	I448S	674	αG/αH	-	neutral	GKYNFiEVWAE	0.242	0.221	0.435	0.255	0.181	0.172	0.523	0.307	VARIANT	I -> S (in dbSNP:rs17886163)		0
O96017/L436M	O96017	CHEK2	CHK2_HUMAN	L436M	636	αF/αG	-	-	RTQVSlDQITS	0.166	0.101	0.51	0.164	0.157	0.132	0.696	0.196	VARIANT	L -> M (in dbSNP:rs17882922)		0
O96017/L512V	O96017	CHEK2	CHK2_HUMAN	L512V	849	C-term-αI	-	-	ALPQVlQPSTS	0.208	0.134	0.407	0.168	0.138	0.168	0.666	0.138	VARIANT	L -> V (in dbSNP:rs17882942)		0
O96017/N446K	O96017	CHEK2	CHK2_HUMAN	N446K	672	αG/αH	-	-	TSGKYnIPEVW	0.112	0.164	0.419	0.153	0.113	0.119	0.669	0.135	VARIANT	N -> K (in dbSNP:rs17880867)		0
O96017/P85L	O96017	CHEK2	CHK2_HUMAN	P85L	-	-	-	-	PEDQEpEPTPA									VARIANT	P -> L (in an osteogenic sarcoma sample; neutral allele among Ashkenazi Jewish women; dbSNP:rs17883862)	11746983,15649950	2
O96017/R117G	O96017	CHEK2	CHK2_HUMAN	R117G	-	-	-	-	NYWFGrKSCEY									VARIANT	R -> G (in BC; dbSNP:rs28909982)	12454775,12610780,15818573	3
O96017/R137Q	O96017	CHEK2	CHK2_HUMAN	R137Q	-	-	-	-	RTDKYrYSKKH									VARIANT	R -> Q (might influence susceptibility to breast cancer; does not cause protein abrogation in familial colorectal cancer; dbSNP:rs368570187)	12454775,15818573	2
O96017/R145P	O96017	CHEK2	CHK2_HUMAN	R145P	-	-	-	-	SKKHFrFREVG									VARIANT	R -> P (in prostate cancer; somatic mutation; dbSNP:rs587781667)	12533788	1
O96017/R145W	O96017	CHEK2	CHK2_HUMAN	R145W	-	-	-	decrease	SKKHFrFREVG									VARIANT	R -> W (in colon cancer and LFS2; does not cause protein abrogation in familial colorectal cancer; loss of the ability to interact with and phosphorylate CDC25A and to promote CDC25A degradation in response to ionizing radiation; dbSNP:rs137853007)	10617473,11298456,11719428,12610780,15535844,15818573	6
O96017/R180C	O96017	CHEK2	CHK2_HUMAN	R180C	-	-	-	-	VGKGKrPLNNN									VARIANT	R -> C (in prostate cancer; somatic mutation; dbSNP:rs77130927)	12533788,21618645	2
O96017/R180H	O96017	CHEK2	CHK2_HUMAN	R180H	-	-	-	-	VGKGKrPLNNN									VARIANT	R -> H (in prostate cancer; somatic mutation; dbSNP:rs137853009)	12454775,12533788,15818573	3
O96017/R181C	O96017	CHEK2	CHK2_HUMAN	R181C	-	-	-	-	GKGKRrLNNNS									VARIANT	R -> C (in prostate cancer; somatic mutation; dbSNP:rs137853010)	12533788	1
O96017/R181H	O96017	CHEK2	CHK2_HUMAN	R181H	-	-	-	-	GKGKRrLNNNS									VARIANT	R -> H (in prostate cancer; somatic mutation; dbSNP:rs121908701)	12533788	1
O96017/R318H	O96017	CHEK2	CHK2_HUMAN	R318H	387	αD/αE-loop	-	-	VVGNKrKEATC	0.301	0.262	0.486	0.21	0.185	0.286	0.61	0.112	VARIANT	R -> H (in prostate cancer; unknown pathological significance; somatic mutation; dbSNP:rs143611747)	12533788	1
O96017/R406H	O96017	CHEK2	CHK2_HUMAN	R406H	596	αF	-	-	TAGYNrVDCWS	0.345	0.333	0.394	0.365	0.362	0.289	0.485	0.23	VARIANT	R -> H (in dbSNP:rs200649225)		0
O96017/S379A	O96017	CHEK2	CHK2_HUMAN	S379A	514	A-loop	p	decrease	ILGETsMRTLC	0.807	0.878	0.381	0.669	0.697	0.725	0.317	0.144	MUTAGEN	S->A: Abrogates autophosphorylation at Ser-379 and prevents ubiquitination.	18644861	1
O96017/S428F	O96017	CHEK2	CHK2_HUMAN	S428F	623	αF/αG	-	-	GYPPFsHRTQV	0.355	0.502	0.595	0.401	0.317	0.342	0.689	0.238	VARIANT	S -> F (may increase breast cancer risk; dbSNP:rs137853011)	15649950	1
O96017/S456A	O96017	CHEK2	CHK2_HUMAN	S456A	781	αH	p	-	VWAEVsKALDL	0.897	0.864	0.382	0.638	0.652	0.782	0.411	0.271	MUTAGEN	S->A: Increased ubiquitination and degradation by the proteasome.	17715138	1
O96017/S500C	O96017	CHEK2	CHK2_HUMAN	S500C	837	C-term-αI	-	-	FQDLLsENEST	0.448	0.49	0.567	0.348	0.278	0.439	0.728	0.077	VARIANT	S -> C (in dbSNP:rs28909981)		0
O96017/S73A	O96017	CHEK2	CHK2_HUMAN	S73A	-	-	p	decrease	TQELYsPEDQE									MUTAGEN	S->A: Impaired activation, phosphorylation by ATM and G2/M transition checkpoint.	16481012	1
O96017/T323P	O96017	CHEK2	CHK2_HUMAN	T323P	399	αE	-	-	RLKEAtKLYFY	0.586	0.537	0.579	0.502	0.351	0.429	0.626	0.365	VARIANT	T -> P (in prostate cancer; somatic mutation; dbSNP:rs750984976)	12533788	1
O96017/T383A	O96017	CHEK2	CHK2_HUMAN	T383A	545	A-loop	p	loss	TSLMRtCGTPT	0.999	1.0	0.173	0.937	0.981	0.993	0.08	0.471	MUTAGEN	T->A: Loss of phosphorylation in response to ionizing radiation.	11390408	1
O96017/T387A	O96017	CHEK2	CHK2_HUMAN	T387A	549	A-loop	p	loss	RTLCGtTYLAP	0.92	0.929	0.383	0.771	0.817	0.913	0.315	0.379	MUTAGEN	T->A: Loss of phosphorylation in response to ionizing radiation.	11390408	1
O96017/T476K	O96017	CHEK2	CHK2_HUMAN	T476K	804	αI	-	-	PKARFtEEALR	0.552	0.452	0.549	0.417	0.386	0.402	0.556	0.42	VARIANT	T -> K (in prostate cancer; somatic mutation)	12533788	1
O96017/T59K	O96017	CHEK2	CHK2_HUMAN	T59K	-	-	-	-	HSSSGtSSLET									VARIANT	T -> K (in multiple cancers; dbSNP:rs149991239)	12052256	1
O96017/T68A	O96017	CHEK2	CHK2_HUMAN	T68A	-	-	p	loss	LETVStELYSI									MUTAGEN	T->A: Loss of activation and phosphorylation.	11901158,15342622	2
O96017/Y327C	O96017	CHEK2	CHK2_HUMAN	Y327C	406	αE	-	-	ATCKLyYQMLL	0.741	0.646	0.613	0.711	0.348	0.564	0.611	0.39	VARIANT	Y -> C (in prostate cancer; unknown pathological significance; somatic mutation; dbSNP:rs587780194)	12533788	1
O96017/Y390C	O96017	CHEK2	CHK2_HUMAN	Y390C	553	A-loop	p	loss	CGTPTyAPEVL	0.955	0.909	0.371	0.661	0.857	0.877	0.241	0.503	VARIANT	Y -> C (in BC; does not phosphorylate p53/TP53; dbSNP:rs200928781)	25619829	1
P00519/A337T	P00519	ABL1	ABL1_HUMAN	A337T	302	αD/αE-loop	-	increase	RQEVNaVLLYM	0.366	0.343	0.502	0.423	0.124	0.228	0.703	0.176	VARIANT	A -> T (in CHDSKM; increases kinase activity; no effect on protein levels; dbSNP:rs1060499548)	28288113	1
P00519/G706V	P00519	ABL1	ABL1_HUMAN	G706V	-	-	-	-	GEEEGgSSSKR									VARIANT	G -> V (in dbSNP:rs34634745)	17344846	1
P00519/K247R	P00519	ABL1	ABL1_HUMAN	K247R	38	β1	-	neutral	ITMKHkGGGQY	0.138	0.118	0.463	0.111	0.13	0.135	0.628	0.136	VARIANT	K -> R (in dbSNP:rs34549764)		0
P00519/L140P	P00519	ABL1	ABL1_HUMAN	L140P	-	-	-	-	NAAEYlSSGIN									VARIANT	L -> P (in dbSNP:rs1064152)	3021337	1
P00519/P810L	P00519	ABL1	ABL1_HUMAN	P810L	-	-	-	neutral	SPGSSpNLTPK									VARIANT	P -> L (in dbSNP:rs2229071)	17344846	1
P00519/P900S	P00519	ABL1	ABL1_HUMAN	P900S	-	-	-	-	LKPAPpPPAAS									VARIANT	P -> S (in dbSNP:rs35266696)		0
P00519/R166K	P00519	ABL1	ABL1_HUMAN	R166K	-	-	-	-	RSISLrEGRVY									VARIANT	R -> K (in a melanoma sample; somatic mutation)	17344846	1
P00519/R47G	P00519	ABL1	ABL1_HUMAN	R47G	-	-	-	-	LSEAArNSKEN									VARIANT	R -> G (in a lung large cell carcinoma sample; somatic mutation)	17344846	1
P00519/S968P	P00519	ABL1	ABL1_HUMAN	S968P	-	-	-	-	TPKPQsKPSGT									VARIANT	S -> P (in dbSNP:rs1064165)		0
P00519/S972L	P00519	ABL1	ABL1_HUMAN	S972L	-	-	-	neutral	QSAKPsTPISP									VARIANT	S -> L (in dbSNP:rs2229067)	17344846	1
P00519/T735A	P00519	ABL1	ABL1_HUMAN	T735A	-	-	p	-	EWRSVtPRDLQ									MUTAGEN	T->A: Abolishes phosphorylation. Loss of binding 		0
P00519/T852P	P00519	ABL1	ABL1_HUMAN	T852P	-	-	p	-	AAEPVtTSKAG									VARIANT	T -> P (in dbSNP:rs1588283506)		0
P00519/Y226C	P00519	ABL1	ABL1_HUMAN	Y226C	13	N-term-β1	p	increase	NKPTVyVSPNY	0.85	0.867	0.499	0.777	0.487	0.688	0.451	0.285	VARIANT	Y -> C (in CHDSKM; increases kinase activity; no effect on protein levels; dbSNP:rs1060499547)	28288113	1
P00533/C1049A	P00533	EGFR	EGFR_HUMAN	C1049A	-	-	-	-	NSTVAcDRNGL									MUTAGEN	C->A: Decreased palmitoylation.	27153536	1
P00533/C1146A	P00533	EGFR	EGFR_HUMAN	C1146A	-	-	-	-	TVQPTcNSTFD									MUTAGEN	C->A: Decreased palmitoylation.	27153536	1
P00533/D587A	P00533	EGFR	EGFR_HUMAN	D587A	-	-	-	-	CAHYIdPHCVK									MUTAGEN	D->A: Increased EGF binding; when associated with A-590 and A-609.	19718021	1
P00533/D974A	P00533	EGFR	EGFR_HUMAN	D974A	819	αI	-	decrease	SKMARdQRYLV	0.773	0.707	0.524	0.531	0.628	0.662	0.515	0.509	MUTAGEN	D->A: Strongly reduced phosphorylation.		0
P00533/E690A	P00533	EGFR	EGFR_HUMAN	E690A	9	N-term-β1	-	decrease	ERELVeLTPSG	0.689	0.694	0.424	0.452	0.594	0.618	0.35	0.473	MUTAGEN	E->A: Reduced phosphorylation.	19560417,19563760	2
P00533/E709A	P00533	EGFR	EGFR_HUMAN	E709A	28	N-term-β1	-	-	LRILKeEFKKI	0.648	0.689	0.546	0.526	0.46	0.572	0.574	0.394	VARIANT	E -> A (found in a lung cancer sample; more sensitive to gefitinib than wild-type; dbSNP:rs397517085)	15623594,16205628,16533793	3
P00533/E709G	P00533	EGFR	EGFR_HUMAN	E709G	28	N-term-β1	-	activating	LRILKeEFKKI	0.67	0.681	0.613	0.605	0.384	0.576	0.672	0.508	VARIANT	E -> G (found in a lung cancer sample; constitutively activated kinase with higher levels of basal autophosphorylation; more sensitive to gefitinib than wild-type; dbSNP:rs397517085)	15623594,16205628	2
P00533/E709K	P00533	EGFR	EGFR_HUMAN	E709K	28	N-term-β1	-	-	LRILKeEFKKI	0.54	0.58	0.541	0.504	0.353	0.39	0.62	0.276	VARIANT	E -> K (found in a lung cancer sample; dbSNP:rs727504256)	16533793	1
P00533/E734K	P00533	EGFR	EGFR_HUMAN	E734K	101	β2/β3-loop	-	-	GLWIPeEKVKI	0.253	0.308	0.624	0.363	0.105	0.121	0.774	0.134	VARIANT	E -> K (found in a lung cancer sample; dbSNP:rs121913420)	16533793	1
P00533/F287A	P00533	EGFR	EGFR_HUMAN	F287A	-	-	-	-	EGKYSfATCVK									MUTAGEN	F->A: Strongly reduced autophosphorylation and activation of downstream kinases; when associated with A-309.	12297050	1
P00533/G428D	P00533	EGFR	EGFR_HUMAN	G428D	-	-	-	loss	LEIIRgTKQHG									VARIANT	G -> D (in NISBD2; loss of function; the mutant does not localize to the cell membrane; has diffuse cytoplasmic localization; dbSNP:rs606231253)	24691054	1
P00533/G719A	P00533	EGFR	EGFR_HUMAN	G719A	40	β1;Gly-rich-loop	-	resistance	KIKVLgGAFGT	0.815	0.727	0.499	0.631	0.539	0.615	0.541	0.694	VARIANT	G -> A (found in a lung cancer sample; dbSNP:rs121913428)	16533793	1
P00533/G719C	P00533	EGFR	EGFR_HUMAN	G719C	40	β1;Gly-rich-loop	-	-	KIKVLgGAFGT	0.833	0.809	0.444	0.741	0.571	0.704	0.474	0.564	VARIANT	G -> C (found in a lung cancer sample; dbSNP:rs28929495)	15623594,16533793	2
P00533/G719D	P00533	EGFR	EGFR_HUMAN	G719D	40	β1;Gly-rich-loop	-	-	KIKVLgGAFGT	0.859	0.876	0.44	0.759	0.606	0.773	0.448	0.459	VARIANT	G -> D (found in a lung cancer sample; dbSNP:rs121913428)	16533793	1
P00533/G719S	P00533	EGFR	EGFR_HUMAN	G719S	40	β1;Gly-rich-loop	-	activating	KIKVLgGAFGT	0.842	0.842	0.453	0.76	0.49	0.791	0.503	0.635	VARIANT	G -> S (found in a lung cancer sample; somatic mutation; strongly increased kinase activity; constitutively activated kinase with higher levels of basal autophosphorylation; more sensitive to gefitinib than wild-type; dbSNP:rs28929495)	15118125,15623594,16205628,16533793,17349580	5
P00533/G724S	P00533	EGFR	EGFR_HUMAN	G724S	45	Gly-rich-loop;β2	-	-	GSGAFgVYKGL	0.884	0.801	0.37	0.662	0.673	0.768	0.378	0.71	VARIANT	G -> S (found in a lung cancer sample; dbSNP:rs1051753269)	16533793	1
P00533/G873E	P00533	EGFR	EGFR_HUMAN	G873E	535	A-loop	-	-	EYHAEgKVPIK	0.499	0.438	0.548	0.427	0.389	0.393	0.591	0.383	VARIANT	G -> E (found in a lung cancer sample)	16533793	1
P00533/H590A	P00533	EGFR	EGFR_HUMAN	H590A	-	-	-	-	YIDGPhVKTCP									MUTAGEN	H->A: Increased EGF binding; when associated with A-587; A-590 and A-609.	19718021	1
P00533/H835L	P00533	EGFR	EGFR_HUMAN	H835L	441	Catalytic-loop;HrD-motif	-	-	DRRLVhDLAAR	0.794	0.759	0.562	0.671	0.588	0.684	0.597	0.5	VARIANT	H -> L (found in a lung cancer sample; more sensitive to gefitinib than wild-type; dbSNP:rs397517128)	15623594,16205628	2
P00533/H988P	P00533	EGFR	EGFR_HUMAN	H988P	833	C-term-αI	-	-	GDERMhPSPTD	0.491	0.53	0.516	0.526	0.337	0.412	0.589	0.375	VARIANT	H -> P (in dbSNP:rs17290699)		0
P00533/I706A	P00533	EGFR	EGFR_HUMAN	I706A	25	N-term-β1	-	loss	QALLRiKETEF	0.793	0.802	0.453	0.58	0.594	0.787	0.485	0.506	MUTAGEN	I->A: Abolishes phosphorylation.	19560417	1
P00533/K609A	P00533	EGFR	EGFR_HUMAN	K609A	-	-	-	-	NTLVWkADAGH									MUTAGEN	K->A: Decreases intramolecular interactions and facilitates EGF binding. Increased EGF binding; when associated with A-587; A-590 and A-609.	12620237,19718021	2
P00533/K745A	P00533	EGFR	EGFR_HUMAN	K745A	129	β3;Catalytic-Lys	m1	loss	IPVAIkLREAT	1.0	1.0	0.016	0.674	0.995	0.999	0.011	0.674	MUTAGEN	K->A,M: Abolishes kinase activity.	19560417	1
P00533/K745M	P00533	EGFR	EGFR_HUMAN	K745M	129	β3;Catalytic-Lys	m1	loss	IPVAIkLREAT	1.0	1.0	0.021	0.681	0.994	0.999	0.014	0.593	MUTAGEN	K->A,M: Abolishes kinase activity.	19560417	1
P00533/L1034R	P00533	EGFR	EGFR_HUMAN	L1034R	-	-	-	-	TSRTPlSSLSA									VARIANT	L -> R (in dbSNP:rs34352568)	17344846	1
P00533/L688A	P00533	EGFR	EGFR_HUMAN	L688A	7	N-term-β1	-	decrease	LQERElEPLTP	0.524	0.405	0.516	0.3	0.406	0.388	0.504	0.438	MUTAGEN	L->A: Strongly reduced phosphorylation.	19560417,19563760	2
P00533/L692A	P00533	EGFR	EGFR_HUMAN	L692A	11	N-term-β1	-	decrease	ELVEPlPSGEA	0.656	0.629	0.428	0.437	0.483	0.54	0.42	0.443	MUTAGEN	L->A,P: Strongly reduced phosphorylation.	19560417,19563760	2
P00533/L692P	P00533	EGFR	EGFR_HUMAN	L692P	11	N-term-β1	-	-	ELVEPlPSGEA	0.625	0.557	0.459	0.442	0.419	0.436	0.498	0.386	MUTAGEN	L->A,P: Strongly reduced phosphorylation.	19560417,19563760	2
P00533/L704A	P00533	EGFR	EGFR_HUMAN	L704A	23	N-term-β1	-	loss	PNQALlILKET	0.715	0.617	0.555	0.578	0.436	0.547	0.624	0.498	MUTAGEN	L->A: Abolishes phosphorylation.	19560417	1
P00533/L747F	P00533	EGFR	EGFR_HUMAN	L747F	131	β3	-	-	VAIKElEATSP	0.7	0.623	0.55	0.655	0.389	0.506	0.672	0.492	VARIANT	L -> F (found in a lung cancer sample)	16533793	1
P00533/L833V	P00533	EGFR	EGFR_HUMAN	L833V	438	Catalytic-loop	-	-	LEDRRlHRDLA	0.322	0.253	0.5	0.298	0.26	0.255	0.585	0.276	VARIANT	L -> V (found in a lung cancer sample; more sensitive to gefitinib than wild-type; dbSNP:rs397517126)	15623594,16205628,16533793	3
P00533/L838V	P00533	EGFR	EGFR_HUMAN	L838V	444	Catalytic-loop	-	-	LVHRDlARNVL	0.572	0.492	0.463	0.476	0.419	0.384	0.556	0.387	VARIANT	L -> V (found in a lung cancer sample; more sensitive to gefitinib than wild-type; dbSNP:rs864621996)	15623594,16205628	2
P00533/L858M	P00533	EGFR	EGFR_HUMAN	L858M	499	A-loop	-	-	ITDFGlKLLGA	0.673	0.702	0.493	0.625	0.405	0.568	0.57	0.45	VARIANT	L -> M (found in a lung cancer sample; dbSNP:rs121913443)	16533793	1
P00533/L858R	P00533	EGFR	EGFR_HUMAN	L858R	499	A-loop	-	activating	ITDFGlKLLGA	0.931	0.878	0.464	0.747	0.502	0.773	0.483	0.567	VARIANT	L -> R (found in a lung cancer sample; somatic mutation; constitutively activated enzyme with strongly increased kinase activity; more sensitive to gefitinib than wild-type; dbSNP:rs121434568)	15118125,15623594,16205628,16533793,17349580	5
P00533/L861Q	P00533	EGFR	EGFR_HUMAN	L861Q	505	A-loop	-	activating	FGLAKlGAEEK	0.9	0.684	0.704	0.9	0.164	0.573	0.732	0.885	VARIANT	L -> Q (found in a lung cancer sample; constitutively activated kinase with higher levels of basal autophosphorylation; more sensitive to gefitinib than wild-type; dbSNP:rs121913444)	15623594,16205628,16533793	3
P00533/N700A	P00533	EGFR	EGFR_HUMAN	N700A	19	N-term-β1	-	loss	SGEAPnALLRI	0.736	0.765	0.391	0.529	0.584	0.704	0.394	0.63	MUTAGEN	N->A: Abolishes phosphorylation.	19560417	1
P00533/P266R	P00533	EGFR	EGFR_HUMAN	P266R	-	-	-	-	KDTCPpMLYNP									VARIANT	P -> R (in dbSNP:rs17336639)		0
P00533/P694A	P00533	EGFR	EGFR_HUMAN	P694A	13	N-term-β1	-	decrease	VEPLTpGEAPN	0.727	0.751	0.294	0.469	0.728	0.689	0.248	0.483	MUTAGEN	P->A: Strongly reduced phosphorylation.	19560417	1
P00533/P699A	P00533	EGFR	EGFR_HUMAN	P699A	18	N-term-β1	-	decrease	PSGEApQALLR	0.765	0.649	0.342	0.355	0.68	0.634	0.313	0.562	MUTAGEN	P->A: Reduced phosphorylation.	19560417	1
P00533/Q1067G	P00533	EGFR	EGFR_HUMAN	Q1067G	-	-	-	-	EDSFLqYSSDP									MUTAGEN	Q->G: No effect on interaction with CBLC.	22888118	1
P00533/Q787R	P00533	EGFR	EGFR_HUMAN	Q787R	242	β5	-	-	LTSTVqITQLM	0.569	0.535	0.547	0.512	0.314	0.35	0.65	0.249	VARIANT	Q -> R (found in a lung cancer sample)	16533793	1
P00533/R1068G	P00533	EGFR	EGFR_HUMAN	R1068G	-	-	-	increase	DSFLQrSSDPT									MUTAGEN	R->G: Strongly decreases interaction with CBLC.	22888118	1
P00533/R309S	P00533	EGFR	EGFR_HUMAN	R309S	-	-	-	-	HGSCVrCGADS									MUTAGEN	R->S: Strongly reduced autophosphorylation and activation of downstream kinases; when associated with A-275. Strongly reduced autophosphorylation and activation of downstream kinases; when associated with A-287.	12297050	1
P00533/R429E	P00533	EGFR	EGFR_HUMAN	R429E	-	-	-	loss	EIIRGrKQHGQ									MUTAGEN	R->E: Abolishes autophosphorylation and activation of downstream kinases.	12297050	1
P00533/R521K	P00533	EGFR	EGFR_HUMAN	R521K	-	-	-	neutral	WGPEPrCVSCR									VARIANT	R -> K (in dbSNP:rs2227983)	17344846	1
P00533/R705A	P00533	EGFR	EGFR_HUMAN	R705A	24	N-term-β1	-	loss	NQALLrLKETE	0.834	0.793	0.468	0.666	0.706	0.774	0.441	0.361	MUTAGEN	R->A: Abolishes phosphorylation.	19560417	1
P00533/R748P	P00533	EGFR	EGFR_HUMAN	R748P	132	β3/αC-loop	-	-	AIKELrATSPK	0.671	0.669	0.518	0.547	0.441	0.533	0.613	0.291	VARIANT	R -> P (found in a lung cancer sample)	16533793	1
P00533/R962G	P00533	EGFR	EGFR_HUMAN	R962G	804	αI	-	-	SRPKFrLIIEF	0.596	0.639	0.532	0.484	0.332	0.466	0.684	0.176	VARIANT	R -> G (in dbSNP:rs17337451)		0
P00533/R977A	P00533	EGFR	EGFR_HUMAN	R977A	822	αI	-	decrease	ARDPQrLVIQG	0.892	0.907	0.392	0.7	0.802	0.854	0.285	0.522	MUTAGEN	R->A: Reduced phosphorylation.	19563760	1
P00533/R98Q	P00533	EGFR	EGFR_HUMAN	R98Q	-	-	-	-	LNTVErPLENL									VARIANT	R -> Q (in dbSNP:rs17289589)		0
P00533/S768I	P00533	EGFR	EGFR_HUMAN	S768I	188	αC/β4-loop	p	activating	AYVMAsDNPHV	0.822	0.774	0.648	0.808	0.297	0.66	0.647	0.629	VARIANT	S -> I (found in a lung cancer sample; constitutively activated kinase with higher levels of basal autophosphorylation; more sensitive to gefitinib than wild-type; dbSNP:rs121913465)	15623594,16205628	2
P00533/T693A	P00533	EGFR	EGFR_HUMAN	T693A	12	N-term-β1	p	-	LVEPLtSGEAP	0.723	0.784	0.457	0.684	0.48	0.64	0.534	0.259	MUTAGEN	T->A: Increased phosphorylation.	19560417	1
P00533/T693D	P00533	EGFR	EGFR_HUMAN	T693D	12	N-term-β1	p	decrease	LVEPLtSGEAP	0.824	0.756	0.654	0.755	0.252	0.562	0.745	0.293	MUTAGEN	T->D: Strongly reduced phosphorylation.	19560417	1
P00533/T790M	P00533	EGFR	EGFR_HUMAN	T790M	248	β5	-	increase,resistance	TVQLItLMPFG	0.673	0.444	0.463	0.374	0.367	0.341	0.554	0.775	VARIANT	T -> M (found in a lung cancer sample; increased kinase activity; dbSNP:rs121434569)	16533793,18227510	2
P00533/V674I	P00533	EGFR	EGFR_HUMAN	V674I	-	-	-	-	RRRHIvKRTLR									VARIANT	V -> I (in dbSNP:rs17337079)		0
P00533/V689A	P00533	EGFR	EGFR_HUMAN	V689A	8	N-term-β1	-	decrease	QERELvPLTPS	0.603	0.532	0.455	0.439	0.525	0.492	0.447	0.399	MUTAGEN	V->A: Reduced autophosphorylation.	19560417	1
P00533/V689M	P00533	EGFR	EGFR_HUMAN	V689M	8	N-term-β1	-	activating	QERELvPLTPS	0.423	0.317	0.462	0.326	0.341	0.273	0.597	0.171	MUTAGEN	V->M: Constitutively activated kinase.	19560417	1
P00533/V769M	P00533	EGFR	EGFR_HUMAN	V769M	189	αC/β4-loop	-	-	YVMASvNPHVC	0.352	0.341	0.499	0.325	0.14	0.237	0.709	0.296	VARIANT	V -> M (found in a lung cancer sample; dbSNP:rs147149347)	15623594	1
P00533/V834L	P00533	EGFR	EGFR_HUMAN	V834L	440	Catalytic-loop	-	-	EDRRLvRDLAA	0.345	0.258	0.54	0.33	0.245	0.24	0.653	0.201	VARIANT	V -> L (found in a lung cancer sample; dbSNP:rs397517127)	16533793	1
P00533/Y1016F	P00533	EGFR	EGFR_HUMAN	Y1016F	-	-	p	-	VDADEyIPQQG									MUTAGEN	Y->F: 50% decrease in interaction with PIK3C2B. 65% decrease in interaction with PIK3C2B; when associated with F-1197. Abolishes interaction with PIK3C2B; when associated with F-1197 and F-1092.	10805725	1
P00533/Y1069F	P00533	EGFR	EGFR_HUMAN	Y1069F	-	-	p	activating	SFLQRySDPTG									MUTAGEN	Y->F: Abolishes interaction with CBLC.	22888118	1
P00533/Y1092F	P00533	EGFR	EGFR_HUMAN	Y1092F	-	-	p	-	LPVPEyNQSVP									MUTAGEN	Y->F: No change in interaction with PIK3C2B. Abolishes interaction with PIK3C2B; when associated with F-1197 and F-1016.	10805725	1
P00533/Y1110F	P00533	EGFR	EGFR_HUMAN	Y1110F	-	-	p	-	VQNPVyNQPLN									MUTAGEN	Y->F: No change in interaction with PIK3C2B.	10805725	1
P00533/Y1172F	P00533	EGFR	EGFR_HUMAN	Y1172F	-	-	p	-	LDNPDyQDFFP									MUTAGEN	Y->F: No change in interaction with PIK3C2B.	10805725	1
P00533/Y1197F	P00533	EGFR	EGFR_HUMAN	Y1197F	-	-	p	-	AENAEyRVAPQ									MUTAGEN	Y->F: No change in interaction with PIK3C2B. 65% decrease in interaction with PIK3C2B; when associated with F-1016. Abolishes interaction with PIK3C2B; when associated with F-1092 and F-1016.	10805725	1
P00533/Y275A	P00533	EGFR	EGFR_HUMAN	Y275A	-	-	-	-	YNPTTyMDVNP									MUTAGEN	Y->A: Strongly reduced autophosphorylation and activation of downstream kinases; when associated with A-309.	12297050	1
P00540/A105S	P00540	MOS	MOS_HUMAN	A105S	172	αC	-	-	RRSFWaLNVAR	0.234	0.227	0.534	0.276	0.239	0.159	0.687	0.249	VARIANT	A -> S (in dbSNP:rs35392772)	15489334,17344846	2
P00540/A123T	P00540	MOS	MOS_HUMAN	A123T	207	β4/β5-loop	-	-	VRVVAaTRTPA	0.605	0.546	0.475	0.491	0.421	0.466	0.523	0.499	VARIANT	A -> T (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
P00540/R96L	P00540	MOS	MOS_HUMAN	R96L	143	αC	-	-	KCTKNrASRRS	0.199	0.198	0.579	0.315	0.164	0.108	0.714	0.173	VARIANT	R -> L (in dbSNP:rs34532635)	17344846	1
P00540/S300P	P00540	MOS	MOS_HUMAN	S300P	672	αG/αH	-	-	LRPSLsAVFED	0.191	0.223	0.487	0.314	0.16	0.165	0.701	0.219	VARIANT	S -> P (in dbSNP:rs56300224)	17344846	1
P04049/A237T	P04049	RAF1	RAF1_HUMAN	A237T	-	-	-	increase	YSTPHaTFNTS									VARIANT	A -> T (in CMD1NN; shows a mild increase in kinase activity; dbSNP:rs587777588)	24777450	1
P04049/D486G	P04049	RAF1	RAF1_HUMAN	D486G	496	A-loop;DFG-motif	-	-	TVKIGdGLATV	0.974	0.964	0.26	0.619	0.886	0.937	0.195	0.687	VARIANT	D -> G (in NS5; dbSNP:rs397516815)	17603483	1
P04049/D486N	P04049	RAF1	RAF1_HUMAN	D486N	496	A-loop;DFG-motif	-	loss	TVKIGdGLATV	0.975	0.989	0.171	0.615	0.96	0.963	0.109	0.601	VARIANT	D -> N (in NS5; has reduced or absent kinase activity; dbSNP:rs80338798)	17603483	1
P04049/H626R	P04049	RAF1	RAF1_HUMAN	H626R	831	C-term-αI	-	increase	SEPSLhAAHTE	0.253	0.259	0.503	0.257	0.243	0.196	0.685	0.157	VARIANT	H -> R (in CMD1NN; shows a mild increase in kinase activity; dbSNP:rs1553609795)	24777450	1
P04049/K375W	P04049	RAF1	RAF1_HUMAN	K375W	129	β3;Catalytic-Lys	-	loss	GDVAVkLKVVD	0.988	0.985	0.094	0.742	0.951	0.98	0.087	0.447	MUTAGEN	K->W: Catalytically inactive.	20956560	1
P04049/L603P	P04049	RAF1	RAF1_HUMAN	L603P	807	αI	-	decrease	LFPQIlSIELL	0.835	0.803	0.556	0.609	0.668	0.648	0.481	0.562	VARIANT	L -> P (in CMD1NN; shows impaired kinase activity and reduced MAPK3 activation with this mutation; dbSNP:rs587777586)	24777450	1
P04049/L613V	P04049	RAF1	RAF1_HUMAN	L613V	818	αI	-	increase	LLQHSlKINRS	0.403	0.38	0.541	0.435	0.186	0.279	0.749	0.194	VARIANT	L -> V (in NS5 and LPRD2; shows in vitro greater kinase activity and enhanced MAPK1 activation than wild-type; dbSNP:rs80338797)	17603482,17603483	2
P04049/P261A	P04049	RAF1	RAF1_HUMAN	P261A	-	-	-	increase	RSTSTpVHMVS									VARIANT	P -> A (in NS5; shows in vitro greater kinase activity and enhanced MAPK1 activation than wild-type; dbSNP:rs121434594)	17603482	1
P04049/P261L	P04049	RAF1	RAF1_HUMAN	P261L	-	-	-	increase	RSTSTpVHMVS									VARIANT	P -> L (in NS5; shows greater kinase activity and enhanced MAPK1 activation than wild-type; dbSNP:rs397516828)	17603483	1
P04049/P261S	P04049	RAF1	RAF1_HUMAN	P261S	-	-	-	increase	RSTSTpVHMVS									VARIANT	P -> S (in NS5; shows in vitro greater kinase activity and enhanced MAPK1 activation than wild-type; dbSNP:rs121434594)	17603482,17603483,20683980	3
P04049/P308L	P04049	RAF1	RAF1_HUMAN	P308L	-	-	-	-	TGWSQpTPVPA									VARIANT	P -> L (in dbSNP:rs5746220)	14702039	1
P04049/P332A	P04049	RAF1	RAF1_HUMAN	P332A	11	N-term-β1	-	increase	KNKIRpGQRDS	0.223	0.314	0.378	0.154	0.309	0.261	0.422	0.157	VARIANT	P -> A (in CMD1NN; shows a mild increase in kinase activity; dbSNP:rs1057403865)	24777450	1
P04049/Q335H	P04049	RAF1	RAF1_HUMAN	Q335H	14	N-term-β1	-	-	IRPRGqDSSYY	0.191	0.249	0.607	0.295	0.19	0.168	0.731	0.149	VARIANT	Q -> H (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
P04049/R256S	P04049	RAF1	RAF1_HUMAN	R256S	-	-	-	-	LSQRQrTSTPN									VARIANT	R -> S (in NS5; dbSNP:rs397516826)	17603483	1
P04049/R563K	P04049	RAF1	RAF1_HUMAN	R563K	652	αG	-	increase	IFMVGrYASPD	0.755	0.772	0.601	0.8	0.265	0.602	0.703	0.369	MUTAGEN	R->K: Loss of methylation. Increased stability and catalytic activity in response to EGF treatment.	21917714	1
P04049/S257L	P04049	RAF1	RAF1_HUMAN	S257L	-	-	p	increase	SQRQRsSTPNV									VARIANT	S -> L (in NS5 and LPRD2; shows in vitro greater kinase activity and enhanced ERK activation than wild-type; dbSNP:rs80338796)	17603482,17603483	2
P04049/S259A	P04049	RAF1	RAF1_HUMAN	S259A	-	-	p	increase	RQRSTsPNVHM									VARIANT	S -> A (in an ovarian serous carcinoma sample; somatic mutation; increased ERK activation; dbSNP:rs3730271)	16630891,17344846	2
P04049/S259F	P04049	RAF1	RAF1_HUMAN	S259F	-	-	p	-	RQRSTsPNVHM									VARIANT	S -> F (in NS5; dbSNP:rs397516827)	17603483	1
P04049/S494D	P04049	RAF1	RAF1_HUMAN	S494D	504	A-loop	p	activating	LATVKsWSGSQ	0.717	0.639	0.649	0.787	0.183	0.355	0.752	0.205	MUTAGEN	S->D: Increased kinase activity but can still be inhibited by PPP5C; when associated with D-491.	16892053	1
P04049/S612T	P04049	RAF1	RAF1_HUMAN	S612T	817	αI	p	-	ELLQHsPKINR	0.551	0.568	0.453	0.557	0.212	0.399	0.635	0.042	VARIANT	S -> T (in NS5; dbSNP:rs1448392469)	17603483	1
P04049/T260I	P04049	RAF1	RAF1_HUMAN	T260I	-	-	p	-	QRSTStNVHMV									VARIANT	T -> I (in hypertrophic cardiomyopathy; unknown pathological significance; dbSNP:rs869025501)	17603483	1
P04049/T260R	P04049	RAF1	RAF1_HUMAN	T260R	-	-	p	-	QRSTStNVHMV									VARIANT	T -> R (in NS5)	17603483	1
P04049/T310A	P04049	RAF1	RAF1_HUMAN	T310A	-	-	-	increase	WSQPKtVPAQR									VARIANT	T -> A (in CMD1NN; shows a mild increase in kinase activity; dbSNP:rs778155315)	24777450	1
P04049/T491D	P04049	RAF1	RAF1_HUMAN	T491D	501	A-loop	p	activating	DFGLAtKSRWS	0.881	0.926	0.731	0.936	0.281	0.823	0.705	0.449	MUTAGEN	T->D: Increased kinase activity but can still be inhibited by PPP5C; when associated with D-494.	16892053	1
P04049/T491I	P04049	RAF1	RAF1_HUMAN	T491I	501	A-loop	p	loss	DFGLAtKSRWS	0.916	0.957	0.478	0.782	0.657	0.855	0.398	0.516	VARIANT	T -> I (in NS5; has reduced or absent kinase activity; dbSNP:rs80338799)	17603483	1
P04049/T491R	P04049	RAF1	RAF1_HUMAN	T491R	501	A-loop	p	-	DFGLAtKSRWS	0.787	0.799	0.537	0.7	0.465	0.689	0.627	0.313	VARIANT	T -> R (in NS5; dbSNP:rs80338799)	17603483	1
P04049/T641M	P04049	RAF1	RAF1_HUMAN	T641M	-	-	-	increase	ACTLTtPRLPV									VARIANT	T -> M (in CMD1NN; shows a mild increase in kinase activity; dbSNP:rs587777587)	24777450	1
P04049/V263A	P04049	RAF1	RAF1_HUMAN	V263A	-	-	-	increase	TSTPNvMVSTT									VARIANT	V -> A (in NS5; shows in vitro greater kinase activity and enhanced MAPK1 activation than wild-type; dbSNP:rs397516830)	17603482	1
P04626/A1216D	P04626	ERBB2	ERBB2_HUMAN	A1216D	-	-	-	neutral	PAFSPaDNLYY									VARIANT	A -> D (in dbSNP:rs55943169)	17344846	1
P04626/A710V	P04626	ERBB2	ERBB2_HUMAN	A710V	19	N-term-β1	-	loss	AMPNQaMRILK	0.571	0.503	0.532	0.442	0.339	0.446	0.617	0.321	VARIANT	A -> V (in VSCN2; almost complete loss of ERBB2 and ERBB3 phosphorylation in the presence or in the absence of NRG1 stimulation, suggesting alteration of downstream signaling; does not affect the subcellular localization at the cell membrane)	33497358	1
P04626/E914K	P04626	ERBB2	ERBB2_HUMAN	E914K	610	αF	-	-	GVTVWeMTFGA	0.784	0.81	0.356	0.581	0.637	0.668	0.36	0.485	VARIANT	E -> K (in GLM; somatic mutation; unknown pathological significance; dbSNP:rs28933368)	15457249	1
P04626/G776S	P04626	ERBB2	ERBB2_HUMAN	G776S	188	αC/β4-loop	-	-	AYVMAgGSPYV	0.228	0.15	0.494	0.282	0.109	0.143	0.704	0.185	VARIANT	G -> S (in GASC; somatic mutation; unknown pathological significance; dbSNP:rs28933369)	15457249,17344846	2
P04626/I654V	P04626	ERBB2	ERBB2_HUMAN	I654V	-	-	-	neutral	SPLTSiSAVVG									VARIANT	I -> V (in allele B3; dbSNP:rs1801201)	17344846,8095488	2
P04626/I655V	P04626	ERBB2	ERBB2_HUMAN	I655V	-	-	-	neutral	PLTSIiAVVGI									VARIANT	I -> V (in allele B2 and allele B3; dbSNP:rs1136201)	17344846,8095488	2
P04626/L755P	P04626	ERBB2	ERBB2_HUMAN	L755P	131	β3	-	-	VAIKVlENTSP	0.941	0.865	0.418	0.688	0.614	0.821	0.463	0.792	VARIANT	L -> P (in LNCR; somatic mutation; unknown pathological significance; dbSNP:rs121913469)	15457249	1
P04626/L768S	P04626	ERBB2	ERBB2_HUMAN	L768S	171	αC	-	-	ANKEIlEAYVM	0.756	0.685	0.412	0.551	0.56	0.609	0.428	0.667	VARIANT	L -> S (in dbSNP:rs56366519)	17344846	1
P04626/M611A	P04626	ERBB2	ERBB2_HUMAN	M611A	-	-	-	-	PDLSYmIWKFP									MUTAGEN	M->A: Prevents synthesis of isoform 2.	16794579	1
P04626/M687A	P04626	ERBB2	ERBB2_HUMAN	M687A	-	-	-	-	IRKYTmRLLQE									MUTAGEN	M->A: Prevents synthesis of isoform 3.	16794579	1
P04626/M706A	P04626	ERBB2	ERBB2_HUMAN	M706A	15	N-term-β1	-	-	TPSGAmNQAQM	0.382	0.346	0.403	0.211	0.341	0.349	0.418	0.272	MUTAGEN	M->A: No effect on isoform production.	16794579	1
P04626/M712A	P04626	ERBB2	ERBB2_HUMAN	M712A	21	N-term-β1	-	-	PNQAQmILKET	0.724	0.637	0.445	0.603	0.378	0.534	0.568	0.539	MUTAGEN	M->A: No effect on isoform production.	16794579	1
P04626/N857S	P04626	ERBB2	ERBB2_HUMAN	N857S	482	Catalytic-loop	-	-	LVKSPnVKITD	0.332	0.269	0.4	0.165	0.263	0.296	0.541	0.363	VARIANT	N -> S (in OC; somatic mutation; unknown pathological significance; dbSNP:rs28933370)	15457249,17344846	2
P04626/P1170A	P04626	ERBB2	ERBB2_HUMAN	P1170A	-	-	-	neutral	ATLERpTLSPG									VARIANT	P -> A (in dbSNP:rs1058808)	17344846,2999974,8104414	3
P04626/W452C	P04626	ERBB2	ERBB2_HUMAN	W452C	-	-	-	neutral	GLGISwGLRSL									VARIANT	W -> C (in dbSNP:rs4252633)		0
P04629/A107V	P04629	NTRK1	NTRK1_HUMAN	A107V	-	-	-	-	GLRFVaDAFHF									VARIANT	A -> V (in an ovarian serous carcinoma sample; somatic mutation; dbSNP:rs540521894)	17344846	1
P04629/A110D	P04629	NTRK1	NTRK1_HUMAN	A110D	-	-	-	-	FVAPDaHFTPR									VARIANT	A -> D (in CIPA)	28328124	1
P04629/C752S	P04629	NTRK1	NTRK1_HUMAN	C752S	761	αG/αH	-	-	ERPRAcPEVYA	0.812	0.801	0.408	0.566	0.637	0.737	0.395	0.699	VARIANT	C -> S (in CIPA; unknown pathological significance; following transfection in neuroblastoma cells and NGF treatment, no effect on neurite outgrowth, nor neurite length; no effect on N-glycosylation, subcellular location, basal and NGF-induced autophosphorylation, nor on NGF-stimulated calcium flux)	27676246	1
P04629/C763S	P04629	NTRK1	NTRK1_HUMAN	C763S	792	αH	-	decrease	AIMRGcQREPQ	0.823	0.796	0.488	0.563	0.694	0.669	0.419	0.619	VARIANT	C -> S (in CIPA; following transfection in neuroblastoma cells and NGF treatment, decreased percentage of cells differentiated into neuronal phenotype and reduced neurite length compared with wild-type; slightly decreased N-glycosylation; reduced expression at the plasma membrane; reduced basal and NGF-induced autophosphorylation; small reduction in NGF-stimulated calcium flux)	27676246	1
P04629/D596N	P04629	NTRK1	NTRK1_HUMAN	D596N	255	β5/αD-loop	-	loss	YMRHGdNRFLR	0.752	0.679	0.468	0.507	0.421	0.553	0.42	0.754	VARIANT	D -> N (in CIPA; abolishes autophosphorylation)	28177573	1
P04629/D674Y	P04629	NTRK1	NTRK1_HUMAN	D674Y	505	A-loop	-	-	FGMSRdYSTDY	0.87	0.762	0.65	0.88	0.22	0.671	0.648	0.935	VARIANT	D -> Y (in CIPA; might impair the function of the enzyme without compromising autophosphorylation; dbSNP:rs80356677)	10982191,11159935,28177573	3
P04629/E492K	P04629	NTRK1	NTRK1_HUMAN	E492K	8	N-term-β1	-	-	QGHIIePQYFS	0.405	0.393	0.513	0.34	0.351	0.322	0.636	0.24	VARIANT	E -> K (in CIPA; dbSNP:rs144901788)	22302274	1
P04629/G18E	P04629	NTRK1	NTRK1_HUMAN	G18E	-	-	-	neutral	HSWAAgGSLLA									VARIANT	G -> E (in dbSNP:rs1007211)		0
P04629/G517E	P04629	NTRK1	NTRK1_HUMAN	G517E	40	β1;Gly-rich-loop	-	-	LKWELgGAFGK	0.886	0.833	0.375	0.694	0.678	0.837	0.313	0.686	VARIANT	G -> E (in CIPA; following transfection in neuroblastoma cells and NGF treatment, small decrease in the percentage of cells differentiated into neuronal phenotype, but in differentiated cells, the average neurite length is comparable to wild-type; no effect on N-glycosylation, subcellular location, nor on basal and NGF-induced autophosphorylation; loss of NGF-stimulated calcium flux; dbSNP:rs606231467)	27676246	1
P04629/G522E	P04629	NTRK1	NTRK1_HUMAN	G522E	45	Gly-rich-loop;β2	-	decrease	GEGAFgVFLAE	0.925	0.918	0.321	0.751	0.845	0.85	0.255	0.587	VARIANT	G -> E (in CIPA; no effect on N-glycosylation, nor on subcellular location; reduced basal autophosphorylation and complete loss of NGF-induced autophosphorylation; loss of NGF-stimulated calcium flux)	27676246	1
P04629/G522R	P04629	NTRK1	NTRK1_HUMAN	G522R	45	Gly-rich-loop;β2	-	decrease	GEGAFgVFLAE	0.941	0.922	0.275	0.795	0.862	0.895	0.214	0.563	VARIANT	G -> R (in CIPA; processed as wild-type but shows significantly diminished autophosphorylation in both neuronal and non-neuronal cells; dbSNP:rs1571699266)	10982191,11159935	2
P04629/G577R	P04629	NTRK1	NTRK1_HUMAN	G577R	222	β4/β5-loop	-	loss	IVRFFgCTEGR	0.867	0.841	0.298	0.673	0.796	0.777	0.285	0.507	VARIANT	G -> R (in CIPA; loss of function; processed as wild-type but shows significantly diminished autophosphorylation in both neuronal and non-neuronal cells; dbSNP:rs121964866)	10567924,10982191,11159935,8696348	4
P04629/G613V	P04629	NTRK1	NTRK1_HUMAN	G613V	306	αD/αE-loop	-	neutral	AKLLAgEDVAP	0.224	0.173	0.588	0.309	0.156	0.134	0.662	0.315	VARIANT	G -> V (in dbSNP:rs6339)	10330344,10391209,10443680,10861667,11159935,11310631,17344846	7
P04629/G714S	P04629	NTRK1	NTRK1_HUMAN	G714S	605	αF	-	decrease	DVWSFgVLWEI	0.724	0.744	0.331	0.605	0.697	0.728	0.258	0.657	VARIANT	G -> S (in CIPA; processed as wild-type but shows significantly diminished autophosphorylation in both neuronal and non-neuronal cells; dbSNP:rs770727871)	10330344,11159935	2
P04629/H604Y	P04629	NTRK1	NTRK1_HUMAN	H604Y	271	αD	-	neutral	RFLRShPDAKL	0.442	0.405	0.609	0.413	0.238	0.325	0.719	0.278	VARIANT	H -> Y (in dbSNP:rs6336)	10330344,10391209,10443680,11159935,11310631,17344846	6
P04629/I572S	P04629	NTRK1	NTRK1_HUMAN	I572S	196	αC/β4-loop	-	-	LQHQHiRFFGV	0.821	0.779	0.522	0.566	0.561	0.662	0.504	0.631	VARIANT	I -> S (in CIPA)	18077166	1
P04629/I699T	P04629	NTRK1	NTRK1_HUMAN	I699T	559	αF	-	decrease	MPPESiYRKFT	0.851	0.792	0.502	0.536	0.623	0.689	0.485	0.615	VARIANT	I -> T (in CIPA; partially decreased N-glycosylation; reduced expression at the plasma membrane; reduced basal autophosphorylation and complete loss of NGF-induced autophosphorylation; loss of NGF-stimulated calcium flux)	27676246	1
P04629/K544A	P04629	NTRK1	NTRK1_HUMAN	K544A	129	β3;Catalytic-Lys	-	-	MLVAVkLKEAS	0.995	0.994	0.011	0.634	1.0	0.989	0.001	0.697	MUTAGEN	K->A: No effect on interaction with GGA3.	26446845	1
P04629/K544N	P04629	NTRK1	NTRK1_HUMAN	K544N	129	β3;Catalytic-Lys	-	loss	MLVAVkLKEAS	0.995	1.0	0.032	0.721	1.0	0.999	0.013	0.552	MUTAGEN	K->N: Loss of kinase activity.	1281417,8155326	2
P04629/L213P	P04629	NTRK1	NTRK1_HUMAN	L213P	-	-	-	decrease	GDDVLlCQVEG									VARIANT	L -> P (in CIPA; aberrantly processed; shows diminished autophosphorylation in neuronal cells; dbSNP:rs747711259)	10330344,11159935	2
P04629/L657P	P04629	NTRK1	NTRK1_HUMAN	L657P	450	Catalytic-loop	-	decrease	ATRNClGQGLV	0.909	0.866	0.409	0.699	0.763	0.783	0.371	0.703	VARIANT	L -> P (in CIPA; following transfection in neuroblastoma cells and NGF treatment, loss of differentiation into neuronal phenotype; partially decreased N-glycosylation; reduced expression at the plasma membrane; reduced basal autophosphorylation and complete loss of NGF-induced autophosphorylation; loss of NGF-stimulated calcium flux)	27676246	1
P04629/L700P	P04629	NTRK1	NTRK1_HUMAN	L700P	567	αF	-	-	PPESIlRKFTT	0.674	0.772	0.625	0.597	0.36	0.496	0.657	0.549	VARIANT	L -> P (in CIPA)	28328124	1
P04629/L717R	P04629	NTRK1	NTRK1_HUMAN	L717R	608	αF	-	-	SFGVVlEIFTY	0.891	0.894	0.392	0.686	0.733	0.785	0.33	0.602	VARIANT	L -> R (in CIPA)	18077166	1
P04629/L93P	P04629	NTRK1	NTRK1_HUMAN	L93P	-	-	-	decrease	RGLGElNLTIV									VARIANT	L -> P (in CIPA; aberrantly processed; shows diminished autophosphorylation in neuronal cells)	10982191,11159935	2
P04629/M566T	P04629	NTRK1	NTRK1_HUMAN	M566T	188	αC/β4-loop	-	-	AELLTmQHQHI	0.246	0.196	0.527	0.328	0.16	0.174	0.682	0.265	VARIANT	M -> T (in dbSNP:rs55892037)	17344846	1
P04629/M587V	P04629	NTRK1	NTRK1_HUMAN	M587V	246	β5	-	-	GRPLLmFEYMR	0.772	0.706	0.545	0.652	0.533	0.66	0.584	0.475	VARIANT	M -> V (in CIPA; dbSNP:rs121964870)	10233776	1
P04629/P695L	P04629	NTRK1	NTRK1_HUMAN	P695L	555	A-loop;APE-motif	-	-	PIRWMpESILY	0.744	0.67	0.565	0.585	0.451	0.585	0.572	0.451	VARIANT	P -> L (in CIPA; dbSNP:rs121964868)	10861667	1
P04629/Q80R	P04629	NTRK1	NTRK1_HUMAN	Q80R	-	-	-	-	NQQHLqLELRD									VARIANT	Q -> R (in dbSNP:rs55891455)	17344846	1
P04629/R260G	P04629	NTRK1	NTRK1_HUMAN	R260G	-	-	-	-	TSDLNrNVTCW									VARIANT	R -> G (in dbSNP:rs35116695)	17344846	1
P04629/R444Q	P04629	NTRK1	NTRK1_HUMAN	R444Q	-	-	-	neutral	LNKCGrNKFGI									VARIANT	R -> Q (in dbSNP:rs56320207)	17344846	1
P04629/R452C	P04629	NTRK1	NTRK1_HUMAN	R452C	-	-	-	-	KFGINrAVLAP									VARIANT	R -> C (in dbSNP:rs34900547)	17344846	1
P04629/R649Q	P04629	NTRK1	NTRK1_HUMAN	R649Q	442	Catalytic-loop;HrD-motif	-	-	LHFVHrLATRN	0.805	0.801	0.42	0.684	0.515	0.724	0.51	0.444	VARIANT	R -> Q (in CIPA; dbSNP:rs786205449)	28328124	1
P04629/R649W	P04629	NTRK1	NTRK1_HUMAN	R649W	442	Catalytic-loop;HrD-motif	-	decrease	LHFVHrLATRN	0.854	0.89	0.4	0.707	0.72	0.754	0.331	0.494	VARIANT	R -> W (in CIPA; processed as wild-type but shows significantly diminished autophosphorylation in both neuronal and non-neuronal cells; dbSNP:rs369353892)	10330344,11159935	2
P04629/R654C	P04629	NTRK1	NTRK1_HUMAN	R654C	447	Catalytic-loop	-	decrease	RDLATrCLVGQ	0.919	0.834	0.311	0.642	0.799	0.869	0.203	0.525	VARIANT	R -> C (in CIPA; processed as wild-type but shows significantly diminished autophosphorylation in both neuronal and non-neuronal cells; dbSNP:rs764992664)	10982191,11159935,22302274	3
P04629/R6W	P04629	NTRK1	NTRK1_HUMAN	R6W	-	-	-	-	MLRGGrGQLGW									VARIANT	R -> W (in dbSNP:rs201472270)	22302274	1
P04629/R771C	P04629	NTRK1	NTRK1_HUMAN	R771C	800	αI	-	decrease	REPQQrSIKDV	0.892	0.893	0.368	0.666	0.736	0.804	0.315	0.42	VARIANT	R -> C (in CIPA; partially decreased N-glycosylation; reduced expression at the plasma membrane; reduced basal autophosphorylation and complete loss of NGF-induced autophosphorylation; loss of NGF-stimulated calcium flux; dbSNP:rs1324983370)	27676246	1
P04629/R780P	P04629	NTRK1	NTRK1_HUMAN	R780P	812	αI	-	loss	KDVHArQALAQ	0.653	0.67	0.537	0.501	0.494	0.485	0.516	0.281	VARIANT	R -> P (in CIPA; loss of function; dbSNP:rs35669708)	10090906	1
P04629/R780Q	P04629	NTRK1	NTRK1_HUMAN	R780Q	812	αI	-	-	KDVHArQALAQ	0.141	0.116	0.427	0.099	0.174	0.131	0.58	0.147	VARIANT	R -> Q (in dbSNP:rs35669708)	10443680,17344846	2
P04629/R85S	P04629	NTRK1	NTRK1_HUMAN	R85S	-	-	-	-	QHLELrLRGLG									VARIANT	R -> S (in dbSNP:rs543320028)	10330344,11159935	2
P04629/T237M	P04629	NTRK1	NTRK1_HUMAN	T237M	-	-	-	neutral	LEQSAtMKSGG									VARIANT	T -> M (in dbSNP:rs55909005)	17344846	1
P04629/V238G	P04629	NTRK1	NTRK1_HUMAN	V238G	-	-	-	-	EQSATvKSGGL									VARIANT	V -> G (in dbSNP:rs56000394)	17344846	1
P04629/V790I	P04629	NTRK1	NTRK1_HUMAN	V790I	822	αI	-	-	AQAPPvLDVLG	0.449	0.444	0.429	0.301	0.336	0.367	0.59	0.164	VARIANT	V -> I (in dbSNP:rs55948542)	17344846	1
P04629/Y359C	P04629	NTRK1	NTRK1_HUMAN	Y359C	-	-	-	-	VNNGNyLLAAN									VARIANT	Y -> C (in CIPA; dbSNP:rs121964869)	11310631	1
P04629/Y496F	P04629	NTRK1	NTRK1_HUMAN	Y496F	12	N-term-β1	p	-	IENPQySDACV	0.872	0.831	0.484	0.79	0.552	0.812	0.488	0.443	MUTAGEN	Y->F: Loss of interaction with SHC1 and altered phosphorylation of SHC1. Altered neurite outgrowth and altered activation of the MAPK pathway; when associated with F-791.	8155326	1
P04629/Y791F	P04629	NTRK1	NTRK1_HUMAN	Y791F	823	αI	p	-	QAPPVyDVLG	0.847	0.848	0.584	0.765	0.53	0.689	0.596	0.389	MUTAGEN	Y->F: Loss of interaction with PLCG1 and altered phosphorylation of PLCG1. Altered neurite outgrowth and altered activation of the MAPK pathway; when associated with F-496.	7510697,8155326	2
P05129/A523D	P05129	PRKCG	KPCG_HUMAN	A523D	555	A-loop;APE-motif	-	-	TPDYIaEIIAY	0.869	0.816	0.383	0.669	0.696	0.762	0.382	0.561	VARIANT	A -> D	9545390	1
P05129/G128D	P05129	PRKCG	KPCG_HUMAN	G128D	-	-	-	-	GLVHQgKCSCC									VARIANT	G -> D (in SCA14; dbSNP:rs121918513)	12644968	1
P05129/G63R	P05129	PRKCG	KPCG_HUMAN	G63R	-	-	-	-	GIGKQgQCQVC									VARIANT	G -> R (in SCA14)	29053796	1
P05129/G63V	P05129	PRKCG	KPCG_HUMAN	G63V	-	-	-	-	GIGKQgQCQVC									VARIANT	G -> V (in SCA14; dbSNP:rs386134159)	29053796	1
P05129/H101Y	P05129	PRKCG	KPCG_HUMAN	H101Y	-	-	-	-	DPRNKhFRLHS									VARIANT	H -> Y (in SCA14; dbSNP:rs121918511)	12644968	1
P05129/H415Q	P05129	PRKCG	KPCG_HUMAN	H415Q	194	αC/β4-loop	-	-	PGGRPhLTQLH	0.507	0.465	0.549	0.582	0.286	0.39	0.667	0.506	VARIANT	H -> Q	9545390	1
P05129/R141C	P05129	PRKCG	KPCG_HUMAN	R141C	-	-	-	-	MNVHRrVRSVP									VARIANT	R -> C	9545390	1
P05129/R659S	P05129	PRKCG	KPCG_HUMAN	R659S	-	-	-	-	LTPPDrVLASI									VARIANT	R -> S (in dbSNP:rs752933837)	9545390	1
P05129/S119P	P05129	PRKCG	KPCG_HUMAN	S119P	-	-	-	-	CDHCGsLYGLV									VARIANT	S -> P (in SCA14; dbSNP:rs121918512)	12644968	1
P05771/P588H	P05771	PRKCB	KPCB_HUMAN	P588H	810	αI	-	-	RLGCGpGERDI	0.211	0.159	0.479	0.234	0.139	0.134	0.593	0.196	VARIANT	P -> H (in dbSNP:rs35631544)	17344846	1
P05771/V144M	P05771	PRKCB	KPCB_HUMAN	V144M	-	-	-	-	VHKRCvNVPSL									VARIANT	V -> M (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs764534677)	17344846	1
P05771/V496M	P05771	PRKCB	KPCB_HUMAN	V496M	514	A-loop	-	-	NIWDGvTKTFC	0.447	0.375	0.438	0.327	0.275	0.278	0.506	0.175	VARIANT	V -> M (in a glioblastoma multiforme sample; somatic mutation; dbSNP:rs1466858740)	17344846	1
P06213/A1002D	P06213	INSR	INSR_HUMAN	A1002D	8	N-term-β1	-	-	PEYLSaDVFPC	0.642	0.616	0.589	0.554	0.4	0.562	0.592	0.468	MUTAGEN	A->D: Reduces interaction with IRS1 but has no effect on interaction with SHC1.	7559478	1
P06213/A1055V	P06213	INSR	INSR_HUMAN	A1055V	127	β3	-	-	AETRVaKTVNE	0.549	0.526	0.402	0.432	0.514	0.47	0.449	0.376	VARIANT	A -> V (in IRAN type A; dbSNP:rs1599874183)	10733238	1
P06213/A1075D	P06213	INSR	INSR_HUMAN	A1075D	174	αC	-	-	EFLNEaVMKGF	0.616	0.544	0.555	0.49	0.392	0.469	0.601	0.354	VARIANT	A -> D (in IRAN type A)	8243830	1
P06213/A1161T	P06213	INSR	INSR_HUMAN	A1161T	445	Catalytic-loop	-	-	VHRDLaRNCMV	0.825	0.807	0.439	0.614	0.705	0.794	0.427	0.435	VARIANT	A -> T (in IRAN type A; dbSNP:rs121913139)	2168397	1
P06213/A1162E	P06213	INSR	INSR_HUMAN	A1162E	446	Catalytic-loop	-	-	HRDLAaNCMVA	0.855	0.843	0.483	0.657	0.687	0.792	0.392	0.568	VARIANT	A -> E (in IRAN type A; impairs proteolytic processing; dbSNP:rs121913154)	8096518	1
P06213/A119V	P06213	INSR	INSR_HUMAN	A119V	-	-	-	decrease	LFFNYaVIFEM									VARIANT	A -> V (in LEPRCH; markedly impairs insulin binding; dbSNP:rs1347473020)	12023989	1
P06213/A842V	P06213	INSR	INSR_HUMAN	A842V	-	-	-	-	AAYVSaTMPEA									VARIANT	A -> V (in RMS; decreases post-translational processing; dbSNP:rs1135401738)	28765322	1
P06213/C228R	P06213	INSR	INSR_HUMAN	C228R	-	-	-	-	CKSHGcAEGLC									VARIANT	C -> R (in a gastric adenocarcinoma sample; somatic mutation)	17344846	1
P06213/C280Y	P06213	INSR	INSR_HUMAN	C280Y	-	-	-	-	FQDWRcNFSFC									VARIANT	C -> Y (in IRAN type A)	11260230	1
P06213/C286Y	P06213	INSR	INSR_HUMAN	C286Y	-	-	-	-	VNFSFcDLHHK									VARIANT	C -> Y (in LEPRCH; abolishes post-translational processing)	24498630	1
P06213/C301Y	P06213	INSR	INSR_HUMAN	C301Y	-	-	-	-	SRRQGcQYVIH									VARIANT	C -> Y (in LEPRCH)	9703342	1
P06213/D1159N	P06213	INSR	INSR_HUMAN	D1159N	443	Catalytic-loop;HrD-motif	-	loss	KFVHRdAARNC	0.96	0.953	0.289	0.695	0.889	0.918	0.246	0.502	MUTAGEN	D->N: Loss of kinase activity.	11598120	1
P06213/D86G	P06213	INSR	INSR_HUMAN	D86G	-	-	-	-	LIMITdLLLFR									VARIANT	D -> G (in IRAN type A)	9175790	1
P06213/E1206D	P06213	INSR	INSR_HUMAN	E1206D	557	A-loop;APE-motif	-	decrease	RWMAPeLKDGV	0.764	0.727	0.399	0.471	0.653	0.675	0.452	0.351	VARIANT	E -> D (in IRAN type A; accelerates degradation of the protein and impairs kinase activity)	7983039	1
P06213/E1206K	P06213	INSR	INSR_HUMAN	E1206K	557	A-loop;APE-motif	-	-	RWMAPeLKDGV	0.858	0.855	0.268	0.546	0.777	0.743	0.254	0.462	VARIANT	E -> K (in LEPRCH)	9249867	1
P06213/E998A	P06213	INSR	INSR_HUMAN	E998A	4	N-term-β1	-	-	ASSNPeLSASD	0.797	0.821	0.39	0.566	0.675	0.776	0.329	0.442	MUTAGEN	E->A: Does not affect interaction with IRS1, SHC1 or PIK3R1.	7537849	1
P06213/F409V	P06213	INSR	INSR_HUMAN	F409V	-	-	-	-	VSLSFfKLRLI									VARIANT	F -> V (in IRAN type A; dbSNP:rs121913142)	8388389	1
P06213/G1035V	P06213	INSR	INSR_HUMAN	G1035V	45	Gly-rich-loop;β2	-	-	GQGSFgVYEGN	0.858	0.811	0.34	0.638	0.693	0.852	0.344	0.561	VARIANT	G -> V (in IRAN type A; dbSNP:rs121913135)	2544998	1
P06213/G386S	P06213	INSR	INSR_HUMAN	G386S	-	-	-	-	LEANLgIEEIS									VARIANT	G -> S (in RMS; may impair receptor processing; dbSNP:rs764221583)	17201797	1
P06213/G393R	P06213	INSR	INSR_HUMAN	G393R	-	-	-	-	IEEISgLKIRR									VARIANT	G -> R (in LEPRCH; Verona-1; dbSNP:rs267607184)	1607067	1
P06213/G58R	P06213	INSR	INSR_HUMAN	G58R	-	-	-	decrease	CSVIEgLQILL									VARIANT	G -> R (in LEPRCH; Helmond; inhibits processing and transport; dbSNP:rs52836744)	1730625	1
P06213/G811S	P06213	INSR	INSR_HUMAN	G811S	-	-	-	-	SLVISgRHFTG									VARIANT	G -> S (in dbSNP:rs35045353)	17344846	1
P06213/H236R	P06213	INSR	INSR_HUMAN	H236R	-	-	-	-	EGLCChECLGN									VARIANT	H -> R (in RMS and LEPRCH; Winnipeg; may impair receptor processing; dbSNP:rs121913145)	17201797,2365819	2
P06213/I1023F	P06213	INSR	INSR_HUMAN	I1023F	29	N-term-β1	-	-	VSREKiLLREL	0.757	0.696	0.603	0.641	0.393	0.628	0.681	0.398	VARIANT	I -> F	8890729	1
P06213/I1143T	P06213	INSR	INSR_HUMAN	I1143T	410	αE	-	decrease	QMAAEiDGMAY	0.803	0.694	0.42	0.523	0.667	0.682	0.373	0.541	VARIANT	I -> T (in RMS; reduces insulin binding)	10443650,12023989	2
P06213/I146M	P06213	INSR	INSR_HUMAN	I146M	-	-	-	-	RGSVRiKNNEL									VARIANT	I -> M (in LEPRCH; mild; dbSNP:rs121913159)	7815442,8326490	2
P06213/I448T	P06213	INSR	INSR_HUMAN	I448T	-	-	-	-	KHNLTiQGKLF									VARIANT	I -> T (in dbSNP:rs1051691)	2859121	1
P06213/I56T	P06213	INSR	INSR_HUMAN	I56T	-	-	-	decrease	ENCSViGHLQI									VARIANT	I -> T (in LEPRCH; abolishes post-translational processing; dbSNP:rs1555689937)	24498630	1
P06213/I925T	P06213	INSR	INSR_HUMAN	I925T	-	-	-	loss	NYSVRiATSLA									VARIANT	I -> T (in LEPRCH; abolishes post-translational processing; abolishes insulin binding; dbSNP:rs1599881881)	12023989,28765322	2
P06213/K1057A	P06213	INSR	INSR_HUMAN	K1057A	129	β3;Catalytic-Lys	ub	loss	TRVAVkVNESA	1.0	0.972	0.033	0.622	0.985	0.982	0.018	0.604	MUTAGEN	K->A: Abolishes the kinase activity and abolishes interaction with IRS1, SHC1, GRB7 and PIK3R1.	10803466,3101064,7537849	3
P06213/K1057M	P06213	INSR	INSR_HUMAN	K1057M	129	β3;Catalytic-Lys	ub	loss	TRVAVkVNESA	0.992	1.0	0.024	0.652	0.991	0.999	0.016	0.449	MUTAGEN	K->M,R: Abolishes the kinase activity.	10803466,3101064,7537849	3
P06213/K1057R	P06213	INSR	INSR_HUMAN	K1057R	129	β3;Catalytic-Lys	ub	loss	TRVAVkVNESA	0.984	0.984	0.05	0.681	0.965	0.991	0.054	0.389	MUTAGEN	K->M,R: Abolishes the kinase activity.	10803466,3101064,7537849	3
P06213/K1095E	P06213	INSR	INSR_HUMAN	K1095E	226	β4/β5-loop	-	-	LGVVSkQPTLV	0.354	0.284	0.575	0.319	0.145	0.178	0.742	0.174	VARIANT	K -> E (in a subject with non-insulin dependent diabetes mellitus; dbSNP:rs909008899)	2040394	1
P06213/K487E	P06213	INSR	INSR_HUMAN	K487E	-	-	-	-	NDIALkNGDQA									VARIANT	K -> E (in LEPRCH; ARK-1; dbSNP:rs121913136)	2834824	1
P06213/L1000A	P06213	INSR	INSR_HUMAN	L1000A	6	N-term-β1	-	-	SNPEYlASDVF	0.546	0.441	0.4	0.402	0.497	0.404	0.381	0.432	MUTAGEN	L->A,R: Severely reduces interaction with SHC1. Has no effect on interaction with IRS1.	7559478	1
P06213/L1000R	P06213	INSR	INSR_HUMAN	L1000R	6	N-term-β1	-	-	SNPEYlASDVF	0.768	0.662	0.433	0.637	0.504	0.617	0.5	0.581	MUTAGEN	L->A,R: Severely reduces interaction with SHC1. Has no effect on interaction with IRS1.	7559478	1
P06213/L1065V	P06213	INSR	INSR_HUMAN	L1065V	137	αC	-	-	NESASlERIEF	0.258	0.236	0.389	0.146	0.198	0.194	0.571	0.165	VARIANT	L -> V (in dbSNP:rs56395521)	17344846	1
P06213/L120Q	P06213	INSR	INSR_HUMAN	L120Q	-	-	-	decrease	FFNYAlIFEMV									VARIANT	L -> Q (in LEPRCH; inhibits receptor processing)	12970295	1
P06213/L260P	P06213	INSR	INSR_HUMAN	L260P	-	-	-	-	CRNFYlGRCVE									VARIANT	L -> P (in LEPRCH; Geldeimalsen; dbSNP:rs121913141)	2479553	1
P06213/L89P	P06213	INSR	INSR_HUMAN	L89P	-	-	-	-	ITDYLlFRVYG									VARIANT	L -> P (in IRAN type A)	9175790	1
P06213/L991A	P06213	INSR	INSR_HUMAN	L991A	-	-	-	-	GPLGPlASSNP									MUTAGEN	L->A: Reduces interaction with IRS1 but has no effect on interaction with SHC1.	7559478	1
P06213/M1180I	P06213	INSR	INSR_HUMAN	M1180I	499	A-loop	-	-	IGDFGmRDIYE	0.61	0.65	0.492	0.534	0.386	0.534	0.576	0.37	VARIANT	M -> I (in a patient with insulin resistance; dbSNP:rs121913157)	1890161	1
P06213/N42K	P06213	INSR	INSR_HUMAN	N42K	-	-	-	-	GMDIRnLTRLH									VARIANT	N -> K (in RMS; impairs transport to the plasma membrane and reduces the affinity to bind insulin; dbSNP:rs121913143)	2121734,2365819	2
P06213/N458D	P06213	INSR	INSR_HUMAN	N458D	-	-	-	decrease	LFFHYnKLCLS									VARIANT	N -> D (in LEPRCH; partially inhibits receptor processing and autophosphorylation; strongly impairs ERK phosphorylation; induces wild-type levels of IRS-1 phosphorylation; dbSNP:rs121913160)	12970295	1
P06213/N489D	P06213	INSR	INSR_HUMAN	N489D	-	-	-	-	IALKTnDQASC									VARIANT	N -> D (in IRAN type A; unknown pathological significance; dbSNP:rs1135401742)	28765322	1
P06213/N489S	P06213	INSR	INSR_HUMAN	N489S	-	-	-	-	IALKTnDQASC									VARIANT	N -> S (in IRAN type A; dbSNP:rs121913147)	2365819	1
P06213/N878S	P06213	INSR	INSR_HUMAN	N878S	-	-	-	-	EPKEPnLIVLY									VARIANT	N -> S (in RMS; impairs post-translational processing; dbSNP:rs887190835)	28765322	1
P06213/N996A	P06213	INSR	INSR_HUMAN	N996A	2	N-term-β1	-	-	LYASSnEYLSA	0.766	0.684	0.449	0.696	0.491	0.592	0.459	0.526	MUTAGEN	N->A: Abolishes interaction with IRS1 and significantly reduces interaction with SHC1. Has no effect on interaction with PIK3R1.	7537849,7559478	2
P06213/P1205L	P06213	INSR	INSR_HUMAN	P1205L	556	A-loop;APE-motif	-	-	VRWMApSLKDG	0.8	0.697	0.6	0.664	0.49	0.589	0.579	0.612	VARIANT	P -> L (in IRAN type A; moderate; dbSNP:rs1295645322)	1563582,8314008	2
P06213/P220L	P06213	INSR	INSR_HUMAN	P220L	-	-	-	-	CQKVCpICKSH									VARIANT	P -> L (in Ins resistance; severe; dbSNP:rs749094324)	8242067	1
P06213/P830L	P06213	INSR	INSR_HUMAN	P830L	-	-	-	-	CNQDTpERCSV									VARIANT	P -> L (in dbSNP:rs2162771)		0
P06213/P874L	P06213	INSR	INSR_HUMAN	P874L	-	-	-	-	LMWQEpEPNGL									VARIANT	P -> L (in RMS; impairs post-translational processing)	28765322	1
P06213/P997A	P06213	INSR	INSR_HUMAN	P997A	3	N-term-β1	-	-	YASSNpYLSAS	0.746	0.651	0.399	0.583	0.557	0.619	0.395	0.584	MUTAGEN	P->A: Abolishes interaction with IRS1 and significantly reduces interaction with SHC1. Has no effect on interaction with PIK3R1.	7537849,7559478	2
P06213/P997T	P06213	INSR	INSR_HUMAN	P997T	3	N-term-β1	-	-	YASSNpYLSAS	0.756	0.636	0.427	0.584	0.507	0.584	0.485	0.588	VARIANT	P -> T (in RMS; reduces insulin binding)	12023989	1
P06213/Q492K	P06213	INSR	INSR_HUMAN	Q492K	-	-	-	-	KTNGDqSCENE									VARIANT	Q -> K	2859121	1
P06213/Q695R	P06213	INSR	INSR_HUMAN	Q695R	-	-	-	-	ESEDSqHNQSE									VARIANT	Q -> R (in dbSNP:rs55906835)	17344846	1
P06213/R1020Q	P06213	INSR	INSR_HUMAN	R1020Q	26	N-term-β1	-	-	EWEVSrKITLL	0.741	0.699	0.505	0.611	0.47	0.603	0.518	0.321	VARIANT	R -> Q (in IRAN type A; dbSNP:rs121913148)	2002058	1
P06213/R1119W	P06213	INSR	INSR_HUMAN	R1119W	272	αD	-	-	YLRSLrEAENN	0.884	0.83	0.595	0.672	0.486	0.754	0.559	0.435	VARIANT	R -> W (in LEPRCH; dbSNP:rs1229730671)	12970295,9249867	2
P06213/R113P	P06213	INSR	INSR_HUMAN	R113P	-	-	-	loss	VIRGSrFFNYA									VARIANT	R -> P (in LEPRCH; Atlanta-1; abolishes insulin binding; dbSNP:rs121913153)	12023989,8419945	2
P06213/R1158Q	P06213	INSR	INSR_HUMAN	R1158Q	442	Catalytic-loop;HrD-motif	-	-	KKFVHrLAARN	0.856	0.782	0.394	0.704	0.642	0.691	0.392	0.458	VARIANT	R -> Q (in T2D)	1470163	1
P06213/R1158W	P06213	INSR	INSR_HUMAN	R1158W	442	Catalytic-loop;HrD-motif	-	loss	KKFVHrLAARN	0.885	0.873	0.381	0.706	0.735	0.761	0.324	0.459	VARIANT	R -> W (in RMS; abolishes insulin binding; dbSNP:rs111993466)	10443650,12023989	2
P06213/R1163Q	P06213	INSR	INSR_HUMAN	R1163Q	447	Catalytic-loop	-	loss	RDLAArCMVAH	0.842	0.783	0.472	0.598	0.654	0.768	0.444	0.35	MUTAGEN	R->Q: Loss of kinase activity.	11598120	1
P06213/R1191Q	P06213	INSR	INSR_HUMAN	R1191Q	531	A-loop	-	-	ETDYYrGGKGL	0.651	0.604	0.537	0.641	0.336	0.463	0.653	0.412	VARIANT	R -> Q (in T2D; dbSNP:rs121913150)	1607076	1
P06213/R1201Q	P06213	INSR	INSR_HUMAN	R1201Q	552	A-loop	-	-	GLLPVrMAPES	0.697	0.713	0.484	0.636	0.463	0.571	0.503	0.371	VARIANT	R -> Q (in HHF5 and IRAN type A; interferes with kinase activation by insulin; dbSNP:rs121913156)	15161766,8082780,8288049	3
P06213/R1201W	P06213	INSR	INSR_HUMAN	R1201W	552	A-loop	-	-	GLLPVrMAPES	0.771	0.769	0.459	0.662	0.569	0.737	0.411	0.406	VARIANT	R -> W (in LEPRCH and RMS; reduces insulin binding possibly due to reduced receptor levels on the cell surface; dbSNP:rs1568426700)	12023989,9703342	2
P06213/R1378Q	P06213	INSR	INSR_HUMAN	R1378Q	-	-	-	-	ILTLPrNPS									VARIANT	R -> Q (in IRAN type A; dbSNP:rs52826008)	8314008	1
P06213/R256C	P06213	INSR	INSR_HUMAN	R256C	-	-	-	-	KCVACrFYLDG									VARIANT	R -> C (in RMS; dbSNP:rs781007453)	28765322	1
P06213/R279C	P06213	INSR	INSR_HUMAN	R279C	-	-	-	-	HFQDWrVNFSF									VARIANT	R -> C (in IRAN type A; inhibits receptor internalization; dbSNP:rs1568470274)	12107746	1
P06213/R279H	P06213	INSR	INSR_HUMAN	R279H	-	-	-	-	HFQDWrVNFSF									VARIANT	R -> H (in IRAN type A; interferes with receptor processing; dbSNP:rs1329693158)	12970295	1
P06213/R762S	P06213	INSR	INSR_HUMAN	R762S	-	-	-	-	PSRKRrLGDVG									VARIANT	R -> S (in IRAN type A; dbSNP:rs121913138)	3283938	1
P06213/R926W	P06213	INSR	INSR_HUMAN	R926W	-	-	-	decrease	YSVRIrTSLAG									VARIANT	R -> W (in LEPRCH; markedly impairs insulin binding;impairs post-translational processing; dbSNP:rs911929963)	12023989,28765322	2
P06213/S350L	P06213	INSR	INSR_HUMAN	S350L	-	-	-	-	EKTIDsTSAQE									VARIANT	S -> L (in RMS and LEPRCH)	12970295,8314008	2
P06213/S635L	P06213	INSR	INSR_HUMAN	S635L	-	-	-	-	SVSNSsQIILK									VARIANT	S -> L (in RMS; decreases post-translational processing)	28765322	1
P06213/S835I	P06213	INSR	INSR_HUMAN	S835I	-	-	-	-	PEERCsAAYVS									VARIANT	S -> I (in RMS; impairs post-translational processing; dbSNP:rs1135401739)	28765322	1
P06213/T1282A	P06213	INSR	INSR_HUMAN	T1282A	802	αI	-	-	PKMRPtLEIVN	0.442	0.397	0.408	0.331	0.395	0.424	0.5	0.216	VARIANT	T -> A (in dbSNP:rs55875349)	17344846	1
P06213/T858A	P06213	INSR	INSR_HUMAN	T858A	-	-	-	-	IVGPVtEIFEN									VARIANT	T -> A (in T2D; dbSNP:rs182552223)	7657032	1
P06213/T937M	P06213	INSR	INSR_HUMAN	T937M	-	-	-	decrease	GNGSWtPTYFY									VARIANT	T -> M (in LEPRCH; impaired receptor processing; impairs post-translational processing)	28765322,9299395	2
P06213/V1012M	P06213	INSR	INSR_HUMAN	V1012M	18	N-term-β1	-	neutral	PCSVYvDEWEV	0.485	0.538	0.404	0.291	0.483	0.364	0.473	0.29	VARIANT	V -> M (in dbSNP:rs1799816)	17344846,8314008,8432414,8458533,9199575	5
P06213/V1054M	P06213	INSR	INSR_HUMAN	V1054M	124	β3	-	-	EAETRvVKTVN	0.507	0.449	0.618	0.517	0.288	0.341	0.684	0.215	VARIANT	V -> M (in IRAN type A; unknown pathological significance; dbSNP:rs1135401741)	28765322	1
P06213/V167L	P06213	INSR	INSR_HUMAN	V167L	-	-	-	-	RILDSvDNYIV									VARIANT	V -> L (in IRAN type A; dbSNP:rs938519025)	10733238	1
P06213/V55A	P06213	INSR	INSR_HUMAN	V55A	-	-	-	-	LENCSvEGHLQ									VARIANT	V -> A (in LEPRCH; Verona-1; dbSNP:rs121913152)	1607067	1
P06213/V657F	P06213	INSR	INSR_HUMAN	V657F	-	-	-	decrease	ITHYLvWERQA									VARIANT	V -> F (in LEPRCH; impairs post-translational processing; dbSNP:rs1135401737)	28765322	1
P06213/W1220L	P06213	INSR	INSR_HUMAN	W1220L	602	αF	-	decrease	TSSDMwFGVVL	0.88	0.88	0.317	0.641	0.771	0.764	0.237	0.489	VARIANT	W -> L (in IRAN type A; accelerates degradation of the protein and impairs kinase activity; dbSNP:rs52800171)	7983039,8390949	2
P06213/W1227S	P06213	INSR	INSR_HUMAN	W1227S	609	αF	-	-	FGVVLwITSLA	0.915	0.889	0.345	0.694	0.717	0.829	0.265	0.726	VARIANT	W -> S (in IRAN type A; dbSNP:rs121913140)	1963473	1
P06213/W439S	P06213	INSR	INSR_HUMAN	W439S	-	-	-	-	NLRQLwWSKHN									VARIANT	W -> S (in LEPRCH; impairs transport of the receptor to the cell surface; dbSNP:rs121913158)	8188715	1
P06213/W659R	P06213	INSR	INSR_HUMAN	W659R	-	-	-	decrease	HYLVFwRQAED									VARIANT	W -> R (in LEPRCH; impairs post-translational processing)	28765322	1
P06213/Y1011A	P06213	INSR	INSR_HUMAN	Y1011A	17	N-term-β1	p	increase	FPCSVyPDEWE	0.912	0.903	0.414	0.842	0.6	0.858	0.383	0.637	MUTAGEN	Y->A: Increases kinase activity.	12707268	1
P06213/Y1189F	P06213	INSR	INSR_HUMAN	Y1189F	511	A-loop	p	-	IYETDyRKGGK	0.966	0.938	0.668	0.895	0.465	0.854	0.658	0.546	MUTAGEN	Y->F: Reduced interaction with GRB7.	10803466	1
P06213/Y1190F	P06213	INSR	INSR_HUMAN	Y1190F	512	A-loop	p	-	YETDYyKGGKG	0.937	0.947	0.546	0.822	0.62	0.823	0.526	0.532	MUTAGEN	Y->F: Strongly reduced interaction with GRB7.	10803466	1
P06213/Y1361C	P06213	INSR	INSR_HUMAN	Y1361C	-	-	p	-	EEHIPyHMNGG									VARIANT	Y -> C (in dbSNP:rs13306449)	7657032	1
P06213/Y171H	P06213	INSR	INSR_HUMAN	Y171H	-	-	-	-	SVEDNyVLNKD									VARIANT	Y -> H (in dbSNP:rs1051692)	2859121	1
P06213/Y818C	P06213	INSR	INSR_HUMAN	Y818C	-	-	-	decrease	RHFTGyIELQA									VARIANT	Y -> C (in LEPRCH; abolishes post-translational processing)	22768670,28765322	2
P06213/Y992A	P06213	INSR	INSR_HUMAN	Y992A	-	-	p	-	PLGPLySSNPE									MUTAGEN	Y->A: Reduces interaction with IRS1 but has no effect on interaction with SHC1.	7559478	1
P06213/Y999E	P06213	INSR	INSR_HUMAN	Y999E	5	N-term-β1	p	-	SSNPEySASDV	0.897	0.859	0.593	0.859	0.591	0.716	0.537	0.619	MUTAGEN	Y->E: Abolishes interaction with IRS1 and SHC1.	2842060,7537849,7559478,9428692	4
P06213/Y999F	P06213	INSR	INSR_HUMAN	Y999F	5	N-term-β1	p	loss	SSNPEySASDV	0.819	0.789	0.426	0.798	0.574	0.755	0.458	0.468	MUTAGEN	Y->F: Has no effect on insulin-stimulated autophosphorylation, but inhibits the biological activity of the receptor. Abolishes interaction with IRS1 and almost completely prevents interaction with SHC1. Has no effect on interaction with PIK3R1. Abolishes interaction with STAT5B.	2842060,7537849,7559478,9428692	4
P06239/A353V	P06239	LCK	LCK_HUMAN	A353V	421	αE	-	-	IAEGMaIEERN	0.529	0.497	0.515	0.399	0.277	0.351	0.593	0.322	VARIANT	A -> V (found in leukemia)	8139546	1
P06239/G201S	P06239	LCK	LCK_HUMAN	G201S	-	-	-	-	RITFPgHELVR									VARIANT	G -> S (in dbSNP:rs11567841)		0
P06239/L341P	P06239	LCK	LCK_HUMAN	L341P	402	αE	-	-	LTINKlDMAAQ	0.829	0.77	0.504	0.592	0.559	0.661	0.462	0.683	VARIANT	L -> P (in IMD22; dbSNP:rs587777335)	22985903	1
P06239/P447L	P06239	LCK	LCK_HUMAN	P447L	640	αG	-	-	PGMTNpVIQNL	0.447	0.454	0.512	0.447	0.299	0.342	0.583	0.405	VARIANT	P -> L (found in leukemia)	8139546	1
P06239/R154K	P06239	LCK	LCK_HUMAN	R154K	-	-	-	-	GSFLIrSESTA									MUTAGEN	R->K: No effect on interaction with SQSTM1.	8618896	1
P06239/S59E	P06239	LCK	LCK_HUMAN	S59E	-	-	p	-	SNPPAsLQDNL									MUTAGEN	S->E: Allows interaction with SQSTM1.	8618896	1
P06239/V28L	P06239	LCK	LCK_HUMAN	V28L	-	-	-	-	CHYPIvLDGKG									VARIANT	V -> L (found in leukemia)	8139546	1
P06241/D506E	P06241	FYN	FYN_HUMAN	D506E	796	αI	-	neutral	HCWKKdEERPT	0.089	0.129	0.472	0.149	0.119	0.113	0.628	0.213	VARIANT	D -> E (in dbSNP:rs28763975)	17344846	1
P06241/G410R	P06241	FYN	FYN_HUMAN	G410R	498	A-loop;DFG-motif	-	-	KIADFgARLIE	0.894	0.869	0.376	0.72	0.636	0.791	0.331	0.423	VARIANT	G -> R (in a metastatic melanoma sample; somatic mutation)	17344846	1
P06241/I445F	P06241	FYN	FYN_HUMAN	I445F	597	αF	-	-	YGRFTiSDVWS	0.636	0.594	0.502	0.477	0.325	0.408	0.608	0.489	VARIANT	I -> F (in dbSNP:rs1801121)		0
P06241/V243L	P06241	FYN	FYN_HUMAN	V243L	1	N-term-β1	-	-	LCCRLvPCHKG	0.493	0.483	0.602	0.423	0.297	0.367	0.68	0.292	VARIANT	V -> L (in a lung squamous cell carcinoma sample; somatic mutation)	17344846	1
P06493/Y4D	P06493	CDK1	CDK1_HUMAN	Y4D	33	β1	p	decrease	MEDyKIEKI	0.943	0.917	0.291	0.728	0.84	0.905	0.191	0.678	MUTAGEN	Y->D,E: Constitutive polyubiquitination.	20395957	1
P06493/Y4E	P06493	CDK1	CDK1_HUMAN	Y4E	33	β1	p	decrease	MEDyKIEKI	0.957	0.937	0.306	0.714	0.842	0.884	0.213	0.712	MUTAGEN	Y->D,E: Constitutive polyubiquitination.	20395957	1
P07332/G463V	P07332	FES	FES_HUMAN	G463V	-	-	-	loss	QLWYHgIPRAE									MUTAGEN	G->V: Abolishes kinase activity.	18775312	1
P07332/K590E	P07332	FES	FES_HUMAN	K590E	129	β3;Catalytic-Lys	-	loss	TLVAVkCRETL	0.986	0.993	0.07	0.711	1.0	0.999	0.047	0.566	MUTAGEN	K->E: Abolishes kinase activity. Fails to inhibit proliferation of melanoma cells.	15485904,28463229	2
P07332/L145P	P07332	FES	FES_HUMAN	L145P	-	-	-	activating	SQYRAlRDSAQ									MUTAGEN	L->P: Constitutively activated kinase that can act as oncogene. Promotes myeloid cell survival and proliferation.	11509660,15485904	2
P07332/L334P	P07332	FES	FES_HUMAN	L334P	-	-	-	loss	EMVTQlQELRN									MUTAGEN	L->P: Abolishes autophosphorylation.	11509660	1
P07332/M323V	P07332	FES	FES_HUMAN	M323V	-	-	-	neutral	AVATEmFRRQE									VARIANT	M -> V (in dbSNP:rs56296062)	17344846	1
P07332/M704V	P07332	FES	FES_HUMAN	M704V	499	A-loop	-	decrease	ISDFGmREEAD	0.651	0.695	0.509	0.489	0.413	0.595	0.59	0.374	MUTAGEN	M->V: Reduced autophosphorylation and strongly reduced kinase activity.	15867340,16455651	2
P07332/R246Q	P07332	FES	FES_HUMAN	R246Q	-	-	-	-	VVAIHrMAAAA									VARIANT	R -> Q (in dbSNP:rs34573430)	17344846	1
P07332/R483M	P07332	FES	FES_HUMAN	R483M	-	-	-	decrease	GDFLVrSQGKQ									MUTAGEN	R->M: Abolishes pTyr binding. Abolishes association with microtubules. Abolishes autophosphorylation. Reduced kinase activity.	15485904,18775312	2
P07332/R706Q	P07332	FES	FES_HUMAN	R706Q	501	A-loop	-	-	DFGMSrEADGV	0.862	0.794	0.535	0.731	0.504	0.76	0.508	0.491	MUTAGEN	R->Q: Negligible effect on autophosphorylation and kinase activity.	15867340,16455651	2
P07332/R85C	P07332	FES	FES_HUMAN	R85C	-	-	-	-	TEGLSrLRQHA									VARIANT	R -> C (in dbSNP:rs56041861)	17344846	1
P07332/S759F	P07332	FES	FES_HUMAN	S759F	632	αF/αG	-	decrease	FSLGAsYPNLS	0.568	0.548	0.381	0.33	0.569	0.514	0.378	0.375	MUTAGEN	S->F: Reduced autophosphorylation and strongly reduced kinase activity.	15867340,16455651	2
P07332/V743M	P07332	FES	FES_HUMAN	V743M	601	αF	-	decrease	SSESDvSFGIL	0.732	0.68	0.508	0.52	0.568	0.61	0.535	0.409	MUTAGEN	V->M: Strongly reduced autophosphorylation and kinase activity.	15867340,16455651	2
P07332/Y713F	P07332	FES	FES_HUMAN	Y713F	511	A-loop	p	decrease	EADGVyASGGL	0.978	0.986	0.457	0.876	0.784	0.928	0.379	0.648	MUTAGEN	Y->F: Reduces kinase activity by over 90%.	7687763	1
P07333/A245S	P07333	CSF1R	CSF1R_HUMAN	A245S	-	-	-	-	NNTKLaPQQSD									VARIANT	A -> S (in dbSNP:rs41338945)		0
P07333/A770P	P07333	CSF1R	CSF1R_HUMAN	A770P	424	αE	-	-	GMAFLaKNCIH	0.682	0.668	0.589	0.54	0.471	0.487	0.621	0.485	VARIANT	A -> P (in HDLS1; dbSNP:rs281860271)	22197934	1
P07333/A781E	P07333	CSF1R	CSF1R_HUMAN	A781E	446	Catalytic-loop	-	decrease	HRDVAaNVLLT	0.898	0.908	0.424	0.69	0.735	0.885	0.356	0.574	VARIANT	A -> E (in HDLS1; impairs autophosphorylation upon stimulation with CSF1; dbSNP:rs587777247)	24336230	1
P07333/C653R	P07333	CSF1R	CSF1R_HUMAN	C653R	224	β4/β5-loop	-	-	NLLGAcHGGPV	0.877	0.847	0.392	0.597	0.703	0.749	0.362	0.648	VARIANT	C -> R (in HDLS1; dbSNP:rs690016559)	24532199	1
P07333/D802V	P07333	CSF1R	CSF1R_HUMAN	D802V	505	A-loop	-	activating	FGLARdMNDSN	0.937	0.957	0.725	0.953	0.224	0.728	0.748	0.926	MUTAGEN	D->V: Constitutive kinase activity. Loss of inhibition by imatinib.	10340379,16170366	2
P07333/D837Y	P07333	CSF1R	CSF1R_HUMAN	D837Y	600	αF	-	-	YTVQSdWSYGI	0.877	0.875	0.224	0.597	0.791	0.759	0.188	0.654	VARIANT	D -> Y (in HDLS1; dbSNP:rs387906662)	22197934	1
P07333/E633K	P07333	CSF1R	CSF1R_HUMAN	E633K	173	αC	-	decrease	EALMSeKIMSH	0.937	0.918	0.327	0.586	0.828	0.797	0.234	0.637	VARIANT	E -> K (in HDLS1; impairs autophosphorylation upon stimulation with CSF1; dbSNP:rs281860269)	22197934	1
P07333/E920D	P07333	CSF1R	CSF1R_HUMAN	E920D	821	αI	-	-	QEDRReDYTNL	0.334	0.256	0.589	0.44	0.121	0.214	0.749	0.352	VARIANT	E -> D (in dbSNP:rs34030164)	17344846,22197934	2
P07333/F849S	P07333	CSF1R	CSF1R_HUMAN	F849S	615	αF	-	-	LLWEIfLGLNP	0.882	0.815	0.492	0.743	0.643	0.764	0.473	0.687	VARIANT	F -> S (in HDLS1; dbSNP:rs281860277)	22197934	1
P07333/G413S	P07333	CSF1R	CSF1R_HUMAN	G413S	-	-	-	neutral	WTFINgGTLLC									VARIANT	G -> S (in dbSNP:rs34951517)	17344846	1
P07333/G589E	P07333	CSF1R	CSF1R_HUMAN	G589E	40	β1;Gly-rich-loop	-	-	FGKTLgGAFGK	0.89	0.853	0.428	0.748	0.636	0.806	0.433	0.639	VARIANT	G -> E (in HDLS1; dbSNP:rs281860268)	22197934	1
P07333/G747R	P07333	CSF1R	CSF1R_HUMAN	G747R	394	αD/αE-loop	-	-	LDKEDgPLELR	0.191	0.177	0.384	0.217	0.131	0.137	0.622	0.112	VARIANT	G -> R (in dbSNP:rs41355444)	22197934	1
P07333/G765D	P07333	CSF1R	CSF1R_HUMAN	G765D	413	αE	-	decrease	SQVAQgAFLAS	0.917	0.856	0.398	0.633	0.807	0.818	0.303	0.465	VARIANT	G -> D (in HDLS1; impairs autophosphorylation upon stimulation with CSF1; dbSNP:rs690016566)	24336230	1
P07333/H362R	P07333	CSF1R	CSF1R_HUMAN	H362R	-	-	-	-	KDTYRhFTLSL									VARIANT	H -> R (in dbSNP:rs10079250)	17344846	1
P07333/H643Q	P07333	CSF1R	CSF1R_HUMAN	H643Q	193	αC/β4-loop	-	-	SHLGQhNIVNL	0.858	0.809	0.462	0.7	0.635	0.694	0.413	0.505	VARIANT	H -> Q (in BANDDOS; dbSNP:rs184499252)	30982608	1
P07333/I775N	P07333	CSF1R	CSF1R_HUMAN	I775N	440	Catalytic-loop	-	decrease	ASKNCiRDVAA	0.934	0.814	0.331	0.721	0.72	0.804	0.287	0.749	VARIANT	I -> N (in HDLS1; impairs autophosphorylation upon stimulation with CSF1; dbSNP:rs281860273)	22197934	1
P07333/I794T	P07333	CSF1R	CSF1R_HUMAN	I794T	494	Catalytic-loop	-	decrease	GHVAKiDFGLA	0.903	0.864	0.317	0.619	0.803	0.81	0.225	0.583	VARIANT	I -> T (in HDLS1; impairs autophosphorylation upon stimulation with CSF1; dbSNP:rs281860274)	22197934,24336230	2
P07333/I843F	P07333	CSF1R	CSF1R_HUMAN	I843F	606	αF	-	-	VWSYGiLWEIF	0.845	0.832	0.382	0.66	0.677	0.75	0.373	0.644	VARIANT	I -> F (in HDLS1; dbSNP:rs690016558)	24532199	1
P07333/I906T	P07333	CSF1R	CSF1R_HUMAN	I906T	806	αI	-	-	PTFQQiSFLQE	0.69	0.669	0.506	0.518	0.532	0.616	0.535	0.611	VARIANT	I -> T (in HDLS1; dbSNP:rs690016560)	24532199	1
P07333/L301S	P07333	CSF1R	CSF1R_HUMAN	L301S	-	-	-	activating	VESAYlLSSEQ									MUTAGEN	L->S: Constitutive kinase activity.	15117969	1
P07333/L536V	P07333	CSF1R	CSF1R_HUMAN	L536V	-	-	-	-	LLLLLlYKYKQ									VARIANT	L -> V (in dbSNP:rs55942044)	17344846	1
P07333/L868P	P07333	CSF1R	CSF1R_HUMAN	L868P	649	αG	-	-	SKFYKlKDGYQ	0.598	0.525	0.538	0.522	0.411	0.454	0.555	0.42	VARIANT	L -> P (in HDLS1; dbSNP:rs281860278)	22197934	1
P07333/M766T	P07333	CSF1R	CSF1R_HUMAN	M766T	414	αE	-	decrease	QVAQGmFLASK	0.922	0.869	0.454	0.67	0.722	0.818	0.338	0.526	VARIANT	M -> T (in HDLS1; impairs autophosphorylation upon stimulation with CSF1; dbSNP:rs281860270)	22197934,23408870	2
P07333/M875T	P07333	CSF1R	CSF1R_HUMAN	M875T	754	αG/αH	-	decrease	KDGYQmQPAFA	0.868	0.829	0.42	0.668	0.703	0.713	0.363	0.579	VARIANT	M -> T (in HDLS1; impairs autophosphorylation upon stimulation with CSF1; dbSNP:rs281860279)	22197934,23408870	2
P07333/P132L	P07333	CSF1R	CSF1R_HUMAN	P132L	-	-	-	decrease	CLLTDpLEAGV									VARIANT	P -> L (in BANDDOS; impairs phosphorylation of JNK kinases upon stimulation with CSF1; dbSNP:rs1351319114)	30982609	1
P07333/P693H	P07333	CSF1R	CSF1R_HUMAN	P693H	310	αD/αE-loop	-	-	SPGQDpGGVDY	0.166	0.11	0.502	0.22	0.122	0.14	0.707	0.212	VARIANT	P -> H (in a lung squamous cell carcinoma sample; somatic mutation)	17344846	1
P07333/P824S	P07333	CSF1R	CSF1R_HUMAN	P824S	556	A-loop;APE-motif	-	decrease	VKWMApSIFDC	0.829	0.737	0.325	0.482	0.685	0.628	0.405	0.618	VARIANT	P -> S (in HDLS1; impairs autophosphorylation upon stimulation with CSF1)	24336230	1
P07333/P878T	P07333	CSF1R	CSF1R_HUMAN	P878T	757	αG/αH	-	-	YQMAQpFAPKN	0.743	0.713	0.422	0.517	0.582	0.647	0.412	0.422	VARIANT	P -> T (in HDLS1; dbSNP:rs281860280)	22197934	1
P07333/R710H	P07333	CSF1R	CSF1R_HUMAN	R710H	327	αD/αE-loop	-	-	EKKYVrDSGFS	0.175	0.173	0.529	0.162	0.143	0.123	0.71	0.134	VARIANT	R -> H (in dbSNP:rs201569135)	22197934	1
P07333/R782H	P07333	CSF1R	CSF1R_HUMAN	R782H	447	Catalytic-loop	-	decrease	RDVAArVLLTN	0.92	0.879	0.323	0.682	0.81	0.837	0.271	0.438	VARIANT	R -> H (in HDLS1; impairs autophosphorylation upon stimulation with CSF1; dbSNP:rs281860281)	23408870	1
P07333/R921Q	P07333	CSF1R	CSF1R_HUMAN	R921Q	822	αI	-	-	EDRRErYTNLP	0.351	0.276	0.514	0.202	0.266	0.348	0.599	0.162	VARIANT	R -> Q (in dbSNP:rs56059682)	17344846	1
P07333/V279M	P07333	CSF1R	CSF1R_HUMAN	V279M	-	-	-	neutral	GNYSCvSNVQG									VARIANT	V -> M (in dbSNP:rs3829986)		0
P07333/V32G	P07333	CSF1R	CSF1R_HUMAN	V32G	-	-	-	neutral	VPELVvPGATV									VARIANT	V -> G (in dbSNP:rs56048668)	17344846	1
P07333/Y708F	P07333	CSF1R	CSF1R_HUMAN	Y708F	325	αD/αE-loop	p	increase	HLEKKyRRDSG	0.636	0.724	0.643	0.707	0.164	0.408	0.733	0.101	MUTAGEN	Y->F: Impairs degradation of activated CSF1R.	10340379	1
P07333/Y809F	P07333	CSF1R	CSF1R_HUMAN	Y809F	512	A-loop	p	decrease	MNDSNyVKGNA	0.975	0.963	0.554	0.896	0.688	0.93	0.455	0.566	MUTAGEN	Y->F: Reduced kinase activity. Reduced interaction with SRC, FYN and YES1.	7681396	1
P07333/Y969C	P07333	CSF1R	CSF1R_HUMAN	Y969C	-	-	-	-	LQPNNyFC									VARIANT	Y -> C (in dbSNP:rs1801271)		0
P07333/Y969F	P07333	CSF1R	CSF1R_HUMAN	Y969F	-	-	-	loss	LQPNNyFC									MUTAGEN	Y->F: Abolishes down-regulation of activated CSF1R.	15117969	1
P07947/I198V	P07947	YES1	YES_HUMAN	I198V	-	-	-	neutral	AYSLSiDWDEI									VARIANT	I -> V (in dbSNP:rs34580680)	17344846	1
P07947/K282R	P07947	YES1	YES_HUMAN	K282R	38	β1	-	-	LRLEVkGQGCF	0.226	0.163	0.486	0.157	0.173	0.174	0.626	0.103	VARIANT	K -> R (in dbSNP:rs35126906)	17344846	1
P07947/Y426F	P07947	YES1	YES_HUMAN	Y426F	533	A-loop	p	increase	IEDNEyARQGA	0.956	0.988	0.531	0.869	0.582	0.913	0.472	0.352	MUTAGEN	Y->F: About 50% loss of CSK-mediated inhibition.	9794236	1
P07948/C3A	P07948	LYN	LYN_HUMAN	C3A	-	-	-	-	MGcKSKGK									MUTAGEN	C->A: Loss of localization to the cell membrane; when associated with A-2.	18817770	1
P07948/D346A	P07948	LYN	LYN_HUMAN	D346A	405	αE	-	-	LPKLIdSAQIA	0.534	0.443	0.407	0.367	0.418	0.447	0.465	0.5	MUTAGEN	D->A: Impedes the trafficking from the Golgi apparatus toward the cell membrane; when associated with A-353; A-498 and A-499.	15173188	1
P07948/D385Y	P07948	LYN	LYN_HUMAN	D385Y	496	A-loop;DFG-motif	-	-	MCKIAdGLARV	0.959	0.981	0.181	0.58	0.913	0.882	0.09	0.645	VARIANT	D -> Y (in a breast pleomorphic lobular carcinoma sample; somatic mutation)	17344846	1
P07948/D498A	P07948	LYN	LYN_HUMAN	D498A	815	αI	-	-	LQSVLdFYTAT	0.356	0.296	0.519	0.408	0.216	0.237	0.632	0.319	MUTAGEN	D->A: Impedes the trafficking from the Golgi apparatus toward the cell membrane; when associated with A-346; A-353 and A-499.	15173188	1
P07948/D499A	P07948	LYN	LYN_HUMAN	D499A	816	αI	-	-	QSVLDdYTATE	0.77	0.698	0.419	0.568	0.504	0.648	0.404	0.644	MUTAGEN	D->A: Impedes the trafficking from the Golgi apparatus toward the cell membrane; when associated with A-346; A-353 and A-498.	15173188	1
P07948/E353A	P07948	LYN	LYN_HUMAN	E353A	412	αE	-	-	SAQIAeMAYIE	0.518	0.516	0.405	0.345	0.482	0.498	0.439	0.482	MUTAGEN	E->A: Impedes the trafficking from the Golgi apparatus toward the cell membrane; when associated with A-346; A-498 and A-499.	15173188	1
P07948/K275A	P07948	LYN	LYN_HUMAN	K275A	129	β3;Catalytic-Lys	-	loss	TKVAVkLKPGT	1.0	1.0	0.032	0.648	0.994	0.999	0.002	0.646	MUTAGEN	K->A: Loss of activity and no effect on localization to the cell membrane. Abundant localization in the nucleus; when associated with A-2 and A-3.	11435302,11517336,15173188,18817770	4
P07948/K275L	P07948	LYN	LYN_HUMAN	K275L	129	β3;Catalytic-Lys	-	loss	TKVAVkLKPGT	0.993	0.995	0.075	0.644	0.975	0.999	0.031	0.508	MUTAGEN	K->L,R: Loss of kinase activity.	11435302,11517336,15173188,18817770	4
P07948/K275R	P07948	LYN	LYN_HUMAN	K275R	129	β3;Catalytic-Lys	-	loss	TKVAVkLKPGT	1.0	1.0	0.063	0.729	0.998	0.992	0.045	0.553	MUTAGEN	K->L,R: Loss of kinase activity.	11435302,11517336,15173188,18817770	4
P07948/Y397F	P07948	LYN	LYN_HUMAN	Y397F	533	A-loop	p	decrease	IEDNEyAREGA	0.958	0.98	0.522	0.861	0.736	0.936	0.402	0.415	MUTAGEN	Y->F: Strongly reduced kinase activity.	16920712	1
P07948/Y508F	P07948	LYN	LYN_HUMAN	Y508F	825	C-term-αI	p	increase	ATEGQyQQP	0.834	0.877	0.604	0.809	0.537	0.746	0.565	0.324	MUTAGEN	Y->F: Abolishes autoinhibition and thereby increases kinase activity.	16920712	1
P07949/A432E	P07949	RET	RET_HUMAN	A432E	-	-	-	-	VENCQaSGINV									VARIANT	A -> E (found in a patient with congenital central hypoventilation syndrome; unknown pathological significance; dbSNP:rs552057730)	14566559	1
P07949/A639G	P07949	RET	RET_HUMAN	A639G	-	-	-	-	CRTVIaAVLFS									VARIANT	A -> G (in MTC; sporadic form)	11692159	1
P07949/A640G	P07949	RET	RET_HUMAN	A640G	-	-	-	-	RTVIAaVLFSF									VARIANT	A -> G (in MEN2A; dbSNP:rs78935588)	10522989	1
P07949/A641G	P07949	RET	RET_HUMAN	A641G	-	-	-	-	TVIAAaLFSFI									VARIANT	A -> G (in MTC; sporadic form)	11692159	1
P07949/A883F	P07949	RET	RET_HUMAN	A883F	452	Catalytic-loop	-	-	RNILVaGRKMK	0.635	0.568	0.634	0.465	0.345	0.513	0.711	0.475	VARIANT	A -> F (in MEN2B; somatic mutation in sporadic medullary thyroid carcinoma; requires 2 nucleotide substitutions; dbSNP:rs377767429)	9294615,9360560	2
P07949/C142S	P07949	RET	RET_HUMAN	C142S	-	-	-	-	CQWPGcRVYFS									VARIANT	C -> S (in HSCR1; sporadic form)		0
P07949/C157Y	P07949	RET	RET_HUMAN	C157Y	-	-	-	-	TSFPAcSLKPR									VARIANT	C -> Y (in HSCR1; unknown pathological significance)		0
P07949/C197Y	P07949	RET	RET_HUMAN	C197Y	-	-	-	-	PVQFLcNISVA									VARIANT	C -> Y (in HSCR1; sporadic form)	9094028	1
P07949/C609G	P07949	RET	RET_HUMAN	C609G	-	-	-	-	AGYGTcCFPEE									VARIANT	C -> G (in MEN2A; dbSNP:rs77558292)		0
P07949/C609R	P07949	RET	RET_HUMAN	C609R	-	-	-	-	AGYGTcCFPEE									VARIANT	C -> R (in MEN2A; dbSNP:rs77558292)		0
P07949/C609W	P07949	RET	RET_HUMAN	C609W	-	-	-	-	AGYGTcCFPEE									VARIANT	C -> W (in HSCR1; familial form; dbSNP:rs377767396)	7881414	1
P07949/C609Y	P07949	RET	RET_HUMAN	C609Y	-	-	-	-	AGYGTcCFPEE									VARIANT	C -> Y (in MTC, MEN2A and HSCR1; familial and sporadic forms; dbSNP:rs77939446)	7633441,7849720,9384613	3
P07949/C611G	P07949	RET	RET_HUMAN	C611G	-	-	-	-	YGTCNcPEEEK									VARIANT	C -> G (in MTC; familial form; dbSNP:rs377767391)	9677065	1
P07949/C611R	P07949	RET	RET_HUMAN	C611R	-	-	-	-	YGTCNcPEEEK									VARIANT	C -> R (in MEN2A; dbSNP:rs377767391)		0
P07949/C611S	P07949	RET	RET_HUMAN	C611S	-	-	-	-	YGTCNcPEEEK									VARIANT	C -> S (in MEN2A; dbSNP:rs377767391)		0
P07949/C611W	P07949	RET	RET_HUMAN	C611W	-	-	-	-	YGTCNcPEEEK									VARIANT	C -> W (in MEN2A and MTC; familial form; dbSNP:rs80069458)	8103403	1
P07949/C611Y	P07949	RET	RET_HUMAN	C611Y	-	-	-	-	YGTCNcPEEEK									VARIANT	C -> Y (in MEN2A; dbSNP:rs377767397)		0
P07949/C618F	P07949	RET	RET_HUMAN	C618F	-	-	-	-	PEEEKcCEPED									VARIANT	C -> F (in MEN2A and MTC; familial form; dbSNP:rs79781594)		0
P07949/C618G	P07949	RET	RET_HUMAN	C618G	-	-	-	-	PEEEKcCEPED									VARIANT	C -> G (in MEN2A; dbSNP:rs76262710)	8099202	1
P07949/C618R	P07949	RET	RET_HUMAN	C618R	-	-	-	-	PEEEKcCEPED									VARIANT	C -> R (in MEN2A, MTC and HSCR1; dbSNP:rs76262710)	7849720,7881414,7915165,9259198	4
P07949/C618S	P07949	RET	RET_HUMAN	C618S	-	-	-	-	PEEEKcCEPED									VARIANT	C -> S (in MEN2A, HSCR1 and MTC; familial and sporadic forms; dbSNP:rs79781594)	7849720,7860065,7915165,8103403,9384613	5
P07949/C618Y	P07949	RET	RET_HUMAN	C618Y	-	-	-	-	PEEEKcCEPED									VARIANT	C -> Y (in MEN2A and MTC; familial form; dbSNP:rs79781594)		0
P07949/C620F	P07949	RET	RET_HUMAN	C620F	-	-	-	-	EEKCFcPEDIQ									VARIANT	C -> F (in MEN2A and MTC; familial form; dbSNP:rs77503355)	7915165	1
P07949/C620G	P07949	RET	RET_HUMAN	C620G	-	-	-	-	EEKCFcPEDIQ									VARIANT	C -> G (in MEN2A and MTC; familial and sporadic forms; dbSNP:rs77316810)		0
P07949/C620R	P07949	RET	RET_HUMAN	C620R	-	-	-	-	EEKCFcPEDIQ									VARIANT	C -> R (in MEN2A, MTC and HSCR1; familial and sporadic forms; dbSNP:rs77316810)	7633441,7881414,7915165,8103403,9090527,9384613	6
P07949/C620S	P07949	RET	RET_HUMAN	C620S	-	-	-	-	EEKCFcPEDIQ									VARIANT	C -> S (in MEN2A and MTC; familial form; dbSNP:rs77503355)	7849720,7860065	2
P07949/C620W	P07949	RET	RET_HUMAN	C620W	-	-	-	-	EEKCFcPEDIQ									VARIANT	C -> W (in MEN2A and HSCR1; dbSNP:rs79890926)	9384613	1
P07949/C620Y	P07949	RET	RET_HUMAN	C620Y	-	-	-	-	EEKCFcPEDIQ									VARIANT	C -> Y (in MEN2A; dbSNP:rs77503355)	8103403	1
P07949/C630F	P07949	RET	RET_HUMAN	C630F	-	-	-	-	IQDPLcELCRT									VARIANT	C -> F (in MEN2A and MTC; familial form; dbSNP:rs377767405)		0
P07949/C630S	P07949	RET	RET_HUMAN	C630S	-	-	-	-	IQDPLcELCRT									VARIANT	C -> S (in MTC; sporadic form; dbSNP:rs377767405)		0
P07949/C630Y	P07949	RET	RET_HUMAN	C630Y	-	-	-	-	IQDPLcELCRT									VARIANT	C -> Y (in MTC; familial and sporadic forms; dbSNP:rs377767405)		0
P07949/C634F	P07949	RET	RET_HUMAN	C634F	-	-	-	-	LCDELcTVIAA									VARIANT	C -> F (in MEN2A and pheochromocytoma; dbSNP:rs75996173)	12000816,7915165,8099202	3
P07949/C634G	P07949	RET	RET_HUMAN	C634G	-	-	-	-	LCDELcTVIAA									VARIANT	C -> G (in MEN2A and pheochromocytoma; dbSNP:rs75076352)	12000816,7915165,8099202	3
P07949/C634R	P07949	RET	RET_HUMAN	C634R	-	-	-	-	LCDELcTVIAA									VARIANT	C -> R (in MEN2A, pheochromocytoma and MTC; familial form; also found as somatic mutation in a sporadic thyroid carcinoma; dbSNP:rs75076352)	12000816,7860065,8103403	3
P07949/C634S	P07949	RET	RET_HUMAN	C634S	-	-	-	-	LCDELcTVIAA									VARIANT	C -> S (in MEN2A, pheochromocytoma and MTC; familial form; dbSNP:rs75076352)	12000816,8099202	2
P07949/C634W	P07949	RET	RET_HUMAN	C634W	-	-	-	-	LCDELcTVIAA									VARIANT	C -> W (in MEN2A, pheochromocytoma and MTC; familial form; dbSNP:rs77709286)	12000816	1
P07949/C634Y	P07949	RET	RET_HUMAN	C634Y	-	-	-	-	LCDELcTVIAA									VARIANT	C -> Y (in MEN2A, pheochromocytoma and MTC; familial form; dbSNP:rs75996173)	12000816,7860065,7915165,8099202	4
P07949/D300N	P07949	RET	RET_HUMAN	D300N	-	-	-	-	TLRVFdDVVPA									VARIANT	D -> N (in HSCR1)	22174939	1
P07949/D353Y	P07949	RET	RET_HUMAN	D353Y	-	-	-	-	RATVHdRLVLN									VARIANT	D -> Y (in HSCR1; dbSNP:rs1837785429)	22174939	1
P07949/D489N	P07949	RET	RET_HUMAN	D489N	-	-	-	neutral	MVVATdQTSRQ									VARIANT	D -> N (in dbSNP:rs9282834)	14566559,17344846	2
P07949/D631G	P07949	RET	RET_HUMAN	D631G	-	-	-	-	QDPLCdLCRTV									VARIANT	D -> G (in thyroid carcinoma; somatic mutation; dbSNP:rs121913308)		0
P07949/D707N	P07949	RET	RET_HUMAN	D707N	11	N-term-β1	-	-	NQVSVdFKILE	0.253	0.246	0.41	0.195	0.292	0.234	0.509	0.211	MUTAGEN	D->N: Impaired cleavage by caspase-3 and loss of induced cell death.	21357690	1
P07949/E251K	P07949	RET	RET_HUMAN	E251K	-	-	-	-	HAGAReVVMVP									VARIANT	E -> K (in HSCR1; familial form; dbSNP:rs562449603)		0
P07949/E480K	P07949	RET	RET_HUMAN	E480K	-	-	-	-	RPKCAeHYMVV									VARIANT	E -> K (in HSCR1; dbSNP:rs537874538)	22174939	1
P07949/E595Q	P07949	RET	RET_HUMAN	E595Q	-	-	-	-	IVGGHeGEPRG									VARIANT	E -> Q (in HSCR1; dbSNP:rs1483605155)	22174939	1
P07949/E762Q	P07949	RET	RET_HUMAN	E762Q	133	β3/αC-loop	-	-	VKMLKeASPSE	0.387	0.356	0.5	0.346	0.281	0.248	0.6	0.299	VARIANT	E -> Q (in HSCR1; sporadic form)	7704557	1
P07949/E768D	P07949	RET	RET_HUMAN	E768D	139	αC	-	-	NASPSeRDLLS	0.388	0.344	0.623	0.376	0.144	0.267	0.786	0.261	VARIANT	E -> D (in MTC; familial and sporadic forms; dbSNP:rs78014899)	7784092,7845675,8807338	3
P07949/E921K	P07949	RET	RET_HUMAN	E921K	557	A-loop;APE-motif	-	-	KWMAIeLFDHI	0.944	0.935	0.228	0.654	0.868	0.883	0.183	0.511	VARIANT	E -> K (in HSCR1; sporadic form)		0
P07949/F1112Y	P07949	RET	RET_HUMAN	F1112Y	-	-	-	-	KLMDTfS									VARIANT	F -> Y (in a bladder transitional cell carcinoma sample; somatic mutation)	17344846	1
P07949/F174S	P07949	RET	RET_HUMAN	F174S	-	-	-	-	ETRPSfIRENR									VARIANT	F -> S (in HSCR1; sporadic form)	9094028	1
P07949/F393L	P07949	RET	RET_HUMAN	F393L	-	-	-	-	VLLLHfVSVLP									VARIANT	F -> L (in HSCR1; familial form; dbSNP:rs78098482)	8114939	1
P07949/F893L	P07949	RET	RET_HUMAN	F893L	497	A-loop;DFG-motif	-	-	MKISDfLSRDV	0.813	0.79	0.381	0.668	0.624	0.747	0.372	0.564	VARIANT	F -> L (in HSCR1; sporadic form)		0
P07949/F961L	P07949	RET	RET_HUMAN	F961L	737	αG/αH	-	-	PPERLfLLKTG	0.456	0.355	0.497	0.374	0.266	0.373	0.605	0.346	VARIANT	F -> L (in HSCR1)	22174939	1
P07949/G423R	P07949	RET	RET_HUMAN	G423R	-	-	-	-	RFAQIgVCVEN									VARIANT	G -> R (in HSCR1; dbSNP:rs767601598)	22174939	1
P07949/G593E	P07949	RET	RET_HUMAN	G593E	-	-	-	-	GSIVGgEPGEP									VARIANT	G -> E (in a colorectal cancer sample; somatic mutation)	16959974	1
P07949/G691S	P07949	RET	RET_HUMAN	G691S	-	-	-	neutral	SYSSSgRRPSL									VARIANT	G -> S (in dbSNP:rs1799939)	14566559,17344846,9223675,9497256	4
P07949/G830R	P07949	RET	RET_HUMAN	G830R	282	αD/αE-loop	-	-	GYLGSgSRNSS	0.085	0.138	0.51	0.186	0.109	0.121	0.688	0.113	VARIANT	G -> R (in HSCR1; dbSNP:rs200127630)	22174939	1
P07949/G894S	P07949	RET	RET_HUMAN	G894S	498	A-loop;DFG-motif	-	activating	KISDFgSRDVY	0.913	0.887	0.432	0.779	0.435	0.803	0.49	0.476	VARIANT	G -> S (in a patient with renal agenesis; unknown pathological significance; constitutively phosphorylated; expressed only the immature intracellular form)	18252215	1
P07949/G93S	P07949	RET	RET_HUMAN	G93S	-	-	-	-	IQEDTgLYLNR									VARIANT	G -> S (in HSCR1; unknown pathological significance; dbSNP:rs1477699803)	7633441	1
P07949/K758R	P07949	RET	RET_HUMAN	K758R	129	β3;Catalytic-Lys	-	loss	TTVAVkLKENA	1.0	0.996	0.047	0.667	0.989	0.999	0.017	0.526	MUTAGEN	K->R: Loss of kinase activity. No effect on interaction with and dissociation from CBLC and CD2AP.	18753381,21357690	2
P07949/K907E	P07949	RET	RET_HUMAN	K907E	532	A-loop	-	-	EDSYVkSQGRI	0.862	0.774	0.739	0.925	0.185	0.463	0.812	0.467	VARIANT	K -> E (in HSCR1; sporadic form; dbSNP:rs377767430)		0
P07949/K907T	P07949	RET	RET_HUMAN	K907T	532	A-loop	-	-	EDSYVkSQGRI	0.822	0.764	0.621	0.73	0.344	0.578	0.678	0.556	VARIANT	K -> T (in HSCR1)	22174939	1
P07949/L1052V	P07949	RET	RET_HUMAN	L1052V	-	-	-	-	PLPRAlSTWIE									VARIANT	L -> V (in HSCR1; dbSNP:rs1564501947)	22174939	1
P07949/L1061P	P07949	RET	RET_HUMAN	L1061P	-	-	-	-	WIENKlGMSDP									VARIANT	L -> P (in HSCR1; dbSNP:rs536486113)	10484767	1
P07949/L40P	P07949	RET	RET_HUMAN	L40P	-	-	-	-	AYWEKlVDQAA									VARIANT	L -> P (in HSCR1)	7704557,9043870	2
P07949/L790F	P07949	RET	RET_HUMAN	L790F	199	β4	-	-	PHVIKlGACSQ	0.75	0.672	0.581	0.679	0.387	0.517	0.633	0.378	VARIANT	L -> F (in MEN2A and MTC; familial form; dbSNP:rs75030001)	9506724	1
P07949/M1064T	P07949	RET	RET_HUMAN	M1064T	-	-	-	-	NKLYGmDPNWP									VARIANT	M -> T (in HSCR1; familial form; dbSNP:rs149513065)	22174939	1
P07949/M918T	P07949	RET	RET_HUMAN	M918T	554	A-loop	-	-	IPVKWmIESLF	0.859	0.755	0.515	0.669	0.396	0.711	0.549	0.626	VARIANT	M -> T (in MEN2B and MTC; sporadic form; somatic mutation; also found in a patient with renal agenesis; dbSNP:rs74799832)	18252215,7906417,7906866,7911697,8595427,8807338	6
P07949/M980T	P07949	RET	RET_HUMAN	M980T	784	αH	-	-	NCSEEmRLMLQ	0.776	0.755	0.63	0.629	0.415	0.612	0.636	0.507	VARIANT	M -> T (in HSCR1; sporadic form)		0
P07949/N359K	P07949	RET	RET_HUMAN	N359K	-	-	-	-	YRLVLnNLSIS									VARIANT	N -> K (in HSCR1; unknown pathological significance)		0
P07949/N394H	P07949	RET	RET_HUMAN	N394H	-	-	-	-	LLLHFnSVLPV									VARIANT	N -> H (in a patient with renal agenesis; unknown pathological significance; prevents phosphorylation in response to GDNF)	18252215	1
P07949/N394K	P07949	RET	RET_HUMAN	N394K	-	-	-	-	LLLHFnSVLPV									VARIANT	N -> K (in HSCR1)	10618407	1
P07949/N783S	P07949	RET	RET_HUMAN	N783S	190	αC/β4-loop	-	-	VLKQVnPHVIK	0.269	0.228	0.596	0.329	0.269	0.218	0.659	0.248	VARIANT	N -> S (in HSCR1; dbSNP:rs587778656)	22174939	1
P07949/P1039L	P07949	RET	RET_HUMAN	P1039L	-	-	-	-	SEEETpVDCNN									VARIANT	P -> L (in HSCR1; dbSNP:rs79853121)	9497256	1
P07949/P1039Q	P07949	RET	RET_HUMAN	P1039Q	-	-	-	-	SEEETpVDCNN									VARIANT	P -> Q (in dbSNP:rs79853121)		0
P07949/P1049L	P07949	RET	RET_HUMAN	P1049L	-	-	-	-	NNAPLpALPST									VARIANT	P -> L (in a patient with renal agenesis; unknown pathological significance; prevents phosphorylation in response to GDNF; dbSNP:rs1490712863)	18252215	1
P07949/P1067S	P07949	RET	RET_HUMAN	P1067S	-	-	-	-	YGMSDpWPGES									VARIANT	P -> S (in a patient with renal agenesis; unknown pathological significance; prevents phosphorylation in response to GDNF; dbSNP:rs775583354)	18252215	1
P07949/P155L	P07949	RET	RET_HUMAN	P155L	-	-	-	-	FNTSFpCSSLK									VARIANT	P -> L (in HSCR1)	22174939	1
P07949/P198T	P07949	RET	RET_HUMAN	P198T	-	-	-	-	VQFLCpISVAY									VARIANT	P -> T (in a patient with renal agenesis; unknown pathological significance; prevents phosphorylation in response to GDNF; dbSNP:rs76736111)	18252215	1
P07949/P20L	P07949	RET	RET_HUMAN	P20L	-	-	-	-	LLLLLpLGKVA									VARIANT	P -> L (in HSCR1; sporadic form)	7633441	1
P07949/P399L	P07949	RET	RET_HUMAN	P399L	-	-	-	-	NVSVLpSLHLP									VARIANT	P -> L (in HSCR1; sporadic form; dbSNP:rs1554818362)	7704557	1
P07949/P64L	P07949	RET	RET_HUMAN	P64L	-	-	-	-	APEEVpFRLGQ									VARIANT	P -> L (in HSCR1; familial form; dbSNP:rs77596424)	8114939	1
P07949/P679L	P07949	RET	RET_HUMAN	P679L	-	-	-	-	MTFRRpQAFPV									VARIANT	P -> L (in HSCR1)	22174939	1
P07949/P973L	P07949	RET	RET_HUMAN	P973L	757	αG/αH	-	-	HRMERpNCSEE	0.622	0.607	0.555	0.514	0.503	0.529	0.548	0.456	VARIANT	P -> L (in HSCR1; familial form)	7704557	1
P07949/Q626K	P07949	RET	RET_HUMAN	Q626K	-	-	-	-	EPEDIqPLCDE									VARIANT	Q -> K (in HSCR1; sporadic form; dbSNP:rs1255575160)	10090908	1
P07949/R114C	P07949	RET	RET_HUMAN	R114C	-	-	-	-	LSVRNrFPLLT									VARIANT	R -> C (in HSCR1; unknown pathological significance; dbSNP:rs747483905)	22174939	1
P07949/R114H	P07949	RET	RET_HUMAN	R114H	-	-	-	-	LSVRNrFPLLT									VARIANT	R -> H (in dbSNP:rs76397662)	12086152,14566559,22174939	3
P07949/R163Q	P07949	RET	RET_HUMAN	R163Q	-	-	-	-	SSLKPrLCFPE									VARIANT	R -> Q (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs149403911)	17344846	1
P07949/R175P	P07949	RET	RET_HUMAN	R175P	-	-	-	-	TRPSFrRENRP									VARIANT	R -> P (in HSCR1)	22174939	1
P07949/R180P	P07949	RET	RET_HUMAN	R180P	-	-	-	-	RIRENrPGTFH									VARIANT	R -> P (in HSCR1; sporadic form)	9090527	1
P07949/R231H	P07949	RET	RET_HUMAN	R231H	-	-	-	-	RWALDrQREKY									VARIANT	R -> H (in HSCR1; familial form; dbSNP:rs79661516)		0
P07949/R287Q	P07949	RET	RET_HUMAN	R287Q	-	-	-	-	VVEFKrEDTVV									VARIANT	R -> Q (in HSCR1; sporadic form; dbSNP:rs1564491460)		0
P07949/R313Q	P07949	RET	RET_HUMAN	R313Q	-	-	-	-	GELVRrTSTLL									VARIANT	R -> Q (in HSCR1; dbSNP:rs77702891)	22174939,9090527	2
P07949/R330Q	P07949	RET	RET_HUMAN	R330Q	-	-	-	-	AQQTFrEHWPN									VARIANT	R -> Q (in HSCR1; dbSNP:rs80236571)	7633441,8114939	2
P07949/R360Q	P07949	RET	RET_HUMAN	R360Q	-	-	-	-	RLVLNrLSISE									VARIANT	R -> Q (in HSCR1; dbSNP:rs762472027)	22174939	1
P07949/R360W	P07949	RET	RET_HUMAN	R360W	-	-	-	-	RLVLNrLSISE									VARIANT	R -> W (in HSCR1)	10618407,16959974	2
P07949/R475Q	P07949	RET	RET_HUMAN	R475Q	-	-	-	-	TKALRrKCAEL									VARIANT	R -> Q (in HSCR1; sporadic form; dbSNP:rs138624658)		0
P07949/R600Q	P07949	RET	RET_HUMAN	R600Q	-	-	-	-	EPGEPrIKAGY									VARIANT	R -> Q (in dbSNP:rs377767393)	10612852	1
P07949/R67H	P07949	RET	RET_HUMAN	R67H	-	-	-	-	EVPSFrGQHLY									VARIANT	R -> H (in dbSNP:rs192489011)	14566559	1
P07949/R694Q	P07949	RET	RET_HUMAN	R694Q	-	-	-	-	SSGARrSLDSM									VARIANT	R -> Q (in HSCR1; dbSNP:rs141185224)	22174939	1
P07949/R749T	P07949	RET	RET_HUMAN	R749T	88	β2/β3-loop	-	-	FHLKGrGYTTV	0.287	0.236	0.536	0.197	0.163	0.23	0.676	0.158	VARIANT	R -> T (in dbSNP:rs34288963)	17344846	1
P07949/R77C	P07949	RET	RET_HUMAN	R77C	-	-	-	-	LYGTYrRLHEN									VARIANT	R -> C (in HSCR1)	10618407	1
P07949/R813Q	P07949	RET	RET_HUMAN	R813Q	265	αD	-	-	KYGSLrFLRES	0.435	0.319	0.532	0.387	0.184	0.275	0.659	0.189	VARIANT	R -> Q (in HSCR1; sporadic form; dbSNP:rs1318733775)	10090908	1
P07949/R844L	P07949	RET	RET_HUMAN	R844L	296	αD/αE-loop	-	-	DHPDErLTMGD	0.609	0.548	0.518	0.545	0.391	0.442	0.578	0.463	VARIANT	R -> L (in MTC; familial form; dbSNP:rs55947360)	10826520,17344846	2
P07949/R873Q	P07949	RET	RET_HUMAN	R873Q	442	Catalytic-loop;HrD-motif	-	-	MKLVHrLAARN	0.901	0.937	0.392	0.774	0.711	0.81	0.37	0.544	VARIANT	R -> Q (in HSCR1; sporadic form; dbSNP:rs1451004715)		0
P07949/R897Q	P07949	RET	RET_HUMAN	R897Q	501	A-loop	-	-	DFGLSrVYEED	0.903	0.921	0.529	0.816	0.492	0.808	0.477	0.548	VARIANT	R -> Q (in HSCR1; sporadic form; dbSNP:rs76087194)	7704557,8114938	2
P07949/R972G	P07949	RET	RET_HUMAN	R972G	756	αG/αH	-	-	GHRMErDNCSE	0.694	0.71	0.578	0.649	0.394	0.614	0.625	0.35	VARIANT	R -> G (in HSCR1; familial form; dbSNP:rs76534745)	7704557,8114938	2
P07949/R982C	P07949	RET	RET_HUMAN	R982C	787	αH	-	neutral	SEEMYrMLQCW	0.385	0.4	0.467	0.343	0.264	0.343	0.503	0.333	VARIANT	R -> C (in dbSNP:rs17158558)	14566559,15489334,17344846,7633441,9760196	5
P07949/S316I	P07949	RET	RET_HUMAN	S316I	-	-	-	-	VRRYTsLLPGD									VARIANT	S -> I (in HSCR1; dbSNP:rs1060499894)	22174939	1
P07949/S32L	P07949	RET	RET_HUMAN	S32L	-	-	-	-	LGLYFsDAYWE									VARIANT	S -> L (in HSCR1; familial form; dbSNP:rs76764689)	10618407,8114939	2
P07949/S339L	P07949	RET	RET_HUMAN	S339L	-	-	-	-	WPNETsQANGS									VARIANT	S -> L (in HSCR1; dbSNP:rs774829203)	22174939	1
P07949/S690P	P07949	RET	RET_HUMAN	S690P	-	-	-	-	VSYSSsARRPS									VARIANT	S -> P (in HSCR1; sporadic form)		0
P07949/S765P	P07949	RET	RET_HUMAN	S765P	136	αC	-	-	LKENAsSELRD	0.545	0.568	0.658	0.592	0.362	0.47	0.702	0.377	VARIANT	S -> P (in HSCR1; dbSNP:rs75075748)	7704557,8114938,9043870	3
P07949/S767R	P07949	RET	RET_HUMAN	S767R	138	αC	-	-	ENASPsLRDLL	0.602	0.521	0.464	0.396	0.432	0.502	0.524	0.47	VARIANT	S -> R (in HSCR1; sporadic form)		0
P07949/S891A	P07949	RET	RET_HUMAN	S891A	495	Catalytic-loop	p	-	RKMKIsFGLSR	0.671	0.701	0.507	0.64	0.296	0.443	0.67	0.365	VARIANT	S -> A (in MTC; familial form; dbSNP:rs75234356)	9398735	1
P07949/S922F	P07949	RET	RET_HUMAN	S922F	558	αF	-	-	WMAIEsFDHIY	0.687	0.656	0.48	0.578	0.48	0.624	0.498	0.601	VARIANT	S -> F (in MTC; sporadic form; dbSNP:rs377767432)	11692159	1
P07949/S922Y	P07949	RET	RET_HUMAN	S922Y	558	αF	-	-	WMAIEsFDHIY	0.695	0.655	0.497	0.578	0.467	0.58	0.473	0.638	VARIANT	S -> Y (in dbSNP:rs377767432)	8595427	1
P07949/T278A	P07949	RET	RET_HUMAN	T278A	-	-	-	-	PAGVDtSAVVE									VARIANT	T -> A (in HSCR1; dbSNP:rs541929171)	22174939	1
P07949/T278N	P07949	RET	RET_HUMAN	T278N	-	-	-	-	PAGVDtSAVVE									VARIANT	T -> N (found in two patients with Hirschsprung disease; dbSNP:rs35118262)	17344846,22174939	2
P07949/T278P	P07949	RET	RET_HUMAN	T278P	-	-	-	-	PAGVDtSAVVE									VARIANT	T -> P (in HSCR1)	22174939	1
P07949/T946M	P07949	RET	RET_HUMAN	T946M	618	αF	-	-	LWEIVtGGNPY	0.867	0.774	0.477	0.575	0.657	0.751	0.429	0.677	VARIANT	T -> M (in MEN2B and MTC; familial form)		0
P07949/V145G	P07949	RET	RET_HUMAN	V145G	-	-	-	-	PGCARvFSFFN									VARIANT	V -> G (in HSCR1; also in a colorectal cancer sample; somatic mutation; dbSNP:rs1588863999)	16959974,22174939	2
P07949/V292M	P07949	RET	RET_HUMAN	V292M	-	-	-	-	RKEDTvATLRV									VARIANT	V -> M (found in patients with Hirschsprung disease; unknown pathological significance; dbSNP:rs34682185)	17344846,22174939	2
P07949/V376A	P07949	RET	RET_HUMAN	V376A	-	-	-	activating	QLAVLvDSDFQ									VARIANT	V -> A (in a patient with renal agenesis; unknown pathological significance; constitutively phosphorylated; expressed only the immature intracellular form)	18252215	1
P07949/V397M	P07949	RET	RET_HUMAN	V397M	-	-	-	-	HFNVSvPVSLH									VARIANT	V -> M (in HSCR1; dbSNP:rs183729115)	22174939	1
P07949/V412M	P07949	RET	RET_HUMAN	V412M	-	-	-	-	TYSLSvRRARR									VARIANT	V -> M (in HSCR1; dbSNP:rs746970700)	22174939	1
P07949/V778I	P07949	RET	RET_HUMAN	V778I	176	αC	-	activating	LSEFNvKQVNH	0.251	0.191	0.533	0.392	0.073	0.104	0.747	0.188	VARIANT	V -> I (in a patient with renal agenesis; unknown pathological significance; constitutively phosphorylated; dbSNP:rs75686697)	18252215	1
P07949/V804L	P07949	RET	RET_HUMAN	V804L	248	β5	-	-	PLLLIvYAKYG	0.692	0.351	0.461	0.396	0.241	0.314	0.616	0.802	VARIANT	V -> L (in MTC; familial form; dbSNP:rs79658334)	7784092	1
P07949/V804M	P07949	RET	RET_HUMAN	V804M	248	β5	-	-	PLLLIvYAKYG	0.706	0.31	0.431	0.238	0.252	0.245	0.638	0.761	VARIANT	V -> M (in MTC; familial form; dbSNP:rs79658334)	10826520,9452077	2
P07949/Y1062C	P07949	RET	RET_HUMAN	Y1062C	-	-	p	-	IENKLyMSDPN									VARIANT	Y -> C (in HSCR1; dbSNP:rs587778659)	22174939	1
P07949/Y1062F	P07949	RET	RET_HUMAN	Y1062F	-	-	p	loss	IENKLyMSDPN									MUTAGEN	Y->F: Abolishes GFRAL-mediated MAPK1/MAPK2 phosphorylation.	28953886	1
P07949/Y791F	P07949	RET	RET_HUMAN	Y791F	200	β4	p	-	HVIKLyACSQD	0.628	0.683	0.486	0.512	0.218	0.388	0.618	0.111	VARIANT	Y -> F (in HSCR1, pheochromocytoma, MTC and MEN2A; familial form; dbSNP:rs77724903)	12000816,9090527,9506724	3
P07949/Y826S	P07949	RET	RET_HUMAN	Y826S	278	αD/αE-loop	p	-	KVGPGyGSGGS	0.782	0.677	0.525	0.655	0.436	0.649	0.565	0.309	VARIANT	Y -> S (in dbSNP:rs34617196)	17344846	1
P08069/A1338T	P08069	IGF1R	IGF1R_HUMAN	A1338T	-	-	-	-	VLVLRaFDERQ									VARIANT	A -> T (in dbSNP:rs34102392)	17344846	1
P08069/A1347V	P08069	IGF1R	IGF1R_HUMAN	A1347V	-	-	-	-	ERQPYaMNGGR									VARIANT	A -> V (in a lung squamous cell carcinoma sample; somatic mutation)	17344846	1
P08069/A828T	P08069	IGF1R	IGF1R_HUMAN	A828T	-	-	-	-	ARTMPaGADDI									VARIANT	A -> T (in dbSNP:rs35224135)		0
P08069/H808R	P08069	IGF1R	IGF1R_HUMAN	H808R	-	-	-	-	IHSCNhAEKLG									VARIANT	H -> R (in dbSNP:rs34061581)		0
P08069/K1033A	P08069	IGF1R	IGF1R_HUMAN	K1033A	129	β3;Catalytic-Lys	ub	loss	TRVAIkVNEAA	1.0	1.0	0.02	0.655	0.995	0.999	0.011	0.683	MUTAGEN	K->A: Kinase inactive. Abolishes tyrosine phosphorylation and abolishes interaction with IRS1, SHC1 and PIK3R1.	7541045	1
P08069/K145N	P08069	IGF1R	IGF1R_HUMAN	K145N	-	-	-	decrease	AIRIEkADLCY									VARIANT	K -> N (in IGF1RES; has decreased IGF1R function; dbSNP:rs121912427)	14657428	1
P08069/N359Y	P08069	IGF1R	IGF1R_HUMAN	N359Y	-	-	-	decrease	TIFKGnLINIR									VARIANT	N -> Y (in IGF1RES; significant decrease in IGF1-induced DNA synthesis and AKT1 phosphorylation in patient fibroblasts)	25040157	1
P08069/N857S	P08069	IGF1R	IGF1R_HUMAN	N857S	-	-	-	neutral	WPEPEnNGLIL									VARIANT	N -> S (in dbSNP:rs45611935)	17344846	1
P08069/R1256S	P08069	IGF1R	IGF1R_HUMAN	R1256S	800	αI	-	decrease	YNPKMrSFLEI	0.922	0.84	0.265	0.579	0.835	0.793	0.239	0.467	VARIANT	R -> S (in IGF1RES; significant decrease in IGF1-induced DNA synthesis and AKT1 phosphorylation in patient fibroblasts)	25040157	1
P08069/R1337C	P08069	IGF1R	IGF1R_HUMAN	R1337C	-	-	-	-	GVLVLrSFDER									VARIANT	R -> C (in IGF1RES; unknown pathological significance; significant decrease in IGF1-induced DNA synthesis; significant increase in IGF1-induced AKT1 phosphorylation in patient fibroblasts; dbSNP:rs141802822)	25040157	1
P08069/R138Q	P08069	IGF1R	IGF1R_HUMAN	R138Q	-	-	-	decrease	LRNITrAIRIE									VARIANT	R -> Q (in IGF1RES; has decreased IGF1R function; dbSNP:rs121912426)	14657428	1
P08069/R437H	P08069	IGF1R	IGF1R_HUMAN	R437H	-	-	-	neutral	WDWDHrLTIKA									VARIANT	R -> H (in dbSNP:rs34516635)	17344846	1
P08069/R511Q	P08069	IGF1R	IGF1R_HUMAN	R511Q	-	-	-	-	IITWHrRPPDY									VARIANT	R -> Q (in dbSNP:rs33958176)		0
P08069/R595H	P08069	IGF1R	IGF1R_HUMAN	R595H	-	-	-	-	ENDHIrAKSEI									VARIANT	R -> H (in dbSNP:rs56248469)	17344846	1
P08069/R605H	P08069	IGF1R	IGF1R_HUMAN	R605H	-	-	-	-	EILYIrNASVP									VARIANT	R -> H (in dbSNP:rs45553041)		0
P08069/R739Q	P08069	IGF1R	IGF1R_HUMAN	R739Q	-	-	-	-	RPERKrDVMQV									VARIANT	R -> Q (in IGF1RES; leads to failure of processing of the IGF1R proreceptor to mature IGF1R; dbSNP:rs121912429)	15928254	1
P08069/V105L	P08069	IGF1R	IGF1R_HUMAN	V105L	-	-	-	-	FPNLTvRGWKL									VARIANT	V -> L (in a renal chromophobe sample; somatic mutation)	17344846	1
P08069/V388M	P08069	IGF1R	IGF1R_HUMAN	V388M	-	-	-	-	VVTGYvIRHSH									VARIANT	V -> M (in dbSNP:rs45445894)		0
P08069/Y1280F	P08069	IGF1R	IGF1R_HUMAN	Y1280F	825	C-term-αI	p	-	REVSFySEENK	0.811	0.851	0.619	0.694	0.392	0.666	0.656	0.151	MUTAGEN	Y->F: No effect on GRB10-binding.	10454568	1
P08069/Y1281F	P08069	IGF1R	IGF1R_HUMAN	Y1281F	826	C-term-αI	p	-	EVSFYyEENKL	0.753	0.843	0.532	0.708	0.318	0.555	0.56	0.289	MUTAGEN	Y->F: No effect on GRB10-binding.	10454568	1
P08069/Y1346F	P08069	IGF1R	IGF1R_HUMAN	Y1346F	-	-	p	-	DERQPyHMNGG									MUTAGEN	Y->F: Loss of GRB10-binding.	10454568	1
P08069/Y865C	P08069	IGF1R	IGF1R_HUMAN	Y865C	-	-	-	decrease	GLILMyIKYGS									VARIANT	Y -> C (in IGF1RES; significant decrease in IGF1-induced DNA synthesis and AKT1 phosphorylation in patient fibroblasts)	25040157	1
P08069/Y980F	P08069	IGF1R	IGF1R_HUMAN	Y980F	9	N-term-β1	p	decrease	SVNPEySAADV	0.846	0.806	0.388	0.748	0.619	0.762	0.372	0.427	MUTAGEN	Y->F: Reduces tyrosine phosphorylation. Abolishes interaction with IRS1 and SHC1. Does not abolish interaction with PIK3R1, nor with GRB10.	10454568,7541045	2
P08581/A320V	P08581	MET	MET_HUMAN	A320V	-	-	-	-	NILQAaVSKPG									VARIANT	A -> V (in dbSNP:rs35776110)	9140397	1
P08581/C385Y	P08581	MET	MET_HUMAN	C385Y	-	-	-	-	KNNVRcQHFYG									VARIANT	C -> Y (found in a case of cancer of unknown primary origin; the mutated receptor is still functional and can sustain the transformed phenotype; somatic mutation; dbSNP:rs752055485)	20949619	1
P08581/D1228H	P08581	MET	MET_HUMAN	D1228H	505	A-loop	-	resistance	FGLARdYDKEY	0.949	0.87	0.656	0.945	0.233	0.685	0.683	0.968	VARIANT	D -> H (in RCCP; somatic mutation; dbSNP:rs121913671)	9140397	1
P08581/D1228N	P08581	MET	MET_HUMAN	D1228N	505	A-loop	-	resistance	FGLARdYDKEY	0.934	0.85	0.629	0.92	0.174	0.653	0.715	0.977	VARIANT	D -> N (in RCCP; germline mutation; dbSNP:rs121913671)	9140397	1
P08581/E168D	P08581	MET	MET_HUMAN	E168D	-	-	-	neutral	SPQIEeSQCPD									VARIANT	E -> D (found in a case of cancer of unknown primary origin; the mutated receptor is still functional and can sustain the transformed phenotype; somatic mutation; dbSNP:rs55985569)	17344846,20949619	2
P08581/F841V	P08581	MET	MET_HUMAN	F841V	-	-	-	-	VHNPVfPFEKP									VARIANT	F -> V (in DFNB97; dbSNP:rs794728016)	25941349	1
P08581/H1094L	P08581	MET	MET_HUMAN	H1094L	54	β2	-	activating	FGCVYhTLLDN	0.712	0.648	0.625	0.721	0.236	0.526	0.731	0.555	VARIANT	H -> L (in RCCP; constitutive autophosphorylation; causes malignant transformation in cell lines)	10327054	1
P08581/H1094R	P08581	MET	MET_HUMAN	H1094R	54	β2	-	-	FGCVYhTLLDN	0.506	0.475	0.477	0.483	0.31	0.377	0.624	0.347	VARIANT	H -> R (in RCCP; causes malignant transformation in cell lines; dbSNP:rs121913243)	10433944,9563489	2
P08581/H1094Y	P08581	MET	MET_HUMAN	H1094Y	54	β2	-	activating	FGCVYhTLLDN	0.708	0.619	0.62	0.694	0.221	0.397	0.705	0.391	VARIANT	H -> Y (in RCCP; constitutive autophosphorylation; causes malignant transformation in cell lines; dbSNP:rs121913244)	10327054	1
P08581/H1106D	P08581	MET	MET_HUMAN	H1106D	119	β3	-	activating	DGKKIhAVKSL	0.548	0.601	0.67	0.64	0.163	0.369	0.796	0.247	VARIANT	H -> D (in RCCP; constitutive autophosphorylation; causes malignant transformation in cell lines)	10327054,10433944	2
P08581/H150Y	P08581	MET	MET_HUMAN	H150Y	-	-	-	-	VFPHNhADIQS									VARIANT	H -> Y (found in a case of cancer of unknown primary origin; the mutated receptor is still functional and can sustain the transformed phenotype; somatic mutation; dbSNP:rs1436957498)	20949619	1
P08581/I316M	P08581	MET	MET_HUMAN	I316M	-	-	-	-	KEVFNiQAAYV									VARIANT	I -> M (in dbSNP:rs35225896)		0
P08581/K1244R	P08581	MET	MET_HUMAN	K1244R	540	A-loop	-	-	NKTGAkPVKWM	0.185	0.247	0.494	0.168	0.198	0.21	0.634	0.139	VARIANT	K -> R (in HCC; dbSNP:rs121913677)	9927037	1
P08581/L1195V	P08581	MET	MET_HUMAN	L1195V	423	αE	-	-	KGMKYlSKKFV	0.841	0.789	0.432	0.675	0.596	0.69	0.463	0.708	VARIANT	L -> V (in RCCP; somatic mutation; dbSNP:rs121913673)	9140397	1
P08581/L238S	P08581	MET	MET_HUMAN	L238S	-	-	-	-	SYIDVlEFRDS									VARIANT	L -> S (in dbSNP:rs34349517)		0
P08581/M1131T	P08581	MET	MET_HUMAN	M1131T	177	αC	-	-	TEGIImDFSHP	0.881	0.793	0.451	0.67	0.543	0.729	0.473	0.692	VARIANT	M -> T (in RCCP; germline mutation; dbSNP:rs121913668)	10433944,9140397	2
P08581/M1250I	P08581	MET	MET_HUMAN	M1250I	554	A-loop	-	-	LPVKWmLESLQ	0.749	0.73	0.483	0.602	0.419	0.58	0.558	0.427	VARIANT	M -> I (in HCC; dbSNP:rs121913676)	9927037	1
P08581/M1250T	P08581	MET	MET_HUMAN	M1250T	554	A-loop	-	-	LPVKWmLESLQ	0.897	0.797	0.453	0.713	0.508	0.747	0.46	0.558	VARIANT	M -> T (in RCCP; somatic mutation; dbSNP:rs121913245)	10433944,9140397	2
P08581/N375K	P08581	MET	MET_HUMAN	N375K	-	-	-	decrease	VNDFFnIVNKN									VARIANT	N -> K (found in lung cancer also including cases carrying EGFR mutations; unknown pathological significance; decreased hepatocyte growth factor-activated receptor activity; decreased interaction with HGF; dbSNP:rs776693512)	28294470	1
P08581/N375S	P08581	MET	MET_HUMAN	N375S	-	-	-	neutral	VNDFFnIVNKN									VARIANT	N -> S (in dbSNP:rs33917957)	17344846	1
P08581/P773L	P08581	MET	MET_HUMAN	P773L	-	-	-	-	NSVSVpMVINV									VARIANT	P -> L (in gastric cancer; dbSNP:rs771333219)	12920089	1
P08581/P991S	P08581	MET	MET_HUMAN	P991S	-	-	-	increase	ARSVSpTEMVS									VARIANT	P -> S (in gastric cancer; prolonged tyrosine phosphorylation in response to HGF/SF; transforming activity in athymic nude mice; dbSNP:rs768678989)	11042681	1
P08581/R143Q	P08581	MET	MET_HUMAN	R143Q	-	-	-	-	RGTCQrVFPHN									VARIANT	R -> Q (in dbSNP:rs35469582)	17344846	1
P08581/R970C	P08581	MET	MET_HUMAN	R970C	-	-	-	neutral	GSELVrDARVH									VARIANT	R -> C (in dbSNP:rs34589476)	17053076,17344846	2
P08581/S156L	P08581	MET	MET_HUMAN	S156L	-	-	-	-	TADIQsVHCIF									VARIANT	S -> L (in dbSNP:rs56311081)	17344846	1
P08581/T1173I	P08581	MET	MET_HUMAN	T1173I	296	αD/αE-loop	-	-	FIRNEtNPTVK	0.572	0.555	0.665	0.512	0.201	0.377	0.74	0.246	VARIANT	T -> I (in HCC; dbSNP:rs121913675)	9927037	1
P08581/T992I	P08581	MET	MET_HUMAN	T992I	-	-	p	neutral	RSVSPtEMVSN									VARIANT	T -> I (found in a case of cancer of unknown primary origin; the mutated receptor is still functional and can sustain the transformed phenotype; somatic mutation; dbSNP:rs56391007)	11042681,17053076,17344846,20949619	4
P08581/V1092I	P08581	MET	MET_HUMAN	V1092I	47	β2	-	activating	GHFGCvHGTLL	0.692	0.624	0.513	0.587	0.298	0.464	0.645	0.239	VARIANT	V -> I (in RCCP; constitutive autophosphorylation; dbSNP:rs786202724)	10327054,10417759,10433944	3
P08581/V1188L	P08581	MET	MET_HUMAN	V1188L	410	αE	-	-	GFGLQvKGMKY	0.576	0.546	0.618	0.55	0.258	0.424	0.639	0.413	VARIANT	V -> L (in RCCP; germline mutation; dbSNP:rs121913669)	10433944,9140397	2
P08581/V1220I	P08581	MET	MET_HUMAN	V1220I	494	Catalytic-loop	-	-	KFTVKvDFGLA	0.211	0.187	0.534	0.296	0.128	0.143	0.702	0.204	VARIANT	V -> I (in RCCP; germline mutation; dbSNP:rs121913670)	9140397	1
P08581/V1294I	P08581	MET	MET_HUMAN	V1294I	652	αG	-	-	TFDITvLLQGR	0.379	0.279	0.476	0.245	0.178	0.267	0.614	0.24	VARIANT	V -> I (found in a case of cancer of unknown primary origin; the mutated receptor is still functional and can sustain the transformed phenotype; somatic mutation; dbSNP:rs1263785859)	20949619	1
P08581/Y1003S	P08581	MET	MET_HUMAN	Y1003S	-	-	p	-	NESVDyATFPE									VARIANT	Y -> S (probable disease-associated variant found in lesional sample from a patient with sporadically occurring, unilateral osteofibrous dysplasia; somatic mutation; complete loss of ligand-induced CBL-mediated ubiquitination, resulting in protein stabilization)	12244174	1
P08581/Y1230C	P08581	MET	MET_HUMAN	Y1230C	507	A-loop	p	resistance	LARDMyKEYYS	0.912	0.907	0.573	0.838	0.528	0.776	0.55	0.742	VARIANT	Y -> C (in RCCP; germline mutation; dbSNP:rs121913246)	10433944,9140397	2
P08581/Y1230D	P08581	MET	MET_HUMAN	Y1230D	507	A-loop	p	activating	LARDMyKEYYS	0.931	0.852	0.641	0.891	0.391	0.772	0.607	0.865	VARIANT	Y -> D (in RCCP; constitutive autophosphorylation; causes malignant transformation in cell lines)	10327054,10433944	2
P08581/Y1230H	P08581	MET	MET_HUMAN	Y1230H	507	A-loop	p	resistance	LARDMyKEYYS	0.881	0.889	0.484	0.833	0.556	0.77	0.508	0.805	VARIANT	Y -> H (in RCCP; somatic mutation; dbSNP:rs121913247)	9140397	1
P08581/Y1234C	P08581	MET	MET_HUMAN	Y1234C	511	A-loop	p	decrease	MYDKEySVHNK	0.958	0.946	0.575	0.903	0.619	0.89	0.494	0.605	VARIANT	Y -> C (in DA11; not phosphorylated in reponse to HGF; severely decreased tyrosin kinase activity; dbSNP:rs1554400286)	30777867	1
P08581/Y1234F	P08581	MET	MET_HUMAN	Y1234F	511	A-loop	p	-	MYDKEySVHNK	0.921	0.961	0.655	0.936	0.53	0.867	0.534	0.577	MUTAGEN	Y->F: Complete loss of kinase activity and of ligand-induced ubiquitination. Alters interaction with PTPN1 and PTPN2. Loss of interaction with PTPN1 and PTPN2; when associated with F-1235.	12244174,18819921	2
P08581/Y1235F	P08581	MET	MET_HUMAN	Y1235F	512	A-loop	p	-	YDKEYyVHNKT	0.929	0.952	0.488	0.842	0.633	0.849	0.433	0.434	MUTAGEN	Y->F: Complete loss of kinase activity. Alters interaction with PTPN1 and PTPN2. Loss of interaction with PTPN1 and PTPN2; when associated with F-1234.	12244174,18819921	2
P08581/Y1313F	P08581	MET	MET_HUMAN	Y1313F	786	αH	p	-	CPDPLyVMLKC	0.769	0.797	0.506	0.616	0.534	0.61	0.552	0.258	MUTAGEN	Y->F: No effect on ligand-induced CBL-mediated ubiquitination; when associated with F-1349, F-1356 and F-1365.	12244174	1
P08581/Y1349F	P08581	MET	MET_HUMAN	Y1349F	823	αI	p	-	FIGEHyHVNAT	0.88	0.864	0.567	0.824	0.577	0.753	0.577	0.418	MUTAGEN	Y->F: No effect on ligand-induced CBL-mediated ubiquitination; when associated with F-1313, F-1356 and F-1365.	12244174	1
P08581/Y1356F	P08581	MET	MET_HUMAN	Y1356F	830	C-term-αI	p	-	HVNATyNVKCV	0.864	0.794	0.45	0.741	0.463	0.742	0.466	0.378	MUTAGEN	Y->F: No effect on ligand-induced CBL-mediated ubiquitination; when associated with F-1313, F-1349 and F-1365.	12244174	1
P08581/Y1365F	P08581	MET	MET_HUMAN	Y1365F	-	-	p	-	KCVAPySLLSS									MUTAGEN	Y->F: No effect on ligand-induced CBL-mediated ubiquitination; when associated with F-1313, F-1349 and F-1356.	12244174	1
P08631/A44T	P08631	HCK	HCK_HUMAN	A44T	-	-	-	neutral	KTETSaPHCPV									VARIANT	A -> T (in dbSNP:rs56029200)	17344846	1
P08631/C24S	P08631	HCK	HCK_HUMAN	C24S	-	-	-	-	APRMGcKSKFL									MUTAGEN	C->S: Palmitoylation is abolished, some cytoplasmic and no calveolar localization; in isoform 2.	7791757	1
P08631/D381E	P08631	HCK	HCK_HUMAN	D381E	443	Catalytic-loop;HrD-motif	-	loss	NYIHRdRAANI	0.996	1.0	0.267	0.727	0.95	0.962	0.175	0.59	MUTAGEN	D->E: Loss of kinase activity.	15998323	1
P08631/D399G	P08631	HCK	HCK_HUMAN	D399G	496	A-loop;DFG-motif	-	-	VCKIAdGLARV	0.972	0.961	0.274	0.65	0.888	0.918	0.179	0.714	VARIANT	D -> G (in an ovarian mucinous carcinoma sample; somatic mutation)	17344846	1
P08631/E305A	P08631	HCK	HCK_HUMAN	E305A	173	αC	-	loss	EAFLAeNVMKT	0.951	0.941	0.256	0.727	0.947	0.898	0.154	0.57	MUTAGEN	E->A: Loss of kinase activity.	10644735	1
P08631/G23A	P08631	HCK	HCK_HUMAN	G23A	-	-	-	-	RAPRMgMKSKF									MUTAGEN	G->A: Myristoylation and palmitoylation are abolished, leading to entirely cytoplasmic localization; in isoform 2.	7791757	1
P08631/G3C	P08631	HCK	HCK_HUMAN	G3C	-	-	-	-	MGgSSCED									MUTAGEN	G->C: Slight palmitoylation, cytoplasmic and caveolar localization; in isoform 1;.	11904303,7791757	2
P08631/G3S	P08631	HCK	HCK_HUMAN	G3S	-	-	-	-	MGgSSCED									MUTAGEN	G->S: Abolishes palmitoylation and localization at the cell membrane.	11904303,7791757	2
P08631/K290E	P08631	HCK	HCK_HUMAN	K290E	129	β3;Catalytic-Lys	-	loss	TKVAVkMKPGS	0.992	0.993	0.066	0.732	1.0	0.999	0.047	0.576	MUTAGEN	K->E: Loss of kinase activity.	11896602	1
P08631/M105L	P08631	HCK	HCK_HUMAN	M105L	-	-	-	neutral	QKGDQmVLEES									VARIANT	M -> L (in dbSNP:rs55722810)	14702039,17344846	2
P08631/P502Q	P08631	HCK	HCK_HUMAN	P502Q	801	αI	-	-	RPEERpFEYIQ	0.752	0.698	0.381	0.528	0.663	0.63	0.372	0.669	VARIANT	P -> Q (in dbSNP:rs17093828)		0
P08631/Y411A	P08631	HCK	HCK_HUMAN	Y411A	533	A-loop	p	decrease	IEDNEyAREGA	0.943	0.985	0.408	0.823	0.813	0.962	0.264	0.627	MUTAGEN	Y->A: Reduced catalytic activity and higher affinity for target peptides.	10644735	1
P08631/Y522F	P08631	HCK	HCK_HUMAN	Y522F	824	C-term-αI	p	activating	ATESQyQQP	0.846	0.858	0.629	0.809	0.413	0.656	0.61	0.286	MUTAGEN	Y->F: Constitutively activated kinase, leading to cellular transformation.	10092522,11896602	2
P08922/C1370R	P08922	ROS1	ROS1_HUMAN	C1370R	-	-	-	-	LEGCQcRVITV									VARIANT	C -> R (in dbSNP:rs36106063)	17344846	1
P08922/D1776H	P08922	ROS1	ROS1_HUMAN	D1776H	-	-	-	neutral	WEKAEdGCRIT									VARIANT	D -> H (in dbSNP:rs12664076)	17344846	1
P08922/D2203N	P08922	ROS1	ROS1_HUMAN	D2203N	798	αI	-	-	WAQEPdRPTFH	0.168	0.151	0.456	0.19	0.11	0.116	0.657	0.123	VARIANT	D -> N (in dbSNP:rs556427413)	17344846	1
P08922/D2213E	P08922	ROS1	ROS1_HUMAN	D2213E	808	αI	-	-	FHRIQdLQLFR	0.088	0.11	0.48	0.172	0.082	0.081	0.76	0.102	VARIANT	D -> E (in dbSNP:rs75510639)	17344846	1
P08922/D2213N	P08922	ROS1	ROS1_HUMAN	D2213N	808	αI	-	neutral	FHRIQdLQLFR	0.089	0.057	0.381	0.063	0.084	0.079	0.668	0.069	VARIANT	D -> N (in dbSNP:rs529038)	17344846,2352949	2
P08922/E1902K	P08922	ROS1	ROS1_HUMAN	E1902K	-	-	-	neutral	TVLINeKELAE									VARIANT	E -> K (in dbSNP:rs9489124)	17344846	1
P08922/F1439S	P08922	ROS1	ROS1_HUMAN	F1439S	-	-	-	-	SVMQPfDKAFL									VARIANT	F -> S (in dbSNP:rs17079086)		0
P08922/F2138S	P08922	ROS1	ROS1_HUMAN	F2138S	574	αF	-	-	LMDGIfTQSDV	0.898	0.853	0.355	0.61	0.7	0.756	0.344	0.728	VARIANT	F -> S (in a gastric adenocarcinoma sample; somatic mutation)	17344846	1
P08922/G126V	P08922	ROS1	ROS1_HUMAN	G126V	-	-	-	-	SANFSgKYIIQ									VARIANT	G -> V (in dbSNP:rs34245787)	17344846	1
P08922/H1999N	P08922	ROS1	ROS1_HUMAN	H1999N	175	αC	-	-	FLKEAhMSKFN	0.6	0.522	0.556	0.521	0.222	0.372	0.712	0.304	VARIANT	H -> N (in dbSNP:rs45569132)	17344846	1
P08922/I537M	P08922	ROS1	ROS1_HUMAN	I537M	-	-	-	neutral	CDLSHiEFGFG									VARIANT	I -> M (in dbSNP:rs28639589)	17344846	1
P08922/K1980M	P08922	ROS1	ROS1_HUMAN	K1980M	129	β3;Catalytic-Lys	-	loss	IKVAVkLKKGS	1.0	1.0	0.019	0.618	0.994	0.999	0.012	0.493	MUTAGEN	K->M: Loss of kinase activity.	12661006	1
P08922/K2003R	P08922	ROS1	ROS1_HUMAN	K2003R	188	αC/β4-loop	-	-	AHLMSkNHPNI	0.153	0.181	0.513	0.278	0.138	0.113	0.762	0.096	VARIANT	K -> R (in a colorectal adenocarcinoma sample; somatic mutation)	17344846	1
P08922/K2228Q	P08922	ROS1	ROS1_HUMAN	K2228Q	824	C-term-αI	-	neutral	LNSIYkRDEAN	0.239	0.222	0.541	0.22	0.093	0.151	0.748	0.071	VARIANT	K -> Q (in dbSNP:rs529156)	17344846,2352949	2
P08922/K2328R	P08922	ROS1	ROS1_HUMAN	K2328R	-	-	-	neutral	YCPSGkEGLNY									VARIANT	K -> R (in dbSNP:rs35932630)		0
P08922/N13S	P08922	ROS1	ROS1_HUMAN	N13S	-	-	-	-	IPKLVnATLGC									VARIANT	N -> S (in dbSNP:rs45606237)	17344846	1
P08922/N2240K	P08922	ROS1	ROS1_HUMAN	N2240K	836	C-term-αI	-	neutral	NSGVInSFEGE	0.644	0.595	0.467	0.606	0.396	0.614	0.468	0.509	VARIANT	N -> K (in dbSNP:rs210968)	17344846	1
P08922/N790S	P08922	ROS1	ROS1_HUMAN	N790S	-	-	-	neutral	VKLLVnMVVDS									VARIANT	N -> S (in dbSNP:rs34582164)		0
P08922/P224S	P08922	ROS1	ROS1_HUMAN	P224S	-	-	-	neutral	QFPGGpLGYNL									VARIANT	P -> S (in dbSNP:rs55959124)	17344846	1
P08922/Q865H	P08922	ROS1	ROS1_HUMAN	Q865H	-	-	-	-	AVLRGqTGDTT									VARIANT	Q -> H (in a lung large cell carcinoma sample; somatic mutation)	17344846	1
P08922/R1506G	P08922	ROS1	ROS1_HUMAN	R1506G	-	-	-	neutral	SDLKYrLEFQD									VARIANT	R -> G (in dbSNP:rs35841892)	17344846	1
P08922/R167Q	P08922	ROS1	ROS1_HUMAN	R167Q	-	-	-	neutral	TEYIFrVWIFT									VARIANT	R -> Q (in dbSNP:rs2243380)	17344846	1
P08922/R2039H	P08922	ROS1	ROS1_HUMAN	R2039H	269	αD	-	-	LLTYLrARMAT	0.617	0.611	0.548	0.56	0.261	0.417	0.654	0.394	VARIANT	R -> H (in dbSNP:rs3752566)		0
P08922/S1109L	P08922	ROS1	ROS1_HUMAN	S1109L	-	-	-	neutral	VNVTPsMSFQL									VARIANT	S -> L (in dbSNP:rs2229079)	17344846	1
P08922/S2229C	P08922	ROS1	ROS1_HUMAN	S2229C	825	C-term-αI	-	neutral	NSIYKsDEANN	0.26	0.316	0.531	0.315	0.241	0.225	0.719	0.123	VARIANT	S -> C (in dbSNP:rs619203)	17344846,2352949	2
P08922/S370P	P08922	ROS1	ROS1_HUMAN	S370P	-	-	-	-	GSGLIsISIDW									VARIANT	S -> P (in dbSNP:rs56274823)	17344846	1
P08922/S653F	P08922	ROS1	ROS1_HUMAN	S653F	-	-	-	neutral	SVRASsKRPGP									VARIANT	S -> F (in dbSNP:rs34203286)	17344846	1
P08922/T145P	P08922	ROS1	ROS1_HUMAN	T145P	-	-	-	neutral	GSWTYtTVSRP									VARIANT	T -> P (in dbSNP:rs1998206)	17344846	1
P08922/Y1239F	P08922	ROS1	ROS1_HUMAN	Y1239F	-	-	-	-	ISRHLyALKES									VARIANT	Y -> F (in dbSNP:rs56192249)	17344846	1
P08922/Y1353S	P08922	ROS1	ROS1_HUMAN	Y1353S	-	-	-	-	EKPLIyAKAQE									VARIANT	Y -> S (in dbSNP:rs35269727)	17344846	1
P08922/Y2274F	P08922	ROS1	ROS1_HUMAN	Y2274F	-	-	p	decrease	REGLNyVLATE									MUTAGEN	Y->F: Loss of phosphorylation at Y-2274 and loss of interaction with PTPN11.	12538861	1
P08922/Y2334F	P08922	ROS1	ROS1_HUMAN	Y2334F	-	-	p	decrease	PEGLNyCLTHS									MUTAGEN	Y->F: Loss of phosphorylation at Y-2334 and loss of interaction with PTPN11.	12538861	1
P08922/Y338C	P08922	ROS1	ROS1_HUMAN	Y338C	-	-	-	-	HQQIVySEGTL									VARIANT	Y -> C (in dbSNP:rs55707658)	17344846	1
P08922/Y419H	P08922	ROS1	ROS1_HUMAN	Y419H	-	-	-	-	IVADSyGYVFY									VARIANT	Y -> H (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs1444274116)	17344846	1
P09619/E1071V	P09619	PDGFRB	PGFRB_HUMAN	E1071V	-	-	-	-	PQDEPeEPQLE									VARIANT	E -> V (in IBGC4; no effect on protein abundance; no effect on receptor activity; decreased PDGF signaling pathway)	24065723,26599395	2
P09619/E282K	P09619	PDGFRB	PGFRB_HUMAN	E282K	-	-	-	-	HIPSAeEDSGT									VARIANT	E -> K (in dbSNP:rs34586048)	17344846	1
P09619/E485K	P09619	PDGFRB	PGFRB_HUMAN	E485K	-	-	-	neutral	VTYWEeQEFEV									VARIANT	E -> K (in dbSNP:rs41287110)	17344846	1
P09619/I29F	P09619	PDGFRB	PGFRB_HUMAN	I29F	-	-	-	neutral	LLEPQiQGLVV									VARIANT	I -> F (in dbSNP:rs17110944)	17344846	1
P09619/K634A	P09619	PDGFRB	PGFRB_HUMAN	K634A	129	β3;Catalytic-Lys	-	loss	MKVAVkLKSTA	1.0	1.0	0.013	0.652	1.0	0.999	0.001	0.683	MUTAGEN	K->A,R: Loss of kinase activity. Abolishes interaction with RASA1. No effect on phosphatidylinositol 3-kinase activity.	1314164,1846866,20494825	3
P09619/K634R	P09619	PDGFRB	PGFRB_HUMAN	K634R	129	β3;Catalytic-Lys	-	loss	MKVAVkLKSTA	1.0	0.996	0.054	0.624	0.989	0.994	0.046	0.457	MUTAGEN	K->A,R: Loss of kinase activity. Abolishes interaction with RASA1. No effect on phosphatidylinositol 3-kinase activity.	1314164,1846866,20494825	3
P09619/L658P	P09619	PDGFRB	PGFRB_HUMAN	L658P	189	αC/β4-loop	-	loss	KIMSHlPHLNV	0.88	0.886	0.438	0.658	0.69	0.791	0.359	0.689	VARIANT	L -> P (in IBGC4; no effect on protein abundance; loss of PDGF beta receptor activity; dbSNP:rs397509381)	23255827,24065723,26599395	3
P09619/N718Y	P09619	PDGFRB	PGFRB_HUMAN	N718Y	317	αD/αE-loop	-	-	AELYSnLPVGL	0.352	0.29	0.556	0.407	0.251	0.276	0.638	0.403	VARIANT	N -> Y (in dbSNP:rs35322465)	17344846	1
P09619/P345S	P09619	PDGFRB	PGFRB_HUMAN	P345S	-	-	-	neutral	FEAYPpTVLWF									VARIANT	P -> S (in dbSNP:rs2229558)		0
P09619/P584R	P09619	PDGFRB	PGFRB_HUMAN	P584R	12	N-term-β1	-	-	YIYVDpQLPYD	0.616	0.631	0.444	0.534	0.365	0.527	0.568	0.478	VARIANT	P -> R (in KOGS; dbSNP:rs863224946)	25454926	1
P09619/P660T	P09619	PDGFRB	PGFRB_HUMAN	P660T	192	αC/β4-loop	-	-	MSHLGpLNVVN	0.548	0.444	0.533	0.459	0.325	0.419	0.566	0.293	VARIANT	P -> T (in IMF1; dbSNP:rs144050370)	23731542	1
P09619/R561C	P09619	PDGFRB	PGFRB_HUMAN	R561C	-	-	-	-	WQKKPrEIRWK									VARIANT	R -> C (in IMF1; dbSNP:rs367543286)	23731537	1
P09619/R987W	P09619	PDGFRB	PGFRB_HUMAN	R987W	-	-	-	-	HPAILrQARLP									VARIANT	R -> W (in IBGC4; decreased protein abundance; no effect on receptor activity; decreased PDGF signaling pathway; dbSNP:rs397509382)	23255827,24065723,26599395	3
P09619/S180F	P09619	PDGFRB	PGFRB_HUMAN	S180F	-	-	-	-	HQRGFsIFEDR									VARIANT	S -> F (in dbSNP:rs17853027)	15489334	1
P09619/T882I	P09619	PDGFRB	PGFRB_HUMAN	T882I	597	αF	-	-	NSLYTtSDVWS	0.378	0.426	0.666	0.462	0.284	0.339	0.748	0.308	VARIANT	T -> I (in a breast infiltrating ductal carcinoma sample; somatic mutation)	17344846	1
P09619/V665A	P09619	PDGFRB	PGFRB_HUMAN	V665A	197	αC/β4-loop	-	activating	PHLNVvLLGAC	0.862	0.828	0.565	0.77	0.359	0.707	0.544	0.752	VARIANT	V -> A (in PENTT; gain of function in protein tyrosine kinase activity; shows ligand-independent constitutive signaling; dbSNP:rs1554108211)	26279204	1
P09619/Y1009F	P09619	PDGFRB	PGFRB_HUMAN	Y1009F	-	-	p	-	TSSVLyAVQPN									MUTAGEN	Y->F: No effect on interaction with GRB10. Abolishes interaction with PLCG1; when associated with F-1021.	10454568,1396585,7691811	3
P09619/Y1021F	P09619	PDGFRB	PGFRB_HUMAN	Y1021F	-	-	p	-	EGDNDyIPLPD									MUTAGEN	Y->F: Strongly reduces up-regulation of cell proliferation. Abolishes interaction with PLCG1; when associated with F-1009. No effect on interaction with GRB10.	10454568,1396585,17620338,21679854	4
P09619/Y579F	P09619	PDGFRB	PGFRB_HUMAN	Y579F	7	N-term-β1	p	decrease	SDGHEyYVDPM	0.749	0.822	0.571	0.767	0.507	0.689	0.595	0.297	MUTAGEN	Y->F: Loss of kinase activity; when associated with F-581. Strongly reduces interaction with SRC family kinases. No effect on interaction with GRB10.	10454568,7685273	2
P09619/Y581F	P09619	PDGFRB	PGFRB_HUMAN	Y581F	9	N-term-β1	p	decrease	GHEYIyDPMQL	0.788	0.824	0.505	0.673	0.533	0.624	0.594	0.189	MUTAGEN	Y->F: Loss of kinase activity; when associated with F-579. No effect on interaction with GRB10.	10454568,7685273	2
P09619/Y589H	P09619	PDGFRB	PGFRB_HUMAN	Y589H	17	N-term-β1	-	-	PMQLPySTWEL	0.721	0.776	0.5	0.585	0.55	0.751	0.508	0.572	VARIANT	Y -> H (in a gastric adenocarcinoma sample; somatic mutation)	17344846	1
P09619/Y716F	P09619	PDGFRB	PGFRB_HUMAN	Y716F	315	αD/αE-loop	p	-	PSAELyNALPV	0.608	0.733	0.469	0.509	0.273	0.473	0.614	0.118	MUTAGEN	Y->F: No effect neither on interaction with GRB10 and RASA1 nor on phosphatidylinositol 3-kinase activity.	10454568,1314164	2
P09619/Y740F	P09619	PDGFRB	PGFRB_HUMAN	Y740F	339	αD/αE-loop	p	-	ESDGGyDMSKD	0.711	0.793	0.525	0.624	0.36	0.496	0.616	0.256	MUTAGEN	Y->F: Strongly reduces up-regulation of cell proliferation; when associated with F-751. Strongly decreases phosphatidylinositol 3-kinase activity. No effect on interaction with GRB10 and RASA1.	10454568,1314164,1375321,21679854	4
P09619/Y751F	P09619	PDGFRB	PGFRB_HUMAN	Y751F	350	αD/αE-loop	p	-	DESVDyPMLDM	0.72	0.731	0.494	0.617	0.36	0.504	0.584	0.193	MUTAGEN	Y->F: Strongly reduces up-regulation of cell proliferation; when associated with F-740. Abolishes phosphatidylinositol 3-kinase activity and interaction with NCK1, and slightly reduces interaction with RASA1. No effect on interaction with GRB10.	10454568,1314164,1375321,1653029,21679854,7692233	6
P09619/Y763F	P09619	PDGFRB	PGFRB_HUMAN	Y763F	362	αD/αE-loop	p	-	KGDVKyDIESS	0.618	0.77	0.477	0.626	0.201	0.451	0.676	0.185	MUTAGEN	Y->F: No effect on interaction with RASA1 and on phosphatidylinositol 3-kinase activity.	1314164	1
P09619/Y771F	P09619	PDGFRB	PGFRB_HUMAN	Y771F	370	αD/αE-loop	p	-	IESSNyAPYDN	0.721	0.777	0.555	0.737	0.329	0.567	0.637	0.237	MUTAGEN	Y->F: Loss of interaction with GRB10. Abolishes interaction with RASA1. No effect on phosphatidylinositol 3-kinase activity.	10454568,1314164,1375321	3
P09619/Y775F	P09619	PDGFRB	PGFRB_HUMAN	Y775F	374	αD/αE-loop	p	-	NYMAPyNYVPS	0.697	0.773	0.595	0.721	0.259	0.526	0.688	0.231	MUTAGEN	Y->F: No effect on interaction with RASA1 and on phosphatidylinositol 3-kinase activity.	1314164	1
P09619/Y778F	P09619	PDGFRB	PGFRB_HUMAN	Y778F	377	αD/αE-loop	p	-	APYDNyPSAPE	0.655	0.712	0.518	0.601	0.313	0.586	0.587	0.158	MUTAGEN	Y->F: Strongly reduces expression levels.	1314164	1
P09619/Y857F	P09619	PDGFRB	PGFRB_HUMAN	Y857F	512	A-loop	p	decrease	MRDSNySKGST	0.971	0.946	0.547	0.883	0.589	0.918	0.467	0.581	MUTAGEN	Y->F: Reduces kinase activity. No effect on interaction with GRB10. Abolishes interaction with RASA1. No effect on phosphatidylinositol 3-kinase activity.	10454568,1314164,1653029,20494825	4
P09769/S130R	P09769	FGR	FGR_HUMAN	S130R	-	-	-	-	TGCIPsYVAPV									VARIANT	S -> R (in dbSNP:rs35334091)	17344846	1
P09769/T110I	P09769	FGR	FGR_HUMAN	T110I	-	-	-	-	HILNNtGDWWE									VARIANT	T -> I (in dbSNP:rs34597831)	17344846	1
P09769/Y523F	P09769	FGR	FGR_HUMAN	Y523F	824	C-term-αI	p	increase	SAEPQyPGDQT	0.842	0.868	0.601	0.851	0.406	0.649	0.617	0.311	MUTAGEN	Y->F: Strongly increased catalytic activity. Functions as oncogene.	1737799	1
P0C1S8/D234H	P0C1S8	WEE2	WEE2_HUMAN	D234H	68	β2/β3-loop	-	decrease	CIKRLdCVYAI	0.817	0.815	0.436	0.614	0.674	0.715	0.413	0.516	VARIANT	D -> H (in OOMD5; decreased WEE2 phosphorylation at serine residues; decreased CDK1/CDC2 phosphorylation at 'Y-15'; dbSNP:rs1554415096)	29606300	1
P0C1S8/D470E	P0C1S8	WEE2	WEE2_HUMAN	D470E	796	αI	-	-	NMIQPdEQRPS	0.46	0.427	0.547	0.414	0.26	0.266	0.651	0.306	VARIANT	D -> E (in dbSNP:rs55901099)	17344846	1
P0C1S8/K8T	P0C1S8	WEE2	WEE2_HUMAN	K8T	-	-	-	neutral	DKDIDkLRQKL									VARIANT	K -> T (in dbSNP:rs35672788)	17344846	1
P0C1S8/N332K	P0C1S8	WEE2	WEE2_HUMAN	N332K	425	αE	-	-	LNYIHnSMVHL	0.08	0.153	0.551	0.16	0.063	0.108	0.789	0.052	VARIANT	N -> K (in a gastric adenocarcinoma sample; somatic mutation)	17344846	1
P0C1S8/R398H	P0C1S8	WEE2	WEE2_HUMAN	R398H	552	A-loop	-	-	EEGDSrLANEI	0.742	0.732	0.599	0.744	0.441	0.619	0.626	0.554	VARIANT	R -> H (in an ovarian mucinous carcinoma sample; somatic mutation; dbSNP:rs200610853)	17344846	1
P0C1S8/Y526D	P0C1S8	WEE2	WEE2_HUMAN	Y526D	-	-	-	neutral	QSPQGyHHGDT									VARIANT	Y -> D (in dbSNP:rs35683659)	17344846	1
P10398/E578D	P10398	ARAF	ARAF_HUMAN	E578D	822	αI	-	-	SLPKIeSASEP	0.473	0.439	0.6	0.376	0.339	0.362	0.658	0.281	VARIANT	E -> D (in dbSNP:rs55852926)	17344846	1
P10398/G331C	P10398	ARAF	ARAF_HUMAN	G331C	111	β2/β3-loop	-	-	RGRWHgVAVKV	0.802	0.72	0.369	0.559	0.666	0.647	0.348	0.66	VARIANT	G -> C (in a colorectal adenocarcinoma sample; somatic mutation)	17344846	1
P10398/M98T	P10398	ARAF	ARAF_HUMAN	M98T	-	-	-	-	DVPLTmNFVRK									VARIANT	M -> T (in dbSNP:rs56197559)	17344846	1
P10721/A533D	P10721	KIT	KIT_HUMAN	A533D	-	-	-	-	GFVIVaMMCII									VARIANT	A -> D (in MASTC; unknown pathological significance; dbSNP:rs753212327)	15173254	1
P10721/A829P	P10721	KIT	KIT_HUMAN	A829P	539	A-loop	-	resistance	VVKGNaLPVKW	0.655	0.62	0.56	0.564	0.33	0.532	0.68	0.561	VARIANT	A -> P (in a germ cell tumor of the testis; somatic mutation; dbSNP:rs1057519713)	16175573,17344846	2
P10721/C691S	P10721	KIT	KIT_HUMAN	C691S	301	αD/αE-loop	-	-	RDSFIcKQEDH	0.344	0.28	0.515	0.344	0.25	0.282	0.649	0.329	VARIANT	C -> S (in dbSNP:rs35200131)	17344846	1
P10721/D737N	P10721	KIT	KIT_HUMAN	D737N	370	αD/αE-loop	-	-	VPTKAdRRSVR	0.133	0.089	0.454	0.18	0.126	0.124	0.663	0.179	VARIANT	D -> N (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs751005114)	17344846	1
P10721/D816F	P10721	KIT	KIT_HUMAN	D816F	505	A-loop	-	activating	FGLARdKNDSN	0.948	0.943	0.709	0.955	0.132	0.765	0.703	0.947	VARIANT	D -> F (in MASTC; sporadic case; somatic mutation; requires 2 nucleotide substitutions; constitutively activated and is much more rapidly autophosphorylated than wild type)	9990072	1
P10721/D816H	P10721	KIT	KIT_HUMAN	D816H	505	A-loop	-	activating,resistance	FGLARdKNDSN	0.855	0.777	0.699	0.889	0.196	0.587	0.746	0.93	VARIANT	D -> H (in a testicular tumor; seminoma; somatic mutation; constitutively activated; dbSNP:rs121913506)	10362788,19164557,20147452	3
P10721/D816I	P10721	KIT	KIT_HUMAN	D816I	505	A-loop	-	activating	FGLARdKNDSN	0.952	0.949	0.698	0.943	0.185	0.721	0.691	0.941	VARIANT	D -> I (in MASTC; somatic mutation; constitutively activated; requires 2 nucleotide substitutions; dbSNP:rs1057519709)	19865100	1
P10721/D816V	P10721	KIT	KIT_HUMAN	D816V	505	A-loop	-	activating	FGLARdKNDSN	0.948	0.948	0.75	0.964	0.159	0.73	0.799	0.927	VARIANT	D -> V (in MASTSYS, MASTC and mast cell leukemia; somatic mutation; constitutively activated; loss of interaction with MPDZ; dbSNP:rs121913507)	11018522,17595334,19164557,19265199,19865100,21640708,7691885,9990072	8
P10721/D816Y	P10721	KIT	KIT_HUMAN	D816Y	505	A-loop	-	activating	FGLARdKNDSN	0.897	0.922	0.725	0.947	0.129	0.699	0.799	0.934	VARIANT	D -> Y (in MASTSYS and MASTC; also found in acute myeloid leukemia and a germ cell tumor of the testis; somatic mutation; constitutively activated; dbSNP:rs121913506)	16175573,17344846,19865100,9657776,9990072	5
P10721/D820G	P10721	KIT	KIT_HUMAN	D820G	509	A-loop	-	resistance	RDIKNdNYVVK	0.775	0.648	0.657	0.705	0.358	0.475	0.687	0.719	VARIANT	D -> G (in mast cell disease; systemic; dbSNP:rs121913682)	9029028	1
P10721/E386A	P10721	KIT	KIT_HUMAN	E386A	-	-	-	decrease	RLKGTeGTYTF									MUTAGEN	E->A: Reduces autophosphorylation in response to KITLG/SCF.	17662946	1
P10721/E583K	P10721	KIT	KIT_HUMAN	E583K	22	N-term-β1	-	-	YDHKWePRNRL	0.758	0.697	0.542	0.655	0.463	0.644	0.609	0.59	VARIANT	E -> K (in PBT; dbSNP:rs121913680)	1376329	1
P10721/E839K	P10721	KIT	KIT_HUMAN	E839K	557	A-loop;APE-motif	-	loss	KWMAPeIFNCV	0.907	0.866	0.24	0.572	0.774	0.767	0.254	0.476	VARIANT	E -> K (in MASTC; sporadic case; somatic mutation; dominant negative mutation; loss of autophosphorylation; dbSNP:rs121913509)	9990072	1
P10721/F584C	P10721	KIT	KIT_HUMAN	F584C	23	N-term-β1	-	-	DHKWEfRNRLS	0.819	0.804	0.465	0.615	0.586	0.698	0.479	0.498	VARIANT	F -> C (in PBT; dbSNP:rs28933371)	11074500	1
P10721/F584L	P10721	KIT	KIT_HUMAN	F584L	23	N-term-β1	-	-	DHKWEfRNRLS	0.639	0.617	0.491	0.521	0.435	0.536	0.529	0.314	VARIANT	F -> L (in PBT; dbSNP:rs794726671)	1370874	1
P10721/G601R	P10721	KIT	KIT_HUMAN	G601R	45	Gly-rich-loop;β2	-	-	GAGAFgVVEAT	0.941	0.925	0.266	0.712	0.845	0.895	0.244	0.66	VARIANT	G -> R (in PBT)	11074500	1
P10721/G664R	P10721	KIT	KIT_HUMAN	G664R	238	β4/β5-loop	-	-	ACTIGgTLVIT	0.672	0.652	0.482	0.671	0.47	0.591	0.502	0.572	VARIANT	G -> R (in PBT; dbSNP:rs121913679)	1717985	1
P10721/G812V	P10721	KIT	KIT_HUMAN	G812V	498	A-loop;DFG-motif	-	-	KICDFgARDIK	0.854	0.87	0.354	0.647	0.68	0.814	0.286	0.421	VARIANT	G -> V (in PBT)	7687267	1
P10721/I571A	P10721	KIT	KIT_HUMAN	I571A	10	N-term-β1	-	-	NNYVYiPTQLP	0.639	0.58	0.392	0.549	0.525	0.59	0.457	0.376	MUTAGEN	I->A: Reduction in SH2B2/APS binding. Abolishes SH2B2/APS binding; when associated with A-939.	12444928	1
P10721/K550I	P10721	KIT	KIT_HUMAN	K550I	-	-	-	-	YKYLQkMYEVQ									VARIANT	K -> I (in GIST; somatic mutation)	9438854	1
P10721/K623M	P10721	KIT	KIT_HUMAN	K623M	129	β3;Catalytic-Lys	-	-	MTVAVkLKPSA	0.999	0.994	0.027	0.584	1.0	0.999	0.023	0.578	MUTAGEN	K->M: Stronger interaction with MPDZ.	11018522	1
P10721/L656P	P10721	KIT	KIT_HUMAN	L656P	199	β4	-	-	MNIVNlGACTI	0.871	0.864	0.464	0.697	0.681	0.776	0.404	0.473	VARIANT	L -> P (in PBT)	11074500	1
P10721/L939A	P10721	KIT	KIT_HUMAN	L939A	826	C-term-αI	-	-	HIYSNlNCSPN	0.613	0.629	0.448	0.537	0.481	0.557	0.428	0.437	MUTAGEN	L->A: Reduction in SH2B2/APS binding. Abolishes SH2B2/APS binding; when associated with A-571.	12444928	1
P10721/M541L	P10721	KIT	KIT_HUMAN	M541L	-	-	-	-	MCIIVmLTYKY									VARIANT	M -> L (in dbSNP:rs3822214)	17344846,19865100	2
P10721/M541V	P10721	KIT	KIT_HUMAN	M541V	-	-	-	-	MCIIVmLTYKY									VARIANT	M -> V (in dbSNP:rs3822214)		0
P10721/N822I	P10721	KIT	KIT_HUMAN	N822I	511	A-loop	-	activating	IKNDSnVVKGN	0.833	0.824	0.606	0.802	0.392	0.702	0.563	0.627	VARIANT	N -> I (in MASTC; constitutively activated; dbSNP:rs993022333)	21689725	1
P10721/N822K	P10721	KIT	KIT_HUMAN	N822K	511	A-loop	-	activating,resistance	IKNDSnVVKGN	0.793	0.812	0.613	0.757	0.453	0.655	0.531	0.542	VARIANT	N -> K (in a germ cell tumor of the testis; somatic mutation; dbSNP:rs121913514)	16175573,17344846	2
P10721/R381A	P10721	KIT	KIT_HUMAN	R381A	-	-	-	decrease	ELHLTrKGTEG									MUTAGEN	R->A: Reduces autophosphorylation in response to KITLG/SCF.	17662946	1
P10721/R791G	P10721	KIT	KIT_HUMAN	R791G	442	Catalytic-loop;HrD-motif	-	-	KNCIHrLAARN	0.728	0.754	0.531	0.651	0.464	0.624	0.593	0.409	VARIANT	R -> G (in PBT; dbSNP:rs1722708855)	7687267	1
P10721/R796G	P10721	KIT	KIT_HUMAN	R796G	447	Catalytic-loop	-	-	RDLAArILLTH	0.868	0.811	0.39	0.65	0.768	0.82	0.31	0.483	VARIANT	R -> G (in PBT; with sensorineural deafness; dbSNP:rs121913684)	9450866	1
P10721/R804W	P10721	KIT	KIT_HUMAN	R804W	482	Catalytic-loop	-	-	LLTHGrTKICD	0.747	0.679	0.494	0.559	0.525	0.626	0.553	0.493	VARIANT	R -> W (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs145602440)	17344846	1
P10721/S451C	P10721	KIT	KIT_HUMAN	S451C	-	-	-	-	TEQRCsSVLPV									VARIANT	S -> C (in MASTC; unknown pathological significance)	24289326	1
P10721/S715N	P10721	KIT	KIT_HUMAN	S715N	325	αD/αE-loop	-	-	KESSCsSTNEY	0.265	0.299	0.547	0.265	0.205	0.17	0.684	0.091	VARIANT	S -> N (in dbSNP:rs56094246)	17344846	1
P10721/S741A	P10721	KIT	KIT_HUMAN	S741A	374	αD/αE-loop	p	-	ADKRRsRIGSY	0.53	0.627	0.392	0.555	0.424	0.426	0.462	0.145	MUTAGEN	S->A: Abolishes down-regulation of kinase activity by PKC/PRKCA-mediated phosphorylation; when associated with A-746.	7539802	1
P10721/S746A	P10721	KIT	KIT_HUMAN	S746A	379	αD/αE-loop	p	-	SVRIGsIERDV	0.541	0.679	0.431	0.5	0.349	0.374	0.551	0.118	MUTAGEN	S->A: Abolishes down-regulation of kinase activity by PKC/PRKCA-mediated phosphorylation; when associated with A-741.	7539802	1
P10721/T847P	P10721	KIT	KIT_HUMAN	T847P	596	αF	-	-	FNCVYtESDVW	0.801	0.825	0.583	0.725	0.476	0.724	0.572	0.468	VARIANT	T -> P (in PBT; dbSNP:rs121913687)	9699740	1
P10721/V532I	P10721	KIT	KIT_HUMAN	V532I	-	-	-	-	IGFVIvGMMCI									VARIANT	V -> I (in dbSNP:rs55792975)	17344846	1
P10721/V559A	P10721	KIT	KIT_HUMAN	V559A	-	-	-	-	EVQWKvEEING									VARIANT	V -> A (in GIST; dbSNP:rs121913517)	11505412	1
P10721/V559D	P10721	KIT	KIT_HUMAN	V559D	-	-	-	-	EVQWKvEEING									VARIANT	V -> D (in GIST; somatic mutation; dbSNP:rs121913517)	9438854	1
P10721/Y823F	P10721	KIT	KIT_HUMAN	Y823F	512	A-loop	p	activating	KNDSNyVKGNA	0.979	0.951	0.554	0.873	0.522	0.914	0.511	0.57	MUTAGEN	Y->F: No decrease in activity. Leads to autophosphorylation at Tyr-900.	20147452	1
P11274/A1104G	P11274	BCR	BCR_HUMAN	A1104G	-	-	-	-	QALKAaDVNNK									VARIANT	A -> G (in dbSNP:rs11558696)	17344846	1
P11274/A1149T	P11274	BCR	BCR_HUMAN	A1149T	-	-	-	-	FYPNFaGIALS									VARIANT	A -> T (in dbSNP:rs200099830)	17344846	1
P11274/A1204G	P11274	BCR	BCR_HUMAN	A1204G	-	-	-	-	SLHNLaVFGPT									VARIANT	A -> G (in dbSNP:rs56265970)	17344846	1
P11274/D1106N	P11274	BCR	BCR_HUMAN	D1106N	-	-	-	-	LKAAFdNNKDV									VARIANT	D -> N (in dbSNP:rs879255379)	17344846	1
P11274/D752E	P11274	BCR	BCR_HUMAN	D752E	-	-	-	neutral	KTQQYdKWYIP									VARIANT	D -> E (in dbSNP:rs12484731)	17344846	1
P11274/E1037K	P11274	BCR	BCR_HUMAN	E1037K	-	-	-	-	KFNSReSLKRM									VARIANT	E -> K (in dbSNP:rs776552570)	17344846	1
P11274/E1161K	P11274	BCR	BCR_HUMAN	E1161K	-	-	-	-	DPVAKeCMLNL									VARIANT	E -> K	17344846	1
P11274/I413M	P11274	BCR	BCR_HUMAN	I413M	-	-	-	-	RKTGQiPNDGE									VARIANT	I -> M (in dbSNP:rs56321828)	17344846	1
P11274/K1187E	P11274	BCR	BCR_HUMAN	K1187E	-	-	-	-	LLDHLkVAEKE									VARIANT	K -> E (in dbSNP:rs1195127922)	17344846	1
P11274/K558T	P11274	BCR	BCR_HUMAN	K558T	-	-	-	-	LYEIHkFYDGL									VARIANT	K -> T (in dbSNP:rs4437065)		0
P11274/N1202A	P11274	BCR	BCR_HUMAN	N1202A	-	-	-	-	KMSLHnATVFG									MUTAGEN	N->A: Loss of GAP activity; when associated with A-1090.	17116687	1
P11274/N796S	P11274	BCR	BCR_HUMAN	N796S	-	-	-	neutral	ISQIKnIQREK									VARIANT	N -> S (in dbSNP:rs140504)	17344846,2407300,3107980,3285291	4
P11274/R1090A	P11274	BCR	BCR_HUMAN	R1090A	-	-	-	-	EVGIYrSGVAT									MUTAGEN	R->A: Loss of GAP activity. Loss of GAP activity; when associated with A-1202.	17116687	1
P11274/S400P	P11274	BCR	BCR_HUMAN	S400P	-	-	-	-	CPVVVsATIVG									VARIANT	S -> P (in a bladder transitional cell carcinoma sample; somatic mutation)	17344846	1
P11274/T1096A	P11274	BCR	BCR_HUMAN	T1096A	-	-	-	-	VSGVAtIQALK									VARIANT	T -> A (in dbSNP:rs745459086)	17344846	1
P11274/T1127M	P11274	BCR	BCR_HUMAN	T1127M	-	-	-	-	NAIAGtKLYFR									VARIANT	T -> M (in dbSNP:rs35812689)		0
P11274/V1091M	P11274	BCR	BCR_HUMAN	V1091M	-	-	-	-	VGIYRvGVATD									VARIANT	V -> M (in dbSNP:rs778229520)	17344846	1
P11274/V1189M	P11274	BCR	BCR_HUMAN	V1189M	-	-	-	-	DHLKRvEKEAV									VARIANT	V -> M (in dbSNP:rs55816482)	17344846	1
P11274/V949I	P11274	BCR	BCR_HUMAN	V949I	-	-	-	neutral	KAKTRvRDTAE									VARIANT	V -> I (in dbSNP:rs2229038)	17344846	1
P11274/W1235R	P11274	BCR	BCR_HUMAN	W1235R	-	-	-	-	TMTDSwLEVMS									VARIANT	W -> R (in dbSNP:rs55719322)	17344846	1
P11274/Y177F	P11274	BCR	BCR_HUMAN	Y177F	-	-	p	-	AEKPFyNVEFH									MUTAGEN	Y->F: Abolishes interaction with FES and GRB2.	15302586,9407116	2
P11274/Y910C	P11274	BCR	BCR_HUMAN	Y910C	-	-	-	-	ESPGLyFLNVI									VARIANT	Y -> C (in dbSNP:rs35537221)	17344846	1
P11309/E124Q	P11309	PIM1	PIM1_HUMAN	E124Q	253	β5/αD-loop	-	-	ILERPeVQDLF	0.246	0.238	0.417	0.188	0.286	0.225	0.576	0.369	VARIANT	E -> Q (in dbSNP:rs35760989)	17344846	1
P11309/E135K	P11309	PIM1	PIM1_HUMAN	E135K	286	αD/αE-loop	-	-	FDFITeGALQE	0.198	0.183	0.479	0.249	0.185	0.137	0.647	0.167	VARIANT	E -> K (in dbSNP:rs200523275)	17344846	1
P11309/E142D	P11309	PIM1	PIM1_HUMAN	E142D	396	αD/αE-loop	-	-	GALQEeARSFF	0.287	0.269	0.526	0.286	0.244	0.155	0.629	0.235	VARIANT	E -> D (in dbSNP:rs33989191)	17344846	1
P11309/H68Y	P11309	PIM1	PIM1_HUMAN	H68Y	130	β3	-	increase	PVAIKhEKDRI	0.547	0.478	0.542	0.503	0.24	0.372	0.651	0.134	MUTAGEN	H->Y: Increased kinase activity.	15808862	1
P11309/L193F	P11309	PIM1	PIM1_HUMAN	L193F	509	A-loop	-	decrease	GSGALlDTVYT	0.719	0.702	0.455	0.601	0.433	0.476	0.541	0.546	MUTAGEN	L->F: Decreased kinase activity.	15808862	1
P11309/N82K	P11309	PIM1	PIM1_HUMAN	N82K	166	αC	-	decrease	WGELPnTRVPM	0.167	0.221	0.521	0.098	0.247	0.199	0.695	0.085	MUTAGEN	N->K: Decreased kinase activity.	15808862	1
P11309/P81S	P11309	PIM1	PIM1_HUMAN	P81S	148	αC	-	decrease	DWGELpGTRVP	0.497	0.476	0.469	0.331	0.391	0.325	0.531	0.385	MUTAGEN	P->S: Decreased kinase activity.	15808862	1
P11309/Y53H	P11309	PIM1	PIM1_HUMAN	Y53H	49	β2	-	-	GFGSVyGIRVS	0.553	0.455	0.519	0.405	0.342	0.456	0.565	0.412	VARIANT	Y -> H (in a colorectal adenocarcinoma sample; somatic mutation)	17344846	1
P11362/A167S	P11362	FGFR1	FGFR1_HUMAN	A167S	-	-	-	-	EKKLHaPAAKT									VARIANT	A -> S (in HH2; with cleft palate, corpus callosum agenesis, unilateral deafness and fusion of fourth and fifth metacarpal bones; dbSNP:rs121909630)	12627230	1
P11362/A343V	P11362	FGFR1	FGFR1_HUMAN	A343V	-	-	-	-	EYTCLaNSIGL									VARIANT	A -> V (in HH2)	16882753	1
P11362/A520T	P11362	FGFR1	FGFR1_HUMAN	A520T	135	β3/αC-loop	-	-	MLKSDaEKDLS	0.56	0.492	0.564	0.462	0.288	0.39	0.689	0.371	VARIANT	A -> T (in HH2; dbSNP:rs749758370)	15605412	1
P11362/A671P	P11362	FGFR1	FGFR1_HUMAN	A671P	558	αF	-	-	WMAPEaFDRIY	0.619	0.452	0.487	0.371	0.51	0.506	0.518	0.455	VARIANT	A -> P (in HH2)	19820032	1
P11362/C101F	P11362	FGFR1	FGFR1_HUMAN	C101F	-	-	-	-	SGLYAcTSSPS									VARIANT	C -> F (in HH2)	17154279	1
P11362/C178S	P11362	FGFR1	FGFR1_HUMAN	C178S	-	-	-	-	TVKFKcSSGTP									VARIANT	C -> S (in HH2; with severe ear anomalies)	16757108	1
P11362/C277Y	P11362	FGFR1	FGFR1_HUMAN	C277Y	-	-	-	-	NVEFMcVYSDP									VARIANT	C -> Y (in HH2)	12627230	1
P11362/C381R	P11362	FGFR1	FGFR1_HUMAN	C381R	-	-	-	-	EIIIYcGAFLI									VARIANT	C -> R (in OGD; dbSNP:rs121909634)	15625620,16470795	2
P11362/C725Y	P11362	FGFR1	FGFR1_HUMAN	C725Y	761	αG/αH	-	-	DKPSNcNELYM	0.793	0.855	0.498	0.617	0.642	0.706	0.5	0.575	VARIANT	C -> Y (in HRTFDS; dbSNP:rs398122945)	23812909	1
P11362/D129A	P11362	FGFR1	FGFR1_HUMAN	D129A	-	-	-	-	SSEDDdDDDSS									VARIANT	D -> A (in HH2; dbSNP:rs765615419)	15605412	1
P11362/D224H	P11362	FGFR1	FGFR1_HUMAN	D224H	-	-	-	-	SVVPSdGNYTC									VARIANT	D -> H (in HH2)	16764984	1
P11362/D623A	P11362	FGFR1	FGFR1_HUMAN	D623A	443	Catalytic-loop;HrD-motif	-	loss	KCIHRdAARNV	0.978	0.975	0.16	0.626	0.953	0.986	0.143	0.601	MUTAGEN	D->A: Loss of kinase activity.	19224897	1
P11362/D623Y	P11362	FGFR1	FGFR1_HUMAN	D623Y	443	Catalytic-loop;HrD-motif	-	-	KCIHRdAARNV	0.978	0.982	0.153	0.719	0.934	0.978	0.095	0.595	VARIANT	D -> Y (in HRTFDS; dbSNP:rs398122946)	23812909	1
P11362/D755V	P11362	FGFR1	FGFR1_HUMAN	D755V	812	αI	-	-	LVEDLdIVALT	0.756	0.71	0.546	0.626	0.482	0.655	0.498	0.421	MUTAGEN	D->V: Abolishes interaction with PLCG1.		0
P11362/D768Y	P11362	FGFR1	FGFR1_HUMAN	D768Y	825	C-term-αI	-	-	NQEYLdSMPLD	0.697	0.65	0.603	0.582	0.364	0.544	0.619	0.629	VARIANT	D -> Y (in HH2; the patient also carries a rare variant in FGF8; dbSNP:rs121909644)	23643382	1
P11362/E274G	P11362	FGFR1	FGFR1_HUMAN	E274G	-	-	-	-	LGSNVeMCKVY									VARIANT	E -> G (in HH2; also found in a family member with isolated anosmia; dbSNP:rs727505369)		0
P11362/E670K	P11362	FGFR1	FGFR1_HUMAN	E670K	557	A-loop;APE-motif	-	-	KWMAPeLFDRI	0.935	0.929	0.249	0.677	0.846	0.855	0.231	0.509	VARIANT	E -> K (in HH2; phenotype consistent with Kallmann syndrome; the patient also carries a rare variant in FLRT3; dbSNP:rs397515446)	23643382	1
P11362/E692G	P11362	FGFR1	FGFR1_HUMAN	E692G	610	αF	-	-	GVLLWeFTLGG	0.896	0.884	0.346	0.582	0.709	0.78	0.362	0.564	VARIANT	E -> G (in HH2; phenotype consistent with Kallmann syndrome; the patient also carries a rare variant in DUSP6; dbSNP:rs397515445)	23643382	1
P11362/G237D	P11362	FGFR1	FGFR1_HUMAN	G237D	-	-	-	-	VENEYgINHTY									VARIANT	G -> D (in HH2)	16764984	1
P11362/G237S	P11362	FGFR1	FGFR1_HUMAN	G237S	-	-	-	-	VENEYgINHTY									VARIANT	G -> S (in HH2; with or without anosmia; also found in a family member with isolated anosmia; may impair proper folding; dbSNP:rs121909635)	16606836	1
P11362/G270D	P11362	FGFR1	FGFR1_HUMAN	G270D	-	-	-	-	KTVALgNVEFM									VARIANT	G -> D (in HH2)	17154279	1
P11362/G348R	P11362	FGFR1	FGFR1_HUMAN	G348R	-	-	-	-	AGNSIgSHHSA									VARIANT	G -> R (in HH2; phenotype consistent with Kallmann syndrome; the patient also carries a mutation in IL17RD; dbSNP:rs886037634)	23643382,25077900	2
P11362/G48S	P11362	FGFR1	FGFR1_HUMAN	G48S	-	-	-	-	FLVHPgLLQLR									VARIANT	G -> S (in HH2; phenotype consistent with normosmic idiopathic hypogonadotropic hypogonadism; dbSNP:rs121909640)	16882753	1
P11362/G490R	P11362	FGFR1	FGFR1_HUMAN	G490R	45	Gly-rich-loop;β2	-	-	GEGCFgVVLAE	0.897	0.908	0.226	0.649	0.831	0.87	0.209	0.601	VARIANT	G -> R (in HRTFDS; dbSNP:rs869025670)	23812909	1
P11362/G687R	P11362	FGFR1	FGFR1_HUMAN	G687R	605	αF	-	-	DVWSFgLLWEI	0.77	0.794	0.321	0.591	0.756	0.678	0.234	0.401	VARIANT	G -> R (in HH2; dbSNP:rs727505376)	15845591,22927827	2
P11362/G703R	P11362	FGFR1	FGFR1_HUMAN	G703R	636	αF/αG	-	-	GSPYPgPVEEL	0.747	0.683	0.486	0.563	0.481	0.54	0.513	0.482	VARIANT	G -> R (in HH2)	16764984	1
P11362/G703S	P11362	FGFR1	FGFR1_HUMAN	G703S	636	αF/αG	-	-	GSPYPgPVEEL	0.553	0.464	0.528	0.494	0.285	0.417	0.617	0.507	VARIANT	G -> S (in HH2; dbSNP:rs768957161)	16764984	1
P11362/G70R	P11362	FGFR1	FGFR1_HUMAN	G70R	-	-	-	-	NWLRDgQLAES									VARIANT	G -> R (in HH2; dbSNP:rs140254426)	25077900	1
P11362/G818R	P11362	FGFR1	FGFR1_HUMAN	G818R	-	-	-	-	QLANGgKRR									VARIANT	G -> R (in dbSNP:rs17182456)		0
P11362/G97D	P11362	FGFR1	FGFR1_HUMAN	G97D	-	-	-	-	VPADSgYACVT									VARIANT	G -> D (in HH2)	12627230	1
P11362/H621R	P11362	FGFR1	FGFR1_HUMAN	H621R	441	Catalytic-loop;HrD-motif	-	-	SKKCIhDLAAR	0.795	0.84	0.287	0.631	0.827	0.843	0.239	0.49	VARIANT	H -> R (in HH2)	17154279	1
P11362/I239T	P11362	FGFR1	FGFR1_HUMAN	I239T	-	-	-	-	NEYGSiHTYQL									VARIANT	I -> T (in HH2; some patients also carry PROKR2 and GNRH1 mutations; impairs the tertiary folding resulting in incomplete glycosylation and reduced cell surface expression)	19820032,23643382	2
P11362/I300T	P11362	FGFR1	FGFR1_HUMAN	I300T	-	-	-	-	VNGSKiPDNLP									VARIANT	I -> T (in TRIGNO1; dbSNP:rs121909633)	11173846	1
P11362/I538V	P11362	FGFR1	FGFR1_HUMAN	I538V	189	αC/β4-loop	-	-	EMMKMiKHKNI	0.366	0.331	0.541	0.331	0.191	0.183	0.667	0.342	VARIANT	I -> V (in HH2)	16764984	1
P11362/I693F	P11362	FGFR1	FGFR1_HUMAN	I693F	613	αF	-	-	VLLWEiTLGGS	0.753	0.781	0.461	0.649	0.474	0.699	0.532	0.566	VARIANT	I -> F (in HH2)	17154279	1
P11362/K514A	P11362	FGFR1	FGFR1_HUMAN	K514A	129	β3;Catalytic-Lys	-	loss	TKVAVkLKSDA	1.0	0.993	0.023	0.641	1.0	0.997	0.004	0.659	MUTAGEN	K->A: Loss of kinase activity.	15117958	1
P11362/K618N	P11362	FGFR1	FGFR1_HUMAN	K618N	428	αE	-	decrease	YLASKkIHRDL	0.352	0.465	0.535	0.477	0.421	0.372	0.539	0.378	VARIANT	K -> N (in HH2; some patients also carry GNRHR mutations; impairs tyrosine kinase activity)	19820032,23643382	2
P11362/K656E	P11362	FGFR1	FGFR1_HUMAN	K656E	532	A-loop	-	activating	IDYYKkTNGRL	0.861	0.78	0.744	0.902	0.131	0.417	0.818	0.448	VARIANT	K -> E (in ECCL; somatic mutation; dbSNP:rs869320694)	26942290	1
P11362/L165S	P11362	FGFR1	FGFR1_HUMAN	L165S	-	-	-	-	KMEKKlAVPAA									VARIANT	L -> S (in HRTFDS; dbSNP:rs397515481)	23812909	1
P11362/L191S	P11362	FGFR1	FGFR1_HUMAN	L191S	-	-	-	-	PTLRWlNGKEF									VARIANT	L -> S (in HRTFDS; dbSNP:rs869025669)	23812909	1
P11362/L245P	P11362	FGFR1	FGFR1_HUMAN	L245P	-	-	-	-	NHTYQlVVERS									VARIANT	L -> P (in HH2)	16882753	1
P11362/L342S	P11362	FGFR1	FGFR1_HUMAN	L342S	-	-	-	-	GEYTClGNSIG									VARIANT	L -> S (in HH2; phenotype consistent with Kallmann syndrome; the patient also carries a splice site mutation in NSMF; dbSNP:rs121909638)	23643382	1
P11362/L769V	P11362	FGFR1	FGFR1_HUMAN	L769V	826	C-term-αI	-	-	QEYLDlMPLDQ	0.571	0.624	0.561	0.534	0.278	0.418	0.678	0.357	VARIANT	L -> V (in dbSNP:rs2956723)	16764984	1
P11362/M719R	P11362	FGFR1	FGFR1_HUMAN	M719R	754	αG/αH	-	-	KEGHRmKPSNC	0.883	0.802	0.423	0.611	0.658	0.753	0.333	0.51	VARIANT	M -> R (in HH2)	12627230	1
P11362/M719V	P11362	FGFR1	FGFR1_HUMAN	M719V	754	αG/αH	-	-	KEGHRmKPSNC	0.752	0.799	0.593	0.646	0.346	0.56	0.604	0.392	VARIANT	M -> V (in HH2; unknown pathological significance; dbSNP:rs1085307879)	26277103	1
P11362/N117S	P11362	FGFR1	FGFR1_HUMAN	N117S	-	-	-	-	TYFSVnSDALP									VARIANT	N -> S (in HH2; some patients also carry GNRHR mutations; dbSNP:rs780765366)	19820032,23643382	2
P11362/N330I	P11362	FGFR1	FGFR1_HUMAN	N330I	-	-	-	-	VLHLRnSFEDA									VARIANT	N -> I (in OGD; dbSNP:rs121909632)	15625620,16470795	2
P11362/N546K	P11362	FGFR1	FGFR1_HUMAN	N546K	198	αC/β4-loop	-	activating,resistance	HKNIInLGACT	0.538	0.419	0.556	0.463	0.13	0.231	0.745	0.522	VARIANT	N -> K (in ECCL; somatic mutation; activating mutation; strongly increased speed of the first autophosphorylation and loss of the normal sequential order of autophosphorylation; dbSNP:rs779707422)	19224897,26942290	2
P11362/N628K	P11362	FGFR1	FGFR1_HUMAN	N628K	448	Catalytic-loop	-	-	DLAARnLVTED	0.908	0.872	0.305	0.707	0.831	0.851	0.245	0.456	VARIANT	N -> K (in HRTFDS; dbSNP:rs869025672)	23812909	1
P11362/N724K	P11362	FGFR1	FGFR1_HUMAN	N724K	760	αG/αH	-	-	MDKPSnTNELY	0.504	0.472	0.516	0.444	0.292	0.446	0.665	0.287	VARIANT	N -> K (in HH2; associated with H-722; also found in a family member with isolated anosmia; reduced tyrosine kinase activity; dbSNP:rs267606806)	16606836,23643382	2
P11362/N77K	P11362	FGFR1	FGFR1_HUMAN	N77K	-	-	-	-	QLAESnTRITG									VARIANT	N -> K (in dbSNP:rs767195580)	17154279	1
P11362/P252R	P11362	FGFR1	FGFR1_HUMAN	P252R	-	-	-	-	VVERSpRPILQ									VARIANT	P -> R (in PS and JWS; dbSNP:rs121909627)	10861678,7874169	2
P11362/P252T	P11362	FGFR1	FGFR1_HUMAN	P252T	-	-	-	-	VVERSpRPILQ									VARIANT	P -> T (in a lung bronchoalveolar carcinoma sample; somatic mutation; dbSNP:rs121913472)	17344846	1
P11362/P283R	P11362	FGFR1	FGFR1_HUMAN	P283R	-	-	-	-	KVYSDpPHIQW									VARIANT	P -> R (in HH2)	17154279	1
P11362/P366L	P11362	FGFR1	FGFR1_HUMAN	P366L	-	-	-	-	ALEERpVMTSP									VARIANT	P -> L (in HH2; with or without anosmia; dbSNP:rs121909641)	16882753	1
P11362/P483T	P11362	FGFR1	FGFR1_HUMAN	P483T	38	β1	-	-	LVLGKpGEGCF	0.215	0.129	0.49	0.231	0.194	0.147	0.634	0.209	VARIANT	P -> T (in HH2; phenotype consistent with Kallmann syndrome; the patient also carries a rare variant in SPRY4; dbSNP:rs397515444)	23643382	1
P11362/P722H	P11362	FGFR1	FGFR1_HUMAN	P722H	757	αG/αH	-	-	HRMDKpNCTNE	0.771	0.741	0.414	0.443	0.62	0.696	0.367	0.564	VARIANT	P -> H (in HH2; associated with K-724; also found in a family member with isolated anosmia; reduced tyrosine kinase activity; dbSNP:rs267606805)	16606836,23643382	2
P11362/P722S	P11362	FGFR1	FGFR1_HUMAN	P722S	757	αG/αH	-	-	HRMDKpNCTNE	0.8	0.738	0.386	0.511	0.64	0.706	0.33	0.549	VARIANT	P -> S (in HH2; dbSNP:rs121909642)	16882753	1
P11362/P745S	P11362	FGFR1	FGFR1_HUMAN	P745S	801	αI	-	-	VPSQRpFKQLV	0.723	0.674	0.398	0.522	0.614	0.631	0.404	0.658	VARIANT	P -> S (in HH2)	15001591,15845591	2
P11362/P772S	P11362	FGFR1	FGFR1_HUMAN	P772S	829	C-term-αI	-	-	LDLSMpDQYSP	0.552	0.43	0.511	0.379	0.321	0.412	0.601	0.461	VARIANT	P -> S (in dbSNP:rs56234888)	12627230,17154279	2
P11362/R22S	P11362	FGFR1	FGFR1_HUMAN	R22S	-	-	-	-	TLCTArSPTLP									VARIANT	R -> S (in dbSNP:rs17175750)		0
P11362/R250Q	P11362	FGFR1	FGFR1_HUMAN	R250Q	-	-	-	-	LDVVErPHRPI									VARIANT	R -> Q (in HH2; with or without anosmia; results in Kallmann syndrome in the presence of HS6ST1 mutation TRP-306; reduces receptor affinity for fibroblast growth factor; dbSNP:rs121909645)	19820032,21700882,23643382,25077900	4
P11362/R250W	P11362	FGFR1	FGFR1_HUMAN	R250W	-	-	-	-	LDVVErPHRPI									VARIANT	R -> W (in HH2)	16882753,17154279	2
P11362/R254Q	P11362	FGFR1	FGFR1_HUMAN	R254Q	-	-	-	-	ERSPHrILQAG									VARIANT	R -> Q (in HH2)	16764984	1
P11362/R470L	P11362	FGFR1	FGFR1_HUMAN	R470L	20	N-term-β1	-	-	LPEDPrELPRD	0.496	0.37	0.581	0.434	0.323	0.318	0.642	0.309	VARIANT	R -> L (in HH2; some patients also carry GNRHR mutations; dbSNP:rs121909637)	19820032,23643382	2
P11362/R577E	P11362	FGFR1	FGFR1_HUMAN	R577E	272	αD	-	decrease	YLQARrPGLEY	0.89	0.873	0.5	0.711	0.705	0.793	0.39	0.505	MUTAGEN	R->E: Strongly reduced autophosphorylation in response to FGF signaling. No effect on in vitro kinase activity.	20133753	1
P11362/R609V	P11362	FGFR1	FGFR1_HUMAN	R609V	412	αE	-	-	AYQVArMEYLA	0.827	0.743	0.47	0.504	0.629	0.718	0.362	0.593	MUTAGEN	R->V: Abolishes interaction with PLCG1.		0
P11362/R622G	P11362	FGFR1	FGFR1_HUMAN	R622G	442	Catalytic-loop;HrD-motif	-	-	KKCIHrLAARN	0.842	0.817	0.539	0.709	0.452	0.67	0.605	0.386	VARIANT	R -> G (in HH2; with severe ear anomalies; dbSNP:rs121909628)	16757108	1
P11362/R622Q	P11362	FGFR1	FGFR1_HUMAN	R622Q	442	Catalytic-loop;HrD-motif	-	-	KKCIHrLAARN	0.914	0.947	0.42	0.776	0.699	0.819	0.384	0.507	VARIANT	R -> Q (in HH2)	16757108	1
P11362/R627T	P11362	FGFR1	FGFR1_HUMAN	R627T	447	Catalytic-loop	-	-	RDLAArVLVTE	0.897	0.806	0.324	0.602	0.794	0.828	0.249	0.525	VARIANT	R -> T (in HRTFDS; dbSNP:rs869025671)	24888332	1
P11362/R78C	P11362	FGFR1	FGFR1_HUMAN	R78C	-	-	-	-	LAESNrRITGE									VARIANT	R -> C (in HH2; dbSNP:rs1554570706)	16764984	1
P11362/S125L	P11362	FGFR1	FGFR1_HUMAN	S125L	-	-	-	-	DALPSsDDDDD									VARIANT	S -> L (in a breast infiltrating ductal carcinoma sample; somatic mutation; dbSNP:rs121913473)	17344846	1
P11362/S332C	P11362	FGFR1	FGFR1_HUMAN	S332C	-	-	-	-	HLRNVsEDAGE									VARIANT	S -> C (in HH2)	17154279	1
P11362/S346C	P11362	FGFR1	FGFR1_HUMAN	S346C	-	-	-	-	CLAGNsGLSHH									VARIANT	S -> C (in HH2; also found in a family member with isolated anosmia)	16764984	1
P11362/S685F	P11362	FGFR1	FGFR1_HUMAN	S685F	603	αF	-	-	QSDVWsGVLLW	0.849	0.845	0.345	0.526	0.752	0.808	0.285	0.55	VARIANT	S -> F (in HH2)	17154279	1
P11362/S96C	P11362	FGFR1	FGFR1_HUMAN	S96C	-	-	-	-	SVPADsLYACV									VARIANT	S -> C (in HH2; unknown pathological significance)	26277103	1
P11362/V102I	P11362	FGFR1	FGFR1_HUMAN	V102I	-	-	-	-	GLYACvSSPSG									VARIANT	V -> I (in HH2; dbSNP:rs55642501)	15605412,16764984	2
P11362/V116I	P11362	FGFR1	FGFR1_HUMAN	V116I	-	-	-	-	TTYFSvVSDAL									VARIANT	V -> I (in HH2; dbSNP:rs747842199)	25077900	1
P11362/V174A	P11362	FGFR1	FGFR1_HUMAN	V174A	-	-	-	-	PAAKTvFKCPS									VARIANT	V -> A (in HH2)	25077900	1
P11362/V273M	P11362	FGFR1	FGFR1_HUMAN	V273M	-	-	-	-	ALGSNvFMCKV									VARIANT	V -> M (in HH2; dbSNP:rs1131691929)	15605412,16764984	2
P11362/V561M	P11362	FGFR1	FGFR1_HUMAN	V561M	248	β5	-	-	PLYVIvYASKG	0.729	0.319	0.425	0.226	0.254	0.239	0.606	0.771	VARIANT	V -> M	26942290	1
P11362/V607M	P11362	FGFR1	FGFR1_HUMAN	V607M	410	αE	-	-	SCAYQvRGMEY	0.61	0.547	0.574	0.558	0.301	0.396	0.623	0.427	VARIANT	V -> M (in HH2; with bimanual synkinesis; dbSNP:rs121909629)	12627230	1
P11362/V664L	P11362	FGFR1	FGFR1_HUMAN	V664L	548	A-loop	-	-	NGRLPvWMAPE	0.584	0.454	0.492	0.483	0.377	0.481	0.494	0.422	VARIANT	V -> L (in a lung large cell carcinoma sample; somatic mutation)	17344846	1
P11362/V795I	P11362	FGFR1	FGFR1_HUMAN	V795I	-	-	-	-	SGEDSvSHEPL									VARIANT	V -> I (in HH2; also found in a family member with isolated anosmia; dbSNP:rs781328162)	16882753	1
P11362/W213G	P11362	FGFR1	FGFR1_HUMAN	W213G	-	-	-	-	VRYATwIIMDS									VARIANT	W -> G (in dbSNP:rs17851623)	15489334	1
P11362/W4C	P11362	FGFR1	FGFR1_HUMAN	W4C	-	-	-	-	MWSwCLLFW									VARIANT	W -> C (in HH2; unknown pathological significance; dbSNP:rs760884357)	26277103	1
P11362/W666R	P11362	FGFR1	FGFR1_HUMAN	W666R	553	A-loop	-	-	RLPVKwAPEAL	0.872	0.864	0.329	0.594	0.766	0.8	0.286	0.46	VARIANT	W -> R (in HH2; with cleft palate; dbSNP:rs1563433902)	12627230	1
P11362/Y228D	P11362	FGFR1	FGFR1_HUMAN	Y228D	-	-	-	-	SDKGNyCIVEN									VARIANT	Y -> D (in HH2; some patients also carry KISS1R mutations; impairs the tertiary folding resulting in incomplete glycosylation and reduced cell surface expression)	19820032,23643382	2
P11362/Y339C	P11362	FGFR1	FGFR1_HUMAN	Y339C	-	-	-	-	EDAGEyCLAGN									VARIANT	Y -> C (in HH2)	16764984	1
P11362/Y374C	P11362	FGFR1	FGFR1_HUMAN	Y374C	-	-	-	increase	MTSPLyEIIIY									VARIANT	Y -> C (in OGD; elevated basal activity and increased FGF2-mediated activity; dbSNP:rs121909631)	15625620	1
P11362/Y653F	P11362	FGFR1	FGFR1_HUMAN	Y653F	511	A-loop	p	-	IHHIDyKKTTN	0.925	0.947	0.661	0.935	0.53	0.896	0.585	0.607	MUTAGEN	Y->F: No effect on kinase activity. Loss of autophosphorylation and kinase activity; when associated with F-654.	8622701	1
P11362/Y654F	P11362	FGFR1	FGFR1_HUMAN	Y654F	512	A-loop	p	decrease	HHIDYyKTTNG	0.958	0.974	0.539	0.881	0.749	0.923	0.439	0.595	MUTAGEN	Y->F: Reduced kinase activity. Loss of autophosphorylation and kinase activity; when associated with F-653.	8622701	1
P11362/Y766F	P11362	FGFR1	FGFR1_HUMAN	Y766F	823	αI	p	decrease	TSNQEyDLSMP	0.942	0.954	0.582	0.854	0.611	0.822	0.53	0.53	MUTAGEN	Y->F: Abolishes interaction with PLCG1 and SHB. Decreases phosphorylation of FRS2, activation of RAS and 		0
P11362/Y99C	P11362	FGFR1	FGFR1_HUMAN	Y99C	-	-	-	-	ADSGLyCVTSS									VARIANT	Y -> C (in HH2; impairs the tertiary folding resulting in incomplete glycosylation and reduced cell surface expression; dbSNP:rs727505373)	12627230,19820032	2
P11801/D218A	P11801	PSKH1	KPSH1_HUMAN	D218A	443	Catalytic-loop;HrD-motif	-	decrease	GITHRdKPENL	0.985	0.997	0.199	0.731	0.974	0.996	0.127	0.583	MUTAGEN	D->A: Loss of autophosphorylation.	11087665	1
P11801/N301S	P11801	PSKH1	KPSH1_HUMAN	N301S	627	αF/αG	-	-	PFEDDnTRLYR	0.527	0.516	0.517	0.467	0.347	0.432	0.594	0.33	VARIANT	N -> S (in dbSNP:rs35552721)	17344846	1
P11802/N41S	P11802	CDK4	CDK4_HUMAN	N41S	138	αC	-	-	SVRVPnGGGGG	0.31	0.341	0.538	0.26	0.231	0.267	0.645	0.228	VARIANT	N -> S (in CMM3; sporadic; dbSNP:rs144890720)	9311594	1
P11802/P173S	P11802	CDK4	CDK4_HUMAN	P173S	545	A-loop	-	decrease	QMALTpVVTLW	0.743	0.802	0.45	0.56	0.556	0.703	0.544	0.152	MUTAGEN	P->S: No effect on in vitro phosphorylation by CDK7. Greatly reduced T-172 phosphorylation and enzyme activity.	19487459	1
P11802/R122H	P11802	CDK4	CDK4_HUMAN	R122H	408	αE	-	-	IKDLMrFLRGL	0.175	0.224	0.501	0.249	0.193	0.146	0.701	0.122	VARIANT	R -> H (in dbSNP:rs34386532)	17344846	1
P11802/R24C	P11802	CDK4	CDK4_HUMAN	R24C	55	β2/β3-loop	-	activating	TVYKArPHSGH	0.735	0.754	0.711	0.796	0.3	0.579	0.729	0.274	VARIANT	R -> C (in CMM3; somatic and familial; generates a dominant oncogene resistant to inhibition by p16(INK4a); dbSNP:rs11547328)	7652577,8528263	2
P11802/R24H	P11802	CDK4	CDK4_HUMAN	R24H	55	β2/β3-loop	-	-	TVYKArPHSGH	0.559	0.602	0.62	0.59	0.334	0.469	0.623	0.213	VARIANT	R -> H (in CMM3; dbSNP:rs104894340)	9425228	1
P11802/R82Q	P11802	CDK4	CDK4_HUMAN	R82Q	213	β4/β5-loop	-	-	VCATSrDREIK	0.085	0.065	0.468	0.122	0.083	0.076	0.652	0.086	VARIANT	R -> Q (in dbSNP:rs3211612)		0
P11802/T172A	P11802	CDK4	CDK4_HUMAN	T172A	544	A-loop	p	decrease	YQMALtVVVTL	0.991	0.98	0.266	0.833	0.856	0.954	0.287	0.489	MUTAGEN	T->A: Weak enzyme activity towards RB1, but no effect on binding of CCDN1 nor CCDN3.	16782892	1
P11802/T172E	P11802	CDK4	CDK4_HUMAN	T172E	544	A-loop	p	-	YQMALtVVVTL	0.926	0.957	0.605	0.884	0.569	0.915	0.578	0.591	MUTAGEN	T->E: Retains moderate enzyme activity.	16782892	1
P12931/A237T	P12931	SRC	SRC_HUMAN	A237T	-	-	-	-	YYSKHaGLCHR									VARIANT	A -> T (in dbSNP:rs34881773)	17344846	1
P12931/E527K	P12931	SRC	SRC_HUMAN	E527K	821	αI	-	increase	YFTSTeQYQPG	0.547	0.471	0.677	0.709	0.113	0.294	0.811	0.346	VARIANT	E -> K (in THC6; increased protein tyrosine kinase activity; increased autophosphorylation at Y-419; causes defective megakaryopoiesis associated with increased overall tyrosine phosphorylation in megakaryocytes; dbSNP:rs879255268)	26936507	1
P12931/K298M	P12931	SRC	SRC_HUMAN	K298M	129	β3;Catalytic-Lys	ub	loss	TRVAIkLKPGT	1.0	1.0	0.05	0.657	0.984	0.999	0.041	0.497	MUTAGEN	K->M: Kinase inactive. Abolishes ubiquitination promoted by CBLC.	14661060	1
P12931/L176F	P12931	SRC	SRC_HUMAN	L176F	-	-	-	-	PRGTFlRESET									VARIANT	L -> F (in dbSNP:rs6018260)		0
P12931/P302E	P12931	SRC	SRC_HUMAN	P302E	133	β3/αC-loop	-	-	IKTLKpTMSPE	0.332	0.359	0.577	0.302	0.297	0.284	0.666	0.225	MUTAGEN	P->E: Kinase active. Interacts with PDLIM4; when associated with E-307 and F-419.	19307596	1
P12931/P307E	P12931	SRC	SRC_HUMAN	P307E	138	αC	-	-	PGTMSpAFLQE	0.409	0.475	0.48	0.372	0.293	0.259	0.546	0.312	MUTAGEN	P->E: Kinase active. Interacts with PDLIM4; when associated with E-302 and F-419.	19307596	1
P12931/Y419F	P12931	SRC	SRC_HUMAN	Y419F	533	A-loop	p	loss	IEDNEyARQGA	0.96	0.969	0.502	0.869	0.676	0.915	0.425	0.338	MUTAGEN	Y->F: Loss of kinase activity. Loss of interaction with PDLIM4.	19307596	1
P14616/A127E	P14616	INSRR	INSRR_HUMAN	A127E	-	-	-	-	HLRDVaPALGA									VARIANT	A -> E (in dbSNP:rs55757706)	17344846	1
P14616/A161V	P14616	INSRR	INSRR_HUMAN	A161V	-	-	-	-	GLLQPaGANHI									VARIANT	A -> V (in dbSNP:rs55971900)	17344846	1
P14616/C246R	P14616	INSRR	INSRR_HUMAN	C246R	-	-	-	-	EDPRAcACRHL									VARIANT	C -> R (in dbSNP:rs56377825)	17344846	1
P14616/E278Q	P14616	INSRR	INSRR_HUMAN	E278Q	-	-	-	-	RCVTAeCASLH									VARIANT	E -> Q (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
P14616/G1065E	P14616	INSRR	INSRR_HUMAN	G1065E	254	β5/αD-loop	-	-	ELMTRgLKSHL	0.83	0.811	0.486	0.682	0.614	0.657	0.42	0.672	VARIANT	G -> E (in a glioblastoma multiforme sample; somatic mutation)	17344846	1
P14616/P928L	P14616	INSRR	INSRR_HUMAN	P928L	-	-	-	neutral	LLTATpGLTLL									VARIANT	P -> L (in dbSNP:rs56252149)	17344846	1
P14616/R244H	P14616	INSRR	INSRR_HUMAN	R244H	-	-	-	neutral	QPEDPrCVACR									VARIANT	R -> H (in dbSNP:rs55951840)	17344846	1
P14616/R554C	P14616	INSRR	INSRR_HUMAN	R554C	-	-	-	-	ELPLSrQEPGV									VARIANT	R -> C (in dbSNP:rs56068937)	17344846	1
P15056/A246P	P15056	BRAF	BRAF_HUMAN	A246P	-	-	-	-	TFFTLaCDFCR									VARIANT	A -> P (in CFC1; dbSNP:rs180177034)	16474404,18042262,19206169	3
P15056/D594G	P15056	BRAF	BRAF_HUMAN	D594G	496	A-loop;DFG-motif	-	-	TVKIGdGLATV	0.976	0.958	0.263	0.604	0.891	0.926	0.203	0.69	VARIANT	D -> G (in NHL; dbSNP:rs121913338)	14612909	1
P15056/D638E	P15056	BRAF	BRAF_HUMAN	D638E	600	αF	-	-	YSFQSdYAFGI	0.763	0.705	0.386	0.516	0.627	0.629	0.388	0.632	VARIANT	D -> E (in CFC1; dbSNP:rs180177042)	19206169	1
P15056/E275K	P15056	BRAF	BRAF_HUMAN	E275K	-	-	-	-	QRCSTePLMCV									VARIANT	E -> K (in CFC1)	19206169	1
P15056/E501G	P15056	BRAF	BRAF_HUMAN	E501G	173	αC	-	-	QAFKNeGVLRK	0.852	0.903	0.387	0.754	0.773	0.841	0.362	0.484	VARIANT	E -> G (in CFC1; dbSNP:rs180177039)	16439621,16474404	2
P15056/E501K	P15056	BRAF	BRAF_HUMAN	E501K	173	αC	-	-	QAFKNeGVLRK	0.906	0.879	0.307	0.685	0.797	0.816	0.277	0.585	VARIANT	E -> K (in CFC1; dbSNP:rs180177038)	16439621,16474404,19206169	3
P15056/E586K	P15056	BRAF	BRAF_HUMAN	E586K	453	Catalytic-loop	-	-	NIFLHeLTVKI	0.412	0.379	0.566	0.472	0.195	0.279	0.67	0.409	VARIANT	E -> K (in ovarian cancer; dbSNP:rs121913340)	12068308	1
P15056/F468S	P15056	BRAF	BRAF_HUMAN	F468S	44	Gly-rich-loop;β1/β2-loop	-	-	IGSGSfTVYKG	0.881	0.766	0.458	0.68	0.59	0.701	0.427	0.772	VARIANT	F -> S (in CFC1; dbSNP:rs397507473)	16439621,18042262	2
P15056/F595L	P15056	BRAF	BRAF_HUMAN	F595L	497	A-loop;DFG-motif	-	-	VKIGDfLATVK	0.847	0.822	0.432	0.687	0.627	0.75	0.384	0.589	VARIANT	F -> L (in CFC1; also found in colon cancer; dbSNP:rs121913341)	12068308,16439621,18042262,19206169	4
P15056/G464E	P15056	BRAF	BRAF_HUMAN	G464E	40	β1;Gly-rich-loop	-	-	VGQRIgGSFGT	0.872	0.885	0.36	0.73	0.599	0.827	0.381	0.666	VARIANT	G -> E (in CRC; dbSNP:rs121913348)	12068308,12198537	2
P15056/G464V	P15056	BRAF	BRAF_HUMAN	G464V	40	β1;Gly-rich-loop	-	increase	VGQRIgGSFGT	0.85	0.828	0.447	0.774	0.511	0.726	0.47	0.559	VARIANT	G -> V (in a colorectal cancer cell line; elevated kinase activity; efficiently induces cell transformation; dbSNP:rs121913348)	12068308	1
P15056/G466A	P15056	BRAF	BRAF_HUMAN	G466A	42	β1;Gly-rich-loop	-	-	QRIGSgFGTVY	0.94	0.928	0.266	0.614	0.809	0.909	0.234	0.485	VARIANT	G -> A (in melanoma; dbSNP:rs121913351)	12068308	1
P15056/G466E	P15056	BRAF	BRAF_HUMAN	G466E	42	β1;Gly-rich-loop	-	-	QRIGSgFGTVY	0.906	0.931	0.412	0.738	0.857	0.904	0.383	0.435	VARIANT	G -> E (in melanoma; dbSNP:rs121913351)	12068308	1
P15056/G466V	P15056	BRAF	BRAF_HUMAN	G466V	42	β1;Gly-rich-loop	-	-	QRIGSgFGTVY	0.944	0.895	0.359	0.678	0.791	0.903	0.358	0.46	VARIANT	G -> V (in LNCR; dbSNP:rs121913351)	12068308,12460919	2
P15056/G469A	P15056	BRAF	BRAF_HUMAN	G469A	45	Gly-rich-loop;β2	-	increase	GSGSFgVYKGK	0.793	0.768	0.467	0.615	0.436	0.675	0.542	0.537	VARIANT	G -> A (in NHL; also in a lung adenocarcinoma sample; somatic mutation; elevated kinase activity; efficiently induces cell transformation; dbSNP:rs121913355)	12068308,14612909,17344846	3
P15056/G469E	P15056	BRAF	BRAF_HUMAN	G469E	45	Gly-rich-loop;β2	-	-	GSGSFgVYKGK	0.908	0.919	0.322	0.775	0.828	0.866	0.298	0.526	VARIANT	G -> E (in CFC1 and colon cancer; dbSNP:rs121913355)	12068308,16439621,16474404,18042262,19206169	5
P15056/G469R	P15056	BRAF	BRAF_HUMAN	G469R	45	Gly-rich-loop;β2	-	-	GSGSFgVYKGK	0.876	0.939	0.313	0.712	0.815	0.863	0.275	0.516	VARIANT	G -> R (in NHL; dbSNP:rs121913357)	14612909	1
P15056/G469V	P15056	BRAF	BRAF_HUMAN	G469V	45	Gly-rich-loop;β2	-	-	GSGSFgVYKGK	0.851	0.818	0.399	0.702	0.676	0.851	0.349	0.525	VARIANT	G -> V (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs121913355)	17344846	1
P15056/G596R	P15056	BRAF	BRAF_HUMAN	G596R	498	A-loop;DFG-motif	-	-	KIGDFgATVKS	0.896	0.877	0.329	0.725	0.652	0.8	0.303	0.41	VARIANT	G -> R (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs121913361)	12068308,17344846	2
P15056/G596V	P15056	BRAF	BRAF_HUMAN	G596V	498	A-loop;DFG-motif	-	-	KIGDFgATVKS	0.885	0.877	0.317	0.625	0.703	0.85	0.253	0.438	VARIANT	G -> V (in CFC1; dbSNP:rs397507483)	16439621	1
P15056/I463S	P15056	BRAF	BRAF_HUMAN	I463S	39	β1	-	-	TVGQRiSGSFG	0.877	0.837	0.265	0.572	0.782	0.814	0.225	0.758	VARIANT	I -> S (in CRC; dbSNP:rs180177033)	12198537	1
P15056/I666R	P15056	BRAF	BRAF_HUMAN	I666R	647	αG	-	decrease	NRDQIiMVGRG	0.754	0.753	0.478	0.595	0.651	0.672	0.461	0.69	MUTAGEN	I->R: No effect on MAP2K1-mediated-BRAF-KSR1 dimerization, however loss of BRAF-mediated phosphorylation of MAP2K1.	29433126	1
P15056/K483S	P15056	BRAF	BRAF_HUMAN	K483S	129	β3;Catalytic-Lys	-	decrease	GDVAVkLNVTA	0.993	0.998	0.066	0.751	0.996	0.983	0.053	0.58	MUTAGEN	K->S: Reduces kinase activity with MAP2K1.	21441910	1
P15056/K499E	P15056	BRAF	BRAF_HUMAN	K499E	171	αC	-	-	QLQAFkEVGVL	0.499	0.431	0.537	0.359	0.372	0.286	0.607	0.398	VARIANT	K -> E (in CFC1; dbSNP:rs180177037)	16439621,16474404,18042262	3
P15056/K499N	P15056	BRAF	BRAF_HUMAN	K499N	171	αC	-	-	QLQAFkEVGVL	0.628	0.51	0.505	0.478	0.34	0.468	0.573	0.244	VARIANT	K -> N (in CFC1; dbSNP:rs397507476)	18042262,19206169	2
P15056/K578R	P15056	BRAF	BRAF_HUMAN	K578R	445	Catalytic-loop	ub	loss	IHRDLkNNIFL	0.912	0.877	0.4	0.758	0.716	0.876	0.331	0.365	MUTAGEN	K->R: Blocks EGF-induced ubiquitination and ERK activation.	23907581	1
P15056/K601E	P15056	BRAF	BRAF_HUMAN	K601E	503	A-loop	ac	-	GLATVkRWSGS	0.597	0.505	0.644	0.684	0.269	0.399	0.727	0.433	VARIANT	K -> E (in CRC; dbSNP:rs121913364)	12198537	1
P15056/K601Q	P15056	BRAF	BRAF_HUMAN	K601Q	503	A-loop	ac	-	GLATVkRWSGS	0.485	0.47	0.496	0.624	0.265	0.385	0.673	0.39	VARIANT	K -> Q (in CFC1; dbSNP:rs121913364)	19206169	1
P15056/K88E	P15056	BRAF	BRAF_HUMAN	K88E	-	-	-	decrease	EEYTSkDALQQ									MUTAGEN	K->E: Reduces interaction with KSR1 and MAP2K1 and thus phosphorylation of MAP2K1.	29433126	1
P15056/L245F	P15056	BRAF	BRAF_HUMAN	L245F	-	-	-	-	KTFFTlFCDFC									VARIANT	L -> F (in CFC1; dbSNP:rs397507466)	19206169	1
P15056/L485F	P15056	BRAF	BRAF_HUMAN	L485F	131	β3	-	-	VAVKMlVTAPT	0.45	0.392	0.6	0.47	0.288	0.324	0.752	0.317	VARIANT	L -> F (in CFC1; dbSNP:rs180177036)	16439621,16474404,19206169	3
P15056/L525P	P15056	BRAF	BRAF_HUMAN	L525P	241	β4/β5-loop	-	-	STKPQlIVTQW	0.611	0.599	0.588	0.544	0.362	0.398	0.624	0.563	VARIANT	L -> P (in CFC1; dbSNP:rs869025340)	19206169	1
P15056/L597R	P15056	BRAF	BRAF_HUMAN	L597R	499	A-loop	-	-	IGDFGlTVKSR	0.816	0.844	0.411	0.697	0.563	0.736	0.401	0.586	VARIANT	L -> R (in LNCR; also found in an ovarian serous carcinoma sample; somatic mutation; dbSNP:rs121913366)	12068308,12460919,17344846	3
P15056/L597V	P15056	BRAF	BRAF_HUMAN	L597V	499	A-loop	-	increase	IGDFGlTVKSR	0.823	0.824	0.573	0.709	0.401	0.642	0.646	0.469	VARIANT	L -> V (in NS7; also in a lung adenocarcinoma sample; somatic mutation; elevated kinase activity; efficiently induces cell transformation; dbSNP:rs121913369)	12068308,17344846,19206169	3
P15056/M53D	P15056	BRAF	BRAF_HUMAN	M53D	-	-	-	decrease	WNIKQmKLTQE									MUTAGEN	M->D: Reduces interaction with KSR1 and MAP2K1 and thus phosphorylation of MAP2K1.	29433126	1
P15056/N580D	P15056	BRAF	BRAF_HUMAN	N580D	447	Catalytic-loop	-	-	RDLKSnIFLHE	0.504	0.489	0.604	0.579	0.389	0.365	0.669	0.301	VARIANT	N -> D (in CFC1)	18042262	1
P15056/N581D	P15056	BRAF	BRAF_HUMAN	N581D	448	Catalytic-loop	-	-	DLKSNnFLHED	0.93	0.913	0.4	0.729	0.774	0.857	0.412	0.554	VARIANT	N -> D (in CFC1; dbSNP:rs180177040)	16439621,16474404,18042262	3
P15056/N581S	P15056	BRAF	BRAF_HUMAN	N581S	448	Catalytic-loop	-	-	DLKSNnFLHED	0.947	0.928	0.313	0.741	0.847	0.922	0.244	0.774	VARIANT	N -> S (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs121913370)	17344846	1
P15056/P301S	P15056	BRAF	BRAF_HUMAN	P301S	-	-	-	-	EHHPIpEEASL									VARIANT	P -> S (in dbSNP:rs34776339)	17344846	1
P15056/Q257R	P15056	BRAF	BRAF_HUMAN	Q257R	-	-	-	-	RKLLFqFRCQT									VARIANT	Q -> R (in CFC1; dbSNP:rs180177035)	16439621,16474404,18042262,19206169	4
P15056/Q262K	P15056	BRAF	BRAF_HUMAN	Q262K	-	-	-	-	QGFRCqCGYKF									VARIANT	Q -> K (in CFC1; dbSNP:rs397507470)	18042262	1
P15056/Q709R	P15056	BRAF	BRAF_HUMAN	Q709R	805	αI	-	-	RPLFPqLASIE	0.593	0.535	0.51	0.538	0.284	0.441	0.631	0.377	VARIANT	Q -> R (in CFC1; dbSNP:rs397507486)	19206169	1
P15056/R462I	P15056	BRAF	BRAF_HUMAN	R462I	38	β1	-	-	ITVGQrGSGSF	0.585	0.549	0.597	0.601	0.397	0.399	0.613	0.34	VARIANT	R -> I (in CRC; dbSNP:rs180177032)	12198537	1
P15056/R509H	P15056	BRAF	BRAF_HUMAN	R509H	190	αC/β4-loop	-	loss	VLRKTrVNILL	0.415	0.411	0.529	0.372	0.445	0.322	0.604	0.164	MUTAGEN	R->H: Loss of MAP2K1-mediated-BRAF-KSR1 dimerization.	29433126	1
P15056/R671K	P15056	BRAF	BRAF_HUMAN	R671K	652	αG	-	increase	IFMVGrYLSPD	0.747	0.765	0.601	0.806	0.265	0.597	0.706	0.353	MUTAGEN	R->K: Increased kinase activity and stability in response to EGF treatment.	21917714	1
P15056/S467A	P15056	BRAF	BRAF_HUMAN	S467A	43	Gly-rich-loop;β1/β2-loop	p	-	RIGSGsGTVYK	0.689	0.707	0.542	0.671	0.383	0.548	0.582	0.285	VARIANT	S -> A (in CFC1; dbSNP:rs869025606)	16439621	1
P15056/T241M	P15056	BRAF	BRAF_HUMAN	T241M	-	-	-	-	NFVRKtFTLAF									VARIANT	T -> M (in NS7; dbSNP:rs387906660)	19206169	1
P15056/T241P	P15056	BRAF	BRAF_HUMAN	T241P	-	-	-	-	NFVRKtFTLAF									VARIANT	T -> P (in CFC1 and LPRD3; dbSNP:rs387906661)	18042262,19206169	2
P15056/T241R	P15056	BRAF	BRAF_HUMAN	T241R	-	-	-	-	NFVRKtFTLAF									VARIANT	T -> R (in NS7; dbSNP:rs387906660)	19206169	1
P15056/T244P	P15056	BRAF	BRAF_HUMAN	T244P	-	-	-	-	RKTFFtAFCDF									VARIANT	T -> P (in CFC1; dbSNP:rs397507465)	18042262	1
P15056/T599R	P15056	BRAF	BRAF_HUMAN	T599R	501	A-loop	p	-	DFGLAtKSRWS	0.777	0.813	0.537	0.691	0.484	0.698	0.611	0.28	VARIANT	T -> R (in CFC1; dbSNP:rs121913375)	19206169	1
P15056/V600D	P15056	BRAF	BRAF_HUMAN	V600D	502	A-loop	-	-	FGLATvSRWSG	0.754	0.77	0.614	0.8	0.4	0.645	0.571	0.559	VARIANT	V -> D (in a melanoma cell line; requires 2 nucleotide substitutions; dbSNP:rs121913377)	12068308	1
P15056/V600E	P15056	BRAF	BRAF_HUMAN	V600E	502	A-loop	-	activating,resistance	FGLATvSRWSG	0.652	0.672	0.579	0.741	0.299	0.454	0.644	0.491	VARIANT	V -> E (in CRC; also found in sarcoma, metastatic melanoma, ovarian serous carcinoma, pilocytic astrocytoma; somatic mutation; most common mutation; constitutive and elevated kinase activity; efficiently induces cell transformation; suppression of mutation in melanoma causes growth arrest and promotes apoptosis; loss of regulation by PMRT5; dbSNP:rs113488022)	12068308,12198537,14500344,16959974,17344846,21917714,23263490,24455489	8
P15056/W531C	P15056	BRAF	BRAF_HUMAN	W531C	250	β5/αD-loop	-	-	AIVTQwEGSSL	0.86	0.842	0.408	0.712	0.619	0.743	0.354	0.891	VARIANT	W -> C (in NS7; dbSNP:rs606231228)	19206169	1
P15735/A317T	P15735	PHKG2	PHKG2_HUMAN	A317T	849	C-term-αI	-	-	VWTVLaGRVAL	0.399	0.346	0.497	0.337	0.21	0.286	0.676	0.234	VARIANT	A -> T (in dbSNP:rs759992249)	17344846	1
P15735/D215N	P15735	PHKG2	PHKG2_HUMAN	D215N	600	αF	-	-	YGKEVdWACGV	0.833	0.859	0.329	0.671	0.704	0.752	0.298	0.534	VARIANT	D -> N (in GSD9C; dbSNP:rs767427889)	12930917	1
P15735/E157K	P15735	PHKG2	PHKG2_HUMAN	E157K	447	Catalytic-loop	-	-	RDLKPeILLDD	0.86	0.847	0.341	0.674	0.794	0.776	0.327	0.659	VARIANT	E -> K (in GSD9C; dbSNP:rs752961445)	12930917	1
P15735/E247G	P15735	PHKG2	PHKG2_HUMAN	E247G	659	αG/αH	-	-	LRMIMeQYQFS	0.381	0.412	0.542	0.43	0.275	0.284	0.678	0.283	VARIANT	E -> G (in dbSNP:rs34006569)		0
P15735/G189E	P15735	PHKG2	PHKG2_HUMAN	G189E	548	A-loop	-	-	LRELCgPGYLA	0.821	0.822	0.49	0.716	0.616	0.774	0.45	0.486	VARIANT	G -> E (in GSD9C; dbSNP:rs137853588)	8896567	1
P15735/V106E	P15735	PHKG2	PHKG2_HUMAN	V106E	247	β5	-	-	SFMFLvDLMRK	0.853	0.793	0.498	0.637	0.599	0.758	0.471	0.582	VARIANT	V -> E (in GSD9C; dbSNP:rs137853589)	8896567	1
P16066/A182V	P16066	NPR1	ANPRA_HUMAN	A182V	-	-	-	neutral	GWERQaMLYAY									VARIANT	A -> V (in dbSNP:rs56019647)	17344846	1
P16066/E967K	P16066	NPR1	ANPRA_HUMAN	E967K	-	-	-	neutral	RHRPQeLRLRI									VARIANT	E -> K (in dbSNP:rs35479618)	17344846	1
P16066/F270C	P16066	NPR1	ANPRA_HUMAN	F270C	-	-	-	-	GEDYVfHLDIF									VARIANT	F -> C (in a breast pleomorphic lobular carcinoma sample; somatic mutation)	17344846	1
P16066/R939Q	P16066	NPR1	ANPRA_HUMAN	R939Q	-	-	-	-	PVRNGrHACEV									VARIANT	R -> Q (in dbSNP:rs35240348)	17344846	1
P16066/V755M	P16066	NPR1	ANPRA_HUMAN	V755M	739	αG/αH	-	-	EIIERvRGEQP	0.297	0.228	0.535	0.334	0.131	0.141	0.662	0.189	VARIANT	V -> M (in dbSNP:rs55837780)	17344846	1
P16234/D1071N	P16234	PDGFRA	PGFRA_HUMAN	D1071N	-	-	-	-	TIEDIdMDDIG									VARIANT	D -> N (in a lung neuroendocrine carcinoma sample; somatic mutation; dbSNP:rs376544204)	17344846	1
P16234/D842V	P16234	PDGFRA	PGFRA_HUMAN	D842V	505	A-loop	-	activating,resistance	FGLARdMHDSN	0.923	0.947	0.704	0.96	0.192	0.703	0.739	0.922	VARIANT	D -> V (in a GIST sample; imatinib resistant, constitutively activated kinase; dbSNP:rs121908585)	12522257,15928335,20972453	3
P16234/D842Y	P16234	PDGFRA	PGFRA_HUMAN	D842Y	505	A-loop	-	activating	FGLARdMHDSN	0.918	0.916	0.72	0.933	0.147	0.707	0.744	0.931	VARIANT	D -> Y (in a GIST sample; imatinib sensitive, constitutively activated kinase; dbSNP:rs121913265)	15928335	1
P16234/D846Y	P16234	PDGFRA	PGFRA_HUMAN	D846Y	509	A-loop	-	-	RDIMHdNYVSK	0.865	0.692	0.598	0.685	0.465	0.614	0.612	0.824	VARIANT	D -> Y (in GISTPS; unknown pathological significance; dbSNP:rs121908588)	14699510	1
P16234/E996K	P16234	PDGFRA	PGFRA_HUMAN	E996K	-	-	-	-	VTYKNeDKLKD									VARIANT	E -> K (in a metastatic melanoma sample; somatic mutation; dbSNP:rs779173667)	17344846	1
P16234/G426D	P16234	PDGFRA	PGFRA_HUMAN	G426D	-	-	-	-	VDDHHgTGGQT									VARIANT	G -> D (in dbSNP:rs55865821)	17344846	1
P16234/G79D	P16234	PDGFRA	PGFRA_HUMAN	G79D	-	-	-	neutral	EENNSgFVTVL									VARIANT	G -> D (in dbSNP:rs36035373)	17344846	1
P16234/G829R	P16234	PDGFRA	PGFRA_HUMAN	G829R	481	Catalytic-loop	-	-	VLLAQgIVKIC	0.595	0.504	0.531	0.529	0.314	0.386	0.581	0.35	VARIANT	G -> R (in a glioblastoma multiforme sample; somatic mutation)	17344846	1
P16234/H570R	P16234	PDGFRA	PGFRA_HUMAN	H570R	5	N-term-β1	-	-	ISPDGhYIYVD	0.563	0.496	0.546	0.522	0.368	0.442	0.641	0.438	VARIANT	H -> R (in a hypereosinophilic syndrome sample; does not lead to constitutive kinase activation)	21224473	1
P16234/H650Q	P16234	PDGFRA	PGFRA_HUMAN	H650Q	188	αC/β4-loop	-	activating	LKIMThGPHLN	0.581	0.53	0.607	0.646	0.242	0.365	0.763	0.288	VARIANT	H -> Q (in a hypereosinophilic syndrome sample; constitutively activated kinase)	21224473	1
P16234/I562M	P16234	PDGFRA	PGFRA_HUMAN	I562M	-	-	-	-	IRWRViSISPD									VARIANT	I -> M (in a hypereosinophilic syndrome sample; does not lead to constitutive kinase activation)	21224473	1
P16234/L507P	P16234	PDGFRA	PGFRA_HUMAN	L507P	-	-	-	-	LAKNLlAENRE									VARIANT	L -> P (in a hypereosinophilic syndrome sample; does not lead to constitutive kinase activation)	21224473	1
P16234/L705P	P16234	PDGFRA	PGFRA_HUMAN	L705P	311	αD/αE-loop	-	-	KPKKElIFGLN	0.495	0.453	0.598	0.392	0.252	0.347	0.656	0.28	VARIANT	L -> P (in a hypereosinophilic syndrome sample; does not lead to constitutive kinase activation)	21224473	1
P16234/N659K	P16234	PDGFRA	PGFRA_HUMAN	N659K	198	αC/β4-loop	-	activating	HLNIVnLGACT	0.646	0.583	0.614	0.709	0.121	0.316	0.78	0.553	VARIANT	N -> K (in GIST sample; constitutively activated kinase; dbSNP:rs1057519700)	15928335	1
P16234/N659S	P16234	PDGFRA	PGFRA_HUMAN	N659S	198	αC/β4-loop	-	activating	HLNIVnLGACT	0.809	0.722	0.578	0.778	0.172	0.434	0.72	0.662	VARIANT	N -> S (in a hypereosinophilic syndrome sample; constitutively activated kinase)	21224473	1
P16234/P653L	P16234	PDGFRA	PGFRA_HUMAN	P653L	192	αC/β4-loop	-	-	MTHLGpLNIVN	0.66	0.59	0.538	0.514	0.451	0.482	0.57	0.607	VARIANT	P -> L (in GISTPS; unknown pathological significance)	25975287	1
P16234/R481G	P16234	PDGFRA	PGFRA_HUMAN	R481G	-	-	-	-	IHSRDrTVEGR									VARIANT	R -> G (in a hypereosinophilic syndrome sample; does not lead to constitutive kinase activation)	21224473	1
P16234/R748G	P16234	PDGFRA	PGFRA_HUMAN	R748G	355	αD/αE-loop	-	activating	VPMLErEVSKY	0.143	0.122	0.583	0.323	0.076	0.108	0.766	0.07	VARIANT	R -> G (in a hypereosinophilic syndrome sample; constitutively activated kinase)	21224473	1
P16234/R764C	P16234	PDGFRA	PGFRA_HUMAN	R764C	371	αD/αE-loop	-	-	RSLYDrASYKK	0.463	0.481	0.569	0.531	0.278	0.356	0.656	0.297	VARIANT	R -> C (in dbSNP:rs34392012)	17344846	1
P16234/S478P	P16234	PDGFRA	PGFRA_HUMAN	S478P	-	-	-	neutral	ITEIHsDRSTV									VARIANT	S -> P (in dbSNP:rs35597368)	14702039,15489334,17344846	3
P16234/V561D	P16234	PDGFRA	PGFRA_HUMAN	V561D	-	-	-	activating	EIRWRvESISP									VARIANT	V -> D (in a GIST sample; constitutively activated kinase; dbSNP:rs121908586)	12522257,15928335	2
P16234/Y555C	P16234	PDGFRA	PGFRA_HUMAN	Y555C	-	-	-	activating	KQKPRyIRWRV									VARIANT	Y -> C (in GISTPS; increased platelet-derived growth factor alpha-receptor activity; constitutively activated kinase; dbSNP:rs121908589)	17087943	1
P16234/Y572F	P16234	PDGFRA	PGFRA_HUMAN	Y572F	7	N-term-β1	p	-	PDGHEyYVDPM	0.772	0.811	0.559	0.786	0.511	0.706	0.578	0.33	MUTAGEN	Y->F: Abolishes interaction with SRC-family members and impairs internalization of the activated receptor; when associated with F-574.	10734113,14644164	2
P16234/Y574F	P16234	PDGFRA	PGFRA_HUMAN	Y574F	9	N-term-β1	p	-	GHEYIyDPMQL	0.776	0.793	0.51	0.677	0.537	0.604	0.585	0.203	MUTAGEN	Y->F: Abolishes interaction with SRC-family members and impairs internalization of the activated receptor; when associated with F-572.	10734113,14644164	2
P16234/Y720F	P16234	PDGFRA	PGFRA_HUMAN	Y720F	326	αD/αE-loop	p	-	ESTRSyILSFE	0.69	0.817	0.481	0.617	0.357	0.569	0.548	0.246	MUTAGEN	Y->F: Strongly reduced interaction with PTPN11 and GRB2.	8943348	1
P16234/Y731F	P16234	PDGFRA	PGFRA_HUMAN	Y731F	337	αD/αE-loop	p	decrease	ENNGDyDMKQA	0.861	0.858	0.535	0.727	0.542	0.636	0.556	0.302	MUTAGEN	Y->F: No effect on autophosphorylation and phosphorylation of PLCG1. Abolishes activation of phosphatidylinositol 3-kinase.	1646396	1
P16234/Y742F	P16234	PDGFRA	PGFRA_HUMAN	Y742F	348	αD/αE-loop	p	decrease	ADTTQyPMLER	0.745	0.792	0.472	0.667	0.556	0.599	0.547	0.226	MUTAGEN	Y->F: No effect on autophosphorylation and phosphorylation of PLCG1. Abolishes activation of phosphatidylinositol 3-kinase.	1646396	1
P16234/Y762F	P16234	PDGFRA	PGFRA_HUMAN	Y762F	369	αD/αE-loop	p	-	IQRSLyRPASY	0.763	0.757	0.593	0.714	0.284	0.559	0.668	0.216	MUTAGEN	Y->F: Abolishes interaction with CRK.	10733900	1
P16234/Y849C	P16234	PDGFRA	PGFRA_HUMAN	Y849C	512	A-loop	p	-	MHDSNySKGST	0.959	0.938	0.5	0.852	0.624	0.883	0.396	0.538	VARIANT	Y -> C (in GIST)	15928335	1
P16234/Y849S	P16234	PDGFRA	PGFRA_HUMAN	Y849S	512	A-loop	p	activating	MHDSNySKGST	0.953	0.925	0.587	0.851	0.378	0.905	0.552	0.678	VARIANT	Y -> S (in a hypereosinophilic syndrome sample; constitutively activated kinase)	21224473	1
P16591/A443P	P16591	FER	FER_HUMAN	A443P	-	-	-	-	ALGSSaSDMIS									VARIANT	A -> P (in dbSNP:rs34259824)	17344846	1
P16591/E404Q	P16591	FER	FER_HUMAN	E404Q	-	-	-	-	VVNYEeARSVT									VARIANT	E -> Q (in an ovarian Endometrioid carcinoma sample; somatic mutation)	17344846	1
P16591/E813Q	P16591	FER	FER_HUMAN	E813Q	810	αI	-	-	SELQKeTIIKR	0.194	0.209	0.518	0.199	0.135	0.113	0.721	0.151	VARIANT	E -> Q (in dbSNP:rs56097357)	17344846	1
P16591/I507T	P16591	FER	FER_HUMAN	I507T	-	-	-	-	RRHFIiYVDNM									VARIANT	I -> T (in dbSNP:rs34204308)		0
P16591/K591R	P16591	FER	FER_HUMAN	K591R	129	β3;Catalytic-Lys	-	loss	TSVAVkCKEDL	1.0	0.991	0.054	0.703	0.999	0.999	0.03	0.525	MUTAGEN	K->R: Abolishes kinase activity.	9722593	1
P16591/L439V	P16591	FER	FER_HUMAN	L439V	-	-	-	neutral	SPKSAlSSALS									VARIANT	L -> V (in dbSNP:rs2229086)	1651563,17344846,2725517	3
P16591/M412V	P16591	FER	FER_HUMAN	M412V	-	-	-	-	RSVTSmRKERL									VARIANT	M -> V (in dbSNP:rs33940843)	17344846	1
P16591/R483Q	P16591	FER	FER_HUMAN	R483Q	-	-	-	loss	GDFLVrSHGKP									MUTAGEN	R->Q: Abolishes kinase activity. Abolishes location at microtubules.	12972546	1
P16591/V128F	P16591	FER	FER_HUMAN	V128F	-	-	-	-	AEMIKvKTELE									VARIANT	V -> F (in dbSNP:rs35150210)	17344846	1
P16591/W460C	P16591	FER	FER_HUMAN	W460C	-	-	-	-	LAEQDwHGAIP									VARIANT	W -> C (in a lung small cell carcinoma sample; somatic mutation)	17344846	1
P17252/D467N	P17252	PRKCA	KPCA_HUMAN	D467N	447	Catalytic-loop	-	-	RDLKLdVMLDS	0.671	0.646	0.338	0.455	0.605	0.618	0.395	0.431	VARIANT	D -> N (in a glioblastoma multiforme sample; somatic mutation)	17344846	1
P17252/M489V	P17252	PRKCA	KPCA_HUMAN	M489V	509	A-loop	-	-	MCKEHmDGVTT	0.518	0.419	0.591	0.433	0.252	0.337	0.624	0.46	VARIANT	M -> V (in dbSNP:rs34406842)	17344846	1
P17252/P98S	P17252	PRKCA	KPCA_HUMAN	P98S	-	-	-	-	PDTDDpSKHKF									VARIANT	P -> S (in a colorectal adenocarcinoma sample; somatic mutation)	17344846	1
P17252/V568I	P17252	PRKCA	KPCA_HUMAN	V568I	788	αH	-	neutral	KEAVSvKGLMT	0.11	0.08	0.49	0.137	0.082	0.094	0.667	0.128	VARIANT	V -> I (in dbSNP:rs6504459)	15489334,19054851,2336401	3
P17612/G137R	P17612	PRKACA	KAPCA_HUMAN	G137R	386	αD/αE-loop	-	-	HLRRIgFSEPH	0.544	0.601	0.442	0.447	0.514	0.501	0.491	0.46	VARIANT	G -> R (in CAFD1; decreased interaction with regulatory subunit PRKAR2B)	33058759	1
P17612/G201A	P17612	PRKACA	KAPCA_HUMAN	G201A	548	A-loop	-	loss	TWTLCgPEYLA	0.835	0.832	0.404	0.73	0.719	0.792	0.29	0.578	MUTAGEN	G->A: No phosphorylation.	12372837	1
P17612/K48R	P17612	PRKACA	KAPCA_HUMAN	K48R	37	β1	-	-	QFERIkLGTGS	0.474	0.428	0.49	0.422	0.256	0.281	0.648	0.317	MUTAGEN	K->R: Enhanced basal kinase activity; when associated with Q-96, L-121, A-124, K-182 and A-184.	21774789	1
P17612/L206R	P17612	PRKACA	KAPCA_HUMAN	L206R	554	A-loop	-	activating	GTPEYlPEIIL	0.841	0.732	0.561	0.765	0.321	0.644	0.638	0.636	VARIANT	L -> R (in PPNAD4; somatic mutation; the mutation results in cAMP-independent basal protein kinase activity and constitutive activation of protein kinase A; dbSNP:rs386352352)	24571724,24700472,24747643,24855271	4
P17612/L41V	P17612	PRKACA	KAPCA_HUMAN	L41V	30	β1	-	-	QNTAHlQFERI	0.156	0.187	0.435	0.204	0.157	0.179	0.617	0.146	VARIANT	L -> V (in dbSNP:rs56029020)	17344846	1
P17612/L96Q	P17612	PRKACA	KAPCA_HUMAN	L96Q	178	αC/β4-loop	-	-	NEKRIlAVNFP	0.915	0.897	0.407	0.68	0.721	0.803	0.298	0.732	MUTAGEN	L->Q: Enhanced basal kinase activity; when associated with R-48, L-121, A-124, K-182 and A-184.	21774789	1
P17612/M121L	P17612	PRKACA	KAPCA_HUMAN	M121L	248	β5	-	-	NLYMVmYVPGG	0.702	0.497	0.493	0.406	0.358	0.345	0.561	0.644	MUTAGEN	M->L: Enhanced basal kinase activity; when associated with R-48, Q-96, A-124, K-182 and A-184.	21774789	1
P17612/Q182K	P17612	PRKACA	KAPCA_HUMAN	Q182K	493	Catalytic-loop	-	-	QQGYIqTDFGF	0.287	0.3	0.479	0.326	0.241	0.201	0.677	0.226	MUTAGEN	Q->K: Enhanced basal kinase activity; when associated with R-48, Q-96, L-121, A-124 and A-184.	21774789	1
P17612/R195A	P17612	PRKACA	KAPCA_HUMAN	R195A	513	A-loop	-	decrease	KRVKGrWTLCG	0.751	0.752	0.397	0.628	0.659	0.721	0.364	0.243	MUTAGEN	R->A: No phosphorylation.	12372837	1
P17612/R46Q	P17612	PRKACA	KAPCA_HUMAN	R46Q	35	β1	-	neutral	LDQFErKTLGT	0.137	0.159	0.466	0.198	0.14	0.132	0.634	0.099	VARIANT	R -> Q (in dbSNP:rs56085217)	17344846	1
P17612/S264C	P17612	PRKACA	KAPCA_HUMAN	S264C	782	αH	-	-	PSHFSsLKDLL	0.562	0.56	0.525	0.5	0.387	0.456	0.528	0.5	VARIANT	S -> C (in dbSNP:rs35635531)	17344846	1
P17612/T184A	P17612	PRKACA	KAPCA_HUMAN	T184A	495	Catalytic-loop	-	-	GYIQVtFGFAK	0.543	0.474	0.407	0.548	0.389	0.407	0.541	0.295	MUTAGEN	T->A: Enhanced basal kinase activity; when associated with R-48, Q-96, L-121, A-124 and K-182.	21774789	1
P17612/T202A	P17612	PRKACA	KAPCA_HUMAN	T202A	549	A-loop	p	loss	WTLCGtEYLAP	0.926	0.92	0.249	0.779	0.873	0.918	0.185	0.436	MUTAGEN	T->A: No phosphorylation.	12372837	1
P17612/V124A	P17612	PRKACA	KAPCA_HUMAN	V124A	252	β5/αD-loop	-	-	MVMEYvGGEMF	0.696	0.615	0.427	0.531	0.501	0.576	0.427	0.512	MUTAGEN	V->A: Enhanced basal kinase activity; when associated with R-48, Q-96, L-121, K-182 and A-184.	21774789	1
P17612/Y205A	P17612	PRKACA	KAPCA_HUMAN	Y205A	553	A-loop	-	decrease	CGTPEyAPEII	0.962	0.905	0.315	0.582	0.835	0.872	0.219	0.695	MUTAGEN	Y->A: Loss of allosteric regulation.	18178622	1
P17948/E144K	P17948	FLT1	VGFR1_HUMAN	E144K	-	-	-	-	YSEIPeIHMTE									VARIANT	E -> K (in dbSNP:rs55974987)	17344846	1
P17948/E982A	P17948	FLT1	VGFR1_HUMAN	E982A	385	αD/αE-loop	-	neutral	LSDVEeEDSDG	0.159	0.12	0.567	0.26	0.146	0.119	0.73	0.237	VARIANT	E -> A (in dbSNP:rs35832528)	17344846	1
P17948/I128L	P17948	FLT1	VGFR1_HUMAN	I128L	-	-	-	-	AIYIFiDTGRP									VARIANT	I -> L (in dbSNP:rs35073261)		0
P17948/K60T	P17948	FLT1	VGFR1_HUMAN	K60T	-	-	-	-	GEAAHkSLPEM									VARIANT	K -> T (in dbSNP:rs56409818)	17344846	1
P17948/K861M	P17948	FLT1	VGFR1_HUMAN	K861M	129	β3;Catalytic-Lys	-	loss	RTVAVkLKEGA	0.999	1.0	0.03	0.61	1.0	0.999	0.015	0.614	MUTAGEN	K->M: Abolishes enzyme activity. Abolishes interaction with PLCG.	9299537	1
P17948/L1061V	P17948	FLT1	VGFR1_HUMAN	L1061V	541	A-loop	-	-	KGDTRlLKWMA	0.716	0.675	0.473	0.541	0.571	0.613	0.464	0.477	VARIANT	L -> V (in a bladder transitional cell carcinoma sample; somatic mutation)	17344846	1
P17948/L422I	P17948	FLT1	VGFR1_HUMAN	L422I	-	-	-	-	NLTATlVNVKP									VARIANT	L -> I (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
P17948/M938V	P17948	FLT1	VGFR1_HUMAN	M938V	308	αD/αE-loop	-	neutral	DAALHmPKKEK	0.066	0.074	0.426	0.08	0.093	0.084	0.68	0.054	VARIANT	M -> V (in dbSNP:rs35549791)	17344846	1
P17948/N1050D	P17948	FLT1	VGFR1_HUMAN	N1050D	509	A-loop	-	increase	RDIYKnDYVRK	0.477	0.496	0.621	0.575	0.158	0.251	0.683	0.41	MUTAGEN	N->D: Strongly increases kinase activity. Increases activity in promoting proliferation of endothelial cells.	16286478	1
P17948/R281Q	P17948	FLT1	VGFR1_HUMAN	R281Q	-	-	-	-	ASVRRrDQSNS									VARIANT	R -> Q (in dbSNP:rs55687105)	17344846	1
P17948/R781Q	P17948	FLT1	VGFR1_HUMAN	R781Q	-	-	-	-	LTLFIrMKRSS									VARIANT	R -> Q (in a glioma low grade oligodendroglioma sample; somatic mutation; dbSNP:rs553261958)	17344846	1
P17948/V767A	P17948	FLT1	VGFR1_HUMAN	V767A	-	-	-	-	LTCTCvATLFW									MUTAGEN	V->A: Abolishes proteolytic cleavage by PSEN1.	22016384	1
P17948/Y1169F	P17948	FLT1	VGFR1_HUMAN	Y1169F	826	C-term-αI	p	-	QDGKDyPINAI	0.828	0.902	0.582	0.814	0.454	0.738	0.557	0.386	MUTAGEN	Y->F: Loss of phosphorylation site. Abolishes interaction with PLCG.	9299537	1
P17948/Y1213F	P17948	FLT1	VGFR1_HUMAN	Y1213F	-	-	p	-	SDDVRyNAFKF									MUTAGEN	Y->F: Loss of phosphorylation site. Abolishes interaction with PIK3R1.	9722576	1
P17948/Y1242F	P17948	FLT1	VGFR1_HUMAN	Y1242F	-	-	p	loss	SMFDDyGDSST									MUTAGEN	Y->F: Loss of phosphorylation site.	9722576	1
P17948/Y1327F	P17948	FLT1	VGFR1_HUMAN	Y1327F	-	-	p	loss	SPPPDySVVLY									MUTAGEN	Y->F: Loss of phosphorylation site.	9722576	1
P17948/Y1333F	P17948	FLT1	VGFR1_HUMAN	Y1333F	-	-	p	-	NSVVLyTPPI									MUTAGEN	Y->F: Loss of phosphorylation site. Abolishes interaction with CBL.	15001553,9722576	2
P17948/Y914F	P17948	FLT1	VGFR1_HUMAN	Y914F	253	β5/αD-loop	-	decrease	VEYCKyNLSNY	0.567	0.494	0.46	0.254	0.497	0.526	0.559	0.2	MUTAGEN	Y->F: Reduces phosphorylation at other tyrosine residues.	9722576	1
P19525/A109S	P19525	EIF2AK2	E2AK2_HUMAN	A109S	-	-	-	-	LINRIaKKRLT									VARIANT	A -> S (in LEUDEN; unknown pathological significance)	32197074	1
P19525/A109V	P19525	EIF2AK2	E2AK2_HUMAN	A109V	-	-	-	-	LINRIaKKRLT									VARIANT	A -> V (in LEUDEN; unknown pathological significance)	32197074	1
P19525/A67E	P19525	EIF2AK2	E2AK2_HUMAN	A67E	-	-	-	loss	EAKNAaKLAVE									MUTAGEN	A->E: Significant loss of activity; loss of dsRNA binding and dimerization.	11337501	1
P19525/G130R	P19525	EIF2AK2	E2AK2_HUMAN	G130R	-	-	-	increase	VHGPEgHYKCK									VARIANT	G -> R (in DYT33; gain-of-function variant resulting in increased levels of phosphorylated EIF2AK2 and EIF2A in patient cells compared to controls)	33236446,33866603,35146068	3
P19525/G138A	P19525	EIF2AK2	E2AK2_HUMAN	G138A	-	-	-	-	YKCKMgKEYSI									VARIANT	G -> A (in DYT33; unknown pathological significance)	33236446	1
P19525/G325S	P19525	EIF2AK2	E2AK2_HUMAN	G325S	824	C-term-αI	-	-	IVHYNgWDGFD	0.457	0.449	0.488	0.383	0.322	0.382	0.542	0.305	VARIANT	G -> S (in LEUDEN; unknown pathological significance)	32197074	1
P19525/I506V	P19525	EIF2AK2	E2AK2_HUMAN	I506V	684	αG/αH	-	-	GIISDiDKKEK	0.115	0.122	0.392	0.093	0.099	0.16	0.617	0.086	VARIANT	I -> V (in dbSNP:rs34821155)	17344846	1
P19525/K296R	P19525	EIF2AK2	E2AK2_HUMAN	K296R	129	β3;Catalytic-Lys	-	loss	KTYVIkVKYNN	1.0	1.0	0.036	0.776	0.982	0.998	0.008	0.523	MUTAGEN	K->R: Loss of activity.	11152499	1
P19525/K60A	P19525	EIF2AK2	E2AK2_HUMAN	K60A	-	-	-	-	GEGRSkEAKNA									MUTAGEN	K->A: Impairs dsRNA binding but not dimerization or activity.	11337501	1
P19525/L114Q	P19525	EIF2AK2	E2AK2_HUMAN	L114Q	-	-	-	-	AQKKRlVNYEQ									VARIANT	L -> Q (found in a patient with dysmorphic facies, syndactyly, congenital microcephaly and global developmental delay; unknown pathological significance)	32197074	1
P19525/L439V	P19525	EIF2AK2	E2AK2_HUMAN	L439V	509	A-loop	-	-	GLVTSlNDGKR	0.563	0.549	0.509	0.472	0.339	0.343	0.584	0.455	VARIANT	L -> V (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
P19525/M11L	P19525	EIF2AK2	E2AK2_HUMAN	M11L	-	-	-	decrease	SAGFFmELNTY									VARIANT	M -> L (in LEUDEN; unknown pathological significance; reduced phosphorylation of eukaryotic translation initiation factor 2-alpha in patient cells)	32197074	1
P19525/N32S	P19525	EIF2AK2	E2AK2_HUMAN	N32S	-	-	-	-	YQELPnGPPHD									VARIANT	N -> S (in LEUDEN; unknown pathological significance)	32197074	1
P19525/N32T	P19525	EIF2AK2	E2AK2_HUMAN	N32T	-	-	-	increase	YQELPnGPPHD									VARIANT	N -> T (in DYT33; unknown pathological significance; gain-of-function variant resulting in increased levels of phosphorylated EIF2AK2 and EIF2A in patient cells compared to controls)	33236446	1
P19525/S242A	P19525	EIF2AK2	E2AK2_HUMAN	S242A	8	N-term-β1	p	-	RKAKRsAPRFD	0.713	0.76	0.406	0.603	0.616	0.701	0.402	0.273	MUTAGEN	S->A: Moderate loss of activity; when associated with A-255 and A-258.	11152499	1
P19525/S461C	P19525	EIF2AK2	E2AK2_HUMAN	S461C	588	αF	-	decrease	SPEQIsQDYGK	0.362	0.359	0.448	0.293	0.416	0.305	0.529	0.132	VARIANT	S -> C (in LEUDEN; unknown pathological significance; reduced phosphorylation of eukaryotic translation initiation factor 2-alpha in patient cells)	32197074	1
P19525/S83A	P19525	EIF2AK2	E2AK2_HUMAN	S83A	-	-	p	-	EKKAVsLLLTT									MUTAGEN	S->A: No effect on enzymatic activity; when associated with A-88; A-89 and A-90.	11152499	1
P19525/S97F	P19525	EIF2AK2	E2AK2_HUMAN	S97F	-	-	p	-	SSEGLsGNYIG									VARIANT	S -> F (in LEUDEN; unknown pathological significance)	32197074	1
P19525/T255A	P19525	EIF2AK2	E2AK2_HUMAN	T255A	21	N-term-β1	p	-	PDMKEtYTVDK	0.675	0.673	0.437	0.604	0.369	0.605	0.522	0.128	MUTAGEN	T->A: Moderate loss of activity; when associated with A-242 and A-255.	11152499	1
P19525/T258A	P19525	EIF2AK2	E2AK2_HUMAN	T258A	24	N-term-β1	p	decrease	KETKYtDKRFG	0.76	0.785	0.442	0.654	0.574	0.658	0.495	0.167	MUTAGEN	T->A: Moderate loss of activity.	11152499	1
P19525/T446A	P19525	EIF2AK2	E2AK2_HUMAN	T446A	544	A-loop	p	decrease	NDGKRtSKGTL	0.926	0.932	0.414	0.801	0.755	0.921	0.423	0.363	MUTAGEN	T->A: Significant loss of activity and impairs autophosphorylation of T-451.	11337501	1
P19525/T451A	P19525	EIF2AK2	E2AK2_HUMAN	T451A	549	A-loop	p	loss	TRSKGtRYMSP	0.947	0.932	0.245	0.788	0.914	0.888	0.179	0.481	MUTAGEN	T->A: Loss of activity.	11337501	1
P19525/T88A	P19525	EIF2AK2	E2AK2_HUMAN	T88A	-	-	p	-	SPLLLtTNSSE									MUTAGEN	T->A: No effect on enzymatic activity; when associated with A-83; A-89 and A-90.	11152499	1
P19525/T89A	P19525	EIF2AK2	E2AK2_HUMAN	T89A	-	-	p	-	PLLLTtNSSEG									MUTAGEN	T->A: No effect on enzymatic activity; when associated with A-83; A-88 and A-90.	11152499	1
P19525/T90A	P19525	EIF2AK2	E2AK2_HUMAN	T90A	-	-	p	-	LLLTTtSSEGL									MUTAGEN	T->A: No effect on enzymatic activity; when associated with A-83; A-88 and A-89.	11152499	1
P19525/V428E	P19525	EIF2AK2	E2AK2_HUMAN	V428E	492	Catalytic-loop	-	-	VDTKQvIGDFG	0.857	0.796	0.457	0.609	0.685	0.712	0.419	0.533	VARIANT	V -> E (in dbSNP:rs56219559)	17344846	1
P19525/Y133F	P19525	EIF2AK2	E2AK2_HUMAN	Y133F	-	-	-	decrease	PEGFHyCKMGQ									VARIANT	Y -> F (in LEUDEN; unknown pathological significance; reduced phosphorylation of eukaryotic translation initiation factor 2-alpha in patient cells)	32197074	1
P19784/E188A	P19784	CSNK2A2	CSK22_HUMAN	E188A	523	A-loop	-	-	YHPAQeNVRVA	0.624	0.602	0.506	0.573	0.404	0.526	0.552	0.404	VARIANT	E -> A (in dbSNP:rs55911801)	17344846	1
P20594/A409T	P20594	NPR2	ANPRB_HUMAN	A409T	-	-	-	-	DFQPAaYSGAE									VARIANT	A -> T (in AMD1)	15146390	1
P20594/A488P	P20594	NPR2	ANPRB_HUMAN	A488P	-	-	-	-	LEKELaMLWRI									VARIANT	A -> P (in ECDM; mutant and wild-type alleles have similar expression levels; the mutation results in increased guanylate cyclase activity; dbSNP:rs587777597)	24259409	1
P20594/D176E	P20594	NPR2	ANPRB_HUMAN	D176E	-	-	-	-	LDARTdRPHYF									VARIANT	D -> E (in AMD1; dbSNP:rs28929479)	15146390	1
P20594/G413E	P20594	NPR2	ANPRB_HUMAN	G413E	-	-	-	decrease	AAHYSgEKQIW									VARIANT	G -> E (in AMD1; markedly deficient activity)	15146390	1
P20594/G959A	P20594	NPR2	ANPRB_HUMAN	G959A	-	-	-	-	LRLRIgHTGPV									VARIANT	G -> A (in AMD1; no effect on subcellular location; changed glycosylation; no effect on C-type natriuretic peptide binding; decreased guanylate cyclase activity)	15146390,26980729	2
P20594/L658F	P20594	NPR2	ANPRB_HUMAN	L658F	492	Catalytic-loop	-	decrease	DSRFVlITDYG	0.548	0.549	0.473	0.465	0.47	0.46	0.615	0.383	VARIANT	L -> F (in AMD1; no effect on subcellular location; changed glycosylation; no effect on C-type natriuretic peptide binding; decreased guanylate cyclase activity; loss of natriuretic peptide receptor activity; dominant negative effect; dbSNP:rs1314542724)	17652215,26980729	2
P20594/M232I	P20594	NPR2	ANPRB_HUMAN	M232I	-	-	-	-	CGPLEmHEILL									VARIANT	M -> I (in dbSNP:rs55747238)	17344846	1
P20594/N24D	P20594	NPR2	ANPRB_HUMAN	N24D	-	-	-	-	PPGARnTLAVV									MUTAGEN	N->D,Q: Decreased glycosylation. Decreased guanylate cyclase activity.	26980729	1
P20594/N24Q	P20594	NPR2	ANPRB_HUMAN	N24Q	-	-	-	-	PPGARnTLAVV									MUTAGEN	N->D,Q: Decreased glycosylation. Decreased guanylate cyclase activity.	26980729	1
P20594/P32T	P20594	NPR2	ANPRB_HUMAN	P32T	-	-	-	-	LAVVLpHNLSY									VARIANT	P -> T (in AMD1; dbSNP:rs28931581)	15146390	1
P20594/Q417E	P20594	NPR2	ANPRB_HUMAN	Q417E	-	-	-	loss	SGAEKqWWTGR									VARIANT	Q -> E (in SNSK; loss of C-type natriuretic peptide-induced signaling; dominant negative effect; no effect on cell surface expression; dbSNP:rs796065356)	24471569	1
P20594/Q771E	P20594	NPR2	ANPRB_HUMAN	Q771E	795	αH/αI	-	-	ERCWAqPAERP	0.121	0.109	0.547	0.175	0.105	0.138	0.754	0.08	VARIANT	Q -> E (in dbSNP:rs5816)		0
P20594/R110C	P20594	NPR2	ANPRB_HUMAN	R110C	-	-	-	loss	AASVArASHWR									VARIANT	R -> C (in SNSK; loss of C-type natriuretic peptide-induced signaling; dominant negative effect; retained in the endoplasmic reticulum; dbSNP:rs758478717)	24471569	1
P20594/R263P	P20594	NPR2	ANPRB_HUMAN	R263P	-	-	-	loss	FGESLrGPTRA									VARIANT	R -> P (in SNSK; loss of C-type natriuretic peptide-induced signaling; dominant negative effect; loss of localization to the plasma membrane; dbSNP:rs139036657)	24001744	1
P20594/R655C	P20594	NPR2	ANPRB_HUMAN	R655C	481	Catalytic-loop	-	-	CVVDSrVLKIT	0.765	0.682	0.477	0.596	0.545	0.632	0.467	0.362	VARIANT	R -> C (in ECDM; the mutation results in increased guanylate cyclase activity; dbSNP:rs587777596)	24057292	1
P20594/R776W	P20594	NPR2	ANPRB_HUMAN	R776W	800	αI	-	-	QDPAErDFGQI	0.856	0.829	0.474	0.686	0.661	0.745	0.445	0.413	VARIANT	R -> W (in AMD1; no effect on subcellular location; changed glycosylation; no effect on C-type natriuretic peptide binding; decreased guanylate cyclase activity; dbSNP:rs1303913631)	15146390,26980729	2
P20594/R819C	P20594	NPR2	ANPRB_HUMAN	R819C	-	-	-	decrease	KLVEErQAYLE									VARIANT	R -> C (in SNSK; loss of C-type natriuretic peptide-induced signaling; dominant negative effect; no effect on cell surface expression; dbSNP:rs766256429)	24001744	1
P20594/R957C	P20594	NPR2	ANPRB_HUMAN	R957C	-	-	-	-	DQLRLrGVHTG									VARIANT	R -> C (in AMD1; dbSNP:rs370158184)	15146390	1
P20594/S76P	P20594	NPR2	ANPRB_HUMAN	S76P	-	-	-	loss	LEGACsYLAPL									VARIANT	S -> P (in SNSK; loss of C-type natriuretic peptide-induced signaling; dominant negative effect; loss of localization to the plasma membrane; dbSNP:rs796065355)	24001744	1
P20594/T297M	P20594	NPR2	ANPRB_HUMAN	T297M	-	-	-	decrease	TVLVItREPPN									VARIANT	T -> M (in AMD1; markedly deficient activity; dbSNP:rs1313765432)	15146390	1
P20594/V187I	P20594	NPR2	ANPRB_HUMAN	V187I	-	-	-	-	FTIEGvEALQG									VARIANT	V -> I (does not affect C-type natriuretic peptide-induced signaling; dbSNP:rs768423636)	24471569	1
P20594/V882I	P20594	NPR2	ANPRB_HUMAN	V882I	-	-	-	-	STPMQvTLLND									VARIANT	V -> I (in dbSNP:rs55700371)	17344846	1
P20594/V882M	P20594	NPR2	ANPRB_HUMAN	V882M	-	-	-	-	STPMQvTLLND									VARIANT	V -> M (in ECDM; the mutation results in higher guanylate cyclase activity; causes a 15-fold increase in basal Vmax; has higher affinity for GTP than wild-type in the presence of NPPC; might lead to a structural change that locks the enzyme in a conformation mimicking the ATP-bound state)	22870295,23827346	2
P20594/W115G	P20594	NPR2	ANPRB_HUMAN	W115G	-	-	-	decrease	RFASHwLPLLT									VARIANT	W -> G (in AMD1; markedly deficient activity; dbSNP:rs28931582)	15146390	1
P20594/Y338C	P20594	NPR2	ANPRB_HUMAN	Y338C	-	-	-	-	IAGCFyGILLY									VARIANT	Y -> C (in AMD1; dbSNP:rs1828087195)	15146390	1
P20594/Y708C	P20594	NPR2	ANPRB_HUMAN	Y708C	602	αF	-	-	QKADVyFGIIL	0.673	0.673	0.554	0.582	0.391	0.534	0.582	0.284	VARIANT	Y -> C (in AMD1; no effect on subcellular location; changed glycosylation; no effect on C-type natriuretic peptide binding; decreased guanylate cyclase activity; dbSNP:rs1305337032)	15146390,26980729	2
P20794/D329E	P20794	MAK	MAK_HUMAN	D329E	-	-	-	-	LPDIIdVVGQP									VARIANT	D -> E (in dbSNP:rs17579447)		0
P20794/F550L	P20794	MAK	MAK_HUMAN	F550L	-	-	-	-	GYIPSfKKEVQ									VARIANT	F -> L (in dbSNP:rs56217305)	17344846	1
P20794/G13S	P20794	MAK	MAK_HUMAN	G13S	42	β1;Gly-rich-loop	-	loss	RQLGDgYGSVL	0.924	0.929	0.248	0.629	0.905	0.913	0.213	0.488	VARIANT	G -> S (in RP62; results in a complete loss of kinase activity compared to wild-type; dbSNP:rs387906647)	21835304	1
P20794/G27R	P20794	MAK	MAK_HUMAN	G27R	72	β2/β3-loop	-	-	KSNESgLVAIK	0.832	0.81	0.459	0.624	0.589	0.703	0.45	0.692	VARIANT	G -> R (in RP62; dbSNP:rs754916169)	21835304	1
P20794/I181T	P20794	MAK	MAK_HUMAN	I181T	598	αF	-	-	VYSSPiVWAVG	0.733	0.73	0.48	0.607	0.579	0.614	0.483	0.611	VARIANT	I -> T (in RP62; dbSNP:rs750559316)	21835304	1
P20794/I189V	P20794	MAK	MAK_HUMAN	I189V	607	αF	-	-	WAVGSiAELYM	0.431	0.422	0.486	0.331	0.345	0.341	0.609	0.326	VARIANT	I -> V (in dbSNP:rs56215624)	17344846	1
P20794/K33R	P20794	MAK	MAK_HUMAN	K33R	129	β3;Catalytic-Lys	-	loss	ELVAIkMKRKF	1.0	0.979	0.087	0.789	0.947	0.984	0.089	0.491	MUTAGEN	K->R: Abolishes autophosphorylation.	12084720	1
P20794/N130H	P20794	MAK	MAK_HUMAN	N130H	448	Catalytic-loop	-	loss	DMKPEnLCMGP	0.962	0.922	0.228	0.758	0.904	0.889	0.166	0.578	VARIANT	N -> H (in RP62; results in a complete loss of kinase activity compared to wild-type; dbSNP:rs387906646)	21835304	1
P20794/N384S	P20794	MAK	MAK_HUMAN	N384S	-	-	-	-	MPTKPnTLSHK									VARIANT	N -> S (in dbSNP:rs55773478)	17344846	1
P20794/P325L	P20794	MAK	MAK_HUMAN	P325L	-	-	-	-	EPKPLpIIDQV									VARIANT	P -> L (in dbSNP:rs371971492)	21835304	1
P20794/P520S	P20794	MAK	MAK_HUMAN	P520S	-	-	-	neutral	PKSLGpGAELA									VARIANT	P -> S (in dbSNP:rs567083)	17344846	1
P20794/R166H	P20794	MAK	MAK_HUMAN	R166H	554	A-loop	-	-	STRWYrPEVLL	0.831	0.84	0.347	0.638	0.568	0.706	0.344	0.585	VARIANT	R -> H (in RP62; dbSNP:rs387906648)	21835304	1
P20794/R272P	P20794	MAK	MAK_HUMAN	R272P	802	αI	-	-	WDPKKrTASQA	0.871	0.83	0.402	0.684	0.703	0.788	0.325	0.46	VARIANT	R -> P (in a breast infiltrating ductal carcinoma sample; somatic mutation)	17344846	1
P20794/T157A	P20794	MAK	MAK_HUMAN	T157A	544	A-loop	p	loss	SQPPYtYVSTR	0.984	0.987	0.334	0.876	0.884	0.977	0.288	0.554	MUTAGEN	T->A: Abolishes autophosphorylation and impairs kinase activity.	21986944	1
P20794/Y159F	P20794	MAK	MAK_HUMAN	Y159F	546	A-loop	p	loss	PPYTDySTRWY	0.996	0.983	0.268	0.851	0.949	0.967	0.19	0.552	MUTAGEN	Y->F: Abolishes autophosphorylation and impairs kinase activity.	21986944	1
P21127/A670V	P21127	CDK11B	CD11B_HUMAN	A670V	687	αG/αH	-	-	YSELPaKKMTF	0.157	0.181	0.471	0.247	0.152	0.116	0.649	0.175	VARIANT	A -> V (in dbSNP:rs1059811)	17344846	1
P21127/G506S	P21127	CDK11B	CD11B_HUMAN	G506S	211	β4/β5-loop	-	-	REIVVgNMDKI	0.527	0.52	0.473	0.359	0.367	0.417	0.535	0.357	VARIANT	G -> S	17344846	1
P21127/I463V	P21127	CDK11B	CD11B_HUMAN	I463V	80	β2/β3-loop	-	-	KKTDEiALKRL	0.371	0.407	0.427	0.278	0.373	0.269	0.509	0.192	VARIANT	I -> V	17344846	1
P21127/K641N	P21127	CDK11B	CD11B_HUMAN	K641N	629	αF/αG	-	-	PLFPGkEIDQI	0.487	0.387	0.5	0.404	0.293	0.349	0.545	0.263	VARIANT	K -> N (in dbSNP:rs1059815)	17344846	1
P21127/L601Q	P21127	CDK11B	CD11B_HUMAN	L601Q	551	A-loop	-	-	PVVVTlYRAPE	0.706	0.582	0.635	0.598	0.308	0.484	0.661	0.441	VARIANT	L -> Q (in dbSNP:rs200190129)	1639388,17344846	2
P21127/R109C	P21127	CDK11B	CD11B_HUMAN	R109C	-	-	-	-	KRKEKrHRSHS									VARIANT	R -> C (in dbSNP:rs1059830)		0
P21127/R201W	P21127	CDK11B	CD11B_HUMAN	R201W	-	-	-	-	RRAEErKEREA									VARIANT	R -> W (in dbSNP:rs1557687207)	17344846	1
P21127/R57C	P21127	CDK11B	CD11B_HUMAN	R57C	-	-	-	-	ELRDHrEITIR									VARIANT	R -> C (in dbSNP:rs752740049)	17344846,8195233	2
P21127/R93W	P21127	CDK11B	CD11B_HUMAN	R93W	-	-	-	-	PQQMSrEKAHH									VARIANT	R -> W (in dbSNP:rs1059831)		0
P21127/S414L	P21127	CDK11B	CD11B_HUMAN	S414L	6	N-term-β1	p	-	DSPALsIELKQ	0.768	0.784	0.528	0.753	0.5	0.644	0.541	0.366	VARIANT	S -> L (in dbSNP:rs1241694892)	17344846	1
P21127/V452A	P21127	CDK11B	CD11B_HUMAN	V452A	48	β2	-	-	GTYGVvRAKDK	0.881	0.839	0.399	0.665	0.719	0.767	0.34	0.745	VARIANT	V -> A	17344846	1
P21675/A297G	P21675	TAF1	TAF1_HUMAN	A297G	-	-	-	neutral	WNYDYaPPPPE									VARIANT	A -> G (in dbSNP:rs35317750)	17344846	1
P21675/C305A	P21675	TAF1	TAF1_HUMAN	C305A	-	-	-	-	PPPEQcSDDEI									MUTAGEN	C->A: Reduces kinase activity; when associated with A-307; A-308; A-309 and A-310.	9660973	1
P21675/C786R	P21675	TAF1	TAF1_HUMAN	C786R	-	-	-	-	VVGQQcLFEVP									VARIANT	C -> R (in MRXS33; dbSNP:rs864321628)	26637982	1
P21675/D145A	P21675	TAF1	TAF1_HUMAN	D145A	-	-	-	-	DEDDYdDCEDI									MUTAGEN	D->A: Reduces kinase activity; when associated with A-147; A-149; A-150; A-152 and A-154.	9660973	1
P21675/D147A	P21675	TAF1	TAF1_HUMAN	D147A	-	-	-	-	DDYDAdEDIDC									MUTAGEN	D->A: Reduces kinase activity; when associated with A-145; A-149; A-150; A-152 and A-154.	9660973	1
P21675/D150A	P21675	TAF1	TAF1_HUMAN	D150A	-	-	-	-	DADCEdDCKLM									MUTAGEN	D->A: Reduces kinase activity; when associated with A-145; A-147; A-149; A-152 and A-154.	9660973	1
P21675/D152A	P21675	TAF1	TAF1_HUMAN	D152A	-	-	-	-	DCEDIdKLMPP									MUTAGEN	D->A: Reduces kinase activity; when associated with A-145; A-147; A-149; A-150 and A-154.	9660973	1
P21675/D308A	P21675	TAF1	TAF1_HUMAN	D308A	-	-	-	-	EQCLSdEITMM									MUTAGEN	D->A: Reduces kinase activity; when associated with A-305; A-307; A-309 and A-310.	9660973	1
P21675/D309A	P21675	TAF1	TAF1_HUMAN	D309A	-	-	-	-	QCLSDdITMMA									MUTAGEN	D->A: Reduces kinase activity; when associated with A-305; A-307; A-308 and A-310.	9660973	1
P21675/D955H	P21675	TAF1	TAF1_HUMAN	D955H	-	-	-	-	VTGVAdTGCGE									VARIANT	D -> H (in MRXS33; dbSNP:rs864321631)	26637982	1
P21675/E149A	P21675	TAF1	TAF1_HUMAN	E149A	-	-	-	-	YDADCeIDCKL									MUTAGEN	E->A: Reduces kinase activity; when associated with A-145; A-147; A-150; A-152 and A-154.	9660973	1
P21675/E310A	P21675	TAF1	TAF1_HUMAN	E310A	-	-	-	-	CLSDDeTMMAP									MUTAGEN	E->A: Reduces kinase activity; when associated with A-305; A-307; A-308 and A-309.	9660973	1
P21675/E651K	P21675	TAF1	TAF1_HUMAN	E651K	-	-	-	-	KAKMReERQAS									VARIANT	E -> K (in a metastatic melanoma sample; somatic mutation)	17344846	1
P21675/E721Q	P21675	TAF1	TAF1_HUMAN	E721Q	-	-	-	decrease	DCKYGeVYCHT									MUTAGEN	E->Q: 25% decrease in histone acetylation.	15870300	1
P21675/G453D	P21675	TAF1	TAF1_HUMAN	G453D	-	-	-	-	YNVQQgAATLD									VARIANT	G -> D (in a colorectal adenocarcinoma sample; somatic mutation)	17344846	1
P21675/I1316T	P21675	TAF1	TAF1_HUMAN	I1316T	-	-	-	-	DNEELiVEGTK									VARIANT	I -> T (in MRXS33; dbSNP:rs864321627)	26637982	1
P21675/K154A	P21675	TAF1	TAF1_HUMAN	K154A	-	-	-	-	EDIDCkMPPPP									MUTAGEN	K->A: Reduces kinase activity; when associated with A-145; A-147; A-149; A-150 and A-152.	9660973	1
P21675/L269V	P21675	TAF1	TAF1_HUMAN	L269V	-	-	-	neutral	KKHRElQEEQI									VARIANT	L -> V (in dbSNP:rs28382158)	17344846	1
P21675/M691I	P21675	TAF1	TAF1_HUMAN	M691I	-	-	-	-	ENGPLmQVGMA									VARIANT	M -> I (in a lung bronchoalveolar carcinoma sample; somatic mutation)	17344846	1
P21675/N1496H	P21675	TAF1	TAF1_HUMAN	N1496H	-	-	-	-	LEKAInLLDDD									VARIANT	N -> H (in MRXS33; unknown pathological significance)	26637982	1
P21675/N472D	P21675	TAF1	TAF1_HUMAN	N472D	-	-	-	-	IFPIDnDLVYG									VARIANT	N -> D (found in a patient with X-linked intellectual disability; unknown pathological significance; dbSNP:rs200177996)	25644381	1
P21675/P575S	P21675	TAF1	TAF1_HUMAN	P575S	-	-	-	-	DEYYYpQQGLR									VARIANT	P -> S (in MRXS33; dbSNP:rs864321630)	26637982	1
P21675/R1169C	P21675	TAF1	TAF1_HUMAN	R1169C	-	-	-	-	CLKIYrFRDEE									VARIANT	R -> C (found in a patient with X-linked intellectual disability; unknown pathological significance; dbSNP:rs1569301036)	25644381	1
P21675/R1225W	P21675	TAF1	TAF1_HUMAN	R1225W	-	-	-	-	MRKERrIQEQL									VARIANT	R -> W (in MRXS33; dbSNP:rs864321629)	26637982	1
P21675/R1431H	P21675	TAF1	TAF1_HUMAN	R1431H	-	-	-	-	DLQTLrNVRKR									VARIANT	R -> H (in MRXS33; unknown pathological significance)	26637982	1
P21675/S137A	P21675	TAF1	TAF1_HUMAN	S137A	-	-	-	-	QPLCHsYDEDD									MUTAGEN	S->A: No decrease in kinase activity.	9660973	1
P21675/S307A	P21675	TAF1	TAF1_HUMAN	S307A	-	-	p	-	PEQCLsDEITM									MUTAGEN	S->A: Reduces kinase activity; when associated with A-305; A-308; A-309 and A-310.	9660973	1
P21675/V1383I	P21675	TAF1	TAF1_HUMAN	V1383I	-	-	-	-	RTDPMvLSSIL									VARIANT	V -> I (in dbSNP:rs7050748)		0
P21709/A585T	P21709	EPHA1	EPHA1_HUMAN	A585T	-	-	-	-	RQRDRaDVDRE									VARIANT	A -> T (in dbSNP:rs34178823)	17344846	1
P21709/E703K	P21709	EPHA1	EPHA1_HUMAN	E703K	249	β5	-	-	IMIITeMENGA	0.776	0.697	0.511	0.642	0.423	0.553	0.557	0.428	VARIANT	E -> K (in a breast pleomorphic lobular carcinoma sample; somatic mutation)	17344846	1
P21709/M900V	P21709	EPHA1	EPHA1_HUMAN	M900V	830	C-term-αI	-	-	NFDPRmLRLPS	0.13	0.143	0.386	0.142	0.194	0.187	0.59	0.064	VARIANT	M -> V (in dbSNP:rs6967117)	10369740,12690205,15489334,17344846,2825356,19369195	6
P21709/P697L	P21709	EPHA1	EPHA1_HUMAN	P697L	240	β4/β5-loop	-	neutral	VTKRKpMIITE	0.359	0.371	0.493	0.322	0.249	0.318	0.502	0.462	VARIANT	P -> L (in dbSNP:rs34372369)	17344846	1
P21709/R351C	P21709	EPHA1	EPHA1_HUMAN	R351C	-	-	-	-	TQLSLrEPPAD									VARIANT	R -> C (in dbSNP:rs56006153)	17344846	1
P21709/R492Q	P21709	EPHA1	EPHA1_HUMAN	R492Q	-	-	-	neutral	NQDEErQMVLE									VARIANT	R -> Q (in dbSNP:rs11768549)	17344846	1
P21709/R575Q	P21709	EPHA1	EPHA1_HUMAN	R575Q	-	-	-	-	SRRAQrRQQRQ									VARIANT	R -> Q (in dbSNP:rs35719334)	17344846	1
P21709/S807R	P21709	EPHA1	EPHA1_HUMAN	S807R	599	αF	-	-	IFTTAsVWSFG	0.723	0.686	0.599	0.577	0.442	0.536	0.61	0.425	VARIANT	S -> R (in dbSNP:rs56244405)	17344846	1
P21709/V160A	P21709	EPHA1	EPHA1_HUMAN	V160A	-	-	-	neutral	TIRDLvGSVKL									VARIANT	V -> A (in dbSNP:rs4725617)	10369740,12690205,15489334,17344846,2825356	5
P21802/A172F	P21802	FGFR2	FGFR2_HUMAN	A172F	-	-	-	-	HAVPAaTVKFR									VARIANT	A -> F (in PS; requires 2 nucleotide substitutions)	11781872	1
P21802/A314S	P21802	FGFR2	FGFR2_HUMAN	A314S	-	-	-	-	LKVLKaGVNTT									VARIANT	A -> S (in craniosynostosis; dbSNP:rs1358919643)	9521581	1
P21802/A315S	P21802	FGFR2	FGFR2_HUMAN	A315S	-	-	-	-	KVLKAaVNTTD									VARIANT	A -> S (in a non-syndromic craniosynostosis patient with abnormal intrauterine history; confers predisposition to craniosynostosis; dbSNP:rs121918504)	10951518,11781872	2
P21802/A337P	P21802	FGFR2	FGFR2_HUMAN	A337P	-	-	-	-	VTFEDaEYTCL									VARIANT	A -> P (in CS; dbSNP:rs387906676)	9677057	1
P21802/A344G	P21802	FGFR2	FGFR2_HUMAN	A344G	-	-	-	-	EYTCLaNSIGI									VARIANT	A -> G (in CS and JWS; dbSNP:rs121918492)	7581378,7874170	2
P21802/A344P	P21802	FGFR2	FGFR2_HUMAN	A344P	-	-	-	-	EYTCLaNSIGI									VARIANT	A -> P (in CS and PS)	8644708	1
P21802/A362S	P21802	FGFR2	FGFR2_HUMAN	A362S	-	-	-	-	LTVLPaGREKE									VARIANT	A -> S (in CS)	10574673	1
P21802/A628T	P21802	FGFR2	FGFR2_HUMAN	A628T	445	Catalytic-loop	-	decrease	IHRDLaRNVLV	0.887	0.845	0.422	0.668	0.741	0.835	0.382	0.436	VARIANT	A -> T (in LADD1; strongly reduced kinase activity; dbSNP:rs121918509)	16501574	1
P21802/A648T	P21802	FGFR2	FGFR2_HUMAN	A648T	500	A-loop	-	-	ADFGLaDINNI	0.629	0.557	0.534	0.516	0.317	0.483	0.631	0.464	VARIANT	A -> T (in LADD1; dbSNP:rs121918508)	16501574	1
P21802/C278F	P21802	FGFR2	FGFR2_HUMAN	C278F	-	-	-	activating	DVEFVcVYSDA									VARIANT	C -> F (in CS, JWS and PS; forms disulfide-linked dimers with constitutive kinase activity, is retained in an intracellular compartment and not detected at the cell surface; dbSNP:rs776587763)	11173845,11781872,16844695,8644708,9677057	5
P21802/C278Y	P21802	FGFR2	FGFR2_HUMAN	C278Y	-	-	-	-	DVEFVcVYSDA									VARIANT	C -> Y (in CS; dbSNP:rs776587763)	11173845	1
P21802/C342F	P21802	FGFR2	FGFR2_HUMAN	C342F	-	-	-	-	AGEYTcAGNSI									VARIANT	C -> F (in CS; dbSNP:rs121918487)	11781872,8644708,9677057	3
P21802/C342G	P21802	FGFR2	FGFR2_HUMAN	C342G	-	-	-	-	AGEYTcAGNSI									VARIANT	C -> G (in PS; dbSNP:rs121918488)	10394936	1
P21802/C342R	P21802	FGFR2	FGFR2_HUMAN	C342R	-	-	-	-	AGEYTcAGNSI									VARIANT	C -> R (in CS, JWS, PS and ABS2; dbSNP:rs121918488)	10633130,11173845,11380921,11781872,7719345,7987400,8528214,8644708,9677057	9
P21802/C342S	P21802	FGFR2	FGFR2_HUMAN	C342S	-	-	-	-	AGEYTcAGNSI									VARIANT	C -> S (in CS, JWS, PS and ABS2; dbSNP:rs121918488)	10633130,11173845,11781872,7581378,7987400,8644708,9385368	7
P21802/C342W	P21802	FGFR2	FGFR2_HUMAN	C342W	-	-	-	-	AGEYTcAGNSI									VARIANT	C -> W (in CS; dbSNP:rs121918496)	11173845,11781872,8528214	3
P21802/C342Y	P21802	FGFR2	FGFR2_HUMAN	C342Y	-	-	-	activating	AGEYTcAGNSI									VARIANT	C -> Y (in CS and PS; dbSNP:rs121918487)	11173845,11380921,11781872,7581378,7719345,7987400,8644708,9677057	8
P21802/D283N	P21802	FGFR2	FGFR2_HUMAN	D283N	-	-	-	-	CKVYSdQPHIQ									VARIANT	D -> N (in a lung squamous cell carcinoma sample; somatic mutation)	17344846	1
P21802/D321A	P21802	FGFR2	FGFR2_HUMAN	D321A	-	-	-	-	GVNTTdEIEVL									VARIANT	D -> A (in PS; dbSNP:rs121918510)	7719333	1
P21802/E565A	P21802	FGFR2	FGFR2_HUMAN	E565A	249	β5	-	activating,resistance	LYVIVeASKGN	0.898	0.811	0.356	0.674	0.627	0.801	0.348	0.739	MUTAGEN	E->A: Constitutive kinase activity.	17803937	1
P21802/E565G	P21802	FGFR2	FGFR2_HUMAN	E565G	249	β5	-	activating	LYVIVeASKGN	0.874	0.879	0.568	0.791	0.426	0.718	0.569	0.645	VARIANT	E -> G (in PS; constitutive kinase activity; dbSNP:rs121918506)	11781872,17803937	2
P21802/F276V	P21802	FGFR2	FGFR2_HUMAN	F276V	-	-	-	-	GGDVEfCKVYS									VARIANT	F -> V (in CS; dbSNP:rs1057519036)	11173845,11781872,9521581	3
P21802/G272V	P21802	FGFR2	FGFR2_HUMAN	G272V	-	-	-	-	STVVGgVEFVC									VARIANT	G -> V (in an ovarian serous carcinoma sample; somatic mutation)	17344846	1
P21802/G338E	P21802	FGFR2	FGFR2_HUMAN	G338E	-	-	-	-	TFEDAgYTCLA									VARIANT	G -> E (in CS; dbSNP:rs1057519044)	8946174	1
P21802/G338R	P21802	FGFR2	FGFR2_HUMAN	G338R	-	-	-	-	TFEDAgYTCLA									VARIANT	G -> R (in CS; dbSNP:rs1057519043)	11781872,7581378,9677057	3
P21802/G384R	P21802	FGFR2	FGFR2_HUMAN	G384R	-	-	-	-	AIYCIgFLIAC									VARIANT	G -> R (in CS; dbSNP:rs1554927408)	8946174	1
P21802/G613R	P21802	FGFR2	FGFR2_HUMAN	G613R	413	αE	-	-	YQLARgEYLAS	0.864	0.857	0.417	0.613	0.704	0.769	0.371	0.491	VARIANT	G -> R	10626794,1309608	2
P21802/G663E	P21802	FGFR2	FGFR2_HUMAN	G663E	539	A-loop	-	-	KKTTNgLPVKW	0.605	0.524	0.644	0.629	0.276	0.382	0.671	0.239	VARIANT	G -> E (in PS)	11781872	1
P21802/I288S	P21802	FGFR2	FGFR2_HUMAN	I288S	-	-	-	-	DAQPHiWIKHV									VARIANT	I -> S (in CS)	11173845	1
P21802/K292E	P21802	FGFR2	FGFR2_HUMAN	K292E	-	-	-	-	HIQWIkVEKNG									VARIANT	K -> E (in CS; dbSNP:rs121918500)	9152842	1
P21802/K526E	P21802	FGFR2	FGFR2_HUMAN	K526E	138	αC	-	activating	DDATEkLSDLV	0.529	0.447	0.633	0.575	0.214	0.279	0.753	0.237	VARIANT	K -> E (in FSPC; constitutive kinase activity; dbSNP:rs121918507)	16061565,17803937	2
P21802/K641R	P21802	FGFR2	FGFR2_HUMAN	K641R	493	Catalytic-loop	-	activating,resistance	ENNVMkADFGL	0.792	0.719	0.496	0.745	0.421	0.576	0.65	0.486	VARIANT	K -> R (in PS; constitutive kinase activity; dbSNP:rs1057519047)	11781872,17803937	2
P21802/K659N	P21802	FGFR2	FGFR2_HUMAN	K659N	532	A-loop	-	activating	IDYYKkTNGRL	0.905	0.835	0.735	0.904	0.196	0.57	0.776	0.482	VARIANT	K -> N (in craniosynostosis; constitutive kinase activity; dbSNP:rs1589722765)	11781872,17803937	2
P21802/M186T	P21802	FGFR2	FGFR2_HUMAN	M186T	-	-	-	neutral	AGGNPmTMRWL									VARIANT	M -> T (in dbSNP:rs755793)	11781872,17344846	2
P21802/M391R	P21802	FGFR2	FGFR2_HUMAN	M391R	-	-	-	decrease	FLIACmVTVIL									VARIANT	M -> R (in BBDS1; the mutation selectively reduces plasma-membrane levels of the protein and markedly diminishes the receptor's responsiveness to extracellular FGF; dbSNP:rs387906677)	22387015	1
P21802/N265Q	P21802	FGFR2	FGFR2_HUMAN	N265Q	-	-	-	-	AGLPAnSTVVG									MUTAGEN	N->Q: Reduced N-glycosylation. Reduced expression at the cell surface.	16844695	1
P21802/N331I	P21802	FGFR2	FGFR2_HUMAN	N331I	-	-	-	-	VLYIRnTFEDA									VARIANT	N -> I (in CS)	8956050	1
P21802/N549H	P21802	FGFR2	FGFR2_HUMAN	N549H	198	αC/β4-loop	-	activating,resistance	HKNIInLGACT	0.647	0.6	0.556	0.61	0.177	0.384	0.678	0.564	VARIANT	N -> H (in CS; constitutive kinase activity; dbSNP:rs1057519045)	11781872,17803937	2
P21802/N549T	P21802	FGFR2	FGFR2_HUMAN	N549T	198	αC/β4-loop	-	activating,resistance	HKNIInLGACT	0.719	0.682	0.568	0.586	0.317	0.558	0.614	0.803	MUTAGEN	N->T: Constitutive kinase activity.	17803937	1
P21802/P253R	P21802	FGFR2	FGFR2_HUMAN	P253R	-	-	-	-	VVERSpRPILQ									VARIANT	P -> R (in APRS; common mutation; dbSNP:rs77543610)	11781872,7668257,7719344,9452027,9677057	5
P21802/P263L	P21802	FGFR2	FGFR2_HUMAN	P263L	-	-	-	-	LQAGLpNASTV									VARIANT	P -> L (in CS; dbSNP:rs779326224)	11173845	1
P21802/Q289P	P21802	FGFR2	FGFR2_HUMAN	Q289P	-	-	-	-	AQPHIqIKHVE									VARIANT	Q -> P (in CS and JWS; dbSNP:rs121918497)	11173845,11380921,11781872,7581378,8644708	5
P21802/R203C	P21802	FGFR2	FGFR2_HUMAN	R203C	-	-	-	-	FKQEHrGGYKV									VARIANT	R -> C (in breast cancer samples; infiltrating ductal carcinoma; somatic mutation)	16959974,17344846	2
P21802/R612T	P21802	FGFR2	FGFR2_HUMAN	R612T	412	αE	-	-	TYQLArMEYLA	0.614	0.58	0.438	0.421	0.531	0.541	0.464	0.417	VARIANT	R -> T (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
P21802/R678G	P21802	FGFR2	FGFR2_HUMAN	R678G	572	αF	-	-	EALFDrYTHQS	0.445	0.332	0.708	0.517	0.156	0.236	0.787	0.274	VARIANT	R -> G (in CS; dbSNP:rs1845559552)	11781872	1
P21802/R6P	P21802	FGFR2	FGFR2_HUMAN	R6P	-	-	-	-	MVSWGrICLVV									VARIANT	R -> P (in dbSNP:rs3750819)		0
P21802/S252F	P21802	FGFR2	FGFR2_HUMAN	S252F	-	-	-	-	DVVERsHRPIL									VARIANT	S -> F (in APRS; requires 2 nucleotide substitutions; dbSNP:rs121918498)	9002682	1
P21802/S252L	P21802	FGFR2	FGFR2_HUMAN	S252L	-	-	-	-	DVVERsHRPIL									VARIANT	S -> L (in dbSNP:rs79184941)	9002682	1
P21802/S252W	P21802	FGFR2	FGFR2_HUMAN	S252W	-	-	-	-	DVVERsHRPIL									VARIANT	S -> W (in APRS and PS; common mutation; dbSNP:rs79184941)	11781872,15190072,7668257,7719344,9452027,9677057,9719378	7
P21802/S267P	P21802	FGFR2	FGFR2_HUMAN	S267P	-	-	-	-	LPANAsVVGGD									VARIANT	S -> P (in CS; dbSNP:rs121918505)	11781872	1
P21802/S347C	P21802	FGFR2	FGFR2_HUMAN	S347C	-	-	-	-	CLAGNsGISFH									VARIANT	S -> C (in CS; dbSNP:rs121918494)	11781872,7874170	2
P21802/S351C	P21802	FGFR2	FGFR2_HUMAN	S351C	-	-	-	-	NSIGIsHSAWL									VARIANT	S -> C (in CS, PS and ABS2; dbSNP:rs121918502)	10633130,8946174,9693549	3
P21802/S354C	P21802	FGFR2	FGFR2_HUMAN	S354C	-	-	-	-	GISFHsWLTVL									VARIANT	S -> C (in CS; dbSNP:rs121918490)	11173845,11781872,7581378,7987400,8528214	5
P21802/S354Y	P21802	FGFR2	FGFR2_HUMAN	S354Y	-	-	-	-	GISFHsWLTVL									VARIANT	S -> Y (in CS)	11173845	1
P21802/S372C	P21802	FGFR2	FGFR2_HUMAN	S372C	-	-	-	-	KEITAsDYLEI									VARIANT	S -> C (in BSTVS; dbSNP:rs121913477)	8696350	1
P21802/S57L	P21802	FGFR2	FGFR2_HUMAN	S57L	-	-	-	neutral	AAPGEsEVRCL									VARIANT	S -> L (in dbSNP:rs56226109)	17344846,26429889	2
P21802/T341P	P21802	FGFR2	FGFR2_HUMAN	T341P	-	-	-	-	DAGEYtLAGNS									VARIANT	T -> P (in PS and CS; dbSNP:rs121918495)	11173845,11781872,7719345	3
P21802/V359F	P21802	FGFR2	FGFR2_HUMAN	V359F	-	-	-	-	SAWLTvPAPGR									VARIANT	V -> F (in CS and PS)	11173845,8644708	2
P21802/W290C	P21802	FGFR2	FGFR2_HUMAN	W290C	-	-	-	-	QPHIQwKHVEK									VARIANT	W -> C (in PS; severe; also in a lung squamous cell carcinoma sample; somatic mutation; dbSNP:rs121918499)	11781872,17344846,9150725	3
P21802/W290G	P21802	FGFR2	FGFR2_HUMAN	W290G	-	-	-	-	QPHIQwKHVEK									VARIANT	W -> G (in CS; dbSNP:rs121918501)	8528214	1
P21802/W290R	P21802	FGFR2	FGFR2_HUMAN	W290R	-	-	-	-	QPHIQwKHVEK									VARIANT	W -> R (in CS; dbSNP:rs121918501)		0
P21802/Y105C	P21802	FGFR2	FGFR2_HUMAN	Y105C	-	-	-	-	RDSGLyCTASR									VARIANT	Y -> C (in CS; dbSNP:rs1434545235)	11781872,8946174	2
P21802/Y281C	P21802	FGFR2	FGFR2_HUMAN	Y281C	-	-	-	-	FVCKVyDAQPH									VARIANT	Y -> C (in CS; dbSNP:rs1057519038)	11380921,11781872	2
P21802/Y301C	P21802	FGFR2	FGFR2_HUMAN	Y301C	-	-	-	-	KNGSKyPDGLP									VARIANT	Y -> C (in CS; dbSNP:rs1554930684)	9521581	1
P21802/Y328C	P21802	FGFR2	FGFR2_HUMAN	Y328C	-	-	-	-	EIEVLyRNVTF									VARIANT	Y -> C (in CS; dbSNP:rs121918493)	7874170	1
P21802/Y340C	P21802	FGFR2	FGFR2_HUMAN	Y340C	-	-	-	-	EDAGEyCLAGN									VARIANT	Y -> C (in PS; dbSNP:rs1554928884)	10394936,11781872	2
P21802/Y340H	P21802	FGFR2	FGFR2_HUMAN	Y340H	-	-	-	-	EDAGEyCLAGN									VARIANT	Y -> H (in CS; dbSNP:rs121918489)	11781872,7987400	2
P21802/Y375C	P21802	FGFR2	FGFR2_HUMAN	Y375C	-	-	-	-	TASPDyEIAIY									VARIANT	Y -> C (in PS and BSTVS; dbSNP:rs121913478)	11781872,12000365,8696350	3
P21802/Y381D	P21802	FGFR2	FGFR2_HUMAN	Y381D	-	-	-	-	LEIAIyIGVFL									VARIANT	Y -> D (in BBDS1; dbSNP:rs387906678)	22387015	1
P21802/Y769F	P21802	FGFR2	FGFR2_HUMAN	Y769F	823	αI	p	decrease	TTNEEyDLSQP	0.935	0.944	0.582	0.865	0.574	0.834	0.564	0.517	MUTAGEN	Y->F: Increases fibroblast proliferation. Decreases phosphorylation of PLCG1 and FRS2. Decreases activation of 		0
P21860/A1337T	P21860	ERBB3	ERBB3_HUMAN	A1337T	-	-	-	increase	RLFPKaAQRT									VARIANT	A -> T (in FERLK; risk factor for erythroleukemia; results in increased ERBB-mediated signaling; results in a block of erythroid differentiation and increased cell proliferation; dbSNP:rs755855285)	27416908	1
P21860/G1271S	P21860	ERBB3	ERBB3_HUMAN	G1271S	-	-	-	-	QRDGGgGGDYA									VARIANT	G -> S (in dbSNP:rs11171743)		0
P21860/I744T	P21860	ERBB3	ERBB3_HUMAN	I744T	131	β3	-	-	VCIKViDKSGR	0.757	0.712	0.463	0.565	0.484	0.684	0.449	0.675	VARIANT	I -> T (in dbSNP:rs55787439)	17344846	1
P21860/K742M	P21860	ERBB3	ERBB3_HUMAN	K742M	129	β3;Catalytic-Lys	-	decrease	IPVCIkIEDKS	1.0	1.0	0.018	0.618	0.999	0.999	0.003	0.591	MUTAGEN	K->M: Strongly reduced autophosphorylation.	20351256	1
P21860/K998R	P21860	ERBB3	ERBB3_HUMAN	K998R	-	-	-	-	HGLTNkLEEVE									VARIANT	K -> R (in dbSNP:rs56259600)	17344846	1
P21860/L1177I	P21860	ERBB3	ERBB3_HUMAN	L1177I	-	-	-	-	SREGTlSVGLS									VARIANT	L -> I (in dbSNP:rs55699040)	17344846	1
P21860/N385S	P21860	ERBB3	ERBB3_HUMAN	N385S	-	-	-	-	DPEKLnFRTVR									VARIANT	N -> S (in dbSNP:rs12320176)		0
P21860/P30L	P21860	ERBB3	ERBB3_HUMAN	P30L	-	-	-	-	SQAVCpTLNGL									VARIANT	P -> L (in dbSNP:rs56017157)	17344846	1
P21860/Q932R	P21860	ERBB3	ERBB3_HUMAN	Q932R	756	αG/αH	-	decrease	GERLAqQICTI	0.686	0.659	0.532	0.53	0.399	0.54	0.646	0.316	VARIANT	Q -> R (in VSCN1; unknown pathological significance; some decrease in ERBB2 phosphorylation upon NG1 treatment, compared to wild-type; does not affect the subcellular localization at the cell membrane)	33497358	1
P21860/R1127H	P21860	ERBB3	ERBB3_HUMAN	R1127H	-	-	-	-	RSPRPrDSAYH									VARIANT	R -> H (in dbSNP:rs2271188)	17344846	1
P21860/R683W	P21860	ERBB3	ERBB3_HUMAN	R683W	3	N-term-β1	-	-	RRYLErESIEP	0.674	0.6	0.56	0.582	0.389	0.474	0.584	0.46	VARIANT	R -> W (in dbSNP:rs56387488)	17344846	1
P21860/S1119C	P21860	ERBB3	ERBB3_HUMAN	S1119C	-	-	-	neutral	MCRSRsSRSPR									VARIANT	S -> C (in dbSNP:rs773123)	17344846	1
P21860/S20Y	P21860	ERBB3	ERBB3_HUMAN	S20Y	-	-	-	-	SLARGsVGNSQ									VARIANT	S -> Y (in dbSNP:rs34379766)	17344846	1
P21860/S717L	P21860	ERBB3	ERBB3_HUMAN	S717L	41	β1;Gly-rich-loop	p	-	LKVLGsVFGTV	0.847	0.887	0.631	0.711	0.49	0.757	0.607	0.638	VARIANT	S -> L (in dbSNP:rs35961836)	17344846	1
P21860/T1254K	P21860	ERBB3	ERBB3_HUMAN	T1254K	-	-	-	-	MPTAGtPDEDY									VARIANT	T -> K (in dbSNP:rs55709407)	17344846	1
P21860/T204I	P21860	ERBB3	ERBB3_HUMAN	T204I	-	-	-	-	SEDCQtTKTIC									VARIANT	T -> I (in dbSNP:rs56107455)	17344846	1
P21860/T787P	P21860	ERBB3	ERBB3_HUMAN	T787P	248	β5	-	loss	SLQLVtYLPLG	0.867	0.845	0.413	0.668	0.721	0.751	0.374	0.795	VARIANT	T -> P (in VSCN1; almost complete loss of ERBB2 and ERBB3 phosphorylation in the presence or in the absence of NRG1 stimulation, suggesting alteration of downstream signaling; does not affect the subcellular localization at the cell membrane)	33497358	1
P21860/T873S	P21860	ERBB3	ERBB3_HUMAN	T873S	541	A-loop	-	decrease	YSEAKtIKWMA	0.407	0.448	0.493	0.26	0.473	0.443	0.559	0.145	VARIANT	T -> S (in VSCN1; unknown pathological significance; some decrease in ERBB2 phosphorylation upon NG1 treatment, compared to wild-type; does not affect the subcellular localization at the cell membrane)	33497358	1
P21860/V104M	P21860	ERBB3	ERBB3_HUMAN	V104M	-	-	-	-	LPNLRvRGTQV									VARIANT	V -> M (in an ovarian mucinous carcinoma sample; somatic mutation; dbSNP:rs1057519893)	17344846	1
P21860/V899M	P21860	ERBB3	ERBB3_HUMAN	V899M	606	αF	-	loss	VWSYGvVWELM	0.538	0.509	0.506	0.47	0.567	0.349	0.536	0.297	VARIANT	V -> M (in VSCN1; almost complete loss of ERBB2 and ERBB3 phosphorylation in the presence or in the absence of NRG1 stimulation, suggesting alteration of downstream signaling; does not affect the subcellular localization at the cell membrane)	33497358	1
P21860/Y868E	P21860	ERBB3	ERBB3_HUMAN	Y868E	533	A-loop	-	decrease	DKQLLyEAKTP	0.732	0.78	0.585	0.597	0.593	0.703	0.449	0.424	MUTAGEN	Y->E: Strongly reduced tyrosine phosphorylation.	20351256	1
P22455/D516N	P22455	FGFR4	FGFR4_HUMAN	D516N	169	αC	-	-	DKDLAdVSEME	0.6	0.592	0.481	0.534	0.302	0.4	0.597	0.44	VARIANT	D -> N (in dbSNP:rs34158682)	17344846	1
P22455/G388R	P22455	FGFR4	FGFR4_HUMAN	G388R	-	-	-	increase	LLLLAgYRGQA									VARIANT	G -> R (in cancer cells, may be associated with accelerated disease progression and increased tumor cell motility, possibly due to increased stability of the protease MMP14; leads to phosphorylation at residue Y-390, resulting in prolonged FGFR4 activity; increases interaction with STAT3, resulting in STAT3 phosphorylation and signaling activation.; dbSNP:rs351855)	18670643,18756523,20876804,21349172,21882254,26675719	6
P22455/G426S	P22455	FGFR4	FGFR4_HUMAN	G426S	-	-	-	-	ESGSSgSSSSL									VARIANT	G -> S (in dbSNP:rs55879131)	17344846	1
P22455/K503R	P22455	FGFR4	FGFR4_HUMAN	K503R	129	β3;Catalytic-Lys	-	loss	STVAVkLKDNA	1.0	1.0	0.044	0.685	0.995	0.995	0.014	0.519	MUTAGEN	K->R: Loss of kinase activity.	11433297,17311277	2
P22455/P136L	P22455	FGFR4	FGFR4_HUMAN	P136L	-	-	-	neutral	KSHRDpNRHSY									VARIANT	P -> L (in dbSNP:rs376618)	10631118,17344846,21882254	3
P22455/P712T	P22455	FGFR4	FGFR4_HUMAN	P712T	758	αG/αH	-	-	RMDRPpCPPEL	0.383	0.355	0.468	0.39	0.366	0.325	0.545	0.364	VARIANT	P -> T (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
P22455/R529Q	P22455	FGFR4	FGFR4_HUMAN	R529Q	192	αC/β4-loop	-	-	MKLIGrKNIIN	0.242	0.192	0.479	0.15	0.166	0.159	0.631	0.113	VARIANT	R -> Q (in dbSNP:rs34284947)		0
P22455/S772N	P22455	FGFR4	FGFR4_HUMAN	S772N	-	-	-	-	SGGDAsTCSSS									VARIANT	S -> N (in a lung neuroendocrine carcinoma sample; somatic mutation)	17344846	1
P22455/T179A	P22455	FGFR4	FGFR4_HUMAN	T179A	-	-	-	neutral	AAGNPtTIRWL									VARIANT	T -> A (in dbSNP:rs55675160)	17344846	1
P22455/V10I	P22455	FGFR4	FGFR4_HUMAN	V10I	-	-	-	-	LALLGvLSVPG									VARIANT	V -> I (in dbSNP:rs1966265)	17344846,21882254	2
P22455/V550M	P22455	FGFR4	FGFR4_HUMAN	V550M	248	β5	-	resistance	PLYVIvCAAKG	0.72	0.27	0.434	0.225	0.229	0.228	0.626	0.791	VARIANT	V -> M (in breast pleomorphic lobular sample; somatic mutation; dbSNP:rs774571806)	17344846	1
P22455/Y754F	P22455	FGFR4	FGFR4_HUMAN	Y754F	822	αI	p	decrease	AVSEEyDLRLT	0.925	0.972	0.509	0.826	0.728	0.874	0.439	0.57	MUTAGEN	Y->F: Loss of interaction with PLCG1.	7518429	1
P22607/A391E	P22607	FGFR3	FGFR3_HUMAN	A391E	-	-	-	activating	FILVVaVTLCR									VARIANT	A -> E (in CAN; dbSNP:rs28931615)	17935505,7493034	2
P22607/A441T	P22607	FGFR3	FGFR3_HUMAN	A441T	-	-	-	-	PLVRIaLSSGE									VARIANT	A -> T (in dbSNP:rs17884368)		0
P22607/A717T	P22607	FGFR3	FGFR3_HUMAN	A717T	758	αG/αH	-	-	RMDKPaCTHDL	0.14	0.156	0.563	0.28	0.12	0.093	0.736	0.151	VARIANT	A -> T (in dbSNP:rs17882190)		0
P22607/C228R	P22607	FGFR3	FGFR3_HUMAN	C228R	-	-	-	-	RGNYTcVENKF									VARIANT	C -> R (in a colorectal adenocarcinoma sample; somatic mutation)	17344846	1
P22607/D513N	P22607	FGFR3	FGFR3_HUMAN	D513N	134	β3/αC-loop	-	-	KMLKDdTDKDL	0.287	0.204	0.467	0.213	0.144	0.13	0.632	0.306	VARIANT	D -> N (in LADD2; unknown pathological significance; dbSNP:rs121913112)	16501574	1
P22607/D646N	P22607	FGFR3	FGFR3_HUMAN	D646N	510	A-loop	-	-	DVHNLdYKKTT	0.677	0.696	0.456	0.657	0.447	0.581	0.587	0.297	VARIANT	D -> N	17344846	1
P22607/E322K	P22607	FGFR3	FGFR3_HUMAN	E322K	-	-	-	-	TDKELeLSLHN									VARIANT	E -> K (in colorectal cancer; dbSNP:rs121913111)	11325814	1
P22607/F384L	P22607	FGFR3	FGFR3_HUMAN	F384L	-	-	-	neutral	YGVGFfFILVV									VARIANT	F -> L (in dbSNP:rs17881656)	17344846	1
P22607/G370C	P22607	FGFR3	FGFR3_HUMAN	G370C	-	-	-	-	EADEAgVYAGI									VARIANT	G -> C (in KERSEB, BLC, keratinocytic non-epidermolytic nevus and TD1; dbSNP:rs121913479)	10471491,15772091,16841094,8845844,9790257	5
P22607/G375C	P22607	FGFR3	FGFR3_HUMAN	G375C	-	-	-	activating	GSVYAgLSYGV									VARIANT	G -> C (in ACH; dbSNP:rs75790268)	7758520	1
P22607/G380R	P22607	FGFR3	FGFR3_HUMAN	G380R	-	-	-	activating	GILSYgGFFLF									VARIANT	G -> R (in keratinocytic non-epidermolytic nevus and ACH; very common mutation; constitutively activated kinase with impaired internalization and degradation, resulting in prolonged FGFR3 signaling; dbSNP:rs28931614)	10611230,12297284,16841094,17561467,7847369,8078586,8599935	7
P22607/G65R	P22607	FGFR3	FGFR3_HUMAN	G65R	-	-	-	-	SCPPPgGPMGP									VARIANT	G -> R (in dbSNP:rs2305178)		0
P22607/I538V	P22607	FGFR3	FGFR3_HUMAN	I538V	196	αC/β4-loop	-	-	GKHKNiNLLGA	0.229	0.166	0.468	0.191	0.114	0.139	0.68	0.289	VARIANT	I -> V (in hypochondroplasia; dbSNP:rs80053154)	10215410	1
P22607/I726F	P22607	FGFR3	FGFR3_HUMAN	I726F	788	αH	-	-	HDLYMiRECWH	0.61	0.544	0.605	0.559	0.275	0.484	0.705	0.54	VARIANT	I -> F (in dbSNP:rs17880763)		0
P22607/K508A	P22607	FGFR3	FGFR3_HUMAN	K508A	129	β3;Catalytic-Lys	-	loss	VTVAVkLKDDA	1.0	0.993	0.023	0.627	1.0	0.997	0.004	0.659	MUTAGEN	K->A: Loss of kinase activity. Abolishes ubiquitination.	12297284,16410555	2
P22607/K650D	P22607	FGFR3	FGFR3_HUMAN	K650D	532	A-loop	-	activating	LDYYKkTNGRL	0.922	0.892	0.8	0.941	0.204	0.608	0.846	0.466	MUTAGEN	K->D: Constitutively activated kinase.		0
P22607/K650E	P22607	FGFR3	FGFR3_HUMAN	K650E	532	A-loop	-	activating	LDYYKkTNGRL	0.922	0.794	0.747	0.961	0.146	0.48	0.802	0.471	VARIANT	K -> E (in KERSEB, TD2, TGCT and BLC; bladder transitional cell carcinoma; somatic mutation; constitutively activated kinase with impaired internalization and degradation, resulting in prolonged FGFR3 signaling; dbSNP:rs78311289)	10471491,11294897,12297284,14534538,15772091,17145761,17344846,17561467,19855393,7773297,8754806,9207791	12
P22607/K650L	P22607	FGFR3	FGFR3_HUMAN	K650L	532	A-loop	-	activating	LDYYKkTNGRL	0.9	0.853	0.773	0.904	0.179	0.615	0.838	0.567	MUTAGEN	K->L: Constitutively activated kinase.		0
P22607/K650M	P22607	FGFR3	FGFR3_HUMAN	K650M	532	A-loop	-	activating	LDYYKkTNGRL	0.902	0.845	0.74	0.92	0.15	0.614	0.839	0.611	VARIANT	K -> M (in KERSEB, ACH, TD1 and SADDAN; constitutively activated kinase with impaired internalization and degradation, resulting in prolonged FGFR3 signaling; dbSNP:rs121913105)	10053006,10671061,15772091,17509076,17561467,9207791	6
P22607/K650Q	P22607	FGFR3	FGFR3_HUMAN	K650Q	532	A-loop	-	activating	LDYYKkTNGRL	0.866	0.721	0.759	0.872	0.128	0.441	0.782	0.486	VARIANT	K -> Q (in hypochondroplasia and BLC; in hypochondroplasia the form is milder than that seen in individuals with the K-540 or M-650 mutations; constitutively activated kinase; dbSNP:rs78311289)	11055896,11314002,8754806	3
P22607/N540K	P22607	FGFR3	FGFR3_HUMAN	N540K	198	αC/β4-loop	-	-	HKNIInLGACT	0.565	0.429	0.549	0.479	0.138	0.228	0.753	0.559	VARIANT	N -> K (in hypochondroplasia; dbSNP:rs28933068)	7670477	1
P22607/N540S	P22607	FGFR3	FGFR3_HUMAN	N540S	198	αC/β4-loop	-	-	HKNIInLGACT	0.69	0.571	0.536	0.625	0.188	0.316	0.703	0.602	VARIANT	N -> S (in hypochondroplasia; mild; dbSNP:rs77722678)	10777366,12707965	2
P22607/N540T	P22607	FGFR3	FGFR3_HUMAN	N540T	198	αC/β4-loop	-	-	HKNIInLGACT	0.737	0.683	0.541	0.594	0.357	0.59	0.587	0.817	VARIANT	N -> T (in hypochondroplasia; dbSNP:rs77722678)	9452043	1
P22607/P250R	P22607	FGFR3	FGFR3_HUMAN	P250R	-	-	-	-	VLERSpRPILQ									VARIANT	P -> R (in MNKS; also some individuals with autosomal dominant congenital sensorineural deafness without craniosynostosis; dbSNP:rs4647924)	11746040,9042914,9525367,9950359	4
P22607/R248C	P22607	FGFR3	FGFR3_HUMAN	R248C	-	-	-	activating	LDVLErPHRPI									VARIANT	R -> C (in KERSEB, BLC, keratinocytic non-epidermolytic nevus and TD1; severe and lethal; also found as somatic mutation in one patient with multiple myeloma; constitutive dimerization and kinase activation; dbSNP:rs121913482)	10360402,10471491,11529856,15772091,16841094,17509076,7773297,8845844	8
P22607/R621H	P22607	FGFR3	FGFR3_HUMAN	R621H	447	Catalytic-loop	-	-	RDLAArVLVTE	0.896	0.887	0.299	0.65	0.775	0.837	0.271	0.441	VARIANT	R -> H (in CATSHLS; dbSNP:rs121913113)	17033969	1
P22607/S249C	P22607	FGFR3	FGFR3_HUMAN	S249C	-	-	-	-	DVLERsHRPIL									VARIANT	S -> C (in KERSEB, BLC, cervical cancer and TD1; dbSNP:rs121913483)	10360402,10471491,15772091,8589699,8845844	5
P22607/S371C	P22607	FGFR3	FGFR3_HUMAN	S371C	-	-	-	-	ADEAGsYAGIL									VARIANT	S -> C (in KERSEB and TD1; dbSNP:rs121913484)	15772091,7773297	2
P22607/T338M	P22607	FGFR3	FGFR3_HUMAN	T338M	-	-	-	-	DAGEYtLAGNS									VARIANT	T -> M	17344846	1
P22607/T79S	P22607	FGFR3	FGFR3_HUMAN	T79S	-	-	-	-	WVKDGtLVPSE									VARIANT	T -> S (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
P22607/Y373C	P22607	FGFR3	FGFR3_HUMAN	Y373C	-	-	-	activating	EAGSVyGILSY									VARIANT	Y -> C (in KERSEB and TD1; disulfide-linked dimer with constitutive kinase activation; dbSNP:rs121913485)	10360402,15772091,17509076,8845844,9207791	5
P22607/Y577F	P22607	FGFR3	FGFR3_HUMAN	Y577F	286	αD/αE-loop	p	increase	PPGLDyFDTCK	0.858	0.802	0.675	0.895	0.27	0.727	0.717	0.44	MUTAGEN	Y->F: Minor effect on kinase activity.	11294897	1
P22607/Y724F	P22607	FGFR3	FGFR3_HUMAN	Y724F	786	αH	p	decrease	CTHDLyIMREC	0.849	0.875	0.479	0.747	0.679	0.753	0.481	0.394	MUTAGEN	Y->F: Strongly reduced kinase activity. Strongly reduced mitogen activity.	11294897	1
P22607/Y760F	P22607	FGFR3	FGFR3_HUMAN	Y760F	823	αI	p	increase	TSTDEyDLSAP	0.943	0.922	0.589	0.871	0.518	0.816	0.57	0.514	MUTAGEN	Y->F: Minor effect on kinase activity.	11294897	1
P22607/Y770F	P22607	FGFR3	FGFR3_HUMAN	Y770F	833	C-term-αI	p	increase	APFEQyPGGQD	0.842	0.794	0.495	0.829	0.425	0.691	0.559	0.271	MUTAGEN	Y->F: Minor effect on kinase activity. Increased mitogen activity.	11294897	1
P22612/H268D	P22612	PRKACG	KAPCG_HUMAN	H268D	787	αH	-	neutral	SSDLKhLRSLL	0.119	0.118	0.613	0.21	0.075	0.106	0.803	0.115	VARIANT	H -> D (in dbSNP:rs3730386)	17344846,2342480	2
P22612/I251N	P22612	PRKACG	KAPCG_HUMAN	I251N	641	αG	-	-	QIYEKiSGRVR	0.857	0.792	0.562	0.651	0.537	0.666	0.484	0.638	VARIANT	I -> N (in dbSNP:rs56287972)	17344846	1
P22612/I74M	P22612	PRKACG	KAPCG_HUMAN	I74M	130	β3	-	decrease	HYAMKiNKQKV	0.601	0.599	0.467	0.468	0.552	0.549	0.529	0.469	VARIANT	I -> M (in BDPLT19; patient platelets show impaired activation; dbSNP:rs724159972)	25061177	1
P22694/G235R	P22694	PRKACB	KAPCB_HUMAN	G235R	616	αF	-	increase	YEMAAgPPFFA	0.863	0.811	0.524	0.763	0.463	0.71	0.566	0.547	VARIANT	G -> R (in CAFD2; increased sensitivity to cAMP activation; decreased interaction with regulatory subunits PRKAR1A and PRKAR2B)	33058759	1
P22694/H88N	P22694	PRKACB	KAPCB_HUMAN	H88N	169	αC	-	-	LKQIEhLNEKR	0.659	0.605	0.561	0.648	0.328	0.472	0.573	0.265	VARIANT	H -> N (in CAFD2)	33058759	1
P22694/H88R	P22694	PRKACB	KAPCB_HUMAN	H88R	169	αC	-	increase	LKQIEhLNEKR	0.56	0.46	0.588	0.624	0.2	0.31	0.696	0.218	VARIANT	H -> R (in CAFD2; increased sensitivity to cAMP activation; dbSNP:rs768056300)	33058759	1
P22694/R106Q	P22694	PRKACB	KAPCB_HUMAN	R106Q	202	β4	-	-	FPFLVrEYAFK	0.353	0.337	0.46	0.247	0.162	0.219	0.612	0.294	VARIANT	R -> Q (in dbSNP:rs36117118)	17344846	1
P22694/S54L	P22694	PRKACB	KAPCB_HUMAN	S54L	43	Gly-rich-loop;β1/β2-loop	p	-	TLGTGsGRVML	0.839	0.811	0.574	0.722	0.552	0.739	0.491	0.372	VARIANT	S -> L (in CAFD2; dbSNP:rs1663748771)	33058759	1
P23443/G289E	P23443	RPS6KB1	KS6B1_HUMAN	G289E	616	αF	-	-	YDMLTgPPFTG	0.805	0.771	0.487	0.589	0.557	0.662	0.432	0.541	VARIANT	G -> E (in a colorectal cancer sample; somatic mutation)	16959974	1
P23443/K167N	P23443	RPS6KB1	KS6B1_HUMAN	K167N	241	β4/β5-loop	-	decrease	FQTGGkYLILE	0.603	0.512	0.431	0.422	0.492	0.385	0.457	0.323	MUTAGEN	K->N: Greatly reduces activity. Greatly reduces phosphorylation at T-412 and moderately reduces phosphorylation at T-252.	17446865	1
P23443/M225I	P23443	RPS6KB1	KS6B1_HUMAN	M225I	450	Catalytic-loop	-	-	KPENImNHQGH	0.6	0.494	0.549	0.466	0.339	0.417	0.627	0.307	VARIANT	M -> I	17344846	1
P23443/R272C	P23443	RPS6KB1	KS6B1_HUMAN	R272C	596	αF	-	-	RSGHNrVDWWS	0.638	0.601	0.456	0.597	0.486	0.53	0.479	0.406	VARIANT	R -> C (in dbSNP:rs766645749)	17344846	1
P23443/S394A	P23443	RPS6KB1	KS6B1_HUMAN	S394A	-	-	p	loss	QTPVDsDDSTL									MUTAGEN	S->A: Loss of activity. Loss of phosphorylation at T-412.	17446865	1
P23443/S398A	P23443	RPS6KB1	KS6B1_HUMAN	S398A	-	-	-	-	DSPDDsLSESA									VARIANT	S -> A	17344846	1
P23443/S434E	P23443	RPS6KB1	KS6B1_HUMAN	S434E	-	-	p	-	EPKIRsRRFIG									MUTAGEN	S->E: Facilitates phosphorylation of T-252 by PDPK1; when associated with E-412; E-441; E-444 and E-447.	9445476	1
P23443/S441E	P23443	RPS6KB1	KS6B1_HUMAN	S441E	-	-	p	-	RRFIGsRTPVS									MUTAGEN	S->E: Facilitates phosphorylation of T-252 by PDPK1; when associated with E-412; E-434; E-444 and E-447.	9445476	1
P23443/S447E	P23443	RPS6KB1	KS6B1_HUMAN	S447E	-	-	p	-	PRTPVsVKFSP									MUTAGEN	S->E: Facilitates phosphorylation of T-252 by PDPK1; when associated with E-412; E-434; E-441 and E-444.	9445476	1
P23443/T412E	P23443	RPS6KB1	KS6B1_HUMAN	T412E	-	-	p	increase	VFLGFtVAPSV									MUTAGEN	T->E: Mimics phosphorylation. Facilitates phosphorylation of T-252 by PDPK1; when associated with E-434; E-441; E-444 and E-447. Mimics phosphorylation. No effect on interaction with PDPK1 and phosphorylation of T-252. Impairs association with the eIF3 complex.	16286006,19570988,9445476	3
P23443/T444E	P23443	RPS6KB1	KS6B1_HUMAN	T444E	-	-	p	-	IGSPRtVSPVK									MUTAGEN	T->E: Facilitates phosphorylation of T-252 by PDPK1; when associated with E-412; E-434; E-441 and E-447.	9445476	1
P23443/W276C	P23443	RPS6KB1	KS6B1_HUMAN	W276C	601	αF	-	-	NRAVDwSLGAL	0.898	0.789	0.444	0.62	0.627	0.739	0.371	0.642	VARIANT	W -> C	17344846	1
P23458/A634D	P23458	JAK1	JAK1_HUMAN	A634D	-	-	-	activating	RDISLaFEAAS									VARIANT	A -> D (in AIIDE; constitutive gain of function resulting in increased receptor signaling pathway via JAK-STAT; no effect on protein abundance)	28111307	1
P23458/K908A	P23458	JAK1	JAK1_HUMAN	K908A	129	β3	ub	loss	EQVAVkLKPES	1.0	1.0	0.025	0.693	1.0	0.997	0.015	0.679	MUTAGEN	K->A: Loss of protein tyrosine kinase activity.	32750333	1
P23458/N973K	P23458	JAK1	JAK1_HUMAN	N973K	296	αD/αE-loop	-	-	LPKNKnINLKQ	0.077	0.12	0.529	0.123	0.076	0.111	0.717	0.098	VARIANT	N -> K (in dbSNP:rs34680086)	17344846	1
P23458/S703I	P23458	JAK1	JAK1_HUMAN	S703I	-	-	-	increase	LASALsLEDKD									VARIANT	S -> I (in AIIDE; increased activation of protein kinase activity; constitutive gain of function through the transactivation of associated JAK kinases; increased receptor signaling pathway via JAK-STAT)	32750333	1
P23458/V658F	P23458	JAK1	JAK1_HUMAN	V658F	-	-	-	activating	LYGVCvDVENI									MUTAGEN	V->F: Constitutively active. Increased receptor signaling pathway via JAK-STAT.	16239216	1
P24723/A19V	P24723	PRKCH	KPCL_HUMAN	A19V	-	-	-	neutral	VRIGEaGLQPT									VARIANT	A -> V (in dbSNP:rs55645551)	17344846	1
P24723/D497Y	P24723	PRKCH	KPCL_HUMAN	D497Y	496	A-loop;DFG-motif	-	-	HCKLAdGMCKE	0.983	0.952	0.218	0.573	0.942	0.916	0.148	0.673	VARIANT	D -> Y (in dbSNP:rs11846991)		0
P24723/D645V	P24723	PRKCH	KPCL_HUMAN	D645V	-	-	-	-	DVSNFdDFIKE									VARIANT	D -> V (in dbSNP:rs35561533)		0
P24723/K65R	P24723	PRKCH	KPCL_HUMAN	K65R	-	-	-	-	KQKTNkTYNEE									VARIANT	K -> R (in dbSNP:rs55737090)	17344846	1
P24723/P612S	P24723	PRKCH	KPCL_HUMAN	P612S	821	αI	-	-	AILRHpFKEID	0.63	0.54	0.596	0.543	0.256	0.405	0.611	0.537	VARIANT	P -> S (in dbSNP:rs34159231)	17344846	1
P24723/R149Q	P24723	PRKCH	KPCL_HUMAN	R149Q	-	-	-	-	TLQRDrFKHFT									VARIANT	R -> Q (in dbSNP:rs55848048)	17344846	1
P24723/R359Q	P24723	PRKCH	KPCL_HUMAN	R359Q	37	β1	-	-	NFEFIrLGKGS	0.152	0.145	0.424	0.174	0.111	0.14	0.634	0.072	VARIANT	R -> Q (in dbSNP:rs55818778)	17344846	1
P24723/T575A	P24723	PRKCH	KPCL_HUMAN	T575A	683	αG/αH	-	-	EVVYPtLHEDA	0.143	0.174	0.384	0.12	0.265	0.201	0.479	0.066	VARIANT	T -> A (in a aLLTEL/AML1+ sample; somatic mutation; dbSNP:rs1378993559)	17344846	1
P24723/T594I	P24723	PRKCH	KPCL_HUMAN	T594I	798	αI	-	-	MTKNPtRLGSL	0.361	0.415	0.539	0.375	0.224	0.296	0.631	0.231	VARIANT	T -> I (in a colorectal adenocarcinoma sample; somatic mutation)	17344846	1
P24723/V374I	P24723	PRKCH	KPCL_HUMAN	V374I	57	β2/β3-loop	-	increase,neutral	VMLARvETGDL	0.233	0.231	0.419	0.208	0.148	0.17	0.624	0.095	VARIANT	V -> I (associated with susceptibility to ischemic stroke; increases autophosphorylation and kinase activity; dbSNP:rs2230500)	17206144,17344846	2
P24941/K9F	P24941	CDK2	CDK2_HUMAN	K9F	38	β1	ub	decrease	FQKVEkGEGTY	0.88	0.819	0.509	0.745	0.708	0.725	0.427	0.61	MUTAGEN	K->F: Reduced phosphorylation by CAK.	17373709	1
P24941/L166R	P24941	CDK2	CDK2_HUMAN	L166R	551	A-loop	-	decrease	HEVVTlYRAPE	0.628	0.615	0.605	0.611	0.403	0.422	0.642	0.455	MUTAGEN	L->R: Reduced phosphorylation by CAK and reduced kinase activity.	17373709	1
P24941/P45L	P24941	CDK2	CDK2_HUMAN	P45L	146	αC	-	-	ETEGVpTAIRE	0.642	0.703	0.452	0.465	0.509	0.558	0.405	0.341	VARIANT	P -> L (in a glioblastoma multiforme sample; somatic mutation)	17344846	1
P24941/T14A	P24941	CDK2	CDK2_HUMAN	T14A	43	Gly-rich-loop;β1/β2-loop	p	increase	KIGEGtGVVYK	0.784	0.779	0.477	0.852	0.349	0.687	0.575	0.408	MUTAGEN	T->A: 2-fold increase in activity.	1396589	1
P24941/T160A	P24941	CDK2	CDK2_HUMAN	T160A	544	A-loop	p	loss	PVRTYtEVVTL	0.987	0.962	0.241	0.848	0.9	0.977	0.248	0.465	MUTAGEN	T->A: Abolishes activity.	1396589	1
P24941/T290S	P24941	CDK2	CDK2_HUMAN	T290S	827	C-term-αI	-	neutral	FFQDVtPVPHL	0.263	0.3	0.456	0.251	0.173	0.176	0.687	0.183	VARIANT	T -> S (in dbSNP:rs2069413)	17344846	1
P24941/V18L	P24941	CDK2	CDK2_HUMAN	V18L	48	β2	-	-	GTYGVvKARNK	0.738	0.732	0.497	0.591	0.499	0.598	0.496	0.588	VARIANT	V -> L (in dbSNP:rs11554376)		0
P24941/Y15F	P24941	CDK2	CDK2_HUMAN	Y15F	44	Gly-rich-loop;β1/β2-loop	p	increase	IGEGTyVVYKA	0.835	0.859	0.642	0.866	0.189	0.59	0.729	0.42	MUTAGEN	Y->F: 2-fold increase in activity.	1396589	1
P24941/Y15S	P24941	CDK2	CDK2_HUMAN	Y15S	44	Gly-rich-loop;β1/β2-loop	p	-	IGEGTyVVYKA	0.939	0.876	0.454	0.837	0.621	0.788	0.345	0.739	VARIANT	Y -> S (in dbSNP:rs3087335)		0
P25092/C30R	P25092	GUCY2C	GUC2C_HUMAN	C30R	-	-	-	-	QVSQNcNGSYE									VARIANT	C -> R (in dbSNP:rs56142849)	17344846	1
P25092/D387G	P25092	GUCY2C	GUC2C_HUMAN	D387G	-	-	-	decrease	LYTSVdKKYKV									VARIANT	D -> G (in MECIL; activation of guanylate cyclase activity is 60% lower than in wild-type; dbSNP:rs587776905)	22521417	1
P25092/E610K	P25092	GUCY2C	GUC2C_HUMAN	E610K	438	Catalytic-loop	-	-	HSSKTeHGRLK	0.214	0.227	0.404	0.143	0.187	0.237	0.594	0.082	VARIANT	E -> K (in dbSNP:rs55897626)	17344846	1
P25092/F281L	P25092	GUCY2C	GUC2C_HUMAN	F281L	-	-	-	-	FNDQYfDNVTA									VARIANT	F -> L (in dbSNP:rs1420635)	15489334,1680854,1718270,8381596	4
P25092/G61R	P25092	GUCY2C	GUC2C_HUMAN	G61R	-	-	-	-	DAVNEgEIVRG									VARIANT	G -> R (in a metastatic melanoma sample; somatic mutation)	17344846	1
P25092/I859V	P25092	GUCY2C	GUC2C_HUMAN	I859V	-	-	-	-	KSFDHiDHHDV									VARIANT	I -> V (in dbSNP:rs34890806)	17344846	1
P25092/Q1045R	P25092	GUCY2C	GUC2C_HUMAN	Q1045R	-	-	-	-	AGIRSqPRRVA									VARIANT	Q -> R (in dbSNP:rs35617837)	17344846	1
P25092/R114Q	P25092	GUCY2C	GUC2C_HUMAN	R114Q	-	-	-	neutral	ISNAQrGCVLI									VARIANT	R -> Q (in dbSNP:rs56275235)	17344846	1
P25092/R464L	P25092	GUCY2C	GUC2C_HUMAN	R464L	-	-	-	-	KDYELrKKWSH									VARIANT	R -> L (in dbSNP:rs55684775)	17344846	1
P25092/S840I	P25092	GUCY2C	GUC2C_HUMAN	S840I	-	-	-	increase	TICKYsPMEVV									VARIANT	S -> I (in DIAR6; activating mutation; exposure of the mutant receptor to its ligands results in markedly increased production of cyclic guanosine monophosphate; dbSNP:rs587776871)	22436048	1
P25098/D10A	P25098	GRK2	ARBK1_HUMAN	D10A	-	-	-	decrease	EAVLAdSYLMA									MUTAGEN	D->A: 95% reduction in phosphorylation of G-protein coupled receptor rhodopsin and beta-2 adrenergic receptor ADRB2. Does not affect binding to ADRB2. Not activated by receptor binding. No effect on phosphorylation of the non-receptor substrate tubulin.	19715378	1
P25098/D3A	P25098	GRK2	ARBK1_HUMAN	D3A	-	-	-	decrease	MAdEAVLA									MUTAGEN	D->A: 85% reduction in phosphorylation of G-protein coupled receptor rhodopsin.	19715378	1
P25098/D3K	P25098	GRK2	ARBK1_HUMAN	D3K	-	-	-	decrease	MAdEAVLA									MUTAGEN	D->K: 95% reduction in phosphorylation of G-protein coupled receptor rhodopsin. 60% reduction in phosphorylation of beta-2 adrenergic receptor ADRB2. Does not affect binding to ADRB2. Not activated by receptor binding. No effect on phosphorylation of the non-receptor substrate tubulin.	19715378	1
P25098/D3N	P25098	GRK2	ARBK1_HUMAN	D3N	-	-	-	decrease	MAdEAVLA									MUTAGEN	D->N: 60% reduction in phosphorylation of G-protein coupled receptor rhodopsin.	19715378	1
P25098/E5A	P25098	GRK2	ARBK1_HUMAN	E5A	-	-	-	decrease	MADLeVLADV									MUTAGEN	E->A: 50% reduction in phosphorylation of G-protein coupled receptor rhodopsin.	19715378	1
P25098/I184T	P25098	GRK2	ARBK1_HUMAN	I184T	25	N-term-β1	-	-	NVELNiLTMND	0.709	0.679	0.55	0.618	0.468	0.674	0.557	0.352	VARIANT	I -> T (in dbSNP:rs55696045)	17344846	1
P25098/L4A	P25098	GRK2	ARBK1_HUMAN	L4A	-	-	-	decrease	MADlAVLAD									MUTAGEN	L->A: 95% reduction in phosphorylation of G-protein coupled receptor rhodopsin. 90% reduction in phosphorylation of beta-2 adrenergic receptor ADRB2. Does not affect binding to ADRB2. Not activated by receptor binding. No effect on phosphorylation of the non-receptor substrate tubulin.	19715378	1
P25098/L4K	P25098	GRK2	ARBK1_HUMAN	L4K	-	-	-	decrease	MADlAVLAD									MUTAGEN	L->K: 95% reduction in phosphorylation of G-protein coupled receptor rhodopsin.	19715378	1
P25098/R578Q	P25098	GRK2	ARBK1_HUMAN	R578Q	-	-	-	-	LTQWQrYFYLF									VARIANT	R -> Q (in a colorectal adenocarcinoma sample; somatic mutation)	17344846	1
P25440/A212P	P25440	BRD2	BRD2_HUMAN	A212P	-	-	-	-	GSVTSaQVPAV									VARIANT	A -> P (in dbSNP:rs35952031)	17344846	1
P25440/A474V	P25440	BRD2	BRD2_HUMAN	A474V	-	-	-	neutral	MPPGLaSSSES									VARIANT	A -> V (in dbSNP:rs3918143)	17344846	1
P25440/A49G	P25440	BRD2	BRD2_HUMAN	A49G	-	-	-	-	ESPTMaVPALQ									VARIANT	A -> G (in dbSNP:rs3918144)	17344846	1
P25440/A49S	P25440	BRD2	BRD2_HUMAN	A49S	-	-	-	neutral	ESPTMaVPALQ									VARIANT	A -> S (in dbSNP:rs55669504)	17344846	1
P25440/A569T	P25440	BRD2	BRD2_HUMAN	A569T	-	-	-	neutral	RGRAGaEDDKG									VARIANT	A -> T (in dbSNP:rs34530779)	17344846	1
P25440/A599P	P25440	BRD2	BRD2_HUMAN	A599P	-	-	-	neutral	GGGSAaGPSGF									VARIANT	A -> P (in dbSNP:rs55952113)	17344846	1
P25440/E170A	P25440	BRD2	BRD2_HUMAN	E170A	-	-	-	loss	MAQTLeIFLQK									MUTAGEN	E->A: Loss of homodimerization.	17148447	1
P25440/G30E	P25440	BRD2	BRD2_HUMAN	G30E	-	-	-	-	EAAAPgRIRKP									VARIANT	G -> E (in a glioblastoma multiforme sample; somatic mutation)	17344846	1
P25440/I154A	P25440	BRD2	BRD2_HUMAN	I154A	-	-	-	-	FTNCYiNKPTD									MUTAGEN	I->A: Partial loss of homodimerization; when associated with A-182.	17148447	1
P25440/L174E	P25440	BRD2	BRD2_HUMAN	L174E	-	-	-	loss	LEKIFlKVASM									MUTAGEN	L->E: Loss of homodimerization.	17148447	1
P25440/L238F	P25440	BRD2	BRD2_HUMAN	L238F	-	-	-	neutral	IPTTVlIPHPS									VARIANT	L -> F (in dbSNP:rs176250)	14574404,17344846	2
P25440/P260Q	P25440	BRD2	BRD2_HUMAN	P260Q	-	-	-	-	HSAGPpLAVTA									VARIANT	P -> Q (in dbSNP:rs35294809)	17344846	1
P25440/P714L	P25440	BRD2	BRD2_HUMAN	P714L	-	-	-	-	KKPRKpTIKKP									VARIANT	P -> L (in a glioblastoma multiforme sample; somatic mutation)	17344846	1
P25440/Q182A	P25440	BRD2	BRD2_HUMAN	Q182A	-	-	-	-	VASMPqEQELV									MUTAGEN	Q->A: Partial loss of homodimerization; when associated with A-154.	17148447	1
P25440/Q78A	P25440	BRD2	BRD2_HUMAN	Q78A	-	-	-	loss	GRVTNqQYLHK									MUTAGEN	Q->A: Loss of homodimerization.	17148447	1
P25440/R547K	P25440	BRD2	BRD2_HUMAN	R547K	-	-	-	-	ISKPKrREKKE									VARIANT	R -> K (in dbSNP:rs1049369)		0
P25440/R558G	P25440	BRD2	BRD2_HUMAN	R558G	-	-	-	-	EKKKKrAEKHR									VARIANT	R -> G (in a gastric adenocarcinoma sample; somatic mutation)	17344846	1
P25440/V177E	P25440	BRD2	BRD2_HUMAN	V177E	-	-	-	loss	IFLQKvSMPQE									MUTAGEN	V->E: Loss of homodimerization.	17148447	1
P25440/Y153K	P25440	BRD2	BRD2_HUMAN	Y153K	-	-	-	loss	MFTNCyYNKPT									MUTAGEN	Y->K: Loss of homodimerization.	17148447	1
P27037/A367T	P27037	ACVR2A	AVR2A_HUMAN	A367T	555	A-loop;APE-motif	-	-	TRRYMaEVLEG	0.81	0.743	0.394	0.587	0.575	0.677	0.442	0.457	VARIANT	A -> T (found in a clear cell renal carcinoma case; somatic mutation)	21248752	1
P27037/D306N	P27037	ACVR2A	AVR2A_HUMAN	D306N	426	αE	-	-	AYLHEdPGLKD	0.634	0.559	0.479	0.489	0.433	0.553	0.618	0.388	VARIANT	D -> N (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs764255410)	17344846	1
P27037/S258R	P27037	ACVR2A	AVR2A_HUMAN	S258R	237	β4/β5-loop	-	-	EKRGTsDVDLW	0.3	0.236	0.556	0.253	0.182	0.281	0.696	0.162	VARIANT	S -> R (in dbSNP:rs34917571)	17344846	1
P27361/E323K	P27361	MAPK3	MK03_HUMAN	E323K	816	αI	-	-	RITVEeLAHPY	0.424	0.368	0.536	0.498	0.206	0.249	0.604	0.345	VARIANT	E -> K (in dbSNP:rs55859133)	17344846	1
P27361/K168R	P27361	MAPK3	MK03_HUMAN	K168R	445	Catalytic-loop	-	-	LHRDLkSNLLI	0.927	0.929	0.402	0.703	0.82	0.879	0.366	0.377	MUTAGEN	K->R: Complete loss of ubiquitination by TRIM15; when associated with R-302.	34497368	1
P27361/K302R	P27361	MAPK3	MK03_HUMAN	K302R	783	αH	m3	-	PKSDSkLDLLD	0.476	0.353	0.492	0.413	0.229	0.332	0.625	0.26	MUTAGEN	K->R: Complete loss of ubiquitination by TRIM15; when associated with R-168.	34497368	1
P27448/R570G	P27448	MARK3	MARK3_HUMAN	R570G	-	-	-	-	FHGQPrRRTAT									VARIANT	R -> G (in VIPB; dbSNP:rs376395495)	29771303	1
P27448/S410F	P27448	MARK3	MARK3_HUMAN	S410F	-	-	-	-	VQRSVsSQKQR									VARIANT	S -> F (in dbSNP:rs10137161)		0
P27448/S443G	P27448	MARK3	MARK3_HUMAN	S443G	-	-	-	neutral	TSTADsLKEDG									VARIANT	S -> G (in dbSNP:rs56305318)	17344846,9543386	2
P27448/T211A	P27448	MARK3	MARK3_HUMAN	T211A	545	A-loop	p	loss	GGKLDtCGSPP	0.999	1.0	0.119	0.921	0.988	0.994	0.043	0.473	MUTAGEN	T->A: Prevents phosphorylation and activation by STK11/LKB1 complex.	14976552	1
P27448/V429A	P27448	MARK3	MARK3_HUMAN	V429A	-	-	-	-	PAIPSvAYPKR									VARIANT	V -> A	17344846	1
P28482/A174V	P28482	MAPK1	MK01_HUMAN	A174V	509	A-loop	-	increase	GLARVaPDHDH	0.469	0.426	0.677	0.621	0.122	0.267	0.809	0.434	VARIANT	A -> V (in NS13; results in increased MAPK signaling; increased translocation to the nucleus; reduced interaction wth DUSP6; no effect on interaction with MAP2K1)	32721402	1
P28482/D318A	P28482	MAPK1	MK01_HUMAN	D318A	828	C-term-αI	-	increase	LEQYYdSDEPI	0.667	0.658	0.498	0.58	0.458	0.564	0.497	0.5	MUTAGEN	D->A: Loss of dephosphorylation by PTPRJ.	18794356,19494114	2
P28482/D318G	P28482	MAPK1	MK01_HUMAN	D318G	828	C-term-αI	-	increase	LEQYYdSDEPI	0.717	0.732	0.626	0.636	0.394	0.546	0.689	0.518	VARIANT	D -> G (in NS13; results in increased MAPK signaling; increased translocation to the nucleus; reduced interaction wth DUSP6; no effect on interaction with MAP2K1)	32721402	1
P28482/D318N	P28482	MAPK1	MK01_HUMAN	D318N	828	C-term-αI	-	-	LEQYYdSDEPI	0.408	0.443	0.585	0.47	0.231	0.325	0.703	0.369	VARIANT	D->N: Inhibits interaction with MAP2K1 but not with TPR; when associated with N-321.	18794356,19494114	2
P28482/D321N	P28482	MAPK1	MK01_HUMAN	D321N	831	C-term-αI	-	-	YYDPSdPIAEA	0.461	0.53	0.485	0.456	0.373	0.392	0.649	0.354	MUTAGEN	D->N: Inhibits interaction with MAP2K1 but not with TPR; when associated with N-318.	18794356	1
P28482/E322Q	P28482	MAPK1	MK01_HUMAN	E322Q	832	C-term-αI	-	-	YDPSDeIAEAP	0.684	0.73	0.492	0.545	0.458	0.68	0.581	0.303	VARIANT	E -> Q (in NS13)	32721402	1
P28482/H80Y	P28482	MAPK1	MK01_HUMAN	H80Y	193	αC/β4-loop	-	increase	LLRFRhNIIGI	0.869	0.861	0.65	0.855	0.35	0.717	0.653	0.528	VARIANT	H -> Y (in NS13; results in increased MAPK signaling; reduced interaction wth DUSP6; no effect on interaction with MAP2K1)	32721402	1
P28482/I74N	P28482	MAPK1	MK01_HUMAN	I74N	176	αC	-	increase	LREIKiLRFRH	0.842	0.849	0.547	0.732	0.402	0.742	0.496	0.502	VARIANT	I -> N (in NS13; results in increased MAPK signaling; reduced interaction wth DUSP6; no effect on interaction with MAP2K1)	32721402	1
P28482/K54R	P28482	MAPK1	MK01_HUMAN	K54R	129	β3;Catalytic-Lys	-	-	VRVAIkISPFE	1.0	1.0	0.104	0.821	0.866	0.997	0.141	0.464	MUTAGEN	K->R: Does not inhibit interaction with MAP2K1.	18794356	1
P28482/L234A	P28482	MAPK1	MK01_HUMAN	L234A	642	αG	-	-	PGKHYlQLNHI	0.681	0.602	0.457	0.463	0.391	0.488	0.512	0.426	MUTAGEN	L->A: Inhibits interaction with TPR.	18794356	1
P28482/P323R	P28482	MAPK1	MK01_HUMAN	P323R	833	C-term-αI	-	increase	DPSDEpAEAPF	0.659	0.666	0.541	0.625	0.407	0.502	0.544	0.336	VARIANT	P -> R (in NS13; results in increased MAPK signaling; increased translocation to the nucleus; reduced interaction wth DUSP6; no effect on interaction with MAP2K1)	32721402	1
P28482/T185A	P28482	MAPK1	MK01_HUMAN	T185A	544	A-loop	p	-	HTGFLtYVATR	0.991	0.985	0.242	0.86	0.911	0.972	0.226	0.576	MUTAGEN	T->A: Inhibits interaction with TPR; when associated with A-187.	18794356	1
P28482/Y187A	P28482	MAPK1	MK01_HUMAN	Y187A	546	A-loop	p	-	GFLTEyATRWY	0.979	0.991	0.227	0.75	0.923	0.933	0.166	0.655	MUTAGEN	Y->A: Inhibits interaction with TPR; when associated with A-185.	18794356	1
P29317/D739N	P29317	EPHA2	EPHA2_HUMAN	D739N	443	Catalytic-loop;HrD-motif	-	increase	NYVHRdAARNI	0.958	0.974	0.297	0.712	0.685	0.945	0.308	0.484	MUTAGEN	D->N: Increases serum-induced chemotaxis. Loss of EFNA1-dependent regulation of cell migration.	19573808	1
P29317/G391R	P29317	EPHA2	EPHA2_HUMAN	G391R	-	-	-	neutral	SEPPHgTRTSV									VARIANT	G -> R (in dbSNP:rs34192549)	17344846	1
P29317/G777S	P29317	EPHA2	EPHA2_HUMAN	G777S	539	A-loop	-	-	YTTSGgIPIRW	0.863	0.805	0.511	0.715	0.535	0.742	0.459	0.69	VARIANT	G -> S (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs922655349)	17344846	1
P29317/G948W	P29317	EPHA2	EPHA2_HUMAN	G948W	-	-	-	-	DIKRIgRLPGH									VARIANT	G -> W (in CTRCT6; reduced protein stability and reduced ability to stimulate cell migration in absence of its ephrin ligand; dbSNP:rs137853199)	19005574,22570727	2
P29317/K646M	P29317	EPHA2	EPHA2_HUMAN	K646M	129	β3;Catalytic-Lys	-	loss	VPVAIkLKAGY	0.992	1.0	0.027	0.661	0.965	0.999	0.006	0.516	MUTAGEN	K->M: Loss of kinase activity.	16236711	1
P29317/K99N	P29317	EPHA2	EPHA2_HUMAN	K99N	-	-	-	-	IFIELkTVRDC									VARIANT	K -> N (in dbSNP:rs1058372)		0
P29317/M631T	P29317	EPHA2	EPHA2_HUMAN	M631T	74	β2/β3-loop	-	neutral	EVYKGmKTSSG	0.112	0.096	0.564	0.219	0.089	0.088	0.739	0.159	VARIANT	M -> T (in dbSNP:rs34021505)		0
P29317/R103E	P29317	EPHA2	EPHA2_HUMAN	R103E	-	-	-	decrease	LKFTVrCNSFP									MUTAGEN	R->E: Significantly reduced response to EFNA1.	19525919	1
P29317/R568H	P29317	EPHA2	EPHA2_HUMAN	R568H	-	-	-	-	KNQRArSPEDV									VARIANT	R -> H (in dbSNP:rs56198600)	17344846	1
P29317/R721Q	P29317	EPHA2	EPHA2_HUMAN	R721Q	408	αE	-	activating	LVGMLrIAAGM	0.467	0.411	0.6	0.595	0.156	0.275	0.767	0.177	VARIANT	R -> Q (in CTRCT6; retained in the cytoplasm and constitutively active it alters EPHA2 signaling; dbSNP:rs116506614)	19649315	1
P29317/R876H	P29317	EPHA2	EPHA2_HUMAN	R876H	817	αI	-	neutral	LDKLIrPDSLK	0.221	0.247	0.444	0.271	0.205	0.229	0.612	0.245	VARIANT	R -> H (in dbSNP:rs35903225)	17344846	1
P29317/S897A	P29317	EPHA2	EPHA2_HUMAN	S897A	-	-	p	-	SIRLPsSGSEG									MUTAGEN	S->A,D: Loss of serum-induced phosphorylation by PKB. Loss of serum-induced chemotaxis.	19573808	1
P29317/S897D	P29317	EPHA2	EPHA2_HUMAN	S897D	-	-	p	loss	SIRLPsSGSEG									MUTAGEN	S->A,D: Loss of serum-induced phosphorylation by PKB. Loss of serum-induced chemotaxis.	19573808	1
P29317/T511M	P29317	EPHA2	EPHA2_HUMAN	T511M	-	-	-	neutral	QVQALtEGQGA									VARIANT	T -> M (in dbSNP:rs55747232)	17344846	1
P29317/T940I	P29317	EPHA2	EPHA2_HUMAN	T940I	-	-	-	-	KVVQMtDDIKR									VARIANT	T -> I (in CTRCT6; reduced protein stability and reduced ability to stimulate cell migration in absence of its ephrin ligand; dbSNP:rs137853200)	19306328,22570727	2
P29320/A777G	P29320	EPHA3	EPHA3_HUMAN	A777G	512	A-loop	-	-	EDDPEaYTTRG	0.594	0.548	0.606	0.548	0.294	0.447	0.717	0.331	VARIANT	A -> G (in dbSNP:rs34437982)	17344846	1
P29320/C568S	P29320	EPHA3	EPHA3_HUMAN	C568S	-	-	-	-	LIGRFcYKSKH									VARIANT	C -> S (in dbSNP:rs56077781)	17344846	1
P29320/D806N	P29320	EPHA3	EPHA3_HUMAN	D806N	600	αF	-	-	FTSASdWSYGI	0.799	0.74	0.306	0.576	0.613	0.618	0.299	0.53	VARIANT	D -> N (in a colorectal cancer sample; somatic mutation)	16959974	1
P29320/F152L	P29320	EPHA3	EPHA3_HUMAN	F152L	-	-	-	loss	AADESfQMDLG									MUTAGEN	F->L: Loss of EFNA5-binding ability and function.	14660665	1
P29320/G518L	P29320	EPHA3	EPHA3_HUMAN	G518L	-	-	-	-	TAAGYgNSRKF									VARIANT	G -> L (in a lung squamous cell carcinoma sample; somatic mutation; requires 2 nucleotide substitutions)	17344846	1
P29320/G766E	P29320	EPHA3	EPHA3_HUMAN	G766E	498	A-loop;DFG-motif	-	-	KVSDFgSRVLE	0.873	0.858	0.417	0.738	0.629	0.795	0.382	0.5	VARIANT	G -> E (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
P29320/I564V	P29320	EPHA3	EPHA3_HUMAN	I564V	-	-	-	neutral	VIYVLiRFCGY									VARIANT	I -> V (in dbSNP:rs55712516)	17344846	1
P29320/I621L	P29320	EPHA3	EPHA3_HUMAN	I621L	29	N-term-β1	-	-	LDATNiIDKVV	0.592	0.611	0.613	0.531	0.27	0.401	0.73	0.23	VARIANT	I -> L (in a colorectal cancer sample; somatic mutation; dbSNP:rs1414714315)	16959974	1
P29320/K207N	P29320	EPHA3	EPHA3_HUMAN	K207N	-	-	-	-	CPFTVkLAMFP									VARIANT	K -> N (in a pancreatic ductal adenocarcinoma sample; somatic mutation; dbSNP:rs200567888)	20838624	1
P29320/L590P	P29320	EPHA3	EPHA3_HUMAN	L590P	-	-	-	-	NGHLKlGLRTY									VARIANT	L -> P (in dbSNP:rs56081642)	17344846	1
P29320/N85S	P29320	EPHA3	EPHA3_HUMAN	N85S	-	-	-	-	NWLRTnVPRNS									VARIANT	N -> S (in a colorectal cancer sample; somatic mutation)	16959974	1
P29320/R914H	P29320	EPHA3	EPHA3_HUMAN	R914H	-	-	-	-	DITTFrTGDWL									VARIANT	R -> H (in dbSNP:rs17801309)	17344846	1
P29320/S229Y	P29320	EPHA3	EPHA3_HUMAN	S229Y	-	-	-	-	VEVRGsVNNSK									VARIANT	S -> Y (in a lung large cell carcinoma sample; somatic mutation)	17344846	1
P29320/S449F	P29320	EPHA3	EPHA3_HUMAN	S449F	-	-	-	-	KKDRTsNSISL									VARIANT	S -> F (in a lung neuroendocrine carcinoma sample; somatic mutation)	17344846	1
P29320/S768A	P29320	EPHA3	EPHA3_HUMAN	S768A	500	A-loop	p	-	SDFGLsVLEDD	0.706	0.8	0.433	0.673	0.436	0.573	0.549	0.351	MUTAGEN	S->A: Full kinase activity; when associated with F-596 and F-602.	18547520	1
P29320/T37K	P29320	EPHA3	EPHA3_HUMAN	T37K	-	-	-	-	LLDSKtQGELG									VARIANT	T -> K (in a colorectal cancer sample; somatic mutation)	16959974	1
P29320/T660K	P29320	EPHA3	EPHA3_HUMAN	T660K	136	αC	-	-	LKVGYtKQRRD	0.476	0.482	0.445	0.404	0.4	0.41	0.524	0.418	VARIANT	T -> K (in a lung carcinoma sample; somatic mutation)	16941478	1
P29320/T933M	P29320	EPHA3	EPHA3_HUMAN	T933M	-	-	-	-	CKEIFtVEYSS									VARIANT	T -> M (in a lung carcinoma sample; somatic mutation; dbSNP:rs372594677)	16941478	1
P29320/V133E	P29320	EPHA3	EPHA3_HUMAN	V133E	-	-	-	loss	DDDHGvFREHQ									MUTAGEN	V->E: Loss of EFNA5-binding ability and function.	14660665	1
P29320/W924R	P29320	EPHA3	EPHA3_HUMAN	W924R	-	-	-	neutral	WLNGVwAHCKE									VARIANT	W -> R (in dbSNP:rs35124509)	1311845,17344846	2
P29320/Y596F	P29320	EPHA3	EPHA3_HUMAN	Y596F	4	N-term-β1	p	-	PGLRTyDPHTY	0.838	0.802	0.541	0.682	0.566	0.682	0.551	0.241	MUTAGEN	Y->F: 10-fold suppression of kinase activity; when associated with F-602. Full kinase activity; when associated with F-602 and F-742. Full kinase activity; when associated with F-602 and A-768.	18547520	1
P29320/Y602F	P29320	EPHA3	EPHA3_HUMAN	Y602F	10	N-term-β1	p	-	VDPHTyDPTQA	0.809	0.86	0.538	0.78	0.515	0.717	0.521	0.377	MUTAGEN	Y->F: 10-fold suppression of kinase activity; when associated with F-596. Full kinase activity; when associated with F-596 and F-742. Full kinase activity; when associated with F-596 and A-768.	18547520	1
P29320/Y742F	P29320	EPHA3	EPHA3_HUMAN	Y742F	438	Catalytic-loop	p	-	LSDMGyHRDLA	0.667	0.726	0.443	0.544	0.381	0.542	0.56	0.085	MUTAGEN	Y->F: Full kinase activity; when associated with F-596 and F-602.	18547520	1
P29322/E612Q	P29322	EPHA8	EPHA8_HUMAN	E612Q	7	N-term-β1	-	neutral	PQFYAeHTYEE	0.433	0.34	0.517	0.327	0.37	0.285	0.598	0.337	VARIANT	E -> Q (in dbSNP:rs999765)	10819331	1
P29322/G45S	P29322	EPHA8	EPHA8_HUMAN	G45S	-	-	-	neutral	IHGDWgLTYPA									VARIANT	G -> S (in dbSNP:rs45498698)	17344846	1
P29322/N123K	P29322	EPHA8	EPHA8_HUMAN	N123K	-	-	-	-	CKETFnYYLES									VARIANT	N -> K (in a breast infiltrating ductal carcinoma sample; somatic mutation)	17344846	1
P29322/P321L	P29322	EPHA8	EPHA8_HUMAN	P321L	-	-	-	neutral	AALDPpSACTR									VARIANT	P -> L (in dbSNP:rs56656925)		0
P29322/P860L	P29322	EPHA8	EPHA8_HUMAN	P860L	757	αG/αH	-	-	YRLPApGCPHA	0.681	0.67	0.506	0.485	0.558	0.573	0.486	0.431	VARIANT	P -> L (in a metastatic melanoma sample; somatic mutation)	17344846	1
P29322/R179C	P29322	EPHA8	EPHA8_HUMAN	R179C	-	-	-	-	GPLSKrFYLAF									VARIANT	R -> C (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs1557556639)	17344846	1
P29322/R198L	P29322	EPHA8	EPHA8_HUMAN	R198L	-	-	-	-	AILSLrYYKKC									VARIANT	R -> L (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
P29322/V444M	P29322	EPHA8	EPHA8_HUMAN	V444M	-	-	-	-	APSQVvIRQER									VARIANT	V -> M (in dbSNP:rs2295021)		0
P29322/V60L	P29322	EPHA8	EPHA8_HUMAN	V60L	-	-	-	-	DSINEvESFQP									VARIANT	V -> L (in dbSNP:rs56402644)	17344846	1
P29323/A279S	P29323	EPHB2	EPHB2_HUMAN	A279S	-	-	-	-	SGTFKaQGDEA									VARIANT	A -> S (in prostate cancer; dbSNP:rs35882952)	15300251,16155194,17344846	3
P29323/C289G	P29323	EPHB2	EPHB2_HUMAN	C289G	-	-	-	-	EACTHcINSRT									VARIANT	C -> G	17344846	1
P29323/D678N	P29323	EPHB2	EPHB2_HUMAN	D678N	190	αC/β4-loop	-	-	IMGQFdPNVIH	0.337	0.327	0.556	0.351	0.291	0.258	0.673	0.226	VARIANT	D -> N (in dbSNP:rs28936395)	17344846	1
P29323/H679N	P29323	EPHB2	EPHB2_HUMAN	H679N	193	αC/β4-loop	-	-	MGQFDhNVIHL	0.781	0.781	0.535	0.703	0.496	0.654	0.523	0.482	VARIANT	H -> N (in prostate cancer)	15300251	1
P29323/I361V	P29323	EPHB2	EPHB2_HUMAN	I361V	-	-	-	-	LVYNIiKSCGS									VARIANT	I -> V (in dbSNP:rs56180036)	17344846	1
P29323/I909M	P29323	EPHB2	EPHB2_HUMAN	I909M	-	-	-	-	LLDRTiDYTSF									VARIANT	I -> M (in prostate cancer)	15300251	1
P29323/K787R	P29323	EPHB2	EPHB2_HUMAN	K787R	548	A-loop	-	-	SALGGkPIRWT	0.589	0.582	0.419	0.456	0.426	0.501	0.53	0.198	MUTAGEN	K->R: No loss of ubiquitination by RNF186.	33280498	1
P29323/K891R	P29323	EPHB2	EPHB2_HUMAN	K891R	822	αI	-	-	NPNSLkMAPLS	0.353	0.309	0.474	0.202	0.279	0.336	0.579	0.152	MUTAGEN	K->R: Complete loss of ubiquitination by RNF186.	33280498	1
P29323/M883V	P29323	EPHB2	EPHB2_HUMAN	M883V	814	αI	-	-	NTLDKmRNPNS	0.649	0.622	0.522	0.526	0.341	0.479	0.611	0.38	VARIANT	M -> V (in prostate cancer; dbSNP:rs372653137)	16155194	1
P29323/R199H	P29323	EPHB2	EPHB2_HUMAN	R199H	-	-	-	-	YRKCPrIQNGA									VARIANT	R -> H (in prostate cancer; dbSNP:rs201754821)	15300251	1
P29323/R745C	P29323	EPHB2	EPHB2_HUMAN	R745C	442	Catalytic-loop;HrD-motif	-	-	MNYVHrLAARN	0.643	0.686	0.509	0.559	0.534	0.594	0.51	0.524	VARIANT	R -> C (in BDPLT22; dbSNP:rs761749948)	30213874	1
P29323/R844W	P29323	EPHB2	EPHB2_HUMAN	R844W	753	αG/αH	-	-	IEQDYrPPPMD	0.865	0.873	0.41	0.662	0.73	0.758	0.322	0.337	VARIANT	R -> W (in dbSNP:rs55826626)	17344846	1
P29323/V650A	P29323	EPHB2	EPHB2_HUMAN	V650A	124	β3	-	-	KREIFvIKTLK	0.76	0.706	0.505	0.679	0.584	0.687	0.501	0.474	VARIANT	V -> A (in prostate cancer; dbSNP:rs142173175)	16155194	1
P29376/C384R	P29376	LTK	LTK_HUMAN	C384R	-	-	-	-	LNCSHcLRDCQ									VARIANT	C -> R (in dbSNP:rs55683312)	17344846	1
P29376/D535N	P29376	LTK	LTK_HUMAN	D535N	88	β2/β3-loop	-	neutral	IGLPGdSPLQV	0.265	0.227	0.494	0.214	0.132	0.157	0.666	0.187	VARIANT	D -> N (in dbSNP:rs35932273)	17344846	1
P29376/E763K	P29376	LTK	LTK_HUMAN	E763K	796	αI	-	increase	QCWQHeELRPS	0.233	0.198	0.638	0.449	0.106	0.123	0.82	0.173	VARIANT	E -> K (may possibly contribute to susceptibility to systemic lupus erythematosus; increases autophosphorylation and interaction with PI3-kinase subunit p85; dbSNP:rs76282169)	14695357	1
P29376/G750E	P29376	LTK	LTK_HUMAN	G750E	782	αH	-	increase	PRGCPgVYRIM	0.475	0.444	0.682	0.611	0.105	0.274	0.775	0.257	MUTAGEN	G->E: Increases autophosphorylation and interaction with PI3-kinase subunit p85 (demonstrated with chimeric EGFR-LTK).	14695357	1
P29376/K544M	P29376	LTK	LTK_HUMAN	K544M	129	β3;Catalytic-Lys	-	loss	LQVAIkLPELC	0.978	1.0	0.035	0.61	0.993	0.997	0.031	0.462	MUTAGEN	K->M: Loss of interaction with PLCG1, PI3-kinase subunit p85, Ras GTPase-activating protein and RAF1.	8084603	1
P29376/P745S	P29376	LTK	LTK_HUMAN	P745S	757	αG/αH	-	-	GRMDPpGCPGP	0.866	0.783	0.512	0.583	0.606	0.683	0.433	0.626	VARIANT	P -> S (in dbSNP:rs55900837)	17344846	1
P29376/P838S	P29376	LTK	LTK_HUMAN	P838S	-	-	-	-	GSPLGpLSSGL									VARIANT	P -> S (in dbSNP:rs56367146)	17344846	1
P29376/R241A	P29376	LTK	LTK_HUMAN	R241A	-	-	-	loss	GRAYLrRDRGR									MUTAGEN	R->A: Abolished homodimerization following interaction with ALKAL1.	34646012	1
P29376/R42Q	P29376	LTK	LTK_HUMAN	R42Q	-	-	-	neutral	ASPSPrPKVSA									VARIANT	R -> Q (in dbSNP:rs2305030)	17344846,7685902	2
P29376/R569S	P29376	LTK	LTK_HUMAN	R569S	190	αC/β4-loop	-	neutral	IISKFrQNIVR	0.209	0.181	0.532	0.232	0.23	0.191	0.633	0.132	VARIANT	R -> S (in dbSNP:rs148513655)	17344846	1
P29376/R673Q	P29376	LTK	LTK_HUMAN	R673Q	508	A-loop	-	-	ARDIYrSYYRR	0.383	0.34	0.506	0.36	0.229	0.289	0.581	0.194	VARIANT	R -> Q (in dbSNP:rs55876255)	17344846	1
P29376/Y753F	P29376	LTK	LTK_HUMAN	Y753F	786	αH	-	loss	CPGPVyIMTQC	0.74	0.686	0.499	0.513	0.532	0.642	0.499	0.422	MUTAGEN	Y->F: Abolishes interaction with PI3-kinase subunit p85, impairs PI3 kinase activity and leads to apoptosis (demonstrated with chimeric EGFR-LTK).	9223670	1
P29376/Y862F	P29376	LTK	LTK_HUMAN	Y862F	-	-	-	decrease	LWNPTyS									MUTAGEN	Y->F: Impairs phosphorylation of CBLC (demonstrated with chimeric EGFR-LTK).	9223670	1
P29597/A81V	P29597	TYK2	TYK2_HUMAN	A81V	-	-	-	-	LFDAQaVWLPP									VARIANT	A -> V (in dbSNP:rs1049619)		0
P29597/A928V	P29597	TYK2	TYK2_HUMAN	A928V	127	β3	-	neutral	TGEMVaKALKA	0.506	0.456	0.415	0.419	0.432	0.452	0.445	0.459	VARIANT	A -> V (in dbSNP:rs35018800)	17344846	1
P29597/D1023N	P29597	TYK2	TYK2_HUMAN	D1023N	443	Catalytic-loop;HrD-motif	-	loss	HYIHRdAARNV	0.975	0.996	0.233	0.625	0.895	0.937	0.167	0.482	MUTAGEN	D->N: Complete loss of catalytic activity.	24843152	1
P29597/E1163G	P29597	TYK2	TYK2_HUMAN	E1163G	804	αI	-	neutral	FRPTFeLIPIL	0.145	0.132	0.454	0.15	0.131	0.122	0.591	0.135	VARIANT	E -> G (in dbSNP:rs55886939)	17344846	1
P29597/G363S	P29597	TYK2	TYK2_HUMAN	G363S	-	-	-	neutral	AHKAVgPADRP									VARIANT	G -> S (in dbSNP:rs2304255)	17344846	1
P29597/H732R	P29597	TYK2	TYK2_HUMAN	H732R	-	-	-	-	NKNLVhNVCGR									VARIANT	H -> R (in a colorectal adenocarcinoma sample; somatic mutation)	17344846	1
P29597/I684S	P29597	TYK2	TYK2_HUMAN	I684S	-	-	-	-	RGPENiVTEYV									VARIANT	I -> S (in dbSNP:rs12720356)	17344846,2216457	2
P29597/K930R	P29597	TYK2	TYK2_HUMAN	K930R	129	β3	-	loss	EMVAVkLKADC	1.0	1.0	0.044	0.716	0.991	0.997	0.02	0.406	MUTAGEN	K->R: Complete loss of catalytic activity.	8702790	1
P29597/P1104A	P29597	TYK2	TYK2_HUMAN	P1104A	637	αF/αG	-	neutral	DSSQSpTKFLE	0.422	0.314	0.545	0.365	0.243	0.343	0.537	0.378	VARIANT	P -> A (in dbSNP:rs34536443)	17344846	1
P29597/P820H	P29597	TYK2	TYK2_HUMAN	P820H	-	-	-	neutral	LQSRSpEKEHF									VARIANT	P -> H (in dbSNP:rs34046749)		0
P29597/R197H	P29597	TYK2	TYK2_HUMAN	R197H	-	-	-	neutral	CHLALrGIPLE									VARIANT	R -> H (in dbSNP:rs12720263)		0
P29597/R442Q	P29597	TYK2	TYK2_HUMAN	R442Q	-	-	-	-	EVAPPrVMSIR									VARIANT	R -> Q (in dbSNP:rs2304254)		0
P29597/R4H	P29597	TYK2	TYK2_HUMAN	R4H	-	-	-	-	MPLrWGMAR									VARIANT	R -> H (in dbSNP:rs12720343)		0
P29597/R703W	P29597	TYK2	TYK2_HUMAN	R703W	-	-	-	-	WLRRErHVPMA									VARIANT	R -> W (in dbSNP:rs55882956)	17344846	1
P29597/V362F	P29597	TYK2	TYK2_HUMAN	V362F	-	-	-	neutral	KAHKAvQPADR									VARIANT	V -> F (in dbSNP:rs2304256)	17344846,2216457	2
P29597/V386M	P29597	TYK2	TYK2_HUMAN	V386M	-	-	-	-	RDITHvLKEHC									VARIANT	V -> M (in dbSNP:rs55956017)	17344846	1
P29597/Y1054F	P29597	TYK2	TYK2_HUMAN	Y1054F	512	A-loop	p	decrease	PEGHEyRVRED	0.953	0.938	0.611	0.894	0.62	0.838	0.559	0.467	MUTAGEN	Y->F: Reduces basal catalytic activity and abolishes IFN-dependent activation.	8702790	1
P29597/Y1055F	P29597	TYK2	TYK2_HUMAN	Y1055F	513	A-loop	p	decrease	EGHEYyVREDG	0.879	0.907	0.383	0.785	0.829	0.891	0.21	0.601	MUTAGEN	Y->F: Reduces basal catalytic activity and abolishes IFN-dependent activation.	8702790	1
P29597/Y1145F	P29597	TYK2	TYK2_HUMAN	Y1145F	786	αH	-	-	CPCEVyLMKNC	0.707	0.653	0.476	0.518	0.571	0.573	0.535	0.329	MUTAGEN	Y->F: Does not affect phosphorylation state and enzymatic activity.	8702790	1
P29597/Y1176F	P29597	TYK2	TYK2_HUMAN	Y1176F	820	αI	-	-	TVHEKyGQAPS	0.62	0.575	0.569	0.486	0.261	0.449	0.656	0.324	MUTAGEN	Y->F: Does not affect phosphorylation state and enzymatic activity.	8702790	1
P30291/G210C	P30291	WEE1	WEE1_HUMAN	G210C	-	-	-	neutral	SVKLRgSLFMD									VARIANT	G -> C (in dbSNP:rs34412975)	17344846	1
P30291/K328R	P30291	WEE1	WEE1_HUMAN	K328R	129	β3;Catalytic-Lys	-	loss	CIYAIkSKKPL	1.0	0.994	0.034	0.663	0.992	0.991	0.016	0.464	MUTAGEN	K->R: Abolishes activity.	8428596	1
P30291/S123A	P30291	WEE1	WEE1_HUMAN	S123A	-	-	p	-	GFGSSsVKSPA									MUTAGEN	S->A: Abolishes phosphorylation by PLK1 and CDK1 and binding of the SCF(BTRC) complex, leading to stabilization of the protein; when associated with A-53.	15070733	1
P30291/S472I	P30291	WEE1	WEE1_HUMAN	S472I	512	A-loop	p	-	VTRISsQVEEG	0.797	0.797	0.693	0.746	0.471	0.65	0.65	0.534	VARIANT	S -> I (in dbSNP:rs56411856)	17344846	1
P30291/S53A	P30291	WEE1	WEE1_HUMAN	S53A	-	-	p	-	STGEDsFQEPD									MUTAGEN	S->A: Abolishes phosphorylation by PLK1 and CDK1 and binding of the SCF(BTRC) complex, leading to stabilization of the protein; when associated with A-123.	15070733	1
P30291/S642A	P30291	WEE1	WEE1_HUMAN	S642A	-	-	p	loss	MNRSVsTIY									MUTAGEN	S->A: Abolishes phosphorylation by BRSK1 and BRSK2.	20026642	1
P30530/D266N	P30530	AXL	UFO_HUMAN	D266N	-	-	-	-	QAVLSdGMGIQ									VARIANT	D -> N (in dbSNP:rs7249222)		0
P30530/E63R	P30530	AXL	UFO_HUMAN	E63R	-	-	-	decrease	LQVQGePEVHW									MUTAGEN	E->R: Slightly reduced affinity for GAS6.	16362042	1
P30530/E66R	P30530	AXL	UFO_HUMAN	E66R	-	-	-	decrease	QGEPPeHWLRD									MUTAGEN	E->R: Reduced affinity for GAS6.	16362042	1
P30530/K567M	P30530	AXL	UFO_HUMAN	K567M	129	β3;Catalytic-Lys	-	loss	LKVAVkMKIAI	0.992	1.0	0.035	0.65	0.993	0.999	0.019	0.547	MUTAGEN	K->M: Catalytically inactive mutant.	28076778	1
P30530/R295W	P30530	AXL	UFO_HUMAN	R295W	-	-	-	-	PPHQLrGSLHP									VARIANT	R -> W (in a lung neuroendocrine carcinoma sample; somatic mutation; dbSNP:rs751738506)	17344846	1
P30530/R499C	P30530	AXL	UFO_HUMAN	R499C	-	-	-	-	LVVRYrRKSYS									VARIANT	R -> C (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs747576071)	17344846	1
P30530/S515G	P30530	AXL	UFO_HUMAN	S515G	7	N-term-β1	-	-	EATLNsGISEE	0.672	0.651	0.484	0.467	0.52	0.557	0.448	0.474	VARIANT	S -> G (in dbSNP:rs1240393707)	17344846	1
P30530/T112M	P30530	AXL	UFO_HUMAN	T112M	-	-	-	-	LQLSDtQYQCL									VARIANT	T -> M (in dbSNP:rs35202236)	17344846	1
P30530/T84R	P30530	AXL	UFO_HUMAN	T84R	-	-	-	decrease	ADSTQtVPLGE									MUTAGEN	T->R: Reduced affinity for GAS6.	16362042	1
P31152/R371P	P31152	MAPK4	MK04_HUMAN	R371P	-	-	-	-	EWRPDrQDASE									VARIANT	R -> P (in dbSNP:rs3752089)	17344846	1
P31152/V38M	P31152	MAPK4	MK04_HUMAN	V38M	55	β2/β3-loop	-	neutral	LVLSAvSRACR	0.09	0.11	0.487	0.176	0.11	0.105	0.677	0.102	VARIANT	V -> M (in dbSNP:rs3752087)	15489334,17344846	2
P31749/E17K	P31749	AKT1	AKT1_HUMAN	E17K	-	-	-	increase	LHKRGeIKTWR									VARIANT	E->K: No effect on membrane localization. Loss of membrane localization; when associated with Q-20.	21775285	1
P31749/K14A	P31749	AKT1	AKT1_HUMAN	K14A	-	-	m1	decrease	EGWLHkGEYIK									MUTAGEN	K->A: Impairs interaction with PtdIns(3,4,5)P3 and PtdIns(3,4)P2.	12176338,19713527,21775285	3
P31749/K14Q	P31749	AKT1	AKT1_HUMAN	K14Q	-	-	m1	decrease	EGWLHkGEYIK									MUTAGEN	K->Q: Substantial reduction of phosphorylation at T-308 and S-473, loss of AKT activation, and loss of binding to PIP3 as well as IGF1-induced membrane recruitment.	12176338,19713527,21775285	3
P31749/K14R	P31749	AKT1	AKT1_HUMAN	K14R	-	-	m1	decrease	EGWLHkGEYIK									MUTAGEN	K->R: Substantial reduction of ubiquitination, phosphorylation at T-308 and S-473, AKT activation, loss of binding to PIP3 as well as IGF1-induced membrane recruitment.	12176338,19713527,21775285	3
P31749/K179M	P31749	AKT1	AKT1_HUMAN	K179M	129	β3;Catalytic-Lys	-	loss	RYYAMkLKKEV	1.0	0.993	0.015	0.664	1.0	0.998	0.01	0.522	MUTAGEN	K->M: Abolished serine/threonine-protein kinase activity.	33594058	1
P31749/K20Q	P31749	AKT1	AKT1_HUMAN	K20Q	-	-	ac	-	RGEYIkWRPRY									MUTAGEN	K->Q: Substantial reduction of phosphorylation at T-308 and S-473, reduced AKT activation, and reduced binding to PIP3 as well as IGF1-induced membrane recruitment. Loss of membrane localization; when associated with K-17.	21775285	1
P31749/K20R	P31749	AKT1	AKT1_HUMAN	K20R	-	-	ac	increase	RGEYIkWRPRY									MUTAGEN	K->R: Slight increase of phosphorylation at T-308 and S-473.	21775285	1
P31749/K8R	P31749	AKT1	AKT1_HUMAN	K8R	-	-	ub	-	DVAIVkGWLHK									MUTAGEN	K->R: Substantial reduction of ubiquitination, phosphorylation at T-308 and S-473, AKT activation as well as IGF1-induced membrane recruitment. Decrease in ubiquitination and phosphorylation at T-308 as well as impaired association with the membrane; when associated with K-17.	19713527	1
P31749/R25A	P31749	AKT1	AKT1_HUMAN	R25A	-	-	-	decrease	KTWRPrFLLKN									MUTAGEN	R->A,C: Impairs interaction with PtdIns(3,4,5)P3 and PtdIns(3,4)P2.	12176338	1
P31749/R25C	P31749	AKT1	AKT1_HUMAN	R25C	-	-	-	decrease	KTWRPrFLLKN									VARIANT	R->A,C: Impairs interaction with PtdIns(3,4,5)P3 and PtdIns(3,4)P2.	12176338	1
P31749/R86A	P31749	AKT1	AKT1_HUMAN	R86A	-	-	-	decrease	TTVIErFHVET									MUTAGEN	R->A: Impairs interaction with PtdIns(3,4,5)P3 and PtdIns(3,4)P2.	12176338	1
P31749/S473D	P31749	AKT1	AKT1_HUMAN	S473D	-	-	p	activating	HFPQFsSASGT									MUTAGEN	S->D: 7-fold activation and 25-fold activation; when associated with D-308.	12244301,8978681	2
P31749/T305A	P31749	AKT1	AKT1_HUMAN	T305A	542	A-loop	gl	increase	IKDGAtKTFCG	0.673	0.651	0.556	0.726	0.293	0.502	0.627	0.249	MUTAGEN	T->A: Reduces O-GlcNAc levels; Reduces O-GlcNAc levels even more; when associated with A-312.	22629392	1
P31749/T305Y	P31749	AKT1	AKT1_HUMAN	T305Y	542	A-loop	gl	loss	IKDGAtKTFCG	0.741	0.702	0.61	0.698	0.419	0.598	0.641	0.33	MUTAGEN	T->Y: Abolishes phosphorylation at Thr-308.	22629392	1
P31749/T308D	P31749	AKT1	AKT1_HUMAN	T308D	545	A-loop	p	activating	GATMKtCGTPE	0.993	1.0	0.873	0.991	0.102	0.959	0.87	0.384	MUTAGEN	T->D: 5-fold activation and 18-fold activation; when associated with D-473.	12244301,8978681	2
P31749/T312A	P31749	AKT1	AKT1_HUMAN	T312A	549	A-loop	p	increase	KTFCGtEYLAP	0.949	0.951	0.4	0.835	0.64	0.917	0.338	0.468	MUTAGEN	T->A: Reduces O-GlcNAc levels; Reduces O-GlcNAc levels even more; when associated with A-305.	22629392	1
P31749/T312Y	P31749	AKT1	AKT1_HUMAN	T312Y	549	A-loop	p	loss	KTFCGtEYLAP	0.945	0.929	0.337	0.779	0.804	0.925	0.206	0.508	MUTAGEN	T->Y: Abolishes phosphorylation at Thr-308.	22629392	1
P31749/T435P	P31749	AKT1	AKT1_HUMAN	T435P	850	C-term-αI	-	-	TSETDtYFDEE	0.534	0.598	0.58	0.523	0.388	0.404	0.647	0.388	VARIANT	T -> P (in CWS6; dbSNP:rs397514645)	23246288	1
P31749/V167A	P31749	AKT1	AKT1_HUMAN	V167A	53	β2	-	-	GKVILvEKATG	0.5	0.41	0.488	0.466	0.29	0.363	0.55	0.356	VARIANT	V -> A (in dbSNP:rs11555433)		0
P31749/Y176F	P31749	AKT1	AKT1_HUMAN	Y176F	81	β2/β3-loop	p	decrease	ATGRYyMKILK	0.844	0.842	0.425	0.693	0.71	0.696	0.448	0.397	MUTAGEN	Y->F: Significant loss of interaction with TNK2. Loss of membrane localization. Significant reduction in phosphorylation on Ser-473.	20333297	1
P31749/Y474F	P31749	AKT1	AKT1_HUMAN	Y474F	-	-	p	decrease	FPQFSyASGTA									MUTAGEN	Y->F: 55% inhibition of activation.	12149249	1
P31751/E17K	P31751	AKT2	AKT2_HUMAN	E17K	-	-	-	activating	LHKRGeIKTWR									VARIANT	E -> K (in HIHGHH; exhibits plasma membrane localization in serum-starved cells and produced inappropriate tonic nuclear exclusion of FOXO1 in preadipocytes; dbSNP:rs387906659)	21979934	1
P31751/I188V	P31751	AKT2	AKT2_HUMAN	I188V	141	αC	-	-	LRKEViAKDEV	0.405	0.294	0.558	0.336	0.182	0.234	0.685	0.214	VARIANT	I -> V (in dbSNP:rs55859611)	17344846	1
P31751/R208K	P31751	AKT2	AKT2_HUMAN	R208K	184	αC/β4-loop	-	-	VLQNTrPFLTA	0.384	0.304	0.392	0.142	0.428	0.289	0.586	0.106	VARIANT	R -> K (in dbSNP:rs35817154)	17344846	1
P31751/R274H	P31751	AKT2	AKT2_HUMAN	R274H	442	Catalytic-loop;HrD-motif	-	increase	RDVVYrIKLEN	0.902	0.909	0.434	0.773	0.499	0.793	0.434	0.427	VARIANT	R -> H (in T2D; associated with typical metabolic dyslipidemia with elevated fastin triglyceride, high VLDL triglyceride/cholesterol ratios, low HDL cholesterol levels and high small dense LDL levels; de novo lipogenesis and liver fat are also significantly elevated in this subject; dbSNP:rs121434593)	15166380,19164855	2
P31751/S474A	P31751	AKT2	AKT2_HUMAN	S474A	-	-	p	-	HFPQFsSASIR									MUTAGEN	S->A: Impairs interaction with TTC3; when associated with A-309.	15890450,20059950	2
P31751/S474D	P31751	AKT2	AKT2_HUMAN	S474D	-	-	p	-	HFPQFsSASIR									MUTAGEN	S->D: Constitutively active; when associated with E-309.	15890450,20059950	2
P31751/T309A	P31751	AKT2	AKT2_HUMAN	T309A	545	A-loop	p	-	GATMKtCGTPE	0.989	1.0	0.145	0.938	0.951	0.987	0.121	0.381	MUTAGEN	T->A: Impairs interaction with TTC3; when associated with A-474.	15890450,20059950	2
P31751/T309E	P31751	AKT2	AKT2_HUMAN	T309E	545	A-loop	p	-	GATMKtCGTPE	0.993	0.993	0.872	0.975	0.204	0.949	0.854	0.392	MUTAGEN	T->E: Constitutively active; when associated with D-474.	15890450,20059950	2
P32298/A116T	P32298	GRK4	GRK4_HUMAN	A116T	-	-	-	neutral	NDKLAaLPEIP									VARIANT	A -> T (in dbSNP:rs34857805)	17344846	1
P32298/A142V	P32298	GRK4	GRK4_HUMAN	A142V	-	-	-	neutral	NPSKKaEECTR									VARIANT	A -> V (in dbSNP:rs1024323)	17344846	1
P32298/A440V	P32298	GRK4	GRK4_HUMAN	A440V	813	αI	-	-	CRGEGaGVKQH	0.228	0.225	0.625	0.321	0.14	0.165	0.734	0.175	VARIANT	A -> V (in dbSNP:rs747003103)		0
P32298/A495T	P32298	GRK4	GRK4_HUMAN	A495T	-	-	-	-	IYLDTaEDFYA									VARIANT	A -> T (in dbSNP:rs35463176)	17344846	1
P32298/D95H	P32298	GRK4	GRK4_HUMAN	D95H	-	-	-	-	YEVADdDRSDC									VARIANT	D -> H (in dbSNP:rs13305979)		0
P32298/H383Q	P32298	GRK4	GRK4_HUMAN	H383Q	618	αF	-	-	EMIQGhPFKKY	0.222	0.129	0.503	0.179	0.151	0.131	0.712	0.164	VARIANT	H -> Q (in dbSNP:rs55852353)	17344846	1
P32298/L425P	P32298	GRK4	GRK4_HUMAN	L425P	793	αH	-	-	ICRMLlKNPSK	0.842	0.857	0.412	0.692	0.696	0.796	0.387	0.659	VARIANT	L -> P	17344846	1
P32298/R65L	P32298	GRK4	GRK4_HUMAN	R65L	-	-	-	neutral	QPIGRrFRQFC									VARIANT	R -> L (in dbSNP:rs2960306)	17344846	1
P32298/T183R	P32298	GRK4	GRK4_HUMAN	T183R	27	N-term-β1	-	-	ERQPVtNTFRH	0.707	0.679	0.561	0.595	0.402	0.6	0.562	0.462	VARIANT	T -> R (in dbSNP:rs45538934)		0
P32298/V247I	P32298	GRK4	GRK4_HUMAN	V247I	200	β4	-	-	VQSRFvSLAYA	0.21	0.135	0.568	0.272	0.111	0.132	0.723	0.164	VARIANT	V -> I (in dbSNP:rs1140085)	17344846	1
P32298/V473I	P32298	GRK4	GRK4_HUMAN	V473I	847	C-term-αI	-	-	PDPHAvCKDVL	0.141	0.175	0.441	0.15	0.15	0.125	0.64	0.115	VARIANT	V -> I (in dbSNP:rs35024854)	17344846	1
P32298/V486A	P32298	GRK4	GRK4_HUMAN	V486A	-	-	-	neutral	IEQFSvKGIYL									VARIANT	V -> A (in dbSNP:rs1801058)	1338872,15489334,17344846,8135832,8626439,9092566	6
P33981/A97V	P33981	TTK	TTK_HUMAN	A97V	-	-	-	neutral	SQAIEaPPDKY									VARIANT	A -> V (in dbSNP:rs2230513)		0
P33981/D664A	P33981	TTK	TTK_HUMAN	D664A	496	A-loop;DFG-motif	-	loss	MLKLIdGIANQ	0.981	0.98	0.089	0.555	0.99	0.977	0.053	0.735	MUTAGEN	D->A: Loss of kinase activity.	18243099,18480048	2
P33981/D758N	P33981	TTK	TTK_HUMAN	D758N	683	αG/αH	-	-	EIEFPdPEKDL	0.14	0.152	0.459	0.252	0.159	0.159	0.69	0.187	VARIANT	D -> N (in dbSNP:rs2230512)		0
P33981/T686A	P33981	TTK	TTK_HUMAN	T686A	549	A-loop	p	loss	DSQVGtNYMPP	0.969	0.968	0.252	0.79	0.881	0.926	0.186	0.469	MUTAGEN	T->A: Loss of kinase activity.	18480048	1
P34925/A485G	P34925	RYK	RYK_HUMAN	A485G	498	A-loop;DFG-motif	-	increase	KITDNaSRDLF	0.579	0.512	0.653	0.56	0.161	0.352	0.803	0.222	MUTAGEN	A->G: Gain of an autophosphorylation activity. Gain of an autophosphorylation activity; when associated with G-334 and F-481.	10454588	1
P34925/K364A	P34925	RYK	RYK_HUMAN	K364A	129	β3;Catalytic-Lys	-	-	KQAFVkVKDQA	0.999	0.993	0.011	0.602	0.991	0.999	0.003	0.659	MUTAGEN	K->A: No induction of the MAPK pathway.	10454588	1
P34925/N484F	P34925	RYK	RYK_HUMAN	N484F	497	A-loop;DFG-motif	-	increase	VKITDnLSRDL	0.699	0.681	0.544	0.627	0.292	0.605	0.651	0.552	MUTAGEN	N->F: Gain of an autophosphorylation activity. Gain of an autophosphorylation activity; when associated with A-359. Gain of an autophosphorylation activity; when associated with G-334 and G-482.	10454588	1
P34925/R227C	P34925	RYK	RYK_HUMAN	R227C	-	-	-	-	PTTSTrFYISV									VARIANT	R -> C (in dbSNP:rs55740278)	17344846	1
P34925/S99N	P34925	RYK	RYK_HUMAN	S99N	-	-	-	neutral	YALSFsLVPSE									VARIANT	S -> N (in dbSNP:rs1131262)	17344846,8386829,8390040,8726462	4
P34925/V243I	P34925	RYK	RYK_HUMAN	V243I	-	-	-	-	AVIFLvIILAV									VARIANT	V -> I (in an ovarian mucinous carcinoma sample; somatic mutation; dbSNP:rs746238409)	17344846	1
P34947/A119V	P34947	GRK5	GRK5_HUMAN	A119V	-	-	-	neutral	SPVFIaVGQDL									VARIANT	A -> V (in dbSNP:rs55980792)	17344846	1
P34947/D163E	P34947	GRK5	GRK5_HUMAN	D163E	9	N-term-β1	-	-	FHEYLdMFFDR	0.261	0.268	0.478	0.201	0.234	0.316	0.607	0.17	VARIANT	D -> E (in a lung neuroendocrine carcinoma sample; somatic mutation)	17344846	1
P34947/F555A	P34947	GRK5	GRK5_HUMAN	F555A	-	-	-	-	LLQRLfRQHQN									MUTAGEN	F->A: No detectable plasma membrane localization; when associated with A-550; A-551; and A-554.	14976207	1
P34947/G122S	P34947	GRK5	GRK5_HUMAN	G122S	-	-	-	-	FIAQVgDLVSQ									VARIANT	G -> S (in dbSNP:rs55902633)	17344846	1
P34947/K215R	P34947	GRK5	GRK5_HUMAN	K215R	129	β3;Catalytic-Lys	-	decrease	KMYACkLEKKR	0.974	1.0	0.07	0.597	0.971	0.991	0.054	0.36	MUTAGEN	K->R: Failed to phosphorylate p53/TP53.	20124405	1
P34947/K389A	P34947	GRK5	GRK5_HUMAN	K389A	627	αF/αG	-	-	PFRGRkKVKRE	0.632	0.61	0.595	0.527	0.451	0.527	0.614	0.397	MUTAGEN	K->A: Nuclear exclusion; when associated with A-388; A-391; A-393 and A-394.	15542828	1
P34947/K391A	P34947	GRK5	GRK5_HUMAN	K391A	629	αF/αG	-	-	RGRKEkKREEV	0.662	0.645	0.536	0.584	0.482	0.541	0.545	0.308	MUTAGEN	K->A: Nuclear exclusion; when associated with A-388; A-389; A-393 and A-394.	15542828	1
P34947/K393A	P34947	GRK5	GRK5_HUMAN	K393A	636	αF/αG	-	-	RKEKVkEEVDR	0.558	0.526	0.513	0.53	0.334	0.411	0.591	0.211	MUTAGEN	K->A: Nuclear exclusion; when associated with A-388; A-389; A-391 and A-394.	15542828	1
P34947/L141I	P34947	GRK5	GRK5_HUMAN	L141I	-	-	-	neutral	KPCKElSACAQ									VARIANT	L -> I (in dbSNP:rs56254855)	17344846	1
P34947/L550A	P34947	GRK5	GRK5_HUMAN	L550A	-	-	-	-	PPKKGlQRLFK									MUTAGEN	L->A: No detectable plasma membrane localization; when associated with A-551; A-554; and A-555.	14976207	1
P34947/L551A	P34947	GRK5	GRK5_HUMAN	L551A	-	-	-	-	PKKGLlRLFKR									MUTAGEN	L->A: No detectable plasma membrane localization; when associated with A-550; A-554; and A-555.	14976207	1
P34947/L554A	P34947	GRK5	GRK5_HUMAN	L554A	-	-	-	-	GLLQRlKRQHQ									MUTAGEN	L->A: No detectable plasma membrane localization; when associated with A-550; A-551; and A-555.	14976207	1
P34947/Q41L	P34947	GRK5	GRK5_HUMAN	Q41L	-	-	-	neutral	FPHISqEDLRR									VARIANT	Q -> L (exerts a protective effect in heart failure and ischemia; dbSNP:rs2230345)	17344846,18425130	2
P34947/R304H	P34947	GRK5	GRK5_HUMAN	R304H	425	αE	-	neutral	LEDLHrNTVYR	0.254	0.15	0.527	0.285	0.131	0.191	0.721	0.117	VARIANT	R -> H (in dbSNP:rs2230349)	17344846	1
P34947/R388A	P34947	GRK5	GRK5_HUMAN	R388A	625	αF/αG	-	-	SPFRGrEKVKR	0.661	0.646	0.58	0.629	0.475	0.532	0.574	0.258	MUTAGEN	R->A: Nuclear exclusion; when associated with A-389; A-391; A-393 and A-394.	15542828	1
P34947/R394A	P34947	GRK5	GRK5_HUMAN	R394A	637	αG	-	-	KEKVKrEVDRR	0.707	0.616	0.449	0.601	0.477	0.533	0.464	0.46	MUTAGEN	R->A: Nuclear exclusion; when associated with A-388; A-389; A-391 and A-393.	15542828	1
P34947/S484A	P34947	GRK5	GRK5_HUMAN	S484A	-	-	p	-	DIEQFsVKGVN									MUTAGEN	S->A: 15-20 fold defects in kinase activity; when associated with A-485.	8144599	1
P34947/T129M	P34947	GRK5	GRK5_HUMAN	T129M	-	-	-	-	DLVSQtEKLLQ									VARIANT	T -> M (in dbSNP:rs34679178)	17344846	1
P34947/T485A	P34947	GRK5	GRK5_HUMAN	T485A	-	-	p	-	IEQFStKGVNL									MUTAGEN	T->A: 15-20 fold defects in kinase activity; when associated with A-484.	8144599	1
P35590/A1104V	P35590	TIE1	TIE1_HUMAN	A1104V	810	αI	-	-	PFAQIaQLGRM	0.125	0.119	0.583	0.218	0.077	0.077	0.731	0.105	VARIANT	A -> V (in dbSNP:rs35573981)	17344846	1
P35590/E1061K	P35590	TIE1	TIE1_HUMAN	E1061K	643	αG	-	-	GMTCAeYEKLP	0.511	0.526	0.506	0.472	0.306	0.351	0.598	0.31	VARIANT	E -> K (in LMPHM11; unknown pathological significance; dbSNP:rs760492428)	32947856	1
P35590/R1109H	P35590	TIE1	TIE1_HUMAN	R1109H	815	αI	-	-	ALQLGrLEARK	0.266	0.259	0.485	0.28	0.217	0.187	0.648	0.23	VARIANT	R -> H (in LMPHM11; unknown pathological significance; dbSNP:rs34993202)	17344846,32947856	2
P35590/R481C	P35590	TIE1	TIE1_HUMAN	R481C	-	-	-	-	PISTVrHYRPQ									VARIANT	R -> C (in LMPHM11; unknown pathological significance; dbSNP:rs139244400)	32947856	1
P35590/V448M	P35590	TIE1	TIE1_HUMAN	V448M	-	-	-	-	VKVPPvLAAPR									VARIANT	V -> M (in dbSNP:rs56302794)	17344846	1
P35626/N60S	P35626	GRK3	ARBK2_HUMAN	N60S	-	-	-	-	FDKIFnKIGFL									VARIANT	N -> S (in dbSNP:rs55740593)	17344846	1
P35626/R104K	P35626	GRK3	ARBK2_HUMAN	R104K	-	-	-	-	EDRLCrRQIYD									VARIANT	R -> K (in a lung bronchoalveolar carcinoma sample; somatic mutation)	17344846	1
P35626/R50S	P35626	GRK3	ARBK2_HUMAN	R50S	-	-	-	-	KYLAErEITFD									VARIANT	R -> S (in dbSNP:rs55700971)	17344846	1
P35626/V409M	P35626	GRK3	ARBK2_HUMAN	V409M	673	αG/αH	-	-	RMTLTvVELPD	0.151	0.209	0.482	0.205	0.116	0.146	0.712	0.085	VARIANT	V -> M (in dbSNP:rs2272859)		0
P35916/A855T	P35916	FLT4	VGFR3_HUMAN	A855T	43	Gly-rich-loop;β1/β2-loop	-	decrease	VLGYGaGKVVE	0.729	0.721	0.517	0.592	0.506	0.616	0.553	0.386	VARIANT	A -> T (in LMPHM1; recessive form; results in reduced autophosphorylation; results in impaired ligand-induced receptor internalization and downstream signaling; dbSNP:rs121909657)	19289394	1
P35916/D1049N	P35916	FLT4	VGFR3_HUMAN	D1049N	482	Catalytic-loop	-	-	LLSESdVKICD	0.231	0.228	0.402	0.173	0.215	0.197	0.592	0.242	VARIANT	D -> N (in dbSNP:rs56310180)	17344846	1
P35916/E1106K	P35916	FLT4	VGFR3_HUMAN	E1106K	610	αF	-	-	GVLLWeFSLGA	0.774	0.86	0.325	0.677	0.657	0.697	0.323	0.523	VARIANT	E -> K (in LMPHM1; dbSNP:rs121909656)	16924388	1
P35916/G857R	P35916	FLT4	VGFR3_HUMAN	G857R	45	Gly-rich-loop;β2	-	loss	GYGAFgVVEAS	0.939	0.924	0.22	0.636	0.882	0.875	0.22	0.622	VARIANT	G -> R (in LMPHM1; loss of kinase activity; dbSNP:rs267606818)	10835628,15102829	2
P35916/H1035Q	P35916	FLT4	VGFR3_HUMAN	H1035Q	441	Catalytic-loop;HrD-motif	-	-	SRKCIhDLAAR	0.766	0.867	0.281	0.655	0.756	0.832	0.274	0.406	VARIANT	H -> Q (probable disease-associated variant found in sporadic congenital lymphedema; de novo mutation)	16965327	1
P35916/H1035R	P35916	FLT4	VGFR3_HUMAN	H1035R	441	Catalytic-loop;HrD-motif	-	loss	SRKCIhDLAAR	0.826	0.883	0.287	0.629	0.857	0.842	0.254	0.48	VARIANT	H -> R (in LMPHM1; loss of kinase activity; dbSNP:rs121909653)	10856194	1
P35916/H868Y	P35916	FLT4	VGFR3_HUMAN	H868Y	74	β2/β3-loop	-	-	SAFGIhGSSCD	0.215	0.156	0.672	0.365	0.078	0.097	0.783	0.186	VARIANT	H -> Y (in dbSNP:rs35171798)	17344846	1
P35916/H890Q	P35916	FLT4	VGFR3_HUMAN	H890Q	140	αC	-	neutral	ATASEhALMSE	0.191	0.151	0.522	0.246	0.112	0.127	0.676	0.187	VARIANT	H -> Q (in dbSNP:rs448012)	11807987,14702039,8386825	3
P35916/I1086T	P35916	FLT4	VGFR3_HUMAN	I1086T	559	αF	-	-	MAPESiDKVYT	0.876	0.783	0.44	0.565	0.579	0.654	0.424	0.633	VARIANT	I -> T (in LMPHM1; dbSNP:rs121909655)	16965327	1
P35916/K516A	P35916	FLT4	VGFR3_HUMAN	K516A	-	-	-	-	VEGKNkVSKLV									MUTAGEN	K->A: Decreases autophosphorylation on tyrosine residues upon ligand binding; when associated with E-446. Abolishes autophosphorylation on tyrosine residues upon ligand binding; when associated with E-446 and A-737.	23878260	1
P35916/K879G	P35916	FLT4	VGFR3_HUMAN	K879G	129	β3;Catalytic-Lys	-	loss	DTVAVkLKEGA	1.0	0.982	0.069	0.632	0.98	0.991	0.043	0.547	MUTAGEN	K->G: Abolishes enzyme activity.	12881528	1
P35916/L1044P	P35916	FLT4	VGFR3_HUMAN	L1044P	450	Catalytic-loop	-	loss	AARNIlSESDV	0.895	0.886	0.423	0.702	0.769	0.814	0.394	0.676	VARIANT	L -> P (in LMPHM1; loss of kinase activity; dbSNP:rs121909651)	10835628	1
P35916/L1173V	P35916	FLT4	VGFR3_HUMAN	L1173V	815	αI	-	-	ILGDLlGRGLQ	0.471	0.484	0.554	0.518	0.222	0.324	0.683	0.417	VARIANT	L -> V (in CHTD7; unknown pathological significance)	30232381	1
P35916/N149D	P35916	FLT4	VGFR3_HUMAN	N149D	-	-	-	neutral	DTLLVnKDAMW									VARIANT	N -> D (in dbSNP:rs34221241)	17344846	1
P35916/N527S	P35916	FLT4	VGFR3_HUMAN	N527S	-	-	-	neutral	VIQNAnSAMYK									VARIANT	N -> S (in dbSNP:rs35874891)	17344846	1
P35916/P1114L	P35916	FLT4	VGFR3_HUMAN	P1114L	633	αF/αG	-	loss	SLGASpPGVQI	0.73	0.693	0.374	0.584	0.71	0.679	0.334	0.484	VARIANT	P -> L (in LMPHM1; loss of kinase activity; dbSNP:rs121909652)	10835628,9817924	2
P35916/P1137S	P35916	FLT4	VGFR3_HUMAN	P1137S	757	αG/αH	-	-	TRMRApLATPA	0.76	0.694	0.46	0.53	0.574	0.669	0.38	0.536	VARIANT	P -> S (in HCI)	11807987	1
P35916/P641S	P35916	FLT4	VGFR3_HUMAN	P641S	-	-	-	neutral	LSLSIpVAPEH									VARIANT	P -> S (in dbSNP:rs55667289)	10835628,17344846	2
P35916/P954S	P35916	FLT4	VGFR3_HUMAN	P954S	308	αD/αE-loop	-	-	CAEKSpQRGRF	0.167	0.122	0.471	0.176	0.141	0.111	0.614	0.178	VARIANT	P -> S (in HCI; dbSNP:rs34255532)	11807987	1
P35916/Q1020L	P35916	FLT4	VGFR3_HUMAN	Q1020L	409	αE	-	-	VCYSFqARGME	0.851	0.876	0.357	0.592	0.676	0.791	0.275	0.559	VARIANT	Q -> L (in LMPHM1)	17458866	1
P35916/R1031Q	P35916	FLT4	VGFR3_HUMAN	R1031Q	427	αE	-	-	EFLASrCIHRD	0.399	0.464	0.566	0.464	0.264	0.353	0.66	0.228	VARIANT	R -> Q (in dbSNP:rs56082504)	17344846	1
P35916/R1041P	P35916	FLT4	VGFR3_HUMAN	R1041P	447	Catalytic-loop	-	loss	RDLAArILLSE	0.946	0.865	0.375	0.651	0.85	0.844	0.272	0.516	VARIANT	R -> P (in LMPHM1; loss of kinase activity; dbSNP:rs121909650)	10835628,12881528	2
P35916/R1075Q	P35916	FLT4	VGFR3_HUMAN	R1075Q	540	A-loop	-	-	RKGSArPLKWM	0.5	0.511	0.463	0.45	0.352	0.396	0.542	0.36	VARIANT	R -> Q (in dbSNP:rs1400220848)	17344846	1
P35916/R1146H	P35916	FLT4	VGFR3_HUMAN	R1146H	787	αH	-	neutral	TPAIRrMLNCW	0.061	0.063	0.386	0.092	0.069	0.073	0.679	0.049	VARIANT	R -> H (in dbSNP:rs1130379)	11807987,17344846,8386825	3
P35916/R378C	P35916	FLT4	VGFR3_HUMAN	R378C	-	-	-	-	KALSGrSPHAL									VARIANT	R -> C (in a renal clear cell carcinoma sample; somatic mutation; dbSNP:rs372947534)	17344846	1
P35916/R737A	P35916	FLT4	VGFR3_HUMAN	R737A	-	-	-	-	KLSIQrREEDA									MUTAGEN	R->A: Decreases autophosphorylation on tyrosine residues upon ligand binding. Abolishes autophosphorylation on tyrosine residues upon ligand binding; when associated with E-446 and A-516.	23878260	1
P35916/S1235C	P35916	FLT4	VGFR3_HUMAN	S1235C	-	-	-	-	YYNWVsPGCLA									VARIANT	S -> C (in LMPHM1; recessive form)	26091405	1
P35916/T1010I	P35916	FLT4	VGFR3_HUMAN	T1010I	398	αE	-	-	WLSPLtEDLVC	0.671	0.63	0.647	0.648	0.347	0.495	0.666	0.34	VARIANT	T -> I (in a metastatic melanoma sample; somatic mutation)	17344846	1
P35916/T446E	P35916	FLT4	VGFR3_HUMAN	T446E	-	-	-	-	QALTCtYGVPL									MUTAGEN	T->E: Decreases autophosphorylation on tyrosine residues upon ligand binding; when associated with A-516. Abolishes autophosphorylation on tyrosine residues upon ligand binding; when associated with A-516 and A-737.	23878260	1
P35916/T494A	P35916	FLT4	VGFR3_HUMAN	T494A	-	-	-	neutral	WRAVTtDAVNP									VARIANT	T -> A (in dbSNP:rs307826)	11807987,17344846	2
P35916/V878M	P35916	FLT4	VGFR3_HUMAN	V878M	128	β3	-	-	CDTVAvMLKEG	0.64	0.64	0.463	0.606	0.503	0.617	0.53	0.524	VARIANT	V -> M (in LMPHM1; dbSNP:rs121909654)	16965327	1
P35916/Y1063F	P35916	FLT4	VGFR3_HUMAN	Y1063F	507	A-loop	p	-	LARDIyDPDYV	0.846	0.833	0.66	0.805	0.456	0.687	0.679	0.644	MUTAGEN	Y->F: Loss of phosphorylation site. No effect on stimulation of cell proliferation and cell migration.	16076871,20431062	2
P35916/Y1068F	P35916	FLT4	VGFR3_HUMAN	Y1068F	512	A-loop	p	loss	YKDPDyRKGSA	0.946	0.964	0.568	0.831	0.693	0.899	0.526	0.57	MUTAGEN	Y->F: Global loss of autophosphorylation. Abolishes stimulation of cell proliferation and cell migration.	16076871,20431062	2
P35916/Y1230F	P35916	FLT4	VGFR3_HUMAN	Y1230F	-	-	p	decrease	SLAARyNWVSF									MUTAGEN	Y->F: Loss of phosphorylation site. Strongly reduces stimulation of cell proliferation and cell migration.	12881528,16076871	2
P35916/Y1231F	P35916	FLT4	VGFR3_HUMAN	Y1231F	-	-	p	decrease	LAARYyWVSFP									MUTAGEN	Y->F: Loss of phosphorylation site. Strongly reduces stimulation of cell proliferation and cell migration.	12881528,16076871	2
P35916/Y1265F	P35916	FLT4	VGFR3_HUMAN	Y1265F	-	-	-	-	MTPTTyGSVDN									MUTAGEN	Y->F: Loss of phosphorylation site. No effect on stimulation of cell proliferation and cell migration.	12881528	1
P35916/Y1333F	P35916	FLT4	VGFR3_HUMAN	Y1333F	-	-	-	decrease	GGQVFySEYGE									MUTAGEN	Y->F: Loss of phosphorylation site. Reduced autophosphorylation.	12881528,7675451	2
P35916/Y1337F	P35916	FLT4	VGFR3_HUMAN	Y1337F	-	-	p	decrease	FYNSEyELSEP									MUTAGEN	Y->F: Reduced autophosphorylation. Strongly reduces stimulation of cell proliferation and cell migration.	12881528,20431062,7675451	3
P35968/A1065T	P35968	KDR	VGFR2_HUMAN	A1065T	539	A-loop	-	-	VRKGDaLPLKW	0.22	0.182	0.527	0.291	0.177	0.17	0.66	0.212	VARIANT	A -> T (in dbSNP:rs56302315)	17344846	1
P35968/A248G	P35968	KDR	VGFR2_HUMAN	A248G	-	-	-	-	VLNCTaTELNV									VARIANT	A -> G (in a renal clear cell carcinoma sample; somatic mutation)	17344846	1
P35968/C1045A	P35968	KDR	VGFR2_HUMAN	C1045A	495	Catalytic-loop	-	increase	NVVKIcFGLAR	0.544	0.485	0.526	0.592	0.243	0.388	0.657	0.419	MUTAGEN	C->A: Significantly higher kinase activity.	23199280	1
P35968/C482R	P35968	KDR	VGFR2_HUMAN	C482R	-	-	-	decrease	TNPYPcEWRSV									VARIANT	C -> R (in HCI; associated with disease susceptibility; expression of FLT1 in hemangioma endothelial cells is markedly reduced and KDR activity is increased compared to controls; low FLT1 expression in hemangioma cells is caused by reduced activity of a pathway involving ITGB1, ANTXR1, KDR and NFATC2IP; the mutation predicts to result in loss-of-function and disruption of the normal association of these molecules; dbSNP:rs34231037)	17344846,18931684	2
P35968/D731A	P35968	KDR	VGFR2_HUMAN	D731A	-	-	-	decrease	RVRKEdGLYTC									MUTAGEN	D->A: Strongly reduced autophosphorylation and activation of MAP kinases.	20080685	1
P35968/D814N	P35968	KDR	VGFR2_HUMAN	D814N	8	N-term-β1	-	-	DELPLdHCERL	0.386	0.311	0.481	0.291	0.27	0.326	0.643	0.237	VARIANT	D -> N (in dbSNP:rs35603373)	17344846	1
P35968/G539R	P35968	KDR	VGFR2_HUMAN	G539R	-	-	-	-	NKVGRgRVISF									VARIANT	G -> R (in dbSNP:rs55716939)	17344846	1
P35968/G873R	P35968	KDR	VGFR2_HUMAN	G873R	134	β3/αC-loop	-	-	KMLKEgTHSEH	0.348	0.263	0.502	0.334	0.36	0.251	0.613	0.404	VARIANT	G -> R (in a colorectal cancer sample; somatic mutation)	16959974	1
P35968/K868M	P35968	KDR	VGFR2_HUMAN	K868M	129	β3;Catalytic-Lys	-	loss	RTVAVkLKEGA	0.999	1.0	0.02	0.603	0.991	0.999	0.01	0.604	MUTAGEN	K->M: Loss of enzyme activity.	11387210	1
P35968/L462V	P35968	KDR	VGFR2_HUMAN	L462V	-	-	-	-	HWYWQlEECAN									VARIANT	L -> V (in dbSNP:rs56286620)	17344846	1
P35968/P1147S	P35968	KDR	VGFR2_HUMAN	P1147S	797	αI	-	-	CWHGEpQRPTF	0.686	0.696	0.494	0.518	0.551	0.648	0.49	0.561	VARIANT	P -> S (in HCI; somatic mutation; dbSNP:rs121917766)	11807987	1
P35968/Q472H	P35968	KDR	VGFR2_HUMAN	Q472H	-	-	-	neutral	ANEPSqVSVTN									VARIANT	Q -> H (in dbSNP:rs1870377)	15489334,17344846	2
P35968/R275L	P35968	KDR	VGFR2_HUMAN	R275L	-	-	-	-	KKLVNrLKTQS									VARIANT	R -> L (in a colorectal cancer sample; somatic mutation)	16959974	1
P35968/R726A	P35968	KDR	VGFR2_HUMAN	R726A	-	-	-	decrease	NLTIRrRKEDE									MUTAGEN	R->A: Strongly reduced autophosphorylation and activation of MAP kinases.	20080685	1
P35968/T689M	P35968	KDR	VGFR2_HUMAN	T689M	-	-	-	neutral	IEVSCtSGNPP									VARIANT	T -> M (in dbSNP:rs34038364)	17344846	1
P35968/V136M	P35968	KDR	VGFR2_HUMAN	V136M	-	-	-	-	DQHGVvITENK									VARIANT	V -> M (in dbSNP:rs35636987)	17344846	1
P35968/V297I	P35968	KDR	VGFR2_HUMAN	V297I	-	-	-	neutral	LTIDGvRSDQG									VARIANT	V -> I (in dbSNP:rs2305948)	17344846	1
P35968/V848E	P35968	KDR	VGFR2_HUMAN	V848E	47	β2	-	decrease	GAFGQvEADAF	0.856	0.876	0.417	0.628	0.759	0.809	0.393	0.512	VARIANT	V -> E (strongly reduced autophosphorylation and kinase activity; dbSNP:rs1139776)	10037737,1656371	2
P35968/V952I	P35968	KDR	VGFR2_HUMAN	V952I	316	αD/αE-loop	-	-	QGKDYvAIPVD	0.086	0.092	0.538	0.18	0.072	0.09	0.739	0.068	VARIANT	V -> I (in dbSNP:rs13129474)		0
P35968/Y1054F	P35968	KDR	VGFR2_HUMAN	Y1054F	507	A-loop	p	-	LARDIyDPDYV	0.837	0.839	0.651	0.799	0.499	0.721	0.64	0.64	MUTAGEN	Y->F: Strongly reduced autophosphorylation. Abolishes phosphorylation of downstream signaling proteins; when associated with F-1059.	10102632	1
P35968/Y1059F	P35968	KDR	VGFR2_HUMAN	Y1059F	512	A-loop	p	-	YKDPDyRKGDA	0.956	0.959	0.577	0.847	0.674	0.913	0.513	0.545	MUTAGEN	Y->F: Strongly reduced autophosphorylation. Abolishes phosphorylation of downstream signaling proteins; when associated with F-1054.	10102632	1
P35968/Y1175F	P35968	KDR	VGFR2_HUMAN	Y1175F	825	C-term-αI	p	loss	QDGKDyVLPIS	0.829	0.882	0.553	0.813	0.62	0.804	0.493	0.415	MUTAGEN	Y->F: Abolishes phosphorylation of PLCG1 and MAP kinases in response to VEGFA.	11387210	1
P35968/Y1214F	P35968	KDR	VGFR2_HUMAN	Y1214F	-	-	p	loss	DPKFHyNTAGI									MUTAGEN	Y->F: Loss of phosphorylation site. Abolishes reorganization of the actin cytoskeleton in response to VEGFA.	16966330	1
P35968/Y801F	P35968	KDR	VGFR2_HUMAN	Y801F	-	-	p	loss	ELKTGySIVMD									MUTAGEN	Y->F: Abolishes stimulation of nitric oxide synthesis.	17303569	1
P35968/Y951F	P35968	KDR	VGFR2_HUMAN	Y951F	315	αD/αE-loop	p	loss	RQGKDyGAIPV	0.634	0.766	0.442	0.585	0.476	0.562	0.528	0.173	MUTAGEN	Y->F: Abolishes reorganization of the actin cytoskeleton and cell migration in response to VEGFA.	15962004	1
P35968/Y996F	P35968	KDR	VGFR2_HUMAN	Y996F	393	αD/αE-loop	p	decrease	APEDLyDFLTL	0.702	0.85	0.606	0.649	0.461	0.577	0.573	0.167	MUTAGEN	Y->F: Strongly reduced autophosphorylation. Reduces phosphorylation of PLCG1.	10102632	1
P36507/F57C	P36507	MAP2K2	MP2K2_HUMAN	F57C	18	N-term-β1	-	resistance	KRLEAfTQKAK	0.803	0.784	0.412	0.639	0.697	0.713	0.37	0.582	VARIANT	F -> C (in CFC4; dbSNP:rs121434497)	16439621	1
P36507/F57V	P36507	MAP2K2	MP2K2_HUMAN	F57V	18	N-term-β1	-	-	KRLEAfTQKAK	0.729	0.705	0.416	0.602	0.551	0.588	0.441	0.481	VARIANT	F -> V (in CFC4; dbSNP:rs121434498)	18042262	1
P36507/P128Q	P36507	MAP2K2	MP2K2_HUMAN	P128Q	194	αC/β4-loop	-	increase	HECNSpIVGFY	0.691	0.633	0.619	0.631	0.289	0.529	0.64	0.66	VARIANT	P -> Q (in CFC4; results in increased kinase activity; dbSNP:rs267607230)	20358587	1
P36507/Y134H	P36507	MAP2K2	MP2K2_HUMAN	Y134H	205	β4/β5-loop	-	-	YIVGFyAFYSD	0.668	0.69	0.538	0.628	0.48	0.59	0.556	0.603	VARIANT	Y -> H (in CFC4; dbSNP:rs121434499)	18042262	1
P36888/D324N	P36888	FLT3	FLT3_HUMAN	D324N	-	-	-	neutral	SVARNdGYYTC									VARIANT	D -> N (in dbSNP:rs35602083)	17344846	1
P36888/D358V	P36888	FLT3	FLT3_HUMAN	D358V	-	-	-	-	TNSSEdEIDQY									VARIANT	D -> V (in dbSNP:rs34172843)	17344846	1
P36888/D7G	P36888	FLT3	FLT3_HUMAN	D7G	-	-	-	neutral	PALARdGQLPL									VARIANT	D -> G (in dbSNP:rs12872889)		0
P36888/D835E	P36888	FLT3	FLT3_HUMAN	D835E	505	A-loop	-	activating	FGLARdMSDSN	0.84	0.817	0.751	0.899	0.132	0.402	0.836	0.827	VARIANT	D -> E (in acute lymphoblastic leukemia patients and acute myelogenous leukemia patients; somatic mutation; constitutively activated; dbSNP:rs121913487)	11290608,14504097	2
P36888/D835H	P36888	FLT3	FLT3_HUMAN	D835H	505	A-loop	-	activating,resistance	FGLARdMSDSN	0.857	0.839	0.718	0.915	0.2	0.617	0.787	0.921	VARIANT	D -> H (in acute lymphoblastic leukemia patients and in acute myelogenous leukemia patients; somatic mutation; constitutively activated; dbSNP:rs121913488)	11290608,11442493,14504097	3
P36888/D835N	P36888	FLT3	FLT3_HUMAN	D835N	505	A-loop	-	activating	FGLARdMSDSN	0.84	0.787	0.704	0.899	0.125	0.468	0.818	0.852	VARIANT	D -> N (in acute lymphoblastic leukemia patients and in acute myelogenous leukemia patients; somatic mutation; constitutively activated; dbSNP:rs121913488)	11290608	1
P36888/D835V	P36888	FLT3	FLT3_HUMAN	D835V	505	A-loop	-	activating,resistance	FGLARdMSDSN	0.942	0.917	0.74	0.958	0.207	0.684	0.748	0.9	VARIANT	D -> V (in acute lymphoblastic leukemia patients and in acute myelogenous leukemia patients; somatic mutation; constitutively activated; dbSNP:rs121909646)	11290608	1
P36888/D835Y	P36888	FLT3	FLT3_HUMAN	D835Y	505	A-loop	-	activating,resistance	FGLARdMSDSN	0.916	0.935	0.699	0.926	0.166	0.732	0.747	0.919	VARIANT	D -> Y (in acute lymphoblastic leukemia patients and in acute myelogenous leukemia patients; somatic mutation; constitutively activated; dbSNP:rs121913488)	11290608,11442493,14504097	3
P36888/I417L	P36888	FLT3	FLT3_HUMAN	I417L	-	-	-	neutral	QPGEYiHAEND									VARIANT	I -> L (in dbSNP:rs56090538)		0
P36888/I836M	P36888	FLT3	FLT3_HUMAN	I836M	506	A-loop	-	-	GLARDiSDSNY	0.454	0.47	0.526	0.437	0.322	0.385	0.564	0.345	VARIANT	I -> M (in acute lymphoblastic leukemia patients; somatic mutation; dbSNP:rs121913232)	14504097	1
P36888/K644A	P36888	FLT3	FLT3_HUMAN	K644A	129	β3;Catalytic-Lys	-	loss	IQVAVkLKEKA	1.0	1.0	0.018	0.655	1.0	0.999	0.001	0.671	MUTAGEN	K->A: Abolishes kinase activity.	15831474	1
P36888/T227M	P36888	FLT3	FLT3_HUMAN	T227M	-	-	-	neutral	HELFGtIRCCA									VARIANT	T -> M (in dbSNP:rs1933437)	15489334,17344846,8394751	3
P36888/V158A	P36888	FLT3	FLT3_HUMAN	V158A	-	-	-	-	TILFTvIRNTL									VARIANT	V -> A (in dbSNP:rs56321896)	17344846	1
P36888/V194M	P36888	FLT3	FLT3_HUMAN	V194M	-	-	-	neutral	VPEPIvWVLCD									VARIANT	V -> M (in dbSNP:rs146030737)	18987736	1
P36888/V557I	P36888	FLT3	FLT3_HUMAN	V557I	-	-	-	neutral	LLFIVvTLLIC									VARIANT	V -> I (in dbSNP:rs35958982)	17344846	1
P36888/Y589F	P36888	FLT3	FLT3_HUMAN	Y589F	8	N-term-β1	p	decrease	SSDNEyYVDFR	0.776	0.87	0.592	0.811	0.517	0.796	0.561	0.333	MUTAGEN	Y->F: Reduced phosphorylation of the wild-type kinase in response to ligand binding. No effect on the phosphorylation of the constitutively activated mutant kinase variants. Abolishes activation of STAT5A.	16627759,16684964,9737679	3
P36888/Y591F	P36888	FLT3	FLT3_HUMAN	Y591F	10	N-term-β1	p	decrease	DNEYFyDFREY	0.745	0.791	0.506	0.771	0.484	0.643	0.593	0.203	MUTAGEN	Y->F: No significant effect on tyrosine phosphorylation. Abolishes activation of STAT5A.	16627759,9737679	2
P36888/Y599F	P36888	FLT3	FLT3_HUMAN	Y599F	18	N-term-β1	p	decrease	FREYEyLKWEF	0.932	0.879	0.476	0.798	0.687	0.853	0.498	0.535	MUTAGEN	Y->F: Abolishes interaction with PTPN11/SHP2 and phosphorylation of PTPN11/SHP2.	16684964	1
P36894/A338D	P36894	BMPR1A	BMR1A_HUMAN	A338D	410	αE	-	-	KLAYSaCGLCH	0.751	0.604	0.536	0.528	0.508	0.539	0.639	0.309	VARIANT	A -> D (in JPS; dbSNP:rs199476086)	11536076	1
P36894/C124R	P36894	BMPR1A	BMR1A_HUMAN	C124R	-	-	-	-	RRTIEcRTNLC									VARIANT	C -> R (in JPS; dbSNP:rs199476087)	11536076	1
P36894/C130R	P36894	BMPR1A	BMR1A_HUMAN	C130R	-	-	-	-	CRTNLcQYLQP									VARIANT	C -> R (in JPS; dbSNP:rs1131691168)	12136244	1
P36894/C376Y	P36894	BMPR1A	BMR1A_HUMAN	C376Y	492	Catalytic-loop	-	-	KKNGScIADLG	0.751	0.762	0.54	0.609	0.551	0.635	0.52	0.518	VARIANT	C -> Y (in JPS; dbSNP:rs199476088)	11536076	1
P36894/C82Y	P36894	BMPR1A	BMR1A_HUMAN	C82Y	-	-	-	-	ITNGHcAIIEE									VARIANT	C -> Y (in JPS)	12417513	1
P36894/F58Y	P36894	BMPR1A	BMR1A_HUMAN	F58Y	-	-	-	-	EDTLPfKCYCS									VARIANT	F -> Y (in a renal clear cell carcinoma sample; somatic mutation)	17344846	1
P36894/M460T	P36894	BMPR1A	BMR1A_HUMAN	M460T	637	αG	-	-	LPYYNmPSDPS	0.491	0.386	0.541	0.383	0.216	0.254	0.639	0.297	VARIANT	M -> T (found in a patient with tubular adenoma and rectal neuroendocrine tumor; unknown pathological significance; dbSNP:rs758309022)	25860647	1
P36894/M470T	P36894	BMPR1A	BMR1A_HUMAN	M470T	650	αG	-	-	PSYEDmEVVCV	0.75	0.593	0.389	0.395	0.556	0.602	0.358	0.541	VARIANT	M -> T (in JPS; dbSNP:rs199476089)	12630959	1
P36894/R443C	P36894	BMPR1A	BMR1A_HUMAN	R443C	620	αF	-	-	WEMARrITGGI	0.905	0.862	0.44	0.711	0.736	0.797	0.365	0.622	VARIANT	R -> C (in JPS; dbSNP:rs35619497)	12417513,17344846	2
P36894/R486Q	P36894	BMPR1A	BMR1A_HUMAN	R486Q	754	αG/αH	-	-	PIVSNrNSDEC	0.427	0.299	0.543	0.375	0.225	0.271	0.644	0.194	VARIANT	R -> Q (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs752802257)	17344846	1
P36894/V450M	P36894	BMPR1A	BMR1A_HUMAN	V450M	627	αF/αG	-	-	ITGGIvEYQLP	0.46	0.496	0.454	0.348	0.326	0.412	0.577	0.321	VARIANT	V -> M (in dbSNP:rs55932635)	17344846	1
P36894/Y62D	P36894	BMPR1A	BMR1A_HUMAN	Y62D	-	-	-	-	PFLKCySGHCP									VARIANT	Y -> D (in JPS)	12417513	1
P36896/F146L	P36896	ACVR1B	ACV1B_HUMAN	F146L	-	-	-	-	IIIIVfVINYH									VARIANT	F -> L (in dbSNP:rs34488074)	17344846	1
P36896/I70A	P36896	ACVR1B	ACV1B_HUMAN	I70A	-	-	-	decrease	HVRTCiKVELV									MUTAGEN	I->A: Decreases binding to activin.	12665502	1
P36896/L408V	P36896	ACVR1B	ACV1B_HUMAN	L408V	606	αF	-	-	IYALGlYWEIA	0.675	0.63	0.508	0.556	0.502	0.562	0.531	0.345	VARIANT	L -> V (in dbSNP:rs928906)		0
P36896/L40A	P36896	ACVR1B	ACV1B_HUMAN	L40A	-	-	-	-	ACTSClANYTC									MUTAGEN	L->A: Increases binding to activin.	12665502	1
P36896/L75A	P36896	ACVR1B	ACV1B_HUMAN	L75A	-	-	-	decrease	IPKVElPAGKP									MUTAGEN	L->A: Decreases binding to activin.	12665502	1
P36896/P77A	P36896	ACVR1B	ACV1B_HUMAN	P77A	-	-	-	decrease	KVELVpGKPFY									MUTAGEN	P->A: Decreases binding to activin.	12665502	1
P36896/T206V	P36896	ACVR1B	ACV1B_HUMAN	T206V	29	N-term-β1	p	activating	RTVARtVLQEI	0.78	0.757	0.546	0.691	0.444	0.589	0.532	0.337	MUTAGEN	T->V: Leads to constitutive activation.	8622651	1
P36896/V73A	P36896	ACVR1B	ACV1B_HUMAN	V73A	-	-	-	-	TCIPKvLVPAG									MUTAGEN	V->A: Increases binding to activin.	12665502	1
P36897/C41Y	P36897	TGFBR1	TGFR1_HUMAN	C41Y	-	-	-	-	CFCHLcKDNFT									VARIANT	C -> Y (in MSSE; hypomorphic variant)	21358634	1
P36897/D266Y	P36897	TGFBR1	TGFR1_HUMAN	D266Y	209	β4/β5-loop	-	-	GFIAAdKDNGT	0.692	0.61	0.521	0.509	0.42	0.511	0.551	0.433	VARIANT	D -> Y (in LDS1)	22113417	1
P36897/D351G	P36897	TGFBR1	TGFR1_HUMAN	D351G	496	A-loop;DFG-motif	-	-	TCCIAdGLAVR	0.957	0.955	0.167	0.583	0.929	0.961	0.12	0.674	VARIANT	D -> G (in LDS1)	19883511	1
P36897/D400G	P36897	TGFBR1	TGFR1_HUMAN	D400G	600	αF	-	-	SFKRAdYAMGL	0.816	0.755	0.259	0.621	0.728	0.692	0.262	0.44	VARIANT	D -> G (in LDS1; dbSNP:rs121918711)	15731757	1
P36897/G52R	P36897	TGFBR1	TGFR1_HUMAN	G52R	-	-	-	-	TCVTDgCFVSV									VARIANT	G -> R (in MSSE; hypomorphic variant; dbSNP:rs587776865)	21358634	1
P36897/I139V	P36897	TGFBR1	TGFR1_HUMAN	I139V	-	-	-	-	VCFVCiLMLMV									VARIANT	I -> V (in dbSNP:rs148176750)	18987736	1
P36897/K232E	P36897	TGFBR1	TGFR1_HUMAN	K232E	129	β3;Catalytic-Lys	-	-	EEVAVkFSSRE	0.993	0.996	0.088	0.686	0.983	0.982	0.074	0.487	VARIANT	K -> E (in LDS1)	16928994	1
P36897/L193G	P36897	TGFBR1	TGFR1_HUMAN	L193G	18	N-term-β1	-	decrease	GSGSGlLLVQR	0.812	0.768	0.406	0.634	0.662	0.718	0.455	0.612	MUTAGEN	L->G: Loss of interaction with FKBP1A.	9233797	1
P36897/M318R	P36897	TGFBR1	TGFR1_HUMAN	M318R	425	αE	-	-	LAHLHmIVGTQ	0.636	0.578	0.537	0.48	0.341	0.512	0.599	0.304	VARIANT	M -> R (in LDS1; dbSNP:rs121918710)	15731757	1
P36897/N267H	P36897	TGFBR1	TGFR1_HUMAN	N267H	210	β4/β5-loop	-	-	FIAADnDNGTW	0.562	0.512	0.565	0.503	0.31	0.415	0.695	0.361	VARIANT	N -> H (in a patient with Marfan syndrome)	16791849	1
P36897/N45S	P36897	TGFBR1	TGFR1_HUMAN	N45S	-	-	-	-	LCTKDnTCVTD									VARIANT	N -> S (in MSSE; hypomorphic variant; dbSNP:rs387906696)	21358634	1
P36897/P194K	P36897	TGFBR1	TGFR1_HUMAN	P194K	19	N-term-β1	-	decrease	SGSGLpLVQRT	0.735	0.76	0.395	0.487	0.556	0.677	0.427	0.453	MUTAGEN	P->K: Loss of interaction with FKBP1A.	9233797	1
P36897/P83L	P36897	TGFBR1	TGFR1_HUMAN	P83L	-	-	-	-	IPRDRpVCAPS									VARIANT	P -> L (in MSSE; hypomorphic variant; dbSNP:rs757374917)	21358634	1
P36897/R487P	P36897	TGFBR1	TGFR1_HUMAN	R487P	816	αI	-	-	RLTALrKKTLS	0.851	0.829	0.523	0.681	0.625	0.657	0.539	0.519	VARIANT	R -> P (in LDS1; dbSNP:rs113605875)	15731757,16928994	2
P36897/R487Q	P36897	TGFBR1	TGFR1_HUMAN	R487Q	816	αI	-	-	RLTALrKKTLS	0.623	0.515	0.603	0.585	0.263	0.444	0.695	0.351	VARIANT	R -> Q (in LDS1; dbSNP:rs113605875)	16791849,16928994,22113417	3
P36897/R487W	P36897	TGFBR1	TGFR1_HUMAN	R487W	816	αI	-	-	RLTALrKKTLS	0.804	0.779	0.509	0.646	0.595	0.64	0.416	0.429	VARIANT	R -> W (in LDS1; dbSNP:rs111426349)	16928994	1
P36897/S187A	P36897	TGFBR1	TGFR1_HUMAN	S187A	12	N-term-β1	p	-	YDMTTsSGSGL	0.799	0.823	0.518	0.749	0.487	0.715	0.594	0.394	MUTAGEN	S->A: Loss of threonine phosphorylation, reduced phosphorylation on serine residues and loss of response to TGF-beta; when associated with 185-VV-186; A-189 and A-191.	7774578	1
P36897/S189A	P36897	TGFBR1	TGFR1_HUMAN	S189A	14	N-term-β1	p	-	MTTSGsSGLPL	0.799	0.745	0.491	0.671	0.493	0.613	0.516	0.302	MUTAGEN	S->A: Loss of threonine phosphorylation, reduced phosphorylation on serine residues and loss of response to TGF-beta; when associated with 185-VV-186; A-187 and A-191.	7774578	1
P36897/S191A	P36897	TGFBR1	TGFR1_HUMAN	S191A	16	N-term-β1	p	-	TSGSGsLPLLV	0.809	0.727	0.438	0.766	0.564	0.722	0.449	0.443	MUTAGEN	S->A: Loss of threonine phosphorylation, reduced phosphorylation on serine residues and loss of response to TGF-beta; when associated with 185-VV-186; A-187 and A-189.	7774578	1
P36897/S241L	P36897	TGFBR1	TGFR1_HUMAN	S241L	143	αC	-	-	SREERsFREAE	0.758	0.721	0.502	0.566	0.504	0.607	0.462	0.473	VARIANT	S -> L (in LDS1; dbSNP:rs111854391)	16596670,16791849	2
P36897/T200D	P36897	TGFBR1	TGFR1_HUMAN	T200D	25	N-term-β1	p	decrease	LLVQRtARTIV	0.889	0.865	0.742	0.853	0.362	0.832	0.721	0.361	MUTAGEN	T->D: Loss of response to TGF-beta.	7774578	1
P36897/T200I	P36897	TGFBR1	TGFR1_HUMAN	T200I	25	N-term-β1	p	-	LLVQRtARTIV	0.845	0.842	0.416	0.724	0.642	0.861	0.377	0.482	VARIANT	T -> I (in LDS1; dbSNP:rs121918712)	15731757	1
P36897/T200V	P36897	TGFBR1	TGFR1_HUMAN	T200V	25	N-term-β1	p	loss	LLVQRtARTIV	0.87	0.843	0.424	0.718	0.638	0.894	0.381	0.441	MUTAGEN	T->V: Loss of phosphorylation. Loss of response to TGF-beta.	7774578	1
P36897/T204D	P36897	TGFBR1	TGFR1_HUMAN	T204D	29	N-term-β1	p	activating	RTIARtVLQES	0.781	0.769	0.739	0.811	0.226	0.51	0.784	0.314	MUTAGEN	T->D: Constitutive activation.	7774578	1
P36897/T204V	P36897	TGFBR1	TGFR1_HUMAN	T204V	29	N-term-β1	p	decrease	RTIARtVLQES	0.8	0.767	0.543	0.682	0.469	0.624	0.513	0.363	MUTAGEN	T->V: Reduced phosphorylation. Reduced response to TGF-beta.	7774578	1
P36897/T375R	P36897	TGFBR1	TGFR1_HUMAN	T375R	549	A-loop	-	-	NHRVGtRYMAP	0.912	0.923	0.292	0.681	0.816	0.855	0.195	0.589	VARIANT	T -> R (in LDS1; dbSNP:rs1827743139)	22113417	1
P36897/V153I	P36897	TGFBR1	TGFR1_HUMAN	V153I	-	-	-	-	CHNRTvHHRVP									VARIANT	V -> I (in dbSNP:rs56014374)	17344846	1
P36897/Y291C	P36897	TGFBR1	TGFR1_HUMAN	Y291C	267	αD	-	-	GSLFDyNRYTV	0.905	0.902	0.485	0.724	0.607	0.825	0.413	0.495	VARIANT	Y -> C (in dbSNP:rs35974499)	17344846	1
P37023/A306P	P37023	ACVRL1	ACVL1_HUMAN	A306P	410	αE	-	loss	RLAVSaCGLAH	0.786	0.753	0.532	0.529	0.608	0.648	0.567	0.388	VARIANT	A -> P (in HHT2; loss of receptor activity in response to BMP9; retained in the endoplasmic reticulum; dbSNP:rs1940807179)	15024723,26176610	2
P37023/A347D	P37023	ACVRL1	ACVL1_HUMAN	A347D	495	Catalytic-loop	-	-	LQCCIaLGLAV	0.854	0.817	0.507	0.713	0.635	0.78	0.483	0.559	VARIANT	A -> D (in HHT2)	20414677	1
P37023/A347P	P37023	ACVRL1	ACVL1_HUMAN	A347P	495	Catalytic-loop	-	-	LQCCIaLGLAV	0.838	0.826	0.386	0.611	0.678	0.715	0.355	0.59	VARIANT	A -> P (in HHT2)	15024723	1
P37023/A400T	P37023	ACVRL1	ACVL1_HUMAN	A400T	603	αF	-	-	WTDIWaGLVLW	0.752	0.693	0.45	0.48	0.59	0.627	0.426	0.337	VARIANT	A -> T (found in a patient with hereditary hemorrhagic talagiectasia; unknown pathological significance)	20414677	1
P37023/A482V	P37023	ACVRL1	ACVL1_HUMAN	A482V	803	αI	-	-	SARLTaRIKKT	0.553	0.515	0.51	0.471	0.344	0.421	0.582	0.4	VARIANT	A -> V (in HHT2; dbSNP:rs139142865)	15024723	1
P37023/C344R	P37023	ACVRL1	ACVL1_HUMAN	C344R	492	Catalytic-loop	-	-	KSNLQcIADLG	0.859	0.752	0.463	0.591	0.636	0.697	0.43	0.546	VARIANT	C -> R (in HHT2; dbSNP:rs1592224412)	16752392	1
P37023/C344Y	P37023	ACVRL1	ACVL1_HUMAN	C344Y	492	Catalytic-loop	-	-	KSNLQcIADLG	0.788	0.708	0.533	0.633	0.548	0.671	0.496	0.539	VARIANT	C -> Y (in HHT2; retained in the endoplasmic reticulum; dbSNP:rs28936688)	10767348,14684682	2
P37023/C34Y	P37023	ACVRL1	ACVL1_HUMAN	C34Y	-	-	-	-	GPLVTcCESPH									VARIANT	C -> Y (in HHT2)	16752392	1
P37023/C41G	P37023	ACVRL1	ACVL1_HUMAN	C41G	-	-	-	loss	CESPHcGPTCR									VARIANT	C -> G (in HHT2; loss of receptor activity in response to BMP9; predominantly retained in the endoplasmic reticulum)	26176610	1
P37023/C41Y	P37023	ACVRL1	ACVL1_HUMAN	C41Y	-	-	-	loss	CESPHcGPTCR									VARIANT	C -> Y (in HHT2; loss of receptor activity in response to BMP9; predominantly retained in the endoplasmic reticulum; dbSNP:rs1184716348)	26176610	1
P37023/C443Y	P37023	ACVRL1	ACVL1_HUMAN	C443Y	763	αG/αH	-	-	MKKVVcDQQTP	0.783	0.742	0.4	0.567	0.511	0.611	0.451	0.535	VARIANT	C -> Y (in HHT2; retained in the endoplasmic reticulum)	26176610	1
P37023/C46G	P37023	ACVRL1	ACVL1_HUMAN	C46G	-	-	-	loss	CKGPTcGAWCT									VARIANT	C -> G (in HHT2; loss of receptor activity in response to BMP9; retained in the endoplasmic reticulum)	26176610	1
P37023/C51Y	P37023	ACVRL1	ACVL1_HUMAN	C51Y	-	-	-	-	CRGAWcVVLVR									VARIANT	C -> Y (in HHT2; dbSNP:rs863223409)	10694922	1
P37023/C69R	P37023	ACVRL1	ACVL1_HUMAN	C69R	-	-	-	-	QEHRGcNLHRE									VARIANT	C -> R (in HHT2)	16525724	1
P37023/C77F	P37023	ACVRL1	ACVL1_HUMAN	C77F	-	-	-	loss	LHRELcGRPTE									VARIANT	C -> F (in HHT2; loss of receptor activity in response to BMP9; retained in the endoplasmic reticulum; dbSNP:rs1330837892)	26176610	1
P37023/C77W	P37023	ACVRL1	ACVL1_HUMAN	C77W	-	-	-	-	LHRELcGRPTE									VARIANT	C -> W (in HHT2; retained in the endoplasmic reticulum)	10694922,14684682	2
P37023/D176Y	P37023	ACVRL1	ACVL1_HUMAN	D176Y	2	N-term-β1	-	-	DSMLGdLDSDC	0.793	0.74	0.52	0.657	0.583	0.707	0.4	0.728	VARIANT	D -> Y (in HHT2)	16525724	1
P37023/D179A	P37023	ACVRL1	ACVL1_HUMAN	D179A	5	N-term-β1	-	-	LGDLLdDCTTG	0.789	0.681	0.527	0.601	0.504	0.602	0.627	0.626	VARIANT	D -> A (in HHT2; mutant protein is capable of targeting the cell surface appropriately; dbSNP:rs753792569)	14684682	1
P37023/D397G	P37023	ACVRL1	ACVL1_HUMAN	D397G	600	αF	-	-	SYKWTdWAFGL	0.83	0.774	0.267	0.62	0.719	0.685	0.27	0.464	VARIANT	D -> G (in HHT2)	15024723	1
P37023/E111D	P37023	ACVRL1	ACVL1_HUMAN	E111D	-	-	-	-	TQPPSePGTDG									VARIANT	E -> D (no loss of receptor activity in response to BMP9; mutant protein is capable of targeting the cell surface appropriately; dbSNP:rs1481094868)	26176610	1
P37023/E159V	P37023	ACVRL1	ACVL1_HUMAN	E159V	-	-	-	-	HSELGeSLILK									VARIANT	E -> V (found in a patient with pulmonary arterial hypertension; unknown pathological significance)	24936649	1
P37023/E215K	P37023	ACVRL1	ACVL1_HUMAN	E215K	46	β2	-	-	KGRYGeWRGLW	0.603	0.565	0.512	0.574	0.29	0.443	0.606	0.522	VARIANT	E -> K (in HHT2; dbSNP:rs754283265)	15024723	1
P37023/E379D	P37023	ACVRL1	ACVL1_HUMAN	E379D	557	A-loop;APE-motif	-	loss	RYMAPeLDEQI	0.87	0.874	0.41	0.641	0.752	0.751	0.446	0.532	VARIANT	E -> D (in HHT2; loss of receptor activity in response to BMP9; retained in the endoplasmic reticulum)	26176610	1
P37023/E379K	P37023	ACVRL1	ACVL1_HUMAN	E379K	557	A-loop;APE-motif	-	loss	RYMAPeLDEQI	0.938	0.926	0.223	0.686	0.861	0.892	0.143	0.58	VARIANT	E -> K (in HHT2; loss of receptor activity in response to BMP9; retained in the endoplasmic reticulum; dbSNP:rs1131691686)	15024723,15712270,26176610	3
P37023/E407D	P37023	ACVRL1	ACVL1_HUMAN	E407D	610	αF	-	-	GLVLWeARRTI	0.75	0.735	0.514	0.519	0.421	0.466	0.607	0.287	VARIANT	E -> D (in HHT2; dbSNP:rs1565595129)	10767348,15712270	2
P37023/E59V	P37023	ACVRL1	ACVL1_HUMAN	E59V	-	-	-	-	VLVREeRHPQE									VARIANT	E -> V (found in a patient with pulmonary arterial hypertension; unknown pathological significance; dbSNP:rs1466116430)	24936649	1
P37023/F425L	P37023	ACVRL1	ACVL1_HUMAN	F425L	646	αG	-	-	DYRPPfDVVPN	0.814	0.755	0.554	0.672	0.506	0.627	0.576	0.62	VARIANT	F -> L (in HHT2)	15024723	1
P37023/F425V	P37023	ACVRL1	ACVL1_HUMAN	F425V	646	αG	-	-	DYRPPfDVVPN	0.825	0.76	0.489	0.653	0.572	0.698	0.451	0.549	VARIANT	F -> V (in HHT2)	15712270	1
P37023/G211D	P37023	ACVRL1	ACVL1_HUMAN	G211D	42	β1;Gly-rich-loop	-	loss	ECVGKgYGEVW	0.889	0.862	0.531	0.732	0.716	0.846	0.486	0.416	VARIANT	G -> D (in HHT2; loss of receptor activity in response to BMP9; retained in the endoplasmic reticulum; dbSNP:rs28936687)	14684682,26176610	2
P37023/G211S	P37023	ACVRL1	ACVL1_HUMAN	G211S	42	β1;Gly-rich-loop	-	loss	ECVGKgYGEVW	0.937	0.88	0.414	0.63	0.894	0.901	0.347	0.447	VARIANT	G -> S (in HHT2; loss of receptor activity in response to BMP9; retained in the endoplasmic reticulum)	26176610	1
P37023/G219D	P37023	ACVRL1	ACVL1_HUMAN	G219D	57	β2/β3-loop	-	-	GEVWRgWHGES	0.803	0.774	0.494	0.678	0.628	0.678	0.437	0.516	VARIANT	G -> D (in HHT2)	16752392	1
P37023/G223R	P37023	ACVRL1	ACVL1_HUMAN	G223R	105	β2/β3-loop	-	-	RGLWHgSVAVK	0.74	0.708	0.431	0.559	0.539	0.557	0.442	0.641	VARIANT	G -> R (in HHT2)	15024723	1
P37023/G416S	P37023	ACVRL1	ACVL1_HUMAN	G416S	636	αF/αG	-	-	RTIVNgVEDYR	0.872	0.803	0.45	0.714	0.629	0.717	0.387	0.754	VARIANT	G -> S (in HHT2)	16525724	1
P37023/G48R	P37023	ACVRL1	ACVL1_HUMAN	G48R	-	-	-	-	GPTCRgWCTVV									VARIANT	G -> R (in HHT2)	15024723	1
P37023/H280R	P37023	ACVRL1	ACVL1_HUMAN	H280R	251	β5/αD-loop	-	-	LITHYhHGSLY	0.845	0.835	0.516	0.656	0.56	0.753	0.488	0.571	VARIANT	H -> R (in HHT2)	20414677	1
P37023/H314Y	P37023	ACVRL1	ACVL1_HUMAN	H314Y	424	αE	-	loss	GLAHLhEIFGT	0.843	0.809	0.401	0.604	0.707	0.689	0.311	0.355	VARIANT	H -> Y (in HHT2; loss of receptor activity in response to BMP9; retained in the endoplasmic reticulum; dbSNP:rs1565594311)	15024723,26176610	2
P37023/H328Q	P37023	ACVRL1	ACVL1_HUMAN	H328Q	441	Catalytic-loop;HrD-motif	-	-	KPAIAhDFKSR	0.812	0.853	0.345	0.628	0.753	0.82	0.335	0.492	VARIANT	H -> Q (in HHT2; dbSNP:rs1565594410)	20414677	1
P37023/H66P	P37023	ACVRL1	ACVL1_HUMAN	H66P	-	-	-	-	RHPQEhGCGNL									VARIANT	H -> P (in HHT2)	16525724	1
P37023/H66Y	P37023	ACVRL1	ACVL1_HUMAN	H66Y	-	-	-	loss	RHPQEhGCGNL									VARIANT	H -> Y (in HHT2; loss of receptor activity in response to BMP9; retained in the endoplasmic reticulum; dbSNP:rs1480110873)	26176610	1
P37023/I245N	P37023	ACVRL1	ACVL1_HUMAN	I245N	174	αC	-	-	FRETEiNTVLL	0.815	0.835	0.332	0.501	0.668	0.736	0.334	0.572	VARIANT	I -> N (in dbSNP:rs1804508)		0
P37023/I245V	P37023	ACVRL1	ACVL1_HUMAN	I245V	174	αC	-	-	FRETEiNTVLL	0.387	0.43	0.522	0.393	0.232	0.281	0.655	0.361	VARIANT	I -> V (in HHT2; no loss of receptor activity in response to BMP9; mutant protein is capable of targeting the cell surface appropriately; affects splicing by inducing the creation of a new donor splice site and the loss of the 3' end of exon 6)	26176610	1
P37023/I260L	P37023	ACVRL1	ACVL1_HUMAN	I260L	200	β4	-	-	NILGFiSDMTS	0.209	0.195	0.476	0.189	0.162	0.137	0.682	0.154	VARIANT	I -> L (in HHT2)	16752392	1
P37023/I398N	P37023	ACVRL1	ACVL1_HUMAN	I398N	601	αF	-	-	YKWTDiAFGLV	0.808	0.833	0.319	0.585	0.707	0.758	0.272	0.503	VARIANT	I -> N (in HHT2; dbSNP:rs121909286)	11170071	1
P37023/I417F	P37023	ACVRL1	ACVL1_HUMAN	I417F	637	αG	-	-	TIVNGiEDYRP	0.344	0.351	0.512	0.433	0.177	0.285	0.649	0.193	VARIANT	I -> F (no loss of receptor activity in response to BMP9; mutant protein is capable of targeting the cell surface appropriately; dbSNP:rs141653630)	26176610	1
P37023/K229R	P37023	ACVRL1	ACVL1_HUMAN	K229R	129	β3;Catalytic-Lys	-	-	ESVAVkFSSRD	0.977	0.977	0.088	0.627	0.985	0.999	0.093	0.384	VARIANT	K -> R (in HHT2)	15024723	1
P37023/K486E	P37023	ACVRL1	ACVL1_HUMAN	K486E	807	αI	-	-	TALRIkTLQKI	0.608	0.391	0.647	0.533	0.202	0.311	0.709	0.284	VARIANT	K -> E (found in a patient with hereditary hemorrhagic talagiectasia; unknown pathological significance; dbSNP:rs113700354)	20414677	1
P37023/K487T	P37023	ACVRL1	ACVL1_HUMAN	K487T	808	αI	-	-	ALRIKkLQKIS	0.839	0.743	0.45	0.63	0.634	0.678	0.395	0.63	VARIANT	K -> T (in HHT2; mutant protein is capable of targeting the cell surface appropriately; dbSNP:rs1085307428)	14684682	1
P37023/K8N	P37023	ACVRL1	ACVL1_HUMAN	K8N	-	-	-	-	LGSPRkLLMLL									VARIANT	K -> N	24936649	1
P37023/L138P	P37023	ACVRL1	ACVL1_HUMAN	L138P	-	-	-	-	VALGVlLWHVR									VARIANT	L -> P	20414677	1
P37023/L285F	P37023	ACVRL1	ACVL1_HUMAN	L285F	264	αD	-	-	HEHGSlDFLQR	0.785	0.787	0.399	0.591	0.597	0.624	0.445	0.531	VARIANT	L -> F (in HHT2; dbSNP:rs1085307410)	15024723	1
P37023/L289P	P37023	ACVRL1	ACVL1_HUMAN	L289P	268	αD	-	-	SLYDFlRQTLE	0.89	0.867	0.448	0.696	0.684	0.82	0.39	0.693	VARIANT	L -> P (in HHT2)	16752392	1
P37023/L294R	P37023	ACVRL1	ACVL1_HUMAN	L294R	300	αD/αE-loop	-	-	LQRQTlPHLAL	0.82	0.77	0.423	0.572	0.657	0.691	0.383	0.676	VARIANT	L -> R (in HHT2)	20414677	1
P37023/L313V	P37023	ACVRL1	ACVL1_HUMAN	L313V	423	αE	-	loss	CGLAHlVEIFG	0.858	0.852	0.347	0.646	0.639	0.71	0.354	0.769	VARIANT	L -> V (in HHT2; loss of receptor activity in response to BMP9; predominantly retained in the endoplasmic reticulum)	26176610	1
P37023/L337P	P37023	ACVRL1	ACVL1_HUMAN	L337P	450	Catalytic-loop	-	-	KSRNVlKSNLQ	0.882	0.878	0.425	0.682	0.709	0.782	0.386	0.652	VARIANT	L -> P (in HHT2; dbSNP:rs1592224349)	15024723	1
P37023/L342P	P37023	ACVRL1	ACVL1_HUMAN	L342P	482	Catalytic-loop	-	-	LVKSNlCCIAD	0.64	0.587	0.485	0.418	0.462	0.475	0.555	0.498	VARIANT	L -> P (in dbSNP:rs762287966)	20414677	1
P37023/L403P	P37023	ACVRL1	ACVL1_HUMAN	L403P	606	αF	-	-	IWAFGlLWEIA	0.843	0.859	0.481	0.717	0.617	0.732	0.481	0.416	VARIANT	L -> P (in HHT2)	16525724	1
P37023/M376R	P37023	ACVRL1	ACVL1_HUMAN	M376R	554	A-loop	-	-	GTKRYmPEVLD	0.842	0.743	0.427	0.683	0.524	0.697	0.489	0.664	VARIANT	M -> R (in HHT2; dbSNP:rs28936399)	8640225	1
P37023/M376V	P37023	ACVRL1	ACVL1_HUMAN	M376V	554	A-loop	-	-	GTKRYmPEVLD	0.883	0.867	0.424	0.706	0.554	0.746	0.475	0.516	VARIANT	M -> V (in HHT2; dbSNP:rs1555153277)	15024723	1
P37023/N335H	P37023	ACVRL1	ACVL1_HUMAN	N335H	448	Catalytic-loop	-	-	DFKSRnLVKSN	0.935	0.923	0.243	0.646	0.887	0.897	0.193	0.498	VARIANT	N -> H (in HHT2)	20414677	1
P37023/N96D	P37023	ACVRL1	ACVL1_HUMAN	N96D	-	-	-	-	DSHLCnNVSLV									VARIANT	N -> D (in HHT2)	10694922	1
P37023/N96S	P37023	ACVRL1	ACVL1_HUMAN	N96S	-	-	-	-	DSHLCnNVSLV									VARIANT	N -> S (in HHT2)	20414677	1
P37023/P30S	P37023	ACVRL1	ACVL1_HUMAN	P30S	-	-	-	-	KPSRGpVTCTC									VARIANT	P -> S (found in a patient with hereditary hemorrhagic talagiectasia; unknown pathological significance; dbSNP:rs149664056)	16752392	1
P37023/P378L	P37023	ACVRL1	ACVL1_HUMAN	P378L	556	A-loop;APE-motif	-	-	KRYMApVLDEQ	0.761	0.699	0.438	0.577	0.616	0.623	0.47	0.624	VARIANT	P -> L (in HHT2; retained in the endoplasmic reticulum)	14684682	1
P37023/P378S	P37023	ACVRL1	ACVL1_HUMAN	P378S	556	A-loop;APE-motif	-	loss	KRYMApVLDEQ	0.794	0.805	0.338	0.498	0.74	0.715	0.348	0.58	VARIANT	P -> S (in HHT2; loss of receptor activity in response to BMP9; retained in the endoplasmic reticulum; dbSNP:rs959973779)	20414677,26176610	2
P37023/P424R	P37023	ACVRL1	ACVL1_HUMAN	P424R	645	αG	-	-	EDYRPpYDVVP	0.763	0.758	0.377	0.542	0.66	0.675	0.342	0.612	VARIANT	P -> R (in HHT2; dbSNP:rs1940906429)	20414677	1
P37023/P424T	P37023	ACVRL1	ACVL1_HUMAN	P424T	645	αG	-	-	EDYRPpYDVVP	0.721	0.706	0.362	0.519	0.644	0.622	0.364	0.607	VARIANT	P -> T (in HHT2; dbSNP:rs1085307419)	9245985	1
P37023/P433R	P37023	ACVRL1	ACVL1_HUMAN	P433R	655	αG/αH	-	-	VVPNDpFEDMK	0.695	0.691	0.385	0.453	0.567	0.517	0.456	0.453	VARIANT	P -> R (in HHT2)	16752392	1
P37023/P449S	P37023	ACVRL1	ACVL1_HUMAN	P449S	769	αG/αH	-	-	VDQQTpIPNRL	0.801	0.735	0.373	0.499	0.626	0.694	0.354	0.584	VARIANT	P -> S (in HHT2; dbSNP:rs1940908457)	20414677	1
P37023/Q237K	P37023	ACVRL1	ACVL1_HUMAN	Q237K	137	αC	-	-	SSRDEqWFRET	0.374	0.29	0.523	0.249	0.271	0.234	0.638	0.21	VARIANT	Q -> K (in HHT2)	16752392	1
P37023/R374Q	P37023	ACVRL1	ACVL1_HUMAN	R374Q	552	A-loop	-	-	RVGTKrMAPEV	0.73	0.763	0.503	0.765	0.492	0.607	0.446	0.469	VARIANT	R -> Q (in HHT2; retained in the endoplasmic reticulum; dbSNP:rs1060503248)	14684682,15024723	2
P37023/R374W	P37023	ACVRL1	ACVL1_HUMAN	R374W	552	A-loop	-	-	RVGTKrMAPEV	0.85	0.806	0.473	0.754	0.614	0.758	0.362	0.512	VARIANT	R -> W (in HHT2; dbSNP:rs28936401)	11170071,14684682,15712270,9245985	4
P37023/R411P	P37023	ACVRL1	ACVL1_HUMAN	R411P	620	αF	-	-	WEIARrIVNGI	0.893	0.879	0.461	0.709	0.688	0.81	0.443	0.522	VARIANT	R -> P (in HHT2; dbSNP:rs121909284)	15024723	1
P37023/R411Q	P37023	ACVRL1	ACVL1_HUMAN	R411Q	620	αF	-	-	WEIARrIVNGI	0.809	0.759	0.427	0.713	0.664	0.73	0.437	0.529	VARIANT	R -> Q (in HHT2; retained in the endoplasmic reticulum; dbSNP:rs121909284)	14684682,15024723,8640225	3
P37023/R411W	P37023	ACVRL1	ACVL1_HUMAN	R411W	620	αF	-	loss	WEIARrIVNGI	0.873	0.855	0.462	0.692	0.629	0.778	0.381	0.523	VARIANT	R -> W (in HHT2; loss of receptor activity in response to BMP9; predominantly retained in the endoplasmic reticulum; dbSNP:rs121909287)	11484689,15024723,15712270,26176610	4
P37023/R479L	P37023	ACVRL1	ACVL1_HUMAN	R479L	800	αI	-	-	PNPSArTALRI	0.906	0.851	0.376	0.661	0.734	0.785	0.322	0.416	VARIANT	R -> L (in HHT2)	15024723	1
P37023/R479P	P37023	ACVRL1	ACVL1_HUMAN	R479P	800	αI	-	-	PNPSArTALRI	0.922	0.892	0.313	0.675	0.835	0.789	0.254	0.488	VARIANT	R -> P (in HHT2; dbSNP:rs1085307426)	20414677	1
P37023/R47P	P37023	ACVRL1	ACVL1_HUMAN	R47P	-	-	-	loss	KGPTCrAWCTV									VARIANT	R -> P (in HHT2; loss of receptor activity in response to BMP9; retained in the endoplasmic reticulum; dbSNP:rs774389618)	26176610	1
P37023/R484W	P37023	ACVRL1	ACVL1_HUMAN	R484W	805	αI	-	-	RLTALrKKTLQ	0.797	0.764	0.474	0.644	0.572	0.637	0.402	0.4	VARIANT	R -> W (in HHT2; dbSNP:rs121909288)	11484689,15024723	2
P37023/R67Q	P37023	ACVRL1	ACVL1_HUMAN	R67Q	-	-	-	-	HPQEHrCGNLH									VARIANT	R -> Q (in HHT2; retained in the endoplasmic reticulum; dbSNP:rs863223414)	14684682,9245985	2
P37023/R67W	P37023	ACVRL1	ACVL1_HUMAN	R67W	-	-	-	-	HPQEHrCGNLH									VARIANT	R -> W (in HHT2; dbSNP:rs1085307405)	15712270	1
P37023/S225C	P37023	ACVRL1	ACVL1_HUMAN	S225C	119	β3	-	-	LWHGEsAVKIF	0.626	0.722	0.473	0.597	0.445	0.533	0.471	0.42	VARIANT	S -> C (found in a patient with pulmonary arterial hypertension; unknown pathological significance)	24936649	1
P37023/S233L	P37023	ACVRL1	ACVL1_HUMAN	S233L	133	β3/αC-loop	-	-	VKIFSsDEQSW	0.557	0.452	0.666	0.511	0.242	0.287	0.752	0.37	VARIANT	S -> L (in HHT2; dbSNP:rs762773076)	16525724	1
P37023/S333I	P37023	ACVRL1	ACVL1_HUMAN	S333I	446	Catalytic-loop	-	-	HRDFKsNVLVK	0.851	0.829	0.673	0.742	0.424	0.7	0.652	0.623	VARIANT	S -> I (in HHT2; retained in the endoplasmic reticulum; dbSNP:rs863223413)	10767348,14684682,9245985	3
P37023/S38C	P37023	ACVRL1	ACVL1_HUMAN	S38C	-	-	-	-	TCTCEsHCKGP									VARIANT	S -> C	20414677	1
P37023/T197I	P37023	ACVRL1	ACVL1_HUMAN	T197I	23	N-term-β1	-	-	FLVQRtARQVA	0.77	0.826	0.408	0.574	0.596	0.763	0.403	0.541	VARIANT	T -> I (in HHT2)	16752392	1
P37023/T265P	P37023	ACVRL1	ACVL1_HUMAN	T265P	226	β4/β5-loop	-	-	IASDMtRNSST	0.643	0.642	0.641	0.5	0.349	0.527	0.751	0.356	VARIANT	T -> P (in HHT2; dbSNP:rs1592223978)	16525724	1
P37023/T277K	P37023	ACVRL1	ACVL1_HUMAN	T277K	248	β5	-	-	QLWLItYHEHG	0.885	0.839	0.413	0.654	0.682	0.698	0.317	0.775	VARIANT	T -> K (found in a patient with hereditary hemorrhagic talagiectasia; unknown pathological significance)	20414677	1
P37023/T396A	P37023	ACVRL1	ACVL1_HUMAN	T396A	599	αF	-	-	ESYKWtIWAFG	0.108	0.157	0.462	0.183	0.19	0.153	0.609	0.077	VARIANT	T -> A (found in patients with pulmonary arterial hypertension; unknown pathological significance)	24936649	1
P37023/T52A	P37023	ACVRL1	ACVL1_HUMAN	T52A	-	-	-	-	RGAWCtVLVRE									VARIANT	T -> A (in HHT2; dbSNP:rs1131691346)	16752392	1
P37023/V226E	P37023	ACVRL1	ACVL1_HUMAN	V226E	124	β3	-	-	WHGESvVKIFS	0.753	0.671	0.548	0.581	0.503	0.526	0.593	0.579	VARIANT	V -> E (in HHT2; dbSNP:rs1565593639)	20414677	1
P37023/V404G	P37023	ACVRL1	ACVL1_HUMAN	V404G	607	αF	-	loss	WAFGLvWEIAR	0.907	0.782	0.457	0.663	0.746	0.759	0.419	0.647	VARIANT	V -> G (in HHT2; loss of receptor activity in response to BMP9; predominantly retained in the endoplasmic reticulum)	26176610	1
P37023/V441M	P37023	ACVRL1	ACVL1_HUMAN	V441M	761	αG/αH	-	-	EDMKKvCVDQQ	0.664	0.569	0.703	0.559	0.339	0.513	0.766	0.414	VARIANT	V -> M (in HHT2; retained in the endoplasmic reticulum; dbSNP:rs1565596498)	26176610	1
P37023/W217G	P37023	ACVRL1	ACVL1_HUMAN	W217G	53	β2	-	-	RYGEVwGLWHG	0.81	0.695	0.403	0.529	0.576	0.714	0.411	0.637	VARIANT	W -> G (in HHT2)	20414677	1
P37023/W399S	P37023	ACVRL1	ACVL1_HUMAN	W399S	602	αF	-	-	KWTDIwFGLVL	0.908	0.837	0.311	0.643	0.777	0.856	0.236	0.704	VARIANT	W -> S (in HHT2; dbSNP:rs121909289)	14684682	1
P37023/W50C	P37023	ACVRL1	ACVL1_HUMAN	W50C	-	-	-	-	TCRGAwTVVLV									VARIANT	W -> C (in HHT2; retained in the endoplasmic reticulum; dbSNP:rs121909285)	10767348,14684682,9245985	3
P37023/W50G	P37023	ACVRL1	ACVL1_HUMAN	W50G	-	-	-	-	TCRGAwTVVLV									VARIANT	W -> G (in HHT2)	16525724	1
P37023/Y426C	P37023	ACVRL1	ACVL1_HUMAN	Y426C	647	αG	-	-	YRPPFyVVPND	0.698	0.672	0.594	0.5	0.501	0.587	0.604	0.543	VARIANT	Y -> C (in HHT2)	16752392	1
P37173/A355P	P37173	TGFBR2	TGFR2_HUMAN	A355P	411	αE	-	-	LGSSLaGIAHL	0.751	0.741	0.526	0.523	0.564	0.604	0.55	0.507	VARIANT	A -> P (in LDS2; dbSNP:rs104893813)	15731757	1
P37173/C514R	P37173	TGFBR2	TGFR2_HUMAN	C514R	786	αH	-	-	GIQMVcTLTEC	0.435	0.399	0.5	0.446	0.355	0.327	0.616	0.293	VARIANT	C -> R (in LDS2; dbSNP:rs193922664)	22113417	1
P37173/C61R	P37173	TGFBR2	TGFR2_HUMAN	C61R	-	-	-	-	VRFSTcNQKSC									VARIANT	C -> R (in a gastric adenocarcinoma sample; somatic mutation)	17344846	1
P37173/D247V	P37173	TGFBR2	TGFR2_HUMAN	D247V	36	β1	-	-	LPIELdLVGKG	0.419	0.35	0.503	0.371	0.299	0.329	0.574	0.447	VARIANT	D -> V (in LDS2; dbSNP:rs761231369)	19533785	1
P37173/D446N	P37173	TGFBR2	TGFR2_HUMAN	D446N	600	αF	-	decrease	SFKQTdYSMAL	0.814	0.842	0.274	0.591	0.693	0.745	0.272	0.578	VARIANT	D -> N (in LDS2; dbSNP:rs886039551)	16251899	1
P37173/E526Q	P37173	TGFBR2	TGFR2_HUMAN	E526Q	798	αI	-	-	WDHDPeRLTAQ	0.334	0.313	0.499	0.343	0.264	0.226	0.595	0.268	VARIANT	E -> Q (in esophageal cancer; dbSNP:rs121918714)	10789724	1
P37173/G357R	P37173	TGFBR2	TGFR2_HUMAN	G357R	413	αE	-	-	SSLARgAHLHS	0.883	0.885	0.379	0.631	0.703	0.774	0.351	0.418	VARIANT	G -> R (in LDS2)	19533785	1
P37173/G357W	P37173	TGFBR2	TGFR2_HUMAN	G357W	413	αE	-	-	SSLARgAHLHS	0.9	0.85	0.381	0.7	0.746	0.803	0.296	0.589	VARIANT	G -> W (in LDS2; dbSNP:rs104893814)	15731757	1
P37173/G509V	P37173	TGFBR2	TGFR2_HUMAN	G509V	780	αG/αH	-	-	WLNHQgQMVCE	0.622	0.47	0.582	0.499	0.352	0.418	0.677	0.34	VARIANT	G -> V (in LDS2; dbSNP:rs863223853)	21949523	1
P37173/H328Y	P37173	TGFBR2	TGFR2_HUMAN	H328Y	251	β5/αD-loop	-	-	LITAFhKGNLQ	0.584	0.528	0.69	0.576	0.24	0.349	0.789	0.332	VARIANT	H -> Y (in a lung neuroendocrine carcinoma sample; somatic mutation)	17344846	1
P37173/H377R	P37173	TGFBR2	TGFR2_HUMAN	H377R	441	Catalytic-loop;HrD-motif	-	-	KMPIVhDLKSS	0.847	0.897	0.318	0.64	0.84	0.858	0.308	0.499	VARIANT	H -> R (in LDS2; dbSNP:rs1553630274)	22113417	1
P37173/I510F	P37173	TGFBR2	TGFR2_HUMAN	I510F	781	αH	-	-	LNHQGiMVCET	0.572	0.597	0.426	0.415	0.277	0.496	0.58	0.176	VARIANT	I -> F (in LDS2)	21949523	1
P37173/I510S	P37173	TGFBR2	TGFR2_HUMAN	I510S	781	αH	-	-	LNHQGiMVCET	0.795	0.714	0.505	0.522	0.566	0.629	0.502	0.458	VARIANT	I -> S (in LDS2)	19883511	1
P37173/I73V	P37173	TGFBR2	TGFR2_HUMAN	I73V	-	-	-	-	MSNCSiSICEK									VARIANT	I -> V (in a colorectal cancer sample; somatic mutation)	16959974	1
P37173/K277R	P37173	TGFBR2	TGFR2_HUMAN	K277R	129	β3;Catalytic-Lys	-	loss	ETVAVkFPYEE	0.955	0.96	0.106	0.561	0.929	0.992	0.094	0.338	MUTAGEN	K->R: Abolishes kinase activity, TGF-beta signaling and interaction with DAXX.	11483955	1
P37173/L308P	P37173	TGFBR2	TGFR2_HUMAN	L308P	200	β4	-	decrease	NILQFlAEERK	0.921	0.873	0.482	0.73	0.675	0.744	0.418	0.644	VARIANT	L -> P (in LDS2; has a negative effect on TGF-beta signaling; dbSNP:rs28934568)	15235604,20358619	2
P37173/L452M	P37173	TGFBR2	TGFR2_HUMAN	L452M	606	αF	-	decrease	VYSMAlLWEMT	0.542	0.504	0.437	0.301	0.52	0.399	0.569	0.317	VARIANT	L -> M (in a breast tumor; signaling of TGF-beta significantly inhibited)	11212236	1
P37173/M36V	P37173	TGFBR2	TGFR2_HUMAN	M36V	-	-	-	-	SVNNDmVTDNN									VARIANT	M -> V (in dbSNP:rs17025864)		0
P37173/M373I	P37173	TGFBR2	TGFR2_HUMAN	M373I	436	Catalytic-loop	-	neutral	CGRPKmIVHRD	0.16	0.154	0.451	0.144	0.124	0.152	0.64	0.234	VARIANT	M -> I (in dbSNP:rs35719192)	17344846	1
P37173/M457K	P37173	TGFBR2	TGFR2_HUMAN	M457K	613	αF	-	-	LVLWEmSRCNA	0.845	0.79	0.554	0.694	0.502	0.619	0.577	0.386	VARIANT	M -> K (in LDS2)	20101701	1
P37173/N435S	P37173	TGFBR2	TGFR2_HUMAN	N435S	565	αF	-	decrease	LESRMnENVES	0.541	0.54	0.556	0.374	0.36	0.4	0.621	0.407	VARIANT	N -> S (in a breast tumor; signaling of TGF-beta significantly inhibited)	11212236	1
P37173/N490S	P37173	TGFBR2	TGFR2_HUMAN	N490S	750	αG/αH	-	-	ESMKDnLRDRG	0.346	0.273	0.494	0.314	0.205	0.198	0.67	0.358	VARIANT	N -> S (in a gastric adenocarcinoma sample; somatic mutation)	17344846	1
P37173/R190H	P37173	TGFBR2	TGFR2_HUMAN	R190H	-	-	-	-	IFYCYrNRQQK									VARIANT	R -> H (in LDS2; dbSNP:rs780542125)	19533785	1
P37173/R460C	P37173	TGFBR2	TGFR2_HUMAN	R460C	620	αF	-	-	WEMTSrNAVGE	0.791	0.798	0.429	0.668	0.629	0.711	0.403	0.599	VARIANT	R -> C (in LDS2; dbSNP:rs104893811)	16027248	1
P37173/R460H	P37173	TGFBR2	TGFR2_HUMAN	R460H	620	αF	-	-	WEMTSrNAVGE	0.865	0.783	0.443	0.671	0.607	0.731	0.47	0.524	VARIANT	R -> H (in LDS2; dbSNP:rs104893816)	16027248	1
P37173/R528C	P37173	TGFBR2	TGFR2_HUMAN	R528C	800	αI	-	-	HDPEArTAQCV	0.867	0.848	0.3	0.601	0.797	0.774	0.229	0.455	VARIANT	R -> C (in LDS2; dbSNP:rs104893810)	15731757	1
P37173/R528H	P37173	TGFBR2	TGFR2_HUMAN	R528H	800	αI	-	-	HDPEArTAQCV	0.905	0.895	0.266	0.696	0.724	0.767	0.25	0.483	VARIANT	R -> H (in LDS2; dbSNP:rs104893815)	15731757,16959974	2
P37173/R537C	P37173	TGFBR2	TGFR2_HUMAN	R537C	812	αI	-	decrease	QCVAErSELEH	0.912	0.842	0.367	0.594	0.783	0.793	0.275	0.461	VARIANT	R -> C (in LDS2; has a negative effect on TGF-beta signaling; dbSNP:rs104893809)	15235604	1
P37173/S449F	P37173	TGFBR2	TGFR2_HUMAN	S449F	603	αF	-	decrease	QTDVYsALVLW	0.838	0.791	0.384	0.59	0.731	0.819	0.33	0.578	VARIANT	S -> F (in LDS2; has a negative effect on TGF-beta signaling; dbSNP:rs104893807)	15235604,22113417	2
P37173/T315M	P37173	TGFBR2	TGFR2_HUMAN	T315M	228	β4/β5-loop	-	-	AEERKtLGKQY	0.214	0.205	0.509	0.219	0.198	0.233	0.641	0.22	VARIANT	T -> M (in HNPCC6; dbSNP:rs34833812)	17344846,9590282	2
P37173/T325P	P37173	TGFBR2	TGFR2_HUMAN	T325P	248	β5	-	-	QYWLItFHAKG	0.845	0.814	0.47	0.658	0.655	0.709	0.486	0.738	VARIANT	T -> P (in LDS2)	19533785	1
P37173/T530I	P37173	TGFBR2	TGFR2_HUMAN	T530I	802	αI	-	-	PEARLtQCVAE	0.609	0.515	0.412	0.46	0.43	0.484	0.537	0.335	VARIANT	T -> I (in LDS2)	19533785	1
P37173/V191I	P37173	TGFBR2	TGFR2_HUMAN	V191I	-	-	-	neutral	FYCYRvRQQKL									VARIANT	V -> I (in dbSNP:rs56105708)	12202987,17344846	2
P37173/V387M	P37173	TGFBR2	TGFR2_HUMAN	V387M	451	Catalytic-loop	-	-	SSNILvNDLTC	0.545	0.54	0.489	0.466	0.354	0.415	0.555	0.307	VARIANT	V -> M (in a breast tumor; dbSNP:rs35766612)	11212236,17344846	2
P37173/V439A	P37173	TGFBR2	TGFR2_HUMAN	V439A	572	αF	-	-	MNLENvSFKQT	0.174	0.203	0.383	0.12	0.189	0.197	0.538	0.206	VARIANT	V -> A (in dbSNP:rs1050833)	1310899,8812462,8840968,8973329	4
P37173/V447A	P37173	TGFBR2	TGFR2_HUMAN	V447A	601	αF	-	decrease	FKQTDvSMALV	0.773	0.758	0.418	0.456	0.6	0.669	0.464	0.478	VARIANT	V -> A (in a breast tumor; signaling of TGF-beta significantly inhibited)	11212236	1
P37173/W521R	P37173	TGFBR2	TGFR2_HUMAN	W521R	793	αH	-	-	TLTECwHDPEA	0.877	0.838	0.286	0.572	0.747	0.81	0.211	0.7	VARIANT	W -> R (in LDS2; dbSNP:rs1575166666)	20358619	1
P37173/Y336N	P37173	TGFBR2	TGFR2_HUMAN	Y336N	267	αD	p	-	GNLQEyTRHVI	0.929	0.889	0.451	0.786	0.728	0.837	0.386	0.483	VARIANT	Y -> N (in LDS2; dbSNP:rs104893812)	15731757	1
P41240/G287D	P41240	CSK	CSK_HUMAN	G287D	301	αD/αE-loop	-	neutral	GRSVLgDCLLK	0.225	0.189	0.503	0.221	0.158	0.117	0.628	0.212	VARIANT	G -> D (in dbSNP:rs34866753)		0
P41240/H442R	P41240	CSK	CSK_HUMAN	H442R	814	αI	-	-	REQLEhKTHEL	0.123	0.119	0.54	0.184	0.173	0.097	0.684	0.165	VARIANT	H -> R (in dbSNP:rs35556162)		0
P41240/P45L	P41240	CSK	CSK_HUMAN	P45L	-	-	-	-	AVTKDpWYKAK									VARIANT	P -> L	17344846	1
P41240/R398Q	P41240	CSK	CSK_HUMAN	R398Q	738	αG/αH	-	-	KDVVPrEKGYK	0.068	0.076	0.491	0.106	0.053	0.084	0.668	0.076	VARIANT	R -> Q (in dbSNP:rs34616395)		0
P41240/S364A	P41240	CSK	CSK_HUMAN	S364A	596	αF	p	decrease	REKKFsKSDVW	0.797	0.877	0.509	0.715	0.619	0.717	0.481	0.291	MUTAGEN	S->A: Strong decrease of phosphorylation by PRKACA (catalytic subunit of PKA).	11181701	1
P41240/Y184F	P41240	CSK	CSK_HUMAN	Y184F	18	N-term-β1	p	loss	AQDEFySGWAL	0.691	0.744	0.453	0.584	0.532	0.617	0.532	0.204	MUTAGEN	Y->F: Abolishes phosphorylation.	9148770	1
P41240/Y304F	P41240	CSK	CSK_HUMAN	Y304F	422	αE	-	decrease	CEAMEyEGNNF	0.737	0.715	0.535	0.568	0.606	0.679	0.54	0.373	MUTAGEN	Y->F: Decreases activity by two-thirds and alters conformation.	9148770	1
P41279/S214F	P41279	MAP3K8	M3K8_HUMAN	S214F	256	β5/αD-loop	-	-	AGEGGsLEKLE	0.676	0.71	0.42	0.629	0.538	0.632	0.418	0.475	VARIANT	S -> F (in dbSNP:rs3087944)		0
P41279/T290A	P41279	MAP3K8	M3K8_HUMAN	T290A	549	A-loop	p	loss	KDLRGtIYMSP	0.891	0.948	0.266	0.746	0.845	0.83	0.254	0.29	MUTAGEN	T->A: Loss of MEK phosphorylation activity and almost abolished autophosphorylation activity. Loss of IL1-stimulated MEK phosphorylation activity but not of IL1-stimulated autophosphorylation activity. No effect on KSR2 binding.	15466476	1
P41279/T290D	P41279	MAP3K8	M3K8_HUMAN	T290D	549	A-loop	p	decrease	KDLRGtIYMSP	0.952	0.972	0.518	0.911	0.764	0.911	0.395	0.422	MUTAGEN	T->D: Impaired MEK phosphorylation and autophosphorylation activities. No effect on KSR2 binding.	15466476	1
P41279/T290E	P41279	MAP3K8	M3K8_HUMAN	T290E	549	A-loop	p	decrease	KDLRGtIYMSP	0.928	0.922	0.505	0.877	0.774	0.93	0.362	0.527	MUTAGEN	T->E: Loss of MEK phosphorylation activity and almost abolished autophosphorylation activity. No effect on KSR2 binding.	15466476	1
P41743/D72A	P41743	PRKCI	KPCI_HUMAN	D72A	-	-	-	decrease	TMKWIdEGDPC									MUTAGEN	D->A: Loss of interaction with ECT2, PARD6A and with SQSTM1.	15143057,15590654,19617897	3
P41743/E85A	P41743	PRKCI	KPCI_HUMAN	E85A	-	-	-	-	VSSQLeEEAFR									MUTAGEN	E->A: Slight decrease of interaction with PARD6A. Loss of interaction with PARD6A; when associated with A-91.	15590654	1
P41743/K274R	P41743	PRKCI	KPCI_HUMAN	K274R	61	β2/β3-loop	-	-	LLVRLkTDRIY	0.172	0.174	0.559	0.216	0.113	0.173	0.694	0.229	MUTAGEN	K->R: No effect on activity.	10906326	1
P41743/K274W	P41743	PRKCI	KPCI_HUMAN	K274W	61	β2/β3-loop	-	loss	LLVRLkTDRIY	0.843	0.786	0.56	0.678	0.583	0.633	0.594	0.414	MUTAGEN	K->W: Abolishes activity.	10906326	1
P41743/K29A	P41743	PRKCI	KPCI_HUMAN	K29A	-	-	-	-	HQVRVkYYRGD									MUTAGEN	K->A: No effect on interaction with SQSTM1.	15143057	1
P41743/P118L	P41743	PRKCI	KPCI_HUMAN	P118L	-	-	-	-	PGMPCpEDKSI									VARIANT	P -> L (in a metastatic melanoma sample; somatic mutation)	17344846	1
P41743/R130C	P41743	PRKCI	KPCI_HUMAN	R130C	-	-	-	-	YRRGArWRKLY									VARIANT	R -> C (in dbSNP:rs56154494)	17344846	1
P41743/R91A	P41743	PRKCI	KPCI_HUMAN	R91A	-	-	-	-	LEEAFrYELNK									MUTAGEN	R->A: Slight decrease of interaction with PARD6A. Loss of interaction with PARD6A; when associated with A-85.	15590654	1
P41743/Y265F	P41743	PRKCI	KPCI_HUMAN	Y265F	44	Gly-rich-loop;β1/β2-loop	-	-	IGRGSyKVLLV	0.657	0.674	0.538	0.624	0.302	0.509	0.653	0.495	MUTAGEN	Y->F: No effect on the SRC-mediated phosphorylation state. No effect on SRC-induced enzyme activity. Little effect on TRAF6-mediated activation of NF-kappa-B. Decreased binding to KPNB1/importin-beta.	11713277,11891849	2
P41743/Y280F	P41743	PRKCI	KPCI_HUMAN	Y280F	81	β2/β3-loop	-	-	KTDRIyMKVVK	0.643	0.634	0.45	0.527	0.583	0.559	0.487	0.311	MUTAGEN	Y->F: No effect on the SRC-mediated phosphorylation state. No effect on SRC-induced enzyme activity. No effect on TRAF6-mediated activation of NF-kappa-B.	11713277	1
P41743/Y334F	P41743	PRKCI	KPCI_HUMAN	Y334F	250	β5/αD-loop	-	-	FFVIEyNGGDL	0.73	0.59	0.49	0.415	0.494	0.529	0.554	0.691	MUTAGEN	Y->F: No effect on the SRC-mediated phosphorylation state. Significant reduction of SRC-induced enzyme activity. Greatly reduced TRAF6-mediated activation of NF-kappa-B. Reduces NGF-dependent cell survival.	11713277	1
P42679/A354T	P42679	MATK	MATK_HUMAN	A354T	445	Catalytic-loop	-	-	VHRDLaRNILV	0.833	0.808	0.521	0.66	0.596	0.82	0.53	0.371	VARIANT	A -> T (in an ovarian mucinous carcinoma sample; somatic mutation)	17344846	1
P42679/A496T	P42679	MATK	MATK_HUMAN	A496T	830	C-term-αI	-	neutral	VSGQDaGSTSP	0.107	0.146	0.49	0.162	0.129	0.183	0.62	0.065	VARIANT	A -> T (in dbSNP:rs35351680)	17344846	1
P42679/R503Q	P42679	MATK	MATK_HUMAN	R503Q	-	-	-	-	GSTSPrQEP									VARIANT	R -> Q (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs778726488)	17344846	1
P42680/R44Q	P42680	TEC	TEC_HUMAN	R44Q	-	-	-	-	TYYEGrEKKYR									VARIANT	R -> Q (in dbSNP:rs35374286)	17344846	1
P42680/R563K	P42680	TEC	TEC_HUMAN	R563K	631	αF/αG	-	-	VFTEGrPFEKY	0.178	0.108	0.509	0.191	0.122	0.142	0.679	0.104	VARIANT	R -> K (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
P42681/K299A	P42681	TXK	TXK_HUMAN	K299A	129	β3;Catalytic-Lys	-	loss	IQVAIkINEGS	1.0	0.992	0.024	0.56	0.997	0.999	0.005	0.63	MUTAGEN	K->A: Impairs kinase activity.	9813138	1
P42681/R336Q	P42681	TXK	TXK_HUMAN	R336Q	237	β4/β5-loop	-	neutral	GVCIQrPLYIV	0.175	0.164	0.438	0.152	0.107	0.177	0.674	0.1	VARIANT	R -> Q (in dbSNP:rs11724347)	17344846	1
P42681/R45H	P42681	TXK	TXK_HUMAN	R45H	-	-	-	neutral	EKYTQrRPWLS									VARIANT	R -> H (in dbSNP:rs7658300)	17344846,7951233	2
P42681/R63C	P42681	TXK	TXK_HUMAN	R63C	-	-	-	-	QSNTGrQPSKR									VARIANT	R -> C (in dbSNP:rs41265727)	17344846	1
P42681/Y91A	P42681	TXK	TXK_HUMAN	Y91A	-	-	p	-	QVKALyFLPRE									MUTAGEN	Y->A: Reduces expression levels if IFN-gamma.	12081135	1
P42684/E99Q	P42684	ABL2	ABL2_HUMAN	E99Q	-	-	-	-	RWSSKeLLGAT									VARIANT	E -> Q (somatic mutation in a breast cancer sample)	17344846	1
P42684/K930R	P42684	ABL2	ABL2_HUMAN	K930R	-	-	-	neutral	TTHNHkPVLIS									VARIANT	K -> R (in dbSNP:rs17277288)	17344846	1
P42684/P996R	P42684	ABL2	ABL2_HUMAN	P996R	-	-	-	neutral	RLLQHpICSDP									VARIANT	P -> R (in dbSNP:rs28913890)	17344846	1
P42684/R519I	P42684	ABL2	ABL2_HUMAN	R519I	790	αH	-	-	VYELMrCWKWS	0.648	0.549	0.603	0.543	0.365	0.354	0.672	0.491	VARIANT	R -> I (somatic mutation in a lung squamous cell carcinoma)	17344846	1
P42684/R78H	P42684	ABL2	ABL2_HUMAN	R78H	-	-	-	-	PEALHrYGCDV									VARIANT	R -> H (in dbSNP:rs55655202)	17344846	1
P42684/S1085N	P42684	ABL2	ABL2_HUMAN	S1085N	-	-	-	-	SADKIsEALLE									VARIANT	S -> N (in dbSNP:rs28913891)		0
P42684/T1101A	P42684	ABL2	ABL2_HUMAN	T1101A	-	-	-	-	LSSALtPVPNS									VARIANT	T -> A (in dbSNP:rs28913892)		0
P42684/T769S	P42684	ABL2	ABL2_HUMAN	T769S	-	-	-	neutral	RAGKPtSDDTS									VARIANT	T -> S (in dbSNP:rs55892721)	17344846	1
P42684/V946M	P42684	ABL2	ABL2_HUMAN	V946M	-	-	-	-	HTPADvLIGTD									VARIANT	V -> M (in dbSNP:rs28913889)		0
P42685/G122R	P42685	FRK	FRK_HUMAN	G122R	-	-	-	neutral	FFGAIgSDAEK									VARIANT	G -> R (in dbSNP:rs3756772)	17344846	1
P42685/I100V	P42685	FRK	FRK_HUMAN	I100V	-	-	-	-	QLQGYiSNYVA									VARIANT	I -> V (in dbSNP:rs34704018)	17344846	1
P42685/K262R	P42685	FRK	FRK_HUMAN	K262R	129	β3;Catalytic-Lys	-	loss	TPVAVkLKPGS	1.0	1.0	0.055	0.705	0.999	0.997	0.033	0.521	MUTAGEN	K->R: Loss of ability to phosphorylate PTEN.	19345329	1
P42685/S133L	P42685	FRK	FRK_HUMAN	S133L	-	-	-	neutral	KQLLYsNKTGS									VARIANT	S -> L (in dbSNP:rs34064900)	17344846	1
P43250/C561S	P43250	GRK6	GRK6_HUMAN	C561S	-	-	-	-	FSRQDcGNCSD									MUTAGEN	C->S: Abolishes palmitoylation; when associated with S-562 and S-565.	7961702	1
P43250/C562S	P43250	GRK6	GRK6_HUMAN	C562S	-	-	-	-	SRQDCcNCSDS									MUTAGEN	C->S: Abolishes palmitoylation; when associated with S-561 and S-565.	7961702	1
P43250/C565S	P43250	GRK6	GRK6_HUMAN	C565S	-	-	-	-	DCCGNcDSEEE									MUTAGEN	C->S: Abolishes palmitoylation; when associated with S-561 and S-562.	7961702	1
P43250/I275M	P43250	GRK6	GRK6_HUMAN	I275M	268	αD	-	-	DLKFHiHMGQA	0.446	0.489	0.547	0.474	0.267	0.302	0.638	0.378	VARIANT	I -> M (in a breast infiltrating ductal carcinoma sample; somatic mutation)	17344846	1
P43250/I6A	P43250	GRK6	GRK6_HUMAN	I6A	-	-	-	-	MELENiANTVL									MUTAGEN	I->A: 12-13 fold defects in kinase activity; 180-fold defects in kinase activity; when associated with A-7.	20729810	1
P43250/L12A	P43250	GRK6	GRK6_HUMAN	L12A	-	-	-	loss	VANTVlKAREG									MUTAGEN	L->A: 1100-fold defects in kinase activity.	20729810	1
P43250/N9A	P43250	GRK6	GRK6_HUMAN	N9A	-	-	-	loss	ENIVAnVLLKA									MUTAGEN	N->A: 140-fold defects in kinase activity.	20729810	1
P43250/R31Q	P43250	GRK6	GRK6_HUMAN	R31Q	-	-	-	-	KSKKWrMLQFP									VARIANT	R -> Q (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs141014084)	17344846	1
P43250/T73M	P43250	GRK6	GRK6_HUMAN	T73M	-	-	-	-	REFCAtPELSR									VARIANT	T -> M (in dbSNP:rs56382815)	17344846	1
P43250/V7A	P43250	GRK6	GRK6_HUMAN	V7A	-	-	-	-	ELENIvNTVLL									MUTAGEN	V->A: 12-13 fold defects in kinase activity; 180-fold defects in kinase activity; when associated with A-6.	20729810	1
P43403/A141E	P43403	ZAP70	ZAP70_HUMAN	A141E	-	-	-	increase	EALEQaISQAP									MUTAGEN	A->E: Increased constitutive kinase activity.	17512407	1
P43403/A507V	P43403	ZAP70	ZAP70_HUMAN	A507V	555	A-loop;APE-motif	-	-	PLKWYaECINF	0.845	0.828	0.383	0.644	0.62	0.725	0.36	0.484	VARIANT	A -> V (in IMD48)	18509675	1
P43403/C564R	P43403	ZAP70	ZAP70_HUMAN	C564R	761	αG/αH	-	-	ECPPEcPELYA	0.846	0.832	0.386	0.537	0.678	0.81	0.347	0.68	VARIANT	C -> R (in IMD48)	18509675	1
P43403/D327P	P43403	ZAP70	ZAP70_HUMAN	D327P	15	N-term-β1	-	increase	PEELKdKLFLK	0.339	0.275	0.494	0.341	0.231	0.239	0.627	0.312	MUTAGEN	D->P: Increases constitutive kinase activity on LAT phosphorylation, strongly increases subcellular localization of CD69 at the cell surface and decreases autoinhibition conformation.	26783323	1
P43403/D461N	P43403	ZAP70	ZAP70_HUMAN	D461N	443	Catalytic-loop;HrD-motif	-	loss	NFVHRdAARNV	1.0	1.0	0.207	0.642	0.958	0.986	0.131	0.699	MUTAGEN	D->N: Abolishes kinase activity.	17512407	1
P43403/D479N	P43403	ZAP70	ZAP70_HUMAN	D479N	496	A-loop;DFG-motif	-	loss	YAKISdGLSKA	0.968	0.976	0.173	0.562	0.965	0.944	0.081	0.632	MUTAGEN	D->N: Abolishes kinase activity.	15292186	1
P43403/G448E	P43403	ZAP70	ZAP70_HUMAN	G448E	413	αE	-	-	HQVSMgKYLEE	0.846	0.844	0.396	0.567	0.758	0.765	0.312	0.42	VARIANT	G -> E (in a head and neck squamous cell carcinoma sample; somatic mutation)	17344846	1
P43403/K304R	P43403	ZAP70	ZAP70_HUMAN	K304R	-	-	ub	-	ITSPDkRPMPM									MUTAGEN	K->R: No effect on ubiquitination.	26903241	1
P43403/K362E	P43403	ZAP70	ZAP70_HUMAN	K362E	101	β2/β3-loop	ub	increase	YRMRKkIDVAI	0.486	0.467	0.667	0.628	0.096	0.25	0.786	0.107	MUTAGEN	K->E: Increases constitutive kinase activity on LAT phosphorylation, strongly increases subcellular localization of CD69 at the cell surface and decreases autoinhibition conformation.	26783323	1
P43403/K538R	P43403	ZAP70	ZAP70_HUMAN	K538R	632	αF/αG	ub	-	LSYGQkYKKMK	0.452	0.394	0.437	0.388	0.33	0.339	0.589	0.127	MUTAGEN	K->R: No effect on ubiquitination.	26903241	1
P43403/K544R	P43403	ZAP70	ZAP70_HUMAN	K544R	638	αG	ub	-	PYKKMkPEVMA	0.369	0.315	0.466	0.376	0.111	0.281	0.667	0.083	MUTAGEN	K->R: Strongly decreased ubiquitination.	26903241	1
P43403/L133A	P43403	ZAP70	ZAP70_HUMAN	L133A	-	-	-	increase	RQTWKlGEALE									MUTAGEN	L->A: Increased constitutive kinase activity.	17512407	1
P43403/L337R	P43403	ZAP70	ZAP70_HUMAN	L337R	25	N-term-β1	-	-	LKRDNlIADIE	0.789	0.81	0.515	0.693	0.612	0.734	0.495	0.683	VARIANT	L -> R (in IMD48; dbSNP:rs1254428002)	18509675	1
P43403/P147A	P43403	ZAP70	ZAP70_HUMAN	P147A	-	-	-	increase	IISQApVEKLI									MUTAGEN	P->A: Increased kinase activity after activation by LCK.	17512407	1
P43403/P191L	P43403	ZAP70	ZAP70_HUMAN	P191L	-	-	-	-	KFLLRpKEQGT									VARIANT	P -> L (in dbSNP:rs56403250)	17344846	1
P43403/Q145A	P43403	ZAP70	ZAP70_HUMAN	Q145A	-	-	-	increase	QAIISqPQVEK									MUTAGEN	Q->A: Increased kinase activity after activation by LCK.	17512407	1
P43403/R175L	P43403	ZAP70	ZAP70_HUMAN	R175L	-	-	-	-	REEAErLYSGA									VARIANT	R -> L (in dbSNP:rs55964305)	17344846	1
P43403/R190K	P43403	ZAP70	ZAP70_HUMAN	R190K	-	-	-	-	GKFLLrRKEQG									MUTAGEN	R->K: Decreases interaction with phosphorylated CD247; when associated with K-37.	26783323	1
P43403/R192W	P43403	ZAP70	ZAP70_HUMAN	R192W	-	-	-	decrease	FLLRPrEQGTY									VARIANT	R -> W (in ADMIO2; decreases interaction with phosphorylated CD247; decreases ZAP70 phosphorylation; no effect on subcellular localization of CD69 at the cell surface; dbSNP:rs199840952)	26783323	1
P43403/R360P	P43403	ZAP70	ZAP70_HUMAN	R360P	93	β2/β3-loop	-	increase	GVYRMrKQIDV	0.475	0.457	0.688	0.586	0.162	0.232	0.785	0.203	VARIANT	R -> P (in ADMIO2; no effect on interaction with phosphorylated CD247; increases TCR-induced Y-319 and Y-493 phosphorylation of ZAP70 and phosphorylation of LAT and LCP2; increases subcellular localization of CD69 at the cell surface; weakly decreases autoinhibition conformation; dbSNP:rs869025224)	26783323	1
P43403/R37K	P43403	ZAP70	ZAP70_HUMAN	R37K	-	-	-	-	GLFLLrCLRSL									MUTAGEN	R->K: Decreases interaction with phosphorylated CD247; when associated with K-190.	26783323	1
P43403/R465C	P43403	ZAP70	ZAP70_HUMAN	R465C	447	Catalytic-loop	-	-	RDLAArVLLVN	0.829	0.787	0.397	0.622	0.738	0.852	0.306	0.464	VARIANT	R -> C (in IMD48; dbSNP:rs113994174)	11123350	1
P43403/R465H	P43403	ZAP70	ZAP70_HUMAN	R465H	447	Catalytic-loop	-	-	RDLAArVLLVN	0.657	0.593	0.402	0.409	0.525	0.56	0.449	0.291	VARIANT	R -> H (in IMD48; dbSNP:rs137853201)	11412303	1
P43403/S144A	P43403	ZAP70	ZAP70_HUMAN	S144A	-	-	-	increase	EQAIIsAPQVE									MUTAGEN	S->A: Increased kinase activity after activation by LCK.	17512407	1
P43403/S518R	P43403	ZAP70	ZAP70_HUMAN	S518R	597	αF	-	-	FRKFSsSDVWS	0.303	0.263	0.537	0.354	0.202	0.187	0.714	0.171	VARIANT	S -> R (in IMD48; dbSNP:rs104893674)	8202713	1
P43403/V314A	P43403	ZAP70	ZAP70_HUMAN	V314A	2	N-term-β1	-	increase	PMDTSvESPYS	0.602	0.552	0.545	0.615	0.317	0.37	0.614	0.361	MUTAGEN	V->A: Increased constitutive kinase activity.		0
P43403/W131A	P43403	ZAP70	ZAP70_HUMAN	W131A	-	-	-	increase	YVRQTwLEGEA									MUTAGEN	W->A: Increased constitutive kinase activity.	17512407	1
P43403/W523L	P43403	ZAP70	ZAP70_HUMAN	W523L	602	αF	-	-	SRSDVwYGVTM	0.833	0.847	0.332	0.665	0.746	0.762	0.292	0.474	VARIANT	W -> L (in dbSNP:rs56189815)	17344846	1
P43403/Y292F	P43403	ZAP70	ZAP70_HUMAN	Y292F	-	-	p	increase	LNSDGyPEPAR									MUTAGEN	Y->F: Induces constitutive TCR stimulation-independent NFAT induction.	8943331	1
P43403/Y315A	P43403	ZAP70	ZAP70_HUMAN	Y315A	3	N-term-β1	p	-	MDTSVySPYSD	0.829	0.808	0.496	0.748	0.449	0.663	0.496	0.519	MUTAGEN	Y->A: Increased constitutive kinase activity; when associated with F-319.	10037717,11828374,17512407,9151714	4
P43403/Y315F	P43403	ZAP70	ZAP70_HUMAN	Y315F	3	N-term-β1	p	-	MDTSVySPYSD	0.771	0.793	0.609	0.677	0.344	0.594	0.658	0.336	MUTAGEN	Y->F: Increased constitutive kinase activity; when associated with F-319. About 75% loss of CD247/CD3Z-binding in stimulated TCR and complete loss of VAV1 interaction.	10037717,11828374,17512407,9151714	4
P43403/Y319A	P43403	ZAP70	ZAP70_HUMAN	Y319A	7	N-term-β1	p	-	VYESPyDPEEL	0.875	0.769	0.445	0.708	0.571	0.703	0.416	0.527	MUTAGEN	Y->A: Increased constitutive kinase activity; when associated with F-315.	10037717,17512407	2
P43403/Y319F	P43403	ZAP70	ZAP70_HUMAN	Y319F	7	N-term-β1	p	-	VYESPyDPEEL	0.75	0.829	0.554	0.652	0.441	0.571	0.623	0.336	MUTAGEN	Y->F: Increased constitutive kinase activity; when associated with F-315. About 80% loss of TCR-induced NFAT activation.	10037717,17512407	2
P43403/Y492F	P43403	ZAP70	ZAP70_HUMAN	Y492F	512	A-loop	p	increase	GADDSyTARSA	0.841	0.885	0.719	0.858	0.35	0.701	0.726	0.318	MUTAGEN	Y->F: Increases kinase activity.	7781602	1
P43403/Y493F	P43403	ZAP70	ZAP70_HUMAN	Y493F	513	A-loop	p	loss	ADDSYyARSAG	0.89	0.917	0.462	0.731	0.757	0.861	0.369	0.542	MUTAGEN	Y->F: Impairs kinase activity.	7781602	1
P43403/Y597A	P43403	ZAP70	ZAP70_HUMAN	Y597A	820	αI	p	increase	RMRACySLASK	0.867	0.868	0.657	0.841	0.204	0.554	0.667	0.524	MUTAGEN	Y->A: Increased kinase activity after activation by LCK.	17512407	1
P43403/Y598A	P43403	ZAP70	ZAP70_HUMAN	Y598A	821	αI	p	increase	MRACYyLASKV	0.908	0.933	0.612	0.901	0.411	0.82	0.614	0.625	MUTAGEN	Y->A: Increased kinase activity after activation by LCK.	17512407	1
P43405/A353T	P43405	SYK	KSYK_HUMAN	A353T	10	N-term-β1	-	activating	YESPYaPEEIR	0.258	0.238	0.525	0.267	0.188	0.2	0.732	0.114	VARIANT	A -> T (in IMD82; constitutively active protein tyrosine kinase activity)	33782605	1
P43405/M450I	P43405	SYK	KSYK_HUMAN	M450I	250	β5/αD-loop	-	activating	MLVMEmELGPL	0.747	0.46	0.656	0.641	0.207	0.349	0.735	0.706	VARIANT	M -> I (in IMD82; constitutively active protein tyrosine kinase activity)	33782605	1
P43405/P342T	P43405	SYK	KSYK_HUMAN	P342T	-	-	-	activating	QREALpDTEVY									VARIANT	P -> T (in IMD82; constitutively active protein tyrosine kinase activity)	33782605	1
P43405/R45H	P43405	SYK	KSYK_HUMAN	R45H	-	-	-	-	LLRQSrYLGGF									VARIANT	R -> H (in dbSNP:rs16906862)		0
P43405/S297A	P43405	SYK	KSYK_HUMAN	S297A	-	-	p	decrease	RIKSYsPKPGH									MUTAGEN	S->A: Abolishes YWHAG binding.	21469132	1
P43405/S550F	P43405	SYK	KSYK_HUMAN	S550F	596	αF	-	activating	NYYKFsKSDVW	0.741	0.752	0.685	0.773	0.207	0.59	0.74	0.325	VARIANT	S -> F (in IMD82; constitutively active protein tyrosine kinase activity)	33782605	1
P43405/S550Y	P43405	SYK	KSYK_HUMAN	S550Y	596	αF	-	activating	NYYKFsKSDVW	0.763	0.747	0.664	0.783	0.22	0.565	0.727	0.376	VARIANT	S -> Y (in IMD82; constitutively active protein tyrosine kinase activity)	33782605	1
P43405/Y630F	P43405	SYK	KSYK_HUMAN	Y630F	818	αI	p	decrease	RLRNYyDVVN	0.856	0.836	0.576	0.692	0.477	0.66	0.63	0.197	MUTAGEN	Y->F: Loss of interaction with BLNK.	18369315	1
P45983/E365K	P45983	MAPK8	MK08_HUMAN	E365K	-	-	-	-	VMDLEeTKNGV									VARIANT	E -> K (in dbSNP:rs45483593)		0
P45983/G171S	P45983	MAPK8	MK08_HUMAN	G171S	498	A-loop;DFG-motif	-	-	KILDFgARTAG	0.938	0.921	0.364	0.734	0.581	0.818	0.285	0.532	VARIANT	G -> S (in a renal clear cell carcinoma sample; somatic mutation)	17344846	1
P45983/G177R	P45983	MAPK8	MK08_HUMAN	G177R	510	A-loop	-	-	LARTAgSFMMT	0.742	0.705	0.562	0.632	0.33	0.533	0.643	0.324	VARIANT	G -> R (in a glioblastoma multiforme sample; somatic mutation)	17344846	1
P45983/K55D	P45983	MAPK8	MK08_HUMAN	K55D	129	β3;Catalytic-Lys	-	loss	RNVAIkLSRPF	1.0	0.993	0.144	0.812	0.979	0.99	0.096	0.451	MUTAGEN	K->D: Abolished protein kinase activity.	22966201,28943315	2
P45983/T183A	P45983	MAPK8	MK08_HUMAN	T183A	544	A-loop	p	decrease	TSFMMtYVVTR	0.995	0.997	0.222	0.865	0.954	0.976	0.211	0.636	MUTAGEN	T->A: Phosphorylation blocked.	7839144	1
P45983/Y185F	P45983	MAPK8	MK08_HUMAN	Y185F	546	A-loop	p	decrease	FMMTPyVTRYY	0.998	0.979	0.251	0.87	0.96	0.964	0.211	0.527	MUTAGEN	Y->F: Phosphorylation blocked.	7839144	1
P45984/A246T	P45984	MAPK9	MK09_HUMAN	A246T	655	αG/αH	-	-	LGTPSaFMKKL	0.127	0.144	0.472	0.108	0.135	0.135	0.669	0.167	VARIANT	A -> T (in dbSNP:rs35421153)	17344846	1
P45984/G268A	P45984	MAPK9	MK09_HUMAN	G268A	694	αG/αH	-	-	RPKYPgKFEEL	0.308	0.318	0.403	0.281	0.284	0.282	0.524	0.235	VARIANT	G -> A (in dbSNP:rs35693958)		0
P45984/K56N	P45984	MAPK9	MK09_HUMAN	K56N	130	β3	-	-	NVAVKkSRPFQ	0.866	0.801	0.458	0.722	0.648	0.705	0.426	0.471	VARIANT	K -> N (in a head & Neck squamous cell carcinoma sample; somatic mutation)	17344846	1
P45984/R366I	P45984	MAPK9	MK09_HUMAN	R366I	-	-	-	-	MDWEErKNGVV									VARIANT	R -> I (in dbSNP:rs55736180)	17344846	1
P45984/V13M	P45984	MAPK9	MK09_HUMAN	V13M	20	N-term-β1	-	-	SQFYSvVADST	0.384	0.263	0.528	0.262	0.195	0.319	0.67	0.193	VARIANT	V -> M (in a colorectal adenocarcinoma sample; somatic mutation)	17344846	1
P45985/A279T	P45985	MAP2K4	MP2K4_HUMAN	A279T	587	αF	-	-	RIDPSaRQGYD	0.091	0.112	0.523	0.112	0.089	0.081	0.729	0.059	VARIANT	A -> T (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs753665559)	17344846	1
P45985/N234I	P45985	MAP2K4	MP2K4_HUMAN	N234I	448	Catalytic-loop	-	-	DIKPSnLLDRS	0.951	0.911	0.244	0.666	0.878	0.9	0.214	0.682	VARIANT	N -> I (in an ovarian serous carcinoma sample; somatic mutation)	17344846	1
P45985/Q142L	P45985	MAP2K4	MP2K4_HUMAN	Q142L	145	αC	-	-	VDEKEqQLLMD	0.39	0.375	0.725	0.545	0.175	0.211	0.801	0.266	VARIANT	Q -> L (in a lung squamous cell carcinoma sample; somatic mutation)	17344846	1
P45985/R154W	P45985	MAP2K4	MP2K4_HUMAN	R154W	180	αC/β4-loop	-	-	LDVVMrSDCPY	0.689	0.624	0.516	0.517	0.504	0.618	0.489	0.488	VARIANT	R -> W (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs1567657403)	17344846	1
P45985/S16R	P45985	MAP2K4	MP2K4_HUMAN	S16R	-	-	-	-	GSGGGsSGTPG									VARIANT	S -> R (in dbSNP:rs17855590)	15489334	1
P45985/S251N	P45985	MAP2K4	MP2K4_HUMAN	S251N	501	A-loop	-	-	CDFGIsQLVDS	0.916	0.91	0.582	0.779	0.623	0.821	0.469	0.599	VARIANT	S -> N (in a metastatic melanoma sample; somatic mutation)	17344846	1
P46734/A84T	P46734	MAP2K3	MP2K3_HUMAN	A84T	61	β2/β3-loop	-	-	EKVRHaSGTIM	0.208	0.248	0.449	0.199	0.206	0.182	0.61	0.231	VARIANT	A -> T (in dbSNP:rs2305873)	17344846	1
P46734/L215V	P46734	MAP2K3	MP2K3_HUMAN	L215V	509	A-loop	-	-	GISGYlDSVAK	0.776	0.724	0.448	0.622	0.549	0.604	0.501	0.619	VARIANT	L -> V (in colon cancer; dbSNP:rs989026404)	11414763	1
P46734/M90I	P46734	MAP2K3	MP2K3_HUMAN	M90I	81	β2/β3-loop	-	-	QSGTImVKRIR	0.401	0.331	0.543	0.346	0.285	0.283	0.62	0.316	VARIANT	M -> I (in dbSNP:rs36076766)	17344846	1
P46734/P40T	P46734	MAP2K3	MP2K3_HUMAN	P40T	7	N-term-β1	-	-	APNPTpRNLDS	0.528	0.364	0.529	0.39	0.302	0.355	0.6	0.441	VARIANT	P -> T (in dbSNP:rs33911218)		0
P46734/R175W	P46734	MAP2K3	MP2K3_HUMAN	R175W	412	αE	-	-	AVSIVrLEHLH	0.713	0.658	0.431	0.437	0.57	0.649	0.415	0.409	VARIANT	R -> W (in colon cancer; dbSNP:rs1339756947)	11414763	1
P46734/R26T	P46734	MAP2K3	MP2K3_HUMAN	R26T	-	-	-	-	RKKDLrSCMSK									VARIANT	R -> T	17344846	1
P46734/R293H	P46734	MAP2K3	MP2K3_HUMAN	R293H	684	αG/αH	-	-	QLPADrSPEFV	0.156	0.181	0.497	0.246	0.167	0.169	0.656	0.115	VARIANT	R -> H (in dbSNP:rs35206134)	17344846	1
P46734/R55T	P46734	MAP2K3	MP2K3_HUMAN	R55T	22	N-term-β1	-	-	ITIGDrFEVEA	0.48	0.406	0.493	0.394	0.31	0.302	0.549	0.276	VARIANT	R -> T (in dbSNP:rs36047035)		0
P46734/R94L	P46734	MAP2K3	MP2K3_HUMAN	R94L	130	β3	-	-	IMAVKrRATVN	0.675	0.603	0.606	0.603	0.404	0.612	0.606	0.357	VARIANT	R -> L (in dbSNP:rs56067280)	17344846	1
P46734/R96W	P46734	MAP2K3	MP2K3_HUMAN	R96W	132	β3/αC-loop	-	-	AVKRIrTVNSQ	0.767	0.726	0.432	0.624	0.556	0.687	0.475	0.322	VARIANT	R -> W (in dbSNP:rs56216806)	17344846	1
P46734/S218A	P46734	MAP2K3	MP2K3_HUMAN	S218A	513	A-loop	p	loss	GYLVDsAKTMD	0.803	0.863	0.436	0.67	0.828	0.735	0.308	0.35	MUTAGEN	S->A: Inactivation.	8622669	1
P46734/S218E	P46734	MAP2K3	MP2K3_HUMAN	S218E	513	A-loop	p	activating	GYLVDsAKTMD	0.823	0.874	0.772	0.891	0.24	0.691	0.772	0.314	MUTAGEN	S->E: Constitutive activation.	8622669	1
P46734/S68P	P46734	MAP2K3	MP2K3_HUMAN	S68P	37	β1	-	-	DLVTIsLGRGA	0.443	0.422	0.429	0.38	0.317	0.326	0.538	0.218	VARIANT	S -> P (in dbSNP:rs34105301)	17344846	1
P46734/T222A	P46734	MAP2K3	MP2K3_HUMAN	T222A	544	A-loop	p	loss	DSVAKtDAGCK	0.956	0.986	0.302	0.826	0.821	0.959	0.312	0.455	MUTAGEN	T->A: Inactivation.	8622669	1
P46734/T222E	P46734	MAP2K3	MP2K3_HUMAN	T222E	544	A-loop	p	activating	DSVAKtDAGCK	0.966	0.982	0.649	0.925	0.323	0.922	0.723	0.512	MUTAGEN	T->E: Constitutive activation.	8622669	1
P46734/V339M	P46734	MAP2K3	MP2K3_HUMAN	V339M	837	C-term-αI	-	-	DIAAFvEILGE	0.566	0.585	0.429	0.323	0.397	0.498	0.591	0.295	VARIANT	V -> M (in dbSNP:rs2363198)	17344846	1
P48729/D297H	P48729	CSNK1A1	KC1A_HUMAN	D297H	-	-	-	-	YDYTFdTMLKQ									VARIANT	D -> H (in a breast pleomorphic lobular carcinoma sample; somatic mutation)	17344846	1
P48730/H46R	P48730	CSNK1D	KC1D_HUMAN	H46R	142	αC	-	decrease	CVKTKhQLHIE	0.681	0.666	0.481	0.465	0.536	0.579	0.462	0.349	VARIANT	H -> R (in FASPS2; strongly reduces kinase activity; dbSNP:rs397514693)	23636092	1
P48730/K38M	P48730	CSNK1D	KC1D_HUMAN	K38M	129	β3;Catalytic-Lys	-	decrease	EEVAIkECVKT	0.991	0.996	0.052	0.648	0.999	0.999	0.023	0.571	MUTAGEN	K->M: Impaired kinase activity and abnormal subcellular localization with exclusive accumulation to the nucleus.	11161704	1
P48730/P401A	P48730	CSNK1D	KC1D_HUMAN	P401A	-	-	-	-	STSQIpRVASS									VARIANT	P -> A (in dbSNP:rs56124628)	17344846	1
P48730/S97C	P48730	CSNK1D	KC1D_HUMAN	S97C	385	αD/αE-loop	-	-	LFNFCsKFSLK	0.549	0.502	0.505	0.402	0.379	0.335	0.562	0.418	VARIANT	S -> C (in breast cancer samples; infiltrating ductal carcinoma; somatic mutation)	16959974,17344846	2
P48730/T176I	P48730	CSNK1D	KC1D_HUMAN	T176I	549	A-loop	p	decrease	KNLTGtRYASI	0.915	0.914	0.456	0.796	0.797	0.902	0.306	0.391	MUTAGEN	T->I: Impaired kinase activity and abnormal subcellular localization with exclusive accumulation to the nucleus.	11161704	1
P48730/T44A	P48730	CSNK1D	KC1D_HUMAN	T44A	138	αC	-	decrease	LECVKtHPQLH	0.482	0.487	0.4	0.297	0.508	0.426	0.446	0.334	VARIANT	T -> A (in FASPS2; strongly reduces kinase activity; dbSNP:rs104894561)	15800623,23636092	2
P49137/A173G	P49137	MAPKAPK2	MAPK2_HUMAN	A173G	413	αE	-	-	KSIGEaQYLHS	0.671	0.567	0.576	0.472	0.393	0.47	0.64	0.477	VARIANT	A -> G (in dbSNP:rs35671930)	17344846	1
P49137/A361S	P49137	MAPKAPK2	MAPK2_HUMAN	A361S	-	-	-	neutral	MTSALaMRVDY									VARIANT	A -> S (in dbSNP:rs55894011)	17344846	1
P49137/D207A	P49137	MAPKAPK2	MAPK2_HUMAN	D207A	496	A-loop;DFG-motif	-	loss	ILKLTdGFAKE	0.987	0.991	0.103	0.545	0.975	0.981	0.041	0.687	MUTAGEN	D->A: Kinase defective mutant, abolishes activity.	8846784	1
P49137/K353R	P49137	MAPKAPK2	MAPK2_HUMAN	K353R	851	C-term-αI	sm	increase	RWEDVkEMTSA	0.508	0.506	0.516	0.49	0.239	0.34	0.706	0.159	MUTAGEN	K->R: Induces decreased sumoylation and increase in protein kinase activity.	21131586	1
P49137/K93R	P49137	MAPKAPK2	MAPK2_HUMAN	K93R	129	β3;Catalytic-Lys	-	loss	EKFALkLQDCP	0.991	0.997	0.048	0.672	0.996	0.996	0.013	0.395	MUTAGEN	K->R: Kinase defective mutant, abolishes activity.	14517288	1
P49137/S272A	P49137	MAPKAPK2	MAPK2_HUMAN	S272A	643	αG	p	decrease	HGLAIsGMKTR	0.796	0.847	0.356	0.696	0.686	0.676	0.405	0.313	MUTAGEN	S->A: Strong decrease in kinase activity.	8846784	1
P49137/S272D	P49137	MAPKAPK2	MAPK2_HUMAN	S272D	643	αG	p	increase	HGLAIsGMKTR	0.793	0.809	0.63	0.83	0.264	0.537	0.72	0.165	MUTAGEN	S->D: Mimicks phosphorylation state, leading to slight increase of basal kinase activity.	8846784	1
P49137/T222A	P49137	MAPKAPK2	MAPK2_HUMAN	T222A	545	A-loop	p	decrease	HNSLTtCYTPY	0.952	0.973	0.181	0.878	0.939	0.981	0.105	0.295	MUTAGEN	T->A: Strong decrease in kinase activity.	14517288,15014438,8846784	3
P49137/T222D	P49137	MAPKAPK2	MAPK2_HUMAN	T222D	545	A-loop	p	increase	HNSLTtCYTPY	0.999	1.0	0.793	0.986	0.233	0.944	0.813	0.39	MUTAGEN	T->D: Mimicks phosphorylation state, leading to slight increase of basal kinase activity.	14517288,15014438,8846784	3
P49137/T222E	P49137	MAPKAPK2	MAPK2_HUMAN	T222E	545	A-loop	p	-	HNSLTtCYTPY	0.992	1.0	0.688	0.972	0.455	0.944	0.697	0.465	MUTAGEN	T->E: Mimicks phosphorylation state and constitutive protein kinase activity; when associated with E-334.	14517288,15014438,8846784	3
P49137/T334A	P49137	MAPKAPK2	MAPK2_HUMAN	T334A	832	C-term-αI	p	decrease	TKVPQtLHTSR	0.847	0.897	0.396	0.696	0.635	0.751	0.427	0.211	MUTAGEN	T->A: Slight decrease in kinase activity.	14517288,15014438,8846784	3
P49137/T334D	P49137	MAPKAPK2	MAPK2_HUMAN	T334D	832	C-term-αI	p	increase	TKVPQtLHTSR	0.867	0.91	0.669	0.883	0.369	0.794	0.693	0.316	MUTAGEN	T->D,E: Mimicks phosphorylation state, leading to elevated basal kinase activity.	14517288,15014438,8846784	3
P49137/T334E	P49137	MAPKAPK2	MAPK2_HUMAN	T334E	832	C-term-αI	p	-	TKVPQtLHTSR	0.867	0.888	0.667	0.809	0.351	0.683	0.743	0.248	MUTAGEN	T->E: Mimicks phosphorylation state and constitutive protein kinase activity; when associated with E-222.	14517288,15014438,8846784	3
P49336/D173A	P49336	CDK8	CDK8_HUMAN	D173A	496	A-loop;DFG-motif	-	loss	RVKIAdGFARL	0.986	0.99	0.082	0.578	0.995	0.972	0.027	0.758	MUTAGEN	D->A: Abrogates kinase activity and TFIIH-dependent transcriptional repression.	10993082,30905399	2
P49336/D189N	P49336	CDK8	CDK8_HUMAN	D189N	542	A-loop	-	-	LKPLAdDPVVV	0.268	0.236	0.473	0.266	0.158	0.197	0.627	0.163	VARIANT	D -> N (in a lung neuroendocrine carcinoma sample; somatic mutation)	17344846	1
P49336/F97L	P49336	CDK8	CDK8_HUMAN	F97L	248	β5	-	-	KVWLLfYAEHD	0.725	0.638	0.571	0.578	0.312	0.448	0.683	0.706	VARIANT	F -> L (in IDDHBA; unknown pathological significance)	30905399	1
P49336/G30S	P49336	CDK8	CDK8_HUMAN	G30S	42	β1;Gly-rich-loop	-	decrease	CKVGRgYGHVY	0.93	0.935	0.263	0.614	0.87	0.923	0.24	0.479	VARIANT	G -> S (in IDDHBA; decreased protein kinase activity; dbSNP:rs1593218890)	30905399	1
P49336/I223M	P49336	CDK8	CDK8_HUMAN	I223M	607	αF	-	decrease	WAIGCiAELLT	0.809	0.734	0.402	0.542	0.6	0.643	0.464	0.471	VARIANT	I -> M (in IDDHBA; decreased protein kinase activity; dbSNP:rs1593310364)	30905399	1
P49336/R178Q	P49336	CDK8	CDK8_HUMAN	R178Q	502	A-loop	-	decrease	DMGFArFNSPL	0.845	0.867	0.553	0.809	0.51	0.671	0.528	0.546	VARIANT	R -> Q (in IDDHBA; decreased protein kinase activity; dbSNP:rs1418353379)	30905399	1
P49336/R29G	P49336	CDK8	CDK8_HUMAN	R29G	41	β1;Gly-rich-loop	-	decrease	GCKVGrTYGHV	0.862	0.805	0.376	0.499	0.707	0.75	0.346	0.489	VARIANT	R -> G (in IDDHBA; decreased protein kinase activity; dbSNP:rs1593218885)	30905399	1
P49336/R424C	P49336	CDK8	CDK8_HUMAN	R424C	-	-	-	-	TSDYQrNPHAA									VARIANT	R -> C (in a colorectal adenocarcinoma sample; somatic mutation)	17344846	1
P49336/S62L	P49336	CDK8	CDK8_HUMAN	S62L	169	αC	-	decrease	TGISMsCREIA	0.692	0.575	0.569	0.532	0.507	0.481	0.493	0.433	VARIANT	S -> L (in IDDHBA; decreased protein kinase activity; dbSNP:rs1565977796)	30905399	1
P49336/V193G	P49336	CDK8	CDK8_HUMAN	V193G	546	A-loop	-	decrease	ADLDPvVTFWY	0.826	0.754	0.543	0.591	0.664	0.639	0.56	0.512	VARIANT	V -> G (in IDDHBA; decreased protein kinase activity; dbSNP:rs1875421510)	30905399	1
P49336/V27L	P49336	CDK8	CDK8_HUMAN	V27L	39	β1	-	decrease	YEGCKvRGTYG	0.511	0.404	0.558	0.404	0.329	0.353	0.663	0.391	VARIANT	V -> L (in IDDHBA; decreased protein kinase activity)	30905399	1
P49674/H413R	P49674	CSNK1E	KC1E_HUMAN	H413R	-	-	-	-	SVPFDhGK									VARIANT	H -> R (in dbSNP:rs35665927)	17344846	1
P49674/K38R	P49674	CSNK1E	KC1E_HUMAN	K38R	129	β3;Catalytic-Lys	-	loss	EEVAIkECVKT	0.981	0.991	0.083	0.619	0.973	0.999	0.057	0.305	MUTAGEN	K->R: Loss of kinase activity.	29222110	1
P49674/R256L	P49674	CSNK1E	KC1E_HUMAN	R256L	-	-	-	-	YLNFCrLRFDD									VARIANT	R -> L (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
P49759/E459G	P49759	CLK1	CLK1_HUMAN	E459G	794	αH/αI	-	-	IQKMLeDPAKR	0.739	0.656	0.46	0.537	0.519	0.58	0.532	0.39	VARIANT	E -> G (in dbSNP:rs12709)		0
P49759/M440T	P49759	CLK1	CLK1_HUMAN	M440T	774	αG/αH	-	-	PLKEFmSQDVE	0.696	0.585	0.57	0.608	0.319	0.487	0.667	0.523	VARIANT	M -> T (in dbSNP:rs35393352)	17344846	1
P49759/N99D	P49759	CLK1	CLK1_HUMAN	N99D	-	-	-	neutral	ESRYQnSSKSS									VARIANT	N -> D (in dbSNP:rs6735666)		0
P49759/P307S	P49759	CLK1	CLK1_HUMAN	P307S	465	Catalytic-loop	-	-	TEAYNpIKRDE	0.155	0.143	0.448	0.191	0.156	0.149	0.623	0.154	VARIANT	P -> S (in dbSNP:rs35412475)	17344846	1
P49759/R118G	P49759	CLK1	CLK1_HUMAN	R118G	-	-	-	-	YKSKHrHHSTS									VARIANT	R -> G (in dbSNP:rs56135616)	17344846	1
P49759/S61F	P49759	CLK1	CLK1_HUMAN	S61F	-	-	p	-	YLESRsNEKDY									VARIANT	S -> F (in dbSNP:rs55989135)	17344846	1
P49761/Q607R	P49761	CLK3	CLK3_HUMAN	Q607R	799	αI	-	-	EFDPAqITLAE	0.234	0.258	0.548	0.3	0.155	0.153	0.734	0.144	VARIANT	Q -> R (in dbSNP:rs910378995)	17344846	1
P49761/R486C	P49761	CLK3	CLK3_HUMAN	R486C	551	A-loop	-	-	TIVATrYRPPE	0.83	0.814	0.417	0.649	0.653	0.765	0.368	0.508	VARIANT	R -> C (in dbSNP:rs975796055)	17344846	1
P49761/R628W	P49761	CLK3	CLK3_HUMAN	R628W	831	C-term-αI	-	-	LTPEErFHTSR	0.65	0.585	0.412	0.454	0.482	0.519	0.432	0.426	VARIANT	R -> W (in dbSNP:rs920443187)	17344846	1
P49840/L461F	P49840	GSK3A	GSK3A_HUMAN	L461F	-	-	-	-	PSSQAlETPTS									VARIANT	L -> F (in dbSNP:rs35454502)	17344846	1
P49840/Q109E	P49840	GSK3A	GSK3A_HUMAN	Q109E	23	N-term-β1	-	-	VATLGqPERSQ	0.548	0.484	0.552	0.49	0.298	0.395	0.624	0.238	VARIANT	Q -> E (in dbSNP:rs35978177)		0
P49841/L128A	P49841	GSK3B	GSK3B_HUMAN	L128A	244	β5	-	loss	KDEVYlLVLDY	0.877	0.833	0.425	0.713	0.72	0.815	0.365	0.504	MUTAGEN	L->A: Abolishes activity toward AXIN1.	11430833	1
P49841/R96A	P49841	GSK3B	GSK3B_HUMAN	R96A	172	αC	-	loss	KRFKNrLQIMR	0.904	0.838	0.275	0.596	0.845	0.826	0.239	0.435	MUTAGEN	R->A: Prevents the phosphorylation of phosphate-primed glycogen synthase.	11430833	1
P49841/S9A	P49841	GSK3B	GSK3B_HUMAN	S9A	-	-	p	activating	RPRTTsAESCK									MUTAGEN	S->A: Loss of phosphorylation; abolished inhibition of activity, leading to constitutively active.	17050006,28992046,7980435	3
P49842/A331V	P49842	STK19	STK19_HUMAN	A331V	-	-	-	-	LLGRRaVVVRL									VARIANT	A -> V (in dbSNP:rs7743647)	17344846	1
P49842/A39D	P49842	STK19	STK19_HUMAN	A39D	-	-	-	-	VDTNVaGAPPR									VARIANT	A -> D (in dbSNP:rs34843142)		0
P49842/D89N	P49842	STK19	STK19_HUMAN	D89N	-	-	-	increase	CSAPEdIFRFS									VARIANT	D -> N (recurrent gain-of-function variant found in metastatic melanoma; promotes NRAS signaling; somatic mutation; dbSNP:rs267600971)	17344846,30712867	2
P49842/K300P	P49842	STK19	STK19_HUMAN	K300P	-	-	-	decrease	AGRFIkFVKGR									MUTAGEN	K->P: Partial loss of activity.	9812991	1
P49842/K315P	P49842	STK19	STK19_HUMAN	K315P	-	-	-	decrease	LSMVRkKYREL									MUTAGEN	K->P: Partial loss of activity.	9812991	1
P49842/K317P	P49842	STK19	STK19_HUMAN	K317P	-	-	-	loss	MVRKAkRELLL									MUTAGEN	K->P: Complete loss of activity.	9812991	1
P49842/L139V	P49842	STK19	STK19_HUMAN	L139V	-	-	-	decrease	VESDPlGEPGS									MUTAGEN	L->V: Prevents inhibition by ZT-12-037-01 (1a) without affecting much the serine/threonine-protein kinase activity.	30712867	1
P49842/S311G	P49842	STK19	STK19_HUMAN	S311G	-	-	-	neutral	RQAVLsVRKAK									VARIANT	S -> G (in dbSNP:rs616634)	14574404,17344846	2
P49842/V134Y	P49842	STK19	STK19_HUMAN	V134Y	-	-	-	decrease	RKRGPvSDPLR									MUTAGEN	V->Y: Prevents inhibition by ZT-12-037-01 (1a) without affecting much the serine/threonine-protein kinase activity.	30712867	1
P50613/F91G	P50613	CDK7	CDK7_HUMAN	F91G	248	β5	-	-	NISLVfFMETD	0.829	0.812	0.525	0.693	0.594	0.756	0.451	0.692	MUTAGEN	F->G: Enhanced capacity to bind ATP analogs.	16327805	1
P50613/G163A	P50613	CDK7	CDK7_HUMAN	G163A	510	A-loop	-	-	LAKSFgPNRAY	0.74	0.689	0.459	0.585	0.409	0.595	0.501	0.296	VARIANT	G -> A		0
P50613/K41A	P50613	CDK7	CDK7_HUMAN	K41A	129	β3;Catalytic-Lys	-	loss	QIVAIkIKLGH	1.0	1.0	0.051	0.736	0.981	0.997	0.023	0.636	MUTAGEN	K->A: Total loss of activity.		0
P50613/K41M	P50613	CDK7	CDK7_HUMAN	K41M	129	β3;Catalytic-Lys	-	-	QIVAIkIKLGH	0.992	1.0	0.057	0.713	0.976	0.998	0.033	0.526	MUTAGEN	K->M: No effect on interaction with HINT1.	10958787	1
P50613/S164A	P50613	CDK7	CDK7_HUMAN	S164A	512	A-loop	p	-	AKSFGsNRAYT	0.834	0.857	0.506	0.748	0.559	0.764	0.456	0.348	MUTAGEN	S->A: No mitotic repression of transcriptional activity of the reconstituted TFIIH complex.	9832506	1
P50613/T170A	P50613	CDK7	CDK7_HUMAN	T170A	544	A-loop	p	loss	PNRAYtQVVTR	0.991	0.979	0.314	0.853	0.871	0.96	0.26	0.57	MUTAGEN	T->A: Total loss of activity. Total loss of transcriptional activity of the reconstituted TFIIH complex.	8069918,9832506	2
P50613/T170E	P50613	CDK7	CDK7_HUMAN	T170E	544	A-loop	p	-	PNRAYtQVVTR	0.95	0.97	0.562	0.918	0.685	0.951	0.458	0.683	MUTAGEN	T->E: No effect on interaction with HINT1.	10958787	1
P50613/T285M	P50613	CDK7	CDK7_HUMAN	T285M	804	αI	-	neutral	PCARItTQALK	0.383	0.369	0.455	0.315	0.322	0.342	0.509	0.221	VARIANT	T -> M (in dbSNP:rs34584424)	17344846	1
P50750/D167N	P50750	CDK9	CDK9_HUMAN	D167N	496	A-loop;DFG-motif	-	loss	VLKLAdGLARA	0.982	0.993	0.172	0.651	0.955	0.952	0.091	0.659	MUTAGEN	D->N: Abrogates kinase activity.	10958691,11145967	2
P50750/F59L	P50750	CDK9	CDK9_HUMAN	F59L	145	αC	-	-	NEKEGfITALR	0.616	0.59	0.534	0.554	0.332	0.4	0.614	0.311	VARIANT	F -> L (in dbSNP:rs55640715)	17344846	1
P50750/G231A	P50750	CDK9	CDK9_HUMAN	G231A	624	αF/αG	-	-	SPIMQgTEQHQ	0.657	0.566	0.47	0.461	0.393	0.515	0.486	0.49	VARIANT	G -> A	10903437,7695608	2
P50750/K44R	P50750	CDK9	CDK9_HUMAN	K44R	80	β2/β3-loop	ac	decrease	RKTGQkALKKV	0.409	0.468	0.529	0.423	0.465	0.341	0.533	0.086	MUTAGEN	K->R: Impaired kinase and transcriptional elongation activities, but normal cyclin T1 and HEXIM1 binding.	17452463	1
P50750/K48Q	P50750	CDK9	CDK9_HUMAN	K48Q	129	β3;Catalytic-Lys	ac	decrease	QKVALkVLMEN	1.0	1.0	0.081	0.807	0.927	0.993	0.07	0.467	MUTAGEN	K->Q: Mimics acetylation; leading to impaired protein kinase activity.	28426094	1
P50750/K48R	P50750	CDK9	CDK9_HUMAN	K48R	129	β3;Catalytic-Lys	ac	activating	QKVALkVLMEN	1.0	1.0	0.146	0.846	0.722	0.997	0.203	0.404	MUTAGEN	K->R: Decreased acetylation; leading to enhanced protein kinase activity.	28426094	1
P50750/R225C	P50750	CDK9	CDK9_HUMAN	R225C	616	αF	-	-	AEMWTrPIMQG	0.679	0.565	0.507	0.547	0.398	0.479	0.528	0.503	VARIANT	R -> C (found in patients with global developmental delay and epilepsy with history of choanal atresia; unknown pathological significance; dbSNP:rs767418586)	30237576	1
P50750/S175A	P50750	CDK9	CDK9_HUMAN	S175A	510	A-loop	p	activating	LARAFsAKNSQ	0.911	0.954	0.55	0.798	0.375	0.831	0.616	0.338	MUTAGEN	S->A: Constitutive kinase activity.	21533037	1
P50750/S175D	P50750	CDK9	CDK9_HUMAN	S175D	510	A-loop	p	loss	LARAFsAKNSQ	0.947	0.913	0.682	0.837	0.498	0.765	0.704	0.381	MUTAGEN	S->D: Mimics phosphorylation, constitutive loss of kinase activity.	21533037	1
P50750/T186A	P50750	CDK9	CDK9_HUMAN	T186A	544	A-loop	p	decrease	QPNRYtRVVTL	0.987	0.978	0.237	0.849	0.92	0.968	0.265	0.499	MUTAGEN	T->A: Abrogates autophosphorylation; no effect on kinase activity, but impaired CTD phosphorylation.	11145967,18566585,21448926	3
P50750/T186D	P50750	CDK9	CDK9_HUMAN	T186D	544	A-loop	p	activating	QPNRYtRVVTL	0.975	0.983	0.6	0.944	0.486	0.924	0.641	0.5	MUTAGEN	T->D: Mimics autophosphorylation; constitutive kinase activity, independently of calcium signaling.	11145967,18566585,21448926	3
P51451/A71T	P51451	BLK	BLK_HUMAN	A71T	-	-	-	decrease,neutral	LYDYTaNDRDL									VARIANT	A -> T (associated with MODY11; reduces the enhancing effect of BLK on insulin secretion; reduces the inducing effect of BLK on the expression of PDX1 and NKX6-1; found as somatic mutation in a colorectal adenocarcinoma sample; dbSNP:rs55758736)	17344846,19667185	2
P51451/T48I	P51451	BLK	BLK_HUMAN	T48I	-	-	-	-	VFNHLtPPPDE									VARIANT	T -> I (in dbSNP:rs35339715)	17344846	1
P51617/C203S	P51617	IRAK1	IRAK1_HUMAN	C203S	22	N-term-β1	-	neutral	FCWPLcISRGT	0.417	0.343	0.53	0.398	0.247	0.24	0.708	0.25	VARIANT	C -> S (in dbSNP:rs10127175)		0
P51617/D340N	P51617	IRAK1	IRAK1_HUMAN	D340N	443	Catalytic-loop;HrD-motif	-	loss	SLIHGdKSSNV	0.955	0.958	0.268	0.665	0.869	0.913	0.152	0.626	MUTAGEN	D->N: Loss of kinase activity.	18691762	1
P51617/F196S	P51617	IRAK1	IRAK1_HUMAN	F196S	15	N-term-β1	-	neutral	QGARPfFCWPL	0.389	0.397	0.582	0.454	0.223	0.247	0.718	0.273	VARIANT	F -> S (in dbSNP:rs1059702)	8599092	1
P51617/G619S	P51617	IRAK1	IRAK1_HUMAN	G619S	-	-	-	-	PLREAgPQGDT									VARIANT	G -> S (in dbSNP:rs34112487)	17344846	1
P51617/K239S	P51617	IRAK1	IRAK1_HUMAN	K239S	129	β3;Catalytic-Lys	-	loss	TVYAVkLKENA	1.0	0.998	0.051	0.669	0.993	0.99	0.044	0.597	MUTAGEN	K->S: Loss of kinase activity.	15084582	1
P51617/Q421H	P51617	IRAK1	IRAK1_HUMAN	Q421H	618	αF	-	-	ETLAGqAVKTH	0.348	0.232	0.549	0.228	0.183	0.171	0.708	0.124	VARIANT	Q -> H (in a breast pleomorphic lobular carcinoma sample; somatic mutation)	17344846	1
P51617/R194H	P51617	IRAK1	IRAK1_HUMAN	R194H	13	N-term-β1	-	neutral	LLQGArFPFCW	0.318	0.252	0.422	0.239	0.295	0.213	0.533	0.123	VARIANT	R -> H (in dbSNP:rs11465830)		0
P51617/R638W	P51617	IRAK1	IRAK1_HUMAN	R638W	-	-	-	-	SGPGSrTAVEG									VARIANT	R -> W (in dbSNP:rs56082801)	17344846	1
P51617/S532L	P51617	IRAK1	IRAK1_HUMAN	S532L	841	C-term-αI	-	neutral	GVPGHsAASCI	0.256	0.237	0.548	0.277	0.193	0.182	0.705	0.226	VARIANT	S -> L (in dbSNP:rs1059703)	17344846,8599092	2
P51617/S690G	P51617	IRAK1	IRAK1_HUMAN	S690G	-	-	-	-	QLLSSsLPGLG									VARIANT	S -> G (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
P51617/T209A	P51617	IRAK1	IRAK1_HUMAN	T209A	28	N-term-β1	p	loss	EISRGtNFSEE	0.898	0.859	0.354	0.776	0.682	0.817	0.32	0.36	MUTAGEN	T->A: Completely abolishes auto-phosphorylation in the kinase domain.	14625308	1
P51617/T387A	P51617	IRAK1	IRAK1_HUMAN	T387A	549	A-loop	p	loss	QTVRGtAYLPE	0.977	0.954	0.355	0.757	0.859	0.907	0.256	0.456	MUTAGEN	T->A: Loss of kinase activity.	14625308	1
P51617/T398M	P51617	IRAK1	IRAK1_HUMAN	T398M	589	αF	-	-	EEYIKtRLAVD	0.54	0.5	0.507	0.436	0.316	0.482	0.609	0.348	VARIANT	T -> M (in dbSNP:rs56340948)	17344846	1
P51617/T625M	P51617	IRAK1	IRAK1_HUMAN	T625M	-	-	-	-	CPQGDtGESSW									VARIANT	T -> M (in dbSNP:rs35638718)	17344846	1
P51617/V412M	P51617	IRAK1	IRAK1_HUMAN	V412M	606	αF	-	-	TFSFGvVLETL	0.527	0.51	0.536	0.506	0.487	0.414	0.552	0.409	VARIANT	V -> M (in a glioblastoma multiforme sample; somatic mutation)	17344846	1
P51812/A225V	P51812	RPS6KA3	KS6A3_HUMAN	A225V	543	A-loop	-	-	DHEKKaSFCGT	0.761	0.774	0.586	0.6	0.363	0.558	0.652	0.321	VARIANT	A -> V (in CLS; dbSNP:rs879027948)	9837815	1
P51812/D154Y	P51812	RPS6KA3	KS6A3_HUMAN	D154Y	256	β5/αD-loop	-	-	FLRGGdFTRLS	0.827	0.826	0.437	0.639	0.642	0.764	0.41	0.619	VARIANT	D -> Y (in CLS)	9837815	1
P51812/F268S	P51812	RPS6KA3	KS6A3_HUMAN	F268S	622	αF/αG	-	-	TGTLPfGKDRK	0.834	0.834	0.422	0.623	0.65	0.734	0.385	0.576	VARIANT	F -> S (in CLS; dbSNP:rs122454131)	14986828	1
P51812/G431D	P51812	RPS6KA3	KS6A3_HUMAN	G431D	42	β1;Gly-rich-loop	-	-	EDIGVgYSVCK	0.771	0.894	0.496	0.66	0.665	0.749	0.491	0.383	VARIANT	G -> D (in CLS)	9837815	1
P51812/G75V	P51812	RPS6KA3	KS6A3_HUMAN	G75V	40	β1;Gly-rich-loop	-	-	LLKVLgGSFGK	0.836	0.825	0.393	0.716	0.614	0.705	0.415	0.693	VARIANT	G -> V (in CLS; dbSNP:rs122454124)	8955270	1
P51812/H127Q	P51812	RPS6KA3	KS6A3_HUMAN	H127Q	193	αC/β4-loop	-	-	LVEVNhFIVKL	0.85	0.804	0.579	0.761	0.499	0.687	0.592	0.453	VARIANT	H -> Q (in CLS)	9837815	1
P51812/I189K	P51812	RPS6KA3	KS6A3_HUMAN	I189K	439	Catalytic-loop	-	-	LHSLGiYRDLK	0.815	0.862	0.511	0.691	0.684	0.693	0.457	0.475	VARIANT	I -> K (in CLS; dbSNP:rs122454130)	10528858	1
P51812/I38S	P51812	RPS6KA3	KS6A3_HUMAN	I38S	3	N-term-β1	-	neutral	MGEEEiPQTEE	0.679	0.629	0.588	0.635	0.422	0.543	0.546	0.474	VARIANT	I -> S (in dbSNP:rs56218010)	17344846,9837815	2
P51812/I416V	P51812	RPS6KA3	KS6A3_HUMAN	I416V	-	-	-	-	LHRNSiFTDGY									VARIANT	I -> V (in a breast cancer sample; somatic mutation; dbSNP:rs148050184)	16959974	1
P51812/L608F	P51812	RPS6KA3	KS6A3_HUMAN	L608F	608	αF	-	-	SLGVLlTMLTG	0.61	0.622	0.517	0.624	0.315	0.434	0.63	0.387	VARIANT	L -> F (in a glioblastoma multiforme sample; somatic mutation)	17344846	1
P51812/R114W	P51812	RPS6KA3	KS6A3_HUMAN	R114W	169	αC	-	-	VRDRVrKMERD	0.584	0.614	0.508	0.549	0.402	0.37	0.564	0.285	VARIANT	R -> W (in CLS; dbSNP:rs122454127)	10094187	1
P51812/R383W	P51812	RPS6KA3	KS6A3_HUMAN	R383W	-	-	-	decrease	AHQLFrFSFVA									VARIANT	R -> W (in XLID19; kinase activity is decreased but not abolished; dbSNP:rs122454129)	10319851	1
P51812/R723C	P51812	RPS6KA3	KS6A3_HUMAN	R723C	-	-	-	-	LEPVGrTLAQR									VARIANT	R -> C (in dbSNP:rs35026425)	17344846	1
P51812/R729Q	P51812	RPS6KA3	KS6A3_HUMAN	R729Q	-	-	-	-	STLAQrGIKKI									VARIANT	R -> Q (in CLS; dbSNP:rs28935171)	10094187	1
P51812/S227A	P51812	RPS6KA3	KS6A3_HUMAN	S227A	545	A-loop	p	-	EKKAYsCGTVE	0.981	0.975	0.196	0.831	0.935	0.994	0.145	0.411	VARIANT	S -> A (in CLS; dbSNP:rs122454125)	8955270	1
P51812/T115S	P51812	RPS6KA3	KS6A3_HUMAN	T115S	170	αC	-	-	RDRVRtMERDI	0.606	0.553	0.486	0.506	0.37	0.451	0.572	0.331	VARIANT	T -> S (in XLID19; dbSNP:rs387906703)	17100996	1
P51812/V82F	P51812	RPS6KA3	KS6A3_HUMAN	V82F	48	β2	-	-	GSFGKvLVKKI	0.837	0.807	0.45	0.634	0.613	0.716	0.473	0.481	VARIANT	V -> F (in CLS; dbSNP:rs122454126)	9837815	1
P51812/Y483C	P51812	RPS6KA3	KS6A3_HUMAN	Y483C	209	β4/β5-loop	p	-	TLKDVyDGKYV	0.819	0.718	0.535	0.731	0.367	0.659	0.632	0.326	VARIANT	Y -> C (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs1271090915)	17344846	1
P51813/R670W	P51813	BMX	BMX_HUMAN	R670W	815	αI	-	-	SIEPLrKDKH	0.333	0.295	0.652	0.455	0.151	0.21	0.818	0.236	VARIANT	R -> W (in a lung large cell carcinoma sample; somatic mutation; dbSNP:rs1029888196)	17344846	1
P51813/S284L	P51813	BMX	BMX_HUMAN	S284L	-	-	-	-	FPESSsEEEEN									VARIANT	S -> L (in dbSNP:rs35353387)	17344846	1
P51813/Y566F	P51813	BMX	BMX_HUMAN	Y566F	533	A-loop	p	loss	VLDDQySSVGT	0.955	0.981	0.488	0.882	0.786	0.937	0.397	0.412	MUTAGEN	Y->F: Abolishes almost completely the SRC-induced phosphorylation of BMX.	10688651	1
P51817/H93Q	P51817	PRKX	PRKX_HUMAN	H93Q	169	αC	-	-	LKQEQhHNEKS	0.669	0.632	0.502	0.622	0.471	0.515	0.527	0.348	MUTAGEN	H->Q: Constitutive kinase activity; when associated with R-202.	16236808	1
P51817/K78R	P51817	PRKX	PRKX_HUMAN	K78R	129	β3;Catalytic-Lys	-	loss	HFFALkMSIPD	1.0	0.996	0.037	0.76	0.987	0.998	0.016	0.452	MUTAGEN	K->R: Loss of function.	12082174	1
P51817/R283L	P51817	PRKX	PRKX_HUMAN	R283L	797	αI	-	increase	LLVVDrRRLGN	0.484	0.514	0.677	0.667	0.197	0.355	0.742	0.219	MUTAGEN	R->L: Increases the affinity for PRKAR2A and PRKAR2B.	20819953	1
P51817/V43A	P51817	PRKX	PRKX_HUMAN	V43A	25	N-term-β1	-	neutral	SPEPPvSLQDF	0.489	0.436	0.395	0.193	0.415	0.477	0.438	0.183	VARIANT	V -> A (in dbSNP:rs3752362)		0
P51817/W202R	P51817	PRKX	PRKX_HUMAN	W202R	544	A-loop	-	-	LVDRTwLCGTP	0.857	0.863	0.391	0.707	0.754	0.779	0.376	0.659	MUTAGEN	W->R: Constitutive kinase activity; when associated with Q-93.	16236808	1
P51841/A1010V	P51841	GUCY2F	GUC2F_HUMAN	A1010V	-	-	-	-	DTVNTaRMEST									VARIANT	A -> V (in dbSNP:rs55735218)	17344846	1
P51841/E1055D	P51841	GUCY2F	GUC2F_HUMAN	E1055D	-	-	-	-	KGKGTeTFWLI									VARIANT	E -> D (in a lung squamous cell carcinoma sample; somatic mutation)	17344846	1
P51841/E794K	P51841	GUCY2F	GUC2F_HUMAN	E794K	795	αH/αI	-	neutral	KQCWAeAEQRP	0.344	0.308	0.498	0.37	0.224	0.256	0.668	0.262	VARIANT	E -> K (in dbSNP:rs35726803)	17344846	1
P51841/G434R	P51841	GUCY2F	GUC2F_HUMAN	G434R	-	-	-	-	ELLRFgTPIHF									VARIANT	G -> R (in dbSNP:rs56293008)	17344846	1
P51841/G568D	P51841	GUCY2F	GUC2F_HUMAN	G568D	10	N-term-β1	-	-	IAIYEgWVWLK	0.665	0.594	0.545	0.53	0.472	0.507	0.524	0.312	VARIANT	G -> D (in a glioblastoma multiforme sample; somatic mutation; dbSNP:rs779221554)	17344846	1
P51841/G872D	P51841	GUCY2F	GUC2F_HUMAN	G872D	-	-	-	-	ESLKKgTVEPE									VARIANT	G -> D (in dbSNP:rs148663380)	23033978	1
P51841/I160N	P51841	GUCY2F	GUC2F_HUMAN	I160N	-	-	-	neutral	ELDNKiYPTFS									VARIANT	I -> N (in dbSNP:rs33971675)	17344846	1
P51841/K1052R	P51841	GUCY2F	GUC2F_HUMAN	K1052R	-	-	-	-	TELKGkTEETF									VARIANT	K -> R (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
P51841/L284P	P51841	GUCY2F	GUC2F_HUMAN	L284P	-	-	-	neutral	VPYDAlYSLPY									VARIANT	L -> P (in dbSNP:rs12008095)	17344846	1
P51841/Q380H	P51841	GUCY2F	GUC2F_HUMAN	Q380H	-	-	-	neutral	AASLVqSRNMQ									VARIANT	Q -> H (in dbSNP:rs2272925)	17344846	1
P51841/R10P	P51841	GUCY2F	GUC2F_HUMAN	R10P	-	-	-	-	LGRFSrVLWFA									VARIANT	R -> P (in a breast cancer sample; somatic mutation; dbSNP:rs755991142)	16959974	1
P51841/R230W	P51841	GUCY2F	GUC2F_HUMAN	R230W	-	-	-	neutral	DSQSMrALQRI									VARIANT	R -> W (in dbSNP:rs33973457)	17344846	1
P51841/R296Q	P51841	GUCY2F	GUC2F_HUMAN	R296Q	-	-	-	neutral	KHTPYrLRNNP									VARIANT	R -> Q (in dbSNP:rs502209)	7777544	1
P51841/R305Q	P51841	GUCY2F	GUC2F_HUMAN	R305Q	-	-	-	-	NNPKLrAYDAV									VARIANT	R -> Q (in dbSNP:rs55966326)	17344846	1
P51841/R628Q	P51841	GUCY2F	GUC2F_HUMAN	R628Q	253	β5/αD-loop	-	neutral	TEFCSrSLEDI	0.473	0.461	0.472	0.482	0.376	0.425	0.564	0.379	VARIANT	R -> Q (in dbSNP:rs7883913)	17344846	1
P51841/S40C	P51841	GUCY2F	GUC2F_HUMAN	S40C	-	-	-	neutral	CLCLLsMSLPQ									VARIANT	S -> C (in dbSNP:rs34228145)	17344846	1
P51841/V677L	P51841	GUCY2F	GUC2F_HUMAN	V677L	450	Catalytic-loop	-	neutral	KSRNCvDGRFV	0.182	0.148	0.559	0.218	0.145	0.156	0.666	0.23	VARIANT	V -> L (in dbSNP:rs35474112)	17344846	1
P51841/Y308C	P51841	GUCY2F	GUC2F_HUMAN	Y308C	-	-	-	neutral	KLREAyAVLTI									VARIANT	Y -> C (in dbSNP:rs16985750)	17344846	1
P51955/C410Y	P51955	NEK2	NEK2_HUMAN	C410Y	-	-	-	-	TSKSKcDLKKR									VARIANT	C -> Y (in dbSNP:rs56102977)	17344846	1
P51955/D141A	P51955	NEK2	NEK2_HUMAN	D141A	443	Catalytic-loop;HrD-motif	-	loss	TVLHRdKPANV	0.996	1.0	0.197	0.713	0.972	0.987	0.098	0.554	MUTAGEN	D->A: Loss of autophosphorylation.	17197699	1
P51955/K37R	P51955	NEK2	NEK2_HUMAN	K37R	129	β3;Catalytic-Lys	-	loss	KILVWkLDYGS	0.959	0.992	0.077	0.601	0.955	0.983	0.053	0.365	MUTAGEN	K->R: Loss of kinase activity and of ability to activate NEK11. Loss of phosphorylation of CCDC102B.	15161910,17197699,30404835	3
P51955/N354S	P51955	NEK2	NEK2_HUMAN	N354S	-	-	-	neutral	ENLLKnSLLKE									VARIANT	N -> S (in dbSNP:rs2230489)	17344846	1
P51955/S171A	P51955	NEK2	NEK2_HUMAN	S171A	523	A-loop	p	-	LNHDTsAKTFV	0.711	0.786	0.401	0.724	0.549	0.599	0.453	0.288	MUTAGEN	S->A: No effect on kinase activity.	17197699	1
P51955/S171D	P51955	NEK2	NEK2_HUMAN	S171D	523	A-loop	p	increase	LNHDTsAKTFV	0.778	0.831	0.789	0.87	0.142	0.461	0.832	0.222	MUTAGEN	S->D: Kinase activity increased by two fold.	17197699	1
P51955/S241A	P51955	NEK2	NEK2_HUMAN	S241A	781	αH	-	loss	IPYRYsELNEI	0.798	0.753	0.417	0.552	0.617	0.694	0.475	0.253	MUTAGEN	S->A: Loss of kinase activity.	17197699	1
P51955/S241D	P51955	NEK2	NEK2_HUMAN	S241D	781	αH	-	loss	IPYRYsELNEI	0.899	0.88	0.488	0.725	0.715	0.755	0.382	0.517	MUTAGEN	S->D: Loss of kinase activity.	17197699	1
P51955/T170A	P51955	NEK2	NEK2_HUMAN	T170A	514	A-loop	-	-	ILNHDtFAKTF	0.58	0.52	0.344	0.405	0.52	0.471	0.343	0.156	MUTAGEN	T->A: No effect on kinase activity.	17197699	1
P51955/T170E	P51955	NEK2	NEK2_HUMAN	T170E	514	A-loop	-	increase	ILNHDtFAKTF	0.555	0.473	0.698	0.638	0.122	0.275	0.802	0.195	MUTAGEN	T->E: Kinase activity increased by two fold.	17197699	1
P51955/T175A	P51955	NEK2	NEK2_HUMAN	T175A	545	A-loop	-	decrease	TSFAKtVGTPY	0.985	0.982	0.171	0.776	0.946	0.958	0.102	0.534	MUTAGEN	T->A: Kinase activity decreased by two fold.	17197699	1
P51955/T175E	P51955	NEK2	NEK2_HUMAN	T175E	545	A-loop	-	increase	TSFAKtVGTPY	0.933	0.95	0.855	0.933	0.166	0.855	0.896	0.317	MUTAGEN	T->E: Kinase activity increased by two fold.	17197699	1
P51955/T179A	P51955	NEK2	NEK2_HUMAN	T179A	549	A-loop	-	loss	KTFVGtYYMSP	0.888	0.863	0.275	0.569	0.814	0.848	0.2	0.481	MUTAGEN	T->A: Loss of kinase activity.	17197699	1
P51955/T179E	P51955	NEK2	NEK2_HUMAN	T179E	549	A-loop	-	loss	KTFVGtYYMSP	0.971	0.941	0.512	0.792	0.777	0.906	0.365	0.502	MUTAGEN	T->E: Loss of kinase activity.	17197699	1
P51956/D461N	P51956	NEK3	NEK3_HUMAN	D461N	-	-	-	-	VDGGHdVILDP									VARIANT	D -> N (in dbSNP:rs34076988)	17344846	1
P51956/E305D	P51956	NEK3	NEK3_HUMAN	E305D	-	-	-	neutral	IALGNeSTVQE									VARIANT	E -> D (in dbSNP:rs55969405)	17344846	1
P51956/E477K	P51956	NEK3	NEK3_HUMAN	E477K	-	-	-	neutral	PGLDEeTDFEE									VARIANT	E -> K (in dbSNP:rs34488913)	17344846	1
P51956/H23L	P51956	NEK3	NEK3_HUMAN	H23L	57	β2/β3-loop	-	neutral	ALLVQhSSNQM	0.447	0.469	0.589	0.505	0.26	0.416	0.644	0.458	VARIANT	H -> L (in dbSNP:rs17482764)	17344846	1
P51956/P170L	P51956	NEK3	NEK3_HUMAN	P170L	555	A-loop;APE-motif	-	-	TPYYVpEIWEN	0.584	0.516	0.577	0.454	0.377	0.355	0.667	0.307	VARIANT	P -> L (in dbSNP:rs56021040)	17344846	1
P51956/P60R	P51956	NEK3	NEK3_HUMAN	P60R	194	αC/β4-loop	-	-	AKMKHpIVAFK	0.769	0.668	0.545	0.57	0.372	0.582	0.582	0.637	VARIANT	P -> R (in dbSNP:rs55946204)	17344846	1
P51956/R122H	P51956	NEK3	NEK3_HUMAN	R122H	427	αE	-	neutral	HIHKKrLHRDI	0.124	0.106	0.427	0.131	0.139	0.134	0.606	0.092	VARIANT	R -> H (in dbSNP:rs56190615)	17344846	1
P51956/R259G	P51956	NEK3	NEK3_HUMAN	R259G	829	C-term-αI	-	-	RGIVArVQKCL	0.218	0.251	0.533	0.31	0.16	0.202	0.674	0.196	VARIANT	R -> G (in dbSNP:rs34077016)	17344846	1
P51957/F567L	P51957	NEK4	NEK4_HUMAN	F567L	-	-	-	neutral	ESPPRfPSHPI									VARIANT	F -> L (in dbSNP:rs34986855)	17344846	1
P51957/P225A	P51957	NEK4	NEK4_HUMAN	P225A	677	αG/αH	-	neutral	EGKLPpPRDYS	0.267	0.245	0.506	0.265	0.249	0.258	0.594	0.277	VARIANT	P -> A (in dbSNP:rs1029871)	15489334,17344846,8208544	3
P51957/P250L	P51957	NEK4	NEK4_HUMAN	P250L	803	αI	-	-	RPEERpVRSIL	0.526	0.485	0.428	0.365	0.469	0.436	0.446	0.426	VARIANT	P -> L (in dbSNP:rs56408749)	17344846	1
P51957/Q456E	P51957	NEK4	NEK4_HUMAN	Q456E	-	-	-	-	QKPKDqLALSP									VARIANT	Q -> E (in dbSNP:rs56019351)	17344846	1
P51957/R239G	P51957	NEK4	NEK4_HUMAN	R239G	790	αH	-	-	LAELIrMLSKR	0.476	0.49	0.538	0.453	0.227	0.307	0.679	0.158	VARIANT	R -> G (in dbSNP:rs35778416)	17344846	1
P51957/R777K	P51957	NEK4	NEK4_HUMAN	R777K	-	-	-	-	SEKIRrVEVLR									VARIANT	R -> K (in a colorectal adenocarcinoma sample; somatic mutation)	17344846	1
P51957/T357I	P51957	NEK4	NEK4_HUMAN	T357I	-	-	-	neutral	DLSNTtLATIS									VARIANT	T -> I (in dbSNP:rs2230537)	17344846	1
P52333/C759R	P52333	JAK3	JAK3_HUMAN	C759R	-	-	-	activating	LLIQQcAYEPV									VARIANT	C -> R (in T(-)B(+)NK(-) SCID; constitutive phosphorylation)	9354668	1
P52333/D169E	P52333	JAK3	JAK3_HUMAN	D169E	-	-	-	-	SLAVLdARMAR									VARIANT	D -> E (in T(-)B(+)NK(-) SCID; dbSNP:rs147181709)	14615376	1
P52333/E481G	P52333	JAK3	JAK3_HUMAN	E481G	-	-	-	-	IPRPKeSNLIV									VARIANT	E -> G (in T(-)B(+)NK(-) SCID)	9354668	1
P52333/G589S	P52333	JAK3	JAK3_HUMAN	G589S	-	-	-	-	LVLLHgCMAGD									VARIANT	G -> S (in T(-)B(+)NK(-) SCID; dbSNP:rs886039394)	14615376	1
P52333/I688F	P52333	JAK3	JAK3_HUMAN	I688F	-	-	-	-	MLTDRiWVAPE									VARIANT	I -> F (in dbSNP:rs35785705)	17344846	1
P52333/K855A	P52333	JAK3	JAK3_HUMAN	K855A	129	β3	ub	loss	ALVAVkLQHSG	1.0	1.0	0.031	0.706	1.0	0.997	0.014	0.653	MUTAGEN	K->A: More than 90% loss of STAT5a activation.	18250158	1
P52333/L521V	P52333	JAK3	JAK3_HUMAN	L521V	-	-	-	-	IPADSlWHENL									VARIANT	L -> V (in dbSNP:rs55666418)	17344846	1
P52333/L527P	P52333	JAK3	JAK3_HUMAN	L527P	-	-	-	-	EWHENlHGSFT									VARIANT	L -> P (in a gastric adenocarcinoma sample; somatic mutation)	17344846	1
P52333/L910S	P52333	JAK3	JAK3_HUMAN	L910S	264	β5/αD-loop	-	-	LPSGClDFLQR	0.872	0.834	0.309	0.541	0.784	0.77	0.262	0.76	VARIANT	L -> S (in T(-)B(+)NK(-) SCID)	10982185	1
P52333/P12L	P52333	JAK3	JAK3_HUMAN	P12L	-	-	-	-	ETPLIpRSCSL									VARIANT	P -> L (in dbSNP:rs56061056)	17344846	1
P52333/P132T	P52333	JAK3	JAK3_HUMAN	P132T	-	-	-	neutral	AILDLpLEHLF									VARIANT	P -> T (in dbSNP:rs3212723)	17344846	1
P52333/P151R	P52333	JAK3	JAK3_HUMAN	P151R	-	-	-	-	VSGRLpGLSLK									VARIANT	P -> R (in T(-)B(+)NK(-) SCID; likely benign variant; dbSNP:rs55778349)	10982185,17344846	2
P52333/R40H	P52333	JAK3	JAK3_HUMAN	R40H	-	-	-	-	PGPPQrSFSFG									VARIANT	R -> H (in dbSNP:rs56384680)	17344846	1
P52333/R582W	P52333	JAK3	JAK3_HUMAN	R582W	-	-	-	-	SQVSYrLVLLH									VARIANT	R -> W (in T(-)B(+)NK(-) SCID; dbSNP:rs193922361)	9753072	1
P52333/V722I	P52333	JAK3	JAK3_HUMAN	V722I	-	-	-	neutral	EVFSGvMPISA									VARIANT	V -> I (in dbSNP:rs3213409)	10982185,14615376,17344846	3
P52333/Y100C	P52333	JAK3	JAK3_HUMAN	Y100C	-	-	-	-	TQVLLyIRFYF									VARIANT	Y -> C (in T(-)B(+)NK(-) SCID; dbSNP:rs137852624)	7659163	1
P52333/Y785F	P52333	JAK3	JAK3_HUMAN	Y785F	-	-	p	decrease	LISSDyLLSDP									MUTAGEN	Y->F: Strong decrease of JAK3 phosphorylation.	15121872	1
P52333/Y904F	P52333	JAK3	JAK3_HUMAN	Y904F	250	β5	p	decrease	RLVMEyPSGCL	0.877	0.788	0.452	0.565	0.561	0.599	0.546	0.68	MUTAGEN	Y->F: About 40% loss of STAT5a activation.	18250158	1
P52333/Y939F	P52333	JAK3	JAK3_HUMAN	Y939F	422	αE	p	loss	CKGMEyGSRRC	0.865	0.848	0.441	0.807	0.708	0.789	0.432	0.464	MUTAGEN	Y->F: About 80% loss of STAT5a activation.	18250158	1
P52564/S207A	P52564	MAP2K6	MP2K6_HUMAN	S207A	513	A-loop	p	loss	GYLVDsAKTID	0.809	0.859	0.443	0.681	0.841	0.733	0.334	0.353	MUTAGEN	S->A: Inactivation.		0
P52564/S207E	P52564	MAP2K6	MP2K6_HUMAN	S207E	513	A-loop	p	activating	GYLVDsAKTID	0.811	0.855	0.774	0.894	0.219	0.682	0.78	0.307	MUTAGEN	S->E: Constitutive activation according to PubMed:8622669, but not to PubMed:8621675.	8622669,8621675	2
P52564/T211A	P52564	MAP2K6	MP2K6_HUMAN	T211A	544	A-loop	p	loss	DSVAKtDAGCK	0.955	0.986	0.294	0.815	0.817	0.954	0.313	0.447	MUTAGEN	T->A: Inactivation.		0
P52564/T211E	P52564	MAP2K6	MP2K6_HUMAN	T211E	544	A-loop	p	activating	DSVAKtDAGCK	0.963	0.982	0.65	0.912	0.307	0.928	0.723	0.515	MUTAGEN	T->E: Constitutive activation according to PubMed:8622669, but not to PubMed:8621675.	8622669,8621675	2
P53004/A3T	P53004	BLVRA	BIEA_HUMAN	A3T	-	-	-	neutral	MNaPERKF									VARIANT	A -> T (in dbSNP:rs699512)	15489334,8950184	2
P53004/L37V	P53004	BLVRA	BIEA_HUMAN	L37V	-	-	-	-	PSSAFlLIGFV									VARIANT	L -> V (in dbSNP:rs17245918)		0
P53004/Q56R	P53004	BLVRA	BIEA_HUMAN	Q56R	-	-	-	neutral	IDGVQqSLEDA									VARIANT	Q -> R (in dbSNP:rs1050916)		0
P53350/C67V	P53350	PLK1	PLK1_HUMAN	C67V	48	β2	-	-	GGFAKcEISDA	0.445	0.339	0.482	0.367	0.234	0.307	0.64	0.33	MUTAGEN	C->V: In analog-sensitive mutant; enlarged catalytic pocket to accommodate purine analogs; when associated with G-130.	19468302	1
P53350/D176N	P53350	PLK1	PLK1_HUMAN	D176N	443	Catalytic-loop;HrD-motif	-	loss	RVIHRdKLGNL	0.975	0.993	0.209	0.645	0.957	0.982	0.119	0.518	MUTAGEN	D->N: Abolishes kinase activity.	18615013	1
P53350/D194A	P53350	PLK1	PLK1_HUMAN	D194A	496	A-loop;DFG-motif	-	-	EVKIGdGLATK	0.998	0.984	0.106	0.577	0.991	0.952	0.04	0.672	MUTAGEN	D->A: Does not interfere with FRY-binding.	22753416	1
P53350/H538A	P53350	PLK1	PLK1_HUMAN	H538A	-	-	-	-	NFFQDhKLILC									MUTAGEN	H->A: In pincer mutant; loss of centrosomal location and decreased interaction with phosphorylated CDC25C and BUB1; when associated with M-540.	14532005,16760428,18477460,19468302	4
P53350/K492R	P53350	PLK1	PLK1_HUMAN	K492R	-	-	ub	-	SEHLLkGANIT									MUTAGEN	K->R: Severe mitotic defects leading to prometaphase delay. Increased localization at kinetochores leading to increased levels of phosphorylated BUBR1.	23455478	1
P53350/K540M	P53350	PLK1	PLK1_HUMAN	K540M	-	-	-	-	FQDHTkILCPL									MUTAGEN	K->M: In pincer mutant; loss of centrosomal location and decreased interaction with phosphorylated CDC25C and BUB1; when associated with A-538.	14532005,16760428,18477460,19468302	4
P53350/K82M	P53350	PLK1	PLK1_HUMAN	K82M	129	β3;Catalytic-Lys	-	loss	EVFAGkVPKSL	0.991	1.0	0.016	0.643	0.999	0.998	0.014	0.504	MUTAGEN	K->M: Loss of kinase activity. No effect on S-phase progression.	12207013,12447691,18174154,24018379	4
P53350/K82R	P53350	PLK1	PLK1_HUMAN	K82R	129	β3;Catalytic-Lys	-	loss	EVFAGkVPKSL	0.999	0.991	0.04	0.665	1.0	0.998	0.019	0.539	MUTAGEN	K->R: Loss of kinase activity. No effect on RIOK2-binding.	18615013,19160488,21880710	3
P53350/L130G	P53350	PLK1	PLK1_HUMAN	L130G	248	β5	-	-	FVFVVlLCRRR	0.879	0.852	0.56	0.699	0.55	0.747	0.503	0.74	MUTAGEN	L->G: In analog-sensitive mutant; enlarged catalytic pocket to accommodate purine analogs; when associated with V-67.	19468302	1
P53350/L261F	P53350	PLK1	PLK1_HUMAN	L261F	658	αG/αH	-	neutral	LKETYlIKKNE	0.16	0.184	0.559	0.169	0.119	0.165	0.768	0.125	VARIANT	L -> F (in dbSNP:rs35056440)	17344846	1
P53350/L332V	P53350	PLK1	PLK1_HUMAN	L332V	850	C-term-αI	-	-	IAPSSlPSNRK	0.239	0.163	0.425	0.153	0.111	0.146	0.639	0.109	VARIANT	L -> V (in dbSNP:rs45489499)	17344846	1
P53350/L340A	P53350	PLK1	PLK1_HUMAN	L340A	-	-	-	-	SNRKPlVLNKG									MUTAGEN	L->A: Interferes with ubiquitination and subsequent proteasomal degradation in anaphase; when associated with A-337.	14734534,18662541	2
P53350/L427A	P53350	PLK1	PLK1_HUMAN	L427A	-	-	-	-	GLGYQlDNSVG									MUTAGEN	L->A: No effect on centrosomal localization, nor on S-phase progression; when associated with A-414. Loss of centrosomal localization and of S-phase progression; when associated with A- 414 and A-415.	24018379	1
P53350/L463H	P53350	PLK1	PLK1_HUMAN	L463H	-	-	-	neutral	GTESYlVSSHP									VARIANT	L -> H (in dbSNP:rs45569335)	17344846	1
P53350/N297D	P53350	PLK1	PLK1_HUMAN	N297D	814	αI	-	-	ARPTInLLNDE	0.216	0.246	0.557	0.265	0.113	0.159	0.715	0.111	VARIANT	N -> D (in dbSNP:rs16972799)		0
P53350/R12L	P53350	PLK1	PLK1_HUMAN	R12L	-	-	-	-	AGKLArPADPG									VARIANT	R -> L (in a lung squamous cell carcinoma sample; somatic mutation)	17344846	1
P53350/R337A	P53350	PLK1	PLK1_HUMAN	R337A	-	-	-	-	LDPSNrPLTVL									MUTAGEN	R->A: Interferes with ubiquitination and subsequent proteasomal degradation in anaphase; when associated with A-340.	14734534,18662541	2
P53350/R518H	P53350	PLK1	PLK1_HUMAN	R518H	-	-	-	-	TWFRTrAIILH									VARIANT	R -> H (in dbSNP:rs56027600)	17344846	1
P53350/R599H	P53350	PLK1	PLK1_HUMAN	R599H	-	-	-	-	RSASNrKAS									VARIANT	R -> H (in dbSNP:rs34954545)		0
P53350/S137A	P53350	PLK1	PLK1_HUMAN	S137A	256	β5/αD-loop	p	-	LCRRRsLELHK	0.828	0.86	0.432	0.722	0.551	0.641	0.439	0.472	MUTAGEN	S->A: No change in activity. Increases activity and restores recovery after DNA damage checkpoint; when associated with D-210.	12207013,18615013	2
P53350/S137D	P53350	PLK1	PLK1_HUMAN	S137D	256	β5/αD-loop	p	increase	LCRRRsLELHK	0.68	0.698	0.654	0.734	0.222	0.358	0.78	0.233	MUTAGEN	S->D: Increases activity. Results in a block in G1/S.	12207013,18615013	2
P53350/S595L	P53350	PLK1	PLK1_HUMAN	S595L	-	-	-	-	LLSSRsSNRLK									VARIANT	S -> L (in dbSNP:rs34001032)		0
P53350/T210A	P53350	PLK1	PLK1_HUMAN	T210A	545	A-loop	p	loss	GERKKtCGTPN	1.0	0.986	0.207	0.897	0.931	0.993	0.143	0.388	MUTAGEN	T->A: Abolishes activity. Abolishes checkpoint recovery.	12207013,12447691,17461553,18615013,19160488	5
P53350/T210D	P53350	PLK1	PLK1_HUMAN	T210D	545	A-loop	p	increase	GERKKtCGTPN	0.992	0.986	0.854	0.981	0.131	0.955	0.86	0.403	MUTAGEN	T->D: Increases activity and restores recovery after 		0
P53350/T210V	P53350	PLK1	PLK1_HUMAN	T210V	545	A-loop	p	decrease	GERKKtCGTPN	0.992	0.962	0.264	0.863	0.893	0.971	0.196	0.502	MUTAGEN	T->V: Reduced catalytic activity, but no effect on affinity for ATP.	12207013,12447691,17461553,18615013,19160488	5
P53350/V415A	P53350	PLK1	PLK1_HUMAN	V415A	-	-	-	-	WVSKWvYSDKY									MUTAGEN	V->A: Loss of centrosomal localization and of S-phase progression; when associated with A- 414 and A-427.	24018379	1
P53350/W414F	P53350	PLK1	PLK1_HUMAN	W414F	-	-	-	-	FWVSKwDYSDK									MUTAGEN	W->F: No effect on centrosomal localization, nor on S-phase progression; when asscociated with A-427. Loss of centrosomal localization and of S-phase progression; when associated with A- 415 and A-427.	24018379	1
P53355/A461S	P53355	DAPK1	DAPK1_HUMAN	A461S	-	-	-	-	GHADVaLLCSF									VARIANT	A -> S	17344846	1
P53355/C540Y	P53355	DAPK1	DAPK1_HUMAN	C540Y	-	-	-	-	ADLNAcKDGHI									VARIANT	C -> Y (in dbSNP:rs56327474)	17344846	1
P53355/D1007Y	P53355	DAPK1	DAPK1_HUMAN	D1007Y	-	-	-	-	LASEEdRRIAQ									VARIANT	D -> Y	17344846	1
P53355/D994E	P53355	DAPK1	DAPK1_HUMAN	D994E	-	-	-	-	QQFVYdQDQLN									VARIANT	D -> E	17344846	1
P53355/E1005Q	P53355	DAPK1	DAPK1_HUMAN	E1005Q	-	-	-	-	NPLASeDLRRI									VARIANT	E -> Q	17344846	1
P53355/G1405V	P53355	DAPK1	DAPK1_HUMAN	G1405V	-	-	-	neutral	KINLDgGQEAY									VARIANT	G -> V (in dbSNP:rs36220450)	17344846	1
P53355/I622M	P53355	DAPK1	DAPK1_HUMAN	I622M	-	-	-	neutral	AANNGiDVVRY									VARIANT	I -> M (in dbSNP:rs36215047)		0
P53355/K42A	P53355	DAPK1	DAPK1_HUMAN	K42A	129	β3;Catalytic-Lys	-	loss	LQYAAkIKKRR	0.999	0.996	0.016	0.651	1.0	0.998	0.003	0.658	MUTAGEN	K->A: Loss of activity, apoptotic function and of autophosphorylation.	11579085,7828849	2
P53355/K978N	P53355	DAPK1	DAPK1_HUMAN	K978N	-	-	-	-	LPSWRkNGPNQ									VARIANT	K -> N	17344846	1
P53355/L1008P	P53355	DAPK1	DAPK1_HUMAN	L1008P	-	-	-	-	ASEEDlRIAQQ									VARIANT	L -> P	17344846	1
P53355/M1272I	P53355	DAPK1	DAPK1_HUMAN	M1272I	-	-	-	neutral	SLTNTmGYKES									VARIANT	M -> I (in dbSNP:rs56169226)	17344846	1
P53355/M941T	P53355	DAPK1	DAPK1_HUMAN	M941T	-	-	-	-	SGSKDmVLRNH									VARIANT	M -> T	17344846	1
P53355/P591L	P53355	DAPK1	DAPK1_HUMAN	P591L	-	-	-	-	KDGNMpVVALC									VARIANT	P -> L (in dbSNP:rs36214022)		0
P53355/R1010C	P53355	DAPK1	DAPK1_HUMAN	R1010C	-	-	-	-	EEDLRrAQQLH									VARIANT	R -> C (in dbSNP:rs371784492)	17344846	1
P53355/R977W	P53355	DAPK1	DAPK1_HUMAN	R977W	-	-	-	-	TLPSWrLNGPN									VARIANT	R -> W	17344846	1
P53355/S1346N	P53355	DAPK1	DAPK1_HUMAN	S1346N	-	-	-	neutral	AKYNTsGAPKD									VARIANT	S -> N (in dbSNP:rs1056719)	15164053,17344846,17974005,7828849	4
P53355/S289A	P53355	DAPK1	DAPK1_HUMAN	S289A	837	C-term-αI	p	activating	LSRKAsVNMEK	0.845	0.869	0.347	0.673	0.668	0.754	0.353	0.132	MUTAGEN	S->A: Loss of phosphorylation and significant increase in proapoptotic activity.		0
P53355/S289E	P53355	DAPK1	DAPK1_HUMAN	S289E	837	C-term-αI	p	decrease	LSRKAsVNMEK	0.837	0.778	0.612	0.767	0.327	0.626	0.726	0.113	MUTAGEN	S->E: Reduction in proapoptotic activity.		0
P53355/S308A	P53355	DAPK1	DAPK1_HUMAN	S308A	-	-	p	increase	KKWKQsRLISL									MUTAGEN	S->A: Elevated Ca(2+)-calmodulin binding and Ca(2+)-calmodulin-independent kinase activity. Increases apoptotic activity.	11579085	1
P53355/S308D	P53355	DAPK1	DAPK1_HUMAN	S308D	-	-	p	decrease	KKWKQsRLISL									MUTAGEN	S->D: Reduced Ca(2+)-calmodulin binding and Ca(2+)-calmodulin-independent kinase activity. Decreases apoptotic activity.	11579085	1
P53355/S313A	P53355	DAPK1	DAPK1_HUMAN	S313A	-	-	-	-	SVRLIsCQRLS									MUTAGEN	S->A: Minimal effect on activity.	11579085	1
P53355/S519A	P53355	DAPK1	DAPK1_HUMAN	S519A	-	-	-	-	PLLTAsRGYHD									VARIANT	S -> A	17344846	1
P53355/T1018A	P53355	DAPK1	DAPK1_HUMAN	T1018A	-	-	-	-	QQLHStEINIM									VARIANT	T -> A	17344846	1
P53355/V416I	P53355	DAPK1	DAPK1_HUMAN	V416I	-	-	-	neutral	GGSNAvWAARH									VARIANT	V -> I (in dbSNP:rs12343465)	17344846	1
P53355/Y993C	P53355	DAPK1	DAPK1_HUMAN	Y993C	-	-	-	-	LQQFVyVQDQL									VARIANT	Y -> C	17344846	1
P53667/C84S	P53667	LIMK1	LIMK1_HUMAN	C84S	-	-	-	increase	RYGEScGCSEQ									MUTAGEN	C->S: Enhances actin aggregation.	10196227	1
P53667/D460A	P53667	LIMK1	LIMK1_HUMAN	D460A	443	Catalytic-loop;HrD-motif	-	loss	NIIHRdNSHNC	0.989	0.997	0.153	0.66	0.98	0.985	0.08	0.594	MUTAGEN	D->N,A: Abrogates kinase activity.	10196227,22328514	2
P53667/D460N	P53667	LIMK1	LIMK1_HUMAN	D460N	443	Catalytic-loop;HrD-motif	-	loss	NIIHRdNSHNC	0.967	0.968	0.202	0.648	0.95	0.976	0.177	0.626	MUTAGEN	D->N,A: Abrogates kinase activity.	10196227,22328514	2
P53667/F580Y	P53667	LIMK1	LIMK1_HUMAN	F580Y	786	αH	-	-	CPPSFfITVRC	0.404	0.336	0.476	0.287	0.375	0.346	0.585	0.236	VARIANT	F -> Y (in dbSNP:rs178412)	8689688,8812460	2
P53667/G190A	P53667	LIMK1	LIMK1_HUMAN	G190A	-	-	-	neutral	PHGPPgGTEHS									VARIANT	G -> A (in dbSNP:rs35827364)	17344846	1
P53667/R422Q	P53667	LIMK1	LIMK1_HUMAN	R422Q	265	αD	-	-	KGGTLrIIKSM	0.526	0.429	0.502	0.436	0.229	0.29	0.656	0.212	VARIANT	R -> Q (in dbSNP:rs55679316)	17344846	1
P53667/S247N	P53667	LIMK1	LIMK1_HUMAN	S247N	-	-	-	-	LIQETsLLQLT									VARIANT	S -> N (in dbSNP:rs55661242)	17344846	1
P53667/T508A	P53667	LIMK1	LIMK1_HUMAN	T508A	535	A-loop	p	loss	RKKRYtVGNPY	0.865	0.896	0.363	0.757	0.799	0.843	0.311	0.439	MUTAGEN	T->A: Abolishes activation by ROCK1.	10196227,10652353	2
P53667/T508E	P53667	LIMK1	LIMK1_HUMAN	T508E	535	A-loop	p	increase	RKKRYtVGNPY	0.864	0.926	0.817	0.927	0.13	0.707	0.892	0.468	MUTAGEN	T->E: Phosphomimetic mutant; enhances kinase activity.	22328514	1
P53667/T508V	P53667	LIMK1	LIMK1_HUMAN	T508V	535	A-loop	p	decrease	RKKRYtVGNPY	0.827	0.904	0.396	0.715	0.81	0.877	0.297	0.461	MUTAGEN	T->V: Reduces kinase activity.	10196227,10652353	2
P53671/D451A	P53671	LIMK2	LIMK2_HUMAN	D451A	443	Catalytic-loop;HrD-motif	-	loss	CIIHRdNSHNC	0.989	1.0	0.161	0.655	0.98	0.985	0.085	0.612	MUTAGEN	D->A: Abrogates kinase activity.	22328514	1
P53671/D45N	P53671	LIMK2	LIMK2_HUMAN	D45N	-	-	-	-	CSECQdLTNWY									VARIANT	D -> N (in dbSNP:rs35923988)	17344846	1
P53671/G35S	P53671	LIMK2	LIMK2_HUMAN	G35S	-	-	-	neutral	NETWHgCFRCS									VARIANT	G -> S (in dbSNP:rs5997917)	17344846	1
P53671/P296R	P53671	LIMK2	LIMK2_HUMAN	P296R	-	-	-	-	SKSPGpSPKEP									VARIANT	P -> R (in dbSNP:rs34875793)	17344846	1
P53671/R213C	P53671	LIMK2	LIMK2_HUMAN	R213C	-	-	-	neutral	NGTPVrLRVEE									VARIANT	R -> C (in dbSNP:rs34930775)	17344846	1
P53671/R381H	P53671	LIMK2	LIMK2_HUMAN	R381H	187	αC/β4-loop	-	-	EVKVMrLDHPN	0.556	0.473	0.517	0.528	0.325	0.404	0.572	0.316	VARIANT	R -> H (in dbSNP:rs2229874)		0
P53671/R418C	P53671	LIMK2	LIMK2_HUMAN	R418C	269	αD	-	-	LKDFLrMDPFP	0.438	0.458	0.676	0.423	0.23	0.324	0.76	0.227	VARIANT	R -> C (in dbSNP:rs35422808)	17344846	1
P53671/T505E	P53671	LIMK2	LIMK2_HUMAN	T505E	535	A-loop	p	increase	RKKRYtVGNPY	0.871	0.917	0.809	0.946	0.151	0.727	0.891	0.493	MUTAGEN	T->E: Phosphomimetic mutant; enhances kinase activity.	11018042,22328514	2
P53671/T505V	P53671	LIMK2	LIMK2_HUMAN	T505V	535	A-loop	p	loss	RKKRYtVGNPY	0.85	0.921	0.392	0.751	0.815	0.884	0.294	0.445	MUTAGEN	T->V: Abolishes cofilin phosphorylation and enhancement of stress fiber formation.	11018042	1
P53778/D179A	P53778	MAPK12	MK12_HUMAN	D179A	510	A-loop	-	activating	LARQAdEMTGY	0.87	0.806	0.657	0.77	0.201	0.625	0.718	0.334	MUTAGEN	D->A: Emulation of the active state.	15284239	1
P53778/D230N	P53778	MAPK12	MK12_HUMAN	D230N	632	αF/αG	-	-	LFKGSdLDQLK	0.545	0.527	0.497	0.397	0.348	0.444	0.534	0.278	VARIANT	D -> N (in dbSNP:rs35396905)	17344846	1
P53778/F330S	P53778	MAPK12	MK12_HUMAN	F330S	842	C-term-αI	-	-	KYDDSfDVDRT	0.724	0.553	0.425	0.449	0.556	0.618	0.441	0.566	MUTAGEN	F->S: No effect.	15284239	1
P53778/T103M	P53778	MAPK12	MK12_HUMAN	T103M	240	β4/β5-loop	-	-	TLDDFtFYLVM	0.288	0.291	0.513	0.245	0.245	0.202	0.586	0.259	VARIANT	T -> M (in dbSNP:rs34422484)	15461802,17344846	2
P53778/T244M	P53778	MAPK12	MK12_HUMAN	T244M	660	αG/αH	-	-	MKVTGtPAEFV	0.554	0.539	0.636	0.473	0.276	0.441	0.742	0.452	VARIANT	T -> M (in dbSNP:rs2066776)		0
P53778/Y185F	P53778	MAPK12	MK12_HUMAN	Y185F	546	A-loop	p	loss	SEMTGyVTRWY	0.993	0.971	0.267	0.843	0.945	0.948	0.2	0.496	MUTAGEN	Y->F: Loss of activity.	8633070	1
P53779/C462S	P53779	MAPK10	MK10_HUMAN	C462S	-	-	-	loss	AGPLGcR									MUTAGEN	C->S: Loss of palmitoylation.	21941371	1
P54646/P371T	P54646	PRKAA2	AAPK2_HUMAN	P371T	-	-	-	-	HPERMpLIADS									VARIANT	P -> T (in breast cancer samples; infiltrating ductal carcinoma; somatic mutation)	16959974,17344846	2
P54646/R407Q	P54646	PRKAA2	AAPK2_HUMAN	R407Q	-	-	-	-	WHLGIrQSKPY									VARIANT	R -> Q (in a gastric adenocarcinoma sample; somatic mutation)	17344846	1
P54646/S523G	P54646	PRKAA2	AAPK2_HUMAN	S523G	-	-	-	-	GSLTGsLSSVS									VARIANT	S -> G (in a breast cancer sample; somatic mutation)	16959974	1
P54646/T172D	P54646	PRKAA2	AAPK2_HUMAN	T172D	545	A-loop	p	-	GEFLRtCGSPN	0.999	0.993	0.859	0.99	0.177	0.964	0.843	0.382	MUTAGEN	T->D: Phosphomimetic mutant.		0
P54753/I579V	P54753	EPHB3	EPHB3_HUMAN	I579V	-	-	-	-	VVVIAiCLRKQ									VARIANT	I -> V (in dbSNP:rs56103851)	17344846	1
P54753/I601L	P54753	EPHB3	EPHB3_HUMAN	I601L	-	-	-	-	KLQQYiPGMKV									VARIANT	I -> L (in dbSNP:rs56129875)	17344846	1
P54753/K665R	P54753	EPHB3	EPHB3_HUMAN	K665R	129	β3;Catalytic-Lys	-	loss	VFVAIkLKVGY	0.983	1.0	0.06	0.608	0.987	0.999	0.031	0.399	MUTAGEN	K->R: Kinase-dead. Loss of autophosphorylation.	9674711	1
P54753/R168L	P54753	EPHB3	EPHB3_HUMAN	R168L	-	-	-	-	DESFSrDAGRV									VARIANT	R -> L (in a lung small cell carcinoma sample; somatic mutation)	17344846	1
P54753/R440C	P54753	EPHB3	EPHB3_HUMAN	R440C	-	-	-	-	SPLPPrAAVNI									VARIANT	R -> C (in dbSNP:rs56029711)	17344846	1
P54753/R724W	P54753	EPHB3	EPHB3_HUMAN	R724W	269	αD	-	-	LDSFLrNDGQF	0.761	0.755	0.617	0.699	0.455	0.574	0.635	0.451	VARIANT	R -> W (in a lung neuroendocrine carcinoma sample; somatic mutation; dbSNP:rs371378866)	17344846	1
P54753/Y614F	P54753	EPHB3	EPHB3_HUMAN	Y614F	10	N-term-β1	p	-	IDPFTyDPNEA	0.8	0.846	0.558	0.833	0.509	0.754	0.56	0.475	MUTAGEN	Y->F: Partial loss of phosphorylation and loss of interaction with SH2-containing proteins.	9674711	1
P54756/A672T	P54756	EPHA5	EPHA5_HUMAN	A672T	26	N-term-β1	-	neutral	AKEIEaCITIE	0.429	0.35	0.486	0.3	0.319	0.31	0.632	0.22	VARIANT	A -> T (in dbSNP:rs36050417)	17344846	1
P54756/E330Q	P54756	EPHA5	EPHA5_HUMAN	E330Q	-	-	-	-	HSYTHeASTSC									VARIANT	E -> Q (in dbSNP:rs56205382)	17344846	1
P54756/E503K	P54756	EPHA5	EPHA5_HUMAN	E503K	-	-	-	-	IILEYeKYFEK									VARIANT	E -> K (in a lung large cell carcinoma sample; somatic mutation)	17344846	1
P54756/G582E	P54756	EPHA5	EPHA5_HUMAN	G582E	-	-	-	-	VSVTVgILLAV									VARIANT	G -> E (in a lung adenocarcinoma sample; somatic mutation; dbSNP:rs1057520012)	17344846	1
P54756/H959R	P54756	EPHA5	EPHA5_HUMAN	H959R	-	-	-	-	NLLAEhPLGSG									VARIANT	H -> R (in dbSNP:rs56312931)	17344846	1
P54756/N1032S	P54756	EPHA5	EPHA5_HUMAN	N1032S	-	-	-	-	KVQLVnMVPL									VARIANT	N -> S (in a lung large cell carcinoma sample; somatic mutation)	17344846	1
P54756/N81T	P54756	EPHA5	EPHA5_HUMAN	N81T	-	-	-	neutral	IAFPKnWEEIG									VARIANT	N -> T (in dbSNP:rs33932471)	17344846	1
P54756/R417Q	P54756	EPHA5	EPHA5_HUMAN	R417Q	-	-	-	-	VRYLPrSGLKN									VARIANT	R -> Q (in a lung adenocarcinoma sample; somatic mutation; dbSNP:rs199614818)	17344846	1
P54756/S235A	P54756	EPHA5	EPHA5_HUMAN	S235A	-	-	-	-	YKKCPsVRHLA									VARIANT	S -> A (in dbSNP:rs55710198)	17344846	1
P54756/S673T	P54756	EPHA5	EPHA5_HUMAN	S673T	27	N-term-β1	-	-	KEIEAsITIER	0.449	0.402	0.488	0.377	0.339	0.32	0.575	0.34	VARIANT	S -> T (in dbSNP:rs56359290)	17344846	1
P54756/T856I	P54756	EPHA5	EPHA5_HUMAN	T856I	596	αF	-	-	AFRKFtASDVW	0.731	0.672	0.623	0.662	0.391	0.531	0.609	0.356	VARIANT	T -> I (in a lung squamous cell carcinoma sample; somatic mutation)	17344846	1
P54756/Y506C	P54756	EPHA5	EPHA5_HUMAN	Y506C	-	-	-	-	EYEIKyEKDQE									VARIANT	Y -> C (in dbSNP:rs56074660)	17344846	1
P54760/A371V	P54760	EPHB4	EPHB4_HUMAN	A371V	-	-	-	neutral	PGGSCaCGGDL									VARIANT	A -> V (in dbSNP:rs55720981)	17344846	1
P54760/A509G	P54760	EPHB4	EPHB4_HUMAN	A509G	-	-	-	-	LVQVRaSEAGY									VARIANT	A -> G (does not affect tyrosine phosphorylation; does not affect interaction with RASA1; dbSNP:rs146937374)	30578106	1
P54760/A725T	P54760	EPHB4	EPHB4_HUMAN	A725T	411	αE	-	-	MLRGIaGMRYL	0.6	0.545	0.607	0.504	0.296	0.453	0.686	0.319	VARIANT	A -> T (in CMAVM2; unknown pathological significance; dbSNP:rs1159930961)	28687708	1
P54760/A882T	P54760	EPHB4	EPHB4_HUMAN	A882T	819	αI	-	neutral	MIRNPaLKIVA	0.203	0.144	0.523	0.224	0.152	0.149	0.668	0.135	VARIANT	A -> T (in dbSNP:rs34918225)	17344846	1
P54760/C107R	P54760	EPHB4	EPHB4_HUMAN	C107R	-	-	-	-	RAGRScETFTV									VARIANT	C -> R (in CMAVM2; unknown pathological significance; dbSNP:rs1562974383)	29444212	1
P54760/C268R	P54760	EPHB4	EPHB4_HUMAN	C268R	-	-	-	-	EGNTKcACAQG									VARIANT	C -> R (in CMAVM2; unknown pathological significance; dbSNP:rs201816920)	28687708	1
P54760/C845R	P54760	EPHB4	EPHB4_HUMAN	C845R	761	αG/αH	-	loss	PPPPDcTSLHQ	0.874	0.896	0.404	0.562	0.737	0.8	0.358	0.67	VARIANT	C -> R (in CMAVM2; the mutant protein is not detected by Western blot; loss of localization to cell membrane; dbSNP:rs1584653054)	28687708	1
P54760/C856Y	P54760	EPHB4	EPHB4_HUMAN	C856Y	792	αH	-	-	QLMLDcQKDRN	0.79	0.816	0.296	0.492	0.73	0.748	0.243	0.603	VARIANT	C -> Y (in CMAVM2; dbSNP:rs1584653005)	28687708	1
P54760/D576E	P54760	EPHB4	EPHB4_HUMAN	D576E	-	-	-	-	EAEYSdHGQYL									VARIANT	D -> E (in dbSNP:rs36050247)	17344846	1
P54760/D802G	P54760	EPHB4	EPHB4_HUMAN	D802G	600	αF	-	-	FTSASdWSYGI	0.879	0.883	0.229	0.56	0.769	0.785	0.164	0.628	VARIANT	D -> G (in CMAVM2; dbSNP:rs776410552)	28730721	1
P54760/E59K	P54760	EPHB4	EPHB4_HUMAN	E59K	-	-	-	-	SVRTYeCDVQR									VARIANT	E -> K (in CMAVM2; unknown pathological significance; dbSNP:rs1584667224)	28687708	1
P54760/E664K	P54760	EPHB4	EPHB4_HUMAN	E664K	173	αC	-	loss	REFLSeSIMGQ	0.886	0.859	0.275	0.595	0.79	0.758	0.247	0.452	VARIANT	E -> K (in CMAVM2; the mutant protein is not detected by Western blot; loss of localization to cell membrane; dbSNP:rs1562969219)	28687708	1
P54760/E890D	P54760	EPHB4	EPHB4_HUMAN	E890D	827	C-term-αI	-	neutral	KIVAReGGASH	0.141	0.145	0.527	0.175	0.068	0.105	0.757	0.137	VARIANT	E -> D (in dbSNP:rs35638378)	17344846	1
P54760/F867L	P54760	EPHB4	EPHB4_HUMAN	F867L	803	αI	-	decrease	NARPRfQVVSA	0.755	0.742	0.456	0.635	0.563	0.6	0.447	0.571	VARIANT	F -> L (in CMAVM2; loss of tyrosine phosphorylation; loss of interaction with RASA1; dbSNP:rs1584652949)	30578106	1
P54760/G516R	P54760	EPHB4	EPHB4_HUMAN	G516R	-	-	-	-	SEAGYgFGQEH									VARIANT	G -> R (in CMAVM2; unknown pathological significance; dbSNP:rs776305185)	28687708	1
P54760/G807R	P54760	EPHB4	EPHB4_HUMAN	G807R	605	αF	-	-	DAWSYgVMWEV	0.771	0.806	0.274	0.658	0.738	0.718	0.231	0.445	VARIANT	G -> R (in CMAVM2; unknown pathological significance; dbSNP:rs1330628156)	28687708	1
P54760/I782S	P54760	EPHB4	EPHB4_HUMAN	I782S	549	A-loop	-	loss	SLGGKiIRWTA	0.846	0.812	0.404	0.626	0.76	0.818	0.346	0.528	VARIANT	I -> S (in LMPHM7; loss of kinase activity; dbSNP:rs1057519264)	27400125	1
P54760/K162R	P54760	EPHB4	EPHB4_HUMAN	K162R	-	-	-	-	GKVNVkLRLGP									VARIANT	K -> R (in dbSNP:rs17854760)	15489334	1
P54760/K650N	P54760	EPHB4	EPHB4_HUMAN	K650N	132	β3/αC-loop	-	decrease	AIKTLkGYTER	0.714	0.717	0.415	0.486	0.588	0.591	0.437	0.342	VARIANT	K -> N (in CMAVM2; highly decreased tyrosine phosphorylation; highly decreased interaction with RASA1; dbSNP:rs1584658113)	30578106	1
P54760/L187P	P54760	EPHB4	EPHB4_HUMAN	L187P	-	-	-	-	GACMAlSLHLF									VARIANT	L -> P (in CMAVM2; unknown pathological significance; dbSNP:rs1584666053)	28687708	1
P54760/L874P	P54760	EPHB4	EPHB4_HUMAN	L874P	811	αI	-	-	QVVSAlKMIRN	0.634	0.6	0.523	0.618	0.41	0.475	0.603	0.525	VARIANT	L -> P (in CMAVM2; unknown pathological significance; dbSNP:rs1584652900)	28687708	1
P54760/L95R	P54760	EPHB4	EPHB4_HUMAN	L95R	-	-	-	decrease	LRFTMlCLSLP									MUTAGEN	L->R: Reduces binding affinity for EFNB2.	16867992	1
P54760/N745D	P54760	EPHB4	EPHB4_HUMAN	N745D	448	Catalytic-loop	-	-	DLAARnLVNSN	0.921	0.9	0.434	0.694	0.74	0.842	0.427	0.499	VARIANT	N -> D (in CMAVM2; dbSNP:rs1584654433)	28687708	1
P54760/P346L	P54760	EPHB4	EPHB4_HUMAN	P346L	-	-	-	-	LEWSApESGGR									VARIANT	P -> L (in a metastatic melanoma sample; somatic mutation; dbSNP:rs267601191)	17344846	1
P54760/P67L	P54760	EPHB4	EPHB4_HUMAN	P67L	-	-	-	-	DVQRApQAHWL									VARIANT	P -> L (in dbSNP:rs34653459)	17344846	1
P54760/P789R	P54760	EPHB4	EPHB4_HUMAN	P789R	556	A-loop;APE-motif	-	-	IRWTApAIAFR	0.812	0.798	0.296	0.564	0.732	0.77	0.222	0.518	VARIANT	P -> R (in CMAVM2; unknown pathological significance; dbSNP:rs753075600)	28687708	1
P54760/P789S	P54760	EPHB4	EPHB4_HUMAN	P789S	556	A-loop;APE-motif	-	-	IRWTApAIAFR	0.847	0.812	0.339	0.534	0.711	0.75	0.3	0.644	VARIANT	P -> S (in CMAVM2; unknown pathological significance; dbSNP:rs1417508111)	28687708	1
P54760/P820L	P54760	EPHB4	EPHB4_HUMAN	P820L	633	αF/αG	-	-	SFGERpWDMSN	0.634	0.695	0.382	0.475	0.6	0.556	0.403	0.408	VARIANT	P -> L (in CMAVM2; unknown pathological significance; dbSNP:rs1584653650)	28687708	1
P54760/P820T	P54760	EPHB4	EPHB4_HUMAN	P820T	633	αF/αG	-	-	SFGERpWDMSN	0.79	0.763	0.33	0.541	0.615	0.659	0.327	0.537	VARIANT	P -> T (in CMAVM2; unknown pathological significance; dbSNP:rs1584653653)	28687708	1
P54760/R656W	P54760	EPHB4	EPHB4_HUMAN	R656W	138	αC	-	-	GGYTErRREFL	0.704	0.681	0.589	0.628	0.375	0.631	0.678	0.329	VARIANT	R -> W (in CMAVM2; unknown pathological significance; dbSNP:rs745584371)	28687708	1
P54760/R678H	P54760	EPHB4	EPHB4_HUMAN	R678H	198	αC/β4-loop	-	-	HPNIIrEGVVT	0.426	0.334	0.492	0.329	0.177	0.229	0.694	0.484	VARIANT	R -> H (in dbSNP:rs55692440)	17344846	1
P54760/R739Q	P54760	EPHB4	EPHB4_HUMAN	R739Q	442	Catalytic-loop;HrD-motif	-	loss	MSYVHrLAARN	0.89	0.931	0.378	0.788	0.755	0.831	0.322	0.554	VARIANT	R -> Q (in LMPHM7; loss of kinase activity; dbSNP:rs1057519263)	27400125	1
P54760/R74P	P54760	EPHB4	EPHB4_HUMAN	R74P	-	-	-	-	QAHWLrGWVPR									VARIANT	R -> P (in CMAVM2; unknown pathological significance; dbSNP:rs61735971)	28687708	1
P54760/R838W	P54760	EPHB4	EPHB4_HUMAN	R838W	753	αG/αH	-	loss	IEQDYrPPPPD	0.849	0.856	0.4	0.654	0.718	0.768	0.31	0.337	VARIANT	R -> W (in CMAVM2; the mutant protein is not detected by Western blot; loss of localization to cell membrane; dbSNP:rs764827256)	28687708	1
P54760/R864W	P54760	EPHB4	EPHB4_HUMAN	R864W	800	αI	-	loss	KDRNArRFPQV	0.905	0.84	0.448	0.651	0.688	0.765	0.403	0.383	VARIANT	R -> W (in CMAVM2; the mutant protein is not detected by Western blot; loss of localization to cell membrane; dbSNP:rs769965440)	28687708	1
P54760/R889W	P54760	EPHB4	EPHB4_HUMAN	R889W	826	C-term-αI	-	-	LKIVArNGGAS	0.487	0.461	0.629	0.513	0.239	0.244	0.736	0.29	VARIANT	R -> W (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs762016655)	17344846	1
P54760/V113I	P54760	EPHB4	EPHB4_HUMAN	V113I	-	-	-	-	KETFTvYYESD									VARIANT	V -> I (in dbSNP:rs55866373)	17344846	1
P54760/V469G	P54760	EPHB4	EPHB4_HUMAN	V469G	-	-	-	-	VLDYEvYHEKG									VARIANT	V -> G (in CMAVM2; unknown pathological significance; dbSNP:rs1584662591)	28687708	1
P54760/V870E	P54760	EPHB4	EPHB4_HUMAN	V870E	806	αI	-	-	PRFPQvSALDK	0.756	0.729	0.554	0.56	0.497	0.633	0.575	0.55	VARIANT	V -> E (in CMAVM2; unknown pathological significance; dbSNP:rs1584652920)	29444212	1
P54762/A912T	P54762	EPHB1	EPHB1_HUMAN	A912T	-	-	-	-	IPDFTaTTVDD									VARIANT	A -> T (in dbSNP:rs56345346)	17344846	1
P54762/G152R	P54762	EPHB1	EPHB1_HUMAN	G152R	-	-	-	-	SQVDFgRLMKV									VARIANT	G -> R (in dbSNP:rs1042793)		0
P54762/I719V	P54762	EPHB1	EPHB1_HUMAN	I719V	303	αD/αE-loop	-	-	GQFTViLVGML	0.145	0.136	0.499	0.19	0.12	0.111	0.737	0.137	VARIANT	I -> V (in a gastric adenocarcinoma sample; somatic mutation)	17344846	1
P54762/K651R	P54762	EPHB1	EPHB1_HUMAN	K651R	129	β3;Catalytic-Lys	-	loss	IYVAIkLKAGY	0.975	1.0	0.06	0.618	0.987	0.999	0.031	0.401	MUTAGEN	K->R: Kinase-dead mutant. Unable to autophosphorylate, to interact with SH2 domain-containing interactors, to activate the MAPK/ERK and JUN signaling cascades. Not ubiquitinated by CBL.	18034775,9430661	2
P54762/M18V	P54762	EPHB1	EPHB1_HUMAN	M18V	-	-	-	-	SAVAAmETLMD									VARIANT	M -> V (in dbSNP:rs55650774)	17344846	1
P54762/M847T	P54762	EPHB1	EPHB1_HUMAN	M847T	758	αG/αH	-	-	RLPPPmCPAAL	0.563	0.551	0.461	0.468	0.393	0.511	0.533	0.445	VARIANT	M -> T (in dbSNP:rs1042785)		0
P54762/R367G	P54762	EPHB1	EPHB1_HUMAN	R367G	-	-	-	-	KCRADrSCSRC									VARIANT	R -> G (in dbSNP:rs1042789)		0
P54762/R485S	P54762	EPHB1	EPHB1_HUMAN	R485S	-	-	-	-	NSSMArQTNTA									VARIANT	R -> S (in dbSNP:rs1042788)		0
P54762/R743Q	P54762	EPHB1	EPHB1_HUMAN	R743Q	442	Catalytic-loop;HrD-motif	-	-	MNYVHrLAARN	0.875	0.921	0.375	0.765	0.747	0.823	0.327	0.545	VARIANT	R -> Q (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs1338928289)	17344846	1
P54762/R973W	P54762	EPHB1	EPHB1_HUMAN	R973W	-	-	-	-	SIHSMrQISQS									VARIANT	R -> W (in dbSNP:rs1042784)	9430661	1
P54762/S707T	P54762	EPHB1	EPHB1_HUMAN	S707T	266	αD	-	-	NGALDsLRQND	0.166	0.128	0.401	0.132	0.157	0.208	0.579	0.139	VARIANT	S -> T (in an ovarian undifferentiated carcinoma sample; somatic mutation)	17344846	1
P54762/T387M	P54762	EPHB1	EPHB1_HUMAN	T387M	-	-	-	-	RQLGLtCRVSI									VARIANT	T -> M (in dbSNP:rs56396912)	17344846	1
P54762/T87S	P54762	EPHB1	EPHB1_HUMAN	T87S	-	-	-	-	AHRIYtMRFTV									VARIANT	T -> S (in dbSNP:rs1042794)		0
P54762/T981M	P54762	EPHB1	EPHB1_HUMAN	T981M	-	-	-	-	ISQSPtMA									VARIANT	T -> M (in dbSNP:rs56186270)	17344846	1
P54762/Y594F	P54762	EPHB1	EPHB1_HUMAN	Y594F	4	N-term-β1	p	decrease	PGMKIyDPFTY	0.885	0.879	0.58	0.738	0.575	0.748	0.52	0.327	MUTAGEN	Y->F: Loss of interaction with NCK1.	9430661	1
P54762/Y600F	P54762	EPHB1	EPHB1_HUMAN	Y600F	10	N-term-β1	p	decrease	IDPFTyDPNEA	0.8	0.832	0.565	0.823	0.501	0.755	0.573	0.466	MUTAGEN	Y->F: Loss of interaction with SHC1 and SRC.	12925710	1
P54762/Y778F	P54762	EPHB1	EPHB1_HUMAN	Y778F	533	A-loop	p	decrease	TSDPTySSLGG	0.983	0.96	0.43	0.874	0.817	0.903	0.311	0.491	MUTAGEN	Y->F: Loss of interaction with SHC1.	12925710	1
P54762/Y928F	P54762	EPHB1	EPHB1_HUMAN	Y928F	-	-	p	decrease	IKMVQyDSFLT									MUTAGEN	Y->F: Disrupts binding with the GRB10 SH2 domain, providing evidence for phosphorylation. Disrupts interaction with GRB7 and ACP1.	12223469,8798570,9499402	3
P54764/E42A	P54764	EPHA4	EPHA4_HUMAN	E42A	-	-	-	-	RSVQGeGWIAS									MUTAGEN	E->A: 10-fold reduced affinity for EFNB2; when associated with A-40.	19875447	1
P54764/G370E	P54764	EPHA4	EPHA4_HUMAN	G370E	-	-	-	-	VCKKCgGDPSK									VARIANT	G -> E (in a bladder carcinoma NOS sample; somatic mutation; dbSNP:rs756952113)	17344846	1
P54764/Q40A	P54764	EPHA4	EPHA4_HUMAN	Q40A	-	-	-	-	DSRSVqELGWI									MUTAGEN	Q->A: 10-fold reduced affinity for EFNB2; when associated with A-42.	19875447	1
P54764/R269Q	P54764	EPHA4	EPHA4_HUMAN	R269Q	-	-	-	-	AGHEErGECQA									VARIANT	R -> Q (in dbSNP:rs35084379)	17344846	1
P54764/R953K	P54764	EPHA4	EPHA4_HUMAN	R953K	-	-	-	-	QEDLArGITAI									VARIANT	R -> K (in dbSNP:rs35341687)		0
P54764/S399F	P54764	EPHA4	EPHA4_HUMAN	S399F	-	-	-	-	KTTKVsTDLLA									VARIANT	S -> F (in a metastatic melanoma sample; somatic mutation; dbSNP:rs868224085)	17344846	1
P57058/E625K	P57058	HUNK	HUNK_HUMAN	E625K	-	-	-	-	VSFAHeKNSPP									VARIANT	E -> K (in dbSNP:rs56021554)	17344846	1
P57058/M648T	P57058	HUNK	HUNK_HUMAN	M648T	-	-	-	-	PSNGPmPLGSP									VARIANT	M -> T (in dbSNP:rs56240027)	17344846	1
P57058/R157W	P57058	HUNK	HUNK_HUMAN	R157W	387	αD/αE-loop	-	-	IYEKKrEESEA	0.723	0.713	0.48	0.571	0.56	0.606	0.457	0.395	VARIANT	R -> W (in dbSNP:rs35133981)	17344846	1
P57058/R591C	P57058	HUNK	HUNK_HUMAN	R591C	-	-	-	neutral	PVSLArNSSER									VARIANT	R -> C (in dbSNP:rs10775648)	17344846	1
P57059/A615V	P57059	SIK1	SIK1_HUMAN	A615V	-	-	-	neutral	RQVCQaASRAS									VARIANT	A -> V (in dbSNP:rs430554)	14702039,15489334,17344846	3
P57059/A725V	P57059	SIK1	SIK1_HUMAN	A725V	-	-	-	neutral	PVASAaLLDTH									VARIANT	A -> V (in dbSNP:rs35596465)	17344846	1
P57059/D142N	P57059	SIK1	SIK1_HUMAN	D142N	425	αE	-	-	VEYCHdHIVHR	0.163	0.163	0.353	0.125	0.149	0.127	0.578	0.118	VARIANT	D -> N (in dbSNP:rs45491503)	17344846	1
P57059/G15S	P57059	SIK1	SIK1_HUMAN	G15S	21	N-term-β1	-	neutral	DPAGQgGQQKP	0.364	0.397	0.483	0.325	0.279	0.345	0.577	0.206	VARIANT	G -> S (in dbSNP:rs3746951)	17344846	1
P57059/G211S	P57059	SIK1	SIK1_HUMAN	G211S	605	αF	-	-	DIWSLgVLYVL	0.697	0.677	0.376	0.528	0.652	0.712	0.335	0.639	VARIANT	G -> S (in a glioblastoma multiforme sample; somatic mutation)	17344846	1
P57059/G469D	P57059	SIK1	SIK1_HUMAN	G469D	-	-	-	-	LPSSTgRHTLA									VARIANT	G -> D (in a metastatic melanoma sample; somatic mutation)	17344846	1
P57059/G636S	P57059	SIK1	SIK1_HUMAN	G636S	-	-	-	-	PAQSPgHGGAA									VARIANT	G -> S (in DEE30; no change in subcellular location; dbSNP:rs786205163)	25839329	1
P57059/K56M	P57059	SIK1	SIK1_HUMAN	K56M	129	β3;Catalytic-Lys	-	loss	TQVAIkIDKTR	0.999	1.0	0.015	0.593	0.995	0.999	0.019	0.575	MUTAGEN	K->M: Loss of kinase activity.	18348280,19622832	2
P57059/P287T	P57059	SIK1	SIK1_HUMAN	P287T	832	C-term-αI	-	-	PCLPGpCPAFS	0.491	0.554	0.439	0.336	0.343	0.497	0.575	0.112	VARIANT	P -> T (in DEE30; no change in subcellular location; dbSNP:rs786205159)	25839329	1
P57059/P696L	P57059	SIK1	SIK1_HUMAN	P696L	-	-	-	neutral	GPGAApPSTLL									VARIANT	P -> L (in dbSNP:rs56386767)	17344846	1
P57059/R430W	P57059	SIK1	SIK1_HUMAN	R430W	-	-	-	-	CSGVFrRPVSP									VARIANT	R -> W (in dbSNP:rs34164089)		0
P57059/S135A	P57059	SIK1	SIK1_HUMAN	S135A	412	αE	-	decrease	FWQILsVEYCH	0.701	0.705	0.392	0.463	0.711	0.618	0.345	0.439	MUTAGEN	S->A: Decreased kinase activity without affecting much autophosphorylation status.	18348280	1
P57059/S186A	P57059	SIK1	SIK1_HUMAN	S186A	549	A-loop	-	loss	STWCGsPYAAP	0.79	0.872	0.281	0.546	0.811	0.803	0.209	0.391	MUTAGEN	S->A,D,C,G: Impaired autophosphorylation and kinase activity.	18348280	1
P57059/S186C	P57059	SIK1	SIK1_HUMAN	S186C	549	A-loop	-	-	STWCGsPYAAP	0.9	0.851	0.329	0.588	0.748	0.834	0.236	0.526	MUTAGEN	S->A,D,C,G: Impaired autophosphorylation and kinase activity.	18348280	1
P57059/S186D	P57059	SIK1	SIK1_HUMAN	S186D	549	A-loop	-	-	STWCGsPYAAP	0.948	0.932	0.456	0.727	0.772	0.846	0.331	0.482	MUTAGEN	S->A,D,C,G: Impaired autophosphorylation and kinase activity.	18348280	1
P57059/S186G	P57059	SIK1	SIK1_HUMAN	S186G	549	A-loop	-	-	STWCGsPYAAP	0.888	0.861	0.37	0.687	0.762	0.795	0.31	0.413	MUTAGEN	S->A,D,C,G: Impaired autophosphorylation and kinase activity.	18348280	1
P57059/S186T	P57059	SIK1	SIK1_HUMAN	S186T	549	A-loop	-	decrease	STWCGsPYAAP	0.672	0.705	0.33	0.394	0.616	0.644	0.331	0.179	MUTAGEN	S->T: Does not autophosphorylation and kinase activity.	18348280	1
P57059/S209A	P57059	SIK1	SIK1_HUMAN	S209A	603	αF	-	decrease	QLDIWsGVVLY	0.518	0.556	0.358	0.263	0.603	0.488	0.359	0.24	MUTAGEN	S->A: Decreased kinase activity without affecting much autophosphorylation status.	18348280	1
P57059/S248A	P57059	SIK1	SIK1_HUMAN	S248A	781	αH	-	decrease	IPFFMsDCESL	0.858	0.841	0.396	0.515	0.696	0.768	0.405	0.328	MUTAGEN	S->A: Decreased kinase activity without affecting much autophosphorylation status.	18348280	1
P57059/S411C	P57059	SIK1	SIK1_HUMAN	S411C	-	-	-	-	DCELQsLQWPL									VARIANT	S -> C (in DEE30; no change in subcellular location)	25839329	1
P57059/S575A	P57059	SIK1	SIK1_HUMAN	S575A	-	-	p	decrease	EGRRAsTSLTQ									MUTAGEN	S->A: Loss of interaction with 14-3-3 proteins in response to cAMP signaling and, thus, still able to inhibit 		0
P57059/S575E	P57059	SIK1	SIK1_HUMAN	S575E	-	-	p	decrease	EGRRAsTSLTQ									MUTAGEN	S->E: Strongly reduced but still present interaction with 14-3-3 proteins in response to cAMP signaling and, thus, still able to inhibit TORC activity.	29211348	1
P57059/T182A	P57059	SIK1	SIK1_HUMAN	T182A	545	A-loop	p	decrease	GEPLStCGSPP	0.996	1.0	0.131	0.94	0.973	0.993	0.071	0.42	MUTAGEN	T->A: Prevents phosphorylation and activation by STK11/LKB1 complex. Reduced inhibition of CRTC3-mediated transcriptional activity.	14976552,29211348	2
P57059/T473A	P57059	SIK1	SIK1_HUMAN	T473A	-	-	p	-	TGRRHtAEVST									MUTAGEN	T->A: Reduced but still present interaction with 14-3-3 proteins in response to cAMP signaling and, thus, still able to inhibit TORC activity. Resistant to inhibition by cAMP signaling and, thus, still able to inhibit TORC activity; when associated with A-575.	29211348	1
P57059/T473E	P57059	SIK1	SIK1_HUMAN	T473E	-	-	p	decrease	TGRRHtAEVST									MUTAGEN	T->E: Reduced but still present interaction with 14-3-3 proteins in response to cAMP signaling and, thus, still able to inhibit TORC activity.	29211348	1
P57078/A12G	P57078	RIPK4	RIPK4_HUMAN	A12G	19	N-term-β1	-	neutral	TPWALaLRTFD	0.363	0.31	0.559	0.307	0.256	0.28	0.722	0.162	VARIANT	A -> G (in dbSNP:rs6586239)		0
P57078/A496P	P57078	RIPK4	RIPK4_HUMAN	A496P	-	-	-	-	HLAVEaQEECA									VARIANT	A -> P (in BPS; unknown pathological significance)	25691407	1
P57078/E284K	P57078	RIPK4	RIPK4_HUMAN	E284K	830	C-term-αI	-	-	NGLNGeIRQVL	0.219	0.246	0.47	0.166	0.204	0.253	0.595	0.118	VARIANT	E -> K (in CHANDS; unknown pathological significance)	26129644	1
P57078/G163D	P57078	RIPK4	RIPK4_HUMAN	G163D	498	A-loop;DFG-motif	-	-	KISDFgAKCNG	0.881	0.877	0.481	0.641	0.522	0.751	0.402	0.65	VARIANT	G -> D (in CHANDS; unknown pathological significance; dbSNP:rs764278537)	23610050	1
P57078/I121N	P57078	RIPK4	RIPK4_HUMAN	I121N	406	αE	-	loss	DLRFRiHETAV	0.847	0.784	0.527	0.713	0.635	0.679	0.45	0.443	VARIANT	I -> N (in BPS; loss of function; dbSNP:rs387906923)	22197489	1
P57078/I462N	P57078	RIPK4	RIPK4_HUMAN	I462N	-	-	-	-	KLVDAiSGDTS									VARIANT	I -> N (in dbSNP:rs55809511)	17344846	1
P57078/I81N	P57078	RIPK4	RIPK4_HUMAN	I81N	200	β4	-	-	AKFRYiPVYGI	0.792	0.75	0.422	0.547	0.619	0.676	0.378	0.52	VARIANT	I -> N (in BPS; dbSNP:rs387906922)	22197488	1
P57078/N562Y	P57078	RIPK4	RIPK4_HUMAN	N562Y	-	-	-	-	HFAAQnDESST									VARIANT	N -> Y (in dbSNP:rs55829311)	17344846	1
P57078/P189L	P57078	RIPK4	RIPK4_HUMAN	P189L	555	A-loop;APE-motif	-	-	TIAYLpERIRE	0.75	0.679	0.552	0.546	0.484	0.588	0.537	0.482	VARIANT	P -> L (in BPS; unknown pathological significance)	25691407	1
P57078/P749S	P57078	RIPK4	RIPK4_HUMAN	P749S	-	-	-	neutral	VLARGpNQTAL									VARIANT	P -> S (in dbSNP:rs35537517)	17344846	1
P57078/R666H	P57078	RIPK4	RIPK4_HUMAN	R666H	-	-	-	-	QRGHYrARILI									VARIANT	R -> H (in BPS; unknown pathological significance; dbSNP:rs763794698)	25691407	1
P57078/R669H	P57078	RIPK4	RIPK4_HUMAN	R669H	-	-	-	-	HYRVArLIDLC									VARIANT	R -> H (in dbSNP:rs56056485)	17344846	1
P57078/S177N	P57078	RIPK4	RIPK4_HUMAN	S177N	542	A-loop	-	-	HSHDLsDGLFG	0.412	0.378	0.498	0.401	0.276	0.347	0.601	0.219	VARIANT	S -> N (in dbSNP:rs12482626)		0
P57078/T184I	P57078	RIPK4	RIPK4_HUMAN	T184I	549	A-loop	-	loss	DGLFGtAYLPP	0.889	0.89	0.354	0.746	0.83	0.894	0.212	0.571	VARIANT	T -> I (in BPS; loss of function)	22197489	1
P57078/V463M	P57078	RIPK4	RIPK4_HUMAN	V463M	-	-	-	-	LVDAIvGDTSK									VARIANT	V -> M (in dbSNP:rs55645753)	17344846	1
P68400/D175G	P68400	CSNK2A1	CSK21_HUMAN	D175G	496	A-loop;DFG-motif	-	-	KLRLIdGLAEF	0.955	0.943	0.195	0.624	0.908	0.926	0.15	0.709	VARIANT	D -> G (in OCNDS; dbSNP:rs869312848)	27048600	1
P68400/K198R	P68400	CSNK2A1	CSK21_HUMAN	K198R	554	A-loop	-	-	ASRYFkPELLV	0.363	0.268	0.492	0.329	0.166	0.279	0.726	0.206	VARIANT	K -> R (in OCNDS; dbSNP:rs869312840)	27048600	1
P68400/R47Q	P68400	CSNK2A1	CSK21_HUMAN	R47Q	41	β1;Gly-rich-loop	-	-	VRKLGrKYSEV	0.702	0.721	0.442	0.463	0.494	0.5	0.57	0.35	VARIANT	R -> Q (in OCNDS; dbSNP:rs869312845)	27048600	1
P68400/Y50S	P68400	CSNK2A1	CSK21_HUMAN	Y50S	44	Gly-rich-loop;β1/β2-loop	p	-	LGRGKyEVFEA	0.888	0.859	0.395	0.784	0.599	0.776	0.354	0.721	VARIANT	Y -> S (in OCNDS; dbSNP:rs869312849)	27048600	1
P78362/G243D	P78362	SRPK2	SRPK2_HUMAN	G243D	-	-	-	-	EWQKAgPPPSG									VARIANT	G -> D (in a glioblastoma multiforme sample; somatic mutation)	17344846	1
P78362/L615I	P78362	SRPK2	SRPK2_HUMAN	L615I	679	αG/αH	-	-	PRHFAlGKYSR	0.405	0.314	0.571	0.376	0.193	0.283	0.693	0.264	VARIANT	L -> I (in dbSNP:rs1050418)		0
P78362/P43L	P78362	SRPK2	SRPK2_HUMAN	P43L	-	-	-	-	PDPTPpPEEEI									VARIANT	P -> L (in dbSNP:rs34699980)	17344846	1
P78362/P515T	P78362	SRPK2	SRPK2_HUMAN	P515T	-	-	-	-	DLLVNpDPRNA									VARIANT	P -> T (in dbSNP:rs56017595)	17344846	1
P78362/S486F	P78362	SRPK2	SRPK2_HUMAN	S486F	-	-	-	-	EESSPsDRSRT									VARIANT	S -> F (in dbSNP:rs56112661)	17344846	1
P78362/S608N	P78362	SRPK2	SRPK2_HUMAN	S608N	660	αG/αH	-	-	IELLGsPRHFA	0.127	0.166	0.481	0.161	0.136	0.13	0.659	0.076	VARIANT	S -> N (in dbSNP:rs1050413)		0
P78362/T426P	P78362	SRPK2	SRPK2_HUMAN	T426P	-	-	-	-	AESDYtSSSYE									VARIANT	T -> P (in dbSNP:rs55743527)	17344846	1
P78368/E194G	P78368	CSNK1G2	KC1G2_HUMAN	E194G	506	A-loop	-	-	FGLAKeIDPET	0.742	0.748	0.491	0.663	0.51	0.585	0.518	0.61	VARIANT	E -> G (in dbSNP:rs55780547)	17344846	1
P78368/E208Q	P78368	CSNK1G2	KC1G2_HUMAN	E208Q	542	A-loop	-	-	HIPYReKSLTG	0.462	0.508	0.456	0.433	0.367	0.405	0.486	0.353	VARIANT	E -> Q (in dbSNP:rs55818316)	17344846	1
P78368/F189L	P78368	CSNK1G2	KC1G2_HUMAN	F189L	497	A-loop;DFG-motif	-	-	IHIIDfLAKEY	0.837	0.766	0.41	0.671	0.558	0.713	0.387	0.666	VARIANT	F -> L (in dbSNP:rs55702630)	17344846	1
P78368/I196T	P78368	CSNK1G2	KC1G2_HUMAN	I196T	510	A-loop	-	-	LAKEYiPETKK	0.797	0.83	0.506	0.683	0.464	0.688	0.499	0.51	VARIANT	I -> T (in dbSNP:rs55923222)	17344846	1
P78368/R207S	P78368	CSNK1G2	KC1G2_HUMAN	R207S	541	A-loop	-	-	KHIPYrHKSLT	0.843	0.827	0.423	0.631	0.652	0.795	0.405	0.45	VARIANT	R -> S (in dbSNP:rs56340103)	17344846	1
P78368/R217C	P78368	CSNK1G2	KC1G2_HUMAN	R217C	552	A-loop	-	-	LTGTArMSINT	0.785	0.77	0.441	0.609	0.638	0.73	0.331	0.587	VARIANT	R -> C (in dbSNP:rs55754218)	17344846	1
P78368/T223M	P78368	CSNK1G2	KC1G2_HUMAN	T223M	558	αF	-	-	YMSINtLGKEQ	0.644	0.56	0.466	0.45	0.432	0.476	0.505	0.415	VARIANT	T -> M (in dbSNP:rs56038081)	17344846	1
P78368/Y206C	P78368	CSNK1G2	KC1G2_HUMAN	Y206C	540	A-loop	-	-	KKHIPyEHKSL	0.843	0.845	0.418	0.632	0.653	0.716	0.34	0.511	VARIANT	Y -> C (in dbSNP:rs56264133)	17344846	1
P78368/Y206H	P78368	CSNK1G2	KC1G2_HUMAN	Y206H	540	A-loop	-	-	KKHIPyEHKSL	0.861	0.825	0.418	0.637	0.631	0.797	0.418	0.633	VARIANT	Y -> H (in dbSNP:rs56108438)	17344846	1
P78527/A1237T	P78527	PRKDC	PRKDC_HUMAN	A1237T	-	-	-	-	PSGILaPTLLY									VARIANT	A -> T (in dbSNP:rs191531119)	17344846	1
P78527/A6S	P78527	PRKDC	PRKDC_HUMAN	A6S	-	-	-	-	MAGSGaVRCSL									VARIANT	A -> S (in dbSNP:rs8177999)	17344846	1
P78527/F649L	P78527	PRKDC	PRKDC_HUMAN	F649L	-	-	-	-	PWVYSfYELIL									VARIANT	F -> L (in dbSNP:rs55811715)	17344846	1
P78527/G1314V	P78527	PRKDC	PRKDC_HUMAN	G1314V	-	-	-	-	AEKCFgGAAGN									VARIANT	G -> V (in dbSNP:rs8178090)		0
P78527/G500S	P78527	PRKDC	PRKDC_HUMAN	G500S	-	-	-	-	VVLPKgESESE									VARIANT	G -> S (in a metastatic melanoma sample; somatic mutation)	17344846	1
P78527/I680M	P78527	PRKDC	PRKDC_HUMAN	I680M	-	-	-	neutral	RNAKKiYFEGV									VARIANT	I -> M (in dbSNP:rs8178040)		0
P78527/K263N	P78527	PRKDC	PRKDC_HUMAN	K263N	-	-	ub	-	PQIDLkYAVPS									VARIANT	K -> N (in a lung adenocarcinoma sample; somatic mutation; dbSNP:rs758032015)	17344846	1
P78527/L1190V	P78527	PRKDC	PRKDC_HUMAN	L1190V	-	-	-	-	HKSIElYKFVP									VARIANT	L -> V (in dbSNP:rs34598508)	17344846	1
P78527/L1279F	P78527	PRKDC	PRKDC_HUMAN	L1279F	-	-	-	-	RTVGAlVLGTE									VARIANT	L -> F	17344846	1
P78527/M333I	P78527	PRKDC	PRKDC_HUMAN	M333I	-	-	-	neutral	AKNAEmKNKLQ									VARIANT	M -> I (in dbSNP:rs8178017)	17344846	1
P78527/N1071S	P78527	PRKDC	PRKDC_HUMAN	N1071S	-	-	-	neutral	LALHPnFKRLG									VARIANT	N -> S (in dbSNP:rs8178070)		0
P78527/P695S	P78527	PRKDC	PRKDC_HUMAN	P695S	-	-	-	-	SLKHSpDPEKY									VARIANT	P -> S (in dbSNP:rs8178046)	17344846	1
P78527/R1136H	P78527	PRKDC	PRKDC_HUMAN	R1136H	-	-	-	-	IDHLCrIEKKH									VARIANT	R -> H (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs781401034)	17344846	1
P78527/T605S	P78527	PRKDC	PRKDC_HUMAN	T605S	-	-	-	neutral	VWMIPtDPAAN									VARIANT	T -> S (in dbSNP:rs8178033)	17344846	1
P78527/V420I	P78527	PRKDC	PRKDC_HUMAN	V420I	-	-	-	-	QSVASvLYLDT									VARIANT	V -> I (in dbSNP:rs55925466)	17344846	1
P80192/A246V	P80192	MAP3K9	M3K9_HUMAN	A246V	407	αE	-	-	ILVNWaQIARG	0.384	0.288	0.515	0.324	0.186	0.233	0.63	0.185	VARIANT	A -> V (in a metastatic melanoma sample; somatic mutation)	17344846	1
P80192/K171A	P80192	MAP3K9	M3K9_HUMAN	K171A	129	β3;Catalytic-Lys	-	loss	DEVAVkARHDP	1.0	1.0	0.032	0.688	0.982	0.999	0.015	0.671	MUTAGEN	K->A: Loss of kinase activity and threonine phosphorylation.	15610029	1
P80192/R467C	P80192	MAP3K9	M3K9_HUMAN	R467C	-	-	-	-	EELLRrEQELA									VARIANT	R -> C (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs773256562)	17344846	1
P80192/R497Q	P80192	MAP3K9	M3K9_HUMAN	R497Q	-	-	-	-	CQEKPrKKRKG									VARIANT	R -> Q (in dbSNP:rs56196343)	17344846	1
P80192/S308A	P80192	MAP3K9	M3K9_HUMAN	S308A	545	A-loop	-	decrease	RTTKMsAGTYA	0.915	0.935	0.176	0.602	0.807	0.905	0.186	0.198	MUTAGEN	S->A: Impairs JNK activation.	15610029	1
P80192/T304A	P80192	MAP3K9	M3K9_HUMAN	T304A	513	A-loop	-	decrease	REWHRtKMSAA	0.754	0.738	0.457	0.46	0.617	0.637	0.409	0.263	MUTAGEN	T->A: Reduces threonine phosphorylation. Impairs JNK activation.	15610029	1
P80192/T305A	P80192	MAP3K9	M3K9_HUMAN	T305A	514	A-loop	-	decrease	EWHRTtMSAAG	0.697	0.712	0.347	0.497	0.641	0.625	0.281	0.338	MUTAGEN	T->A: Little effect on threonine phosphorylation. Mildly impairs JNK activation.	15610029	1
P80192/T312A	P80192	MAP3K9	M3K9_HUMAN	T312A	549	A-loop	p	loss	MSAAGtAWMAP	0.966	0.976	0.25	0.718	0.922	0.948	0.168	0.647	MUTAGEN	T->A: Loss of threonine phosphorylation. Strongly impairs JNK activation.	15610029	1
P80192/Y646C	P80192	MAP3K9	M3K9_HUMAN	Y646C	-	-	-	neutral	SLVDGyQWSSS									VARIANT	Y -> C (in dbSNP:rs34322726)	17344846	1
Q00526/I124T	Q00526	CDK3	CDK3_HUMAN	I124T	440	Catalytic-loop	-	-	HSHRViRDLKP	0.687	0.605	0.475	0.636	0.546	0.617	0.417	0.663	VARIANT	I -> T (in dbSNP:rs34918446)	17344846	1
Q00526/M264T	Q00526	CDK3	CDK3_HUMAN	M264T	790	αH	-	-	GRDLLmLLQYD	0.377	0.337	0.566	0.432	0.159	0.223	0.726	0.19	VARIANT	M -> T (in dbSNP:rs17884251)	17344846	1
Q00526/R214H	Q00526	CDK3	CDK3_HUMAN	R214H	653	αG/αH	-	-	IDQLFrFRMLG	0.264	0.245	0.502	0.257	0.173	0.215	0.657	0.137	VARIANT	R -> H (in dbSNP:rs34670267)	17344846	1
Q00526/S106N	Q00526	CDK3	CDK3_HUMAN	S106N	405	αE	-	-	LHLIKsLFQLL	0.205	0.23	0.603	0.323	0.188	0.153	0.733	0.21	VARIANT	S -> N (in a glioblastoma multiforme sample; somatic mutation)	17344846	1
Q00526/T226I	Q00526	CDK3	CDK3_HUMAN	T226I	674	αG/αH	-	neutral	TPSEDtPGVTQ	0.109	0.108	0.489	0.178	0.095	0.137	0.689	0.111	VARIANT	T -> I (in dbSNP:rs2069532)		0
Q00532/K342N	Q00532	CDKL1	CDKL1_HUMAN	K342N	-	-	-	-	PALDNkYYCDT									VARIANT	K -> N (in dbSNP:rs770928060)		0
Q00532/L330V	Q00532	CDKL1	CDKL1_HUMAN	L330V	-	-	-	neutral	QYLPQlGSSIL									VARIANT	L -> V (in dbSNP:rs9323183)	17344846	1
Q00532/L67P	Q00532	CDKL1	CDKL1_HUMAN	L67P	204	β4	-	-	PNLVNlEVFRR	0.849	0.896	0.545	0.699	0.542	0.725	0.475	0.478	VARIANT	L -> P (in dbSNP:rs11570814)		0
Q00532/Q275E	Q00532	CDKL1	CDKL1_HUMAN	Q275E	799	αI	-	neutral	HMDPTqLTCEQ	0.063	0.077	0.55	0.142	0.065	0.074	0.789	0.101	VARIANT	Q -> E (in dbSNP:rs7161563)	1639063,17344846,29420175	3
Q00534/A197T	Q00534	CDK6	CDK6_HUMAN	A197T	595	αF	-	-	LQSSYaPVDLW	0.344	0.343	0.511	0.316	0.192	0.233	0.678	0.168	VARIANT	A -> T (in MCPH12; dbSNP:rs606231255)	23918663	1
Q00534/D110N	Q00534	CDK6	CDK6_HUMAN	D110N	269	αD	-	neutral	LTTYLdVPEPG	0.189	0.159	0.467	0.168	0.128	0.145	0.648	0.18	VARIANT	D -> N (in dbSNP:rs35654944)	17344846	1
Q00534/P199L	Q00534	CDK6	CDK6_HUMAN	P199L	597	αF	-	-	SSYATpDLWSV	0.629	0.653	0.579	0.537	0.406	0.5	0.637	0.412	VARIANT	P -> L (in a metastatic melanoma sample; somatic mutation)	17344846	1
Q00535/E225D	Q00535	CDK5	CDK5_HUMAN	E225D	673	αG/αH	-	-	GTPTEeWPSMT	0.184	0.162	0.494	0.237	0.139	0.118	0.673	0.223	VARIANT	E -> D (in dbSNP:rs35186917)	17344846	1
Q00535/S159A	Q00535	CDK5	CDK5_HUMAN	S159A	544	A-loop	p	-	PVRCYsEVVTL	0.965	0.951	0.345	0.775	0.767	0.885	0.365	0.458	MUTAGEN	S->A: No phenotype.	11583627	1
Q00535/S159T	Q00535	CDK5	CDK5_HUMAN	S159T	544	A-loop	p	decrease	PVRCYsEVVTL	0.808	0.787	0.465	0.69	0.554	0.765	0.56	0.339	MUTAGEN	S->T: Impaired p35/p25 (CDK5R1) binding.	11583627	1
Q00536/K194A	Q00536	CDK16	CDK16_HUMAN	K194A	129	β3;Catalytic-Lys	ub	loss	NLVALkIRLEH	1.0	1.0	0.055	0.74	0.982	0.997	0.038	0.633	MUTAGEN	K->A: Loss of kinase activity. Abolishes effect on insulin secretion.	22184064,22798068	2
Q00536/K194R	Q00536	CDK16	CDK16_HUMAN	K194R	129	β3;Catalytic-Lys	ub	loss	NLVALkIRLEH	1.0	1.0	0.104	0.791	0.944	0.997	0.156	0.413	MUTAGEN	K->R: Loss of kinase activity.	22184064,22798068	2
Q00536/S119A	Q00536	CDK16	CDK16_HUMAN	S119A	-	-	p	decrease	INKRLsPADIR									MUTAGEN	S->A: Strongly reduces interaction with CCNY.	22184064	1
Q00536/S12A	Q00536	CDK16	CDK16_HUMAN	S12A	-	-	p	loss	IKRQLsTLRGG									MUTAGEN	S->A: Abolishes phosphorylation by BRSK2. Abolishes effect on insulin secretion.	22798068	1
Q00536/S153A	Q00536	CDK16	CDK16_HUMAN	S153A	21	N-term-β1	p	activating	RLRRVsSEIGF	0.834	0.782	0.486	0.724	0.407	0.679	0.557	0.329	MUTAGEN	S->A: Constitutively activated, due to loss of an inhibitory phosphorylation site. Increases interaction with CCNY.	22184064,22798068	2
Q00536/S153D	Q00536	CDK16	CDK16_HUMAN	S153D	21	N-term-β1	p	decrease	RLRRVsSEIGF	0.831	0.784	0.667	0.826	0.314	0.667	0.659	0.449	MUTAGEN	S->D: Abolishes interaction with CCNY.	22184064,22798068	2
Q00537/T214I	Q00537	CDK17	CDK17_HUMAN	T214I	68	β2/β3-loop	-	-	GRSKLtNLVAL	0.64	0.519	0.608	0.541	0.32	0.458	0.668	0.299	VARIANT	T -> I (found in a renal cell carcinoma sample; somatic mutation; dbSNP:rs764448325)	21248752	1
Q01973/C482G	Q01973	ROR1	ROR1_HUMAN	C482G	-	-	-	-	EELGEcFGKIY									MUTAGEN	C->G: No effect on kinase activity.	25029443	1
Q01973/E562D	Q01973	ROR1	ROR1_HUMAN	E562D	-	-	-	-	QGDLHeLIMRS									VARIANT	E -> D (in a breast cancer sample; somatic mutation; dbSNP:rs760789417)	16959974	1
Q01973/F150L	Q01973	ROR1	ROR1_HUMAN	F150L	-	-	-	-	VLFVKfPPPTA									VARIANT	F -> L (in an ovarian mucinous carcinoma sample; somatic mutation)	17344846	1
Q01973/G144E	Q01973	ROR1	ROR1_HUMAN	G144E	-	-	-	-	VVSSTgLFVKF									VARIANT	G -> E (in a metastatic melanoma sample; somatic mutation)	17344846	1
Q01973/G624R	Q01973	ROR1	ROR1_HUMAN	G624R	-	-	-	-	RNILIgQLHVK									VARIANT	G -> R (in dbSNP:rs55832740)	17344846	1
Q01973/I301V	Q01973	ROR1	ROR1_HUMAN	I301V	-	-	-	-	CIRIGiMADPI									VARIANT	I -> V (in a renal clear cell carcinoma sample; somatic mutation)	17344846	1
Q01973/R567I	Q01973	ROR1	ROR1_HUMAN	R567I	-	-	-	-	EFLIMrPHSDV									VARIANT	R -> I (in a colorectal adenocarcinoma sample; somatic mutation)	17344846	1
Q01973/R736T	Q01973	ROR1	ROR1_HUMAN	R736T	-	-	-	-	EIPSRrRFKDI									VARIANT	R -> T (in DFNB108; impairs plasma membrane location; abolishes downstream NFkB activation; dbSNP:rs1553163562)	27162350	1
Q01973/S776N	Q01973	ROR1	ROR1_HUMAN	S776N	-	-	-	-	TSLSAsVSNLS									VARIANT	S -> N (in a colorectal adenocarcinoma sample; somatic mutation)	17344846	1
Q01973/T518M	Q01973	ROR1	ROR1_HUMAN	T518M	-	-	-	neutral	NPQQWtFQQEA									VARIANT	T -> M (in dbSNP:rs7527017)	1334494,17344846	2
Q01973/Y646C	Q01973	ROR1	ROR1_HUMAN	Y646C	-	-	-	-	YSADYyVQSKS									VARIANT	Y -> C (in dbSNP:rs34109134)	17344846	1
Q01974/C182Y	Q01974	ROR2	ROR2_HUMAN	C182Y	-	-	-	-	YRGIAcRFIGN									VARIANT	C -> Y (in RRS1)	10932187	1
Q01974/D482G	Q01974	ROR2	ROR2_HUMAN	D482G	42	β1;Gly-rich-loop	-	increase	EELGEdFGKVY	0.686	0.48	0.561	0.491	0.289	0.471	0.655	0.396	MUTAGEN	D->G: Slight increase in kinase activity.	25029443	1
Q01974/D644N	Q01974	ROR2	ROR2_HUMAN	D644N	510	A-loop	-	-	EVYAAdYKLLG	0.903	0.87	0.419	0.775	0.666	0.829	0.359	0.573	VARIANT	D -> N (in dbSNP:rs55798732)	17344846	1
Q01974/D672N	Q01974	ROR2	ROR2_HUMAN	D672N	598	αF	-	-	GKFSIdDIWSY	0.597	0.546	0.528	0.526	0.375	0.431	0.634	0.3	VARIANT	D -> N (in dbSNP:rs55651110)	17344846	1
Q01974/D935E	Q01974	ROR2	ROR2_HUMAN	D935E	-	-	-	neutral	DTLQVdAQVQL									VARIANT	D -> E (in dbSNP:rs41277835)	17344846	1
Q01974/G490A	Q01974	ROR2	ROR2_HUMAN	G490A	57	β2/β3-loop	-	-	GKVYKgLFGPA	0.55	0.6	0.481	0.473	0.324	0.448	0.506	0.414	VARIANT	G -> A (in dbSNP:rs56197744)	17344846	1
Q01974/G695R	Q01974	ROR2	ROR2_HUMAN	G695R	636	αF/αG	-	neutral	LQPYCgSNQDV	0.51	0.527	0.366	0.418	0.438	0.482	0.368	0.406	VARIANT	G -> R (in dbSNP:rs34431454)	17344846	1
Q01974/H349D	Q01974	ROR2	ROR2_HUMAN	H349D	-	-	-	neutral	HPHSHhSSTDF									VARIANT	H -> D (in dbSNP:rs55983376)	17344846	1
Q01974/N620K	Q01974	ROR2	ROR2_HUMAN	N620K	448	Catalytic-loop	-	-	DLATRnLVYDK	0.903	0.929	0.222	0.574	0.878	0.848	0.224	0.43	VARIANT	N -> K (in RRS1)	10932186	1
Q01974/P548S	Q01974	ROR2	ROR2_HUMAN	P548S	240	β4/β5-loop	-	-	VTKDQpSMIFS	0.725	0.652	0.48	0.594	0.474	0.635	0.389	0.626	VARIANT	P -> S (in dbSNP:rs35764413)	17344846	1
Q01974/R184C	Q01974	ROR2	ROR2_HUMAN	R184C	-	-	-	-	GIACArIGNRT									VARIANT	R -> C (in RRS1; dbSNP:rs121909084)	10932186	1
Q01974/R189W	Q01974	ROR2	ROR2_HUMAN	R189W	-	-	-	-	RFIGNrIYVDS									VARIANT	R -> W (in RRS1; dbSNP:rs199975149)	10932186	1
Q01974/R244Q	Q01974	ROR2	ROR2_HUMAN	R244Q	-	-	-	-	CDARSrPKPRE									VARIANT	R -> Q (in dbSNP:rs55737262)	17344846	1
Q01974/R366W	Q01974	ROR2	ROR2_HUMAN	R366W	-	-	-	-	GHAYCrPGGQM									VARIANT	R -> W (in RRS1)	10932186	1
Q01974/R530Q	Q01974	ROR2	ROR2_HUMAN	R530Q	188	αC/β4-loop	-	neutral	AMLRArQHPNV	0.099	0.121	0.486	0.197	0.075	0.097	0.707	0.091	VARIANT	R -> Q (in dbSNP:rs35852786)	17344846	1
Q01974/R738C	Q01974	ROR2	ROR2_HUMAN	R738C	802	αI	-	-	PSRRPrKDIHS	0.769	0.715	0.53	0.587	0.419	0.584	0.494	0.289	VARIANT	R -> C (in dbSNP:rs56231927)	17344846	1
Q01974/S557L	Q01974	ROR2	ROR2_HUMAN	S557L	252	β5/αD-loop	-	-	IFSYCsGDLHE	0.451	0.388	0.519	0.393	0.307	0.33	0.589	0.421	VARIANT	S -> L (in dbSNP:rs56099091)	17344846	1
Q01974/S762L	Q01974	ROR2	ROR2_HUMAN	S762L	828	C-term-αI	-	-	SSAQTsASNTT	0.613	0.616	0.672	0.556	0.247	0.43	0.763	0.41	VARIANT	S -> L (in dbSNP:rs34491822)	17344846	1
Q01974/T245A	Q01974	ROR2	ROR2_HUMAN	T245A	-	-	-	neutral	DARSRtKPREL									VARIANT	T -> A (in dbSNP:rs10820900)	10700182,10986040,1334494,17344846	4
Q01974/V542M	Q01974	ROR2	ROR2_HUMAN	V542M	223	β4/β5-loop	-	-	VCLLGvTKDQP	0.536	0.495	0.551	0.506	0.303	0.396	0.614	0.382	VARIANT	V -> M (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs140213020)	17344846	1
Q01974/V819I	Q01974	ROR2	ROR2_HUMAN	V819I	-	-	-	neutral	PPQLYvVNGYQ									VARIANT	V -> I (in dbSNP:rs10761129)	10700182,17344846	2
Q02156/A333V	Q02156	PRKCE	KPCE_HUMAN	A333V	-	-	-	-	ESPQPaGSSPS									VARIANT	A -> V (in dbSNP:rs55989965)	17344846	1
Q02156/A654T	Q02156	PRKCE	KPCE_HUMAN	A654T	807	αI	-	neutral	RLGCVaQNGED	0.066	0.055	0.388	0.068	0.086	0.073	0.663	0.034	VARIANT	A -> T (in dbSNP:rs35777875)		0
Q02156/E143K	Q02156	PRKCE	KPCE_HUMAN	E143K	-	-	-	-	APKDNeRVFRE									VARIANT	E -> K (in a colorectal cancer sample; somatic mutation; dbSNP:rs772834505)	16959974	1
Q02156/K437W	Q02156	PRKCE	KPCE_HUMAN	K437W	129	β3;Catalytic-Lys	-	loss	EVYAVkLKKDV	0.994	0.992	0.046	0.671	0.986	0.993	0.018	0.461	MUTAGEN	K->W: Abolishes activity and S-729 phosphorylation.	11964154	1
Q02156/P389R	Q02156	PRKCE	KPCE_HUMAN	P389R	13	N-term-β1	-	-	GQLMSpENGEV	0.359	0.385	0.426	0.326	0.345	0.265	0.556	0.208	VARIANT	P -> R (in dbSNP:rs55767130)	17344846	1
Q02156/S729A	Q02156	PRKCE	KPCE_HUMAN	S729A	-	-	p	decrease	EFKGFsFGEDL									MUTAGEN	S->A: Enhances T-566 dephosphorylation.	11964154	1
Q02156/T563M	Q02156	PRKCE	KPCE_HUMAN	T563M	523	A-loop	-	neutral	ILNGVtTTFCG	0.214	0.263	0.591	0.343	0.169	0.229	0.709	0.202	VARIANT	T -> M (in dbSNP:rs34077350)	17344846	1
Q02156/T566A	Q02156	PRKCE	KPCE_HUMAN	T566A	545	A-loop	p	loss	GVTTTtCGTPD	0.987	1.0	0.192	0.915	0.893	0.994	0.169	0.436	MUTAGEN	T->A: Abolishes phosphorylation by PDK1, and S-729 phosphorylation.	11964154	1
Q02156/T566E	Q02156	PRKCE	KPCE_HUMAN	T566E	545	A-loop	p	-	GVTTTtCGTPD	0.974	0.985	0.891	0.965	0.213	0.931	0.884	0.456	MUTAGEN	T->E: No effect on S-729 phosphorylation.	11964154	1
Q02156/T710E	Q02156	PRKCE	KPCE_HUMAN	T710E	-	-	p	-	EEPVLtVDEAI									MUTAGEN	T->E: No effect on activity; no effect on S-729 phosphorylation.	11964154	1
Q02750/A220L	Q02750	MAP2K1	MP2K1_HUMAN	A220L	543	A-loop	-	-	LIDSMaSFVGT	0.594	0.633	0.575	0.481	0.402	0.469	0.649	0.241	MUTAGEN	A->L: Increases interaction with KSR1 and BRAF; when associated with w-219.	29433126	1
Q02750/F311S	Q02750	MAP2K1	MP2K1_HUMAN	F311S	18	N-term-β1	-	decrease	PPMAIfLLDYI	0.815	0.848	0.387	0.553	0.679	0.758	0.381	0.68	MUTAGEN	F->S: Loss of interaction with BRAF and KSR1. Loss of BRAF-KSR1 dimerization.	29433126	1
Q02750/F53S	Q02750	MAP2K1	MP2K1_HUMAN	F53S	18	N-term-β1	-	-	KRLEAfTQKQK	0.833	0.783	0.451	0.685	0.613	0.695	0.486	0.605	VARIANT	F -> S (in CFC3; dbSNP:rs121908594)	16439621	1
Q02750/G128V	Q02750	MAP2K1	MP2K1_HUMAN	G128V	202	β4	-	resistance	SPYIVgYGAFY	0.663	0.498	0.532	0.44	0.365	0.357	0.593	0.697	VARIANT	G -> V (in CFC3; dbSNP:rs121908596)	18042262	1
Q02750/K57E	Q02750	MAP2K1	MP2K1_HUMAN	K57E	22	N-term-β1	ub	activating,resistance	AFLTQkKVGEL	0.714	0.648	0.638	0.628	0.335	0.424	0.723	0.327	VARIANT	K -> E (in MEL; somatic mutation; dbSNP:rs397516790)	29643386	1
Q02750/K57N	Q02750	MAP2K1	MP2K1_HUMAN	K57N	22	N-term-β1	ub	increase,resistance	AFLTQkKVGEL	0.754	0.684	0.635	0.703	0.312	0.57	0.725	0.413	VARIANT	K -> N (in MEL; somatic mutation; results in increased MAPK signal transduction; dbSNP:rs869025608)	29643386	1
Q02750/K97A	Q02750	MAP2K1	MP2K1_HUMAN	K97A	129	β3;Catalytic-Lys	ub	loss	LVMARkIHLEI	1.0	1.0	0.028	0.674	0.995	0.997	0.017	0.645	MUTAGEN	K->A: Loss of catalytic activity. Strongly reduces phosphorylation upon UV irradiation.	20956560	1
Q02750/K97R	Q02750	MAP2K1	MP2K1_HUMAN	K97R	129	β3;Catalytic-Lys	ub	loss	LVMARkIHLEI	1.0	0.991	0.035	0.734	0.983	0.997	0.028	0.497	MUTAGEN	K->R: Loss of catalytic activity. No effect on BRAF-KSR1 or BRAF-KSR2 dimerization.	29433126,8131746	2
Q02750/M219V	Q02750	MAP2K1	MP2K1_HUMAN	M219V	514	A-loop	-	increase	QLIDSmNSFVG	0.644	0.558	0.639	0.656	0.167	0.376	0.697	0.202	MUTAGEN	M->V: Increases interaction with KSR1 and BRAF.	29433126	1
Q02750/M219W	Q02750	MAP2K1	MP2K1_HUMAN	M219W	514	A-loop	-	-	QLIDSmNSFVG	0.756	0.756	0.578	0.693	0.481	0.632	0.593	0.434	MUTAGEN	M->W: Increases interaction with KSR1 and BRAF; when associated with L-220.	29433126	1
Q02750/N221Y	Q02750	MAP2K1	MP2K1_HUMAN	N221Y	544	A-loop	-	increase	IDSMAnFVGTR	0.797	0.796	0.525	0.702	0.413	0.686	0.573	0.557	MUTAGEN	N->Y: Increases interaction with KSR1 and BRAF.	29433126	1
Q02750/Q56P	Q02750	MAP2K1	MP2K1_HUMAN	Q56P	21	N-term-β1	-	activating	EAFLTqQKVGE	0.614	0.648	0.522	0.554	0.313	0.478	0.609	0.398	VARIANT	Q -> P (in MEL; somatic mutation; dbSNP:rs1057519729)	29643386	1
Q02750/S150A	Q02750	MAP2K1	MP2K1_HUMAN	S150A	256	β5/αD-loop	-	-	HMDGGsDQVLK	0.699	0.67	0.428	0.566	0.524	0.601	0.465	0.516	MUTAGEN	S->A: No loss of activity.	8131746	1
Q02750/S212A	Q02750	MAP2K1	MP2K1_HUMAN	S212A	501	A-loop	p	-	CDFGVsQLIDS	0.857	0.884	0.539	0.762	0.442	0.639	0.602	0.267	MUTAGEN	S->A: No loss of activity.	8131746	1
Q02750/S218A	Q02750	MAP2K1	MP2K1_HUMAN	S218A	513	A-loop	p	-	GQLIDsANSFV	0.794	0.864	0.419	0.654	0.827	0.747	0.337	0.298	MUTAGEN	S->A: Loss of catalytic activity. No effect on BRAF-KSR1 dimerization; when associated with A-222.	29433126,8131746	2
Q02750/S218D	Q02750	MAP2K1	MP2K1_HUMAN	S218D	513	A-loop	p	-	GQLIDsANSFV	0.806	0.859	0.713	0.825	0.393	0.614	0.652	0.233	MUTAGEN	S->D: No effect on BRAF-KSR1 dimerization; when associated with D-222.	29433126	1
Q02750/S222A	Q02750	MAP2K1	MP2K1_HUMAN	S222A	545	A-loop	p	-	DSMANsVGTRS	0.96	0.979	0.191	0.817	0.899	0.978	0.187	0.545	MUTAGEN	S->A: Loss of catalytic activity. No effect on BRAF-KSR1 dimerization; when associated with A-218.	29433126,8131746	2
Q02750/S222D	Q02750	MAP2K1	MP2K1_HUMAN	S222D	545	A-loop	p	-	DSMANsVGTRS	0.982	0.952	0.769	0.954	0.323	0.931	0.842	0.323	MUTAGEN	S->D: No effect on BRAF-KSR1 dimerization; when associated with D-218.	29433126	1
Q02750/Y130C	Q02750	MAP2K1	MP2K1_HUMAN	Y130C	205	β4/β5-loop	-	-	YIVGFyAFYSD	0.875	0.846	0.446	0.717	0.606	0.748	0.433	0.676	VARIANT	Y -> C (in CFC3; dbSNP:rs121908595)	16439621	1
Q02763/A226V	Q02763	TEK	TIE2_HUMAN	A226V	-	-	-	-	NHLCTaMNNGV									VARIANT	A -> V (in dbSNP:rs35814893)	17344846	1
Q02763/A724T	Q02763	TEK	TIE2_HUMAN	A724T	-	-	-	neutral	GSSNPaSHELV									VARIANT	A -> T (in dbSNP:rs4631561)	17344846	1
Q02763/A925S	Q02763	TEK	TIE2_HUMAN	A925S	287	αD/αE-loop	-	increase	LETDPaAIANS	0.205	0.2	0.587	0.38	0.046	0.088	0.793	0.106	VARIANT	A -> S (in VMCM; increased ligand-independent autophosphorylation and kinase activation)	19888299	1
Q02763/C224S	Q02763	TEK	TIE2_HUMAN	C224S	-	-	-	decrease	ECNHLcACMNN									MUTAGEN	C->S: Reduces protein abundance.	27270174	1
Q02763/C233Y	Q02763	TEK	TIE2_HUMAN	C233Y	-	-	-	-	MNNGVcEDTGE									VARIANT	C -> Y (in GLC3E; enhanced proteasomal degradation)	27270174	1
Q02763/I148T	Q02763	TEK	TIE2_HUMAN	I148T	-	-	-	neutral	FKKVLiEEDAV									VARIANT	I -> T (in dbSNP:rs35969327)	17344846	1
Q02763/K1100N	Q02763	TEK	TIE2_HUMAN	K1100N	820	αI	-	increase	MLEERkYVNTT	0.506	0.417	0.641	0.605	0.105	0.205	0.735	0.316	VARIANT	K -> N (in VMCM; strongly increased ligand-independent autophosphorylation and kinase activation)	19888299	1
Q02763/K117N	Q02763	TEK	TIE2_HUMAN	K117N	-	-	-	-	RIRTMkRQQAS									VARIANT	K -> N (in breast cancer samples; infiltrating ductal carcinoma; somatic mutation)	16959974,17344846	2
Q02763/K294N	Q02763	TEK	TIE2_HUMAN	K294N	-	-	-	-	CATGWkLQCNE									VARIANT	K -> N (in GLC3E; unknown pathological significance; 10-fold decrease of Tyr-1102 phosphorylation; no effect on membrane location; dbSNP:rs146169480)	27270174	1
Q02763/K855R	Q02763	TEK	TIE2_HUMAN	K855R	129	β3;Catalytic-Lys	-	loss	MDAAIkMKEYA	1.0	0.988	0.051	0.672	1.0	0.991	0.019	0.527	MUTAGEN	K->R: Loss of kinase activity.	12609966,15851516	2
Q02763/L634F	Q02763	TEK	TIE2_HUMAN	L634F	-	-	-	-	LTAWTlDILPP									VARIANT	L -> F (in dbSNP:rs35378598)	17344846	1
Q02763/L914F	Q02763	TEK	TIE2_HUMAN	L914F	268	αD	-	increase	NLLDFlKSRVL	0.641	0.704	0.677	0.708	0.282	0.563	0.739	0.431	VARIANT	L -> F (found in patients with solitary and multiple sporadic venous malformations; increased ligand-independent autophosphorylation; novel location at endoplasmic reticulum and Golgi apparatus; partially retained at endoplasmic reticulum and Golgi apparatus; dbSNP:rs1825682849)	19079259	1
Q02763/P883A	Q02763	TEK	TIE2_HUMAN	P883A	194	αC/β4-loop	-	-	KLGHHpIINLL	0.539	0.502	0.449	0.427	0.37	0.447	0.492	0.386	VARIANT	P -> A (in an ovarian serous carcinoma sample; somatic mutation; dbSNP:rs1490428165)	17344846	1
Q02763/Q346P	Q02763	TEK	TIE2_HUMAN	Q346P	-	-	-	-	EREGIqMTPKI									VARIANT	Q -> P (in dbSNP:rs682632)	14702039,15489334,8382358	3
Q02763/R849W	Q02763	TEK	TIE2_HUMAN	R849W	110	β2/β3-loop	-	increase	KKDGLrDAAIK	0.65	0.616	0.655	0.666	0.173	0.444	0.712	0.258	VARIANT	R -> W (in VMCM; increased ligand-independent autophosphorylation and kinase activation; no effect on location at membrane; dbSNP:rs80338908)	10369874,19079259,19888299,8980225	4
Q02763/R915C	Q02763	TEK	TIE2_HUMAN	R915C	269	αD	-	increase	LLDFLrSRVLE	0.866	0.81	0.684	0.788	0.319	0.639	0.693	0.4	VARIANT	R -> C (found in a patient with solitary sporadic venous malformations; increased ligand-independent autophosphorylation; dbSNP:rs1825682922)	19079259	1
Q02763/R915H	Q02763	TEK	TIE2_HUMAN	R915H	269	αD	-	increase	LLDFLrSRVLE	0.466	0.484	0.603	0.56	0.186	0.325	0.695	0.372	VARIANT	R -> H (in VMCM; strongly increased ligand-independent autophosphorylation and kinase activation; dbSNP:rs387906745)	19888299	1
Q02763/R915L	Q02763	TEK	TIE2_HUMAN	R915L	269	αD	-	-	LLDFLrSRVLE	0.749	0.675	0.7	0.743	0.329	0.485	0.725	0.475	VARIANT	R -> L (found in a patient with multiple sporadic venous malformations; increased ligand-independent autophosphorylation; the autophosphorylation increases when associated with Phe-897)	19079259	1
Q02763/R918C	Q02763	TEK	TIE2_HUMAN	R918C	272	αD	-	increase	FLRKSrLETDP	0.935	0.921	0.673	0.849	0.329	0.777	0.613	0.347	VARIANT	R -> C (in VMCM; strongly increased ligand-independent autophosphorylation and kinase activation; dbSNP:rs1825683100)	19888299	1
Q02763/S917I	Q02763	TEK	TIE2_HUMAN	S917I	271	αD	-	increase	DFLRKsVLETD	0.684	0.6	0.657	0.777	0.213	0.457	0.726	0.346	VARIANT	S -> I (found in a patient with solitary sporadic venous malformations; increased ligand-independent autophosphorylation)	19079259	1
Q02763/T391I	Q02763	TEK	TIE2_HUMAN	T391I	-	-	-	neutral	VKPDGtLHPKD									VARIANT	T -> I (in dbSNP:rs34032300)		0
Q02763/V486I	Q02763	TEK	TIE2_HUMAN	V486I	-	-	-	neutral	LLYKPvHYEAW									VARIANT	V -> I (in dbSNP:rs1334811)	17344846	1
Q02763/V600L	Q02763	TEK	TIE2_HUMAN	V600L	-	-	-	neutral	GNLTSvLNNLH									VARIANT	V -> L (in dbSNP:rs35030851)	17344846	1
Q02763/V676I	Q02763	TEK	TIE2_HUMAN	V676I	-	-	-	-	TIRYKvGKNED									VARIANT	V -> I (in dbSNP:rs56367117)	17344846	1
Q02763/V919L	Q02763	TEK	TIE2_HUMAN	V919L	273	αD/αE-loop	-	increase	LRKSRvETDPA	0.351	0.378	0.577	0.467	0.138	0.222	0.762	0.18	VARIANT	V -> L (in VMCM; increased ligand-independent autophosphorylation and kinase activation)	19888299	1
Q02763/Y1102F	Q02763	TEK	TIE2_HUMAN	Y1102F	822	αI	p	decrease	EERKTyNTTLY	0.921	0.938	0.55	0.831	0.732	0.902	0.452	0.497	MUTAGEN	Y->F: Abolishes interaction with SHC1.	14665640	1
Q02763/Y611C	Q02763	TEK	TIE2_HUMAN	Y611C	-	-	-	loss	HPREQyVRARV									VARIANT	Y -> C (in GLC3E; reduced response to ligand; loss of ligand-induced phosphorylation; no effect on basal membrane location; dbSNP:rs1306527531)	27270174	1
Q02763/Y897C	Q02763	TEK	TIE2_HUMAN	Y897C	240	β4/β5-loop	p	increase	CEHRGyYLAIE	0.765	0.821	0.674	0.877	0.177	0.512	0.748	0.22	VARIANT	Y -> C (in VMCM; increased ligand-independent autophosphorylation and kinase activation; dbSNP:rs80338909)	19888299	1
Q02763/Y897F	Q02763	TEK	TIE2_HUMAN	Y897F	240	β4/β5-loop	p	-	CEHRGyYLAIE	0.737	0.837	0.522	0.727	0.315	0.595	0.58	0.199	VARIANT	Y -> F (found in a patient with multiple sporadic venous malformations; increased ligand-independent autophosphorylation; the hyperphosphorylation increases when associated with Leu-915)	19079259	1
Q02763/Y897H	Q02763	TEK	TIE2_HUMAN	Y897H	240	β4/β5-loop	p	increase	CEHRGyYLAIE	0.743	0.799	0.693	0.879	0.137	0.424	0.781	0.304	VARIANT	Y -> H (found in a patient with solitary sporadic venous malformations; increased ligand-independent autophosphorylation)	19079259	1
Q02763/Y897S	Q02763	TEK	TIE2_HUMAN	Y897S	240	β4/β5-loop	p	increase	CEHRGyYLAIE	0.837	0.813	0.72	0.833	0.133	0.427	0.804	0.42	VARIANT	Y -> S (in VMCM; also found in a patient with solitary sporadic venous malformations; increased ligand-independent autophosphorylation and kinase activation; dbSNP:rs80338909)	10369874,19079259,19888299	3
Q02779/G107E	Q02779	MAP3K10	M3K10_HUMAN	G107E	42	β1;Gly-rich-loop	-	-	EIIGVgFGKVY	0.886	0.914	0.408	0.731	0.839	0.873	0.387	0.43	VARIANT	G -> E (in a metastatic melanoma sample; somatic mutation)	17344846	1
Q02779/P168Q	Q02779	MAP3K10	M3K10_HUMAN	P168Q	238	β4/β5-loop	-	neutral	ACLNPpLCLVM	0.38	0.388	0.63	0.356	0.223	0.393	0.643	0.419	VARIANT	P -> Q (in dbSNP:rs36102209)		0
Q02846/A328V	Q02846	GUCY2D	GUC2D_HUMAN	A328V	-	-	-	-	DSLRRaERREL									VARIANT	A -> V (in dbSNP:rs56280231)	17344846	1
Q02846/A362S	Q02846	GUCY2D	GUC2D_HUMAN	A362S	-	-	-	-	LARGVaARAAA									VARIANT	A -> S (in LCA1; dbSNP:rs61749677)		0
Q02846/A52S	Q02846	GUCY2D	GUC2D_HUMAN	A52S	-	-	-	-	PPALSaFTVGV									VARIANT	A -> S (in LCA1; unknown pathological significance; dbSNP:rs61749665)	21602930,8944027	2
Q02846/A693E	Q02846	GUCY2D	GUC2D_HUMAN	A693E	508	A-loop	-	-	GRLLEaKVLPE	0.174	0.222	0.576	0.268	0.158	0.149	0.701	0.113	VARIANT	A -> E (in dbSNP:rs35146471)	17344846	1
Q02846/A710V	Q02846	GUCY2D	GUC2D_HUMAN	A710V	555	A-loop;APE-motif	-	loss	DQLWTaELLRD	0.745	0.717	0.546	0.593	0.526	0.544	0.604	0.346	VARIANT	A -> V (in LCA1; loss of basal and GUCA1A-induced guanylate cyclase activity; does not affect endoplasmic reticulum membrane localization; dbSNP:rs781725943)	27475985,30319355	2
Q02846/C105Y	Q02846	GUCY2D	GUC2D_HUMAN	C105Y	-	-	-	-	LLPEPcTPGSL									VARIANT	C -> Y (in LCA1; does not affect basal guanylate cyclase activity; reduces GUCA1A-induced guanylate cyclase activity; dbSNP:rs61749669)	11035546,15123990	2
Q02846/C997D	Q02846	GUCY2D	GUC2D_HUMAN	C997D	-	-	-	-	TMPRYcFGDTV									MUTAGEN	C->D: Changes the substrate specificity from GTP to ATP.	9600905	1
Q02846/D728H	Q02846	GUCY2D	GUC2D_HUMAN	D728H	600	αF	-	-	GTLAGdFSLAI	0.875	0.889	0.225	0.679	0.771	0.769	0.265	0.625	VARIANT	D -> H (in LCA1)	21602930	1
Q02846/E103V	Q02846	GUCY2D	GUC2D_HUMAN	E103V	-	-	-	-	VALLPeCRTPG									VARIANT	E -> V (in LCA1)	21602930	1
Q02846/E837D	Q02846	GUCY2D	GUC2D_HUMAN	E837D	-	-	-	-	EDLIReTEELE									VARIANT	E -> D (in CORD6; dbSNP:rs28933695)	9618177	1
Q02846/E841K	Q02846	GUCY2D	GUC2D_HUMAN	E841K	-	-	-	-	RERTEeELEKQ									VARIANT	E -> K (in CORD6; decreases basal and GUCA1A-induced guanylate cyclase activity; inhibition by RD3 is less effective; does not affect endoplasmic reticulum membrane localization; dbSNP:rs1341592819)	25515582,30319355	2
Q02846/E925K	Q02846	GUCY2D	GUC2D_HUMAN	E925K	-	-	-	-	DVYKVeIGDAY									MUTAGEN	E->K: Changes the substrate specificity from GTP to ATP.	9600905	1
Q02846/F565S	Q02846	GUCY2D	GUC2D_HUMAN	F565S	14	N-term-β1	-	loss	VWLKKfGDQHI	0.701	0.607	0.516	0.5	0.457	0.575	0.507	0.557	VARIANT	F -> S (in LCA1; loss of activity; dbSNP:rs61749755)	9888789	1
Q02846/G431D	Q02846	GUCY2D	GUC2D_HUMAN	G431D	-	-	-	-	SFLSAgRMHFP									VARIANT	G -> D (in a metastatic melanoma sample; somatic mutation; dbSNP:rs1451501407)	17344846	1
Q02846/I573V	Q02846	GUCY2D	GUC2D_HUMAN	I573V	22	N-term-β1	-	-	DQHIAiPATKT	0.378	0.321	0.479	0.298	0.21	0.218	0.606	0.233	VARIANT	I -> V (in LCA1; dbSNP:rs61749756)		0
Q02846/I734A	Q02846	GUCY2D	GUC2D_HUMAN	I734A	606	αF	-	-	VFSLAiMQEVV	0.713	0.719	0.558	0.617	0.432	0.568	0.562	0.378	VARIANT	I -> A (in LCA1; requires 2 nucleotide substitutions)	21602930	1
Q02846/I949T	Q02846	GUCY2D	GUC2D_HUMAN	I949T	-	-	-	-	RHAAEiNMSLD									VARIANT	I -> T (in CORD6; dbSNP:rs267606857)	20517349	1
Q02846/K846N	Q02846	GUCY2D	GUC2D_HUMAN	K846N	-	-	-	-	ELELEkKTDRL									VARIANT	K -> N (in CORD6; decreases basal and GUCA1A-induced guanylate cyclase activity; inhibition by RD3 is less effective; does not affect endoplasmic reticulum membrane localization; dbSNP:rs1598150539)	25515582,30319355	2
Q02846/L325P	Q02846	GUCY2D	GUC2D_HUMAN	L325P	-	-	-	-	SVLDSlRAQER									VARIANT	L -> P (in LCA1; does not affect basal guanylate cyclase activity; reduces GUCA1A-induced guanylate cyclase activity; dbSNP:rs61749675)	11035546,15123990	2
Q02846/L325R	Q02846	GUCY2D	GUC2D_HUMAN	L325R	-	-	-	-	SVLDSlRAQER									VARIANT	L -> R (found in a patient with LCA1)	17724218	1
Q02846/L782H	Q02846	GUCY2D	GUC2D_HUMAN	L782H	787	αH	-	neutral	PVECIlMKQCW	0.191	0.171	0.559	0.233	0.143	0.153	0.748	0.242	VARIANT	L -> H (in dbSNP:rs8069344)	17344846	1
Q02846/L954P	Q02846	GUCY2D	GUC2D_HUMAN	L954P	-	-	-	-	IANMSlILSAV									VARIANT	L -> P (in LCA1; severely impairs basal and GUCA1A induced guanylate cyclase; dbSNP:rs61750182)	12365911,15123990	2
Q02846/M784R	Q02846	GUCY2D	GUC2D_HUMAN	M784R	789	αH	-	-	ECILLmQCWAE	0.9	0.845	0.43	0.756	0.654	0.746	0.378	0.686	VARIANT	M -> R (in LCA1; dbSNP:rs375010731)	21602930	1
Q02846/M823R	Q02846	GUCY2D	GUC2D_HUMAN	M823R	831	C-term-αI	-	decrease	DSMLRmEQYSS	0.455	0.453	0.539	0.494	0.387	0.401	0.622	0.335	MUTAGEN	M->R: Fails to become activated by GUCA1A and by GUCA1B. Does not affect the binding to RP3.	26100624	1
Q02846/P701S	Q02846	GUCY2D	GUC2D_HUMAN	P701S	535	A-loop	-	neutral	VLPEPpAEDQL	0.3	0.296	0.515	0.337	0.22	0.236	0.695	0.234	VARIANT	P -> S (at homozygosity may be associated with Leber congenital amaurosis in some populations; dbSNP:rs34598902)	17344846,17724218,21602930	3
Q02846/P858S	Q02846	GUCY2D	GUC2D_HUMAN	P858S	-	-	-	-	LTQMLpSVAEA									VARIANT	P -> S (in LCA1; severely impairs basal and GUCA1A-induced guanylate cyclase activity; dbSNP:rs61750176)	11035546,15123990	2
Q02846/P873R	Q02846	GUCY2D	GUC2D_HUMAN	P873R	-	-	-	loss	GTPVEpYFEQV									VARIANT	P -> R (in CORD6; loss basal and GUCA1A-induced guanylate cyclase activity; does not affect endoplasmic reticulum membrane localization; dbSNP:rs1567961680)	30319355	1
Q02846/R331S	Q02846	GUCY2D	GUC2D_HUMAN	R331S	-	-	-	-	RRAQErELPSD									VARIANT	R -> S (in dbSNP:rs34596269)		0
Q02846/R438C	Q02846	GUCY2D	GUC2D_HUMAN	R438C	-	-	-	-	RMHFPrGSAPG									VARIANT	R -> C (in LCA1; dbSNP:rs565948960)	21602930	1
Q02846/R602W	Q02846	GUCY2D	GUC2D_HUMAN	R602W	227	β4/β5-loop	-	-	GLFLArAEGPA	0.439	0.42	0.524	0.463	0.334	0.303	0.624	0.247	VARIANT	R -> W (in dbSNP:rs770740012)		0
Q02846/R660Q	Q02846	GUCY2D	GUC2D_HUMAN	R660Q	427	αE	-	-	RYLHHrVAHGR	0.168	0.173	0.48	0.149	0.178	0.186	0.611	0.163	VARIANT	R -> Q (in LCA1; dbSNP:rs61750162)	21602930	1
Q02846/R722W	Q02846	GUCY2D	GUC2D_HUMAN	R722W	573	αF	-	-	PALERrTLAGD	0.51	0.46	0.498	0.525	0.375	0.365	0.556	0.305	VARIANT	R -> W (in dbSNP:rs34331388)		0
Q02846/R768W	Q02846	GUCY2D	GUC2D_HUMAN	R768W	752	αG/αH	-	-	PPPLCrLVSMD	0.822	0.803	0.469	0.665	0.544	0.683	0.495	0.557	VARIANT	R -> W (in LCA1 and CSNB1I; dbSNP:rs61750168)	17724218,21602930,29559409	3
Q02846/R795Q	Q02846	GUCY2D	GUC2D_HUMAN	R795Q	800	αI	-	-	EQPELrSMDHT	0.636	0.648	0.382	0.541	0.542	0.58	0.394	0.516	VARIANT	R -> Q (in LCA1; dbSNP:rs61750171)	17724218	1
Q02846/R822P	Q02846	GUCY2D	GUC2D_HUMAN	R822P	830	C-term-αI	-	decrease	IDSMLrLEQYS	0.558	0.529	0.518	0.55	0.374	0.418	0.602	0.303	MUTAGEN	R->P: Fails to become activated by GUCA1A and by GUCA1B. Does not affect the binding to RP3.	26100624	1
Q02846/R838C	Q02846	GUCY2D	GUC2D_HUMAN	R838C	-	-	-	-	DLIRErEELEL									VARIANT	R -> C (in CORD6; dbSNP:rs61750172)	12552567,18487367,25515582,9618177	4
Q02846/R838G	Q02846	GUCY2D	GUC2D_HUMAN	R838G	-	-	-	-	DLIRErEELEL									VARIANT	R -> G (in CORD6)	18487367	1
Q02846/R838H	Q02846	GUCY2D	GUC2D_HUMAN	R838H	-	-	-	-	DLIRErEELEL									VARIANT	R -> H (in CORD6; dbSNP:rs61750173)	12552567,18487367,22194653,24480840	4
Q02846/R838P	Q02846	GUCY2D	GUC2D_HUMAN	R838P	-	-	-	-	DLIRErEELEL									VARIANT	R -> P (in CORD6; dbSNP:rs61750173)	21552474	1
Q02846/S1007L	Q02846	GUCY2D	GUC2D_HUMAN	S1007L	-	-	-	-	TVNTAsMESTG									VARIANT	S -> L (in LCA1)	21602930	1
Q02846/T312M	Q02846	GUCY2D	GUC2D_HUMAN	T312M	-	-	-	-	AVLTLtHCPSE									VARIANT	T -> M (in LCA1; dbSNP:rs61749673)	21602930	1
Q02846/T55M	Q02846	GUCY2D	GUC2D_HUMAN	T55M	-	-	-	-	LSAVFtGVLGP									VARIANT	T -> M (in LCA1; dbSNP:rs201414567)	21602930	1
Q02846/T849A	Q02846	GUCY2D	GUC2D_HUMAN	T849A	-	-	-	-	LEKQKtRLLTQ									VARIANT	T -> A (in CORD6)	23734073	1
Q02846/V507M	Q02846	GUCY2D	GUC2D_HUMAN	V507M	-	-	-	-	KIILTvDITFL									VARIANT	V -> M (in dbSNP:rs746002871)	17344846	1
Q02846/V902L	Q02846	GUCY2D	GUC2D_HUMAN	V902L	-	-	-	increase	EPIEVvLLNDL									VARIANT	V -> L (in LCA1; increases basal and GUCA1A-induced guanylate cyclase activity; inhibition by RD3 is less effective; does not affect endoplasmic reticulum membrane localization; dbSNP:rs1598150793)	30319355	1
Q02846/V933A	Q02846	GUCY2D	GUC2D_HUMAN	V933A	-	-	-	-	GDAYMvSGLPQ									VARIANT	V -> A (in CACD1; unknown pathological significance; dbSNP:rs1567961904)	22695961	1
Q02846/W21R	Q02846	GUCY2D	GUC2D_HUMAN	W21R	-	-	-	neutral	LCGPAwAPSLP									VARIANT	W -> R (in dbSNP:rs9905402)	21602930	1
Q02846/W640L	Q02846	GUCY2D	GUC2D_HUMAN	W640L	302	αD/αE-loop	-	-	EIKLDwFKSSL	0.722	0.671	0.531	0.605	0.563	0.651	0.553	0.669	VARIANT	W -> L (in LCA1)	21602930	1
Q04759/A148E	Q04759	PRKCQ	KPCT_HUMAN	A148E	-	-	-	activating	HQRRGaKQAKV									MUTAGEN	A->E: Constitutively active form.	10652356	1
Q04759/D306V	Q04759	PRKCQ	KPCT_HUMAN	D306V	-	-	-	-	ARCLRdEQIFR									VARIANT	D -> V (in dbSNP:rs45590231)	17344846	1
Q04759/D354N	Q04759	PRKCQ	KPCT_HUMAN	D354N	4	N-term-β1	-	-	PLDEVdMCHLP	0.294	0.314	0.392	0.194	0.328	0.363	0.498	0.141	VARIANT	D -> N (in dbSNP:rs34524148)	17344846	1
Q04759/K240N	Q04759	PRKCQ	KPCT_HUMAN	K240N	-	-	-	-	KVYNYkPTFCE									VARIANT	K -> N (in a colorectal adenocarcinoma sample; somatic mutation)	17344846	1
Q04759/K409A	Q04759	PRKCQ	KPCT_HUMAN	K409A	129	β3;Catalytic-Lys	-	loss	QFFAIkLKKDV	1.0	1.0	0.016	0.645	0.996	0.998	0.005	0.672	MUTAGEN	K->A,E: Loss of kinase activity.	10652356	1
Q04759/K409E	Q04759	PRKCQ	KPCT_HUMAN	K409E	129	β3;Catalytic-Lys	-	loss	QFFAIkLKKDV	1.0	1.0	0.076	0.71	0.991	0.996	0.035	0.44	MUTAGEN	K->A,E: Loss of kinase activity.	10652356	1
Q04759/P330L	Q04759	PRKCQ	KPCT_HUMAN	P330L	-	-	-	neutral	KNEARpCLPTP									VARIANT	P -> L (in dbSNP:rs2236379)	17344846,7686153	2
Q04759/S676A	Q04759	PRKCQ	KPCT_HUMAN	S676A	-	-	p	decrease	EKPRLsADRAL									MUTAGEN	S->A: Reduction in kinase activity.	16252004	1
Q04759/S695A	Q04759	PRKCQ	KPCT_HUMAN	S695A	-	-	p	decrease	MFRNFsMNPGM									MUTAGEN	S->A: Reduction in kinase activity.	11772397,16252004	2
Q04759/T219A	Q04759	PRKCQ	KPCT_HUMAN	T219A	-	-	p	-	INSREtFHKER									MUTAGEN	T->A: Loss of transactivation of the IL2 promoter and translocation to the plasma membrane. No effect on kinase activity.	16252004	1
Q04759/T538A	Q04759	PRKCQ	KPCT_HUMAN	T538A	545	A-loop	p	loss	DAKTNtCGTPD	0.999	1.0	0.157	0.902	0.913	0.987	0.15	0.324	MUTAGEN	T->A: Loss of kinase activity.	11772397,16252004	2
Q04759/Y90F	Q04759	PRKCQ	KPCT_HUMAN	Y90F	-	-	p	-	TTVELyLAERC									MUTAGEN	Y->F: Loss of function in T-cells proliferation. No effect on kinase activity.	10652356	1
Q04771/A15G	Q04771	ACVR1	ACVR1_HUMAN	A15G	-	-	-	neutral	VLIMIaPSPSM									VARIANT	A -> G (in dbSNP:rs13406336)	17344846	1
Q04771/G325A	Q04771	ACVR1	ACVR1_HUMAN	G325A	430	Catalytic-loop	-	-	HIEIFgQGKPA	0.643	0.589	0.441	0.47	0.435	0.497	0.469	0.436	MUTAGEN	G->A: Almost complete loss of alcaline phosphatase induction; in association with V-203.	25354296	1
Q04771/G328E	Q04771	ACVR1	ACVR1_HUMAN	G328E	434	Catalytic-loop	-	-	IFGTQgPAIAH	0.613	0.632	0.563	0.556	0.372	0.536	0.606	0.434	VARIANT	G -> E (in FOP; variant phenotype; dbSNP:rs387906589)	19085907,19330033	2
Q04771/G328R	Q04771	ACVR1	ACVR1_HUMAN	G328R	434	Catalytic-loop	-	-	IFGTQgPAIAH	0.706	0.68	0.491	0.551	0.499	0.6	0.509	0.481	VARIANT	G -> R (in FOP; variant phenotype; dbSNP:rs387906588)	19085907	1
Q04771/G328W	Q04771	ACVR1	ACVR1_HUMAN	G328W	434	Catalytic-loop	-	-	IFGTQgPAIAH	0.789	0.685	0.412	0.568	0.629	0.684	0.362	0.425	VARIANT	G -> W (in FOP; variant phenotype; dbSNP:rs387906588)	19085907	1
Q04771/G356D	Q04771	ACVR1	ACVR1_HUMAN	G356D	498	A-loop;DFG-motif	-	-	CIADLgAVMHS	0.878	0.825	0.548	0.693	0.508	0.659	0.516	0.564	VARIANT	G -> D (in FOP; variant phenotype; dbSNP:rs121912679)	19085907	1
Q04771/H47Q	Q04771	ACVR1	ACVR1_HUMAN	H47Q	-	-	-	-	CGNEDhEGQQC									VARIANT	H -> Q (in dbSNP:rs34056189)	17344846	1
Q04771/P115S	Q04771	ACVR1	ACVR1_HUMAN	P115S	-	-	-	-	KGKSFpTQNFH									VARIANT	P -> S (in a melanoma sample; somatic mutation)	17344846	1
Q04771/Q207D	Q04771	ACVR1	ACVR1_HUMAN	Q207D	27	N-term-β1	-	increase	RTVARqTLLEC	0.607	0.597	0.641	0.622	0.294	0.387	0.682	0.318	MUTAGEN	Q->D: Strong induction of SMAD1 phosphorylation.	9748228	1
Q04771/Q207E	Q04771	ACVR1	ACVR1_HUMAN	Q207E	27	N-term-β1	-	activating	RTVARqTLLEC	0.541	0.525	0.594	0.643	0.208	0.385	0.714	0.316	VARIANT	Q -> E (in FOP; with some atypical features)	19085907	1
Q04771/R202I	Q04771	ACVR1	ACVR1_HUMAN	R202I	22	N-term-β1	-	-	PFLVQrVARQI	0.833	0.816	0.538	0.623	0.545	0.722	0.466	0.587	VARIANT	R -> I (in FOP; with some atypical features; dbSNP:rs387906591)	19330033	1
Q04771/R206H	Q04771	ACVR1	ACVR1_HUMAN	R206H	26	N-term-β1	-	activating	QRTVArITLLE	0.471	0.42	0.38	0.333	0.348	0.388	0.513	0.233	VARIANT	R -> H (in FOP; dbSNP:rs121912678)	16642017,19085907	2
Q04771/R375P	Q04771	ACVR1	ACVR1_HUMAN	R375P	539	A-loop	-	-	VGNNPrGTKRY	0.732	0.666	0.521	0.569	0.505	0.555	0.534	0.4	VARIANT	R -> P (in FOP; variant phenotype; dbSNP:rs387906590)	19085907	1
Q04771/S41F	Q04771	ACVR1	ACVR1_HUMAN	S41F	-	-	-	-	VCEGLsGNEDH									VARIANT	S -> F (in dbSNP:rs55957214)	17344846	1
Q04771/T203V	Q04771	ACVR1	ACVR1_HUMAN	T203V	23	N-term-β1	p	-	FLVQRtARQIT	0.917	0.85	0.421	0.751	0.646	0.859	0.415	0.47	MUTAGEN	T->V: Almost complete loss of alcaline phosphatase induction; in association with A-325.	25354296	1
Q04912/A327T	Q04912	MST1R	RON_HUMAN	A327T	-	-	-	-	RVAHSaVGAQL									VARIANT	A -> T (in NPCA3; unknown pathological significance; dbSNP:rs200757776)	26951679	1
Q04912/A973T	Q04912	MST1R	RON_HUMAN	A973T	-	-	-	-	LVAALaALVFS									VARIANT	A -> T (in NPCA3; unknown pathological significance; dbSNP:rs773053723)	26951679	1
Q04912/G1195S	Q04912	MST1R	RON_HUMAN	G1195S	413	αE	-	-	LQVARgEYLAE	0.823	0.774	0.339	0.564	0.659	0.731	0.292	0.59	VARIANT	G -> S (in dbSNP:rs7433231)		0
Q04912/G356D	Q04912	MST1R	RON_HUMAN	G356D	-	-	-	-	VTGKDgPGVGP									VARIANT	G -> D (in dbSNP:rs35924402)	17344846	1
Q04912/G465D	Q04912	MST1R	RON_HUMAN	G465D	-	-	-	-	TVAHMgMDGRI									VARIANT	G -> D (in dbSNP:rs34564898)	17344846	1
Q04912/N440S	Q04912	MST1R	RON_HUMAN	N440S	-	-	-	neutral	RVDLFnLLGPV									VARIANT	N -> S (in dbSNP:rs2230592)		0
Q04912/P95T	Q04912	MST1R	RON_HUMAN	P95T	-	-	-	-	SLATGpGDPGC									VARIANT	P -> T (in dbSNP:rs55908300)	17344846	1
Q04912/Q523R	Q04912	MST1R	RON_HUMAN	Q523R	-	-	-	neutral	FQVPIqPGCRH									VARIANT	Q -> R (in dbSNP:rs2230590)	17344846,8386824	2
Q04912/Q613P	Q04912	MST1R	RON_HUMAN	Q613P	-	-	-	neutral	QVTVGqPCRPL									VARIANT	Q -> P (in dbSNP:rs35986685)	17344846	1
Q04912/R1304G	Q04912	MST1R	RON_HUMAN	R1304G	752	αG/αH	-	-	FLAQGrLPQPE	0.586	0.571	0.666	0.589	0.353	0.434	0.708	0.285	VARIANT	R -> G (in dbSNP:rs528985327)	17344846	1
Q04912/R1335G	Q04912	MST1R	RON_HUMAN	R1335G	804	αI	-	neutral	VRPTFrLVGEV	0.108	0.124	0.424	0.116	0.115	0.102	0.632	0.074	VARIANT	R -> G (in dbSNP:rs1062633)	17344846	1
Q04912/R185C	Q04912	MST1R	RON_HUMAN	R185C	-	-	-	-	SPLGTrTVVEQ									VARIANT	R -> C (in dbSNP:rs55633379)	17344846	1
Q04912/R306H	Q04912	MST1R	RON_HUMAN	R306H	-	-	-	-	RFAPKrRRGAP									VARIANT	R -> H (in NPCA3; dbSNP:rs200046052)	26951679	1
Q04912/R322Q	Q04912	MST1R	RON_HUMAN	R322Q	-	-	-	neutral	PYPVLrAHSAP									VARIANT	R -> Q (in dbSNP:rs2230593)	17344846,8386824	2
Q04912/R504C	Q04912	MST1R	RON_HUMAN	R504C	-	-	-	-	QRDVSrGDHLL									VARIANT	R -> C (in dbSNP:rs34350470)	17344846	1
Q04912/R75S	Q04912	MST1R	RON_HUMAN	R75S	-	-	-	neutral	VFVAIrRLHVL									VARIANT	R -> S (in dbSNP:rs35887539)	17344846	1
Q04912/S434L	Q04912	MST1R	RON_HUMAN	S434L	-	-	-	neutral	VSSSFsVDLFN									VARIANT	S -> L (in dbSNP:rs2230591)	17344846	1
Q04912/V670G	Q04912	MST1R	RON_HUMAN	V670G	-	-	-	-	GKHFRvGTSVL									VARIANT	V -> G (in NPCA3; unknown pathological significance; dbSNP:rs201024956)	26951679	1
Q04912/V900M	Q04912	MST1R	RON_HUMAN	V900M	-	-	-	-	GINVTvGESCQ									VARIANT	V -> M (in dbSNP:rs56091918)	17344846	1
Q04912/Y1360C	Q04912	MST1R	RON_HUMAN	Y1360C	832	C-term-αI	p	-	QLPATyNLGPS	0.934	0.931	0.457	0.848	0.635	0.885	0.408	0.456	VARIANT	Y -> C (in dbSNP:rs56330223)	17344846	1
Q05397/D1030E	Q05397	PTK2	FAK1_HUMAN	D1030E	-	-	-	-	HALAVdKNLLD									VARIANT	D -> E	17344846	1
Q05397/H292P	Q05397	PTK2	FAK1_HUMAN	H292P	-	-	-	-	GCNPThADFTQ									VARIANT	H -> P	17344846	1
Q05397/H292Q	Q05397	PTK2	FAK1_HUMAN	H292Q	-	-	-	-	GCNPThADFTQ									VARIANT	H -> Q	17344846	1
Q05397/K1044E	Q05397	PTK2	FAK1_HUMAN	K1044E	-	-	-	-	DQARLkLGQTR									VARIANT	K -> E (in a metastatic melanoma sample; somatic mutation)	17344846	1
Q05397/L1034S	Q05397	PTK2	FAK1_HUMAN	L1034S	-	-	-	decrease	VDAKNlDVIDQ									MUTAGEN	L->S: Loss of interaction with TGFB1I1.	9756887	1
Q05397/V793A	Q05397	PTK2	FAK1_HUMAN	V793A	-	-	-	-	VEDSTvDLRGI									VARIANT	V -> A (in a glioblastoma multiforme sample; somatic mutation)	17344846	1
Q05397/V928G	Q05397	PTK2	FAK1_HUMAN	V928G	-	-	-	decrease	KVYENvGLVKA									MUTAGEN	V->G: Loss of interaction with TGFB1I1.	9756887	1
Q05397/Y397F	Q05397	PTK2	FAK1_HUMAN	Y397F	3	N-term-β1	p	decrease	SETDDyEIIDE	0.891	0.873	0.538	0.842	0.509	0.786	0.512	0.459	MUTAGEN	Y->F: Abolishes autophosphorylation. Abolishes interaction with SRC and activation of BMX. Reduces phosphorylation of NEDD9.	11331870,9360983	2
Q05513/D62A	Q05513	PRKCZ	KPCZ_HUMAN	D62A	-	-	-	decrease	TLKWVdEGDPC									MUTAGEN	D->A: Loss of interaction with SQSTM1 and PARD6B.	12887891	1
Q05513/D66A	Q05513	PRKCZ	KPCZ_HUMAN	D66A	-	-	-	decrease	VDSEGdCTVSS									MUTAGEN	D->A: Loss of interaction with SQSTM1 and PARD6B.	12887891	1
Q05513/K19A	Q05513	PRKCZ	KPCZ_HUMAN	K19A	-	-	-	-	GRVRLkHYGGD									MUTAGEN	K->A: No effect on interaction with SQSTM1 and PARD6B.	12887891	1
Q05513/R49H	Q05513	PRKCZ	KPCZ_HUMAN	R49H	-	-	-	neutral	VRDMCrHQQHP									VARIANT	R -> H (in dbSNP:rs35271800)		0
Q05513/R519C	Q05513	PRKCZ	KPCZ_HUMAN	R519C	824	C-term-αI	-	-	SHAFFrIDWDL	0.597	0.566	0.571	0.477	0.414	0.451	0.573	0.375	VARIANT	R -> C (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs376894109)	17344846	1
Q05513/R84H	Q05513	PRKCZ	KPCZ_HUMAN	R84H	-	-	-	-	AFRLArCRDEG									VARIANT	R -> H (in dbSNP:rs56017162)	17344846	1
Q05513/S514F	Q05513	PRKCZ	KPCZ_HUMAN	S514F	819	αI	-	-	FSDIKsAFFRS	0.636	0.568	0.601	0.504	0.425	0.433	0.605	0.464	VARIANT	S -> F (in a colorectal cancer sample; somatic mutation)	16959974	1
Q05655/F375S	Q05655	PRKCD	KPCD_HUMAN	F375S	81	β2/β3-loop	-	-	GRGEYfIKALK	0.877	0.829	0.479	0.672	0.565	0.71	0.433	0.572	VARIANT	F -> S (in dbSNP:rs1056998)	8357834	1
Q05655/L410F	Q05655	PRKCD	KPCD_HUMAN	L410F	200	β4	-	-	AENPFlHLICT	0.614	0.595	0.488	0.487	0.361	0.412	0.548	0.32	VARIANT	L -> F (in dbSNP:rs34502209)		0
Q05655/M494V	Q05655	PRKCD	KPCD_HUMAN	M494V	499	A-loop	-	-	IADFGmKENIF	0.667	0.68	0.533	0.631	0.419	0.57	0.616	0.36	VARIANT	M -> V	7988719	1
Q05655/N348S	Q05655	PRKCD	KPCD_HUMAN	N348S	30	β1	-	-	KCNINnIFHKV	0.194	0.23	0.509	0.258	0.162	0.181	0.687	0.185	VARIANT	N -> S (in dbSNP:rs33911937)		0
Q05655/R483W	Q05655	PRKCD	KPCD_HUMAN	R483W	456	Catalytic-loop	-	-	NVLLDrGHIKI	0.485	0.459	0.526	0.438	0.311	0.319	0.605	0.294	VARIANT	R -> W (in dbSNP:rs35891605)		0
Q05655/S299A	Q05655	PRKCD	KPCD_HUMAN	S299A	-	-	p	loss	VTQRAsRSDSA									MUTAGEN	S->A: Loss of phosphorylation.	17603046	1
Q05655/T507A	Q05655	PRKCD	KPCD_HUMAN	T507A	545	A-loop	p	-	ESRAStCGTPD	0.999	0.994	0.2	0.908	0.914	0.987	0.14	0.477	MUTAGEN	T->A: No effect on kinase activity.	11772397	1
Q05655/V593M	Q05655	PRKCD	KPCD_HUMAN	V593M	813	αI	-	-	TKRLGvGNIKI	0.175	0.203	0.401	0.155	0.133	0.185	0.625	0.112	VARIANT	V -> M	8357834	1
Q05823/A289T	Q05823	RNASEL	RN5A_HUMAN	A289T	-	-	-	-	KLKKIaLLCKR									VARIANT	A -> T (in dbSNP:rs35553278)	17344846	1
Q05823/D541E	Q05823	RNASEL	RN5A_HUMAN	D541E	850	C-term-αI	-	neutral	SISFEdKAQSN	0.254	0.222	0.582	0.286	0.177	0.158	0.753	0.261	VARIANT	D -> E (no change in enzymatic activity; dbSNP:rs627928)	11799394,11941539,12415269,17344846	4
Q05823/D661A	Q05823	RNASEL	RN5A_HUMAN	D661A	-	-	-	loss	QNTVGdLKFIR									MUTAGEN	D->A: Complete loss of enzymatic activity.	11333017	1
Q05823/G59S	Q05823	RNASEL	RN5A_HUMAN	G59S	-	-	-	neutral	QEEEGgTPLHN									VARIANT	G -> S (in dbSNP:rs151296858)	11799394,11941539	2
Q05823/H583A	Q05823	RNASEL	RN5A_HUMAN	H583A	-	-	-	-	SDLLGhFFWTW									MUTAGEN	H->A: No change in enzymatic activity.	11333017	1
Q05823/H672A	Q05823	RNASEL	RN5A_HUMAN	H672A	-	-	-	loss	RNLGEhDEEKH									MUTAGEN	H->A: Complete loss of enzymatic activity. No change in 2-5A binding activity and enzyme dimerization.	11333017	1
Q05823/I97L	Q05823	RNASEL	RN5A_HUMAN	I97L	-	-	-	neutral	GATPFiAAIAG									VARIANT	I -> L (in dbSNP:rs56250729)	17344846	1
Q05823/K240N	Q05823	RNASEL	RN5A_HUMAN	K240N	-	-	-	-	RGERGkPLILA									MUTAGEN	K->N: Reduced 2-5A binding activity; almost complete loss of 2-5A binding activity; when associated with N-274.	7680958	1
Q05823/K274N	Q05823	RNASEL	RN5A_HUMAN	K274N	-	-	-	-	TDSDGkALLLA									MUTAGEN	K->N: Reduced 2-5A binding activity; almost complete loss of 2-5A binding activity; when associated with N-240.	7680958	1
Q05823/K392R	Q05823	RNASEL	RN5A_HUMAN	K392R	129	β3;Catalytic-Lys	-	loss	QEVAVkFCEGS	0.999	0.997	0.028	0.762	0.993	0.999	0.016	0.448	MUTAGEN	K->R: Complete loss of enzymatic activity and enzyme dimerization. No change in binding to 2-5A and RNA.	9862963	1
Q05823/P584A	Q05823	RNASEL	RN5A_HUMAN	P584A	-	-	-	-	DLLGHpFWTWE									MUTAGEN	P->A: No change in enzymatic activity.	11333017	1
Q05823/R462Q	Q05823	RNASEL	RN5A_HUMAN	R462Q	401	αE	-	decrease,neutral	EDEFArVLSSI	0.166	0.097	0.48	0.137	0.162	0.148	0.66	0.112	VARIANT	R -> Q (risk factor for prostate cancer; reduced enzymatic activity; dbSNP:rs486907)	11799394,11941539,12415269,17344846	4
Q05823/R592H	Q05823	RNASEL	RN5A_HUMAN	R592H	-	-	-	-	WTWESrRTLRN									VARIANT	R -> H (in dbSNP:rs35896902)	17344846	1
Q05823/R667A	Q05823	RNASEL	RN5A_HUMAN	R667A	-	-	-	loss	LLKFIrLGEHI									MUTAGEN	R->A: Complete loss of enzymatic activity. No change in 2-5A binding and enzyme dimerization.	11333017	1
Q05823/S406F	Q05823	RNASEL	RN5A_HUMAN	S406F	175	αC	-	-	AQREVsLQSSR	0.633	0.617	0.484	0.451	0.463	0.609	0.457	0.44	VARIANT	S -> F (in dbSNP:rs145787003)	11941539	1
Q05823/W632A	Q05823	RNASEL	RN5A_HUMAN	W632A	-	-	-	-	KSFDKwTKINE									MUTAGEN	W->A: No change in enzymatic activity.	11333017	1
Q06187/A508D	Q06187	BTK	BTK_HUMAN	A508D	413	αE	-	-	KDVCEaEYLES	0.852	0.802	0.557	0.729	0.53	0.693	0.571	0.369	VARIANT	A -> D (in XLA)		0
Q06187/A523E	Q06187	BTK	BTK_HUMAN	A523E	445	Catalytic-loop	-	-	LHRDLaRNCLV	0.879	0.81	0.544	0.749	0.631	0.718	0.449	0.58	VARIANT	A -> E (in XLA)		0
Q06187/A582V	Q06187	BTK	BTK_HUMAN	A582V	603	αF	-	-	KSDIWaGVLMW	0.792	0.761	0.425	0.529	0.713	0.66	0.372	0.62	VARIANT	A -> V (in XLA)	7711734,7809124	2
Q06187/A607D	Q06187	BTK	BTK_HUMAN	A607D	646	αG	-	-	TNSETaHIAQG	0.694	0.694	0.54	0.528	0.474	0.607	0.532	0.498	VARIANT	A -> D (in XLA; mild; dbSNP:rs128621208)	8162056	1
Q06187/A622P	Q06187	BTK	BTK_HUMAN	A622P	761	αG/αH	-	-	YRPHLaEKVYT	0.673	0.63	0.421	0.514	0.459	0.612	0.512	0.548	VARIANT	A -> P (in XLA)	9545398	1
Q06187/C154S	Q06187	BTK	BTK_HUMAN	C154S	-	-	-	-	DGQYLcSQTAK									VARIANT	C -> S (in XLA)	9280283	1
Q06187/C155G	Q06187	BTK	BTK_HUMAN	C155G	-	-	-	-	GQYLCcQTAKN									VARIANT	C -> G (in XLA)		0
Q06187/C155R	Q06187	BTK	BTK_HUMAN	C155R	-	-	-	-	GQYLCcQTAKN									VARIANT	C -> R (in XLA)	9280283,9445504	2
Q06187/C481S	Q06187	BTK	BTK_HUMAN	C481S	255	β5/αD-loop	-	resistance	YMANGcLNYLR	0.473	0.263	0.556	0.22	0.174	0.235	0.639	0.759	VARIANT	C -> S (found in patients with chronic lymphocytic leukemia; unknown pathological significance; results in resistance to ibrutinib therapy; results in a protein that is reversibly inhibited by ibrutinib; disrupts the covalent binding between the enzyme and ibrutinib; dbSNP:rs1057519825 and dbSNP:rs1057519826)	24869597,24869598,25189416	3
Q06187/C502F	Q06187	BTK	BTK_HUMAN	C502F	407	αE	-	-	QLLEMcDVCEA	0.549	0.462	0.575	0.573	0.393	0.449	0.709	0.372	VARIANT	C -> F (in XLA)		0
Q06187/C502W	Q06187	BTK	BTK_HUMAN	C502W	407	αE	-	-	QLLEMcDVCEA	0.764	0.708	0.412	0.639	0.623	0.619	0.425	0.48	VARIANT	C -> W (in XLA; dbSNP:rs41310709)	8695804	1
Q06187/C506R	Q06187	BTK	BTK_HUMAN	C506R	411	αE	-	-	MCKDVcAMEYL	0.855	0.788	0.366	0.568	0.688	0.704	0.326	0.661	VARIANT	C -> R (in XLA; dbSNP:rs128621200)	7880320	1
Q06187/C506Y	Q06187	BTK	BTK_HUMAN	C506Y	411	αE	-	-	MCKDVcAMEYL	0.846	0.784	0.508	0.672	0.548	0.699	0.432	0.587	VARIANT	C -> Y (in XLA)	9445504	1
Q06187/C633Y	Q06187	BTK	BTK_HUMAN	C633Y	792	αH	-	-	TIMYScHEKAD	0.812	0.809	0.295	0.514	0.715	0.764	0.237	0.614	VARIANT	C -> Y (in XLA)	8695804	1
Q06187/D308E	Q06187	BTK	BTK_HUMAN	D308E	-	-	-	-	GFIVRdSKAGK									VARIANT	D -> E (in XLA)		0
Q06187/D521G	Q06187	BTK	BTK_HUMAN	D521G	443	Catalytic-loop;HrD-motif	-	-	QFLHRdAARNC	0.964	0.962	0.184	0.644	0.893	0.941	0.153	0.509	VARIANT	D -> G (in XLA)	9445504	1
Q06187/D521H	Q06187	BTK	BTK_HUMAN	D521H	443	Catalytic-loop;HrD-motif	-	-	QFLHRdAARNC	1.0	0.996	0.164	0.702	0.911	0.95	0.13	0.692	VARIANT	D -> H (in XLA; severe)	8695804	1
Q06187/D521N	Q06187	BTK	BTK_HUMAN	D521N	443	Catalytic-loop;HrD-motif	-	-	QFLHRdAARNC	0.941	0.937	0.221	0.591	0.832	0.885	0.2	0.616	VARIANT	D -> N (in XLA; severe)		0
Q06187/E41K	Q06187	BTK	BTK_HUMAN	E41K	-	-	-	activating	KLSYYeDFERG									MUTAGEN	E->K: No effect on phosphorylation of GTF2I.	9012831	1
Q06187/E445D	Q06187	BTK	BTK_HUMAN	E445D	173	αC	-	-	DEFIEeKVMMN	0.85	0.872	0.544	0.673	0.605	0.681	0.523	0.399	VARIANT	E -> D (in XLA)	9545398	1
Q06187/E567K	Q06187	BTK	BTK_HUMAN	E567K	557	A-loop;APE-motif	-	-	RWSPPeLMYSK	0.932	0.917	0.288	0.669	0.857	0.885	0.244	0.555	VARIANT	E -> K (in XLA; severe)	7633420	1
Q06187/E589D	Q06187	BTK	BTK_HUMAN	E589D	610	αF	-	-	GVLMWeYSLGK	0.732	0.797	0.513	0.652	0.585	0.621	0.546	0.44	VARIANT	E -> D (in XLA)		0
Q06187/E589G	Q06187	BTK	BTK_HUMAN	E589G	610	αF	-	decrease	GVLMWeYSLGK	0.894	0.917	0.362	0.633	0.732	0.788	0.39	0.467	VARIANT	E -> G (in XLA; moderate; interferes with substrate binding; dbSNP:rs128621206)	7809124,7849721	2
Q06187/E589K	Q06187	BTK	BTK_HUMAN	E589K	610	αF	-	-	GVLMWeYSLGK	0.798	0.796	0.453	0.686	0.592	0.655	0.469	0.476	VARIANT	E -> K (in XLA)	10612838	1
Q06187/F25S	Q06187	BTK	BTK_HUMAN	F25S	-	-	-	-	TSPLNfKRLFL									VARIANT	F -> S (in XLA)	7711734	1
Q06187/F559S	Q06187	BTK	BTK_HUMAN	F559S	549	A-loop	-	-	SVGSKfVRWSP	0.868	0.838	0.456	0.629	0.669	0.814	0.367	0.655	VARIANT	F -> S (in XLA)	9445504	1
Q06187/F583S	Q06187	BTK	BTK_HUMAN	F583S	604	αF	-	-	SDIWAfVLMWE	0.834	0.81	0.384	0.636	0.698	0.763	0.299	0.463	VARIANT	F -> S (in XLA)		0
Q06187/F644L	Q06187	BTK	BTK_HUMAN	F644L	803	αI	-	-	DERPTfILLSN	0.797	0.762	0.453	0.667	0.558	0.638	0.518	0.578	VARIANT	F -> L (in XLA)		0
Q06187/F644S	Q06187	BTK	BTK_HUMAN	F644S	803	αI	-	-	DERPTfILLSN	0.884	0.861	0.339	0.626	0.764	0.792	0.25	0.593	VARIANT	F -> S (in XLA)	8695804	1
Q06187/G302E	Q06187	BTK	BTK_HUMAN	G302E	-	-	-	-	QEGKEgFIVRD									VARIANT	G -> E (in XLA)	7627183,8695804	2
Q06187/G302R	Q06187	BTK	BTK_HUMAN	G302R	-	-	-	-	QEGKEgFIVRD									VARIANT	G -> R (in XLA)		0
Q06187/G414R	Q06187	BTK	BTK_HUMAN	G414R	45	Gly-rich-loop;β2	-	-	GTGQFgVKYGK	0.887	0.915	0.295	0.683	0.813	0.878	0.275	0.544	VARIANT	G -> R (in XLA)	9445504	1
Q06187/G462D	Q06187	BTK	BTK_HUMAN	G462D	222	β4/β5-loop	-	-	LVQLYgCTKQR	0.766	0.702	0.586	0.599	0.639	0.659	0.63	0.432	VARIANT	G -> D (in XLA)		0
Q06187/G462V	Q06187	BTK	BTK_HUMAN	G462V	222	β4/β5-loop	-	-	LVQLYgCTKQR	0.867	0.836	0.284	0.521	0.75	0.854	0.235	0.728	VARIANT	G -> V (in XLA)		0
Q06187/G594E	Q06187	BTK	BTK_HUMAN	G594E	620	αF	-	decrease	EIYSLgMPYER	0.86	0.867	0.52	0.684	0.739	0.744	0.443	0.622	VARIANT	G -> E (in XLA; mild; interferes with substrate binding)	7809124,9445504	2
Q06187/G594R	Q06187	BTK	BTK_HUMAN	G594R	620	αF	-	-	EIYSLgMPYER	0.664	0.727	0.474	0.556	0.559	0.629	0.46	0.504	VARIANT	G -> R (in XLA; dbSNP:rs1555977339)	7711734	1
Q06187/G613D	Q06187	BTK	BTK_HUMAN	G613D	652	αG	-	decrease	EHIAQgRLYRP	0.658	0.666	0.575	0.539	0.435	0.492	0.62	0.387	VARIANT	G -> D (in XLA; mild; interferes with substrate binding and/or domain interactions; dbSNP:rs128621209)	7809124,7849721	2
Q06187/H362Q	Q06187	BTK	BTK_HUMAN	H362Q	-	-	-	-	ELINYhHNSAG									VARIANT	H -> Q (in XLA)		0
Q06187/H364P	Q06187	BTK	BTK_HUMAN	H364P	-	-	-	-	INYHQhSAGLI									VARIANT	H -> P (in XLA)		0
Q06187/I370M	Q06187	BTK	BTK_HUMAN	I370M	-	-	-	-	NSAGLiRLKYP									VARIANT	I -> M (in XLA)	7711734	1
Q06187/I429N	Q06187	BTK	BTK_HUMAN	I429N	128	β3	-	-	QYDVAiMIKEG	0.832	0.833	0.374	0.642	0.701	0.74	0.322	0.434	VARIANT	I -> N (in XLA)	8634718	1
Q06187/I61N	Q06187	BTK	BTK_HUMAN	I61N	-	-	-	-	IDVEKiCVETV									VARIANT	I -> N (in XLA)	9445504	1
Q06187/K12R	Q06187	BTK	BTK_HUMAN	K12R	-	-	-	-	ESIFLkSQQKK									VARIANT	K -> R (in XLA)	8695804	1
Q06187/K19E	Q06187	BTK	BTK_HUMAN	K19E	-	-	-	-	SQQKKkSPLNF									VARIANT	K -> E (in XLA)	9445504	1
Q06187/K27R	Q06187	BTK	BTK_HUMAN	K27R	-	-	-	-	PLNFKkLFLLT									VARIANT	K -> R (in XLA)		0
Q06187/K430E	Q06187	BTK	BTK_HUMAN	K430E	129	β3;Catalytic-Lys	-	loss	YDVAIkIKEGS	0.986	0.993	0.073	0.677	0.996	0.996	0.055	0.555	VARIANT	K -> E (in XLA; loss of phosphorylation of GTF2I; dbSNP:rs128620184)	7809124	1
Q06187/K430R	Q06187	BTK	BTK_HUMAN	K430R	129	β3;Catalytic-Lys	-	-	YDVAIkIKEGS	0.993	0.984	0.046	0.719	0.99	0.996	0.029	0.547	VARIANT	K -> R (in XLA)	9545398	1
Q06187/L11P	Q06187	BTK	BTK_HUMAN	L11P	-	-	-	-	LESIFlRSQQK									VARIANT	L -> P (in XLA; dbSNP:rs1603020228)		0
Q06187/L295P	Q06187	BTK	BTK_HUMAN	L295P	-	-	-	-	QAEQLlQEGKE									VARIANT	L -> P (in XLA)	8723128,9445504	2
Q06187/L358F	Q06187	BTK	BTK_HUMAN	L358F	-	-	-	-	STIPElNYHQH									VARIANT	L -> F (in XLA)	7897635	1
Q06187/L369F	Q06187	BTK	BTK_HUMAN	L369F	-	-	-	-	HNSAGlSRLKY									VARIANT	L -> F (in XLA)	9445504	1
Q06187/L408P	Q06187	BTK	BTK_HUMAN	L408P	39	β1	-	-	TFLKElTGQFG	0.883	0.759	0.296	0.601	0.644	0.719	0.338	0.719	VARIANT	L -> P (in XLA; moderate; dbSNP:rs128621198)	7849721	1
Q06187/L512P	Q06187	BTK	BTK_HUMAN	L512P	423	αE	-	-	EAMEYlSKQFL	0.897	0.88	0.314	0.655	0.786	0.843	0.302	0.692	VARIANT	L -> P (in XLA)	10612838	1
Q06187/L512Q	Q06187	BTK	BTK_HUMAN	L512Q	423	αE	-	-	EAMEYlSKQFL	0.918	0.893	0.286	0.628	0.774	0.849	0.203	0.849	VARIANT	L -> Q (in XLA)	10612838	1
Q06187/L518R	Q06187	BTK	BTK_HUMAN	L518R	440	Catalytic-loop	-	-	ESKQFlRDLAA	0.85	0.774	0.374	0.643	0.631	0.749	0.346	0.747	VARIANT	L -> R (in XLA)		0
Q06187/L542P	Q06187	BTK	BTK_HUMAN	L542P	499	A-loop	-	-	VSDFGlRYVLD	0.837	0.862	0.394	0.682	0.664	0.8	0.366	0.515	VARIANT	L -> P (in XLA; growth hormone deficiency; dbSNP:rs128621203)	7849697	1
Q06187/L647P	Q06187	BTK	BTK_HUMAN	L647P	806	αI	-	-	PTFKIlSNILD	0.9	0.87	0.505	0.689	0.577	0.772	0.49	0.605	VARIANT	L -> P (in XLA)		0
Q06187/L652P	Q06187	BTK	BTK_HUMAN	L652P	813	αI	-	-	LLSNIlVMDEE	0.238	0.252	0.526	0.307	0.222	0.188	0.654	0.228	VARIANT	L -> P (in XLA; dbSNP:rs128622212)	7849697	1
Q06187/M477R	Q06187	BTK	BTK_HUMAN	M477R	251	β5/αD-loop	-	-	IITEYmNGCLL	0.905	0.868	0.385	0.633	0.658	0.792	0.331	0.724	VARIANT	M -> R (in XLA)	8634718	1
Q06187/M509I	Q06187	BTK	BTK_HUMAN	M509I	414	αE	-	-	DVCEAmYLESK	0.806	0.663	0.559	0.698	0.405	0.556	0.603	0.507	VARIANT	M -> I (in XLA)		0
Q06187/M509V	Q06187	BTK	BTK_HUMAN	M509V	414	αE	-	-	DVCEAmYLESK	0.77	0.7	0.56	0.69	0.448	0.508	0.593	0.453	VARIANT	M -> V (in XLA)	7711734	1
Q06187/M587L	Q06187	BTK	BTK_HUMAN	M587L	608	αF	-	-	AFGVLmEIYSL	0.215	0.187	0.558	0.348	0.107	0.134	0.722	0.161	VARIANT	M -> L (in XLA; mild; dbSNP:rs1603001822)	7633420	1
Q06187/M630I	Q06187	BTK	BTK_HUMAN	M630I	789	αH	-	-	KVYTImSCWHE	0.508	0.473	0.626	0.425	0.264	0.337	0.734	0.27	VARIANT	M -> I		0
Q06187/M630K	Q06187	BTK	BTK_HUMAN	M630K	789	αH	-	-	KVYTImSCWHE	0.912	0.864	0.293	0.67	0.763	0.809	0.239	0.737	VARIANT	M -> K (in XLA; dbSNP:rs128621210)	7849697,7880320	2
Q06187/M630T	Q06187	BTK	BTK_HUMAN	M630T	789	αH	-	-	KVYTImSCWHE	0.926	0.878	0.394	0.703	0.74	0.814	0.38	0.726	VARIANT	M -> T (in XLA)		0
Q06187/N365Y	Q06187	BTK	BTK_HUMAN	N365Y	-	-	-	-	NYHQHnAGLIS									VARIANT	N -> Y (in XLA)		0
Q06187/N526K	Q06187	BTK	BTK_HUMAN	N526K	448	Catalytic-loop	-	-	DLAARnLVNDQ	0.941	0.936	0.234	0.679	0.875	0.888	0.224	0.523	VARIANT	N -> K (in XLA; dbSNP:rs1569291237)	7711734	1
Q06187/P189A	Q06187	BTK	BTK_HUMAN	P189A	-	-	-	-	TKKPLpTPEED									MUTAGEN	P->A: No effect on phosphorylation of GTF2I.	9012831	1
Q06187/P190K	Q06187	BTK	BTK_HUMAN	P190K	-	-	-	-	KKPLPpPEEDQ									VARIANT	P -> K (in a lung large cell carcinoma sample; somatic mutation; requires 2 nucleotide substitutions)	17344846	1
Q06187/P619A	Q06187	BTK	BTK_HUMAN	P619A	757	αG/αH	-	-	LRLYRpLASEK	0.705	0.691	0.45	0.519	0.559	0.672	0.362	0.409	VARIANT	P -> A (in XLA)		0
Q06187/P619S	Q06187	BTK	BTK_HUMAN	P619S	757	αG/αH	-	-	LRLYRpLASEK	0.814	0.732	0.463	0.507	0.589	0.668	0.448	0.474	VARIANT	P -> S (in XLA)		0
Q06187/P619T	Q06187	BTK	BTK_HUMAN	P619T	757	αG/αH	-	-	LRLYRpLASEK	0.715	0.689	0.513	0.532	0.517	0.634	0.514	0.416	VARIANT	P -> T (in XLA)	9445504	1
Q06187/Q127H	Q06187	BTK	BTK_HUMAN	Q127H	-	-	-	-	KRWIHqKNVIR									VARIANT	Q -> H (in XLA)	9445504	1
Q06187/R288Q	Q06187	BTK	BTK_HUMAN	R288Q	-	-	-	-	SKHMTrQAEQL									VARIANT	R -> Q (in XLA; dbSNP:rs1555978277)	9545398	1
Q06187/R288W	Q06187	BTK	BTK_HUMAN	R288W	-	-	-	-	SKHMTrQAEQL									VARIANT	R -> W (in XLA; dbSNP:rs128621194)	7711734,8162018,8162056,8834236	4
Q06187/R28C	Q06187	BTK	BTK_HUMAN	R28C	-	-	-	-	LNFKKrFLLTV									VARIANT	R -> C (in XLA; no effect on phosphorylation of GTF2I)		0
Q06187/R28H	Q06187	BTK	BTK_HUMAN	R28H	-	-	-	-	LNFKKrFLLTV									VARIANT	R -> H (in XLA; moderate; dbSNP:rs128620185)	7849721,8162018,9445504	3
Q06187/R28P	Q06187	BTK	BTK_HUMAN	R28P	-	-	-	-	LNFKKrFLLTV									VARIANT	R -> P (in XLA)	8695804	1
Q06187/R307G	Q06187	BTK	BTK_HUMAN	R307G	-	-	-	loss	GGFIVrSSKAG									VARIANT	R -> G (in XLA; loss of activity; dbSNP:rs128621195)	8162056	1
Q06187/R307K	Q06187	BTK	BTK_HUMAN	R307K	-	-	-	loss	GGFIVrSSKAG									MUTAGEN	R->K: Loss of phosphorylation of GTF2I.	9012831	1
Q06187/R307T	Q06187	BTK	BTK_HUMAN	R307T	-	-	-	-	GGFIVrSSKAG									VARIANT	R -> T (in XLA)	9545398	1
Q06187/R372G	Q06187	BTK	BTK_HUMAN	R372G	-	-	-	-	AGLISrKYPVS									VARIANT	R -> G (in XLA)	9445504	1
Q06187/R520Q	Q06187	BTK	BTK_HUMAN	R520Q	442	Catalytic-loop;HrD-motif	-	loss	KQFLHrLAARN	0.884	0.911	0.435	0.786	0.678	0.779	0.384	0.495	VARIANT	R -> Q (in XLA; severe; prevents activation due to absence of contact between the catalytic loop and the regulatory phosphorylated residue; dbSNP:rs128621202)	7633429,7809124,7849697,7880320	4
Q06187/R525G	Q06187	BTK	BTK_HUMAN	R525G	447	Catalytic-loop	-	-	RDLAArCLVND	0.822	0.775	0.446	0.636	0.655	0.792	0.384	0.405	VARIANT	R -> G (in XLA; dbSNP:rs886041149)	9545398	1
Q06187/R525P	Q06187	BTK	BTK_HUMAN	R525P	447	Catalytic-loop	-	-	RDLAArCLVND	0.764	0.699	0.446	0.559	0.58	0.701	0.43	0.35	VARIANT	R -> P (in XLA)	7711734	1
Q06187/R525Q	Q06187	BTK	BTK_HUMAN	R525Q	447	Catalytic-loop	-	decrease	RDLAArCLVND	0.801	0.718	0.428	0.557	0.62	0.7	0.445	0.289	VARIANT	R -> Q (in XLA; severe; disturbs ATP-binding; dbSNP:rs128620183)	7809124,9445504	2
Q06187/R544G	Q06187	BTK	BTK_HUMAN	R544G	501	A-loop	-	-	DFGLSrVLDDE	0.855	0.786	0.584	0.818	0.544	0.765	0.562	0.498	VARIANT	R -> G (in XLA)	10612838	1
Q06187/R544K	Q06187	BTK	BTK_HUMAN	R544K	501	A-loop	-	-	DFGLSrVLDDE	0.711	0.699	0.576	0.587	0.394	0.571	0.612	0.29	VARIANT	R -> K (in XLA)	8834236	1
Q06187/R562P	Q06187	BTK	BTK_HUMAN	R562P	552	A-loop	-	-	SKFPVrSPPEV	0.721	0.702	0.564	0.625	0.411	0.541	0.59	0.493	VARIANT	R -> P (in XLA; dbSNP:rs104894770)	10678660,7809124	2
Q06187/R562W	Q06187	BTK	BTK_HUMAN	R562W	552	A-loop	-	-	SKFPVrSPPEV	0.699	0.668	0.558	0.674	0.539	0.534	0.522	0.379	VARIANT	R -> W (in XLA; dbSNP:rs128621204)	7711734,7849697,7880320,9445504	4
Q06187/R641C	Q06187	BTK	BTK_HUMAN	R641C	800	αI	-	-	EKADErTFKIL	0.877	0.836	0.406	0.664	0.712	0.768	0.399	0.428	VARIANT	R -> C (in XLA)	7633429	1
Q06187/R641H	Q06187	BTK	BTK_HUMAN	R641H	800	αI	-	-	EKADErTFKIL	0.827	0.815	0.363	0.622	0.656	0.682	0.334	0.439	VARIANT	R -> H (in XLA; severe)	7633420,9445504	2
Q06187/R82K	Q06187	BTK	BTK_HUMAN	R82K	-	-	-	-	RQIPRrEESSE									VARIANT	R -> K (in dbSNP:rs56035945)	17344846	1
Q06187/S115F	Q06187	BTK	BTK_HUMAN	S115F	-	-	-	-	PLYVFsTEELR									VARIANT	S -> F (in XLA)		0
Q06187/S14F	Q06187	BTK	BTK_HUMAN	S14F	-	-	-	-	IFLKRsQKKKT									VARIANT	S -> F (in XLA; dbSNP:rs1057520682)		0
Q06187/S366F	Q06187	BTK	BTK_HUMAN	S366F	-	-	-	-	YHQHNsGLISR									VARIANT	S -> F (in XLA)		0
Q06187/S578Y	Q06187	BTK	BTK_HUMAN	S578Y	599	αF	-	-	KFSSKsIWAFG	0.788	0.757	0.533	0.638	0.5	0.608	0.548	0.508	VARIANT	S -> Y (in XLA)	10612838	1
Q06187/S592P	Q06187	BTK	BTK_HUMAN	S592P	617	αF	-	-	MWEIYsGKMPY	0.75	0.769	0.641	0.659	0.44	0.67	0.684	0.485	VARIANT	S -> P (in XLA; dbSNP:rs1603001783)	8834236	1
Q06187/T117P	Q06187	BTK	BTK_HUMAN	T117P	-	-	-	-	YVFSPtELRKR									VARIANT	T -> P (in XLA)	9445504	1
Q06187/T184P	Q06187	BTK	BTK_HUMAN	T184P	-	-	-	-	SSHRKtKPLPP									VARIANT	T -> P (in XLA)		0
Q06187/T33P	Q06187	BTK	BTK_HUMAN	T33P	-	-	-	-	RLFLLtHKLSY									VARIANT	T -> P (in XLA; severe; dbSNP:rs128620189)	7633429,7849721	2
Q06187/V113D	Q06187	BTK	BTK_HUMAN	V113D	-	-	-	-	EGPLYvSPTEE									VARIANT	V -> D (in XLA; dbSNP:rs128621190)	7849697	1
Q06187/V319A	Q06187	BTK	BTK_HUMAN	V319A	-	-	-	-	KYTVSvAKSTG									VARIANT	V -> A (in XLA; moderate)		0
Q06187/V535F	Q06187	BTK	BTK_HUMAN	V535F	492	Catalytic-loop	-	-	NDQGVvVSDFG	0.661	0.647	0.625	0.6	0.45	0.515	0.647	0.411	VARIANT	V -> F (in XLA)	9545398	1
Q06187/V626G	Q06187	BTK	BTK_HUMAN	V626G	784	αH	-	-	LASEKvTIMYS	0.872	0.83	0.493	0.676	0.553	0.695	0.529	0.539	VARIANT	V -> G (in XLA)	9445504	1
Q06187/V64D	Q06187	BTK	BTK_HUMAN	V64D	-	-	-	-	EKITCvTVVPE									VARIANT	V -> D (in XLA)		0
Q06187/V64F	Q06187	BTK	BTK_HUMAN	V64F	-	-	-	-	EKITCvTVVPE									VARIANT	V -> F (in XLA)	7849006	1
Q06187/W251L	Q06187	BTK	BTK_HUMAN	W251L	-	-	-	-	ESNLPwRARDK									MUTAGEN	W->L: No effect on phosphorylation of GTF2I.	9012831	1
Q06187/W563L	Q06187	BTK	BTK_HUMAN	W563L	553	A-loop	-	-	KFPVRwPPEVL	0.901	0.927	0.276	0.62	0.819	0.824	0.21	0.611	VARIANT	W -> L (in XLA; dbSNP:rs1555977474)	9545398	1
Q06187/W581R	Q06187	BTK	BTK_HUMAN	W581R	602	αF	-	-	SKSDIwFGVLM	0.902	0.858	0.31	0.686	0.749	0.802	0.262	0.575	VARIANT	W -> R (in XLA; dbSNP:rs128621205)		0
Q06187/Y223F	Q06187	BTK	BTK_HUMAN	Y223F	-	-	p	loss	KVVALyYMPMN									MUTAGEN	Y->F: Loss of phosphorylation of GTF2I.	8630736,9012831	2
Q06187/Y334S	Q06187	BTK	BTK_HUMAN	Y334S	-	-	-	-	GVIRHyVCSTP									VARIANT	Y -> S (in XLA; dbSNP:rs128621196)	7880320	1
Q06187/Y361C	Q06187	BTK	BTK_HUMAN	Y361C	-	-	p	-	PELINyQHNSA									VARIANT	Y -> C (in XLA; mild; dbSNP:rs28935478)	7849697	1
Q06187/Y39S	Q06187	BTK	BTK_HUMAN	Y39S	-	-	-	-	VHKLSyEYDFE									VARIANT	Y -> S (in XLA)	10612838	1
Q06187/Y40C	Q06187	BTK	BTK_HUMAN	Y40C	-	-	-	-	HKLSYyYDFER									VARIANT	Y -> C (in XLA; dbSNP:rs1555980875)		0
Q06187/Y40N	Q06187	BTK	BTK_HUMAN	Y40N	-	-	-	-	HKLSYyYDFER									VARIANT	Y -> N (in XLA)		0
Q06187/Y418H	Q06187	BTK	BTK_HUMAN	Y418H	54	β2	-	-	FGVVKyKWRGQ	0.399	0.328	0.529	0.336	0.245	0.31	0.681	0.249	VARIANT	Y -> H (in XLA; dbSNP:rs144079566)		0
Q06187/Y476D	Q06187	BTK	BTK_HUMAN	Y476D	250	β5/αD-loop	-	-	FIITEyANGCL	0.856	0.825	0.481	0.677	0.648	0.769	0.413	0.804	VARIANT	Y -> D (in XLA)	7627183	1
Q06187/Y551F	Q06187	BTK	BTK_HUMAN	Y551F	533	A-loop	p	loss	VLDDEySSVGS	0.96	0.981	0.484	0.872	0.786	0.94	0.393	0.394	MUTAGEN	Y->F: Loss of phosphorylation of GTF2I.	9012831	1
Q06187/Y598C	Q06187	BTK	BTK_HUMAN	Y598C	634	αF/αG	-	-	LGKMPyRFTNS	0.878	0.901	0.439	0.638	0.768	0.719	0.327	0.453	VARIANT	Y -> C (in XLA)		0
Q06187/Y617E	Q06187	BTK	BTK_HUMAN	Y617E	755	αG/αH	-	decrease	QGLRLyPHLAS	0.516	0.432	0.515	0.342	0.375	0.397	0.59	0.305	MUTAGEN	Y->E: Defective in mediating calcium response.	15375214	1
Q06418/A815V	Q06418	TYRO3	TYRO3_HUMAN	A815V	-	-	-	-	AEEPTaGSLEL									VARIANT	A -> V (in dbSNP:rs1042057)	7857658	1
Q06418/A831T	Q06418	TYRO3	TYRO3_HUMAN	A831T	-	-	-	-	QPYSGaDGSGM									VARIANT	A -> T	17344846	1
Q06418/G542S	Q06418	TYRO3	TYRO3_HUMAN	G542S	111	β2/β3-loop	-	-	LKQEDgFVKVA	0.428	0.374	0.455	0.379	0.266	0.328	0.583	0.383	VARIANT	G -> S (in dbSNP:rs17857363)	15489334	1
Q06418/I346N	Q06418	TYRO3	TYRO3_HUMAN	I346N	-	-	-	neutral	EWEEViEAPLE									VARIANT	I -> N (in dbSNP:rs12148316)		0
Q06418/I99R	Q06418	TYRO3	TYRO3_HUMAN	I99R	-	-	-	loss	SEQHWiFLSLK									MUTAGEN	I->R: Abolishes dimerization.	14623883	1
Q06418/L819M	Q06418	TYRO3	TYRO3_HUMAN	L819M	-	-	-	-	TAGGSlLPGRD									VARIANT	L -> M (in dbSNP:rs17854579)	15489334	1
Q06418/P21L	Q06418	TYRO3	TYRO3_HUMAN	P21L	-	-	-	-	PLPPPpLGLLL									VARIANT	P -> L (in dbSNP:rs17854578)	15489334	1
Q06418/R824G	Q06418	TYRO3	TYRO3_HUMAN	R824G	-	-	-	-	LELPGrQPYSG									VARIANT	R -> G (in dbSNP:rs17857364)	15489334	1
Q07002/G48S	Q07002	CDK18	CDK18_HUMAN	G48S	-	-	-	-	ENLQLgLGRDP									VARIANT	G -> S (in dbSNP:rs35134237)	17344846	1
Q07002/G67R	Q07002	CDK18	CDK18_HUMAN	G67R	-	-	-	neutral	SPTDSgEPGQL									VARIANT	G -> R (in dbSNP:rs4623769)	17344846	1
Q07002/T166M	Q07002	CDK18	CDK18_HUMAN	T166M	68	β2/β3-loop	-	neutral	GRSKLtNLVAL	0.36	0.365	0.491	0.37	0.327	0.402	0.566	0.279	VARIANT	T -> M (in dbSNP:rs17850752)	15489334,17344846	2
Q07912/E346K	Q07912	TNK2	ACK1_HUMAN	E346K	750	αG/αH	-	increase	HKIDKeERLPR	0.575	0.519	0.675	0.612	0.179	0.383	0.726	0.316	VARIANT	E -> K (in an ovarian endometrioid cancer sample; somatic mutation; undergoes autoactivation and causes phosphorylation on Y-284 leading to activation of AKT1; increased autophosphorylation at Y-284; increased function in phosphorylation of peptide substrates and WASP; no effect on catalytic activity itself as the purified kinase domain has activity in vitro comparable to wild-type protein; no effect on subcellular localization to perinuclear region; dbSNP:rs970946035)	17344846,20110370,20333297	3
Q07912/K158R	Q07912	TNK2	ACK1_HUMAN	K158R	129	β3;Catalytic-Lys	-	loss	VSVAVkLKPDV	1.0	1.0	0.038	0.687	0.984	0.999	0.017	0.43	MUTAGEN	K->R: Loss of autophosphorylation at Y-284.	16288044,20110370	2
Q07912/K71R	Q07912	TNK2	ACK1_HUMAN	K71R	-	-	-	-	RKALCkKSWMS									VARIANT	K -> R (in dbSNP:rs56036945)	17344846	1
Q07912/L120Q	Q07912	TNK2	ACK1_HUMAN	L120Q	23	N-term-β1	-	-	QSLTClGEKDL	0.812	0.838	0.488	0.591	0.615	0.773	0.46	0.66	MUTAGEN	L->Q: No effect on autophosphorylation at Y-284.	20110370	1
Q07912/L197Q	Q07912	TNK2	ACK1_HUMAN	L197Q	225	β4/β5-loop	-	-	LYGVVlPPMKM	0.812	0.722	0.362	0.59	0.61	0.724	0.367	0.619	MUTAGEN	L->Q: No effect on autophosphorylation at Y-284.	20110370	1
Q07912/L487F	Q07912	TNK2	ACK1_HUMAN	L487F	-	-	-	activating	IDELYlNPMDP									MUTAGEN	L->F: Constantly active kinase.	16288044	1
Q07912/M409I	Q07912	TNK2	ACK1_HUMAN	M409I	-	-	-	increase	KLHIQmDVITV									VARIANT	M -> I (in a gastric adenocarcinoma sample; somatic mutation; increased autophosphorylation at Y-284; increased function in phosphorylation of peptide substrates and WASP; no effect on subcellular localization to perinuclear region)	17344846,20110370	2
Q07912/P507S	Q07912	TNK2	ACK1_HUMAN	P507S	-	-	-	-	STSRPpHLGGV									VARIANT	P -> S (in dbSNP:rs35759128)	17344846	1
Q07912/P725L	Q07912	TNK2	ACK1_HUMAN	P725L	-	-	-	neutral	APAGSpPSPSP									VARIANT	P -> L (in dbSNP:rs56260729)	14702039,17344846	2
Q07912/P802L	Q07912	TNK2	ACK1_HUMAN	P802L	-	-	-	-	PPGSSpPPRLS									VARIANT	P -> L (in dbSNP:rs3749333)		0
Q07912/R34L	Q07912	TNK2	ACK1_HUMAN	R34L	-	-	-	increase	DLNVTrSHFEY									VARIANT	R -> L (in a lung adenocarcinoma sample; somatic mutation; increased autophosphorylation at Y-284; increased function in phosphorylation of peptide substrates; no effect on subcellular localization to perinuclear region)	17344846,20110370	2
Q07912/R748Q	Q07912	TNK2	ACK1_HUMAN	R748Q	-	-	-	-	VPIPPrTRPHV									VARIANT	R -> Q (in dbSNP:rs57872314)	17344846	1
Q07912/R99Q	Q07912	TNK2	ACK1_HUMAN	R99Q	2	N-term-β1	-	increase	SQSTFrTSPAP	0.369	0.306	0.568	0.49	0.223	0.222	0.663	0.27	VARIANT	R -> Q (in an ovarian mucinous carcinoma sample; somatic mutation; increased autophosphorylation at Y-284; increased function in phosphorylation of peptide substrates and WASP; no effect on subcellular localization to perinuclear region; dbSNP:rs113498671)	17344846,20110370	2
Q07912/R99W	Q07912	TNK2	ACK1_HUMAN	R99W	2	N-term-β1	-	neutral	SQSTFrTSPAP	0.725	0.739	0.664	0.683	0.365	0.557	0.664	0.498	VARIANT	R -> W (in dbSNP:rs3747673)	17344846	1
Q07912/T152M	Q07912	TNK2	ACK1_HUMAN	T152M	105	β2/β3-loop	-	-	APSGKtSVAVK	0.557	0.525	0.493	0.431	0.29	0.474	0.544	0.317	VARIANT	T -> M (in dbSNP:rs56161912)	17344846	1
Q07912/V365R	Q07912	TNK2	ACK1_HUMAN	V365R	790	αH	-	increase	IYNVMvCWAHK	0.562	0.512	0.636	0.667	0.135	0.317	0.738	0.354	MUTAGEN	V->R: Increased autophosphorylation at Y-284.	20110370	1
Q07912/V638M	Q07912	TNK2	ACK1_HUMAN	V638M	-	-	-	increase,neutral	PAYDDvQDEDD									VARIANT	V -> M (found in patients with childhood-onset epilepsy; unknown pathological significance; loss of interaction with NEDD4 and NEDD4L; increased protein abundance; dbSNP:rs201407161)	23686771	1
Q08345/A170D	Q08345	DDR1	DDR1_HUMAN	A170D	-	-	-	-	RFYPRaRVMSV									VARIANT	A -> D (in dbSNP:rs56231803)	17344846	1
Q08345/G707A	Q08345	DDR1	DDR1_HUMAN	G707A	254	β5/αD-loop	-	increase	DYMENgLNQFL	0.808	0.801	0.444	0.607	0.466	0.675	0.489	0.688	MUTAGEN	G->A: Confers over 20-fold resistance to the ability of an inhibitor to inhibit autophosphorylation.	23899692	1
Q08345/K655A	Q08345	DDR1	DDR1_HUMAN	K655A	129	β3;Catalytic-Lys	-	-	LLVAVkLRPDA	0.995	0.985	0.026	0.603	0.99	0.983	0.017	0.646	MUTAGEN	K->A: Loss of kinase activity. Complete loss of the collagen-independent constitutive activation; when associated with Q-211.	24509848	1
Q08345/L833V	Q08345	DDR1	DDR1_HUMAN	L833V	608	αF	-	-	AFGVTlEVLML	0.455	0.41	0.492	0.414	0.34	0.274	0.608	0.42	VARIANT	L -> V (in dbSNP:rs2524235)	8390675,8977099	2
Q08345/N211A	Q08345	DDR1	DDR1_HUMAN	N211A	-	-	-	activating	EAVYLnSTYDG									MUTAGEN	N->A: Phosphorylates regardless of collagen presence, collagen addition does not alter significantly the levels of constitutive phosphorylation.	24509848	1
Q08345/N211Q	Q08345	DDR1	DDR1_HUMAN	N211Q	-	-	-	-	EAVYLnSTYDG									MUTAGEN	N->Q: Sustained phosphorylation regardless of collagen presence, collagen addition does not alter significantly the levels of constitutive phosphorylation. Located intracellularly and at the cell surface. Displays a reduced rate of receptor internalization, which is not altered in the presence of collagen. Able to bind collagen as wild-type. Exhibits enhanced collagen-independent receptor dimerization. Complete loss of the collagen-independent constitutive activation; when associated with A-655.	24509848	1
Q08345/N260Q	Q08345	DDR1	DDR1_HUMAN	N260Q	-	-	-	decrease	YVGWSnSFSSG									MUTAGEN	N->Q: Phosphorylates in response to collagen, but at lower levels compared to wild-type. No activation in the absence of collagen.	24509848	1
Q08345/N371Q	Q08345	DDR1	DDR1_HUMAN	N371Q	-	-	-	decrease	SDVVNnSPALG									MUTAGEN	N->Q: Phosphorylates in response to collagen, but at lower levels compared to wild-type. No activation in the absence of collagen.	24509848	1
Q08345/N394Q	Q08345	DDR1	DDR1_HUMAN	N394Q	-	-	-	decrease	GPPPTnSSLEL									MUTAGEN	N->Q: Phosphorylates in response to collagen, but at lower levels compared to wild-type. No activation in the absence of collagen.	24509848	1
Q08345/R105A	Q08345	DDR1	DDR1_HUMAN	R105A	-	-	-	decrease	VGTQGrAGGLG									MUTAGEN	R->A: Inhibits collagen-induced phosphorylation.	24509848	1
Q08345/R169Q	Q08345	DDR1	DDR1_HUMAN	R169Q	-	-	-	-	VRFYPrDRVMS									VARIANT	R -> Q (in dbSNP:rs55980643)	17344846	1
Q08345/R306W	Q08345	DDR1	DDR1_HUMAN	R306W	-	-	-	-	VECRFrGPAMA									VARIANT	R -> W (in dbSNP:rs56024191)	17344846	1
Q08345/S17G	Q08345	DDR1	DDR1_HUMAN	S17G	-	-	-	-	LLLVAsDADMK									VARIANT	S -> G (in dbSNP:rs55901302)	17344846	1
Q08345/S213A	Q08345	DDR1	DDR1_HUMAN	S213A	-	-	-	activating	VYLNDsYDGHT									MUTAGEN	S->A: Phosphorylates regardless of collagen presence, collagen addition does not alter significantly the levels of constitutive phosphorylation.	24509848	1
Q08345/S496A	Q08345	DDR1	DDR1_HUMAN	S496A	-	-	-	-	GNPPHsPCVPN									VARIANT	S -> A (in a lung squamous cell carcinoma sample; somatic mutation)	17344846	1
Q08345/T379A	Q08345	DDR1	DDR1_HUMAN	T379A	-	-	-	-	PALGGtPPAPW									MUTAGEN	T->A: Phosphorylates in response to collagen, but at lower levels compared to wild-type. Phosphorylates in response to collagen, but at lower levels compared to wild-type; when associated with A-393.	24509848	1
Q08345/T393A	Q08345	DDR1	DDR1_HUMAN	T393A	-	-	-	-	PGPPPtFSSLE									MUTAGEN	T->A: Phosphorylates in response to collagen, but at lower levels compared to wild-type. Phosphorylates in response to collagen, but at lower levels compared to wild-type; when associated with A-379.	24509848	1
Q08345/V100A	Q08345	DDR1	DDR1_HUMAN	V100A	-	-	-	-	HLVALvTQGRH									VARIANT	V -> A (in dbSNP:rs34544756)	17344846	1
Q08345/Y740F	Q08345	DDR1	DDR1_HUMAN	Y740F	399	αE	p	decrease	GPTISyMLLHV	0.89	0.809	0.562	0.733	0.569	0.624	0.547	0.382	MUTAGEN	Y->F: Abolishes interaction with PTPN11.	16337946	1
Q08881/P23L	Q08881	ITK	ITK_HUMAN	P23L	-	-	-	-	KRRTSpNFKVR									VARIANT	P -> L (in a metastatic melanoma sample; somatic mutation)	17344846	1
Q08881/P288G	Q08881	ITK	ITK_HUMAN	P288G	-	-	-	decrease	VSENNpIKHYH									MUTAGEN	P->G: Complete loss of interaction with PPIA/CYPA.	15308100	1
Q08881/R193Q	Q08881	ITK	ITK_HUMAN	R193Q	-	-	-	-	QELALrNEEYC									VARIANT	R -> Q (in dbSNP:rs17054374)		0
Q08881/R19K	Q08881	ITK	ITK_HUMAN	R19K	-	-	-	-	KSQQKrTSPSN									VARIANT	R -> K (in a metastatic melanoma sample; somatic mutation)	17344846	1
Q08881/R335W	Q08881	ITK	ITK_HUMAN	R335W	1	N-term-β1	-	-	LVTRLrPVCFG	0.726	0.735	0.615	0.733	0.43	0.629	0.627	0.447	VARIANT	R -> W (in LPFS1; shows nearly undetectable mutant 		0
Q08881/R451Q	Q08881	ITK	ITK_HUMAN	R451Q	295	αD/αE-loop	-	-	YLRTQrLFAAE	0.122	0.074	0.444	0.147	0.095	0.104	0.643	0.132	VARIANT	R -> Q (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs779372373)	17344846	1
Q08881/R581W	Q08881	ITK	ITK_HUMAN	R581W	758	αG/αH	-	-	RLYKPrASTHV	0.581	0.394	0.487	0.411	0.408	0.279	0.56	0.355	VARIANT	R -> W (in dbSNP:rs34482255)	17344846	1
Q08881/V587I	Q08881	ITK	ITK_HUMAN	V587I	784	αH	-	neutral	LASTHvQIMNH	0.117	0.107	0.469	0.164	0.061	0.124	0.683	0.104	VARIANT	V -> I (in dbSNP:rs56005928)	17344846	1
Q09013/K100A	Q09013	DMPK	DMPK_HUMAN	K100A	129	β3;Catalytic-Lys	-	loss	QVYAMkMNKWD	1.0	1.0	0.012	0.641	1.0	0.999	0.005	0.638	MUTAGEN	K->A: Loss of kinase activity.	15598648	1
Q09013/L423V	Q09013	DMPK	DMPK_HUMAN	L423V	-	-	-	neutral	PTPMElAEQLL									VARIANT	L -> V (in dbSNP:rs527221)	1310900,7905855,8469976,8499920	4
Q09013/L428V	Q09013	DMPK	DMPK_HUMAN	L428V	-	-	-	-	LEAEQlEPHVQ									VARIANT	L -> V (in a lung small cell carcinoma sample; somatic mutation)	17344846	1
Q12852/E409K	Q12852	MAP3K12	M3K12_HUMAN	E409K	-	-	-	-	LHRLEeLVMRR									VARIANT	E -> K (in a breast pleomorphic lobular carcinoma sample; somatic mutation)	17344846	1
Q12852/G628R	Q12852	MAP3K12	M3K12_HUMAN	G628R	-	-	-	-	RGATGgGDPGS									VARIANT	G -> R (in dbSNP:rs34366500)	17344846	1
Q12852/G640S	Q12852	MAP3K12	M3K12_HUMAN	G640S	-	-	-	neutral	PPPARgTPPSE									VARIANT	G -> S (in dbSNP:rs55794887)	17344846	1
Q12866/A282T	Q12866	MERTK	MERTK_HUMAN	A282T	-	-	-	-	QINIKaPSPPT									VARIANT	A -> T (in dbSNP:rs7588635)	11062461,17344846	2
Q12866/A446G	Q12866	MERTK	MERTK_HUMAN	A446G	-	-	-	-	QNGSRaISVQV									VARIANT	A -> G (in a renal clear cell carcinoma sample; somatic mutation)	17344846	1
Q12866/A708S	Q12866	MERTK	MERTK_HUMAN	A708S	411	αE	-	-	FMVDIaGMEYL	0.587	0.507	0.471	0.506	0.341	0.411	0.609	0.39	VARIANT	A -> S (in a head & Neck squamous cell carcinoma sample; somatic mutation)	17344846	1
Q12866/E289K	Q12866	MERTK	MERTK_HUMAN	E289K	-	-	-	-	PSPPTeSIRNS									VARIANT	E -> K (in dbSNP:rs766215580)	17344846	1
Q12866/E540K	Q12866	MERTK	MERTK_HUMAN	E540K	-	-	-	-	GNAFTeDSELV									VARIANT	E -> K (in RP38; dbSNP:rs113485015)	11062461	1
Q12866/E823Q	Q12866	MERTK	MERTK_HUMAN	E823Q	758	αG/αH	-	-	RLKQPeCLDEL	0.182	0.121	0.516	0.18	0.179	0.121	0.694	0.269	VARIANT	E -> Q (in dbSNP:rs55924349)	17344846	1
Q12866/F214V	Q12866	MERTK	MERTK_HUMAN	F214V	-	-	-	-	TRNTAfLTCQA									VARIANT	F -> V (found in a patient with Leber congenital amaurosis; dbSNP:rs1475870132)	21602930	1
Q12866/I518V	Q12866	MERTK	MERTK_HUMAN	I518V	-	-	-	neutral	ILIGLiYISLA									VARIANT	I -> V (in dbSNP:rs2230515)	11062461,17344846	2
Q12866/I871T	Q12866	MERTK	MERTK_HUMAN	I871T	832	C-term-αI	-	-	NQADViVNTQL	0.802	0.79	0.626	0.641	0.446	0.739	0.633	0.543	VARIANT	I -> T (in RP38; dbSNP:rs377341255)	11062461	1
Q12866/I871V	Q12866	MERTK	MERTK_HUMAN	I871V	832	C-term-αI	-	-	NQADViVNTQL	0.58	0.628	0.419	0.376	0.328	0.564	0.6	0.222	VARIANT	I -> V	11062461	1
Q12866/N329S	Q12866	MERTK	MERTK_HUMAN	N329S	-	-	-	-	ADPLSnSVMIF									VARIANT	N -> S (in dbSNP:rs34943572)		0
Q12866/N498S	Q12866	MERTK	MERTK_HUMAN	N498S	-	-	-	neutral	TPAPGnDPVLI									VARIANT	N -> S (in dbSNP:rs35858762)	11062461,17344846	2
Q12866/P958L	Q12866	MERTK	MERTK_HUMAN	P958L	-	-	-	-	KNSVLpERLVR									VARIANT	P -> L (found in a patient with Leber congenital amaurosis; dbSNP:rs201460398)	21602930	1
Q12866/Q662E	Q12866	MERTK	MERTK_HUMAN	Q662E	235	β4/β5-loop	-	neutral	IEMSSqIPKPM	0.142	0.105	0.528	0.191	0.056	0.075	0.789	0.105	VARIANT	Q -> E (in dbSNP:rs56209758)	17344846	1
Q12866/R20S	Q12866	MERTK	MERTK_HUMAN	R20S	-	-	-	-	PALWRrITEAR									VARIANT	R -> S (in dbSNP:rs35898499)	11062461,17344846	2
Q12866/R293H	Q12866	MERTK	MERTK_HUMAN	R293H	-	-	-	neutral	TEVSIrSTAHS									VARIANT	R -> H (in dbSNP:rs34072093)	11062461,17344846	2
Q12866/R466K	Q12866	MERTK	MERTK_HUMAN	R466K	-	-	-	neutral	IAAVTrGVGPF									VARIANT	R -> K (in dbSNP:rs7604639)	11062461,17344846	2
Q12866/R865W	Q12866	MERTK	MERTK_HUMAN	R865W	826	C-term-αI	-	neutral	SLPDVrQADVI	0.486	0.405	0.686	0.545	0.228	0.266	0.764	0.2	VARIANT	R -> W (in dbSNP:rs2230516)	17344846	1
Q12866/S118N	Q12866	MERTK	MERTK_HUMAN	S118N	-	-	-	neutral	FNCSIsPNIYQ									VARIANT	S -> N (in dbSNP:rs13027171)	11062461,17344846,8086340	3
Q12866/S661C	Q12866	MERTK	MERTK_HUMAN	S661C	234	β4/β5-loop	-	-	CIEMSsGIPKP	0.256	0.254	0.577	0.337	0.206	0.193	0.692	0.221	VARIANT	S -> C (in RP38)	11062461	1
Q12866/V185M	Q12866	MERTK	MERTK_HUMAN	V185M	-	-	-	-	NNEEIvDPIYI									VARIANT	V -> M (in dbSNP:rs56205303)	17344846	1
Q12866/V452L	Q12866	MERTK	MERTK_HUMAN	V452L	-	-	-	-	RISVQvNATCT									VARIANT	V -> L (in dbSNP:rs34010621)	17344846	1
Q12866/V870I	Q12866	MERTK	MERTK_HUMAN	V870I	831	C-term-αI	-	neutral	RNQADvYVNTQ	0.17	0.17	0.403	0.22	0.161	0.174	0.695	0.083	VARIANT	V -> I (in dbSNP:rs2230517)	17344846	1
Q12979/K517R	Q12979	ABR	ABR_HUMAN	K517R	-	-	-	neutral	SAKGFkSANLY									VARIANT	K -> R (in dbSNP:rs34169260)	14702039	1
Q12979/N795A	Q12979	ABR	ABR_HUMAN	N795A	-	-	-	-	KMSLHnATVFG									MUTAGEN	N->A: Loss of GAP activity; when associated with A-683.	17116687	1
Q12979/R683A	Q12979	ABR	ABR_HUMAN	R683A	-	-	-	-	EVGIYrSGVAT									MUTAGEN	R->A: Reduces GAP activity. Loss of GAP activity; when associated with A-795.	17116687	1
Q13043/D326N	Q13043	STK4	STK4_HUMAN	D326N	-	-	-	-	EEDEMdGTMVR									MUTAGEN	D->N: Resistant to proteolytic cleavage by caspase during apoptosis; when associated with N-349.	11278283	1
Q13043/D349N	Q13043	STK4	STK4_HUMAN	D349N	-	-	-	-	ASTMTdANTMI									MUTAGEN	D->N: Resistant to proteolytic cleavage by caspase during apoptosis; when associated with N-326.	11278283	1
Q13043/H162N	Q13043	STK4	STK4_HUMAN	H162N	482	Catalytic-loop	-	-	LNTEGhKLADF	0.379	0.242	0.569	0.273	0.214	0.279	0.699	0.283	VARIANT	H -> N (in dbSNP:rs55850759)	17344846	1
Q13043/I355T	Q13043	STK4	STK4_HUMAN	I355T	-	-	-	neutral	GANTMiHDDTL									VARIANT	I -> T (in dbSNP:rs35944046)	17344846	1
Q13043/K59R	Q13043	STK4	STK4_HUMAN	K59R	129	β3;Catalytic-Lys	m2	loss	QIVAIkVPVES	1.0	0.993	0.047	0.736	0.976	0.997	0.037	0.582	MUTAGEN	K->R: Loss of activity.	15109305,16930133	2
Q13043/L444P	Q13043	STK4	STK4_HUMAN	L444P	-	-	-	loss	WTVEDlKRLLA									MUTAGEN	L->P: Loss of homodimerization, activation, and autophosphorylation.	15109305	1
Q13043/P416L	Q13043	STK4	STK4_HUMAN	P416L	-	-	-	neutral	FGKSVpPLKNS									VARIANT	P -> L (in dbSNP:rs33963346)	17344846	1
Q13043/R310Q	Q13043	STK4	STK4_HUMAN	R310Q	852	C-term-αI	-	-	QESQQrVDQDD	0.374	0.399	0.464	0.396	0.362	0.404	0.569	0.298	VARIANT	R -> Q (in dbSNP:rs35447878)	17344846	1
Q13043/T175A	Q13043	STK4	STK4_HUMAN	T175A	510	A-loop	-	-	VAGQLtTMAKR	0.839	0.81	0.559	0.714	0.405	0.716	0.534	0.377	MUTAGEN	T->A: No effect on activity.	15109305	1
Q13043/T177A	Q13043	STK4	STK4_HUMAN	T177A	513	A-loop	p	-	GQLTDtAKRNT	0.807	0.831	0.467	0.781	0.677	0.776	0.435	0.333	MUTAGEN	T->A: No effect on activity.	15109305	1
Q13043/T183A	Q13043	STK4	STK4_HUMAN	T183A	545	A-loop	p	loss	MAKRNtIGTPF	0.999	1.0	0.227	0.911	0.914	0.988	0.139	0.451	MUTAGEN	T->A: Loss of activity.	15109305	1
Q13043/V312M	Q13043	STK4	STK4_HUMAN	V312M	-	-	-	neutral	SQQREvQDDEE									VARIANT	V -> M (in dbSNP:rs17420378)	17344846,7665586	2
Q13131/M10L	Q13131	PRKAA1	AAPK1_HUMAN	M10L	14	N-term-β1	-	-	SSWRKmTAEKQ	0.107	0.124	0.495	0.195	0.164	0.116	0.631	0.102	VARIANT	M -> L (in dbSNP:rs17855679)	15489334	1
Q13131/Q16R	Q13131	PRKAA1	AAPK1_HUMAN	Q16R	20	N-term-β1	-	-	ATAEKqHDGRV	0.248	0.196	0.446	0.129	0.176	0.258	0.674	0.092	VARIANT	Q -> R (in a breast cancer sample; somatic mutation; dbSNP:rs928784854)	16959974	1
Q13131/V307G	Q13131	PRKAA1	AAPK1_HUMAN	V307G	851	C-term-αI	-	activating	EALKEvEKFEC	0.765	0.616	0.497	0.587	0.469	0.581	0.559	0.526	MUTAGEN	V->G,Q: Activates the kinase activity.	17088252	1
Q13131/V307Q	Q13131	PRKAA1	AAPK1_HUMAN	V307Q	851	C-term-αI	-	increase	EALKEvEKFEC	0.706	0.593	0.533	0.515	0.44	0.519	0.524	0.566	MUTAGEN	V->G,Q: Activates the kinase activity.	17088252	1
Q13153/D389N	Q13153	PAK1	PAK1_HUMAN	D389N	443	Catalytic-loop;HrD-motif	-	-	QVIHRdKSDNI	0.989	0.999	0.217	0.715	0.932	0.979	0.172	0.598	MUTAGEN	D->N: Abolishes kinase activity; when associated with R-299.	22153498	1
Q13153/D393A	Q13153	PAK1	PAK1_HUMAN	D393A	447	Catalytic-loop	-	loss	RDIKSdILLGM	0.585	0.611	0.412	0.394	0.656	0.638	0.439	0.44	MUTAGEN	D->A: Abolishes autophosphorylation at Thr-423.	22153498	1
Q13153/H83L	Q13153	PAK1	PAK1_HUMAN	H83L	-	-	-	-	PSDFEhIHVGF									MUTAGEN	H->L: Abolishes interaction with CDC42, leading to strongly decreased activity; when associated with L-86.	10551809,9774440	2
Q13153/H86L	Q13153	PAK1	PAK1_HUMAN	H86L	-	-	-	-	FEHTIhGFDAV									MUTAGEN	H->L: Abolishes interaction with CDC42, leading to strongly decreased activity; when associated with L-83.	10551809,9774440	2
Q13153/K299R	Q13153	PAK1	PAK1_HUMAN	K299R	129	β3;Catalytic-Lys	-	-	QEVAIkMNLQQ	0.994	0.993	0.032	0.647	0.994	0.989	0.018	0.462	MUTAGEN	K->R: Strongly decreases activity. Abolishes kinase activity; when associated with N-389.	22153498	1
Q13153/L107F	Q13153	PAK1	PAK1_HUMAN	L107F	-	-	-	activating	QWARLlTSNIT									MUTAGEN	L->F: Abolishes autoinhibition, leading to constitutive kinase activity.	10551809	1
Q13153/L515V	Q13153	PAK1	PAK1_HUMAN	L515V	817	αI	-	-	GSAKElQHQFL	0.623	0.504	0.599	0.67	0.306	0.453	0.71	0.378	VARIANT	L -> V (in dbSNP:rs35345144)		0
Q13153/T423A	Q13153	PAK1	PAK1_HUMAN	T423A	545	A-loop	p	decrease	QSKRStVGTPY	0.999	1.0	0.195	0.927	0.947	0.996	0.076	0.488	MUTAGEN	T->A: Decreases CDC42-stimulated activity and autophosphorylation.	10551809	1
Q13153/T423E	Q13153	PAK1	PAK1_HUMAN	T423E	545	A-loop	p	activating	QSKRStVGTPY	0.991	0.988	0.869	0.982	0.197	0.946	0.851	0.461	MUTAGEN	T->E: Constitutive kinase activity.	10551809	1
Q13153/Y131C	Q13153	PAK1	PAK1_HUMAN	Y131C	-	-	-	increase	DVLEFySKKTS									VARIANT	Y -> C (in IDDMSSD; gain of function; enhanced PAK1 kinase activity and significantly reduced homodimerization; dbSNP:rs1565638316)	30290153	1
Q13153/Y429C	Q13153	PAK1	PAK1_HUMAN	Y429C	552	A-loop	-	increase	MVGTPyMAPEV	0.817	0.843	0.655	0.71	0.31	0.656	0.642	0.626	VARIANT	Y -> C (in IDDMSSD; gain-of-function; enhanced PAK1 kinase activity and significantly reduced homodimerization; dbSNP:rs1565583382)	30290153	1
Q13163/A427V	Q13163	MAP2K5	MP2K5_HUMAN	A427V	831	C-term-αI	-	-	FNDGNaVVSMW	0.256	0.191	0.496	0.225	0.205	0.181	0.679	0.221	VARIANT	A -> V (in dbSNP:rs1226964455)	17344846	1
Q13163/A428T	Q13163	MAP2K5	MP2K5_HUMAN	A428T	832	C-term-αI	-	-	NDGNAaVSMWV	0.436	0.499	0.387	0.246	0.303	0.461	0.618	0.099	VARIANT	A -> T (in dbSNP:rs55811347)	17344846	1
Q13163/H118R	Q13163	MAP2K5	MP2K5_HUMAN	H118R	-	-	-	-	GERNIhLKVNT									VARIANT	H -> R (in dbSNP:rs56241934)	17344846	1
Q13163/K195M	Q13163	MAP2K5	MP2K5_HUMAN	K195M	129	β3;Catalytic-Lys	-	loss	KILAVkILLDI	1.0	0.996	0.037	0.612	0.983	0.998	0.03	0.498	MUTAGEN	K->M: Inactivation.	7759517	1
Q13163/S311A	Q13163	MAP2K5	MP2K5_HUMAN	S311A	513	A-loop	p	loss	TQLVNsAKTYV	0.792	0.852	0.449	0.663	0.796	0.754	0.342	0.359	MUTAGEN	S->A: Inactivation.	7759517	1
Q13163/T315A	Q13163	MAP2K5	MP2K5_HUMAN	T315A	545	A-loop	p	loss	NSIAKtVGTNA	0.995	0.986	0.269	0.889	0.89	0.987	0.209	0.49	MUTAGEN	T->A: Inactivation.	7759517	1
Q13164/G550A	Q13164	MAPK7	MK07_HUMAN	G550A	-	-	-	-	AGASGgSTDPL									VARIANT	G -> A (in dbSNP:rs56388327)	17344846	1
Q13164/R535H	Q13164	MAPK7	MK07_HUMAN	R535H	-	-	-	-	EREKRrERERK									VARIANT	R -> H	17344846	1
Q13177/D212N	Q13177	PAK2	PAK2_HUMAN	D212N	-	-	-	-	GDSHVdAAKSL									MUTAGEN	D->N: Inhibits caspase-mediated cleavage.	9171063	1
Q13177/E435K	Q13177	PAK2	PAK2_HUMAN	E435K	610	αF	-	loss	GIMAIeVEGEP	0.888	0.906	0.359	0.662	0.691	0.749	0.334	0.534	VARIANT	E -> K (in KNO2; loss of protein serine/threonine kinase activity)	33693784	1
Q13177/G213A	Q13177	PAK2	PAK2_HUMAN	G213A	-	-	-	-	DSHVDgAKSLD									MUTAGEN	G->A: Abolishes myristoylation of PAK-2p34 and membrane location.	16617111	1
Q13177/K278R	Q13177	PAK2	PAK2_HUMAN	K278R	129	β3;Catalytic-Lys	ub	loss	QEVAIkINLQK	0.994	0.985	0.045	0.75	0.959	0.999	0.049	0.496	MUTAGEN	K->R: Abolishes kinase activity and autophosphorylation.	9786869	1
Q13177/T402A	Q13177	PAK2	PAK2_HUMAN	T402A	545	A-loop	p	loss	QSKRStVGTPY	0.999	1.0	0.195	0.93	0.947	0.996	0.08	0.492	MUTAGEN	T->A: Abolishes kinase activity and greatly inhibits autophosphorylation of PAK-2p27 and PAK-2p34.	9786869	1
Q13188/D322N	Q13188	STK3	STK3_HUMAN	D322N	-	-	-	-	DEDELdHTMVK									MUTAGEN	D->N: Resistant to proteolytic cleavage.	11278283	1
Q13188/F418C	Q13188	STK3	STK3_HUMAN	F418C	-	-	-	-	NMHEPfMSKNV									VARIANT	F -> C (in dbSNP:rs36047674)		0
Q13188/K56R	Q13188	STK3	STK3_HUMAN	K56R	129	β3;Catalytic-Lys	ub	loss	QVVAIkVPVES	1.0	0.993	0.049	0.757	0.976	0.997	0.037	0.577	MUTAGEN	K->R: Loss of activity.	16930133	1
Q13188/V60L	Q13188	STK3	STK3_HUMAN	V60L	136	αC	-	-	IKQVPvSDLQE	0.161	0.144	0.504	0.168	0.132	0.194	0.686	0.123	VARIANT	V -> L (in an ovarian clear cell carcinoma sample; somatic mutation)	17344846	1
Q13233/C443S	Q13233	MAP3K1	M3K1_HUMAN	C443S	-	-	-	-	EEEQMcICLLG									VARIANT	C -> S	17344846	1
Q13233/D806N	Q13233	MAP3K1	M3K1_HUMAN	D806N	-	-	-	neutral	ALQSIdSHSMV									VARIANT	D -> N (in dbSNP:rs702689)		0
Q13233/G616R	Q13233	MAP3K1	M3K1_HUMAN	G616R	-	-	-	-	GSSPSgATSGS									VARIANT	G -> R (in SRXY6; unknown pathological significance; dbSNP:rs143853590)	21129722	1
Q13233/L189P	Q13233	MAP3K1	M3K1_HUMAN	L189P	-	-	-	increase	MIREKlATCMP									VARIANT	L -> P (in SRXY6; increases phosphorylation of the downstream target MAPK3/MAPK1 compared to wild-type and enhances binding of RHOA to the mutant MAP3K1 complex; dbSNP:rs387906788)	21129722	1
Q13233/L189R	Q13233	MAP3K1	M3K1_HUMAN	L189R	-	-	-	increase	MIREKlATCMP									VARIANT	L -> R (in SRXY6; increases phosphorylation of the downstream targets MAPK14 and MAPK3/MAPK1 compared to wild-type and enhances binding of RHOA to the mutant MAP3K1 complex; dbSNP:rs387906788)	21129722	1
Q13233/S92N	Q13233	MAP3K1	M3K1_HUMAN	S92N	-	-	-	-	SSTSPsEPADA									VARIANT	S -> N	17344846	1
Q13233/V906I	Q13233	MAP3K1	M3K1_HUMAN	V906I	-	-	-	neutral	SPECTvLEKTG									VARIANT	V -> I (in dbSNP:rs832582)		0
Q13237/D412A	Q13237	PRKG2	KGP2_HUMAN	D412A	-	-	-	-	NLNRDdKRHAK									MUTAGEN	D->A: Reduces cGMP binding affinity; when associated with A-415.	26769964	1
Q13237/H106R	Q13237	PRKG2	KGP2_HUMAN	H106R	-	-	-	-	VPLEVhKTSGL									VARIANT	H -> R (in dbSNP:rs34616910)	17344846	1
Q13237/R415A	Q13237	PRKG2	KGP2_HUMAN	R415A	-	-	-	-	RDDEKrAKRSM									MUTAGEN	R->A: Reduces cGMP binding affinity; when associated with A-412.	26769964	1
Q13237/T22S	Q13237	PRKG2	KGP2_HUMAN	T22S	-	-	-	-	HSGNLtDALRN									VARIANT	T -> S (in dbSNP:rs34956759)		0
Q13237/W716R	Q13237	PRKG2	KGP2_HUMAN	W716R	828	C-term-αI	-	-	LNGFNwGLKAR	0.817	0.761	0.429	0.624	0.632	0.671	0.378	0.495	VARIANT	W -> R (in a colorectal adenocarcinoma sample; somatic mutation)	17344846	1
Q13263/C651A	Q13263	TRIM28	TIF1B_HUMAN	C651A	-	-	-	-	CFHLDcLPALQ									MUTAGEN	C->A: Complete loss of the PHD finger-mediated stimulatory effect on sumoylation. Loss of binding UBE2I.	18082607,18488044	2
Q13263/C65A	Q13263	TRIM28	TIF1B_HUMAN	C65A	-	-	-	-	ELLEHcVCRER									MUTAGEN	C->A: Reduces nuclear localization activity of ZNF268; when associated with A-68.	23665872	1
Q13263/C68A	Q13263	TRIM28	TIF1B_HUMAN	C68A	-	-	-	-	EHCGVcERLRP									MUTAGEN	C->A: Reduces nuclear localization activity of ZNF268; when associated with A-65.	23665872	1
Q13263/F370A	Q13263	TRIM28	TIF1B_HUMAN	F370A	-	-	-	-	KKLIYfLHRAL									MUTAGEN	F->A: Some reduction in interaction with PPP1CA.	20424263	1
Q13263/F370G	Q13263	TRIM28	TIF1B_HUMAN	F370G	-	-	-	-	KKLIYfLHRAL									MUTAGEN	F->G: Some reduction in interaction with PPP1CA.	20424263	1
Q13263/I368G	Q13263	TRIM28	TIF1B_HUMAN	I368G	-	-	-	-	LSKKLiFQLHR									MUTAGEN	I->G: Increased interaction with PPP1CA. Greatly decreased phosphorylation on S-824.	20424263	1
Q13263/K366G	Q13263	TRIM28	TIF1B_HUMAN	K366G	-	-	ub	-	LLLSKkIYFQL									MUTAGEN	K->G: Greatly reduced interaction with PPP1CA.	20424263	1
Q13263/K554R	Q13263	TRIM28	TIF1B_HUMAN	K554R	-	-	sm	-	GMAIVkEETEA									MUTAGEN	K->R: Moderately reduces sumoylation and repression. Abolishes both sumoylation and repression; when associated with R-575. Relieves the repressor activity on Dox-induced GADD45A transcription and 2-fold increase in phosphorylation at Ser-824; when associated with R-779 and R-804.	17079232,17942393,18082607	3
Q13263/K575R	Q13263	TRIM28	TIF1B_HUMAN	K575R	-	-	sm	-	EGPETkVLMAL									MUTAGEN	K->R: Modestly reduced sumoylation and repression. Abolishes both sumoylation and repression; when associated with R-554.	17079232,18082607	2
Q13263/K676R	Q13263	TRIM28	TIF1B_HUMAN	K676R	-	-	sm	-	VLPDLkEDGSL									MUTAGEN	K->R: Modestly reduces sumoylation and repression.	17079232,18082607	2
Q13263/K750R	Q13263	TRIM28	TIF1B_HUMAN	K750R	-	-	ub	-	ARLQEkSPPYS									MUTAGEN	K->R: Some reduced sumoylation and repression.	18082607	1
Q13263/K779R	Q13263	TRIM28	TIF1B_HUMAN	K779R	-	-	ub	-	KLTEDkDVQSI									MUTAGEN	K->R: Abolishes both sumoylation and repression; when associated with R-804. Relieves the repressor activity on Dox-induced GADD45A transcription and 2-fold increase in phosphorylation at Ser-824; when associated with R-554 and R-804.	17079232,17942393,18082607	3
Q13263/K804R	Q13263	TRIM28	TIF1B_HUMAN	K804R	-	-	sm	-	AFGDTkSAVLV									MUTAGEN	K->R: Abolishes both sumoylation and repression; when associated with R-779. Relieves the repressor activity on Dox-induced GADD45A transcription and 2-fold increase in phosphorylation at Ser-824; when associated with R-554 and R-779.	17079232,17942393,18082607	3
Q13263/L306P	Q13263	TRIM28	TIF1B_HUMAN	L306P	-	-	-	-	QIMKElKRGRV									MUTAGEN	L->P: Disrupts the interaction with ZNF350 and amost completely relieves the transcription repressive effect of sumoylated TRIM28.	17942393	1
Q13263/L490E	Q13263	TRIM28	TIF1B_HUMAN	L490E	-	-	-	-	VPRVSlRLDLD									MUTAGEN	L->E: Abolishes interaction with CBX5; when associated with E-488.	20562864	1
Q13263/L653A	Q13263	TRIM28	TIF1B_HUMAN	L653A	-	-	-	-	HLDCHlALQDV									MUTAGEN	L->A: Greatly reduced sumoylation. Little further effect on sumoylation; when associated with A-668 and/or A-709.	18488044	1
Q13263/L668A	Q13263	TRIM28	TIF1B_HUMAN	L668A	-	-	-	-	EWSCSlHVLPD									MUTAGEN	L->A: Little effect on sumoylation. Little further effect on sumoylation; when associated with A-653 and/or A-709.	18488044	1
Q13263/L709A	Q13263	TRIM28	TIF1B_HUMAN	L709A	-	-	-	-	CERVLlLFCHE									MUTAGEN	L->A: Greatly reduced sumoylation. Little further effect on sumoylation; when associated with A-653 and/or A-668.	18488044	1
Q13263/S440A	Q13263	TRIM28	TIF1B_HUMAN	S440A	-	-	p	-	QGSGSsPMEVQ									MUTAGEN	S->A: No effect on interaction with PPP1CA nor on sumoylation levels. Decreased sumoylation levels; when associated with D-501 and D-824.	20424263	1
Q13263/S501A	Q13263	TRIM28	TIF1B_HUMAN	S501A	-	-	p	-	DLTADsPPVFK									MUTAGEN	S->A: No effect on interaction with PPP1CA nor on sumoylation levels. Decreased sumoylation levels; when associated with D-440 and D-824.	20424263	1
Q13263/S824A	Q13263	TRIM28	TIF1B_HUMAN	S824A	-	-	p	-	GAGLSsELSGG									MUTAGEN	S->A: Suppresses Dox-induced CDKN1A/p21 promoter activation. No effect on sumoylation levels. Decreased sumoylation levels; when associated with D-440 and D-501.	17942393,20424263	2
Q13263/S824D	Q13263	TRIM28	TIF1B_HUMAN	S824D	-	-	p	-	GAGLSsELSGG									MUTAGEN	S->D: Enhances Dox-induced CDKN1A/p21 promoter activation. Decreased sumoylation with or without Dox-treatment.	17942393,20424263	2
Q13263/T794M	Q13263	TRIM28	TIF1B_HUMAN	T794M	-	-	-	-	QRFFEtMNEAF									VARIANT	T -> M (in dbSNP:rs56229738)	17344846	1
Q13263/V488E	Q13263	TRIM28	TIF1B_HUMAN	V488E	-	-	-	-	RKVPRvLERLD									MUTAGEN	V->E: Abolishes interaction with CBX5; when associated with E-490.	20562864	1
Q13308/A777V	Q13308	PTK7	PTK7_HUMAN	A777V	-	-	-	neutral	LGSGPaTNKRH									VARIANT	A -> V (in dbSNP:rs34764696)	17344846	1
Q13308/A933V	Q13308	PTK7	PTK7_HUMAN	A933V	-	-	-	-	HKDLAaNCLVS									VARIANT	A -> V (in a colorectal adenocarcinoma sample; somatic mutation)	17344846	1
Q13308/E745D	Q13308	PTK7	PTK7_HUMAN	E745D	-	-	-	neutral	EGEEPeECLNG									VARIANT	E -> D (in dbSNP:rs9472017)	17344846	1
Q13308/E766Q	Q13308	PTK7	PTK7_HUMAN	E766Q	-	-	-	-	AEIQEeALTSL									VARIANT	E -> Q (in dbSNP:rs56216742)	17344846	1
Q13308/H783R	Q13308	PTK7	PTK7_HUMAN	H783R	-	-	-	-	ATNKRhTSDKM									VARIANT	H -> R (in dbSNP:rs55820547)	17344846	1
Q13308/L622D	Q13308	PTK7	PTK7_HUMAN	L622D	-	-	-	-	GDPKPlQWKGK									MUTAGEN	L->D: Prevents proteolysis by MMP14.	20837484	1
Q13308/M641R	Q13308	PTK7	PTK7_HUMAN	M641R	-	-	-	-	KLGPRmIFQNG									MUTAGEN	M->R: No impact on proteolysis by MMP14.	20837484	1
Q13308/M701D	Q13308	PTK7	PTK7_HUMAN	M701D	-	-	-	-	PPPYKmQTIGL									MUTAGEN	M->D: No impact on proteolysis by MMP14.	20837484	1
Q13308/P1029T	Q13308	PTK7	PTK7_HUMAN	P1029T	-	-	-	-	ARLPQpGCPSK									VARIANT	P -> T (in dbSNP:rs55755163)	17344846	1
Q13308/R1038Q	Q13308	PTK7	PTK7_HUMAN	R1038Q	-	-	-	neutral	PSKLYrMQRCW									VARIANT	R -> Q (in dbSNP:rs34865794)	17344846	1
Q13308/R276H	Q13308	PTK7	PTK7_HUMAN	R276H	-	-	-	-	RPPHLrATVFA									VARIANT	R -> H (in dbSNP:rs56188167)	17344846	1
Q13308/T410S	Q13308	PTK7	PTK7_HUMAN	T410S	-	-	-	neutral	NITVAtPSWLK									VARIANT	T -> S (in dbSNP:rs34021075)	17344846	1
Q13315/A350T	Q13315	ATM	ATM_HUMAN	A350T	-	-	-	-	LIELMaICHQV									VARIANT	A -> T (in B-cell chronic lymphocytic leukemia; dbSNP:rs371713984)	10023947	1
Q13315/A869G	Q13315	ATM	ATM_HUMAN	A869G	-	-	-	-	SSVSDaEPGES									VARIANT	A -> G (found in a patient with familial pancreatic cancer; unknown pathological significance)	28726808	1
Q13315/C540Y	Q13315	ATM	ATM_HUMAN	C540Y	-	-	-	-	SCPAVcLTLAL									VARIANT	C -> Y (in a colorectal adenocarcinoma sample; somatic mutation)	17344846	1
Q13315/D126E	Q13315	ATM	ATM_HUMAN	D126E	-	-	-	neutral	LNYIMdVKDSS									VARIANT	D -> E (in dbSNP:rs2234997)	17344846,9711876	2
Q13315/D140H	Q13315	ATM	ATM_HUMAN	D140H	-	-	-	-	AIYGAdSNILL									VARIANT	D -> H (in dbSNP:rs55633650)	17344846	1
Q13315/D661A	Q13315	ATM	ATM_HUMAN	D661A	-	-	-	-	TFDKMdLTIVR									VARIANT	D -> A (found in a patient with familial breast cancer; unknown pathological significance)	28202063	1
Q13315/D814E	Q13315	ATM	ATM_HUMAN	D814E	-	-	-	neutral	SKLMNdADICK									VARIANT	D -> E (in dbSNP:rs3218695)		0
Q13315/E1091D	Q13315	ATM	ATM_HUMAN	E1091D	-	-	-	-	RMLAAeINRLF									VARIANT	E -> D (in AT)	9792409	1
Q13315/E1313Q	Q13315	ATM	ATM_HUMAN	E1313Q	-	-	-	-	MAQQReATKVY									VARIANT	E -> Q (in dbSNP:rs3092841)		0
Q13315/E699G	Q13315	ATM	ATM_HUMAN	E699G	-	-	-	-	LLGLSeLLNNY									VARIANT	E -> G (found in a patient with familial pancreatic cancer; unknown pathological significance)	28726808	1
Q13315/E848Q	Q13315	ATM	ATM_HUMAN	E848Q	-	-	-	-	NGNLMeEDQSS									VARIANT	E -> Q (in a lung adenocarcinoma sample; somatic mutation; dbSNP:rs879254046)	17344846	1
Q13315/F570S	Q13315	ATM	ATM_HUMAN	F570S	-	-	-	-	EVNRSfLKESI									VARIANT	F -> S (in AT; dbSNP:rs777301065)	9887333	1
Q13315/F582L	Q13315	ATM	ATM_HUMAN	F582L	-	-	-	-	MKWLLfQLEGD									VARIANT	F -> L (in dbSNP:rs2235006)	17344846	1
Q13315/F858L	Q13315	ATM	ATM_HUMAN	F858L	-	-	-	neutral	SSMNLfDYPDS									VARIANT	F -> L (in dbSNP:rs1800056)	10534763,17344846,18384426,28202063,8797579,9043869,9792409,9887333	8
Q13315/F897I	Q13315	ATM	ATM_HUMAN	F897I	-	-	-	-	KQDLLfDMLKF									VARIANT	F -> I (found in a patient with familial pancreatic cancer; unknown pathological significance)	28726808	1
Q13315/G514D	Q13315	ATM	ATM_HUMAN	G514D	-	-	-	neutral	GAIIQgLVEVD									VARIANT	G -> D (in dbSNP:rs2235000)	17344846,9711876	2
Q13315/H1082L	Q13315	ATM	ATM_HUMAN	H1082L	-	-	-	-	FLADNhQVRML									VARIANT	H -> L (in AT; unknown pathological significance)	10873394	1
Q13315/H1380Y	Q13315	ATM	ATM_HUMAN	H1380Y	-	-	-	neutral	APNPPhPSHVI									VARIANT	H -> Y (in dbSNP:rs3092856)	17344846	1
Q13315/I323V	Q13315	ATM	ATM_HUMAN	I323V	-	-	-	-	LLVNEiHIGSR									VARIANT	I -> V (in AT; loss of protein expression; dbSNP:rs587781511)	10817650,27664052	2
Q13315/I352T	Q13315	ATM	ATM_HUMAN	I352T	-	-	-	-	ELMADiHQVFN									VARIANT	I -> T (in B-cell chronic lymphocytic leukemia; dbSNP:rs369203092)	10023947	1
Q13315/I68V	Q13315	ATM	ATM_HUMAN	I68V	-	-	-	-	FLQKYiKETEC									VARIANT	I -> V (found in a patient with familial pancreatic cancer; unknown pathological significance)	28726808	1
Q13315/K224E	Q13315	ATM	ATM_HUMAN	K224E	-	-	-	-	CARQEkSSGLN									VARIANT	K -> E (in AT; unknown pathological significance; dbSNP:rs145053092)	10817650	1
Q13315/L1001Q	Q13315	ATM	ATM_HUMAN	L1001Q	-	-	-	-	HVVKNlQSNMD									VARIANT	L -> Q (in AT; associated with T-cell acute lymphoblastic leukemia)	9463314	1
Q13315/L1046P	Q13315	ATM	ATM_HUMAN	L1046P	-	-	-	-	ALVNClTLLEA									VARIANT	L -> P (in AT; loss of protein expression; dbSNP:rs568461905)	27664052	1
Q13315/L1255V	Q13315	ATM	ATM_HUMAN	L1255V	-	-	-	-	SCYKVlPHLVI									VARIANT	L -> V (found in a patient with early-onset breast cancer; unknown pathological significance)	18384426	1
Q13315/L1322I	Q13315	ATM	ATM_HUMAN	L1322I	-	-	-	-	KVYDMlSENLL									VARIANT	L -> I (no effect on phosphorylation of target proteins; dbSNP:rs144535256)	19431188	1
Q13315/L546V	Q13315	ATM	ATM_HUMAN	L546V	-	-	-	neutral	CLTLAlTSIVP									VARIANT	L -> V (no effect on phosphorylation of target proteins; dbSNP:rs2227924)	17344846,19431188	2
Q13315/L942F	Q13315	ATM	ATM_HUMAN	L942F	-	-	-	-	EPTKSlLHMYL									VARIANT	L -> F (in dbSNP:rs3218688)		0
Q13315/L950R	Q13315	ATM	ATM_HUMAN	L950R	-	-	-	-	HMYLMlKELPG									VARIANT	L -> R (in AT; dbSNP:rs786203054)		0
Q13315/M1040V	Q13315	ATM	ATM_HUMAN	M1040V	-	-	-	neutral	IFSVRmLVNCL									VARIANT	M -> V (found in B-cell non-Hodgkin lymphoma; unknown pathological significance; dbSNP:rs3092857)	9288106	1
Q13315/M1321I	Q13315	ATM	ATM_HUMAN	M1321I	-	-	-	-	TKVYDmKSENL									VARIANT	M -> I (in dbSNP:rs35184530)	17344846	1
Q13315/N504S	Q13315	ATM	ATM_HUMAN	N504S	-	-	-	-	QIQAEnGLLGA									VARIANT	N -> S (in dbSNP:rs56365018)	17344846	1
Q13315/N768D	Q13315	ATM	ATM_HUMAN	N768D	-	-	-	-	FKNKTnEFRIG									VARIANT	N -> D (in AT)	9463314	1
Q13315/N813S	Q13315	ATM	ATM_HUMAN	N813S	-	-	-	-	TSKLMnIADIC									VARIANT	N -> S (found in a patient with familial pancreatic cancer; unknown pathological significance)	28726808	1
Q13315/P1054R	Q13315	ATM	ATM_HUMAN	P1054R	-	-	-	-	LLEADpSKWAI									VARIANT	P -> R (in AT, B-cell chronic lymphocytic leukemia, breast cancer patients and familial cancer patients; no effect on phosphorylation of target proteins; dbSNP:rs1800057)	10023947,10217116,17344846,18384426,19431188,28202063,8665503,8797579,9043869,9792409,9887333	11
Q13315/P1382S	Q13315	ATM	ATM_HUMAN	P1382S	-	-	-	-	NPPHFpHVIKA									VARIANT	P -> S (in dbSNP:rs55859590)	17344846	1
Q13315/P292L	Q13315	ATM	ATM_HUMAN	P292L	-	-	-	-	IYIHHpGAKTQ									VARIANT	P -> L (in AT; associated with lymphoma; decrease phosphorylation of target proteins; increases protein abundance; dbSNP:rs747727055)	10873394,19431188,9463314	3
Q13315/P597L	Q13315	ATM	ATM_HUMAN	P597L	-	-	-	-	STEVPpLHSNF									VARIANT	P -> L (found in a patient with familial pancreatic cancer; unknown pathological significance)	28726808	1
Q13315/P872S	Q13315	ATM	ATM_HUMAN	P872S	-	-	-	neutral	SDANEpESQST									VARIANT	P -> S (in dbSNP:rs3218673)	17344846	1
Q13315/R23Q	Q13315	ATM	ATM_HUMAN	R23Q	-	-	-	-	DRATErKEVEK									VARIANT	R -> Q (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs587779858)	17344846	1
Q13315/R250Q	Q13315	ATM	ATM_HUMAN	R250Q	-	-	-	-	VNFRIrCELGD									VARIANT	R -> Q (in dbSNP:rs56123940)	17344846	1
Q13315/R337C	Q13315	ATM	ATM_HUMAN	R337C	-	-	-	-	YSSGFrIAVKE									VARIANT	R -> C (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs138398778)	17344846	1
Q13315/R337H	Q13315	ATM	ATM_HUMAN	R337H	-	-	-	-	YSSGFrIAVKE									VARIANT	R -> H (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs202160435)	17344846	1
Q13315/R45W	Q13315	ATM	ATM_HUMAN	R45W	-	-	-	-	IKHLDrSDSKQ									VARIANT	R -> W (found in a patient with breast cancer; unknown pathological significance; dbSNP:rs3218684)	11897822	1
Q13315/R785C	Q13315	ATM	ATM_HUMAN	R785C	-	-	-	-	MQLCTrLSNCT									VARIANT	R -> C (in AT; dbSNP:rs587778065)	9887333	1
Q13315/R924W	Q13315	ATM	ATM_HUMAN	R924W	-	-	-	-	RAADIrKLLML									VARIANT	R -> W (found in a patient with familial breast cancer; unknown pathological significance; dbSNP:rs55723361)	17344846,28202063	2
Q13315/S1179F	Q13315	ATM	ATM_HUMAN	S1179F	-	-	-	-	FALCKsKENGL									VARIANT	S -> F (in a gastric adenocarcinoma sample; somatic mutation)	17344846	1
Q13315/S333F	Q13315	ATM	ATM_HUMAN	S333F	-	-	-	-	SRGKYsGFRNI									VARIANT	S -> F (in dbSNP:rs28904919)	17344846	1
Q13315/S367A	Q13315	ATM	ATM_HUMAN	S367A	-	-	p	loss	RSLEIsSYTTT									MUTAGEN	S->A: Loss of IR-induced S-367 autophosphorylation. Reduced correction of cell cycle checkpoint defects and DNA-repair activity. No effect on S-1893 nor S-1981 autophosphorylation.	16858402	1
Q13315/S49C	Q13315	ATM	ATM_HUMAN	S49C	-	-	-	-	DRHSDsQGKYL									VARIANT	S -> C (in AT; increases protein abundance; dbSNP:rs1800054)	10425038,10534763,10873394,11897822,17344846,18384426,8665503,8797579,9887333	9
Q13315/S707P	Q13315	ATM	ATM_HUMAN	S707P	-	-	-	neutral	LNNYSsITNSE									VARIANT	S -> P (in dbSNP:rs4986761)	10534763,17344846,28202063	3
Q13315/S759G	Q13315	ATM	ATM_HUMAN	S759G	-	-	-	-	QCAGEsTLFKN									VARIANT	S -> G (found in a patient with familial pancreatic cancer; unknown pathological significance)	28726808	1
Q13315/S788R	Q13315	ATM	ATM_HUMAN	S788R	-	-	-	-	CTRCLsCTKKS									VARIANT	S -> R (in dbSNP:rs641252)		0
Q13315/T761S	Q13315	ATM	ATM_HUMAN	T761S	-	-	-	-	AGESItFKNKT									VARIANT	T -> S (in dbSNP:rs2235011)		0
Q13315/T935A	Q13315	ATM	ATM_HUMAN	T935A	-	-	-	-	LIDSStEPTKS									VARIANT	T -> A (in dbSNP:rs35813135)	17344846	1
Q13315/T935M	Q13315	ATM	ATM_HUMAN	T935M	-	-	-	-	LIDSStEPTKS									VARIANT	T -> M (in dbSNP:rs3218708)		0
Q13315/V182L	Q13315	ATM	ATM_HUMAN	V182L	-	-	-	-	KPSQDvRVLVA									VARIANT	V -> L (in dbSNP:rs3218707)	10534763	1
Q13315/V341I	Q13315	ATM	ATM_HUMAN	V341I	-	-	-	-	FRNIAvENLIE									VARIANT	V -> I (found in a patient with familial pancreatic cancer; unknown pathological significance)	28726808	1
Q13315/V410A	Q13315	ATM	ATM_HUMAN	V410A	-	-	-	neutral	NDFDLvWLQIA									VARIANT	V -> A (in dbSNP:rs56128736)	17344846	1
Q13315/Y332C	Q13315	ATM	ATM_HUMAN	Y332C	-	-	-	-	GSRGKySGFRN									VARIANT	Y -> C (in B-cell chronic lymphocytic leukemia)	9892178	1
Q13418/A262V	Q13418	ILK	ILK_HUMAN	A262V	237	β4/β5-loop	-	-	CQSPPaHPTLI	0.255	0.274	0.568	0.273	0.141	0.235	0.74	0.136	VARIANT	A -> V (found in a patient with severe dilated cardiomyopathy; unknown pathological significance; dbSNP:rs387907366)	17646580	1
Q13418/E359K	Q13418	ILK	ILK_HUMAN	E359K	557	A-loop;APE-motif	-	loss	AWVAPeLQKKP	0.928	0.921	0.279	0.654	0.854	0.885	0.225	0.565	MUTAGEN	E->K: Inactivation of ILK.	9736715	1
Q13418/H99D	Q13418	ILK	ILK_HUMAN	H99D	-	-	-	-	NAVNEhNVPLH									MUTAGEN	H->D: Alters interaction with LIMS1.	19074270	1
Q13464/C1264R	Q13464	ROCK1	ROCK1_HUMAN	C1264R	-	-	-	-	LECRRcVKCHR									VARIANT	C -> R (in dbSNP:rs2663698)	17344846	1
Q13464/D1113A	Q13464	ROCK1	ROCK1_HUMAN	D1113A	-	-	-	-	SADETdNLPES									MUTAGEN	D->A: Abolishes cleavage by caspase-3.	11283607	1
Q13464/P1193S	Q13464	ROCK1	ROCK1_HUMAN	P1193S	-	-	-	-	ETEEIpIFQIL									VARIANT	P -> S (in a lung neuroendocrine carcinoma sample; somatic mutation; dbSNP:rs1057520015)	17344846	1
Q13464/Q1217E	Q13464	ROCK1	ROCK1_HUMAN	Q1217E	-	-	-	-	MEPVQqEKTNF									VARIANT	Q -> E (in dbSNP:rs2847092)	17344846	1
Q13464/R1262Q	Q13464	ROCK1	ROCK1_HUMAN	R1262Q	-	-	-	-	PALECrCHVKC									VARIANT	R -> Q (in dbSNP:rs1045142)	17344846	1
Q13464/S108N	Q13464	ROCK1	ROCK1_HUMAN	S108N	132	β3/αC-loop	-	-	AMKLLsFEMIK	0.304	0.326	0.435	0.236	0.317	0.33	0.476	0.114	VARIANT	S -> N (in dbSNP:rs55811609)	17344846	1
Q13464/T1112P	Q13464	ROCK1	ROCK1_HUMAN	T1112P	-	-	-	neutral	PSADEtGNLPE									VARIANT	T -> P (in dbSNP:rs35881519)	17344846	1
Q13464/T773S	Q13464	ROCK1	ROCK1_HUMAN	T773S	-	-	-	neutral	EVKNLtQLEQE									VARIANT	T -> S (in dbSNP:rs45562542)	17344846	1
Q13470/R339K	Q13470	TNK1	TNK1_HUMAN	R339K	751	αG/αH	-	-	QRLEDrRLPRP	0.278	0.254	0.633	0.379	0.082	0.168	0.8	0.143	VARIANT	R -> K (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
Q13470/R539C	Q13470	TNK1	TNK1_HUMAN	R539C	-	-	-	-	PGLPPrPLSSS									VARIANT	R -> C (in dbSNP:rs36046975)	17344846	1
Q13470/S546C	Q13470	TNK1	TNK1_HUMAN	S546C	-	-	-	neutral	PLSSSsQPSQP									VARIANT	S -> C (in dbSNP:rs56093628)	17344846	1
Q13470/T514K	Q13470	TNK1	TNK1_HUMAN	T514K	-	-	p	-	LGPRPtGGSSP									VARIANT	T -> K (in dbSNP:rs55641092)	17344846	1
Q13470/V278I	Q13470	TNK1	TNK1_HUMAN	V278I	531	A-loop	-	neutral	ARGRYvGGPRP	0.248	0.205	0.532	0.306	0.121	0.166	0.673	0.251	VARIANT	V -> I (in dbSNP:rs55939858)	17344846	1
Q13470/V598M	Q13470	TNK1	TNK1_HUMAN	V598M	-	-	-	-	RKIMEvLSVHG									VARIANT	V -> M (in dbSNP:rs6503018)	17344846,8632913	2
Q13523/F658L	Q13523	PRPF4B	PRP4B_HUMAN	F658L	-	-	-	-	GIGKDfENPNL									VARIANT	F -> L (in a breast cancer sample; somatic mutation; dbSNP:rs1230491406)	16959974,17344846	2
Q13523/I584V	Q13523	PRPF4B	PRP4B_HUMAN	I584V	-	-	-	-	PSPDDiERVAA									VARIANT	I -> V (in dbSNP:rs56267049)	17344846	1
Q13523/I83V	Q13523	PRPF4B	PRP4B_HUMAN	I83V	-	-	-	neutral	HKRKEiDASDK									VARIANT	I -> V (in dbSNP:rs9503893)	11418604,12077342,14702039,9628581,17081983,18669648,19413330,20068231,21406692,23186163	10
Q13546/A220V	Q13546	RIPK1	RIPK1_HUMAN	A220V	610	αF	-	-	AVVLWaFANKE	0.362	0.356	0.401	0.225	0.282	0.227	0.63	0.194	VARIANT	A -> V (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs759012409)	17344846	1
Q13546/A404S	Q13546	RIPK1	RIPK1_HUMAN	A404S	-	-	-	-	PRQNVaNREEE									VARIANT	A -> S (in dbSNP:rs34872409)	17344846	1
Q13546/A438V	Q13546	RIPK1	RIPK1_HUMAN	A438V	-	-	-	-	EGKGTaSSAAS									VARIANT	A -> V (in dbSNP:rs3173519)	15489334,7538908,8612133	3
Q13546/A443V	Q13546	RIPK1	RIPK1_HUMAN	A443V	-	-	-	-	AYSSAaHGNAV									VARIANT	A -> V (in dbSNP:rs35722193)	17344846	1
Q13546/A569V	Q13546	RIPK1	RIPK1_HUMAN	A569V	-	-	-	neutral	FKEEPaKYQAI									VARIANT	A -> V (in dbSNP:rs55861377)	17344846	1
Q13546/A64V	Q13546	RIPK1	RIPK1_HUMAN	A64V	174	αC	-	-	ALLEEaMMNRL	0.212	0.179	0.51	0.24	0.139	0.238	0.621	0.295	VARIANT	A -> V (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs774996232)	17344846	1
Q13546/D324H	Q13546	RIPK1	RIPK1_HUMAN	D324H	-	-	-	increase	QSLQLdVAVPS									VARIANT	D -> H (in AIEFL; prevents cleavage by CASP8; increased kinase activity; increased inflammatory response)	31827280,31827281	2
Q13546/D324K	Q13546	RIPK1	RIPK1_HUMAN	D324K	-	-	-	-	QSLQLdVAVPS									MUTAGEN	D->K: Abolishes cleavage by caspase-8.	10521396	1
Q13546/D324N	Q13546	RIPK1	RIPK1_HUMAN	D324N	-	-	-	-	QSLQLdVAVPS									VARIANT	D -> N (in AIEFL; prevents cleavage by CASP8; changed inflammatory response; dbSNP:rs1760720617)	31827281	1
Q13546/D324V	Q13546	RIPK1	RIPK1_HUMAN	D324V	-	-	-	increase	QSLQLdVAVPS									VARIANT	D -> V (in AIEFL; prevents cleavage by CASP8; increased kinase activity; increased inflammatory response)	31827280	1
Q13546/D324Y	Q13546	RIPK1	RIPK1_HUMAN	D324Y	-	-	-	-	QSLQLdVAVPS									VARIANT	D -> Y (in AIEFL; prevents cleavage by CASP8; changed inflammatory response)	31827281	1
Q13546/E234K	Q13546	RIPK1	RIPK1_HUMAN	E234K	651	αG	-	-	ENAICeQLIMC	0.13	0.156	0.556	0.281	0.095	0.128	0.7	0.103	VARIANT	E -> K (in dbSNP:rs17548383)		0
Q13546/K377R	Q13546	RIPK1	RIPK1_HUMAN	K377R	-	-	ub	-	PSLQSkQDEAN									MUTAGEN	K->R: Abolishes RIP-mediated NF-Kappa-B activation.	16603398	1
Q13546/K45A	Q13546	RIPK1	RIPK1_HUMAN	K45A	129	β3;Catalytic-Lys	-	loss	GLMIMkVYKGP	0.899	0.907	0.136	0.494	0.899	0.956	0.095	0.465	MUTAGEN	K->A: Abolishes kinase activity.	30988283,8612133	2
Q13546/K599R	Q13546	RIPK1	RIPK1_HUMAN	K599R	-	-	-	-	LGKHWkCARKL									MUTAGEN	K->R: Blocks homodimerization, necroptosis and apoptosis.	29440439	1
Q13546/R603A	Q13546	RIPK1	RIPK1_HUMAN	R603A	-	-	-	-	WKNCArLGFTQ									MUTAGEN	R->A: Abolished GlcNAcylation by E.coli NleB1.	30979585	1
Q13546/S161A	Q13546	RIPK1	RIPK1_HUMAN	S161A	501	A-loop	p	decrease	DLGLAsKMWSK	0.86	0.895	0.475	0.771	0.624	0.715	0.494	0.219	MUTAGEN	S->A: Decreases RIPK1 kinase activity.	18408713	1
Q13546/S161E	Q13546	RIPK1	RIPK1_HUMAN	S161E	501	A-loop	p	-	DLGLAsKMWSK	0.828	0.826	0.616	0.813	0.44	0.689	0.623	0.311	MUTAGEN	S->E: No effect on RIPK1 autophosphorylation.	18408713	1
Q13546/S25D	Q13546	RIPK1	RIPK1_HUMAN	S25D	41	β1;Gly-rich-loop	p	loss	SAELDsGFGKV	0.904	0.88	0.636	0.776	0.556	0.751	0.635	0.297	MUTAGEN	S->D: Phophomimetic mutant. Significant loss of kinase activity.	30988283	1
Q13546/S536C	Q13546	RIPK1	RIPK1_HUMAN	S536C	-	-	-	-	YTIYNsGIQIG									MUTAGEN	S->C: Strongly reduced homodimerization and interaction with RIPK3.	29681455	1
Q13546/V81I	Q13546	RIPK1	RIPK1_HUMAN	V81I	223	β4/β5-loop	-	-	VKLLGvIEEGK	0.226	0.173	0.508	0.3	0.213	0.189	0.663	0.334	VARIANT	V -> I (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs758268804)	17344846	1
Q13554/E110K	Q13554	CAMK2B	KCC2B_HUMAN	E110K	395	αD/αE-loop	-	increase	REYYSeDASHC	0.864	0.779	0.675	0.797	0.288	0.599	0.74	0.515	VARIANT	E -> K (in MRD54; decreased protein abundance; increased autophosphorylation; decreased neuronal migration; dbSNP:rs1554402092)	29100089	1
Q13554/E237K	Q13554	CAMK2B	KCC2B_HUMAN	E237K	679	αG/αH	-	increase	DFPSPeDTVTP	0.539	0.517	0.582	0.63	0.207	0.352	0.73	0.28	VARIANT	E -> K (in MRD54; no effect on protein abundance; increased autophosphorylation; decreased neuronal migration; dbSNP:rs1554386687)	29100089	1
Q13554/E510K	Q13554	CAMK2B	KCC2B_HUMAN	E510K	-	-	-	neutral	GTPEAePSPVG									VARIANT	E -> K (in dbSNP:rs35452727)	17344846	1
Q13554/K301E	Q13554	CAMK2B	KCC2B_HUMAN	K301E	852	C-term-αI	m1	loss	ARRKLkAILTT	0.674	0.707	0.56	0.75	0.475	0.619	0.574	0.43	VARIANT	K -> E (in MRD54; no effect on protein abundance; loss of autophosphorylation; changed function in neuronal migration; dbSNP:rs1554385111)	29100089	1
Q13554/P139L	Q13554	CAMK2B	KCC2B_HUMAN	P139L	446	Catalytic-loop	-	increase	HRDLKpNLLLA	0.767	0.738	0.558	0.693	0.287	0.677	0.583	0.615	VARIANT	P -> L (in MRD54; decreased protein abundance; increased autophosphorylation; decreased neuronal migration; dbSNP:rs1554389088)	29100089	1
Q13554/P213L	Q13554	CAMK2B	KCC2B_HUMAN	P213L	621	αF/αG	-	-	LVGYPpWDEDQ	0.755	0.681	0.488	0.619	0.555	0.647	0.427	0.599	VARIANT	P -> L (in MRD54; dbSNP:rs1554387293)	29560374	1
Q13554/P489L	Q13554	CAMK2B	KCC2B_HUMAN	P489L	-	-	-	-	GPLSSpPRISD									VARIANT	P -> L (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs555460132)	17344846	1
Q13554/R284S	Q13554	CAMK2B	KCC2B_HUMAN	R284S	835	C-term-αI	-	-	ASMMHrETVEC	0.545	0.505	0.618	0.526	0.333	0.402	0.644	0.336	VARIANT	R -> S (in MRD54; dbSNP:rs1554385203)	29560374	1
Q13555/R292P	Q13555	CAMK2G	KCC2G_HUMAN	R292P	843	C-term-αI	-	activating	TVECLrFNARR	0.603	0.603	0.562	0.536	0.397	0.445	0.67	0.349	VARIANT	R -> P (in MRD59; gain-of-function variant affecting regulation of neurite formation and arborization; results in constitutive autophosphorylation; dbSNP:rs397514627)	23033978,30184290	2
Q13555/S36P	Q13555	CAMK2G	KCC2G_HUMAN	S36P	68	β2/β3-loop	-	-	CVKKTsQEYAA	0.532	0.525	0.539	0.457	0.377	0.45	0.619	0.336	VARIANT	S -> P (in dbSNP:rs17853266)	15489334	1
Q13557/D167E	Q13557	CAMK2D	KCC2D_HUMAN	D167E	513	A-loop	-	neutral	IEVQGdQAWFG	0.216	0.298	0.443	0.261	0.254	0.216	0.581	0.129	VARIANT	D -> E (in dbSNP:rs35367671)	17344846	1
Q13557/Q463E	Q13557	CAMK2D	KCC2D_HUMAN	Q463E	-	-	-	-	RDGKWqVHFHR									VARIANT	Q -> E (in dbSNP:rs1053668)		0
Q13557/T493I	Q13557	CAMK2D	KCC2D_HUMAN	T493I	-	-	-	-	NFSGGtLWQNI									VARIANT	T -> I (in dbSNP:rs35765784)	17344846	1
Q13627/A679P	Q13627	DYRK1A	DYR1A_HUMAN	A679P	-	-	-	-	NQGNQaQNRPV									VARIANT	A -> P (in dbSNP:rs55720916)	17344846,8975710	2
Q13627/K188R	Q13627	DYRK1A	DYR1A_HUMAN	K188R	129	β3;Catalytic-Lys	-	loss	EWVAIkIKNKK	1.0	1.0	0.046	0.745	0.999	0.999	0.007	0.496	MUTAGEN	K->R: Abolished protein kinase activity.	23665168,25620562	2
Q13627/Q681H	Q13627	DYRK1A	DYR1A_HUMAN	Q681H	-	-	-	-	GNQAYqRPVAA									VARIANT	Q -> H	10329007	1
Q13627/Y321F	Q13627	DYRK1A	DYR1A_HUMAN	Y321F	546	A-loop	p	decrease	QRIYQyQSRFY	0.983	0.971	0.373	0.799	0.89	0.911	0.3	0.392	MUTAGEN	Y->F: Mildly reduces kinase activity. Does not abolish autophosphorylation on tyrosine residues.	23665168	1
Q13627/Y415F	Q13627	DYRK1A	DYR1A_HUMAN	Y415F	706	αG/αH	-	-	DGKREyPPGTR	0.696	0.669	0.529	0.589	0.333	0.615	0.572	0.295	VARIANT	Y -> F	10329007	1
Q13705/E459D	Q13705	ACVR2B	AVR2B_HUMAN	E459D	791	αH	-	-	CVTIEeWDHDA	0.352	0.286	0.49	0.238	0.327	0.249	0.61	0.253	VARIANT	E -> D (in dbSNP:rs500611)	9621519	1
Q13705/P176R	Q13705	ACVR2B	AVR2B_HUMAN	P176R	11	N-term-β1	-	-	DIHEDpPPPPS	0.598	0.481	0.547	0.452	0.39	0.453	0.58	0.267	VARIANT	P -> R (in dbSNP:rs35882617)	17344846	1
Q13705/R40H	Q13705	ACVR2B	AVR2B_HUMAN	R40H	-	-	-	-	NWELErNQSGL									VARIANT	R -> H (in HTX4; dbSNP:rs121434437)	9916847	1
Q13705/V494I	Q13705	ACVR2B	AVR2B_HUMAN	V494I	846	C-term-αI	-	-	TSDCLvLVTSV	0.121	0.096	0.445	0.105	0.096	0.127	0.698	0.087	VARIANT	V -> I (in HTX4; dbSNP:rs121434438)	9916847	1
Q13873/A162P	Q13873	BMPR2	BMPR2_HUMAN	A162P	-	-	-	-	SVSVLaLIVAL									VARIANT	A -> P (in PPH1; unknown pathological significance; unchanged subcellular localization)	24936649,28507310	2
Q13873/C117Y	Q13873	BMPR2	BMPR2_HUMAN	C117Y	-	-	-	-	TYRFCcSTDLC									VARIANT	C -> Y (in PPH1; dbSNP:rs1085307215)	11015450	1
Q13873/C118W	Q13873	BMPR2	BMPR2_HUMAN	C118W	-	-	-	-	YRFCCcTDLCN									VARIANT	C -> W (in PPH1; dbSNP:rs137852743)	10973254	1
Q13873/C123R	Q13873	BMPR2	BMPR2_HUMAN	C123R	-	-	-	-	CSTDLcVNFTE									VARIANT	C -> R (in PPH1; dbSNP:rs137852750)	11115378	1
Q13873/C123S	Q13873	BMPR2	BMPR2_HUMAN	C123S	-	-	-	-	CSTDLcVNFTE									VARIANT	C -> S (in PPH1; dbSNP:rs137852750)	11115378	1
Q13873/C347Y	Q13873	BMPR2	BMPR2_HUMAN	C347Y	492	Catalytic-loop	-	-	KNDGTcISDFG	0.727	0.744	0.578	0.619	0.548	0.674	0.525	0.51	VARIANT	C -> Y (in PPH1; dbSNP:rs137852744)	10973254	1
Q13873/C420R	Q13873	BMPR2	BMPR2_HUMAN	C420R	618	αF	-	-	EIFMRcDLFPG	0.772	0.698	0.367	0.497	0.619	0.653	0.381	0.657	VARIANT	C -> R (in PPH1; dbSNP:rs1085307324)	11115378	1
Q13873/C483R	Q13873	BMPR2	BMPR2_HUMAN	C483R	792	αH	-	-	ETIEDcDQDAE	0.888	0.812	0.354	0.556	0.711	0.683	0.334	0.648	VARIANT	C -> R (in PPH1; sporadic; dbSNP:rs1085307354)	11015450,12358323	2
Q13873/C60Y	Q13873	BMPR2	BMPR2_HUMAN	C60Y	-	-	-	-	NGTILcKGSTC									VARIANT	C -> Y (in PPH1; dbSNP:rs1085307172)	11015450	1
Q13873/C84F	Q13873	BMPR2	BMPR2_HUMAN	C84F	-	-	-	-	LVKQGcSHIGD									VARIANT	C -> F (in PPH1; alters alternative splicing of BMPR2; dbSNP:rs1085307197)	24936649,28507310	2
Q13873/D264N	Q13873	BMPR2	BMPR2_HUMAN	D264N	209	β4/β5-loop	-	-	RFIVGdRVTAD	0.436	0.344	0.433	0.291	0.302	0.325	0.596	0.299	VARIANT	D -> N (in PPH1; unknown pathological significance; unchanged subcellular localization)	24936649,28507310	2
Q13873/D485G	Q13873	BMPR2	BMPR2_HUMAN	D485G	794	αH/αI	-	loss	IEDCWdDAEAR	0.801	0.735	0.538	0.541	0.527	0.666	0.566	0.563	VARIANT	D -> G (in PPH1; complete loss of function; dbSNP:rs137852745)	10973254,11115378	2
Q13873/E224D	Q13873	BMPR2	BMPR2_HUMAN	E224D	72	β2/β3-loop	-	-	KGSLDePVAVK	0.184	0.159	0.59	0.312	0.124	0.123	0.7	0.104	VARIANT	E -> D (in dbSNP:rs754343081)	11115378	1
Q13873/G182D	Q13873	BMPR2	BMPR2_HUMAN	G182D	10	N-term-β1	-	-	GDRKQgHSMNM	0.352	0.352	0.511	0.317	0.308	0.262	0.618	0.315	VARIANT	G -> D (in PPH1; dbSNP:rs137852754)	12358323	1
Q13873/H87Y	Q13873	BMPR2	BMPR2_HUMAN	H87Y	-	-	-	-	QGCWShGDPQE									VARIANT	H -> Y (in PPH1; unknown pathological significance; unchanged subcellular localization)	24936649,28507310	2
Q13873/I77L	Q13873	BMPR2	BMPR2_HUMAN	I77L	-	-	-	-	KSKGDiLVKQG									VARIANT	I -> L (in PPH1; unknown pathological significance; unchanged subcellular localization)	24936649,28507310	2
Q13873/K467R	Q13873	BMPR2	BMPR2_HUMAN	K467R	677	αG/αH	-	-	FPEAWkNSLAV	0.138	0.133	0.524	0.161	0.122	0.11	0.713	0.14	VARIANT	K -> R (in PPH1; unknown pathological significance; unchanged subcellular localization)	28507310	1
Q13873/K512T	Q13873	BMPR2	BMPR2_HUMAN	K512T	839	C-term-αI	-	-	IWERNkVSPTV	0.516	0.486	0.469	0.455	0.268	0.345	0.59	0.266	VARIANT	K -> T (in PPH1; dbSNP:rs1085307364)	11115378	1
Q13873/N519K	Q13873	BMPR2	BMPR2_HUMAN	N519K	846	C-term-αI	-	-	VSPTVnMSTAM	0.499	0.464	0.492	0.371	0.3	0.356	0.637	0.313	VARIANT	N -> K (in PPH1; dbSNP:rs1085307365)		0
Q13873/P138A	Q13873	BMPR2	BMPR2_HUMAN	P138A	-	-	-	-	PPDTTpSPPHS									VARIANT	P -> A (in PPH1; unknown pathological significance; unchanged subcellular localization)	28507310	1
Q13873/Q109H	Q13873	BMPR2	BMPR2_HUMAN	Q109H	-	-	-	-	TPPSIqGTYRF									VARIANT	Q -> H (in PPH1; unknown pathological significance; unchanged subcellular localization)	28507310	1
Q13873/Q82H	Q13873	BMPR2	BMPR2_HUMAN	Q82H	-	-	-	-	INLVKqCWSHI									VARIANT	Q -> H (in PPH1; dbSNP:rs1085307185)	12358323	1
Q13873/Q92L	Q13873	BMPR2	BMPR2_HUMAN	Q92L	-	-	-	-	HIGDPqCHYEE									VARIANT	Q -> L (in PPH1; unknown pathological significance; unchanged subcellular localization)	24936649,28507310	2
Q13873/R248G	Q13873	BMPR2	BMPR2_HUMAN	R248G	179	αC/β4-loop	-	-	EKNIYrPLMEH	0.369	0.347	0.508	0.369	0.194	0.267	0.652	0.135	VARIANT	R -> G (in PPH1; unknown pathological significance; unchanged subcellular localization)	28507310	1
Q13873/R491Q	Q13873	BMPR2	BMPR2_HUMAN	R491Q	802	αI	-	-	QDAEArTAQCA	0.865	0.869	0.397	0.64	0.675	0.732	0.34	0.545	VARIANT	R -> Q (in PPH1; sporadic; dbSNP:rs137852749)	10903931	1
Q13873/R491W	Q13873	BMPR2	BMPR2_HUMAN	R491W	802	αI	-	-	QDAEArTAQCA	0.887	0.882	0.346	0.675	0.747	0.771	0.282	0.463	VARIANT	R -> W (in PPH1; dbSNP:rs137852746)	10903931	1
Q13873/R899P	Q13873	BMPR2	BMPR2_HUMAN	R899P	-	-	-	activating	PLEGGrNSNNN									VARIANT	R -> P (in PPH1; leads to constitutive activation of the MAPK14 pathway; dbSNP:rs137852752)	15965979	1
Q13873/S64R	Q13873	BMPR2	BMPR2_HUMAN	S64R	-	-	-	-	LCSKGsCYGLW									VARIANT	S -> R (in PPH1; unknown pathological significance; unchanged subcellular localization)	28507310	1
Q13873/S775N	Q13873	BMPR2	BMPR2_HUMAN	S775N	-	-	-	neutral	RLKFGsHKSNL									VARIANT	S -> N (unchanged subcellular localization; dbSNP:rs2228545)	17344846,24936649,28507310	3
Q13873/S863N	Q13873	BMPR2	BMPR2_HUMAN	S863N	-	-	p	-	LNINSsDEHEP									VARIANT	S -> N (in PPH1; abnormal subcellular localization; significant increase in apoptosis of endothelial cells; significant decrease in proliferation of endothelial cells; significant decrease in nitric oxide synthesis by endothelial cells; significant increase in endothelin 1 synthesis by endothelial cells; dbSNP:rs1006246556)	25187962	1
Q13873/V341M	Q13873	BMPR2	BMPR2_HUMAN	V341M	451	Catalytic-loop	-	-	SRNVLvNDGTC	0.58	0.597	0.459	0.517	0.445	0.458	0.512	0.34	VARIANT	V -> M (in PPH1; unknown pathological significance; unchanged subcellular localization; dbSNP:rs767882551)	24936649,28507310	2
Q13873/Y67C	Q13873	BMPR2	BMPR2_HUMAN	Y67C	-	-	-	-	KGSTCyLWEKS									VARIANT	Y -> C (in PPH1; significant decrease in nitric oxide synthesis by endothelial cells; dbSNP:rs1085307177)	25187962	1
Q13882/A436T	Q13882	PTK6	PTK6_HUMAN	A436T	805	αI	-	-	RPCFKaRERLS	0.176	0.101	0.413	0.172	0.08	0.108	0.68	0.082	VARIANT	A -> T (in dbSNP:rs56145017)	17344846	1
Q13882/K219M	Q13882	PTK6	PTK6_HUMAN	K219M	129	β3;Catalytic-Lys	-	loss	VQVAIkISRDN	1.0	1.0	0.038	0.592	0.99	0.999	0.031	0.471	MUTAGEN	K->M: Abolishes kinase activity and cell transformation, and phosphorylation of STAP2.	10980601,15471878,8940083	3
Q13882/K219R	Q13882	PTK6	PTK6_HUMAN	K219R	129	β3;Catalytic-Lys	-	loss	VQVAIkISRDN	1.0	1.0	0.05	0.708	1.0	0.999	0.029	0.53	MUTAGEN	K->R: Abolishes kinase activity.	27480927	1
Q13882/L16F	Q13882	PTK6	PTK6_HUMAN	L16F	-	-	-	-	PKYVGlDFKSR									VARIANT	L -> F (in a renal papillary sample; somatic mutation)	17344846	1
Q13882/R105L	Q13882	PTK6	PTK6_HUMAN	R105L	-	-	-	decrease	GAFLIrSEKPS									MUTAGEN	R->L: Decrease in STAP2 phosphorylation.	10980601	1
Q13882/W184A	Q13882	PTK6	PTK6_HUMAN	W184A	23	N-term-β1	-	loss	PHWDDwRPREE	0.896	0.87	0.285	0.583	0.763	0.866	0.241	0.687	MUTAGEN	W->A: Abrogates interaction between PTK6-domain kinase and PTK6-linker. Abrogates autophosphorylation and phosphorylation of KHDRBS1.	15961400	1
Q13882/W44A	Q13882	PTK6	PTK6_HUMAN	W44A	-	-	-	decrease	RKEEQwWATLL									MUTAGEN	W->A: Strong decrease in STAP2 phosphorylation. Markedly decreased interaction between SH3 domain the linker region.	10980601,17822667	2
Q13882/Y342A	Q13882	PTK6	PTK6_HUMAN	Y342A	511	A-loop	p	decrease	IKEDVySHDHN	0.951	0.894	0.445	0.833	0.771	0.897	0.3	0.694	MUTAGEN	Y->A: 3-fold lower specific kinase activity. Decreased, but still significant, autophosphorylation. Decreased, but still significant, autophosphorylation; when associated with A-447.	12121988	1
Q13882/Y447F	Q13882	PTK6	PTK6_HUMAN	Y447F	819	αI	p	increase	SSFTSyNPT	0.847	0.885	0.619	0.875	0.323	0.721	0.631	0.326	MUTAGEN	Y->F: Decrease in transforming potential and increase in the kinase activity level. Decreased, but still significant, autophosphorylation; when associated with A-342.	12121988,15471878,8940083	3
Q13882/Y66A	Q13882	PTK6	PTK6_HUMAN	Y66A	-	-	-	decrease	YVPHNyAERET									MUTAGEN	Y->A: Decrease in STAP2 phosphorylation.	10980601	1
Q13976/G666A	Q13976	PRKG1	KGP1_HUMAN	G666A	-	-	-	-	PDDNSgDIDF									VARIANT	G -> A (in dbSNP:rs750949508)	23910461	1
Q13976/I19A	Q13976	PRKG1	KGP1_HUMAN	I19A	-	-	-	-	LKEERiELEKR									MUTAGEN	I->A: Loss of binding to PPP1R12A.	10567269	1
Q13976/I249V	Q13976	PRKG1	KGP1_HUMAN	I249V	-	-	-	-	NGEYIiQGARG									VARIANT	I -> V (in dbSNP:rs56082459)	17344846	1
Q13976/I33A	Q13976	PRKG1	KGP1_HUMAN	I33A	-	-	-	-	EKEEEiELKRK									MUTAGEN	I->A: Loss of binding to PPP1R12A.	10567269	1
Q13976/L12A	Q13976	PRKG1	KGP1_HUMAN	L12A	-	-	-	-	DFAKIlLKEER									MUTAGEN	L->A: Loss of binding to PPP1R12A.	10567269	1
Q13976/L26P	Q13976	PRKG1	KGP1_HUMAN	L26P	-	-	-	-	ELEKRlEKEEE									MUTAGEN	L->P: Loss of binding to PPP1R12A.	10567269	1
Q13976/L281A	Q13976	PRKG1	KGP1_HUMAN	L281A	-	-	-	-	EDPVFlTLGKG									MUTAGEN	L->A: Reduces cGMP binding affinity.	24239458	1
Q13976/L40A	Q13976	PRKG1	KGP1_HUMAN	L40A	-	-	-	-	ELKRKlKCQSV									MUTAGEN	L->A: Loss of binding to PPP1R12A.	10567269	1
Q13976/N267S	Q13976	PRKG1	KGP1_HUMAN	N267S	-	-	-	neutral	SKGTVnTREDS									VARIANT	N -> S (in dbSNP:rs34997494)	17344846	1
Q13976/R177Q	Q13976	PRKG1	KGP1_HUMAN	R177Q	-	-	-	activating	LYNCTrATVKT									VARIANT	R -> Q (in AAT8; impairs cGMP binding; the mutant protein is constitutively active; dbSNP:rs397515330)	23910461	1
Q13976/R282A	Q13976	PRKG1	KGP1_HUMAN	R282A	-	-	-	-	DPVFLrLGKGD									MUTAGEN	R->A: Reduces cGMP binding affinity.	24239458	1
Q13976/T302A	Q13976	PRKG1	KGP1_HUMAN	T302A	-	-	-	-	GEDVRtNVIAA									MUTAGEN	T->A: Reduces cGMP binding affinity.	24239458	1
Q13976/Y336A	Q13976	PRKG1	KGP1_HUMAN	Y336A	8	N-term-β1	-	-	VSNKAyDAEAK	0.47	0.49	0.441	0.291	0.505	0.441	0.446	0.232	MUTAGEN	Y->A: Reduces cGMP binding affinity.	24239458	1
Q13976/Y474F	Q13976	PRKG1	KGP1_HUMAN	Y474F	419	αE	-	-	VEAFAyHSKGI	0.732	0.677	0.532	0.609	0.432	0.585	0.563	0.566	VARIANT	Y -> F (in dbSNP:rs149710600)	23910461	1
Q14004/G714R	Q14004	CDK13	CDK13_HUMAN	G714R	42	β1;Gly-rich-loop	-	-	GIIGEgYGQVY	0.906	0.897	0.33	0.655	0.832	0.853	0.295	0.395	VARIANT	G -> R (in CHDFIDD; dbSNP:rs1057519633)	27479907	1
Q14004/G717R	Q14004	CDK13	CDK13_HUMAN	G717R	45	Gly-rich-loop;β2	-	-	GEGTYgVYKAR	0.898	0.898	0.295	0.695	0.856	0.851	0.268	0.478	VARIANT	G -> R (in CHDFIDD; dbSNP:rs1057519632)	27479907	1
Q14004/K734E	Q14004	CDK13	CDK13_HUMAN	K734E	129	β3;Catalytic-Lys	-	-	EMVALkVRLDN	1.0	0.997	0.1	0.759	0.982	0.985	0.111	0.474	VARIANT	K -> E (in CHDFIDD; dbSNP:rs1064795731)	28807008	1
Q14004/L403F	Q14004	CDK13	CDK13_HUMAN	L403F	-	-	-	neutral	PYSPVlRSGKS									VARIANT	L -> F (in dbSNP:rs3735137)		0
Q14004/N842D	Q14004	CDK13	CDK13_HUMAN	N842D	448	Catalytic-loop	-	-	DIKCSnLLNNR	0.942	0.933	0.403	0.745	0.8	0.879	0.383	0.492	VARIANT	N -> D (in CHDFIDD; dbSNP:rs1554333853)	28807008	1
Q14004/N842S	Q14004	CDK13	CDK13_HUMAN	N842S	448	Catalytic-loop	-	-	DIKCSnLLNNR	0.946	0.922	0.242	0.649	0.905	0.885	0.156	0.646	VARIANT	N -> S (in CHDFIDD; dbSNP:rs878853160)	27479907,28807008	2
Q14004/P356A	Q14004	CDK13	CDK13_HUMAN	P356A	-	-	-	-	YSRRLpSPSPY									VARIANT	P -> A (in dbSNP:rs17537669)		0
Q14004/Q103R	Q14004	CDK13	CDK13_HUMAN	Q103R	-	-	-	-	RAGGRqRRRGP									VARIANT	Q -> R (in RNA edited version)		0
Q14004/R410Q	Q14004	CDK13	CDK13_HUMAN	R410Q	-	-	-	-	RSGKSrRSPYS									VARIANT	R -> Q (in dbSNP:rs17496261)		0
Q14004/R700L	Q14004	CDK13	CDK13_HUMAN	R700L	26	N-term-β1	-	-	IDWGKrVDKFD	0.774	0.782	0.565	0.628	0.572	0.657	0.498	0.385	VARIANT	R -> L (in dbSNP:rs1057000)	11162436,1731328	2
Q14004/R751Q	Q14004	CDK13	CDK13_HUMAN	R751Q	172	αC	-	-	PITAIrIKILR	0.81	0.841	0.421	0.664	0.708	0.768	0.373	0.467	VARIANT	R -> Q (in CHDFIDD; dbSNP:rs1057519634)	27479907	1
Q14004/S340F	Q14004	CDK13	CDK13_HUMAN	S340F	-	-	p	-	LRSRKsSPAGG									VARIANT	S -> F (in dbSNP:rs13622)		0
Q14004/S624G	Q14004	CDK13	CDK13_HUMAN	S624G	-	-	-	-	DKEADsRGNIS									VARIANT	S -> G (in dbSNP:rs17496275)		0
Q14004/T494A	Q14004	CDK13	CDK13_HUMAN	T494A	-	-	p	-	ASNTStTKGNT									VARIANT	T -> A (in dbSNP:rs34624759)	17344846	1
Q14004/T500A	Q14004	CDK13	CDK13_HUMAN	T500A	-	-	-	neutral	PTKGNtTSASA									VARIANT	T -> A (in dbSNP:rs3735135)	17344846	1
Q14004/T670R	Q14004	CDK13	CDK13_HUMAN	T670R	-	-	-	neutral	PEEKKtTQLHS									VARIANT	T -> R (in dbSNP:rs34775357)	17344846	1
Q14004/V1062M	Q14004	CDK13	CDK13_HUMAN	V1062M	-	-	-	-	NTPQGvPSSQL									VARIANT	V -> M (in dbSNP:rs17496712)		0
Q14004/V1170M	Q14004	CDK13	CDK13_HUMAN	V1170M	-	-	-	neutral	TIQPKvTDAAQ									VARIANT	V -> M (in dbSNP:rs3204309)	11162436,17344846	2
Q14012/E361K	Q14012	CAMK1	KCC1A_HUMAN	E361K	-	-	-	neutral	VEPGTeSPTLP									VARIANT	E -> K (in dbSNP:rs56033923)	17344846	1
Q14012/K49A	Q14012	CAMK1	KCC1A_HUMAN	K49A	129	β3;Catalytic-Lys	-	loss	KLVAIkIAKEA	0.999	0.994	0.011	0.647	1.0	0.998	0.005	0.673	MUTAGEN	K->A: Catalytically inactive form; prevents CDK4 activation.	14754892,7641687	2
Q14012/P217S	Q14012	CAMK1	KCC1A_HUMAN	P217S	621	αF/αG	-	-	LCGYPpYDEND	0.841	0.778	0.493	0.694	0.52	0.699	0.426	0.647	VARIANT	P -> S (in a metastatic melanoma sample; somatic mutation; dbSNP:rs907102077)	17344846	1
Q14012/T177A	Q14012	CAMK1	KCC1A_HUMAN	T177A	545	A-loop	p	loss	GSVLStCGTPG	0.993	0.988	0.19	0.917	0.96	0.993	0.101	0.423	MUTAGEN	T->A: Loss of activation by CaMKK1.	7641687	1
Q14012/T177D	Q14012	CAMK1	KCC1A_HUMAN	T177D	545	A-loop	p	increase	GSVLStCGTPG	0.999	0.993	0.86	0.985	0.106	0.952	0.894	0.433	MUTAGEN	T->D: Partial activation in absence of CaMKK1.	7641687	1
Q14164/A371T	Q14164	IKBKE	IKKE_HUMAN	A371T	-	-	-	neutral	SAQHIaTTASS									VARIANT	A -> T (in dbSNP:rs17021877)	17344846	1
Q14164/A602V	Q14164	IKBKE	IKKE_HUMAN	A602V	-	-	-	neutral	VQKYQaLVTHG									VARIANT	A -> V (in dbSNP:rs12059562)	17344846	1
Q14164/E128K	Q14164	IKBKE	IKKE_HUMAN	E128K	425	αE	-	-	MNHLReGIVHR	0.174	0.123	0.465	0.184	0.149	0.158	0.627	0.165	VARIANT	E -> K (in dbSNP:rs41296028)		0
Q14164/E168A	Q14164	IKBKE	IKKE_HUMAN	E168A	514	A-loop	-	decrease	ELDDDeFVSVY	0.803	0.843	0.463	0.593	0.648	0.714	0.408	0.479	MUTAGEN	E->A: Slight decrease of kinase activity.	10421793	1
Q14164/E515D	Q14164	IKBKE	IKKE_HUMAN	E515D	-	-	-	neutral	SQNITeQESLS									VARIANT	E -> D (in dbSNP:rs41299015)		0
Q14164/G660E	Q14164	IKBKE	IKKE_HUMAN	G660E	-	-	-	-	QDRAKgQASPP									VARIANT	G -> E (in dbSNP:rs55822317)	17344846	1
Q14164/I543M	Q14164	IKBKE	IKKE_HUMAN	I543M	-	-	-	neutral	RSIQQiCCLDK									VARIANT	I -> M (in dbSNP:rs41299037)		0
Q14164/K231R	Q14164	IKBKE	IKKE_HUMAN	K231R	831	C-term-αI	sm	-	GPRRNkIMYRI	0.477	0.409	0.505	0.471	0.307	0.325	0.689	0.151	MUTAGEN	K->R: Loss of sumoylation and loss of targeting to nuclear bodies.	20188669	1
Q14164/K30A	Q14164	IKBKE	IKKE_HUMAN	K30A	65	β2/β3-loop	ub	decrease	KARNKkGELVA	0.839	0.819	0.372	0.692	0.75	0.728	0.35	0.459	MUTAGEN	K->A: Loss of ubiquitination and decreased kinase activity. No effect on homodimerization.	23453969	1
Q14164/K30R	Q14164	IKBKE	IKKE_HUMAN	K30R	65	β2/β3-loop	ub	decrease	KARNKkGELVA	0.52	0.419	0.445	0.322	0.523	0.387	0.538	0.239	MUTAGEN	K->R: Loss of ubiquitination and decreased kinase activity. Decreases interaction with IKBKB, IKBKG and MYD88. No effect on homodimerization.	23453969	1
Q14164/K38A	Q14164	IKBKE	IKKE_HUMAN	K38A	129	β3;Catalytic-Lys	-	loss	ELVAVkFNTTS	1.0	1.0	0.007	0.621	1.0	0.999	0.001	0.663	MUTAGEN	K->A: Loss of kinase activity and loss of nuclear import.	10421793	1
Q14164/K401A	Q14164	IKBKE	IKKE_HUMAN	K401A	-	-	ub	decrease	ALDVPkVPKVD									MUTAGEN	K->A: Loss of ubiquitination and decreased kinase activity. No effect on homodimerization.	23453969	1
Q14164/K401R	Q14164	IKBKE	IKKE_HUMAN	K401R	-	-	ub	decrease	ALDVPkVPKVD									MUTAGEN	K->R: Loss of ubiquitination and decreased kinase activity. Decreases interaction with IKBKB, IKBKG and MYD88. No effect on homodimerization.	23453969	1
Q14164/K416A	Q14164	IKBKE	IKKE_HUMAN	K416A	-	-	-	-	DYNTAkVLGAG									MUTAGEN	K->A: No effect on ubiquitination.	23453969	1
Q14164/K416R	Q14164	IKBKE	IKKE_HUMAN	K416R	-	-	-	-	DYNTAkVLGAG									MUTAGEN	K->R: No effect on ubiquitination.	23453969	1
Q14164/P713L	Q14164	IKBKE	IKKE_HUMAN	P713L	-	-	-	neutral	NRVPApDV									VARIANT	P -> L (in dbSNP:rs3748022)	17344846	1
Q14164/S172A	Q14164	IKBKE	IKKE_HUMAN	S172A	545	A-loop	p	loss	DEKFVsYGTEE	0.99	0.996	0.155	0.874	0.976	0.972	0.139	0.322	MUTAGEN	S->A: Loss of autophosphorylation and of kinase activity.	10421793	1
Q14164/S172E	Q14164	IKBKE	IKKE_HUMAN	S172E	545	A-loop	p	decrease	DEKFVsYGTEE	0.984	0.984	0.739	0.968	0.539	0.947	0.736	0.225	MUTAGEN	S->E: Decrease in kinase activity.	10421793	1
Q14164/T483M	Q14164	IKBKE	IKKE_HUMAN	T483M	-	-	-	neutral	SSVAGtEIQEL									VARIANT	T -> M (in dbSNP:rs52817862)	17344846	1
Q14289/E970K	Q14289	PTK2B	FAK2_HUMAN	E970K	-	-	-	-	VTSLSeCKRQM									VARIANT	E -> K (in dbSNP:rs56263944)	17344846	1
Q14289/K457A	Q14289	PTK2B	FAK2_HUMAN	K457A	129	β3;Catalytic-Lys	-	loss	INVAVkCKKDC	1.0	0.993	0.008	0.586	1.0	0.999	0.003	0.654	MUTAGEN	K->A: Abolishes kinase activity.	15166227	1
Q14289/K838T	Q14289	PTK2B	FAK2_HUMAN	K838T	-	-	-	neutral	VYMNDkPLTPE									VARIANT	K -> T (in dbSNP:rs751019)	17344846,19369195	2
Q14289/L808P	Q14289	PTK2B	FAK2_HUMAN	L808P	-	-	-	-	KMRQIlKQQKQ									VARIANT	L -> P (in dbSNP:rs55747955)	17344846	1
Q14289/P859A	Q14289	PTK2B	FAK2_HUMAN	P859A	-	-	-	-	GPPQKpRLGAQ									MUTAGEN	P->A: Loss of interaction with NPHP1.	11493697	1
Q14289/Q359E	Q14289	PTK2B	FAK2_HUMAN	Q359E	-	-	-	neutral	LQGEHqSLIIH									VARIANT	Q -> E (in dbSNP:rs56175011)	17344846	1
Q14289/R698H	Q14289	PTK2B	FAK2_HUMAN	R698H	831	C-term-αI	-	-	QERNArRTPKI	0.216	0.263	0.633	0.28	0.256	0.164	0.801	0.134	VARIANT	R -> H (in dbSNP:rs35174236)	17344846	1
Q14289/Y402F	Q14289	PTK2B	FAK2_HUMAN	Y402F	5	N-term-β1	p	loss	IESDIyEIPDE	0.849	0.857	0.512	0.861	0.55	0.765	0.476	0.44	MUTAGEN	Y->F: Abolishes autophosphorylation. Abolishes interaction with SRC.	8849729	1
Q14289/Y881F	Q14289	PTK2B	FAK2_HUMAN	Y881F	-	-	p	decrease	TDDLVyNVMEL									MUTAGEN	Y->F: Loss of phosphorylation site. Strongly reduced interaction with GRB2.	20521079	1
Q14296/A436V	Q14296	FASTK	FASTK_HUMAN	A436V	-	-	-	-	DFLLCaSSGAV									VARIANT	A -> V (in dbSNP:rs2288648)		0
Q14296/M35G	Q14296	FASTK	FASTK_HUMAN	M35G	-	-	-	-	PSPNSmRVLLS									MUTAGEN	M->G: Abolishes isoform 4 expression.	25704814	1
Q14296/V424L	Q14296	FASTK	FASTK_HUMAN	V424L	-	-	-	-	RQDLTvPGYCT									VARIANT	V -> L (in a lung adenocarcinoma sample; somatic mutation; dbSNP:rs758691941)	17344846	1
Q14680/C154A	Q14680	MELK	MELK_HUMAN	C154A	501	A-loop	-	-	IDFGLcKPKGN	0.752	0.773	0.507	0.585	0.442	0.658	0.476	0.501	MUTAGEN	C->A: Abolishes dependence to reducing agents; when associated with V-29; V-70; A-89; A-168; A-169; A-204; A-286 and A-339.	16216881	1
Q14680/C168A	Q14680	MELK	MELK_HUMAN	C168A	546	A-loop	-	-	YHLQTcGSLAY	0.808	0.815	0.464	0.585	0.665	0.728	0.448	0.509	MUTAGEN	C->A: Abolishes dependence to reducing agents; when associated with V-29; V-70; A-89; A-154; A-169; A-204; A-286 and A-339.	16216881	1
Q14680/C169A	Q14680	MELK	MELK_HUMAN	C169A	547	A-loop	-	-	HLQTCcSLAYA	0.82	0.797	0.462	0.665	0.608	0.726	0.385	0.679	MUTAGEN	C->A: Abolishes dependence to reducing agents; when associated with V-29; V-70; A-89; A-154; A-168; A-204; A-286 and A-339.	16216881	1
Q14680/C204A	Q14680	MELK	MELK_HUMAN	C204A	614	αF	-	-	LYVLMcFLPFD	0.654	0.671	0.509	0.52	0.381	0.505	0.568	0.365	MUTAGEN	C->A: Abolishes dependence to reducing agents; when associated with V-29; V-70; A-89; A-154; A-168; A-169; A-286 and A-339.	16216881	1
Q14680/C286A	Q14680	MELK	MELK_HUMAN	C286A	846	C-term-αI	-	-	HLDDDcTELSV	0.533	0.416	0.434	0.436	0.455	0.461	0.439	0.449	MUTAGEN	C->A: Abolishes dependence to reducing agents; when associated with V-29; V-70; A-89; A-154; A-168; A-169; A-204; and A-339.	16216881	1
Q14680/C29V	Q14680	MELK	MELK_HUMAN	C29V	55	β2/β3-loop	-	-	KVKLAcILTGE	0.144	0.136	0.465	0.166	0.17	0.167	0.609	0.186	MUTAGEN	C->V: Abolishes dependence to reducing agents; when associated with V-70; A-89; A-154; A-168; A-169; A-204; A-286 and A-339.	16216881	1
Q14680/C339A	Q14680	MELK	MELK_HUMAN	C339A	-	-	-	-	LSSFScQASAT									MUTAGEN	C->A: Abolishes dependence to reducing agents; when associated with V-29; V-70; A-89; A-154; A-168; A-169; A-204 and A-286.	16216881	1
Q14680/C70V	Q14680	MELK	MELK_HUMAN	C70V	201	β4	-	-	RHQHIcLYHVL	0.319	0.293	0.513	0.327	0.206	0.235	0.646	0.309	MUTAGEN	C->V: Abolishes dependence to reducing agents; when associated with V-29; A-89; A-154; A-168; A-169; A-204; A-286 and A-339.	16216881	1
Q14680/C89A	Q14680	MELK	MELK_HUMAN	C89A	252	β5/αD-loop	-	-	MVLEYcGGELF	0.633	0.69	0.436	0.588	0.484	0.575	0.503	0.525	MUTAGEN	C->A: Abolishes dependence to reducing agents; when associated with V-29; V-70; A-154; A-168; A-169; A-204; A-286 and A-339.	16216881	1
Q14680/D150A	Q14680	MELK	MELK_HUMAN	D150A	496	A-loop;DFG-motif	-	loss	KLKLIdGLCAK	0.996	0.981	0.094	0.528	0.994	0.974	0.042	0.65	MUTAGEN	D->A: Abolishes enzymatic activity.	14699119,16216881,17280616	3
Q14680/K219R	Q14680	MELK	MELK_HUMAN	K219R	637	αG	-	neutral	VMALYkIMRGK	0.07	0.076	0.448	0.074	0.067	0.071	0.691	0.077	VARIANT	K -> R (in dbSNP:rs35142210)	17344846	1
Q14680/R333K	Q14680	MELK	MELK_HUMAN	R333K	-	-	-	neutral	KPVRLrSSFSC									VARIANT	R -> K (in dbSNP:rs34655121)	17344846	1
Q14680/S171A	Q14680	MELK	MELK_HUMAN	S171A	549	A-loop	p	loss	QTCCGsAYAAP	0.899	0.932	0.278	0.685	0.839	0.845	0.192	0.433	MUTAGEN	S->A: Abolishes activation of serine/threonine-protein kinase activity and has only weak activity.	16216881	1
Q14680/S171D	Q14680	MELK	MELK_HUMAN	S171D	549	A-loop	p	loss	QTCCGsAYAAP	0.954	0.963	0.569	0.835	0.688	0.873	0.488	0.412	MUTAGEN	S->D: Inactive.	16216881	1
Q14680/T167A	Q14680	MELK	MELK_HUMAN	T167A	545	A-loop	p	loss	DYHLQtCGSLA	0.999	1.0	0.157	0.911	0.95	0.994	0.11	0.446	MUTAGEN	T->A: Abolishes activation of serine/threonine-protein kinase activity and has only weak activity.	14976552	1
Q14680/T167D	Q14680	MELK	MELK_HUMAN	T167D	545	A-loop	p	-	DYHLQtCGSLA	0.999	0.993	0.862	0.991	0.117	0.945	0.881	0.373	MUTAGEN	T->D,E: Phosphomimetic mutant that has similar kinase activity as wild-type.	14976552	1
Q14680/T167E	Q14680	MELK	MELK_HUMAN	T167E	545	A-loop	p	activating	DYHLQtCGSLA	0.994	0.997	0.849	0.985	0.185	0.942	0.879	0.382	MUTAGEN	T->D,E: Phosphomimetic mutant that has similar kinase activity as wild-type.	14976552	1
Q14680/T345A	Q14680	MELK	MELK_HUMAN	T345A	-	-	-	-	GQASAtFTDIK									MUTAGEN	T->A: No effect on interaction with PPP1R8.	14699119	1
Q14680/T348I	Q14680	MELK	MELK_HUMAN	T348I	-	-	-	neutral	SATPFtIKSNN									VARIANT	T -> I (in dbSNP:rs55845414)	17344846	1
Q14680/T387A	Q14680	MELK	MELK_HUMAN	T387A	-	-	-	-	STGAAtRTSQF									MUTAGEN	T->A: No effect on interaction with PPP1R8.	14699119	1
Q14680/T409A	Q14680	MELK	MELK_HUMAN	T409A	-	-	p	-	ESKSLtALCRT									MUTAGEN	T->A: No effect on interaction with PPP1R8.	14699119	1
Q14680/T415A	Q14680	MELK	MELK_HUMAN	T415A	-	-	p	-	PALCRtANKLK									MUTAGEN	T->A: No effect on interaction with PPP1R8.	14699119	1
Q14680/T428A	Q14680	MELK	MELK_HUMAN	T428A	-	-	p	-	KENVYtKSAVK									MUTAGEN	T->A: No effect on interaction with PPP1R8.	14699119	1
Q14680/T446A	Q14680	MELK	MELK_HUMAN	T446A	-	-	p	-	FPEPKtVNKNQ									MUTAGEN	T->A: Inhibits interaction with PPP1R8.	14699119	1
Q14680/T460A	Q14680	MELK	MELK_HUMAN	T460A	-	-	p	-	REILTtNRYTT									MUTAGEN	T->A: Inhibits interaction with PPP1R8.	14699119	1
Q14680/T460M	Q14680	MELK	MELK_HUMAN	T460M	-	-	p	-	REILTtNRYTT									VARIANT	T -> M (in an ovarian mucinous carcinoma sample; somatic mutation; dbSNP:rs144052967)	17344846	1
Q14680/T466A	Q14680	MELK	MELK_HUMAN	T466A	-	-	-	-	PNRYTtSKARN									MUTAGEN	T->A: Inhibits interaction with PPP1R8.	14699119	1
Q14680/T478A	Q14680	MELK	MELK_HUMAN	T478A	-	-	p	-	QCLKEtIKIPV									MUTAGEN	T->A: Strongly inhibits interaction with PPP1R8. Enhances enzymatic activity.	14699119	1
Q14680/T518A	Q14680	MELK	MELK_HUMAN	T518A	-	-	p	-	AHMEEtKRKGA									MUTAGEN	T->A: No effect on interaction with PPP1R8.	14699119	1
Q14680/T56M	Q14680	MELK	MELK_HUMAN	T56M	172	αC	p	-	LPRIKtIEALK	0.687	0.702	0.494	0.57	0.416	0.602	0.489	0.288	VARIANT	T -> M (in dbSNP:rs35233455)	17344846	1
Q14680/Y163F	Q14680	MELK	MELK_HUMAN	Y163F	524	A-loop	p	decrease	KGNKDyLQTCC	0.666	0.734	0.42	0.528	0.523	0.595	0.498	0.168	MUTAGEN	Y->F: Abolishes autophosphorylation on tyrosine but still active on exogenous substrates.	16216881	1
Q15059/A161T	Q15059	BRD3	BRD3_HUMAN	A161T	-	-	-	-	GRKPAaAQSAG									VARIANT	A -> T (in a gastric adenocarcinoma sample; somatic mutation)	17344846	1
Q15059/A172V	Q15059	BRD3	BRD3_HUMAN	A172V	-	-	-	neutral	GTQQVaVSSVS									VARIANT	A -> V (in dbSNP:rs34609592)	17344846	1
Q15059/K435Q	Q15059	BRD3	BRD3_HUMAN	K435Q	-	-	-	neutral	APMVSkAESSR									VARIANT	K -> Q (in dbSNP:rs36093130)	17344846	1
Q15059/R441H	Q15059	BRD3	BRD3_HUMAN	R441H	-	-	-	-	GAESSrSEESS									VARIANT	R -> H (in dbSNP:rs56017928)	17344846	1
Q15059/S447P	Q15059	BRD3	BRD3_HUMAN	S447P	-	-	-	-	SSEESsDSGSS									VARIANT	S -> P (in dbSNP:rs55754444)	17344846	1
Q15059/T36N	Q15059	BRD3	BRD3_HUMAN	T36N	-	-	-	-	KPGRKtQLQYM									VARIANT	T -> N (in a renal clear cell carcinoma sample; somatic mutation)	17344846	1
Q15118/A134T	Q15118	PDK1	PDK1_HUMAN	A134T	-	-	-	neutral	AEDAKaYDFTD									VARIANT	A -> T (in dbSNP:rs35661499)		0
Q15118/N412T	Q15118	PDK1	PDK1_HUMAN	N412T	-	-	-	-	AWKHYnNHEAD									VARIANT	N -> T (in dbSNP:rs34250425)	17344846	1
Q15119/G342R	Q15119	PDK2	PDK2_HUMAN	G342R	-	-	-	-	AKYFQgLQLFS									VARIANT	G -> R (in a glioblastoma multiforme sample; somatic mutation; dbSNP:rs17855787)	15489334,17344846	2
Q15120/D121N	Q15120	PDK3	PDK3_HUMAN	D121N	-	-	-	-	RNRHNdVPTMA									MUTAGEN	D->N: No effect on kinase activity; when associated with H-120.	23297365	1
Q15120/E219A	Q15120	PDK3	PDK3_HUMAN	E219A	-	-	-	-	VAPELeEEFNA									VARIANT	E -> A (in a head & neck squamous cell carcinoma sample; somatic mutation)	17344846	1
Q15120/K114T	Q15120	PDK3	PDK3_HUMAN	K114T	-	-	-	-	LQVLIkRNRHN									VARIANT	K -> T (in dbSNP:rs146331370)	23297365	1
Q15120/N120H	Q15120	PDK3	PDK3_HUMAN	N120H	-	-	-	-	VRNRHnVVPTM									MUTAGEN	N->H: No effect on kinase activity; when associated with N-121.	23297365	1
Q15120/R158H	Q15120	PDK3	PDK3_HUMAN	R158H	-	-	-	activating	RFYTNrSFRML									VARIANT	R -> H (in CMTX6; gain of function; results in a 5-fold increase in kinase activity, decreased sensitivity to pyruvate inhibition, reduced affinity for nucleotides and increased affinity for pyruvate dehydrogenase complex component E2 (PDC-E2), leading to PDC hyperphosphorylation and increased inactivation; dbSNP:rs397515323)	23297365	1
Q15120/Y334S	Q15120	PDK3	PDK3_HUMAN	Y334S	-	-	-	-	PISRLyRYFQG									VARIANT	Y -> S	23297365	1
Q15131/C358Y	Q15131	CDK10	CDK10_HUMAN	C358Y	-	-	-	neutral	GQSKRcP									VARIANT	C -> Y (in dbSNP:rs56242003)	17344846	1
Q15131/N168S	Q15131	CDK10	CDK10_HUMAN	N168S	448	Catalytic-loop	-	-	DLKVSnLMTDK	0.939	0.921	0.259	0.681	0.901	0.877	0.186	0.625	VARIANT	N -> S (in dbSNP:rs56340740)	17344846	1
Q15131/P96L	Q15131	CDK10	CDK10_HUMAN	P96L	194	αC/β4-loop	-	neutral	LRLRHpIVELK	0.356	0.397	0.477	0.327	0.323	0.362	0.506	0.486	VARIANT	P -> L (in dbSNP:rs55819627)	17344846	1
Q15131/R342H	Q15131	CDK10	CDK10_HUMAN	R342H	842	C-term-αI	-	-	TFPHHrKRAAP	0.518	0.375	0.505	0.347	0.269	0.272	0.675	0.322	VARIANT	R -> H (in dbSNP:rs55757604)	17344846	1
Q15139/E857K	Q15139	PRKD1	KPCD1_HUMAN	E857K	841	C-term-αI	-	-	ECKIGeYITHE	0.12	0.124	0.489	0.195	0.136	0.119	0.688	0.129	VARIANT	E -> K (in a colorectal cancer sample; somatic mutation)	16959974	1
Q15139/G592R	Q15139	PRKD1	KPCD1_HUMAN	G592R	42	β1;Gly-rich-loop	-	-	EVLGSgFGIVY	0.886	0.917	0.399	0.703	0.781	0.86	0.383	0.456	VARIANT	G -> R (in CHDED; dbSNP:rs1057519635)	27479907	1
Q15139/H152Y	Q15139	PRKD1	KPCD1_HUMAN	H152Y	-	-	-	-	HALFVhYRAPA									VARIANT	H -> Y (in a colorectal cancer sample; somatic mutation; dbSNP:rs1383618278)	16959974	1
Q15139/H891R	Q15139	PRKD1	KPCD1_HUMAN	H891R	-	-	-	neutral	NPSAShDTPET									VARIANT	H -> R (in dbSNP:rs45582934)	17344846	1
Q15139/K478Q	Q15139	PRKD1	KPCD1_HUMAN	K478Q	-	-	-	-	SLEPVkSALIP									VARIANT	K -> Q (in dbSNP:rs55852813)	17344846	1
Q15139/K612W	Q15139	PRKD1	KPCD1_HUMAN	K612W	129	β3;Catalytic-Lys	-	loss	RDVAIkIDKLR	1.0	0.985	0.017	0.667	0.996	0.995	0.013	0.509	MUTAGEN	K->W: Loss of kinase activity.	12637538	1
Q15139/L299W	Q15139	PRKD1	KPCD1_HUMAN	L299W	-	-	-	-	LFRQGlCKDCR									VARIANT	L -> W (in CHDED; dbSNP:rs1057519636)	27479907	1
Q15139/P157G	Q15139	PRKD1	KPCD1_HUMAN	P157G	-	-	-	-	HSYRApFCDHC									MUTAGEN	P->G: Increase in ability to bind phorbol ester, loss of ability to bind DAG.	18076381	1
Q15139/P281G	Q15139	PRKD1	KPCD1_HUMAN	P281G	-	-	-	-	HSYTRpVCQYC									MUTAGEN	P->G: No effect on ability to bind phorbol ester, slight increase in ability to bind DAG.	18076381	1
Q15139/P585S	Q15139	PRKD1	KPCD1_HUMAN	P585S	31	β1	-	-	VYQIFpEVLGS	0.605	0.515	0.48	0.416	0.348	0.456	0.614	0.286	VARIANT	P -> S (in a metastatic melanoma sample; somatic mutation)	17344846	1
Q15139/P679L	Q15139	PRKD1	KPCD1_HUMAN	P679L	394	αD/αE-loop	-	-	EKGRLpHITKF	0.581	0.528	0.58	0.484	0.31	0.419	0.687	0.363	VARIANT	P -> L (in dbSNP:rs34588699)	17344846	1
Q15139/R677M	Q15139	PRKD1	KPCD1_HUMAN	R677M	387	αD/αE-loop	-	-	SSEKGrPEHIT	0.847	0.809	0.476	0.668	0.635	0.736	0.449	0.425	VARIANT	R -> M (in a lung bronchoalveolar carcinoma sample; somatic mutation)	17344846	1
Q15139/R825K	Q15139	PRKD1	KPCD1_HUMAN	R825K	798	αI	-	-	LQVKMrRYSVD	0.254	0.295	0.583	0.344	0.156	0.166	0.711	0.198	VARIANT	R -> K (in dbSNP:rs11161065)		0
Q15139/S225P	Q15139	PRKD1	KPCD1_HUMAN	S225P	-	-	-	-	AELSTsPDEPL									VARIANT	S -> P	17344846	1
Q15139/Y432E	Q15139	PRKD1	KPCD1_HUMAN	Y432E	-	-	p	-	GWMVHySKDTL									MUTAGEN	Y->E: Decreased phosphorylation level when coexpressed with SRC in HeLa cells. Unchanged phosphorylation level when coexpressed with ABL.	12637538	1
Q15139/Y432F	Q15139	PRKD1	KPCD1_HUMAN	Y432F	-	-	p	-	GWMVHySKDTL									MUTAGEN	Y->F: Decreased phosphorylation level when coexpressed with SRC in HeLa cells. Unchanged phosphorylation level when coexpressed with ABL. Unaltered kinase activity. Decreased kinase activity; when associated with F-463 and F-502.	12637538	1
Q15139/Y463E	Q15139	PRKD1	KPCD1_HUMAN	Y463E	-	-	p	activating	TGSRYyEIPLS									MUTAGEN	Y->E: Constitutive activation and constitutive phosphorylation of S-738 and S-742.	12637538	1
Q15139/Y463F	Q15139	PRKD1	KPCD1_HUMAN	Y463F	-	-	p	decrease	TGSRYyEIPLS									MUTAGEN	Y->F: Decreased phosphorylation level when coexpressed with either SRC or ABL in HeLa cells. Decreased kinase activity.	12637538	1
Q15139/Y502E	Q15139	PRKD1	KPCD1_HUMAN	Y502E	-	-	p	loss	ANVVYyGENVV									MUTAGEN	Y->E: Loss of activation.	12637538	1
Q15139/Y502F	Q15139	PRKD1	KPCD1_HUMAN	Y502F	-	-	p	-	ANVVYyGENVV									MUTAGEN	Y->F: Decreased phosphorylation level when coexpressed with SRC in HeLa cells. Unchanged phosphorylation level when coexpressed with ABL. Unaltered kinase activity. Decreased kinase activity; when associated with F-432 and F-502.	12637538	1
Q15208/D145N	Q15208	STK38	STK38_HUMAN	D145N	184	αC/β4-loop	-	-	ILVEAdLWVVK	0.469	0.383	0.462	0.186	0.423	0.33	0.576	0.159	VARIANT	D -> N (in dbSNP:rs56005153)	17344846	1
Q15208/E18K	Q15208	STK38	STK38_HUMAN	E18K	-	-	-	-	SNHTKeVTMTK									VARIANT	E -> K (in a metastatic melanoma sample; somatic mutation)	17344846	1
Q15208/K118A	Q15208	STK38	STK38_HUMAN	K118A	129	β3;Catalytic-Lys	ub	loss	HVYAMkLRKAD	1.0	1.0	0.016	0.692	1.0	0.998	0.013	0.66	MUTAGEN	K->A: Loss of autophosphorylation and kinase activity.	12493777,7761441	2
Q15208/K267R	Q15208	STK38	STK38_HUMAN	K267R	-	-	-	-	MNSKRkETWKR									VARIANT	K -> R (in dbSNP:rs56105564)	17344846	1
Q15208/S281A	Q15208	STK38	STK38_HUMAN	S281A	-	-	p	loss	RQLAFsVGTPD									MUTAGEN	S->A: Loss of autophosphorylation and kinase activity.	12493777	1
Q15208/T444A	Q15208	STK38	STK38_HUMAN	T444A	-	-	p	decrease	VFINYtKRFEG									MUTAGEN	T->A: Decreases autophosphorylation and kinase activity.	12493777	1
Q15208/T74A	Q15208	STK38	STK38_HUMAN	T74A	18	N-term-β1	p	decrease	HARKEtFLRLK	0.809	0.806	0.324	0.664	0.665	0.647	0.364	0.263	MUTAGEN	T->A: Decreases autophosphorylation and kinase activity. Reduced binding of S100B.	12493777	1
Q15303/A773S	Q15303	ERBB4	ERBB4_HUMAN	A773S	187	αC/β4-loop	-	-	EALIMaMDHPH	0.381	0.355	0.523	0.391	0.285	0.316	0.646	0.318	MUTAGEN	A->S: No effect on kinase activity.	19098003	1
Q15303/D1000A	Q15303	ERBB4	ERBB4_HUMAN	D1000A	-	-	-	-	LPSPNdKFFQN									MUTAGEN	D->A: Abolishes APC/C-mediated degradation; when associated with A-992 and A-995.	17638867	1
Q15303/D843N	Q15303	ERBB4	ERBB4_HUMAN	D843N	443	Catalytic-loop;HrD-motif	-	loss	RLVHRdAARNV	0.913	0.929	0.336	0.632	0.783	0.877	0.256	0.402	MUTAGEN	D->N: Loss of kinase activity.	16978839	1
Q15303/D861Y	Q15303	ERBB4	ERBB4_HUMAN	D861Y	496	A-loop;DFG-motif	-	loss	HVKITdGLARL	0.969	0.974	0.17	0.585	0.92	0.932	0.075	0.684	MUTAGEN	D->Y: Loss of kinase activity.	19098003	1
Q15303/E810K	Q15303	ERBB4	ERBB4_HUMAN	E810K	294	αD/αE-loop	-	-	LEYVHeKDNIG	0.209	0.2	0.427	0.217	0.172	0.179	0.632	0.255	MUTAGEN	E->K: No effect on kinase activity.	19098003	1
Q15303/E872K	Q15303	ERBB4	ERBB4_HUMAN	E872K	510	A-loop	-	-	LLEGDeEYNAD	0.63	0.611	0.572	0.581	0.339	0.475	0.69	0.35	MUTAGEN	E->K: No effect on kinase activity.	19098003	1
Q15303/I947R	Q15303	ERBB4	ERBB4_HUMAN	I947R	782	αH	-	activating	PPICTiVYMVM	0.514	0.455	0.615	0.685	0.19	0.359	0.763	0.305	MUTAGEN	I->R: Constitutively autophosphorylated.	18287036	1
Q15303/K751R	Q15303	ERBB4	ERBB4_HUMAN	K751R	129	β3;Catalytic-Lys	-	loss	IPVAIkLNETT	0.999	0.998	0.025	0.687	0.998	0.992	0.009	0.476	MUTAGEN	K->R: Abolishes kinase activity. Abolishes phosphorylation, proteolytic processing and nuclear localization.	11390655,17486069,17638867	3
Q15303/L710N	Q15303	ERBB4	ERBB4_HUMAN	L710N	21	N-term-β1	-	decrease	PNQAQlILKET	0.772	0.727	0.486	0.616	0.527	0.666	0.51	0.517	MUTAGEN	L->N: Strongly reduced autophosphorylation.	18287036	1
Q15303/L864R	Q15303	ERBB4	ERBB4_HUMAN	L864R	499	A-loop	-	decrease	ITDFGlRLLEG	0.918	0.864	0.425	0.705	0.598	0.783	0.446	0.597	MUTAGEN	L->R: Strongly reduced autophosphorylation.	18287036	1
Q15303/L995A	Q15303	ERBB4	ERBB4_HUMAN	L995A	833	C-term-αI	-	-	DDRMKlSPNDS	0.506	0.551	0.484	0.45	0.328	0.439	0.496	0.373	MUTAGEN	L->A: Abolishes APC/C-mediated degradation; when associated with A-992 and A-1000.	17638867	1
Q15303/M766R	Q15303	ERBB4	ERBB4_HUMAN	M766R	171	αC	-	decrease	ANVEFmEALIM	0.891	0.792	0.406	0.653	0.67	0.7	0.373	0.634	MUTAGEN	M->R: Strongly reduced autophosphorylation.	18287036	1
Q15303/P854Q	Q15303	ERBB4	ERBB4_HUMAN	P854Q	481	Catalytic-loop	-	-	VLVKSpHVKIT	0.591	0.497	0.518	0.445	0.383	0.39	0.525	0.6	MUTAGEN	P->Q: No effect on kinase activity.	19098003	1
Q15303/Q646C	Q15303	ERBB4	ERBB4_HUMAN	Q646C	-	-	-	activating	HSTLPqARTPL									MUTAGEN	Q->C: Constitutively activated kinase.	17120616	1
Q15303/R1275W	Q15303	ERBB4	ERBB4_HUMAN	R1275W	-	-	-	decrease	QNGRIrIVAEN									VARIANT	R -> W (in ALS19; reduces autophosphorylation upon NRG1 stimulation; dbSNP:rs397514263)	24119685	1
Q15303/R782Q	Q15303	ERBB4	ERBB4_HUMAN	R782Q	198	αC/β4-loop	-	-	HPHLVrLGVCL	0.564	0.419	0.509	0.399	0.198	0.297	0.662	0.418	MUTAGEN	R->Q: No effect on kinase activity.	19098003	1
Q15303/R927Q	Q15303	ERBB4	ERBB4_HUMAN	R927Q	734	αG/αH	-	decrease	DGIPTrIPDLL	0.222	0.173	0.444	0.239	0.247	0.221	0.587	0.117	VARIANT	R -> Q (in ALS19; reduces autophosphorylation upon NRG1 stimulation; dbSNP:rs397514262)	24119685	1
Q15303/R992A	Q15303	ERBB4	ERBB4_HUMAN	R992A	830	C-term-αI	-	-	IQGDDrKLPSP	0.348	0.361	0.482	0.428	0.286	0.282	0.553	0.151	MUTAGEN	R->A: Abolishes APC/C-mediated degradation; when associated with A-995 and A-1000.	17638867	1
Q15303/S303Y	Q15303	ERBB4	ERBB4_HUMAN	S303Y	-	-	-	-	VVDSSsVRACP									VARIANT	S -> Y (in a lung squamous cell carcinoma sample; somatic mutation)	17344846	1
Q15303/T140I	Q15303	ERBB4	ERBB4_HUMAN	T140I	-	-	-	-	GLKNLtILNGG									VARIANT	T -> I (in a colorectal adenocarcinoma sample; somatic mutation)	17344846	1
Q15303/T926M	Q15303	ERBB4	ERBB4_HUMAN	T926M	639	αG	-	-	YDGIPtEIPDL	0.178	0.172	0.545	0.239	0.174	0.119	0.681	0.219	MUTAGEN	T->M: No effect on kinase activity.	19098003	1
Q15303/V675A	Q15303	ERBB4	ERBB4_HUMAN	V675A	-	-	-	-	TFAVYvRKSIK									MUTAGEN	V->A: Abolishes proteolytic processing and nuclear localization.	15746097,17638867	2
Q15303/V721I	Q15303	ERBB4	ERBB4_HUMAN	V721I	36	β1	-	-	TELKRvVLGSG	0.165	0.124	0.504	0.217	0.118	0.116	0.725	0.203	MUTAGEN	V->I: No effect on kinase activity.	19098003	1
Q15303/Y1035A	Q15303	ERBB4	ERBB4_HUMAN	Y1035A	-	-	-	-	IPPPIySRARI									MUTAGEN	Y->A: No effect on interaction with WWOX. Abolishes interaction with WWOX; when associated with A-1301.	16061658	1
Q15303/Y1056A	Q15303	ERBB4	ERBB4_HUMAN	Y1056A	-	-	p	loss	SPPPAyPMSGN									MUTAGEN	Y->A: Abolishes interaction with NEDD4 and impairs ubiquitination. Promotes nuclear translocation of ERBB4 intracellular domain E4ICD1.	19561640	1
Q15303/Y1056F	Q15303	ERBB4	ERBB4_HUMAN	Y1056F	-	-	p	-	SPPPAyPMSGN									MUTAGEN	Y->F: Abolishes interaction with WWP1; when associated with F-1301.	19561640	1
Q15303/Y1301A	Q15303	ERBB4	ERBB4_HUMAN	Y1301A	-	-	-	-	LPPPPyHRNTV									MUTAGEN	Y->A: No effect on interaction with WWOX. Abolishes interaction with WWOX; when associated with A-1035. Loss of interaction with YAP1 and stimulation of transcription.	12807903,16061658,19561640	3
Q15303/Y1301F	Q15303	ERBB4	ERBB4_HUMAN	Y1301F	-	-	-	-	LPPPPyHRNTV									MUTAGEN	Y->F: Abolishes interaction with WWP1; when associated with F-1056.	12807903,16061658,19561640	3
Q15349/E311K	Q15349	RPS6KA2	KS6A2_HUMAN	E311K	-	-	-	-	IDGVEeKRHPF									VARIANT	E -> K (in a metastatic melanoma sample; somatic mutation; dbSNP:rs267600891)	17344846	1
Q15375/E170K	Q15375	EPHA7	EPHA7_HUMAN	E170K	-	-	-	-	MKLNTeREIGP									VARIANT	E -> K (in a colorectal adenocarcinoma sample; somatic mutation)	17344846	1
Q15375/G232R	Q15375	EPHA7	EPHA7_HUMAN	G232R	-	-	-	-	LVEVRgCVSSA									VARIANT	G -> R (in a metastatic melanoma sample; somatic mutation)	17344846	1
Q15375/I138V	Q15375	EPHA7	EPHA7_HUMAN	I138V	-	-	-	neutral	DTGRNiENLYV									VARIANT	I -> V (in dbSNP:rs2278107)	15489334,17344846	2
Q15375/P278S	Q15375	EPHA7	EPHA7_HUMAN	P278S	-	-	-	neutral	GDTCEpGRGFY									VARIANT	P -> S (in dbSNP:rs2278106)	17344846	1
Q15375/P903S	Q15375	EPHA7	EPHA7_HUMAN	P903S	825	C-term-αI	-	-	NSLKTpGTCSR	0.521	0.461	0.558	0.408	0.317	0.333	0.673	0.287	VARIANT	P -> S (in a metastatic melanoma sample; somatic mutation)	17344846	1
Q15375/R371W	Q15375	EPHA7	EPHA7_HUMAN	R371W	-	-	-	-	RILCKrSWEQG									VARIANT	R -> W (in a colorectal cancer sample; somatic mutation; dbSNP:rs371089003)	16959974	1
Q15418/K335T	Q15418	RPS6KA1	KS6A1_HUMAN	K335T	-	-	-	neutral	YRREIkPFKPA									VARIANT	K -> T (in dbSNP:rs2229712)	17344846,8141249	2
Q15569/D175A	Q15569	TESK1	TESK1_HUMAN	D175A	443	Catalytic-loop;HrD-motif	-	-	GVFHRdTSKNC	0.996	0.996	0.139	0.677	0.978	0.985	0.083	0.6	MUTAGEN	D->A: Abolishes inhibition of SPRY4-mediated repression of cell spreading. No effect on interaction with SPRY4 or colocalization with SPRY4 at vesicular spots in the cytoplasm.	15584898	1
Q15569/G574S	Q15569	TESK1	TESK1_HUMAN	G574S	-	-	-	-	PGCCLgFSFGF									VARIANT	G -> S (in dbSNP:rs55673450)	17344846	1
Q15569/H539Y	Q15569	TESK1	TESK1_HUMAN	H539Y	-	-	-	-	WNRAQhLPRAA									VARIANT	H -> Y (in breast cancer samples; infiltrating ductal carcinoma; somatic mutation; dbSNP:rs1373248755)	16959974,17344846	2
Q15746/A128V	Q15746	MYLK	MYLK_HUMAN	A128V	-	-	-	neutral	VEGSFaQLGQP									VARIANT	A -> V (in dbSNP:rs143896146)	21055718	1
Q15746/A1491S	Q15746	MYLK	MYLK_HUMAN	A1491S	127	β3	-	decrease	TRKVWaKFFKA	0.791	0.773	0.456	0.645	0.685	0.755	0.412	0.48	VARIANT	A -> S (in AAT7; decreases kinase activity; dbSNP:rs1576422965)	29544503	1
Q15746/A1527V	Q15746	MYLK	MYLK_HUMAN	A1527V	207	β4/β5-loop	-	-	VQCVDaEEKAN	0.353	0.387	0.534	0.458	0.264	0.211	0.604	0.334	VARIANT	A -> V (in dbSNP:rs34982967)	17344846	1
Q15746/A1754T	Q15746	MYLK	MYLK_HUMAN	A1754T	-	-	-	decrease	GNAVRaGRLSS									VARIANT	A -> T (in AAT7; 4-fold reduced affinity for calmodulin; decreased kinase activity compared to wild-type protein)	21055718	1
Q15746/A701T	Q15746	MYLK	MYLK_HUMAN	A701T	-	-	-	neutral	EAWNSaEVRTQ									VARIANT	A -> T (in dbSNP:rs142835596)	17344846	1
Q15746/D914E	Q15746	MYLK	MYLK_HUMAN	D914E	-	-	-	neutral	TLSEDdKEIPA									VARIANT	D -> E (in dbSNP:rs3732487)		0
Q15746/E1399K	Q15746	MYLK	MYLK_HUMAN	E1399K	-	-	-	-	LLPDHeKFRVR									VARIANT	E -> K (in dbSNP:rs181663420)	21055718	1
Q15746/K608A	Q15746	MYLK	MYLK_HUMAN	K608A	-	-	ac	loss	KKSSRkEYLLP									MUTAGEN	K->A: Loss of acetylation and no kinase activity repression by NAA10/ARD1.	19826488	1
Q15746/L861P	Q15746	MYLK	MYLK_HUMAN	L861P	-	-	-	neutral	RGQGWlEEDGE									VARIANT	L -> P (in dbSNP:rs3732486)		0
Q15746/M405V	Q15746	MYLK	MYLK_HUMAN	M405V	-	-	-	-	NRRIPmGQRDS									VARIANT	M -> V (in dbSNP:rs35436690)	17344846	1
Q15746/P1588L	Q15746	MYLK	MYLK_HUMAN	P1588L	446	Catalytic-loop	-	-	HLDLKpNIMCV	0.592	0.546	0.608	0.52	0.32	0.512	0.662	0.468	VARIANT	P -> L (in an ovarian mucinous carcinoma sample; somatic mutation; dbSNP:rs1576401641)	17344846	1
Q15746/P160R	Q15746	MYLK	MYLK_HUMAN	P160R	-	-	-	neutral	IWGECpKFATK									VARIANT	P -> R (in dbSNP:rs111256888)	21055718	1
Q15746/P21H	Q15746	MYLK	MYLK_HUMAN	P21H	-	-	-	neutral	SLSVDpRVDSM									VARIANT	P -> H (in dbSNP:rs28497577)		0
Q15746/P336L	Q15746	MYLK	MYLK_HUMAN	P336L	-	-	-	-	TAPQTpLQKTS									VARIANT	P -> L (in dbSNP:rs35912339)		0
Q15746/P443S	Q15746	MYLK	MYLK_HUMAN	P443S	-	-	-	-	SGIPKpVAWFL									VARIANT	P -> S (in dbSNP:rs35156360)	17344846	1
Q15746/P652A	Q15746	MYLK	MYLK_HUMAN	P652A	-	-	-	-	SGNPPpVIWLH									VARIANT	P -> A (in dbSNP:rs750686734)	17344846	1
Q15746/Q133H	Q15746	MYLK	MYLK_HUMAN	Q133H	-	-	-	neutral	AKQLGqVVSKT									VARIANT	Q -> H (in dbSNP:rs140148380)	21055718	1
Q15746/R378H	Q15746	MYLK	MYLK_HUMAN	R378H	-	-	-	-	RPAPPrATFPT									VARIANT	R -> H (in dbSNP:rs56378658)	17344846	1
Q15746/R607G	Q15746	MYLK	MYLK_HUMAN	R607G	-	-	-	-	EKKSSrSEYLL									VARIANT	R -> G	17344846	1
Q15746/R845C	Q15746	MYLK	MYLK_HUMAN	R845C	-	-	-	neutral	GGGSDrGSLRP									VARIANT	R -> C (in dbSNP:rs3732485)		0
Q15746/S1759P	Q15746	MYLK	MYLK_HUMAN	S1759P	-	-	p	-	AIGRLsMAMIS									VARIANT	S -> P (in AAT7; 7-fold reduced affinity for calmodulin; 6-fold decreased Vmax; dbSNP:rs387906781)	21055718	1
Q15746/T1085A	Q15746	MYLK	MYLK_HUMAN	T1085A	-	-	-	neutral	GHAGTtNEKRS									VARIANT	T -> A (in dbSNP:rs75370906)	21055718	1
Q15746/T276A	Q15746	MYLK	MYLK_HUMAN	T276A	-	-	-	-	VRKEVtVISKE									VARIANT	T -> A (in dbSNP:rs55846245)	17344846	1
Q15746/T692M	Q15746	MYLK	MYLK_HUMAN	T692M	-	-	-	-	PEDTGtTCEAW									VARIANT	T -> M (in dbSNP:rs776858093)	17344846	1
Q15746/V1213M	Q15746	MYLK	MYLK_HUMAN	V1213M	-	-	-	-	SSLPPvGTESD									VARIANT	V -> M (in AAT7; unknown pathological significance; dbSNP:rs368390254)	21055718	1
Q15746/V261A	Q15746	MYLK	MYLK_HUMAN	V261A	-	-	-	neutral	ANRSFvETKAT									VARIANT	V -> A (in dbSNP:rs3796164)	17344846	1
Q15746/V709M	Q15746	MYLK	MYLK_HUMAN	V709M	-	-	-	-	VRTQAvTVQEP									VARIANT	V -> M (in dbSNP:rs112537316)	17344846	1
Q15746/V877M	Q15746	MYLK	MYLK_HUMAN	V877M	-	-	-	-	VLKRRvTRQHT									VARIANT	V -> M (in dbSNP:rs34542174)		0
Q15746/W656C	Q15746	MYLK	MYLK_HUMAN	W656C	-	-	-	-	PPEVIwHNGNE									VARIANT	W -> C (in dbSNP:rs138172035)	17344846,21055718	2
Q15759/A221V	Q15759	MAPK11	MK11_HUMAN	A221V	619	αF	-	-	LLQGKaFPGSD	0.18	0.126	0.462	0.162	0.153	0.127	0.674	0.121	VARIANT	A -> V (in a lung neuroendocrine carcinoma sample; somatic mutation)	17344846	1
Q15759/R275H	Q15759	MAPK11	MK11_HUMAN	R275H	778	αG/αH	-	neutral	LSSIFrANPLA	0.068	0.068	0.452	0.086	0.06	0.072	0.673	0.059	VARIANT	R -> H (in dbSNP:rs33932986)	17344846	1
Q15759/T180A	Q15759	MAPK11	MK11_HUMAN	T180A	544	A-loop	p	loss	ADEEMtYVATR	0.978	0.977	0.248	0.875	0.936	0.956	0.187	0.551	MUTAGEN	T->A: Inactivation.	15356147	1
Q15759/Y182F	Q15759	MAPK11	MK11_HUMAN	Y182F	546	A-loop	p	loss	EEMTGyATRWY	0.983	0.982	0.26	0.869	0.951	0.962	0.186	0.515	MUTAGEN	Y->F: Inactivation.	15356147	1
Q15772/A1135V	Q15772	SPEG	SPEG_HUMAN	A1135V	-	-	-	-	DEGLYaSAVNT									VARIANT	A -> V (in dbSNP:rs55670811)	17344846	1
Q15772/E1178D	Q15772	SPEG	SPEG_HUMAN	E1178D	-	-	-	-	IPEEPeGELER									VARIANT	E -> D (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs757589345)	17344846	1
Q15772/P1103L	Q15772	SPEG	SPEG_HUMAN	P1103L	-	-	-	-	THFGCpEESEN									VARIANT	P -> L (in dbSNP:rs56334571)	17344846	1
Q15772/R1234W	Q15772	SPEG	SPEG_HUMAN	R1234W	-	-	-	-	QSSDDrMTQYR									VARIANT	R -> W (in dbSNP:rs55916864)	17344846	1
Q15772/R1340Q	Q15772	SPEG	SPEG_HUMAN	R1340Q	-	-	-	-	LVTGLrPGWAA									VARIANT	R -> Q (in dbSNP:rs34994343)	17344846	1
Q15772/R206H	Q15772	SPEG	SPEG_HUMAN	R206H	-	-	-	neutral	SGGGTrLPGSP									VARIANT	R -> H (in dbSNP:rs55821435)	17344846	1
Q15772/R934C	Q15772	SPEG	SPEG_HUMAN	R934C	-	-	-	-	ILAAErDAGFY									VARIANT	R -> C (in dbSNP:rs34398769)	17344846	1
Q15772/R966Q	Q15772	SPEG	SPEG_HUMAN	R966Q	-	-	-	-	AHPESrLAVLA									VARIANT	R -> Q (in dbSNP:rs34861443)	17344846	1
Q15831/A205T	Q15831	STK11	STK11_HUMAN	A205T	514	A-loop	-	-	ALHPFaDDTCR	0.397	0.33	0.486	0.346	0.208	0.212	0.631	0.199	VARIANT	A -> T (in sporadic cancer; somatic mutation; no effect heterotrimeric complex assembly with STRADA and CAB39; dbSNP:rs730881981)	19892943	1
Q15831/D176N	Q15831	STK11	STK11_HUMAN	D176N	443	Catalytic-loop;HrD-motif	-	loss	GIVHKdKPGNL	0.996	0.991	0.191	0.67	0.965	0.975	0.097	0.568	VARIANT	D -> N (in PJS; loss of kinase activity, leading to greatly reduced autophosphorylation; fails to phosphorylate 		0
Q15831/D176Y	Q15831	STK11	STK11_HUMAN	D176Y	443	Catalytic-loop;HrD-motif	-	loss	GIVHKdKPGNL	0.996	0.988	0.228	0.693	0.913	0.965	0.104	0.653	VARIANT	D -> Y (in sporadic cancer; somatic mutation; Loss of kinase activity)	12805220,19892943	2
Q15831/D194A	Q15831	STK11	STK11_HUMAN	D194A	496	A-loop;DFG-motif	-	loss	TLKISdGVAEA	0.996	0.982	0.108	0.513	0.989	0.949	0.043	0.699	MUTAGEN	D->A: Loss of kinase activity.	14517248,14976552,19892943	3
Q15831/D194N	Q15831	STK11	STK11_HUMAN	D194N	496	A-loop;DFG-motif	-	-	TLKISdGVAEA	0.977	0.951	0.196	0.567	0.947	0.952	0.102	0.581	VARIANT	D -> N (in PJS; dbSNP:rs121913315)	10408777	1
Q15831/D194V	Q15831	STK11	STK11_HUMAN	D194V	496	A-loop;DFG-motif	-	-	TLKISdGVAEA	0.958	0.929	0.133	0.545	0.901	0.931	0.072	0.7	VARIANT	D -> V (in lung cancer; somatic mutation; dbSNP:rs121913316)	10079245	1
Q15831/D194Y	Q15831	STK11	STK11_HUMAN	D194Y	496	A-loop;DFG-motif	-	-	TLKISdGVAEA	0.989	0.943	0.183	0.52	0.936	0.918	0.086	0.703	VARIANT	D -> Y (in melanoma; sporadic malignant; somatic mutation; dbSNP:rs121913315)	10208439	1
Q15831/D208N	Q15831	STK11	STK11_HUMAN	D208N	541	A-loop	-	-	PFAADdCRTSQ	0.615	0.55	0.413	0.479	0.492	0.573	0.46	0.435	VARIANT	D -> N (in colorectal cancer; somatic mutation; no effect heterotrimeric complex assembly with STRADA and CAB39; dbSNP:rs1555738372)	9731485	1
Q15831/D277Y	Q15831	STK11	STK11_HUMAN	D277Y	684	αG/αH	-	-	YAIPGdGPPLS	0.234	0.331	0.533	0.374	0.162	0.214	0.621	0.236	VARIANT	D -> Y (in sporadic cancer; somatic mutation; no effect on kinase activity nor in heterotrimeric complex assembly with STRADA and CAB39)	19892943	1
Q15831/E14K	Q15831	STK11	STK11_HUMAN	E14K	-	-	-	-	LGMFTeELMSV									VARIANT	E -> K (in cervical cancer; somatic mutation)	12533684	1
Q15831/E16G	Q15831	STK11	STK11_HUMAN	E16G	-	-	-	-	MFTEGeMSVGM									VARIANT	E -> G (in PJS)	21411391	1
Q15831/E199K	Q15831	STK11	STK11_HUMAN	E199K	502	A-loop	-	loss	DLGVAeLHPFA	0.727	0.63	0.491	0.487	0.476	0.477	0.565	0.337	VARIANT	E -> K (in colorectal cancer; somatic mutation; impaired kinase activity; dbSNP:rs121913317)	9731485	1
Q15831/E199Q	Q15831	STK11	STK11_HUMAN	E199Q	502	A-loop	-	-	DLGVAeLHPFA	0.732	0.588	0.516	0.545	0.409	0.479	0.587	0.416	VARIANT	E -> Q (in sporadic cancer; somatic mutation; does not affect kinase activity)	19892943	1
Q15831/E223V	Q15831	STK11	STK11_HUMAN	E223V	557	A-loop;APE-motif	-	loss	AFQPPeANGLD	0.915	0.923	0.23	0.66	0.888	0.909	0.213	0.497	VARIANT	E -> V (in sporadic cancer; somatic mutation; impairs heterotrimeric complex assembly with STRADA and CAB39)	19892943	1
Q15831/F157S	Q15831	STK11	STK11_HUMAN	F157S	407	αE	-	-	QAHGYfQLIDG	0.878	0.808	0.469	0.625	0.609	0.743	0.413	0.672	VARIANT	F -> S (in sporadic cancer; somatic mutation; impairs heterotrimeric complex assembly with STRADA and CAB39)	19892943	1
Q15831/F204A	Q15831	STK11	STK11_HUMAN	F204A	513	A-loop	-	-	EALHPfADDTC	0.688	0.678	0.4	0.484	0.587	0.646	0.314	0.472	MUTAGEN	F->A: No effect. Impaired formation of a heterotrimeric complex with STRADA and CAB39; when associated with A-74.	19892943	1
Q15831/F231L	Q15831	STK11	STK11_HUMAN	F231L	593	αF	-	-	NGLDTfGFKVD	0.486	0.427	0.479	0.446	0.381	0.398	0.587	0.357	VARIANT	F -> L (in cervical cancer; somatic mutation; dbSNP:rs929783669)	12533684	1
Q15831/F354L	Q15831	STK11	STK11_HUMAN	F354L	-	-	-	-	EDEDLfIEDDI									VARIANT	F -> L (in colorectal cancer; somatic mutation; dbSNP:rs59912467)	9731485	1
Q15831/G135R	Q15831	STK11	STK11_HUMAN	G135R	255	β5/αD-loop	-	-	EYCVCgQEMLD	0.79	0.697	0.53	0.505	0.441	0.578	0.475	0.749	VARIANT	G -> R (in melanoma; sporadic malignant; somatic mutation; dbSNP:rs137853081)	10201537	1
Q15831/G163D	Q15831	STK11	STK11_HUMAN	G163D	413	αE	-	decrease	CQLIDgEYLHS	0.867	0.874	0.378	0.569	0.787	0.789	0.263	0.383	VARIANT	G -> D (in TGCT; a tumor with seminoma and teratoma components; associated with severely impaired but detectable kinase activity; somatic mutation; impairs heterotrimeric complex assembly with STRADA and CAB39; predominantly nuclear localization; dbSNP:rs137853078)	19892943,9605748,9887330	3
Q15831/G171S	Q15831	STK11	STK11_HUMAN	G171S	427	αE	-	loss	YLHSQgVHKDI	0.661	0.557	0.49	0.434	0.443	0.504	0.489	0.541	VARIANT	G -> S (in colorectal cancer; somatic mutation; impairs heterotrimeric complex assembly with STRADA and CAB39; dbSNP:rs1599926499)	19892943,9731485	2
Q15831/G215D	Q15831	STK11	STK11_HUMAN	G215D	548	A-loop	-	-	CRTSQgPAFQP	0.846	0.866	0.553	0.649	0.592	0.753	0.474	0.449	VARIANT	G -> D (in colorectal cancer; somatic mutation; dbSNP:rs1057520038)	9731485	1
Q15831/H174R	Q15831	STK11	STK11_HUMAN	H174R	441	Catalytic-loop;HrD-motif	-	loss	SQGIVhDIKPG	0.86	0.886	0.377	0.722	0.798	0.815	0.364	0.458	VARIANT	H -> R (in sporadic cancer; somatic mutation; impairs heterotrimeric complex assembly with STRADA and CAB39)	19892943	1
Q15831/I177N	Q15831	STK11	STK11_HUMAN	I177N	444	Catalytic-loop	-	loss	IVHKDiPGNLL	0.883	0.869	0.311	0.564	0.816	0.774	0.205	0.685	VARIANT	I -> N (in sporadic cancer; somatic mutation; impairs heterotrimeric complex assembly with STRADA and CAB39; dbSNP:rs1057520041)	19892943	1
Q15831/K44R	Q15831	STK11	STK11_HUMAN	K44R	24	N-term-β1	-	-	RRKRAkIGKYL	0.547	0.494	0.444	0.48	0.394	0.443	0.578	0.283	MUTAGEN	K->R: No effect on kinase activity.	18687677	1
Q15831/K48Q	Q15831	STK11	STK11_HUMAN	K48Q	28	N-term-β1	ac	-	AKLIGkLMGDL	0.599	0.599	0.477	0.478	0.299	0.507	0.617	0.182	MUTAGEN	K->Q: No effect on basal nucleocytoplasmic localization, but fails to translocate to the cytoplasm when coexpressed with SIRT1.	18687677	1
Q15831/K48R	Q15831	STK11	STK11_HUMAN	K48R	28	N-term-β1	ac	increase	AKLIGkLMGDL	0.562	0.487	0.48	0.455	0.308	0.423	0.608	0.151	MUTAGEN	K->R: Enhanced phosphorylation at Thr-336 and Ser-428, enhanced cytoplasmic localization and increased kinase activity.	18687677	1
Q15831/K78I	Q15831	STK11	STK11_HUMAN	K78I	129	β3;Catalytic-Lys	-	loss	CRRAVkLKKKK	0.992	1.0	0.029	0.633	0.979	0.999	0.029	0.54	MUTAGEN	K->I: Loss of kinase activity, leading to greatly reduced autophosphorylation.	11430832,9837816	2
Q15831/K78M	Q15831	STK11	STK11_HUMAN	K78M	129	β3;Catalytic-Lys	-	loss	CRRAVkLKKKK	0.999	1.0	0.014	0.633	0.999	0.998	0.008	0.527	MUTAGEN	K->M: Loss of kinase activity, leading to reduced autophosphorylation and acting as a dominant-negative mutant.	11430832,9837816	2
Q15831/K96R	Q15831	STK11	STK11_HUMAN	K96R	171	αC	ac	-	GEANVkEIQLL	0.483	0.492	0.532	0.428	0.331	0.407	0.657	0.116	MUTAGEN	K->R: No effect on kinase activity.	18687677	1
Q15831/K97R	Q15831	STK11	STK11_HUMAN	K97R	172	αC	ac	-	EANVKkIQLLR	0.442	0.409	0.444	0.333	0.252	0.353	0.618	0.22	MUTAGEN	K->R: No effect on kinase activity.	18687677	1
Q15831/L160P	Q15831	STK11	STK11_HUMAN	L160P	410	αE	-	-	GYFCQlDGLEY	0.918	0.871	0.479	0.715	0.657	0.736	0.424	0.411	VARIANT	L -> P (in cervical cancer; somatic mutation)	12533684	1
Q15831/L245R	Q15831	STK11	STK11_HUMAN	L245R	608	αF	-	-	SAGVTlNITTG	0.875	0.884	0.476	0.662	0.603	0.747	0.375	0.541	VARIANT	L -> R (in sporadic cancer; somatic mutation; impairs heterotrimeric complex assembly with STRADA and CAB39)	19892943	1
Q15831/L285Q	Q15831	STK11	STK11_HUMAN	L285Q	788	αH	-	-	PPLSDlKGMLE	0.844	0.734	0.439	0.582	0.622	0.645	0.411	0.618	VARIANT	L -> Q (in sporadic cancer; somatic mutation; impairs heterotrimeric complex assembly with STRADA and CAB39)	19892943	1
Q15831/L67P	Q15831	STK11	STK11_HUMAN	L67P	55	β2/β3-loop	-	loss	KVKEVlSETLC	0.841	0.758	0.466	0.636	0.562	0.699	0.425	0.6	VARIANT	L -> P (in PJS; abolishes kinase activity, leading to loss of autophosphorylation; dbSNP:rs137853077)	9428765,9837816	2
Q15831/N181E	Q15831	STK11	STK11_HUMAN	N181E	448	Catalytic-loop	-	loss	DIKPGnLLTTG	0.946	0.937	0.313	0.707	0.871	0.871	0.25	0.583	VARIANT	N -> E (in sporadic cancer; somatic mutation; impairs heterotrimeric complex assembly with STRADA and CAB39; requires 2 nucleotide substitutions; dbSNP:rs1568707668)	19892943	1
Q15831/P281L	Q15831	STK11	STK11_HUMAN	P281L	783	αH	-	-	GDCGPpSDLLK	0.315	0.364	0.538	0.307	0.283	0.249	0.617	0.228	VARIANT	P -> L (in ovarian carcinoma; somatic mutation; dbSNP:rs121913322)	10429654	1
Q15831/P314H	Q15831	STK11	STK11_HUMAN	P314H	828	C-term-αI	-	-	FRKKHpAEAPV	0.36	0.352	0.575	0.415	0.189	0.222	0.65	0.369	VARIANT	P -> H (in colorectal cancer; no effect heterotrimeric complex assembly with STRADA and CAB39)	9809980	1
Q15831/P315S	Q15831	STK11	STK11_HUMAN	P315S	829	C-term-αI	-	-	RKKHPpEAPVP	0.212	0.199	0.457	0.249	0.172	0.208	0.629	0.232	VARIANT	P -> S (in PJS; pathogenicity uncertain; no effect heterotrimeric complex assembly with STRADA and CAB39; dbSNP:rs786202431)	12372054,19892943	2
Q15831/P324L	Q15831	STK11	STK11_HUMAN	P324L	838	C-term-αI	-	-	PVPIPpPDTKD	0.625	0.629	0.586	0.609	0.494	0.597	0.561	0.665	VARIANT	P -> L (in gastric carcinoma; no effect heterotrimeric complex assembly with STRADA and CAB39; dbSNP:rs367807476)	9683800	1
Q15831/Q123R	Q15831	STK11	STK11_HUMAN	Q123R	240	β4/β5-loop	-	-	YNEEKqMYMVM	0.328	0.385	0.513	0.348	0.164	0.181	0.636	0.167	VARIANT	Q -> R (in sporadic cancer; somatic mutation; no effect on kinase activity nor in heterotrimeric complex assembly with STRADA and CAB39; dbSNP:rs764449808)	19892943	1
Q15831/Q170P	Q15831	STK11	STK11_HUMAN	Q170P	426	αE	-	loss	EYLHSqIVHKD	0.786	0.777	0.47	0.64	0.628	0.633	0.509	0.438	VARIANT	Q -> P (in sporadic cancer; somatic mutation; impairs heterotrimeric complex assembly with STRADA and CAB39)	19892943	1
Q15831/R297K	Q15831	STK11	STK11_HUMAN	R297K	802	αI	-	-	YEPAKrSIRQI	0.638	0.641	0.47	0.521	0.404	0.483	0.513	0.414	VARIANT	R -> K (in PJS; dbSNP:rs1568710381)	10408777	1
Q15831/R74A	Q15831	STK11	STK11_HUMAN	R74A	80	β2/β3-loop	-	-	SETLCrAVKIL	0.815	0.768	0.511	0.563	0.64	0.733	0.463	0.443	MUTAGEN	R->A: Impaired formation of a heterotrimeric complex with STRADA and CAB39; when associated with A-204.	19892943	1
Q15831/R86G	Q15831	STK11	STK11_HUMAN	R86G	142	αC	-	-	KKKKLrIPNGE	0.515	0.551	0.556	0.557	0.349	0.437	0.647	0.297	VARIANT	R -> G (in sporadic cancer; somatic mutation; no effect on kinase activity nor in heterotrimeric complex assembly with STRADA and CAB39; dbSNP:rs1057520039)	19892943	1
Q15831/R87K	Q15831	STK11	STK11_HUMAN	R87K	143	αC	-	-	KKKLRrPNGEA	0.13	0.113	0.401	0.165	0.145	0.093	0.659	0.097	VARIANT	R -> K (in a metastatic melanoma sample; somatic mutation; dbSNP:rs1568690463)	17344846	1
Q15831/S216F	Q15831	STK11	STK11_HUMAN	S216F	549	A-loop	-	loss	RTSQGsAFQPP	0.919	0.929	0.429	0.74	0.743	0.891	0.26	0.578	VARIANT	S -> F (in sporadic cancer; somatic mutation; impairs heterotrimeric complex assembly with STRADA and CAB39; dbSNP:rs1057520017)	19892943	1
Q15831/S232P	Q15831	STK11	STK11_HUMAN	S232P	594	αF	-	-	GLDTFsFKVDI	0.518	0.516	0.498	0.407	0.32	0.367	0.549	0.279	VARIANT	S -> P (in sporadic cancer; somatic mutation; no effect heterotrimeric complex assembly with STRADA and CAB39)	19892943	1
Q15831/S428A	Q15831	STK11	STK11_HUMAN	S428A	-	-	p	-	KIRRLsCKQQ									MUTAGEN	S->A,E: No effect on kinase activity.	18854309	1
Q15831/S428E	Q15831	STK11	STK11_HUMAN	S428E	-	-	p	-	KIRRLsCKQQ									MUTAGEN	S->A,E: No effect on kinase activity.	18854309	1
Q15831/T189A	Q15831	STK11	STK11_HUMAN	T189A	482	Catalytic-loop	p	decrease	LTTGGtKISDL	0.819	0.792	0.369	0.671	0.62	0.625	0.406	0.259	MUTAGEN	T->A: Reduced phosphorylation.	11430832	1
Q15831/T230P	Q15831	STK11	STK11_HUMAN	T230P	592	αF	-	-	ANGLDtSGFKV	0.35	0.434	0.549	0.447	0.234	0.229	0.671	0.273	VARIANT	T -> P (in sporadic cancer; somatic mutation; no effect heterotrimeric complex assembly with STRADA and CAB39)	19892943	1
Q15831/T250P	Q15831	STK11	STK11_HUMAN	T250P	614	αF	-	-	LYNITtLYPFE	0.795	0.896	0.539	0.668	0.578	0.754	0.568	0.544	VARIANT	T -> P (in sporadic cancer; somatic mutation; impairs heterotrimeric complex assembly with STRADA and CAB39)	19892943	1
Q15831/T367M	Q15831	STK11	STK11_HUMAN	T367M	-	-	-	-	YTQDFtPGQVP									VARIANT	T -> M (in colorectal cancer; somatic mutation; dbSNP:rs587782835)	9731485	1
Q15831/V66M	Q15831	STK11	STK11_HUMAN	V66M	53	β2	-	-	GKVKEvDSETL	0.173	0.121	0.478	0.242	0.134	0.147	0.692	0.118	VARIANT	V -> M (in cervical carcinoma; somatic mutation; dbSNP:rs1599915144)	12533684,19892943	2
Q15831/W239C	Q15831	STK11	STK11_HUMAN	W239C	602	αF	-	-	FKVDIwAGVTL	0.911	0.882	0.269	0.58	0.809	0.765	0.207	0.53	VARIANT	W -> C (in PJS; late onset suggests reduced penetrance; dbSNP:rs137853082)	12372054	1
Q15831/W308C	Q15831	STK11	STK11_HUMAN	W308C	822	αI	-	loss	IRQHSwRKKHP	0.957	0.902	0.368	0.66	0.845	0.868	0.241	0.609	VARIANT	W -> C (in PJS; abolishes kinase activity, leading to loss of autophosphorylation; dbSNP:rs1057520042)	9837816	1
Q15831/Y272H	Q15831	STK11	STK11_HUMAN	Y272H	675	αG/αH	-	-	IGKGSyIPGDC	0.699	0.571	0.506	0.441	0.439	0.511	0.533	0.405	VARIANT	Y -> H (in sporadic cancer; somatic mutation; no effect on kinase activity nor in heterotrimeric complex assembly with STRADA and CAB39)	19892943	1
Q15831/Y49D	Q15831	STK11	STK11_HUMAN	Y49D	29	N-term-β1	-	-	KLIGKyMGDLL	0.82	0.73	0.571	0.684	0.654	0.741	0.501	0.561	VARIANT	Y -> D (in melanoma; sporadic malignant; somatic mutation; dbSNP:rs137853080)	10201537	1
Q15835/C514S	Q15835	GRK1	GRK1_HUMAN	C514S	-	-	-	-	FATGNcIPWQE									VARIANT	C -> S (in dbSNP:rs771561763)	9268593	1
Q15835/E136Q	Q15835	GRK1	GRK1_HUMAN	E136Q	-	-	-	-	VAKFKePVEIQ									VARIANT	E -> Q (in dbSNP:rs542688076)	9268593	1
Q15835/K219A	Q15835	GRK1	GRK1_HUMAN	K219A	129	β3;Catalytic-Lys	-	loss	KLYACkLNKKR	1.0	1.0	0.051	0.717	0.984	0.99	0.018	0.615	MUTAGEN	K->A: Loss of autophosphorylation and RHO phosphorylation.	15946941	1
Q15835/M522T	Q15835	GRK1	GRK1_HUMAN	M522T	-	-	-	-	PWQEEmETGIF									VARIANT	M -> T (in dbSNP:rs779749742)	9268593	1
Q15835/N330S	Q15835	GRK1	GRK1_HUMAN	N330S	482	Catalytic-loop	-	-	LDNDGnRISDL	0.425	0.359	0.452	0.296	0.294	0.305	0.605	0.245	VARIANT	N -> S (in dbSNP:rs375409897)	9268593	1
Q15835/P391H	Q15835	GRK1	GRK1_HUMAN	P391H	621	αF/αG	-	-	IAARGpRARGE	0.849	0.843	0.371	0.589	0.668	0.778	0.296	0.619	VARIANT	P -> H (in CSNBO2; dbSNP:rs570621429)	17070587	1
Q15835/R438H	Q15835	GRK1	GRK1_HUMAN	R438H	802	αI	-	-	KDPEKrGFRDE	0.866	0.828	0.382	0.638	0.565	0.732	0.397	0.512	VARIANT	R -> H (in dbSNP:rs750619057)	9268593	1
Q15835/S21E	Q15835	GRK1	GRK1_HUMAN	S21E	-	-	p	-	IAARGsDGSSS									MUTAGEN	S->E: Not phosphorylated by PKA.	15946941	1
Q15835/S536L	Q15835	GRK1	GRK1_HUMAN	S536L	-	-	-	-	LNVWRsGQMPD									VARIANT	S -> L (in dbSNP:rs553969577)	9268593	1
Q15835/T298M	Q15835	GRK1	GRK1_HUMAN	T298M	407	αE	-	-	RALFYtQIICG	0.501	0.366	0.626	0.42	0.216	0.341	0.72	0.373	VARIANT	T -> M (in dbSNP:rs572803634)	9268593	1
Q15835/V380D	Q15835	GRK1	GRK1_HUMAN	V380D	606	αF	-	-	YFALGvLYEMI	0.799	0.831	0.548	0.707	0.61	0.681	0.52	0.395	VARIANT	V -> D (in CSNBO2; dbSNP:rs777094000)	9020843	1
Q16288/A664S	Q16288	NTRK3	NTRK3_HUMAN	A664S	411	αE	-	-	IASQIaGMVYL	0.265	0.286	0.474	0.294	0.236	0.219	0.618	0.264	VARIANT	A -> S (in a lung carcinoma sample; somatic mutation)	18293376	1
Q16288/E781K	Q16288	NTRK3	NTRK3_HUMAN	E781K	648	αG	-	-	NTEVIeITQGR	0.075	0.087	0.41	0.112	0.069	0.087	0.686	0.085	VARIANT	E -> K (in dbSNP:rs56393451)	17344846	1
Q16288/H677Y	Q16288	NTRK3	NTRK3_HUMAN	H677Y	441	Catalytic-loop;HrD-motif	-	-	SQHFVhDLATR	0.672	0.579	0.59	0.506	0.396	0.562	0.677	0.493	VARIANT	H -> Y (in a lung adenocarcinoma sample; somatic mutation)	17344846,18293376	2
Q16288/I533F	Q16288	NTRK3	NTRK3_HUMAN	I533F	24	N-term-β1	-	-	TYVQHiRRDIV	0.532	0.48	0.487	0.451	0.407	0.46	0.535	0.224	VARIANT	I -> F (probable disease-associated variant found in patients with CHD; associated with CHD susceptibility; no change in autophosphorylation; changed NTRK3 signaling with decreased apoptosis in absence of NTF3; dbSNP:rs869112057)	25196463	1
Q16288/I71V	Q16288	NTRK3	NTRK3_HUMAN	I71V	-	-	-	-	NGNASiITDIS									VARIANT	I -> V (found in patients with CHD; unknown pathological significance; dbSNP:rs200923715)	25196463	1
Q16288/I817M	Q16288	NTRK3	NTRK3_HUMAN	I817M	803	αI	-	-	QQRLNiEIYKI	0.141	0.181	0.455	0.106	0.174	0.138	0.626	0.107	VARIANT	I -> M (probable disease-associated variant found in patients with CHD; associated with CHD susceptibility; no change in autophosphorylation; changed NTRK3 signaling with decreased apoptosis in absence of NTF3; dbSNP:rs869209165)	25196463	1
Q16288/K572N	Q16288	NTRK3	NTRK3_HUMAN	K572N	129	β3;Catalytic-Lys	-	loss	MLVAVkLKDPT	1.0	1.0	0.03	0.711	0.994	0.999	0.013	0.559	MUTAGEN	K->N: Loss of autophosphorylation and loss of NTRK3 signaling.	25196463	1
Q16288/K768R	Q16288	NTRK3	NTRK3_HUMAN	K768R	631	αF/αG	-	-	IFTYGkPWFQL	0.144	0.149	0.478	0.179	0.203	0.167	0.673	0.075	VARIANT	K -> R (in dbSNP:rs55770052)	17344846	1
Q16288/L336Q	Q16288	NTRK3	NTRK3_HUMAN	L336Q	-	-	-	-	PTLHWlNGQPL									VARIANT	L -> Q (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
Q16288/N163I	Q16288	NTRK3	NTRK3_HUMAN	N163I	-	-	-	-	EQNFFnSCDIR									VARIANT	N -> I (found in patients with CHD; unknown pathological significance; no change in autophosphorylation; no effect on NTRK3 signaling; dbSNP:rs547862658)	25196463	1
Q16288/R306C	Q16288	NTRK3	NTRK3_HUMAN	R306C	-	-	-	-	VYYPPrVSLEE									VARIANT	R -> C (in dbSNP:rs56386352)	17344846	1
Q16288/R678Q	Q16288	NTRK3	NTRK3_HUMAN	R678Q	442	Catalytic-loop;HrD-motif	-	-	QHFVHrLATRN	0.765	0.759	0.434	0.71	0.527	0.636	0.5	0.415	VARIANT	R -> Q (in dbSNP:rs55890138)	17344846	1
Q16288/R735F	Q16288	NTRK3	NTRK3_HUMAN	R735F	552	A-loop	-	-	TMLPIrMPPES	0.82	0.833	0.478	0.648	0.601	0.765	0.348	0.388	VARIANT	R -> F (in a lung large cell carcinoma sample; somatic mutation; requires 2 nucleotide substitutions)		0
Q16288/R745P	Q16288	NTRK3	NTRK3_HUMAN	R745P	572	αF	-	-	ESIMYrFTTES	0.746	0.684	0.577	0.566	0.447	0.522	0.633	0.428	VARIANT	R -> P (in a lung carcinoma sample; somatic mutation)	18293376	1
Q16288/T149R	Q16288	NTRK3	NTRK3_HUMAN	T149R	-	-	-	-	WQLFQtSLREL									VARIANT	T -> R (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs368222977)	17344846	1
Q16288/T93M	Q16288	NTRK3	NTRK3_HUMAN	T93M	-	-	-	decrease	WRSLHtNAVDM									VARIANT	T -> M (probable disease-associated variant found in patients with CHD; associated with CHD susceptibility; significantly reduced autophosphorylation; decreased NTRK3 signaling associated with decreased apoptosis in absence of NTF3; dbSNP:rs147992979)	25196463	1
Q16288/V21F	Q16288	NTRK3	NTRK3_HUMAN	V21F	-	-	-	-	FLLGSvLDYVG									VARIANT	V -> F (in dbSNP:rs200822610)	25196463	1
Q16288/V307L	Q16288	NTRK3	NTRK3_HUMAN	V307L	-	-	-	-	YYPPRvSLEEP									VARIANT	V -> L (in a lung adenocarcinoma sample; somatic mutation; dbSNP:rs1388363572)	17344846	1
Q16288/W736C	Q16288	NTRK3	NTRK3_HUMAN	W736C	553	A-loop	-	-	MLPIRwPPESI	0.934	0.911	0.275	0.625	0.835	0.835	0.206	0.562	VARIANT	W -> C (in a lung carcinoma sample; somatic mutation)	18293376	1
Q16288/Y766F	Q16288	NTRK3	NTRK3_HUMAN	Y766F	619	αF	-	-	WEIFTyKQPWF	0.329	0.335	0.429	0.284	0.241	0.276	0.624	0.161	VARIANT	Y -> F (in a lung carcinoma sample; somatic mutation)	18293376	1
Q16512/A197E	Q16512	PKN1	PKN1_HUMAN	A197E	-	-	-	-	QLENQaPDDTQ									VARIANT	A -> E (in dbSNP:rs1287763348)	17344846	1
Q16512/A921V	Q16512	PKN1	PKN1_HUMAN	A921V	-	-	-	-	SPPRDaPLTAA									VARIANT	A -> V (in a colorectal adenocarcinoma sample; somatic mutation)	17344846	1
Q16512/D108A	Q16512	PKN1	PKN1_HUMAN	D108A	-	-	-	-	PAATHdPQSPG									MUTAGEN	D->A: Abolishes cleavage by caspase-3 and formation of AF1 fragment.	9751706	1
Q16512/D451A	Q16512	PKN1	PKN1_HUMAN	D451A	-	-	-	loss	FLKLEdLDNER									MUTAGEN	D->A: Abolishes cleavage by caspase-3 and formation of 70 kDa fragment.	9751706	1
Q16512/D454A	Q16512	PKN1	PKN1_HUMAN	D454A	-	-	-	loss	LEDFLdERHEV									MUTAGEN	D->A: Abolishes cleavage by caspase-3 and formation of 70 kDa fragment.	9751706	1
Q16512/D558A	Q16512	PKN1	PKN1_HUMAN	D558A	-	-	-	loss	LNLGTdDSSPQ									MUTAGEN	D->A: Abolishes cleavage by caspase-3 and formation of AF3 fragment.	9751706	1
Q16512/D560A	Q16512	PKN1	PKN1_HUMAN	D560A	-	-	-	loss	LGTDSdSPQKS									MUTAGEN	D->A: Abolishes cleavage by caspase-3 and formation of AF3 fragment.	9751706	1
Q16512/F873L	Q16512	PKN1	PKN1_HUMAN	F873L	822	αI	-	-	VKKQPfRTLGW	0.845	0.828	0.58	0.742	0.58	0.735	0.531	0.482	VARIANT	F -> L (in a breast infiltrating ductal carcinoma sample; somatic mutation)	17344846	1
Q16512/I718V	Q16512	PKN1	PKN1_HUMAN	I718V	401	αE	-	-	SEPRAiYSACV	0.087	0.078	0.415	0.141	0.138	0.105	0.64	0.065	VARIANT	I -> V (in dbSNP:rs2230539)	17344846,7988719	2
Q16512/K644E	Q16512	PKN1	PKN1_HUMAN	K644E	129	β3;Catalytic-Lys	ub	loss	ELFAIkLKKGD	1.0	1.0	0.049	0.766	1.0	0.998	0.035	0.489	MUTAGEN	K->E: Abolishes Serine/threonine-protein kinase activity.	18066052,8135837	2
Q16512/K644R	Q16512	PKN1	PKN1_HUMAN	K644R	129	β3;Catalytic-Lys	ub	decrease	ELFAIkLKKGD	0.999	0.993	0.046	0.761	0.999	0.998	0.033	0.495	MUTAGEN	K->R: Substantial reduction of autophosphorylation.	18066052,8135837	2
Q16512/L555I	Q16512	PKN1	PKN1_HUMAN	L555I	-	-	-	-	VEKLNlTDSDS									VARIANT	L -> I (in dbSNP:rs34309238)	14702039,17344846	2
Q16512/R181A	Q16512	PKN1	PKN1_HUMAN	R181A	-	-	-	-	KIDIIrQLRRA									MUTAGEN	R->A: Abolishes interaction with bacterial SspH1.	24248594	1
Q16512/R181K	Q16512	PKN1	PKN1_HUMAN	R181K	-	-	-	-	KIDIIrQLRRA									MUTAGEN	R->K: Decreases interaction with bacterial SspH1.	24248594	1
Q16512/R185A	Q16512	PKN1	PKN1_HUMAN	R185A	-	-	-	-	IRMQLrALQAG									MUTAGEN	R->A: Abolishes interaction with bacterial SspH1.	24248594	1
Q16512/R185C	Q16512	PKN1	PKN1_HUMAN	R185C	-	-	-	-	IRMQLrALQAG									VARIANT	R -> C (in a metastatic melanoma sample; somatic mutation; dbSNP:rs267605306)	17344846	1
Q16512/R436W	Q16512	PKN1	PKN1_HUMAN	R436W	-	-	-	neutral	LAVFWrQRGLC									VARIANT	R -> W (in dbSNP:rs35132656)	17344846	1
Q16512/R520Q	Q16512	PKN1	PKN1_HUMAN	R520Q	-	-	-	-	WVRLLrLIPNA									VARIANT	R -> Q (in dbSNP:rs56273055)	17344846	1
Q16512/R635Q	Q16512	PKN1	PKN1_HUMAN	R635Q	61	β2/β3-loop	-	neutral	LLSEFrSGELF	0.138	0.158	0.434	0.147	0.155	0.117	0.64	0.139	VARIANT	R -> Q (in dbSNP:rs35416389)	17344846	1
Q16512/V901I	Q16512	PKN1	PKN1_HUMAN	V901I	850	C-term-αI	-	neutral	SGRTDvNFDEE	0.374	0.308	0.519	0.312	0.155	0.204	0.685	0.243	VARIANT	V -> I (in dbSNP:rs10846)	14702039,15489334,17344846	3
Q16513/A197E	Q16513	PKN2	PKN2_HUMAN	A197E	-	-	-	-	MQILQaQTNEL									VARIANT	A -> E (in dbSNP:rs35207128)		0
Q16513/D117A	Q16513	PKN2	PKN2_HUMAN	D117A	-	-	-	-	PEDITdPRTPD									MUTAGEN	D->A: Prevents proteolytic processing by caspase-3 during apoptosis. Diminishes pro-apoptotic function; when associated with E-700.	10926925,9368003	2
Q16513/D700E	Q16513	PKN2	PKN2_HUMAN	D700E	168	αC	-	-	ARDEVdLMCEK	0.19	0.171	0.447	0.204	0.176	0.121	0.645	0.218	MUTAGEN	D->E: Prevents proteolytic processing by caspase-3 during apoptosis. Diminishes pro-apoptotic function; when associated with A-117.	10926925,9368003	2
Q16513/D978A	Q16513	PKN2	PKN2_HUMAN	D978A	-	-	-	-	MFRDFdIADWC									MUTAGEN	D->A: Does not inhibit catalytic activity.	10226025,18835241	2
Q16513/D978S	Q16513	PKN2	PKN2_HUMAN	D978S	-	-	-	-	MFRDFdIADWC									MUTAGEN	D->A,S: Abolishes interaction with PDPK1 and prevents the phosphorylation of AKT1 at 'Ser-473'.	10226025,18835241	2
Q16513/E94D	Q16513	PKN2	PKN2_HUMAN	E94D	-	-	-	-	SNKKLeLHHKL									VARIANT	E -> D (in dbSNP:rs12039846)		0
Q16513/F974A	Q16513	PKN2	PKN2_HUMAN	F974A	-	-	-	-	EEQEMfDFDYI									MUTAGEN	F->A: Abolishes interaction with PDPK1 and prevents the phosphorylation of AKT1 at 'Ser-473'.	10226025	1
Q16513/F977A	Q16513	PKN2	PKN2_HUMAN	F977A	-	-	-	decrease	EMFRDfYIADW									MUTAGEN	F->A,L: Abolishes interaction with PDPK1 and prevents the phosphorylation of AKT1 at 'Ser-473'. Reduces catalytic activity by 90%.	10226025,18835241	2
Q16513/F977L	Q16513	PKN2	PKN2_HUMAN	F977L	-	-	-	decrease	EMFRDfYIADW									MUTAGEN	F->A,L: Abolishes interaction with PDPK1 and prevents the phosphorylation of AKT1 at 'Ser-473'. Reduces catalytic activity by 90%.	10226025,18835241	2
Q16513/F977W	Q16513	PKN2	PKN2_HUMAN	F977W	-	-	-	decrease	EMFRDfYIADW									MUTAGEN	F->W,Y: Reduces catalytic activity by 50%.	10226025,18835241	2
Q16513/F977Y	Q16513	PKN2	PKN2_HUMAN	F977Y	-	-	-	decrease	EMFRDfYIADW									MUTAGEN	F->W,Y: Reduces catalytic activity by 50%.	10226025,18835241	2
Q16513/K686R	Q16513	PKN2	PKN2_HUMAN	K686R	129	β3;Catalytic-Lys	-	-	EMFAIkLKKGD	0.999	0.993	0.041	0.739	0.998	0.998	0.014	0.492	MUTAGEN	K->R: Does not inhibit interaction with PTPN13.	11356191	1
Q16513/Q655R	Q16513	PKN2	PKN2_HUMAN	Q655R	27	N-term-β1	-	neutral	FQFNLqFRCCA	0.332	0.289	0.533	0.254	0.193	0.217	0.693	0.178	VARIANT	Q -> R (in dbSNP:rs12085658)		0
Q16513/T121A	Q16513	PKN2	PKN2_HUMAN	T121A	-	-	p	-	TDCPRtDTPNN									MUTAGEN	T->A: Does not suppress ciliogenesis; when associated with A-124.	27104747	1
Q16513/T124A	Q16513	PKN2	PKN2_HUMAN	T124A	-	-	p	-	PRTPDtNNDPR									MUTAGEN	T->A: Does not suppress ciliogenesis; when associated with A-121.	27104747	1
Q16513/T816A	Q16513	PKN2	PKN2_HUMAN	T816A	545	A-loop	p	decrease	GDRTStCGTPE	0.988	1.0	0.166	0.917	0.936	0.98	0.133	0.36	MUTAGEN	T->A: Reduces catalytic activity.	18835241	1
Q16513/T958A	Q16513	PKN2	PKN2_HUMAN	T958A	-	-	p	loss	EAPILtPREPR									MUTAGEN	T->A: Abolishes catalytic activity.	18835241	1
Q16513/Y979A	Q16513	PKN2	PKN2_HUMAN	Y979A	-	-	-	decrease	FRDFDyADWC									MUTAGEN	Y->A: Reduces catalytic activity by 50%.	10226025,18835241	2
Q16513/Y979F	Q16513	PKN2	PKN2_HUMAN	Y979F	-	-	-	decrease	FRDFDyADWC									MUTAGEN	Y->F,L,W: Reduces catalytic activity by 25%.	10226025,18835241	2
Q16513/Y979L	Q16513	PKN2	PKN2_HUMAN	Y979L	-	-	-	decrease	FRDFDyADWC									MUTAGEN	Y->F,L,W: Reduces catalytic activity by 25%.	10226025,18835241	2
Q16513/Y979W	Q16513	PKN2	PKN2_HUMAN	Y979W	-	-	-	decrease	FRDFDyADWC									MUTAGEN	Y->F,L,W: Reduces catalytic activity by 25%.	10226025,18835241	2
Q16539/A320T	Q16539	MAPK14	MK14_HUMAN	A320T	835	C-term-αI	-	decrease	DDEPVaPYDQS	0.394	0.36	0.525	0.424	0.231	0.217	0.649	0.212	MUTAGEN	A->T: Lowered kinase activity.	15284239	1
Q16539/A34V	Q16539	MAPK14	MK14_HUMAN	A34V	43	Gly-rich-loop;β1/β2-loop	-	decrease	PVGSGaGSVCA	0.66	0.568	0.521	0.396	0.525	0.524	0.525	0.267	MUTAGEN	A->V: Lowered kinase activity.	7493921	1
Q16539/A51V	Q16539	MAPK14	MK14_HUMAN	A51V	127	β3	-	-	TGLRVaKKLSR	0.635	0.64	0.407	0.541	0.63	0.645	0.453	0.436	VARIANT	A -> V (in a gastric adenocarcinoma sample; somatic mutation)	17344846	1
Q16539/D168A	Q16539	MAPK14	MK14_HUMAN	D168A	496	A-loop;DFG-motif	-	loss	ELKILdGLARH	0.95	0.917	0.102	0.551	0.896	0.935	0.099	0.719	MUTAGEN	D->A: Loss of kinase activity.	7493921	1
Q16539/D176A	Q16539	MAPK14	MK14_HUMAN	D176A	510	A-loop	-	increase	LARHTdEMTGY	0.868	0.839	0.655	0.81	0.183	0.652	0.714	0.368	MUTAGEN	D->A: Emulation of the active state. Increase in activity; when associated with S-327 or L-327.	15284239	1
Q16539/D177A	Q16539	MAPK14	MK14_HUMAN	D177A	512	A-loop	-	loss	ARHTDdMTGYV	0.744	0.663	0.55	0.526	0.562	0.606	0.512	0.54	MUTAGEN	D->A: Loss of kinase activity.	15284239	1
Q16539/D343G	Q16539	MAPK14	MK14_HUMAN	D343G	-	-	-	-	KSLTYdVISFV									VARIANT	D -> G (in dbSNP:rs45496794)	17344846	1
Q16539/F327L	Q16539	MAPK14	MK14_HUMAN	F327L	842	C-term-αI	-	increase	PYDQSfSRDLL	0.562	0.509	0.543	0.53	0.267	0.397	0.651	0.363	MUTAGEN	F->L: Emulation of the active state. Increase in activity; when associated with A-176.	15284239	1
Q16539/F327S	Q16539	MAPK14	MK14_HUMAN	F327S	842	C-term-αI	-	increase	PYDQSfSRDLL	0.75	0.609	0.415	0.444	0.563	0.657	0.421	0.613	MUTAGEN	F->S: Emulation of the active state. Increase in activity; when associated with A-176.	15284239	1
Q16539/K53R	Q16539	MAPK14	MK14_HUMAN	K53R	129	β3;Catalytic-Lys	ac	loss	LRVAVkLSRPF	1.0	1.0	0.099	0.828	0.904	0.997	0.148	0.447	MUTAGEN	K->R: Loss of kinase activity.	7493921	1
Q16539/K54R	Q16539	MAPK14	MK14_HUMAN	K54R	130	β3	ub	decrease	RVAVKkSRPFQ	0.714	0.737	0.493	0.596	0.629	0.703	0.53	0.283	MUTAGEN	K->R: Impairs MAP2K6/MKK6-dependent autophosphorylation.	11010976	1
Q16539/P322R	Q16539	MAPK14	MK14_HUMAN	P322R	837	C-term-αI	-	-	EPVADpDQSFE	0.777	0.833	0.503	0.576	0.587	0.728	0.542	0.494	VARIANT	P -> R (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
Q16539/T175A	Q16539	MAPK14	MK14_HUMAN	T175A	509	A-loop	p	-	GLARHtDEMTG	0.72	0.702	0.395	0.669	0.48	0.664	0.493	0.353	MUTAGEN	T->A: No effect on either the kinase activity or tyrosine phosphorylation.	7493921	1
Q16539/T180E	Q16539	MAPK14	MK14_HUMAN	T180E	544	A-loop	p	loss	TDDEMtYVATR	0.895	0.944	0.524	0.834	0.751	0.896	0.463	0.607	MUTAGEN	T->E: Loss of kinase activity.	7493921	1
Q16539/W337R	Q16539	MAPK14	MK14_HUMAN	W337R	852	C-term-αI	-	loss	LLIDEwSLTYD	0.767	0.698	0.438	0.618	0.592	0.751	0.366	0.7	MUTAGEN	W->R: Loss of kinase activity.	15284239	1
Q16539/Y182F	Q16539	MAPK14	MK14_HUMAN	Y182F	546	A-loop	p	loss	DEMTGyATRWY	0.98	0.984	0.262	0.868	0.951	0.962	0.213	0.513	MUTAGEN	Y->F: Loss of kinase activity.	7493921	1
Q16539/Y69H	Q16539	MAPK14	MK14_HUMAN	Y69H	171	αC	-	decrease	HAKRTyELRLL	0.874	0.834	0.438	0.619	0.637	0.758	0.4	0.674	MUTAGEN	Y->H: Lowered kinase activity.	15284239	1
Q16566/D178N	Q16566	CAMK4	KCC4_HUMAN	D178N	483	Catalytic-loop	-	-	ATPAPdPLKIA	0.229	0.216	0.471	0.205	0.158	0.167	0.622	0.191	VARIANT	D -> N (in dbSNP:rs35548075)	17344846	1
Q16566/E150G	Q16566	CAMK4	KCC4_HUMAN	E150G	412	αE	-	-	VKQILeVAYLH	0.569	0.583	0.409	0.392	0.491	0.463	0.486	0.393	VARIANT	E -> G (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
Q16566/I469M	Q16566	CAMK4	KCC4_HUMAN	I469M	-	-	-	-	PQQDViPEY									VARIANT	I -> M (in a lung large cell carcinoma sample; somatic mutation; dbSNP:rs1239950009)	17344846	1
Q16566/K75E	Q16566	CAMK4	KCC4_HUMAN	K75E	129	β3;Catalytic-Lys	-	loss	KPYALkLKKTV	1.0	1.0	0.077	0.718	0.998	0.996	0.043	0.45	MUTAGEN	K->E: Loss of activity; dominant negative form.	10617605	1
Q16566/Q465R	Q16566	CAMK4	KCC4_HUMAN	Q465R	-	-	-	neutral	GFEVPqDVILP									VARIANT	Q -> R (in dbSNP:rs56360861)	17344846	1
Q16566/S12A	Q16566	CAMK4	KCC4_HUMAN	S12A	-	-	p	loss	PSCSAsCSSVT									MUTAGEN	S->A: Loss of activity.	8702940	1
Q16566/S13A	Q16566	CAMK4	KCC4_HUMAN	S13A	-	-	p	loss	SCSASsSSVTA									MUTAGEN	S->A: Loss of activity.	8702940	1
Q16566/S189A	Q16566	CAMK4	KCC4_HUMAN	S189A	501	A-loop	p	increase	ADFGLsIVEHQ	0.868	0.933	0.616	0.824	0.326	0.789	0.627	0.289	MUTAGEN	S->A: Increases phosphorylation of CREB1 2-fold. Decreases total O-linked glycosylation 2-fold. Increases ATP-binding affinity.	19506079	1
Q16566/T200A	Q16566	CAMK4	KCC4_HUMAN	T200A	545	A-loop	p	loss	QVLMKtCGTPG	0.999	1.0	0.165	0.918	0.959	0.992	0.075	0.45	MUTAGEN	T->A: Loss of activation by CaMKK1 or CaMKK2.	8855261	1
Q16584/A282G	Q16584	MAP3K11	M3K11_HUMAN	A282G	539	A-loop	-	-	TTQMSaGTYAW	0.391	0.349	0.499	0.385	0.227	0.348	0.59	0.443	VARIANT	A -> G (in dbSNP:rs34594252)	17344846	1
Q16584/D151V	Q16584	MAP3K11	M3K11_HUMAN	D151V	136	αC	-	-	ARQDPdDISVT	0.682	0.679	0.585	0.554	0.352	0.54	0.717	0.39	VARIANT	D -> V (in dbSNP:rs34178129)	17344846	1
Q16584/E164A	Q16584	MAP3K11	M3K11_HUMAN	E164A	173	αC	-	decrease	ESVRQeRLFAM	0.941	0.895	0.248	0.703	0.907	0.887	0.205	0.547	MUTAGEN	E->A: Greatly reduced autophosphorylation activity.	8195146	1
Q16584/K144A	Q16584	MAP3K11	M3K11_HUMAN	K144A	129	β3;Catalytic-Lys	-	decrease	ELVAVkARQDP	1.0	1.0	0.033	0.688	0.985	0.999	0.015	0.667	MUTAGEN	K->A: Greatly reduced autophosphorylation activity.	11053428,8195146	2
Q16584/K144R	Q16584	MAP3K11	M3K11_HUMAN	K144R	129	β3;Catalytic-Lys	-	loss	ELVAVkARQDP	1.0	0.996	0.066	0.714	0.969	0.99	0.047	0.505	MUTAGEN	K->R: Loss of kinase activity. Prevents activation of SAPK and MAPK14.	11053428,8195146	2
Q16584/P252H	Q16584	MAP3K11	M3K11_HUMAN	P252H	454	Catalytic-loop	-	neutral	ILLLQpESDDM	0.167	0.136	0.484	0.183	0.153	0.145	0.573	0.239	VARIANT	P -> H (in dbSNP:rs17855912)	15489334	1
Q16584/S281A	Q16584	MAP3K11	M3K11_HUMAN	S281A	535	A-loop	p	decrease	KTTQMsAGTYA	0.811	0.909	0.347	0.671	0.79	0.767	0.31	0.212	MUTAGEN	S->A: Reduced autophosphorylation activity. Reduced activation of SAPK and MAPK14.	11053428	1
Q16584/S281E	Q16584	MAP3K11	M3K11_HUMAN	S281E	535	A-loop	p	-	KTTQMsAGTYA	0.777	0.852	0.712	0.849	0.262	0.616	0.829	0.3	MUTAGEN	S->E: No effect on SAPK activation.	11053428	1
Q16584/T277A	Q16584	MAP3K11	M3K11_HUMAN	T277A	509	A-loop	p	decrease	REWHKtQMSAA	0.91	0.855	0.53	0.766	0.673	0.769	0.46	0.502	MUTAGEN	T->A: Severely reduced autophosphorylation activity. Prevents phosphorylation of SAPK and MAPK14.	11053428	1
Q16584/T277E	Q16584	MAP3K11	M3K11_HUMAN	T277E	509	A-loop	p	-	REWHKtQMSAA	0.835	0.755	0.706	0.855	0.28	0.54	0.687	0.487	MUTAGEN	T->E: No effect on SAPK activation.	11053428	1
Q16584/T278A	Q16584	MAP3K11	M3K11_HUMAN	T278A	510	A-loop	-	-	EWHKTtMSAAG	0.75	0.827	0.428	0.646	0.547	0.718	0.387	0.334	MUTAGEN	T->A: No effect on autophosphorylation activity or activation of SAPK and MAPK14.	11053428	1
Q16620/G309R	Q16620	NTRK2	NTRK2_HUMAN	G309R	-	-	-	-	PFTVKgPKPAL									VARIANT	G -> R		0
Q16620/G545V	Q16620	NTRK2	NTRK2_HUMAN	G545V	40	β1;Gly-rich-loop	-	-	LKRELgGAFGK	0.822	0.815	0.413	0.711	0.584	0.703	0.385	0.508	VARIANT	G -> V (in dbSNP:rs1075108)		0
Q16620/L138F	Q16620	NTRK2	NTRK2_HUMAN	L138F	-	-	-	-	KHFRHlLSELI									VARIANT	L -> F (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
Q16620/M697I	Q16620	NTRK2	NTRK2_HUMAN	M697I	499	A-loop	-	-	IGDFGmRDVYS	0.666	0.675	0.487	0.604	0.437	0.576	0.598	0.406	VARIANT	M -> I (in a lung carcinoma sample; somatic mutation)	18293376	1
Q16620/N338Y	Q16620	NTRK2	NTRK2_HUMAN	N338Y	-	-	-	-	KIHVTnTEYHG									VARIANT	N -> Y (in dbSNP:rs1047856)		0
Q16620/R699G	Q16620	NTRK2	NTRK2_HUMAN	R699G	501	A-loop	-	-	DFGMSrVYSTD	0.893	0.894	0.438	0.766	0.649	0.801	0.351	0.461	VARIANT	R -> G (in a lung carcinoma sample; somatic mutation)	18293376	1
Q16620/R718C	Q16620	NTRK2	NTRK2_HUMAN	R718C	552	A-loop	-	-	TMLPIrMPPES	0.818	0.826	0.453	0.663	0.622	0.708	0.37	0.449	VARIANT	R -> C (in a lung carcinoma sample; somatic mutation; dbSNP:rs1324578301)	18293376	1
Q16620/T704I	Q16620	NTRK2	NTRK2_HUMAN	T704I	509	A-loop	-	-	RDVYStYYRVG	0.792	0.663	0.59	0.613	0.46	0.527	0.598	0.651	VARIANT	T -> I (in OBHD; unknown pathological significance; dbSNP:rs1554774973)	29100083	1
Q16620/Y434C	Q16620	NTRK2	NTRK2_HUMAN	Y434C	-	-	-	-	EHLSVyVVVIA									VARIANT	Y -> C (in DEE58; unknown pathological significance; dbSNP:rs886041091)	29100083	1
Q16620/Y706C	Q16620	NTRK2	NTRK2_HUMAN	Y706C	511	A-loop	p	decrease	VYSTDyRVGGH	0.962	0.947	0.601	0.881	0.632	0.908	0.537	0.644	VARIANT	Y -> C (in OBHD; expressed normally on the cell surface; results in markedly impaired ligand-induced phosphorylation as well as impaired downstream MAPK1 phosphorylation; dbSNP:rs121434633)	15494731	1
Q16644/D276Y	Q16644	MAPKAPK3	MAPK3_HUMAN	D276Y	783	αH	-	-	SEVSEdKQLIR	0.607	0.553	0.496	0.488	0.37	0.42	0.604	0.361	VARIANT	D -> Y (in dbSNP:rs56107897)	17344846	1
Q16644/E105A	Q16644	MAPKAPK3	MAPK3_HUMAN	E105A	210	β4/β5-loop	-	-	ILDVYeMHHGK	0.761	0.7	0.605	0.637	0.338	0.6	0.624	0.534	VARIANT	E -> A (in an ovarian endometrioid sample; somatic mutation)	17344846	1
Q16644/K73M	Q16644	MAPKAPK3	MAPK3_HUMAN	K73M	129	β3;Catalytic-Lys	-	loss	QKCALkLYDSP	0.999	0.993	0.021	0.655	0.994	0.998	0.013	0.555	MUTAGEN	K->M: Higher affinity toward PCH2.	15563468	1
Q16644/L173P	Q16644	MAPKAPK3	MAPK3_HUMAN	L173P	450	Catalytic-loop	-	-	KPENLlTSKEK	0.888	0.883	0.459	0.715	0.748	0.769	0.406	0.634	VARIANT	L -> P (in MDPT3; decreased localization to the nucleus; dbSNP:rs886037913)	26744326	1
Q16644/P28S	Q16644	MAPKAPK3	MAPK3_HUMAN	P28S	14	N-term-β1	-	-	GLGGApGRREP	0.126	0.186	0.499	0.238	0.147	0.127	0.661	0.166	VARIANT	P -> S (in a glioblastoma multiforme sample; somatic mutation; dbSNP:rs375412266)	17344846	1
Q16654/A17V	Q16654	PDK4	PDK4_HUMAN	A17V	-	-	-	-	GSLNGaLVPRE									VARIANT	A -> V (in dbSNP:rs56391840)	17344846	1
Q16654/D109G	Q16654	PDK4	PDK4_HUMAN	D109G	-	-	-	-	EKSPDdKALSD									VARIANT	D -> G (in dbSNP:rs34898343)	17344846	1
Q16654/D394A	Q16654	PDK4	PDK4_HUMAN	D394A	-	-	-	-	SSEADdCIPSR									MUTAGEN	D->A: Loss of activity; when associated with A-395.	18658136	1
Q16654/L19M	Q16654	PDK4	PDK4_HUMAN	L19M	-	-	-	-	LNGAGlPREVE									VARIANT	L -> M (in dbSNP:rs55761955)	17344846	1
Q16654/R161A	Q16654	PDK4	PDK4_HUMAN	R161A	-	-	-	loss	QYFLDrYMNRI									MUTAGEN	R->A: Loss of activity.	18658136	1
Q16654/W395A	Q16654	PDK4	PDK4_HUMAN	W395A	-	-	-	-	SEADDwIPSRE									MUTAGEN	W->A: Loss of activity; when associated with A-394.	18658136	1
Q16654/Y157F	Q16654	PDK4	PDK4_HUMAN	Y157F	-	-	-	loss	NQNLQyLDRFY									MUTAGEN	Y->F: Loss of activity.	18658136	1
Q16659/L290V	Q16659	MAPK6	MK06_HUMAN	L290V	785	αH	-	-	ISREAlFLEQI	0.164	0.132	0.536	0.223	0.098	0.081	0.753	0.129	VARIANT	L -> V (in dbSNP:rs35697691)	15489334,17344846	2
Q16671/D426G	Q16671	AMHR2	AMHR2_HUMAN	D426G	621	αF/αG	-	-	LSRCPdRPDSS	0.818	0.818	0.452	0.677	0.556	0.713	0.475	0.644	VARIANT	D -> G (in PMDS2)	8872466	1
Q16671/D491H	Q16671	AMHR2	AMHR2_HUMAN	D491H	796	αI	-	-	DCWDAdEARLT	0.742	0.678	0.639	0.62	0.292	0.552	0.661	0.343	VARIANT	D -> H (in PMDS2; dbSNP:rs780680518)	8872466	1
Q16671/G142V	Q16671	AMHR2	AMHR2_HUMAN	G142V	-	-	-	-	PQAAPgSIWMA									VARIANT	G -> V (in PMDS2)	8872466	1
Q16671/H282Q	Q16671	AMHR2	AMHR2_HUMAN	H282Q	252	β5/αD-loop	-	-	LVLELhKGSLC	0.778	0.701	0.505	0.64	0.527	0.571	0.544	0.553	VARIANT	H -> Q (in PMDS2; dbSNP:rs539695176)	8872466	1
Q16671/R319H	Q16671	AMHR2	AMHR2_HUMAN	R319H	427	αE	-	-	FLHEErQNGQY	0.234	0.182	0.585	0.304	0.164	0.145	0.734	0.082	VARIANT	R -> H (in dbSNP:rs144236183)		0
Q16671/R406Q	Q16671	AMHR2	AMHR2_HUMAN	R406Q	596	αF	-	-	WGMALrADIYS	0.341	0.295	0.496	0.356	0.206	0.198	0.634	0.184	VARIANT	R -> Q (in PMDS2; dbSNP:rs137853104)	11549681	1
Q16671/R504C	Q16671	AMHR2	AMHR2_HUMAN	R504C	824	C-term-αI	-	-	ECVQQrAALAH	0.875	0.849	0.517	0.701	0.646	0.732	0.419	0.443	VARIANT	R -> C (in PMDS2; dbSNP:rs772294564)	8872466	1
Q16671/R54C	Q16671	AMHR2	AMHR2_HUMAN	R54C	-	-	-	-	LPRAIrLYSRC									VARIANT	R -> C (in PMDS2; dbSNP:rs534999427)	8872466	1
Q16671/V458A	Q16671	AMHR2	AMHR2_HUMAN	V458A	686	αG/αH	-	-	LWALAvERRRP	0.381	0.352	0.483	0.326	0.388	0.365	0.516	0.37	VARIANT	V -> A (in PMDS2; dbSNP:rs775889926)	8872466	1
Q16816/R323C	Q16816	PHKG1	PHKG1_HUMAN	R323C	-	-	-	-	IYYQYrVKPVT									VARIANT	R -> C (in dbSNP:rs149458708)	17344846	1
Q16816/V48M	Q16816	PHKG1	PHKG1_HUMAN	V48M	128	β3	-	-	SQEYAvVIDVT	0.503	0.496	0.483	0.532	0.416	0.404	0.618	0.259	VARIANT	V -> M (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs368370244)	17344846	1
Q16832/E113K	Q16832	DDR2	DDR2_HUMAN	E113K	-	-	-	-	GGHGIeAPMYK									VARIANT	E -> K (in SEMD-SL; abolishes collagen binding; dbSNP:rs397514747)	20223752	1
Q16832/I726R	Q16832	DDR2	DDR2_HUMAN	I726R	494	Catalytic-loop	-	-	NYTIKiDFGMS	0.803	0.851	0.351	0.636	0.723	0.783	0.291	0.486	VARIANT	I -> R (in SEMD-SL; causes retention in an intracellular compartment and thereby abolishes signaling in response collagen binding; dbSNP:rs121964864)	19110212,20223752	2
Q16832/K608A	Q16832	DDR2	DDR2_HUMAN	K608A	129	β3;Catalytic-Lys	-	loss	VLVAVkLRADA	0.995	0.985	0.022	0.596	0.99	0.983	0.017	0.627	MUTAGEN	K->A: Abolishes kinase activity.	16186108	1
Q16832/L610P	Q16832	DDR2	DDR2_HUMAN	L610P	131	β3	-	increase	VAVKMlADANK	0.931	0.845	0.518	0.699	0.445	0.784	0.548	0.753	VARIANT	L -> P (in WRCN; increased autophosphorylation in patient fibroblasts)	30449416	1
Q16832/M441I	Q16832	DDR2	DDR2_HUMAN	M441I	-	-	-	neutral	MLDDEmVSLSL									VARIANT	M -> I (in dbSNP:rs34722354)	17344846	1
Q16832/R105S	Q16832	DDR2	DDR2_HUMAN	R105S	-	-	-	-	VGTQGrAGGHG									VARIANT	R -> S (in a lung large cell carcinoma sample; somatic mutation)	16140923,17344846	2
Q16832/R124W	Q16832	DDR2	DDR2_HUMAN	R124W	-	-	-	-	KINYSrGTRWI									VARIANT	R -> W (in SEMD-SL)	26463668	1
Q16832/R478C	Q16832	DDR2	DDR2_HUMAN	R478C	-	-	-	-	RIFPLrDYQEP									VARIANT	R -> C (in dbSNP:rs34869543)	17344846	1
Q16832/R752C	Q16832	DDR2	DDR2_HUMAN	R752C	552	A-loop	-	-	AVLPIrMSWES	0.828	0.81	0.472	0.674	0.588	0.725	0.362	0.386	VARIANT	R -> C (in SEMD-SL; causes retention in an intracellular compartment and thereby abolishes signaling in response collagen binding; dbSNP:rs121964863)	19110212,20223752	2
Q16832/T713I	Q16832	DDR2	DDR2_HUMAN	T713I	446	Catalytic-loop	-	-	HRDLAtNCLVG	0.758	0.726	0.677	0.609	0.339	0.633	0.703	0.529	VARIANT	T -> I (in SEMD-SL; causes retention in an intracellular compartment and thereby abolishes signaling in response collagen binding; dbSNP:rs121964865)	19110212,20223752	2
Q16832/V543F	Q16832	DDR2	DDR2_HUMAN	V543F	9	N-term-β1	-	-	YSVPAvMDLLS	0.362	0.452	0.559	0.399	0.328	0.404	0.698	0.159	VARIANT	V -> F (in dbSNP:rs55973200)	17344846	1
Q16832/W52A	Q16832	DDR2	DDR2_HUMAN	W52A	-	-	-	-	TASSQwESTAA									MUTAGEN	W->A: Abolishes collagen binding.	20004161,20223752	2
Q16832/Y736F	Q16832	DDR2	DDR2_HUMAN	Y736F	507	A-loop	p	decrease	MSRNLyGDYYR	0.897	0.865	0.53	0.787	0.57	0.718	0.563	0.539	MUTAGEN	Y->F: Reduces autophosphorylation. Abolishes phosphorylation by SRC; when associated with F-740 and F-741.	16186108	1
Q16832/Y740C	Q16832	DDR2	DDR2_HUMAN	Y740C	511	A-loop	p	increase	LYSGDyRIQGR	0.981	0.963	0.596	0.905	0.491	0.917	0.581	0.636	VARIANT	Y -> C (in WRCN; increased autophosphorylation in patient fibroblasts)	30449416	1
Q16832/Y740F	Q16832	DDR2	DDR2_HUMAN	Y740F	511	A-loop	p	increase	LYSGDyRIQGR	0.976	0.95	0.664	0.939	0.409	0.875	0.613	0.568	MUTAGEN	Y->F: Promotes autophosphorylation. Abolishes phosphorylation by SRC; when associated with F-736 and F-741.	16186108	1
Q16832/Y741F	Q16832	DDR2	DDR2_HUMAN	Y741F	512	A-loop	p	decrease	YSGDYyIQGRA	0.928	0.943	0.514	0.811	0.711	0.867	0.402	0.48	MUTAGEN	Y->F: Reduces autophosphorylation. Abolishes phosphorylation by SRC; when associated with F-736 and F-740.	16186108	1
Q2M2I8/D176A	Q2M2I8	AAK1	AAK1_HUMAN	D176A	443	Catalytic-loop;HrD-motif	-	loss	PIIHRdKVENI	0.989	0.995	0.15	0.629	0.969	0.995	0.106	0.601	MUTAGEN	D->A: Inhibits autophosphorylation and phosphorylation of AP2M1. Does not affect NUMB localization.	12952931,18657069	2
Q2M2I8/G835D	Q2M2I8	AAK1	AAK1_HUMAN	G835D	-	-	-	-	ESLIPgEPPVP									VARIANT	G -> D	17344846	1
Q2M2I8/I59V	Q2M2I8	AAK1	AAK1_HUMAN	I59V	46	β2	-	-	EGGFAiFLVRT	0.348	0.246	0.547	0.361	0.226	0.207	0.702	0.322	VARIANT	I -> V (in dbSNP:rs34535244)	17344846	1
Q2M2I8/K509Q	Q2M2I8	AAK1	AAK1_HUMAN	K509Q	-	-	-	-	HPATQkAIAQF									VARIANT	K -> Q (in dbSNP:rs6715776)	10470851,15489334	2
Q2M2I8/K74A	Q2M2I8	AAK1	AAK1_HUMAN	K74A	129	β3;Catalytic-Lys	-	loss	MKCALkMFVNN	1.0	0.997	0.036	0.659	0.988	0.999	0.01	0.658	MUTAGEN	K->A: Inhibits autophosphorylation and phosphorylation of AP2M1. Does not affect NUMB localization. Does not interact with monoubiquitinated NOTCH1.	12952931,18657069,21464124	3
Q2M2I8/P725T	Q2M2I8	AAK1	AAK1_HUMAN	P725T	-	-	-	-	GEGKHpKLGGS									VARIANT	P -> T (in dbSNP:rs35285785)	17344846	1
Q2M2I8/P771R	Q2M2I8	AAK1	AAK1_HUMAN	P771R	-	-	-	neutral	VDSGLpLSVSD									VARIANT	P -> R (in dbSNP:rs34422616)	17344846	1
Q2M2I8/Q533H	Q2M2I8	AAK1	AAK1_HUMAN	Q533H	-	-	-	-	MQNFYqQQQQQ									VARIANT	Q -> H (in dbSNP:rs1263928487)	17344846	1
Q2M2I8/T694M	Q2M2I8	AAK1	AAK1_HUMAN	T694M	-	-	-	neutral	PSEGStNPFDD									VARIANT	T -> M (in dbSNP:rs55889248)	17344846	1
Q2M2I8/V603A	Q2M2I8	AAK1	AAK1_HUMAN	V603A	-	-	-	neutral	RQQPKvTTPPP									VARIANT	V -> A (in dbSNP:rs56038532)	17344846	1
Q32MK0/G390R	Q32MK0	MYLK3	MYLK3_HUMAN	G390R	-	-	-	-	PGTEPgQTPEG									VARIANT	G -> R (in a colorectal cancer sample; somatic mutation; dbSNP:rs141602742)	16959974	1
Q32MK0/S70T	Q32MK0	MYLK3	MYLK3_HUMAN	S70T	-	-	-	-	HRLEAsAPGPG									VARIANT	S -> T (in dbSNP:rs9923813)		0
Q32MK0/V180L	Q32MK0	MYLK3	MYLK3_HUMAN	V180L	-	-	-	neutral	LSTSGvSDARE									VARIANT	V -> L (in dbSNP:rs28407821)	15489334	1
Q38SD2/A1803T	Q38SD2	LRRK1	LRRK1_HUMAN	A1803T	-	-	-	-	AASHTaPKVPE									VARIANT	A -> T	17344846	1
Q38SD2/D1927G	Q38SD2	LRRK1	LRRK1_HUMAN	D1927G	-	-	-	-	PRRGGdIVIGL									VARIANT	D -> G	17344846	1
Q38SD2/F1022C	Q38SD2	LRRK1	LRRK1_HUMAN	F1022C	-	-	-	loss	VFKMSfPVGFW									MUTAGEN	F->C: No effect on GTP-binding but loss of subsequent stimulation of kinase activity.	16243488	1
Q38SD2/I1412T	Q38SD2	LRRK1	LRRK1_HUMAN	I1412T	499	A-loop	-	decrease	LSDYGiRQSFH	0.764	0.775	0.504	0.596	0.458	0.617	0.623	0.497	MUTAGEN	I->T: No effect on GTP-binding but reduction in subsequent stimulation of kinase activity.	16243488	1
Q38SD2/K1270W	Q38SD2	LRRK1	LRRK1_HUMAN	K1270W	129	β3;Catalytic-Lys	-	loss	QPVAVkFHIKK	1.0	0.985	0.055	0.641	0.986	0.993	0.032	0.412	MUTAGEN	K->W: Loss of autophosphorylation.	16243488	1
Q38SD2/K651A	Q38SD2	LRRK1	LRRK1_HUMAN	K651A	-	-	-	-	PPRQGkTLLEI									MUTAGEN	K->A: Loss of GTP/GDP-binding.	16243488	1
Q38SD2/K746G	Q38SD2	LRRK1	LRRK1_HUMAN	K746G	-	-	-	decrease	LNIEAkPNAVV									MUTAGEN	K->G: No effect on GTP-binding but reduction in subsequent stimulation of kinase activity.	16243488	1
Q38SD2/L1824F	Q38SD2	LRRK1	LRRK1_HUMAN	L1824F	-	-	-	-	MYSEElTQILI									VARIANT	L -> F	17344846	1
Q38SD2/S1847N	Q38SD2	LRRK1	LRRK1_HUMAN	S1847N	-	-	-	-	SSYSSsPRQAA									VARIANT	S -> N	17344846	1
Q3MIX3/S17R	Q3MIX3	ADCK5	ADCK5_HUMAN	S17R	-	-	-	neutral	SALLHsQKPWP									VARIANT	S -> R (in dbSNP:rs6599528)	14702039	1
Q52WX2/A261S	Q52WX2	SBK1	SBK1_HUMAN	A261S	635	αF/αG	-	-	ASGADaFEEFV	0.086	0.089	0.509	0.152	0.086	0.087	0.737	0.083	VARIANT	A -> S	17344846	1
Q52WX2/K92E	Q52WX2	SBK1	SBK1_HUMAN	K92E	168	αC	-	-	SKTKLkFLREV	0.224	0.228	0.581	0.333	0.153	0.18	0.707	0.208	VARIANT	K -> E (in an ovarian mucinous carcinoma sample; somatic mutation)	17344846	1
Q52WX2/N250T	Q52WX2	SBK1	SBK1_HUMAN	N250T	618	αF	-	-	CVLTGnPWEAA	0.3	0.245	0.521	0.203	0.248	0.231	0.654	0.331	VARIANT	N -> T (in dbSNP:rs56072383)	17344846	1
Q52WX2/R12H	Q52WX2	SBK1	SBK1_HUMAN	R12H	-	-	-	-	EPEPPrLTCCG									VARIANT	R -> H (in dbSNP:rs35448675)		0
Q56UN5/E676Q	Q56UN5	MAP3K19	M3K19_HUMAN	E676Q	-	-	-	neutral	YCHVReERDEN									VARIANT	E -> Q (in dbSNP:rs1112542)		0
Q56UN5/E812G	Q56UN5	MAP3K19	M3K19_HUMAN	E812G	-	-	-	neutral	LSIVEeSMEES									VARIANT	E -> G (in dbSNP:rs3905317)		0
Q56UN5/I500M	Q56UN5	MAP3K19	M3K19_HUMAN	I500M	-	-	-	-	PKEPViKPSLQ									VARIANT	I -> M (in a breast pleomorphic lobular carcinoma sample; somatic mutation)	17344846	1
Q56UN5/T438I	Q56UN5	MAP3K19	M3K19_HUMAN	T438I	-	-	-	neutral	ILEECtLKSLS									VARIANT	T -> I (in dbSNP:rs16831235)		0
Q58A45/F293A	Q58A45	PAN3	PAN3_HUMAN	F293A	-	-	-	-	PTASEfPKGGS									MUTAGEN	F->A: Reduces interaction with polyadenylate-binding protein.	17595167,18056425	2
Q58A45/Y203A	Q58A45	PAN3	PAN3_HUMAN	Y203A	-	-	-	-	DSAKPyAHDPL									MUTAGEN	Y->A: Reduces interaction with polyadenylate-binding protein.	18056425	1
Q58F21/A89V	Q58F21	BRDT	BRDT_HUMAN	A89V	-	-	-	-	ENKYYaASECI									VARIANT	A -> V (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs781375003)	17344846	1
Q58F21/E357K	Q58F21	BRDT	BRDT_HUMAN	E357K	-	-	-	-	NPPDHeVTMAR									VARIANT	E -> K (in dbSNP:rs34674879)	17344846	1
Q58F21/G928D	Q58F21	BRDT	BRDT_HUMAN	G928D	-	-	-	-	REAMVgIDMTL									VARIANT	G -> D (in SPGF21; no effect on protein expression; unknown pathological significance; dbSNP:rs754258809)	28199965	1
Q58F21/H288Y	Q58F21	BRDT	BRDT_HUMAN	H288Y	-	-	-	-	MLAKKhSYAWP									VARIANT	H -> Y (in a lung neuroendocrine carcinoma sample; somatic mutation)	17344846	1
Q58F21/K238N	Q58F21	BRDT	BRDT_HUMAN	K238N	-	-	-	neutral	PTFTEkVALPP									VARIANT	K -> N (in dbSNP:rs1156281)	15489334,17344846	2
Q58F21/K336T	Q58F21	BRDT	BRDT_HUMAN	K336T	-	-	-	-	YKDAYkAADVR									VARIANT	K -> T (in dbSNP:rs1064567)		0
Q58F21/N410K	Q58F21	BRDT	BRDT_HUMAN	N410K	-	-	-	neutral	ASSEGnSDDSE									VARIANT	N -> K (in dbSNP:rs3088232)	15489334,17344846	2
Q58F21/P542A	Q58F21	BRDT	BRDT_HUMAN	P542A	-	-	-	-	IQSREpLSNSN									VARIANT	P -> A (in dbSNP:rs55912588)	17344846	1
Q58F21/P696L	Q58F21	BRDT	BRDT_HUMAN	P696L	-	-	-	neutral	KNECIpEGRTG									VARIANT	P -> L (in dbSNP:rs10747493)	14702039,15647849,9367677	3
Q58F21/Q62K	Q58F21	BRDT	BRDT_HUMAN	Q62K	-	-	-	neutral	DAVKLqPDYYT									VARIANT	Q -> K (in dbSNP:rs10783071)	14702039,15489334,15647849,9367677	4
Q58F21/R605Q	Q58F21	BRDT	BRDT_HUMAN	R605Q	-	-	-	-	QELEKrLDVNN									VARIANT	R -> Q (in dbSNP:rs35327986)		0
Q58F21/R6Q	Q58F21	BRDT	BRDT_HUMAN	R6Q	-	-	-	-	MSLPSrTAIIV									VARIANT	R -> Q (in dbSNP:rs56273490)	17344846	1
Q59H18/A785G	Q59H18	TNNI3K	TNI3K_HUMAN	A785G	-	-	-	-	ALSQSaQYSSQ									VARIANT	A -> G (in dbSNP:rs45578635)		0
Q59H18/D151H	Q59H18	TNNI3K	TNI3K_HUMAN	D151H	-	-	-	-	HLEAAdLLQHG									VARIANT	D -> H (in dbSNP:rs34874695)	17344846	1
Q59H18/D833Y	Q59H18	TNNI3K	TNI3K_HUMAN	D833Y	-	-	-	-	SSSFEdS									VARIANT	D -> Y (in dbSNP:rs45614933)		0
Q59H18/F309L	Q59H18	TNNI3K	TNI3K_HUMAN	F309L	-	-	-	-	FSETAfSACTY									VARIANT	F -> L	17344846	1
Q59H18/G526D	Q59H18	TNNI3K	TNI3K_HUMAN	G526D	222	β4/β5-loop	-	decrease	VIQFVgCLNDP	0.873	0.837	0.525	0.709	0.7	0.764	0.525	0.485	VARIANT	G -> D (in CCDD; the mutation results in decreased protein solubility; causes abnormal aggregation; markedly reduced protein expression is observed in the sarcoplasm and nuclei of patient cardiomyocytes; dbSNP:rs606231469)	24925317	1
Q59H18/I686T	Q59H18	TNNI3K	TNI3K_HUMAN	I686T	756	αG/αH	-	neutral	HIRPPiYSIPK	0.374	0.325	0.46	0.345	0.298	0.393	0.541	0.391	VARIANT	I -> T (in dbSNP:rs3737564)	17344846	1
Q59H18/K490R	Q59H18	TNNI3K	TNI3K_HUMAN	K490R	129	β3;Catalytic-Lys	-	loss	KIVAIkYRANT	0.976	0.973	0.061	0.678	0.986	0.989	0.049	0.512	MUTAGEN	K->R: Loss of autophosphorylation activity.	12721663	1
Q59H18/M798I	Q59H18	TNNI3K	TNI3K_HUMAN	M798I	-	-	-	-	LSLEEmRSLQY									VARIANT	M -> I (in a head & Neck squamous cell carcinoma sample; somatic mutation; dbSNP:rs201613442)	17344846	1
Q59H18/P263L	Q59H18	TNNI3K	TNI3K_HUMAN	P263L	-	-	-	neutral	DLEVQpVVNIY									VARIANT	P -> L (in dbSNP:rs34521608)	17344846	1
Q59H18/R629G	Q59H18	TNNI3K	TNI3K_HUMAN	R629G	552	A-loop	-	-	QPGNLrMAPEV	0.412	0.419	0.586	0.531	0.23	0.347	0.66	0.18	VARIANT	R -> G (in a colorectal cancer sample; somatic mutation)	16959974	1
Q59H18/S430L	Q59H18	TNNI3K	TNI3K_HUMAN	S430L	-	-	-	-	YVSVPsLGKIK									VARIANT	S -> L (in a colorectal adenocarcinoma sample; somatic mutation)	17344846	1
Q59H18/T637M	Q59H18	TNNI3K	TNI3K_HUMAN	T637M	566	αF	-	neutral	APEVFtCTRYT	0.145	0.142	0.569	0.255	0.122	0.09	0.719	0.146	VARIANT	T -> M (in dbSNP:rs2274260)	17344846	1
Q59H18/V510L	Q59H18	TNNI3K	TNI3K_HUMAN	V510L	174	αC	-	-	MFCREvILCQL	0.255	0.276	0.568	0.341	0.177	0.169	0.706	0.167	VARIANT	V -> L (in dbSNP:rs34335537)	17344846	1
Q5JZY3/A956T	Q5JZY3	EPHA10	EPHAA_HUMAN	A956T	-	-	-	-	KDSFAaGYGSL									VARIANT	A -> T	17344846	1
Q5JZY3/F281I	Q5JZY3	EPHA10	EPHAA_HUMAN	F281I	-	-	-	neutral	QERGDfEACPP									VARIANT	F -> I (in dbSNP:rs4653328)	17344846	1
Q5JZY3/G749E	Q5JZY3	EPHA10	EPHAA_HUMAN	G749E	-	-	-	neutral	AGQLMgLPGLA									VARIANT	G -> E (in dbSNP:rs6671088)		0
Q5JZY3/H775R	Q5JZY3	EPHA10	EPHAA_HUMAN	H775R	-	-	-	-	GLAARhLVSSD									VARIANT	H -> R (in a breast infiltrating ductal carcinoma sample; somatic mutation)	17344846	1
Q5JZY3/L629P	Q5JZY3	EPHA10	EPHAA_HUMAN	L629P	-	-	-	neutral	QSCGDlQAVHL									VARIANT	L -> P (in dbSNP:rs17511304)		0
Q5JZY3/L630P	Q5JZY3	EPHA10	EPHAA_HUMAN	L630P	-	-	-	-	SCGDLlAVHLF									VARIANT	L -> P	17344846	1
Q5JZY3/R150H	Q5JZY3	EPHA10	EPHAA_HUMAN	R150H	-	-	-	-	GGSRPrIDTIA									VARIANT	R -> H (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs771803475)	17344846	1
Q5JZY3/R807Q	Q5JZY3	EPHA10	EPHAA_HUMAN	R807Q	-	-	-	neutral	TTMSGrPALWA									VARIANT	R -> Q (in dbSNP:rs6670599)		0
Q5JZY3/T220K	Q5JZY3	EPHA10	EPHAA_HUMAN	T220K	-	-	-	neutral	VRGLAtPATAA									VARIANT	T -> K (in dbSNP:rs56276182)	17344846	1
Q5JZY3/V103L	Q5JZY3	EPHA10	EPHAA_HUMAN	V103L	-	-	-	-	GQRIFvLQFTL									VARIANT	V -> L (in dbSNP:rs34557762)		0
Q5JZY3/V645I	Q5JZY3	EPHA10	EPHAA_HUMAN	V645I	-	-	-	neutral	LDAKSvLERSL									VARIANT	V -> I (in dbSNP:rs12405650)		0
Q5S007/A419V	Q5S007	LRRK2	LRRK2_HUMAN	A419V	-	-	-	-	VFQASaALSTL									VARIANT	A -> V (in dbSNP:rs34594498)	17344846	1
Q5S007/A716V	Q5S007	LRRK2	LRRK2_HUMAN	A716V	-	-	-	-	VMLERaDQNNS									VARIANT	A -> V (in dbSNP:rs281865043)	18213618	1
Q5S007/C228S	Q5S007	LRRK2	LRRK2_HUMAN	C228S	-	-	-	-	LHVLHcHSLAI									VARIANT	C -> S (in dbSNP:rs56108242)	18213618	1
Q5S007/C727D	Q5S007	LRRK2	LRRK2_HUMAN	C727D	-	-	-	decrease	SIMVEcLLLGA									MUTAGEN	C->D: Decreased kinase activity. Loss of RAB29-mediated activation and autophosphorylation of S-910, S-935, S-955, S-973 and S-1292. Decreased membrane association; when associated with G-1441, C-1699 and S-2019.	29212815	1
Q5S007/D1375E	Q5S007	LRRK2	LRRK2_HUMAN	D1375E	-	-	-	-	GIDVKdPIQIR									VARIANT	D -> E (in dbSNP:rs28365226)		0
Q5S007/D1994A	Q5S007	LRRK2	LRRK2_HUMAN	D1994A	443	Catalytic-loop;HrD-motif	-	loss	MIIYRdKPHNV	0.975	0.994	0.178	0.654	0.985	0.956	0.085	0.544	MUTAGEN	D->A: Loss of kinase activity.	28720718	1
Q5S007/D1994N	Q5S007	LRRK2	LRRK2_HUMAN	D1994N	443	Catalytic-loop;HrD-motif	-	loss	MIIYRdKPHNV	0.963	1.0	0.239	0.686	0.942	0.944	0.131	0.55	MUTAGEN	D->N: Loss of kinase activity. No loss of interaction with SEC16A and no loss of ability to recruit SEC16A to endoplasmic reticulum exit sites. Decreases proteosomal degradation of MAPT; when associated with A-1906 and A-2017.	25201882,26014385,26824392	3
Q5S007/D2017A	Q5S007	LRRK2	LRRK2_HUMAN	D2017A	496	A-loop;DFG-motif	-	loss	IAKIAdGIAQY	0.97	0.985	0.108	0.549	0.983	0.94	0.069	0.714	MUTAGEN	D->A: Loss of kinase activity. Decreases proteosomal degradation of MAPT; when associated with A-1906 and N-1994. Loss of phosphorylation of RAB10; when associated with G-1441, C-1699, or S-2019.	26014385,29125462,29212815,30635421	4
Q5S007/D2175H	Q5S007	LRRK2	LRRK2_HUMAN	D2175H	-	-	-	-	GCGHTdGQLSF									VARIANT	D -> H (in PARK8; shows decreased WD domain homodimerization; no effect on kinase activity; dbSNP:rs72547981)	30635421	1
Q5S007/D944Y	Q5S007	LRRK2	LRRK2_HUMAN	D944Y	-	-	-	-	IFDHEdLKRKR									VARIANT	D -> Y (in dbSNP:rs17519916)		0
Q5S007/E2395K	Q5S007	LRRK2	LRRK2_HUMAN	E2395K	-	-	-	-	VHFLReMVKEN									VARIANT	E -> K (in dbSNP:rs78964014)	18213618	1
Q5S007/E2395R	Q5S007	LRRK2	LRRK2_HUMAN	E2395R	-	-	-	-	VHFLReMVKEN									MUTAGEN	E->R: Decreases WD domain homodimerization. No effect on kinase activity.	30635421	1
Q5S007/F2344A	Q5S007	LRRK2	LRRK2_HUMAN	F2344A	-	-	-	-	RTSQLfYAAFS									MUTAGEN	F->A: Decreases WD domain homodimerization. No effect on kinase activity.	30635421	1
Q5S007/G2019S	Q5S007	LRRK2	LRRK2_HUMAN	G2019S	498	A-loop;DFG-motif	-	activating	KIADYgAQYCC	0.913	0.913	0.459	0.774	0.446	0.819	0.445	0.6	VARIANT	G->S: Decreased membrane association when associated with D-727, D-728, or D-729. Inhibits autophosphorylation and RAB10 phosphorylation when associated with N-1348 or A-2017.	29212815	1
Q5S007/G2385R	Q5S007	LRRK2	LRRK2_HUMAN	G2385R	-	-	-	-	TEKLCgIDCVH									VARIANT	G -> R (in PARK8; under conditions of oxidative stress the variant protein is more toxic and is associated with a higher rate of apoptosis; reduced binding to synaptic vesicles; no loss of interaction with SEC16A; shows an increase in activity in phosphorylation of RAB8A and RAB10; shows decreased WD domain homodimerization; reduced autophosphorylation at Ser-935; dbSNP:rs34778348)	16172858,17019612,24687852,25201882,26824392,29212815,30635421	7
Q5S007/H2391D	Q5S007	LRRK2	LRRK2_HUMAN	H2391D	-	-	-	increase	LIDCVhLREVM									MUTAGEN	H->D: Increases kinase activity.	30635421	1
Q5S007/I1122V	Q5S007	LRRK2	LRRK2_HUMAN	I1122V	-	-	-	-	NKISGiSPLRL									VARIANT	I -> V (in PARK8; dbSNP:rs34805604)	15541309,16172858	2
Q5S007/I1371V	Q5S007	LRRK2	LRRK2_HUMAN	I1371V	-	-	-	-	SATVGiVKDWP									VARIANT	I -> V (in PARK8; unknown pathological significance; dbSNP:rs17466213)	16157901,16333314	2
Q5S007/I2012T	Q5S007	LRRK2	LRRK2_HUMAN	I2012T	491	Catalytic-loop	-	-	PNAAIiKIADY	0.532	0.461	0.525	0.49	0.4	0.423	0.541	0.49	VARIANT	I -> T (in PARK8; unknown pathological significance; dbSNP:rs34015634)	16172858	1
Q5S007/I2020T	Q5S007	LRRK2	LRRK2_HUMAN	I2020T	499	A-loop	-	increase	IADYGiQYCCR	0.742	0.777	0.519	0.61	0.389	0.596	0.642	0.496	VARIANT	I -> T (in PARK8; significant increase in autophosphorylation of about 40% in comparison to wild-type protein in vitro; shows a progressive reduction in neurite length and branching; shows an increase in activity in phosphorylation of RAB8A and RAB10; dbSNP:rs35870237)	15541309,15880653,16172858,16251215,16321986,17114044,26824392,29212815	8
Q5S007/I723V	Q5S007	LRRK2	LRRK2_HUMAN	I723V	-	-	-	neutral	DQNNSiVECLL									VARIANT	I -> V (in dbSNP:rs10878307)	16172858,17344846,22415848	3
Q5S007/K1347A	Q5S007	LRRK2	LRRK2_HUMAN	K1347A	-	-	-	loss	NTGSGkTLLQQ									MUTAGEN	K->A: GTPase-dead mutant. Loss of interaction with SEC16A and impaired ability to recruit SEC16A to endoplasmic reticulum exit sites.	25201882	1
Q5S007/K1359I	Q5S007	LRRK2	LRRK2_HUMAN	K1359I	-	-	-	-	LMKTKkDLGMQ									VARIANT	K -> I (found in a renal cell carcinoma sample; somatic mutation)	21248752	1
Q5S007/K1906A	Q5S007	LRRK2	LRRK2_HUMAN	K1906A	129	β3;Catalytic-Lys	-	loss	EEVAVkFNKHT	1.0	1.0	0.022	0.667	1.0	0.997	0.007	0.64	MUTAGEN	K->A: Loss of kinase activity. Decreases proteosomal degradation of MAPT; when associated with N-1994 and A-2017.	26014385	1
Q5S007/K1906M	Q5S007	LRRK2	LRRK2_HUMAN	K1906M	129	β3;Catalytic-Lys	-	-	EEVAVkFNKHT	0.999	0.996	0.019	0.657	0.994	0.997	0.01	0.578	VARIANT	K -> M (does not inhibit interaction with RAB29; shows a progressive increase in neurite length and branching)	17114044,23395371	2
Q5S007/K871E	Q5S007	LRRK2	LRRK2_HUMAN	K871E	-	-	-	-	EDVLSkDEWTF									VARIANT	K -> E (in dbSNP:rs281865044)	18213618	1
Q5S007/L119P	Q5S007	LRRK2	LRRK2_HUMAN	L119P	-	-	-	-	VHQLIlMLTVH									VARIANT	L -> P (in dbSNP:rs33995463)	16172858,17344846	2
Q5S007/L1870F	Q5S007	LRRK2	LRRK2_HUMAN	L1870F	19	N-term-β1	-	-	PRNIMlNDELE	0.492	0.421	0.41	0.232	0.319	0.39	0.619	0.185	VARIANT	L -> F (in dbSNP:rs281865053)	18213618	1
Q5S007/L2343D	Q5S007	LRRK2	LRRK2_HUMAN	L2343D	-	-	-	-	TRTSQlSYAAF									MUTAGEN	L->D: Decreases WD domain homodimerization. No effect on kinase activity.	30635421	1
Q5S007/L2439I	Q5S007	LRRK2	LRRK2_HUMAN	L2439I	-	-	-	-	ILLLDlTRRLI									VARIANT	L -> I (in PARK8; shows decreased WD domain homodimerization; no effect on kinase activity; dbSNP:rs72547983)	30635421	1
Q5S007/L2466H	Q5S007	LRRK2	LRRK2_HUMAN	L2466H	-	-	-	-	AQLGSlNVMLV									VARIANT	L -> H (in PARK8; dbSNP:rs281865057)	18213618	1
Q5S007/L728D	Q5S007	LRRK2	LRRK2_HUMAN	L728D	-	-	-	decrease	IMVEClLLGAD									MUTAGEN	L->D: Decreased kinase activity. Loss of RAB29-mediated activation and autophosphorylation of S-910, S-935, S-955, S-973 and S-1292. Decreased membrane association; when associated with G-1441, C-1699 and S-2019.	29212815	1
Q5S007/L729D	Q5S007	LRRK2	LRRK2_HUMAN	L729D	-	-	-	decrease	MVECLlLGADA									MUTAGEN	L->D: Decreased kinase activity. Loss of RAB29-mediated activation and autophosphorylation of S-910, S-935, S-955, S-973 and S-1292. Decreased membrane association; when associated with G-1441, C-1699 and S-2019.	29212815	1
Q5S007/L760D	Q5S007	LRRK2	LRRK2_HUMAN	L760D	-	-	-	decrease	PKLVElLNSGS									MUTAGEN	L->D: Decreased kinase activity and loss of RAB29-mediated activation.	29212815	1
Q5S007/L761D	Q5S007	LRRK2	LRRK2_HUMAN	L761D	-	-	-	decrease	KLVELlNSGSR									MUTAGEN	L->D: Decreased kinase activity and loss of RAB29-mediated activation.	29212815	1
Q5S007/L762D	Q5S007	LRRK2	LRRK2_HUMAN	L762D	-	-	-	decrease	LVELLlSGSRE									MUTAGEN	L->D: Decreased kinase activity and loss of RAB29-mediated activation.	29212815	1
Q5S007/L789D	Q5S007	LRRK2	LRRK2_HUMAN	L789D	-	-	-	-	SQIISlLRRLA									MUTAGEN	L->D: No effect on kinase activity and RAB29-mediated activation.	29212815	1
Q5S007/L790D	Q5S007	LRRK2	LRRK2_HUMAN	L790D	-	-	-	-	QIISLlRRLAL									MUTAGEN	L->D: No effect on kinase activity and RAB29-mediated activation.	29212815	1
Q5S007/L791D	Q5S007	LRRK2	LRRK2_HUMAN	L791D	-	-	-	-	IISLLlRLALD									MUTAGEN	L->D: No effect on kinase activity and RAB29-mediated activation.	29212815	1
Q5S007/M1646T	Q5S007	LRRK2	LRRK2_HUMAN	M1646T	-	-	-	neutral	FPKNYmQYFKL									VARIANT	M -> T (in dbSNP:rs35303786)	16172858,22415848	2
Q5S007/M1869T	Q5S007	LRRK2	LRRK2_HUMAN	M1869T	18	N-term-β1	-	-	LPRNImNNDEL	0.444	0.439	0.445	0.25	0.386	0.334	0.531	0.29	VARIANT	M -> T (in PARK8; unknown pathological significance; dbSNP:rs35602796)	16157908,16172858	2
Q5S007/M2397T	Q5S007	LRRK2	LRRK2_HUMAN	M2397T	-	-	-	neutral	FLREVmKENKE									VARIANT	M -> T (in dbSNP:rs3761863)	16157901,16172858,22415848	3
Q5S007/M2408A	Q5S007	LRRK2	LRRK2_HUMAN	M2408A	-	-	-	-	ESKHKmYSGRV									MUTAGEN	M->A,E: No effect on WD domain homodimerization. No effect on kinase activity.	30635421	1
Q5S007/M2408E	Q5S007	LRRK2	LRRK2_HUMAN	M2408E	-	-	-	-	ESKHKmYSGRV									MUTAGEN	M->A,E: No effect on WD domain homodimerization. No effect on kinase activity.	30635421	1
Q5S007/M712V	Q5S007	LRRK2	LRRK2_HUMAN	M712V	-	-	-	-	YLKNVmERACD									VARIANT	M -> V (in PARK8; dbSNP:rs199566791)	18213618	1
Q5S007/N2081D	Q5S007	LRRK2	LRRK2_HUMAN	N2081D	638	αG	-	-	GLKFPnFDELE	0.27	0.289	0.615	0.408	0.162	0.184	0.757	0.215	VARIANT	N -> D (in dbSNP:rs33995883)	16172858,22415848	2
Q5S007/N2261I	Q5S007	LRRK2	LRRK2_HUMAN	N2261I	-	-	-	-	QSKQKnLLVGT									VARIANT	N -> I (in dbSNP:rs12581902)	16172858	1
Q5S007/N551K	Q5S007	LRRK2	LRRK2_HUMAN	N551K	-	-	-	neutral	VLAALnFIGNP									VARIANT	N -> K (in dbSNP:rs7308720)	16172858,16251215,17344846,22415848	4
Q5S007/P1262A	Q5S007	LRRK2	LRRK2_HUMAN	P1262A	-	-	-	neutral	LKEIPpIGCLE									VARIANT	P -> A (in dbSNP:rs4640000)	16172858	1
Q5S007/P1542S	Q5S007	LRRK2	LRRK2_HUMAN	P1542S	-	-	-	-	ERKNVpEFPVI									VARIANT	P -> S (in PARK8; unknown pathological significance; dbSNP:rs33958906)	16172858,17344846,22415848	3
Q5S007/P2119L	Q5S007	LRRK2	LRRK2_HUMAN	P2119L	797	αI	-	-	CLKENpERPTS	0.751	0.722	0.457	0.549	0.54	0.657	0.424	0.443	VARIANT	P -> L (in dbSNP:rs12423862)	16172858	1
Q5S007/P755L	Q5S007	LRRK2	LRRK2_HUMAN	P755L	-	-	-	-	EKESSpLVELL									VARIANT	P -> L (in dbSNP:rs34410987)		0
Q5S007/Q930R	Q5S007	LRRK2	LRRK2_HUMAN	Q930R	-	-	-	-	CSPNLqHSNSL									VARIANT	Q -> R (in PARK8; unknown pathological significance; dbSNP:rs281865045)	16251215	1
Q5S007/R1067Q	Q5S007	LRRK2	LRRK2_HUMAN	R1067Q	-	-	-	-	NLDVSrDIGPS									VARIANT	R -> Q (in PARK8; dbSNP:rs111341148)	16247070	1
Q5S007/R1398H	Q5S007	LRRK2	LRRK2_HUMAN	R1398H	-	-	-	-	WDFAGrEFYST									VARIANT	R -> H (in dbSNP:rs7133914)	16157901,16172858,17344846,22415848	4
Q5S007/R1398Q	Q5S007	LRRK2	LRRK2_HUMAN	R1398Q	-	-	-	-	WDFAGrEFYST									MUTAGEN	R->Q: Decreased kinase activity; when associated with G-1343.	18230735	1
Q5S007/R1441C	Q5S007	LRRK2	LRRK2_HUMAN	R1441C	-	-	-	increase	FNIKArSSSPV									VARIANT	R -> C (in PARK8; shows an increase in activity in both autophosphorylation and phosphorylation of a generic substrate; loss of interaction with SEC16A; shows an increase in activity in phosphorylation of RAB10; decreases phosphorylation-dependent binding to YWHAG; dbSNP:rs33939927)	15541309,16157909,16172858,16269541,16333314,16533964,25201882,26824392,28202711,29212815	10
Q5S007/R1441G	Q5S007	LRRK2	LRRK2_HUMAN	R1441G	-	-	-	increase	FNIKArSSSPV									VARIANT	R->G: Decreased membrane association when associated with D-727, D-728, or D-729. Inhibits autophosphorylation and RAB10 phosphorylation when associated with N-1348 or A-2017.	29212815	1
Q5S007/R1441H	Q5S007	LRRK2	LRRK2_HUMAN	R1441H	-	-	-	increase	FNIKArSSSPV									VARIANT	R -> H (in PARK8; shows an increase in activity in phosphorylation of RAB8A and RAB10; decreases phosphorylation-dependent binding to YWHAG; dbSNP:rs34995376)	16157909,16172858,26824392,29212815	4
Q5S007/R1514Q	Q5S007	LRRK2	LRRK2_HUMAN	R1514Q	-	-	-	-	LNFKIrQLVVG									VARIANT	R -> Q (in PARK8; unknown pathological significance; dbSNP:rs35507033)	16172858,17344846,22415848	3
Q5S007/R1550Q	Q5S007	LRRK2	LRRK2_HUMAN	R1550Q	-	-	-	-	FPVIDrRLLQL									VARIANT	R -> Q (in an ovarian mucinous carcinoma sample; somatic mutation; dbSNP:rs200212150)	17344846	1
Q5S007/R1628P	Q5S007	LRRK2	LRRK2_HUMAN	R1628P	-	-	-	-	KGIISrDVEKF									VARIANT	R -> P (may be associated with Parkinson disease in some populations; dbSNP:rs33949390)	16172858,21641266,22415848	3
Q5S007/R1723P	Q5S007	LRRK2	LRRK2_HUMAN	R1723P	-	-	-	-	YMLSGrRALRP									VARIANT	R -> P (in an ovarian serous carcinoma sample; somatic mutation)	17344846	1
Q5S007/R1728H	Q5S007	LRRK2	LRRK2_HUMAN	R1728H	-	-	-	increase	RERALrNRMYW									VARIANT	R -> H (in PARK8; shows an increase in activity in phosphorylation of RAB8A and RAB10; dbSNP:rs145364431)	18213618,26824392,29212815	3
Q5S007/R1728L	Q5S007	LRRK2	LRRK2_HUMAN	R1728L	-	-	-	-	RERALrNRMYW									VARIANT	R -> L (in PARK8; dbSNP:rs145364431)	18213618	1
Q5S007/R1941H	Q5S007	LRRK2	LRRK2_HUMAN	R1941H	211	β4/β5-loop	-	-	LAAGIrRMLVM	0.171	0.177	0.528	0.281	0.087	0.118	0.753	0.084	VARIANT	R -> H (in PARK8; dbSNP:rs77428810)	16272164	1
Q5S007/R2143H	Q5S007	LRRK2	LRRK2_HUMAN	R2143H	837	C-term-αI	-	-	VCLTRrLLPKN	0.4	0.456	0.424	0.326	0.308	0.441	0.635	0.098	VARIANT	R -> H (in PARK8; dbSNP:rs201271001)	18213618	1
Q5S007/R2394E	Q5S007	LRRK2	LRRK2_HUMAN	R2394E	-	-	-	-	CVHFLrVMVKE									MUTAGEN	R->E: Decreases WD domain homodimerization. Increases kinase activity and autophosphorylation at Ser-1292.	30635421	1
Q5S007/R50H	Q5S007	LRRK2	LRRK2_HUMAN	R50H	-	-	-	-	FTYSErSKLFQ									VARIANT	R -> H (in dbSNP:rs2256408)		0
Q5S007/R793M	Q5S007	LRRK2	LRRK2_HUMAN	R793M	-	-	-	-	SLLLRrALDVA									VARIANT	R -> M (in PARK8; unknown pathological significance; dbSNP:rs35173587)	16157908,16172858,16251215	3
Q5S007/S1096C	Q5S007	LRRK2	LRRK2_HUMAN	S1096C	-	-	-	-	SYNQLsVPENL									VARIANT	S -> C (in PARK8; unknown pathological significance; dbSNP:rs76535406)		0
Q5S007/S1228T	Q5S007	LRRK2	LRRK2_HUMAN	S1228T	-	-	-	-	RELLFsNQISI									VARIANT	S -> T (in PARK8; dbSNP:rs60185966)	16251215	1
Q5S007/S1647T	Q5S007	LRRK2	LRRK2_HUMAN	S1647T	-	-	-	neutral	PKNYMsYFKLL									VARIANT	S -> T (in dbSNP:rs11564148)	16172858,22415848	2
Q5S007/S2345D	Q5S007	LRRK2	LRRK2_HUMAN	S2345D	-	-	-	-	TSQLFsAAFSD									MUTAGEN	S->D: Decreases WD domain homodimerization. No effect on kinase activity.	30635421	1
Q5S007/S2409A	Q5S007	LRRK2	LRRK2_HUMAN	S2409A	-	-	-	-	SKHKMsSGRVK									MUTAGEN	S->A: Decreases WD domain homodimerization.	30635421	1
Q5S007/T1343G	Q5S007	LRRK2	LRRK2_HUMAN	T1343G	-	-	p	-	MIVGNtSGKTT									MUTAGEN	T->G: Decreased kinase activity; when associated with Q-1398.	18230735	1
Q5S007/T1348N	Q5S007	LRRK2	LRRK2_HUMAN	T1348N	-	-	p	-	TGSGKtLLQQL									MUTAGEN	T->N: Loss of GTP binding. Inhibits autophosphorylation and RAB10 phosphorylation; when associated with G-1441, C-1699, or S-2019.	29212815	1
Q5S007/T2031S	Q5S007	LRRK2	LRRK2_HUMAN	T2031S	545	A-loop	p	increase	RMGIKtEGTPG	0.934	0.948	0.412	0.833	0.383	0.828	0.586	0.177	VARIANT	T -> S (in PARK8; shows an increase in activity in phosphorylation of RAB8A and RAB10; dbSNP:rs78029637)	26824392,29212815	2
Q5S007/T2141M	Q5S007	LRRK2	LRRK2_HUMAN	T2141M	835	C-term-αI	-	-	ELVCLtRILLP	0.238	0.234	0.446	0.23	0.159	0.206	0.599	0.126	VARIANT	T -> M (in PARK8; dbSNP:rs111691891)	18213618	1
Q5S007/T2356I	Q5S007	LRRK2	LRRK2_HUMAN	T2356I	-	-	-	-	DSNIItVVDTA									VARIANT	T -> I (in PARK8; shows decreased WD domain homodimerization; no effect on kinase activity; dbSNP:rs113511708)	16272164,30635421	2
Q5S007/V1598E	Q5S007	LRRK2	LRRK2_HUMAN	V1598E	-	-	-	-	SDLYFvPKWLC									VARIANT	V -> E (in PARK8; unknown pathological significance; dbSNP:rs721710)	16172858	1
Q5S007/V2390M	Q5S007	LRRK2	LRRK2_HUMAN	V2390M	-	-	-	-	GLIDCvFLREV									VARIANT	V -> M (in PARK8; shows decreased WD domain homodimerization; no effect on kinase activity; dbSNP:rs79546190)	30635421	1
Q5S007/Y1699C	Q5S007	LRRK2	LRRK2_HUMAN	Y1699C	-	-	-	-	LYEMPyPMGFW									VARIANT	Y->C: Decreased membrane association when associated with D-727, D-728, or D-729. Inhibits autophosphorylation and RAB10 phosphorylation when associated with N-1348 or A-2017.	29212815	1
Q5S007/Y2189C	Q5S007	LRRK2	LRRK2_HUMAN	Y2189C	-	-	-	-	LNTEGySEEVA									VARIANT	Y -> C (in PARK8; no effect on WD domain homodimerization; no effect on kinase activity; dbSNP:rs35658131)	30635421	1
Q5S007/Y2346A	Q5S007	LRRK2	LRRK2_HUMAN	Y2346A	-	-	-	-	SQLFSyAFSDS									MUTAGEN	Y->A: Decreases WD domain homodimerization. No effect on kinase activity.	30635421	1
Q5TCX8/C784G	Q5TCX8	MAP3K21	M3K21_HUMAN	C784G	-	-	-	-	SLPSTcEASSP									VARIANT	C -> G (in dbSNP:rs963981)	17344846	1
Q5TCX8/D420N	Q5TCX8	MAP3K21	M3K21_HUMAN	D420N	833	C-term-αI	-	-	HSMQDdKLEIQ	0.429	0.452	0.46	0.471	0.26	0.317	0.599	0.347	VARIANT	D -> N (in dbSNP:rs35465006)	17344846	1
Q5TCX8/E563D	Q5TCX8	MAP3K21	M3K21_HUMAN	E563D	-	-	-	-	QLTSDeNKTWG									VARIANT	E -> D (in dbSNP:rs35758282)	17344846	1
Q5TCX8/E741D	Q5TCX8	MAP3K21	M3K21_HUMAN	E741D	-	-	-	-	GLDLReHKAQA									VARIANT	E -> D (in dbSNP:rs3795374)	17344846	1
Q5TCX8/P982L	Q5TCX8	MAP3K21	M3K21_HUMAN	P982L	-	-	-	-	RPGPHpQFLAA									VARIANT	P -> L (in dbSNP:rs34794284)	17344846	1
Q5TCX8/R892W	Q5TCX8	MAP3K21	M3K21_HUMAN	R892W	-	-	-	-	PSHHRrMSDGN									VARIANT	R -> W (in dbSNP:rs55681416)	17344846	1
Q5TCX8/R977C	Q5TCX8	MAP3K21	M3K21_HUMAN	R977C	-	-	-	-	ACVVGrGPHPT									VARIANT	R -> C (in dbSNP:rs56065162)	17344846	1
Q5TCX8/S597F	Q5TCX8	MAP3K21	M3K21_HUMAN	S597F	-	-	-	-	TWGPNsQMKDR									VARIANT	S -> F (in dbSNP:rs34984140)	17344846	1
Q5TCX8/T900I	Q5TCX8	MAP3K21	M3K21_HUMAN	T900I	-	-	-	-	SDGNPtTGATI									VARIANT	T -> I (in dbSNP:rs34499091)	17344846	1
Q5TCX8/V728I	Q5TCX8	MAP3K21	M3K21_HUMAN	V728I	-	-	-	-	LYGCTvLASVA									VARIANT	V -> I (in dbSNP:rs3795375)	17344846	1
Q5TCY1/D741E	Q5TCY1	TTBK1	TTBK1_HUMAN	D741E	-	-	-	-	EEEEEdEEEEE									VARIANT	D -> E (in dbSNP:rs56377340)	17344846	1
Q5TCY1/E744D	Q5TCY1	TTBK1	TTBK1_HUMAN	E744D	-	-	-	-	EEDEEeEEDEE									VARIANT	E -> D (in dbSNP:rs3800295)	17344846	1
Q5TCY1/G623A	Q5TCY1	TTBK1	TTBK1_HUMAN	G623A	-	-	-	-	PQLSQgGRSET									VARIANT	G -> A (in dbSNP:rs3800294)	17344846	1
Q5TCY1/K1145R	Q5TCY1	TTBK1	TTBK1_HUMAN	K1145R	-	-	-	neutral	AALPRkGRAAA									VARIANT	K -> R (in dbSNP:rs3800297)	17344846	1
Q5TCY1/L1184S	Q5TCY1	TTBK1	TTBK1_HUMAN	L1184S	-	-	-	neutral	GAAPAlTAITS									VARIANT	L -> S (in dbSNP:rs3800298)	17344846	1
Q5TCY1/P613L	Q5TCY1	TTBK1	TTBK1_HUMAN	P613L	-	-	-	neutral	LQHLPpPLPPQ									VARIANT	P -> L (in dbSNP:rs34993661)	17344846	1
Q5TCY1/P649R	Q5TCY1	TTBK1	TTBK1_HUMAN	P649R	-	-	-	neutral	HSGPRpRRESD									VARIANT	P -> R (in dbSNP:rs35175743)	17344846	1
Q5TCY1/P855S	Q5TCY1	TTBK1	TTBK1_HUMAN	P855S	-	-	-	-	TAELApPDLGT									VARIANT	P -> S (in a metastatic melanoma sample; somatic mutation; dbSNP:rs267601046)	17344846	1
Q5TCY1/S806F	Q5TCY1	TTBK1	TTBK1_HUMAN	S806F	-	-	-	-	QEGAPsLLADD									VARIANT	S -> F (in a lung large cell carcinoma sample; somatic mutation)	17344846	1
Q5VST9/A1086S	Q5VST9	OBSCN	OBSCN_HUMAN	A1086S	-	-	-	neutral	HNEVQaAGASA									VARIANT	A -> S (in dbSNP:rs117147433)	17344846	1
Q5VST9/A1090T	Q5VST9	OBSCN	OBSCN_HUMAN	A1090T	-	-	-	-	QAEAGaAMLSC									VARIANT	A -> T (in dbSNP:rs752906025)	17344846	1
Q5VST9/A1101P	Q5VST9	OBSCN	OBSCN_HUMAN	A1101P	-	-	-	-	CEVAQaTEVTW									VARIANT	A -> P (in dbSNP:rs780907202)	17344846	1
Q5VST9/A1136V	Q5VST9	OBSCN	OBSCN_HUMAN	A1136V	-	-	-	-	LVLPQaKADAG									VARIANT	A -> V (in a colorectal cancer sample; somatic mutation; dbSNP:rs950055015)	16959974,17344846	2
Q5VST9/A51T	Q5VST9	OBSCN	OBSCN_HUMAN	A51T	-	-	-	neutral	DQQPVaGARFR									VARIANT	A -> T (in dbSNP:rs1771487)	11448995	1
Q5VST9/A908T	Q5VST9	OBSCN	OBSCN_HUMAN	A908T	-	-	-	neutral	EAGASaLSCEV									VARIANT	A -> T (in dbSNP:rs1757153)		0
Q5VST9/G1121R	Q5VST9	OBSCN	OBSCN_HUMAN	G1121R	-	-	-	-	SSSKVgEVKGC									VARIANT	G -> R	17344846	1
Q5VST9/G804S	Q5VST9	OBSCN	OBSCN_HUMAN	G804S	-	-	-	-	HKDMAgCVDAV									VARIANT	G -> S (in dbSNP:rs55950009)	17344846	1
Q5VST9/H1156Q	Q5VST9	OBSCN	OBSCN_HUMAN	H1156Q	-	-	-	-	QRVSFhHITEP									VARIANT	H -> Q	17344846	1
Q5VST9/K1027R	Q5VST9	OBSCN	OBSCN_HUMAN	K1027R	-	-	-	neutral	LSSSLkHVEAK									VARIANT	K -> R (in dbSNP:rs55760713)	17344846	1
Q5VST9/L1133V	Q5VST9	OBSCN	OBSCN_HUMAN	L1133V	-	-	-	-	TRRLVlQAGKA									VARIANT	L -> V (in dbSNP:rs777214598)	17344846	1
Q5VST9/Q1248H	Q5VST9	OBSCN	OBSCN_HUMAN	Q1248H	-	-	-	neutral	QRVSFqHITEP									VARIANT	Q -> H (in dbSNP:rs199523598)	17344846	1
Q5VST9/Q502R	Q5VST9	OBSCN	OBSCN_HUMAN	Q502R	-	-	-	neutral	CQTSTqCVSAP									VARIANT	Q -> R (in dbSNP:rs1771487)	11448995,17344846	2
Q5VST9/S1091T	Q5VST9	OBSCN	OBSCN_HUMAN	S1091T	-	-	-	-	AEAGAsMLSCE									VARIANT	S -> T (in dbSNP:rs965007403)	17344846	1
Q5VT25/A1148T	Q5VT25	CDC42BPA	MRCKA_HUMAN	A1148T	-	-	-	-	VSSVLaDVIHA									VARIANT	A -> T (in dbSNP:rs56219089)	17344846	1
Q5VT25/A1469V	Q5VT25	CDC42BPA	MRCKA_HUMAN	A1469V	-	-	-	-	VYSENaDIFDV									VARIANT	A -> V (in dbSNP:rs55687355)	17344846	1
Q5VT25/A1699V	Q5VT25	CDC42BPA	MRCKA_HUMAN	A1699V	-	-	-	neutral	PRHSTaNSSNL									VARIANT	A -> V (in dbSNP:rs2802269)		0
Q5VT25/A1712V	Q5VT25	CDC42BPA	MRCKA_HUMAN	A1712V	-	-	-	neutral	SPPSPaPRKTK									VARIANT	A -> V (in dbSNP:rs2802269)	17974005,9455484	2
Q5VT25/D478A	Q5VT25	CDC42BPA	MRCKA_HUMAN	D478A	-	-	-	loss	QYSTVdPLTAS									MUTAGEN	D->A: Prevents cleavage by CASP3, impairs the increase of its kinase activity and impairs extrusion apical actin ring assembly.	29162624	1
Q5VT25/D984A	Q5VT25	CDC42BPA	MRCKA_HUMAN	D984A	-	-	-	-	GRRTVdTPLSV									MUTAGEN	D->A: Prevents cleavage by CASP3.	29162624	1
Q5VT25/E50K	Q5VT25	CDC42BPA	MRCKA_HUMAN	E50K	6	N-term-β1	-	-	SPLRReNILEY	0.567	0.536	0.506	0.461	0.355	0.41	0.579	0.361	VARIANT	E -> K (in a lung neuroendocrine carcinoma sample; somatic mutation)	17344846	1
Q5VT25/H1579A	Q5VT25	CDC42BPA	MRCKA_HUMAN	H1579A	-	-	-	-	PTNFNhAHMGP									MUTAGEN	H->A: Loss of CDC42 binding; when associated with A-1582.	9418861	1
Q5VT25/H1582A	Q5VT25	CDC42BPA	MRCKA_HUMAN	H1582A	-	-	-	-	FNHIAhGPGDG									MUTAGEN	H->A: Loss of CDC42 binding; when associated with A-1579.	9418861	1
Q5VT25/I1418K	Q5VT25	CDC42BPA	MRCKA_HUMAN	I1418K	-	-	-	-	ICAVEiSKEYL									VARIANT	I -> K	17344846	1
Q5VT25/I537T	Q5VT25	CDC42BPA	MRCKA_HUMAN	I537T	-	-	-	-	AYEKQiTLQQE									VARIANT	I -> T (in dbSNP:rs56364976)	17344846	1
Q5VT25/K106A	Q5VT25	CDC42BPA	MRCKA_HUMAN	K106A	129	β3;Catalytic-Lys	-	loss	KVFAMkLNKWE	1.0	1.0	0.021	0.653	1.0	0.996	0.005	0.626	MUTAGEN	K->A: Loss of kinase activity.	11283256	1
Q5VT25/R1211H	Q5VT25	CDC42BPA	MRCKA_HUMAN	R1211H	-	-	-	neutral	NKFRDrVYVPK									VARIANT	R -> H (in dbSNP:rs961490)	17344846	1
Q5VT25/S222L	Q5VT25	CDC42BPA	MRCKA_HUMAN	S222L	499	A-loop	p	-	LADFGsLKLME	0.743	0.747	0.547	0.67	0.457	0.642	0.568	0.557	MUTAGEN	S->L: Increase in autophosphorylation but not kinase activity.	11283256	1
Q5VT25/S234A	Q5VT25	CDC42BPA	MRCKA_HUMAN	S234A	543	A-loop	p	loss	DGTVQsVAVGT	0.851	0.862	0.528	0.652	0.674	0.807	0.465	0.318	MUTAGEN	S->A: Loss of autophosphorylation and kinase activity.	11283256	1
Q5VT25/T1618A	Q5VT25	CDC42BPA	MRCKA_HUMAN	T1618A	-	-	-	neutral	SIPSItSRPEP									VARIANT	T -> A (in dbSNP:rs2297417)	17344846	1
Q5VT25/T231M	Q5VT25	CDC42BPA	MRCKA_HUMAN	T231M	523	A-loop	-	-	LMEDGtQSSVA	0.33	0.411	0.501	0.415	0.25	0.233	0.577	0.148	VARIANT	T -> M (in dbSNP:rs34614709)	17344846	1
Q5VT25/T240A	Q5VT25	CDC42BPA	MRCKA_HUMAN	T240A	549	A-loop	p	loss	SVAVGtDYISP	0.908	0.928	0.231	0.761	0.88	0.924	0.188	0.432	MUTAGEN	T->A: Loss of autophosphorylation and kinase activity.	11283256	1
Q5VT25/T403A	Q5VT25	CDC42BPA	MRCKA_HUMAN	T403A	-	-	p	loss	PFVGFtTSSCV									MUTAGEN	T->A: Loss of autophosphorylation and kinase activity.	11283256	1
Q5VT25/T780M	Q5VT25	CDC42BPA	MRCKA_HUMAN	T780M	-	-	-	-	ENKKLtELDKL									VARIANT	T -> M (in dbSNP:rs56119119)	17344846	1
Q5VT25/V1317I	Q5VT25	CDC42BPA	MRCKA_HUMAN	V1317I	-	-	-	neutral	KGCQTvSGKVR									VARIANT	V -> I (in dbSNP:rs1929860)	17344846,17974005	2
Q5VT25/Y790C	Q5VT25	CDC42BPA	MRCKA_HUMAN	Y790C	-	-	-	-	KLTTLyNLSIH									VARIANT	Y -> C (in dbSNP:rs34943764)	17344846	1
Q6DT37/A537D	Q6DT37	CDC42BPG	MRCKG_HUMAN	A537D	-	-	-	neutral	REAATaQTRAL									VARIANT	A -> D (in dbSNP:rs34241745)	17344846	1
Q6DT37/P168L	Q6DT37	CDC42BPG	MRCKG_HUMAN	P168L	394	αD/αE-loop	-	neutral	FEDRLpELAQF	0.466	0.412	0.582	0.415	0.201	0.326	0.696	0.298	VARIANT	P -> L (in dbSNP:rs34454471)	17344846	1
Q6DT37/Q1135R	Q6DT37	CDC42BPG	MRCKG_HUMAN	Q1135R	-	-	-	neutral	CRRVQqTLSPS									VARIANT	Q -> R (in dbSNP:rs3741395)		0
Q6DT37/S280F	Q6DT37	CDC42BPG	MRCKG_HUMAN	S280F	627	αF/αG	-	-	PFYAEsVETYG	0.766	0.75	0.415	0.567	0.674	0.663	0.382	0.385	VARIANT	S -> F (in a glioblastoma multiforme sample; somatic mutation; dbSNP:rs770462360)	17344846	1
Q6DT37/T362P	Q6DT37	CDC42BPG	MRCKG_HUMAN	T362P	848	C-term-αI	-	-	RGPMDtNFDVD	0.735	0.679	0.604	0.635	0.335	0.518	0.635	0.402	VARIANT	T -> P (in dbSNP:rs55688429)	17344846	1
Q6IQ55/A184E	Q6IQ55	TTBK2	TTBK2_HUMAN	A184E	544	A-loop	-	loss	PPRAVaFRGTV	0.892	0.926	0.458	0.765	0.742	0.825	0.395	0.642	MUTAGEN	A->E,G: Impaired serine/threonine-protein kinase activity.	21548880	1
Q6IQ55/A184G	Q6IQ55	TTBK2	TTBK2_HUMAN	A184G	544	A-loop	-	loss	PPRAVaFRGTV	0.86	0.869	0.402	0.725	0.716	0.873	0.426	0.437	MUTAGEN	A->E,G: Impaired serine/threonine-protein kinase activity.	21548880	1
Q6IQ55/D163A	Q6IQ55	TTBK2	TTBK2_HUMAN	D163A	496	A-loop;DFG-motif	-	loss	KCYMLdGLARQ	0.983	0.989	0.067	0.541	0.99	0.974	0.03	0.749	MUTAGEN	D->A: Abolishes serine/threonine-protein kinase activity.	21548880	1
Q6IQ55/D635G	Q6IQ55	TTBK2	TTBK2_HUMAN	D635G	-	-	-	-	SEQYTdLELQP									VARIANT	D -> G (in a lung small cell carcinoma sample; somatic mutation)	17344846	1
Q6IQ55/E842G	Q6IQ55	TTBK2	TTBK2_HUMAN	E842G	-	-	-	-	QDKNNeMKLLT									VARIANT	E -> G (found in a patient with SCA11; unknown pathological significance; dbSNP:rs202004988)	19533200	1
Q6IQ55/G724E	Q6IQ55	TTBK2	TTBK2_HUMAN	G724E	-	-	-	-	GEPPSgSRTDL									VARIANT	G -> E (in dbSNP:rs201524659)	26063658	1
Q6IQ55/K1241T	Q6IQ55	TTBK2	TTBK2_HUMAN	K1241T	-	-	-	-	SKPASkSR									VARIANT	K -> T (in dbSNP:rs36104367)	17344846	1
Q6IQ55/K143A	Q6IQ55	TTBK2	TTBK2_HUMAN	K143A	445	Catalytic-loop	-	loss	LHRDIkSNFAM	0.928	0.913	0.238	0.637	0.891	0.945	0.163	0.584	MUTAGEN	K->E,A: Leads to inactivation/destabilization of the protein.	21548880	1
Q6IQ55/K143E	Q6IQ55	TTBK2	TTBK2_HUMAN	K143E	445	Catalytic-loop	-	loss	LHRDIkSNFAM	0.938	0.902	0.446	0.707	0.827	0.888	0.294	0.567	MUTAGEN	K->E,A: Leads to inactivation/destabilization of the protein.	21548880	1
Q6IQ55/K367I	Q6IQ55	TTBK2	TTBK2_HUMAN	K367I	-	-	-	-	GVSPDkPGSLG									VARIANT	K -> I (in dbSNP:rs764753481)	26063658	1
Q6IQ55/K50A	Q6IQ55	TTBK2	TTBK2_HUMAN	K50A	129	β3;Catalytic-Lys	-	loss	ENVALkESAQQ	0.991	0.996	0.017	0.585	0.979	0.992	0.013	0.683	MUTAGEN	K->E,A: Leads to inactivation/destabilization of the protein.	21548880	1
Q6IQ55/K50E	Q6IQ55	TTBK2	TTBK2_HUMAN	K50E	129	β3;Catalytic-Lys	-	loss	ENVALkESAQQ	1.0	1.0	0.07	0.699	0.991	0.999	0.028	0.549	MUTAGEN	K->E,A: Leads to inactivation/destabilization of the protein.	21548880	1
Q6IQ55/L8P	Q6IQ55	TTBK2	TTBK2_HUMAN	L8P	19	N-term-β1	-	neutral	GGGEQlILSVG	0.506	0.447	0.541	0.391	0.271	0.357	0.727	0.222	VARIANT	L -> P (in dbSNP:rs6493068)	15489334,17344846,19533200	3
Q6IQ55/P1122R	Q6IQ55	TTBK2	TTBK2_HUMAN	P1122R	-	-	-	-	NGSQKpSTTQC									VARIANT	P -> R (in dbSNP:rs56142516)	17344846	1
Q6IQ55/R1110H	Q6IQ55	TTBK2	TTBK2_HUMAN	R1110H	-	-	-	-	SDLFSrAQILQ									VARIANT	R -> H (found in a patient with SCA11; unknown pathological significance; dbSNP:rs146279300)	19533200	1
Q6IQ55/R120Q	Q6IQ55	TTBK2	TTBK2_HUMAN	R120Q	405	αE	-	-	ISTTLrGRQIL	0.524	0.534	0.494	0.523	0.258	0.439	0.588	0.317	VARIANT	R -> Q (in dbSNP:rs35328266)	17344846	1
Q6IQ55/R181A	Q6IQ55	TTBK2	TTBK2_HUMAN	R181A	541	A-loop	-	loss	DVRPPrVAGFR	0.926	0.883	0.315	0.559	0.862	0.881	0.214	0.479	MUTAGEN	R->E,A: Impaired serine/threonine-protein kinase activity.	21548880	1
Q6IQ55/R181E	Q6IQ55	TTBK2	TTBK2_HUMAN	R181E	541	A-loop	-	loss	DVRPPrVAGFR	0.888	0.849	0.365	0.62	0.791	0.805	0.32	0.448	MUTAGEN	R->E,A: Impaired serine/threonine-protein kinase activity.	21548880	1
Q6IQ55/R500P	Q6IQ55	TTBK2	TTBK2_HUMAN	R500P	-	-	-	-	VPAVSrDHIWH									VARIANT	R -> P (in dbSNP:rs56039839)	17344846	1
Q6IQ55/T1062I	Q6IQ55	TTBK2	TTBK2_HUMAN	T1062I	-	-	-	neutral	VSWVNtQVNSS									VARIANT	T -> I (in dbSNP:rs55833708)	17344846	1
Q6IQ55/T1084M	Q6IQ55	TTBK2	TTBK2_HUMAN	T1084M	-	-	-	neutral	PGKPPtPGVEA									VARIANT	T -> M (in dbSNP:rs34348991)	17344846	1
Q6IQ55/T313A	Q6IQ55	TTBK2	TTBK2_HUMAN	T313A	-	-	-	neutral	TTTTStPQLHT									VARIANT	T -> A (in dbSNP:rs56017612)	17344846	1
Q6IQ55/V1097A	Q6IQ55	TTBK2	TTBK2_HUMAN	V1097A	-	-	-	-	LRRYKvGSSNS									VARIANT	V -> A (in dbSNP:rs55796513)	17344846	1
Q6IQ55/V440M	Q6IQ55	TTBK2	TTBK2_HUMAN	V440M	-	-	-	-	RDIPLvKLRSI									VARIANT	V -> M (in dbSNP:rs56311523)	17344846	1
Q6J9G0/L237S	Q6J9G0	STYK1	STYK1_HUMAN	L237S	412	αE	-	-	GKQVLlLEFLQ	0.312	0.354	0.508	0.378	0.24	0.229	0.732	0.19	VARIANT	L -> S (in dbSNP:rs55877878)	17344846	1
Q6J9G0/R210W	Q6J9G0	STYK1	STYK1_HUMAN	R210W	272	αD	-	-	FLWTCrDVMTM	0.862	0.82	0.561	0.745	0.576	0.77	0.581	0.392	VARIANT	R -> W (in dbSNP:rs34981955)	17344846	1
Q6J9G0/R379H	Q6J9G0	STYK1	STYK1_HUMAN	R379H	812	αI	-	-	RELRLrEAAIK	0.159	0.126	0.457	0.184	0.138	0.146	0.616	0.104	VARIANT	R -> H (in dbSNP:rs34638573)	17344846	1
Q6J9G0/R71G	Q6J9G0	STYK1	STYK1_HUMAN	R71G	-	-	-	neutral	PVPPPrLSWEA									VARIANT	R -> G (in dbSNP:rs6650202)		0
Q6J9G0/S204G	Q6J9G0	STYK1	STYK1_HUMAN	S204G	266	αD	-	neutral	QGDLLsLWTCR	0.164	0.159	0.424	0.139	0.146	0.133	0.613	0.143	VARIANT	S -> G (in dbSNP:rs3759259)	12841579,14702039,15489334,17344846,17974005	5
Q6J9G0/V395I	Q6J9G0	STYK1	STYK1_HUMAN	V395I	828	C-term-αI	-	-	EAVLQvELVVP	0.184	0.2	0.534	0.382	0.094	0.103	0.744	0.152	VARIANT	V -> I (in a glioblastoma multiforme sample; somatic mutation)	17344846	1
Q6J9G0/V400L	Q6J9G0	STYK1	STYK1_HUMAN	V400L	833	C-term-αI	-	-	VPELVvELYAA	0.354	0.328	0.544	0.418	0.186	0.254	0.676	0.189	VARIANT	V -> L (in dbSNP:rs55766125)	17344846	1
Q6P0Q8/A1463T	Q6P0Q8	MAST2	MAST2_HUMAN	A1463T	-	-	-	neutral	LSGKGaPGKGV									VARIANT	A -> T (in dbSNP:rs3737738)	17344846	1
Q6P0Q8/D1221E	Q6P0Q8	MAST2	MAST2_HUMAN	D1221E	-	-	-	-	RSRGKdQESRK									VARIANT	D -> E (in dbSNP:rs56060730)	17344846	1
Q6P0Q8/D1551G	Q6P0Q8	MAST2	MAST2_HUMAN	D1551G	-	-	-	neutral	PFPSRdRSLGP									VARIANT	D -> G (in dbSNP:rs1052610)	12117771,17344846,9872452	3
Q6P0Q8/D388E	Q6P0Q8	MAST2	MAST2_HUMAN	D388E	-	-	-	neutral	FYELQdLEKLL									VARIANT	D -> E (in dbSNP:rs11211247)	12117771,17344846	2
Q6P0Q8/G1468A	Q6P0Q8	MAST2	MAST2_HUMAN	G1468A	-	-	-	-	ALPGKgLQPAP									VARIANT	G -> A (in dbSNP:rs3737737)	17344846	1
Q6P0Q8/G1703E	Q6P0Q8	MAST2	MAST2_HUMAN	G1703E	-	-	-	-	SPREQgTQPPS									VARIANT	G -> E	17344846	1
Q6P0Q8/G655A	Q6P0Q8	MAST2	MAST2_HUMAN	G655A	498	A-loop;DFG-motif	-	-	KLTDFgSKIGL	0.918	0.915	0.354	0.728	0.652	0.888	0.301	0.533	VARIANT	G -> A (in a breast mucinous carcinoma sample; somatic mutation)	17344846	1
Q6P0Q8/I659M	Q6P0Q8	MAST2	MAST2_HUMAN	I659M	506	A-loop	-	neutral	FGLSKiLMSLT	0.178	0.194	0.463	0.207	0.151	0.179	0.639	0.102	VARIANT	I -> M (in dbSNP:rs1707336)	12117771,15489334,17344846,9872452	4
Q6P0Q8/K1197R	Q6P0Q8	MAST2	MAST2_HUMAN	K1197R	-	-	-	neutral	ENTSIkGPARK									VARIANT	K -> R (in dbSNP:rs1052607)	17344846	1
Q6P0Q8/K1673R	Q6P0Q8	MAST2	MAST2_HUMAN	K1673R	-	-	-	neutral	ASPSRkTMAGG									VARIANT	K -> R (in dbSNP:rs34070850)	17344846	1
Q6P0Q8/K275E	Q6P0Q8	MAST2	MAST2_HUMAN	K275E	-	-	-	-	LHFLTkFSTES									VARIANT	K -> E (in an ovarian mucinous carcinoma sample; somatic mutation)	17344846	1
Q6P0Q8/L69F	Q6P0Q8	MAST2	MAST2_HUMAN	L69F	-	-	-	-	GVSPLlRKLSN									VARIANT	L -> F (in dbSNP:rs55914403)	17344846	1
Q6P0Q8/R1246L	Q6P0Q8	MAST2	MAST2_HUMAN	R1246L	-	-	-	-	LLHTSrLSSLN									VARIANT	R -> L (in dbSNP:rs56309943)	17344846	1
Q6P0Q8/R991L	Q6P0Q8	MAST2	MAST2_HUMAN	R991L	-	-	-	neutral	EEAVGrSGSSP									VARIANT	R -> L (in dbSNP:rs56114653)	17344846	1
Q6P0Q8/T1608I	Q6P0Q8	MAST2	MAST2_HUMAN	T1608I	-	-	-	-	GQSGAtPIPPE									VARIANT	T -> I (in dbSNP:rs35474583)		0
Q6P0Q8/V1304M	Q6P0Q8	MAST2	MAST2_HUMAN	V1304M	-	-	-	neutral	SPSSSvSSPAG									VARIANT	V -> M (in dbSNP:rs33931638)	17344846	1
Q6P2M8/Q262H	Q6P2M8	PNCK	KCC1B_HUMAN	Q262H	814	αI	-	-	KRFTCqALRHL	0.187	0.156	0.518	0.16	0.158	0.137	0.665	0.095	VARIANT	Q -> H (in dbSNP:rs56060609)	17344846	1
Q6P3R8/C531R	Q6P3R8	NEK5	NEK5_HUMAN	C531R	-	-	-	-	EFRSCcGWSAM									VARIANT	C -> R	17344846	1
Q6P3R8/K255Q	Q6P3R8	NEK5	NEK5_HUMAN	K255Q	819	αI	-	neutral	INSILkPFLEN	0.154	0.142	0.508	0.193	0.123	0.165	0.638	0.139	VARIANT	K -> Q (in dbSNP:rs34756139)		0
Q6P3R8/R290H	Q6P3R8	NEK5	NEK5_HUMAN	R290H	-	-	-	-	GAPASrAGKVV									VARIANT	R -> H	17344846	1
Q6P3W7/P357L	Q6P3W7	SCYL2	SCYL2_HUMAN	P357L	853	C-term-αI	-	neutral	FFKGLpVLPKL	0.611	0.582	0.544	0.636	0.464	0.542	0.535	0.504	VARIANT	P -> L (in dbSNP:rs33968174)	14702039,17344846	2
Q6P3W7/Q863H	Q6P3W7	SCYL2	SCYL2_HUMAN	Q863H	-	-	-	-	QQKPNqLNQFV									VARIANT	Q -> H (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
Q6P3W7/T720S	Q6P3W7	SCYL2	SCYL2_HUMAN	T720S	-	-	-	-	QTKDLtTLMDN									VARIANT	T -> S (in dbSNP:rs763873645)	17344846	1
Q6P5Z2/A180E	Q6P5Z2	PKN3	PKN3_HUMAN	A180E	-	-	-	-	GPELLaELQHR									VARIANT	A -> E (in dbSNP:rs56251280)	17344846	1
Q6P5Z2/K588E	Q6P5Z2	PKN3	PKN3_HUMAN	K588E	129	β3;Catalytic-Lys	-	loss	KYYAIkLKKQE	1.0	0.993	0.062	0.722	0.988	0.998	0.029	0.489	MUTAGEN	K->E: Abolishes autophosphorylation and catalytic activity.	10441506,15282551	2
Q6P5Z2/K588R	Q6P5Z2	PKN3	PKN3_HUMAN	K588R	129	β3;Catalytic-Lys	-	loss	KYYAIkLKKQE	0.991	0.996	0.041	0.705	1.0	0.998	0.017	0.473	MUTAGEN	K->R: Abolishes catalytic activity.	10441506,15282551	2
Q6P5Z2/T718A	Q6P5Z2	PKN3	PKN3_HUMAN	T718A	545	A-loop	p	loss	GDRTStCGTPE	0.987	1.0	0.173	0.925	0.914	0.989	0.157	0.378	MUTAGEN	T->A: Abolishes phosphorylation.	15282551	1
Q6P5Z2/V404L	Q6P5Z2	PKN3	PKN3_HUMAN	V404L	-	-	-	-	LSLSLvQGLLF									VARIANT	V -> L (in dbSNP:rs12932)		0
Q6PHR2/K139R	Q6PHR2	ULK3	ULK3_HUMAN	K139R	445	Catalytic-loop	-	loss	SHLDLkQNILL	0.89	0.857	0.386	0.666	0.727	0.824	0.313	0.351	MUTAGEN	K->R: Loss of kinase activity. Does not promote GLI1 nuclear localization.	19878745,20643644	2
Q6PHR2/K445R	Q6PHR2	ULK3	ULK3_HUMAN	K445R	-	-	-	-	LKEQVkRESRW									VARIANT	K -> R (in dbSNP:rs12898397)		0
Q6PHR2/K44R	Q6PHR2	ULK3	ULK3_HUMAN	K44R	129	β3;Catalytic-Lys	-	decrease	EVVAIkVAKKS	0.993	0.993	0.054	0.682	0.982	0.998	0.037	0.456	MUTAGEN	K->R: Decreased kinase activity.	19878745	1
Q6PHR2/R101H	Q6PHR2	ULK3	ULK3_HUMAN	R101H	266	αD	-	neutral	GGDLSrIHTRR	0.148	0.12	0.469	0.12	0.101	0.141	0.655	0.093	VARIANT	R -> H (in dbSNP:rs34945944)		0
Q6SA08/H33Y	Q6SA08	TSSK4	TSSK4_HUMAN	H33Y	41	β1;Gly-rich-loop	-	-	GKAIGhSYGSV	0.711	0.652	0.497	0.403	0.486	0.453	0.64	0.327	VARIANT	H -> Y (in dbSNP:rs36036137)	17344846	1
Q6SA08/K54M	Q6SA08	TSSK4	TSSK4_HUMAN	K54M	129	β3;Catalytic-Lys	-	loss	VMVAVkISKKK	0.991	0.982	0.034	0.64	0.993	0.999	0.01	0.511	MUTAGEN	K->M: Loss of kinase activity.	15964553	1
Q6SA08/Q196R	Q6SA08	TSSK4	TSSK4_HUMAN	Q196R	544	A-loop	-	neutral	FSHLSqYCGSF	0.275	0.369	0.422	0.279	0.304	0.32	0.602	0.173	VARIANT	Q -> R (in dbSNP:rs1270764)	17344846	1
Q6SA08/V145M	Q6SA08	TSSK4	TSSK4_HUMAN	V145M	440	Catalytic-loop	-	-	HSKSIvRDLKL	0.674	0.567	0.487	0.574	0.383	0.512	0.473	0.557	VARIANT	V -> M (in dbSNP:rs35468205)	17344846	1
Q6SA08/Y89C	Q6SA08	TSSK4	TSSK4_HUMAN	Y89C	205	β4/β5-loop	-	-	YLINFyAIEST	0.814	0.725	0.481	0.678	0.486	0.629	0.497	0.598	VARIANT	Y -> C (in dbSNP:rs34083933)	17344846	1
Q6VAB6/A879L	Q6VAB6	KSR2	KSR2_HUMAN	A879L	-	-	-	-	FKTQPaAIIWQ									MUTAGEN	A->L: Impairs MAP2K1 binding.	21441910	1
Q6VAB6/D786A	Q6VAB6	KSR2	KSR2_HUMAN	D786A	-	-	-	loss	GILHKdKSKNV									MUTAGEN	D->A: Loss of kinase activity.	21441910	1
Q6VAB6/R676S	Q6VAB6	KSR2	KSR2_HUMAN	R676S	-	-	-	-	LIGKGrGQVYH									VARIANT	R -> S (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
Q6VAB6/R718H	Q6VAB6	KSR2	KSR2_HUMAN	R718H	-	-	-	-	AYRQTrENVVL									MUTAGEN	R->H: Impairs formation of heterotetramers with MAP2K1, but not the formation of heterodimers.	21441910	1
Q6XUX3/D200G	Q6XUX3	DSTYK	DUSTY_HUMAN	D200G	-	-	-	-	QENNEdAHVLA									VARIANT	D -> G (in CAKUT1)	23862974	1
Q6XUX3/K681Q	Q6XUX3	DSTYK	DUSTY_HUMAN	K681Q	129	β3;Catalytic-Lys	-	-	FPCALkVVPPD	0.992	1.0	0.031	0.669	0.998	0.985	0.017	0.451	MUTAGEN	K->Q: No change.	15178406	1
Q6XUX3/L432V	Q6XUX3	DSTYK	DUSTY_HUMAN	L432V	-	-	-	neutral	MKEELlDATNM									VARIANT	L -> V (in dbSNP:rs35845538)		0
Q6XUX3/R29Q	Q6XUX3	DSTYK	DUSTY_HUMAN	R29Q	-	-	m1	-	IRELCrFGRYR									VARIANT	R -> Q (in CAKUT1; unknown pathological significance; dbSNP:rs200780796)	23862974	1
Q6XUX3/S843L	Q6XUX3	DSTYK	DUSTY_HUMAN	S843L	614	αF	-	-	FWYICsSVKLP	0.492	0.503	0.671	0.482	0.228	0.225	0.754	0.382	VARIANT	S -> L (in CAKUT1; dbSNP:rs778586547)	23862974	1
Q6ZMQ8/A1332T	Q6ZMQ8	AATK	LMTK1_HUMAN	A1332T	-	-	-	neutral	PTPTPaFSRFT									VARIANT	A -> T (in dbSNP:rs55713566)	17344846	1
Q6ZMQ8/E1160K	Q6ZMQ8	AATK	LMTK1_HUMAN	E1160K	-	-	-	-	EGRPEeEEDSE									VARIANT	E -> K (in dbSNP:rs55793641)	17344846	1
Q6ZMQ8/F1266S	Q6ZMQ8	AATK	LMTK1_HUMAN	F1266S	-	-	-	neutral	ESPPTfRGSPG									VARIANT	F -> S (in dbSNP:rs36000545)	15489334,17344846	2
Q6ZMQ8/G703C	Q6ZMQ8	AATK	LMTK1_HUMAN	G703C	-	-	-	-	PVSAGgAEGCP									VARIANT	G -> C (in dbSNP:rs7503604)	14702039,17344846,9734811	3
Q6ZMQ8/L97V	Q6ZMQ8	AATK	LMTK1_HUMAN	L97V	-	-	-	-	VYVLPlEVSLP									VARIANT	L -> V (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
Q6ZMQ8/M104V	Q6ZMQ8	AATK	LMTK1_HUMAN	M104V	7	N-term-β1	-	-	EVSLPmKQPGR	0.518	0.383	0.467	0.418	0.293	0.447	0.587	0.32	VARIANT	M -> V (in an ovarian mucinous carcinoma sample; somatic mutation; dbSNP:rs1337040042)	17344846	1
Q6ZMQ8/P1192S	Q6ZMQ8	AATK	LMTK1_HUMAN	P1192S	-	-	-	neutral	SEEEApVPVVV									VARIANT	P -> S (in dbSNP:rs55856613)	17344846	1
Q6ZMQ8/S815R	Q6ZMQ8	AATK	LMTK1_HUMAN	S815R	-	-	-	-	PSEEAsPDAPD									VARIANT	S -> R (in dbSNP:rs56032966)	17344846	1
Q6ZMQ8/S81F	Q6ZMQ8	AATK	LMTK1_HUMAN	S81F	-	-	-	-	DLAQGsATAAQ									VARIANT	S -> F (in an ovarian mucinous carcinoma sample; somatic mutation)	17344846	1
Q6ZMQ8/S923L	Q6ZMQ8	AATK	LMTK1_HUMAN	S923L	-	-	-	-	EVFSPsTGPSG									VARIANT	S -> L (in dbSNP:rs56313973)	17344846	1
Q6ZMQ8/T118M	Q6ZMQ8	AATK	LMTK1_HUMAN	T118M	21	N-term-β1	-	neutral	QLLKStVGRHS	0.576	0.509	0.454	0.383	0.351	0.447	0.511	0.342	VARIANT	T -> M (in dbSNP:rs8082016)		0
Q6ZN16/A192T	Q6ZN16	MAP3K15	M3K15_HUMAN	A192T	-	-	-	neutral	IVTPCaYFCCE									VARIANT	A -> T (in dbSNP:rs5909299)	17344846	1
Q6ZN16/D226H	Q6ZN16	MAP3K15	M3K15_HUMAN	D226H	-	-	-	-	CMPLVdFISLL									VARIANT	D -> H (in dbSNP:rs56338727)	17344846	1
Q6ZN16/G838S	Q6ZN16	MAP3K15	M3K15_HUMAN	G838S	605	αF	-	neutral	DIWSLgTIIEM	0.484	0.509	0.317	0.398	0.532	0.562	0.253	0.623	VARIANT	G -> S (in dbSNP:rs56381411)	17344846	1
Q6ZN16/N1029H	Q6ZN16	MAP3K15	M3K15_HUMAN	N1029H	-	-	-	-	NQVASnQECVA									VARIANT	N -> H (in dbSNP:rs55787622)	17344846	1
Q6ZN16/Q1251E	Q6ZN16	MAP3K15	M3K15_HUMAN	Q1251E	-	-	-	neutral	DWLRLqADAKT									VARIANT	Q -> E (in dbSNP:rs15943)	17344846	1
Q6ZN16/R255S	Q6ZN16	MAP3K15	M3K15_HUMAN	R255S	-	-	-	-	DIRKArKYQGE									VARIANT	R -> S (in a lung squamous cell carcinoma sample; somatic mutation)	17344846	1
Q6ZN16/R494C	Q6ZN16	MAP3K15	M3K15_HUMAN	R494C	-	-	-	-	LLLIRrKKTII									VARIANT	R -> C (in dbSNP:rs41305349)	17344846	1
Q6ZN16/R677Q	Q6ZN16	MAP3K15	M3K15_HUMAN	R677Q	80	β2/β3-loop	-	-	LSNQVrAIKEI	0.29	0.298	0.44	0.243	0.395	0.27	0.574	0.201	VARIANT	R -> Q (in a metastatic melanoma sample; somatic mutation)	17344846	1
Q6ZN16/S199N	Q6ZN16	MAP3K15	M3K15_HUMAN	S199N	-	-	-	neutral	YFCCEsAQRRA									VARIANT	S -> N (in dbSNP:rs55916006)	17344846	1
Q6ZN16/S456G	Q6ZN16	MAP3K15	M3K15_HUMAN	S456G	-	-	-	neutral	QFFSVsLAHDV									VARIANT	S -> G (in dbSNP:rs56212339)	17344846	1
Q6ZN16/S562L	Q6ZN16	MAP3K15	M3K15_HUMAN	S562L	-	-	-	-	SLWHVsTEMKQ									VARIANT	S -> L (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
Q6ZN16/S993L	Q6ZN16	MAP3K15	M3K15_HUMAN	S993L	-	-	-	neutral	DRGLAsPEDRD									VARIANT	S -> L (in dbSNP:rs56233219)	17344846	1
Q6ZN16/W1247R	Q6ZN16	MAP3K15	M3K15_HUMAN	W1247R	-	-	-	-	KELIDwRLQGA									VARIANT	W -> R (in a colorectal adenocarcinoma sample; somatic mutation)	17344846	1
Q6ZWH5/A66V	Q6ZWH5	NEK10	NEK10_HUMAN	A66V	-	-	-	-	EPAIRaGHRAR									VARIANT	A -> V (in an ovarian mucinous carcinoma sample; somatic mutation; dbSNP:rs201821707)	17344846	1
Q6ZWH5/E379K	Q6ZWH5	NEK10	NEK10_HUMAN	E379K	-	-	-	-	DLSPReQENTF									VARIANT	E -> K (in a metastatic melanoma sample; somatic mutation)	17344846	1
Q6ZWH5/F50L	Q6ZWH5	NEK10	NEK10_HUMAN	F50L	-	-	-	-	LPAINfSAQNS									VARIANT	F -> L (in dbSNP:rs56125830)	17344846	1
Q6ZWH5/G67S	Q6ZWH5	NEK10	NEK10_HUMAN	G67S	-	-	-	neutral	PAIRAgHRARG									VARIANT	G -> S (in dbSNP:rs55958314)	17344846	1
Q6ZWH5/K548R	Q6ZWH5	NEK10	NEK10_HUMAN	K548R	129	β3;Catalytic-Lys	-	decrease	NLLAMkVNLHN	0.991	0.996	0.081	0.705	0.977	0.99	0.021	0.37	MUTAGEN	K->R: Catalytically inactive. Impaired mucociliary transport.	20956560,31959991	2
Q6ZWH5/L513S	Q6ZWH5	NEK10	NEK10_HUMAN	L513S	27	N-term-β1	-	neutral	QNKAPlYIGNY	0.278	0.269	0.515	0.298	0.247	0.245	0.651	0.237	VARIANT	L -> S (in dbSNP:rs10510592)	17344846,17974005	2
Q6ZWH5/L701V	Q6ZWH5	NEK10	NEK10_HUMAN	L701V	559	αF	-	neutral	SCPEVlSEPYG	0.114	0.117	0.402	0.119	0.111	0.114	0.632	0.134	VARIANT	L -> V (in dbSNP:rs34313679)	17344846	1
Q6ZWH5/N659S	Q6ZWH5	NEK10	NEK10_HUMAN	N659S	447	Catalytic-loop	-	neutral	RDLTPnIMLGD	0.405	0.341	0.454	0.346	0.377	0.42	0.45	0.374	VARIANT	N -> S (in dbSNP:rs55833401)	17344846	1
Q6ZWH5/P748L	Q6ZWH5	NEK10	NEK10_HUMAN	P748L	677	αG/αH	-	-	EAVYEpPEGIY	0.606	0.587	0.513	0.486	0.477	0.505	0.549	0.471	VARIANT	P -> L (in CILD44; unknown pathological significance; dbSNP:rs1575215909)	31959991	1
Q6ZWH5/R773C	Q6ZWH5	NEK10	NEK10_HUMAN	R773C	802	αI	-	-	PDAEArDIVEV	0.883	0.891	0.433	0.702	0.645	0.763	0.353	0.401	VARIANT	R -> C (in CILD44; unknown pathological significance; dbSNP:rs766982731)	31959991	1
Q6ZWH5/S684D	Q6ZWH5	NEK10	NEK10_HUMAN	S684D	514	A-loop	-	-	QKQENsLTSVV	0.624	0.557	0.658	0.651	0.245	0.342	0.671	0.277	MUTAGEN	S->D: Increased mucociliary transport.	31959991	1
Q76MJ5/A318T	Q76MJ5	ERN2	ERN2_HUMAN	A318T	-	-	-	-	RGLTLaADGPT									VARIANT	A -> T (in dbSNP:rs56191901)	17344846	1
Q76MJ5/H858Y	Q76MJ5	ERN2	ERN2_HUMAN	H858Y	-	-	-	-	VRNKKhYRELP									VARIANT	H -> Y (in dbSNP:rs56137182)	17344846	1
Q76MJ5/K548A	Q76MJ5	ERN2	ERN2_HUMAN	K548A	129	β3;Catalytic-Lys	-	loss	RAVAVkLLREC	1.0	1.0	0.028	0.682	1.0	0.997	0.015	0.63	MUTAGEN	K->A: Loss of autophosphorylation, of induction of apoptosis and of 28S rRNA cleavage, attenuation of repression of protein synthesis.	11175748	1
Q76MJ5/L410F	Q76MJ5	ERN2	ERN2_HUMAN	L410F	-	-	-	-	LSREKlDSELH									VARIANT	L -> F (in dbSNP:rs55687638)	17344846	1
Q76MJ5/L504F	Q76MJ5	ERN2	ERN2_HUMAN	L504F	14	N-term-β1	-	-	KQAQPlDPEAE	0.18	0.18	0.463	0.18	0.136	0.173	0.695	0.147	VARIANT	L -> F (in dbSNP:rs56001432)	17344846	1
Q76MJ5/R118C	Q76MJ5	ERN2	ERN2_HUMAN	R118C	-	-	-	-	HASPCrSDGVF									VARIANT	R -> C (in dbSNP:rs56117885)	17344846	1
Q76MJ5/R184C	Q76MJ5	ERN2	ERN2_HUMAN	R184C	-	-	-	-	NTTYRrSAPPM									VARIANT	R -> C (in dbSNP:rs34683474)	17344846	1
Q76MJ5/R271Q	Q76MJ5	ERN2	ERN2_HUMAN	R271Q	-	-	-	-	PASGPrTATLF									VARIANT	R -> Q (in dbSNP:rs55772851)	11175748,17344846	2
Q76MJ5/R537Q	Q76MJ5	ERN2	ERN2_HUMAN	R537Q	50	β2	-	-	GTFVFrQFEGR	0.488	0.406	0.481	0.466	0.213	0.315	0.596	0.221	VARIANT	R -> Q (in dbSNP:rs56176960)	17344846	1
Q76MJ5/S487T	Q76MJ5	ERN2	ERN2_HUMAN	S487T	-	-	-	neutral	LHSGAsRSQKR									VARIANT	S -> T (in dbSNP:rs26764)	11175748,17344846	2
Q76MJ5/V69I	Q76MJ5	ERN2	ERN2_HUMAN	V69I	-	-	-	neutral	LRDDPvEGPMY									VARIANT	V -> I (in dbSNP:rs9932495)	17344846	1
Q7KZI7/T208A	Q7KZI7	MARK2	MARK2_HUMAN	T208A	545	A-loop	p	loss	GNKLDtCGSPP	0.995	1.0	0.121	0.916	0.98	0.989	0.055	0.464	MUTAGEN	T->A: Prevents phosphorylation and activation by STK11/LKB1 complex.	14976552	1
Q7KZI7/T596A	Q7KZI7	MARK2	MARK2_HUMAN	T596A	-	-	p	-	VSSRStHAGQL									MUTAGEN	T->A: Loss of membrane dissociation and binding to YWHAZ.	15084291,15324659	2
Q7L7X3/A855T	Q7L7X3	TAOK1	TAOK1_HUMAN	A855T	-	-	-	-	EEEMLaQNERT									VARIANT	A -> T (in dbSNP:rs34151057)	17344846	1
Q7L7X3/D169A	Q7L7X3	TAOK1	TAOK1_HUMAN	D169A	496	A-loop;DFG-motif	-	loss	QVKLAdGSASM	0.991	0.999	0.081	0.527	0.986	0.979	0.043	0.684	MUTAGEN	D->A: Loss of serine/threonine-protein kinase activity.	17396146	1
Q7L7X3/D305A	Q7L7X3	TAOK1	TAOK1_HUMAN	D305A	848	C-term-αI	-	-	AVRELdLQYRK	0.723	0.719	0.502	0.637	0.379	0.579	0.508	0.505	VARIANT	D -> A (in DDIB)	31230721	1
Q7L7X3/D376N	Q7L7X3	TAOK1	TAOK1_HUMAN	D376N	-	-	-	-	LPDVSdKSELD									MUTAGEN	D->N: Does not abolish cleavage by caspase-3 (CASP3).	16407310	1
Q7L7X3/E17G	Q7L7X3	TAOK1	TAOK1_HUMAN	E17G	22	N-term-β1	-	-	DPEIAeFFKED	0.535	0.421	0.474	0.411	0.265	0.348	0.597	0.365	VARIANT	E -> G (in DDIB)	31230721	1
Q7L7X3/K298E	Q7L7X3	TAOK1	TAOK1_HUMAN	K298E	841	C-term-αI	-	-	LIQRTkAVREL	0.56	0.446	0.577	0.597	0.259	0.367	0.658	0.277	VARIANT	K -> E (in DDIB)	31230721	1
Q7L7X3/K57A	Q7L7X3	TAOK1	TAOK1_HUMAN	K57A	129	β3;Catalytic-Lys	-	loss	EVVAIkMSYSG	1.0	0.991	0.044	0.656	1.0	0.997	0.018	0.615	MUTAGEN	K->A: Abolishes kinase activity, ability to activate the MAPK8/JNK cascade and cleavage by caspase-3 (CASP3).	16407310	1
Q7L7X3/L167R	Q7L7X3	TAOK1	TAOK1_HUMAN	L167R	494	Catalytic-loop	-	-	PGQVKlDFGSA	0.854	0.816	0.344	0.614	0.693	0.781	0.261	0.481	VARIANT	L -> R (in DDIB; affects neuron maturation and migration)	33565190	1
Q7L7X3/L315F	Q7L7X3	TAOK1	TAOK1_HUMAN	L315F	-	-	-	-	RKMKKlFQEAH									VARIANT	L -> F (in DDIB; unknown pathological significance)	33565190	1
Q7L7X3/L548P	Q7L7X3	TAOK1	TAOK1_HUMAN	L548P	-	-	-	-	QQKKElSFLES									VARIANT	L -> P (in DDIB; affects neuron maturation and migration)	33565190	1
Q7L7X3/M231V	Q7L7X3	TAOK1	TAOK1_HUMAN	M231V	629	αF/αG	-	-	FNMNAmALYHI	0.777	0.772	0.48	0.559	0.56	0.716	0.459	0.468	VARIANT	M -> V (in DDIB; unknown pathological significance)	33565190	1
Q7L7X3/R150I	Q7L7X3	TAOK1	TAOK1_HUMAN	R150I	442	Catalytic-loop;HrD-motif	-	-	HTMIHrIKAGN	0.882	0.818	0.43	0.647	0.615	0.725	0.338	0.627	VARIANT	R -> I (in DDIB)	33565190	1
Q7L7X3/S111F	Q7L7X3	TAOK1	TAOK1_HUMAN	S111F	256	β5/αD-loop	-	-	EYCLGsSDLLE	0.803	0.849	0.426	0.741	0.62	0.749	0.395	0.516	VARIANT	S -> F (in DDIB; dbSNP:rs2030976698)	31230721	1
Q7L7X3/S990A	Q7L7X3	TAOK1	TAOK1_HUMAN	S990A	-	-	p	-	STSVTsISNGS									MUTAGEN	S->A: Abolishes phosphorylation by ATM; when associated with A-643 and A-785.	17396146	1
Q7L7X3/T643A	Q7L7X3	TAOK1	TAOK1_HUMAN	T643A	-	-	p	-	LNKRQtKDLEH									MUTAGEN	T->A: Abolishes phosphorylation by ATM; when associated with A-785 and A-990.	17396146	1
Q7L7X3/T785A	Q7L7X3	TAOK1	TAOK1_HUMAN	T785A	-	-	p	-	NEMLStALRLD									MUTAGEN	T->A: Abolishes phosphorylation by ATM; when associated with A-643 and A-990.	17396146	1
Q7RTN6/F233A	Q7RTN6	STRADA	STRAA_HUMAN	F233A	-	-	-	-	RVVHDfKYSVK									MUTAGEN	F->A: Inhibits interaction with STK11/LKB1; when associated with A-.	19892943	1
Q7RTN6/H231A	Q7RTN6	STRADA	STRAA_HUMAN	H231A	-	-	-	-	RQRVVhFPKYS									MUTAGEN	H->A: Inhibits interaction with STK11/LKB1; when associated with A-.	19892943	1
Q7RTN6/L241A	Q7RTN6	STRADA	STRAA_HUMAN	L241A	-	-	-	-	YSVKVlWLSPE									MUTAGEN	L->A: Inhibits interaction with STK11/LKB1.	19892943	1
Q7RTN6/P64S	Q7RTN6	STRADA	STRAA_HUMAN	P64S	-	-	-	-	MSSFLpGGCYE									VARIANT	P -> S (in dbSNP:rs55695051)	17344846	1
Q7RTN6/Q251A	Q7RTN6	STRADA	STRAA_HUMAN	Q251A	-	-	-	-	PEVLQqLQGYD									MUTAGEN	Q->A: Inhibits interaction with STK11/LKB1.	19892943	1
Q7RTN6/R13W	Q7RTN6	STRADA	STRAA_HUMAN	R13W	-	-	-	-	PERIRrVSEKF									VARIANT	R -> W (in dbSNP:rs35808156)	17344846	1
Q7RTN6/S60I	Q7RTN6	STRADA	STRAA_HUMAN	S60I	-	-	-	-	KQEVMsFLPEG									VARIANT	S -> I (in dbSNP:rs56271007)	17344846	1
Q7RTN6/T329A	Q7RTN6	STRADA	STRAA_HUMAN	T329A	-	-	p	loss	SDSLTtTPRPS									MUTAGEN	T->A: Loss of STK11/LKB1-mediated phosphorylation.	12805220	1
Q7RTN6/T419A	Q7RTN6	STRADA	STRAA_HUMAN	T419A	-	-	p	loss	IFGLVtLEELE									MUTAGEN	T->A: Loss of STK11/LKB1-mediated phosphorylation.	12805220	1
Q7RTN6/Y185F	Q7RTN6	STRADA	STRAA_HUMAN	Y185F	-	-	-	-	LKALDyHHMGY									MUTAGEN	Y->F: Suppresses STK11/LKB1 activation without affecting complex assembly.	19892943	1
Q7Z2Y5/A1121P	Q7Z2Y5	NRK	NRK_HUMAN	A1121P	-	-	-	-	IDSGAaSAPDH									VARIANT	A -> P (in dbSNP:rs35720774)	17344846	1
Q7Z2Y5/A993E	Q7Z2Y5	NRK	NRK_HUMAN	A993E	-	-	-	-	PSCPRaYGRDG									VARIANT	A -> E (in dbSNP:rs16984889)		0
Q7Z2Y5/D971G	Q7Z2Y5	NRK	NRK_HUMAN	D971G	-	-	-	-	CKDHDdNNKFV									VARIANT	D -> G (in dbSNP:rs35334892)	17344846	1
Q7Z2Y5/E579G	Q7Z2Y5	NRK	NRK_HUMAN	E579G	-	-	-	-	EAEEPeLRVNA									VARIANT	E -> G (in dbSNP:rs56350428)	17344846	1
Q7Z2Y5/E679G	Q7Z2Y5	NRK	NRK_HUMAN	E679G	-	-	-	-	FYSQPeAREKK									VARIANT	E -> G (in dbSNP:rs35115195)	17344846	1
Q7Z2Y5/G1471A	Q7Z2Y5	NRK	NRK_HUMAN	G1471A	-	-	-	-	DCLGIgMLTFN									VARIANT	G -> A (in dbSNP:rs34232354)	17344846	1
Q7Z2Y5/H1276L	Q7Z2Y5	NRK	NRK_HUMAN	H1276L	-	-	-	-	RLRVYhTWLRN									VARIANT	H -> L (in dbSNP:rs35942881)	17344846	1
Q7Z2Y5/I880L	Q7Z2Y5	NRK	NRK_HUMAN	I880L	-	-	-	-	FKVGKiPPVYL									VARIANT	I -> L (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs764355898)	17344846	1
Q7Z2Y5/M1472L	Q7Z2Y5	NRK	NRK_HUMAN	M1472L	-	-	-	-	CLGIGmLTFNA									VARIANT	M -> L (in dbSNP:rs35609510)	17344846	1
Q7Z2Y5/P1106S	Q7Z2Y5	NRK	NRK_HUMAN	P1106S	-	-	-	-	YLQEEpGGNEA									VARIANT	P -> S (in dbSNP:rs35393519)	17344846	1
Q7Z2Y5/P426A	Q7Z2Y5	NRK	NRK_HUMAN	P426A	-	-	-	-	ALDSApPLKGQ									VARIANT	P -> A (in dbSNP:rs55635933)	17344846	1
Q7Z2Y5/Q355H	Q7Z2Y5	NRK	NRK_HUMAN	Q355H	-	-	-	-	EAIKEqTVRRF									VARIANT	Q -> H (in dbSNP:rs55862725)	17344846	1
Q7Z2Y5/R727H	Q7Z2Y5	NRK	NRK_HUMAN	R727H	-	-	-	neutral	ARRQRrRRWED									VARIANT	R -> H (in dbSNP:rs33936206)		0
Q7Z2Y5/S424C	Q7Z2Y5	NRK	NRK_HUMAN	S424C	-	-	-	-	LQALDsPKPLK									VARIANT	S -> C (in a breast infiltrating ductal carcinoma sample; somatic mutation)	17344846	1
Q7Z2Y5/V358M	Q7Z2Y5	NRK	NRK_HUMAN	V358M	-	-	-	-	KEQYTvRFRGP									VARIANT	V -> M (in dbSNP:rs209373)	17344846	1
Q7Z695/P622L	Q7Z695	ADCK2	ADCK2_HUMAN	P622L	-	-	-	neutral	FLLTGpCPP									VARIANT	P -> L (in dbSNP:rs1046515)	17344846	1
Q7Z695/S307P	Q7Z695	ADCK2	ADCK2_HUMAN	S307P	-	-	-	neutral	ATNLIsAVKVL									VARIANT	S -> P (in dbSNP:rs1140034)	17344846	1
Q7Z695/S66G	Q7Z695	ADCK2	ADCK2_HUMAN	S66G	-	-	-	neutral	APDVLsRRVRC									VARIANT	S -> G (in dbSNP:rs2968558)		0
Q7Z695/V418L	Q7Z695	ADCK2	ADCK2_HUMAN	V418L	-	-	-	neutral	QAGIPvLKRKI									VARIANT	V -> L (in dbSNP:rs3748092)	17344846	1
Q7Z695/V418M	Q7Z695	ADCK2	ADCK2_HUMAN	V418M	-	-	-	neutral	QAGIPvLKRKI									VARIANT	V -> M (in dbSNP:rs3748092)		0
Q7Z7A4/A525V	Q7Z7A4	PXK	PXK_HUMAN	A525V	-	-	-	neutral	PPPPPaPLPPA									VARIANT	A -> V (in dbSNP:rs34579268)		0
Q7Z7A4/A535V	Q7Z7A4	PXK	PXK_HUMAN	A535V	-	-	-	neutral	PASTEaAQLSS									VARIANT	A -> V (in dbSNP:rs34579268)		0
Q7Z7A4/I426V	Q7Z7A4	PXK	PXK_HUMAN	I426V	-	-	-	-	IAKECiKRLIE									VARIANT	I -> V (in dbSNP:rs55973253)	17344846	1
Q7Z7A4/K481R	Q7Z7A4	PXK	PXK_HUMAN	K481R	-	-	-	neutral	EEHSAkSNSNN									VARIANT	K -> R (in dbSNP:rs56384862)	16142408,17344846	2
Q7Z7A4/R54Q	Q7Z7A4	PXK	PXK_HUMAN	R54Q	-	-	-	-	SWQIVrYSDFD									MUTAGEN	R->Q: No effect on subcellular location.	16142408	1
Q7Z7A4/R92L	Q7Z7A4	PXK	PXK_HUMAN	R92L	-	-	-	-	EFIAErKGLQN									MUTAGEN	R->L: Results in redistribution of protein from cytoplasm throughout entire cell.	16142408	1
Q7Z7A4/Y56A	Q7Z7A4	PXK	PXK_HUMAN	Y56A	-	-	-	-	QIVRRyDFDLL									MUTAGEN	Y->A: Results in redistribution of protein from cytoplasm throughout entire cell.	16142408	1
Q86SG6/A497P	Q86SG6	NEK8	NEK8_HUMAN	A497P	-	-	-	-	PPGQEaRVVCG									VARIANT	A -> P (in NPHP9; a full-length mouse NEK8 construct containing the mutation shows a defect in ciliary localization with no apparent effect on ciliation, mitosis or centriole number; dbSNP:rs146326420)	18199800	1
Q86SG6/H425Y	Q86SG6	NEK8	NEK8_HUMAN	H425Y	-	-	-	-	NGCLGhSLTDI									VARIANT	H -> Y (in NPHP9; a full-length mouse NEK8 construct containing the mutation shows a defect in ciliary localization with no apparent effect on ciliation, mitosis or centriole number; dbSNP:rs118204032)	18199800	1
Q86SG6/L330F	Q86SG6	NEK8	NEK8_HUMAN	L330F	-	-	-	-	LRLPMlTEVVQ									VARIANT	L -> F (in NPHP9; a full-length mouse NEK8 construct containing the mutation shows a defect in ciliary localization with no apparent effect on ciliation, mitosis or centriole number; dbSNP:rs199962228)	18199800	1
Q86TB3/A1551S	Q86TB3	ALPK2	ALPK2_HUMAN	A1551S	-	-	-	-	PIMTHaLGVDT									VARIANT	A -> S (in dbSNP:rs3809983)	17974005,28668886	2
Q86TB3/A1919T	Q86TB3	ALPK2	ALPK2_HUMAN	A1919T	-	-	-	-	LRGQIaEELHF									VARIANT	A -> T (in dbSNP:rs374271622)	28668886	1
Q86TB3/A1978T	Q86TB3	ALPK2	ALPK2_HUMAN	A1978T	-	-	-	-	RNYKLaQECYV									VARIANT	A -> T (in dbSNP:rs146618330)	28668886	1
Q86TB3/A202T	Q86TB3	ALPK2	ALPK2_HUMAN	A202T	-	-	-	neutral	RHTGEaDPSNT									VARIANT	A -> T (in dbSNP:rs115979836)	28668886	1
Q86TB3/A29V	Q86TB3	ALPK2	ALPK2_HUMAN	A29V	-	-	-	-	PEKSDaLRCII									VARIANT	A -> V (in dbSNP:rs138405027)	28668886	1
Q86TB3/A457V	Q86TB3	ALPK2	ALPK2_HUMAN	A457V	-	-	-	-	PTAPEaENDYP									VARIANT	A -> V (in dbSNP:rs199872766)	28668886	1
Q86TB3/A969T	Q86TB3	ALPK2	ALPK2_HUMAN	A969T	-	-	-	-	PSPSAaTTATP									VARIANT	A -> T (in dbSNP:rs371835741)	28668886	1
Q86TB3/E1969K	Q86TB3	ALPK2	ALPK2_HUMAN	E1969K	-	-	-	-	TRNNDeIQRNY									VARIANT	E -> K (in dbSNP:rs1313881443)		0
Q86TB3/E942K	Q86TB3	ALPK2	ALPK2_HUMAN	E942K	-	-	-	-	SGGLDeQLLSS									VARIANT	E -> K (in an ovarian undifferentiated carcinoma sample; somatic mutation)	17344846	1
Q86TB3/G1063V	Q86TB3	ALPK2	ALPK2_HUMAN	G1063V	-	-	-	neutral	DHILSgTIKST									VARIANT	G -> V (in dbSNP:rs34347938)		0
Q86TB3/G810S	Q86TB3	ALPK2	ALPK2_HUMAN	G810S	-	-	-	neutral	ECFEAgQGTCF									VARIANT	G -> S (in dbSNP:rs3809970)	10021370,14702039,17974005,28668886	4
Q86TB3/H1174P	Q86TB3	ALPK2	ALPK2_HUMAN	H1174P	-	-	-	neutral	LVPTAhPASSR									VARIANT	H -> P (in dbSNP:rs3809977)	10021370,14702039,17974005,28668886	4
Q86TB3/H1767Y	Q86TB3	ALPK2	ALPK2_HUMAN	H1767Y	-	-	-	-	ETSLShEEKQD									VARIANT	H -> Y (in dbSNP:rs7234999)	28668886	1
Q86TB3/H719Q	Q86TB3	ALPK2	ALPK2_HUMAN	H719Q	-	-	-	neutral	TCGPQhEKQDR									VARIANT	H -> Q (in dbSNP:rs12103986)	10021370,14702039,17974005,28668886	4
Q86TB3/I2157V	Q86TB3	ALPK2	ALPK2_HUMAN	I2157V	-	-	-	neutral	TNSMTiKAGPE									VARIANT	I -> V (in dbSNP:rs7240666)	14702039,17974005,28668886	3
Q86TB3/K1134N	Q86TB3	ALPK2	ALPK2_HUMAN	K1134N	-	-	-	-	RGSETkGVQQQ									VARIANT	K -> N (in dbSNP:rs35791514)		0
Q86TB3/K1476T	Q86TB3	ALPK2	ALPK2_HUMAN	K1476T	-	-	-	-	QEGSMkEAEQI									VARIANT	K -> T (in a melanoma metastatic sample; somatic mutation)	17344846	1
Q86TB3/K1729E	Q86TB3	ALPK2	ALPK2_HUMAN	K1729E	-	-	-	-	AEGVKkILSRV									VARIANT	K -> E (in dbSNP:rs34409558)		0
Q86TB3/K1730E	Q86TB3	ALPK2	ALPK2_HUMAN	K1730E	-	-	-	neutral	EGVKKkLSRVA									VARIANT	K -> E (in dbSNP:rs17065127)	28668886	1
Q86TB3/K1745N	Q86TB3	ALPK2	ALPK2_HUMAN	K1745N	-	-	-	-	LKLEEkNIRKN									VARIANT	K -> N (in dbSNP:rs56206581)	28668886	1
Q86TB3/K829N	Q86TB3	ALPK2	ALPK2_HUMAN	K829N	-	-	-	neutral	GRPVDkSPQEI									VARIANT	K -> N (in dbSNP:rs3809973)	28668886	1
Q86TB3/L1057V	Q86TB3	ALPK2	ALPK2_HUMAN	L1057V	-	-	-	neutral	PSQVQlHILSG									VARIANT	L -> V (in dbSNP:rs3809976)	10021370,14702039,17974005,28668886	4
Q86TB3/L1288S	Q86TB3	ALPK2	ALPK2_HUMAN	L1288S	-	-	-	-	AVVPElPSEIA									VARIANT	L -> S (in dbSNP:rs35882005)	28668886	1
Q86TB3/L1296V	Q86TB3	ALPK2	ALPK2_HUMAN	L1296V	-	-	-	neutral	SEIAAlHSPED									VARIANT	L -> V (in dbSNP:rs3809976)		0
Q86TB3/N916K	Q86TB3	ALPK2	ALPK2_HUMAN	N916K	-	-	-	neutral	LAKVEnTYPLA									VARIANT	N -> K (in dbSNP:rs4940404)	10021370,14702039,17974005,28668886	4
Q86TB3/P1449S	Q86TB3	ALPK2	ALPK2_HUMAN	P1449S	-	-	-	neutral	EAEIQpILQVP									VARIANT	P -> S (in dbSNP:rs3809982)	10021370,14702039,17974005,28668886	4
Q86TB3/Q1579R	Q86TB3	ALPK2	ALPK2_HUMAN	Q1579R	-	-	-	neutral	EPRKRqVFPVS									VARIANT	Q -> R (in dbSNP:rs33910491)	28668886	1
Q86TB3/Q1853E	Q86TB3	ALPK2	ALPK2_HUMAN	Q1853E	-	-	-	-	ASPKDqLYYCC									VARIANT	Q -> E (rare variant found in East Asian patients; decreases luminal apoptosis, cell aggregation and basolateral membrane localization in colorectal cancer cells; dbSNP:rs55674018)	28668886	1
Q86TB3/R136S	Q86TB3	ALPK2	ALPK2_HUMAN	R136S	-	-	-	neutral	THEEErNQIDE									VARIANT	R -> S (in dbSNP:rs9944810)	28668886	1
Q86TB3/R1884C	Q86TB3	ALPK2	ALPK2_HUMAN	R1884C	-	-	-	neutral	KQLSSrDTKGC									VARIANT	R -> C (in dbSNP:rs33969768)	28668886	1
Q86TB3/R825T	Q86TB3	ALPK2	ALPK2_HUMAN	R825T	-	-	-	neutral	DSLVGrVDKYS									VARIANT	R -> T (in dbSNP:rs3809972)	10021370,14702039,17974005,28668886	4
Q86TB3/S388L	Q86TB3	ALPK2	ALPK2_HUMAN	S388L	-	-	-	-	CGSRVsDAGPM									VARIANT	S -> L (in dbSNP:rs147887741)	28668886	1
Q86TB3/S884L	Q86TB3	ALPK2	ALPK2_HUMAN	S884L	-	-	-	neutral	SKDGNsMSPLF									VARIANT	S -> L (in dbSNP:rs3809974)	28668886	1
Q86TB3/S977T	Q86TB3	ALPK2	ALPK2_HUMAN	S977T	-	-	-	-	TATPAsSSIVS									VARIANT	S -> T (in dbSNP:rs3809975)	28668886	1
Q86TB3/T397I	Q86TB3	ALPK2	ALPK2_HUMAN	T397I	-	-	-	neutral	GPMVAtGFCGH									VARIANT	T -> I (in dbSNP:rs79863383)	28668886	1
Q86TB3/T875P	Q86TB3	ALPK2	ALPK2_HUMAN	T875P	-	-	-	neutral	ETSVStKSSKD									VARIANT	T -> P (in dbSNP:rs34109891)	28668886	1
Q86TB3/T891I	Q86TB3	ALPK2	ALPK2_HUMAN	T891I	-	-	-	neutral	MSPLFtTFTLN									VARIANT	T -> I (in dbSNP:rs3826593)	10021370,14702039,17974005,28668886	4
Q86TW2/A164G	Q86TW2	ADCK1	ADCK1_HUMAN	A164G	-	-	-	-	TPLGTaLAQVH									MUTAGEN	A->G: No effect on role in maintaining mitochondrial structure and function.	31125351	1
Q86TW2/D315A	Q86TW2	ADCK1	ADCK1_HUMAN	D315A	-	-	-	-	GFVHCdHPGNV									MUTAGEN	D->A: No effect on role in maintaining mitochondrial structure and function.	31125351	1
Q86TW2/K183I	Q86TW2	ADCK1	ADCK1_HUMAN	K183I	-	-	-	-	RTVAVkQHPKV									MUTAGEN	K->I: No effect on role in maintaining mitochondrial structure and function.	31125351	1
Q86UE8/A108G	Q86UE8	TLK2	TLK2_HUMAN	A108G	-	-	-	-	SVPPVaSSPQH									VARIANT	A -> G	17344846	1
Q86UE8/A95G	Q86UE8	TLK2	TLK2_HUMAN	A95G	-	-	-	-	FAGGSaGTSPG									VARIANT	A -> G (in dbSNP:rs2598147)	17344846	1
Q86UE8/D551G	Q86UE8	TLK2	TLK2_HUMAN	D551G	256	β5/αD-loop	-	decrease	YCEGNdDFYLK	0.881	0.826	0.423	0.631	0.653	0.708	0.412	0.659	VARIANT	D -> G (in MRD57; unknown pathological significance; exhibits abnormal perinuclear localization instead of diffuse nuclear localization; mildly impairs kinase activity; reduced phosphorylation of ASF1A; dbSNP:rs2082811958)	33323470	1
Q86UE8/D592V	Q86UE8	TLK2	TLK2_HUMAN	D592V	443	Catalytic-loop;HrD-motif	-	loss	PIIHYdKPGNI	0.98	0.982	0.163	0.638	0.968	0.976	0.084	0.585	MUTAGEN	D->V: Loss of kinase activity. No impact on interaction with ASF1A.	33323470,35136069	2
Q86UE8/D613A	Q86UE8	TLK2	TLK2_HUMAN	D613A	496	A-loop;DFG-motif	-	loss	EIKITdGLSKI	0.982	0.97	0.119	0.576	0.97	0.942	0.078	0.668	MUTAGEN	D->A: Loss of kinase activity.	10523312,11470414,29955062	3
Q86UE8/D629N	Q86UE8	TLK2	TLK2_HUMAN	D629N	527	A-loop	-	decrease	SYNSVdMELTS	0.299	0.261	0.433	0.19	0.365	0.224	0.491	0.202	VARIANT	D -> N (in MRD57; reduced phosphorylation of ASF1A; dbSNP:rs1568006217)	29861108,29955062	2
Q86UE8/E447K	Q86UE8	TLK2	TLK2_HUMAN	E447K	15	N-term-β1	-	-	KRIHNeNSQFK	0.718	0.7	0.511	0.623	0.419	0.563	0.604	0.377	VARIANT	E -> K (in MRD57; unknown pathological significance; dbSNP:rs1567959483)	29861108	1
Q86UE8/E54D	Q86UE8	TLK2	TLK2_HUMAN	E54D	-	-	-	-	EVETPeKQNDQ									VARIANT	E -> D	17344846	1
Q86UE8/F173L	Q86UE8	TLK2	TLK2_HUMAN	F173L	-	-	-	-	GAGLCfFVSAQ									VARIANT	F -> L (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs1331331651)	17344846	1
Q86UE8/G297D	Q86UE8	TLK2	TLK2_HUMAN	G297D	-	-	-	-	DRLRLgFTTVR									VARIANT	G -> D (in MRD57; unknown pathological significance; dbSNP:rs1555639254)	29861108	1
Q86UE8/H493R	Q86UE8	TLK2	TLK2_HUMAN	H493R	131	β3	-	decrease	VAVKIhLNKNW	0.875	0.834	0.349	0.695	0.704	0.791	0.326	0.605	VARIANT	H -> R (in MRD57; reduced kinase activity; dbSNP:rs1567974030)	29861108,29955062	2
Q86UE8/H518N	Q86UE8	TLK2	TLK2_HUMAN	H518N	178	αC/β4-loop	-	decrease	REYRIhELDHP	0.843	0.865	0.392	0.611	0.715	0.746	0.324	0.568	MUTAGEN	H->N: Reduced kinase activity.	29955062	1
Q86UE8/H518R	Q86UE8	TLK2	TLK2_HUMAN	H518R	178	αC/β4-loop	-	decrease	REYRIhELDHP	0.871	0.85	0.418	0.657	0.669	0.767	0.316	0.561	VARIANT	H -> R (in MRD57; severely reduced kinase activity; dbSNP:rs1567995650)	29861108,29955062	2
Q86UE8/H6R	Q86UE8	TLK2	TLK2_HUMAN	H6R	-	-	-	-	MMEELhLDPRR									VARIANT	H -> R (in dbSNP:rs45550140)	17344846,9427565	2
Q86UE8/P680R	Q86UE8	TLK2	TLK2_HUMAN	P680R	621	αF/αG	-	-	LYGRKpGHNQS	0.792	0.765	0.351	0.512	0.619	0.69	0.352	0.589	VARIANT	P -> R (in MRD57; dbSNP:rs1568018905)	29861108	1
Q86UE8/R109L	Q86UE8	TLK2	TLK2_HUMAN	R109L	-	-	-	-	VPPVArSPQHS									VARIANT	R -> L (in dbSNP:rs1555617262)	17344846	1
Q86UE8/R262Q	Q86UE8	TLK2	TLK2_HUMAN	R262Q	-	-	-	-	EKYKErNRCVT									VARIANT	R -> Q (in dbSNP:rs762409144)	17344846	1
Q86UE8/R339Q	Q86UE8	TLK2	TLK2_HUMAN	R339Q	-	-	-	-	EIERQrMLAKR									VARIANT	R -> Q (in MRD57; unknown pathological significance; dbSNP:rs1567948287)	29861108	1
Q86UE8/R339W	Q86UE8	TLK2	TLK2_HUMAN	R339W	-	-	-	-	EIERQrMLAKR									VARIANT	R -> W (in MRD57; unknown pathological significance; dbSNP:rs1567948262)	29861108	1
Q86UE8/R568W	Q86UE8	TLK2	TLK2_HUMAN	R568W	401	αE	-	-	SEKEArIIMQI	0.671	0.629	0.511	0.425	0.399	0.593	0.534	0.375	VARIANT	R -> W (in MRD57; dbSNP:rs1283838287)	29861108	1
Q86UE8/R720A	Q86UE8	TLK2	TLK2_HUMAN	R720A	791	αH	-	decrease	KAFIRrLAYRK	0.871	0.832	0.397	0.576	0.76	0.722	0.3	0.522	MUTAGEN	R->A: Reduced phosphorylation of ASF1A.	29955062	1
Q86UE8/S617A	Q86UE8	TLK2	TLK2_HUMAN	S617A	501	A-loop	p	increase	TDFGLsIMDDD	0.95	0.899	0.494	0.875	0.434	0.86	0.564	0.473	MUTAGEN	S->A: Increase in autophosphorylation.	29955062	1
Q86UE8/S617D	Q86UE8	TLK2	TLK2_HUMAN	S617D	501	A-loop	p	loss	TDFGLsIMDDD	0.954	0.931	0.56	0.857	0.651	0.884	0.439	0.612	MUTAGEN	S->D: Loss of kinase activity.	29955062	1
Q86UE8/S617L	Q86UE8	TLK2	TLK2_HUMAN	S617L	501	A-loop	p	decrease	TDFGLsIMDDD	0.919	0.869	0.55	0.793	0.6	0.815	0.474	0.498	VARIANT	S -> L (in MRD57; exhibits abnormal perinuclear localization instead of diffuse nuclear localization; impairs kinase activity; reduced phosphorylation of ASF1A; dbSNP:rs2082914686)	21572417,33323470	2
Q86UE8/S659A	Q86UE8	TLK2	TLK2_HUMAN	S659A	595	αF	-	decrease	EPPKIsKVDVW	0.748	0.697	0.442	0.491	0.669	0.704	0.412	0.326	MUTAGEN	S->A: Reduced kinase activity.	29955062	1
Q86UE8/S686A	Q86UE8	TLK2	TLK2_HUMAN	S686A	628	αF/αG	p	decrease	FGHNQsQDILQ	0.907	0.884	0.33	0.691	0.722	0.811	0.286	0.259	MUTAGEN	S->A: Reduced kinase activity.	29955062	1
Q86UE8/S686D	Q86UE8	TLK2	TLK2_HUMAN	S686D	628	αF/αG	p	decrease	FGHNQsQDILQ	0.913	0.913	0.554	0.823	0.618	0.798	0.475	0.448	MUTAGEN	S->D: Reduced kinase activity.	29955062	1
Q86UE8/T695A	Q86UE8	TLK2	TLK2_HUMAN	T695A	656	αG/αH	-	decrease	ILQENtLKATE	0.684	0.7	0.369	0.511	0.631	0.622	0.413	0.308	MUTAGEN	T->A: Reduced kinase activity.	29955062	1
Q86UX6/A454T	Q86UX6	STK32C	ST32C_HUMAN	A454T	-	-	-	-	REPLPaESRDA									VARIANT	A -> T (in dbSNP:rs56109103)	17344846	1
Q86UX6/E467K	Q86UX6	STK32C	ST32C_HUMAN	E467K	-	-	-	neutral	EPVEDeERSAL									VARIANT	E -> K (in dbSNP:rs55812591)	17344846	1
Q86UX6/R376H	Q86UX6	STK32C	ST32C_HUMAN	R376H	-	-	-	-	VPNKGrHCDPT									VARIANT	R -> H (in a colorectal cancer sample; somatic mutation; dbSNP:rs764558009)	16959974	1
Q86UX6/T334A	Q86UX6	STK32C	ST32C_HUMAN	T334A	794	αH/αI	-	-	LRKLLtNPEHR	0.329	0.282	0.432	0.19	0.354	0.274	0.573	0.232	VARIANT	T -> A (in dbSNP:rs17854384)	15489334	1
Q86UX6/V151L	Q86UX6	STK32C	ST32C_HUMAN	V151L	194	αC/β4-loop	-	-	QEIEHvLVNLW	0.385	0.4	0.538	0.45	0.18	0.288	0.665	0.372	VARIANT	V -> L (found in a patient with global developmental delay; unknown pathological significance)	28940097	1
Q86Y07/I157M	Q86Y07	VRK2	VRK2_HUMAN	I157M	420	αE	-	-	DVLEYiENEYV	0.339	0.303	0.507	0.358	0.22	0.231	0.651	0.281	VARIANT	I -> M (in dbSNP:rs35966666)	17344846	1
Q86Y07/I167V	Q86Y07	VRK2	VRK2_HUMAN	I167V	444	Catalytic-loop	-	neutral	YVHGDiAANLL	0.287	0.311	0.459	0.36	0.271	0.238	0.563	0.229	VARIANT	I -> V (in dbSNP:rs1051061)	15489334,16704422,17344846,9344656	4
Q86Y07/N211S	Q86Y07	VRK2	VRK2_HUMAN	N211S	547	A-loop	-	-	PRKGHnTIEFT	0.675	0.636	0.466	0.531	0.504	0.578	0.463	0.522	VARIANT	N -> S (in dbSNP:rs36081172)		0
Q86Y07/N50D	Q86Y07	VRK2	VRK2_HUMAN	N50D	65	β2/β3-loop	-	-	LAFPTnPEKDA	0.202	0.228	0.461	0.193	0.306	0.212	0.659	0.153	VARIANT	N -> D (in dbSNP:rs34130684)	17344846	1
Q86YV5/A1113T	Q86YV5	PRAG1	PRAG1_HUMAN	A1113T	-	-	-	-	AASHQaPEAYE									VARIANT	A -> T (in dbSNP:rs12549973)	17344846,17974005	2
Q86YV5/F1271A	Q86YV5	PRAG1	PRAG1_HUMAN	F1271A	-	-	-	-	HQPNPfVRAQL									MUTAGEN	F->A: Decreases homodimerization. Decreases interaction with PEAK1.	29079850	1
Q86YV5/F1366A	Q86YV5	PRAG1	PRAG1_HUMAN	F1366A	-	-	-	-	LMMMKfEKAVD									MUTAGEN	F->A: Decreases homodimerization. Abolished interaction with PEAK1. Decreases cell migration.	29079850	1
Q86YV5/H851R	Q86YV5	PRAG1	PRAG1_HUMAN	H851R	-	-	-	-	KLNLShETNVH									VARIANT	H -> R (in dbSNP:rs56215812)	17344846	1
Q86YV5/I1243A	Q86YV5	PRAG1	PRAG1_HUMAN	I1243A	-	-	-	-	RLAPEiSASQY									MUTAGEN	I->A: No effect on homodimerization. Decreases oligomerization. Decreases interaction with PEAK1.	29079850	1
Q86YV5/L122I	Q86YV5	PRAG1	PRAG1_HUMAN	L122I	-	-	-	-	PGKLPlKQEDA									VARIANT	L -> I (in dbSNP:rs55764617)	17344846	1
Q86YV5/L955A	Q86YV5	PRAG1	PRAG1_HUMAN	L955A	-	-	-	-	GTYAKlGLYTQ									MUTAGEN	L->A: Decreases homodimerization. Abolished interaction with PEAK1. No effect on cell migration.	29079850	1
Q86YV5/L966A	Q86YV5	PRAG1	PRAG1_HUMAN	L966A	-	-	-	-	QSLARlAKCED									MUTAGEN	L->A: Decreases homodimerization. Abolished interaction with PEAK1. Decreases cell migration.	29079850	1
Q86YV5/P569L	Q86YV5	PRAG1	PRAG1_HUMAN	P569L	-	-	-	-	GPPVSpADLSD									VARIANT	P -> L (in dbSNP:rs4840955)	17344846	1
Q86YV5/P595A	Q86YV5	PRAG1	PRAG1_HUMAN	P595A	-	-	-	-	QGPADpPSCRT									VARIANT	P -> A (in dbSNP:rs55994745)	17344846	1
Q86YV5/P662T	Q86YV5	PRAG1	PRAG1_HUMAN	P662T	-	-	-	-	ETKNGpDHSNS									VARIANT	P -> T (in dbSNP:rs56351643)	17344846	1
Q86YV5/P814L	Q86YV5	PRAG1	PRAG1_HUMAN	P814L	-	-	-	-	PQQPPpPQKKI									VARIANT	P -> L (in dbSNP:rs56207906)	17344846	1
Q86YV5/R1278A	Q86YV5	PRAG1	PRAG1_HUMAN	R1278A	-	-	-	-	VRAQLrRDYRQ									MUTAGEN	R->A: Decreases homodimerization.	29079850	1
Q86YV5/R1315H	Q86YV5	PRAG1	PRAG1_HUMAN	R1315H	-	-	-	-	ADPIKrRIGEA									VARIANT	R -> H (in dbSNP:rs1314830862)	17344846	1
Q86YV5/R137G	Q86YV5	PRAG1	PRAG1_HUMAN	R137G	-	-	-	-	YLGSFrVQKPA									VARIANT	R -> G (in dbSNP:rs56290960)	17344846	1
Q86YV5/R404Q	Q86YV5	PRAG1	PRAG1_HUMAN	R404Q	-	-	-	-	PPAHPrATQPE									VARIANT	R -> Q (in dbSNP:rs3896980)	17344846	1
Q86YV5/S1003L	Q86YV5	PRAG1	PRAG1_HUMAN	S1003L	-	-	-	-	KPCCDsDAIYY									VARIANT	S -> L (in dbSNP:rs56289289)	17344846	1
Q86YV5/S578C	Q86YV5	PRAG1	PRAG1_HUMAN	S578C	-	-	-	-	LSDGSsGSSIG									VARIANT	S -> C (in dbSNP:rs4840953)	17344846	1
Q86YV5/V1041M	Q86YV5	PRAG1	PRAG1_HUMAN	V1041M	-	-	-	-	YCSPSvVHFNI									VARIANT	V -> M (in dbSNP:rs28533138)	17344846	1
Q86YV5/V139I	Q86YV5	PRAG1	PRAG1_HUMAN	V139I	-	-	-	-	GSFRGvKPAGP									VARIANT	V -> I (in dbSNP:rs34346032)	17344846	1
Q86YV5/W1382A	Q86YV5	PRAG1	PRAG1_HUMAN	W1382A	-	-	-	-	VELEDwCCQYL									MUTAGEN	W->A: Decreases homodimerization. Abolished interaction with PEAK1. Decreases cell migration.	29079850	1
Q86YV5/Y1282A	Q86YV5	PRAG1	PRAG1_HUMAN	Y1282A	-	-	-	-	LRERDyQEDLP									MUTAGEN	Y->A: No effect on homodimerization. Decreases oligomerization. Decreases interaction with PEAK1. No effect on cell migration.	29079850	1
Q86Z02/D315N	Q86Z02	HIPK1	HIPK1_HUMAN	D315N	443	Catalytic-loop;HrD-motif	-	loss	GLIHAdKPENI	0.989	1.0	0.171	0.633	0.939	0.971	0.118	0.594	MUTAGEN	D->N: Loss of kinase activity and impaired MAP3K5-JNK inactivation.	15701637	1
Q86Z02/G310C	Q86Z02	HIPK1	HIPK1_HUMAN	G310C	427	αE	-	-	KLKSLgIHADL	0.639	0.627	0.427	0.543	0.532	0.624	0.358	0.406	VARIANT	G -> C (in dbSNP:rs34335651)	17344846	1
Q86Z02/K1203R	Q86Z02	HIPK1	HIPK1_HUMAN	K1203R	-	-	-	-	PLSPTkSQYSY									MUTAGEN	K->R: Nuclear subcellular location. Impaired sumoylation and cytoplasmic subcellular location; when associated with R-25; R-317; R-440 and R-556.	15701637	1
Q86Z02/K219A	Q86Z02	HIPK1	HIPK1_HUMAN	K219A	129	β3;Catalytic-Lys	-	loss	EIVAIkLKNHP	0.999	0.997	0.018	0.562	1.0	0.997	0.009	0.671	MUTAGEN	K->A: Loss of kinase activity.	19646965	1
Q86Z02/K25R	Q86Z02	HIPK1	HIPK1_HUMAN	K25R	-	-	-	-	SAKKLkEPSGW									MUTAGEN	K->R: Reduced sumoylation and cytoplasmic subcellular location. Impaired sumoylation and cytoplasmic subcellular location; when associated with R-317; R-440; R-556 and R-1203.	15701637	1
Q86Z02/K317R	Q86Z02	HIPK1	HIPK1_HUMAN	K317R	445	Catalytic-loop	-	-	IHADLkENIML	0.942	0.928	0.353	0.708	0.79	0.896	0.285	0.476	MUTAGEN	K->R: Nuclear subcellular location. Impaired sumoylation and cytoplasmic subcellular location; when associated with R-25; R-440; R-556 and R-1203.	15701637	1
Q86Z02/K440R	Q86Z02	HIPK1	HIPK1_HUMAN	K440R	693	αG/αH	ub	-	PLWRLkPEEHE	0.584	0.506	0.511	0.536	0.308	0.386	0.628	0.354	MUTAGEN	K->R: Nuclear subcellular location. Impaired sumoylation and cytoplasmic subcellular location; when associated with R-25; R-317; R-556 and R-1203.	15701637	1
Q86Z02/K556R	Q86Z02	HIPK1	HIPK1_HUMAN	K556R	-	-	-	-	TVSQIkPFTTH									MUTAGEN	K->R: Nuclear subcellular location. Impaired sumoylation and cytoplasmic subcellular location; when associated with R-25; R-317; R-440 and R-1203.	15701637	1
Q86Z02/L1165V	Q86Z02	HIPK1	HIPK1_HUMAN	L1165V	-	-	-	-	VGPSLlSASVA									VARIANT	L -> V	17344846	1
Q86Z02/Q6R	Q86Z02	HIPK1	HIPK1_HUMAN	Q6R	-	-	-	-	MASQLqFSPPS									VARIANT	Q -> R (in dbSNP:rs35324789)		0
Q8IU85/I66M	Q8IU85	CAMK1D	KCC1D_HUMAN	I66M	170	αC	-	neutral	GKESSiNEIAV	0.107	0.12	0.457	0.112	0.128	0.091	0.593	0.088	VARIANT	I -> M (in dbSNP:rs34194224)	17344846	1
Q8IU85/K52A	Q8IU85	CAMK1D	KCC1D_HUMAN	K52A	129	β3;Catalytic-Lys	ub	loss	KLFAVkIPKKA	0.999	0.986	0.018	0.679	1.0	0.998	0.018	0.668	MUTAGEN	K->A: Catalytically inactive form.	16324104	1
Q8IU85/T180A	Q8IU85	CAMK1D	KCC1D_HUMAN	T180A	545	A-loop	p	loss	GDVMStCGTPG	0.993	0.988	0.186	0.921	0.965	0.99	0.086	0.442	MUTAGEN	T->A: Loss of ionomycin-induced activation.	12935886,16324104	2
Q8IV63/C288Y	Q8IV63	VRK3	VRK3_HUMAN	C288Y	-	-	-	neutral	VLQVAcLLDAL									VARIANT	C -> Y (in dbSNP:rs10409482)	17344846	1
Q8IV63/F171L	Q8IV63	VRK3	VRK3_HUMAN	F171L	-	-	-	neutral	WKLKSfTRDNQ									VARIANT	F -> L (in dbSNP:rs11547883)	17344846	1
Q8IV63/H304L	Q8IV63	VRK3	VRK3_HUMAN	H304L	-	-	-	-	ENEYVhNVTAE									VARIANT	H -> L (in dbSNP:rs35261919)		0
Q8IV63/P105T	Q8IV63	VRK3	VRK3_HUMAN	P105T	-	-	-	neutral	SRPPTpSSPQK									VARIANT	P -> T (in dbSNP:rs11547882)	17344846	1
Q8IV63/R370C	Q8IV63	VRK3	VRK3_HUMAN	R370C	-	-	-	-	CGPSRrDLQSL									VARIANT	R -> C (in dbSNP:rs35331034)	17344846	1
Q8IV63/S170P	Q8IV63	VRK3	VRK3_HUMAN	S170P	-	-	-	-	QWKLKsQTRDN									VARIANT	S -> P (in dbSNP:rs11547881)		0
Q8IV63/S268L	Q8IV63	VRK3	VRK3_HUMAN	S268L	-	-	-	neutral	GRSLQsLDVSP									VARIANT	S -> L (in dbSNP:rs10410075)	17344846	1
Q8IV63/S371G	Q8IV63	VRK3	VRK3_HUMAN	S371G	-	-	-	neutral	GPSRRsLQSLG									VARIANT	S -> G (in dbSNP:rs56407496)	17344846	1
Q8IV63/S59F	Q8IV63	VRK3	VRK3_HUMAN	S59F	-	-	p	neutral	SSFETsKKVKW									VARIANT	S -> F (in dbSNP:rs2033262)	17344846	1
Q8IV63/T188A	Q8IV63	VRK3	VRK3_HUMAN	T188A	-	-	-	neutral	AAPTStTCDSG									VARIANT	T -> A (in dbSNP:rs11879620)		0
Q8IVH8/H424Q	Q8IVH8	MAP4K3	M4K3_HUMAN	H424Q	-	-	-	-	DDESKhTLKAK									VARIANT	H -> Q (in dbSNP:rs56317466)	17344846	1
Q8IVH8/K45E	Q8IVH8	MAP4K3	M4K3_HUMAN	K45E	129	β3;Catalytic-Lys	-	loss	ELAAIkIKLEP	1.0	1.0	0.05	0.728	0.995	0.999	0.037	0.57	MUTAGEN	K->E: Loss of kinase activity and ability to activate JNK family.	9275185	1
Q8IVH8/T669S	Q8IVH8	MAP4K3	M4K3_HUMAN	T669S	-	-	-	-	AKIPEtWCQKC									VARIANT	T -> S (in a lung squamous cell carcinoma sample; somatic mutation)	17344846	1
Q8IVH8/V200L	Q8IVH8	MAP4K3	M4K3_HUMAN	V200L	604	αF	-	-	CDLWAvITAIE	0.151	0.135	0.499	0.21	0.113	0.113	0.748	0.14	VARIANT	V -> L (in dbSNP:rs35957290)	17344846	1
Q8IVT5/A637F	Q8IVT5	KSR1	KSR1_HUMAN	A637F	-	-	-	-	WHGEVaRLLEM									MUTAGEN	A->F: No effect on MAP2K1 or MAP2K2 mediated-BRAF-KSR1 dimerization and BRAF activation.	29433126	1
Q8IVT5/C62D	Q8IVT5	KSR1	KSR1_HUMAN	C62D	-	-	-	-	GLRTKcVSNDL									MUTAGEN	C->D: Reduces interaction with BRAF and MAP2K1 and thus phosphorylation of MAP2K1.	29433126	1
Q8IVT5/E72K	Q8IVT5	KSR1	KSR1_HUMAN	E72K	-	-	-	decrease	DLTQQeRTLEA									MUTAGEN	E->K: Loss of interaction with BRAF and MAP2K1 and severe decrease in MAP2K1 phosphorylation levels.	29433126	1
Q8IVT5/L47D	Q8IVT5	KSR1	KSR1_HUMAN	L47D	-	-	-	-	GQLQKlDISIG									MUTAGEN	L->D: Reduces interaction with BRAF and MAP2K1 and thus phosphorylation of MAP2K1.	29433126	1
Q8IVT5/Q663H	Q8IVT5	KSR1	KSR1_HUMAN	Q663H	-	-	-	-	VMNYRqRHENV									VARIANT	Q -> H	17344846	1
Q8IVT5/R639M	Q8IVT5	KSR1	KSR1_HUMAN	R639M	-	-	-	-	GEVAIrLEMDG									MUTAGEN	R->M: No effect on MAP2K1 mediated-BRAF-KSR1 dimerization and BRAF activation.	29433126	1
Q8IVT5/R665H	Q8IVT5	KSR1	KSR1_HUMAN	R665H	-	-	-	-	NYRQTrENVVL									MUTAGEN	R->H: Loss of MAP2K1 mediated-BRAF-KSR1 dimerization.	29433126	1
Q8IVT5/S227P	Q8IVT5	KSR1	KSR1_HUMAN	S227P	-	-	-	-	AQGPRsSVSAL									VARIANT	S -> P	17344846	1
Q8IVT5/V359A	Q8IVT5	KSR1	KSR1_HUMAN	V359A	-	-	-	-	SWLSQvHVCQK									VARIANT	V -> A	17344846	1
Q8IVT5/W831R	Q8IVT5	KSR1	KSR1_HUMAN	W831R	-	-	-	-	AEASIwIGSGE									MUTAGEN	W->R: Loss of the interaction with MAP2K1 resulting in loss of BRAF-KSR1 dimerization and BRAF activation. No effect on ATP binding or interaction with HSP90AA1, 14-3-3 and CDC37.	29433126	1
Q8IVW4/M394T	Q8IVW4	CDKL3	CDKL3_HUMAN	M394T	-	-	-	-	ENVHPmPDTKL									VARIANT	M -> T (in dbSNP:rs35687772)	17344846	1
Q8IW41/K51M	Q8IW41	MAPKAPK5	MAPK5_HUMAN	K51M	129	β3;Catalytic-Lys	-	loss	ERFALkLLDRP	0.999	0.993	0.023	0.61	0.995	0.998	0.011	0.605	MUTAGEN	K->M: Kinase defective mutant, abolishes activity.	12808055	1
Q8IW41/L337G	Q8IW41	MAPKAPK5	MAPK5_HUMAN	L337G	-	-	-	activating	AHAEQlNMRIQ									MUTAGEN	L->G: Induces constitutive protein kinase activity.	21329882	1
Q8IW41/M67I	Q8IW41	MAPKAPK5	MAPK5_HUMAN	M67I	179	αC/β4-loop	-	-	EVRLHmCATHP	0.449	0.347	0.495	0.389	0.314	0.305	0.549	0.382	VARIANT	M -> I (in dbSNP:rs34132040)	17344846	1
Q8IW41/R282K	Q8IW41	MAPKAPK5	MAPK5_HUMAN	R282K	790	αH	-	-	AKDVVrLLKVK	0.167	0.213	0.461	0.186	0.117	0.142	0.722	0.145	VARIANT	R -> K (in dbSNP:rs34843470)	17344846	1
Q8IW41/S212D	Q8IW41	MAPKAPK5	MAPK5_HUMAN	S212D	586	αF	p	increase	GIIPTsTPYTY	0.64	0.664	0.659	0.765	0.115	0.285	0.798	0.124	MUTAGEN	S->D: Mimicks phosphorylation state and displays a slightly higher protein kinase activity.	12808055	1
Q8IW41/T182A	Q8IW41	MAPKAPK5	MAPK5_HUMAN	T182A	545	A-loop	p	-	QGDLMtQFTPY	0.938	0.966	0.137	0.867	0.891	0.947	0.12	0.315	MUTAGEN	T->A: No p38-beta/MAPK11-induced activation.	12808055,21329882,9628874	3
Q8IW41/T182D	Q8IW41	MAPKAPK5	MAPK5_HUMAN	T182D	545	A-loop	p	activating	QGDLMtQFTPY	0.999	0.987	0.715	0.961	0.349	0.95	0.752	0.418	MUTAGEN	T->D: Mimicks phosphorylation state and induces constitutive protein kinase activity.	12808055,21329882,9628874	3
Q8IWB6/D88G	Q8IWB6	TEX14	TEX14_HUMAN	D88G	-	-	-	-	NHRCFdSTPVH									VARIANT	D -> G (in dbSNP:rs56292204)	17344846	1
Q8IWB6/I559M	Q8IWB6	TEX14	TEX14_HUMAN	I559M	-	-	-	-	TPDMEiELKEM									VARIANT	I -> M	17344846	1
Q8IWB6/K321E	Q8IWB6	TEX14	TEX14_HUMAN	K321E	-	-	-	-	SQDLEkRLVYE									VARIANT	K -> E (in a gastric adenocarcinoma sample; somatic mutation)	17344846	1
Q8IWB6/S443C	Q8IWB6	TEX14	TEX14_HUMAN	S443C	-	-	-	-	DIYSFsIMQEI									VARIANT	S -> C	17344846	1
Q8IWQ3/G310A	Q8IWQ3	BRSK2	BRSK2_HUMAN	G310A	-	-	-	decrease	SMHSLgFRDRN									MUTAGEN	G->A: Decreased activation of kinase activity.	18339622	1
Q8IWQ3/K48M	Q8IWQ3	BRSK2	BRSK2_HUMAN	K48M	129	β3;Catalytic-Lys	-	loss	QKVAIkVNREK	0.999	1.0	0.019	0.641	0.999	0.998	0.016	0.471	MUTAGEN	K->M: Loss of catalytic activity. Causes disintegration of actin stress fibers.	22669945,22798068	2
Q8IWQ3/T174A	Q8IWQ3	BRSK2	BRSK2_HUMAN	T174A	545	A-loop	p	loss	DSLLEtCGSPH	0.999	1.0	0.143	0.934	0.985	0.994	0.066	0.414	MUTAGEN	T->A: Prevents phosphorylation and activation by STK11/LKB1 complex.	14976552,18339622,22798068	3
Q8IWQ3/T174E	Q8IWQ3	BRSK2	BRSK2_HUMAN	T174E	545	A-loop	p	activating	DSLLEtCGSPH	0.994	0.984	0.739	0.97	0.228	0.934	0.786	0.353	MUTAGEN	T->E: Constitutively activated.	14976552,18339622,22798068	3
Q8IWQ3/T260A	Q8IWQ3	BRSK2	BRSK2_HUMAN	T260A	804	αI	p	decrease	AARRLtEHIQK	0.884	0.924	0.333	0.743	0.786	0.868	0.291	0.397	MUTAGEN	T->A: Decreased phosphorylation. Nearly abolishes stimulation of insulin secretion.	16870137,22669945	2
Q8IWQ3/T443A	Q8IWQ3	BRSK2	BRSK2_HUMAN	T443A	-	-	p	activating	GSPLPtKGTPV									MUTAGEN	T->A: Constitutively activated. Promotes formation of actin stress fibers.	22669945	1
Q8IWU2/A1341G	Q8IWU2	LMTK2	LMTK2_HUMAN	A1341G	-	-	-	neutral	PTAANaDPLPE									VARIANT	A -> G (in dbSNP:rs56343792)	17344846	1
Q8IWU2/A862T	Q8IWU2	LMTK2	LMTK2_HUMAN	A862T	-	-	-	neutral	DISPDaTVPVE									VARIANT	A -> T (in dbSNP:rs34005293)	17344846	1
Q8IWU2/D1061N	Q8IWU2	LMTK2	LMTK2_HUMAN	D1061N	-	-	-	-	PATTGdGHSGL									VARIANT	D -> N (in dbSNP:rs3801295)	17344846	1
Q8IWU2/D1220N	Q8IWU2	LMTK2	LMTK2_HUMAN	D1220N	-	-	-	-	FETQDdPCTLA									VARIANT	D -> N (in dbSNP:rs35912712)	17344846	1
Q8IWU2/D484H	Q8IWU2	LMTK2	LMTK2_HUMAN	D484H	-	-	-	-	EAAKHdFDERS									VARIANT	D -> H (in a lung large cell carcinoma sample; somatic mutation; dbSNP:rs147940573)	17344846	1
Q8IWU2/I693T	Q8IWU2	LMTK2	LMTK2_HUMAN	I693T	-	-	-	neutral	EKPRKiDSEPL									VARIANT	I -> T (in dbSNP:rs56204700)	17344846	1
Q8IWU2/L780M	Q8IWU2	LMTK2	LMTK2_HUMAN	L780M	-	-	-	-	ENKPGlLLQEN									VARIANT	L -> M (in dbSNP:rs11765552)	10470851,17344846	2
Q8IWU2/P30A	Q8IWU2	LMTK2	LMTK2_HUMAN	P30A	-	-	-	neutral	GAAPLpTGAGE									VARIANT	P -> A (in dbSNP:rs3735252)		0
Q8IWU2/S1401N	Q8IWU2	LMTK2	LMTK2_HUMAN	S1401N	-	-	-	neutral	GSPYLsCINSE									VARIANT	S -> N (in dbSNP:rs45488394)	17344846	1
Q8IWU2/S916R	Q8IWU2	LMTK2	LMTK2_HUMAN	S916R	-	-	-	-	RVSVGsLPELG									VARIANT	S -> R (in dbSNP:rs55867257)	17344846	1
Q8IWU2/V595I	Q8IWU2	LMTK2	LMTK2_HUMAN	V595I	-	-	-	-	TALRSvLEESS									VARIANT	V -> I (in dbSNP:rs34461195)	17344846	1
Q8IWU2/V624M	Q8IWU2	LMTK2	LMTK2_HUMAN	V624M	-	-	-	-	PGDLHvSGPES									VARIANT	V -> M (in dbSNP:rs34628253)	17344846	1
Q8IWU2/V849F	Q8IWU2	LMTK2	LMTK2_HUMAN	V849F	-	-	-	-	CLDVIvEDCLH									VARIANT	V -> F (in dbSNP:rs56196840)	17344846	1
Q8IY84/E64Q	Q8IY84	NIM1K	NIM1_HUMAN	E64Q	23	N-term-β1	-	-	EKVVReTLGKR	0.444	0.45	0.433	0.299	0.325	0.371	0.517	0.253	VARIANT	E -> Q (in dbSNP:rs55663207)	17344846	1
Q8IY84/L260I	Q8IY84	NIM1K	NIM1_HUMAN	L260I	607	αF	-	-	WALGVlYFMVT	0.297	0.278	0.587	0.292	0.204	0.218	0.718	0.186	VARIANT	L -> I (in dbSNP:rs35659008)	17344846	1
Q8IY84/M320I	Q8IY84	NIM1K	NIM1_HUMAN	M320I	818	αI	-	-	GIDCImDEWMQ	0.473	0.365	0.56	0.409	0.239	0.278	0.727	0.221	VARIANT	M -> I (in dbSNP:rs55770078)	17344846	1
Q8IY84/P333S	Q8IY84	NIM1K	NIM1_HUMAN	P333S	831	C-term-αI	-	-	VPYPTpEPFQL	0.253	0.279	0.523	0.315	0.219	0.24	0.7	0.113	VARIANT	P -> S (in a lung neuroendocrine carcinoma sample; somatic mutation; dbSNP:rs866026698)	17344846	1
Q8IY84/P411T	Q8IY84	NIM1K	NIM1_HUMAN	P411T	-	-	-	-	MMLPDpERDLK									VARIANT	P -> T (in a lung large cell carcinoma sample; somatic mutation)	17344846	1
Q8IY84/R21W	Q8IY84	NIM1K	NIM1_HUMAN	R21W	-	-	-	-	YARWDrDSVES									VARIANT	R -> W (in dbSNP:rs55664335)	17344846	1
Q8IY84/T229A	Q8IY84	NIM1K	NIM1_HUMAN	T229A	545	A-loop	-	loss	GEMLNtCGSPP	0.981	0.963	0.275	0.83	0.847	0.956	0.296	0.485	MUTAGEN	T->A: Loss of autophosphorylation and kinase activity.	15733851	1
Q8IY84/T229E	Q8IY84	NIM1K	NIM1_HUMAN	T229E	545	A-loop	-	activating	GEMLNtCGSPP	0.979	0.98	0.852	0.94	0.165	0.902	0.856	0.452	MUTAGEN	T->E: Constitutively active.	15733851	1
Q8IYT8/A662V	Q8IYT8	ULK2	ULK2_HUMAN	A662V	-	-	-	-	EQQSKaFGRSV									VARIANT	A -> V (in a metastatic melanoma sample; somatic mutation)	17344846	1
Q8IYT8/D842E	Q8IYT8	ULK2	ULK2_HUMAN	D842E	-	-	-	-	TECVLdTAMRG									VARIANT	D -> E (in dbSNP:rs35107651)	17344846	1
Q8IYT8/G627E	Q8IYT8	ULK2	ULK2_HUMAN	G627E	-	-	-	-	LVTRHgAEEQS									VARIANT	G -> E (in a metastatic melanoma sample; somatic mutation)	17344846	1
Q8IYT8/G752R	Q8IYT8	ULK2	ULK2_HUMAN	G752R	-	-	-	-	RTTSVgSNSGG									VARIANT	G -> R (in dbSNP:rs55730189)	17344846	1
Q8IYT8/K39R	Q8IYT8	ULK2	ULK2_HUMAN	K39R	129	β3;Catalytic-Lys	-	decrease	WEVAIkINKKN	0.994	1.0	0.05	0.773	0.998	0.998	0.007	0.412	MUTAGEN	K->R: Decreased kinase activity and decreased autophosphorylation.	18936157	1
Q8IYT8/P242S	Q8IYT8	ULK2	ULK2_HUMAN	P242S	782	αH	-	neutral	PRETSpLANLL	0.142	0.111	0.518	0.188	0.133	0.12	0.657	0.086	VARIANT	P -> S (in dbSNP:rs34670978)	17344846	1
Q8IYT8/T533I	Q8IYT8	ULK2	ULK2_HUMAN	T533I	-	-	-	-	SAPTLtIYQNK									VARIANT	T -> I (in dbSNP:rs4462660)		0
Q8IYT8/V370M	Q8IYT8	ULK2	ULK2_HUMAN	V370M	-	-	-	neutral	SCDMPvTAGRR									VARIANT	V -> M (in dbSNP:rs150122)	15489334,9734811	2
Q8IZE3/G597A	Q8IZE3	SCYL3	PACE1_HUMAN	G597A	-	-	-	neutral	KPVTSgQKPIP									VARIANT	G -> A (in dbSNP:rs12143301)	15489334	1
Q8IZE3/Q621R	Q8IZE3	SCYL3	PACE1_HUMAN	Q621R	-	-	-	neutral	KSSLPqISLVQ									VARIANT	Q -> R (in dbSNP:rs4656197)	12651155,14702039	2
Q8IZL9/A137T	Q8IZL9	CDK20	CDK20_HUMAN	A137T	456	Catalytic-loop	-	-	NLLISaGQLKI	0.145	0.113	0.566	0.237	0.086	0.112	0.767	0.099	VARIANT	A -> T (in dbSNP:rs28364955)		0
Q8IZL9/K281R	Q8IZL9	CDK20	CDK20_HUMAN	K281R	816	αI	-	-	RIAASkLLHQY	0.209	0.086	0.455	0.179	0.092	0.113	0.698	0.201	VARIANT	K -> R (in dbSNP:rs28364963)		0
Q8IZL9/S106N	Q8IZL9	CDK20	CDK20_HUMAN	S106N	405	αE	-	-	QAQVKsLQMLL	0.216	0.228	0.568	0.206	0.173	0.163	0.733	0.178	VARIANT	S -> N (in dbSNP:rs41286029)	17344846	1
Q8IZL9/S86L	Q8IZL9	CDK20	CDK20_HUMAN	S86L	254	β5/αD-loop	-	-	FEFMLsLAEVV	0.482	0.374	0.551	0.415	0.308	0.269	0.586	0.584	VARIANT	S -> L (in dbSNP:rs28364953)		0
Q8IZL9/T161A	Q8IZL9	CDK20	CDK20_HUMAN	T161A	544	A-loop	-	decrease	GSRLYtQVATR	0.849	0.872	0.239	0.63	0.76	0.853	0.257	0.469	MUTAGEN	T->A: Impairs CDK2 T-160 phosphorylation and activity.	14597612	1
Q8IZX4/A1540T	Q8IZX4	TAF1L	TAF1L_HUMAN	A1540T	-	-	-	-	TQKMMaPDSWP									VARIANT	A -> T (in dbSNP:rs55782058)	17344846	1
Q8IZX4/E794D	Q8IZX4	TAF1L	TAF1L_HUMAN	E794D	-	-	-	-	GYYIReVDIFV									VARIANT	E -> D (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
Q8IZX4/G256A	Q8IZX4	TAF1L	TAF1L_HUMAN	G256A	-	-	-	neutral	PEFRPgVLRFL									VARIANT	G -> A (in dbSNP:rs55991718)	17344846	1
Q8IZX4/G47A	Q8IZX4	TAF1L	TAF1L_HUMAN	G47A	-	-	-	-	FGNISgGQLEG									VARIANT	G -> A (in a lung small cell carcinoma sample; somatic mutation)	17344846	1
Q8IZX4/H1549Y	Q8IZX4	TAF1L	TAF1L_HUMAN	H1549Y	-	-	-	-	SWPFHhVNKKF									VARIANT	H -> Y (in a glioblastoma multiforme sample; somatic mutation; dbSNP:rs1587670372)	17344846	1
Q8IZX4/H1824Q	Q8IZX4	TAF1L	TAF1L_HUMAN	H1824Q	-	-	-	-	EHKDGhK									VARIANT	H -> Q (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
Q8IZX4/I1411V	Q8IZX4	TAF1L	TAF1L_HUMAN	I1411V	-	-	-	-	SILESiNDMRD									VARIANT	I -> V (in dbSNP:rs34500740)	17344846	1
Q8IZX4/I1805V	Q8IZX4	TAF1L	TAF1L_HUMAN	I1805V	-	-	-	neutral	VGYGGiPKQPF									VARIANT	I -> V (in dbSNP:rs16918393)		0
Q8IZX4/I532N	Q8IZX4	TAF1L	TAF1L_HUMAN	I532N	-	-	-	-	NLILEiDEKEE									VARIANT	I -> N (in dbSNP:rs56128445)	17344846	1
Q8IZX4/K1038N	Q8IZX4	TAF1L	TAF1L_HUMAN	K1038N	-	-	-	-	EEEIKkSRWEV									VARIANT	K -> N (in dbSNP:rs55767137)	17344846	1
Q8IZX4/K1731N	Q8IZX4	TAF1L	TAF1L_HUMAN	K1731N	-	-	-	neutral	EEEDGkKPPAP									VARIANT	K -> N (in dbSNP:rs34241003)	17344846	1
Q8IZX4/L750F	Q8IZX4	TAF1L	TAF1L_HUMAN	L750F	-	-	-	-	HTSPFlSLHPG									VARIANT	L -> F (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
Q8IZX4/L762I	Q8IZX4	TAF1L	TAF1L_HUMAN	L762I	-	-	-	-	QLLQAlNNLFR									VARIANT	L -> I (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
Q8IZX4/M371V	Q8IZX4	TAF1L	TAF1L_HUMAN	M371V	-	-	-	neutral	RLWYDmGVSED									VARIANT	M -> V (in dbSNP:rs17219559)	17344846	1
Q8IZX4/P1389S	Q8IZX4	TAF1L	TAF1L_HUMAN	P1389S	-	-	-	-	DYLNIpKSIHR									VARIANT	P -> S (in dbSNP:rs56393725)	17344846	1
Q8IZX4/P1810L	Q8IZX4	TAF1L	TAF1L_HUMAN	P1810L	-	-	-	-	IRPKQpMLQHA									VARIANT	P -> L (in dbSNP:rs56342342)	17344846	1
Q8IZX4/P637S	Q8IZX4	TAF1L	TAF1L_HUMAN	P637S	-	-	-	-	RQFHRpLKKYS									VARIANT	P -> S (in dbSNP:rs56157814)	17344846	1
Q8IZX4/Q171E	Q8IZX4	TAF1L	TAF1L_HUMAN	Q171E	-	-	-	-	KKDKDqAITCV									VARIANT	Q -> E (in dbSNP:rs56352331)	17344846	1
Q8IZX4/R1016C	Q8IZX4	TAF1L	TAF1L_HUMAN	R1016C	-	-	-	neutral	DADLRrSLKNA									VARIANT	R -> C (in dbSNP:rs35905429)	17344846	1
Q8IZX4/R1356C	Q8IZX4	TAF1L	TAF1L_HUMAN	R1356C	-	-	-	-	NVHEVrKSLVL									VARIANT	R -> C (in dbSNP:rs56107531)	17344846	1
Q8IZX4/R845Q	Q8IZX4	TAF1L	TAF1L_HUMAN	R845Q	-	-	-	-	RPRRIrEDIKK									VARIANT	R -> Q (in dbSNP:rs34787787)	17344846	1
Q8IZX4/T1169I	Q8IZX4	TAF1L	TAF1L_HUMAN	T1169I	-	-	-	neutral	HRDDVtSMTSL									VARIANT	T -> I (in dbSNP:rs55976674)	17344846	1
Q8IZX4/V1312L	Q8IZX4	TAF1L	TAF1L_HUMAN	V1312L	-	-	-	-	PPSKPvMTEEQ									VARIANT	V -> L (in dbSNP:rs55824107)	17344846	1
Q8N2I9/A10V	Q8N2I9	STK40	STK40_HUMAN	A10V	-	-	-	-	ASDRGaETSAR									VARIANT	A -> V (in dbSNP:rs56314546)	17344846	1
Q8N2I9/A395T	Q8N2I9	STK40	STK40_HUMAN	A395T	-	-	-	neutral	SSIHDaSWVPK									VARIANT	A -> T (in dbSNP:rs3795498)	14702039,15489334,17344846	3
Q8N2I9/M133T	Q8N2I9	STK40	STK40_HUMAN	M133T	238	β4/β5-loop	-	-	RMVKKmKRICL	0.302	0.311	0.531	0.296	0.157	0.205	0.67	0.18	VARIANT	M -> T (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs755089893)	17344846	1
Q8N2I9/R211Q	Q8N2I9	STK40	STK40_HUMAN	R211Q	491	Catalytic-loop	-	-	NKRTHrTITNF	0.427	0.288	0.459	0.341	0.275	0.345	0.631	0.17	VARIANT	R -> Q (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs539738963)	17344846	1
Q8N4C8/A514T	Q8N4C8	MINK1	MINK1_HUMAN	A514T	-	-	-	-	RGMNPaKPAWA									VARIANT	A -> T (in dbSNP:rs56131206)	17344846	1
Q8N4C8/E1010V	Q8N4C8	MINK1	MINK1_HUMAN	E1010V	-	-	-	-	HSETPeRKYKK									VARIANT	E -> V (in a gastric adenocarcinoma sample; somatic mutation)	17344846	1
Q8N4C8/I1200V	Q8N4C8	MINK1	MINK1_HUMAN	I1200V	-	-	-	-	GNSYDiIPVHI									VARIANT	I -> V	17344846	1
Q8N4C8/P775L	Q8N4C8	MINK1	MINK1_HUMAN	P775L	-	-	-	neutral	GVSSKpSSPVL									VARIANT	P -> L (in dbSNP:rs11556635)	15469942,15489334,18669648,18691976,19369195,19413330,19690332,23186163	8
Q8N4C8/V771A	Q8N4C8	MINK1	MINK1_HUMAN	V771A	-	-	-	-	RNRVGvSKPDS									VARIANT	V -> A (in dbSNP:rs11556634)	15469942,15489334	2
Q8N4C8/V863I	Q8N4C8	MINK1	MINK1_HUMAN	V863I	-	-	-	neutral	GDTDSvTMVVH									VARIANT	V -> I (in dbSNP:rs2302319)	17344846	1
Q8N568/G119C	Q8N568	DCLK2	DCLK2_HUMAN	G119C	-	-	-	-	VNLPQgRTIYT									VARIANT	G -> C (in dbSNP:rs56327537)	17344846	1
Q8N568/I583V	Q8N568	DCLK2	DCLK2_HUMAN	I583V	610	αF	-	-	GVITYiLCGFP	0.218	0.222	0.464	0.144	0.2	0.186	0.627	0.152	VARIANT	I -> V (in dbSNP:rs35745104)	17344846	1
Q8N568/R372H	Q8N568	DCLK2	DCLK2_HUMAN	R372H	11	N-term-β1	-	-	GPELDrISPEG	0.263	0.247	0.466	0.201	0.215	0.223	0.552	0.084	VARIANT	R -> H (in dbSNP:rs34386880)	17344846	1
Q8N568/V212M	Q8N568	DCLK2	DCLK2_HUMAN	V212M	-	-	-	-	KPRKAvILLNK									VARIANT	V -> M (found in a patient with hereditary motor and sensory neuropathy; unknown pathological significance; dbSNP:rs759398144)	25512093	1
Q8N5S9/E375G	Q8N5S9	CAMKK1	KKCC1_HUMAN	E375G	681	αG/αH	-	-	VVFPEeEISEE	0.319	0.314	0.587	0.379	0.18	0.217	0.682	0.267	VARIANT	E -> G (in dbSNP:rs7214723)	15489334,17344846	2
Q8N752/A257T	Q8N752	CSNK1A1L	KC1AL_HUMAN	A257T	845	C-term-αI	-	-	FPAEFaYLNYC	0.117	0.098	0.489	0.184	0.13	0.103	0.67	0.101	VARIANT	A -> T (in dbSNP:rs55895045)	17344846	1
Q8N752/D42E	Q8N752	CSNK1A1L	KC1AL_HUMAN	D42E	80	β2/β3-loop	-	neutral	TTNGEdAVKLE	0.138	0.178	0.504	0.148	0.264	0.122	0.672	0.071	VARIANT	D -> E (in dbSNP:rs9576175)	15489334	1
Q8N752/E177K	Q8N752	CSNK1A1L	KC1AL_HUMAN	E177K	542	A-loop	-	neutral	HIPYReKHLIG	0.35	0.365	0.512	0.359	0.324	0.315	0.535	0.333	VARIANT	E -> K (in dbSNP:rs17054882)	17344846	1
Q8N752/K230N	Q8N752	CSNK1A1L	KC1AL_HUMAN	K230N	637	αG	-	neutral	RAMTKkKYEKI	0.26	0.255	0.603	0.299	0.214	0.209	0.726	0.26	VARIANT	K -> N (in dbSNP:rs56252523)	17344846	1
Q8N752/P220L	Q8N752	CSNK1A1L	KC1AL_HUMAN	P220L	621	αF/αG	-	-	NRTSLpQGLRA	0.693	0.688	0.401	0.558	0.557	0.537	0.413	0.398	VARIANT	P -> L (in dbSNP:rs56252856)	17344846	1
Q8N752/R170S	Q8N752	CSNK1A1L	KC1AL_HUMAN	R170S	524	A-loop	-	neutral	RDNRTrHIPYR	0.336	0.318	0.558	0.303	0.178	0.226	0.687	0.156	VARIANT	R -> S (in dbSNP:rs17773251)	17344846	1
Q8N752/R21Q	Q8N752	CSNK1A1L	KC1AL_HUMAN	R21Q	37	β1	-	-	KYKLVrIGSGS	0.283	0.225	0.506	0.325	0.14	0.182	0.658	0.141	VARIANT	R -> Q (in a colorectal cancer sample; somatic mutation; dbSNP:rs373362769)	16959974	1
Q8N752/R21W	Q8N752	CSNK1A1L	KC1AL_HUMAN	R21W	37	β1	-	neutral	KYKLVrIGSGS	0.438	0.421	0.463	0.45	0.366	0.415	0.471	0.406	VARIANT	R -> W (in dbSNP:rs56158728)	17344846	1
Q8N752/S5G	Q8N752	CSNK1A1L	KC1AL_HUMAN	S5G	21	N-term-β1	-	-	MTNNsSKAEL	0.609	0.584	0.573	0.592	0.362	0.523	0.61	0.362	VARIANT	S -> G (in dbSNP:rs56224973)	17344846	1
Q8NB16/C86S	Q8NB16	MLKL	MLKL_HUMAN	C86S	-	-	-	-	NRSNIcFLTAS									MUTAGEN	C->S: Abolishes binding to necrosulfonamide inhibitor.	22265413	1
Q8NB16/D100E	Q8NB16	MLKL	MLKL_HUMAN	D100E	-	-	-	neutral	KILFKdNRKLS									VARIANT	D -> E (in dbSNP:rs33987771)	17344846	1
Q8NB16/E351K	Q8NB16	MLKL	MLKL_HUMAN	E351K	-	-	-	increase	KLAGFeRKTQT									MUTAGEN	E->K: Binds ATP with an enhanced affinity.	24219132	1
Q8NB16/F398I	Q8NB16	MLKL	MLKL_HUMAN	F398I	-	-	-	-	SEIYSfIVLWE									VARIANT	F -> I (in a gastric adenocarcinoma sample; somatic mutation)	17344846	1
Q8NB16/I76G	Q8NB16	MLKL	MLKL_HUMAN	I76G	-	-	-	-	EANGEiKFSNR									MUTAGEN	I->G: Does not affect formation of homotrimers, while translocation to the plasma membrane on necroptosis induction is impaired; when associated with G-58.	24316671	1
Q8NB16/K230M	Q8NB16	MLKL	MLKL_HUMAN	K230M	-	-	-	loss	APVAIkFKKLQ									MUTAGEN	K->M: Abolishes ATP-binding.	24219132	1
Q8NB16/K331N	Q8NB16	MLKL	MLKL_HUMAN	K331N	-	-	ub	loss	PELHGkRSSNF									MUTAGEN	K->N: Impairs ATP-binding.	24219132	1
Q8NB16/L162G	Q8NB16	MLKL	MLKL_HUMAN	L162G	-	-	-	-	KIEASlRLEIN									MUTAGEN	L->G: Impairs formation of homotrimers and translocation to the plasma membrane on necroptosis induction; when associated with G-165.	24316671	1
Q8NB16/L165G	Q8NB16	MLKL	MLKL_HUMAN	L165G	-	-	-	-	ASLRRlINMKE									MUTAGEN	L->G: Impairs formation of homotrimers and translocation to the plasma membrane on necroptosis induction; when associated with G-162.	24316671	1
Q8NB16/L291P	Q8NB16	MLKL	MLKL_HUMAN	L291P	-	-	-	-	CELGTlELLDR									VARIANT	L -> P (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs1313508921)	17344846	1
Q8NB16/L58G	Q8NB16	MLKL	MLKL_HUMAN	L58G	-	-	-	-	VPSEKlTAMNR									MUTAGEN	L->G: Does not affect formation of homotrimers, while translocation to the plasma membrane on necroptosis induction is impaired; when associated with G-76.	24316671	1
Q8NB16/M169L	Q8NB16	MLKL	MLKL_HUMAN	M169L	-	-	-	neutral	RLEINmEIKET									VARIANT	M -> L (in dbSNP:rs55929310)	17344846	1
Q8NB16/R146Q	Q8NB16	MLKL	MLKL_HUMAN	R146Q	-	-	-	neutral	ADEDRrFQMLR									VARIANT	R -> Q (in dbSNP:rs34515646)	17344846	1
Q8NB16/R421H	Q8NB16	MLKL	MLKL_HUMAN	R421H	-	-	-	-	NSEKIrLVAVK									VARIANT	R -> H (in dbSNP:rs55987292)	17344846	1
Q8NB16/S132P	Q8NB16	MLKL	MLKL_HUMAN	S132P	-	-	-	neutral	ISQGAsAQEDQ									VARIANT	S -> P (in dbSNP:rs35589326)	17344846	1
Q8NB16/S358A	Q8NB16	MLKL	MLKL_HUMAN	S358A	-	-	p	-	RKTQTsSLGTT									MUTAGEN	S->A: No effect. Abolishes ability to mediate necroptosis; when associated with A-357.	22265413	1
Q8NB16/S52T	Q8NB16	MLKL	MLKL_HUMAN	S52T	-	-	-	neutral	DQGKRsPSEKL									VARIANT	S -> T (in dbSNP:rs34251827)	17344846	1
Q8NB16/T357A	Q8NB16	MLKL	MLKL_HUMAN	T357A	-	-	p	-	LRKTQtMSLGT									MUTAGEN	T->A: No effect. Abolishes ability to mediate necroptosis; when associated with A-358.	22265413	1
Q8NB16/T364M	Q8NB16	MLKL	MLKL_HUMAN	T364M	-	-	-	-	MSLGTtEKTDR									VARIANT	T -> M (in dbSNP:rs34389205)	17344846	1
Q8NCB2/E279D	Q8NCB2	CAMKV	CAMKV_HUMAN	E279D	-	-	-	-	RITAEeISHEW									VARIANT	E -> D (in dbSNP:rs56071455)	17344846	1
Q8NCB2/G60S	Q8NCB2	CAMKV	CAMKV_HUMAN	G60S	-	-	-	-	FQKRDgKVRKA									VARIANT	G -> S (in an ovarian serous carcinoma sample; somatic mutation)	17344846	1
Q8NCB2/P472L	Q8NCB2	CAMKV	CAMKV_HUMAN	P472L	-	-	-	-	PDSTApGATGQ									VARIANT	P -> L (in dbSNP:rs56307047)	17344846	1
Q8NCB2/R274W	Q8NCB2	CAMKV	CAMKV_HUMAN	R274W	-	-	-	-	VEQDQrTAEEA									VARIANT	R -> W (in a colorectal adenocarcinoma sample; somatic mutation)	17344846	1
Q8NCB2/R40W	Q8NCB2	CAMKV	CAMKV_HUMAN	R40W	-	-	-	-	FCEIFrKDKTT									VARIANT	R -> W (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs1407808379)	17344846	1
Q8NCB2/Y491C	Q8NCB2	CAMKV	CAMKV_HUMAN	Y491C	-	-	-	-	EEAAGyQESQR									VARIANT	Y -> C (in dbSNP:rs17849325)	15489334	1
Q8NE28/E473K	Q8NE28	STKLD1	STKL1_HUMAN	E473K	-	-	-	-	LNSSLeRDVCA									VARIANT	E -> K (in dbSNP:rs3124747)		0
Q8NE28/G139D	Q8NE28	STKLD1	STKL1_HUMAN	G139D	-	-	-	-	MQNVLgVLDAL									VARIANT	G -> D (in a glioblastoma multiforme sample; somatic mutation)	17344846	1
Q8NE28/R568Q	Q8NE28	STKLD1	STKL1_HUMAN	R568Q	-	-	-	-	VNNAYrLASLV									VARIANT	R -> Q (in dbSNP:rs17150554)		0
Q8NE63/A106T	Q8NE63	HIPK4	HIPK4_HUMAN	A106T	388	αD/αE-loop	-	-	KENNFaLPARH	0.1	0.105	0.473	0.113	0.108	0.124	0.673	0.085	VARIANT	A -> T (in dbSNP:rs34434715)	17344846	1
Q8NE63/A386T	Q8NE63	HIPK4	HIPK4_HUMAN	A386T	-	-	-	neutral	TPVVAaDGTPY									VARIANT	A -> T (in dbSNP:rs56365273)	17344846	1
Q8NE63/G421S	Q8NE63	HIPK4	HIPK4_HUMAN	G421S	-	-	-	neutral	EEKAPgQRAID									VARIANT	G -> S (in dbSNP:rs56117722)	17344846	1
Q8NE63/R302Q	Q8NE63	HIPK4	HIPK4_HUMAN	R302Q	766	αG/αH	-	neutral	GSVASrTFPDR	0.085	0.073	0.452	0.073	0.071	0.093	0.68	0.056	VARIANT	R -> Q (in dbSNP:rs11670988)		0
Q8NE63/R481C	Q8NE63	HIPK4	HIPK4_HUMAN	R481C	-	-	-	-	AFYSSrAGRHK									VARIANT	R -> C (in dbSNP:rs55801979)	17344846	1
Q8NE63/S406R	Q8NE63	HIPK4	HIPK4_HUMAN	S406R	-	-	-	neutral	AAGMGsAGSSP									VARIANT	S -> R (in dbSNP:rs56094851)	17344846	1
Q8NE63/T381M	Q8NE63	HIPK4	HIPK4_HUMAN	T381M	-	-	-	neutral	EGKPPtVVAAE									VARIANT	T -> M (in dbSNP:rs55760165)	17344846	1
Q8NE63/V171M	Q8NE63	HIPK4	HIPK4_HUMAN	V171M	542	A-loop	-	-	SEVRYvEPYIQ	0.324	0.296	0.432	0.315	0.254	0.249	0.614	0.21	VARIANT	V -> M (in dbSNP:rs55964225)	17344846	1
Q8NER5/G216R	Q8NER5	ACVR1C	ACV1C_HUMAN	G216R	105	β2/β3-loop	-	-	HGRWCgDVAVK	0.713	0.661	0.442	0.528	0.509	0.542	0.392	0.603	VARIANT	G -> R (in dbSNP:rs34742924)	17344846	1
Q8NER5/I195T	Q8NER5	ACVR1C	ACV1C_HUMAN	I195T	28	N-term-β1	-	-	TIARTiLQEIV	0.696	0.672	0.509	0.58	0.499	0.587	0.538	0.559	VARIANT	I -> T (in dbSNP:rs56188432)	17344846	1
Q8NER5/I355V	Q8NER5	ACVR1C	ACV1C_HUMAN	I355V	513	A-loop	-	-	SILNTiIPQNP	0.244	0.268	0.395	0.245	0.21	0.258	0.591	0.153	VARIANT	I -> V (in dbSNP:rs35500979)	17344846	1
Q8NER5/I482V	Q8NER5	ACVR1C	ACV1C_HUMAN	I482V	813	αI	-	neutral	RIKKTiQLCVK	0.134	0.099	0.489	0.173	0.112	0.104	0.672	0.131	VARIANT	I -> V (in dbSNP:rs7594480)	17344846	1
Q8NER5/K222R	Q8NER5	ACVR1C	ACV1C_HUMAN	K222R	129	β3;Catalytic-Lys	-	loss	EDVAVkFSSRD	0.977	0.977	0.09	0.599	0.981	0.991	0.091	0.378	MUTAGEN	K->R: Loss of response to NODAL and SMAD2 phosphorylation.	12063393,15531507	2
Q8NER5/T194D	Q8NER5	ACVR1C	ACV1C_HUMAN	T194D	27	N-term-β1	-	-	RTIARtVLQEI	0.506	0.415	0.71	0.537	0.181	0.267	0.8	0.302	MUTAGEN	T->D: Pro-apoptotic.	15531507	1
Q8NER5/W267R	Q8NER5	ACVR1C	ACV1C_HUMAN	W267R	242	β5	-	-	TWTQLwVSEYH	0.842	0.726	0.579	0.64	0.508	0.637	0.57	0.646	VARIANT	W -> R (in a lung squamous cell carcinoma sample; somatic mutation)	17344846	1
Q8NEV4/A1032T	Q8NEV4	MYO3A	MYO3A_HUMAN	A1032T	-	-	-	neutral	GLDNWaGKTKV									VARIANT	A -> T (in dbSNP:rs34918608)	17344846	1
Q8NEV4/A833S	Q8NEV4	MYO3A	MYO3A_HUMAN	A833S	-	-	-	neutral	GIHHYaKVLYN									VARIANT	A -> S (in dbSNP:rs33947968)	17344846	1
Q8NEV4/D1347H	Q8NEV4	MYO3A	MYO3A_HUMAN	D1347H	-	-	-	-	AQEEEdAAVFI									VARIANT	D -> H (in a renal clear cell carcinoma sample; somatic mutation)	17344846	1
Q8NEV4/D204N	Q8NEV4	MYO3A	MYO3A_HUMAN	D204N	589	αF	-	-	CEQQLdTYDAR	0.402	0.357	0.427	0.241	0.266	0.294	0.607	0.271	VARIANT	D -> N (in dbSNP:rs3737274)		0
Q8NEV4/I348V	Q8NEV4	MYO3A	MYO3A_HUMAN	I348V	-	-	-	neutral	LATLEiDENTV									VARIANT	I -> V (in dbSNP:rs3824699)	17344846	1
Q8NEV4/K1488E	Q8NEV4	MYO3A	MYO3A_HUMAN	K1488E	-	-	-	neutral	KGEEPkLRPPR									VARIANT	K -> E (in dbSNP:rs34204285)	17344846	1
Q8NEV4/N525K	Q8NEV4	MYO3A	MYO3A_HUMAN	N525K	-	-	-	-	AIGEKnHIFYY									VARIANT	N -> K (in an ovarian mucinous carcinoma sample; somatic mutation; dbSNP:rs1423134583)	17344846	1
Q8NEV4/P1287T	Q8NEV4	MYO3A	MYO3A_HUMAN	P1287T	-	-	-	neutral	KKTLEpLSQRS									VARIANT	P -> T (in dbSNP:rs35575696)	17344846	1
Q8NEV4/R1313S	Q8NEV4	MYO3A	MYO3A_HUMAN	R1313S	-	-	-	neutral	SVVTQrPICSQ									VARIANT	R -> S (in dbSNP:rs1999240)	10936054,12032315,17344846	3
Q8NEV4/R319H	Q8NEV4	MYO3A	MYO3A_HUMAN	R319H	-	-	-	-	TEKARrRIHTK									VARIANT	R -> H (in dbSNP:rs3824700)	17344846	1
Q8NEV4/S956N	Q8NEV4	MYO3A	MYO3A_HUMAN	S956N	-	-	-	neutral	CIKPNsRQARK									VARIANT	S -> N (in dbSNP:rs3758449)	17344846	1
Q8NEV4/S956R	Q8NEV4	MYO3A	MYO3A_HUMAN	S956R	-	-	-	-	CIKPNsRQARK									VARIANT	S -> R (in an ovarian serous carcinoma sample; somatic mutation)	17344846	1
Q8NEV4/T1284S	Q8NEV4	MYO3A	MYO3A_HUMAN	T1284S	-	-	-	neutral	TSFKKtEPTLS									VARIANT	T -> S (in dbSNP:rs3740231)	17344846	1
Q8NEV4/T1417I	Q8NEV4	MYO3A	MYO3A_HUMAN	T1417I	-	-	-	neutral	KDSKAtEREAC									VARIANT	T -> I (in dbSNP:rs34151474)	17344846	1
Q8NEV4/T178I	Q8NEV4	MYO3A	MYO3A_HUMAN	T178I	513	A-loop	p	neutral	AQLTStHRRNT	0.492	0.474	0.495	0.533	0.317	0.426	0.478	0.279	VARIANT	T -> I (in dbSNP:rs33968748)	17344846	1
Q8NEV4/V1045M	Q8NEV4	MYO3A	MYO3A_HUMAN	V1045M	-	-	-	neutral	LKYYHvQLNLM									VARIANT	V -> M (in dbSNP:rs35447806)	17344846	1
Q8NEV4/V1137M	Q8NEV4	MYO3A	MYO3A_HUMAN	V1137M	-	-	-	-	TRESFvKQAEN									VARIANT	V -> M (in dbSNP:rs35449183)	17344846	1
Q8NEV4/V1195A	Q8NEV4	MYO3A	MYO3A_HUMAN	V1195A	-	-	-	-	KKMNNvEEEVK									VARIANT	V -> A (in dbSNP:rs35675577)	17344846	1
Q8NEV4/V369I	Q8NEV4	MYO3A	MYO3A_HUMAN	V369I	-	-	-	neutral	RDQIYvVGDIL									VARIANT	V -> I (in dbSNP:rs3817420)	17344846	1
Q8NFD2/A239T	Q8NFD2	ANKK1	ANKK1_HUMAN	A239T	657	αG/αH	-	neutral	IIIRVaGMRPS	0.097	0.093	0.402	0.086	0.093	0.099	0.654	0.103	VARIANT	A -> T (in dbSNP:rs7118900)	17344846	1
Q8NFD2/D4Y	Q8NFD2	ANKK1	ANKK1_HUMAN	D4Y	7	N-term-β1	-	-	MAAdTELRL	0.571	0.461	0.549	0.441	0.405	0.488	0.599	0.415	VARIANT	D -> Y (in dbSNP:rs35657708)	17344846	1
Q8NFD2/E376K	Q8NFD2	ANKK1	ANKK1_HUMAN	E376K	-	-	-	-	AQGSVeVRLLL									VARIANT	E -> K (in dbSNP:rs56299709)	17344846	1
Q8NFD2/E426K	Q8NFD2	ANKK1	ANKK1_HUMAN	E426K	-	-	-	-	ANRVDeGWAPL									VARIANT	E -> K (in dbSNP:rs55699907)	17344846	1
Q8NFD2/E713K	Q8NFD2	ANKK1	ANKK1_HUMAN	E713K	-	-	-	neutral	LKVLVeGAQLD									VARIANT	E -> K (in dbSNP:rs1800497)	14741327,17344846	2
Q8NFD2/G318R	Q8NFD2	ANKK1	ANKK1_HUMAN	G318R	-	-	-	-	SLRQPgVNEDI									VARIANT	G -> R (in dbSNP:rs11604671)	17344846	1
Q8NFD2/G442R	Q8NFD2	ANKK1	ANKK1_HUMAN	G442R	-	-	-	neutral	QNGDDgARLLL									VARIANT	G -> R (in dbSNP:rs4938016)	17344846	1
Q8NFD2/G451R	Q8NFD2	ANKK1	ANKK1_HUMAN	G451R	-	-	-	-	LLLDHgCVDAQ									VARIANT	G -> R (in dbSNP:rs34983219)	17344846	1
Q8NFD2/H367Q	Q8NFD2	ANKK1	ANKK1_HUMAN	H367Q	-	-	-	neutral	KVTPLhLVAQG									VARIANT	H -> Q (in dbSNP:rs34298987)	17344846	1
Q8NFD2/H490R	Q8NFD2	ANKK1	ANKK1_HUMAN	H490R	-	-	-	neutral	ADPNLhAEGKT									VARIANT	H -> R (in dbSNP:rs2734849)	17344846	1
Q8NFD2/K347T	Q8NFD2	ANKK1	ANKK1_HUMAN	K347T	-	-	-	-	QLSDRkLVPRD									VARIANT	K -> T (in a breast infiltrating ductal carcinoma sample; somatic mutation)	17344846	1
Q8NFD2/L366F	Q8NFD2	ANKK1	ANKK1_HUMAN	L366F	-	-	-	-	NKVTPlFLVAQ									VARIANT	L -> F (in dbSNP:rs56339158)	17344846	1
Q8NFD2/N653S	Q8NFD2	ANKK1	ANKK1_HUMAN	N653S	-	-	-	-	CGADPnAEQSG									VARIANT	N -> S (in dbSNP:rs55849504)	17344846	1
Q8NFD2/P276L	Q8NFD2	ANKK1	ANKK1_HUMAN	P276L	801	αI	-	neutral	DPKKRpFLDIT	0.473	0.425	0.356	0.392	0.418	0.44	0.374	0.381	VARIANT	P -> L (in dbSNP:rs35488601)	17344846	1
Q8NFD2/P596L	Q8NFD2	ANKK1	ANKK1_HUMAN	P596L	-	-	-	-	HQGWTpHLAAY									VARIANT	P -> L (in dbSNP:rs7104979)	17344846	1
Q8NFD2/Q717L	Q8NFD2	ANKK1	ANKK1_HUMAN	Q717L	-	-	-	-	VEAGAqDVQDG									VARIANT	Q -> L (in a lung large cell carcinoma sample; somatic mutation)	17344846	1
Q8NFD2/R122H	Q8NFD2	ANKK1	ANKK1_HUMAN	R122H	405	αE	-	-	WKLRFrIHETS	0.669	0.653	0.517	0.591	0.362	0.541	0.601	0.25	VARIANT	R -> H (in dbSNP:rs35877321)	17344846	1
Q8NFD2/R736L	Q8NFD2	ANKK1	ANKK1_HUMAN	R736L	-	-	-	-	LALRSrQGIMS									VARIANT	R -> L (in a lung squamous cell carcinoma sample; somatic mutation)	17344846	1
Q8NFD2/S670G	Q8NFD2	ANKK1	ANKK1_HUMAN	S670G	-	-	-	neutral	LAVQRsFLSVI									VARIANT	S -> G (in dbSNP:rs56006094)	17344846	1
Q8NFD2/T595I	Q8NFD2	ANKK1	ANKK1_HUMAN	T595I	-	-	-	-	THQGWtLHLAA									VARIANT	T -> I (in dbSNP:rs55787008)	17344846	1
Q8NG66/D617N	Q8NG66	NEK11	NEK11_HUMAN	D617N	-	-	-	-	VPQASdFEVDQ									VARIANT	D -> N (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs765563230)	17344846	1
Q8NG66/E451K	Q8NG66	NEK11	NEK11_HUMAN	E451K	-	-	-	neutral	SMDLHeESIVE									VARIANT	E -> K (in dbSNP:rs35409692)	17344846	1
Q8NG66/E488V	Q8NG66	NEK11	NEK11_HUMAN	E488V	-	-	-	neutral	FDSYCeSDEEE									VARIANT	E -> V (in dbSNP:rs3738000)	12154088,14702039,17344846,17974005	4
Q8NG66/E492K	Q8NG66	NEK11	NEK11_HUMAN	E492K	-	-	-	-	CEESDeEEEIA									VARIANT	E -> K (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs140599545)	17344846	1
Q8NG66/E606K	Q8NG66	NEK11	NEK11_HUMAN	E606K	-	-	-	-	EAEIReLEKVV									VARIANT	E -> K (in dbSNP:rs55944737)	17344846	1
Q8NG66/I263V	Q8NG66	NEK11	NEK11_HUMAN	I263V	788	αH	-	-	KELNAiESMLN	0.179	0.1	0.506	0.197	0.124	0.122	0.686	0.186	VARIANT	I -> V (in dbSNP:rs35567155)	17344846	1
Q8NG66/K61R	Q8NG66	NEK11	NEK11_HUMAN	K61R	129	β3;Catalytic-Lys	-	loss	ELKVLkISVGE	0.994	0.991	0.068	0.676	0.98	0.998	0.036	0.317	MUTAGEN	K->R: Loss of kinase activity.	12154088	1
Q8NG66/M548T	Q8NG66	NEK11	NEK11_HUMAN	M548T	-	-	-	-	KTITTmEDMSP									VARIANT	M -> T (in dbSNP:rs55813244)	17344846	1
Q8NG66/S213L	Q8NG66	NEK11	NEK11_HUMAN	S213L	598	αF	-	-	GYDTKsIWSLA	0.565	0.495	0.569	0.557	0.401	0.374	0.548	0.421	VARIANT	S -> L (in dbSNP:rs55920129)	17344846	1
Q8NG66/T108M	Q8NG66	NEK11	NEK11_HUMAN	T108M	248	β5	-	-	NFCIItYCEGR	0.603	0.337	0.492	0.274	0.283	0.272	0.616	0.681	VARIANT	T -> M (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs200709914)	17344846	1
Q8NG66/V562A	Q8NG66	NEK11	NEK11_HUMAN	V562A	-	-	-	neutral	PIFNSvARTKM									VARIANT	V -> A (in dbSNP:rs16836266)	17344846	1
Q8NG66/Y123C	Q8NG66	NEK11	NEK11_HUMAN	Y123C	271	αD	-	neutral	DKIQEyQAGKI	0.145	0.196	0.505	0.188	0.175	0.195	0.595	0.083	VARIANT	Y -> C (in dbSNP:rs55806123)	17344846	1
Q8NI60/A215G	Q8NI60	COQ8A	COQ8A_HUMAN	A215G	-	-	-	-	RIGRLaFGGLA									MUTAGEN	A->I,L,G: Does not impair homodimerization.	25216398	1
Q8NI60/A215I	Q8NI60	COQ8A	COQ8A_HUMAN	A215I	-	-	-	-	RIGRLaFGGLA									MUTAGEN	A->I,L,G: Does not impair homodimerization.	25216398	1
Q8NI60/A215L	Q8NI60	COQ8A	COQ8A_HUMAN	A215L	-	-	-	-	RIGRLaFGGLA									MUTAGEN	A->I,L,G: Does not impair homodimerization.	25216398	1
Q8NI60/A221L	Q8NI60	COQ8A	COQ8A_HUMAN	A221L	-	-	-	-	NFGGLaGLGFG									MUTAGEN	A->L: Slightly impaired homodimerization.	25216398	1
Q8NI60/A228F	Q8NI60	COQ8A	COQ8A_HUMAN	A228F	-	-	-	-	GLGFGaAEVAK									MUTAGEN	A->I,L,F: Does not impair homodimerization.	25216398	1
Q8NI60/A228I	Q8NI60	COQ8A	COQ8A_HUMAN	A228I	-	-	-	-	GLGFGaAEVAK									MUTAGEN	A->I,L,F: Does not impair homodimerization.	25216398	1
Q8NI60/A228L	Q8NI60	COQ8A	COQ8A_HUMAN	A228L	-	-	-	-	GLGFGaAEVAK									MUTAGEN	A->I,L,F: Does not impair homodimerization.	25216398	1
Q8NI60/A230I	Q8NI60	COQ8A	COQ8A_HUMAN	A230I	-	-	-	-	GFGALaVAKKS									MUTAGEN	A->I: Slightly impaired homodimerization.	25216398	1
Q8NI60/A304T	Q8NI60	COQ8A	COQ8A_HUMAN	A304T	-	-	-	-	RVRQSaFMPLK									VARIANT	A -> T (in COQ10D4; dbSNP:rs778798354)	22036850	1
Q8NI60/A304V	Q8NI60	COQ8A	COQ8A_HUMAN	A304V	-	-	-	-	RVRQSaFMPLK									VARIANT	A -> V (in COQ10D4; dbSNP:rs748118737)	22036850	1
Q8NI60/A339G	Q8NI60	COQ8A	COQ8A_HUMAN	A339G	-	-	-	-	RPFAAaIGQVH									MUTAGEN	A->G: Enables autophosphorylation but inhibits coenzyme Q biosynthesis in vivo.	25498144	1
Q8NI60/D488N	Q8NI60	COQ8A	COQ8A_HUMAN	D488N	-	-	-	-	HFMQTdNWSNF									MUTAGEN	D->N: Impaired binding ADP or ATP.	25498144	1
Q8NI60/D507N	Q8NI60	COQ8A	COQ8A_HUMAN	D507N	-	-	-	-	KVALLdGATRE									MUTAGEN	D->N: Strongly impairs binding ADP or ATP. Impaired multi-subunit COQ enzyme complex.	25498144,27499294	2
Q8NI60/E405A	Q8NI60	COQ8A	COQ8A_HUMAN	E405A	-	-	-	-	RELALeDYQRE									MUTAGEN	E->A,Q: Slightly affects selectivity for binding ADP or ATP.	25498144	1
Q8NI60/E405Q	Q8NI60	COQ8A	COQ8A_HUMAN	E405Q	-	-	-	-	RELALeDYQRE									MUTAGEN	E->A,Q: Slightly affects selectivity for binding ADP or ATP.	25498144	1
Q8NI60/E411Q	Q8NI60	COQ8A	COQ8A_HUMAN	E411Q	-	-	-	-	CDYQReACARK									MUTAGEN	E->Q: Impaired binding ADP or ATP.	25498144	1
Q8NI60/E551K	Q8NI60	COQ8A	COQ8A_HUMAN	E551K	-	-	-	-	FLTGYeKVMED									VARIANT	E -> K (in COQ10D4; decreased stability; dbSNP:rs119468004)	18319072,22036850,25498144	3
Q8NI60/F217A	Q8NI60	COQ8A	COQ8A_HUMAN	F217A	-	-	-	-	GRLANfGLAVG									MUTAGEN	F->A: Slightly impaired homodimerization.	25216398	1
Q8NI60/F226A	Q8NI60	COQ8A	COQ8A_HUMAN	F226A	-	-	-	-	AVGLGfALAEV									MUTAGEN	F->A: Slightly impaired homodimerization.	25216398	1
Q8NI60/F578V	Q8NI60	COQ8A	COQ8A_HUMAN	F578V	-	-	-	-	DEPFDfTQSTT									VARIANT	F -> V (in COQ10D4; unknown pathological significance)	27106809	1
Q8NI60/G218F	Q8NI60	COQ8A	COQ8A_HUMAN	G218F	-	-	-	-	RLANFgLAVGL									MUTAGEN	G->I,L,F: Slightly impaired homodimerization.	25216398	1
Q8NI60/G218I	Q8NI60	COQ8A	COQ8A_HUMAN	G218I	-	-	-	-	RLANFgLAVGL									MUTAGEN	G->I,L,F: Slightly impaired homodimerization.	25216398	1
Q8NI60/G218L	Q8NI60	COQ8A	COQ8A_HUMAN	G218L	-	-	-	-	RLANFgLAVGL									MUTAGEN	G->I,L,F: Slightly impaired homodimerization.	25216398	1
Q8NI60/G219A	Q8NI60	COQ8A	COQ8A_HUMAN	G219A	-	-	-	-	LANFGgAVGLG									MUTAGEN	G->A,F: Slightly impaired homodimerization.	25216398	1
Q8NI60/G219F	Q8NI60	COQ8A	COQ8A_HUMAN	G219F	-	-	-	-	LANFGgAVGLG									MUTAGEN	G->A,F: Slightly impaired homodimerization.	25216398	1
Q8NI60/G219I	Q8NI60	COQ8A	COQ8A_HUMAN	G219I	-	-	-	-	LANFGgAVGLG									MUTAGEN	G->I: Strongly impairs homodimerization.	25216398	1
Q8NI60/G223A	Q8NI60	COQ8A	COQ8A_HUMAN	G223A	-	-	-	-	GGLAVgGFGAL									MUTAGEN	G->A,I,L,F: Strongly impairs homodimerization.	25216398	1
Q8NI60/G223F	Q8NI60	COQ8A	COQ8A_HUMAN	G223F	-	-	-	-	GGLAVgGFGAL									MUTAGEN	G->A,I,L,F: Strongly impairs homodimerization.	25216398	1
Q8NI60/G223I	Q8NI60	COQ8A	COQ8A_HUMAN	G223I	-	-	-	-	GGLAVgGFGAL									MUTAGEN	G->A,I,L,F: Strongly impairs homodimerization.	25216398	1
Q8NI60/G223L	Q8NI60	COQ8A	COQ8A_HUMAN	G223L	-	-	-	-	GGLAVgGFGAL									MUTAGEN	G->A,I,L,F: Strongly impairs homodimerization.	25216398	1
Q8NI60/G225L	Q8NI60	COQ8A	COQ8A_HUMAN	G225L	-	-	-	-	LAVGLgGALAE									MUTAGEN	G->L: Slightly impaired homodimerization.	25216398	1
Q8NI60/G227F	Q8NI60	COQ8A	COQ8A_HUMAN	G227F	-	-	-	-	VGLGFgLAEVA									MUTAGEN	G->V,F,L,I: Strongly impairs homodimerization.	25216398	1
Q8NI60/G227I	Q8NI60	COQ8A	COQ8A_HUMAN	G227I	-	-	-	-	VGLGFgLAEVA									MUTAGEN	G->V,F,L,I: Strongly impairs homodimerization.	25216398	1
Q8NI60/G227L	Q8NI60	COQ8A	COQ8A_HUMAN	G227L	-	-	-	-	VGLGFgLAEVA									MUTAGEN	G->V,F,L,I: Strongly impairs homodimerization.	25216398	1
Q8NI60/G227V	Q8NI60	COQ8A	COQ8A_HUMAN	G227V	-	-	-	-	VGLGFgLAEVA									MUTAGEN	G->V,F,L,I: Strongly impairs homodimerization.	25216398	1
Q8NI60/G272D	Q8NI60	COQ8A	COQ8A_HUMAN	G272D	-	-	-	-	LCKVRgALKLG									VARIANT	G -> D (in COQ10D4; dbSNP:rs119468006)	18319072,22036850	2
Q8NI60/G272V	Q8NI60	COQ8A	COQ8A_HUMAN	G272V	-	-	-	-	LCKVRgALKLG									VARIANT	G -> V (in COQ10D4; dbSNP:rs119468006)	18319072,22036850	2
Q8NI60/G549S	Q8NI60	COQ8A	COQ8A_HUMAN	G549S	-	-	-	-	MKFLTgEVKVM									VARIANT	G -> S (in COQ10D4; decreased stability; dbSNP:rs119468009)	18319074,22036850,25498144	3
Q8NI60/H85Q	Q8NI60	COQ8A	COQ8A_HUMAN	H85Q	-	-	-	-	HFSVPhAGAST									VARIANT	H -> Q (in dbSNP:rs2297411)		0
Q8NI60/I341T	Q8NI60	COQ8A	COQ8A_HUMAN	I341T	-	-	-	-	FAAASiQVHLA									VARIANT	I -> T (in dbSNP:rs55798516)	17344846	1
Q8NI60/K276H	Q8NI60	COQ8A	COQ8A_HUMAN	K276H	-	-	-	-	RGAALkGQMLS									MUTAGEN	K->R,H: Does not affect selectivity for binding ADP or ATP. Impaired multi-subunit COQ enzyme complex.	25498144,27499294	2
Q8NI60/K276R	Q8NI60	COQ8A	COQ8A_HUMAN	K276R	-	-	-	-	RGAALkGQMLS									MUTAGEN	K->R,H: Does not affect selectivity for binding ADP or ATP. Impaired multi-subunit COQ enzyme complex.	25498144,27499294	2
Q8NI60/K358R	Q8NI60	COQ8A	COQ8A_HUMAN	K358R	-	-	-	-	REVAMkQYPGV									MUTAGEN	K->R: Abolishes binding ADP or ATP.	25498144	1
Q8NI60/L214A	Q8NI60	COQ8A	COQ8A_HUMAN	L214A	-	-	-	-	TRIGRlNFGGL									MUTAGEN	L->A,I,L,F: Strongly impairs homodimerization.	25216398	1
Q8NI60/L214F	Q8NI60	COQ8A	COQ8A_HUMAN	L214F	-	-	-	-	TRIGRlNFGGL									MUTAGEN	L->I,F,G,V: Slightly impaired homodimerization.	25216398	1
Q8NI60/L214G	Q8NI60	COQ8A	COQ8A_HUMAN	L214G	-	-	-	-	TRIGRlNFGGL									MUTAGEN	L->I,F,G,V: Slightly impaired homodimerization.	25216398	1
Q8NI60/L214I	Q8NI60	COQ8A	COQ8A_HUMAN	L214I	-	-	-	-	TRIGRlNFGGL									MUTAGEN	L->I,F,G,V: Slightly impaired homodimerization.	25216398	1
Q8NI60/L214V	Q8NI60	COQ8A	COQ8A_HUMAN	L214V	-	-	-	-	TRIGRlNFGGL									MUTAGEN	L->I,F,G,V: Slightly impaired homodimerization.	25216398	1
Q8NI60/L220G	Q8NI60	COQ8A	COQ8A_HUMAN	L220G	-	-	-	-	ANFGGlVGLGF									MUTAGEN	L->G: Impaired homodimerization.	25216398	1
Q8NI60/L224V	Q8NI60	COQ8A	COQ8A_HUMAN	L224V	-	-	-	-	GLAVGlFGALA									MUTAGEN	L->V: Impaired homodimerization.	25216398	1
Q8NI60/L229A	Q8NI60	COQ8A	COQ8A_HUMAN	L229A	-	-	-	-	LGFGAlEVAKK									MUTAGEN	L->A: Slightly impaired homodimerization.	25216398	1
Q8NI60/N216A	Q8NI60	COQ8A	COQ8A_HUMAN	N216A	-	-	-	-	IGRLAnGGLAV									MUTAGEN	N->A,L,F,M: Does not impair homodimerization.	25216398	1
Q8NI60/N216F	Q8NI60	COQ8A	COQ8A_HUMAN	N216F	-	-	-	-	IGRLAnGGLAV									MUTAGEN	N->A,L,F,M: Does not impair homodimerization.	25216398	1
Q8NI60/N216L	Q8NI60	COQ8A	COQ8A_HUMAN	N216L	-	-	-	-	IGRLAnGGLAV									MUTAGEN	N->A,L,F,M: Does not impair homodimerization.	25216398	1
Q8NI60/N216M	Q8NI60	COQ8A	COQ8A_HUMAN	N216M	-	-	-	-	IGRLAnGGLAV									MUTAGEN	N->A,L,F,M: Does not impair homodimerization.	25216398	1
Q8NI60/N493A	Q8NI60	COQ8A	COQ8A_HUMAN	N493A	-	-	-	-	DPNWSnFYDPQ									MUTAGEN	N->A: Impaired binding ADP or ATP.	25498144	1
Q8NI60/P602R	Q8NI60	COQ8A	COQ8A_HUMAN	P602R	-	-	-	-	HRLVPpEETYS									VARIANT	P -> R (in COQ10D4; dbSNP:rs61995958)	24048965	1
Q8NI60/Q279H	Q8NI60	COQ8A	COQ8A_HUMAN	Q279H	-	-	-	-	ALKLGqLSIQD									MUTAGEN	Q->R,H: Does not affect selectivity for binding ADP or ATP.	25498144	1
Q8NI60/Q279R	Q8NI60	COQ8A	COQ8A_HUMAN	Q279R	-	-	-	-	ALKLGqLSIQD									MUTAGEN	Q->R,H: Does not affect selectivity for binding ADP or ATP.	25498144	1
Q8NI60/R213W	Q8NI60	COQ8A	COQ8A_HUMAN	R213W	-	-	-	-	VTRIGrANFGG									VARIANT	R -> W (in COQ10D4; dbSNP:rs119468005)	18319072,22036850	2
Q8NI60/R271C	Q8NI60	COQ8A	COQ8A_HUMAN	R271C	-	-	-	-	TLCKVrAALKL									VARIANT	R -> C (in COQ10D4; dbSNP:rs145034527)	22036850	1
Q8NI60/R299W	Q8NI60	COQ8A	COQ8A_HUMAN	R299W	-	-	-	-	AKIFErRQSAD									VARIANT	R -> W (in COQ10D4; decreased stability; dbSNP:rs201908721)	22036850,25498144,27106809	3
Q8NI60/R611A	Q8NI60	COQ8A	COQ8A_HUMAN	R611A	-	-	-	-	TYSLHrMGGSF									MUTAGEN	R->A,Q: Does not affect selectivity for binding ADP or ATP.	25498144	1
Q8NI60/R611Q	Q8NI60	COQ8A	COQ8A_HUMAN	R611Q	-	-	-	-	TYSLHrMGGSF									MUTAGEN	R->A,Q: Does not affect selectivity for binding ADP or ATP.	25498144	1
Q8NI60/V222A	Q8NI60	COQ8A	COQ8A_HUMAN	V222A	-	-	-	-	FGGLAvLGFGA									MUTAGEN	V->A: Slightly impaired homodimerization.	25216398	1
Q8NI60/Y429C	Q8NI60	COQ8A	COQ8A_HUMAN	Y429C	-	-	-	-	GHPFFyPEIVD									VARIANT	Y -> C (in COQ10D4; decreased stability; dbSNP:rs144147839)	22036850,25498144	2
Q8NI60/Y514C	Q8NI60	COQ8A	COQ8A_HUMAN	Y514C	-	-	-	-	GATREyRSFTD									VARIANT	Y -> C (in COQ10D4; dbSNP:rs119468008)	18319074	1
Q8TAS1/K54A	Q8TAS1	UHMK1	UHMK1_HUMAN	K54A	129	β3;Catalytic-Lys	-	loss	PPGALkFLPPG	1.0	1.0	0.03	0.619	1.0	0.992	0.012	0.621	MUTAGEN	K->A: Loss of kinase activity.	12093740	1
Q8TAS1/L159V	Q8TAS1	UHMK1	UHMK1_HUMAN	L159V	444	Catalytic-loop	-	-	YVHADlPRNIL	0.395	0.386	0.455	0.338	0.381	0.275	0.522	0.331	VARIANT	L -> V (in dbSNP:rs34466082)	17344846	1
Q8TAS1/Y197D	Q8TAS1	UHMK1	UHMK1_HUMAN	Y197D	553	A-loop	-	-	IQTDGyAPEAE	0.915	0.885	0.387	0.636	0.811	0.833	0.25	0.682	VARIANT	Y -> D (in dbSNP:rs56201055)	17344846	1
Q8TD08/D155A	Q8TD08	MAPK15	MK15_HUMAN	D155A	496	A-loop;DFG-motif	-	loss	TVKLCdGLARS	0.99	0.999	0.081	0.567	0.994	0.978	0.027	0.743	MUTAGEN	D->A: Unable to induce the formation of autophagosomal structures. Is able to bind to MAP1LC3B and to colocalize with this protein to autophagosomal structures. Does not induce phosphorylation by methyl methanesulfonate. Loas of phosphorylation. Dominant negative mutant. Not phosphorylated at Thr-175 and Tyr-177.	16336213,19166846,22948227	3
Q8TD08/K42A	Q8TD08	MAPK15	MK15_HUMAN	K42A	129	β3;Catalytic-Lys	-	-	EVVAIkIFDAF	1.0	1.0	0.053	0.691	0.971	0.985	0.03	0.626	MUTAGEN	K->A: Not phosphorylated at Thr-175 and Tyr-177.	16336213	1
Q8TD08/K42R	Q8TD08	MAPK15	MK15_HUMAN	K42R	129	β3;Catalytic-Lys	-	loss	EVVAIkIFDAF	1.0	1.0	0.075	0.777	0.965	0.985	0.111	0.458	MUTAGEN	K->R: Loss of autophosphorylation and activity. Does not increase dopamine transporter activity. Impairs kinase activity. Does not rescue cilium assembly in MAPK15-depleted cells.	11875070,28842414,29021280	3
Q8TD08/P390A	Q8TD08	MAPK15	MK15_HUMAN	P390A	-	-	-	-	GPRPRpSSPGH									MUTAGEN	P->A: Impairs chromatin binding; when associated with A-398. Increases kinase activity; when associated with A-398.	20733054	1
Q8TD08/P398A	Q8TD08	MAPK15	MK15_HUMAN	P398A	-	-	-	-	SPGHDpEHESP									MUTAGEN	P->A: Impairs chromatin binding; when associated with A-390. Increases kinase activity; when associated with A-390.	20733054	1
Q8TD08/Q300A	Q8TD08	MAPK15	MK15_HUMAN	Q300A	819	αI	-	-	ATQALqPYVQR	0.435	0.325	0.527	0.39	0.382	0.298	0.506	0.32	MUTAGEN	Q->A: Impairs interaction with PCNA. Associates with chromatin.	20733054	1
Q8TD08/R59Q	Q8TD08	MAPK15	MK15_HUMAN	R59Q	172	αC	-	loss	AQRTFrITLLQ	0.824	0.855	0.425	0.697	0.71	0.742	0.363	0.46	MUTAGEN	R->Q: Does not increase dopamine transporter activity. Impairs kinase activity.	28842414	1
Q8TD08/S505P	Q8TD08	MAPK15	MK15_HUMAN	S505P	-	-	-	neutral	RMFSTsLQGAQ									VARIANT	S -> P (in dbSNP:rs56038219)		0
Q8TD08/T175A	Q8TD08	MAPK15	MK15_HUMAN	T175A	544	A-loop	p	loss	EDQAVtYVATR	0.986	0.981	0.235	0.872	0.925	0.974	0.238	0.648	MUTAGEN	T->A: Loss of autophosphorylation and activity. Still heavily phosphorylated at Tyr-177. Does not rescues inhibition of O-glycosylation in MAPK15-depleted cells; when associated with F-177.	11875070,16336213,24618899	3
Q8TD08/T221K	Q8TD08	MAPK15	MK15_HUMAN	T221K	629	αF/αG	-	neutral	PLFPGtTLHQL	0.25	0.276	0.641	0.301	0.145	0.241	0.728	0.283	VARIANT	T -> K (in dbSNP:rs60732298)		0
Q8TD08/Y177A	Q8TD08	MAPK15	MK15_HUMAN	Y177A	546	A-loop	p	loss	QAVTEyATRWY	0.962	0.975	0.229	0.735	0.904	0.883	0.177	0.63	MUTAGEN	Y->A: Loss of autophosphorylation and activity. Heavily phosphorylated at Thr-175.	11875070,16336213	2
Q8TD08/Y177F	Q8TD08	MAPK15	MK15_HUMAN	Y177F	546	A-loop	p	-	QAVTEyATRWY	0.996	0.962	0.25	0.823	0.964	0.948	0.205	0.548	MUTAGEN	Y->F: Does not rescue inhibition of O-glycosylation in MAPK15-depleted cells; when associated with A-175.	24618899	1
Q8TD19/I167T	Q8TD19	NEK9	NEK9_HUMAN	I167T	420	αE	-	increase	SAVSCiKAGIL	0.759	0.676	0.552	0.66	0.319	0.587	0.56	0.551	VARIANT	I -> T (in NC; increased autophosphorylation at T-210; dbSNP:rs879253775)	27153399	1
Q8TD19/I573T	Q8TD19	NEK9	NEK9_HUMAN	I573T	-	-	-	increase	QCMSGiNHEAY									VARIANT	I -> T (in NC; increased autophosphorylation at T-210; dbSNP:rs1555352529)	27153399	1
Q8TD19/K81M	Q8TD19	NEK9	NEK9_HUMAN	K81M	129	β3;Catalytic-Lys	ub	loss	SLVVWkVDLTR	1.0	0.992	0.027	0.684	0.997	0.997	0.026	0.509	MUTAGEN	K->M: Loss of activity and autophosphorylation.	12101123	1
Q8TD19/P828T	Q8TD19	NEK9	NEK9_HUMAN	P828T	-	-	-	neutral	PMPDSpPLSAA									VARIANT	P -> T (in dbSNP:rs36014869)	17344846	1
Q8TD19/P870S	Q8TD19	NEK9	NEK9_HUMAN	P870S	-	-	-	-	VEASSpLNPAV									VARIANT	P -> S (in a lung neuroendocrine carcinoma sample; somatic mutation)	17344846	1
Q8TD19/R429H	Q8TD19	NEK9	NEK9_HUMAN	R429H	-	-	-	neutral	QGKAIrVSCGD									VARIANT	R -> H (in dbSNP:rs10146482)	11864968,12056414,17344846	3
Q8TD19/R681H	Q8TD19	NEK9	NEK9_HUMAN	R681H	-	-	-	-	NGGNGrAMTPT									VARIANT	R -> H (in APUG; dbSNP:rs142859694)	26633546	1
Q8TD19/T210A	Q8TD19	NEK9	NEK9_HUMAN	T210A	545	A-loop	p	decrease	YSMAEtVGTPY	0.992	0.994	0.129	0.927	0.962	0.993	0.074	0.471	MUTAGEN	T->A: Significant reduction of autophosphorylation.	11864968	1
Q8TD19/T214A	Q8TD19	NEK9	NEK9_HUMAN	T214A	549	A-loop	-	-	ETLVGtYYMSP	0.811	0.836	0.25	0.554	0.713	0.797	0.221	0.493	MUTAGEN	T->A: No effect on autophosphorylation.	11864968	1
Q8TDC3/G327A	Q8TDC3	BRSK1	BRSK1_HUMAN	G327A	-	-	-	loss	SMASLgFRDRE									MUTAGEN	G->A: Abolishes activation of kinase activity.	18339622	1
Q8TDC3/G391E	Q8TDC3	BRSK1	BRSK1_HUMAN	G391E	-	-	-	-	MLSRHgRRPER									VARIANT	G -> E (in a metastatic melanoma sample; somatic mutation)	17344846	1
Q8TDC3/G749S	Q8TDC3	BRSK1	BRSK1_HUMAN	G749S	-	-	-	-	LQPPPgPDPEL									VARIANT	G -> S (in dbSNP:rs12978445)	17344846	1
Q8TDC3/K59A	Q8TDC3	BRSK1	BRSK1_HUMAN	K59A	80	β2/β3-loop	-	loss	CITGQkAIKIV	0.734	0.796	0.406	0.587	0.626	0.68	0.33	0.472	MUTAGEN	K->A: Loss of kinase activity.	15150265	1
Q8TDC3/P764A	Q8TDC3	BRSK1	BRSK1_HUMAN	P764A	-	-	-	neutral	PRRGPpDKKLL									VARIANT	P -> A (in dbSNP:rs55796422)	17344846	1
Q8TDC3/R303W	Q8TDC3	BRSK1	BRSK1_HUMAN	R303W	842	C-term-αI	-	-	PAPGRrAMRSL	0.408	0.397	0.453	0.342	0.335	0.294	0.52	0.258	VARIANT	R -> W (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs144130246)	17344846	1
Q8TDC3/T189A	Q8TDC3	BRSK1	BRSK1_HUMAN	T189A	545	A-loop	p	loss	DSLLEtCGSPH	0.999	1.0	0.127	0.92	0.98	0.998	0.065	0.444	MUTAGEN	T->A: Prevents phosphorylation and activation by STK11/LKB1 complex.	14976552	1
Q8TDC3/T531N	Q8TDC3	BRSK1	BRSK1_HUMAN	T531N	-	-	-	-	ASPTGtGTTPP									VARIANT	T -> N (in dbSNP:rs55892637)	17344846	1
Q8TDC3/V319I	Q8TDC3	BRSK1	BRSK1_HUMAN	V319I	-	-	-	-	ELDPDvESMAS									VARIANT	V -> I (in a lung large cell carcinoma sample; somatic mutation)	17344846	1
Q8TDR2/K231M	Q8TDR2	STK35	STK35_HUMAN	K231M	129	β3;Catalytic-Lys	-	loss	ARVAVkIRCDA	1.0	1.0	0.058	0.706	0.983	0.997	0.025	0.51	MUTAGEN	K->M: No autophosphorylation.	11973348	1
Q8TDX7/D261A	Q8TDX7	NEK7	NEK7_HUMAN	D261A	683	αG/αH	-	-	PPLPSdYSEEL	0.506	0.437	0.438	0.386	0.329	0.422	0.496	0.376	MUTAGEN	D->A: Does not affect interaction with NEK9.	26522158	1
Q8TDX7/D290R	Q8TDX7	NEK7	NEK7_HUMAN	D290R	827	C-term-αI	-	-	VTYVYdAKRMH	0.302	0.246	0.449	0.265	0.164	0.193	0.631	0.268	MUTAGEN	D->R: Does not affect interaction with NLRP3.	31189953	1
Q8TDX7/E280R	Q8TDX7	NEK7	NEK7_HUMAN	E280R	798	αI	-	-	INPDPeRPDVT	0.318	0.363	0.491	0.334	0.259	0.229	0.597	0.331	MUTAGEN	E->V,R: Does not affect interaction with NLRP3.	31189953	1
Q8TDX7/E280V	Q8TDX7	NEK7	NEK7_HUMAN	E280V	798	αI	-	-	INPDPeRPDVT	0.616	0.611	0.613	0.574	0.276	0.446	0.688	0.35	MUTAGEN	E->V,R: Does not affect interaction with NLRP3.	31189953	1
Q8TDX7/H125A	Q8TDX7	NEK7	NEK7_HUMAN	H125A	270	αD	-	-	SRMIKhKKQKR	0.599	0.539	0.493	0.538	0.373	0.453	0.577	0.354	MUTAGEN	H->A: Does not affect interaction with NEK9.	26522158	1
Q8TDX7/H262A	Q8TDX7	NEK7	NEK7_HUMAN	H262A	684	αG/αH	-	-	PLPSDhSEELR	0.279	0.253	0.394	0.321	0.282	0.283	0.516	0.123	MUTAGEN	H->A: Does not affect interaction with NEK9.	26522158	1
Q8TDX7/I169F	Q8TDX7	NEK7	NEK7_HUMAN	I169F	451	Catalytic-loop	-	-	PANVFiATGVV	0.475	0.458	0.529	0.431	0.313	0.393	0.618	0.23	MUTAGEN	I->F: Does not affect interaction with NEK9.	26522158	1
Q8TDX7/I275M	Q8TDX7	NEK7	NEK7_HUMAN	I275M	793	αH	-	-	LVNMCiPDPEK	0.381	0.384	0.524	0.402	0.263	0.284	0.641	0.367	VARIANT	I -> M (in an ovarian serous carcinoma sample; somatic mutation)	17344846	1
Q8TDX7/K128E	Q8TDX7	NEK7	NEK7_HUMAN	K128E	285	αD/αE-loop	-	-	IKHFKkKRLIP	0.277	0.255	0.59	0.347	0.12	0.145	0.763	0.182	MUTAGEN	K->E: Does not affect interaction with NLRP3.	31189953	1
Q8TDX7/K130A	Q8TDX7	NEK7	NEK7_HUMAN	K130A	385	αD/αE-loop	-	-	HFKKQkLIPER	0.424	0.406	0.49	0.354	0.299	0.249	0.636	0.279	MUTAGEN	K->A,E: Does not affect interaction with NEK9.	26522158	1
Q8TDX7/K130E	Q8TDX7	NEK7	NEK7_HUMAN	K130E	385	αD/αE-loop	-	-	HFKKQkLIPER	0.169	0.174	0.572	0.237	0.097	0.129	0.72	0.167	MUTAGEN	K->A,E: Does not affect interaction with NEK9.	26522158	1
Q8TDX7/K96E	Q8TDX7	NEK7	NEK7_HUMAN	K96E	202	β4	-	increase	HPNVIkYASFI	0.499	0.502	0.629	0.535	0.11	0.259	0.779	0.314	MUTAGEN	K->E: Strongly increased protein kinase activity.	26522158	1
Q8TDX7/L132D	Q8TDX7	NEK7	NEK7_HUMAN	L132D	387	αD/αE-loop	-	loss	KKQKRlPERTV	0.758	0.665	0.575	0.576	0.489	0.571	0.555	0.627	MUTAGEN	L->D: Abolished interaction with NEK9 and subsequent activation of NEK7 kinase activity.	26522158	1
Q8TDX7/L132W	Q8TDX7	NEK7	NEK7_HUMAN	L132W	387	αD/αE-loop	-	-	KKQKRlPERTV	0.684	0.571	0.555	0.625	0.364	0.472	0.638	0.35	MUTAGEN	L->W: Does not affect interaction with NEK9.	26522158	1
Q8TDX7/L31A	Q8TDX7	NEK7	NEK7_HUMAN	L31A	29	N-term-β1	-	decrease	MGYNTlNFRIE	0.737	0.69	0.434	0.447	0.551	0.53	0.411	0.428	MUTAGEN	L->A: Significant decrease in catalytic activity; when associated with A-28.	19941817	1
Q8TDX7/M122A	Q8TDX7	NEK7	NEK7_HUMAN	M122A	267	αD	-	decrease	GDLSRmKHFKK	0.903	0.707	0.442	0.613	0.681	0.688	0.384	0.405	MUTAGEN	M->A,R: Decreased interaction with NEK9 and subsequent activation of NEK7 kinase activity.	26522158	1
Q8TDX7/M122R	Q8TDX7	NEK7	NEK7_HUMAN	M122R	267	αD	-	decrease	GDLSRmKHFKK	0.712	0.601	0.525	0.543	0.614	0.58	0.526	0.458	MUTAGEN	M->A,R: Decreased interaction with NEK9 and subsequent activation of NEK7 kinase activity.	26522158	1
Q8TDX7/N33D	Q8TDX7	NEK7	NEK7_HUMAN	N33D	31	β1	-	decrease	YNTLAnRIEKK	0.37	0.373	0.583	0.256	0.224	0.305	0.713	0.2	MUTAGEN	N->D: Significant decrease in catalytic activity.	19941817	1
Q8TDX7/N90A	Q8TDX7	NEK7	NEK7_HUMAN	N90A	184	αC/β4-loop	-	decrease	LLKQLnPNVIK	0.802	0.742	0.427	0.461	0.653	0.64	0.423	0.336	MUTAGEN	N->A: Reduced protein kinase activity.	26522158	1
Q8TDX7/N90K	Q8TDX7	NEK7	NEK7_HUMAN	N90K	184	αC/β4-loop	-	decrease	LLKQLnPNVIK	0.617	0.524	0.455	0.293	0.602	0.4	0.49	0.347	MUTAGEN	N->R,K: Strongly reduced protein kinase activity.	26522158	1
Q8TDX7/N90R	Q8TDX7	NEK7	NEK7_HUMAN	N90R	184	αC/β4-loop	-	decrease	LLKQLnPNVIK	0.54	0.422	0.46	0.197	0.544	0.382	0.506	0.313	MUTAGEN	N->R,K: Strongly reduced protein kinase activity.	26522158	1
Q8TDX7/Q129R	Q8TDX7	NEK7	NEK7_HUMAN	Q129R	286	αD/αE-loop	-	-	KHFKKqRLIPE	0.336	0.331	0.524	0.393	0.236	0.251	0.62	0.392	MUTAGEN	Q->R: Decreased interaction with NLRP3.	31189953	1
Q8TDX7/R131A	Q8TDX7	NEK7	NEK7_HUMAN	R131A	386	αD/αE-loop	-	loss	FKKQKrIPERT	0.794	0.725	0.465	0.638	0.62	0.665	0.483	0.344	MUTAGEN	R->A,D: Abolished interaction with NEK9 and subsequent activation of NEK7 kinase activity.	26522158	1
Q8TDX7/R131D	Q8TDX7	NEK7	NEK7_HUMAN	R131D	386	αD/αE-loop	-	loss	FKKQKrIPERT	0.724	0.66	0.622	0.603	0.384	0.579	0.676	0.249	MUTAGEN	R->A,D: Abolished interaction with NEK9 and subsequent activation of NEK7 kinase activity.	26522158	1
Q8TDX7/R131E	Q8TDX7	NEK7	NEK7_HUMAN	R131E	386	αD/αE-loop	-	-	FKKQKrIPERT	0.558	0.511	0.658	0.473	0.274	0.423	0.695	0.209	MUTAGEN	R->E: Decreased interaction with NLRP3.	31189953	1
Q8TDX7/R136E	Q8TDX7	NEK7	NEK7_HUMAN	R136E	396	αD/αE-loop	-	-	RLIPErVWKYF	0.172	0.189	0.563	0.24	0.09	0.09	0.768	0.096	MUTAGEN	R->E: Decreased interaction with NLRP3.	31189953	1
Q8TDX7/R155E	Q8TDX7	NEK7	NEK7_HUMAN	R155E	426	αE	-	decrease	EHMHSrVMHRD	0.313	0.367	0.628	0.289	0.323	0.334	0.699	0.134	MUTAGEN	R->E: Strongly reduced protein kinase activity.	26522158	1
Q8TDX7/R294E	Q8TDX7	NEK7	NEK7_HUMAN	R294E	831	C-term-αI	-	-	YDVAKrHACTA	0.177	0.201	0.548	0.266	0.176	0.17	0.736	0.12	MUTAGEN	R->E: Does not affect interaction with NLRP3.	31189953	1
Q8TDX7/R35G	Q8TDX7	NEK7	NEK7_HUMAN	R35G	34	β1	-	neutral	TLANFrEKKIG	0.282	0.253	0.498	0.268	0.196	0.205	0.591	0.154	VARIANT	R -> G (in dbSNP:rs55833332)	17344846	1
Q8TDX7/S195A	Q8TDX7	NEK7	NEK7_HUMAN	S195A	545	A-loop	p	loss	TTAAHsVGTPY	0.975	0.981	0.23	0.825	0.94	0.973	0.204	0.49	MUTAGEN	S->A: Abolished phosphorylation with NEK9 and protein kinase activity.	26522158	1
Q8TDX7/T172A	Q8TDX7	NEK7	NEK7_HUMAN	T172A	480	Catalytic-loop	-	-	VFITAtVVKLG	0.286	0.295	0.407	0.337	0.334	0.262	0.559	0.155	MUTAGEN	T->A: Does not affect interaction with NEK9.	26522158	1
Q8TDX7/Y28A	Q8TDX7	NEK7	NEK7_HUMAN	Y28A	26	N-term-β1	-	decrease	RPDMGyTLANF	0.736	0.626	0.449	0.509	0.495	0.595	0.456	0.384	MUTAGEN	Y->A: Significant decrease in catalytic activity; when associated with A-31.	19941817	1
Q8TDX7/Y97A	Q8TDX7	NEK7	NEK7_HUMAN	Y97A	204	β4	p	increase	PNVIKyASFIE	0.91	0.882	0.66	0.871	0.234	0.679	0.677	0.518	MUTAGEN	Y->A: 5-fold increase in catalytic activity.	19941817,26522158	2
Q8TDX7/Y97F	Q8TDX7	NEK7	NEK7_HUMAN	Y97F	204	β4	p	increase	PNVIKyASFIE	0.828	0.897	0.742	0.873	0.195	0.562	0.789	0.362	MUTAGEN	Y->F,L: Moderate increase in catalytic activity.	19941817	1
Q8TDX7/Y97L	Q8TDX7	NEK7	NEK7_HUMAN	Y97L	204	β4	p	increase	PNVIKyASFIE	0.801	0.787	0.723	0.863	0.178	0.497	0.784	0.446	MUTAGEN	Y->F,L: Moderate increase in catalytic activity.	19941817	1
Q8TEA7/D265N	Q8TEA7	TBCK	TBCK_HUMAN	D265N	-	-	-	-	KRPTPdLMKDK									VARIANT	D -> N (in dbSNP:rs34770077)	17344846	1
Q8TEA7/I151M	Q8TEA7	TBCK	TBCK_HUMAN	I151M	-	-	-	-	DVDFPiYPSYL									VARIANT	I -> M (in dbSNP:rs35835241)	17344846	1
Q8TEA7/I806V	Q8TEA7	TBCK	TBCK_HUMAN	I806V	-	-	-	-	NSEDFiGHISG									VARIANT	I -> V (in a head & Neck squamous cell carcinoma sample; somatic mutation)	17344846	1
Q8TEA7/K489N	Q8TEA7	TBCK	TBCK_HUMAN	K489N	-	-	-	-	GAIHAkDAIDK									VARIANT	K -> N (in dbSNP:rs2305685)	17344846	1
Q8TEA7/L551P	Q8TEA7	TBCK	TBCK_HUMAN	L551P	-	-	-	-	QGLDSlAPFLY									VARIANT	L -> P (in IHPRF3)	27040691	1
Q8TEA7/M471I	Q8TEA7	TBCK	TBCK_HUMAN	M471I	-	-	-	neutral	DIPPLmGLTWA									VARIANT	M -> I (in dbSNP:rs34961213)	17344846	1
Q8TEA7/Q266E	Q8TEA7	TBCK	TBCK_HUMAN	Q266E	-	-	-	neutral	RPTPDqMKDKV									VARIANT	Q -> E (in dbSNP:rs3775091)	14702039,15815621,19077034	3
Q8TEA7/R503I	Q8TEA7	TBCK	TBCK_HUMAN	R503I	-	-	-	-	PIPTDrIEVDI									VARIANT	R -> I (in a colorectal adenocarcinoma sample; somatic mutation)	17344846	1
Q8TEA7/R511H	Q8TEA7	TBCK	TBCK_HUMAN	R511H	-	-	-	-	EVDIPrHQYDE									VARIANT	R -> H (in IHPRF3; dbSNP:rs869320711)	27040692	1
Q8TEA7/R66L	Q8TEA7	TBCK	TBCK_HUMAN	R66L	-	-	-	-	RGKHErVVVAE									VARIANT	R -> L (in dbSNP:rs35784409)	17344846	1
Q8TEA7/R692C	Q8TEA7	TBCK	TBCK_HUMAN	R692C	-	-	-	-	EIDIErVRESI									VARIANT	R -> C (in dbSNP:rs35790205)	17344846	1
Q8TEA7/T425M	Q8TEA7	TBCK	TBCK_HUMAN	T425M	-	-	-	neutral	LSAAAtPLIIR									VARIANT	T -> M (in dbSNP:rs34307452)	17344846	1
Q8TF76/D707L	Q8TF76	HASPIN	HASP_HUMAN	D707L	-	-	-	decrease	CDVSMdDLFTG									MUTAGEN	D->L: Markedly reduced affinity for histone H3 and reduced histone H3 phosphorylation.	19918049	1
Q8TF76/D709N	Q8TF76	HASPIN	HASP_HUMAN	D709N	-	-	-	decrease	VSMDEdFTGDG									MUTAGEN	D->N: Markedly reduced affinity for histone H3 and reduced histone H3 phosphorylation.	19918049	1
Q8TF76/D716L	Q8TF76	HASPIN	HASP_HUMAN	D716L	-	-	-	decrease	FTGDGdQFDIY									MUTAGEN	D->L: Markedly reduced histone H3 phosphorylation.	19918049	1
Q8TF76/E492A	Q8TF76	HASPIN	HASP_HUMAN	E492A	41	β1;Gly-rich-loop	-	decrease	CEKIGeVFGEV	0.913	0.896	0.311	0.572	0.816	0.895	0.196	0.757	MUTAGEN	E->A: Markedly reduced affinity for histone H3 and reduced histone H3 phosphorylation.	19918049	1
Q8TF76/G204D	Q8TF76	HASPIN	HASP_HUMAN	G204D	-	-	-	-	SAVPSgHLPEV									VARIANT	G -> D (in dbSNP:rs220462)	11311556,15489334,17344846	3
Q8TF76/G283S	Q8TF76	HASPIN	HASP_HUMAN	G283S	-	-	-	-	GNGPEgGLSST									VARIANT	G -> S (in dbSNP:rs56224301)	17344846	1
Q8TF76/G713F	Q8TF76	HASPIN	HASP_HUMAN	G713F	-	-	-	decrease	EDLFTgGDYQF									MUTAGEN	G->F: Markedly reduced affinity for histone H3 and reduced histone H3 phosphorylation.	19918049	1
Q8TF76/H651A	Q8TF76	HASPIN	HASP_HUMAN	H651A	445	Catalytic-loop	-	decrease	EHRDLhGNVLL	0.916	0.915	0.281	0.621	0.816	0.908	0.254	0.45	MUTAGEN	H->A: Strongly reduced enzyme activity, markedly reduced affinity for histone H3.	19918049,19918057	2
Q8TF76/I328T	Q8TF76	HASPIN	HASP_HUMAN	I328T	-	-	-	-	IVPRGiRLERT									VARIANT	I -> T (in dbSNP:rs220461)	11311556,15489334,17344846	3
Q8TF76/K511A	Q8TF76	HASPIN	HASP_HUMAN	K511A	129	β3;Catalytic-Lys	-	decrease	TPVAIkIAIEG	1.0	0.997	0.009	0.541	0.998	0.999	0.003	0.633	MUTAGEN	K->A: Strongly reduced enzyme activity.	19918057	1
Q8TF76/M706V	Q8TF76	HASPIN	HASP_HUMAN	M706V	-	-	-	-	FCDVSmEDLFT									VARIANT	M -> V (in dbSNP:rs56134695)	17344846	1
Q8TF76/N422D	Q8TF76	HASPIN	HASP_HUMAN	N422D	-	-	-	-	LSECSnPVMNR									VARIANT	N -> D (in dbSNP:rs7223226)		0
Q8TF76/Q301L	Q8TF76	HASPIN	HASP_HUMAN	Q301L	-	-	-	-	GQDSCqRGLQE									VARIANT	Q -> L (in dbSNP:rs55649477)	17344846	1
Q8TF76/R145H	Q8TF76	HASPIN	HASP_HUMAN	R145H	-	-	-	-	SRDSGrSPDLS									VARIANT	R -> H (in dbSNP:rs55991903)	17344846	1
Q8TF76/R82C	Q8TF76	HASPIN	HASP_HUMAN	R82C	-	-	-	-	RRRRRrGGRVP									VARIANT	R -> C (in dbSNP:rs9907144)	11311556,14702039,15489334,17344846	4
Q8TF76/V378A	Q8TF76	HASPIN	HASP_HUMAN	V378A	-	-	-	-	TPLQNvFWTKT									VARIANT	V -> A (in dbSNP:rs3809806)	11311556,15489334,17344846	3
Q8TF76/V76E	Q8TF76	HASPIN	HASP_HUMAN	V76E	-	-	-	-	FPGSPvRRRRR									VARIANT	V -> E (in dbSNP:rs11653889)	17344846	1
Q8WTQ7/C113W	Q8WTQ7	GRK7	GRK7_HUMAN	C113W	-	-	-	-	GLVATcSAPAP									VARIANT	C -> W (in dbSNP:rs56070798)	17344846	1
Q8WTQ7/E309Q	Q8WTQ7	GRK7	GRK7_HUMAN	E309Q	425	αE	-	neutral	MLHLHeGIVYR	0.09	0.094	0.461	0.128	0.11	0.095	0.713	0.108	VARIANT	E -> Q (in dbSNP:rs55824414)	17344846	1
Q8WTQ7/E443G	Q8WTQ7	GRK7	GRK7_HUMAN	E443G	816	αI	-	-	RLGSReSDDPR	0.365	0.23	0.496	0.339	0.149	0.192	0.666	0.334	VARIANT	E -> G (in dbSNP:rs36009541)	17344846	1
Q8WTQ7/P460T	Q8WTQ7	GRK7	GRK7_HUMAN	P460T	840	C-term-αI	-	-	KTINFpLEAGL	0.089	0.078	0.446	0.13	0.108	0.098	0.687	0.081	VARIANT	P -> T (in dbSNP:rs33928105)	17344846	1
Q8WTQ7/R226W	Q8WTQ7	GRK7	GRK7_HUMAN	R226W	138	αC	-	-	KLDKKrKKKGG	0.802	0.768	0.488	0.708	0.625	0.757	0.445	0.403	VARIANT	R -> W (in dbSNP:rs35566288)	17344846	1
Q8WTQ7/R461C	Q8WTQ7	GRK7	GRK7_HUMAN	R461C	841	C-term-αI	-	-	TINFPrEAGLI	0.838	0.804	0.503	0.658	0.615	0.724	0.476	0.507	VARIANT	R -> C (in dbSNP:rs36004830)		0
Q8WTQ7/R81H	Q8WTQ7	GRK7	GRK7_HUMAN	R81H	-	-	-	-	TVPTFrAATFL									VARIANT	R -> H (in dbSNP:rs34429284)	17344846	1
Q8WTQ7/S115C	Q8WTQ7	GRK7	GRK7_HUMAN	S115C	-	-	-	neutral	VATCAsPAPGN									VARIANT	S -> C (in dbSNP:rs34769632)	17344846	1
Q8WTQ7/S127T	Q8WTQ7	GRK7	GRK7_HUMAN	S127T	-	-	-	-	PQPFLsAVATK									VARIANT	S -> T (in dbSNP:rs35318124)	17344846	1
Q8WTQ7/S23A	Q8WTQ7	GRK7	GRK7_HUMAN	S23A	-	-	p	-	QARKPsCDSKE									MUTAGEN	S->A: No effect on kinase activity. Increase kinase activity; when associated with A-36.	15946941	1
Q8WTQ7/S253F	Q8WTQ7	GRK7	GRK7_HUMAN	S253F	202	β4	-	-	SPFIVsAYAFE	0.734	0.692	0.43	0.553	0.523	0.63	0.441	0.624	VARIANT	S -> F (in a metastatic melanoma sample; somatic mutation)	17344846	1
Q8WTQ7/S36A	Q8WTQ7	GRK7	GRK7_HUMAN	S36A	-	-	p	-	QRRRRsALPGL									MUTAGEN	S->A: No effect on kinase activity. Increase kinase activity; when associated with A-23.	15946941	1
Q8WTQ7/V196G	Q8WTQ7	GRK7	GRK7_HUMAN	V196G	38	β1	-	-	FTEFRvGKGGF	0.734	0.695	0.503	0.562	0.574	0.634	0.504	0.507	VARIANT	V -> G (in dbSNP:rs55707760)	17344846	1
Q8WTQ7/V196M	Q8WTQ7	GRK7	GRK7_HUMAN	V196M	38	β1	-	-	FTEFRvGKGGF	0.398	0.398	0.443	0.296	0.307	0.32	0.531	0.251	VARIANT	V -> M (in dbSNP:rs56019094)	17344846	1
Q8WTQ7/V313I	Q8WTQ7	GRK7	GRK7_HUMAN	V313I	440	Catalytic-loop	-	-	HELGIvRDMKP	0.316	0.265	0.498	0.32	0.189	0.192	0.669	0.157	VARIANT	V -> I (in dbSNP:rs56076641)	17344846	1
Q8WU08/K58M	Q8WU08	STK32A	ST32A_HUMAN	K58M	138	αC	-	neutral	YMNKQkVERNE	0.365	0.459	0.44	0.436	0.404	0.395	0.486	0.324	VARIANT	K -> M (in dbSNP:rs35852718)	17344846	1
Q8WU08/M316I	Q8WU08	STK32A	ST32A_HUMAN	M316I	-	-	-	-	FELEEmLESKP									VARIANT	M -> I (in a lung neuroendocrine carcinoma sample; somatic mutation)	17344846	1
Q8WU08/S89F	Q8WU08	STK32A	ST32A_HUMAN	S89F	207	β4/β5-loop	-	-	VNLWYsQDEED	0.473	0.388	0.522	0.377	0.359	0.384	0.564	0.339	VARIANT	S -> F (in a metastatic melanoma sample; somatic mutation)	17344846	1
Q8WXR4/A406T	Q8WXR4	MYO3B	MYO3B_HUMAN	A406T	-	-	-	neutral	HGVKRaNPPHI									VARIANT	A -> T (in dbSNP:rs10168181)	17344846	1
Q8WXR4/E352Q	Q8WXR4	MYO3B	MYO3B_HUMAN	E352Q	-	-	-	-	DLVNLeLDEDT									VARIANT	E -> Q (in dbSNP:rs56179904)	17344846	1
Q8WXR4/E773G	Q8WXR4	MYO3B	MYO3B_HUMAN	E773G	-	-	-	neutral	DAVPVeEDNRP									VARIANT	E -> G (in dbSNP:rs33962844)	14702039,17344846	2
Q8WXR4/E798K	Q8WXR4	MYO3B	MYO3B_HUMAN	E798K	-	-	-	-	ALLDEeRFPQA									VARIANT	E -> K (in dbSNP:rs11892763)		0
Q8WXR4/H316L	Q8WXR4	MYO3B	MYO3B_HUMAN	H316L	846	C-term-αI	-	-	LQDQKhNPVAK	0.162	0.163	0.625	0.314	0.129	0.136	0.746	0.242	VARIANT	H -> L (in dbSNP:rs55633190)	17344846	1
Q8WXR4/I1092V	Q8WXR4	MYO3B	MYO3B_HUMAN	I1092V	-	-	-	-	REKGAiIQSAW									VARIANT	I -> V (in dbSNP:rs34219776)	17344846	1
Q8WXR4/I275V	Q8WXR4	MYO3B	MYO3B_HUMAN	I275V	794	αH/αI	-	neutral	ISQCLiDFERR	0.098	0.127	0.482	0.149	0.116	0.131	0.687	0.088	VARIANT	I -> V (in dbSNP:rs10209102)	17344846	1
Q8WXR4/K309E	Q8WXR4	MYO3B	MYO3B_HUMAN	K309E	839	C-term-αI	-	neutral	QKQLAkLQDQK	0.142	0.158	0.543	0.222	0.096	0.119	0.712	0.096	VARIANT	K -> E (in dbSNP:rs4668246)	14702039,17344846	2
Q8WXR4/N267S	Q8WXR4	MYO3B	MYO3B_HUMAN	N267S	785	αH	-	-	WCEEFnFISQC	0.092	0.126	0.481	0.103	0.074	0.111	0.72	0.096	VARIANT	N -> S (in dbSNP:rs34509373)	17344846	1
Q8WXR4/N388S	Q8WXR4	MYO3B	MYO3B_HUMAN	N388S	-	-	-	-	LNPFQnSIYSP									VARIANT	N -> S (in dbSNP:rs34273653)	17344846	1
Q8WXR4/P21S	Q8WXR4	MYO3B	MYO3B_HUMAN	P21S	26	N-term-β1	-	-	GLESLpPTDTW	0.564	0.458	0.531	0.396	0.399	0.367	0.615	0.375	VARIANT	P -> S (in dbSNP:rs35391761)	17344846	1
Q8WXR4/Q638P	Q8WXR4	MYO3B	MYO3B_HUMAN	Q638P	-	-	-	-	NAEALqAASVL									VARIANT	Q -> P (in dbSNP:rs55911627)	17344846	1
Q8WXR4/R1082K	Q8WXR4	MYO3B	MYO3B_HUMAN	R1082K	-	-	-	neutral	ARRYKrREKRE									VARIANT	R -> K (in dbSNP:rs10185178)	11991710,14702039	2
Q8WXR4/R1165C	Q8WXR4	MYO3B	MYO3B_HUMAN	R1165C	-	-	-	neutral	RGSVHrSHSQA									VARIANT	R -> C (in dbSNP:rs56052422)	17344846	1
Q8WXR4/R185H	Q8WXR4	MYO3B	MYO3B_HUMAN	R185H	514	A-loop	-	neutral	QLTSTrRRNTS	0.314	0.25	0.46	0.285	0.178	0.17	0.593	0.132	VARIANT	R -> H (in dbSNP:rs55911154)	17344846	1
Q8WXR4/R918Q	Q8WXR4	MYO3B	MYO3B_HUMAN	R918Q	-	-	-	-	TLEVIrPEETT									VARIANT	R -> Q (in dbSNP:rs55769829)	17344846	1
Q8WXR4/R990C	Q8WXR4	MYO3B	MYO3B_HUMAN	R990C	-	-	-	-	TVSIRrGYSHR									VARIANT	R -> C (in dbSNP:rs34236931)	17344846	1
Q8WXR4/S969C	Q8WXR4	MYO3B	MYO3B_HUMAN	S969C	-	-	-	-	EALQFsERVLA									VARIANT	S -> C (in dbSNP:rs35857918)	17344846	1
Q8WXR4/V1137I	Q8WXR4	MYO3B	MYO3B_HUMAN	V1137I	-	-	-	neutral	GPHSPvAGTRG									VARIANT	V -> I (in dbSNP:rs34546065)	17344846	1
Q8WXR4/V770I	Q8WXR4	MYO3B	MYO3B_HUMAN	V770I	-	-	-	neutral	EGIDAvVEYED									VARIANT	V -> I (in dbSNP:rs6736609)	14702039,17344846	2
Q8WZ42/A1081T	Q8WZ42	TTN	TITIN_HUMAN	A1081T	-	-	-	-	PGEPAaYFITK									VARIANT	A -> T (in dbSNP:rs55914517)	17344846	1
Q8WZ42/A1347T	Q8WZ42	TTN	TITIN_HUMAN	A1347T	-	-	-	-	LQDGRaLRIPV									VARIANT	A -> T (in a metastatic melanoma sample; somatic mutation; dbSNP:rs267599092)	17344846	1
Q8WZ42/A743V	Q8WZ42	TTN	TITIN_HUMAN	A743V	-	-	-	-	KERISaKVAEP									VARIANT	A -> V (in CMD1G; affects interaction with TCAP/telethonin; dbSNP:rs267607157)	11846417	1
Q8WZ42/D60Y	Q8WZ42	TTN	TITIN_HUMAN	D60Y	-	-	-	-	QISFSdRAKLT									VARIANT	D -> Y (in dbSNP:rs35683768)	17344846	1
Q8WZ42/E937D	Q8WZ42	TTN	TITIN_HUMAN	E937D	-	-	-	-	VPAPVePVTPP									VARIANT	E -> D (in a gastric adenocarcinoma sample; somatic mutation)	17344846	1
Q8WZ42/G1137R	Q8WZ42	TTN	TITIN_HUMAN	G1137R	-	-	-	-	YNKQTgCKLVI									VARIANT	G -> R (in dbSNP:rs72647870)	17344846	1
Q8WZ42/G1345D	Q8WZ42	TTN	TITIN_HUMAN	G1345D	-	-	-	neutral	DFLQDgASLRI									VARIANT	G -> D (in dbSNP:rs36021856)	17344846	1
Q8WZ42/I1393V	Q8WZ42	TTN	TITIN_HUMAN	I1393V	-	-	-	neutral	GAPTYiTLEPV									VARIANT	I -> V (in dbSNP:rs16866531)	17344846	1
Q8WZ42/K1201E	Q8WZ42	TTN	TITIN_HUMAN	K1201E	-	-	-	neutral	FVQEPkGETAP									VARIANT	K -> E (in dbSNP:rs10497520)	17344846,7569978	2
Q8WZ42/R1350H	Q8WZ42	TTN	TITIN_HUMAN	R1350H	-	-	-	-	GRASLrPVVLP									VARIANT	R -> H (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs539470256)	17344846	1
Q8WZ42/R279W	Q8WZ42	TTN	TITIN_HUMAN	R279W	-	-	-	-	KAQLArQSPSP									VARIANT	R -> W (in MFM9; disrupts NBR1-binding; dbSNP:rs138060032)	15802564	1
Q8WZ42/R328C	Q8WZ42	TTN	TITIN_HUMAN	R328C	-	-	-	neutral	SPLLMrTQAST									VARIANT	R -> C (in dbSNP:rs16866538)	11846417,17344846	2
Q8WZ42/R360T	Q8WZ42	TTN	TITIN_HUMAN	R360T	-	-	-	neutral	SEAEMrTTLTT									VARIANT	R -> T (in dbSNP:rs56128843)	17344846	1
Q8WZ42/R740L	Q8WZ42	TTN	TITIN_HUMAN	R740L	-	-	-	-	YGYKErSAAKV									VARIANT	R -> L (in CMH9; dbSNP:rs28933405)	10462489	1
Q8WZ42/R922H	Q8WZ42	TTN	TITIN_HUMAN	R922H	-	-	-	-	EVLHGrAKVTE									VARIANT	R -> H (in dbSNP:rs56046320)	17344846	1
Q8WZ42/S1249L	Q8WZ42	TTN	TITIN_HUMAN	S1249L	-	-	-	neutral	EFHISsEERLI									VARIANT	S -> L (in dbSNP:rs1552280)		0
Q8WZ42/S1295L	Q8WZ42	TTN	TITIN_HUMAN	S1295L	-	-	-	neutral	ESGFDsIKNYR									VARIANT	S -> L (in dbSNP:rs1552280)	10850961,11717165,17344846	3
Q8WZ42/T799M	Q8WZ42	TTN	TITIN_HUMAN	T799M	-	-	-	-	TTDLTtRLVHV									VARIANT	T -> M (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs149061352)	17344846	1
Q8WZ42/T811I	Q8WZ42	TTN	TITIN_HUMAN	T811I	-	-	-	neutral	DKRPRtSPHFT									VARIANT	T -> I (in dbSNP:rs35813871)	17344846	1
Q8WZ42/V115M	Q8WZ42	TTN	TITIN_HUMAN	V115M	-	-	-	-	LQSMTvQGSQV									VARIANT	V -> M (in a metastatic melanoma sample; somatic mutation; dbSNP:rs564777385)	17344846	1
Q8WZ42/V1202A	Q8WZ42	TTN	TITIN_HUMAN	V1202A	-	-	-	-	VQEPKvETAPG									VARIANT	V -> A (in dbSNP:rs150667217)	17344846	1
Q8WZ42/V1353L	Q8WZ42	TTN	TITIN_HUMAN	V1353L	-	-	-	-	SLRIPvLPEDE									VARIANT	V -> L (in dbSNP:rs36062108)	17344846	1
Q8WZ42/V498I	Q8WZ42	TTN	TITIN_HUMAN	V498I	-	-	-	neutral	SRTKEvTTKQE									VARIANT	V -> I (in dbSNP:rs72647851)	17344846,7569978	2
Q8WZ42/V54M	Q8WZ42	TTN	TITIN_HUMAN	V54M	-	-	-	-	STLPGvISFSD									VARIANT	V -> M (in CMD1G; affects interaction with TCAP/telethonin; dbSNP:rs139517732)	11846417	1
Q8WZ42/W976R	Q8WZ42	TTN	TITIN_HUMAN	W976R	-	-	-	-	SPTVTwREDYQ									VARIANT	W -> R (in CMD1G; dbSNP:rs267607155)	11788824	1
Q92519/H4R	Q92519	TRIB2	TRIB2_HUMAN	H4R	-	-	-	neutral	MNIhSTPIT									VARIANT	H -> R (in dbSNP:rs55813198)	17344846	1
Q92630/F455Y	Q92630	DYRK2	DYRK2_HUMAN	F455Y	685	αG/αH	-	-	KRAKNfSSKGY	0.36	0.265	0.563	0.321	0.223	0.235	0.629	0.457	VARIANT	F -> Y (in dbSNP:rs55774594)	17344846	1
Q92630/H245N	Q92630	DYRK2	DYRK2_HUMAN	H245N	72	β2/β3-loop	-	neutral	YDHKVhHVALK	0.134	0.145	0.553	0.216	0.09	0.08	0.756	0.086	VARIANT	H -> N (in dbSNP:rs34166200)	17344846	1
Q92630/K251R	Q92630	DYRK2	DYRK2_HUMAN	K251R	129	β3;Catalytic-Lys	-	loss	QHVALkVRNEK	1.0	0.991	0.057	0.708	0.999	0.999	0.007	0.463	MUTAGEN	K->R: Abolishes protein serine/threonine kinase activity.	23362280	1
Q92630/N295S	Q92630	DYRK2	DYRK2_HUMAN	N295S	240	β4/β5-loop	-	-	NFTFRnICMTF	0.665	0.571	0.498	0.556	0.243	0.418	0.599	0.368	VARIANT	N -> S (in dbSNP:rs56293072)	17344846	1
Q92630/P198L	Q92630	DYRK2	DYRK2_HUMAN	P198L	9	N-term-β1	-	-	GMTGGpNGGYD	0.631	0.685	0.605	0.534	0.384	0.578	0.66	0.425	VARIANT	P -> L (in a glioblastoma multiforme sample; somatic mutation; dbSNP:rs1384093596)	17344846	1
Q92630/R451Q	Q92630	DYRK2	DYRK2_HUMAN	R451Q	673	αG/αH	-	-	LDASKrKNFVS	0.594	0.546	0.599	0.535	0.272	0.451	0.723	0.281	VARIANT	R -> Q (in dbSNP:rs35688869)	17344846	1
Q92630/S442A	Q92630	DYRK2	DYRK2_HUMAN	S442A	654	αG/αH	p	-	LLGMPsKLLDA	0.462	0.593	0.504	0.408	0.221	0.307	0.642	0.11	MUTAGEN	S->A: Impaired ATM-mediated phosphorylation, reduced affinity with MDM2 and altered MDM2-triggered ubiquitination.	19965871	1
Q92630/S98G	Q92630	DYRK2	DYRK2_HUMAN	S98G	-	-	-	-	LFEDNsKRTVL									VARIANT	S -> G (in dbSNP:rs35139851)	17344846	1
Q92630/T106A	Q92630	DYRK2	DYRK2_HUMAN	T106A	-	-	p	-	RTVLTtPNGLT									MUTAGEN	T->A: Impaired ATM-mediated phosphorylation, reduced affinity with MDM2 and altered MDM2-triggered ubiquitination.	19965871	1
Q92772/A411V	Q92772	CDKL2	CDKL2_HUMAN	A411V	-	-	-	-	RNPSVaPPLTH									VARIANT	A -> V (in dbSNP:rs56231363)	17344846	1
Q92772/I132T	Q92772	CDKL2	CDKL2_HUMAN	I132T	449	Catalytic-loop	-	-	IKPENiVSQSG	0.889	0.816	0.547	0.697	0.579	0.704	0.535	0.627	VARIANT	I -> T (in dbSNP:rs17000707)		0
Q92772/L98I	Q92772	CDKL2	CDKL2_HUMAN	L98I	391	αD/αE-loop	-	-	LFPNGlYQVVQ	0.287	0.228	0.567	0.357	0.206	0.236	0.658	0.243	VARIANT	L -> I (in an ovarian papillary serous adenocarcinoma sample; somatic mutation)	17344846	1
Q92772/M197T	Q92772	CDKL2	CDKL2_HUMAN	M197T	614	αF	-	-	VTEMFmEPLFP	0.28	0.288	0.475	0.32	0.126	0.152	0.683	0.256	VARIANT	M -> T (in dbSNP:rs56343717)	17344846	1
Q92772/R149Q	Q92772	CDKL2	CDKL2_HUMAN	R149Q	502	A-loop	-	-	DFGFArLAAPG	0.827	0.819	0.512	0.771	0.403	0.607	0.544	0.53	VARIANT	R -> Q (in an ovarian mucinous carcinoma sample; somatic mutation; dbSNP:rs755711267)	17344846	1
Q92772/Y77S	Q92772	CDKL2	CDKL2_HUMAN	Y77S	243	β5	-	-	KKKRWyVFEFV	0.912	0.82	0.569	0.686	0.464	0.722	0.588	0.658	VARIANT	Y -> S (in dbSNP:rs35921414)		0
Q92918/N811S	Q92918	MAP4K1	M4K1_HUMAN	N811S	-	-	-	-	ISPHCnLLPGS									VARIANT	N -> S (in dbSNP:rs12975825)		0
Q92918/P312T	Q92918	MAP4K1	M4K1_HUMAN	P312T	-	-	-	-	EPELPpIPRRI									VARIANT	P -> T (in dbSNP:rs55924696)	17344846	1
Q92918/P351S	Q92918	MAP4K1	M4K1_HUMAN	P351S	-	-	-	neutral	GMETRpANTAR									VARIANT	P -> S (in dbSNP:rs34591617)	17344846	1
Q92918/P361L	Q92918	MAP4K1	M4K1_HUMAN	P361L	-	-	-	-	ARLQPpDLRSS									VARIANT	P -> L (in dbSNP:rs56060067)	17344846	1
Q92918/S737F	Q92918	MAP4K1	M4K1_HUMAN	S737F	-	-	-	-	VTPEGsVRGLR									VARIANT	S -> F (in a metastatic melanoma sample; somatic mutation; dbSNP:rs1238066548)	17344846	1
Q92918/T355A	Q92918	MAP4K1	M4K1_HUMAN	T355A	-	-	p	activating	RPPANtRLQPP									MUTAGEN	T->A: Retains kinase activity. Not degraded by the Cul7-RING ubiquitin-protein ligase complex containing FBXW8.	24362026	1
Q96BR1/A92V	Q96BR1	SGK3	SGK3_HUMAN	A92V	-	-	-	-	IKQRRaLNEFI									VARIANT	A -> V (in a breast cancer sample; somatic mutation)	16959974	1
Q96BR1/K191M	Q96BR1	SGK3	SGK3_HUMAN	K191M	129	β3;Catalytic-Lys	-	loss	KFYAVkLQKKI	1.0	1.0	0.02	0.636	1.0	0.998	0.016	0.521	MUTAGEN	K->M: Abolishes activity.	16790420	1
Q96BR1/L355P	Q96BR1	SGK3	SGK3_HUMAN	L355P	612	αF	-	-	VLYEMlGLPPF	0.904	0.854	0.495	0.704	0.695	0.777	0.463	0.555	VARIANT	L -> P (in dbSNP:rs750700898)	17344846	1
Q96BR1/R90A	Q96BR1	SGK3	SGK3_HUMAN	R90A	-	-	-	-	DFIKQrAGLNE									MUTAGEN	R->A: Partially localized to the membrane.	16790420	1
Q96BR1/S486D	Q96BR1	SGK3	SGK3_HUMAN	S486D	-	-	p	increase	AFVGFsAPPSE									MUTAGEN	S->D: Increased activation.	10548550	1
Q96C45/A1261V	Q96C45	ULK4	ULK4_HUMAN	A1261V	-	-	-	neutral	SFADSaAPLAL									VARIANT	A -> V (in dbSNP:rs6769117)		0
Q96C45/A542T	Q96C45	ULK4	ULK4_HUMAN	A542T	-	-	-	neutral	LASHTaLQENT									VARIANT	A -> T (in dbSNP:rs1052501)		0
Q96C45/A715T	Q96C45	ULK4	ULK4_HUMAN	A715T	-	-	-	neutral	MLTLFaMLSCG									VARIANT	A -> T (in dbSNP:rs17215589)		0
Q96C45/I224V	Q96C45	ULK4	ULK4_HUMAN	I224V	-	-	-	neutral	FFSESiELTEK									VARIANT	I -> V (in dbSNP:rs1716975)		0
Q96C45/K39R	Q96C45	ULK4	ULK4_HUMAN	K39R	-	-	-	neutral	CTDKCkPEITN									VARIANT	K -> R (in dbSNP:rs2272007)	17344846	1
Q96C45/K569R	Q96C45	ULK4	ULK4_HUMAN	K569R	-	-	-	neutral	NFRNSkKQCLL									VARIANT	K -> R (in dbSNP:rs3774372)		0
Q96C45/L603S	Q96C45	ULK4	ULK4_HUMAN	L603S	-	-	-	neutral	CWAVPlAYTVL									VARIANT	L -> S (in dbSNP:rs17063572)		0
Q96C45/N139K	Q96C45	ULK4	ULK4_HUMAN	N139K	-	-	-	neutral	TLKFSnCLAKV									VARIANT	N -> K (in dbSNP:rs35833603)	17344846	1
Q96C45/S1260N	Q96C45	ULK4	ULK4_HUMAN	S1260N	-	-	-	neutral	GSFADsVAPLA									VARIANT	S -> N (in dbSNP:rs12488691)		0
Q96C45/S223N	Q96C45	ULK4	ULK4_HUMAN	S223N	-	-	-	-	PFFSEsSELTE									VARIANT	S -> N (in dbSNP:rs55840267)	17344846	1
Q96C45/S348G	Q96C45	ULK4	ULK4_HUMAN	S348G	-	-	-	-	EFRPKsLEGQL									VARIANT	S -> G (in dbSNP:rs35263917)	14702039,17344846	2
Q96C45/S417P	Q96C45	ULK4	ULK4_HUMAN	S417P	-	-	-	neutral	LIYTDsLVVTP									VARIANT	S -> P (in dbSNP:rs75907560)	17344846	1
Q96C45/S640A	Q96C45	ULK4	ULK4_HUMAN	S640A	-	-	-	neutral	TFSAQsGFITG									VARIANT	S -> A (in dbSNP:rs4973986)		0
Q96C45/T415M	Q96C45	ULK4	ULK4_HUMAN	T415M	-	-	-	-	RELIYtSDLVV									VARIANT	T -> M (in dbSNP:rs371185820)	17344846	1
Q96C45/V18A	Q96C45	ULK4	ULK4_HUMAN	V18A	-	-	-	-	GSKTVvKGRRK									VARIANT	V -> A (in dbSNP:rs34538622)	17344846	1
Q96D53/A498E	Q96D53	COQ8B	COQ8B_HUMAN	A498E	-	-	-	-	AGAFLaAHLRA									VARIANT	A -> E (in NPHS9)	25967120	1
Q96D53/D286G	Q96D53	COQ8B	COQ8B_HUMAN	D286G	-	-	-	-	LAWECdRREAA									VARIANT	D -> G (in NPHS9; dbSNP:rs398122979)	24270420	1
Q96D53/H174R	Q96D53	COQ8B	COQ8B_HUMAN	H174R	-	-	-	-	SPQLQhFERVR									VARIANT	H -> R (in dbSNP:rs3865452)	17344846	1
Q96D53/L98R	Q96D53	COQ8B	COQ8B_HUMAN	L98R	-	-	-	-	ANFGGlVGLGL									VARIANT	L -> R (in NPHS9)	25967120	1
Q96D53/P310L	Q96D53	COQ8B	COQ8B_HUMAN	P310L	-	-	-	-	PFFRVpVVKEL									VARIANT	P -> L (in NPHS9)	25967120	1
Q96D53/R178W	Q96D53	COQ8B	COQ8B_HUMAN	R178W	-	-	-	-	QHIFErRQSAD									VARIANT	R -> W (in NPHS9; dbSNP:rs398122978)	24270420,25967120	2
Q96D53/R320W	Q96D53	COQ8B	COQ8B_HUMAN	R320W	-	-	-	-	ELCTTrLGMEL									VARIANT	R -> W (in NPHS9; dbSNP:rs369573693)	24270420	1
Q96D53/R343W	Q96D53	COQ8B	COQ8B_HUMAN	R343W	-	-	-	-	LSQDLrQICFQ									VARIANT	R -> W (in NPHS9; dbSNP:rs398122981)	24270420	1
Q96D53/R477Q	Q96D53	COQ8B	COQ8B_HUMAN	R477Q	-	-	-	-	VLLRHrCPPPE									VARIANT	R -> Q (in NPHS9; dbSNP:rs1057519347)	24270420	1
Q96D53/R78C	Q96D53	COQ8B	COQ8B_HUMAN	R78C	-	-	-	-	PQLSDrRERKV									VARIANT	R -> C (in dbSNP:rs11538384)	17344846	1
Q96D53/T318M	Q96D53	COQ8B	COQ8B_HUMAN	T318M	-	-	-	-	VKELCtRVLGM									VARIANT	T -> M (in dbSNP:rs55899516)	17344846	1
Q96D53/T352R	Q96D53	COQ8B	COQ8B_HUMAN	T352R	-	-	-	-	CFQLLtCLREL									VARIANT	T -> R (in dbSNP:rs36012476)	17344846	1
Q96D53/T462M	Q96D53	COQ8B	COQ8B_HUMAN	T462M	-	-	-	-	FGSGEtRRIQD									VARIANT	T -> M (in dbSNP:rs56083906)	17344846	1
Q96GD4/A52V	Q96GD4	AURKB	AURKB_HUMAN	A52V	8	N-term-β1	-	neutral	VQPTAaGQKVM	0.332	0.343	0.534	0.343	0.287	0.271	0.632	0.272	VARIANT	A -> V (in dbSNP:rs55878091)	17344846	1
Q96GD4/H100Q	Q96GD4	AURKB	AURKB_HUMAN	H100Q	72	β2/β3-loop	-	-	REKKShIVALK	0.114	0.141	0.511	0.162	0.103	0.132	0.726	0.11	VARIANT	H -> Q (in dbSNP:rs3027254)		0
Q96GD4/K106R	Q96GD4	AURKB	AURKB_HUMAN	K106R	129	β3;Catalytic-Lys	-	loss	FIVALkLFKSQ	0.993	0.99	0.061	0.668	0.987	0.998	0.034	0.39	MUTAGEN	K->R: Leads to loss of kinase activity and severely impairs mitotic progression.	12686604,12925766,14722118,16179162	4
Q96GD4/K215Q	Q96GD4	AURKB	AURKB_HUMAN	K215Q	493	Catalytic-loop	ac	activating	LKGELkADFGW	0.865	0.893	0.555	0.802	0.333	0.674	0.641	0.509	MUTAGEN	K->Q: Mimics acetylation, promoting accurate chromosome segregation.	26829474	1
Q96GD4/K215R	Q96GD4	AURKB	AURKB_HUMAN	K215R	493	Catalytic-loop	ac	loss	LKGELkADFGW	0.77	0.773	0.488	0.661	0.507	0.564	0.618	0.425	MUTAGEN	K->R: Abolished acetylation by KAT5, leading to impaired chromosome segregation.	26829474	1
Q96GD4/M298T	Q96GD4	AURKB	AURKB_HUMAN	M298T	782	αH	-	neutral	PASVPmAQDLI	0.089	0.1	0.437	0.136	0.092	0.117	0.708	0.072	VARIANT	M -> T (in dbSNP:rs1059476)	11471245,15489334,16762494,9514916,9809983,9858806	6
Q96GD4/T179M	Q96GD4	AURKB	AURKB_HUMAN	T179M	405	αE	-	-	EQRTAtMEELA	0.458	0.415	0.434	0.36	0.419	0.401	0.515	0.355	VARIANT	T -> M (in dbSNP:rs55871613)	17344846	1
Q96GX5/D606Y	Q96GX5	MASTL	GWL_HUMAN	D606Y	-	-	-	-	ESNIEdLIVTP									VARIANT	D -> Y (in dbSNP:rs35413630)		0
Q96GX5/E167D	Q96GX5	MASTL	GWL_HUMAN	E167D	480	Catalytic-loop	-	-	MLISNeHIKLT	0.18	0.144	0.505	0.201	0.179	0.142	0.656	0.21	VARIANT	E -> D (found in a large family with autosomal dominant thrombocytopenia; unknown pathological significance; no effect on nuclear localization; dbSNP:rs28941470)	12890928,19460416	2
Q96GX5/K72M	Q96GX5	MASTL	GWL_HUMAN	K72M	144	αC	-	activating	ADMINkMTHQV	0.603	0.543	0.549	0.511	0.201	0.342	0.612	0.384	MUTAGEN	K->M: Hyperactive form.	21164014	1
Q96GX5/P620A	Q96GX5	MASTL	GWL_HUMAN	P620A	-	-	-	-	QEKTSpGVENP									VARIANT	P -> A (in dbSNP:rs3802526)	17344846	1
Q96GX5/T337K	Q96GX5	MASTL	GWL_HUMAN	T337K	-	-	-	neutral	EALGPtMSWNA									VARIANT	T -> K (in dbSNP:rs36121140)	17344846	1
Q96GX5/V610I	Q96GX5	MASTL	GWL_HUMAN	V610I	-	-	-	neutral	EDPLIvPDCQE									VARIANT	V -> I (in dbSNP:rs35571315)	17344846	1
Q96J92/A601S	Q96J92	WNK4	WNK4_HUMAN	A601S	-	-	-	neutral	DASDPaQPPGG									VARIANT	A -> S (in dbSNP:rs55781437)		0
Q96J92/D564A	Q96J92	WNK4	WNK4_HUMAN	D564A	-	-	-	-	EEPEAdHQPFL									VARIANT	D -> A (in PHA2B; impaired interaction with KLHL3; dbSNP:rs137853094)	11498583,23453970	2
Q96J92/E434D	Q96J92	WNK4	WNK4_HUMAN	E434D	825	C-term-αI	-	-	HAFFReRGVHV	0.49	0.425	0.552	0.511	0.306	0.322	0.63	0.288	VARIANT	E -> D (in an ovarian mucinous carcinoma sample; somatic mutation)	17344846	1
Q96J92/E562K	Q96J92	WNK4	WNK4_HUMAN	E562K	-	-	-	-	EPEEPeDQHQP									VARIANT	E -> K (in PHA2B; impaired interaction with KLHL3; dbSNP:rs137853093)	11498583,23387299,23576762	3
Q96J92/L1013P	Q96J92	WNK4	WNK4_HUMAN	L1013P	-	-	-	-	EGKPQlGRFQV									VARIANT	L -> P	17344846	1
Q96J92/P813L	Q96J92	WNK4	WNK4_HUMAN	P813L	-	-	-	-	GTPLSpNPFSP									VARIANT	P -> L	17344846	1
Q96J92/P961S	Q96J92	WNK4	WNK4_HUMAN	P961S	-	-	-	neutral	PPSPLpLPLPP									VARIANT	P -> S (in dbSNP:rs2290041)		0
Q96J92/P992S	Q96J92	WNK4	WNK4_HUMAN	P992S	-	-	-	-	EASPPpRPLPG									VARIANT	P -> S (in a metastatic melanoma sample; somatic mutation)	17344846	1
Q96J92/Q565E	Q96J92	WNK4	WNK4_HUMAN	Q565E	-	-	-	-	EPEADqQPFLF									VARIANT	Q -> E (in PHA2B; impaired interaction with KLHL3; dbSNP:rs137853092)	11498583,23387299,23576762	3
Q96J92/R1185C	Q96J92	WNK4	WNK4_HUMAN	R1185C	-	-	-	-	AMLSSrRRLSK									VARIANT	R -> C (in PHA2B; dbSNP:rs137853095)	11498583	1
Q96J92/R677W	Q96J92	WNK4	WNK4_HUMAN	R677W	-	-	-	neutral	PRSRLrTSVSD									VARIANT	R -> W (in dbSNP:rs9896991)		0
Q96KB5/E220D	Q96KB5	PBK	TOPK_HUMAN	E220D	589	αF	-	neutral	KEAVEeGVITD	0.16	0.126	0.511	0.141	0.124	0.106	0.719	0.137	VARIANT	E -> D (in dbSNP:rs17057901)		0
Q96KB5/M241L	Q96KB5	PBK	TOPK_HUMAN	M241L	612	αF	-	-	TLWEMmLSIPH	0.265	0.161	0.438	0.264	0.154	0.181	0.631	0.269	VARIANT	M -> L (in dbSNP:rs36086402)	17344846	1
Q96KB5/N107S	Q96KB5	PBK	TOPK_HUMAN	N107S	238	β4/β5-loop	-	neutral	AFTEAnGSLCL	0.168	0.154	0.429	0.088	0.089	0.143	0.673	0.059	VARIANT	N -> S (in dbSNP:rs3779620)	10779557,11378444,14702039,17344846	4
Q96KB5/T320A	Q96KB5	PBK	TOPK_HUMAN	T320A	827	C-term-αI	-	-	VEALEtV	0.196	0.216	0.345	0.148	0.273	0.215	0.54	0.12	MUTAGEN	T->A: Decrease in the binding to DLG1.	10779557	1
Q96KB5/T9E	Q96KB5	PBK	TOPK_HUMAN	T9E	7	N-term-β1	p	-	ISNFKtSKLSE	0.854	0.733	0.644	0.787	0.55	0.72	0.587	0.449	MUTAGEN	T->E: TP53-binding.	17482142	1
Q96KG9/H495Y	Q96KG9	SCYL1	SCYL1_HUMAN	H495Y	-	-	-	-	GFAAThLYSMN									VARIANT	H -> Y (in a metastatic melanoma sample; somatic mutation)	17344846	1
Q96KG9/P479L	Q96KG9	SCYL1	SCYL1_HUMAN	P479L	-	-	-	-	RATRDpAPSRV									VARIANT	P -> L (in dbSNP:rs55977709)	17344846	1
Q96KG9/Q663H	Q96KG9	SCYL1	SCYL1_HUMAN	Q663H	-	-	-	neutral	SVLAQqDWSTG									VARIANT	Q -> H (in dbSNP:rs56076708)	17344846	1
Q96KG9/W755S	Q96KG9	SCYL1	SCYL1_HUMAN	W755S	-	-	-	-	PRPDSwEDNWE									VARIANT	W -> S (in dbSNP:rs56077405)	17344846	1
Q96L34/R377Q	Q96L34	MARK4	MARK4_HUMAN	R377Q	-	-	-	-	EEGGDrAPGLA									VARIANT	R -> Q (in dbSNP:rs35070611)	17344846	1
Q96L34/R418C	Q96L34	MARK4	MARK4_HUMAN	R418C	-	-	-	-	SSTYHrRRHSD									VARIANT	R -> C (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs780763668)	17344846	1
Q96L34/T214A	Q96L34	MARK4	MARK4_HUMAN	T214A	545	A-loop	p	loss	GSKLDtCGSPP	0.999	1.0	0.11	0.923	0.978	0.991	0.063	0.467	MUTAGEN	T->A: Prevents phosphorylation and activation by STK11/LKB1 complex.	14976552	1
Q96L34/T214E	Q96L34	MARK4	MARK4_HUMAN	T214E	545	A-loop	p	increase	GSKLDtCGSPP	0.999	0.997	0.867	0.996	0.091	0.939	0.901	0.442	MUTAGEN	T->E: Mimicks phosphorylation state, leading to increased activity. Decreases mTORC1 activity.	14976552,23184942	2
Q96L96/A1137G	Q96L96	ALPK3	ALPK3_HUMAN	A1137G	-	-	-	-	TSSEGaAQVPD									VARIANT	A -> G (in dbSNP:rs34173528)		0
Q96L96/A1557D	Q96L96	ALPK3	ALPK3_HUMAN	A1557D	-	-	-	neutral	NEHGSaTDFCL									VARIANT	A -> D (in dbSNP:rs34775428)	17344846	1
Q96L96/A1873V	Q96L96	ALPK3	ALPK3_HUMAN	A1873V	-	-	-	neutral	GTRKSaSSKAT									VARIANT	A -> V (in dbSNP:rs36002219)		0
Q96L96/E1013K	Q96L96	ALPK3	ALPK3_HUMAN	E1013K	-	-	-	neutral	HEGSVeVGGER									VARIANT	E -> K (in dbSNP:rs35633849)		0
Q96L96/E929D	Q96L96	ALPK3	ALPK3_HUMAN	E929D	-	-	-	-	GQSEQeATSLG									VARIANT	E -> D (in dbSNP:rs56191073)	17344846	1
Q96L96/G1364E	Q96L96	ALPK3	ALPK3_HUMAN	G1364E	-	-	-	-	EELALgRRKRF									VARIANT	G -> E (in a metastatic melanoma sample; somatic mutation)	17344846	1
Q96L96/G579E	Q96L96	ALPK3	ALPK3_HUMAN	G579E	-	-	-	neutral	GRAARgGSSGT									VARIANT	G -> E (in dbSNP:rs3803405)	17344846	1
Q96L96/G663D	Q96L96	ALPK3	ALPK3_HUMAN	G663D	-	-	-	neutral	SEGVPgPGQPT									VARIANT	G -> D (in dbSNP:rs34409363)	17344846	1
Q96L96/L1622P	Q96L96	ALPK3	ALPK3_HUMAN	L1622P	-	-	-	neutral	GYGCGlKASQA									VARIANT	L -> P (in dbSNP:rs187316)	17344846	1
Q96L96/P1299L	Q96L96	ALPK3	ALPK3_HUMAN	P1299L	-	-	-	neutral	EGEVSpGPGLL									VARIANT	P -> L (in dbSNP:rs306197)	10021370,10718198,17344846	3
Q96L96/Q433E	Q96L96	ALPK3	ALPK3_HUMAN	Q433E	-	-	-	-	RLSGAqPGPSV									VARIANT	Q -> E (in a lung large cell carcinoma sample; somatic mutation)	17344846	1
Q96L96/Q602R	Q96L96	ALPK3	ALPK3_HUMAN	Q602R	-	-	-	neutral	TPDKAqAPGPG									VARIANT	Q -> R (in dbSNP:rs55702300)	17344846	1
Q96L96/R1412W	Q96L96	ALPK3	ALPK3_HUMAN	R1412W	-	-	-	neutral	PGTPGrRRSPT									VARIANT	R -> W (in dbSNP:rs55752937)	17344846	1
Q96L96/R336H	Q96L96	ALPK3	ALPK3_HUMAN	R336H	-	-	-	neutral	THQGNrTLQLY									VARIANT	R -> H (in dbSNP:rs34407151)	17344846	1
Q96L96/R836L	Q96L96	ALPK3	ALPK3_HUMAN	R836L	-	-	-	-	TAQRTrDRKTQ									VARIANT	R -> L (in dbSNP:rs34906636)	17344846	1
Q96L96/T338I	Q96L96	ALPK3	ALPK3_HUMAN	T338I	-	-	-	-	QGNRHtQLYRC									VARIANT	T -> I (in dbSNP:rs56015306)	17344846	1
Q96L96/T414S	Q96L96	ALPK3	ALPK3_HUMAN	T414S	-	-	-	neutral	PGEVDtRKLSP									VARIANT	T -> S (in dbSNP:rs3803403)	17344846	1
Q96L96/T761M	Q96L96	ALPK3	ALPK3_HUMAN	T761M	-	-	-	neutral	ECQTTtPTMSA									VARIANT	T -> M (in dbSNP:rs16974569)	17344846	1
Q96NX5/A443T	Q96NX5	CAMK1G	KCC1G_HUMAN	A443T	-	-	-	-	TLLKKaKKQNF									VARIANT	A -> T (in a breast infiltrating ductal carcinoma sample; somatic mutation; dbSNP:rs1228276529)	17344846	1
Q96NX5/E259Q	Q96NX5	CAMK1G	KCC1G_HUMAN	E259Q	794	αH/αI	-	-	ICHLLeDPNER	0.124	0.147	0.425	0.147	0.161	0.166	0.683	0.09	VARIANT	E -> Q (in dbSNP:rs35561962)	17344846	1
Q96NX5/V329I	Q96NX5	CAMK1G	KCC1G_HUMAN	V329I	-	-	-	neutral	LHSPGvPEVEN									VARIANT	V -> I (in dbSNP:rs11119315)	10645953,17344846	2
Q96PF2/C245S	Q96PF2	TSSK2	TSSK2_HUMAN	C245S	784	αH	-	-	NLTCEcDLIYR	0.72	0.59	0.46	0.533	0.557	0.604	0.446	0.677	VARIANT	C -> S (in dbSNP:rs8140743)		0
Q96PF2/E244K	Q96PF2	TSSK2	TSSK2_HUMAN	E244K	783	αH	-	-	KNLTCeKDLIY	0.332	0.338	0.477	0.282	0.253	0.3	0.578	0.296	VARIANT	E -> K (in dbSNP:rs35048893)		0
Q96PF2/K27R	Q96PF2	TSSK2	TSSK2_HUMAN	K27R	49	β2	-	-	SYAKVkAYSER	0.239	0.133	0.474	0.202	0.156	0.138	0.657	0.123	VARIANT	K -> R (may be associated with infertility; dbSNP:rs3747052)	17344846,19926886	2
Q96PF2/M61V	Q96PF2	TSSK2	TSSK2_HUMAN	M61V	174	αC	-	-	FLPREmILATV	0.147	0.17	0.413	0.163	0.123	0.147	0.591	0.16	VARIANT	M -> V (in dbSNP:rs35532431)	17344846	1
Q96PF2/T280M	Q96PF2	TSSK2	TSSK2_HUMAN	T280M	831	C-term-αI	-	neutral	PKPKAtSASFK	0.162	0.207	0.519	0.211	0.205	0.168	0.71	0.139	VARIANT	T -> M (in dbSNP:rs1052763)	17344846	1
Q96PF2/Y197C	Q96PF2	TSSK2	TSSK2_HUMAN	Y197C	599	αF	-	neutral	YQPKVyIWSLG	0.311	0.286	0.552	0.367	0.177	0.28	0.71	0.191	VARIANT	Y -> C (in dbSNP:rs56279111)	17344846	1
Q96PN8/A140T	Q96PN8	TSSK3	TSSK3_HUMAN	A140T	449	Catalytic-loop	-	-	LKCENaLQGFN	0.3	0.247	0.331	0.139	0.274	0.286	0.533	0.095	VARIANT	A -> T (in dbSNP:rs55786268)	17344846	1
Q96PN8/I71V	Q96PN8	TSSK3	TSSK3_HUMAN	I71V	201	β4	-	neutral	DHKNIiVYEML	0.155	0.116	0.402	0.174	0.124	0.118	0.602	0.198	VARIANT	I -> V (in dbSNP:rs35508255)		0
Q96PN8/S235L	Q96PN8	TSSK3	TSSK3_HUMAN	S235L	781	αH	-	-	THLSIsDCQDL	0.753	0.756	0.643	0.607	0.366	0.622	0.671	0.348	VARIANT	S -> L (in dbSNP:rs35457991)	17344846	1
Q96PY6/A294P	Q96PY6	NEK1	NEK1_HUMAN	A294P	-	-	-	-	PAKRPaGQNSI									VARIANT	A -> P (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
Q96PY6/A463V	Q96PY6	NEK1	NEK1_HUMAN	A463V	-	-	-	neutral	AEDNEaWKREI									VARIANT	A -> V (in dbSNP:rs34540355)	17344846	1
Q96PY6/A598T	Q96PY6	NEK1	NEK1_HUMAN	A598T	-	-	-	neutral	EGSEEaMRRKK									VARIANT	A -> T (in dbSNP:rs33933790)	17344846	1
Q96PY6/D1180N	Q96PY6	NEK1	NEK1_HUMAN	D1180N	-	-	-	-	SECECdVFNHL									VARIANT	D -> N (in dbSNP:rs35503975)	17344846	1
Q96PY6/E25K	Q96PY6	NEK1	NEK1_HUMAN	E25K	65	β2/β3-loop	-	-	LVKSTeGRQYV	0.279	0.26	0.462	0.212	0.355	0.217	0.588	0.133	VARIANT	E -> K (in a lung large cell carcinoma sample; somatic mutation)	17344846	1
Q96PY6/E724G	Q96PY6	NEK1	NEK1_HUMAN	E724G	-	-	-	neutral	NLKAQeEKGKQ									VARIANT	E -> G (in dbSNP:rs34099167)	17344846,17974005	2
Q96PY6/G145R	Q96PY6	NEK1	NEK1_HUMAN	G145R	495	Catalytic-loop	-	-	GTVQLgFGIAR	0.833	0.772	0.448	0.693	0.63	0.639	0.399	0.594	VARIANT	G -> R (in SRTD6; dbSNP:rs431905508)	22499340	1
Q96PY6/I10F	Q96PY6	NEK1	NEK1_HUMAN	I10F	39	β1	-	-	VRLQKiEGSFG	0.83	0.787	0.415	0.717	0.659	0.693	0.436	0.651	VARIANT	I -> F (in dbSNP:rs34214559)	17344846	1
Q96PY6/K745N	Q96PY6	NEK1	NEK1_HUMAN	K745N	-	-	-	-	VHEDAkHEKEK									VARIANT	K -> N	17344846	1
Q96PY6/L253S	Q96PY6	NEK1	NEK1_HUMAN	L253S	818	αI	-	-	SVNSIlKGFIA	0.915	0.863	0.424	0.707	0.668	0.784	0.375	0.774	VARIANT	L -> S (in SRTD6)	22499340	1
Q96PY6/L76V	Q96PY6	NEK1	NEK1_HUMAN	L76V	242	β5	-	-	EENGSlIVMDY	0.257	0.277	0.557	0.351	0.165	0.133	0.717	0.186	VARIANT	L -> V (in dbSNP:rs35093214)	17344846	1
Q96PY6/N717K	Q96PY6	NEK1	NEK1_HUMAN	N717K	-	-	-	neutral	ILRRLnNLKAQ									VARIANT	N -> K (in dbSNP:rs34324114)		0
Q96PY6/Q883E	Q96PY6	NEK1	NEK1_HUMAN	Q883E	-	-	-	neutral	SEASPqSLKLE									VARIANT	Q -> E (in dbSNP:rs6828134)	17344846	1
Q96PY6/R261H	Q96PY6	NEK1	NEK1_HUMAN	R261H	827	C-term-αI	-	-	GFIAKrEKFLS	0.441	0.342	0.508	0.409	0.223	0.326	0.63	0.238	VARIANT	R -> H (in ALS24; associated with disease susceptibility; dbSNP:rs200161705)	27455347	1
Q96PY6/R355G	Q96PY6	NEK1	NEK1_HUMAN	R355G	-	-	-	-	NTGEErKISEE									VARIANT	R -> G (in dbSNP:rs35763578)	17344846	1
Q96Q04/L929V	Q96Q04	LMTK3	LMTK3_HUMAN	L929V	-	-	-	neutral	NGVTVlNGDQR									VARIANT	L -> V (in dbSNP:rs1643478)		0
Q96Q04/V900L	Q96Q04	LMTK3	LMTK3_HUMAN	V900L	-	-	-	neutral	GNREKvGLNRD									VARIANT	V -> L (in dbSNP:rs1643478)		0
Q96Q15/A167V	Q96Q15	SMG1	SMG1_HUMAN	A167V	-	-	-	-	RDRRLaVKQLK									VARIANT	A -> V (in dbSNP:rs1382468496)	17344846	1
Q96Q15/A35T	Q96Q15	SMG1	SMG1_HUMAN	A35T	-	-	-	neutral	PRTDSaADPDN									VARIANT	A -> T (in dbSNP:rs12051350)	17344846	1
Q96Q15/A588S	Q96Q15	SMG1	SMG1_HUMAN	A588S	-	-	-	-	LQLPEaSEIKH									VARIANT	A -> S (in dbSNP:rs750840136)	17344846	1
Q96Q15/A952G	Q96Q15	SMG1	SMG1_HUMAN	A952G	-	-	-	-	IRSLAaTLNPD									VARIANT	A -> G (in dbSNP:rs555078480)	17344846	1
Q96Q15/D160N	Q96Q15	SMG1	SMG1_HUMAN	D160N	-	-	-	-	RITREdRDRRL									VARIANT	D -> N	17344846	1
Q96Q15/D320G	Q96Q15	SMG1	SMG1_HUMAN	D320G	-	-	-	-	FRDTVdLVGWH									VARIANT	D -> G	17344846	1
Q96Q15/F1016L	Q96Q15	SMG1	SMG1_HUMAN	F1016L	-	-	-	-	VIRTFfTNRQT									VARIANT	F -> L (in dbSNP:rs1394431566)	17344846	1
Q96Q15/G465S	Q96Q15	SMG1	SMG1_HUMAN	G465S	-	-	-	-	VGVLLgLDPSM									VARIANT	G -> S (in dbSNP:rs200419100)	17344846	1
Q96Q15/H546R	Q96Q15	SMG1	SMG1_HUMAN	H546R	-	-	-	-	VVAVAhVYQAV									VARIANT	H -> R (in dbSNP:rs376234691)	17344846	1
Q96Q15/I1332V	Q96Q15	SMG1	SMG1_HUMAN	I1332V	-	-	-	-	TSRIAiPLRLS									VARIANT	I -> V (in dbSNP:rs949474935)	17344846	1
Q96Q15/I612K	Q96Q15	SMG1	SMG1_HUMAN	I612K	-	-	-	-	AKFVViDLSAL									VARIANT	I -> K (in dbSNP:rs17842615)	15175154,17344846	2
Q96Q15/N1103H	Q96Q15	SMG1	SMG1_HUMAN	N1103H	-	-	-	-	SIVGKnLWINS									VARIANT	N -> H (in dbSNP:rs563883658)	17344846	1
Q96Q15/N151Y	Q96Q15	SMG1	SMG1_HUMAN	N151Y	-	-	-	-	ESRLSnLRRIT									VARIANT	N -> Y (in dbSNP:rs750788715)	17344846	1
Q96Q15/N832D	Q96Q15	SMG1	SMG1_HUMAN	N832D	-	-	-	-	DVVLSnNHTEI									VARIANT	N -> D (in dbSNP:rs80176913)	17344846	1
Q96Q15/N969S	Q96Q15	SMG1	SMG1_HUMAN	N969S	-	-	-	-	WTTADnEGHGN									VARIANT	N -> S (in dbSNP:rs1412788971)	17344846	1
Q96Q15/P1275R	Q96Q15	SMG1	SMG1_HUMAN	P1275R	-	-	-	-	MKKLLpMLSPD									VARIANT	P -> R	17344846	1
Q96Q15/Q1292P	Q96Q15	SMG1	SMG1_HUMAN	Q1292P	-	-	-	-	KSIEVqLRSSV									VARIANT	Q -> P (in dbSNP:rs375411122)	17344846	1
Q96Q15/R1029Q	Q96Q15	SMG1	SMG1_HUMAN	R1029Q	-	-	-	-	QDWLTrRLSIM									VARIANT	R -> Q	17344846	1
Q96Q15/R126C	Q96Q15	SMG1	SMG1_HUMAN	R126C	-	-	-	-	VQHGSrLATKD									VARIANT	R -> C (in dbSNP:rs752796432)	17344846	1
Q96Q15/R812C	Q96Q15	SMG1	SMG1_HUMAN	R812C	-	-	-	-	VHSGTrRQAFG									VARIANT	R -> C (in dbSNP:rs1233400465)	17344846	1
Q96Q15/S1358P	Q96Q15	SMG1	SMG1_HUMAN	S1358P	-	-	-	-	QLYCSsLENTV									VARIANT	S -> P	17344846	1
Q96Q15/S144C	Q96Q15	SMG1	SMG1_HUMAN	S144C	-	-	-	-	RSMSYsESRLS									VARIANT	S -> C (in dbSNP:rs766737607)	15175154,17344846	2
Q96Q15/S753C	Q96Q15	SMG1	SMG1_HUMAN	S753C	-	-	-	-	YAPLFsPSFHK									VARIANT	S -> C (in dbSNP:rs569679854)	17344846	1
Q96Q15/S809C	Q96Q15	SMG1	SMG1_HUMAN	S809C	-	-	-	-	VQLVHsTRIRQ									VARIANT	S -> C (in dbSNP:rs919788709)	17344846	1
Q96Q15/T1072S	Q96Q15	SMG1	SMG1_HUMAN	T1072S	-	-	-	-	NELEVtMMVVE									VARIANT	T -> S (in dbSNP:rs45516593)	17344846	1
Q96Q15/V829I	Q96Q15	SMG1	SMG1_HUMAN	V829I	-	-	-	-	IPLDVvSNNNH									VARIANT	V -> I	17344846	1
Q96Q40/E276D	Q96Q40	CDK15	CDK15_HUMAN	E276D	591	αF	-	-	LLGATeSSELD	0.186	0.2	0.562	0.234	0.121	0.144	0.716	0.24	VARIANT	E -> D (in a breast infiltrating ductal carcinoma sample; somatic mutation; dbSNP:rs1490814436)	17344846	1
Q96Q40/K93E	Q96Q40	CDK15	CDK15_HUMAN	K93E	21	N-term-β1	-	-	GFQWRkLPFGA	0.382	0.396	0.503	0.358	0.22	0.33	0.592	0.206	VARIANT	K -> E (in a renal clear cell carcinoma sample; somatic mutation)	17344846	1
Q96Q40/Q127R	Q96Q40	CDK15	CDK15_HUMAN	Q127R	76	β2/β3-loop	-	-	SRINGqVALKV	0.233	0.171	0.521	0.186	0.142	0.203	0.662	0.149	VARIANT	Q -> R (in dbSNP:rs56135556)	17344846	1
Q96Q40/R64G	Q96Q40	CDK15	CDK15_HUMAN	R64G	-	-	-	-	GLQAArQKFKS									VARIANT	R -> G (in dbSNP:rs34776344)	17344846	1
Q96Q40/T255I	Q96Q40	CDK15	CDK15_HUMAN	T255I	542	A-loop	-	neutral	SIPSQtSSEVV	0.332	0.33	0.526	0.393	0.245	0.374	0.565	0.294	VARIANT	T -> I (in dbSNP:rs34851370)	17344846	1
Q96QP1/A1160G	Q96QP1	ALPK1	ALPK1_HUMAN	A1160G	-	-	-	-	TEYGLaGHFSY									VARIANT	A -> G (in dbSNP:rs55696324)	17344846	1
Q96QP1/D231A	Q96QP1	ALPK1	ALPK1_HUMAN	D231A	-	-	-	-	ALPQPdKGLST									MUTAGEN	D->A: Impaired ADP-D-glycero-beta-D-manno-heptose-binding and ability to activate the serine/threonine-protein kinase activity; when associated with A-67.	30111836	1
Q96QP1/E910D	Q96QP1	ALPK1	ALPK1_HUMAN	E910D	-	-	-	neutral	CTTTEeNQPGN									VARIANT	E -> D (in dbSNP:rs35308602)	17344846	1
Q96QP1/F295K	Q96QP1	ALPK1	ALPK1_HUMAN	F295K	-	-	-	-	AYTPLfLTAVN									MUTAGEN	F->K: Impaired ADP-D-glycero-beta-D-manno-heptose-binding and ability to activate the serine/threonine-protein kinase activity; when associated with E-237.	30111836	1
Q96QP1/G565D	Q96QP1	ALPK1	ALPK1_HUMAN	G565D	-	-	-	neutral	SDYSNgGAVFN									VARIANT	G -> D (in dbSNP:rs2074388)	10021370,10819331,14702039,17344846	4
Q96QP1/G681D	Q96QP1	ALPK1	ALPK1_HUMAN	G681D	-	-	-	neutral	PHNTPgFLAPG									VARIANT	G -> D (in dbSNP:rs35519493)	14702039,17344846	2
Q96QP1/G870S	Q96QP1	ALPK1	ALPK1_HUMAN	G870S	-	-	-	-	CTNGHgHRLCI									VARIANT	G -> S (in dbSNP:rs2074380)	17344846	1
Q96QP1/H1008P	Q96QP1	ALPK1	ALPK1_HUMAN	H1008P	-	-	-	-	KPSQLhAHSAL									VARIANT	H -> P (in dbSNP:rs34079946)		0
Q96QP1/H642R	Q96QP1	ALPK1	ALPK1_HUMAN	H642R	-	-	-	neutral	AMHSLhQLHDL									VARIANT	H -> R (in dbSNP:rs13148353)	10021370,10819331,14702039,17344846	4
Q96QP1/K1067M	Q96QP1	ALPK1	ALPK1_HUMAN	K1067M	-	-	-	loss	GRYVGkYKEQK									MUTAGEN	K->M: Abolishes the serine/threonine-protein kinase and ability to initiate the innate immune response.	30111836	1
Q96QP1/K233A	Q96QP1	ALPK1	ALPK1_HUMAN	K233A	-	-	-	-	PQPDKkLSTSL									MUTAGEN	K->A: Impaired ADP-D-glycero-beta-D-manno-heptose-binding and ability to activate the serine/threonine-protein kinase activity.	30111836	1
Q96QP1/K339E	Q96QP1	ALPK1	ALPK1_HUMAN	K339E	-	-	-	-	IGLLTkDDEPV									VARIANT	K -> E (in an ovarian mucinous carcinoma sample; somatic mutation)	17344846	1
Q96QP1/K383E	Q96QP1	ALPK1	ALPK1_HUMAN	K383E	-	-	-	neutral	ASQLCkAMGKL									VARIANT	K -> E (in dbSNP:rs147641444)	17344846	1
Q96QP1/L1117P	Q96QP1	ALPK1	ALPK1_HUMAN	L1117P	-	-	-	-	PSTILlLEDKT									VARIANT	L -> P (in dbSNP:rs35756863)	17344846	1
Q96QP1/L320M	Q96QP1	ALPK1	ALPK1_HUMAN	L320M	-	-	-	-	DCPPElNLHLC									VARIANT	L -> M (in dbSNP:rs757602009)	17344846	1
Q96QP1/M732I	Q96QP1	ALPK1	ALPK1_HUMAN	M732I	-	-	-	neutral	GRPKNmTHPSV									VARIANT	M -> I (in dbSNP:rs2074379)	10021370,10819331,14702039,17344846	4
Q96QP1/M861T	Q96QP1	ALPK1	ALPK1_HUMAN	M861T	-	-	-	neutral	QLLDSmVPCTN									VARIANT	M -> T (in dbSNP:rs11726117)	10021370,10819331,14702039,17344846	4
Q96QP1/N175D	Q96QP1	ALPK1	ALPK1_HUMAN	N175D	-	-	-	neutral	SLISNnATGTW									VARIANT	N -> D (in dbSNP:rs6533616)	17344846	1
Q96QP1/N916D	Q96QP1	ALPK1	ALPK1_HUMAN	N916D	-	-	-	neutral	GNQPGnLNCSQ									VARIANT	N -> D (in dbSNP:rs2074381)	17344846	1
Q96QP1/P660L	Q96QP1	ALPK1	ALPK1_HUMAN	P660L	-	-	-	neutral	NDNLEpQNQPQ									VARIANT	P -> L (in dbSNP:rs35389530)	17344846	1
Q96QP1/P935L	Q96QP1	ALPK1	ALPK1_HUMAN	P935L	-	-	-	-	WWLKSpFSSGS									VARIANT	P -> L (in dbSNP:rs34780600)	17344846	1
Q96QP1/Q67A	Q96QP1	ALPK1	ALPK1_HUMAN	Q67A	-	-	-	-	VPEKWqKQAVG									MUTAGEN	Q->A: Impaired ADP-D-glycero-beta-D-manno-heptose-binding and ability to activate the serine/threonine-protein kinase activity; when associated with A-231.	30111836	1
Q96QP1/Q67R	Q96QP1	ALPK1	ALPK1_HUMAN	Q67R	-	-	-	neutral	VPEKWqKQAVG									VARIANT	Q -> R (in dbSNP:rs33943680)	17344846	1
Q96QP1/R1084Q	Q96QP1	ALPK1	ALPK1_HUMAN	R1084Q	-	-	-	neutral	FTDVErMTAQH									VARIANT	R -> Q (in dbSNP:rs34677416)	17344846	1
Q96QP1/R116A	Q96QP1	ALPK1	ALPK1_HUMAN	R116A	-	-	-	-	VFLVDrLYGLD									MUTAGEN	R->A: Impaired ADP-D-glycero-beta-D-manno-heptose-binding and ability to activate the serine/threonine-protein kinase activity.	30111836	1
Q96QP1/R150A	Q96QP1	ALPK1	ALPK1_HUMAN	R150A	-	-	-	-	PQVVIrARISV									MUTAGEN	R->A: Impaired ADP-D-glycero-beta-D-manno-heptose-binding and ability to activate the serine/threonine-protein kinase activity.	30111836	1
Q96QP1/R153A	Q96QP1	ALPK1	ALPK1_HUMAN	R153A	-	-	-	-	VIRQArSVNSG									MUTAGEN	R->A: Impaired ADP-D-glycero-beta-D-manno-heptose-binding and ability to activate the serine/threonine-protein kinase activity.	30111836	1
Q96QP1/R873I	Q96QP1	ALPK1	ALPK1_HUMAN	R873I	-	-	-	neutral	GHGSHrCILRQ									VARIANT	R -> I (in dbSNP:rs34946272)	17344846	1
Q96QP1/T237E	Q96QP1	ALPK1	ALPK1_HUMAN	T237E	-	-	-	-	KKGLStLGILA									MUTAGEN	T->E: Impaired ADP-D-glycero-beta-D-manno-heptose-binding and ability to activate the serine/threonine-protein kinase activity; when associated with K-295.	30111836	1
Q96QP1/T237M	Q96QP1	ALPK1	ALPK1_HUMAN	T237M	-	-	-	-	KKGLStLGILA									VARIANT	T -> M (in ROSAH)	30967659,31939038	2
Q96QP1/T292M	Q96QP1	ALPK1	ALPK1_HUMAN	T292M	-	-	-	-	AFSAYtLFVLT									VARIANT	T -> M (in dbSNP:rs34120296)	17344846	1
Q96QS6/A176S	Q96QS6	PSKH2	KPSH2_HUMAN	A176S	425	αE	-	neutral	IRYLHaQITHR	0.069	0.079	0.462	0.125	0.102	0.093	0.667	0.084	VARIANT	A -> S (in dbSNP:rs6998760)	17344846	1
Q96QS6/G211R	Q96QS6	PSKH2	KPSH2_HUMAN	G211R	509	A-loop	-	neutral	GLAYSgKSGDW	0.282	0.345	0.441	0.354	0.241	0.256	0.559	0.347	VARIANT	G -> R (in dbSNP:rs36074412)	17344846	1
Q96QS6/G72D	Q96QS6	PSKH2	KPSH2_HUMAN	G72D	42	β1;Gly-rich-loop	-	-	ALIGTgFSRVV	0.876	0.898	0.368	0.724	0.765	0.834	0.354	0.416	VARIANT	G -> D (in dbSNP:rs56407605)	17344846	1
Q96QS6/I336V	Q96QS6	PSKH2	KPSH2_HUMAN	I336V	839	C-term-αI	-	neutral	NLQRAiRNLMQ	0.085	0.092	0.445	0.113	0.096	0.101	0.631	0.129	VARIANT	I -> V (in dbSNP:rs16876805)	17344846	1
Q96QS6/K212I	Q96QS6	PSKH2	KPSH2_HUMAN	K212I	510	A-loop	-	-	LAYSGkSGDWT	0.74	0.736	0.67	0.72	0.346	0.643	0.728	0.388	VARIANT	K -> I (in a lung adenocarcinoma sample; somatic mutation; dbSNP:rs778066815)	17344846	1
Q96QS6/Q132R	Q96QS6	PSKH2	KPSH2_HUMAN	Q132R	241	β4/β5-loop	-	neutral	FETEDqYMVME	0.151	0.135	0.414	0.128	0.171	0.123	0.555	0.13	VARIANT	Q -> R (in dbSNP:rs16879427)	17344846	1
Q96QS6/R114Q	Q96QS6	PSKH2	KPSH2_HUMAN	R114Q	180	αC/β4-loop	-	-	LSVLRrSHRYI	0.398	0.434	0.508	0.382	0.359	0.387	0.559	0.271	VARIANT	R -> Q (in dbSNP:rs35915498)	17344846	1
Q96QS6/R148Q	Q96QS6	PSKH2	KPSH2_HUMAN	R148Q	267	αD	-	-	GELFDrIAQGS	0.705	0.595	0.453	0.523	0.459	0.62	0.492	0.284	VARIANT	R -> Q (in dbSNP:rs56356246)	17344846	1
Q96QS6/R79K	Q96QS6	PSKH2	KPSH2_HUMAN	R79K	50	β2	-	neutral	FSRVVrEQKTT	0.121	0.108	0.471	0.188	0.081	0.11	0.633	0.152	VARIANT	R -> K (in dbSNP:rs35315725)	17344846	1
Q96QS6/S116I	Q96QS6	PSKH2	KPSH2_HUMAN	S116I	184	αC/β4-loop	-	-	VLRRVsRYIVQ	0.614	0.556	0.603	0.476	0.418	0.464	0.634	0.227	VARIANT	S -> I (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
Q96QS6/S266R	Q96QS6	PSKH2	KPSH2_HUMAN	S266R	627	αF/αG	-	neutral	PFDDEsTRLYR	0.16	0.195	0.413	0.207	0.235	0.151	0.552	0.079	VARIANT	S -> R (in dbSNP:rs34037815)	17344846	1
Q96QS6/T225A	Q96QS6	PSKH2	KPSH2_HUMAN	T225A	549	A-loop	-	neutral	KTLCGtEYIAP	0.55	0.603	0.267	0.488	0.621	0.592	0.23	0.348	VARIANT	T -> A (in dbSNP:rs34457516)	17344846	1
Q96QT4/A1033G	Q96QT4	TRPM7	TRPM7_HUMAN	A1033G	-	-	-	-	PSWTLaDIVFH									VARIANT	A -> G (in dbSNP:rs34530969)		0
Q96QT4/A1254V	Q96QT4	TRPM7	TRPM7_HUMAN	A1254V	-	-	-	-	LTAQKaEASKV									VARIANT	A -> V (in dbSNP:rs56288221)	17344846	1
Q96QT4/D1306E	Q96QT4	TRPM7	TRPM7_HUMAN	D1306E	-	-	-	-	SLPQGdESNNP									VARIANT	D -> E (in dbSNP:rs55970334)	17344846	1
Q96QT4/F949Y	Q96QT4	TRPM7	TRPM7_HUMAN	F949Y	-	-	-	-	GAKWNfNAYDN									VARIANT	F -> Y (in dbSNP:rs55681028)	17344846	1
Q96QT4/G1046D	Q96QT4	TRPM7	TRPM7_HUMAN	G1046D	-	-	-	-	YWMIFgVYAYE									VARIANT	G -> D (probable disease-associated variant found in a patient with hypomagnesemia and secondary hypocalcemia; de novo variant; causes severely reduced Mg(2+) uptake in transfected cells; dbSNP:rs2059709974)	35561741	1
Q96QT4/G1799D	Q96QT4	TRPM7	TRPM7_HUMAN	G1799D	-	-	-	loss	GPANLgDAIKN									MUTAGEN	G->D: Loss of kinase activity.	12887921	1
Q96QT4/G68V	Q96QT4	TRPM7	TRPM7_HUMAN	G68V	-	-	-	-	SDVKLgHFNQA									VARIANT	G -> V (in dbSNP:rs56064201)	17344846	1
Q96QT4/I1145V	Q96QT4	TRPM7	TRPM7_HUMAN	I1145V	-	-	-	-	SLFCCiKRRKK									VARIANT	I -> V (in dbSNP:rs34711809)		0
Q96QT4/I1211T	Q96QT4	TRPM7	TRPM7_HUMAN	I1211T	-	-	-	-	QMCIQiEVGDR									VARIANT	I -> T (in dbSNP:rs56090496)	17344846	1
Q96QT4/I459T	Q96QT4	TRPM7	TRPM7_HUMAN	I459T	-	-	-	-	FVKLLiNGVSM									VARIANT	I -> T (in dbSNP:rs55924090)	17344846	1
Q96QT4/K1648R	Q96QT4	TRPM7	TRPM7_HUMAN	K1648R	-	-	-	loss	HLYIIkFLPEV									MUTAGEN	K->R: Loss of kinase activity.	12887921	1
Q96QT4/K574N	Q96QT4	TRPM7	TRPM7_HUMAN	K574N	-	-	-	-	ADKKEkRHNHF									VARIANT	K -> N (in dbSNP:rs56040619)	17344846	1
Q96QT4/M830V	Q96QT4	TRPM7	TRPM7_HUMAN	M830V	-	-	-	-	EGKNEmIQMKS									VARIANT	M -> V (in a gastric adenocarcinoma sample; somatic mutation)	17344846	1
Q96QT4/Q1064R	Q96QT4	TRPM7	TRPM7_HUMAN	Q1064R	-	-	-	-	DSVIPqCGPGT									VARIANT	Q -> R (in dbSNP:rs56298128)	17344846	1
Q96QT4/R1444K	Q96QT4	TRPM7	TRPM7_HUMAN	R1444K	-	-	-	-	AFVGHrSMDLQ									VARIANT	R -> K (in dbSNP:rs55840070)	17344846	1
Q96QT4/S406C	Q96QT4	TRPM7	TRPM7_HUMAN	S406C	-	-	-	-	KGTNAsFDQLI									VARIANT	S -> C (in an ovarian serous carcinoma sample; somatic mutation)	17344846	1
Q96QT4/T1482I	Q96QT4	TRPM7	TRPM7_HUMAN	T1482I	-	-	p	-	SLAGFtCHRTS									VARIANT	T -> I (mutant channels are functional but show increased susceptibility to inhibition by intracellular magnesium concentrations compared to wild-type channels; dbSNP:rs8042919)	14702039,16051700,17344846	3
Q96QT4/T720S	Q96QT4	TRPM7	TRPM7_HUMAN	T720S	-	-	-	-	NWSNStLKLAV									VARIANT	T -> S (in a breast infiltrating ductal carcinoma sample; somatic mutation; dbSNP:rs1040254222)	17344846	1
Q96RG2/A1151K	Q96RG2	PASK	PASK_HUMAN	A1151K	502	A-loop	-	decrease	DFGSAaLERGK	0.678	0.647	0.571	0.499	0.473	0.542	0.576	0.32	MUTAGEN	A->K: Induces lower protein kinase activity and ability to autophosphorylate.	20943661	1
Q96RG2/E11K	Q96RG2	PASK	PASK_HUMAN	E11K	-	-	-	-	LTAFEeQRCLS									VARIANT	E -> K (in a metastatic melanoma sample; somatic mutation; dbSNP:rs1277219458)	17344846	1
Q96RG2/E796K	Q96RG2	PASK	PASK_HUMAN	E796K	-	-	-	neutral	VLDDReLLLTG									VARIANT	E -> K (in dbSNP:rs35129131)	17344846	1
Q96RG2/F1266C	Q96RG2	PASK	PASK_HUMAN	F1266C	838	C-term-αI	-	-	TWEEVfVNKPE	0.307	0.254	0.441	0.279	0.228	0.252	0.625	0.177	VARIANT	F -> C (in dbSNP:rs1131293)	11459942,17344846,8590280	3
Q96RG2/G725D	Q96RG2	PASK	PASK_HUMAN	G725D	-	-	-	neutral	TDLPGgEAVEA									VARIANT	G -> D (in dbSNP:rs2005771)	17344846	1
Q96RG2/K1028R	Q96RG2	PASK	PASK_HUMAN	K1028R	129	β3;Catalytic-Lys	-	loss	KEVVVkIKKEK	1.0	1.0	0.039	0.727	0.998	0.998	0.009	0.41	MUTAGEN	K->R: Loss of autophosphorylating activity.	11459942,20943661	2
Q96RG2/L514S	Q96RG2	PASK	PASK_HUMAN	L514S	-	-	-	neutral	QQITAlREEPV									VARIANT	L -> S (in dbSNP:rs2240543)	17344846	1
Q96RG2/P1301S	Q96RG2	PASK	PASK_HUMAN	P1301S	-	-	-	-	ELCGGpPGEAP									VARIANT	P -> S	17344846	1
Q96RG2/P684R	Q96RG2	PASK	PASK_HUMAN	P684R	-	-	-	-	HAELVpECQAV									VARIANT	P -> R (in dbSNP:rs56372985)	17344846	1
Q96RG2/P844Q	Q96RG2	PASK	PASK_HUMAN	P844Q	-	-	-	neutral	SDRESpHVPST									VARIANT	P -> Q (in dbSNP:rs36082918)	17344846	1
Q96RG2/Q426R	Q96RG2	PASK	PASK_HUMAN	Q426R	-	-	-	-	TLDPWqQDPAE									VARIANT	Q -> R (in dbSNP:rs35187712)	17344846	1
Q96RG2/R1058A	Q96RG2	PASK	PASK_HUMAN	R1058A	180	αC/β4-loop	-	decrease	IAILSrEHANI	0.485	0.489	0.434	0.301	0.492	0.422	0.415	0.164	MUTAGEN	R->A: Induces lower protein kinase activity.	20943661	1
Q96RG2/R1058K	Q96RG2	PASK	PASK_HUMAN	R1058K	180	αC/β4-loop	-	-	IAILSrEHANI	0.236	0.221	0.426	0.177	0.286	0.218	0.539	0.156	MUTAGEN	R->K: Does not affect protein kinase activity.	20943661	1
Q96RG2/R937H	Q96RG2	PASK	PASK_HUMAN	R937H	-	-	-	neutral	LLHSQrSAART									VARIANT	R -> H (in dbSNP:rs56139954)	17344846	1
Q96RG2/T1161A	Q96RG2	PASK	PASK_HUMAN	T1161A	545	A-loop	p	loss	GKLFYtCGTIE	0.96	0.977	0.188	0.8	0.869	0.94	0.186	0.246	MUTAGEN	T->A: Loss of catalytic activity (PubMed:11459942). According to another report, does not affect the protein kinase activity (PubMed:20943661). Does not affect protein translation.	11459942,20943661,11459942,17595531,20943661	5
Q96RG2/T1165A	Q96RG2	PASK	PASK_HUMAN	T1165A	549	A-loop	p	loss	YTFCGtEYCAP	0.952	0.956	0.3	0.814	0.896	0.943	0.205	0.588	MUTAGEN	T->A: Loss of catalytic activity. Does not affect protein translation.	11459942,17595531	2
Q96RG2/T512A	Q96RG2	PASK	PASK_HUMAN	T512A	-	-	-	-	KDQQItLGREE									VARIANT	T -> A (in dbSNP:rs56033464)	17344846	1
Q96RG2/V1210M	Q96RG2	PASK	PASK_HUMAN	V1210M	671	αG/αH	-	neutral	ELEETvAAIHP	0.083	0.059	0.438	0.103	0.067	0.075	0.687	0.056	VARIANT	V -> M (in dbSNP:rs10167000)	17344846	1
Q96RG2/V250I	Q96RG2	PASK	PASK_HUMAN	V250I	-	-	-	neutral	QSDGTvSCDSL									VARIANT	V -> I (in dbSNP:rs1470414)	15489334,17344846	2
Q96RG2/V694M	Q96RG2	PASK	PASK_HUMAN	V694M	-	-	-	neutral	AVTAPvSCDLG									VARIANT	V -> M (in dbSNP:rs6727226)	8590280	1
Q96RG2/Y1152F	Q96RG2	PASK	PASK_HUMAN	Y1152F	506	A-loop	-	decrease	FGSAAyERGKL	0.45	0.469	0.427	0.275	0.498	0.424	0.505	0.121	MUTAGEN	Y->F: Induces lower protein kinase activity.	20943661	1
Q96RR4/A182T	Q96RR4	CAMKK2	KKCC2_HUMAN	A182T	53	β2	-	-	GVVKLaNENDN	0.748	0.785	0.444	0.614	0.555	0.636	0.504	0.531	VARIANT	A -> T (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs1207121718)	17344846	1
Q96RR4/C123Y	Q96RR4	CAMKK2	KKCC2_HUMAN	C123Y	-	-	-	neutral	NGRCIcSLPYS									VARIANT	C -> Y (in dbSNP:rs35403710)	17344846	1
Q96RR4/P127L	Q96RR4	CAMKK2	KKCC2_HUMAN	P127L	-	-	-	-	ICPSLpSPVSS									VARIANT	P -> L (in a lung neuroendocrine carcinoma sample; somatic mutation)	17344846	1
Q96RR4/R363C	Q96RR4	CAMKK2	KKCC2_HUMAN	R363C	590	αF	-	neutral	SLSETrIFSGK	0.225	0.203	0.555	0.334	0.182	0.159	0.686	0.179	VARIANT	R -> C (in dbSNP:rs1132780)		0
Q96RR4/R492H	Q96RR4	CAMKK2	KKCC2_HUMAN	R492H	-	-	-	-	VKTMIrRSFGN									VARIANT	R -> H (in dbSNP:rs34129994)	17344846	1
Q96RR4/S10N	Q96RR4	CAMKK2	KKCC2_HUMAN	S10N	-	-	-	neutral	VSSQPsNRAAP									VARIANT	S -> N (in dbSNP:rs28360477)	17344846	1
Q96RR4/T85S	Q96RR4	CAMKK2	KKCC2_HUMAN	T85S	-	-	p	neutral	EVPLDtGSQAR									VARIANT	T -> S (in dbSNP:rs3817190)	11395482,15489334,17344846,9872452	4
Q96RU7/E347K	Q96RU7	TRIB3	TRIB3_HUMAN	E347K	-	-	-	-	LDEAReEGDRE									VARIANT	E -> K (in dbSNP:rs56342286)	17344846	1
Q96RU7/Q84R	Q96RU7	TRIB3	TRIB3_HUMAN	Q84R	-	-	-	-	GGRAYqLHCPT									VARIANT	Q -> R (in dbSNP:rs2295490)	15489334,17344846	2
Q96RU7/R153H	Q96RU7	TRIB3	TRIB3_HUMAN	R153H	-	-	-	neutral	VRSRHrPEPEA									VARIANT	R -> H (in dbSNP:rs35051116)	17344846	1
Q96RU7/R274H	Q96RU7	TRIB3	TRIB3_HUMAN	R274H	-	-	-	-	LFGKIrGAYAL									VARIANT	R -> H (in dbSNP:rs56291463)	17344846	1
Q96RU7/T60I	Q96RU7	TRIB3	TRIB3_HUMAN	T60I	-	-	-	-	APDRAtVATAS									VARIANT	T -> I (in a glioblastoma multiforme sample; somatic mutation; dbSNP:rs757496714)	17344846	1
Q96RU8/D355A	Q96RU8	TRIB1	TRIB1_HUMAN	D355A	-	-	-	-	EIGTSdIVPEY									MUTAGEN	D->A: Decreased interaction with COP1.	27041596	1
Q96RU8/E360A	Q96RU8	TRIB1	TRIB1_HUMAN	E360A	-	-	-	-	DQIVPeQEDSD									VARIANT	E->A: Decreased interaction with COP1.	27041596	1
Q96RU8/E360D	Q96RU8	TRIB1	TRIB1_HUMAN	E360D	-	-	-	neutral	DQIVPeQEDSD									VARIANT	E -> D (in dbSNP:rs16900603)	17344846	1
Q96RU8/I357A	Q96RU8	TRIB1	TRIB1_HUMAN	I357A	-	-	-	-	GTSDQiPEYQE									MUTAGEN	I->A: Decreased interaction with COP1.	27041596	1
Q96RU8/P359A	Q96RU8	TRIB1	TRIB1_HUMAN	P359A	-	-	-	-	SDQIVpYQEDS									MUTAGEN	P->A: Strongly decreased interaction with COP1.	27041596	1
Q96RU8/Q356A	Q96RU8	TRIB1	TRIB1_HUMAN	Q356A	-	-	-	-	IGTSDqVPEYQ									MUTAGEN	Q->A: Decreased interaction with COP1.	27041596	1
Q96RU8/R298C	Q96RU8	TRIB1	TRIB1_HUMAN	R298C	-	-	-	-	FSKIRrQFCIP									VARIANT	R -> C (in dbSNP:rs55953723)	17344846	1
Q96RU8/S173R	Q96RU8	TRIB1	TRIB1_HUMAN	S173R	-	-	-	-	HSYVRsKRLRE									VARIANT	S -> R (in dbSNP:rs56285697)	17344846	1
Q96RU8/T215M	Q96RU8	TRIB1	TRIB1_HUMAN	T215M	-	-	-	-	KFVFStERTQL									VARIANT	T -> M (in dbSNP:rs34349706)	17344846	1
Q96RU8/V267I	Q96RU8	TRIB1	TRIB1_HUMAN	V267I	-	-	-	-	GKAADvSLGVM									VARIANT	V -> I (in dbSNP:rs56056430)	17344846	1
Q96RU8/V358A	Q96RU8	TRIB1	TRIB1_HUMAN	V358A	-	-	-	-	TSDQIvEYQED									MUTAGEN	V->I,A: Loss of interaction with COP1.	27041596	1
Q96RU8/V358I	Q96RU8	TRIB1	TRIB1_HUMAN	V358I	-	-	-	-	TSDQIvEYQED									MUTAGEN	V->I,A: Loss of interaction with COP1.	27041596	1
Q96RU8/Y361A	Q96RU8	TRIB1	TRIB1_HUMAN	Y361A	-	-	-	-	QIVPEyEDSDI									MUTAGEN	Y->A: No effect on interaction with COP1.	27041596	1
Q96S38/A546P	Q96S38	RPS6KC1	KS6C1_HUMAN	A546P	-	-	-	neutral	GVDTKaKSFPA									VARIANT	A -> P (in dbSNP:rs35281247)	17344846	1
Q96S38/C1003Y	Q96S38	RPS6KC1	KS6C1_HUMAN	C1003Y	624	αF/αG	-	-	KTLVEcPAGIN	0.705	0.71	0.471	0.598	0.468	0.659	0.531	0.554	VARIANT	C -> Y (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
Q96S38/E1022K	Q96S38	RPS6KC1	KS6C1_HUMAN	E1022K	782	αH	-	-	PECVSeARSLI	0.135	0.159	0.529	0.197	0.114	0.12	0.715	0.113	VARIANT	E -> K (in a breast infiltrating ductal carcinoma sample; somatic mutation)	17344846	1
Q96S38/E96K	Q96S38	RPS6KC1	KS6C1_HUMAN	E96K	-	-	-	-	DETVIeRRQCA									VARIANT	E -> K (in dbSNP:rs56032860)	17344846	1
Q96S38/G663A	Q96S38	RPS6KC1	KS6C1_HUMAN	G663A	-	-	-	-	DTISRgDDSVP									VARIANT	G -> A (in an ovarian mucinous carcinoma sample; somatic mutation)	17344846	1
Q96S38/L554I	Q96S38	RPS6KC1	KS6C1_HUMAN	L554I	-	-	-	-	SFPAHlADSDS									VARIANT	L -> I (in a lung neuroendocrine carcinoma sample; somatic mutation)	17344846	1
Q96S38/L853F	Q96S38	RPS6KC1	KS6C1_HUMAN	L853F	-	-	-	neutral	DQTDDlKEEPT									VARIANT	L -> F (in dbSNP:rs34080597)	17344846	1
Q96S38/N575S	Q96S38	RPS6KC1	KS6C1_HUMAN	N575S	-	-	-	neutral	LKFFPnDPEAV									VARIANT	N -> S (in dbSNP:rs56060894)	17344846	1
Q96S38/P319L	Q96S38	RPS6KC1	KS6C1_HUMAN	P319L	-	-	-	neutral	DVSQPpSLSSR									VARIANT	P -> L (in dbSNP:rs56369827)	17344846	1
Q96S38/P424L	Q96S38	RPS6KC1	KS6C1_HUMAN	P424L	-	-	-	neutral	FLNRSpESFDI									VARIANT	P -> L (in dbSNP:rs56183862)	17344846	1
Q96S38/P42T	Q96S38	RPS6KC1	KS6C1_HUMAN	P42T	-	-	-	-	VSRRNpDVQEI									VARIANT	P -> T (in dbSNP:rs56087470)	17344846	1
Q96S38/P561R	Q96S38	RPS6KC1	KS6C1_HUMAN	P561R	-	-	-	-	ADSDSpTQLRA									VARIANT	P -> R (in dbSNP:rs17020314)		0
Q96S44/A25T	Q96S44	TP53RK	PRPK_HUMAN	A25T	-	-	-	-	EALAAaERSSR									VARIANT	A -> T		0
Q96S44/G42D	Q96S44	TP53RK	PRPK_HUMAN	G42D	-	-	-	-	ELVKQgEARVF									VARIANT	G -> D (in GAMOS4; dbSNP:rs773814837)	28805828	1
Q96S44/R123Q	Q96S44	TP53RK	PRPK_HUMAN	R123Q	265	αD	-	neutral	GSVTVrYIQST	0.181	0.133	0.492	0.174	0.109	0.127	0.674	0.066	VARIANT	R -> Q (in dbSNP:rs34983477)	17344846	1
Q96S44/R243L	Q96S44	TP53RK	PRPK_HUMAN	R243L	-	-	-	-	KLDEVrRGRKR									VARIANT	R -> L (in GAMOS4; dbSNP:rs776588426)	28805828	1
Q96S44/T129A	Q96S44	TP53RK	PRPK_HUMAN	T129A	285	αD/αE-loop	-	neutral	DYIQStETEKT	0.206	0.2	0.477	0.189	0.269	0.178	0.565	0.11	VARIANT	T -> A (in dbSNP:rs11550540)	17344846	1
Q96S44/T145A	Q96S44	TP53RK	PRPK_HUMAN	T145A	409	αE	-	-	SNLAKtGQVLA	0.197	0.199	0.337	0.131	0.247	0.242	0.512	0.163	VARIANT	T -> A (in dbSNP:rs56008408)	17344846	1
Q96S44/T81R	Q96S44	TP53RK	PRPK_HUMAN	T81R	170	αC	-	-	LGRRRtQEARA	0.693	0.543	0.418	0.488	0.454	0.551	0.456	0.409	VARIANT	T -> R (in GAMOS4; abolished interaction with TPRKB; dbSNP:rs1432218739)	28805828	1
Q96S53/G11A	Q96S53	TESK2	TESK2_HUMAN	G11A	-	-	-	-	RNSIAgPPRVE									VARIANT	G -> A (in a breast infiltrating ductal carcinoma sample; somatic mutation; dbSNP:rs1428512439)	17344846	1
Q96SB4/I72T	Q96SB4	SRPK1	SRPK1_HUMAN	I72T	25	N-term-β1	-	-	YHLVKiDLFNG	0.758	0.79	0.434	0.582	0.587	0.806	0.419	0.468	VARIANT	I -> T (in dbSNP:rs35519113)		0
Q96SB4/S222A	Q96SB4	SRPK1	SRPK1_HUMAN	S222A	452	Catalytic-loop	-	-	ENILLsNEQYI	0.367	0.299	0.541	0.316	0.227	0.252	0.694	0.265	MUTAGEN	S->A: No effect on protein phosphorylation.	12565829	1
Q96SB4/S311G	Q96SB4	SRPK1	SRPK1_HUMAN	S311G	-	-	p	-	QEESEsVERPL									MUTAGEN	S->G: No effect on protein phosphorylation.	12565829	1
Q96SB4/S37A	Q96SB4	SRPK1	SRPK1_HUMAN	S37A	-	-	p	-	GSAPHsSDLPE									MUTAGEN	S->A: No effect on protein phosphorylation.	12565829	1
Q96SB4/S436G	Q96SB4	SRPK1	SRPK1_HUMAN	S436G	-	-	-	-	STVGQsSEQHI									MUTAGEN	S->G: No effect on protein phosphorylation.	12565829	1
Q96SB4/S51A	Q96SB4	SRPK1	SRPK1_HUMAN	S51A	4	N-term-β1	p	decrease	EEILGsDDEQE	0.85	0.863	0.554	0.789	0.615	0.785	0.564	0.5	MUTAGEN	S->A: Protein phosphorylation impaired at this position.	12565829	1
Q96SB4/S555A	Q96SB4	SRPK1	SRPK1_HUMAN	S555A	627	αF/αG	p	decrease	LFEPHsEEYTR	0.792	0.849	0.487	0.77	0.655	0.664	0.491	0.16	MUTAGEN	S->A: Protein phosphorylation impaired at this position.	12565829	1
Q96SB4/S619A	Q96SB4	SRPK1	SRPK1_HUMAN	S619A	777	αG/αH	-	-	EKYEWsEEAAG	0.271	0.27	0.471	0.234	0.34	0.219	0.528	0.144	MUTAGEN	S->A: No effect on protein phosphorylation.	12565829	1
Q99558/G514K	Q99558	MAP3K14	M3K14_HUMAN	G514K	442	Catalytic-loop;HrD-motif	-	-	RRILHgVKADN	0.294	0.236	0.417	0.334	0.26	0.227	0.604	0.155	VARIANT	G -> K (in a lung neuroendocrine carcinoma sample; somatic mutation; requires 2 nucleotide substitutions)	17344846	1
Q99558/H674Y	Q99558	MAP3K14	M3K14_HUMAN	H674Y	851	C-term-αI	-	-	YKEPRhPPNQA	0.373	0.393	0.498	0.372	0.168	0.255	0.677	0.258	VARIANT	H -> Y (in dbSNP:rs11867907)		0
Q99558/P928H	Q99558	MAP3K14	M3K14_HUMAN	P928H	-	-	-	-	QCTLApGSFAW									VARIANT	P -> H (in dbSNP:rs56036201)	17344846	1
Q99558/S140N	Q99558	MAP3K14	M3K14_HUMAN	S140N	-	-	-	-	KGKRRsARKKR									VARIANT	S -> N (in dbSNP:rs11574819)	17344846	1
Q99558/T255M	Q99558	MAP3K14	M3K14_HUMAN	T255M	-	-	-	-	PLPLPtPFPYS									VARIANT	T -> M (in dbSNP:rs11574820)		0
Q99558/T559A	Q99558	MAP3K14	M3K14_HUMAN	T559A	549	A-loop	p	-	DYIPGtTHMAP	0.836	0.871	0.435	0.782	0.799	0.829	0.355	0.36	MUTAGEN	T->A: Abolishes 'Lys-63'-linked ubiquitination.	20682767	1
Q99558/T764A	Q99558	MAP3K14	M3K14_HUMAN	T764A	-	-	-	-	PERKAtPEQEL									VARIANT	T -> A (in dbSNP:rs56302559)	17344846	1
Q99558/T852I	Q99558	MAP3K14	M3K14_HUMAN	T852I	-	-	-	-	ARGRPtTPSYF									VARIANT	T -> I (in an ovarian mucinous carcinoma sample; somatic mutation)	17344846	1
Q99570/D393N	Q99570	PIK3R4	PI3R4_HUMAN	D393N	-	-	-	-	TLKYCdKLAAL									VARIANT	D -> N (in dbSNP:rs34633532)	17344846	1
Q99570/F273L	Q99570	PIK3R4	PI3R4_HUMAN	F273L	653	αG/αH	-	-	RNGHFfEQVLN	0.301	0.298	0.435	0.282	0.227	0.251	0.568	0.344	VARIANT	F -> L (in dbSNP:rs55951445)	17344846	1
Q99570/G1043V	Q99570	PIK3R4	PI3R4_HUMAN	G1043V	-	-	-	-	YSRIGgVKTLT									VARIANT	G -> V (in dbSNP:rs56160735)	17344846	1
Q99570/L699V	Q99570	PIK3R4	PI3R4_HUMAN	L699V	-	-	-	neutral	KLMPYlPYITQ									VARIANT	L -> V (in dbSNP:rs56369596)	17344846	1
Q99570/R342H	Q99570	PIK3R4	PI3R4_HUMAN	R342H	-	-	-	-	LSADErLVIRK									VARIANT	R -> H (in dbSNP:rs56295394)	17344846	1
Q99570/R347W	Q99570	PIK3R4	PI3R4_HUMAN	R347W	-	-	-	-	RILVIrDLGNI									VARIANT	R -> W (in dbSNP:rs34797184)	17344846	1
Q99570/R936Q	Q99570	PIK3R4	PI3R4_HUMAN	R936Q	-	-	-	-	STYQIrTTCKT									VARIANT	R -> Q (in a breast cancer sample; somatic mutation; dbSNP:rs181132426)	16959974	1
Q99570/T388I	Q99570	PIK3R4	PI3R4_HUMAN	T388I	-	-	-	-	TSCLQtKYCDS									VARIANT	T -> I (in dbSNP:rs34663155)	17344846	1
Q99640/D251A	Q99640	PKMYT1	PMYT1_HUMAN	D251A	496	A-loop;DFG-motif	-	loss	RCKLGdGLLVE	0.985	0.994	0.097	0.505	0.992	0.972	0.08	0.712	MUTAGEN	D->A: Loss of kinase activity.	10504341	1
Q99640/E103Q	Q99640	PKMYT1	PMYT1_HUMAN	E103Q	26	N-term-β1	-	-	DPSRPeFFQQS	0.396	0.304	0.476	0.22	0.27	0.321	0.574	0.201	VARIANT	E -> Q (in dbSNP:rs55834293)	17344846	1
Q99640/E351K	Q99640	PKMYT1	PMYT1_HUMAN	E351K	814	αI	-	-	LRATAeLLALP	0.226	0.177	0.535	0.257	0.123	0.141	0.703	0.201	VARIANT	E -> K (in dbSNP:rs56382954)	17344846	1
Q99640/N238A	Q99640	PKMYT1	PMYT1_HUMAN	N238A	448	Catalytic-loop	-	loss	DVKPAnFLGPR	0.954	0.946	0.201	0.667	0.921	0.934	0.166	0.722	MUTAGEN	N->A: Loss of kinase activity.	10373560	1
Q99640/P417R	Q99640	PKMYT1	PMYT1_HUMAN	P417R	-	-	-	-	TPPGSpCSLLL									VARIANT	P -> R (in dbSNP:rs4149800)		0
Q99640/R140C	Q99640	PKMYT1	PMYT1_HUMAN	R140C	130	β3	-	-	LYAVKrMSPFR	0.631	0.671	0.578	0.594	0.444	0.567	0.596	0.501	VARIANT	R -> C (in dbSNP:rs4149796)	17344846	1
Q99640/R246H	Q99640	PKMYT1	PMYT1_HUMAN	R246H	482	Catalytic-loop	-	-	LGPRGrKLGDF	0.346	0.229	0.544	0.265	0.229	0.233	0.709	0.172	VARIANT	R -> H (in dbSNP:rs35192104)	17344846	1
Q99640/V445A	Q99640	PKMYT1	PMYT1_HUMAN	V445A	-	-	-	-	LSPEAvARTVG									VARIANT	V -> A (in dbSNP:rs10546)		0
Q99683/D1315N	Q99683	MAP3K5	M3K5_HUMAN	D1315N	-	-	-	neutral	DSELTdLRVNG									VARIANT	D -> N (in dbSNP:rs41288957)	17344846	1
Q99683/G1006R	Q99683	MAP3K5	M3K5_HUMAN	G1006R	-	-	-	-	RAKSCgRDVKG									VARIANT	G -> R (in dbSNP:rs45626535)	17344846	1
Q99683/I1214T	Q99683	MAP3K5	M3K5_HUMAN	I1214T	-	-	-	-	RPQAViDAVAT									VARIANT	I -> T (in dbSNP:rs56379668)	17344846	1
Q99683/I1250V	Q99683	MAP3K5	M3K5_HUMAN	I1250V	-	-	-	neutral	LGRMKiTNRLL									VARIANT	I -> V (in dbSNP:rs35551087)	17344846	1
Q99683/K709M	Q99683	MAP3K5	M3K5_HUMAN	K709M	129	β3;Catalytic-Lys	-	loss	VRIAIkIPERD	1.0	0.996	0.033	0.643	0.994	0.998	0.026	0.514	MUTAGEN	K->M: Loss of kinase activity. Inhibits activation of JNK and apoptosis mediated by TNFRSF6 and DAXX. Does not affect interaction with TRIM48.	17210579,29186683,9743501	3
Q99683/K709R	Q99683	MAP3K5	M3K5_HUMAN	K709R	129	β3;Catalytic-Lys	-	loss	VRIAIkIPERD	1.0	1.0	0.028	0.716	0.998	0.999	0.025	0.508	MUTAGEN	K->R: Loss of kinase activity. Abolishes DAXX-mediated apoptosis. Loss of RC3H2-mediated ubiquitination.	17210579,24448648,9743501	3
Q99683/R32K	Q99683	MAP3K5	M3K5_HUMAN	R32K	-	-	-	-	GGICRrGAAAV									MUTAGEN	R->K: No effect on methylation by PRMT1.	22095282	1
Q99683/R78K	Q99683	MAP3K5	M3K5_HUMAN	R78K	-	-	-	-	SSSATrRGSSV									MUTAGEN	R->K: Reduced methylation by PRMT1. Abolishes methylation by PRMT1 and PRMT1-mediated inhibition of MAPK35 activation; when associated with K-80.	22095282	1
Q99683/R80K	Q99683	MAP3K5	M3K5_HUMAN	R80K	-	-	-	-	SATRGrSSVGG									MUTAGEN	R->K: Reduced methylation by PRMT1. Abolishes methylation by PRMT1 and PRMT1-mediated inhibition of MAPK35 activation; when associated with K-78.	22095282	1
Q99683/S1033A	Q99683	MAP3K5	M3K5_HUMAN	S1033A	-	-	p	increase	HSAPPsEEKDS									MUTAGEN	S->A: Enhanced induction of apoptosis and increased kinase activity.	15094778	1
Q99683/S966A	Q99683	MAP3K5	M3K5_HUMAN	S966A	852	C-term-αI	p	increase	YLRSIsPVPVL	0.725	0.718	0.414	0.641	0.541	0.619	0.492	0.326	MUTAGEN	S->A: Enhanced induction of apoptosis, increased kinase activity, and loss of YWHAG binding.	10411906,15094778	2
Q99683/T1314I	Q99683	MAP3K5	M3K5_HUMAN	T1314I	-	-	-	neutral	EDSELtWLRVN									VARIANT	T -> I (in dbSNP:rs45599539)	17344846	1
Q99683/T838A	Q99683	MAP3K5	M3K5_HUMAN	T838A	545	A-loop	p	-	NPCTEtTGTLQ	0.975	0.959	0.405	0.879	0.659	0.956	0.365	0.375	MUTAGEN	T->A: Does not affect interaction with TRIM48.	29186683	1
Q99759/A325G	Q99759	MAP3K3	M3K3_HUMAN	A325G	-	-	-	-	ENMGLaQYLDP									VARIANT	A -> G (in dbSNP:rs34042309)		0
Q99759/A435G	Q99759	MAP3K3	M3K3_HUMAN	A435G	238	β4/β5-loop	-	-	CLRDRaKTLTI	0.15	0.15	0.499	0.192	0.157	0.095	0.633	0.226	VARIANT	A -> G (in dbSNP:rs9910858)		0
Q99759/V281M	Q99759	MAP3K3	M3K3_HUMAN	V281M	-	-	-	neutral	PRRYHvVHHKD									VARIANT	V -> M (in dbSNP:rs36109904)	17344846	1
Q99986/K179A	Q99986	VRK1	VRK1_HUMAN	K179A	445	Catalytic-loop	-	-	VHGDIkSNLLL	0.899	0.884	0.268	0.636	0.857	0.912	0.206	0.523	MUTAGEN	K->A: Does not affect phosphorylation at S-342.	19103756	1
Q99986/S125A	Q99986	VRK1	VRK1_HUMAN	S125A	240	β4/β5-loop	-	-	DKNGKsRFMIM	0.414	0.462	0.383	0.372	0.366	0.28	0.471	0.24	MUTAGEN	S->A: Does not abolish autophosphorylation.	10951572	1
Q99986/S14A	Q99986	VRK1	VRK1_HUMAN	S14A	5	N-term-β1	-	-	AGRQSsKRHLA	0.309	0.276	0.399	0.224	0.397	0.377	0.496	0.276	MUTAGEN	S->A: Does not abolish autophosphorylation.	10951572	1
Q99986/S150A	Q99986	VRK1	VRK1_HUMAN	S150A	394	αD/αE-loop	-	-	NAKRFsKTVLQ	0.394	0.378	0.401	0.316	0.395	0.27	0.499	0.183	MUTAGEN	S->A: Does not abolish autophosphorylation.	10951572	1
Q99986/S158A	Q99986	VRK1	VRK1_HUMAN	S158A	407	αE	-	-	TVLQLsRILDI	0.172	0.228	0.462	0.165	0.166	0.188	0.581	0.07	MUTAGEN	S->A: Does not abolish autophosphorylation.	10951572	1
Q99986/S239A	Q99986	VRK1	VRK1_HUMAN	S239A	595	αF	-	-	NGVAPsRGDLE	0.709	0.699	0.383	0.482	0.663	0.704	0.36	0.407	MUTAGEN	S->A: Does not abolish autophosphorylation.	10951572	1
Q99986/S342A	Q99986	VRK1	VRK1_HUMAN	S342A	-	-	p	decrease	GKLDLsVENGG									MUTAGEN	S->A: Abolishes phosphorylation by PLK3 and induction of Golgi fragmentation during mitosis. Strongly reduced autophosphorylation.	19103756,21543316	2
Q99986/T102A	Q99986	VRK1	VRK1_HUMAN	T102A	207	β4/β5-loop	-	-	QKWIRtKLKYL	0.118	0.174	0.391	0.085	0.248	0.182	0.527	0.115	MUTAGEN	T->A: Does not abolish autophosphorylation.	10951572	1
Q99986/T305A	Q99986	VRK1	VRK1_HUMAN	T305A	841	C-term-αI	-	-	AKYMEtKLLDY	0.179	0.206	0.384	0.189	0.263	0.234	0.477	0.088	MUTAGEN	T->A: Does not abolish autophosphorylation.	10951572	1
Q99986/T312A	Q99986	VRK1	VRK1_HUMAN	T312A	848	C-term-αI	-	-	KLLDYtKPLYE	0.357	0.341	0.444	0.254	0.259	0.3	0.562	0.188	MUTAGEN	T->A: Does not abolish autophosphorylation.	10951572	1
Q99986/T353A	Q99986	VRK1	VRK1_HUMAN	T353A	-	-	-	decrease	GLKAKtTKKRK									MUTAGEN	T->A: Strongly reduced autophosphorylation.	21543316	1
Q99986/T355A	Q99986	VRK1	VRK1_HUMAN	T355A	-	-	p	-	KAKTItKRKKE									MUTAGEN	T->A: Does not abolish autophosphorylation.	10951572	1
Q99986/T390A	Q99986	VRK1	VRK1_HUMAN	T390A	-	-	-	-	QTRSRtKRVQK									MUTAGEN	T->A: Does not abolish autophosphorylation.	10951572	1
Q9BQI3/F292L	Q9BQI3	EIF2AK1	E2AK1_HUMAN	F292L	-	-	-	-	EKEKRfESDTE									VARIANT	F -> L (in dbSNP:rs55982710)	17344846	1
Q9BQI3/G202S	Q9BQI3	EIF2AK1	E2AK1_HUMAN	G202S	138	αC	-	-	KILIKgTKTVC	0.359	0.328	0.39	0.226	0.289	0.294	0.568	0.317	VARIANT	G -> S (in a lung adenocarcinoma sample; somatic mutation; dbSNP:rs1216460058)	17344846	1
Q9BQI3/I448V	Q9BQI3	EIF2AK1	E2AK1_HUMAN	I448V	449	Catalytic-loop	-	decrease	LKPRNiLHGPD	0.411	0.401	0.541	0.295	0.388	0.343	0.685	0.284	VARIANT	I -> V (in LEMSPAD; unknown pathological significance; mildly reduced phosphorylation of eukaryotic translation initiation factor 2-alpha; dbSNP:rs1583476115)	32197074	1
Q9BQI3/K132T	Q9BQI3	EIF2AK1	E2AK1_HUMAN	K132T	-	-	-	-	LMRSAkRVRQD									VARIANT	K -> T (in dbSNP:rs34851195)	17344846	1
Q9BQI3/K558R	Q9BQI3	EIF2AK1	E2AK1_HUMAN	K558R	787	αH	-	neutral	CPVQAkIQHLT	0.085	0.093	0.491	0.092	0.106	0.109	0.64	0.1	VARIANT	K -> R (in dbSNP:rs2640)	14702039,17344846,28501589	3
Q9BQI3/L319H	Q9BQI3	EIF2AK1	E2AK1_HUMAN	L319H	-	-	-	neutral	RESGElSTLEL									VARIANT	L -> H (in dbSNP:rs34909691)	17344846	1
Q9BQI3/P139S	Q9BQI3	EIF2AK1	E2AK1_HUMAN	P139S	5	N-term-β1	-	-	RVRQDpEDISR	0.308	0.166	0.482	0.227	0.245	0.224	0.601	0.258	VARIANT	P -> S (in dbSNP:rs55963745)	17344846	1
Q9BQI3/R117T	Q9BQI3	EIF2AK1	E2AK1_HUMAN	R117T	-	-	-	-	EFSSLrHHNRA									VARIANT	R -> T (in dbSNP:rs34889754)	17344846	1
Q9BQI3/R134K	Q9BQI3	EIF2AK1	E2AK1_HUMAN	R134K	-	-	-	neutral	RSAKErRQDPC									VARIANT	R -> K (in dbSNP:rs55744865)	17344846	1
Q9BQI3/R145H	Q9BQI3	EIF2AK1	E2AK1_HUMAN	R145H	11	N-term-β1	-	-	CEDISrQKIRS	0.233	0.187	0.423	0.14	0.168	0.157	0.535	0.058	VARIANT	R -> H (in dbSNP:rs55971369)	17344846	1
Q9BRS2/D324A	Q9BRS2	RIOK1	RIOK1_HUMAN	D324A	-	-	-	loss	RLVHAdSEFNM									MUTAGEN	D->A: Abolishes autophosphorylation activity; enhances association with pre-40S ribosomal subunits; inhibits processing of 18S-E pre-rRNA to the mature 18S rRNA.	22072790	1
Q9BRS2/V375I	Q9BRS2	RIOK1	RIOK1_HUMAN	V375I	-	-	-	-	RHSVAvTVREL									VARIANT	V -> I (in dbSNP:rs56067778)		0
Q9BUB5/D232A	Q9BUB5	MKNK1	MKNK1_HUMAN	D232A	496	Catalytic-loop	-	-	PVKICdDLGSG	0.957	0.913	0.166	0.608	0.931	0.919	0.13	0.642	MUTAGEN	D->A: Loss of kinase activity; when associated with K-78.	11463832	1
Q9BUB5/D308N	Q9BUB5	MKNK1	MKNK1_HUMAN	D308N	632	αF/αG	-	neutral	GHCGAdGWDRG	0.386	0.413	0.442	0.263	0.315	0.36	0.568	0.24	VARIANT	D -> N (in dbSNP:rs55791614)	17344846	1
Q9BUB5/K49Q	Q9BUB5	MKNK1	MKNK1_HUMAN	K49Q	30	β1	-	-	FEDMYkTSELL	0.215	0.181	0.472	0.24	0.15	0.147	0.652	0.137	VARIANT	K -> Q (in dbSNP:rs56351860)	17344846	1
Q9BUB5/K78M	Q9BUB5	MKNK1	MKNK1_HUMAN	K78M	129	β3;Catalytic-Lys	-	-	KEYAVkIEKQA	0.999	1.0	0.015	0.6	0.995	0.998	0.017	0.56	MUTAGEN	K->M: Loss of kinase activity; when associated with D-232.	11463832	1
Q9BUB5/L158V	Q9BUB5	MKNK1	MKNK1_HUMAN	L158V	414	αE	-	-	DVAAAlFLHTK	0.198	0.228	0.549	0.201	0.186	0.223	0.646	0.196	VARIANT	L -> V (in dbSNP:rs56408722)	17344846	1
Q9BUB5/R446Q	Q9BUB5	MKNK1	MKNK1_HUMAN	R446Q	-	-	-	neutral	KSRLArRALAQ									VARIANT	R -> Q (in dbSNP:rs34881418)	17344846	1
Q9BUB5/T250A	Q9BUB5	MKNK1	MKNK1_HUMAN	T250A	540	A-loop	p	-	CTPITtELTTP	0.769	0.717	0.505	0.696	0.417	0.655	0.628	0.293	MUTAGEN	T->A: Loss of kinase activity; when associated with T-255.	11463832	1
Q9BUB5/T255A	Q9BUB5	MKNK1	MKNK1_HUMAN	T255A	545	A-loop	p	-	TPELTtCGSAE	0.999	0.994	0.18	0.916	0.927	0.991	0.101	0.506	MUTAGEN	T->A: Loss of kinase activity; when associated with T-250.	11463832	1
Q9BUB5/T385D	Q9BUB5	MKNK1	MKNK1_HUMAN	T385D	834	C-term-αI	p	activating	EKGLPtQVLQR	0.747	0.743	0.688	0.846	0.259	0.503	0.692	0.221	MUTAGEN	T->D: Constitutively active.	11463832	1
Q9BVS4/D246A	Q9BVS4	RIOK2	RIOK2_HUMAN	D246A	-	-	-	loss	HITMIdPQMVS									MUTAGEN	D->A: Abolishes autophosphorylation; impairs release of pre-40S trans-acting factors and rRNA processing; when associated with A-123.	19564402	1
Q9BVS4/E409D	Q9BVS4	RIOK2	RIOK2_HUMAN	E409D	-	-	-	-	KGQVVeNSVTE									VARIANT	E -> D (in dbSNP:rs35829000)	17344846	1
Q9BVS4/G349R	Q9BVS4	RIOK2	RIOK2_HUMAN	G349R	-	-	-	neutral	KAEVYgENESE									VARIANT	G -> R (in dbSNP:rs160632)	14702039,17344846	2
Q9BVS4/H144R	Q9BVS4	RIOK2	RIOK2_HUMAN	H144R	-	-	-	neutral	RDYHKhHNVSW									VARIANT	H -> R (in dbSNP:rs35165987)	17344846	1
Q9BVS4/H144Y	Q9BVS4	RIOK2	RIOK2_HUMAN	H144Y	-	-	-	-	RDYHKhHNVSW									VARIANT	H -> Y (in dbSNP:rs17849382)	15489334	1
Q9BVS4/I216T	Q9BVS4	RIOK2	RIOK2_HUMAN	I216T	-	-	-	-	EAMELiKLANH									VARIANT	I -> T (in a renal clear cell carcinoma sample; somatic mutation; dbSNP:rs147608663)	17344846	1
Q9BVS4/I403A	Q9BVS4	RIOK2	RIOK2_HUMAN	I403A	-	-	-	-	QALEEiGQVVE									MUTAGEN	I->A: Nuclear relocalization; when associated with A-400.	19564402	1
Q9BVS4/K123A	Q9BVS4	RIOK2	RIOK2_HUMAN	K123A	-	-	-	loss	QQFALkHRLGR									MUTAGEN	K->A: Abolishes autophosphorylation; impairs release of pre-40S trans-acting factors and rRNA processing; when associated with A-246.	19564402	1
Q9BVS4/L400A	Q9BVS4	RIOK2	RIOK2_HUMAN	L400A	-	-	-	-	EFNQAlEIKGQ									MUTAGEN	L->A: Nuclear relocalization; when associated with A-403.	19564402	1
Q9BVS4/M244V	Q9BVS4	RIOK2	RIOK2_HUMAN	M244V	-	-	-	neutral	SDHITmDFPQM									VARIANT	M -> V (in dbSNP:rs33996030)	17344846	1
Q9BVS4/N397S	Q9BVS4	RIOK2	RIOK2_HUMAN	N397S	-	-	-	neutral	EMTEFnALEEI									VARIANT	N -> S (in dbSNP:rs12188395)	17344846	1
Q9BVS4/R155H	Q9BVS4	RIOK2	RIOK2_HUMAN	R155H	-	-	-	-	WLYLSrSAMKE									VARIANT	R -> H (in dbSNP:rs34916955)	17344846	1
Q9BVS4/R507H	Q9BVS4	RIOK2	RIOK2_HUMAN	R507H	-	-	-	neutral	KQKVKrLTKQQ									VARIANT	R -> H (in dbSNP:rs34555783)	17344846	1
Q9BVS4/S335A	Q9BVS4	RIOK2	RIOK2_HUMAN	S335A	-	-	p	-	EGSEFsSDGEV									MUTAGEN	S->A: Does not affect autophosphorylation activity; when associated with A-380 and A-548. Does not affect the timing of metaphase-anaphase transition; when associated with A-380 and A-548.	21880710	1
Q9BVS4/S335D	Q9BVS4	RIOK2	RIOK2_HUMAN	S335D	-	-	p	-	EGSEFsSDGEV									MUTAGEN	S->D: Increases time spent in metaphase; when associated with D-380 and D-548.	21880710	1
Q9BVS4/S380A	Q9BVS4	RIOK2	RIOK2_HUMAN	S380A	-	-	p	-	QIKEDsSEESA									MUTAGEN	S->A: Does not affect autophosphorylation activity; when associated with A-335 and A-548. Does not affect the timing of metaphase-anaphase transition; when associated with A-335 and A-548.	21880710	1
Q9BVS4/S380D	Q9BVS4	RIOK2	RIOK2_HUMAN	S380D	-	-	p	-	QIKEDsSEESA									MUTAGEN	S->D: Increases time spent in metaphase; when associated with D-335 and D-548.	21880710	1
Q9BVS4/S548A	Q9BVS4	RIOK2	RIOK2_HUMAN	S548A	-	-	p	-	SLEAAsWGE									MUTAGEN	S->A: Does not affect autophosphorylation activity; when associated with A-335 and A-380. Does not affect the timing of metaphase-anaphase transition; when associated with A-335 and A-380.	21880710	1
Q9BVS4/S548D	Q9BVS4	RIOK2	RIOK2_HUMAN	S548D	-	-	p	-	SLEAAsWGE									MUTAGEN	S->D: Increases time spent in metaphase; when associated with D-335 and D-380.	21880710	1
Q9BVS4/S96C	Q9BVS4	RIOK2	RIOK2_HUMAN	S96C	-	-	-	-	RQVVEsGNQMG									VARIANT	S -> C (in dbSNP:rs2544773)	17344846	1
Q9BVS4/V175I	Q9BVS4	RIOK2	RIOK2_HUMAN	V175I	-	-	-	neutral	ERKFPvKPIDY									VARIANT	V -> I (in dbSNP:rs35713904)	17344846	1
Q9BWU1/F197L	Q9BWU1	CDK19	CDK19_HUMAN	F197L	551	A-loop	-	-	PVVVTfYRAPE	0.567	0.343	0.663	0.544	0.219	0.292	0.768	0.37	VARIANT	F -> L (in DEE87; dbSNP:rs1779473436)	33495529	1
Q9BWU1/G28A	Q9BWU1	CDK19	CDK19_HUMAN	G28A	40	β1;Gly-rich-loop	-	-	EGCKVgGTYGH	0.767	0.697	0.419	0.64	0.543	0.666	0.469	0.506	VARIANT	G -> A (in DEE87; dbSNP:rs1783518890)	33495529	1
Q9BWU1/G28R	Q9BWU1	CDK19	CDK19_HUMAN	G28R	40	β1;Gly-rich-loop	-	decrease	EGCKVgGTYGH	0.897	0.869	0.347	0.754	0.682	0.859	0.339	0.715	VARIANT	G -> R (in DEE87; decreased protein kinase activity)	33495529	1
Q9BWU1/R200W	Q9BWU1	CDK19	CDK19_HUMAN	R200W	554	A-loop	-	-	VTFWYrPELLL	0.779	0.802	0.361	0.613	0.612	0.726	0.386	0.534	VARIANT	R -> W (in DEE87; dbSNP:rs1779472995)	33495529	1
Q9BWU1/T196A	Q9BWU1	CDK19	CDK19_HUMAN	T196A	549	A-loop	-	-	DPVVVtWYRAP	0.898	0.929	0.23	0.666	0.843	0.907	0.17	0.459	VARIANT	T -> A (in DEE87; fails to rescue neurologic phenotypes in a Drosophila model system; dbSNP:rs1779473650)	32330417	1
Q9BWU1/W198C	Q9BWU1	CDK19	CDK19_HUMAN	W198C	552	A-loop	-	-	VVVTFwRAPEL	0.828	0.772	0.557	0.709	0.461	0.697	0.485	0.583	VARIANT	W -> C (in DEE87; dbSNP:rs1779473213)	33495529	1
Q9BWU1/Y32C	Q9BWU1	CDK19	CDK19_HUMAN	Y32C	44	Gly-rich-loop;β1/β2-loop	-	-	VGRGTyHVYKA	0.901	0.853	0.504	0.687	0.611	0.803	0.437	0.731	VARIANT	Y -> C (in DEE87; dbSNP:rs1783517622)	33495529	1
Q9BWU1/Y32H	Q9BWU1	CDK19	CDK19_HUMAN	Y32H	44	Gly-rich-loop;β1/β2-loop	-	increase	VGRGTyHVYKA	0.896	0.79	0.569	0.797	0.333	0.698	0.624	0.682	VARIANT	Y -> H (in DEE87; fails to rescue neurologic phenotypes in a Drosophila model system; increased protein kinase activity; dbSNP:rs1236246272)	32330417,33134521,33495529	3
Q9BX84/E872G	Q9BX84	TRPM6	TRPM6_HUMAN	E872G	-	-	-	loss	QPSVQeLVSIY									VARIANT	E -> G (in HOMG1; loss of function; no effect on cell membrane localization)	23942199	1
Q9BX84/F948L	Q9BX84	TRPM6	TRPM6_HUMAN	F948L	-	-	-	-	CIDIIfFSRLL									VARIANT	F -> L (in dbSNP:rs13290391)		0
Q9BX84/G75V	Q9BX84	TRPM6	TRPM6_HUMAN	G75V	-	-	-	-	ISAAKgESEQW									VARIANT	G -> V (in a lung adenocarcinoma sample; somatic mutation; dbSNP:rs1193127627)	17344846	1
Q9BX84/H1243R	Q9BX84	TRPM6	TRPM6_HUMAN	H1243R	-	-	-	-	LAKRKhTCKKL									VARIANT	H -> R (in dbSNP:rs55694430)	17344846	1
Q9BX84/K1584E	Q9BX84	TRPM6	TRPM6_HUMAN	K1584E	-	-	-	neutral	DRRLSkKKNTQ									VARIANT	K -> E (in dbSNP:rs2274924)	17344846	1
Q9BX84/K1804R	Q9BX84	TRPM6	TRPM6_HUMAN	K1804R	-	-	-	loss	QVFIVkFLPEV									MUTAGEN	K->R: Abolishes kinase activity but does not affect expression levels or binding to RACK1.	18258429	1
Q9BX84/L1143P	Q9BX84	TRPM6	TRPM6_HUMAN	L1143P	-	-	-	loss	LSKEDlKLHDF									VARIANT	L -> P (in HOMG1; loss of function; no effect on cell membrane localization)	23942199	1
Q9BX84/L1673S	Q9BX84	TRPM6	TRPM6_HUMAN	L1673S	-	-	-	-	LSKNSlNSRST									VARIANT	L -> S (in dbSNP:rs56254742)	17344846	1
Q9BX84/L708P	Q9BX84	TRPM6	TRPM6_HUMAN	L708P	-	-	-	loss	SNSTClLAVSG									VARIANT	L -> P (in HOMG1; loss of function; no effect on cell membrane localization)	23942199	1
Q9BX84/M338I	Q9BX84	TRPM6	TRPM6_HUMAN	M338I	-	-	-	neutral	LADEGmRPQVK									VARIANT	M -> I (in dbSNP:rs56155062)	17344846	1
Q9BX84/N1071D	Q9BX84	TRPM6	TRPM6_HUMAN	N1071D	-	-	-	-	IAFFNnYLDME									VARIANT	N -> D (in dbSNP:rs2274922)		0
Q9BX84/Q1274R	Q9BX84	TRPM6	TRPM6_HUMAN	Q1274R	-	-	-	neutral	GEKKYqYSMPS									VARIANT	Q -> R (in dbSNP:rs34608911)	17344846	1
Q9BX84/Q1663R	Q9BX84	TRPM6	TRPM6_HUMAN	Q1663R	-	-	-	neutral	SDYLKqQEDLS									VARIANT	Q -> R (no effect on function or cell membrane localization; dbSNP:rs55679040)	17344846,23942199	2
Q9BX84/S141L	Q9BX84	TRPM6	TRPM6_HUMAN	S141L	-	-	p	decrease	PKLVIsHGGIQ									VARIANT	S -> L (in HOMG1; impairs heterodimer formation resulting in intracellular retention; dbSNP:rs121912625)	12032568,14976260	2
Q9BX84/S1754N	Q9BX84	TRPM6	TRPM6_HUMAN	S1754N	-	-	-	loss	LNLDKsSSWSQ									VARIANT	S -> N (in HOMG1; loss of function; no effect on cell membrane localization)	23942199	1
Q9BX84/T1724I	Q9BX84	TRPM6	TRPM6_HUMAN	T1724I	-	-	-	-	MRLSQtPFTPV									VARIANT	T -> I (in dbSNP:rs56290308)	17344846	1
Q9BX84/T1851A	Q9BX84	TRPM6	TRPM6_HUMAN	T1851A	-	-	p	decrease	QVKPQtPYTPR									MUTAGEN	T->A: Significantly decreases autophosphorylation. Does not alter binding to RACK1 but prevents inhibition by RACK1.	18258429	1
Q9BX84/T1851D	Q9BX84	TRPM6	TRPM6_HUMAN	T1851D	-	-	p	loss	QVKPQtPYTPR									MUTAGEN	T->D: Significantly decreases autophosphorylation. Does not alter binding to RACK1 or inhibition by RACK1.	18258429	1
Q9BX84/V1393I	Q9BX84	TRPM6	TRPM6_HUMAN	V1393I	-	-	-	neutral	TGQTPvSDWAS									VARIANT	V -> I (in dbSNP:rs3750425)	17344846	1
Q9BX84/W1007C	Q9BX84	TRPM6	TRPM6_HUMAN	W1007C	-	-	-	-	KEPPSwLARDI									VARIANT	W -> C (in a lung large cell carcinoma sample; somatic mutation)	17344846	1
Q9BX84/Y1053C	Q9BX84	TRPM6	TRPM6_HUMAN	Y1053C	-	-	-	loss	FLQAVyFVQYI									VARIANT	Y -> C (in HOMG1; loss of function; no effect on cell membrane localization)	23942199	1
Q9BXA6/D135N	Q9BXA6	TSSK6	TSSK6_HUMAN	D135N	443	Catalytic-loop;HrD-motif	-	loss	HLVHRdKCENV	0.989	0.993	0.205	0.715	0.933	0.985	0.112	0.592	MUTAGEN	D->N: Loss of kinase activity. No effect of binding to TSACC.	15870294,20829357	2
Q9BXA6/K41M	Q9BXA6	TSSK6	TSSK6_HUMAN	K41M	129	β3;Catalytic-Lys	-	loss	GTVAIkVDRRR	0.999	1.0	0.018	0.623	0.995	0.998	0.008	0.512	MUTAGEN	K->M: Loss of kinase activity. Loss of binding to TSACC.	15870294,20829357	2
Q9BXA7/A50T	Q9BXA7	TSSK1B	TSSK1_HUMAN	A50T	143	αC	-	-	RKKAPaFLEKF	0.076	0.076	0.376	0.079	0.124	0.092	0.683	0.06	VARIANT	A -> T (in dbSNP:rs747955728)	17344846	1
Q9BXA7/G288W	Q9BXA7	TSSK1B	TSSK1_HUMAN	G288W	839	C-term-αI	-	neutral	AINKEgSSRGT	0.468	0.475	0.555	0.418	0.333	0.341	0.628	0.305	VARIANT	G -> W (in dbSNP:rs34696815)	17344846	1
Q9BXA7/G293E	Q9BXA7	TSSK1B	TSSK1_HUMAN	G293E	844	C-term-αI	-	neutral	GESSRgEPLWT	0.178	0.24	0.508	0.271	0.214	0.171	0.616	0.265	VARIANT	G -> E (in dbSNP:rs11953478)	17344846	1
Q9BXA7/H83Y	Q9BXA7	TSSK1B	TSSK1_HUMAN	H83Y	239	β4/β5-loop	-	-	IFETShKVYIV	0.268	0.219	0.517	0.285	0.147	0.184	0.753	0.104	VARIANT	H -> Y (in dbSNP:rs55930004)	17344846	1
Q9BXA7/R237C	Q9BXA7	TSSK1B	TSSK1_HUMAN	R237C	679	αG/αH	-	-	RVNFPrKHLTG	0.563	0.555	0.587	0.483	0.273	0.438	0.702	0.28	VARIANT	R -> C (in dbSNP:rs55738530)	17344846	1
Q9BXA7/T174A	Q9BXA7	TSSK1B	TSSK1_HUMAN	T174A	545	A-loop	-	loss	MALSKtCGSPA	0.985	0.964	0.186	0.829	0.931	0.952	0.11	0.515	MUTAGEN	T->A: Loss of kinase activity.	15733851	1
Q9BXA7/T174E	Q9BXA7	TSSK1B	TSSK1_HUMAN	T174E	545	A-loop	-	activating	MALSKtCGSPA	0.953	0.975	0.847	0.966	0.133	0.886	0.873	0.403	MUTAGEN	T->E: Constitutively active.	15733851	1
Q9BXA7/V233L	Q9BXA7	TSSK1B	TSSK1_HUMAN	V233L	673	αG/αH	-	-	QKEHRvFPRSK	0.116	0.143	0.424	0.105	0.133	0.1	0.614	0.107	VARIANT	V -> L (in dbSNP:rs55940513)	17344846	1
Q9BXM7/A124V	Q9BXM7	PINK1	PINK1_HUMAN	A124V	-	-	-	-	RRAVSaQEIQA									VARIANT	A -> V (in dbSNP:rs1274588239)	18330912	1
Q9BXM7/A168P	Q9BXM7	PINK1	PINK1_HUMAN	A168P	-	-	-	-	GKGCSaVYEAT									VARIANT	A -> P (in PARK6; no effect on autophosphorylation; localizes to the mitochondria and immunogold experiments reveal that both wild-type and mutant proteins face the mitochondrial intermembrane space; dbSNP:rs768091663)	15349860,16009891,16207731,24784582	4
Q9BXM7/A217D	Q9BXM7	PINK1	PINK1_HUMAN	A217D	-	-	-	-	PAFPLaKMMWN									VARIANT	A -> D (in PARK6; dbSNP:rs74315360)	16966503	1
Q9BXM7/A280T	Q9BXM7	PINK1	PINK1_HUMAN	A280T	207	β4/β5-loop	-	-	IRVLRaTSSVP	0.168	0.164	0.483	0.185	0.21	0.175	0.577	0.271	VARIANT	A -> T (in PARK6; early-onset; dbSNP:rs772510148)	16482571	1
Q9BXM7/A339T	Q9BXM7	PINK1	PINK1_HUMAN	A339T	400	αE	-	-	PSPRLaMMLLQ	0.09	0.114	0.508	0.166	0.088	0.096	0.7	0.094	VARIANT	A -> T (in dbSNP:rs55831733)	15596610,16969854,17344846,18330912	4
Q9BXM7/A340T	Q9BXM7	PINK1	PINK1_HUMAN	A340T	401	αE	-	neutral	SPRLAaMLLQL	0.068	0.067	0.424	0.079	0.111	0.096	0.673	0.077	VARIANT	A -> T (in dbSNP:rs3738136)	14702039,15349860,15596610,16009891,16257123,16482571,17344846	7
Q9BXM7/A383T	Q9BXM7	PINK1	PINK1_HUMAN	A383T	495	Catalytic-loop	-	-	PWLVIaFGCCL	0.201	0.186	0.445	0.232	0.148	0.138	0.679	0.177	VARIANT	A -> T (in dbSNP:rs45515602)	16969854,18330912	2
Q9BXM7/A537T	Q9BXM7	PINK1	PINK1_HUMAN	A537T	-	-	-	-	LQQSAaLLANR									VARIANT	A -> T (in dbSNP:rs771032673)	18330912	1
Q9BXM7/C125G	Q9BXM7	PINK1	PINK1_HUMAN	C125G	-	-	-	-	RAVSAcEIQAI									VARIANT	C -> G (in PARK6)	16401616	1
Q9BXM7/C377F	Q9BXM7	PINK1	PINK1_HUMAN	C377F	484	Catalytic-loop	-	-	LDPDGcWLVIA	0.731	0.702	0.477	0.575	0.43	0.639	0.526	0.519	VARIANT	C -> F (in dbSNP:rs34203620)	17344846	1
Q9BXM7/C388R	Q9BXM7	PINK1	PINK1_HUMAN	C388R	501	A-loop	-	-	ADFGCcADESI	0.894	0.855	0.535	0.735	0.602	0.8	0.533	0.629	VARIANT	C -> R (in PARK6; dbSNP:rs1553146806)	15955953	1
Q9BXM7/C575R	Q9BXM7	PINK1	PINK1_HUMAN	C575R	-	-	-	-	AALLLcWRAAL									VARIANT	C -> R (may predispose to Parkinson disease development; shows decreased mitochondrial membrane potential under stress conditions; dbSNP:rs1553147052)	16969854	1
Q9BXM7/C92F	Q9BXM7	PINK1	PINK1_HUMAN	C92F	-	-	-	-	VRAWGcGPCGR									VARIANT	C -> F (in PARK6; dbSNP:rs1553145550)	15349860	1
Q9BXM7/D362A	Q9BXM7	PINK1	PINK1_HUMAN	D362A	443	Catalytic-loop;HrD-motif	-	-	GIAHRdKSDNI	0.969	0.975	0.218	0.659	0.931	0.955	0.139	0.495	MUTAGEN	D->A: Abolishes MFN2 phosphorylation and interaction with PRKN; when associated with A-219 and A-384. Loss of enzyme activity and impaired localization of PRKN to mitochondria; when associated with M-219 and A-384.	18957282,23620051,32047033	3
Q9BXM7/D362H	Q9BXM7	PINK1	PINK1_HUMAN	D362H	443	Catalytic-loop;HrD-motif	-	-	GIAHRdKSDNI	0.981	0.996	0.171	0.647	0.914	0.956	0.119	0.622	VARIANT	D -> H	15596610	1
Q9BXM7/D384A	Q9BXM7	PINK1	PINK1_HUMAN	D384A	496	A-loop;DFG-motif	-	-	WLVIAdGCCLA	0.975	0.943	0.169	0.565	0.943	0.923	0.105	0.636	MUTAGEN	D->A: Abolishes MFN2 phosphorylation and interaction with PRKN; when associated with A-219 and A-362. Loss of enzyme activity and impaired localization of PRKN to mitochondria; when associated with M-219 and A-362.	18957282,23620051,32047033	3
Q9BXM7/D384N	Q9BXM7	PINK1	PINK1_HUMAN	D384N	496	A-loop;DFG-motif	-	loss	WLVIAdGCCLA	0.931	0.959	0.251	0.579	0.871	0.866	0.178	0.535	MUTAGEN	D->N: Loss of activity. Abolishes Drp1 phosphorylation. No effect on localization to mitochondria.	32484300	1
Q9BXM7/D525N	Q9BXM7	PINK1	PINK1_HUMAN	D525N	845	C-term-αI	-	-	KNLKLdMVGWL	0.148	0.097	0.357	0.094	0.117	0.159	0.598	0.084	VARIANT	D -> N (in dbSNP:rs531477772)	15349860,18330912	2
Q9BXM7/E231G	Q9BXM7	PINK1	PINK1_HUMAN	E231G	-	-	-	-	AGSSSeILNTM									VARIANT	E -> G (in dbSNP:rs1303935100)	15596610	1
Q9BXM7/E240K	Q9BXM7	PINK1	PINK1_HUMAN	E240K	6	N-term-β1	-	-	NTMSQeVPASR	0.736	0.75	0.485	0.61	0.433	0.601	0.499	0.432	VARIANT	E -> K (in PARK6; dbSNP:rs573931674)	15596610,16401616	2
Q9BXM7/E417G	Q9BXM7	PINK1	PINK1_HUMAN	E417G	557	A-loop;APE-motif	-	-	CLMAPeSTARP	0.899	0.865	0.304	0.552	0.791	0.827	0.266	0.507	VARIANT	E -> G (in PARK6; dbSNP:rs1553146822)	15349870	1
Q9BXM7/E476K	Q9BXM7	PINK1	PINK1_HUMAN	E476K	683	αG/αH	-	neutral	LPALPeVPPDV	0.096	0.094	0.406	0.088	0.081	0.094	0.695	0.105	VARIANT	E -> K (may predispose to Parkinson disease development; shows decreased mitochondrial membrane potential under stress conditions; dbSNP:rs115477764)	15349860,15596610,16009891,16969854,18330912	5
Q9BXM7/G309D	Q9BXM7	PINK1	PINK1_HUMAN	G309D	237	β4/β5-loop	-	decrease	HPEGLgGRTLF	0.603	0.529	0.613	0.526	0.348	0.418	0.647	0.226	VARIANT	G -> D (in PARK6; fails to maintain mitochondrial membrane potential; full-length mutant has no effect on autophosphorylation; strongly reduces interaction with PRKN; decreases PRKN and SNCAIP ubiquitination and degradation; decreases Drp1 phosphorylation; dbSNP:rs74315355)	15087508,16207731,19229105,20798600,32484300	5
Q9BXM7/G386A	Q9BXM7	PINK1	PINK1_HUMAN	G386A	498	A-loop;DFG-motif	-	loss	VIADFgCLADE	0.932	0.898	0.374	0.692	0.649	0.841	0.284	0.499	VARIANT	G -> A (in PARK6; abolishes kinase activity)	16401616,24784582	2
Q9BXM7/G395V	Q9BXM7	PINK1	PINK1_HUMAN	G395V	514	A-loop	-	-	ADESIgQLPFS	0.836	0.803	0.538	0.666	0.459	0.61	0.529	0.473	VARIANT	G -> V (in dbSNP:rs1035071310)	18330912	1
Q9BXM7/G409V	Q9BXM7	PINK1	PINK1_HUMAN	G409V	548	A-loop	-	-	YVDRGgGCLMA	0.78	0.777	0.549	0.703	0.564	0.639	0.523	0.522	VARIANT	G -> V (in PARK6; dbSNP:rs1553146818)	16401616	1
Q9BXM7/G411S	Q9BXM7	PINK1	PINK1_HUMAN	G411S	551	A-loop	-	neutral	DRGGNgLMAPE	0.333	0.26	0.486	0.335	0.258	0.229	0.616	0.243	VARIANT	G -> S (in dbSNP:rs45478900)	16969854	1
Q9BXM7/H271Q	Q9BXM7	PINK1	PINK1_HUMAN	H271Q	193	αC/β4-loop	-	-	KQLAPhNIIRV	0.819	0.809	0.422	0.672	0.598	0.684	0.393	0.41	VARIANT	H -> Q (in PARK6; dbSNP:rs28940284)	15349870	1
Q9BXM7/I111S	Q9BXM7	PINK1	PINK1_HUMAN	I111S	-	-	-	-	LGLGLiEKQAE									VARIANT	I -> S (in dbSNP:rs1553145560)	18330912	1
Q9BXM7/I442T	Q9BXM7	PINK1	PINK1_HUMAN	I442T	607	αF	-	-	WAVGAiYEIFG	0.821	0.725	0.533	0.608	0.54	0.661	0.574	0.552	VARIANT	I -> T (in dbSNP:rs1553146877)	15349860,18330912	2
Q9BXM7/K186N	Q9BXM7	PINK1	PINK1_HUMAN	K186N	-	-	ub	-	NLEVTkTGLLP									VARIANT	K -> N (in dbSNP:rs143204084)	18330912	1
Q9BXM7/K219A	Q9BXM7	PINK1	PINK1_HUMAN	K219A	-	-	-	-	FPLAIkMWNIS									MUTAGEN	K->A: Abolishes MFN2 phosphorylation and interaction with PRKN; when associated with Ala-362 and Ala-384.	23620051	1
Q9BXM7/K219M	Q9BXM7	PINK1	PINK1_HUMAN	K219M	-	-	-	-	FPLAIkMWNIS									MUTAGEN	K->M: Loss of enzyme activity and impaired localization of PRKN to mitochondria; when associated with A-362 and A-384.	18957282,32047033	2
Q9BXM7/L148W	Q9BXM7	PINK1	PINK1_HUMAN	L148W	-	-	-	-	LDTRRlGFRLE									VARIANT	L -> W (in dbSNP:rs56297806)	17344846	1
Q9BXM7/L268V	Q9BXM7	PINK1	PINK1_HUMAN	L268V	183	αC/β4-loop	-	-	RGPKQlPHPNI	0.266	0.182	0.526	0.248	0.148	0.178	0.683	0.329	VARIANT	L -> V (in PARK6; dbSNP:rs372280083)	16207217,18330912	2
Q9BXM7/L347P	Q9BXM7	PINK1	PINK1_HUMAN	L347P	411	αE	-	decrease	MLLQLlGVDHL	0.909	0.887	0.386	0.685	0.84	0.807	0.258	0.73	VARIANT	L -> P (in PARK6; strongly reduces interaction with PRKN; reduced ubiquitination of MIRO1; dbSNP:rs28940285)	15349870,15596610,20798600,22396657,22956510	5
Q9BXM7/L369P	Q9BXM7	PINK1	PINK1_HUMAN	L369P	450	Catalytic-loop	-	-	KSDNIlELDPD	0.888	0.876	0.406	0.673	0.711	0.751	0.37	0.699	VARIANT	L -> P (in PARK6; dbSNP:rs1195888869)	16401616	1
Q9BXM7/L461S	Q9BXM7	PINK1	PINK1_HUMAN	L461S	635	αF/αG	-	-	QGKAHlSRSYQ	0.651	0.612	0.504	0.433	0.456	0.542	0.449	0.539	VARIANT	L -> S	16969854	1
Q9BXM7/L489P	Q9BXM7	PINK1	PINK1_HUMAN	L489P	792	αH	-	-	QLVRAlQREAS	0.868	0.76	0.477	0.654	0.641	0.706	0.455	0.58	VARIANT	L -> P (in PARK6; dbSNP:rs1553146903)	15596610	1
Q9BXM7/L67F	Q9BXM7	PINK1	PINK1_HUMAN	L67F	-	-	-	-	GLPNRlFFRQS									VARIANT	L -> F (in dbSNP:rs763142730)	18330912	1
Q9BXM7/M318L	Q9BXM7	PINK1	PINK1_HUMAN	M318L	248	β5	-	-	TLFLVmNYPCT	0.677	0.601	0.563	0.612	0.324	0.42	0.631	0.688	VARIANT	M -> L (in dbSNP:rs139226733)	15596610	1
Q9BXM7/M341I	Q9BXM7	PINK1	PINK1_HUMAN	M341I	405	αE	-	-	PRLAAmLLQLL	0.248	0.244	0.501	0.233	0.156	0.197	0.669	0.16	VARIANT	M -> I (in dbSNP:rs35813094)	17344846	1
Q9BXM7/N235I	Q9BXM7	PINK1	PINK1_HUMAN	N235I	-	-	-	-	SEAILnMSQEL									VARIANT	N -> I (in dbSNP:rs1557562082)	15596610	1
Q9BXM7/N451S	Q9BXM7	PINK1	PINK1_HUMAN	N451S	619	αF	-	-	IFGLVnFYGQG	0.682	0.566	0.512	0.465	0.394	0.512	0.585	0.388	VARIANT	N -> S (may predispose to Parkinson disease development; shows decreased mitochondrial membrane potential under stress conditions; dbSNP:rs747400197)	16969854	1
Q9BXM7/N521T	Q9BXM7	PINK1	PINK1_HUMAN	N521T	841	C-term-αI	-	neutral	ILALKnKLDKM	0.269	0.224	0.435	0.148	0.187	0.185	0.688	0.111	VARIANT	N -> T (in dbSNP:rs1043424)	14702039,15349860,15596610,16009891,16257123,16482571,17344846	7
Q9BXM7/P196L	Q9BXM7	PINK1	PINK1_HUMAN	P196L	-	-	-	-	LPGRGpTSAPG									VARIANT	P -> L (in PARK6; dbSNP:rs138302371)	16009891	1
Q9BXM7/P196S	Q9BXM7	PINK1	PINK1_HUMAN	P196S	-	-	-	-	LPGRGpTSAPG									VARIANT	P -> S (in dbSNP:rs35802484)	17344846	1
Q9BXM7/P209L	Q9BXM7	PINK1	PINK1_HUMAN	P209L	-	-	-	-	GQERApAPAFP									VARIANT	P -> L (in dbSNP:rs34677717)	17344846	1
Q9BXM7/P215L	Q9BXM7	PINK1	PINK1_HUMAN	P215L	-	-	-	-	GAPAFpAIKMM									VARIANT	P -> L (in a glioblastoma multiforme sample; somatic mutation; dbSNP:rs371854396)	17344846	1
Q9BXM7/P296L	Q9BXM7	PINK1	PINK1_HUMAN	P296L	224	β4/β5-loop	-	-	ALVDYpVLPSR	0.602	0.561	0.513	0.511	0.343	0.46	0.567	0.455	VARIANT	P -> L (in dbSNP:rs779060308)	15349860,18330912	2
Q9BXM7/P305L	Q9BXM7	PINK1	PINK1_HUMAN	P305L	233	β4/β5-loop	-	-	PSRLHpGLGHG	0.547	0.45	0.543	0.426	0.333	0.401	0.634	0.529	VARIANT	P -> L (in dbSNP:rs7349186)		0
Q9BXM7/P322L	Q9BXM7	PINK1	PINK1_HUMAN	P322L	253	β5/αD-loop	-	-	VMKNYpTLRQY	0.511	0.424	0.5	0.398	0.379	0.408	0.593	0.339	VARIANT	P -> L (in dbSNP:rs768019187)	18330912	1
Q9BXM7/P399L	Q9BXM7	PINK1	PINK1_HUMAN	P399L	526	A-loop	-	decrease	IGLQLpSSWYV	0.652	0.59	0.527	0.497	0.423	0.579	0.585	0.418	VARIANT	P -> L (probable disease-associated variant found in early-onset Parkinson disease with digenic inheritance; found in a patient also carrying mutation S-39 in PARK7; decreases PRKN and SNCAIP ubiquitination and degradation; dbSNP:rs119451946)	16632486,19229105	2
Q9BXM7/P425S	Q9BXM7	PINK1	PINK1_HUMAN	P425S	588	αF	-	-	TARPGpAVIDY	0.395	0.323	0.523	0.291	0.286	0.272	0.624	0.236	VARIANT	P -> S (in dbSNP:rs554114655)	15596610	1
Q9BXM7/Q115L	Q9BXM7	PINK1	PINK1_HUMAN	Q115L	-	-	-	neutral	LIEEKqESRRA									VARIANT	Q -> L (in dbSNP:rs148871409)	15970950,16009891	2
Q9BXM7/Q126P	Q9BXM7	PINK1	PINK1_HUMAN	Q126P	-	-	-	-	AVSACqIQAIF									VARIANT	Q -> P (in PARK6; strongly reduces interaction with PRKN; dbSNP:rs775809722)	18286320,20798600	2
Q9BXM7/R147H	Q9BXM7	PINK1	PINK1_HUMAN	R147H	-	-	-	-	PLDTRrQGFRL									VARIANT	R -> H (in PARK6; unknown pathological significance; dbSNP:rs138050841)	15505171	1
Q9BXM7/R263G	Q9BXM7	PINK1	PINK1_HUMAN	R263G	29	N-term-β1	-	-	YRKSKrPKQLA	0.515	0.447	0.484	0.383	0.262	0.324	0.615	0.211	VARIANT	R -> G (in dbSNP:rs1553146419)	15596610	1
Q9BXM7/R276Q	Q9BXM7	PINK1	PINK1_HUMAN	R276Q	202	β4	-	-	HPNIIrLRAFT	0.329	0.3	0.451	0.242	0.115	0.194	0.649	0.262	VARIANT	R -> Q (in dbSNP:rs548506734)	18330912	1
Q9BXM7/R279H	Q9BXM7	PINK1	PINK1_HUMAN	R279H	206	β4/β5-loop	-	-	IIRVLrFTSSV	0.249	0.274	0.461	0.208	0.242	0.192	0.561	0.147	VARIANT	R -> H (in PARK6; dbSNP:rs74315358)	15970950	1
Q9BXM7/R407Q	Q9BXM7	PINK1	PINK1_HUMAN	R407Q	546	A-loop	-	-	SWYVDrGNGCL	0.449	0.502	0.4	0.313	0.471	0.45	0.465	0.097	VARIANT	R -> Q (in PARK6; early-onset; dbSNP:rs556540177)	16257123	1
Q9BXM7/R464H	Q9BXM7	PINK1	PINK1_HUMAN	R464H	638	αG	-	-	AHLESrYQEAQ	0.464	0.388	0.481	0.345	0.231	0.235	0.63	0.236	VARIANT	R -> H (in PARK6; dbSNP:rs764328076)	15349860	1
Q9BXM7/R501P	Q9BXM7	PINK1	PINK1_HUMAN	R501P	814	αI	-	-	KRPSArAANVL	0.611	0.578	0.549	0.507	0.306	0.373	0.603	0.249	VARIANT	R -> P (may predispose to Parkinson disease development; shows decreased mitochondrial membrane potential under stress conditions; dbSNP:rs61744200)	16969854	1
Q9BXM7/R68P	Q9BXM7	PINK1	PINK1_HUMAN	R68P	-	-	-	-	LPNRLrFRQSV									VARIANT	R -> P (in dbSNP:rs1385309950)	18330912	1
Q9BXM7/R98W	Q9BXM7	PINK1	PINK1_HUMAN	R98W	-	-	-	-	AGPCGrVFLAF									VARIANT	R -> W (in dbSNP:rs575668171)	18330912	1
Q9BXM7/S477T	Q9BXM7	PINK1	PINK1_HUMAN	S477T	684	αG/αH	-	-	PALPEsPPDVR	0.127	0.154	0.456	0.139	0.166	0.178	0.658	0.092	VARIANT	S -> T (in dbSNP:rs34416410)	17344846	1
Q9BXM7/T145M	Q9BXM7	PINK1	PINK1_HUMAN	T145M	-	-	-	-	PDPLDtRLQGF									VARIANT	T -> M (in dbSNP:rs45604240)	18330912	1
Q9BXM7/T257I	Q9BXM7	PINK1	PINK1_HUMAN	T257I	23	N-term-β1	p	-	EYGAVtRKSKR	0.736	0.718	0.466	0.658	0.514	0.551	0.492	0.192	VARIANT	T -> I (in dbSNP:rs370906995)		0
Q9BXM7/T313M	Q9BXM7	PINK1	PINK1_HUMAN	T313M	241	β4/β5-loop	p	decrease	LGHGRtFLVMK	0.849	0.765	0.377	0.563	0.599	0.696	0.363	0.417	VARIANT	T -> M (in PARK6; decreases PRKN and SNCAIP ubiquitination and degradation; slightly decreases Drp1 phosphorylation; dbSNP:rs74315359)	17030667,18785233,19229105,32484300	4
Q9BXM7/V170G	Q9BXM7	PINK1	PINK1_HUMAN	V170G	-	-	-	-	GCSAAvEATMP									VARIANT	V -> G (in PARK6; dbSNP:rs1553145929)	24652937	1
Q9BXM7/V317I	Q9BXM7	PINK1	PINK1_HUMAN	V317I	247	β5	-	-	RTLFLvKNYPC	0.245	0.23	0.476	0.227	0.15	0.141	0.689	0.151	VARIANT	V -> I (in dbSNP:rs200949139)	16969854,18330912	2
Q9BXM7/Y431H	Q9BXM7	PINK1	PINK1_HUMAN	Y431H	595	αF	-	-	RAVIDyKADAW	0.862	0.78	0.409	0.531	0.684	0.792	0.328	0.537	VARIANT	Y -> H (may predispose to Parkinson disease development; shows decreased mitochondrial membrane potential under stress conditions; dbSNP:rs74315361)	16969854	1
Q9BXU1/A393T	Q9BXU1	STK31	STK31_HUMAN	A393T	-	-	-	-	KDLSDaQVLDE									VARIANT	A -> T (in dbSNP:rs56244148)	17344846	1
Q9BXU1/A489P	Q9BXU1	STK31	STK31_HUMAN	A489P	-	-	-	-	QAKEGaSDEIL									VARIANT	A -> P (in dbSNP:rs34414354)	17344846	1
Q9BXU1/A600T	Q9BXU1	STK31	STK31_HUMAN	A600T	-	-	-	neutral	EERLIaVQAKY									VARIANT	A -> T (in dbSNP:rs55796076)	17344846	1
Q9BXU1/E261K	Q9BXU1	STK31	STK31_HUMAN	E261K	-	-	-	neutral	KGHLSeMTLDL									VARIANT	E -> K (in dbSNP:rs10264952)	17344846	1
Q9BXU1/E709K	Q9BXU1	STK31	STK31_HUMAN	E709K	-	-	-	-	PLLHPeGLLKY									VARIANT	E -> K (in dbSNP:rs56181834)	17344846	1
Q9BXU1/G410E	Q9BXU1	STK31	STK31_HUMAN	G410E	-	-	-	neutral	PASLNgEIIWA									VARIANT	G -> E (in dbSNP:rs4722266)	17344846	1
Q9BXU1/H684R	Q9BXU1	STK31	STK31_HUMAN	H684R	-	-	-	-	FQEIYhREEYE									VARIANT	H -> R (in dbSNP:rs41273999)	17344846	1
Q9BXU1/H684Y	Q9BXU1	STK31	STK31_HUMAN	H684Y	-	-	-	-	FQEIYhREEYE									VARIANT	H -> Y (in a lung neuroendocrine carcinoma sample; somatic mutation)	17344846	1
Q9BXU1/I277K	Q9BXU1	STK31	STK31_HUMAN	I277K	-	-	-	-	DAGNLiFPKES									VARIANT	I -> K (in dbSNP:rs55950645)	17344846	1
Q9BXU1/K1009T	Q9BXU1	STK31	STK31_HUMAN	K1009T	-	-	-	neutral	DKCMEkRNGEA									VARIANT	K -> T (in dbSNP:rs33998018)		0
Q9BXU1/K268N	Q9BXU1	STK31	STK31_HUMAN	K268N	-	-	-	neutral	MTLDLkENDAG									VARIANT	K -> N (in dbSNP:rs10264967)	17344846	1
Q9BXU1/N621K	Q9BXU1	STK31	STK31_HUMAN	N621K	-	-	-	neutral	LIEYLnSPSVD									VARIANT	N -> K (in dbSNP:rs10263079)	17344846	1
Q9BXU1/Q71H	Q9BXU1	STK31	STK31_HUMAN	Q71H	-	-	-	-	SEVCPqSSVLG									VARIANT	Q -> H (in dbSNP:rs6945306)	15489334,17344846	2
Q9BXU1/R385C	Q9BXU1	STK31	STK31_HUMAN	R385C	-	-	-	neutral	VDISVrGKDLS									VARIANT	R -> C (in dbSNP:rs35995607)		0
Q9BXU1/S125F	Q9BXU1	STK31	STK31_HUMAN	S125F	-	-	-	-	EILNRsIVEIP									VARIANT	S -> F (in dbSNP:rs56268851)	17344846	1
Q9BXU1/S623I	Q9BXU1	STK31	STK31_HUMAN	S623I	-	-	-	neutral	EYLNKsSVDHL									VARIANT	S -> I (in dbSNP:rs10247878)	17344846	1
Q9BXU1/T1000M	Q9BXU1	STK31	STK31_HUMAN	T1000M	-	-	-	-	EEEIKtNLDKC									VARIANT	T -> M (in dbSNP:rs55794023)	17344846	1
Q9BXU1/T1010S	Q9BXU1	STK31	STK31_HUMAN	T1010S	-	-	-	-	KCMEKtNGEAN									VARIANT	T -> S (in dbSNP:rs56391043)	17344846	1
Q9BXU1/T362P	Q9BXU1	STK31	STK31_HUMAN	T362P	-	-	-	-	KTYIDtMKNLA									VARIANT	T -> P (in dbSNP:rs35545265)		0
Q9BXU1/V860L	Q9BXU1	STK31	STK31_HUMAN	V860L	449	Catalytic-loop	-	-	LHQNNvALNRE	0.641	0.64	0.55	0.521	0.412	0.569	0.612	0.319	VARIANT	V -> L (in a lung small cell carcinoma sample; somatic mutation)	17344846	1
Q9BYP7/A998T	Q9BYP7	WNK3	WNK3_HUMAN	A998T	-	-	-	-	GLTKQaIFIPV									VARIANT	A -> T (in dbSNP:rs56404148)	17344846	1
Q9BYP7/D294A	Q9BYP7	WNK3	WNK3_HUMAN	D294A	496	A-loop;DFG-motif	-	loss	SVKIGdGLATL	0.993	0.992	0.098	0.603	0.979	0.971	0.043	0.729	MUTAGEN	D->A: Catalytically inactive form. Inhibits sodium-coupled chloride cotransporters and activates potassium-coupled chloride cotransporters.	16275913,21613606	2
Q9BYP7/K1169E	Q9BYP7	WNK3	WNK3_HUMAN	K1169E	-	-	-	-	SHCGIkSPVQS									VARIANT	K -> E (in dbSNP:rs55903619)	17344846	1
Q9BYP7/L1533F	Q9BYP7	WNK3	WNK3_HUMAN	L1533F	-	-	-	-	IEDEDlVELQR									VARIANT	L -> F (in a lung large cell carcinoma sample; somatic mutation)	17344846	1
Q9BYP7/Q704H	Q9BYP7	WNK3	WNK3_HUMAN	Q704H	-	-	-	neutral	VRSLNqVATTK									VARIANT	Q -> H (in dbSNP:rs56077971)	17344846	1
Q9BYP7/S1634P	Q9BYP7	WNK3	WNK3_HUMAN	S1634P	-	-	-	-	ESNAAsQQSPA									VARIANT	S -> P (in a renal clear cell carcinoma sample; somatic mutation)	17344846	1
Q9BYP7/S854C	Q9BYP7	WNK3	WNK3_HUMAN	S854C	-	-	-	-	QINSTsQTSNE									VARIANT	S -> C (in a lung squamous cell carcinoma sample; somatic mutation)	17344846	1
Q9BYP7/T1375I	Q9BYP7	WNK3	WNK3_HUMAN	T1375I	-	-	-	-	EAFIKtKSQLV									VARIANT	T -> I (in dbSNP:rs55879434)	17344846	1
Q9BYT3/A437T	Q9BYT3	STK33	STK33_HUMAN	A437T	-	-	-	neutral	GNVPDaYTSDE									VARIANT	A -> T (in dbSNP:rs3751095)	17344846	1
Q9BYT3/A458E	Q9BYT3	STK33	STK33_HUMAN	A458E	-	-	-	neutral	EKQFPaSKDNF									VARIANT	A -> E (in dbSNP:rs35296353)	17344846	1
Q9BYT3/D436E	Q9BYT3	STK33	STK33_HUMAN	D436E	-	-	-	neutral	WGNVPdNYTSD									VARIANT	D -> E (in dbSNP:rs3751096)	17344846	1
Q9BYT3/E98D	Q9BYT3	STK33	STK33_HUMAN	E98D	15	N-term-β1	-	neutral	RGNFTeKVPHI	0.23	0.273	0.553	0.266	0.182	0.201	0.683	0.184	VARIANT	E -> D (in dbSNP:rs34525052)	17344846	1
Q9BYT3/K60E	Q9BYT3	STK33	STK33_HUMAN	K60E	-	-	-	-	ISLERkEKNIN									VARIANT	K -> E (in dbSNP:rs60786172)		0
Q9BYT3/L160V	Q9BYT3	STK33	STK33_HUMAN	L160V	170	αC	-	-	SAVKLlREVNI	0.247	0.253	0.496	0.296	0.166	0.181	0.589	0.276	VARIANT	L -> V (in a lung large cell carcinoma sample; somatic mutation)	17344846	1
Q9BZL6/A496V	Q9BZL6	PRKD2	KPCD2_HUMAN	A496V	-	-	-	-	GQGAEaRGWET									VARIANT	A -> V (in dbSNP:rs55716765)	17344846	1
Q9BZL6/A835V	Q9BZL6	PRKD2	KPCD2_HUMAN	A835V	851	C-term-αI	-	-	HESDDaWEQFA	0.34	0.293	0.474	0.335	0.18	0.187	0.633	0.246	VARIANT	A -> V (in dbSNP:rs314665)		0
Q9BZL6/D695A	Q9BZL6	PRKD2	KPCD2_HUMAN	D695A	496	A-loop;DFG-motif	-	loss	QVKLCdGFARI	0.99	0.969	0.137	0.576	0.986	0.967	0.068	0.668	MUTAGEN	D->A: Loss of kinase activity.	23503467	1
Q9BZL6/G848E	Q9BZL6	PRKD2	KPCD2_HUMAN	G848E	-	-	-	-	EHPLPgGLPTD									VARIANT	G -> E (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
Q9BZL6/G870E	Q9BZL6	PRKD2	KPCD2_HUMAN	G870E	-	-	-	-	DHDMQgAERIS									VARIANT	G -> E (in a gastric adenocarcinoma sample; somatic mutation)	17344846	1
Q9BZL6/P275G	Q9BZL6	PRKD2	KPCD2_HUMAN	P275G	-	-	-	-	HSYTRpVCQAC									MUTAGEN	P->G: Increase in ability to bind phorbol ester, slight increase in ability to bind DAG.	18076381	1
Q9BZL6/S244E	Q9BZL6	PRKD2	KPCD2_HUMAN	S244E	-	-	p	-	SSSSAsYTGRP									MUTAGEN	S->E: Constitutive kinase activity; when associated with E-706 and E-710.	23503467	1
Q9BZL6/S604G	Q9BZL6	PRKD2	KPCD2_HUMAN	S604G	180	αC/β4-loop	-	-	VAILQsRHPGI	0.538	0.602	0.524	0.488	0.318	0.489	0.646	0.257	VARIANT	S -> G (in dbSNP:rs34325043)	17344846	1
Q9BZL6/S706A	Q9BZL6	PRKD2	KPCD2_HUMAN	S706A	514	A-loop	p	-	IIGEKsRRSVV	0.832	0.884	0.43	0.751	0.591	0.748	0.437	0.287	MUTAGEN	S->A: Abolishes phosphorylation. Loss of Tyr-717 phosphorylation and any other tyrosine phosphorylation, and increases NF-kappa-B activation in response to oxidative stress; when associated with A-710.	28428613	1
Q9BZL6/S706E	Q9BZL6	PRKD2	KPCD2_HUMAN	S706E	514	A-loop	p	-	IIGEKsRRSVV	0.879	0.915	0.758	0.896	0.35	0.77	0.687	0.556	MUTAGEN	S->E: Constitutive kinase activity; when associated with E-710 or with E-244 and E-710. Increases Tyr-717 phosphorylation; when associated with E-710 or with E-710 and D-438.	23503467,28428613	2
Q9BZL6/S710A	Q9BZL6	PRKD2	KPCD2_HUMAN	S710A	545	A-loop	p	-	KSFRRsVGTPA	0.983	0.997	0.181	0.898	0.926	0.957	0.178	0.366	MUTAGEN	S->A: Abolishes phosphorylation. Loss of Tyr-717 phosphorylation and any other tyrosine phosphorylation, and increases NF-kappa-B activation in response to oxidative stress; when associated with A-706.	28428613	1
Q9BZL6/S710E	Q9BZL6	PRKD2	KPCD2_HUMAN	S710E	545	A-loop	p	-	KSFRRsVGTPA	0.988	0.974	0.755	0.958	0.384	0.947	0.744	0.326	MUTAGEN	S->E: Constitutive kinase activity; when associated with E-706 or with E-244 and E-706. when associated with E-710 or with E-244 and E-710. Increases Tyr-717 phosphorylation; when associated with E-710 or with E-710 and D-438.	23503467,28428613	2
Q9BZL6/V324M	Q9BZL6	PRKD2	KPCD2_HUMAN	V324M	-	-	-	-	LINGDvMEEAT									VARIANT	V -> M (in dbSNP:rs45455991)	17344846	1
Q9BZL6/W773R	Q9BZL6	PRKD2	KPCD2_HUMAN	W773R	681	αG/αH	-	-	YPASPwHISAG	0.82	0.751	0.37	0.518	0.705	0.709	0.338	0.678	VARIANT	W -> R (in dbSNP:rs55933311)	17344846	1
Q9BZL6/Y438D	Q9BZL6	PRKD2	KPCD2_HUMAN	Y438D	-	-	-	increase	TTNRYyEIPLS									MUTAGEN	Y->D: Slight increase in Tyr-717 phosphorylation. No effect on Ser-706 or/and Ser-710 phosphorylation. Increase in Tyr-717 phosphorylation; when associated with E-706 and E-710.	28428613	1
Q9BZL6/Y438F	Q9BZL6	PRKD2	KPCD2_HUMAN	Y438F	-	-	-	decrease	TTNRYyEIPLS									MUTAGEN	Y->F: Loss of phosphorylation. No effect on phosphorylation of Tyr-717 and on Ser-706 or/and Ser-710 phosphorylation.	15604256,28428613	2
Q9BZL6/Y717F	Q9BZL6	PRKD2	KPCD2_HUMAN	Y717F	553	A-loop	p	loss	VGTPAyAPEVL	0.951	0.907	0.383	0.835	0.819	0.846	0.36	0.468	MUTAGEN	Y->F: Abolishes phosphorylation. Decreases substrate affinity and increases catalytic efficiency. Increases Ser-706 or/and Ser-710 phosphorylation. Increases NF-kappa-B activation in response to oxidative stress.	28428613	1
Q9BZL6/Y87F	Q9BZL6	PRKD2	KPCD2_HUMAN	Y87F	-	-	p	-	PECGFyLYDKI									MUTAGEN	Y->F: Loss of phosphorylation. No effect on the interaction with PRKCD. No effect on Ser-706 or/and Ser-710 phosphorylation.	28428613	1
Q9C098/E422K	Q9C098	DCLK3	DCLK3_HUMAN	E422K	210	β4/β5-loop	-	-	LHEVYeDMEIY	0.633	0.619	0.568	0.524	0.328	0.482	0.659	0.356	VARIANT	E -> K (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs373605259)	17344846	1
Q9C098/E633D	Q9C098	DCLK3	DCLK3_HUMAN	E633D	843	C-term-αI	-	neutral	VSPSSeHFRSQ	0.215	0.146	0.586	0.235	0.13	0.137	0.74	0.218	VARIANT	E -> D (in dbSNP:rs35704209)	17344846	1
Q9C098/G570R	Q9C098	DCLK3	DCLK3_HUMAN	G570R	659	αG/αH	-	-	NIIQLgFEFLP	0.851	0.809	0.462	0.592	0.554	0.631	0.487	0.592	VARIANT	G -> R (in a renal clear cell carcinoma sample; somatic mutation)	17344846	1
Q9C098/P108L	Q9C098	DCLK3	DCLK3_HUMAN	P108L	-	-	-	-	EPSSKpREATL									VARIANT	P -> L (in a breast infiltrating ductal carcinoma sample; somatic mutation)	17344846	1
Q9C098/R24Q	Q9C098	DCLK3	DCLK3_HUMAN	R24Q	-	-	-	neutral	YPNKArLTLAQ									VARIANT	R -> Q (in dbSNP:rs56070233)	17344846	1
Q9C098/R554C	Q9C098	DCLK3	DCLK3_HUMAN	R554C	623	αF/αG	-	-	GFPPFrPERDQ	0.69	0.616	0.521	0.539	0.55	0.566	0.533	0.363	VARIANT	R -> C (in a lung squamous cell carcinoma sample; somatic mutation; dbSNP:rs374711533)	17344846	1
Q9C098/S472N	Q9C098	DCLK3	DCLK3_HUMAN	S472N	427	αE	-	-	HMHDKsVHRDL	0.092	0.129	0.438	0.142	0.119	0.1	0.62	0.049	VARIANT	S -> N (in a lung large cell carcinoma sample; somatic mutation)	17344846	1
Q9C098/V596A	Q9C098	DCLK3	DCLK3_HUMAN	V596A	795	αH/αI	-	-	SRLLVvPKKRY	0.56	0.545	0.44	0.51	0.404	0.486	0.564	0.391	VARIANT	V -> A (in a colorectal adenocarcinoma sample; somatic mutation)	17344846	1
Q9C0K7/G155E	Q9C0K7	STRADB	STRAB_HUMAN	G155E	-	-	-	-	TYFPEgSETLI									VARIANT	G -> E (in a metastatic melanoma sample; somatic mutation)	17344846	1
Q9C0K7/P386L	Q9C0K7	STRADB	STRAB_HUMAN	P386L	-	-	-	-	LSLLPpYNKPS									VARIANT	P -> L (in dbSNP:rs35636836)	17344846	1
Q9H093/A516V	Q9H093	NUAK2	NUAK2_HUMAN	A516V	-	-	-	neutral	TALELaPTTFG									VARIANT	A -> V (in dbSNP:rs35070935)	17344846	1
Q9H093/G541E	Q9H093	NUAK2	NUAK2_HUMAN	G541E	-	-	-	-	ASRPSgVSEDS									VARIANT	G -> E (in a breast pleomorphic lobular carcinoma sample; somatic mutation)	17344846	1
Q9H093/K503R	Q9H093	NUAK2	NUAK2_HUMAN	K503R	-	-	-	-	RKGILkNGKFS									VARIANT	K -> R (in an ovarian Endometrioid carcinoma sample; somatic mutation; dbSNP:rs1271546767)	17344846	1
Q9H093/K81R	Q9H093	NUAK2	NUAK2_HUMAN	K81R	129	β3;Catalytic-Lys	-	loss	RLVAIkIRKDK	0.999	0.993	0.044	0.713	0.997	0.998	0.021	0.495	MUTAGEN	K->R: Loss of autophosphorylation, kinase activity and of anti-apoptotic activity.	15345718	1
Q9H093/R341L	Q9H093	NUAK2	NUAK2_HUMAN	R341L	-	-	-	-	LRRSSrLLENG									VARIANT	R -> L (in dbSNP:rs35208615)	17344846	1
Q9H093/T208A	Q9H093	NUAK2	NUAK2_HUMAN	T208A	545	A-loop	p	loss	GKFLQtCGSPL	0.996	0.986	0.159	0.905	0.912	0.988	0.102	0.367	MUTAGEN	T->A: Prevents phosphorylation and activation by STK11/LKB1 complex.	14976552	1
Q9H093/T309S	Q9H093	NUAK2	NUAK2_HUMAN	T309S	829	C-term-αI	-	-	NWGYAtVGEQE	0.163	0.144	0.448	0.198	0.155	0.186	0.623	0.153	VARIANT	T -> S (in dbSNP:rs55745939)	17344846	1
Q9H0K1/P825L	Q9H0K1	SIK2	SIK2_HUMAN	P825L	-	-	-	-	QQQPPpPPPPP									VARIANT	P -> L (in dbSNP:rs55889697)	17344846	1
Q9H0K1/P828L	Q9H0K1	SIK2	SIK2_HUMAN	P828L	-	-	-	-	PPPPPpPPPRQ									VARIANT	P -> L (in dbSNP:rs45520245)		0
Q9H0K1/P829S	Q9H0K1	SIK2	SIK2_HUMAN	P829S	-	-	-	-	PPPPPpPPRQP									VARIANT	P -> S (in dbSNP:rs45586732)		0
Q9H0K1/R809Q	Q9H0K1	SIK2	SIK2_HUMAN	R809Q	-	-	-	-	STSGPrAPPLP									VARIANT	R -> Q (in dbSNP:rs34223841)	17344846	1
Q9H0K1/T175A	Q9H0K1	SIK2	SIK2_HUMAN	T175A	545	A-loop	p	loss	GELLAtCGSPP	0.995	1.0	0.134	0.929	0.968	0.993	0.089	0.445	MUTAGEN	T->A: Prevents phosphorylation and activation by STK11/LKB1 complex.	14976552	1
Q9H0K1/T175E	Q9H0K1	SIK2	SIK2_HUMAN	T175E	545	A-loop	p	activating	GELLAtCGSPP	0.999	0.993	0.86	0.994	0.149	0.961	0.871	0.46	MUTAGEN	T->E: Constitutively active.	14976552	1
Q9H0K1/T458I	Q9H0K1	SIK2	SIK2_HUMAN	T458I	-	-	-	-	DEGLEtGEAEE									VARIANT	T -> I (in dbSNP:rs35789057)	17344846	1
Q9H1R3/A117V	Q9H1R3	MYLK2	MYLK2_HUMAN	A117V	-	-	-	-	KAEQGaGSQDP									VARIANT	A -> V (in a lung neuroendocrine carcinoma sample; somatic mutation; dbSNP:rs1229709568)	17344846	1
Q9H1R3/A87V	Q9H1R3	MYLK2	MYLK2_HUMAN	A87V	-	-	-	-	RGGGPaGSAGP									VARIANT	A -> V (in CMH; dbSNP:rs121908107)	11733062	1
Q9H1R3/A95E	Q9H1R3	MYLK2	MYLK2_HUMAN	A95E	-	-	-	-	SAGPPaLPQQT									VARIANT	A -> E (in CMH; dbSNP:rs121908108)	11733062	1
Q9H1R3/G142V	Q9H1R3	MYLK2	MYLK2_HUMAN	G142V	-	-	-	-	AAARRgPAFLH									VARIANT	G -> V (in dbSNP:rs56385445)	17344846	1
Q9H1R3/K324N	Q9H1R3	MYLK2	MYLK2_HUMAN	K324N	144	αC	-	-	QTPKDkMVLLE	0.461	0.409	0.521	0.425	0.24	0.257	0.62	0.226	VARIANT	K -> N (in dbSNP:rs34146416)	17344846	1
Q9H1R3/P144A	Q9H1R3	MYLK2	MYLK2_HUMAN	P144A	-	-	-	-	ARRGSpFLHSP									VARIANT	P -> A (in dbSNP:rs34396614)	17344846	1
Q9H2G2/A658G	Q9H2G2	SLK	SLK_HUMAN	A658G	-	-	-	neutral	VRSVVaTDQKA									VARIANT	A -> G (in dbSNP:rs56400929)	17344846	1
Q9H2G2/C552Y	Q9H2G2	SLK	SLK_HUMAN	C552Y	-	-	-	neutral	DVIGTcAADVA									VARIANT	C -> Y (in dbSNP:rs805657)	17344846	1
Q9H2G2/E604Q	Q9H2G2	SLK	SLK_HUMAN	E604Q	-	-	-	-	EVPIKeVEMNE									VARIANT	E -> Q (in an ovarian serous carcinoma sample; somatic mutation; dbSNP:rs190220654)	17344846	1
Q9H2G2/G666E	Q9H2G2	SLK	SLK_HUMAN	G666E	-	-	-	neutral	DQKALgEVQDA									VARIANT	G -> E (in dbSNP:rs7071400)		0
Q9H2G2/I679T	Q9H2G2	SLK	SLK_HUMAN	I679T	-	-	-	neutral	KVTTQiKEKKE									VARIANT	I -> T (in dbSNP:rs34326537)	17344846	1
Q9H2G2/K63R	Q9H2G2	SLK	SLK_HUMAN	K63R	129	β3;Catalytic-Lys	-	loss	VLAAAkIDTKS	1.0	1.0	0.032	0.674	0.999	0.999	0.007	0.523	MUTAGEN	K->R: Loss of activity.	10699464	1
Q9H2G2/K683N	Q9H2G2	SLK	SLK_HUMAN	K683N	-	-	-	-	QIDKEkEIPVS									VARIANT	K -> N (in dbSNP:rs35389916)	17344846	1
Q9H2G2/Q405K	Q9H2G2	SLK	SLK_HUMAN	Q405K	-	-	-	-	HITDAqEAMTE									VARIANT	Q -> K (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
Q9H2G2/T697I	Q9H2G2	SLK	SLK_HUMAN	T697I	-	-	-	neutral	KEPEVtVSQPT									VARIANT	T -> I (in dbSNP:rs3740469)	17344846	1
Q9H2K8/C727Y	Q9H2K8	TAOK3	TAOK3_HUMAN	C727Y	-	-	-	-	QFQDTcVQTKQ									VARIANT	C -> Y (in dbSNP:rs55857273)	17344846	1
Q9H2K8/D165A	Q9H2K8	TAOK3	TAOK3_HUMAN	D165A	496	A-loop;DFG-motif	-	loss	QVKLAdGSASM	0.991	0.999	0.08	0.527	0.986	0.979	0.042	0.689	MUTAGEN	D->A: Loss of serine/threonine-protein kinase activity.	17396146	1
Q9H2K8/P20T	Q9H2K8	TAOK3	TAOK3_HUMAN	P20T	26	N-term-β1	-	-	FYKDDpELFIG	0.781	0.764	0.365	0.509	0.704	0.703	0.307	0.54	VARIANT	P -> T (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
Q9H2K8/S324A	Q9H2K8	TAOK3	TAOK3_HUMAN	S324A	-	-	p	-	GPLNEsEDEED									MUTAGEN	S->A: Inhibits activation of the p38/MAPK14 stress-activated MAPK cascade in response to DNA damage.	17396146	1
Q9H2K8/S392Y	Q9H2K8	TAOK3	TAOK3_HUMAN	S392Y	-	-	-	-	TINSSsVVHKK									VARIANT	S -> Y (in a lung small cell carcinoma sample; somatic mutation)	17344846	1
Q9H2K8/S47N	Q9H2K8	TAOK3	TAOK3_HUMAN	S47N	72	β2/β3-loop	-	neutral	TNAHTsVVAIK	0.085	0.119	0.504	0.156	0.101	0.092	0.702	0.041	VARIANT	S -> N (in dbSNP:rs428073)	13679851,17344846	2
Q9H2K8/T181A	Q9H2K8	TAOK3	TAOK3_HUMAN	T181A	549	A-loop	-	-	NSFVGtYWMAP	0.867	0.907	0.239	0.548	0.788	0.829	0.22	0.478	MUTAGEN	T->A: No autophosphorylation and no kinase activity; when associated with F-183.	10559204	1
Q9H2K8/Y183F	Q9H2K8	TAOK3	TAOK3_HUMAN	Y183F	552	A-loop	-	-	FVGTPyMAPEV	0.501	0.483	0.554	0.413	0.292	0.393	0.629	0.193	MUTAGEN	Y->F: No autophosphorylation and no kinase activity; when associated with A-181.	10559204	1
Q9H2X6/K228A	Q9H2X6	HIPK2	HIPK2_HUMAN	K228A	129	β3;Catalytic-Lys	-	loss	EIVAIkLKNHP	0.999	0.997	0.018	0.552	1.0	0.997	0.009	0.667	MUTAGEN	K->A: Locates in the nucleoplasm, no effect on interaction with RANBP9, but loss of kinase activity toward PML, RUNX1, EP300 and DAZAP2.	11267674,11740489,11925430,12220523,12874272,12907596,14678985,18695000,19015637,33591310	10
Q9H2X6/K228R	Q9H2X6	HIPK2	HIPK2_HUMAN	K228R	129	β3;Catalytic-Lys	-	loss	EIVAIkLKNHP	1.0	1.0	0.054	0.755	0.975	0.997	0.023	0.463	MUTAGEN	K->R: Abolishes enzymatic activity, no effect on interaction with TP53 and TP73 or on BMP-induced transcriptional activation. Enhances BMP-induced transcriptional activation; when associated with 359-AAF-361.	11267674,11740489,11925430,12220523,12874272,12907596,14678985,18695000,19015637	9
Q9H2X6/K803A	Q9H2X6	HIPK2	HIPK2_HUMAN	K803A	-	-	ub	-	TTSSRkKQHQS									MUTAGEN	K->A: Impaired nuclear localization; when associated with A-805.	21145359	1
Q9H2X6/K805A	Q9H2X6	HIPK2	HIPK2_HUMAN	K805A	-	-	ub	-	SSRKSkHQSSV									MUTAGEN	K->A: Impaired nuclear localization; when associated with A-803.	21145359	1
Q9H2X6/K835E	Q9H2X6	HIPK2	HIPK2_HUMAN	K835E	-	-	-	-	RSKRVkNTPPR									MUTAGEN	K->E: Impaired nuclear localization.	21145359	1
Q9H2X6/R1027Q	Q9H2X6	HIPK2	HIPK2_HUMAN	R1027Q	-	-	-	-	TYRQQrGPHFQ									VARIANT	R -> Q (in dbSNP:rs35255718)	17344846	1
Q9H2X6/R792Q	Q9H2X6	HIPK2	HIPK2_HUMAN	R792Q	-	-	-	-	VAHVMrQPTST									VARIANT	R -> Q (in dbSNP:rs56132157)	17344846	1
Q9H2X6/R833A	Q9H2X6	HIPK2	HIPK2_HUMAN	R833A	-	-	-	-	PQRSKrKENTP									MUTAGEN	R->A: Impaired nuclear localization.	21145359	1
Q9H3Y6/A397V	Q9H3Y6	SRMS	SRMS_HUMAN	A397V	558	αF	-	neutral	WTAPEaNYRVF	0.115	0.151	0.514	0.216	0.068	0.128	0.759	0.073	VARIANT	A -> V (in dbSNP:rs6011889)	17344846	1
Q9H3Y6/A453T	Q9H3Y6	SRMS	SRMS_HUMAN	A453T	782	αH	-	neutral	PAACPaVYVLM	0.071	0.077	0.411	0.085	0.052	0.068	0.722	0.053	VARIANT	A -> T (in dbSNP:rs310655)	17344846	1
Q9H3Y6/D377E	Q9H3Y6	SRMS	SRMS_HUMAN	D377E	508	A-loop	-	-	ARLLKdIYSPS	0.205	0.211	0.576	0.29	0.188	0.185	0.693	0.201	VARIANT	D -> E (in dbSNP:rs55838540)	17344846	1
Q9H3Y6/G75R	Q9H3Y6	SRMS	SRMS_HUMAN	G75R	-	-	-	-	LSVRRgRLCAL									VARIANT	G -> R (in dbSNP:rs55863722)	17344846	1
Q9H3Y6/I88V	Q9H3Y6	SRMS	SRMS_HUMAN	I88V	-	-	-	neutral	EGGGYiARRLS									VARIANT	I -> V (in dbSNP:rs35558836)	17344846	1
Q9H3Y6/K258M	Q9H3Y6	SRMS	SRMS_HUMAN	K258M	129	β3;Catalytic-Lys	-	loss	LPVAIkIKSAN	1.0	1.0	0.029	0.584	0.999	0.999	0.025	0.506	MUTAGEN	K->M: Loss of kinase activity. Exhibits a diffused cytoplasmic localization. No effect on interaction with KHDRBS1 or VIM but abolishes tyrosine phosphorylation of both substrates.	23822091,29496907	2
Q9H3Y6/P218L	Q9H3Y6	SRMS	SRMS_HUMAN	P218L	17	N-term-β1	-	neutral	MPQKApQDVWE	0.239	0.25	0.559	0.297	0.249	0.162	0.666	0.182	VARIANT	P -> L (in dbSNP:rs378483)		0
Q9H3Y6/P325L	Q9H3Y6	SRMS	SRMS_HUMAN	P325L	303	αD/αE-loop	-	-	RALRLpLLGFA	0.477	0.403	0.52	0.445	0.343	0.356	0.608	0.37	VARIANT	P -> L (in dbSNP:rs8122355)		0
Q9H3Y6/P452L	Q9H3Y6	SRMS	SRMS_HUMAN	P452L	781	αH	-	-	RPAACpEVYVL	0.75	0.714	0.626	0.633	0.467	0.66	0.628	0.403	VARIANT	P -> L (in dbSNP:rs8120713)	17344846	1
Q9H3Y6/R73C	Q9H3Y6	SRMS	SRMS_HUMAN	R73C	-	-	-	-	GELSVrGDRLC									VARIANT	R -> C (in dbSNP:rs56053583)	17344846	1
Q9H3Y6/S465T	Q9H3Y6	SRMS	SRMS_HUMAN	S465T	795	αH/αI	-	neutral	LECWRsPEERP	0.099	0.096	0.377	0.118	0.078	0.099	0.625	0.103	VARIANT	S -> T (in dbSNP:rs33933649)	17344846	1
Q9H3Y6/V255M	Q9H3Y6	SRMS	SRMS_HUMAN	V255M	124	β3	-	neutral	LGSLPvIKVIK	0.388	0.399	0.577	0.464	0.284	0.396	0.638	0.332	VARIANT	V -> M (in dbSNP:rs34969822)		0
Q9H3Y6/V301L	Q9H3Y6	SRMS	SRMS_HUMAN	V301L	247	β5	-	-	EPVYIvELMRK	0.475	0.512	0.533	0.467	0.26	0.362	0.699	0.257	VARIANT	V -> L (in dbSNP:rs310657)	17344846	1
Q9H3Y6/V457L	Q9H3Y6	SRMS	SRMS_HUMAN	V457L	787	αH	-	-	PAEVYvMLECW	0.197	0.176	0.509	0.194	0.086	0.132	0.723	0.123	VARIANT	V -> L (in dbSNP:rs310654)	17344846	1
Q9H3Y6/W223A	Q9H3Y6	SRMS	SRMS_HUMAN	W223A	22	N-term-β1	-	loss	PRQDVwRPHSE	0.906	0.88	0.292	0.618	0.772	0.843	0.249	0.74	MUTAGEN	W->A: Loss of kinase activity.	23822091	1
Q9H3Y6/Y380F	Q9H3Y6	SRMS	SRMS_HUMAN	Y380F	511	A-loop	p	decrease	LKDDIyPSSSS	0.934	0.956	0.541	0.849	0.735	0.881	0.446	0.492	MUTAGEN	Y->F: Significant reduction in phosphorylation.	23822091	1
Q9H422/C191R	Q9H422	HIPK3	HIPK3_HUMAN	C191R	27	N-term-β1	-	-	QHEVLcMKNTY	0.783	0.725	0.458	0.604	0.463	0.613	0.53	0.58	VARIANT	C -> R (in dbSNP:rs35689361)	17344846	1
Q9H422/G170E	Q9H422	HIPK3	HIPK3_HUMAN	G170E	6	N-term-β1	-	neutral	VTATTgKQNCT	0.296	0.239	0.532	0.317	0.327	0.214	0.615	0.225	VARIANT	G -> E (in dbSNP:rs34698015)	17344846	1
Q9H422/K226R	Q9H422	HIPK3	HIPK3_HUMAN	K226R	129	β3;Catalytic-Lys	-	loss	EIVAIkLKNHP	1.0	1.0	0.055	0.757	0.975	0.997	0.023	0.461	MUTAGEN	K->R: Loss of kinase activity and impaired activation of SF1.	17210646	1
Q9H422/P729L	Q9H422	HIPK3	HIPK3_HUMAN	P729L	-	-	-	-	YNSVMpPLLTN									VARIANT	P -> L (in dbSNP:rs55807239)	17344846	1
Q9H422/Q142R	Q9H422	HIPK3	HIPK3_HUMAN	Q142R	-	-	-	-	HSSAMqVDELS									VARIANT	Q -> R (in dbSNP:rs34193811)	17344846	1
Q9H422/S500N	Q9H422	HIPK3	HIPK3_HUMAN	S500N	787	αH	-	neutral	RREFVsLKKML	0.067	0.092	0.404	0.096	0.082	0.083	0.638	0.044	VARIANT	S -> N (in dbSNP:rs11032229)	17344846	1
Q9H422/V474I	Q9H422	HIPK3	HIPK3_HUMAN	V474I	760	αG/αH	-	neutral	NSLDDvHVNTV	0.075	0.058	0.496	0.1	0.045	0.088	0.743	0.054	VARIANT	V -> I (in dbSNP:rs266472)		0
Q9H4A3/A141T	Q9H4A3	WNK1	WNK1_HUMAN	A141T	-	-	-	neutral	QPPAAaPGEQA									VARIANT	A -> T (in dbSNP:rs11554421)	17344846	1
Q9H4A3/A149V	Q9H4A3	WNK1	WNK1_HUMAN	A149V	-	-	-	neutral	GEQAVaPAPST									VARIANT	A -> V (in dbSNP:rs34880640)	17344846	1
Q9H4A3/A1546V	Q9H4A3	WNK1	WNK1_HUMAN	A1546V	-	-	-	-	AFSLSaSSSSS									VARIANT	A -> V (in dbSNP:rs56351358)	17344846	1
Q9H4A3/C1506S	Q9H4A3	WNK1	WNK1_HUMAN	C1506S	-	-	-	neutral	TASQLcQLSSS									VARIANT	C -> S (in dbSNP:rs7955371)	11571656,9205841	2
Q9H4A3/D527G	Q9H4A3	WNK1	WNK1_HUMAN	D527G	-	-	-	-	IEFSFdERDVP									VARIANT	D -> G (in dbSNP:rs34408667)	17344846	1
Q9H4A3/E1199G	Q9H4A3	WNK1	WNK1_HUMAN	E1199G	-	-	-	-	EDVSVeEGDQG									VARIANT	E -> G (in a colorectal cancer sample; somatic mutation)	16959974	1
Q9H4A3/E419Q	Q9H4A3	WNK1	WNK1_HUMAN	E419Q	618	αF	-	-	EMATSePYSEC	0.648	0.692	0.513	0.571	0.411	0.585	0.597	0.435	VARIANT	E -> Q (in a breast pleomorphic lobular carcinoma sample; somatic mutation)	17344846	1
Q9H4A3/F2362L	Q9H4A3	WNK1	WNK1_HUMAN	F2362L	-	-	-	-	ASLQNfISNLQ									VARIANT	F -> L (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
Q9H4A3/H823R	Q9H4A3	WNK1	WNK1_HUMAN	H823R	-	-	-	-	VHSGAhLPVGQ									VARIANT	H -> R (in dbSNP:rs56015776)	17344846	1
Q9H4A3/I509T	Q9H4A3	WNK1	WNK1_HUMAN	I509T	853	C-term-αI	-	neutral	LRIEDiKLKGK	0.592	0.543	0.474	0.469	0.406	0.533	0.537	0.451	VARIANT	I -> T (in dbSNP:rs34728563)	17344846	1
Q9H4A3/M1808I	Q9H4A3	WNK1	WNK1_HUMAN	M1808I	-	-	-	neutral	TLSPEmTVTSA									VARIANT	M -> I (in dbSNP:rs12828016)	11571656,17344846	2
Q9H4A3/P1823L	Q9H4A3	WNK1	WNK1_HUMAN	P1823L	-	-	-	neutral	VSMAApAITEA									VARIANT	P -> L (in dbSNP:rs17755373)	17344846	1
Q9H4A3/Q1799E	Q9H4A3	WNK1	WNK1_HUMAN	Q1799E	-	-	-	-	EDLDAqRRTLS									VARIANT	Q -> E (in breast cancer samples; infiltrating ductal carcinoma; somatic mutation)	16959974,17344846	2
Q9H4A3/R1957H	Q9H4A3	WNK1	WNK1_HUMAN	R1957H	-	-	-	-	ANKVGrSVSKT									VARIANT	R -> H (in dbSNP:rs36083875)	17344846	1
Q9H4A3/R2380W	Q9H4A3	WNK1	WNK1_HUMAN	R2380W	-	-	m1	-	PGSNLrT									VARIANT	R -> W (in dbSNP:rs56262445)	17344846	1
Q9H4A3/S2190C	Q9H4A3	WNK1	WNK1_HUMAN	S2190C	-	-	-	-	LKPSPsDNLYS									VARIANT	S -> C (in a breast pleomorphic lobular carcinoma sample; somatic mutation)	17344846	1
Q9H4A3/T1056P	Q9H4A3	WNK1	WNK1_HUMAN	T1056P	-	-	-	neutral	VAVAQtATQPT									VARIANT	T -> P (in dbSNP:rs956868)	11571656,9205841	2
Q9H4A3/T665I	Q9H4A3	WNK1	WNK1_HUMAN	T665I	-	-	-	neutral	GSSVFtSRVSS									VARIANT	T -> I (in dbSNP:rs2286007)	17344846	1
Q9H4A3/T674A	Q9H4A3	WNK1	WNK1_HUMAN	T674A	-	-	-	neutral	VSSQQtSYGSQ									VARIANT	T -> A (in dbSNP:rs11833299)	17344846	1
Q9H4B4/D203A	Q9H4B4	PLK3	PLK3_HUMAN	D203A	496	A-loop;DFG-motif	-	loss	ELKVGdGLAAR	0.998	0.982	0.114	0.569	0.996	0.967	0.043	0.685	MUTAGEN	D->A: Kinase defective mutant, abolishes activity.	11156373	1
Q9H4B4/D491N	Q9H4B4	PLK3	PLK3_HUMAN	D491N	-	-	-	-	AVLFNdTHMAL									VARIANT	D -> N (in dbSNP:rs17855444)	15489334	1
Q9H4B4/K91R	Q9H4B4	PLK3	PLK3_HUMAN	K91R	129	β3;Catalytic-Lys	-	loss	SAYAVkIPQSR	0.999	0.993	0.049	0.678	0.994	0.998	0.009	0.466	MUTAGEN	K->R: Kinase defective mutant, abolishes activity.	11447225,14980500,17804415,19103756,19490146,20889502,20940307	7
Q9H4B4/L283F	Q9H4B4	PLK3	PLK3_HUMAN	L283F	685	αG/αH	-	-	TLPASlLPARQ	0.364	0.362	0.598	0.459	0.185	0.225	0.756	0.206	VARIANT	L -> F (in dbSNP:rs17880471)		0
Q9H4B4/L68F	Q9H4B4	PLK3	PLK3_HUMAN	L68F	39	β1	-	-	LKGRLlKGGFA	0.742	0.696	0.403	0.56	0.523	0.639	0.449	0.62	VARIANT	L -> F (in dbSNP:rs17884316)		0
Q9H4B4/R483C	Q9H4B4	PLK3	PLK3_HUMAN	R483C	-	-	-	-	YQLSSrVAVLF									VARIANT	R -> C (in dbSNP:rs17884653)		0
Q9H4B4/S498L	Q9H4B4	PLK3	PLK3_HUMAN	S498L	-	-	-	-	THMALsNRKTV									VARIANT	S -> L (in dbSNP:rs17880829)		0
Q9H4B4/S618P	Q9H4B4	PLK3	PLK3_HUMAN	S618P	-	-	-	-	CTYLAsLRQLG									VARIANT	S -> P (in dbSNP:rs17881786)		0
Q9H4B4/T219E	Q9H4B4	PLK3	PLK3_HUMAN	T219E	545	A-loop	p	loss	EQRKKtCGTPN	0.999	0.991	0.832	0.976	0.309	0.94	0.822	0.442	MUTAGEN	T->E: Kinase-defective mutant.	16478733	1
Q9H4B4/T61S	Q9H4B4	PLK3	PLK3_HUMAN	T61S	30	β1	-	-	PRSGRtLKGRL	0.16	0.238	0.452	0.188	0.159	0.161	0.628	0.055	VARIANT	T -> S (in dbSNP:rs17884581)		0
Q9H5K3/L137R	Q9H5K3	POMK	SG196_HUMAN	L137R	199	β4	-	loss	THVVTlGYCED	0.817	0.784	0.555	0.643	0.652	0.678	0.497	0.404	VARIANT	L -> R (in MDDGA12; loss of kinase activity; dbSNP:rs397509385)	23519211,23929950	2
Q9H5K3/M301T	Q9H5K3	POMK	SG196_HUMAN	M301T	-	-	-	-	IEGSDmRFHLF									VARIANT	M -> T (in dbSNP:rs33920561)	17344846	1
Q9H5K3/M342I	Q9H5K3	POMK	SG196_HUMAN	M342I	-	-	-	-	TLRDAmSQARE									VARIANT	M -> I (in a lung small cell carcinoma sample; somatic mutation)	17344846	1
Q9H5K3/Q258R	Q9H5K3	POMK	SG196_HUMAN	Q258R	-	-	-	-	FVAPEqWPYGE									VARIANT	Q -> R (in MDDGA12; dbSNP:rs397509386)	23519211	1
Q9H5K3/S48P	Q9H5K3	POMK	SG196_HUMAN	S48P	-	-	-	-	IAPRQsVDPTH									VARIANT	S -> P (in dbSNP:rs34466747)	17344846	1
Q9H5K3/V254M	Q9H5K3	POMK	SG196_HUMAN	V254M	-	-	-	-	LHGDFvPEQLW									VARIANT	V -> M (in dbSNP:rs34715198)	17344846	1
Q9H5K3/V302D	Q9H5K3	POMK	SG196_HUMAN	V302D	-	-	-	-	EGSDMvFHLFD									VARIANT	V -> D (in MDDGA12; dbSNP:rs199756983)	24925318	1
Q9H5K3/Y140F	Q9H5K3	POMK	SG196_HUMAN	Y140F	223	β4/β5-loop	-	-	VTLLGyEDDNT	0.274	0.325	0.42	0.147	0.242	0.284	0.578	0.08	VARIANT	Y -> F (in dbSNP:rs34750053)	17344846	1
Q9H792/A1707D	Q9H792	PEAK1	PEAK1_HUMAN	A1707D	-	-	-	-	LMIKFaKSLDR									MUTAGEN	A->D: Disrupts homodimerization.	29212708	1
Q9H792/D836E	Q9H792	PEAK1	PEAK1_HUMAN	D836E	-	-	-	-	APQTTdPTTKV									VARIANT	D -> E (in dbSNP:rs56388121)	17344846	1
Q9H792/F1609A	Q9H792	PEAK1	PEAK1_HUMAN	F1609A	-	-	-	-	HLPNPfENPEL									MUTAGEN	F->A: No effect on interaction with PRAG1.	29079850	1
Q9H792/G213R	Q9H792	PEAK1	PEAK1_HUMAN	G213R	-	-	-	-	HVILSgTEVIS									VARIANT	G -> R (in dbSNP:rs35459975)	17344846	1
Q9H792/H611Q	Q9H792	PEAK1	PEAK1_HUMAN	H611Q	-	-	-	-	FPIIIhEPTYA									VARIANT	H -> Q (in a bladder carcinoma NOS sample; somatic mutation)	17344846	1
Q9H792/P1145L	Q9H792	PEAK1	PEAK1_HUMAN	P1145L	-	-	-	-	TDQEApASQPT									VARIANT	P -> L (in a metastatic melanoma sample; somatic mutation)	17344846	1
Q9H792/P1408Q	Q9H792	PEAK1	PEAK1_HUMAN	P1408Q	-	-	-	neutral	LPWEDpDPEKD									VARIANT	P -> Q (in dbSNP:rs56079860)	17344846	1
Q9H792/R1071K	Q9H792	PEAK1	PEAK1_HUMAN	R1071K	-	-	-	neutral	GKQDGrCTSVT									VARIANT	R -> K (in dbSNP:rs12909704)	17344846	1
Q9H792/R1699G	Q9H792	PEAK1	PEAK1_HUMAN	R1699G	-	-	-	-	WLDIKrLLMIK									VARIANT	R -> G (in dbSNP:rs34004337)	17344846	1
Q9H792/S1035F	Q9H792	PEAK1	PEAK1_HUMAN	S1035F	-	-	-	-	KKRSHsPSQIP									VARIANT	S -> F (in a metastatic melanoma sample; somatic mutation)	17344846	1
Q9H792/S1542T	Q9H792	PEAK1	PEAK1_HUMAN	S1542T	-	-	-	neutral	GPAEPsTSSYP									VARIANT	S -> T (in dbSNP:rs1867780)	17344846	1
Q9H792/S440P	Q9H792	PEAK1	PEAK1_HUMAN	S440P	-	-	-	neutral	EESKAsDVAGQ									VARIANT	S -> P (in dbSNP:rs35335169)	17344846	1
Q9H792/S792I	Q9H792	PEAK1	PEAK1_HUMAN	S792I	-	-	p	-	GPKACsEELYA									VARIANT	S -> I (in dbSNP:rs34885462)	17344846	1
Q9H792/T1077P	Q9H792	PEAK1	PEAK1_HUMAN	T1077P	-	-	-	neutral	GCTSVtALSLP									VARIANT	T -> P (in dbSNP:rs56133554)	17344846	1
Q9H792/V240I	Q9H792	PEAK1	PEAK1_HUMAN	V240I	-	-	-	-	ESEEDvFSNME									VARIANT	V -> I (in dbSNP:rs56129428)	17344846	1
Q9H792/Y1188F	Q9H792	PEAK1	PEAK1_HUMAN	Y1188F	-	-	-	-	MANPTyIDPNW									MUTAGEN	Y->F: Fails to bind SHC1. Reduced recruitment of SHC1 to focal adhesions. Slightly reduces interaction with GRB2. Does not affect interaction with RASAL2. Does not affect association with integrin ITGB1.	23846654,35687021	2
Q9H792/Y635E	Q9H792	PEAK1	PEAK1_HUMAN	Y635E	-	-	p	-	INPNAyNLAIY									MUTAGEN	Y->E: 50% reduction in interaction with GRB2. No effect on interaction with SHC1.		0
Q9H792/Y635F	Q9H792	PEAK1	PEAK1_HUMAN	Y635F	-	-	p	-	INPNAyNLAIY									MUTAGEN	Y->F: Impairs interaction with tensin TNS3 and association with integrin ITGB1. 50% reduction in interaction with GRB2. No effect on interaction with unphosphorylated SHC1 but reduces interaction with tyrosine-phosphorylated SHC1. Reduces focal adhesion localization. Reduces cell migration.	35687021	1
Q9H792/Y665E	Q9H792	PEAK1	PEAK1_HUMAN	Y665E	-	-	p	-	VISHTyEIETE									MUTAGEN	Y->E: No effect on localization with actin. Decreases localization in focal adhesion. Fails to regulate focal adhesion dynamics. Decreases cell migration.	23105102	1
Q9H792/Y665F	Q9H792	PEAK1	PEAK1_HUMAN	Y665F	-	-	p	-	VISHTyEIETE									MUTAGEN	Y->F: No effect on focal adhesion subcellular localization. Does not affect colocalization with F-actin.	23105102	1
Q9HAZ1/I363V	Q9HAZ1	CLK4	CLK4_HUMAN	I363V	604	αF	-	-	CDVWSiCILIE	0.36	0.255	0.519	0.394	0.223	0.217	0.683	0.224	VARIANT	I -> V (in dbSNP:rs55746655)	17344846	1
Q9HAZ1/K189R	Q9HAZ1	CLK4	CLK4_HUMAN	K189R	129	β3;Catalytic-Lys	-	loss	MHVAVkVKNVG	0.993	1.0	0.055	0.723	0.994	0.989	0.034	0.448	MUTAGEN	K->R: Loss of function.	11170754	1
Q9HAZ1/L352F	Q9HAZ1	CLK4	CLK4_HUMAN	L352F	590	αF	-	neutral	EVILAlWSQPC	0.356	0.33	0.482	0.328	0.256	0.343	0.552	0.343	VARIANT	L -> F (in dbSNP:rs35272416)	17344846	1
Q9HBH9/D228G	Q9HBH9	MKNK2	MKNK2_HUMAN	D228G	498	A-loop;DFG-motif	-	decrease	KICDFdGSGIK	0.61	0.684	0.447	0.429	0.467	0.516	0.528	0.305	MUTAGEN	D->G: Reduced phosphorylation.	16917500	1
Q9HBH9/D73N	Q9HBH9	MKNK2	MKNK2_HUMAN	D73N	19	N-term-β1	-	-	RGRATdFSGRF	0.375	0.405	0.39	0.206	0.275	0.309	0.631	0.13	VARIANT	D -> N (in dbSNP:rs56158214)	17344846	1
Q9HBH9/Q10K	Q9HBH9	MKNK2	MKNK2_HUMAN	Q10K	-	-	-	neutral	KPAELqFHRSF									VARIANT	Q -> K (in dbSNP:rs3746101)		0
Q9HBH9/R428Q	Q9HBH9	MKNK2	MKNK2_HUMAN	R428Q	-	-	-	neutral	QPVLVrTSRCL									VARIANT	R -> Q (in dbSNP:rs34475638)		0
Q9HBH9/T244A	Q9HBH9	MKNK2	MKNK2_HUMAN	T244A	540	A-loop	-	-	CSPIStELLTP	0.476	0.412	0.478	0.365	0.376	0.399	0.638	0.251	MUTAGEN	T->A: Loss of kinase activity; when associated with T-249.	11463832	1
Q9HBH9/T249A	Q9HBH9	MKNK2	MKNK2_HUMAN	T249A	545	A-loop	-	-	TPELLtCGSAE	0.984	0.96	0.196	0.831	0.923	0.947	0.118	0.468	MUTAGEN	T->A: Loss of kinase activity; when associated with T-244.	11463832	1
Q9HBH9/T379D	Q9HBH9	MKNK2	MKNK2_HUMAN	T379D	834	C-term-αI	-	activating	ENTLPtMVLQR	0.468	0.42	0.672	0.571	0.175	0.268	0.717	0.214	MUTAGEN	T->D: Constitutively active.	11463832	1
Q9HBY8/E199K	Q9HBY8	SGK2	SGK2_HUMAN	E199K	552	A-loop	-	-	FCGTPeLAPEV	0.765	0.732	0.477	0.637	0.433	0.549	0.54	0.394	VARIANT	E -> K (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
Q9HBY8/H289Y	Q9HBY8	SGK2	SGK2_HUMAN	H289Y	820	αI	-	-	LEIKNhFFSPI	0.853	0.832	0.563	0.737	0.495	0.734	0.558	0.58	VARIANT	H -> Y (in dbSNP:rs35793869)	17344846	1
Q9HBY8/S356D	Q9HBY8	SGK2	SGK2_HUMAN	S356D	-	-	-	increase	AFLGFsAPEDD									MUTAGEN	S->D: Increased activation.	10548550	1
Q9HC98/K74M	Q9HC98	NEK6	NEK6_HUMAN	K74M	129	β3;Catalytic-Lys	-	-	KTVALkVQIFE	1.0	0.991	0.035	0.665	0.986	0.99	0.021	0.46	MUTAGEN	K->M: Loss of autophosphorylation and of kinase activity and induction of apoptosis; when associated with M-75.	14563848,19001501	2
Q9HC98/K75M	Q9HC98	NEK6	NEK6_HUMAN	K75M	130	β3	-	-	TVALKkQIFEM	0.692	0.663	0.582	0.585	0.491	0.626	0.597	0.437	MUTAGEN	K->M: Loss of autophosphorylation and of kinase activity and induction of apoptosis; when associated with M-74.	14563848,19001501	2
Q9HC98/Y108A	Q9HC98	NEK6	NEK6_HUMAN	Y108A	204	β4	p	increase	PNIIKyDSFIE	0.921	0.907	0.632	0.897	0.258	0.721	0.664	0.481	MUTAGEN	Y->A: Increase in catalytic activity.	19941817	1
Q9HCP0/N169A	Q9HCP0	CSNK1G1	KC1G1_HUMAN	N169A	448	Catalytic-loop	-	loss	DVKPEnLIGRQ	0.955	0.949	0.213	0.615	0.907	0.934	0.197	0.672	MUTAGEN	N->A: Loss of kinase activity.	21680713	1
Q9HCP0/R206K	Q9HCP0	CSNK1G1	KC1G1_HUMAN	R206K	541	A-loop	-	-	KHIPYrHKSLT	0.699	0.756	0.437	0.554	0.507	0.624	0.458	0.376	VARIANT	R -> K (in dbSNP:rs55799101)	17344846	1
Q9HCP0/R230W	Q9HCP0	CSNK1G1	KC1G1_HUMAN	R230W	596	αF	-	-	GKEQSrDDLEA	0.809	0.849	0.549	0.729	0.524	0.706	0.527	0.368	VARIANT	R -> W (probable disease-associated variant found in a patient with non-syndromic early-onset epilepsy associated with severe developmental delay and microcephaly; dbSNP:rs587777544)	24463883	1
Q9HCP0/V329I	Q9HCP0	CSNK1G1	KC1G1_HUMAN	V329I	-	-	-	neutral	YAYDWvRPIPT									VARIANT	V -> I (in dbSNP:rs55699712)	17344846	1
Q9NQU5/A376V	Q9NQU5	PAK6	PAK6_HUMAN	A376V	-	-	-	-	TVAKGaAGEDT									VARIANT	A -> V (in dbSNP:rs55806501)	17344846	1
Q9NQU5/E184K	Q9NQU5	PAK6	PAK6_HUMAN	E184K	-	-	-	-	SLGPAeQGASQ									VARIANT	E -> K (in dbSNP:rs56349744)	17344846	1
Q9NQU5/E475K	Q9NQU5	PAK6	PAK6_HUMAN	E475K	240	β4/β5-loop	-	-	SYLVGeLWVLM	0.506	0.444	0.582	0.541	0.184	0.286	0.679	0.395	VARIANT	E -> K (in dbSNP:rs34445577)		0
Q9NQU5/G205E	Q9NQU5	PAK6	PAK6_HUMAN	G205E	-	-	-	-	QSSPPgSPPTG									VARIANT	G -> E (in dbSNP:rs55920845)	17344846	1
Q9NQU5/H215R	Q9NQU5	PAK6	PAK6_HUMAN	H215R	-	-	-	neutral	TGTNRhMKAAK									VARIANT	H -> R (in dbSNP:rs3743135)	17344846	1
Q9NQU5/L514R	Q9NQU5	PAK6	PAK6_HUMAN	L514R	414	αE	-	-	AVLQAlYLHAQ	0.885	0.838	0.357	0.608	0.693	0.756	0.313	0.693	VARIANT	L -> R (in a lung small cell carcinoma sample; somatic mutation)	17344846	1
Q9NQU5/M76V	Q9NQU5	PAK6	PAK6_HUMAN	M76V	-	-	-	neutral	VRGSAmVDGYI									VARIANT	M -> V (in dbSNP:rs2412504)	17344846	1
Q9NQU5/P208T	Q9NQU5	PAK6	PAK6_HUMAN	P208T	-	-	-	-	PPGASpTGTNR									VARIANT	P -> T (in dbSNP:rs35501648)	17344846	1
Q9NQU5/P337L	Q9NQU5	PAK6	PAK6_HUMAN	P337L	-	-	-	neutral	SLRTApTGQLP									VARIANT	P -> L (in dbSNP:rs3743137)	17344846	1
Q9NQU5/R103C	Q9NQU5	PAK6	PAK6_HUMAN	R103C	-	-	-	-	NTLRGrPTSRR									VARIANT	R -> C (in dbSNP:rs36081263)		0
Q9NQU5/R3H	Q9NQU5	PAK6	PAK6_HUMAN	R3H	-	-	-	-	MFrKKKKR									VARIANT	R -> H (in a colorectal cancer sample; somatic mutation; dbSNP:rs201346085)	16959974	1
Q9NQU5/S165A	Q9NQU5	PAK6	PAK6_HUMAN	S165A	-	-	p	-	WPEPQsRVLPN									MUTAGEN	S->A: Almost complete loss of PAK6 activation by MAP2K6/MAPKK6; when associated with F-566.	15550393	1
Q9NQU5/S560A	Q9NQU5	PAK6	PAK6_HUMAN	S560A	545	A-loop	p	-	VPKRKsVGTPY	0.951	0.978	0.18	0.869	0.895	0.984	0.155	0.524	MUTAGEN	S->A: Complete loss of PAK6 activation by MAP2K6/MAPKK6; when associated with A-165.	15550393	1
Q9NQU5/T151I	Q9NQU5	PAK6	PAK6_HUMAN	T151I	-	-	-	-	SCNGGtAGHKQ									VARIANT	T -> I (in dbSNP:rs35593179)		0
Q9NQU5/T210M	Q9NQU5	PAK6	PAK6_HUMAN	T210M	-	-	-	-	GASPPtTNRHG									VARIANT	T -> M (in dbSNP:rs34869667)	17344846	1
Q9NQU5/Y566F	Q9NQU5	PAK6	PAK6_HUMAN	Y566F	552	A-loop	p	-	LVGTPyMAPEV	0.838	0.87	0.562	0.816	0.38	0.67	0.549	0.34	MUTAGEN	Y->F: Complete loss of PAK6 activation by MAP2K6/MAPKK6; when associated with A-165.	15550393	1
Q9NR20/A61T	Q9NR20	DYRK4	DYRK4_HUMAN	A61T	-	-	-	-	EILGYaLWFLG									VARIANT	A -> T (in dbSNP:rs12306130)		0
Q9NR20/A70S	Q9NR20	DYRK4	DYRK4_HUMAN	A70S	-	-	-	-	FLGLEaKLDTA									VARIANT	A -> S	17344846	1
Q9NR20/D454V	Q9NR20	DYRK4	DYRK4_HUMAN	D454V	-	-	-	neutral	TEKTKdPTKHV									VARIANT	D -> V (in dbSNP:rs1801016)		0
Q9NR20/K133R	Q9NR20	DYRK4	DYRK4_HUMAN	K133R	129	β3;Catalytic-Lys	-	loss	ELVALkIRNKK	1.0	1.0	0.051	0.767	1.0	0.999	0.007	0.491	MUTAGEN	K->R: Loss of kinase activity.	17292540	1
Q9NR20/N189S	Q9NR20	DYRK4	DYRK4_HUMAN	N189S	255	β5/αD-loop	-	neutral	ELLGInYELMK	0.403	0.387	0.503	0.358	0.238	0.394	0.513	0.632	VARIANT	N -> S (in dbSNP:rs3741927)	11062477	1
Q9NR20/V95I	Q9NR20	DYRK4	DYRK4_HUMAN	V95I	24	N-term-β1	-	-	GFYLKvHDHIA	0.488	0.471	0.547	0.376	0.393	0.416	0.642	0.396	VARIANT	V -> I (in dbSNP:rs746486416)	11062477	1
Q9NR20/Y264F	Q9NR20	DYRK4	DYRK4_HUMAN	Y264F	546	A-loop	p	loss	QKVYTyQSRFY	0.977	0.957	0.355	0.784	0.88	0.907	0.269	0.408	MUTAGEN	Y->F: Abolishes kinase activity.	21127067	1
Q9NRH2/G611S	Q9NRH2	SNRK	SNRK_HUMAN	G611S	-	-	-	-	GSPSSgGGNPT									VARIANT	G -> S (in an ovarian mucinous carcinoma sample; somatic mutation; dbSNP:rs368877591)	17344846	1
Q9NRH2/L260S	Q9NRH2	SNRK	SNRK_HUMAN	L260S	813	αI	-	-	KRRASlEIENH	0.657	0.616	0.491	0.492	0.395	0.597	0.512	0.437	VARIANT	L -> S (in dbSNP:rs35624204)	17344846	1
Q9NRH2/P391S	Q9NRH2	SNRK	SNRK_HUMAN	P391S	-	-	-	neutral	TVPQSpRAADS									VARIANT	P -> S (in dbSNP:rs56104180)	17344846	1
Q9NRH2/P748L	Q9NRH2	SNRK	SNRK_HUMAN	P748L	-	-	-	-	NIQRNpEGLLC									VARIANT	P -> L (in an ovarian serous carcinoma sample; somatic mutation)	17344846	1
Q9NRH2/T173A	Q9NRH2	SNRK	SNRK_HUMAN	T173A	545	A-loop	p	loss	GKKLTtCGSLA	0.999	1.0	0.143	0.912	0.972	0.996	0.068	0.506	MUTAGEN	T->A,E: Prevents phosphorylation and activation by STK11/LKB1 complex.	15733851	1
Q9NRH2/T173E	Q9NRH2	SNRK	SNRK_HUMAN	T173E	545	A-loop	p	loss	GKKLTtCGSLA	0.991	0.997	0.656	0.967	0.544	0.977	0.562	0.444	MUTAGEN	T->A,E: Prevents phosphorylation and activation by STK11/LKB1 complex.	15733851	1
Q9NRL2/D344E	Q9NRL2	BAZ1A	BAZ1A_HUMAN	D344E	-	-	-	-	KKEKEdEKKRE									VARIANT	D -> E (in dbSNP:rs1133285)		0
Q9NRL2/N1366K	Q9NRL2	BAZ1A	BAZ1A_HUMAN	N1366K	-	-	-	neutral	RKSANnPENSP									VARIANT	N -> K (in dbSNP:rs1044140)	10880450,17974005	2
Q9NRM7/A1014G	Q9NRM7	LATS2	LATS2_HUMAN	A1014G	-	-	-	neutral	SPWNDaEGSTK									VARIANT	A -> G (in dbSNP:rs45523141)	17344846	1
Q9NRM7/A324V	Q9NRM7	LATS2	LATS2_HUMAN	A324V	-	-	-	-	KQAGPaHQLHV									VARIANT	A -> V (in dbSNP:rs558614)	10673337	1
Q9NRM7/G363S	Q9NRM7	LATS2	LATS2_HUMAN	G363S	-	-	-	neutral	DLYELgTSVQQ									VARIANT	G -> S (in dbSNP:rs2770928)		0
Q9NRM7/G40E	Q9NRM7	LATS2	LATS2_HUMAN	G40E	-	-	-	-	QGLPAgNSDTS									VARIANT	G -> E (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
Q9NRM7/I799V	Q9NRM7	LATS2	LATS2_HUMAN	I799V	451	Catalytic-loop	-	-	PDNILiLDGHI	0.207	0.163	0.463	0.301	0.212	0.173	0.603	0.261	VARIANT	I -> V (in dbSNP:rs35368391)	17344846	1
Q9NRM7/K697A	Q9NRM7	LATS2	LATS2_HUMAN	K697A	129	β3;Catalytic-Lys	-	loss	ALYAMkLRKKD	1.0	1.0	0.015	0.655	1.0	0.996	0.003	0.667	MUTAGEN	K->A: Loss of kinase activity, autophosphorylation and tumor suppressor activity.	10871863,12853976	2
Q9NRM7/L1025P	Q9NRM7	LATS2	LATS2_HUMAN	L1025P	-	-	-	-	KAWDTlSPNNK									VARIANT	L -> P (in dbSNP:rs56116059)	17344846	1
Q9NRM7/S83C	Q9NRM7	LATS2	LATS2_HUMAN	S83C	-	-	p	-	REIRYsLPFAN									MUTAGEN	S->C: Fails to localize at the centromere during interphase.	15147269	1
Q9NRM7/S83E	Q9NRM7	LATS2	LATS2_HUMAN	S83E	-	-	p	-	REIRYsLPFAN									MUTAGEN	S->E: Fails to localize at the centromere during interphase.	15147269	1
Q9NRM7/S872A	Q9NRM7	LATS2	LATS2_HUMAN	S872A	545	β1	p	loss	RCLAHsVGTPN	0.915	0.919	0.203	0.789	0.947	0.961	0.171	0.496	MUTAGEN	S->A: Loss of tumor suppressor activity.	12853976	1
Q9NRM7/S91L	Q9NRM7	LATS2	LATS2_HUMAN	S91L	-	-	-	-	PFANEsTSAAA									VARIANT	S -> L (in dbSNP:rs55842804)	17344846	1
Q9NRP7/D329N	Q9NRP7	STK36	STK36_HUMAN	D329N	-	-	-	neutral	ALEQEdTSKVA									VARIANT	D -> N (in dbSNP:rs34027859)	17344846	1
Q9NRP7/F476S	Q9NRP7	STK36	STK36_HUMAN	F476S	-	-	-	-	HILPAfVLSSL									VARIANT	F -> S (in dbSNP:rs34128793)	17344846	1
Q9NRP7/G1003D	Q9NRP7	STK36	STK36_HUMAN	G1003D	-	-	-	neutral	ADLLIgLADLR									VARIANT	G -> D (in dbSNP:rs1863704)	14702039,17344846	2
Q9NRP7/H1313P	Q9NRP7	STK36	STK36_HUMAN	H1313P	-	-	-	-	LLRPAhM									VARIANT	H -> P	17344846	1
Q9NRP7/I90M	Q9NRP7	STK36	STK36_HUMAN	I90M	267	αD	-	-	GELFQiEDDGK	0.576	0.514	0.471	0.358	0.399	0.504	0.5	0.342	VARIANT	I -> M (in dbSNP:rs55706732)	17344846	1
Q9NRP7/K295R	Q9NRP7	STK36	STK36_HUMAN	K295R	-	-	-	neutral	HRLAPkNQSRI									VARIANT	K -> R (in dbSNP:rs1863703)	17344846	1
Q9NRP7/K33R	Q9NRP7	STK36	STK36_HUMAN	K33R	129	β3;Catalytic-Lys	-	-	QVVALkIPKLG	1.0	1.0	0.033	0.715	0.999	0.998	0.007	0.478	MUTAGEN	K->R: No effect on nuclear localization of GLI1 or GLI2 or on GLI-mediated transcription.	10806483	1
Q9NRP7/K463N	Q9NRP7	STK36	STK36_HUMAN	K463N	-	-	-	-	GGQILkILEGA									VARIANT	K -> N (in dbSNP:rs17856747)	15489334	1
Q9NRP7/L462V	Q9NRP7	STK36	STK36_HUMAN	L462V	-	-	-	neutral	AGGQIlGILEG									VARIANT	L -> V (in dbSNP:rs45586733)	17344846	1
Q9NRP7/L672P	Q9NRP7	STK36	STK36_HUMAN	L672P	-	-	-	-	TAPVGlDCWDA									VARIANT	L -> P (in dbSNP:rs35448374)	17344846	1
Q9NRP7/L840V	Q9NRP7	STK36	STK36_HUMAN	L840V	-	-	-	neutral	PAEVRlPPGSC									VARIANT	L -> V (in dbSNP:rs36099639)	17344846	1
Q9NRP7/P1185S	Q9NRP7	STK36	STK36_HUMAN	P1185S	-	-	-	-	AYQAGpGPALA									VARIANT	P -> S (in an ovarian endometrioid sample; somatic mutation)	17344846	1
Q9NRP7/Q1138K	Q9NRP7	STK36	STK36_HUMAN	Q1138K	-	-	-	-	LGHLLqSMALR									VARIANT	Q -> K (in an ovarian serous carcinoma sample; somatic mutation)	17344846	1
Q9NRP7/Q638P	Q9NRP7	STK36	STK36_HUMAN	Q638P	-	-	-	-	PVHTPqAPQVS									VARIANT	Q -> P (in dbSNP:rs6709303)		0
Q9NRP7/R1112Q	Q9NRP7	STK36	STK36_HUMAN	R1112Q	-	-	-	neutral	SDESYrLRSLL									VARIANT	R -> Q (in dbSNP:rs12993599)	17344846	1
Q9NRP7/R240W	Q9NRP7	STK36	STK36_HUMAN	R240W	798	αI	-	-	LTKDPrRLSWP	0.543	0.522	0.598	0.579	0.348	0.467	0.692	0.221	VARIANT	R -> W (in dbSNP:rs35038757)	17344846	1
Q9NRP7/R477W	Q9NRP7	STK36	STK36_HUMAN	R477W	-	-	-	neutral	ILPAFrLSSLL									VARIANT	R -> W (in dbSNP:rs16859180)	17344846	1
Q9NRP7/R583Q	Q9NRP7	STK36	STK36_HUMAN	R583Q	-	-	-	neutral	SEQTLrDSLMC									VARIANT	R -> Q (in dbSNP:rs1344642)	17344846	1
Q9NRP7/R839Q	Q9NRP7	STK36	STK36_HUMAN	R839Q	-	-	-	-	APAEVrTPPGS									VARIANT	R -> Q (in dbSNP:rs13023540)	17344846	1
Q9NRP7/S660C	Q9NRP7	STK36	STK36_HUMAN	S660C	-	-	-	-	PGAISsLAAIC									VARIANT	S -> C (in a breast pleomorphic lobular carcinoma sample; somatic mutation; dbSNP:rs1244829273)	17344846	1
Q9NRP7/S767T	Q9NRP7	STK36	STK36_HUMAN	S767T	-	-	-	-	TLYFLsLVFRL									VARIANT	S -> T (in dbSNP:rs17856748)	15489334	1
Q9NRP7/S767Y	Q9NRP7	STK36	STK36_HUMAN	S767Y	-	-	-	-	TLYFLsLVFRL									VARIANT	S -> Y (in an ovarian papillary serous adenocarcinoma sample; somatic mutation)	17344846	1
Q9NRP7/T816A	Q9NRP7	STK36	STK36_HUMAN	T816A	-	-	-	-	GQQGVtDLQPM									VARIANT	T -> A (in dbSNP:rs34271431)	17344846	1
Q9NRP7/V1004I	Q9NRP7	STK36	STK36_HUMAN	V1004I	-	-	-	neutral	DLLIGvADLRD									VARIANT	V -> I (in dbSNP:rs55633575)		0
Q9NRP7/Y1111C	Q9NRP7	STK36	STK36_HUMAN	Y1111C	-	-	-	-	GSDESyPLRSL									VARIANT	Y -> C (in dbSNP:rs56278660)	17344846	1
Q9NSY1/D212V	Q9NSY1	BMP2K	BMP2K_HUMAN	D212V	523	A-loop	-	-	LNPQKdVNVVE	0.33	0.373	0.586	0.465	0.179	0.242	0.629	0.332	VARIANT	D -> V (in dbSNP:rs56143363)	17344846	1
Q9NSY1/G405S	Q9NSY1	BMP2K	BMP2K_HUMAN	G405S	-	-	-	neutral	APGEFgHRPKG									VARIANT	G -> S (in dbSNP:rs2288255)	15489334	1
Q9NSY1/Q486H	Q9NSY1	BMP2K	BMP2K_HUMAN	Q486H	-	-	-	neutral	QQQQQqHHHHH									VARIANT	Q -> H (in dbSNP:rs2114202)		0
Q9NSY1/R288H	Q9NSY1	BMP2K	BMP2K_HUMAN	R288H	782	αH	-	-	NSRYSrIHCLI	0.205	0.172	0.458	0.189	0.138	0.184	0.644	0.259	VARIANT	R -> H (in dbSNP:rs55782848)	17344846	1
Q9NSY1/T1002S	Q9NSY1	BMP2K	BMP2K_HUMAN	T1002S	-	-	-	neutral	HHGTPtTKKTL									VARIANT	T -> S (in dbSNP:rs12507099)		0
Q9NSY1/V68M	Q9NSY1	BMP2K	BMP2K_HUMAN	V68M	53	β2	-	-	STVFLvTHGGI	0.506	0.543	0.561	0.57	0.331	0.445	0.61	0.341	VARIANT	V -> M (in a lung squamous cell carcinoma sample; somatic mutation; dbSNP:rs770167074)	17344846	1
Q9NWZ3/A428T	Q9NWZ3	IRAK4	IRAK4_HUMAN	A428T	783	αH	-	neutral	STSVEaYSVAS	0.153	0.076	0.53	0.146	0.082	0.089	0.772	0.145	VARIANT	A -> T (in dbSNP:rs4251545)	17344846	1
Q9NWZ3/G298D	Q9NWZ3	IRAK4	IRAK4_HUMAN	G298D	413	αE	-	decrease	QGAANgNFLHE	0.761	0.81	0.348	0.577	0.792	0.657	0.246	0.367	VARIANT	G -> D (in IMD67; decreases inhibition of NF-kappa-B complex activation; impairs neutrophil migration and phagocytosis; dbSNP:rs568782766)	19663824,21057262,24316379	3
Q9NWZ3/H390R	Q9NWZ3	IRAK4	IRAK4_HUMAN	H390R	637	αG	-	-	PAVDEhEPQLL	0.209	0.228	0.523	0.196	0.119	0.169	0.716	0.163	VARIANT	H -> R (in dbSNP:rs4251583)		0
Q9NWZ3/I26T	Q9NWZ3	IRAK4	IRAK4_HUMAN	I26T	-	-	-	-	KLSDFiPQEGW									VARIANT	I -> T (no effect on inhibition of NF-kappa-B activation; no effect on interaction with MYD88; dbSNP:rs138116867)	24316379	1
Q9NWZ3/I39V	Q9NWZ3	IRAK4	IRAK4_HUMAN	I39V	-	-	-	-	KLAVAiKPSGD									VARIANT	I -> V (no effect on inhibition of NF-kappa-B activation; no effect on interaction with MYD88; dbSNP:rs113588409)	24316379	1
Q9NWZ3/I5V	Q9NWZ3	IRAK4	IRAK4_HUMAN	I5V	-	-	-	-	MNKPiPSTYV									VARIANT	I -> V (no effect on inhibition of NF-kappa-B activation; no effect on interaction with MYD88; dbSNP:rs56312115)	17344846,24316379	2
Q9NWZ3/K213A	Q9NWZ3	IRAK4	IRAK4_HUMAN	K213A	129	β3;Catalytic-Lys	-	loss	TTVAVkLAAMV	1.0	1.0	0.043	0.645	0.986	0.99	0.018	0.628	MUTAGEN	K->A: Loss of kinase activity.	15084582	1
Q9NWZ3/M355V	Q9NWZ3	IRAK4	IRAK4_HUMAN	M355V	554	A-loop	-	-	GTTAYmPEALR	0.307	0.299	0.512	0.354	0.198	0.253	0.707	0.293	VARIANT	M -> V (in dbSNP:rs142376871)	17344846	1
Q9NWZ3/R12C	Q9NWZ3	IRAK4	IRAK4_HUMAN	R12C	-	-	-	-	PSTYVrLNVGL									VARIANT	R -> C (in IMD67; no effect on inhibition of NF-kappa-B complex activation; loss of interaction with MYD88; decreases protein stability; dbSNP:rs377584435)	17878374,24316379	2
Q9NWZ3/R20W	Q9NWZ3	IRAK4	IRAK4_HUMAN	R20W	-	-	-	-	NVGLIrLSDFI									VARIANT	R -> W (increases inhibition of NF-kappa-B complex activation; decreases interaction with MYD88; decreases protein stability; dbSNP:rs143625818)	24316379	1
Q9NWZ3/R391H	Q9NWZ3	IRAK4	IRAK4_HUMAN	R391H	638	αG	-	neutral	AVDEHrPQLLL	0.393	0.286	0.51	0.335	0.237	0.318	0.623	0.18	VARIANT	R -> H (in dbSNP:rs55944915)	17344846,17878374	2
Q9NWZ3/S98R	Q9NWZ3	IRAK4	IRAK4_HUMAN	S98R	-	-	-	-	FFAPAsLLPDA									VARIANT	S -> R (no effect on inhibition of NF-kappa-B activation; no effect on interaction with MYD88; dbSNP:rs4251469)	24316379	1
Q9NY57/D310V	Q9NY57	STK32B	ST32B_HUMAN	D310V	851	C-term-αI	-	-	GRLNCdTFELE	0.612	0.624	0.499	0.584	0.385	0.436	0.546	0.314	VARIANT	D -> V (in dbSNP:rs56259884)	17344846	1
Q9NY57/G35E	Q9NY57	STK32B	ST32B_HUMAN	G35E	45	Gly-rich-loop;β2	-	-	GKGSFgVCIVQ	0.891	0.89	0.356	0.71	0.819	0.831	0.329	0.532	VARIANT	G -> E (in a metastatic melanoma sample; somatic mutation)	17344846	1
Q9NY57/K342T	Q9NY57	STK32B	ST32B_HUMAN	K342T	-	-	-	-	SRDGTkSCPLN									VARIANT	K -> T (in dbSNP:rs55961955)	17344846	1
Q9NY57/R198G	Q9NY57	STK32B	ST32B_HUMAN	R198G	588	αF	-	neutral	QVYMDrPGYSY	0.154	0.161	0.511	0.144	0.11	0.111	0.714	0.095	VARIANT	R -> G (in dbSNP:rs3733182)	15489334,17344846	2
Q9NY57/R244H	Q9NY57	STK32B	ST32B_HUMAN	R244H	674	αG/αH	-	-	MFKVErHYSST	0.201	0.168	0.455	0.16	0.141	0.145	0.616	0.174	VARIANT	R -> H (in dbSNP:rs35207488)	17344846	1
Q9NYL2/A281T	Q9NYL2	MAP3K20	M3K20_HUMAN	A281T	833	C-term-αI	-	-	FLHNKaWRCEI	0.221	0.269	0.536	0.288	0.157	0.165	0.706	0.08	VARIANT	A -> T (in an ovarian endometrioid sample; somatic mutation)	17344846	1
Q9NYL2/A281V	Q9NYL2	MAP3K20	M3K20_HUMAN	A281V	833	C-term-αI	-	-	FLHNKaWRCEI	0.333	0.33	0.594	0.406	0.182	0.211	0.68	0.153	VARIANT	A -> V (in dbSNP:rs34683477)	17344846	1
Q9NYL2/A505S	Q9NYL2	MAP3K20	M3K20_HUMAN	A505S	-	-	-	-	WIVGIaSQTVE									VARIANT	A -> S (in SFMMP; mild destabilization of the protein)	32266845	1
Q9NYL2/F368C	Q9NYL2	MAP3K20	M3K20_HUMAN	F368C	-	-	-	-	VYASLfENNIT									VARIANT	F -> C (in SFMMP; produces protein aggregation; dbSNP:rs863225437)	26755636	1
Q9NYL2/K45M	Q9NYL2	MAP3K20	M3K20_HUMAN	K45M	129	β3;Catalytic-Lys	-	loss	KEVAVkLLKIE	1.0	1.0	0.037	0.619	1.0	0.998	0.022	0.495	MUTAGEN	K->M: Loss of kinase activity. Does not affect ability to activate EIF2AK4/GCN2 in response to mild ribosome collision.	11836244,32610081,35857590	3
Q9NYL2/K784T	Q9NYL2	MAP3K20	M3K20_HUMAN	K784T	-	-	-	-	RPSPAkNKERA									VARIANT	K -> T (in dbSNP:rs55830025)	17344846	1
Q9NYL2/P740T	Q9NYL2	MAP3K20	M3K20_HUMAN	P740T	-	-	-	-	RDLHQpTIPGM									VARIANT	P -> T (in dbSNP:rs56202258)	17344846	1
Q9NYL2/R250W	Q9NYL2	MAP3K20	M3K20_HUMAN	R250W	800	αI	-	-	ADAKKrSFKQI	0.884	0.874	0.466	0.75	0.698	0.744	0.383	0.405	VARIANT	R -> W (in CNM6; unknown pathological significance; dbSNP:rs763481300)	30237576	1
Q9NYL2/R580W	Q9NYL2	MAP3K20	M3K20_HUMAN	R580W	-	-	-	-	DTLRMrIASNT									VARIANT	R -> W (in dbSNP:rs7593622)	17344846	1
Q9NYL2/S165A	Q9NYL2	MAP3K20	M3K20_HUMAN	S165A	535	A-loop	p	loss	HTTHMsVGTFP	0.792	0.9	0.358	0.584	0.705	0.711	0.355	0.203	MUTAGEN	S->A: Loss of autophosphorylation activity.	15342622	1
Q9NYL2/S531L	Q9NYL2	MAP3K20	M3K20_HUMAN	S531L	-	-	-	-	TKHVHsQWSRT									VARIANT	S -> L (in dbSNP:rs3769148)	10924358,11042189,11836244,17344846	4
Q9NYL2/S657A	Q9NYL2	MAP3K20	M3K20_HUMAN	S657A	-	-	-	-	LNSRDsFSSGN									MUTAGEN	S->A: Abolished association with BTRC without affecting protein stability.	32289254	1
Q9NYL2/T161A	Q9NYL2	MAP3K20	M3K20_HUMAN	T161A	509	A-loop	p	loss	RFHNHtHMSLV	0.914	0.879	0.511	0.786	0.648	0.825	0.423	0.536	MUTAGEN	T->A: Loss of autophosphorylation activity.	15342622	1
Q9NYL2/T162A	Q9NYL2	MAP3K20	M3K20_HUMAN	T162A	510	A-loop	p	decrease	FHNHTtMSLVG	0.901	0.937	0.387	0.719	0.686	0.832	0.356	0.354	MUTAGEN	T->A: Slight loss of autophosphorylation activity.	15342622	1
Q9NYL2/T267M	Q9NYL2	MAP3K20	M3K20_HUMAN	T267M	819	αI	-	-	SMSNDtLPDKC	0.3	0.238	0.501	0.24	0.194	0.267	0.576	0.185	VARIANT	T -> M (in dbSNP:rs6758025)	17344846	1
Q9NYL2/Y773H	Q9NYL2	MAP3K20	M3K20_HUMAN	Y773H	-	-	-	-	WTKVEyKKPHR									VARIANT	Y -> H (in dbSNP:rs35608243)	17344846	1
Q9NYV4/D877N	Q9NYV4	CDK12	CDK12_HUMAN	D877N	496	A-loop;DFG-motif	-	loss	QIKLAdGLARL	0.982	0.993	0.138	0.593	0.974	0.95	0.079	0.651	MUTAGEN	D->N: Abolishes kinase activity.	24662513	1
Q9NYV4/L1189Q	Q9NYV4	CDK12	CDK12_HUMAN	L1189Q	-	-	-	neutral	SAPVIlSAEQT									VARIANT	L -> Q (in dbSNP:rs56362165)	17344846	1
Q9NYV4/P1275L	Q9NYV4	CDK12	CDK12_HUMAN	P1275L	-	-	-	neutral	PGPPPpPPPPL									VARIANT	P -> L (in dbSNP:rs34070318)	17344846	1
Q9NYV4/P530A	Q9NYV4	CDK12	CDK12_HUMAN	P530A	-	-	-	-	TPPPLpIASPP									VARIANT	P -> A (in dbSNP:rs56121596)	17344846	1
Q9NYV4/R912H	Q9NYV4	CDK12	CDK12_HUMAN	R912H	591	αF	-	-	LLGEErTPAID	0.213	0.2	0.45	0.229	0.173	0.17	0.596	0.162	VARIANT	R -> H (in a colorectal adenocarcinoma sample; somatic mutation)	17344846	1
Q9NYY3/E436K	Q9NYY3	PLK2	PLK2_HUMAN	E436K	-	-	-	-	GTPAVeKQQIG									VARIANT	E -> K (in dbSNP:rs55768901)	17344846	1
Q9NYY3/G92S	Q9NYY3	PLK2	PLK2_HUMAN	G92S	43	Gly-rich-loop;β1/β2-loop	-	-	VLGKGgAKCYE	0.834	0.672	0.517	0.576	0.506	0.648	0.496	0.488	VARIANT	G -> S (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
Q9NYY3/H629A	Q9NYY3	PLK2	PLK2_HUMAN	H629A	-	-	-	-	NFYHDhKIIIC									MUTAGEN	H->A: Impairs localization to the centrosome and centriole duplication; when associated with F-503 and M-631.	19001868	1
Q9NYY3/K631M	Q9NYY3	PLK2	PLK2_HUMAN	K631M	-	-	-	-	YHDHTkIICSQ									MUTAGEN	K->M: Impairs localization to the centrosome and centriole duplication; when associated with F-503 and A-631.	19001868	1
Q9NYY3/N210A	Q9NYY3	PLK2	PLK2_HUMAN	N210A	448	Catalytic-loop	-	loss	DLKLGnFINEA	0.981	0.951	0.253	0.732	0.933	0.917	0.159	0.662	MUTAGEN	N->A: Loss of kinase activity.	19001868	1
Q9NYY3/P487L	Q9NYY3	PLK2	PLK2_HUMAN	P487L	-	-	-	-	CLENMpADCIP									VARIANT	P -> L (in dbSNP:rs55645589)	17344846	1
Q9NYY3/S14T	Q9NYY3	PLK2	PLK2_HUMAN	S14T	-	-	-	-	YQPAAsKMCEQ									VARIANT	S -> T (in an ovarian Endometrioid carcinoma sample; somatic mutation; dbSNP:rs1404394734)	17344846	1
Q9NYY3/W503F	Q9NYY3	PLK2	PLK2_HUMAN	W503F	-	-	-	-	STSFQwTKWVD									MUTAGEN	W->F: Impairs localization to the centrosome and centriole duplication; when associated with A-629 and M-631.	19001868	1
Q9NZJ5/A704S	Q9NZJ5	EIF2AK3	E2AK3_HUMAN	A704S	-	-	-	-	RMDPFaKEHIE									VARIANT	A -> S (in dbSNP:rs1805165)	10026192,10677345,15489334	3
Q9NZJ5/D566V	Q9NZJ5	EIF2AK3	E2AK3_HUMAN	D566V	5	N-term-β1	-	-	TENKYdVSGEA	0.658	0.564	0.504	0.541	0.398	0.483	0.543	0.447	VARIANT	D -> V (in dbSNP:rs55791823)	17344846	1
Q9NZJ5/P716L	Q9NZJ5	EIF2AK3	E2AK3_HUMAN	P716L	-	-	-	-	IIAPSpRSRSF									VARIANT	P -> L (in dbSNP:rs55861585)	17344846	1
Q9NZJ5/Q166R	Q9NZJ5	EIF2AK3	E2AK3_HUMAN	Q166R	-	-	-	neutral	LFQWDqRESME									VARIANT	Q -> R (in dbSNP:rs13045)	10026192,10677345,15489334	3
Q9NZJ5/R588Q	Q9NZJ5	EIF2AK3	E2AK3_HUMAN	R588Q	27	N-term-β1	-	-	SGYISrLTDFE	0.559	0.491	0.571	0.611	0.295	0.383	0.611	0.344	VARIANT	R -> Q (in WRS; dbSNP:rs121908569)	10932183	1
Q9NZJ5/S136C	Q9NZJ5	EIF2AK3	E2AK3_HUMAN	S136C	-	-	-	neutral	DVGSGsVSSSL									VARIANT	S -> C (in dbSNP:rs867529)	10932183,17344846	2
Q9P0L2/E691G	Q9P0L2	MARK1	MARK1_HUMAN	E691G	-	-	-	-	ERDKEeKDSKP									VARIANT	E -> G (in dbSNP:rs55688276)	17344846	1
Q9P0L2/N355T	Q9P0L2	MARK1	MARK1_HUMAN	N355T	-	-	-	-	NDALInKYDEV									VARIANT	N -> T (in an ovarian serous carcinoma sample; somatic mutation)	17344846	1
Q9P0L2/P578L	Q9P0L2	MARK1	MARK1_HUMAN	P578L	-	-	-	-	SEAYRpTTQRV									VARIANT	P -> L (in dbSNP:rs55691439)	17344846	1
Q9P0L2/R645G	Q9P0L2	MARK1	MARK1_HUMAN	R645G	-	-	-	-	AFAHArGTSTG									VARIANT	R -> G (in dbSNP:rs12123778)		0
Q9P0L2/R698S	Q9P0L2	MARK1	MARK1_HUMAN	R698S	-	-	-	-	KDSKPrLRFTW									MUTAGEN	R->S: Impairs phospholipid-binding, targeting to membrane and vesicle-binding; when associated with S-701.	21145462	1
Q9P0L2/R701S	Q9P0L2	MARK1	MARK1_HUMAN	R701S	-	-	-	-	KPRSLrTWSMK									MUTAGEN	R->S: Impairs phospholipid-binding, targeting to membrane and vesicle-binding; when associated with S-698.	21145462	1
Q9P0L2/T215A	Q9P0L2	MARK1	MARK1_HUMAN	T215A	545	A-loop	p	loss	GNKLDtCGSPP	0.999	1.0	0.12	0.921	0.987	0.995	0.053	0.478	MUTAGEN	T->A: Prevents phosphorylation and activation by STK11/LKB1 complex.	14976552	1
Q9P0L2/T215E	Q9P0L2	MARK1	MARK1_HUMAN	T215E	545	A-loop	p	activating	GNKLDtCGSPP	0.999	0.997	0.87	1.0	0.118	0.956	0.889	0.445	MUTAGEN	T->E: Constitutively active.	14976552	1
Q9P0L2/V530M	Q9P0L2	MARK1	MARK1_HUMAN	V530M	-	-	-	-	LTEMSvSISSA									VARIANT	V -> M (in dbSNP:rs56212551)	17344846	1
Q9P0L2/Y233C	Q9P0L2	MARK1	MARK1_HUMAN	Y233C	592	αF	-	-	FQGKKyGPEVD	0.841	0.862	0.376	0.592	0.656	0.734	0.331	0.463	VARIANT	Y -> C (in a gastric adenocarcinoma sample; somatic mutation)	17344846	1
Q9P1W9/G138D	Q9P1W9	PIM2	PIM2_HUMAN	G138D	396	αD/αE-loop	-	-	GPLGEgSRCFF	0.265	0.251	0.579	0.372	0.149	0.176	0.728	0.129	VARIANT	G -> D (in dbSNP:rs35044770)	17344846	1
Q9P1W9/I280V	Q9P1W9	PIM2	PIM2_HUMAN	I280V	817	αI	-	-	PSLEEiLDPWM	0.09	0.078	0.459	0.152	0.11	0.122	0.633	0.102	VARIANT	I -> V (in dbSNP:rs35208542)	17344846	1
Q9P286/A555S	Q9P286	PAK5	PAK5_HUMAN	A555S	413	αE	-	-	LSVLRaSYLHN	0.687	0.624	0.511	0.485	0.443	0.531	0.604	0.341	VARIANT	A -> S (in dbSNP:rs34102290)	17344846	1
Q9P286/G118D	Q9P286	PAK5	PAK5_HUMAN	G118D	-	-	-	-	SSHGPgAEENG									VARIANT	G -> D (in dbSNP:rs55923311)	17344846	1
Q9P286/G704S	Q9P286	PAK5	PAK5_HUMAN	G704S	827	C-term-αI	-	-	FLKLAgPSCIV	0.392	0.359	0.478	0.318	0.198	0.212	0.629	0.321	VARIANT	G -> S (in a metastatic melanoma sample; somatic mutation; dbSNP:rs1484691555)	17344846	1
Q9P286/P187A	Q9P286	PAK5	PAK5_HUMAN	P187A	-	-	-	-	YSEVKpKSDFA									VARIANT	P -> A (in dbSNP:rs34280805)	17344846	1
Q9P286/R335P	Q9P286	PAK5	PAK5_HUMAN	R335P	-	-	-	-	KVDYDrQMVLS									VARIANT	R -> P (in dbSNP:rs11700112)	17344846	1
Q9P286/S312P	Q9P286	PAK5	PAK5_HUMAN	S312P	-	-	-	-	HPQGHsNSYTY									VARIANT	S -> P (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs952665081)	17344846	1
Q9P286/S511N	Q9P286	PAK5	PAK5_HUMAN	S511N	206	β4/β5-loop	-	-	VVDMYsYLVGD	0.223	0.223	0.538	0.271	0.183	0.162	0.592	0.211	VARIANT	S -> N (in dbSNP:rs2297345)	14702039,17344846	2
Q9P286/T538N	Q9P286	PAK5	PAK5_HUMAN	T538N	386	αD/αE-loop	-	-	DIVTHtMNEEQ	0.474	0.43	0.587	0.435	0.213	0.339	0.698	0.175	VARIANT	T -> N (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
Q9P286/V604I	Q9P286	PAK5	PAK5_HUMAN	V604I	547	A-loop	-	-	KRKSLvTPYWM	0.415	0.341	0.658	0.481	0.19	0.33	0.762	0.279	VARIANT	V -> I (in a metastatic melanoma sample; somatic mutation)	17344846	1
Q9P289/G36W	Q9P289	STK26	STK26_HUMAN	G36W	45	Gly-rich-loop;β2	-	-	GKGSFgVFKGI	0.88	0.846	0.326	0.613	0.796	0.824	0.343	0.448	VARIANT	G -> W (in a gastric adenocarcinoma sample; somatic mutation)	17344846	1
Q9P289/K53E	Q9P289	STK26	STK26_HUMAN	K53E	129	β3;Catalytic-Lys	-	loss	QVVAIkIDLEE	1.0	1.0	0.039	0.734	0.994	0.999	0.035	0.552	MUTAGEN	K->E: Abolished serine/threonine-protein kinase activity.	29232556	1
Q9P289/Q9R	Q9P289	STK26	STK26_HUMAN	Q9R	18	N-term-β1	-	-	SPVAVqPGMQN	0.495	0.404	0.454	0.444	0.359	0.386	0.561	0.257	VARIANT	Q -> R (in dbSNP:rs56035648)	17344846	1
Q9P289/R45C	Q9P289	STK26	STK26_HUMAN	R45C	65	β2/β3-loop	-	-	KGIDNrQQVVA	0.749	0.722	0.523	0.638	0.505	0.669	0.525	0.367	VARIANT	R -> C (in dbSNP:rs56044451)	17344846	1
Q9P2K8/D872V	Q9P2K8	EIF2AK4	E2AK4_HUMAN	D872V	506	A-loop	-	-	FGLATdLAFSA	0.409	0.383	0.565	0.425	0.375	0.332	0.583	0.301	VARIANT	D -> V (in dbSNP:rs34665481)	17344846	1
Q9P2K8/G1306C	Q9P2K8	EIF2AK4	E2AK4_HUMAN	G1306C	-	-	-	neutral	LLKKLgKLQVL									VARIANT	G -> C (in dbSNP:rs35602605)	15489334,17344846	2
Q9P2K8/H137R	Q9P2K8	EIF2AK4	E2AK4_HUMAN	H137R	-	-	-	-	SFLSEhKPPPK									VARIANT	H -> R (in dbSNP:rs35509999)	17344846	1
Q9P2K8/H939Y	Q9P2K8	EIF2AK4	E2AK4_HUMAN	H939Y	616	αF	-	-	FEMSYhMVTAS	0.497	0.397	0.462	0.445	0.278	0.312	0.546	0.359	VARIANT	H -> Y (in a lung neuroendocrine carcinoma sample; somatic mutation)	17344846	1
Q9P2K8/I441L	Q9P2K8	EIF2AK4	E2AK4_HUMAN	I441L	494	Catalytic-loop	-	neutral	EGTVKiDYSIS	0.144	0.183	0.513	0.141	0.109	0.126	0.642	0.148	VARIANT	I -> L (in dbSNP:rs2291627)	17344846,17974005	2
Q9P2K8/K1336R	Q9P2K8	EIF2AK4	E2AK4_HUMAN	K1336R	-	-	-	neutral	FVAFIkRQRAV									VARIANT	K -> R (in dbSNP:rs35480871)	17344846	1
Q9P2K8/L643R	Q9P2K8	EIF2AK4	E2AK4_HUMAN	L643R	183	αC/β4-loop	-	-	TLLSRlHENIV	0.929	0.853	0.301	0.559	0.748	0.813	0.235	0.795	VARIANT	L -> R (in PVOD2; dbSNP:rs757852728)	24292273	1
Q9P2K8/Q1406H	Q9P2K8	EIF2AK4	E2AK4_HUMAN	Q1406H	-	-	-	-	VVSVGqSMSRA									VARIANT	Q -> H (in dbSNP:rs55721315)	17344846	1
Q9P2K8/R166W	Q9P2K8	EIF2AK4	E2AK4_HUMAN	R166W	-	-	-	-	LLEAKrEEQEQ									VARIANT	R -> W (in dbSNP:rs34439704)	17344846	1
Q9P2K8/R585Q	Q9P2K8	EIF2AK4	E2AK4_HUMAN	R585Q	-	-	-	-	QRQFSrFIEFE									VARIANT	R -> Q (in PVOD2; dbSNP:rs587777106)	24292273	1
Q9P2K8/T1060R	Q9P2K8	EIF2AK4	E2AK4_HUMAN	T1060R	-	-	-	-	NFSIRtKMQQH									VARIANT	T -> R (in dbSNP:rs55781333)	17344846	1
Q9UBE8/A343T	Q9UBE8	NLK	NLK_HUMAN	A343T	624	αF/αG	-	-	RILFQaSPIQQ	0.559	0.523	0.533	0.493	0.244	0.376	0.588	0.306	VARIANT	A -> T (in a glioblastoma multiforme sample; somatic mutation)	17344846	1
Q9UBE8/K167N	Q9UBE8	NLK	NLK_HUMAN	K167N	129	β3;Catalytic-Lys	-	loss	KRVALkMPNVF	0.995	1.0	0.084	0.747	0.928	0.977	0.088	0.501	MUTAGEN	K->N: Abrogates kinase activity.	20061393	1
Q9UBE8/V177A	Q9UBE8	NLK	NLK_HUMAN	V177A	144	αC	-	-	VFQNLvCKRVF	0.349	0.358	0.389	0.265	0.296	0.296	0.507	0.282	VARIANT	V -> A (in dbSNP:rs11871287)		0
Q9UBS0/A420V	Q9UBS0	RPS6KB2	KS6B2_HUMAN	A420V	-	-	-	neutral	NSSPRaVSPLK									VARIANT	A -> V (in dbSNP:rs13859)	10490847,15489334,17344846,9804755,9878560,23186163	6
Q9UBS0/P267L	Q9UBS0	RPS6KB2	KS6B2_HUMAN	P267L	619	αF	-	-	MLTGSpFTAEN	0.612	0.568	0.581	0.435	0.457	0.46	0.565	0.419	VARIANT	P -> L (in dbSNP:rs55987642)	17344846	1
Q9UBS0/T443M	Q9UBS0	RPS6KB2	KS6B2_HUMAN	T443M	-	-	-	-	SLPEPtLPLPP									VARIANT	T -> M (in an ovarian mucinous carcinoma sample; somatic mutation; dbSNP:rs374535834)	17344846	1
Q9UBS0/V368M	Q9UBS0	RPS6KB2	KS6B2_HUMAN	V368M	-	-	-	-	TRQTPvSPDDT									VARIANT	V -> M (in dbSNP:rs55642995)	17344846	1
Q9UEE5/E126D	Q9UEE5	STK17A	ST17A_HUMAN	E126D	206	β4/β5-loop	-	neutral	VINLHeYETAS	0.124	0.143	0.452	0.182	0.169	0.115	0.634	0.147	VARIANT	E -> D (in dbSNP:rs56286238)	17344846	1
Q9UEE5/E286Q	Q9UEE5	STK17A	ST17A_HUMAN	E286Q	679	αG/αH	-	neutral	SYSEEeDVLSE	0.133	0.113	0.5	0.221	0.094	0.116	0.665	0.157	VARIANT	E -> Q (in dbSNP:rs3779062)	17344846	1
Q9UEE5/K362E	Q9UEE5	STK17A	ST17A_HUMAN	K362E	-	-	-	neutral	DKSETkSIVTE									VARIANT	K -> E (in dbSNP:rs1044141)	12690205,15489334,17344846,9786912	4
Q9UEE5/K90A	Q9UEE5	STK17A	ST17A_HUMAN	K90A	129	β3;Catalytic-Lys	-	loss	KEFAAkMRKRR	0.999	1.0	0.02	0.648	1.0	0.998	0.01	0.665	MUTAGEN	K->A: Loss of activity and of apoptotic function.	9786912	1
Q9UEE5/M167T	Q9UEE5	STK17A	ST17A_HUMAN	M167T	407	αE	-	-	DVQRLmQILEG	0.586	0.504	0.49	0.563	0.321	0.415	0.514	0.388	VARIANT	M -> T (in dbSNP:rs35940029)	17344846	1
Q9UF33/A711V	Q9UF33	EPHA6	EPHA6_HUMAN	A711V	817	αI	-	neutral	AIGVEaCPSFL	0.099	0.102	0.46	0.181	0.126	0.143	0.615	0.172	VARIANT	A -> V (in dbSNP:rs4857276)		0
Q9UF33/F704S	Q9UF33	EPHA6	EPHA6_HUMAN	F704S	810	αI	-	-	VTKRSfAIGVE	0.708	0.607	0.471	0.469	0.426	0.537	0.55	0.512	VARIANT	F -> S	17344846	1
Q9UHD2/A533T	Q9UHD2	TBK1	TBK1_HUMAN	A533T	-	-	-	-	PGGSLaAWAHQ									VARIANT	A -> T (no effect on IFNB induction)	32972995	1
Q9UHD2/A571V	Q9UHD2	TBK1	TBK1_HUMAN	A571V	-	-	-	-	FKKDKaRRLAY									VARIANT	A -> V (in FTDALS4; dbSNP:rs765035140)	25803835	1
Q9UHD2/D135N	Q9UHD2	TBK1	TBK1_HUMAN	D135N	443	Catalytic-loop;HrD-motif	-	loss	GIVHRdKPGNI	0.969	0.987	0.238	0.635	0.921	0.952	0.177	0.446	MUTAGEN	D->N: Loss of kinase activity.	21931631,23453971,23453972,30842653	4
Q9UHD2/D296H	Q9UHD2	TBK1	TBK1_HUMAN	D296H	-	-	-	-	KCWGFdFFAET									VARIANT	D -> H (in a breast pleomorphic lobular carcinoma sample; somatic mutation)	17344846	1
Q9UHD2/D33A	Q9UHD2	TBK1	TBK1_HUMAN	D33A	76	β2/β3-loop	-	decrease	HKKTGdFAIKV	0.491	0.385	0.42	0.259	0.436	0.415	0.417	0.277	MUTAGEN	D->A: Decreases phosphorylation and kinase activity.	23453971	1
Q9UHD2/D50A	Q9UHD2	TBK1	TBK1_HUMAN	D50A	146	αC	-	-	FLRPVdQMREF	0.536	0.53	0.484	0.453	0.324	0.405	0.545	0.314	VARIANT	D -> A (in IIAE8; decreased expression levels; dbSNP:rs1010930015)	22851595	1
Q9UHD2/E355R	Q9UHD2	TBK1	TBK1_HUMAN	E355R	-	-	-	-	QELIYeRRLVL									MUTAGEN	E->R: Decreases phosphorylation and kinase activity. Abolishes dimerization; when associated with A-357 or R-448.	23453971,23453972	2
Q9UHD2/E448R	Q9UHD2	TBK1	TBK1_HUMAN	E448R	-	-	-	-	IRWLIeIKDDY									MUTAGEN	E->R: Decreases phosphorylation and kinase activity. Abolishes dimerization; when associated with R-355.	23453972	1
Q9UHD2/E580A	Q9UHD2	TBK1	TBK1_HUMAN	E580A	-	-	-	decrease	LAYNEeIHKFD									MUTAGEN	E->A: Decreases kinase activity.	23453971	1
Q9UHD2/E653Q	Q9UHD2	TBK1	TBK1_HUMAN	E653Q	-	-	-	-	QEYTNeQETLP									VARIANT	E -> Q (no effect on IFNB induction)	32972995	1
Q9UHD2/E696K	Q9UHD2	TBK1	TBK1_HUMAN	E696K	-	-	-	loss	KKLKEeEGVVK									VARIANT	E -> K (in FTDALS4; loss of kinase activity; impairs binding to OPTN; dbSNP:rs748112833)	25803835,25943890	2
Q9UHD2/F24S	Q9UHD2	TBK1	TBK1_HUMAN	F24S	49	β2	-	-	ATANVfGRHKK	0.891	0.803	0.378	0.6	0.678	0.759	0.357	0.736	VARIANT	F -> S (loss of IFNB induction)	32972995	1
Q9UHD2/F470E	Q9UHD2	TBK1	TBK1_HUMAN	F470E	-	-	-	-	VITLDfIRNIE									MUTAGEN	F->E: Abolishes dimerization and decreases kinase activity but no effect on phosphorylation; when associated with E-459 and E-466.	23453972	1
Q9UHD2/G159A	Q9UHD2	TBK1	TBK1_HUMAN	G159A	498	A-loop;DFG-motif	-	loss	KLTDFgARELE	0.936	0.941	0.376	0.74	0.671	0.877	0.302	0.597	VARIANT	G -> A (in IIAE8; loss of kinase activity; loss of autophosphorylation at S-172; loss of IFNB induction; dbSNP:rs1555202947)	22851595,32972995	2
Q9UHD2/G410R	Q9UHD2	TBK1	TBK1_HUMAN	G410R	-	-	-	-	RYDLDgASMAK									VARIANT	G -> R (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs1262765773)	17344846	1
Q9UHD2/H459E	Q9UHD2	TBK1	TBK1_HUMAN	H459E	-	-	-	-	YNETVhKTEVV									MUTAGEN	H->E: Abolishes dimerization and decreases kinase activity but no effect on phosphorylation; when associated with E-466 and E-470.	23453972	1
Q9UHD2/I207V	Q9UHD2	TBK1	TBK1_HUMAN	I207V	604	αF	-	-	VDLWSiVTFYH	0.417	0.309	0.512	0.351	0.231	0.251	0.648	0.361	VARIANT	I -> V (in IIAE8; unknown pathological significance; dbSNP:rs1555203557)	26513235	1
Q9UHD2/I305T	Q9UHD2	TBK1	TBK1_HUMAN	I305T	-	-	-	-	AETSDiHRMVI									VARIANT	I -> T (in FTDALS4; dbSNP:rs770942184)	25803835	1
Q9UHD2/I397T	Q9UHD2	TBK1	TBK1_HUMAN	I397T	-	-	-	-	LIYEKiLPKVH									VARIANT	I -> T (no effect on IFNB induction)	32972995	1
Q9UHD2/I466E	Q9UHD2	TBK1	TBK1_HUMAN	I466E	-	-	-	-	KTEVViLDFCI									MUTAGEN	I->E: Abolishes dimerization and decreases kinase activity but no effect on phosphorylation; when associated with E-459 and E-470.	23453972	1
Q9UHD2/I522M	Q9UHD2	TBK1	TBK1_HUMAN	I522M	-	-	-	-	TSLQDiSRLSP									VARIANT	I -> M (no effect on IFNB induction)	32972995	1
Q9UHD2/I582A	Q9UHD2	TBK1	TBK1_HUMAN	I582A	-	-	-	decrease	YNEEQiKFDKQ									MUTAGEN	I->A: Decreases kinase activity.	23453971	1
Q9UHD2/K291E	Q9UHD2	TBK1	TBK1_HUMAN	K291E	-	-	-	-	EADQEkWGFDQ									VARIANT	K -> E (in dbSNP:rs34774243)	17344846	1
Q9UHD2/K30R	Q9UHD2	TBK1	TBK1_HUMAN	K30R	65	β2/β3-loop	ub	-	RGRHKkGDLFA	0.474	0.401	0.438	0.307	0.518	0.341	0.558	0.2	MUTAGEN	K->R: Decreases ubiquitination. Abolishes ubiquitination, phosphorylation and kinase activity; when associated with R-401.	23453971	1
Q9UHD2/K38A	Q9UHD2	TBK1	TBK1_HUMAN	K38A	129	β3;Catalytic-Lys	-	loss	DLFAIkFNNIS	1.0	1.0	0.006	0.617	1.0	0.999	0.001	0.663	MUTAGEN	K->A: Loss of kinase activity.	10581243,22851595,23453971,23453972,31709703	5
Q9UHD2/K401E	Q9UHD2	TBK1	TBK1_HUMAN	K401E	-	-	ub	-	KISLPkHPRYD									VARIANT	K -> E (in FTDALS4; dbSNP:rs756751089)	25943890	1
Q9UHD2/K401R	Q9UHD2	TBK1	TBK1_HUMAN	K401R	-	-	ub	-	KISLPkHPRYD									MUTAGEN	K->R: Decreases ubiquitination. Abolishes ubiquitination, phosphorylation and kinase activity; when associated with R-30.	23453971	1
Q9UHD2/K570Q	Q9UHD2	TBK1	TBK1_HUMAN	K570Q	-	-	-	-	QFKKDkERRLA									VARIANT	K -> Q (in dbSNP:rs17853341)	15489334	1
Q9UHD2/K589D	Q9UHD2	TBK1	TBK1_HUMAN	K589D	-	-	-	decrease	KFDKQkYYHAT									MUTAGEN	K->D: Decreases phosphorylation and kinase activity.	23453971	1
Q9UHD2/K694E	Q9UHD2	TBK1	TBK1_HUMAN	K694E	-	-	-	-	GMKKLkEMEGV									MUTAGEN	K->E: Strongly decreases interaction with TANK and TBKBP1. No effect on phosphorylation.	21931631	1
Q9UHD2/L306I	Q9UHD2	TBK1	TBK1_HUMAN	L306I	-	-	-	-	ETSDIlRMVIH									VARIANT	L -> I (in FTDALS4; unknown pathological significance; dbSNP:rs201970436)	21447600,25943890	2
Q9UHD2/L316E	Q9UHD2	TBK1	TBK1_HUMAN	L316E	-	-	-	decrease	IHVFSlQMTAH									MUTAGEN	L->E: Decreases kinase activity. No effect on phosphorylation.	23453972	1
Q9UHD2/L508I	Q9UHD2	TBK1	TBK1_HUMAN	L508I	-	-	-	-	TKLLRlSSQGT									VARIANT	L -> I (no effect on IFNB induction)	32972995	1
Q9UHD2/L693A	Q9UHD2	TBK1	TBK1_HUMAN	L693A	-	-	-	-	LGMKKlEEMEG									MUTAGEN	L->A: Almost abolishes interaction with TANK.	21931631	1
Q9UHD2/L704A	Q9UHD2	TBK1	TBK1_HUMAN	L704A	-	-	-	-	GVVKElENNHI									MUTAGEN	L->A: Strongly decreases interaction with AZI2, TANK and TBKBP1. No effect on phosphorylation.	21931631	1
Q9UHD2/L711A	Q9UHD2	TBK1	TBK1_HUMAN	L711A	-	-	-	-	ENNHIlRFGSL									MUTAGEN	L->A: Almost abolishes interaction with TANK.	21931631	1
Q9UHD2/M559R	Q9UHD2	TBK1	TBK1_HUMAN	M559R	-	-	-	loss	VLLNCmEIYYQ									VARIANT	M -> R (in FTDALS4; loss of kinase activity)	25803835	1
Q9UHD2/M598V	Q9UHD2	TBK1	TBK1_HUMAN	M598V	-	-	-	-	HATKAmHFTDE									VARIANT	M -> V (in FTDALS4; dbSNP:rs899858451)	25803835	1
Q9UHD2/M690A	Q9UHD2	TBK1	TBK1_HUMAN	M690A	-	-	-	-	EMTLGmKLKEE									MUTAGEN	M->A: Decreases interaction with TANK.	21931631	1
Q9UHD2/N388D	Q9UHD2	TBK1	TBK1_HUMAN	N388D	-	-	-	-	SREPLnIGLIY									VARIANT	N -> D (in dbSNP:rs17857028)	15489334	1
Q9UHD2/N388S	Q9UHD2	TBK1	TBK1_HUMAN	N388S	-	-	-	-	SREPLnIGLIY									VARIANT	N -> S (no effect on IFNB induction)	32972995	1
Q9UHD2/N578A	Q9UHD2	TBK1	TBK1_HUMAN	N578A	-	-	-	decrease	RRLAYnEQIHK									MUTAGEN	N->A: Reduced phosphorylation of STING1.	30842653	1
Q9UHD2/N708A	Q9UHD2	TBK1	TBK1_HUMAN	N708A	-	-	-	-	ELAENnILERF									MUTAGEN	N->A: Decreases interaction with TANK.	21931631	1
Q9UHD2/P659S	Q9UHD2	TBK1	TBK1_HUMAN	P659S	-	-	-	-	LQETLpKMFTA									VARIANT	P -> S (no effect on IFNB induction)	32972995	1
Q9UHD2/Q581A	Q9UHD2	TBK1	TBK1_HUMAN	Q581A	-	-	-	decrease	AYNEEqHKFDK									MUTAGEN	Q->A: Reduced phosphorylation of STING1.	30842653	1
Q9UHD2/R271Q	Q9UHD2	TBK1	TBK1_HUMAN	R271Q	-	-	-	-	SCSLSrLQVLL									VARIANT	R -> Q (in dbSNP:rs56196591)	17344846	1
Q9UHD2/R308Q	Q9UHD2	TBK1	TBK1_HUMAN	R308Q	-	-	-	decrease	SDILHrVIHVF									VARIANT	R -> Q (in FTDALS4; reduced kinase activity)	25803835	1
Q9UHD2/R357A	Q9UHD2	TBK1	TBK1_HUMAN	R357A	-	-	-	-	LIYEGrLVLEP									MUTAGEN	R->A: Decreases phosphorylation and kinase activity. Abolishes dimerization; when associated with R-355.	23453971	1
Q9UHD2/R357Q	Q9UHD2	TBK1	TBK1_HUMAN	R357Q	-	-	-	decrease	LIYEGrLVLEP									VARIANT	R -> Q (in FTDALS4; reduced kinase activity; dbSNP:rs758357594)	25803835	1
Q9UHD2/R384Q	Q9UHD2	TBK1	TBK1_HUMAN	R384Q	-	-	-	-	IFVVSrPLNTI									VARIANT	R -> Q (no effect on IFNB induction)	32972995	1
Q9UHD2/R47H	Q9UHD2	TBK1	TBK1_HUMAN	R47H	143	αC	-	loss	NISFLrVDVQM	0.608	0.553	0.523	0.473	0.422	0.446	0.626	0.361	VARIANT	R -> H (in FTDALS4; loss of kinase activity)	25803835	1
Q9UHD2/R547D	Q9UHD2	TBK1	TBK1_HUMAN	R547D	-	-	-	decrease	THPKDrVEKLQ									MUTAGEN	R->D: Decreases phosphorylation and kinase activity. Abolishes dimerization.	23453971	1
Q9UHD2/S151F	Q9UHD2	TBK1	TBK1_HUMAN	S151F	483	Catalytic-loop	-	-	GEDGQsYKLTD	0.631	0.637	0.512	0.52	0.373	0.497	0.551	0.494	VARIANT	S -> F (in dbSNP:rs55824172)	21447600	1
Q9UHD2/S172A	Q9UHD2	TBK1	TBK1_HUMAN	S172A	545	A-loop	p	loss	DEQFVsYGTEE	0.992	0.996	0.157	0.874	0.979	0.964	0.127	0.303	MUTAGEN	S->A: Loss of kinase activity. No effect on dimerization. Loss of localization to cytoplasmic spherical structures.	11839743,23453972,36640307	3
Q9UHD2/S172E	Q9UHD2	TBK1	TBK1_HUMAN	S172E	545	A-loop	p	decrease	DEQFVsYGTEE	0.99	0.984	0.742	0.953	0.551	0.954	0.735	0.217	MUTAGEN	S->E: Decreased kinase activity.	11839743,23453972	2
Q9UHD2/V152L	Q9UHD2	TBK1	TBK1_HUMAN	V152L	491	Catalytic-loop	-	-	EDGQSvKLTDF	0.486	0.416	0.583	0.436	0.187	0.317	0.755	0.234	VARIANT	V -> L (no effect on IFNB induction)	32972995	1
Q9UHD2/V464A	Q9UHD2	TBK1	TBK1_HUMAN	V464A	-	-	-	neutral	HKKTEvITLDF									VARIANT	V -> A (in dbSNP:rs35635889)	17344846,21447600	2
Q9UHD2/Y105C	Q9UHD2	TBK1	TBK1_HUMAN	Y105C	386	αD/αE-loop	-	-	EPSNAyLPESE	0.734	0.776	0.5	0.555	0.566	0.646	0.476	0.352	VARIANT	Y -> C (in FTDALS4; dbSNP:rs1366668789)	25803835	1
Q9UHD2/Y179A	Q9UHD2	TBK1	TBK1_HUMAN	Y179A	553	A-loop	p	-	YGTEEyHPDMY	0.967	0.938	0.332	0.728	0.833	0.864	0.298	0.566	MUTAGEN	Y->A: Loss of localization to cytoplasmic spherical structures.	36640307	1
Q9UHD2/Y325E	Q9UHD2	TBK1	TBK1_HUMAN	Y325E	-	-	p	loss	TAHKIyHSYNT									MUTAGEN	Y->E: Abolishes phosphorylation and kinase activity.	23453972	1
Q9UHD2/Y577A	Q9UHD2	TBK1	TBK1_HUMAN	Y577A	-	-	p	decrease	ERRLAyEEQIH									MUTAGEN	Y->A: Decreases kinase activity. Reduced phosphorylation of STING1.	23453971,30842653	2
Q9UHY1/H460R	Q9UHY1	NRBP1	NRBP_HUMAN	H460R	-	-	-	-	EEGVKhLTLLL									VARIANT	H -> R (in dbSNP:rs34260196)	17344846	1
Q9UHY1/P432L	Q9UHY1	NRBP1	NRBP_HUMAN	P432L	-	-	-	-	PSVKTpPEPAE									VARIANT	P -> L (in an ovarian mucinous carcinoma sample; somatic mutation; dbSNP:rs753734841)	17344846	1
Q9UHY1/V365I	Q9UHY1	NRBP1	NRBP_HUMAN	V365I	-	-	-	neutral	MDTSAvAEIPA									VARIANT	V -> I (in dbSNP:rs56004639)	17344846	1
Q9UIG0/C338A	Q9UIG0	BAZ1B	BAZ1B_HUMAN	C338A	-	-	-	loss	NPKLWcVHLKK									MUTAGEN	C->A: Loss of tyrosine-protein kinase activity.	19092802	1
Q9UIK4/K52A	Q9UIK4	DAPK2	DAPK2_HUMAN	K52A	129	β3;Catalytic-Lys	-	loss	LEYAAkIKKRQ	1.0	1.0	0.019	0.632	1.0	0.991	0.003	0.647	MUTAGEN	K->A: Loss of activity, apoptotic function and of autophosphorylation.	10376525,10629061,11230133	3
Q9UIK4/R271W	Q9UIK4	DAPK2	DAPK2_HUMAN	R271W	798	αI	-	-	LVKETrRLTIQ	0.613	0.573	0.58	0.574	0.386	0.47	0.666	0.309	VARIANT	R -> W (in dbSNP:rs34270163)	17344846	1
Q9UIK4/R60W	Q9UIK4	DAPK2	DAPK2_HUMAN	R60W	142	αC	-	-	KKRQSrSRRGV	0.376	0.324	0.499	0.318	0.302	0.204	0.565	0.128	VARIANT	R -> W (in dbSNP:rs56047843)	17344846	1
Q9UIK4/S299A	Q9UIK4	DAPK2	DAPK2_HUMAN	S299A	837	C-term-αI	p	-	MVRREsVNLEN	0.779	0.793	0.369	0.654	0.522	0.642	0.497	0.073	MUTAGEN	S->A: No effect on Ca(2+)-calmodulin independent phosphorylation or apoptotic activity.	11230133	1
Q9UIK4/S318A	Q9UIK4	DAPK2	DAPK2_HUMAN	S318A	-	-	p	activating	RRWKLsSIVSL									MUTAGEN	S->A: Loss of Ca(2+)-calmodulin independent phosphorylation, increase in apoptotic activity.	11230133	1
Q9UIK4/S318D	Q9UIK4	DAPK2	DAPK2_HUMAN	S318D	-	-	p	-	RRWKLsSIVSL									MUTAGEN	S->D: Abolishes apoptotic activity.	11230133	1
Q9UIK4/S320A	Q9UIK4	DAPK2	DAPK2_HUMAN	S320A	-	-	-	-	WKLSFsVSLCN									MUTAGEN	S->A: No effect on Ca(2+)-calmodulin independent phosphorylation or apoptotic activity.	11230133	1
Q9UIK4/S323A	Q9UIK4	DAPK2	DAPK2_HUMAN	S323A	-	-	-	-	SFSIVsCNHLT									MUTAGEN	S->A: No effect on Ca(2+)-calmodulin independent phosphorylation or apoptotic activity.	11230133	1
Q9UIK4/S367A	Q9UIK4	DAPK2	DAPK2_HUMAN	S367A	-	-	-	-	HPRRRsTS									MUTAGEN	S->A: No effect on interaction with YWHAE.	26047703	1
Q9UIK4/S368A	Q9UIK4	DAPK2	DAPK2_HUMAN	S368A	-	-	-	-	PRRRSsS									MUTAGEN	S->A: No effect on interaction with YWHAE.	26047703	1
Q9UIK4/T329A	Q9UIK4	DAPK2	DAPK2_HUMAN	T329A	-	-	-	-	LCNHLtSLMKK									MUTAGEN	T->A: No effect on Ca(2+)-calmodulin independent phosphorylation or apoptotic activity.	11230133	1
Q9UK32/D692N	Q9UK32	RPS6KA6	KS6A6_HUMAN	D692N	832	C-term-αI	-	neutral	DQLPNdPKRND	0.477	0.57	0.379	0.265	0.343	0.517	0.535	0.148	VARIANT	D -> N (in dbSNP:rs6616890)	17344846	1
Q9UK32/S258T	Q9UK32	RPS6KA6	KS6A6_HUMAN	S258T	603	αF	-	-	SADWWsGVLMF	0.848	0.846	0.333	0.595	0.724	0.776	0.295	0.471	VARIANT	S -> T (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
Q9UK32/S372A	Q9UK32	RPS6KA6	KS6A6_HUMAN	S372A	-	-	p	-	KTPKDsGLPAS									MUTAGEN	S->A: No effect on activity.	15632195	1
Q9UK32/S389A	Q9UK32	RPS6KA6	KS6A6_HUMAN	S389A	-	-	p	decrease	LFKGFsVATSI									MUTAGEN	S->A: Strongly decreases activity.	15632195	1
Q9UK32/T581A	Q9UK32	RPS6KA6	KS6A6_HUMAN	T581A	545	A-loop	p	-	NGLLLtCYTAN	0.955	0.977	0.164	0.836	0.864	0.946	0.195	0.151	MUTAGEN	T->A: No effect on activity.	15632195	1
Q9UK32/Y140C	Q9UK32	RPS6KA6	KS6A6_HUMAN	Y140C	206	β4/β5-loop	-	-	IVKLHyFQTEG	0.85	0.809	0.584	0.721	0.479	0.703	0.543	0.41	VARIANT	Y -> C (in a lung large cell carcinoma sample; somatic mutation)	17344846	1
Q9UKE5/A999T	Q9UKE5	TNIK	TNIK_HUMAN	A999T	-	-	-	neutral	EESSAaLFTSE									VARIANT	A -> T (in dbSNP:rs17857452)	17344846	1
Q9UKE5/G910E	Q9UKE5	TNIK	TNIK_HUMAN	G910E	-	-	-	-	IRETSgKKRSG									VARIANT	G -> E (in dbSNP:rs35090763)	17344846	1
Q9UKE5/K54A	Q9UKE5	TNIK	TNIK_HUMAN	K54A	129	β3;Catalytic-Lys	-	loss	QLAAIkMDVTG	1.0	1.0	0.035	0.636	0.995	0.999	0.015	0.626	MUTAGEN	K->A: Kinase dead. Loss of autophosphorylation and loss of function in cytoskeleton regulation.	15342639,19816403	2
Q9UKE5/K778E	Q9UKE5	TNIK	TNIK_HUMAN	K778E	-	-	-	-	PHEPAkKPEES									VARIANT	K -> E (in dbSNP:rs55778284)	17344846	1
Q9UKI8/D607A	Q9UKI8	TLK1	TLK1_HUMAN	D607A	496	A-loop;DFG-motif	-	loss	EIKITdGLSKI	0.982	0.977	0.118	0.598	0.97	0.949	0.072	0.668	MUTAGEN	D->A: Loss of kinase activity.	10523312,11470414	2
Q9UKI8/R121C	Q9UKI8	TLK1	TLK1_HUMAN	R121C	-	-	-	-	QSESSrRKRKA									VARIANT	R -> C	17344846	1
Q9UKI8/S743A	Q9UKI8	TLK1	TLK1_HUMAN	S743A	832	C-term-αI	p	loss	MRRSNsGNLHM	0.815	0.899	0.47	0.639	0.578	0.736	0.557	0.202	MUTAGEN	S->A: Loss of kinase inhibition in response to DNA damage.	12660173	1
Q9UKI8/S743D	Q9UKI8	TLK1	TLK1_HUMAN	S743D	832	C-term-αI	p	loss	MRRSNsGNLHM	0.827	0.891	0.729	0.825	0.286	0.69	0.784	0.246	MUTAGEN	S->D: Loss of kinase inhibition in response to DNA damage.	12660173	1
Q9UKI8/S743E	Q9UKI8	TLK1	TLK1_HUMAN	S743E	832	C-term-αI	p	loss	MRRSNsGNLHM	0.783	0.793	0.751	0.786	0.219	0.607	0.8	0.2	MUTAGEN	S->E: Loss of kinase inhibition in response to DNA damage.	12660173	1
Q9UL54/D169A	Q9UL54	TAOK2	TAOK2_HUMAN	D169A	496	A-loop;DFG-motif	-	loss	LVKLGdGSASI	0.991	0.999	0.086	0.533	0.971	0.979	0.046	0.668	MUTAGEN	D->A: Loss of kinase activity; No effect on MAP3K7-mediated activation of NF-kappa-B.	16893890	1
Q9UL54/D919N	Q9UL54	TAOK2	TAOK2_HUMAN	D919N	-	-	-	-	PRDPGdCPSPD									MUTAGEN	D->N: No effect on kinase activity, nor on JNK activation, but severe reduction in nuclear localization and apoptotic membrane blebbing.	17158878	1
Q9UL54/K57A	Q9UL54	TAOK2	TAOK2_HUMAN	K57A	129	β3;Catalytic-Lys	-	loss	EVVAIkMSYSG	1.0	1.0	0.045	0.652	1.0	0.997	0.021	0.615	MUTAGEN	K->A: Loss of kinase activity. In isoform 1, excluded from the nucleus. No effect on microtubule-binding.	10660600,12639963,16893890,17158878	4
Q9UM73/A1234T	Q9UM73	ALK	ALK_HUMAN	A1234T	411	αE	-	-	VARDIaGCQYL	0.7	0.646	0.595	0.627	0.434	0.554	0.657	0.347	VARIANT	A -> T (in NBLST3; somatic mutation)	18923525	1
Q9UM73/A1274T	Q9UM73	ALK	ALK_HUMAN	A1274T	500	A-loop	-	-	GDFGMaDIYRA	0.476	0.481	0.514	0.438	0.265	0.382	0.692	0.348	VARIANT	A -> T (in dbSNP:rs45502292)	17344846	1
Q9UM73/A704T	Q9UM73	ALK	ALK_HUMAN	A704T	-	-	-	-	AQCNNaQNSNL									VARIANT	A -> T (in dbSNP:rs34829159)	17344846	1
Q9UM73/A877S	Q9UM73	ALK	ALK_HUMAN	A877S	-	-	-	-	GNSGAaGGGGW									VARIANT	A -> S (in an ovarian serous carcinoma sample; somatic mutation; dbSNP:rs746442213)	17344846	1
Q9UM73/D1091N	Q9UM73	ALK	ALK_HUMAN	D1091N	3	N-term-β1	-	-	STIMTdNPNYC	0.545	0.427	0.457	0.478	0.266	0.396	0.601	0.424	VARIANT	D -> N (in NBLST3; somatic mutation; dbSNP:rs864309584)	18724359	1
Q9UM73/D1529E	Q9UM73	ALK	ALK_HUMAN	D1529E	-	-	-	neutral	KKEPHdGNLGL									VARIANT	D -> E (in dbSNP:rs1881421)	17344846,17625570,9053841	3
Q9UM73/E1419K	Q9UM73	ALK	ALK_HUMAN	E1419K	-	-	-	-	RPKDPeVPPLL									VARIANT	E -> K (in dbSNP:rs56181542)	17344846	1
Q9UM73/E296Q	Q9UM73	ALK	ALK_HUMAN	E296Q	-	-	-	-	RRIPSeASQMD									VARIANT	E -> Q (in dbSNP:rs56077855)	17344846	1
Q9UM73/E859A	Q9UM73	ALK	ALK_HUMAN	E859A	-	-	-	-	DTFHPeLENNS									MUTAGEN	E->A: Slightly decreased autophosphorylation. Decreased autophosphorylation and subsequent activation; when associated with A-974.	34819673	1
Q9UM73/E974A	Q9UM73	ALK	ALK_HUMAN	E974A	-	-	-	-	ALKVMeHGEVN									MUTAGEN	E->A: Slightly decreased autophosphorylation. Decreased autophosphorylation and subsequent activation; when associated with A-859.	34819673	1
Q9UM73/E994A	Q9UM73	ALK	ALK_HUMAN	E994A	-	-	-	-	HCEVDeHMDPE									MUTAGEN	E->A: SlStrongly reduced autophosphorylation and subsequent activation; when associated with A-966.	34819673	1
Q9UM73/F1174C	Q9UM73	ALK	ALK_HUMAN	F1174C	189	αC/β4-loop	-	-	LIISKfHQNIV	0.645	0.595	0.543	0.509	0.363	0.529	0.629	0.503	VARIANT	F -> C (in NBLST3; dbSNP:rs1057519697)	18923523	1
Q9UM73/F1174I	Q9UM73	ALK	ALK_HUMAN	F1174I	189	αC/β4-loop	-	-	LIISKfHQNIV	0.52	0.442	0.664	0.472	0.178	0.335	0.766	0.445	VARIANT	F -> I (in NBLST3; somatic mutation; dbSNP:rs281864719)	18724359	1
Q9UM73/F1174L	Q9UM73	ALK	ALK_HUMAN	F1174L	189	αC/β4-loop	-	activating,resistance	LIISKfHQNIV	0.313	0.267	0.598	0.284	0.142	0.163	0.738	0.317	VARIANT	F -> L (in NBLST3; somatic mutation; constitutively activated; retained in the endoplasmic reticulum and Golgi compartments; dbSNP:rs863225281)	18923523,18923525,21242967	3
Q9UM73/F1174V	Q9UM73	ALK	ALK_HUMAN	F1174V	189	αC/β4-loop	-	activating,resistance	LIISKfHQNIV	0.505	0.463	0.621	0.445	0.197	0.33	0.735	0.417	VARIANT	F -> V (in NBLST3; somatic mutation; constitutively activated; retained in the endoplasmic reticulum and Golgi compartments; dbSNP:rs281864719)	18923523,21242967	2
Q9UM73/F1245C	Q9UM73	ALK	ALK_HUMAN	F1245C	438	Catalytic-loop	-	-	LEENHfHRDIA	0.512	0.403	0.5	0.476	0.279	0.416	0.622	0.279	VARIANT	F -> C (in NBLST3; somatic mutation; dbSNP:rs863225283)	18724359,18923525	2
Q9UM73/F1245V	Q9UM73	ALK	ALK_HUMAN	F1245V	438	Catalytic-loop	-	-	LEENHfHRDIA	0.492	0.513	0.552	0.489	0.332	0.409	0.653	0.282	VARIANT	F -> V (in NBLST3; somatic mutation; dbSNP:rs281864720)		0
Q9UM73/F1376S	Q9UM73	ALK	ALK_HUMAN	F1376S	803	αI	-	-	EDRPNfIILER	0.883	0.894	0.361	0.609	0.776	0.793	0.301	0.581	VARIANT	F -> S (in dbSNP:rs17694720)		0
Q9UM73/G1121D	Q9UM73	ALK	ALK_HUMAN	G1121D	38	β1	-	-	ITLIRgGHGAF	0.469	0.48	0.643	0.55	0.255	0.376	0.722	0.247	VARIANT	G -> D (in dbSNP:rs55760835)	17344846	1
Q9UM73/G1128A	Q9UM73	ALK	ALK_HUMAN	G1128A	45	Gly-rich-loop;β2	-	-	GHGAFgVYEGQ	0.822	0.743	0.442	0.583	0.476	0.682	0.516	0.555	VARIANT	G -> A (in NBLST3; dbSNP:rs113994088)	18724359	1
Q9UM73/I1171N	Q9UM73	ALK	ALK_HUMAN	I1171N	177	αC	-	resistance	MEALIiKFNHQ	0.823	0.736	0.497	0.598	0.586	0.652	0.492	0.794	VARIANT	I -> N (in NBLST3; somatic mutation; dbSNP:rs1057519698)	18724359	1
Q9UM73/I1250T	Q9UM73	ALK	ALK_HUMAN	I1250T	444	Catalytic-loop	-	-	FIHRDiARNCL	0.852	0.84	0.314	0.651	0.8	0.781	0.235	0.653	VARIANT	I -> T (in NBLST3; somatic mutation; dbSNP:rs113994092)	18724359	1
Q9UM73/I1461V	Q9UM73	ALK	ALK_HUMAN	I1461V	-	-	-	neutral	PTAAEiVRVPR									VARIANT	I -> V (in dbSNP:rs1670283)	17625570,8122112,9053841,9174053	4
Q9UM73/K1416N	Q9UM73	ALK	ALK_HUMAN	K1416N	-	-	-	-	VPVRPkPEGVP									VARIANT	K -> N (in dbSNP:rs55782189)	17344846	1
Q9UM73/K1491R	Q9UM73	ALK	ALK_HUMAN	K1491R	-	-	-	neutral	PSELHkHGSRN									VARIANT	K -> R (in dbSNP:rs1881420)	17344846,17625570,9053841	3
Q9UM73/L560F	Q9UM73	ALK	ALK_HUMAN	L560F	-	-	-	-	LIRGVlGNVSL									VARIANT	L -> F (in a breast pleomorphic lobular carcinoma sample; somatic mutation)	17344846	1
Q9UM73/L868Q	Q9UM73	ALK	ALK_HUMAN	L868Q	-	-	-	-	NNSSVlLNGNS									VARIANT	L -> Q (in dbSNP:rs55941323)		0
Q9UM73/M1166R	Q9UM73	ALK	ALK_HUMAN	M1166R	172	αC	-	-	ELDFLmALIIS	0.441	0.39	0.571	0.507	0.275	0.296	0.678	0.28	VARIANT	M -> R (in NBLST3; somatic mutation; dbSNP:rs1057520019)	18724359	1
Q9UM73/M1328L	Q9UM73	ALK	ALK_HUMAN	M1328L	632	αF/αG	-	-	FSLGYmYPSKS	0.595	0.557	0.535	0.481	0.445	0.46	0.575	0.363	VARIANT	M -> L (in dbSNP:rs56160491)	17344846	1
Q9UM73/P1599H	Q9UM73	ALK	ALK_HUMAN	P1599H	-	-	-	-	EAATApAGHYE									VARIANT	P -> H (in dbSNP:rs1881423)		0
Q9UM73/Q1429R	Q9UM73	ALK	ALK_HUMAN	Q1429R	-	-	-	-	LLVSQqKREEE									VARIANT	Q -> R (in dbSNP:rs55906201)	17344846	1
Q9UM73/R1192P	Q9UM73	ALK	ALK_HUMAN	R1192P	241	β4/β5-loop	-	-	LQSLPrILLEL	0.254	0.206	0.52	0.316	0.272	0.231	0.607	0.224	VARIANT	R -> P (in NBLST3; dbSNP:rs113994089)	18724359,18923523	2
Q9UM73/R1275L	Q9UM73	ALK	ALK_HUMAN	R1275L	501	A-loop	-	-	DFGMArIYRAS	0.903	0.818	0.518	0.768	0.547	0.836	0.425	0.655	VARIANT	R -> L (observed in neuroblastoma; dbSNP:rs113994087)	18923523	1
Q9UM73/R1275Q	Q9UM73	ALK	ALK_HUMAN	R1275Q	501	A-loop	-	activating	DFGMArIYRAS	0.902	0.849	0.596	0.781	0.399	0.773	0.587	0.499	VARIANT	R -> Q (in NBLST3; constitutively activated; retained in the endoplasmic reticulum and Golgi compartments; dbSNP:rs113994087)	18724359,18923523,18923525,21242967,22932897	5
Q9UM73/S90L	Q9UM73	ALK	ALK_HUMAN	S90L	-	-	-	-	PEARGsALDCA									VARIANT	S -> L (in dbSNP:rs34617074)	17344846	1
Q9UM73/T1012M	Q9UM73	ALK	ALK_HUMAN	T1012M	-	-	-	-	FCDHGtLAEDG									VARIANT	T -> M (in dbSNP:rs35073634)	17344846	1
Q9UM73/T1151M	Q9UM73	ALK	ALK_HUMAN	T1151M	130	β3	-	-	QVAVKtPEVCS	0.495	0.477	0.442	0.384	0.305	0.384	0.579	0.308	VARIANT	T -> M (in NBLST3; dbSNP:rs113994091)	18923525	1
Q9UM73/T680I	Q9UM73	ALK	ALK_HUMAN	T680I	-	-	-	-	PIFDPtHWLFT									VARIANT	T -> I (in dbSNP:rs35228363)	17344846	1
Q9UM73/V163L	Q9UM73	ALK	ALK_HUMAN	V163L	-	-	-	-	PGEAAvLLQFN									VARIANT	V -> L (in dbSNP:rs55697431)	17344846	1
Q9UM73/V476A	Q9UM73	ALK	ALK_HUMAN	V476A	-	-	-	neutral	CRKLPvFYCNF									VARIANT	V -> A (in dbSNP:rs35093491)	17344846	1
Q9UM73/Y1278S	Q9UM73	ALK	ALK_HUMAN	Y1278S	507	A-loop	p	-	MARDIyASYYR	0.76	0.762	0.499	0.767	0.483	0.673	0.526	0.602	VARIANT	Y -> S (in NBLST3; somatic mutation; dbSNP:rs863225285)	18923523	1
Q9UM73/Y1507F	Q9UM73	ALK	ALK_HUMAN	Y1507F	-	-	p	-	LWNPTySWFTE									MUTAGEN	Y->F: Impairs interaction with SHC1.	17274988	1
Q9UM73/Y966A	Q9UM73	ALK	ALK_HUMAN	Y966A	-	-	-	-	PLGILyPALKV									MUTAGEN	Y->A: Slightly decreased autophosphorylation. Strongly reduced autophosphorylation and subsequent activation; when associated with A-994.	34819673	1
Q9UPE1/E233K	Q9UPE1	SRPK3	SRPK3_HUMAN	E233K	-	-	-	-	RRLAAeTEWQQ									VARIANT	E -> K (in dbSNP:rs34497419)	17344846	1
Q9UPE1/G114E	Q9UPE1	SRPK3	SRPK3_HUMAN	G114E	138	αC	-	-	VVKSAgYTETA	0.315	0.383	0.523	0.3	0.24	0.228	0.63	0.161	VARIANT	G -> E (in dbSNP:rs35865042)	17344846	1
Q9UPE1/R101C	Q9UPE1	SRPK3	SRPK3_HUMAN	R101C	68	β2/β3-loop	-	-	CWDIQrRFVAL	0.488	0.337	0.603	0.481	0.286	0.315	0.697	0.306	VARIANT	R -> C (in dbSNP:rs55910507)	17344846	1
Q9UPN9/C125A	Q9UPN9	TRIM33	TRI33_HUMAN	C125A	-	-	-	-	SLLDTcVCQQS									MUTAGEN	C->A: Abolishes E3 activity but does not affect interaction with SMAD4; when associated with A-128.	15820681	1
Q9UPN9/C128A	Q9UPN9	TRIM33	TRI33_HUMAN	C128A	-	-	-	-	DTCAVcQSLQS									MUTAGEN	C->A: Abolishes E3 activity but does not affect interaction with SMAD4; when associated with A-125.	15820681	1
Q9UPN9/E811K	Q9UPN9	TRIM33	TRI33_HUMAN	E811K	-	-	-	-	MLSSPeSLTPP									VARIANT	E -> K (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
Q9UPN9/I840T	Q9UPN9	TRIM33	TRI33_HUMAN	I840T	-	-	-	neutral	ENHVKiPADMN									VARIANT	I -> T (in dbSNP:rs6537825)	10022127,10439047,10470851,11331580	4
Q9UPN9/L696S	Q9UPN9	TRIM33	TRI33_HUMAN	L696S	-	-	-	-	AGSSSlNLLSR									VARIANT	L -> S (in dbSNP:rs56151583)	17344846	1
Q9UPN9/M580I	Q9UPN9	TRIM33	TRI33_HUMAN	M580I	-	-	-	-	MQRGNmCGAFQ									VARIANT	M -> I (in a glioblastoma multiforme sample; somatic mutation)	17344846	1
Q9UPN9/P1090T	Q9UPN9	TRIM33	TRI33_HUMAN	P1090T	-	-	-	-	TFAPLpFEQEE									VARIANT	P -> T (in dbSNP:rs55784699)	17344846	1
Q9UPN9/P885S	Q9UPN9	TRIM33	TRI33_HUMAN	P885S	-	-	-	-	NKDDDpEDWCA									VARIANT	P -> S (in a glioblastoma multiforme sample; somatic mutation)	17344846	1
Q9UPN9/V67A	Q9UPN9	TRIM33	TRI33_HUMAN	V67A	-	-	-	neutral	PDDGGvAASSG									VARIANT	V -> A (in dbSNP:rs6691166)		0
Q9UPN9/V961M	Q9UPN9	TRIM33	TRI33_HUMAN	V961M	-	-	-	-	QGLSPvQRKCE									VARIANT	V -> M (in dbSNP:rs55688622)	17344846	1
Q9UPZ9/A615T	Q9UPZ9	CILK1	CILK1_HUMAN	A615T	-	-	-	-	PRPPAaPVHGR									VARIANT	A -> T (in EJM10; unknown pathological significance; impairs mitosis, cell-cycle exit and radial neuroblast migration, while promoting apoptosis, when tested in a heterologous system; dbSNP:rs55932059)	17344846,29539279	2
Q9UPZ9/F115Y	Q9UPZ9	CILK1	CILK1_HUMAN	F115Y	419	αE	-	-	LQGLAfHKHGF	0.216	0.159	0.522	0.182	0.124	0.124	0.705	0.207	VARIANT	F -> Y (in a renal clear cell carcinoma sample; somatic mutation)	17344846	1
Q9UPZ9/I102L	Q9UPZ9	CILK1	CILK1_HUMAN	I102L	400	αE	-	-	FPESAiNIMYQ	0.49	0.429	0.513	0.446	0.251	0.355	0.662	0.386	VARIANT	I -> L (in EJM10; unknown pathological significance; dbSNP:rs748539319)	29539279	1
Q9UPZ9/K220E	Q9UPZ9	CILK1	CILK1_HUMAN	K220E	671	αG/αH	-	-	VLGTPkTDWPE	0.241	0.162	0.53	0.24	0.1	0.176	0.665	0.186	VARIANT	K -> E (in EJM10; impairs mitosis, cell-cycle exit and radial neuroblast migration, while promoting apoptosis, when tested in a heterologous system)	29539279	1
Q9UPZ9/K305T	Q9UPZ9	CILK1	CILK1_HUMAN	K305T	844	C-term-αI	-	-	SEKPQkILEKA	0.115	0.116	0.468	0.158	0.116	0.127	0.658	0.096	VARIANT	K -> T (in EJM10; impairs mitosis, cell-cycle exit and radial neuroblast migration, while promoting apoptosis, when tested in a heterologous system; dbSNP:rs765078446)	29539279	1
Q9UPZ9/K33R	Q9UPZ9	CILK1	CILK1_HUMAN	K33R	129	β3;Catalytic-Lys	-	-	ELIAIkMKRKF	1.0	0.994	0.086	0.782	0.953	0.997	0.098	0.509	MUTAGEN	K->R: Loss of activity and autophosphorylation; when associated with R-34; R-36 and R-38.	10699974	1
Q9UPZ9/K34R	Q9UPZ9	CILK1	CILK1_HUMAN	K34R	130	β3	-	-	LIAIKkKRKFY	0.45	0.45	0.551	0.372	0.456	0.47	0.613	0.223	MUTAGEN	K->R: Loss of activity and autophosphorylation; when associated with R-33; R-36 and R-38.	10699974	1
Q9UPZ9/K36R	Q9UPZ9	CILK1	CILK1_HUMAN	K36R	132	β3/αC-loop	-	-	AIKKMkKFYSW	0.644	0.585	0.498	0.518	0.395	0.515	0.538	0.364	MUTAGEN	K->R: Loss of activity and autophosphorylation; when associated with R-33; R-34 and R-38.	10699974	1
Q9UPZ9/K38R	Q9UPZ9	CILK1	CILK1_HUMAN	K38R	137	αC	-	-	KKMKRkYSWEE	0.446	0.364	0.559	0.291	0.213	0.316	0.641	0.314	MUTAGEN	K->R: Loss of activity and autophosphorylation; when associated with R-33; R-34 and R-36.	10699974	1
Q9UPZ9/P98L	Q9UPZ9	CILK1	CILK1_HUMAN	P98L	394	αD/αE-loop	-	-	RNKLFpSAIRN	0.434	0.455	0.583	0.428	0.269	0.317	0.682	0.254	VARIANT	P -> L (in dbSNP:rs1493105)		0
Q9UPZ9/R272Q	Q9UPZ9	CILK1	CILK1_HUMAN	R272Q	802	αI	-	decrease	WDPKKrTASQA	0.911	0.876	0.41	0.695	0.708	0.785	0.358	0.478	VARIANT	R -> Q (in ECO; significantly impairs kinase activity; decreased localization at the ciliary tips; impaired ciliogenesis; results in abnormally elongated cilia; impairs mitosis, cell-cycle exit and radial neuroblast migration, while promoting apoptosis, when tested in a heterologous system; loss of nuclear localization; dbSNP:rs118203918)	19185282,24797473,24853502,29539279	4
Q9UPZ9/R476Q	Q9UPZ9	CILK1	CILK1_HUMAN	R476Q	-	-	-	-	TSYQRrTPTLR									VARIANT	R -> Q (in dbSNP:rs55895113)	17344846	1
Q9UPZ9/T157A	Q9UPZ9	CILK1	CILK1_HUMAN	T157A	544	A-loop	p	decrease	SKPPYtYVSTR	0.982	0.987	0.339	0.874	0.877	0.975	0.305	0.554	MUTAGEN	T->A: Reduction of activity and loss of autophosphorylation. Loss of activity and autophosphorylation; when associated with F-159.	10699974	1
Q9UPZ9/T471K	Q9UPZ9	CILK1	CILK1_HUMAN	T471K	-	-	-	-	SAPTQtYQRRD									VARIANT	T -> K (in dbSNP:rs56164633)	17344846	1
Q9UPZ9/V320I	Q9UPZ9	CILK1	CILK1_HUMAN	V320I	-	-	-	-	PYIKPvPAQPP									VARIANT	V -> I (in dbSNP:rs33936662)	17344846,29539279	2
Q9UPZ9/Y159F	Q9UPZ9	CILK1	CILK1_HUMAN	Y159F	546	A-loop	p	decrease	PPYTDySTRWY	0.996	0.974	0.272	0.846	0.95	0.96	0.193	0.523	MUTAGEN	Y->F: Reduction of activity and loss of autophosphorylation. Loss of activity and autophosphorylation; when associated with A-157.	10699974	1
Q9UQ07/D86N	Q9UQ07	MOK	MOK_HUMAN	D86N	253	β5/αD-loop	-	neutral	ICELMdNIYEL	0.348	0.303	0.496	0.267	0.279	0.257	0.599	0.403	VARIANT	D -> N (in dbSNP:rs34084056)	17344846	1
Q9UQ07/E272D	Q9UQ07	MOK	MOK_HUMAN	E272D	799	αI	-	-	AYDPDeIAAHQ	0.096	0.131	0.617	0.18	0.066	0.087	0.721	0.106	VARIANT	E -> D (in a breast pleomorphic lobular carcinoma sample; somatic mutation; dbSNP:rs1567133856)	17344846	1
Q9UQ07/K230R	Q9UQ07	MOK	MOK_HUMAN	K230R	672	αG/αH	-	neutral	ILTKFkSRAMN	0.086	0.101	0.606	0.183	0.067	0.098	0.772	0.114	VARIANT	K -> R (in dbSNP:rs34965156)	17344846	1
Q9UQ07/P248S	Q9UQ07	MOK	MOK_HUMAN	P248S	774	αG/αH	-	neutral	KGSGIpLTTNL	0.088	0.092	0.456	0.127	0.092	0.078	0.718	0.137	VARIANT	P -> S (in dbSNP:rs34299975)	17344846	1
Q9UQ07/Q398R	Q9UQ07	MOK	MOK_HUMAN	Q398R	-	-	-	neutral	KKTDPqDLKPA									VARIANT	Q -> R (in dbSNP:rs2236493)	17344846	1
Q9UQ07/R38H	Q9UQ07	MOK	MOK_HUMAN	R38H	137	αC	-	neutral	KQMKQrESIEQ	0.17	0.121	0.428	0.146	0.198	0.108	0.584	0.123	VARIANT	R -> H (in dbSNP:rs34114580)	17344846	1
Q9UQ07/V217I	Q9UQ07	MOK	MOK_HUMAN	V217I	644	αG	-	-	SKIHDvGTPAQ	0.095	0.148	0.465	0.162	0.078	0.106	0.666	0.106	VARIANT	V -> I (in dbSNP:rs148360666)	14702039	1
Q9UQB9/D166Y	Q9UQB9	AURKC	AURKC_HUMAN	D166Y	443	Catalytic-loop;HrD-motif	-	decrease	KVIHRdKPENL	0.992	0.983	0.252	0.725	0.941	0.968	0.103	0.552	MUTAGEN	D->Y: Impairs kinase activity, and keeps AURKC with the chromosomes until the end of mitosis.	15938719	1
Q9UQB9/E148Q	Q9UQB9	AURKC	AURKC_HUMAN	E148Q	408	αE	-	-	TATIIeLADAL	0.15	0.198	0.49	0.242	0.161	0.118	0.661	0.142	VARIANT	E -> Q (in a lung squamous cell carcinoma sample; somatic mutation)	17344846	1
Q9UQB9/G52E	Q9UQB9	AURKC	AURKC_HUMAN	G52E	42	β1;Gly-rich-loop	-	-	RPLGKgFGNVY	0.902	0.913	0.359	0.698	0.835	0.838	0.321	0.433	VARIANT	G -> E (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
Q9UQB9/H244Q	Q9UQB9	AURKC	AURKC_HUMAN	H244Q	628	αF/αG	-	-	FESAShETYRR	0.482	0.48	0.426	0.244	0.296	0.457	0.48	0.178	VARIANT	H -> Q (in a lung adenocarcinoma sample; somatic mutation)	17344846	1
Q9UQB9/K72R	Q9UQB9	AURKC	AURKC_HUMAN	K72R	129	β3;Catalytic-Lys	-	decrease	FIVALkLFKSQ	0.985	0.996	0.068	0.672	0.979	0.998	0.04	0.344	MUTAGEN	K->R: Impairs kinase activity.	15316025,15499654	2
Q9UQB9/T198A	Q9UQB9	AURKC	AURKC_HUMAN	T198A	545	A-loop	p	decrease	SLRRKtCGTLD	0.992	1.0	0.307	0.928	0.69	0.992	0.241	0.363	MUTAGEN	T->A: Impairs kinase activity.	15316025,15670791	2
Q9UQM7/A112V	Q9UQM7	CAMK2A	KCC2A_HUMAN	A112V	400	αE	-	-	YSEADaHCIQQ	0.469	0.389	0.592	0.508	0.199	0.286	0.732	0.313	VARIANT	A -> V (in MRD53; unknown pathological significance)	29100089	1
Q9UQM7/E109D	Q9UQM7	CAMK2A	KCC2A_HUMAN	E109D	395	αD/αE-loop	-	increase	REYYSeDASHC	0.619	0.549	0.607	0.641	0.155	0.295	0.727	0.359	VARIANT	E -> D (in MRD53; no effect on protein abundance; increased autophosphorylation; decreased neuronal migration)	29100089	1
Q9UQM7/E183V	Q9UQM7	CAMK2A	KCC2A_HUMAN	E183V	557	A-loop;APE-motif	-	decrease	GYLSPeLRKDP	0.898	0.871	0.275	0.647	0.875	0.906	0.236	0.609	VARIANT	E -> V (in MRD53; increased ubiquitin-mediated proteasomal degradation with a dominant negative effect on wild-type protein; decreased localization to dendritic spines; no effect on holoenzyme assembly; loss of interaction with SHANK3; loss of interaction with GRIN2B; loss of interaction with CACNB2; loss of interaction with LRRC7; loss of interaction with GRM5; decreased protein serine/threonine kinase activity with a dominant negative effect on wild-type protein; decreased autophosphorylation; changed dendritic spine development; decreased neuronal migration; dbSNP:rs1554122129)	28130356,29100089	2
Q9UQM7/F98S	Q9UQM7	CAMK2A	KCC2A_HUMAN	F98S	265	αD	-	decrease	TGGELfDIVAR	0.903	0.811	0.436	0.694	0.742	0.791	0.338	0.726	VARIANT	F -> S (in MRD53; no effect on protein abundance; decreased autophosphorylation; decreased neuronal migration; dbSNP:rs1554122526)	29100089	1
Q9UQM7/H282R	Q9UQM7	CAMK2A	KCC2A_HUMAN	H282R	834	C-term-αI	-	increase	VASCMhQETVD	0.67	0.628	0.445	0.527	0.464	0.528	0.543	0.429	VARIANT	H -> R (in MRD53; decreased protein abundance; increased autophosphorylation; decreased neuronal migration; dbSNP:rs1554121875)	29100089	1
Q9UQM7/H466Y	Q9UQM7	CAMK2A	KCC2A_HUMAN	H466Y	-	-	-	-	KWQIVhHRSGA									VARIANT	H -> Y (in MRT63; decreased oligomerization; dbSNP:rs1554119274)	29784083	1
Q9UQM7/K42R	Q9UQM7	CAMK2A	KCC2A_HUMAN	K42R	129	β3;Catalytic-Lys	-	-	QEYAAkINTKK	0.935	0.956	0.069	0.582	0.981	0.983	0.037	0.33	MUTAGEN	K->R: No effect on protein stability or degradation. No effect on neuronal migration; when associated with P-286.	29100089	1
Q9UQM7/P138A	Q9UQM7	CAMK2A	KCC2A_HUMAN	P138A	446	Catalytic-loop	-	-	HRDLKpNLLLA	0.814	0.762	0.436	0.715	0.597	0.79	0.331	0.574	VARIANT	P -> A (in MRD53; unknown pathological significance; no effect on protein abundance; no effect on autophosphorylation; no effect on neuronal migration)	25533962,29100089	2
Q9UQM7/P212L	Q9UQM7	CAMK2A	KCC2A_HUMAN	P212L	621	αF/αG	-	-	LVGYPpWDEDQ	0.756	0.71	0.48	0.642	0.565	0.661	0.446	0.597	VARIANT	P -> L (in MRD53; unknown pathological significance; no effect on protein abundance; no effect on autophosphorylation; no effect on neuronal migration; dbSNP:rs926027867)	29100089	1
Q9UQM7/P212Q	Q9UQM7	CAMK2A	KCC2A_HUMAN	P212Q	621	αF/αG	-	increase	LVGYPpWDEDQ	0.803	0.789	0.484	0.737	0.489	0.731	0.464	0.669	VARIANT	P -> Q (in MRD53; increased basal autophosphorylation)	29560374	1
Q9UQM7/P235L	Q9UQM7	CAMK2A	KCC2A_HUMAN	P235L	677	αG/αH	-	-	YDFPSpWDTVT	0.576	0.618	0.499	0.508	0.456	0.514	0.458	0.329	VARIANT	P -> L (in MRD53; unknown pathological significance; no effect on protein abundance; no effect on autophosphorylation; no effect on neuronal migration; dbSNP:rs864309606)	29100089,29560374	2
Q9UQM7/T286A	Q9UQM7	CAMK2A	KCC2A_HUMAN	T286A	838	C-term-αI	p	-	MHRQEtDCLKK	0.74	0.755	0.477	0.694	0.451	0.621	0.526	0.293	MUTAGEN	T->A: No effect on neuronal migration.	29100089	1
Q9UQM7/T286D	Q9UQM7	CAMK2A	KCC2A_HUMAN	T286D	838	C-term-αI	p	-	MHRQEtDCLKK	0.726	0.708	0.666	0.723	0.291	0.484	0.687	0.436	MUTAGEN	T->D: Loss of neuronal migration.	29100089	1
Q9UQM7/T286P	Q9UQM7	CAMK2A	KCC2A_HUMAN	T286P	838	C-term-αI	p	-	MHRQEtDCLKK	0.778	0.745	0.615	0.694	0.338	0.607	0.662	0.46	VARIANT	T->P: No effect on neuronal migration; when associated with R-42.	29100089	1
Q9Y243/E17K	Q9Y243	AKT3	AKT3_HUMAN	E17K	-	-	-	activating	VQKRGeIKNWR									VARIANT	E -> K (in MPPH2 and melanoma; results in activation of AKT; dbSNP:rs397514606)	18813315,22500628,22729223	3
Q9Y243/G171R	Q9Y243	AKT3	AKT3_HUMAN	G171R	72	β2/β3-loop	-	-	REKASgYYAMK	0.667	0.607	0.49	0.55	0.335	0.503	0.546	0.4	VARIANT	G -> R (in a glioblastoma multiforme sample; somatic mutation; dbSNP:rs1402272180)	17344846	1
Q9Y243/N229S	Q9Y243	AKT3	AKT3_HUMAN	N229S	253	β5/αD-loop	-	-	VMEYVnGELFF	0.576	0.417	0.492	0.474	0.407	0.397	0.527	0.429	VARIANT	N -> S (in MPPH2; dbSNP:rs397514605)	22729224,23745724	2
Q9Y243/R465W	Q9Y243	AKT3	AKT3_HUMAN	R465W	-	-	-	-	MDNERrHFPQF									VARIANT	R -> W (in MPPH2; disease phenotype overlaps with megalencephaly-capillary malformation syndrome; dbSNP:rs587776935)	22729224	1
Q9Y243/S472A	Q9Y243	AKT3	AKT3_HUMAN	S472A	-	-	p	decrease	HFPQFsSASGR									MUTAGEN	S->A: 67% decrease of activity after pervanadate treatment.	10092583	1
Q9Y243/S472D	Q9Y243	AKT3	AKT3_HUMAN	S472D	-	-	p	increase	HFPQFsSASGR									MUTAGEN	S->D: 1.4-fold increase of phosphorylation steady state level, 50% decrease of activity after pervanadate treatment.	10092583	1
Q9Y243/T305A	Q9Y243	AKT3	AKT3_HUMAN	T305A	545	A-loop	p	-	AATMKtCGTPE	0.982	1.0	0.156	0.916	0.959	0.989	0.098	0.398	MUTAGEN	T->A: No activation after pervanadate treatment.	11387345	1
Q9Y243/T305D	Q9Y243	AKT3	AKT3_HUMAN	T305D	545	A-loop	p	increase	AATMKtCGTPE	0.993	1.0	0.873	0.985	0.108	0.959	0.878	0.374	MUTAGEN	T->D: 2-fold increase of phosphorylation steady state level, no activation after pervanadate treatment.	11387345	1
Q9Y243/T447A	Q9Y243	AKT3	AKT3_HUMAN	T447A	-	-	p	-	QTITItPEKYD									MUTAGEN	T->A: No effect.	11387345	1
Q9Y243/T447D	Q9Y243	AKT3	AKT3_HUMAN	T447D	-	-	p	-	QTITItPEKYD									MUTAGEN	T->D: No effect.	11387345	1
Q9Y2H1/G99A	Q9Y2H1	STK38L	ST38L_HUMAN	G99A	42	β1;Gly-rich-loop	-	-	KVIGRgFGEVR	0.903	0.911	0.249	0.592	0.862	0.877	0.197	0.469	VARIANT	G -> A (in a aLLTEL/AML1+ sample; somatic mutation)	17344846	1
Q9Y2H1/K119A	Q9Y2H1	STK38L	ST38L_HUMAN	K119A	129	β3;Catalytic-Lys	-	loss	HIYAMkLRKSD	1.0	1.0	0.011	0.649	1.0	0.998	0.003	0.66	MUTAGEN	K->A: Loss of autophosphorylation and kinase activity.	15037617	1
Q9Y2H1/S282A	Q9Y2H1	STK38L	ST38L_HUMAN	S282A	32	-	p	loss	RQLAYsVGTPD	0.895	0.864	0.29	0.801	0.743	0.872	0.29	0.518	MUTAGEN	S->A: Loss of autophosphorylation and kinase activity.	15037617	1
Q9Y2H1/T442A	Q9Y2H1	STK38L	ST38L_HUMAN	T442A	-	-	p	decrease	VFLNYtKRFEG									MUTAGEN	T->A: Decreased kinase activity.	15037617	1
Q9Y2H1/T75A	Q9Y2H1	STK38L	ST38L_HUMAN	T75A	18	N-term-β1	p	decrease	HARKEtFLRLK	0.799	0.823	0.324	0.663	0.665	0.657	0.36	0.258	MUTAGEN	T->A: Decreased kinase activity. Reduced binding of S100B.	15037617	1
Q9Y2H9/A1048S	Q9Y2H9	MAST1	MAST1_HUMAN	A1048S	-	-	-	-	SGNKVaTTTPF									VARIANT	A -> S (in dbSNP:rs35052801)		0
Q9Y2H9/A269T	Q9Y2H9	MAST1	MAST1_HUMAN	A269T	-	-	-	-	ESLEVaVTQLV									VARIANT	A -> T (in a metastatic melanoma sample; somatic mutation)	17344846	1
Q9Y2H9/A915T	Q9Y2H9	MAST1	MAST1_HUMAN	A915T	-	-	-	-	IKSASaALSVM									VARIANT	A -> T (in a patient with neurodevelopmental abnormalities; de novo variant; unknown pathological significance)	30449657	1
Q9Y2H9/G517S	Q9Y2H9	MAST1	MAST1_HUMAN	G517S	498	A-loop;DFG-motif	-	-	KLTDFgSKMGL	0.926	0.903	0.412	0.728	0.563	0.824	0.341	0.549	VARIANT	G -> S (in MCCCHCM; dbSNP:rs1568413207)	30449657	1
Q9Y2H9/G98V	Q9Y2H9	MAST1	MAST1_HUMAN	G98V	-	-	-	-	SLPSSgGTNTP									VARIANT	G -> V (in a patient with neurodevelopmental abnormalities; de novo variant; unknown pathological significance)	30449657	1
Q9Y2H9/H1240Y	Q9Y2H9	MAST1	MAST1_HUMAN	H1240Y	-	-	-	-	FPAKLhSPPVV									VARIANT	H -> Y (in an ovarian serous carcinoma sample; somatic mutation; dbSNP:rs1411105125)	17344846	1
Q9Y2H9/P1177R	Q9Y2H9	MAST1	MAST1_HUMAN	P1177R	-	-	-	-	SHHIRpTLHGL									VARIANT	P -> R (in a patient with neurodevelopmental abnormalities; de novo variant; unknown pathological significance)	30449657	1
Q9Y2H9/P1292S	Q9Y2H9	MAST1	MAST1_HUMAN	P1292S	-	-	-	-	LEVGHpFRKDF									VARIANT	P -> S (in dbSNP:rs35071862)	17344846	1
Q9Y2H9/S93L	Q9Y2H9	MAST1	MAST1_HUMAN	S93L	-	-	-	-	RWSLAsPSSGY									VARIANT	S -> L (in a patient with neurodevelopmental abnormalities; de novo variant; unknown pathological significance; dbSNP:rs878853165)	30449657	1
Q9Y2K2/A1161V	Q9Y2K2	SIK3	SIK3_HUMAN	A1161V	-	-	-	-	HQPTAaSKNKV									VARIANT	A -> V (in a breast cancer sample; somatic mutation)	16959974	1
Q9Y2K2/D1098E	Q9Y2K2	SIK3	SIK3_HUMAN	D1098E	-	-	-	neutral	ESMEEdSCEGA									VARIANT	D -> E (in dbSNP:rs11216163)		0
Q9Y2K2/H389L	Q9Y2K2	SIK3	SIK3_HUMAN	H389L	-	-	-	-	DRHKRhTLRLG									VARIANT	H -> L (in a breast cancer sample; somatic mutation; dbSNP:rs376144593)	16959974	1
Q9Y2K2/P1136R	Q9Y2K2	SIK3	SIK3_HUMAN	P1136R	-	-	-	-	GGPGDpSLLGT									VARIANT	P -> R (in dbSNP:rs12225230)		0
Q9Y2K2/R187C	Q9Y2K2	SIK3	SIK3_HUMAN	R187C	442	Catalytic-loop;HrD-motif	-	decrease	RNIVHrLKAEN	0.874	0.795	0.473	0.716	0.639	0.713	0.39	0.553	VARIANT	R -> C (in SEMDK; decreased protein expression; decreased kinase activity; no effect on the interaction with DEPTOR, MLST8/GbetaL, RICTOR and RPTOR; dbSNP:rs1565460853)	30232230	1
Q9Y2K2/S551A	Q9Y2K2	SIK3	SIK3_HUMAN	S551A	-	-	p	loss	LGRRAsGGANI									MUTAGEN	S->A: Loss of interaction with 14-3-3 proteins in response to cAMP signaling; inhibits cAMP signaling.	29211348	1
Q9Y2K2/S551E	Q9Y2K2	SIK3	SIK3_HUMAN	S551E	-	-	p	loss	LGRRAsGGANI									MUTAGEN	S->E: Loss of interaction with 14-3-3 proteins in response to cAMP signaling; inhibits cAMP signaling.	29211348	1
Q9Y2K2/S626A	Q9Y2K2	SIK3	SIK3_HUMAN	S626A	-	-	p	-	PVRRFsGAASI									MUTAGEN	S->A: No effect on interaction with 14-3-3 proteins, nor on cAMP signaling.	29211348	1
Q9Y2K2/S626E	Q9Y2K2	SIK3	SIK3_HUMAN	S626E	-	-	p	-	PVRRFsGAASI									MUTAGEN	S->E: No effect on cAMP signaling.	29211348	1
Q9Y2K2/T221A	Q9Y2K2	SIK3	SIK3_HUMAN	T221A	545	A-loop	p	loss	GQLLKtCGSPP	0.999	1.0	0.118	0.92	0.978	0.991	0.083	0.461	MUTAGEN	T->A: Prevents phosphorylation and activation by STK11/LKB1 complex.	14976552	1
Q9Y2K2/T469A	Q9Y2K2	SIK3	SIK3_HUMAN	T469A	-	-	p	loss	SMRRHtGVADP									MUTAGEN	T->A: Loss of interaction with 14-3-3 proteins in response to cAMP signaling; inhibits cAMP signaling.	29211348	1
Q9Y2K2/T469E	Q9Y2K2	SIK3	SIK3_HUMAN	T469E	-	-	p	loss	SMRRHtGVADP									MUTAGEN	T->E: Loss of interaction with 14-3-3 proteins in response to cAMP signaling; inhibits cAMP signaling.	29211348	1
Q9Y2U5/D140G	Q9Y2U5	MAP3K2	M3K2_HUMAN	D140G	-	-	-	-	SLEDLdTVFGA									VARIANT	D -> G (in dbSNP:rs56307783)	17344846	1
Q9Y2U5/I110V	Q9Y2U5	MAP3K2	M3K2_HUMAN	I110V	-	-	-	-	LLDRSiMKSLK									VARIANT	I -> V (in dbSNP:rs55767983)	17344846	1
Q9Y2U5/M112I	Q9Y2U5	MAP3K2	M3K2_HUMAN	M112I	-	-	-	-	DRSIHmSLKIL									VARIANT	M -> I (in a lung large cell carcinoma sample; somatic mutation)	17344846	1
Q9Y3S1/R974L	Q9Y3S1	WNK2	WNK2_HUMAN	R974L	-	-	-	-	PPQPTrPQPVL									VARIANT	R -> L (in dbSNP:rs10114908)		0
Q9Y3S1/V828M	Q9Y3S1	WNK2	WNK2_HUMAN	V828M	-	-	-	neutral	ATVPPvPPQYF									VARIANT	V -> M (in dbSNP:rs10761203)		0
Q9Y463/D239A	Q9Y463	DYRK1B	DYR1B_HUMAN	D239A	443	Catalytic-loop;HrD-motif	-	loss	SIIHCdKPENI	0.975	0.984	0.141	0.586	0.959	0.988	0.101	0.538	MUTAGEN	D->A: Abolishes kinase activity.	32611815	1
Q9Y463/H90P	Q9Y463	DYRK1B	DYR1B_HUMAN	H90P	12	N-term-β1	-	increase	KKVLNhYDDDN	0.626	0.586	0.58	0.521	0.336	0.472	0.685	0.333	VARIANT	H -> P (in AOMS3; expression of glucose-6-phosphatase is significantly higher than wild-type; dbSNP:rs587777380)	24827035	1
Q9Y463/K140R	Q9Y463	DYRK1B	DYR1B_HUMAN	K140R	129	β3;Catalytic-Lys	-	-	ELVAIkIKNKK	1.0	1.0	0.052	0.758	1.0	0.999	0.007	0.49	MUTAGEN	K->R: Abolishes kinase activity.	10910078	1
Q9Y463/L28P	Q9Y463	DYRK1B	DYR1B_HUMAN	L28P	-	-	-	neutral	LPDVRlPRRLP									VARIANT	L -> P (in dbSNP:rs34587974)	17344846	1
Q9Y463/Q275R	Q9Y463	DYRK1B	DYR1B_HUMAN	Q275R	548	A-loop	-	-	IYQYIqRFYRS	0.819	0.825	0.448	0.648	0.657	0.735	0.428	0.545	VARIANT	Q -> R (in a metastatic melanoma sample; somatic mutation)	17344846	1
Q9Y463/R102C	Q9Y463	DYRK1B	DYR1B_HUMAN	R102C	24	N-term-β1	-	decrease	HDYIVrGERWL	0.458	0.448	0.58	0.432	0.329	0.335	0.668	0.21	VARIANT	R -> C (in AOMS3; accumulation of intracellular lipid is significantly greater than with wild-type protein; cells expressing the variant are able to transform into mature adipocytes without requiring adipogenic medium; expression levels of CEBPA, PPARG forms 1 and 2 and PPARGC1A are higher and those of GLI1 and CDKN1B are lower in cells transfected with the mutant protein compared to wild-type; WNT1 signaling activity is lower in mutant cells compared to wild-type; dbSNP:rs367643250)	24827035	1
Q9Y463/R102H	Q9Y463	DYRK1B	DYR1B_HUMAN	R102H	24	N-term-β1	-	-	HDYIVrGERWL	0.357	0.344	0.435	0.254	0.337	0.342	0.539	0.301	VARIANT	R -> H (in dbSNP:rs55687541)	17344846	1
Q9Y463/S234G	Q9Y463	DYRK1B	DYR1B_HUMAN	S234G	427	αE	-	-	ATPELsIHCDL	0.219	0.168	0.542	0.287	0.152	0.135	0.665	0.175	VARIANT	S -> G (in dbSNP:rs35858874)	17344846	1
Q9Y463/Y271F	Q9Y463	DYRK1B	DYR1B_HUMAN	Y271F	544	A-loop	p	-	LGQRIyYIQSR	0.796	0.808	0.607	0.818	0.388	0.764	0.64	0.304	MUTAGEN	Y->F: Abolishes kinase activity; when associated with F-273.	10910078	1
Q9Y463/Y273F	Q9Y463	DYRK1B	DYR1B_HUMAN	Y273F	546	A-loop	p	-	QRIYQyQSRFY	0.977	0.971	0.356	0.796	0.898	0.912	0.295	0.417	MUTAGEN	Y->F: Abolishes kinase activity; when associated with F-271.	10910078	1
Q9Y4A5/A1043T	Q9Y4A5	TRRAP	TRRAP_HUMAN	A1043T	-	-	-	-	ALPFVaLIRHY									VARIANT	A -> T (in DEDDFA; dbSNP:rs1562945106)	30827496	1
Q9Y4A5/D394N	Q9Y4A5	TRRAP	TRRAP_HUMAN	D394N	-	-	-	-	HLPLSdSLAVQ									VARIANT	D -> N (in DFNA75; unknown pathological significance; dbSNP:rs1554407965)	31231791	1
Q9Y4A5/E1104G	Q9Y4A5	TRRAP	TRRAP_HUMAN	E1104G	-	-	-	-	CMAYEeELCKI									VARIANT	E -> G (in DEDDFA; dbSNP:rs1790257064)	30827496	1
Q9Y4A5/E1106K	Q9Y4A5	TRRAP	TRRAP_HUMAN	E1106K	-	-	-	-	AYEEKeCKIGE									VARIANT	E -> K (in DEDDFA; dbSNP:rs1584324956)	30827496	1
Q9Y4A5/F860L	Q9Y4A5	TRRAP	TRRAP_HUMAN	F860L	-	-	-	-	NLQPDfYDHIQ									VARIANT	F -> L (in DEDDFA; unknown pathological significance)	30827496	1
Q9Y4A5/G1111W	Q9Y4A5	TRRAP	TRRAP_HUMAN	G1111W	-	-	-	-	ELCKIgVALAV									VARIANT	G -> W (in DEDDFA; unknown pathological significance)	30827496	1
Q9Y4A5/G1159R	Q9Y4A5	TRRAP	TRRAP_HUMAN	G1159R	-	-	-	-	WYAKLgVVSIK									VARIANT	G -> R (in DEDDFA; dbSNP:rs1790288810)	30827496	1
Q9Y4A5/I1031M	Q9Y4A5	TRRAP	TRRAP_HUMAN	I1031M	-	-	-	-	FMSAViDLRPS									VARIANT	I -> M (in DEDDFA)	30827496	1
Q9Y4A5/L805F	Q9Y4A5	TRRAP	TRRAP_HUMAN	L805F	-	-	-	-	QHMKDlVELCL									VARIANT	L -> F (in DEDDFA; unknown pathological significance; dbSNP:rs1562940289)	30827496	1
Q9Y4A5/R1035Q	Q9Y4A5	TRRAP	TRRAP_HUMAN	R1035Q	-	-	-	-	VIKDLrSALPF									VARIANT	R -> Q (in DEDDFA; unknown pathological significance)	30827496	1
Q9Y4A5/R171C	Q9Y4A5	TRRAP	TRRAP_HUMAN	R171C	-	-	-	-	PKVVNrFENPQ									VARIANT	R -> C (in DFNA75; unknown pathological significance; dbSNP:rs200157211)	31231791	1
Q9Y4A5/R878L	Q9Y4A5	TRRAP	TRRAP_HUMAN	R878L	-	-	-	-	MQALWrLRNPA									VARIANT	R -> L (in dbSNP:rs17161510)		0
Q9Y4A5/R893C	Q9Y4A5	TRRAP	TRRAP_HUMAN	R893C	-	-	-	-	SHVAYrLGKFG									VARIANT	R -> C (in an ovarian serous carcinoma sample; somatic mutation)	17344846	1
Q9Y4A5/R893L	Q9Y4A5	TRRAP	TRRAP_HUMAN	R893L	-	-	-	-	SHVAYrLGKFG									VARIANT	R -> L (in DEDDFA; unknown pathological significance)	30827496	1
Q9Y4A5/S1037R	Q9Y4A5	TRRAP	TRRAP_HUMAN	S1037R	-	-	-	-	KDLRPsLPFVA									VARIANT	S -> R (in DEDDFA; unknown pathological significance)	30827496	1
Q9Y4A5/S1070G	Q9Y4A5	TRRAP	TRRAP_HUMAN	S1070G	-	-	-	-	CYQVGsPSTAM									VARIANT	S -> G (in dbSNP:rs55920979)	17344846	1
Q9Y4A5/S722F	Q9Y4A5	TRRAP	TRRAP_HUMAN	S722F	-	-	-	-	VFGSVsFAAEN									VARIANT	S -> F (found in a cutaneous malignant melanoma sample; somatic mutation; induces cell transformation and confers resistance to apoptosis; dbSNP:rs147405090)	21499247	1
Q9Y4K4/A334T	Q9Y4K4	MAP4K5	M4K5_HUMAN	A334T	-	-	-	neutral	RAERTaEINFD									VARIANT	A -> T (in dbSNP:rs12881869)	17344846	1
Q9Y4K4/H41Y	Q9Y4K4	MAP4K5	M4K5_HUMAN	H41Y	65	β2/β3-loop	-	-	KARNVhGELAA	0.466	0.465	0.556	0.425	0.36	0.373	0.677	0.185	VARIANT	H -> Y (in dbSNP:rs34726242)		0
Q9Y4K4/I446V	Q9Y4K4	MAP4K5	M4K5_HUMAN	I446V	-	-	-	-	AETSSiNGDGI									VARIANT	I -> V (in dbSNP:rs55815015)	17344846	1
Q9Y4K4/K473N	Q9Y4K4	MAP4K5	M4K5_HUMAN	K473N	-	-	-	neutral	QLPRKkKRDFP									VARIANT	K -> N (in dbSNP:rs35768475)	9038372	1
Q9Y4K4/K49R	Q9Y4K4	MAP4K5	M4K5_HUMAN	K49R	129	β3;Catalytic-Lys	-	loss	ELAAVkIKLEP	1.0	1.0	0.03	0.701	0.995	0.999	0.011	0.503	MUTAGEN	K->R: Loss of kinase activity and ability to activate JNK family.	9038372	1
Q9Y4K4/P407L	Q9Y4K4	MAP4K5	M4K5_HUMAN	P407L	-	-	-	neutral	PEDNFpEEKAS									VARIANT	P -> L (in dbSNP:rs34818002)	17344846	1
Q9Y4K4/R552Q	Q9Y4K4	MAP4K5	M4K5_HUMAN	R552Q	-	-	-	-	EQLFPrCTWLY									VARIANT	R -> Q (in dbSNP:rs55997280)	17344846	1
Q9Y4K4/T633M	Q9Y4K4	MAP4K5	M4K5_HUMAN	T633M	-	-	-	neutral	VRNPYtHKYLC									VARIANT	T -> M (in dbSNP:rs17780143)	17344846	1
Q9Y572/D142N	Q9Y572	RIPK3	RIPK3_HUMAN	D142N	443	Catalytic-loop;HrD-motif	-	loss	VLLHRdKPSNV	0.962	0.978	0.237	0.649	0.924	0.959	0.198	0.434	MUTAGEN	D->N: Abolishes kinase activity and ability to mediate necroptosis.	22265413	1
Q9Y572/E260V	Q9Y572	RIPK3	RIPK3_HUMAN	E260V	787	αH	-	-	LEGLKeMQLCW	0.638	0.531	0.502	0.518	0.418	0.461	0.491	0.621	VARIANT	E -> V (in dbSNP:rs7153640)		0
Q9Y572/K363R	Q9Y572	RIPK3	RIPK3_HUMAN	K363R	-	-	-	-	PSSVPkCPSLT									MUTAGEN	K->R: Loss of PELI1-mediated ubiquitination. No loss of interaction with PELI1.	29883609	1
Q9Y572/K50A	Q9Y572	RIPK3	RIPK3_HUMAN	K50A	129	β3;Catalytic-Lys	-	loss	YDVAVkVNSKA	1.0	1.0	0.015	0.62	0.998	0.996	0.004	0.634	MUTAGEN	K->A: Abolishes kinase activity. Loss of PGAM5- and MLKL-binding. No effect on RIPK1-binding. Loss of interaction with PELI1 and PELI1-mediated ubiquitination. No loss of STUB1-mediated ubiquitination.	10339433,10358032,22265414,29883609	4
Q9Y572/K50D	Q9Y572	RIPK3	RIPK3_HUMAN	K50D	129	β3;Catalytic-Lys	-	loss	YDVAVkVNSKA	0.985	1.0	0.113	0.718	0.979	0.997	0.058	0.416	MUTAGEN	K->D: Abolishes kinase activity.	10339433,10358032,22265414	3
Q9Y572/P492Q	Q9Y572	RIPK3	RIPK3_HUMAN	P492Q	-	-	-	neutral	GLQHPpVGSQE									VARIANT	P -> Q (in dbSNP:rs3212254)	17344846	1
Q9Y572/S227A	Q9Y572	RIPK3	RIPK3_HUMAN	S227A	632	αF/αG	p	decrease	LPTEPsVYEAV	0.745	0.789	0.379	0.581	0.647	0.674	0.359	0.097	MUTAGEN	S->A: Abolishes ability to mediate necroptosis. Partial loss of kinase activity. No loss of PELI1-mediated degradation.	22265413,29883609	2
Q9Y572/S227D	Q9Y572	RIPK3	RIPK3_HUMAN	S227D	632	αF/αG	p	-	LPTEPsVYEAV	0.728	0.717	0.665	0.718	0.337	0.509	0.708	0.11	MUTAGEN	S->D: No loss of PELI1-mediated degradation.	29883609	1
Q9Y572/T182A	Q9Y572	RIPK3	RIPK3_HUMAN	T182A	549	A-loop	p	loss	GEPGGtGYLAP	0.946	0.949	0.254	0.808	0.912	0.939	0.2	0.397	MUTAGEN	T->A: Abolishes kinase activity. Loss of interaction with PELI1 and PELI1-mediated ubiquitination. No loss of interaction with STUB1 and STUB1-mediated ubiquitination. No loss of interaction with RIPK1. Loss of ability to mediate TNF-induced necroptosis. Loss of autophosphorylation at Ser-227.	29883609	1
Q9Y572/T182S	Q9Y572	RIPK3	RIPK3_HUMAN	T182S	549	A-loop	p	-	GEPGGtGYLAP	0.925	0.925	0.383	0.795	0.769	0.929	0.307	0.533	MUTAGEN	T->S: No loss of interaction with PELI1 and PELI1-mediated ubiquitination. No loss of interaction with RIPK1 and MLKL.	29883609	1
Q9Y572/T300M	Q9Y572	RIPK3	RIPK3_HUMAN	T300M	843	C-term-αI	-	-	NAAVStKDFLS	0.581	0.48	0.482	0.426	0.324	0.418	0.583	0.317	VARIANT	T -> M (in dbSNP:rs34106261)	17344846	1
Q9Y572/Y185A	Q9Y572	RIPK3	RIPK3_HUMAN	Y185A	553	A-loop	-	-	GGTLGyAPELF	0.942	0.912	0.376	0.623	0.817	0.857	0.281	0.556	MUTAGEN	Y->A,F: Loss of interaction with PELI1 and PELI1-mediated ubiquitination.	29883609	1
Q9Y572/Y185F	Q9Y572	RIPK3	RIPK3_HUMAN	Y185F	553	A-loop	-	-	GGTLGyAPELF	0.596	0.592	0.422	0.338	0.542	0.521	0.503	0.3	MUTAGEN	Y->A,F: Loss of interaction with PELI1 and PELI1-mediated ubiquitination.	29883609	1
Q9Y5P4/D324A	Q9Y5P4	CERT1	CERT_HUMAN	D324A	-	-	-	-	EEEFFdVEAAL									MUTAGEN	D->A: Impairs the endoplasmic reticulum-to-Golgi ceramide trafficking and abolishes the interaction with 		0
Q9Y5P4/E472A	Q9Y5P4	CERT1	CERT_HUMAN	E472A	-	-	-	-	VRNDWeTIENF									MUTAGEN	E->A: Reduces ceramide transfer.	18184806	1
Q9Y5P4/G243R	Q9Y5P4	CERT1	CERT_HUMAN	G243R	-	-	-	-	GIDFKgAITFK									VARIANT	G -> R (in MRD34; associated with authism and epilepsy)	25356899	1
Q9Y5P4/K599R	Q9Y5P4	CERT1	CERT_HUMAN	K599R	-	-	-	-	LRAVAkEYPKF									VARIANT	K -> R (in dbSNP:rs55882089)		0
Q9Y5P4/N530A	Q9Y5P4	CERT1	CERT_HUMAN	N530A	-	-	-	-	TWIVCnSVDHD									MUTAGEN	N->A: Reduces ceramide transfer.	18184806	1
Q9Y5P4/Q493A	Q9Y5P4	CERT1	CERT_HUMAN	Q493A	-	-	-	-	AIIIYqHKRVW									MUTAGEN	Q->A: No effect on ceramide transfer activity.	18184806	1
Q9Y5P4/S132A	Q9Y5P4	CERT1	CERT_HUMAN	S132A	-	-	p	loss	LRRHGsVSLVS									MUTAGEN	S->A: Abolishes the phosphorylation. Strongly reduces the interaction with phosphatidylinositol 4-phosphate. Increases the ceramide transfer activity.	17591919	1
Q9Y5P4/S132L	Q9Y5P4	CERT1	CERT_HUMAN	S132L	-	-	p	-	LRRHGsVSLVS									VARIANT	S -> L (in MRD34; dbSNP:rs1064794019)	25533962	1
Q9Y5P4/S138C	Q9Y5P4	CERT1	CERT_HUMAN	S138C	-	-	-	-	MVSLVsASGYS									VARIANT	S -> C (found in a patient with intellectual disability)	23033978	1
Q9Y5P4/W499A	Q9Y5P4	CERT1	CERT_HUMAN	W499A	-	-	-	-	THKRVwASQRD									MUTAGEN	W->A: Reduces affinity for membranes. Abolishes ceramide transfer; when associated with A-588.	20036255	1
Q9Y5P4/W588A	Q9Y5P4	CERT1	CERT_HUMAN	W588A	-	-	-	-	VNPGGwPASVL									MUTAGEN	W->A: Abolishes ceramide transfer; when associated with A-499.		0
Q9Y5S2/A142T	Q9Y5S2	CDC42BPB	MRCKB_HUMAN	A142T	207	β4/β5-loop	-	-	TALHYaQDENH	0.085	0.101	0.485	0.111	0.118	0.098	0.662	0.062	VARIANT	A -> T (in CHOCNS; unknown pathological significance)	32031333	1
Q9Y5S2/D175Y	Q9Y5S2	CDC42BPB	MRCKB_HUMAN	D175Y	396	αD/αE-loop	-	-	DKLPEdARFYI	0.565	0.504	0.522	0.474	0.366	0.358	0.568	0.302	VARIANT	D -> Y (in CHOCNS; unknown pathological significance)	32031333	1
Q9Y5S2/E1315K	Q9Y5S2	CDC42BPB	MRCKB_HUMAN	E1315K	-	-	-	-	SLDGAeSFDIK									VARIANT	E -> K (in a lung large cell carcinoma sample; somatic mutation)	17344846	1
Q9Y5S2/I1077V	Q9Y5S2	CDC42BPB	MRCKB_HUMAN	I1077V	-	-	-	-	PQVCPiPEQSK									VARIANT	I -> V (in dbSNP:rs34822377)		0
Q9Y5S2/I293M	Q9Y5S2	CDC42BPB	MRCKB_HUMAN	I293M	641	αG	-	-	ETYGKiNHEER	0.608	0.583	0.484	0.484	0.408	0.477	0.51	0.408	VARIANT	I -> M (in CHOCNS; unknown pathological significance)	32031333	1
Q9Y5S2/K500E	Q9Y5S2	CDC42BPB	MRCKB_HUMAN	K500E	-	-	-	-	ERLKNkADSNR									VARIANT	K -> E (in a breast infiltrating ductal carcinoma sample; somatic mutation; dbSNP:rs1158962067)	17344846	1
Q9Y5S2/L871P	Q9Y5S2	CDC42BPB	MRCKB_HUMAN	L871P	-	-	-	-	RRSQKlMSARL									VARIANT	L -> P (in CHOCNS; unknown pathological significance)	32031333	1
Q9Y5S2/R1203K	Q9Y5S2	CDC42BPB	MRCKB_HUMAN	R1203K	-	-	-	-	NENEKrWVGIL									VARIANT	R -> K (in dbSNP:rs146298297)	10574461,15489334	2
Q9Y5S2/R1299Q	Q9Y5S2	CDC42BPB	MRCKB_HUMAN	R1299Q	-	-	-	-	ILLCGrHHVHL									VARIANT	R -> Q (in CHOCNS; unknown pathological significance)	32031333	1
Q9Y5S2/R1350P	Q9Y5S2	CDC42BPB	MRCKB_HUMAN	R1350P	-	-	-	-	FVAVKrILCYE									VARIANT	R -> P (in CHOCNS; unknown pathological significance)	32031333	1
Q9Y5S2/R555Q	Q9Y5S2	CDC42BPB	MRCKB_HUMAN	R555Q	-	-	-	neutral	VEASErKSQAK									VARIANT	R -> Q (in dbSNP:rs36001612)	17344846	1
Q9Y5S2/R671Q	Q9Y5S2	CDC42BPB	MRCKB_HUMAN	R671Q	-	-	m1	-	VKQGGrAGATL									VARIANT	R -> Q (in dbSNP:rs55948035)	17344846	1
Q9Y5S2/R867C	Q9Y5S2	CDC42BPB	MRCKB_HUMAN	R867C	-	-	-	-	LWKVRrQKLDM									VARIANT	R -> C (in CHOCNS)	32031333	1
Q9Y5S2/R876P	Q9Y5S2	CDC42BPB	MRCKB_HUMAN	R876P	-	-	-	-	LDMSArELQSA									VARIANT	R -> P (in CHOCNS)	32031333	1
Q9Y5S2/R876W	Q9Y5S2	CDC42BPB	MRCKB_HUMAN	R876W	-	-	-	-	LDMSArELQSA									VARIANT	R -> W (in a colorectal adenocarcinoma sample and CHOCNS; somatic mutation; dbSNP:rs1595472741)	17344846,32031333	2
Q9Y5S2/S1633Y	Q9Y5S2	CDC42BPB	MRCKB_HUMAN	S1633Y	-	-	-	-	ARQPPsNKPYI									VARIANT	S -> Y (in dbSNP:rs56412851)	17344846	1
Q9Y616/D482N	Q9Y616	IRAK3	IRAK3_HUMAN	D482N	-	-	-	-	IPVEDdSQNNN									VARIANT	D -> N (in dbSNP:rs35756811)	17344846	1
Q9Y616/E214L	Q9Y616	IRAK3	IRAK3_HUMAN	E214L	-	-	-	-	FLSELeLLLFH									MUTAGEN	E->L: Enhances dimerization.	33238146	1
Q9Y616/G269S	Q9Y616	IRAK3	IRAK3_HUMAN	G269S	-	-	-	-	WHIRIgLIGIS									VARIANT	G -> S (in dbSNP:rs35823766)		0
Q9Y616/G84S	Q9Y616	IRAK3	IRAK3_HUMAN	G84S	-	-	-	-	KNKTIgLLQVL									VARIANT	G -> S (in dbSNP:rs34443407)	17344846	1
Q9Y616/H57R	Q9Y616	IRAK3	IRAK3_HUMAN	H57R	-	-	-	-	WLDVRhEKYVD									VARIANT	H -> R (in dbSNP:rs35239505)	17344846	1
Q9Y616/I147V	Q9Y616	IRAK3	IRAK3_HUMAN	I147V	-	-	-	-	HNEKGiLKSSI									VARIANT	I -> V (in dbSNP:rs1152888)	10383454,14702039,15489334,17344846	4
Q9Y616/I171V	Q9Y616	IRAK3	IRAK3_HUMAN	I171V	-	-	-	-	HKDFLiEGEIF									VARIANT	I -> V (in dbSNP:rs34682166)	17344846	1
Q9Y616/I270V	Q9Y616	IRAK3	IRAK3_HUMAN	I270V	-	-	-	-	HIRIGiIGISK									VARIANT	I -> V (in dbSNP:rs11465972)		0
Q9Y616/L210E	Q9Y616	IRAK3	IRAK3_HUMAN	L210E	-	-	-	-	HWKRFlELEVL									MUTAGEN	L->E: Abolishes dimerization.	33238146	1
Q9Y616/L400V	Q9Y616	IRAK3	IRAK3_HUMAN	L400V	-	-	-	-	GLDSClFLDKK									VARIANT	L -> V (may be associated with ASRT5; dbSNP:rs146120640)	17503328	1
Q9Y616/M391T	Q9Y616	IRAK3	IRAK3_HUMAN	M391T	-	-	-	-	LLRELmKRGLD									VARIANT	M -> T (in dbSNP:rs35737689)	17344846	1
Q9Y616/P111A	Q9Y616	IRAK3	IRAK3_HUMAN	P111A	-	-	-	-	GAVLSpEKSYQ									VARIANT	P -> A (may be associated with ASRT5; abolishes phosphorylation of Ser-110; abolishes interaction with PIN1; no effect on cytoplasmic localization; reduces protein stability; dbSNP:rs373806603)	17503328,29686383	2
Q9Y616/P22L	Q9Y616	IRAK3	IRAK3_HUMAN	P22L	-	-	-	-	LFDLPpLLGEL									VARIANT	P -> L (may be associated with ASRT5; dbSNP:rs536546109)	17503328	1
Q9Y616/R384Q	Q9Y616	IRAK3	IRAK3_HUMAN	R384Q	-	-	-	-	KHIQLrLLREL									VARIANT	R -> Q (in dbSNP:rs34272472)	17344846	1
Q9Y616/R429Q	Q9Y616	IRAK3	IRAK3_HUMAN	R429Q	-	-	-	-	RCAATrKLRPS									VARIANT	R -> Q (may be associated with ASRT5; dbSNP:rs140671957)	17503328	1
Q9Y616/S110A	Q9Y616	IRAK3	IRAK3_HUMAN	S110A	-	-	p	-	YGAVLsSEKSY									MUTAGEN	S->A: Abolishes phosphorylation. Abolishes interaction with PIN1. Reduces protein stability.	29686383	1
Q9Y616/S110E	Q9Y616	IRAK3	IRAK3_HUMAN	S110E	-	-	p	-	YGAVLsSEKSY									MUTAGEN	S->E: Phosphomimic. Slight decrease in the interaction with PIN1. Weak interaction with PIN1 in absence of IL33-mediated dendritic cell stimulation. Increases resistant to degradation. Localizes to the nucleus in absence of stimulus. Does not affect isomerization of Pro-111 peptide bond.	29686383	1
Q9Y616/S288L	Q9Y616	IRAK3	IRAK3_HUMAN	S288L	-	-	-	-	NVQPCsICGSI									VARIANT	S -> L (in dbSNP:rs35574245)	17344846	1
Q9Y616/S467A	Q9Y616	IRAK3	IRAK3_HUMAN	S467A	-	-	p	-	SFRCPsLFLEN									MUTAGEN	S->A: No effect on the interaction with PIN1.	29686383	1
Q9Y616/V134M	Q9Y616	IRAK3	IRAK3_HUMAN	V134M	-	-	-	-	TANVTvNVLIP									VARIANT	V -> M (may be associated with ASRT5; dbSNP:rs138559915)	17503328	1
Q9Y6E0/A414V	Q9Y6E0	STK24	STK24_HUMAN	A414V	-	-	-	-	YLAEEaPGISD									VARIANT	A -> V (in dbSNP:rs55953606)	10644707,17344846	2
Q9Y6E0/D321N	Q9Y6E0	STK24	STK24_HUMAN	D321N	-	-	-	-	SSEDSdETDGQ									MUTAGEN	D->N: Loss of proteolytic cleavage by caspases.	12107159	1
Q9Y6E0/K65A	Q9Y6E0	STK24	STK24_HUMAN	K65A	129	β3;Catalytic-Lys	-	loss	KVVAIkIDLEE	1.0	1.0	0.034	0.636	0.995	0.999	0.013	0.629	MUTAGEN	K->A: Loss of activity and autophosphorylation.	12107159	1
Q9Y6E0/L426I	Q9Y6E0	STK24	STK24_HUMAN	L426I	-	-	-	-	TMVAQlQRLQR									VARIANT	L -> I (in dbSNP:rs55897869)	17344846	1
Q9Y6E0/T18A	Q9Y6E0	STK24	STK24_HUMAN	T18A	15	N-term-β1	p	loss	NKRRAtPHPGG	0.593	0.661	0.429	0.524	0.451	0.503	0.581	0.18	MUTAGEN	T->A: Loss of phosphorylation by PKA.	10644707	1
Q9Y6E0/T190A	Q9Y6E0	STK24	STK24_HUMAN	T190A	545	A-loop	p	loss	QIKRNtVGTPF	0.999	0.996	0.216	0.919	0.926	0.996	0.093	0.444	MUTAGEN	T->A: Loss of activity and autophosphorylation.	17046825	1
Q9Y6R4/A1492V	Q9Y6R4	MAP3K4	M3K4_HUMAN	A1492V	514	A-loop	-	-	KLKNNaTMPGE	0.613	0.548	0.656	0.553	0.198	0.358	0.769	0.37	VARIANT	A -> V (in dbSNP:rs41267837)	17344846	1
Q9Y6R4/E1413Q	Q9Y6R4	MAP3K4	M3K4_HUMAN	E1413Q	240	β4/β5-loop	-	-	VELHReMYIFM	0.45	0.354	0.491	0.37	0.204	0.26	0.61	0.354	VARIANT	E -> Q (in an ovarian serous carcinoma sample; somatic mutation)	17344846	1
Q9Y6R4/H906P	Q9Y6R4	MAP3K4	M3K4_HUMAN	H906P	-	-	-	neutral	LLLTKhDRARD									VARIANT	H -> P (in dbSNP:rs35533223)	17344846	1
Q9Y6R4/I294T	Q9Y6R4	MAP3K4	M3K4_HUMAN	I294T	-	-	-	-	QAIPDiNEILT									VARIANT	I -> T (in dbSNP:rs35842248)	17344846	1
Q9Y6R4/K1372R	Q9Y6R4	MAP3K4	M3K4_HUMAN	K1372R	129	β3;Catalytic-Lys	-	loss	ELMAMkIRFQP	0.994	1.0	0.026	0.7	0.991	0.994	0.02	0.481	MUTAGEN	K->R: Loss of activity.	12052864,9305639	2
Q9Y6R4/Q584H	Q9Y6R4	MAP3K4	M3K4_HUMAN	Q584H	-	-	-	-	GSDYVqSRTPP									VARIANT	Q -> H (in dbSNP:rs34018542)	17344846	1
Q9Y6R4/R157H	Q9Y6R4	MAP3K4	M3K4_HUMAN	R157H	-	-	-	neutral	TTERDrKNVQC									VARIANT	R -> H (in dbSNP:rs4559074)	15489334	1
Q9Y6R4/R566H	Q9Y6R4	MAP3K4	M3K4_HUMAN	R566H	-	-	-	-	LVKNDrVEFSE									VARIANT	R -> H (in dbSNP:rs55765351)	17344846	1
Q9Y6R4/V335I	Q9Y6R4	MAP3K4	M3K4_HUMAN	V335I	-	-	-	-	PGTKIvYSTHH									VARIANT	V -> I (in dbSNP:rs35730939)	17344846	1
Q9Y6S9/P121L	Q9Y6S9	RPS6KL1	RPKL1_HUMAN	P121L	-	-	-	neutral	CHLQRpSSGAS									VARIANT	P -> L (in dbSNP:rs2286913)	17344846	1
Q9Y6S9/R21Q	Q9Y6S9	RPS6KL1	RPKL1_HUMAN	R21Q	-	-	-	neutral	PEPCSrRSQAH									VARIANT	R -> Q (in dbSNP:rs7156590)	17344846	1
Q9Y6S9/R332W	Q9Y6S9	RPS6KL1	RPKL1_HUMAN	R332W	-	-	-	-	HLQARrGQNSD									VARIANT	R -> W (in dbSNP:rs55871101)	17344846	1
